Citrus Sinensis ID: 041702
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 840 | 2.2.26 [Sep-21-2011] | |||||||
| O81832 | 783 | G-type lectin S-receptor- | yes | no | 0.9 | 0.965 | 0.427 | 0.0 | |
| O81905 | 850 | Receptor-like serine/thre | no | no | 0.942 | 0.931 | 0.414 | 0.0 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.947 | 0.939 | 0.422 | 0.0 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.933 | 0.930 | 0.418 | 1e-179 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.895 | 0.902 | 0.417 | 1e-174 | |
| Q09092 | 857 | Putative serine/threonine | N/A | no | 0.965 | 0.946 | 0.401 | 1e-170 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.920 | 0.910 | 0.409 | 1e-170 | |
| Q9LPZ3 | 845 | G-type lectin S-receptor- | no | no | 0.905 | 0.900 | 0.409 | 1e-168 | |
| Q9SY89 | 842 | Putative G-type lectin S- | no | no | 0.894 | 0.891 | 0.405 | 1e-166 | |
| P0DH86 | 853 | G-type lectin S-receptor- | no | no | 0.932 | 0.917 | 0.403 | 1e-164 |
| >sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4 | Back alignment and function desciption |
|---|
Score = 647 bits (1668), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 368/861 (42%), Positives = 499/861 (57%), Gaps = 105/861 (12%)
Query: 3 NLSSFYIISYLTSLLALQFSLAADSITPATFIRDGEKLVSPSQRFELGFFSPGNSKNRYL 62
N+ IIS +++L Q A D + ++DG+ +VS FE+GFFSPG S+NRYL
Sbjct: 5 NVLHLLIISLFSTILLAQ---ATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRYL 61
Query: 63 GVWYKK-SPDTVVWVANRNCPILDPHGILAINNNGNLVLLNQANGTIWSSN-----MSKE 116
G+WYKK S TVVWVANR+ P+ D G L ++ NG+L L N N IWSS+
Sbjct: 62 GIWYKKISLQTVVWVANRDSPLYDLSGTLKVSENGSLCLFNDRNHIIWSSSSSPSSQKAS 121
Query: 117 AKSPVAQLLDTGNLVLRENFSNNTSEGSYLWQSFDFPSDTLLPGMKVGWDLKTGRERYLT 176
++P+ Q+LDTGNLV+R N+ + Y+WQS D+P D LPGMK G + TG R+LT
Sbjct: 122 LRNPIVQILDTGNLVVR----NSGDDQDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLT 177
Query: 177 SWRTADDPSPGKFTYRLDIHVLPQIFLYKGSLKLARIGPWNGFIFEDGPTFI-DYLYKII 235
SWR DDPS G +T ++D + +PQ FL K S+ + R GPWNG F P + +Y+
Sbjct: 178 SWRAIDDPSTGNYTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRYE 237
Query: 236 LVDTEDEIYYRYESYNNLSIMMLKINPLGKIQRLLWNEGSSGWQVMFSAPGDVCQNYGHC 295
V TE+E+YY Y+ N + +++NP G +QR W + W SA D C Y C
Sbjct: 238 YVFTEEEVYYTYKLENPSVLTRMQLNPNGALQRYTWVDNLQSWNFYLSAMMDSCDQYTLC 297
Query: 296 GANSICNVDNPPKCECLKGF---KPNSQHNQTWATTCVRSHLSDC-KTANQFKRFDDMKV 351
G+ CN++ P C CLKGF P + W+ CVR DC K + F + +K+
Sbjct: 298 GSYGSCNINESPACRCLKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKL 357
Query: 352 PDLLDVSLNEGMNLEECGAECLNNCTCRAYAYFNLTRGGSGCLMWFGDLIDMRKTLANLT 411
PD ++ M+L EC CL NCTC AY+ F++ GG GC++WFGDLID+R+ N
Sbjct: 358 PDTRTSWYDKNMDLNECKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIRE--YNEN 415
Query: 412 GQSIYLRVPASEPGKKRPLWIVVLAALPVAILPAFLIFYRRKKKLKEKERRTEASQDMLL 471
GQ +Y+R+ +SE I L +++ R + +D+ L
Sbjct: 416 GQDLYVRLASSE--------IETL-----------------QRESSRVSSRKQEEEDLEL 450
Query: 472 FEINMGNMSRAKEFCEGDSAGTGKSKESWFLFFSLSSISAATDNFSEENKLGEGGFGPVY 531
+++ +S A T FS NKLG+GGFGPVY
Sbjct: 451 PFLDLDTVSEA------------------------------TSGFSAGNKLGQGGFGPVY 480
Query: 532 KSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGC 591
K G L G+EVAVKRLS S QG+EEFKNE+ LIAKLQHRNLV++ G
Sbjct: 481 K-------------GTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGY 527
Query: 592 CIEQGEKISIYEFD-------IVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVI 644
C+++ E++ IYE+ + D R+ LDW RV II+G+A+G+LYLH+ SRLR+I
Sbjct: 528 CVDEEERMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRII 587
Query: 645 HRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIK 704
HRDLKASNVLLDSDMN KISDFG+ART GGDE ++NT R+VGTYGYMSPEY + G FS+K
Sbjct: 588 HRDLKASNVLLDSDMNAKISDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLK 647
Query: 705 SDVFSFGVLLLEILSSKKNTRFYNTD-SLTLLGHAWNLWKDDKAWKLMDPTMQNEAL-YS 762
SDVFSFGVL+LEI+S ++N F N + L LLGHAW + +DKA++++D + S
Sbjct: 648 SDVFSFGVLVLEIVSGRRNRGFRNEEHKLNLLGHAWRQFLEDKAYEIIDEAVNESCTDIS 707
Query: 763 MVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSPHQPAFSYVQIVERSVLLAN- 821
V R I + LLCVQ++ DRP M VV ++ + L P QP F ER++L ++
Sbjct: 708 EVLRVIHIGLLCVQQDPKDRPNM-SVVVLMLSSEMLLLDPRQPGF----FNERNLLFSDT 762
Query: 822 --INAEASLGNCLTLSVVDAR 840
IN E N T+SV+D R
Sbjct: 763 VSINLEIPSNNFQTMSVIDPR 783
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 641 bits (1653), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 354/854 (41%), Positives = 504/854 (59%), Gaps = 62/854 (7%)
Query: 21 FSLAADSITPAT--FIRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKK-SPDTVVWVA 77
+S++A++++ + I +VSP FELGFF PG YLG+WYK S T VWVA
Sbjct: 25 YSISANTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVWVA 84
Query: 78 NRNCPILDPHGILAINNNGNLVLLNQANGTIWSSNMSK-EAKSP-VAQLLDTGNLVLREN 135
NR+ P+ G L I+++ NLV+L+Q++ +WS+N++ + +SP VA+LLD GN VLR+
Sbjct: 85 NRDTPLSSSIGTLKISDS-NLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRD- 142
Query: 136 FSNNTSEGSYLWQSFDFPSDTLLPGMKVGWDLKTGRERYLTSWRTADDPSPGKFTYRLDI 195
S N++ LWQSFDFP+DTLLP MK+GWD KTG R++ SW++ DDPS G F+++L+
Sbjct: 143 -SKNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLET 201
Query: 196 HVLPQIFLYKGSLKLARIGPWNGFIFEDGPTFIDYLYKII-LVDTEDEIYYRYESYNNLS 254
P+IFL+ ++ R GPWNG F P + Y + +++E+ Y + +
Sbjct: 202 EGFPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKEEVTYSFRITKSDV 261
Query: 255 IMMLKINPLGKIQRLLWNEGSSGWQVMFSAPGDVCQNYGHCGANSICNVDNPPKCECLKG 314
L I+ G +QR W E + W + AP D C Y CG C+ + P C C+KG
Sbjct: 262 YSRLSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKG 321
Query: 315 FKPNSQHNQTW-----ATTCVRSHLSDCKTANQFKRFDDMKVPDLLDVSLNEGMNLEECG 369
FKP ++ Q W + CVR L C + F R MK+PD S++ G+ ++EC
Sbjct: 322 FKP--RNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECE 379
Query: 370 AECLNNCTCRAYAYFNLTRGGSGCLMWFGDLIDMRKTLANLTGQSIYLRVPASEPGKKRP 429
+CL +C C A+A ++ GSGC+ W G+L D+R GQ +Y+R+ A++ KR
Sbjct: 380 QKCLRDCNCTAFANTDIRGSGSGCVTWTGELFDIRNYAKG--GQDLYVRLAATDLEDKRN 437
Query: 430 LWIVVLAA---LPVAILPAFLIFYRRKKKLKEK-------ERRTEASQDMLLFEINMGNM 479
++ + + V +L +F+IF+ K+K K S+D+L+ E+ + +
Sbjct: 438 RSAKIIGSSIGVSVLLLLSFIIFFLWKRKQKRSILIETPIVDHQLRSRDLLMNEVVISSR 497
Query: 480 SRAKEFCEGDSAGTGKSKESWFLFFSLSSISAATDNFSEENKLGEGGFGPVYKSIERYVE 539
D ++ AT+NFS NKLG+GGFG VYK
Sbjct: 498 RHISRENNTDDLE--------LPLMEFEEVAMATNNFSNANKLGQGGFGIVYK------- 542
Query: 540 ICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKI 599
GKLL+G+E+AVKRLS S QG +EFKNE+ LIA+LQH NLVRL CC++ GEK+
Sbjct: 543 ------GKLLDGQEMAVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKM 596
Query: 600 SIYEF-------DIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASN 652
IYE+ + D +R L+W R II G+A+GLLYLHQ SR R+IHRDLKASN
Sbjct: 597 LIYEYLENLSLDSHLFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASN 656
Query: 653 VLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGV 712
+LLD M PKISDFG+AR FG DE ++NT ++VGTYGYMSPEYA+ G+FS+KSDVFSFGV
Sbjct: 657 ILLDKYMTPKISDFGMARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGV 716
Query: 713 LLLEILSSKKNTRFYNTD-SLTLLGHAWNLWKDDKAWKLMDPTMQNEA---LYSMVTRYI 768
LLLEI+SSK+N FYN+D L LLG W WK+ K +++DP + + + + R I
Sbjct: 717 LLLEIISSKRNKGFYNSDRDLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCI 776
Query: 769 KVALLCVQENATDRPTMLEVVAMLKDEIVNLPSPHQPAFSYVQIVERSVLLA--NINAEA 826
++ LLCVQE A DRPTM V+ ML E +P P P + + + + + + E+
Sbjct: 777 QIGLLCVQERAEDRPTMSLVILMLGSESTTIPQPKAPGYCLERSLLDTDSSSSKQRDDES 836
Query: 827 SLGNCLTLSVVDAR 840
N +T+SV+DAR
Sbjct: 837 WTVNQITVSVLDAR 850
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 635 bits (1639), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 361/854 (42%), Positives = 509/854 (59%), Gaps = 58/854 (6%)
Query: 15 SLLALQFSLAADSITPATFIRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKKSP-DTV 73
S+ A FS A +S+T I + ++SPSQ FELGFF+P +S YLG+WYK P T
Sbjct: 24 SVYASNFS-ATESLT----ISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRTY 78
Query: 74 VWVANRNCPILDPHGILAINNNGNLVLLNQANGTIWSSNMSK-EAKSPVA-QLLDTGNLV 131
VWVANR+ P+ +G L I++N NLV+ +Q++ +WS+N++ + +SPVA +LLD GN V
Sbjct: 79 VWVANRDNPLSSSNGTLKISDN-NLVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGNFV 137
Query: 132 LRENFSNNTSEGSYLWQSFDFPSDTLLPGMKVGWDLKTGR-ERYLTSWRTADDPSPGKFT 190
LR+ S N +LWQSFDFP+DTLL MK+GWD K+G R L SW+T DDPS G F+
Sbjct: 138 LRD--SKNNKPSGFLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFS 195
Query: 191 YRLDIHVLPQIFLYKGSLKLARIGPWNGFIFEDGPTF--IDYLYKIILVDTEDEIY-YRY 247
+L P+ ++Y R GPW G F P +DY+ + + +Y YR
Sbjct: 196 TKLRTSGFPEFYIYNKESITYRSGPWLGNRFSSVPGMKPVDYIDNSFTENNQQVVYSYRV 255
Query: 248 ESYNNLSIMMLKINPLGKIQRLLWNEGSSGWQVMFSAPGDVCQNYGHCGANSICNVDNPP 307
N SI L ++ G +QRL W E + W+ ++ +P D+C NY CG C+ + P
Sbjct: 256 NKTNIYSI--LSLSSTGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCDANTSP 313
Query: 308 KCECLKGFKPNSQHN--QTWATTCVRSHLSDCKTANQFKRFDDMKVPDLLDVSLNEGMNL 365
C C+KGF+P ++ + + CVR C + F R M++PD + S+++G+ L
Sbjct: 314 ICNCIKGFEPMNEQAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGL 373
Query: 366 EECGAECLNNCTCRAYAYFNLTRGGSGCLMWFGDLIDMRKTLANLTGQSIYLRVPASEPG 425
+EC CL C C A+A ++ GGSGC++W G L D+R GQ +Y+RV A +
Sbjct: 374 KECEERCLKGCNCTAFANTDIRNGGSGCVIWSGGLFDIRNYAKG--GQDLYVRVAAGDLE 431
Query: 426 KKRPLWIVVLAA---LPVAILPAFLIFYRRKKKLKEKERRTEASQDMLLFEINMGNMSRA 482
KR ++ + + + +L +F+IF+ K+K K D++ + ++ N
Sbjct: 432 DKRIKSKKIIGSSIGVSILLLLSFIIFHFWKRKQKRSITIQTPIVDLVRSQDSLMN---- 487
Query: 483 KEFCEGDSAGTGKSKESWFLFFSL---SSISAATDNFSEENKLGEGGFGPVYKSIERYVE 539
E + + T K ++ +L L +++ AT+NFS +NKLG+GGFG VYK
Sbjct: 488 -ELVKASRSYTSKENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYK------- 539
Query: 540 ICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKI 599
G LL+G+E+AVKRLS S QG +EF NE+ LIAKLQH NLVRL GCC+++GEK+
Sbjct: 540 ------GMLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKM 593
Query: 600 SIYEF-------DIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASN 652
IYE+ + D R L+W R II G+A+GLLYLHQ SR R+IHRDLKASN
Sbjct: 594 LIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASN 653
Query: 653 VLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGV 712
VLLD +M PKISDFG+AR FG +E ++NT R+VGTYGYMSPEYA+ G+FS+KSDVFSFGV
Sbjct: 654 VLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGV 713
Query: 713 LLLEILSSKKNTRFYNTD-SLTLLGHAWNLWKDDKAWKLMDP----TMQNEALYSMVTRY 767
LLLEI+S K+N FYN++ L LLG W WK+ K +++DP + +E + R
Sbjct: 714 LLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRC 773
Query: 768 IKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSPHQPAFSYVQIVERSVLLANINAEAS 827
I++ LLCVQE A DRP M V+ ML E +P P +P F + ++ +
Sbjct: 774 IQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDE 833
Query: 828 LG-NCLTLSVVDAR 840
N +TLSV+DAR
Sbjct: 834 CTVNQVTLSVIDAR 847
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 630 bits (1624), Expect = e-179, Method: Compositional matrix adjust.
Identities = 359/857 (41%), Positives = 513/857 (59%), Gaps = 73/857 (8%)
Query: 21 FSLAADSI--TPATFIRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKKSP-DTVVWVA 77
FS++ +++ T + I + ++SPSQ FELGFF+P +S YLG+WYK P T VWVA
Sbjct: 23 FSVSPNTLSATESLTISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKIIPIRTYVWVA 82
Query: 78 NRNCPILDPHGILAINNNGNLVLLNQANGTIWSSNMSK-EAKSPVA-QLLDTGNLVLREN 135
NR+ P+ +G L I+ N NLV+ +Q++ +WS+N++ + +SPVA +LLD GN +LR+
Sbjct: 83 NRDNPLSSSNGTLKISGN-NLVIFDQSDRPVWSTNITGGDVRSPVAAELLDNGNFLLRD- 140
Query: 136 FSNNTSEGSYLWQSFDFPSDTLLPGMKVGWDLKTGRERYLTSWRTADDPSPGKFTYRLDI 195
SNN LWQSFDFP+DTLL MK+GWD KTG R L SW+T DDPS G+F+ +L+
Sbjct: 141 -SNN----RLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLET 195
Query: 196 HVLPQIFLYKGSLKLARIGPWNGFIFEDGPTFIDYLYKII-LVDTEDEIYYRYESYNNLS 254
P+ ++ L R GPWNG F P I Y + +++E+ Y Y
Sbjct: 196 SEFPEFYICSKESILYRSGPWNGMRFSSVPGTIQVDYMVYNFTASKEEVTYSYRINKTNL 255
Query: 255 IMMLKINPLGKIQRLLWNEGSSGWQVMFSAPGDVCQNYGHCGANSICNVDNPPKCECLKG 314
L +N G +QRL W E + W+ ++ +P D+C NY CG C+ ++ P C C+KG
Sbjct: 256 YSRLYLNSAGLLQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDSNSLPNCYCIKG 315
Query: 315 FKPNSQHNQTW-----ATTCVRSHLSDCKTANQFKRFDDMKVPDLLDVSLNEGMNLEECG 369
FKP ++ Q W + C+R C + F R MK+PD ++ + L+ C
Sbjct: 316 FKPVNE--QAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCK 373
Query: 370 AECLNNCTCRAYAYFNLTRGGSGCLMWFGDLIDMRKTLANLTGQSIYLRVPASEPGKKRP 429
CL +C C A+A ++ GGSGC++W +++DMR GQ +Y+R+ A+E KR
Sbjct: 374 ERCLEDCNCTAFANADIRNGGSGCVIWTREILDMRNYAKG--GQDLYVRLAAAELEDKRI 431
Query: 430 LWIVVLAA---LPVAILPAFLIFY--RRKKK----LKEKERRTEASQDMLLFEINMGNMS 480
++ + + + +L +F+IF+ +RK+K ++ SQD L+ ++ +
Sbjct: 432 KNEKIIGSSIGVSILLLLSFVIFHFWKRKQKRSITIQTPNVDQVRSQDSLINDVVVSR-- 489
Query: 481 RAKEFCEGDSAGTGKSKESWFLFFSLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEI 540
G ++ KS+ L +++ AT+NFS +NKLG+GGFG VYK
Sbjct: 490 ------RGYTSKEKKSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYK-------- 535
Query: 541 CNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKIS 600
G+LL+G+E+AVKRLS S QG +EF NE+ LIAKLQH NLVRL GCC+++GEK+
Sbjct: 536 -----GRLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKML 590
Query: 601 IYEF-------DIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNV 653
IYE+ + D R L+W R II G+A+GLLYLHQ SR R+IHRDLKASNV
Sbjct: 591 IYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNV 650
Query: 654 LLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVL 713
LLD +M PKISDFG+AR FG +E ++NT R+VGTYGYMSPEYA+ G+FS+KSDVFSFGVL
Sbjct: 651 LLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVL 710
Query: 714 LLEILSSKKNTRFYNTD-SLTLLGHAWNLWKDDKAWKLMDP----TMQNEALYSMVTRYI 768
LLEI+S K+N FYN++ L LLG W WK+ +++DP ++ ++ + R I
Sbjct: 711 LLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCI 770
Query: 769 KVALLCVQENATDRPTMLEVVAMLKDEIVNLPSPHQPAFSYVQIVERSVLLANINAEASL 828
++ LLCVQE A DRP M V+ ML E +P P +P F + RS L A+ ++
Sbjct: 771 QIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGF----CIGRSPLEADSSSSTQR 826
Query: 829 G-----NCLTLSVVDAR 840
N +TLSV+DAR
Sbjct: 827 DDECTVNQITLSVIDAR 843
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 613 bits (1580), Expect = e-174, Method: Compositional matrix adjust.
Identities = 342/819 (41%), Positives = 474/819 (57%), Gaps = 67/819 (8%)
Query: 23 LAADSITPATFIRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKK-SPDTVVWVANRNC 81
++ D+I +RDGE ++S +RF GFFS G+S+ RY+G+WY + S T+VWVANR+
Sbjct: 17 ISVDTIMRRQSLRDGEVILSAGKRFAFGFFSLGDSELRYVGIWYAQISQQTIVWVANRDH 76
Query: 82 PILDPHGILAINNNGNLVLLNQANGT--IWSSNMSKEAKSP--VAQLLDTGNLVLRENFS 137
PI D G++ +N GNL + N T IWS+N+S P VA L D GNLVL + +
Sbjct: 77 PINDTSGMVKFSNRGNLSVYASDNETELIWSTNVSDSMLEPTLVATLSDLGNLVLFDPVT 136
Query: 138 NNTSEGSYLWQSFDFPSDTLLPGMKVGWDLKTGRERYLTSWRTADDPSPGKFTYRLDIHV 197
G W+SFD P+DT LP M++G+ K G +R LTSW++ DP G R++
Sbjct: 137 -----GRSFWESFDHPTDTFLPFMRLGFTRKDGLDRSLTSWKSHGDPGSGDLILRMERRG 191
Query: 198 LPQIFLYKGSLKLARIGPWNGFIFEDGPTF-IDYLYKIILVDTEDEIYYRYESYNNLSIM 256
PQ+ LYKG R+G W G + P I Y++ V+ EDE+ + Y + I
Sbjct: 192 FPQLILYKGVTPWWRMGSWTGHRWSGVPEMPIGYIFNNSFVNNEDEVSFTYGVTDASVIT 251
Query: 257 MLKINPLGKIQRLLWNEGSSGWQVMFSAPGDVCQNYGHCGANSICNVDNPP----KCECL 312
+N G + R W W +S P + C NY HCG N C D+P +C CL
Sbjct: 252 RTMVNETGTMHRFTWIARDKRWNDFWSVPKEQCDNYAHCGPNGYC--DSPSSKTFECTCL 309
Query: 313 KGFKPNSQHN---QTWATTCVRS-HLSDCKTANQFKRFDDMKVPDLLDVSLNEGMNLEEC 368
GF+P + + + C + S C + F + MK+PD D S++ + L+EC
Sbjct: 310 PGFEPKFPRHWFLRDSSGGCTKKKRASICSEKDGFVKLKRMKIPDTSDASVDMNITLKEC 369
Query: 369 GAECLNNCTCRAYA--YFNLTRGGSGCLMWFGDLIDMRKTLANLTGQSIYLRVPASE--- 423
CL NC+C AYA Y RG GCL W G ++D R L +GQ Y+RV E
Sbjct: 370 KQRCLKNCSCVAYASAYHESKRGAIGCLKWHGGMLDARTYLN--SGQDFYIRVDKEELAR 427
Query: 424 ------PGKKRPLWIVVLAALPVAILPAFLIFYRRKKKLKEKERRTEASQDMLLFEINMG 477
GK+R L I++ V +L L R+++ + R + A+ + F+
Sbjct: 428 WNRNGLSGKRRVLLILISLIAAVMLLTVILFCVVRERRKSNRHRSSSANFAPVPFD---- 483
Query: 478 NMSRAKEFCEGDSAGTGKSKESWFLFFSLSSISAATDNFSEENKLGEGGFGPVYKSIERY 537
F E K++ F L++I AAT+NFS +NKLG GGFGPVYK
Sbjct: 484 -------FDESFRFEQDKARNRELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYK----- 531
Query: 538 VEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGE 597
G L N E+AVKRLS SGQG+EEFKNE+ LI+KLQHRNLVR+ GCC+E E
Sbjct: 532 --------GVLQNRMEIAVKRLSRNSGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEE 583
Query: 598 KISIYEF-------DIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKA 650
K+ +YE+ + ++ LDW R+ I+ G+A+G+LYLHQ SRLR+IHRDLKA
Sbjct: 584 KMLVYEYLPNKSLDYFIFHEEQRAELDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKA 643
Query: 651 SNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSF 710
SN+LLDS+M PKISDFG+AR FGG++M+ T+R+VGT+GYM+PEYA+ G FSIKSDV+SF
Sbjct: 644 SNILLDSEMIPKISDFGMARIFGGNQMEGCTSRVVGTFGYMAPEYAMEGQFSIKSDVYSF 703
Query: 711 GVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSM-VTRYIK 769
GVL+LEI++ KKN+ F+ +S L+GH W+LW++ +A +++D M E V + I+
Sbjct: 704 GVLMLEIITGKKNSAFHE-ESSNLVGHIWDLWENGEATEIIDNLMDQETYDEREVMKCIQ 762
Query: 770 VALLCVQENATDRPTMLEVVAMLKDEIVNLPSPHQPAFS 808
+ LLCVQENA+DR M VV ML NLP+P PAF+
Sbjct: 763 IGLLCVQENASDRVDMSSVVIMLGHNATNLPNPKHPAFT 801
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 599 bits (1544), Expect = e-170, Method: Compositional matrix adjust.
Identities = 356/886 (40%), Positives = 512/886 (57%), Gaps = 75/886 (8%)
Query: 1 MENLSSFYIISYLTSLL----------ALQFSLAADSITPATFIRDGEKLVSPSQRFELG 50
M+ + Y SY++ LL AL + S T + I + LVSP FE+G
Sbjct: 1 MKGARNIYHHSYMSFLLVFVVMILIHPALSIYINTLSSTESLTISSNKTLVSPGSIFEVG 60
Query: 51 FFSPGNSKNRYLGVWYKKSPD-TVVWVANRNCPILDPHGILAINNNGNLVLLNQANGTIW 109
FF NS+ YLG+WYKK D T VWVANR+ P+ + G L I+ N NLVLL+ +N +W
Sbjct: 61 FFRT-NSR-WYLGMWYKKVSDRTYVWVANRDNPLSNAIGTLKISGN-NLVLLDHSNKPVW 117
Query: 110 SSNMSK-EAKSPV-AQLLDTGNLVLRENFSNNTSEGSYLWQSFDFPSDTLLPGMKVGWDL 167
+N+++ +SPV A+LL GN V+R++ +N+ SE YLWQSFD+P+DTLLP MK+G++L
Sbjct: 118 WTNLTRGNERSPVVAELLANGNFVMRDSSNNDASE--YLWQSFDYPTDTLLPEMKLGYNL 175
Query: 168 KTGRERYLTSWRTADDPSPGKFTYRLDIHVLPQIFLYKGSLKLARIGPWNGFIFEDGPTF 227
KTG R+LTSWR++DDPS G F+Y+L+ LP+ +L + + + R GPWNG F P
Sbjct: 176 KTGLNRFLTSWRSSDDPSSGNFSYKLETQSLPEFYLSRENFPMHRSGPWNGIRFSGIPED 235
Query: 228 IDYLYKII-LVDTEDEIYYRYESYNNLSIMMLKINPLGKIQRLLWNEGSSGWQVMFSAPG 286
Y + ++ +E+ Y + NN L + G QRL W W +S+P
Sbjct: 236 QKLSYMVYNFIENNEEVAYTFRMTNNSFYSRLTLISEGYFQRLTWYPSIRIWNRFWSSPV 295
Query: 287 D-VCQNYGHCGANSICNVDNPPKCECLKGFKP-NSQH--NQTWATTCVRSHLSDCKTANQ 342
D C Y CG + C+V+ P C C++GF P N Q + WA C+R C + +
Sbjct: 296 DPQCDTYIMCGPYAYCDVNTSPVCNCIQGFNPRNIQQWDQRVWAGGCIRRTQLSC-SGDG 354
Query: 343 FKRFDDMKVPDLLDVSLNEGMNLEECGAECLNNCTCRAYAYFNLTRGGSGCLMWFGDLID 402
F R MK+P+ +++ + ++EC C+++C C A+A ++ GGSGC++W L D
Sbjct: 355 FTRMKKMKLPETTMATVDRSIGVKECKKRCISDCNCTAFANADIRNGGSGCVIWTERLED 414
Query: 403 MRKTLAN-LTGQSIYLRVPASEPGKKR----PLWIVVLAALPVAILPAFLIFYRRKKKLK 457
+R + + GQ +Y+R+ A++ KKR + + + + +L F ++ R++K+ K
Sbjct: 415 IRNYATDAIDGQDLYVRLAAADIAKKRNASGKIISLTVGVSVLLLLIMFCLWKRKQKRAK 474
Query: 458 EKERRTEASQDMLLFEINMGNMSRAKEFCEGDSAGTGKSKESWFLFFSLSSISAATDNFS 517
+Q +N +S +EF +G K +E + ++ AT+NFS
Sbjct: 475 ASAISIANTQRNQNLPMNEMVLSSKREF-----SGEYKFEELELPLIEMETVVKATENFS 529
Query: 518 EENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLI 577
NKLG+GGFG VYK G+LL+G+E+AVKRLS S QG +EF NE+ LI
Sbjct: 530 SCNKLGQGGFGIVYK-------------GRLLDGKEIAVKRLSKTSVQGTDEFMNEVTLI 576
Query: 578 AKLQHRNLVRLFGCCIEQGEKISIYEF-------DIVTDPARKDLLDWTTRVRIIEGVAQ 630
A+LQH NLV++ GCCIE EK+ IYE+ + R+ L+W R I GVA+
Sbjct: 577 ARLQHINLVQVLGCCIEGDEKMLIYEYLENLSLDSYLFGKTRRSKLNWNERFDITNGVAR 636
Query: 631 GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGY 690
GLLYLHQ SR R+IHRDLK SN+LLD +M PKISDFG+AR F DE ++NT ++VGTYGY
Sbjct: 637 GLLYLHQDSRFRIIHRDLKVSNILLDKNMIPKISDFGMARIFERDETEANTMKVVGTYGY 696
Query: 691 MSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLT-LLGHAWNLWKDDKAWK 749
MSPEYA++G+FS KSDVFSFGV++LEI+S KKN FYN D LL + W+ WK+ +A +
Sbjct: 697 MSPEYAMYGIFSEKSDVFSFGVIVLEIVSGKKNRGFYNLDYENDLLSYVWSRWKEGRALE 756
Query: 750 LMDPTMQNEALYSM--------VTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPS 801
++DP + ++L S V + I++ LLCVQE A RP M VV M E +P
Sbjct: 757 IVDPVIV-DSLSSQPSIFQPQEVLKCIQIGLLCVQELAEHRPAMSSVVWMFGSEATEIPQ 815
Query: 802 PHQPAFSYVQIVERSVLLANINA-------EASLGNCLTLSVVDAR 840
P P + V RS + ++ E+ N T SV+DAR
Sbjct: 816 PKPPGYC----VRRSPYELDPSSSWQCDENESWTVNQYTCSVIDAR 857
|
Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Brassica oleracea var. acephala (taxid: 3713) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 598 bits (1541), Expect = e-170, Method: Compositional matrix adjust.
Identities = 344/840 (40%), Positives = 495/840 (58%), Gaps = 67/840 (7%)
Query: 5 SSFYIISYLTSLLALQFSLAADSITPATFIRDG---EKLVSPSQRFELGFFSPGNSKNRY 61
+S Y+ +L L + S+AA++I +RDG + LVSP + FELGFFSPG+S +R+
Sbjct: 7 TSLYLSLFLYFFL-YESSMAANTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRF 65
Query: 62 LGVWYKKSPD-TVVWVANRNCPILDPHGILAINNNGNLVLLNQANGTIWSSNMSKEA--- 117
LG+WY D VVWVANR PI D G+L I+N+GNLVLL+ N T+WSSN+
Sbjct: 66 LGIWYGNIEDKAVVWVANRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNN 125
Query: 118 KSPVAQLLDTGNLVLRENFSNNTSEGSYLWQSFDFPSDTLLPGMKVGWDLKTGRERYLTS 177
+ V + DTGN VL E T +W+SF+ P+DT LP M+V + +TG S
Sbjct: 126 NNRVVSIHDTGNFVLSE-----TDTDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVS 180
Query: 178 WRTADDPSPGKFTYRLDIHVLPQIFLYKGS-LKLARIGPWNGFIFEDGPT---FIDYLYK 233
WR+ DPSPG ++ +D P+I L++G+ + R G WN IF P +YLY
Sbjct: 181 WRSETDPSPGNYSLGVDPSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYG 240
Query: 234 IILVDTEDE---IYYRYESYNNLSIMMLKINPLGKIQRLLWNEGSSGWQVMFSAPGDVCQ 290
L DE +Y+ Y + ++ K+ G + L WNE W S P C
Sbjct: 241 FKLSSPPDETGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECD 300
Query: 291 NYGHCGANSICNVDNPPK-CECLKGFKPNSQHNQTWATTCVRSHLSDCKT-----ANQFK 344
Y CG IC++ C C+ G++ S N W+ C R C+ ++F
Sbjct: 301 QYNRCGKFGICDMKGSNGICSCIHGYEQVSVGN--WSRGCRRRTPLKCERNISVGEDEFL 358
Query: 345 RFDDMKVPDLLDVSLNEGMNLEECGAECLNNCTCRAYAYFNLTRGGSGCLMWFGDLIDMR 404
+K+PD ++ + ++ E+C CL NC+C AY+ GG GC++W DL+D++
Sbjct: 359 TLKSVKLPDF-EIPEHNLVDPEDCRERCLRNCSCNAYSLV----GGIGCMIWNQDLVDLQ 413
Query: 405 KTLANLTGQSIYLRVPASEPGKKRPLWIVVLAALPVAILPA---FLIFYRRKKKLKEKER 461
+ A G S+++R+ SE G+ R I V+ A+ V ++ L+ +R K+K
Sbjct: 414 QFEAG--GSSLHIRLADSEVGENRKTKIAVIVAVLVGVILIGIFALLLWRFKRKKDVSGA 471
Query: 462 RTEASQDMLLFEINMGNMSRAKEFCEGDSAGT-----GKS-KESWFLFFSLSSISAATDN 515
+ D + + +++++KE S GK+ S FSL++I+ AT++
Sbjct: 472 YCGKNTDT---SVVVADLTKSKETTSAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATND 528
Query: 516 FSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMM 575
F +EN+LG GGFGPVYK G L +G E+AVKRLS KSGQG++EFKNE++
Sbjct: 529 FCKENELGRGGFGPVYK-------------GVLEDGREIAVKRLSGKSGQGVDEFKNEII 575
Query: 576 LIAKLQHRNLVRLFGCCIEQGEKISIYEFD-------IVTDPARKDLLDWTTRVRIIEGV 628
LIAKLQHRNLVRL GCC E EK+ +YE+ + D ++ L+DW R IIEG+
Sbjct: 576 LIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSIIEGI 635
Query: 629 AQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTY 688
A+GLLYLH+ SRLR+IHRDLK SNVLLD++MNPKISDFG+AR FGG++ ++NT R+VGTY
Sbjct: 636 ARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGTY 695
Query: 689 GYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAW 748
GYMSPEYA+ GLFS+KSDV+SFGVLLLEI+S K+NT +++ +L+G+AW L+ ++
Sbjct: 696 GYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHGSLIGYAWYLYTHGRSE 755
Query: 749 KLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSPHQPAFS 808
+L+DP ++ R I VA+LCVQ++A +RP M V+ ML+ + L +P QP F+
Sbjct: 756 ELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESDTATLAAPRQPTFT 815
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 593 bits (1530), Expect = e-168, Method: Compositional matrix adjust.
Identities = 336/821 (40%), Positives = 486/821 (59%), Gaps = 60/821 (7%)
Query: 20 QFSLAADSITPATFIRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKK-SPDTVVWVAN 78
Q + ++I + ++DG+ + S +RF GFFS GNSK RY+G+WY + S T+VWVAN
Sbjct: 17 QSCYSDNTILRSQSLKDGDVIYSEGKRFAFGFFSLGNSKLRYVGIWYAQVSEQTIVWVAN 76
Query: 79 RNCPILDPHGILAINNNGNLVLLNQANGT--IWSSNMSKEAKSP--VAQLLDTGNLVLRE 134
R+ PI D G++ + GNL + NGT IWS+++ + P VA+L D GNLVL +
Sbjct: 77 RDHPINDTSGLIKFSTRGNLCVYASGNGTEPIWSTDVIDMIQEPALVAKLSDLGNLVLLD 136
Query: 135 NFSNNTSEGSYLWQSFDFPSDTLLPGMKVGWDLKTGRERYLTSWRTADDPSPGKFTYRLD 194
+ G W+SF+ P++TLLP MK G+ ++G +R +TSWR+ DP G TYR++
Sbjct: 137 PVT-----GKSFWESFNHPTNTLLPFMKFGFTRQSGVDRIMTSWRSPGDPGSGNITYRIE 191
Query: 195 IHVLPQIFLYKGSLKLARIGPWNGFIFEDGPTFID-YLYKIILVDTEDEIYYRYESYNNL 253
PQ+ +YKG R G W G + P + +++ I V+ DE+ Y +
Sbjct: 192 RRGFPQMMMYKGLTLWWRTGSWTGQRWSGVPEMTNKFIFNISFVNNPDEVSITYGVLDAS 251
Query: 254 SIMMLKINPLGKIQRLLWNEGSSGWQVMFSAPGDVCQNYGHCGANSICNVDNPPK--CEC 311
+ +N G +QR WN W +SAP D C Y HCG N C+ + K C C
Sbjct: 252 VTTRMVLNETGTLQRFRWNGRDKKWIGFWSAPEDKCDIYNHCGFNGYCDSTSTEKFECSC 311
Query: 312 LKGFKPNSQHN---QTWATTCVRSHL-SDCKTANQFKRFDDMKVPDLLDVSLNEGMNLEE 367
L G++P + + + + C R S C F + +K+P+ V+++ + L+E
Sbjct: 312 LPGYEPKTPRDWFLRDASDGCTRIKADSICNGKEGFAKLKRVKIPNTSAVNVDMNITLKE 371
Query: 368 CGAECLNNCTCRAY--AYFNLTRGGSGCLMWFGDLIDMRKTLANLTGQSIYLRVPASE-- 423
C CL NC+C AY AY G GCL W G+++D R L+ +GQ YLRV SE
Sbjct: 372 CEQRCLKNCSCVAYASAYHESQDGAKGCLTWHGNMLDTRTYLS--SGQDFYLRVDKSELA 429
Query: 424 -------PGKKRPLWIVV-LAALPVAILPAFLIFYRRKKKLKEKERRTEASQDMLLFEIN 475
GKKR + I++ L A+ + +L +F + R++++ + R +A +
Sbjct: 430 RWNGNGASGKKRLVLILISLIAVVMLLLISFHCYLRKRRQRTQSNRLRKAPSSFAPSSFD 489
Query: 476 MGNMSRAKEFCEGDSAGTGKSKESWFLFFSLSSISAATDNFSEENKLGEGGFGPVYKSIE 535
+ + +E + KS+ F LS+I+ AT+NF+ +NKLG GGFGPVYK
Sbjct: 490 LEDSFILEELED-------KSRSRELPLFELSTIATATNNFAFQNKLGAGGFGPVYK--- 539
Query: 536 RYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQ 595
G L NG E+AVKRLS SGQG+EEFKNE+ LI+KLQHRNLVR+ GCC+E
Sbjct: 540 ----------GVLQNGMEIAVKRLSKSSGQGMEEFKNEVKLISKLQHRNLVRILGCCVEF 589
Query: 596 GEKISIYEF-------DIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDL 648
EK+ +YE+ + ++ LDW R+ II G+ +G+LYLHQ SRLR+IHRDL
Sbjct: 590 EEKMLVYEYLPNKSLDYFIFHEEQRAELDWPKRMGIIRGIGRGILYLHQDSRLRIIHRDL 649
Query: 649 KASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVF 708
KASNVLLD++M PKI+DFG+AR FGG++++ +TNR+VGTYGYMSPEYA+ G FSIKSDV+
Sbjct: 650 KASNVLLDNEMIPKIADFGLARIFGGNQIEGSTNRVVGTYGYMSPEYAMDGQFSIKSDVY 709
Query: 709 SFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEAL-YSMVTRY 767
SFGVL+LEI++ K+N+ FY +SL L+ H W+ W++ +A +++D M E V +
Sbjct: 710 SFGVLILEIITGKRNSAFYE-ESLNLVKHIWDRWENGEAIEIIDKLMGEETYDEGEVMKC 768
Query: 768 IKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSPHQPAFS 808
+ + LLCVQEN++DRP M VV ML ++LPSP PAF+
Sbjct: 769 LHIGLLCVQENSSDRPDMSSVVFMLGHNAIDLPSPKHPAFT 809
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SY89|Y1661_ARATH Putative G-type lectin S-receptor-like serine/threonine-protein kinase At1g61610 OS=Arabidopsis thaliana GN=At1g61610 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 584 bits (1506), Expect = e-166, Method: Compositional matrix adjust.
Identities = 331/816 (40%), Positives = 472/816 (57%), Gaps = 65/816 (7%)
Query: 24 AADSITPATFIRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKK-SPDTVVWVANRNCP 82
++S T IR+G+ L+S + FELGFF+P NS RY+G+WYK P TVVWVANR P
Sbjct: 28 TSNSFTRNHTIREGDSLISEDESFELGFFTPKNSTLRYVGIWYKNIEPQTVVWVANREKP 87
Query: 83 ILDPHGILAINNNGNLVLLNQANGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSE 142
+LD G L I ++GNLV++N N TIWS+N+ E+ + VA L TG+LVL +++
Sbjct: 88 LLDHKGALKIADDGNLVIVNGQNETIWSTNVEPESNNTVAVLFKTGDLVL----CSDSDR 143
Query: 143 GSYLWQSFDFPSDTLLPGMKVGWDLKTGRERYLTSWRTADDPSPGKFTYRLDIHVLPQIF 202
+ W+SF+ P+DT LPGM+V + G R W++ DPSPGK++ +D +I
Sbjct: 144 RKWYWESFNNPTDTFLPGMRVRVNPSLGENRAFIPWKSESDPSPGKYSMGIDPVGALEIV 203
Query: 203 LYKGSLKLARIGPWNGFIFEDGPT---FIDYLYKIILV---DTEDEIYYRYESYNNLSIM 256
+++G + R GPWN IF P F +Y+Y L D + +Y+ Y + ++ +
Sbjct: 204 IWEGEKRKWRSGPWNSAIFTGIPDMLRFTNYIYGFKLSSPPDRDGSVYFTYVASDSSDFL 263
Query: 257 MLKINPLGKIQRLLWNEGSSGWQVMFSAPGDVCQNYGHCGANSICNVD---NPPKCECLK 313
I P G ++ WN+ W ++ P C+ Y CG S+C+ + KC C+
Sbjct: 264 RFWIRPDGVEEQFRWNKDIRNWNLLQWKPSTECEKYNRCGNYSVCDDSKEFDSGKCSCID 323
Query: 314 GFKPNSQ---HNQTWATTCVRSHLSDCKTA------NQFKRFDDMKVPDLLDVSLNEGMN 364
GF+P Q +N+ ++ C R +C + + F +KVPD V L+ N
Sbjct: 324 GFEPVHQDQWNNRDFSGGCQRRVPLNCNQSLVAGQEDGFTVLKGIKVPDFGSVVLHN--N 381
Query: 365 LEECGAECLNNCTCRAYAYFNLTRGGSGCLMWFGDLIDMRKTLANLTGQSIYLRVPASEP 424
E C C +C+C+AYA G GC++W DLIDM G SI +R+ S+
Sbjct: 382 SETCKDVCARDCSCKAYALVV----GIGCMIWTRDLIDMEH--FERGGNSINIRLAGSKL 435
Query: 425 GKKR---PLWIVVLAALPVAILP-AFLIFYRRKKKLKEKERRTEASQDMLLFEI--NMGN 478
G + LWI+V + + +L I ++ KK LK + +D+ + +I N
Sbjct: 436 GGGKENSTLWIIVFSVIGAFLLGLCIWILWKFKKSLKAFLWK---KKDITVSDIIENRDY 492
Query: 479 MSRAKEFCEGDSAGTGKSKESWFLFFSLSSISAATDNFSEENKLGEGGFGPVYKSIERYV 538
S + GD T FS S+++AT +F+EENKLG+GGFG VYK
Sbjct: 493 SSSPIKVLVGDQVDTPD-----LPIFSFDSVASATGDFAEENKLGQGGFGTVYK------ 541
Query: 539 EICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEK 598
G G E+AVKRLS KS QGLEEFKNE++LIAKLQHRNLVRL GCCIE EK
Sbjct: 542 -------GNFSEGREIAVKRLSGKSKQGLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEK 594
Query: 599 ISIYEF-------DIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKAS 651
+ +YE+ + D +++ LDW R +I G+A+GLLYLH+ SRL++IHRDLKAS
Sbjct: 595 MLLYEYMPNKSLDRFLFDESKQGSLDWRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKAS 654
Query: 652 NVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFG 711
N+LLD++MNPKISDFG+AR F + +NT R+VGTYGYM+PEYA+ G+FS KSDV+SFG
Sbjct: 655 NILLDTEMNPKISDFGMARIFNYRQDHANTIRVVGTYGYMAPEYAMEGIFSEKSDVYSFG 714
Query: 712 VLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVA 771
VL+LEI+S +KN F TD +L+G+AW+LW K +++DP +++ + R I V
Sbjct: 715 VLILEIVSGRKNVSFRGTDHGSLIGYAWHLWSQGKTKEMIDPIVKDTRDVTEAMRCIHVG 774
Query: 772 LLCVQENATDRPTMLEVVAMLKDEIVNLPSPHQPAF 807
+LC Q++ RP M V+ ML+ + LP P QP F
Sbjct: 775 MLCTQDSVIHRPNMGSVLLMLESQTSQLPPPRQPTF 810
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P0DH86|SRK_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SRK OS=Arabidopsis thaliana GN=SRK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 580 bits (1495), Expect = e-164, Method: Compositional matrix adjust.
Identities = 349/865 (40%), Positives = 504/865 (58%), Gaps = 82/865 (9%)
Query: 19 LQFSLAADSITPATFIRDGEKLVSPSQRFELGFFSP-GNSKNRYLGVWYKK-SPDTVVWV 76
L S+ S T + I + +VSP FELGFF G+S YLG+WYKK S T VWV
Sbjct: 28 LSISVNTLSATESLTISSNKTIVSPGGVFELGFFRILGDSW--YLGIWYKKISQRTYVWV 85
Query: 77 ANRNCPILDPHGILAINNNGNLVLLNQANGTIWSSNMSKEAKSPV-AQLLDTGNLVLREN 135
ANR+ P+ +P GIL I+N NLV+L+ ++ +WS+N++ +S V A+LLD GN VLR +
Sbjct: 86 ANRDTPLSNPIGILKISN-ANLVILDNSDTHVWSTNLTGAVRSSVVAELLDNGNFVLRGS 144
Query: 136 FSNNTSEGSYLWQSFDFPSDTLLPGMKVGWDLKTGRERYLTSWRTADDPSPGKFTYRLDI 195
N + E +LWQSFDFP+DTLLP MK+G D K G R++TSW+++ DPS G F ++L+
Sbjct: 145 KINESDE--FLWQSFDFPTDTLLPQMKLGRDHKRGLNRFVTSWKSSFDPSSGSFMFKLET 202
Query: 196 HVLPQIFLYKGSLKLARIGPWNGFIFE---DGPTFIDYLYKIILVDTEDEIYYRYESYNN 252
LP+ F + L++ R GPW+G F + + D +Y + +E+ Y + ++
Sbjct: 203 LGLPEFFGFTSFLEVYRSGPWDGLRFSGILEMQQWDDIIYN--FTENREEVAYTFRVTDH 260
Query: 253 LSIMMLKINPLGKIQRLLWNEGSSGWQVMFSAPGDVCQNYGHCGANSICNVDNPPKCECL 312
S L IN +G+++ +W W + + P D C YG CG + C++ P C C+
Sbjct: 261 NSYSRLTINTVGRLEGFMWEPTQQEWNMFWFMPKDTCDLYGICGPYAYCDMSTSPTCNCI 320
Query: 313 KGFKPNSQHNQTWAT-----TCVRSHLSDCKTANQFKRFDDMKVPDLLDVSLNEGMNLEE 367
KGF+P S Q WA+ C R C ++F R +MK+P +++ + L+E
Sbjct: 321 KGFQPLSP--QDWASGDVTGRCRRKTQLTCG-EDRFFRLMNMKIPATTAAIVDKRIGLKE 377
Query: 368 CGAECLNNCTCRAYAYFNLTRGGSGCLMWFGDLIDMRKTLANLTGQSIYLRVPASEPGKK 427
C +C +C C AYA ++ GGSGC++W G+ D+R A+ GQ +++R+ A+E G++
Sbjct: 378 CEEKCKTHCNCTAYANSDIRNGGSGCIIWIGEFRDIRNYAAD--GQDLFVRLAAAEFGER 435
Query: 428 RPLWIVVLAAL---PVAILPAFLIFYRRKKKLKEKERRTEASQDMLLFEINMGNMSRAKE 484
R + ++ + + ++ +F+I+ KKK K + R T A +G R +E
Sbjct: 436 RTIRGKIIGLIIGISLMLVLSFIIYCFWKKKQK-RARATAAP---------IGYRDRIQE 485
Query: 485 F--CEGDSAGTGK-----SKESWFLFFSLSSISAATDNFSEENKLGEGGFGPVYKSIERY 537
G +G+ ++ ++ AT+NFS+ N LG GGFG VYK
Sbjct: 486 LIITNGVVMSSGRRLLGEEEDLELPLTEFETVVMATENFSDSNILGRGGFGIVYK----- 540
Query: 538 VEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGE 597
G+LL+G+E+AVKRLS S QG EFKNE+ LIA+LQH NLVRL CCI E
Sbjct: 541 --------GRLLDGQEIAVKRLSEMSSQGTNEFKNEVRLIARLQHINLVRLLSCCIYADE 592
Query: 598 KISIYEF--------DIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLK 649
KI IYE+ + + L+W TR II G+A+GLLYLHQ SR ++IHRDLK
Sbjct: 593 KILIYEYLENGSLDSHLFETTQSSNKLNWQTRFSIINGIARGLLYLHQDSRFKIIHRDLK 652
Query: 650 ASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFS 709
ASNVLLD +M PKISDFG+AR F DE ++NT ++VGTYGYMSPEYA+ G+FS+KSDVFS
Sbjct: 653 ASNVLLDKNMTPKISDFGMARIFERDETEANTRKVVGTYGYMSPEYAMEGIFSVKSDVFS 712
Query: 710 FGVLLLEILSSKKNTRFYNT-DSLTLLGHAWNLWKDDKAWKLMDPTMQNE----ALYS-- 762
FGVL+LEI+S K+N F+N+ LLG+ W WK+ K +++D + + +L+
Sbjct: 713 FGVLVLEIVSGKRNRGFHNSGQDNNLLGYTWENWKEGKGLEIVDSIIVDSSSSMSLFQPH 772
Query: 763 MVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSPHQPAFSYVQIVERSVL---- 818
V R I++ LLCVQE A DRP M VV ML E +P P +P + V RS L
Sbjct: 773 EVLRCIQIGLLCVQERAEDRPKMSSVVLMLGSEKGEIPQPKRPGY----CVGRSSLDTAD 828
Query: 819 ---LANINAEASLGNCLTLSVVDAR 840
++E+ N +T+SV++AR
Sbjct: 829 SSSSTKRDSESLTVNQITVSVINAR 853
|
Female specificity determinant of self-incompatibility. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 840 | ||||||
| 224115098 | 802 | predicted protein [Populus trichocarpa] | 0.932 | 0.976 | 0.490 | 0.0 | |
| 359493711 | 1081 | PREDICTED: G-type lectin S-receptor-like | 0.910 | 0.707 | 0.485 | 0.0 | |
| 224122858 | 831 | predicted protein [Populus trichocarpa] | 0.930 | 0.941 | 0.473 | 0.0 | |
| 359493715 | 1603 | PREDICTED: uncharacterized protein LOC10 | 0.877 | 0.459 | 0.477 | 0.0 | |
| 357446263 | 839 | Serine/threonine protein kinase [Medicag | 0.929 | 0.930 | 0.443 | 0.0 | |
| 255587572 | 822 | S-locus-specific glycoprotein S6 precurs | 0.903 | 0.923 | 0.475 | 0.0 | |
| 147816068 | 819 | hypothetical protein VITISV_030742 [Viti | 0.934 | 0.958 | 0.460 | 0.0 | |
| 359493723 | 867 | PREDICTED: G-type lectin S-receptor-like | 0.916 | 0.888 | 0.466 | 0.0 | |
| 224076591 | 834 | predicted protein [Populus trichocarpa] | 0.944 | 0.950 | 0.445 | 0.0 | |
| 359493740 | 2422 | PREDICTED: uncharacterized protein LOC10 | 0.927 | 0.321 | 0.446 | 0.0 |
| >gi|224115098|ref|XP_002316939.1| predicted protein [Populus trichocarpa] gi|222860004|gb|EEE97551.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 755 bits (1949), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 421/859 (49%), Positives = 540/859 (62%), Gaps = 76/859 (8%)
Query: 1 MENLSSFYIIS--YLTSLLALQFSLAADSITPATFIRDGEKLVSPSQRFELGFFSPGNSK 58
ME+L F S ++ SL L FS AD ITP ++DG+ L+S SQ FELGFFSPG SK
Sbjct: 1 MESLPFFIFFSTLFIQSLHFLSFS--ADIITPDLPVKDGQTLISVSQSFELGFFSPGTSK 58
Query: 59 NRYLGVWYKKSPDTVVWVANRNCPILDPHGILAINNNGNLVLLNQANGTIWSSNMSKEAK 118
RY+G+WYKKSP+TVVWVANRN P+ D G+L I+N GNLVLL+Q IWSSN S
Sbjct: 59 YRYVGIWYKKSPETVVWVANRNNPLTDHFGVLTIDNRGNLVLLDQIKNIIWSSNSSSIIA 118
Query: 119 SPVAQLLDTGNLVLRENFSNNTSEGSYLWQSFDFPSDTLLPGMKVGWDLKTGRERYLTSW 178
PVAQLLD+GNLV+R+N S+ +E SY WQSFD PSDTLLPGMK+GW+LKTG+ERYL +W
Sbjct: 119 GPVAQLLDSGNLVVRDNGSSRNTE-SYRWQSFDQPSDTLLPGMKLGWNLKTGQERYLITW 177
Query: 179 RTADDPSPGKFTYRLDIHVLPQIFLYKGSLKLARIGPWNGFIFEDGPTFIDYLYKIILVD 238
R+ DPSPG FTYRLDIH LPQ+F+ GS+K R GPWNG F P + +++ ILV
Sbjct: 178 RSISDPSPGDFTYRLDIHGLPQLFIVVGSVKKVRSGPWNGIFFGGTPKVHNSVFEPILVR 237
Query: 239 TEDEIYYRYESYNNLSIMMLKINPLGKIQRLLWNEGSSGWQVMFSAPGDVCQNYGHCGAN 298
EDEIYY Y NN L +N G ++RL+ +SGW ++S P D C+NYG CGAN
Sbjct: 238 NEDEIYYTYRLLNNSVCSRLTLNQSGAVERLVMYGQNSGWTTIYSVPVDTCENYGQCGAN 297
Query: 299 SICNVDNPPKCECLKGFK--PNSQ---HNQTWATTCVRSHLSDCKTANQFKRFDDMKVPD 353
IC P CECLKGFK P + N + C DC++ F + +K+PD
Sbjct: 298 GICRTRTSPICECLKGFKSIPEEELDIQNFYGSRKCETRLTLDCQSGEGFLKLPGVKLPD 357
Query: 354 LLDVSLNEGMNLEECGAECLNNCTCRAYAYFNLTRGG--SGCLMWFGDLIDMRKTLANLT 411
LL+ LNE MNL+EC AEC NC+C A+A NL+ GG SGCLMWFG+LID+R+ +
Sbjct: 358 LLEFRLNESMNLKECEAECFKNCSCSAFATTNLSGGGDGSGCLMWFGNLIDIREQSGSTI 417
Query: 412 GQSIYLRVPASEPGKKRPLWIVVLAALPVAILPAFLIFYRRKKKLKEKERRTEASQDMLL 471
GQ I++RVPASE R +RKK LK AS LL
Sbjct: 418 GQDIHIRVPASELEMARS--------------------SKRKKMLKTA---LVASMSALL 454
Query: 472 FEINMGNMSRAKEFCEGDSAGTGKSKESWFLFFSLSSISAATDNFSEENKLGEGGFGPVY 531
I + M R KE E F L +I+ AT+NF+ ++ +G GGFG VY
Sbjct: 455 -GIFVSGMDRRKEGMEAP-------------LFDLDTIATATNNFAPDSIIGAGGFGSVY 500
Query: 532 KSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGC 591
K GKLL G+E+AVK+LS SGQG+EEF+NE++LIAKLQHRNLV L G
Sbjct: 501 K-------------GKLLTGQEIAVKKLSMNSGQGVEEFRNEVVLIAKLQHRNLVGLLGS 547
Query: 592 CIEQGEKISIYEFD-------IVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVI 644
CI + E++ IYE+ + D R LL W R II G+A+GLLYLHQ S+L+++
Sbjct: 548 CIHREERMLIYEYMPNKSLDYFIFDHERSALLGWKERFVIILGIARGLLYLHQDSKLQIV 607
Query: 645 HRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIK 704
HRDLK SNVLLDS++ PKISDFG+AR G D ++ T R++GTYGYM+PEYA+ G FS+K
Sbjct: 608 HRDLKPSNVLLDSNLIPKISDFGLARISGDDGKETKTRRVIGTYGYMAPEYAIDGKFSVK 667
Query: 705 SDVFSFGVLLLEILSSKKNTRFYNTD-SLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSM 763
SDVFS GVLLLEI+S KKN F + D LLGHAW +W + +A +L+D +++ + S
Sbjct: 668 SDVFSLGVLLLEIISGKKNRGFVHPDHHHHLLGHAWLMWNEGRASELIDTGLEDTSGKSQ 727
Query: 764 VTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSPHQPAFSYVQIVERSVL--LAN 821
+ R I+V LLCVQ+ DRP M VV ML +E LP P QP F +ER + +
Sbjct: 728 LLRCIQVGLLCVQKLPEDRPVMSTVVFMLANEGAVLPQPKQPGF----FIERGSVSEATS 783
Query: 822 INAEASLGNCLTLSVVDAR 840
N ++ N +++++AR
Sbjct: 784 RNEDSYSTNEANITILEAR 802
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493711|ref|XP_002281022.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 746 bits (1926), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 406/837 (48%), Positives = 520/837 (62%), Gaps = 72/837 (8%)
Query: 25 ADSITPATFIRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKKSPDTVVWVANRNCPIL 84
ADSI I D E LVS Q FELGFFSPG+SKNRYLG+WYK +P T VWVANRN PI
Sbjct: 296 ADSIRMDQSISDSETLVSSGQSFELGFFSPGSSKNRYLGIWYKNTPQTAVWVANRNNPIA 355
Query: 85 DPHGILAINNNGNLVLLNQANGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSEGS 144
D +G+L I NNG LVLLNQ+ IWS N+S+ ++PVAQLL+TGNLVLR+ SN TS+ S
Sbjct: 356 DSYGVLTIINNGALVLLNQSKSVIWSPNLSRVPENPVAQLLETGNLVLRDG-SNETSK-S 413
Query: 145 YLWQSFDFPSDTLLPGMKVGWDLKTGRERYLTSWRTADDPSPGKFTYRLDIHVLPQIFLY 204
Y+WQSFD PSDT+LPGMKVGW+LKTG +R LTSW+++DDPS G F+Y DI+VLP + L
Sbjct: 414 YIWQSFDDPSDTMLPGMKVGWNLKTGLQRKLTSWKSSDDPSLGDFSYGFDINVLPYLVLG 473
Query: 205 KGSLKLARIGPWNGFIFEDGPTFIDYLYKIILVDTEDEIYYRYESYNNLSIMMLKINPLG 264
GS K+ R GPWNG F + +YK + V DE+Y YES NN I L +N G
Sbjct: 474 VGSSKIVRSGPWNGLEFNGVYVLDNSVYKAVFVANNDEVYALYESNNNKIISRLTLNHSG 533
Query: 265 KIQRLLWNEGSSGWQVMFSAPGDVCQNYGHCGANSICNVDNPPKCECLKGFKPNSQHNQT 324
+QRLL +GSS W ++S P ++C+NYGHCGAN IC + CECL GF P SQ +
Sbjct: 534 FLQRLLLKKGSSVWDELYSIPSELCENYGHCGANGICRIGKLQICECLTGFTPKSQ--EE 591
Query: 325 W-----ATTCVRSHLSDCKTANQFKRFDDMKVPDLLDVSLNEGMNLEECGAECLNNCTCR 379
W ++ C R DC+ F + +K+PDL+D + G++L EC CLNNC+C
Sbjct: 592 WDMFNTSSGCTRRMPLDCQIEEGFVKVTGVKLPDLIDFHVIMGVSLRECKVSCLNNCSCT 651
Query: 380 AYAYFNLTRGGSGCLMWFGDLIDMRKTLANLTGQSIYLRVPASEPG-----KKRPLWIVV 434
AYAY N G GCLMW GDLID+R+ + + IY+R+ SE G KK+ L I++
Sbjct: 652 AYAYTN-PNGSGGCLMWSGDLIDIRELTSEKHAEDIYIRMHTSELGLNTNQKKKKLVIIL 710
Query: 435 LAALPVAILPAFLIFYRRKKKLKEKERRTEASQDMLLFEINMGNMSRAKEFCEGDSAGTG 494
+ + IL L F+ R K + E+ ++ L +
Sbjct: 711 VISTFSGILTLGLSFWFRFWKKRTMGTDQESKKENLELPL-------------------- 750
Query: 495 KSKESWFLFFSLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEV 554
F L +I+ AT+NFS NK+G GGFG VYK G L G V
Sbjct: 751 ---------FDLPTIATATNNFSNTNKIGAGGFGSVYK-------------GNLPEGVAV 788
Query: 555 AVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF-------DIV 607
AVKRLS S QG++EFKNE +LIAKLQH+NLVRL GCCI+ E+I +YE+ +
Sbjct: 789 AVKRLSKNSAQGVQEFKNEAVLIAKLQHKNLVRLLGCCIQGEERILLYEYMPNKSLDYFI 848
Query: 608 TDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667
D R+ LL W R I+ G+A+GLLYLHQ SR ++IHRDLK SN+LLD ++NPKISDFG
Sbjct: 849 FDQNRRALLAWDKRCEIVMGIARGLLYLHQDSRFQIIHRDLKTSNILLDDNLNPKISDFG 908
Query: 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFY 727
+AR FG +EM++ T RIVGTYGYMSPEY + G FSIK DVFSFGVLLLEI+S +KN F
Sbjct: 909 LARIFGENEMETRTKRIVGTYGYMSPEYVIDGHFSIKLDVFSFGVLLLEIVSGEKNRGFS 968
Query: 728 NTD-SLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTML 786
+ D LLGHAW LW+ ++A +LMD +++ + S V R I+V LLCVQ DRP M
Sbjct: 969 HPDHHHNLLGHAWLLWEQNRALELMDACLEDSCVASQVLRCIQVGLLCVQNLPADRPAMS 1028
Query: 787 EVVAMLKDEIVNLPSPHQPAFSYVQIVERSVLLANINA---EASLGNCLTLSVVDAR 840
V+ ML +E LP P P F ERS + + + E N +T+S++ R
Sbjct: 1029 SVIFMLGNEGATLPQPKHPGF----FTERSSVDTDTMSGKIELHSENAVTISMLKGR 1081
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122858|ref|XP_002330381.1| predicted protein [Populus trichocarpa] gi|222871766|gb|EEF08897.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 733 bits (1893), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 399/842 (47%), Positives = 529/842 (62%), Gaps = 60/842 (7%)
Query: 22 SLAADSITPATFIRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKK-SPDTVVWVANRN 80
S A +SI + DG+ LVS FELGFFSPGNS+NRY+G+WYKK S TVVWVANRN
Sbjct: 27 STAIESINATQSLEDGDTLVSSEGHFELGFFSPGNSRNRYMGIWYKKISSFTVVWVANRN 86
Query: 81 CPILDPHGILAINNNGNLVLLNQANGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNT 140
P+ D G+L ++GNL +N NGTIWSSN+S+ A +PVAQLLDTGNLV+R N+
Sbjct: 87 TPLNDSSGMLKFVDHGNLAFINSTNGTIWSSNISRAAINPVAQLLDTGNLVVRA--ENDN 144
Query: 141 SEGSYLWQSFDFPSDTLLPGMKVGWDLKTGRERYLTSWRTADDPSPGKFTYRLDIHVLPQ 200
++LWQSFD+P D+ LPGMK G TG RYLTSW++ DPS GK+T +LD + LPQ
Sbjct: 145 DPENFLWQSFDYPGDSFLPGMKYGISFVTGLNRYLTSWKSPSDPSTGKYTNKLDPNGLPQ 204
Query: 201 IFLYKGSLKLARIGPWNGFIFEDGPTFI-DYLYKIILVDTEDEIYYRYESYNNLSIMMLK 259
FL +GS+ R GPWNG F + +Y V ++EIYY+Y+ N+ + +
Sbjct: 205 YFLSQGSVDQFRSGPWNGLRFSGMINLKPNPIYTFEFVFNQEEIYYKYQIANSSVLSRMV 264
Query: 260 INPLGKIQRLLWNEGSSGWQVMFSAPGDVCQNYGHCGANSICNVDNPPKCECLKGFKPNS 319
++P G +QR W + + W + +A D C + CGA+ +CN++N P C+CLK F+P S
Sbjct: 265 LSPDGVLQRFTWIDRTQDWTLYLTANMDNCDRFALCGAHGVCNINNSPACDCLKEFEPKS 324
Query: 320 QHNQT---WATTCVRSHLSDCKTANQFKRFDDMKVPDLLDVSLNEGMNLEECGAECLNNC 376
T W+ CVR DC F ++ +KVPD N+ +NLEEC CL NC
Sbjct: 325 LEEWTAADWSQGCVRKAPLDCSNGEGFIKYTGIKVPDTRKSWYNKTINLEECEEVCLKNC 384
Query: 377 TCRAYAYFNLTRGGSGCLMWFGDLIDMRKTLANLTGQSIYLRV-------PASEPGKKRP 429
+C AYA ++ GGSGC++WFGDLID+R+ N GQ IY+R+ P GKKR
Sbjct: 385 SCTAYANLDVRDGGSGCVLWFGDLIDIRQ--YNENGQDIYIRIAASVIDKPVKSRGKKRV 442
Query: 430 LWIVVLAALPVAILPAFLIFYRRKKKLKEKERRTEASQDMLLFEINMGNMSRAKEFCEGD 489
IV+ +L L A +F R +K K+++ E GN+ E D
Sbjct: 443 RIIVIPVSLVAFSLLALCLFLRFLRKNKQQQLTRE------------GNVVTNPE---QD 487
Query: 490 SAGTGKSKESWFLFFSLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLL 549
++++ F L++++ AT+ FS NKLG+GGFGPVYK I L
Sbjct: 488 RTKESRNEDLELPLFDLATLTDATNCFSINNKLGQGGFGPVYKGI-------------LQ 534
Query: 550 NGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF----- 604
+G+E+AVKRLS +S QG+ EF+NE++ IAKLQHRNLV+L GCCIE E++ IYE+
Sbjct: 535 DGQEIAVKRLSKRSRQGINEFRNEVVCIAKLQHRNLVKLLGCCIELEERMLIYEYMPNKS 594
Query: 605 --DIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPK 662
+ D R LLDWT R II G+A+GLLYLHQ SRLR+IHRDLKASN+LLD +MNPK
Sbjct: 595 LDSFIFDKRRNMLLDWTKRFPIINGIARGLLYLHQDSRLRIIHRDLKASNILLDYEMNPK 654
Query: 663 ISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKK 722
ISDFG+AR+FGGDE +NT+RIVGTYGYMSPEYA+ GLFS+KSDVFSFGVL+LEI+S +K
Sbjct: 655 ISDFGMARSFGGDETSANTSRIVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGRK 714
Query: 723 NTRFYNTD-SLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATD 781
N F + + L LLGHAW L K+ + L+D ++ + + S V R I+VALLCVQ++ D
Sbjct: 715 NRGFRHAEHKLNLLGHAWMLHKEGRPLDLIDESIVDTCIISEVLRSIEVALLCVQKSPED 774
Query: 782 RPTMLEVVAMLKDEIVNLPSPHQPAFSYVQIVERSV---LLANINAEASLGNCLTLSVVD 838
RP M VV ML +IV LP P +P F ER + + I E S N LT ++++
Sbjct: 775 RPKMSIVVLMLSSDIV-LPQPKEPGF----FTERDLSNDSSSTIKHEISSVNELTSTLLE 829
Query: 839 AR 840
AR
Sbjct: 830 AR 831
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493715|ref|XP_002280938.2| PREDICTED: uncharacterized protein LOC100246941 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 706 bits (1823), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 388/812 (47%), Positives = 507/812 (62%), Gaps = 75/812 (9%)
Query: 25 ADSITPATFIRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKK-SPDTVVWVANRNCPI 83
D+I +RDGE L S FELGFF P NS RYLG+WYKK S TVVWVANR P+
Sbjct: 813 VDTIALNQLLRDGEILTSAGGSFELGFFRPDNSSRRYLGMWYKKVSIRTVVWVANRETPL 872
Query: 84 LDPHGILAINNNGNLVLLNQANGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSEG 143
D G+L + + G L +LN N +WSSN S+ A++P AQ+L++GNLV+++ N+ +
Sbjct: 873 ADSSGVLKVTDQGTLAVLNGTNTILWSSNSSRSARNPTAQILESGNLVMKD--GNDDNPE 930
Query: 144 SYLWQSFDFPSDTLLPGMKVGWDLKTGRERYLTSWRTADDPSPGKFTYRLDIHVLPQIFL 203
++LWQSFD+P +TLLPGMK+G + TG +RYL++W++ADDPS G FTYRLD PQ+ L
Sbjct: 931 NFLWQSFDYPCNTLLPGMKLGRNTVTGLDRYLSAWKSADDPSKGDFTYRLDPRGYPQLIL 990
Query: 204 YKGSLKLARIGPWNGFIF----EDGPTFIDYLYKIILVDTEDEIYYRYESYNNLSIMMLK 259
KGS R GPWNG F E GP I Y Y+ + E E+Y+RYE N+ + L
Sbjct: 991 RKGSAVTFRSGPWNGVRFSGFPELGPNSI-YTYEFVF--NEKEMYFRYELVNSSVVSRLV 1047
Query: 260 INPLGKIQRLLWNEGSSGWQVMFSAPGDVCQNYGHCGANSICNVDNPPKCECLKGFKPNS 319
+NP G QR+ W + ++GW + SAP D C +Y CG ICN++ PKCEC++GF P
Sbjct: 1048 LNPDGSKQRVNWIDRTNGWILYSSAPKDDCDSYALCGVYGICNINRSPKCECMEGFVPKF 1107
Query: 320 QHN---QTWATTCVRSHLSDCKTANQFKRFDDMKVPDLLDVSLNEGMNLEECGAECLNNC 376
Q++ W+ CVRS DC+ F +F +K+PD + N M L EC A CL+NC
Sbjct: 1108 QNDWDMADWSNGCVRSTPLDCQNGEGFVKFSGVKLPDTRNSWFNRSMGLMECAAVCLSNC 1167
Query: 377 TCRAYAYFNLTRGGSGCLMWFGDLIDMRKTLANLTGQSIYLRVPASE-----------PG 425
+C AY ++ GGSGCL+WFGDLID+R+ N GQ IY+R+ ASE G
Sbjct: 1168 SCTAYTNLDIRDGGSGCLLWFGDLIDIRE--FNENGQEIYVRMAASELGGSKESGSNLKG 1225
Query: 426 KKRPLWIVV--LAALPVAILPAFLIFYRRKKKLKEKERRTEASQDMLLFEINMGNMSRAK 483
KKR WI+V ++++ + ++ FL Y K K + K+ G M
Sbjct: 1226 KKRK-WIIVGSVSSVVIILVSLFLTLYLLKTKRQRKK----------------GTMGYNL 1268
Query: 484 EFCEGDSAGTGKSKESWFLFFSLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNW 543
E G ++S F +++S AT++FS +NKLGEGGFG VYK I
Sbjct: 1269 E--------VGHKEDSKLQLFDFATVSKATNHFSFDNKLGEGGFGLVYKGI--------- 1311
Query: 544 KQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYE 603
L G+E+AVKRLS SGQGL+E KNE++ IAKLQHRNLVRL GCCI EK+ IYE
Sbjct: 1312 ----LQEGQEIAVKRLSKDSGQGLDELKNEVIYIAKLQHRNLVRLLGCCIHGEEKMLIYE 1367
Query: 604 F-------DIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLD 656
+ + D + LDW R II G+A+GLLYLHQ SRLR+IHRDLKA N+LLD
Sbjct: 1368 YMSNKSLDSFIFDKTQSMELDWNKRFLIINGIARGLLYLHQDSRLRIIHRDLKAGNILLD 1427
Query: 657 SDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLE 716
+M PKISDFG+AR+FGG+E ++NT R+VGTYGYMSPEYA+ GL+S KSDVFSFGVL+LE
Sbjct: 1428 EEMAPKISDFGMARSFGGNETEANTKRVVGTYGYMSPEYAIDGLYSTKSDVFSFGVLVLE 1487
Query: 717 ILSSKKNTRFYNTD-SLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCV 775
I+S K+N F + D SL LLGHAW L+ + + +LMD + + S V R I V LLCV
Sbjct: 1488 IVSGKRNRGFSHPDHSLNLLGHAWTLYTEGRYLELMDAMVGDTFQPSEVLRSIHVGLLCV 1547
Query: 776 QENATDRPTMLEVVAMLKDEIVNLPSPHQPAF 807
Q A DRP+M VV ML E+ LP P +P F
Sbjct: 1548 QHCADDRPSMSSVVLMLSSEVA-LPQPREPGF 1578
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357446263|ref|XP_003593409.1| Serine/threonine protein kinase [Medicago truncatula] gi|355482457|gb|AES63660.1| Serine/threonine protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 706 bits (1823), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 380/856 (44%), Positives = 531/856 (62%), Gaps = 75/856 (8%)
Query: 12 YLTSLLALQFSLAADSITPATFIRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKK-SP 70
+LT+L + S A D+ITP FI + L+SPSQ FELGFF+P NS YLG+WYK+
Sbjct: 16 HLTTLFPIP-SKAEDTITPPQFITGNQTLISPSQNFELGFFTPKNSTYTYLGIWYKQIHI 74
Query: 71 DTVVWVANRNCPILDPHGILAINNNGNLVLLNQANGTIWSSNMSKEAKSPVAQLLDTGNL 130
+VWVANR+ P+LD +G L NN+G L++LN +W+SN S AK+PVAQLLDTGN
Sbjct: 75 KNIVWVANRDKPLLDHNGTLTFNNDGKLIILNYGGSVLWASNSSGPAKTPVAQLLDTGNF 134
Query: 131 VLRENFSNNTSEGSYLWQSFDFPSDTLLPGMKVGWDLKTGRERYLTSWRTADDPSPGKFT 190
VL+ NF + SE LWQSFD+PS+TLLPGMK+G + KTG +LTSW+ D+PS G+++
Sbjct: 135 VLK-NFEDENSE-EILWQSFDYPSNTLLPGMKLGRNFKTGLNIHLTSWKNIDNPSSGEYS 192
Query: 191 YRLDIHVLPQIFLYKGSLKLARIGPWNGFIFEDGPTFIDY-LYKIILVDTEDEIYYRYES 249
Y +D LPQ+FL KG K+ R GPW ++ P + ++K + V DE+YY +E+
Sbjct: 193 YSVDPRGLPQLFLQKGKKKIFRSGPWYVEQYKGDPVLRENPIFKPVFVFDSDEVYYSFET 252
Query: 250 YNNLSIMMLKINPLGKIQRLLWNEGSSGWQVMFSAPGDVCQNYGHCGANSICNVDNPPKC 309
+++ + ++ G IQ WN+ S W F+ GD C +YG CGA CN+ N P C
Sbjct: 253 KDDI-VSRFVLSESGLIQHFTWNDHRSNWFSEFNVQGDRCDDYGICGAYGTCNIKNSPIC 311
Query: 310 ECLKGFKPNSQHNQT---WATTCVRSHLSDCKTANQFKRFDDMKVPDLLDVSLNEGMNLE 366
+CL GF+P + H+ W++ CVR + C+ + FK+F MK+PD ++ +N +N++
Sbjct: 312 KCLNGFEPRNMHDWKMLDWSSGCVRENSKVCRNGDVFKKFIGMKLPDSVEFHVNYSINID 371
Query: 367 ECGAECLNNCTCRAYAYFNLTRGGSGCLMWFGDLIDMRKTLANLTGQSIYLRVPASE--- 423
+C EC NC+C AYA ++ G+GC+ WFGDL D+R+ N Q ++RV ASE
Sbjct: 372 QCEVECSKNCSCVAYAKLDINASGNGCIAWFGDLFDIREDSVN--EQDFFVRVSASELDS 429
Query: 424 --PGKKRPLWIVVLAALPVA---ILPAFLIFYRRKKKLKEKERRTEASQDMLLFEINMGN 478
KR I++ ++ VA I A + ++ ++ + KE S D
Sbjct: 430 NVERNKRKKLILLFVSISVASTIITSALWLIIKKWRRNRAKETGIRLSVD---------- 479
Query: 479 MSRAKEFCEGDSAGTGKSKESWFLFFSLSSISAATDNFSEENKLGEGGFGPVYKSIERYV 538
T KS E FF ++ I AAT NFS NK+GEGGFGPVYK
Sbjct: 480 --------------TSKS-EFELPFFEIAIIEAATRNFSFYNKIGEGGFGPVYK------ 518
Query: 539 EICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEK 598
G+L +G+E+AVKRLS SGQGL+EFKNE++ I++LQHRNLV+L GCCI+ +K
Sbjct: 519 -------GQLPSGQEIAVKRLSENSGQGLQEFKNEVIFISQLQHRNLVKLLGCCIQGEDK 571
Query: 599 ISIYEF-------DIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKAS 651
+ +YE+ ++ D ++ L W R+ II+G+A+GL+YLH+ SRLR+IHRDLKAS
Sbjct: 572 MLVYEYMPNRSLDSLLFDETKRSALSWQKRLDIIDGIARGLVYLHRDSRLRIIHRDLKAS 631
Query: 652 NVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFG 711
NVLLD +MNPKISDFG+AR FGGD+ + T R+VGTYGYM PEYA+ G FS KSDV+SFG
Sbjct: 632 NVLLDGEMNPKISDFGMARMFGGDQTEEKTKRVVGTYGYMPPEYAMDGHFSFKSDVYSFG 691
Query: 712 VLLLEILSSKKNTRFYNTD-SLTLLGHAWNLWKDDKAWKLMDPTMQNE-ALYSMVTRYIK 769
VLLLE+LS KKN F++ D L LLGHAW LW + K +LMDP ++++ + + + I+
Sbjct: 692 VLLLELLSGKKNRGFFHPDHKLNLLGHAWKLWNEGKVIELMDPLLEDQVSTPESILKCIQ 751
Query: 770 VALLCVQENATDRPTMLEVVAMLKDEIVNLPSPHQPAFSYVQIVERSVLLANINAEASLG 829
+ LLCVQ++ +RPTM VV ML E V LP P +P ER L + ++ L
Sbjct: 752 IGLLCVQQHPEERPTMSSVVLMLDGESVLLPKPRRPGL----YSERCFLETDSSSRGMLN 807
Query: 830 N-----CLTLSVVDAR 840
+ +T +VV+ R
Sbjct: 808 SGSNDITVTTTVVEGR 823
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255587572|ref|XP_002534316.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] gi|223525508|gb|EEF28065.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 705 bits (1819), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 382/804 (47%), Positives = 500/804 (62%), Gaps = 45/804 (5%)
Query: 26 DSITPATFIRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKKSP-DTVVWVANRNCPIL 84
+++ P ++DGE L+S FELGFFS G+S++RYLG+WYK+ P TVVWV NR P
Sbjct: 10 ETLYPGQSMKDGETLISADGNFELGFFSQGDSRSRYLGIWYKRIPVKTVVWVGNREVPSF 69
Query: 85 DPHGILAINNNGNLVLLNQANGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSEGS 144
D G+L +N G ++L N G IWSSN S+ AK+PV QLLD+GNL++++ NN +
Sbjct: 70 DNLGVLQVNEQGVIILQNSTKGIIWSSNSSRTAKNPVLQLLDSGNLIVKDGNGNNPD--N 127
Query: 145 YLWQSFDFPSDTLLPGMKVGWDLKTGRERYLTSWRTADDPSPGKFTYRLDIHVLPQIFLY 204
+WQSFDFP +TLLP MK+GW+L G RYLTSW++ DDP+ G F+ +D+ PQ+F+
Sbjct: 128 IVWQSFDFPYNTLLPSMKLGWNLDKGLNRYLTSWKSIDDPAQGNFSCLIDLRGFPQLFMK 187
Query: 205 KGSLKLARIGPWNGFIFEDGPTF-IDYLYKIILVDTEDEIYYRYESYNNLSIMMLKINPL 263
KG R GPWNG F P + ++ V + EIYY YE N + L ++
Sbjct: 188 KGDAVQVRSGPWNGLQFTGSPQLNPNPVFNFSFVSNKHEIYYSYELKNTSVVSRLIVSEK 247
Query: 264 GKIQRLLWNEGSSGWQVMFSAPGDVCQNYGHCGANSICNVDNPPKCECLKGFKPNSQHNQ 323
G ++R W + + W + FS P D C Y CGA + CN+++ P C CL+GF P S +
Sbjct: 248 GALERHNWIDRTQSWTLFFSVPTDQCDTYLLCGAYASCNINSYPVCSCLEGFVPKSPTDW 307
Query: 324 T---WATTCVRSHLSDCKTANQFKRFDDMKVPDLLDVSLNEGMNLEECGAECLNNCTCRA 380
+ W+ CVR C T + F++ MK+PD ++ M+L+EC CL NC+C A
Sbjct: 308 SASDWSDGCVRRTELSCHTGDGFRKLKGMKLPDTSSSWVDMSMDLKECEGMCLRNCSCLA 367
Query: 381 YAYFNLTRGGSGCLMWFGDLIDMRKTLANLTGQSIYLRVPASEPGK-----KRPLWIVVL 435
YA ++ GSGCL+WF LIDMRK GQ +Y+R+ ASE K KR IV
Sbjct: 368 YANSDIR--GSGCLLWFDHLIDMRKFTEG--GQDLYIRIAASELAKGKSHGKRVAIIVSC 423
Query: 436 AALPVAILPAFLIFYRRKKKLKEKERRTEASQDMLL---FEINMGNMSR-AKEFCEGDSA 491
+ + + + Y RK+K + +A +LL F I+ +S AKE +
Sbjct: 424 LIIGMGMTALGSLLYTRKRK---RNILGQAVPLVLLVSSFAIHFYIISGLAKETYIENYG 480
Query: 492 GTGKSKESWFLFFSLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNG 551
G +++ + F L +I AT NFS NKLGEGGFGPVYK G LL+G
Sbjct: 481 DNGAKEDTELIAFDLITIRNATGNFSNYNKLGEGGFGPVYK-------------GTLLDG 527
Query: 552 EEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF------- 604
+E+AVKRLS SGQG +EFKNE++LIA+LQHRNLV+L GCCI EK+ IYE+
Sbjct: 528 QEIAVKRLSETSGQGGKEFKNEVILIARLQHRNLVKLLGCCIHGDEKMLIYEYMPNKSLD 587
Query: 605 DIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664
+ D R LLDW RII G+A+GLLYLHQ SRLR+IHRDLKASN+LLD DMNPKIS
Sbjct: 588 SFIFDKKRSMLLDWHMCFRIIGGIARGLLYLHQDSRLRIIHRDLKASNILLDCDMNPKIS 647
Query: 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNT 724
DFG+ARTFG D+ +NT R+VGTYGYMSPEYA+ GLFS+KSDVFSFGVL+LEI+S K+N
Sbjct: 648 DFGLARTFGKDQNAANTKRVVGTYGYMSPEYAVDGLFSVKSDVFSFGVLVLEIVSGKRNR 707
Query: 725 RFYNTD-SLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRP 783
F + D SL LLGHAW LW +++A +L D Q+E S V R I+V LLCVQ DRP
Sbjct: 708 GFSHLDHSLNLLGHAWRLWMEERALELFDKFSQDEYSVSQVLRCIQVGLLCVQRLPHDRP 767
Query: 784 TMLEVVAMLKDEIVNLPSPHQPAF 807
M VV ML E +LP P QP F
Sbjct: 768 DMSAVVVMLGSE-SSLPQPKQPGF 790
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147816068|emb|CAN61538.1| hypothetical protein VITISV_030742 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 702 bits (1812), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 395/857 (46%), Positives = 523/857 (61%), Gaps = 72/857 (8%)
Query: 9 IISYLTSLLALQFSLAADSITPATFIRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKK 68
I +Y+ SLL + S+ D+IT I D E + S FELGFFSP NSK+RYLG+ YKK
Sbjct: 10 IFTYVFSLL--RISIGVDTITVNQLITDAETITSAGGSFELGFFSPANSKHRYLGIRYKK 67
Query: 69 SPD-TVVWVANRNCPILDPHGILAINNNGNLVLLNQANGTIWSSNMSKEAKSPVAQLLDT 127
+ VVWVANR P+ D G+L + + G LV+L+ AN T+WSS S+ A++P AQLLD+
Sbjct: 68 ELNRAVVWVANRENPLNDSSGVLKVTSQGILVVLDGANKTLWSSTSSRPAQNPNAQLLDS 127
Query: 128 GNLVLRENFSNNTSEGSYLWQSFDFPSDTLLPGMKVGWDLKTGRERYLTSWRTADDPSPG 187
GNLV++ N+ + ++LWQSFD+P +TLLPGMK+GW+ TG +RYL+SW++ADDPS G
Sbjct: 128 GNLVMKN--GNDGNPENFLWQSFDYPCNTLLPGMKLGWNRVTGLDRYLSSWKSADDPSIG 185
Query: 188 KFTYRLDIHVLPQIFLYKGSLKLARIGPWNGFIFEDGPTFID---YLYKIILVDTEDEIY 244
FTY +D PQIF+ S+ R GPWNG F P F Y Y +L E EIY
Sbjct: 186 TFTYGIDPSGSPQIFVRNVSVVTFRSGPWNGIRFSGYPHFTPNPVYTYDFVL--NEKEIY 243
Query: 245 YRYESYNNLSIMMLKINPLGKIQRLLWNEGSSGWQVMFSAPGDVCQNYGHCGANSICNVD 304
+ Y N+ + L + P G QR W + W S D C NY CGAN IC +D
Sbjct: 244 FIYYLVNSSLLTRLVLTPDGYAQRFTWIDEKGQWVKYSSVQNDDCDNYALCGANGICKID 303
Query: 305 NPPKCECLKGFKPNSQHN---QTWATTCVRSHLSDCKTANQFKRFDDMKVPDLLDVSLNE 361
PKCEC+KGF+P Q N W+ CVRS DC+ ++F +F +K+PD NE
Sbjct: 304 QSPKCECMKGFRPRFQSNWDMADWSDGCVRSTPLDCQKGDRFVKFSGVKLPDTRTSWFNE 363
Query: 362 GMNLEECGAECLNNCTCRAYAYFNLTRGGSGCLMWFGDLIDMRKTLANLTGQSIYLRVPA 421
MNL+EC + CL NC+C AY N++ GSGCL+WFG+L D+R+ N GQ Y+R+ A
Sbjct: 364 SMNLKECASLCLRNCSCTAYVNSNISGEGSGCLLWFGNLTDIREFAEN--GQEFYVRMSA 421
Query: 422 SEPG----------KKRPLWIVVLAALPVAILPAFLIFYRRKKKLKEKERRTEASQDMLL 471
SE KK+ IV+ ++ +L ++ + KK+K++ +R + +
Sbjct: 422 SESDAFSSTNISSKKKQKQVIVISISITGIVLLILVLTWYMLKKMKQQLKR----KGYME 477
Query: 472 FEINMGNMSRAKEFCEGDSAGTGKSKESWFLFFSLSSISAATDNFSEENKLGEGGFGPVY 531
+ G S +E E F L+++ AT+NFS +NKLGEGGFGPVY
Sbjct: 478 HNSDGGETSEGQEHLE-------------LPLFELATLLNATNNFSSDNKLGEGGFGPVY 524
Query: 532 KSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGC 591
K I L +GEE+AVKRLS S QGL+EFKNE+ IAKLQHRNLV+L GC
Sbjct: 525 KGI-------------LEDGEEIAVKRLSKTSRQGLKEFKNEVESIAKLQHRNLVKLLGC 571
Query: 592 CIEQGEKISIYEF------DI-VTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVI 644
CI EK+ IYE+ D+ + D R +LDW R II G+A+GLLYLHQ SRLR+I
Sbjct: 572 CICGREKMLIYEYLPNKSLDLFIFDQMRGIVLDWPKRFLIINGIARGLLYLHQDSRLRII 631
Query: 645 HRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIK 704
HRDLKA NVLLD+DMNPKISDFGIAR+FGG+E+ ++T R+ GT GYMSPEYA GL+S K
Sbjct: 632 HRDLKAENVLLDNDMNPKISDFGIARSFGGNELXASTTRVAGTLGYMSPEYASEGLYSTK 691
Query: 705 SDVFSFGVLLLEILSSKKNTRFYNTD-SLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSM 763
SDV+SFGVL+LEI S K+N F + D L LLGHAW L+ + + + +D ++ N S
Sbjct: 692 SDVYSFGVLVLEIXSGKRNRGFSHPDHDLNLLGHAWTLYIEGGSSEFIDASIANTYNLSE 751
Query: 764 VTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSPHQPAFSYVQIVERSVLLANIN 823
V R I V LLCVQ DRP+M VV ML E LP P +P F +RS++ N
Sbjct: 752 VLRSINVGLLCVQRFPDDRPSMHSVVLMLSSEGA-LPRPKEPCF----FTDRSMMEVN-- 804
Query: 824 AEASLGNCLTLSVVDAR 840
+S G+ T++ ++AR
Sbjct: 805 --SSSGSHTTITQLEAR 819
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493723|ref|XP_002280706.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 699 bits (1803), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 391/838 (46%), Positives = 513/838 (61%), Gaps = 68/838 (8%)
Query: 9 IISYLTSLLALQFSLAADSITPATFIRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKK 68
I +Y+ SLL + S+ D+IT I D E + S FELGFFSP NSK+RYLG+ YKK
Sbjct: 10 IFTYVFSLL--RISIGVDTITVNQLITDAETITSAGGSFELGFFSPANSKHRYLGIRYKK 67
Query: 69 SPD-TVVWVANRNCPILDPHGILAINNNGNLVLLNQANGTIWSSNMSKEAKSPVAQLLDT 127
+ VVWVANR P+ D G+L + + G LV+L+ AN T+WSS S+ A++P AQLLD+
Sbjct: 68 ELNRAVVWVANRENPLNDSSGVLKVTSQGILVVLDGANKTLWSSTSSRPAQNPNAQLLDS 127
Query: 128 GNLVLRENFSNNTSEGSYLWQSFDFPSDTLLPGMKVGWDLKTGRERYLTSWRTADDPSPG 187
GNLV++ N+ + ++LWQSFD+P +TLLPGMK+GW+ TG +RYL+SW++ADDPS G
Sbjct: 128 GNLVMKN--GNDGNPENFLWQSFDYPCNTLLPGMKLGWNRVTGLDRYLSSWKSADDPSIG 185
Query: 188 KFTYRLDIHVLPQIFLYKGSLKLARIGPWNGFIFEDGPTFID---YLYKIILVDTEDEIY 244
FTY +D PQIF+ S+ R GPWNG F P F Y Y +L E EIY
Sbjct: 186 TFTYGIDPSGSPQIFVRNVSVVTFRSGPWNGIRFSGYPHFTPNPVYTYDFVL--NEKEIY 243
Query: 245 YRYESYNNLSIMMLKINPLGKIQRLLWNEGSSGWQVMFSAPGDVCQNYGHCGANSICNVD 304
+ Y N+ + L + P G QR W + W S D C NY CGAN IC +D
Sbjct: 244 FIYYLVNSSLLTRLVLTPDGYAQRFTWIDEKGQWVKYSSVQNDDCDNYALCGANGICKID 303
Query: 305 NPPKCECLKGFKPNSQHN---QTWATTCVRSHLSDCKTANQFKRFDDMKVPDLLDVSLNE 361
PKCEC+KGF+P Q N W+ CVRS DC+ ++F +F +K+PD NE
Sbjct: 304 QSPKCECMKGFRPRFQSNWDMADWSDGCVRSTPLDCQKGDRFVKFSGVKLPDTRTSWFNE 363
Query: 362 GMNLEECGAECLNNCTCRAYAYFNLTRGGSGCLMWFGDLIDMRKTLANLTGQSIYLRVPA 421
MNL+EC + CL NC+C AY N++ GSGCL+WFG+L D+R+ N GQ Y+R+ A
Sbjct: 364 SMNLKECASLCLRNCSCTAYVNSNISGEGSGCLLWFGNLTDIREFAEN--GQEFYVRMSA 421
Query: 422 SEPG----------KKRPLWIVVLAALPVAILPAFLIFYRRKKKLKEKERRTEASQDMLL 471
SE KK+ IV+ ++ +L ++ + KK+K++ +R + +
Sbjct: 422 SESDAFSSTNISSKKKQKQVIVISISITGIVLLILVLTWYMLKKMKQQLKR----KGYME 477
Query: 472 FEINMGNMSRAKEFCEGDSAGTGKSKESWFLFFSLSSISAATDNFSEENKLGEGGFGPVY 531
+ G S +E E F L+++ AT+NFS +NKLGEGGFGPVY
Sbjct: 478 HNSDGGETSEGQEHLE-------------LPLFELATLLNATNNFSSDNKLGEGGFGPVY 524
Query: 532 KSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGC 591
K I L +GEE+AVKRLS S QGL+EFKNE+ IAKLQHRNLV+L GC
Sbjct: 525 KGI-------------LEDGEEIAVKRLSKTSRQGLKEFKNEVESIAKLQHRNLVKLLGC 571
Query: 592 CIEQGEKISIYEF------DI-VTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVI 644
CI EK+ IYE+ D+ + D R +LDW R II G+A+GLLYLHQ SRLR+I
Sbjct: 572 CICGREKMLIYEYLPNKSLDLFIFDQMRGIVLDWPKRFLIINGIARGLLYLHQDSRLRII 631
Query: 645 HRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIK 704
HRDLKA NVLLD+DMNPKISDFGIAR+FGG+E+ ++T R+ GT GYMSPEYA GL+S K
Sbjct: 632 HRDLKAENVLLDNDMNPKISDFGIARSFGGNELGASTTRVAGTLGYMSPEYASEGLYSTK 691
Query: 705 SDVFSFGVLLLEILSSKKNTRFYNTD-SLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSM 763
SDV+SFGVL+LEILS K+N F + D L LLGHAW L+ + + + +D ++ N S
Sbjct: 692 SDVYSFGVLVLEILSGKRNRGFSHPDHDLNLLGHAWTLYIEGGSSEFIDASIANTYNLSE 751
Query: 764 VTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSPHQPAFSYVQIVERSVLLAN 821
V R I V LLCVQ DRP+M VV ML E LP P +P F +RS++ N
Sbjct: 752 VLRSINVGLLCVQRFPDDRPSMHSVVLMLSSEGA-LPRPKEPCF----FTDRSMMEVN 804
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224076591|ref|XP_002304966.1| predicted protein [Populus trichocarpa] gi|222847930|gb|EEE85477.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 698 bits (1802), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 379/850 (44%), Positives = 527/850 (62%), Gaps = 57/850 (6%)
Query: 15 SLLALQFSLAADSITPATFIRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKKSPDTVV 74
SL + +F+ + D++T + +G+ L+S SQ FELGFF+PGNS+N Y+G+WYK P T V
Sbjct: 18 SLFSSKFASSLDTLTATQSLINGQTLISTSQGFELGFFTPGNSRNWYVGIWYKNIPRTYV 77
Query: 75 WVANRNCPILDPHGILAINNNGNLVLLNQANGTIWSSNMSKEAKSPVAQLLDTGNLVLRE 134
WVANR+ P+ + G I N ++ L + A +WSSN + A++PV QLLD+GNLVL+E
Sbjct: 78 WVANRDKPLSNSSGTFKIFNQ-SIALFDLAGKVVWSSNQTN-ARNPVMQLLDSGNLVLKE 135
Query: 135 NFSNNTSEGSYLWQSFDFPSDTLLPGMKVGWDLKTGRERYLTSWRTADDPSPGKFTYRLD 194
S + G +LWQSFD+P+DTLLP MK+GWDL TG +RYL+SW++++DP G F+++L+
Sbjct: 136 QVSES---GQFLWQSFDYPTDTLLPDMKLGWDLNTGLDRYLSSWKSSEDPGTGDFSFKLE 192
Query: 195 IHVLPQIFLYKGSLKLARIGPWNGFIFEDGPTF--IDYLYKIILVDTEDEIYYRYESYNN 252
H P++FL+K + R GPWNG F P +DYL + +DE+YY +
Sbjct: 193 YHGFPEVFLWKDNEIEYRSGPWNGQRFSGVPEMKPVDYL-SFNFITEQDEVYYSFHIATK 251
Query: 253 LSIMMLKINPLGKIQRLLWNEGSSGWQVMFSAPGDVCQNYGHCGANSICNVDNPPKCECL 312
L + G +QR W + W + AP D C NY CGA IC+ + P C+CL
Sbjct: 252 NLYSRLTVTSSGLLQRFAWIPETQQWNKFWYAPKDQCDNYKECGAYGICDSNASPVCKCL 311
Query: 313 KGFKPNSQHNQTW-----ATTCVRSHLSDCKTANQFKRFDDMKVPDLLDVSLNEGMNLEE 367
KGF+P +++Q W + CVR +C ++F +MK+P ++ M+L+
Sbjct: 312 KGFQP--KNHQAWDLRDGSGGCVRKTNLEC-LKDKFLHMKNMKLPQSTTSFVDRSMSLKN 368
Query: 368 CGAECLNNCTCRAYAYFNLTRGGSGCLMWFGDLIDMRKTLANLTGQSIYLRVPASEPGKK 427
C C NC+C AYA N++ GGSGC++W G+L D+R+ GQ +Y+R+ AS+ G
Sbjct: 369 CELLCSRNCSCTAYANSNISNGGSGCVIWTGELFDLRQYPEG--GQDLYVRLAASDIGDG 426
Query: 428 RPL-WIVVLAALPVAILPAFLI---FYRRKKKLK-----EKERRTEASQDMLLFEINMGN 478
I++ A+ + IL L ++RK+ L +++ E SQD+LL E+ +
Sbjct: 427 GSADTIIICIAVGIGILILSLTGFSIWKRKRLLSVCNGTQQKGPQERSQDLLLNEVVIN- 485
Query: 479 MSRAKEFCEGDSAGTGKSKESWFLFFSLSSISAATDNFSEENKLGEGGFGPVYKSIERYV 538
+ D +G + E F S+I+AAT NF +ENKLGEGGFG V+K
Sbjct: 486 --------KKDYSGEKSTDELELPLFDFSTIAAATGNFCDENKLGEGGFGCVHK------ 531
Query: 539 EICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEK 598
G+L+ G+EVAVKRLS KSGQG EEFKNE+ LIA+LQHRNLVRL GCCIE EK
Sbjct: 532 -------GRLVEGQEVAVKRLSKKSGQGTEEFKNEVRLIARLQHRNLVRLLGCCIEMDEK 584
Query: 599 ISIYEF-------DIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKAS 651
I IYEF ++ + A+ LL+W R II G A+GLLYLHQ SR R+IHRDLKAS
Sbjct: 585 ILIYEFMENRSLDSVLFNKAKSSLLNWQRRFNIICGTARGLLYLHQDSRFRIIHRDLKAS 644
Query: 652 NVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFG 711
N+LLD + PKISDFG+AR FGGD+ Q+NT RIVGTYGYMSPEYA+ GLFS+KSDVFSFG
Sbjct: 645 NILLDGEWTPKISDFGMARIFGGDQTQANTRRIVGTYGYMSPEYAMDGLFSVKSDVFSFG 704
Query: 712 VLLLEILSSKKNTRFYNTDS-LTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKV 770
VL+LEI+ +KN FY+++S L LLG+ W WKD +++D ++ + S V R I+V
Sbjct: 705 VLVLEIVCGEKNRGFYHSNSELNLLGNVWRQWKDGNGLEVLDISVGSSYSPSEVLRCIQV 764
Query: 771 ALLCVQENATDRPTMLEVVAMLKDEIVNLPSPHQPAFSYVQIVERSVLLANINAEASLGN 830
LLCVQE A DRPTM V ML E ++P P P + + + ++ E+ N
Sbjct: 765 GLLCVQERAEDRPTMASAVLMLSSETASMPQPKTPGYCLGRSPFETDSSSSKQDESFTVN 824
Query: 831 CLTLSVVDAR 840
+T++V+DAR
Sbjct: 825 QVTVTVLDAR 834
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493740|ref|XP_002280379.2| PREDICTED: uncharacterized protein LOC100262430 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 697 bits (1798), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 392/878 (44%), Positives = 524/878 (59%), Gaps = 99/878 (11%)
Query: 19 LQFSLAADSITPATFIRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKK-SPDTVVWVA 77
L+ S+A D++T I DGE + S FELGFFSP +S+NRY+G+WYKK + TVVWVA
Sbjct: 14 LRVSIAVDTLTVNQIITDGETITSAGGSFELGFFSPDSSRNRYVGIWYKKVATRTVVWVA 73
Query: 78 NRNCPILDPHGILAINNNGNLVLLNQANGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFS 137
NR P+ GIL + + G LV+LN N TIWSSN S+ A++P AQLLD+GNLV++
Sbjct: 74 NRQIPLTASSGILKVTDRGTLVILNGTNTTIWSSNSSRPAQNPNAQLLDSGNLVMKN--G 131
Query: 138 NNTSEGSYLWQSFDFPSDTLLPGMKVGWDLKTGRERYLTSWRTADDPSPGKFTYRLDIHV 197
N++ ++LWQSFD+P +TLLPGMK G + TG +RYL+SW+T DDPS G FTYRLD
Sbjct: 132 NDSDSENFLWQSFDYPCNTLLPGMKFGRNRVTGLDRYLSSWKTTDDPSIGNFTYRLDPGG 191
Query: 198 LPQIFLYKGSLKLARIGPWNGFIFEDGPTF-IDYLYKIILVDTEDEIYYRYESYNNLSIM 256
PQ+ + GS R GPWNG F P + +Y + + E YY +E N+ I
Sbjct: 192 SPQLLVRNGSTVTFRSGPWNGLRFSGFPQLRPNSVYSYAFIFNDKETYYTFELVNSSVIT 251
Query: 257 MLKINPLGKIQRLLWNEGSSGWQVMFSAPGDVCQNYGHCGANSICNVDNPPKCECLKGFK 316
L ++P G QR W + +S W + SA D C +Y CG IC ++ PKCEC+KGF+
Sbjct: 252 RLVLSPEGYAQRFTWIDRTSDWILYSSAQTDDCDSYALCGVYGICEINRSPKCECMKGFE 311
Query: 317 PNSQHN---QTWATTCVRSHLSDCKTANQFKRFDDMKVPDLLDVSLNEGMNLEECGAECL 373
P Q N W+ CVRS C+ +N F ++ +K+PD + NE MNL+EC + CL
Sbjct: 312 PKFQSNWDMADWSDGCVRSTPMVCQKSNGFLKYSGVKLPDTRNSWFNESMNLKECASLCL 371
Query: 374 NNCTCRAYAYFNLTRGGSGCLMWFGDLIDMRKTLANLTGQSIYLRVPASE---------- 423
NC+C AY ++ GGSGCL+WFGDLID+R+ N GQ Y+R+ SE
Sbjct: 372 GNCSCTAYTNSDIRGGGSGCLLWFGDLIDIREYTEN--GQDFYIRMAKSELGMSLSVPYL 429
Query: 424 ---------------------------PGKKRPLWIVVLAALPVAILPAFLI---FYRRK 453
G KR W++V V I+ L+ + RK
Sbjct: 430 RIINSVQVFNDKYCTCVYAFAMTNSGSKGAKRK-WVIVSTVSIVGIILLSLVLTLYVLRK 488
Query: 454 KKLKEKERRTEASQDMLLFEINMGNMSRAKEFCEGDSAGTGKSKESWFL-FFSLSSISAA 512
K+L+ K GN +K C+G A + +E L F L +I A
Sbjct: 489 KRLRRK-----------------GNNLYSKHNCKG--AEINEREEDLELPLFDLDTILNA 529
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN 572
TDNFS +NKLGEGGFGPVYK G L +G+E+AVKRLS +S QGL+EFKN
Sbjct: 530 TDNFSNDNKLGEGGFGPVYK-------------GMLQDGKEIAVKRLSKESRQGLDEFKN 576
Query: 573 EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFD-------IVTDPARKDLLDWTTRVRII 625
E+ I+KLQHRNLV+L GCCI EK+ IYE+ + D + +LDW R II
Sbjct: 577 EVTHISKLQHRNLVKLLGCCIHGEEKMLIYEYMPNKSLDFFIFDGMQSLVLDWPKRFVII 636
Query: 626 EGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIV 685
G+A+GLLYLHQ SRLR+IHRDLKA NVLLD++MNP+ISDFG+AR+F G+E ++ T R+V
Sbjct: 637 NGIARGLLYLHQDSRLRIIHRDLKADNVLLDNEMNPRISDFGMARSFRGNESEARTKRVV 696
Query: 686 GTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTD-SLTLLGHAWNLWKD 744
GTYGYMSPEYA+ G++SIKSDVFSFGVL+LEI++ K+N F + D +L LLGHAW L+ +
Sbjct: 697 GTYGYMSPEYAIDGVYSIKSDVFSFGVLVLEIVTGKRNRGFNHPDHALNLLGHAWTLYME 756
Query: 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSPHQ 804
K +L+D +M + S V R + V LLCVQ + DRP+M VV ML E L P +
Sbjct: 757 GKPLELIDASMGDSCNQSEVLRALNVGLLCVQRSPDDRPSMSSVVLMLSSESA-LHQPKE 815
Query: 805 PAFSYVQIVERSVLLANINAEASL---GNCLTLSVVDA 839
P F ER++L + +A GN T+++++
Sbjct: 816 PGF----FTERNMLEGSSSASKHAIFSGNEHTITLIEV 849
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 840 | ||||||
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.490 | 0.526 | 0.423 | 3.1e-179 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.371 | 0.367 | 0.528 | 7e-169 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.371 | 0.368 | 0.528 | 6.3e-168 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.370 | 0.368 | 0.527 | 1.5e-166 | |
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.335 | 0.346 | 0.570 | 2.3e-157 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.338 | 0.334 | 0.549 | 5.7e-152 | |
| TAIR|locus:2197729 | 805 | SD1-29 "S-domain-1 29" [Arabid | 0.373 | 0.390 | 0.522 | 6.6e-149 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.338 | 0.337 | 0.532 | 2.9e-148 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.336 | 0.340 | 0.539 | 1.6e-145 | |
| TAIR|locus:2200888 | 804 | AT1G61500 [Arabidopsis thalian | 0.338 | 0.353 | 0.552 | 3e-144 |
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 912 (326.1 bits), Expect = 3.1e-179, Sum P(2) = 3.1e-179
Identities = 183/432 (42%), Positives = 255/432 (59%)
Query: 3 NLSSFYIISYLTSLLALQFSLAADSITPATFIRDGEKLVSPSQRFELGFFSPGNSKNRYL 62
N+ IIS +++L Q A D + ++DG+ +VS FE+GFFSPG S+NRYL
Sbjct: 5 NVLHLLIISLFSTILLAQ---ATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRYL 61
Query: 63 GVWYKK-SPDTVVWVANRNCPILDPHGILAINNNGNLVLLNQANGTIWSSNMSKEA---- 117
G+WYKK S TVVWVANR+ P+ D G L ++ NG+L L N N IWSS+ S +
Sbjct: 62 GIWYKKISLQTVVWVANRDSPLYDLSGTLKVSENGSLCLFNDRNHIIWSSSSSPSSQKAS 121
Query: 118 -KSPVAQLLDTGNLVLRENFSNNTSEGSYLWQSFDFPSDTLLPGMKVGWDLKTGRERYLT 176
++P+ Q+LDTGNLV+R N+ + Y+WQS D+P D LPGMK G + TG R+LT
Sbjct: 122 LRNPIVQILDTGNLVVR----NSGDDQDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLT 177
Query: 177 SWRTADDPSPGKFTYRLDIHVLPQIFLYKGSLKLARIGPWNGFIFEDGPTFI-DYLYKII 235
SWR DDPS G +T ++D + +PQ FL K S+ + R GPWNG F P + +Y+
Sbjct: 178 SWRAIDDPSTGNYTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRYE 237
Query: 236 LVDTEDEIYYRYESYNNLSIMMLKINPLGKIQRLLWNEGSSGWQVMFSAPGDVCQNYGHC 295
V TE+E+YY Y+ N + +++NP G +QR W + W SA D C Y C
Sbjct: 238 YVFTEEEVYYTYKLENPSVLTRMQLNPNGALQRYTWVDNLQSWNFYLSAMMDSCDQYTLC 297
Query: 296 GANSICNVDNPPKCECLKGF---KPNSQHNQTWATTCVRSHLSDC-KTANQFKRFDDMKV 351
G+ CN++ P C CLKGF P + W+ CVR DC K + F + +K+
Sbjct: 298 GSYGSCNINESPACRCLKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKL 357
Query: 352 PDLLDVSLNEGMNLEECGAECLNNCTCRAYAYFNLTRGGSGCLMWFGDLIDMRKTLANLT 411
PD ++ M+L EC CL NCTC AY+ F++ GG GC++WFGDLID+R+ N
Sbjct: 358 PDTRTSWYDKNMDLNECKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIREY--NEN 415
Query: 412 GQSIYLRVPASE 423
GQ +Y+R+ +SE
Sbjct: 416 GQDLYVRLASSE 427
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 842 (301.5 bits), Expect = 7.0e-169, Sum P(2) = 7.0e-169
Identities = 183/346 (52%), Positives = 236/346 (68%)
Query: 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFK 571
AT+NFS NKLG+GGFG VYK GKLL+G+E+AVKRLS S QG +EFK
Sbjct: 522 ATNNFSNANKLGQGGFGIVYK-------------GKLLDGQEMAVKRLSKTSVQGTDEFK 568
Query: 572 NEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF------DI-VTDPARKDLLDWTTRVRI 624
NE+ LIA+LQH NLVRL CC++ GEK+ IYE+ D + D +R L+W R I
Sbjct: 569 NEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQMRFDI 628
Query: 625 IEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRI 684
I G+A+GLLYLHQ SR R+IHRDLKASN+LLD M PKISDFG+AR FG DE ++NT ++
Sbjct: 629 INGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETEANTRKV 688
Query: 685 VGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTD-SLTLLGHAWNLWK 743
VGTYGYMSPEYA+ G+FS+KSDVFSFGVLLLEI+SSK+N FYN+D L LLG W WK
Sbjct: 689 VGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLLGCVWRNWK 748
Query: 744 DDKAWKLMDPTM-QNEALYSM--VTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLP 800
+ K +++DP + + + + + R I++ LLCVQE A DRPTM V+ ML E +P
Sbjct: 749 EGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVILMLGSESTTIP 808
Query: 801 SPHQPAFSYVQIVERSVLLANINA------EASLGNCLTLSVVDAR 840
P P + +ERS+L + ++ E+ N +T+SV+DAR
Sbjct: 809 QPKAPGYC----LERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 839 (300.4 bits), Expect = 6.3e-168, Sum P(2) = 6.3e-168
Identities = 183/346 (52%), Positives = 232/346 (67%)
Query: 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFK 571
AT+NFS +NKLG+GGFG VYK G LL+G+E+AVKRLS S QG +EF
Sbjct: 519 ATNNFSTDNKLGQGGFGIVYK-------------GMLLDGKEIAVKRLSKMSSQGTDEFM 565
Query: 572 NEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF------DI-VTDPARKDLLDWTTRVRI 624
NE+ LIAKLQH NLVRL GCC+++GEK+ IYE+ D + D R L+W R I
Sbjct: 566 NEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDI 625
Query: 625 IEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRI 684
I G+A+GLLYLHQ SR R+IHRDLKASNVLLD +M PKISDFG+AR FG +E ++NT R+
Sbjct: 626 INGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRV 685
Query: 685 VGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTD-SLTLLGHAWNLWK 743
VGTYGYMSPEYA+ G+FS+KSDVFSFGVLLLEI+S K+N FYN++ L LLG W WK
Sbjct: 686 VGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWK 745
Query: 744 DDKAWKLMDP----TMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNL 799
+ K +++DP + +E + R I++ LLCVQE A DRP M V+ ML E +
Sbjct: 746 EGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAI 805
Query: 800 PSPHQPAFSYVQIVERSVLLANINAEASLGN-C----LTLSVVDAR 840
P P +P F V RS L + ++ + C +TLSV+DAR
Sbjct: 806 PQPKRPGFC----VGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 839 (300.4 bits), Expect = 1.5e-166, Sum P(2) = 1.5e-166
Identities = 183/347 (52%), Positives = 235/347 (67%)
Query: 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFK 571
AT+NFS +NKLG+GGFG VYK G+LL+G+E+AVKRLS S QG +EF
Sbjct: 515 ATNNFSNDNKLGQGGFGIVYK-------------GRLLDGKEIAVKRLSKMSSQGTDEFM 561
Query: 572 NEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF------DI-VTDPARKDLLDWTTRVRI 624
NE+ LIAKLQH NLVRL GCC+++GEK+ IYE+ D + D R L+W R I
Sbjct: 562 NEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDI 621
Query: 625 IEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRI 684
I G+A+GLLYLHQ SR R+IHRDLKASNVLLD +M PKISDFG+AR FG +E ++NT R+
Sbjct: 622 INGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRV 681
Query: 685 VGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTD-SLTLLGHAWNLWK 743
VGTYGYMSPEYA+ G+FS+KSDVFSFGVLLLEI+S K+N FYN++ L LLG W WK
Sbjct: 682 VGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWK 741
Query: 744 DDKAWKLMDPTMQNEALYSM-----VTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVN 798
+ +++DP + ++L S + R I++ LLCVQE A DRP M V+ ML E
Sbjct: 742 EGNELEIVDP-INIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTA 800
Query: 799 LPSPHQPAFSYVQIVERSVLLANINAEASLGN-C----LTLSVVDAR 840
+P P +P F + RS L A+ ++ + C +TLSV+DAR
Sbjct: 801 IPQPKRPGFC----IGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843
|
|
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 834 (298.6 bits), Expect = 2.3e-157, Sum P(2) = 2.3e-157
Identities = 174/305 (57%), Positives = 216/305 (70%)
Query: 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFK 571
ATD+FS N LG GGFGPVYK GKL +G+E+AVKRLS+ SGQG+EEFK
Sbjct: 496 ATDDFSYVNFLGRGGFGPVYK-------------GKLEDGQEIAVKRLSANSGQGVEEFK 542
Query: 572 NEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF------DI-VTDPARKDLLDWTTRVRI 624
NE+ LIAKLQHRNLVRL GCCI+ E + IYE+ D + D R LDW R+ I
Sbjct: 543 NEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELDWKKRMNI 602
Query: 625 IEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRI 684
I GVA+G+LYLHQ SRLR+IHRDLKA NVLLD+DMNPKISDFG+A++FGGD+ +S+TNR+
Sbjct: 603 INGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSESSTNRV 662
Query: 685 VGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTD-SLTLLGHAWNLWK 743
VGTYGYM PEYA+ G FS+KSDVFSFGVL+LEI++ K N F + D L LLGH W +W
Sbjct: 663 VGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRHADHDLNLLGHVWKMWV 722
Query: 744 DDKAWKLMDPT-MQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSP 802
+D+ ++ + ++ ++ V R I VALLCVQ+ DRPTM VV M + +LP P
Sbjct: 723 EDREIEVPEEEWLEETSVIPEVLRCIHVALLCVQQKPEDRPTMASVVLMFGSDS-SLPHP 781
Query: 803 HQPAF 807
QP F
Sbjct: 782 TQPGF 786
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 837 (299.7 bits), Expect = 5.7e-152, Sum P(2) = 5.7e-152
Identities = 167/304 (54%), Positives = 223/304 (73%)
Query: 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFK 571
AT++F +EN+LG GGFGPVYK G L +G E+AVKRLS KSGQG++EFK
Sbjct: 525 ATNDFCKENELGRGGFGPVYK-------------GVLEDGREIAVKRLSGKSGQGVDEFK 571
Query: 572 NEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF------DI-VTDPARKDLLDWTTRVRI 624
NE++LIAKLQHRNLVRL GCC E EK+ +YE+ D + D ++ L+DW R I
Sbjct: 572 NEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSI 631
Query: 625 IEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRI 684
IEG+A+GLLYLH+ SRLR+IHRDLK SNVLLD++MNPKISDFG+AR FGG++ ++NT R+
Sbjct: 632 IEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRV 691
Query: 685 VGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD 744
VGTYGYMSPEYA+ GLFS+KSDV+SFGVLLLEI+S K+NT +++ +L+G+AW L+
Sbjct: 692 VGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHGSLIGYAWYLYTH 751
Query: 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSPHQ 804
++ +L+DP ++ R I VA+LCVQ++A +RP M V+ ML+ + L +P Q
Sbjct: 752 GRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESDTATLAAPRQ 811
Query: 805 PAFS 808
P F+
Sbjct: 812 PTFT 815
|
|
| TAIR|locus:2197729 SD1-29 "S-domain-1 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 810 (290.2 bits), Expect = 6.6e-149, Sum P(2) = 6.6e-149
Identities = 176/337 (52%), Positives = 224/337 (66%)
Query: 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFK 571
AT+NFS NKLG+GGFGPVYK GKL++G+E+ VKRL+S SGQG EEF
Sbjct: 484 ATNNFSPSNKLGQGGFGPVYK-------------GKLVDGKEIGVKRLASSSGQGTEEFM 530
Query: 572 NEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF------DI-VTDPARKDLLDWTTRVRI 624
NE+ LI+KLQHRNLVRL G CI+ EK+ IYEF DI + DP K LDW R I
Sbjct: 531 NEITLISKLQHRNLVRLLGYCIDGEEKLLIYEFMVNKSLDIFIFDPCLKFELDWPKRFNI 590
Query: 625 IEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRI 684
I+G+A+GLLYLH+ SRLRVIHRDLK SN+LLD MNPKISDFG+AR F G + Q NT R+
Sbjct: 591 IQGIARGLLYLHRDSRLRVIHRDLKVSNILLDDRMNPKISDFGLARMFQGTQYQDNTRRV 650
Query: 685 VGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRF-YNTDSLTLLGHAWNLWK 743
VGT GYMSPEYA GLFS KSD++SFGVL+LEI+S K+ +RF Y +S LL + W+ W
Sbjct: 651 VGTLGYMSPEYAWAGLFSEKSDIYSFGVLMLEIISGKRISRFIYGDESKGLLAYTWDSWC 710
Query: 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSPH 803
+ L+D + + V R +++ LLCVQ A DRP L+V++ML +LP P
Sbjct: 711 ETGGSNLLDRDLTDTCQAFEVARCVQIGLLCVQHEAVDRPNTLQVLSMLTSA-TDLPVPK 769
Query: 804 QPAFSYVQIVERSVLLANINAEASLGNCLTLSVVDAR 840
QP F+ + + +L AN S+ N +T S++ R
Sbjct: 770 QPIFAVHTLNDMPMLQANSQDFLSV-NEMTESMIQGR 805
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 809 (289.8 bits), Expect = 2.9e-148, Sum P(2) = 2.9e-148
Identities = 162/304 (53%), Positives = 216/304 (71%)
Query: 511 AATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEF 570
+AT +F+EENKLG+GGFG VYK N+ +G+ E+AVKRLS KS QGLEEF
Sbjct: 520 SATGDFAEENKLGQGGFGTVYKG--------NFSEGR-----EIAVKRLSGKSKQGLEEF 566
Query: 571 KNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF------D-IVTDPARKDLLDWTTRVR 623
KNE++LIAKLQHRNLVRL GCCIE EK+ +YE+ D + D +++ LDW R
Sbjct: 567 KNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLDWRKRWE 626
Query: 624 IIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNR 683
+I G+A+GLLYLH+ SRL++IHRDLKASN+LLD++MNPKISDFG+AR F + +NT R
Sbjct: 627 VIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDHANTIR 686
Query: 684 IVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWK 743
+VGTYGYM+PEYA+ G+FS KSDV+SFGVL+LEI+S +KN F TD +L+G+AW+LW
Sbjct: 687 VVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTDHGSLIGYAWHLWS 746
Query: 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSPH 803
K +++DP +++ + R I V +LC Q++ RP M V+ ML+ + LP P
Sbjct: 747 QGKTKEMIDPIVKDTRDVTEAMRCIHVGMLCTQDSVIHRPNMGSVLLMLESQTSQLPPPR 806
Query: 804 QPAF 807
QP F
Sbjct: 807 QPTF 810
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 803 (287.7 bits), Expect = 1.6e-145, Sum P(2) = 1.6e-145
Identities = 164/304 (53%), Positives = 215/304 (70%)
Query: 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFK 571
AT+NFS NKLG+GGFG VYK G+L G ++AVKRLS SGQG+EEF
Sbjct: 508 ATNNFSITNKLGQGGFGAVYK-------------GRLQEGLDIAVKRLSRTSGQGVEEFV 554
Query: 572 NEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF------DI-VTDPARKDLLDWTTRVRI 624
NE+++I+KLQHRNLVRL G CIE E++ +YEF D + DP ++ LLDW TR I
Sbjct: 555 NEVVVISKLQHRNLVRLLGFCIEGEERMLVYEFMPENCLDAYLFDPVKQRLLDWKTRFNI 614
Query: 625 IEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRI 684
I+G+ +GL+YLH+ SRL++IHRDLKASN+LLD ++NPKISDFG+AR F G+E + +T R+
Sbjct: 615 IDGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFQGNEDEVSTVRV 674
Query: 685 VGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNT-DSLTLLGHAWNLWK 743
VGTYGYM+PEYA+ GLFS KSDVFS GV+LLEI+S ++N+ FYN + L +AW LW
Sbjct: 675 VGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIVSGRRNSSFYNDGQNPNLSAYAWKLWN 734
Query: 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSPH 803
+ L+DP + E + + R + V LLCVQ++A DRP++ V+ ML E NLP P
Sbjct: 735 TGEDIALVDPVIFEECFENEIRRCVHVGLLCVQDHANDRPSVATVIWMLSSENSNLPEPK 794
Query: 804 QPAF 807
QPAF
Sbjct: 795 QPAF 798
|
|
| TAIR|locus:2200888 AT1G61500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 803 (287.7 bits), Expect = 3.0e-144, Sum P(2) = 3.0e-144
Identities = 169/306 (55%), Positives = 211/306 (68%)
Query: 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFK 571
AT+NFS NKLG+GGFG VYK GKL +G+E+AVKRLSS SGQG EEF
Sbjct: 487 ATNNFSLSNKLGQGGFGSVYK-------------GKLQDGKEIAVKRLSSSSGQGKEEFM 533
Query: 572 NEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF------DIVTDPARKDL-LDWTTRVRI 624
NE++LI+KLQHRNLVR+ GCCIE+ EK+ IYEF D +RK L +DW R I
Sbjct: 534 NEIVLISKLQHRNLVRVLGCCIEEEEKLLIYEFMVNKSLDTFLFDSRKRLEIDWPKRFDI 593
Query: 625 IEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRI 684
I+G+A+GLLYLH SRLRVIHRDLK SN+LLD MNPKISDFG+AR + G E Q NT R+
Sbjct: 594 IQGIARGLLYLHHDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRV 653
Query: 685 VGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRF-YNTDSLTLLGHAWNLWK 743
VGT GYMSPEYA G+FS KSD++SFGVL+LEI+S +K +RF Y + TL+ +AW W
Sbjct: 654 VGTLGYMSPEYAWTGMFSEKSDIYSFGVLMLEIISGEKISRFSYGVEGKTLIAYAWESWS 713
Query: 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSPH 803
+ + L+D + + V R I++ LLCVQ DRP LE++AML +LPSP
Sbjct: 714 EYRGIDLLDQDLADSCHPLEVGRCIQIGLLCVQHQPADRPNTLELLAMLTTTS-DLPSPK 772
Query: 804 QPAFSY 809
QP F++
Sbjct: 773 QPTFAF 778
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O81832 | Y4729_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4274 | 0.9 | 0.9655 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 840 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-46 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-46 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-44 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-42 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-42 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-39 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-39 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 1e-38 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 4e-36 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 6e-33 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-32 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-30 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-30 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 6e-29 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-28 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-28 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-27 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-27 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-27 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-26 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-26 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-25 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-25 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-25 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-25 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-24 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-24 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-24 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 9e-24 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-23 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 5e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-22 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-22 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-22 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-22 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-22 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-22 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-21 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-21 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-21 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-21 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 9e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-20 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-20 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-20 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-20 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 1e-19 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-19 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-19 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-19 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-19 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 9e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-19 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-18 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-18 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-18 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-17 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-17 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-17 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-17 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-17 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-17 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-17 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-16 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-16 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-16 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-16 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-16 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-16 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 9e-16 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-15 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-15 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-15 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-15 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-15 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-15 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-15 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-15 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-15 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-14 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-14 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-14 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-14 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-13 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-13 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-13 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-12 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-12 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 7e-12 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 8e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-10 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-10 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 3e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-09 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-09 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 9e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-08 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 9e-08 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-07 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-07 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-07 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 8e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 9e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 9e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 7e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.001 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 0.002 | |
| cd01328 | 86 | cd01328, FSL_SPARC, Follistatin-like SPARC (secret | 0.002 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.002 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 0.004 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 1e-46
Identities = 90/289 (31%), Positives = 123/289 (42%), Gaps = 49/289 (16%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRL-SSKSGQGLEEFKNEMMLI 577
KLGEG FG VYK K EVAVK L S Q +EEF E ++
Sbjct: 4 GKKLGEGAFGEVYKGT--------LKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIM 55
Query: 578 AKLQHRNLVRLFGCCIEQGEKISIYEF-------DIVTDPARKDLLDWTTRVRIIEGVAQ 630
KL H N+V+L G C E+ + + E+ D + R L + + +A+
Sbjct: 56 RKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKN-RPKELSLSDLLSFALQIAR 114
Query: 631 GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGY 690
G+ YL IHRDL A N L+ ++ KISDFG++R D+ + +
Sbjct: 115 GMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL-PIRW 170
Query: 691 MSPEYALHGLFSIKSDVFSFGVLLLEILS-------SKKNTRFYNTDSLTLLGHAWNLWK 743
M+PE G F+ KSDV+SFGVLL EI + N
Sbjct: 171 MAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLE--------------Y 216
Query: 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAML 792
K ++L P LY K+ L C E+ DRPT E+V +L
Sbjct: 217 LKKGYRLPKPPNCPPELY-------KLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 4e-46
Identities = 87/295 (29%), Positives = 123/295 (41%), Gaps = 62/295 (21%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRL-SSKSGQGLEEFKNEMMLI 577
KLGEG FG VYK K EVAVK L S Q +EEF E ++
Sbjct: 4 GKKLGEGAFGEVYKGK--------LKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIM 55
Query: 578 AKLQHRNLVRLFGCCIEQGEKISIYEF-------DIVTDPARKDLLDWTTRVRIIEGVAQ 630
KL H N+V+L G C E+ + E+ + + L + + +A+
Sbjct: 56 RKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRK--NRPKLSLSDLLSFALQIAR 113
Query: 631 GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGY 690
G+ YL IHRDL A N L+ ++ KISDFG++R D+ + +
Sbjct: 114 GMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL-PIRW 169
Query: 691 MSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKL 750
M+PE G F+ KSDV+SFGVLL EI + LG ++ +
Sbjct: 170 MAPESLKEGKFTSKSDVWSFGVLLWEIFT---------------LG--------EQPY-- 204
Query: 751 MDPTMQNEALYSMVTRY-------------IKVALLCVQENATDRPTMLEVVAML 792
P M NE + + + L C E+ DRPT E+V +L
Sbjct: 205 --PGMSNEEVLEYLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 1e-44
Identities = 90/289 (31%), Positives = 130/289 (44%), Gaps = 42/289 (14%)
Query: 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRL-SSKSGQGLEEFKNEMMLIA 578
KLGEG FG VYK K GK EVAVK L S + ++F E ++
Sbjct: 1 KKLGEGAFGEVYK--------GKLK-GKDGKTTEVAVKTLKEDASEEERKDFLKEARVMK 51
Query: 579 KLQHRNLVRLFGCCIEQGEKISIYEF-------------DIVTDPARKDLLDWTTRVRII 625
KL H N+VRL G C E+ + E+ V K L +
Sbjct: 52 KLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFA 111
Query: 626 EGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIAR-TFGGDEMQSNTNRI 684
+A+G+ YL + +HRDL A N L+ D+ KISDFG++R + D + T
Sbjct: 112 IQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGK 168
Query: 685 VGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD 744
+ +M+PE G+F+ KSDV+SFGVLL EI + T + + +L + +
Sbjct: 169 LPIR-WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGA-TPYPGLSNEEVLEYL----RK 222
Query: 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLK 793
+L P + LY ++ L C Q + DRPT E+V L+
Sbjct: 223 GY--RLPKPEYCPDELY-------ELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 2e-42
Identities = 74/206 (35%), Positives = 110/206 (53%), Gaps = 29/206 (14%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLS-SKSGQGLEEFKNEMMLIAKL 580
LGEGGFG VY K+ G++VA+K + S LEE E+ ++ KL
Sbjct: 1 LGEGGFGTVYL--------ARDKK----TGKKVAIKIIKKEDSSSLLEELLREIEILKKL 48
Query: 581 QHRNLVRLFGCCIEQGEKISIYEF-------DIVTDPARKDLLDWTTRVRIIEGVAQGLL 633
H N+V+L+G ++ + E+ D++ + K L +RI+ + +GL
Sbjct: 49 NHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLE 106
Query: 634 YLHQYSRLRVIHRDLKASNVLLDSD-MNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMS 692
YLH +IHRDLK N+LLDSD K++DFG+++ D+ T IVGT YM+
Sbjct: 107 YLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMA 161
Query: 693 PEYALH-GLFSIKSDVFSFGVLLLEI 717
PE L G +S KSD++S GV+L E+
Sbjct: 162 PEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 3e-42
Identities = 83/292 (28%), Positives = 122/292 (41%), Gaps = 59/292 (20%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAK 579
KLGEG FG VYK K +VAVK L + + EEF E ++ K
Sbjct: 6 KLGEGAFGEVYK--------GTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKK 57
Query: 580 LQHRNLVRLFGCCIEQGEKISIYEF----DIVTD-PARKDLLDWTTRVRIIEGVAQGLLY 634
L H N+VRL G C + + E+ D++ + L +++ +A+G+ Y
Sbjct: 58 LSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEY 117
Query: 635 LHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIART-FGGDEMQSNTNRIVGTYGYMSP 693
L +HRDL A N L+ ++ KISDFG++R + D + + +M+P
Sbjct: 118 LE---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKL-PIKWMAP 173
Query: 694 EYALHGLFSIKSDVFSFGVLLLEILS-------SKKNTRFYNTDSLTLLGHAWNLWKDDK 746
E G F+ KSDV+SFGVLL EI + N
Sbjct: 174 ESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLE------------------ 215
Query: 747 AWKLMD----PTMQN--EALYSMVTRYIKVALLCVQENATDRPTMLEVVAML 792
L D P +N + LY ++ + C + DRPT E+V L
Sbjct: 216 --LLEDGYRLPRPENCPDELYELMLQ-------CWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 146 bits (372), Expect = 1e-39
Identities = 79/287 (27%), Positives = 122/287 (42%), Gaps = 47/287 (16%)
Query: 516 FSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLS-SKSGQGLEEFKNEM 574
+ KLGEG FG VY + ++ G+ VA+K + K + E E+
Sbjct: 1 YEILEKLGEGSFGKVYLARDK------------KTGKLVAIKVIKKKKIKKDRERILREI 48
Query: 575 MLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK-DLLDW-TTRVRIIEGVAQ-- 630
++ KL+H N+VRL+ ++ + +Y +V + DL D R R+ E A+
Sbjct: 49 KILKKLKHPNIVRLYDVFEDEDK---LY---LVMEYCEGGDLFDLLKKRGRLSEDEARFY 102
Query: 631 ------GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRI 684
L YLH ++HRDLK N+LLD D + K++DFG+AR E
Sbjct: 103 LRQILSALEYLHS---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTF 156
Query: 685 VGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD 744
VGT YM+PE L + D++S GV+L E+L+ K F D L L +
Sbjct: 157 VGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGK--PPFPGDDQLLEL---FKKIGK 211
Query: 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791
K + ++ + LL + R T E +
Sbjct: 212 PKPPFPPPEWDISPEAKDLIRK-----LLVK--DPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 7e-39
Identities = 69/222 (31%), Positives = 104/222 (46%), Gaps = 26/222 (11%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRL--SSKSGQGLEEFKNEMMLIA 578
KLG G FG VYK+ + G+ VAVK L S+ + + + E+ ++
Sbjct: 6 KLGSGSFGTVYKAKHKG------------TGKIVAVKILKKRSEKSKKDQTARREIRILR 53
Query: 579 KLQHRNLVRLFGCCIEQGEKISIYEF----DIVTDPARKDLLDWTTRVRIIEGVAQGLLY 634
+L H N+VRL ++ + E+ D+ +R L +I + +GL Y
Sbjct: 54 RLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEY 113
Query: 635 LHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPE 694
LH +IHRDLK N+LLD + KI+DFG+A+ S+ VGT YM+PE
Sbjct: 114 LH---SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKS--SSSLTTFVGTPWYMAPE 168
Query: 695 -YALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLL 735
+ K DV+S GV+L E+L+ F + L L
Sbjct: 169 VLLGGNGYGPKVDVWSLGVILYELLT--GKPPFSGENILDQL 208
|
Length = 260 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 1e-38
Identities = 56/116 (48%), Positives = 69/116 (59%), Gaps = 7/116 (6%)
Query: 70 PDTVVWVANRNCPILDPHGILAINNNGNLVLLNQANGTIWSSNMSKEAKSPVAQLLDTGN 129
TVVWVANR P+ D L + ++GNLVL + +WSSN S + VA L D GN
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGN 60
Query: 130 LVLRENFSNNTSEGSYLWQSFDFPSDTLLPGMKVGWDLKTGRERYLTSWRTADDPS 185
LVL +N G LWQSFD P+DTLLPG K G ++ G R LTSW++ DPS
Sbjct: 61 LVLYDN------SGKVLWQSFDHPTDTLLPGQKDG-NVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 4e-36
Identities = 50/120 (41%), Positives = 69/120 (57%), Gaps = 7/120 (5%)
Query: 34 IRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKKSPDTVVWVANRNCPILDPHGILAIN 93
+ G+ LVS FELGFF Y + YK S TVVWVANR+ P L +
Sbjct: 4 LSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNP-SGSSCTLTLQ 62
Query: 94 NNGNLVLLNQANGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSEGSYLWQSFDFP 153
++GNLV+ + + +WSSN ++ + V LLD GNLVL + S+G++LWQSFD+P
Sbjct: 63 SDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYD------SDGNFLWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 6e-33
Identities = 51/119 (42%), Positives = 71/119 (59%), Gaps = 8/119 (6%)
Query: 34 IRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKKSPDTVVWVANRNCPILDPHGILAIN 93
+ G+ LVS + FELGFF+ N Y + YK S TVVWVANR+ P+ D L +
Sbjct: 4 LSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSSRTVVWVANRDNPVSDS-CTLTLQ 61
Query: 94 NNGNLVLLNQANGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSEGSYLWQSFDF 152
++GNLVL + +WSSN + + V LLD GNLV+ + S+G++LWQSFD+
Sbjct: 62 SDGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYD------SDGNFLWQSFDY 114
|
Length = 114 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 4e-32
Identities = 61/219 (27%), Positives = 106/219 (48%), Gaps = 41/219 (18%)
Query: 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVK--RLSSKSGQGLEEFKNEMMLI 577
LG G FG VY ++++ GE +AVK LS S + LE + E+ ++
Sbjct: 6 ELLGRGSFGSVYLALDK------------DTGELMAVKSVELSGDSEEELEALEREIRIL 53
Query: 578 AKLQHRNLVRLFGCCIEQGEK-ISIY--------------EFDIVTDPARKDLLDWTTRV 622
+ LQH N+VR +G ++ + ++I+ +F + +P R
Sbjct: 54 SSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEP--------VIRK 105
Query: 623 RIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTN 682
+ + +GL YLH ++HRD+K +N+L+DSD K++DFG A+ G E T
Sbjct: 106 YTRQ-ILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTG 161
Query: 683 RIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSK 721
+ GT +M+PE + +D++S G ++E+ + K
Sbjct: 162 SVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 63/208 (30%), Positives = 108/208 (51%), Gaps = 27/208 (12%)
Query: 516 FSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMM 575
F K+G+GGFG VYK+ + G+EVA+K + +S + E+ NE+
Sbjct: 2 FEILEKIGKGGFGEVYKARHK------------RTGKEVAIKVIKLESKEKKEKIINEIQ 49
Query: 576 LIAKLQHRNLVRLFGCCIEQGEKISIYEF-------DIVTDPARKDLLDWTTRVRIIEGV 628
++ K +H N+V+ +G +++ E + EF D++ + L + + + +
Sbjct: 50 ILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLK--STNQTLTESQIAYVCKEL 107
Query: 629 AQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTY 688
+GL YLH +IHRD+KA+N+LL SD K+ DFG++ D NT +VGT
Sbjct: 108 LKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQL-SDTKARNT--MVGTP 161
Query: 689 GYMSPEYALHGLFSIKSDVFSFGVLLLE 716
+M+PE + K+D++S G+ +E
Sbjct: 162 YWMAPEVINGKPYDYKADIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 6e-30
Identities = 75/219 (34%), Positives = 110/219 (50%), Gaps = 42/219 (19%)
Query: 516 FSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMM 575
F+ E KLG G FG V+ +G N VA+K L S ++F+ E+
Sbjct: 8 FTLERKLGSGYFGEVW-------------EGLWKNRVRVAIKILKSDDLLKQQDFQKEVQ 54
Query: 576 LIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK-DLLDWTTRVRIIEG------- 627
+ +L+H++L+ LF C GE I+T+ K LL + +R EG
Sbjct: 55 ALKRLRHKHLISLFAVCSV-GEP-----VYIITELMEKGSLLAF---LRSPEGQVLPVAS 105
Query: 628 -------VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSN 680
VA+G+ YL + IHRDL A N+L+ D+ K++DFG+AR D S+
Sbjct: 106 LIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSS 162
Query: 681 TNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
+I Y + +PE A HG FS KSDV+SFG+LL E+ +
Sbjct: 163 DKKI--PYKWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 6e-29
Identities = 40/112 (35%), Positives = 53/112 (47%), Gaps = 7/112 (6%)
Query: 212 RIGPWNGFIF----EDGPTFIDYLYKIILVDTEDEIYYRYESYNNLSIMMLKINPLGKIQ 267
R GPWNG F E Y + +E+YY Y NN L ++ G ++
Sbjct: 2 RSGPWNGIRFSGIPEMQKL---SYYVYNFTENNEEVYYTYRMTNNSIYSRLTLSSEGSLE 58
Query: 268 RLLWNEGSSGWQVMFSAPGDVCQNYGHCGANSICNVDNPPKCECLKGFKPNS 319
R W S W + +SAP D C YG CG C+V+ PKC C+KGF P +
Sbjct: 59 RFTWIPNSQDWNLFWSAPKDQCDVYGRCGPYGYCDVNTSPKCNCIKGFVPKN 110
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 76/215 (35%), Positives = 103/215 (47%), Gaps = 44/215 (20%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQ-GLEEFKNEMMLI 577
E KLG G FG V+ G +VAVK L K G E F E ++
Sbjct: 11 ERKLGAGQFGEVWM-------------GTWNGTTKVAVKTL--KPGTMSPEAFLQEAQIM 55
Query: 578 AKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK-DLLDW-----------TTRVRII 625
KL+H LV+L+ C + E IY IVT+ K LLD+ V +
Sbjct: 56 KKLRHDKLVQLYAVC-SEEE--PIY---IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMA 109
Query: 626 EGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIV 685
+A+G+ YL IHRDL A N+L+ ++ KI+DFG+AR DE +
Sbjct: 110 AQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTARE---- 162
Query: 686 GT---YGYMSPEYALHGLFSIKSDVFSFGVLLLEI 717
G + +PE A +G F+IKSDV+SFG+LL EI
Sbjct: 163 GAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 65/212 (30%), Positives = 98/212 (46%), Gaps = 26/212 (12%)
Query: 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLS-SKSGQGLEEFKNEMMLIA 578
+LGEG FG V C + GE+VAVK L+ S Q +F+ E+ ++
Sbjct: 10 KQLGEGHFGKVEL--------CRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILR 61
Query: 579 KLQHRNLVRLFGCCIEQGEKIS--IYEF-------DIVTDPARKDLLDWTTRVRIIEGVA 629
L H N+V+ G C + G + I E+ D + +D ++ + +
Sbjct: 62 TLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQIC 119
Query: 630 QGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIAR--TFGGDEMQSNTNRIVGT 687
+G+ YL R IHRDL A N+L++S+ KISDFG+A+ D
Sbjct: 120 KGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI 176
Query: 688 YGYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
+ Y +PE FS SDV+SFGV L E+ +
Sbjct: 177 FWY-APECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAK 579
LG+G G VYK + G+ A+K++ + ++ E+ +
Sbjct: 8 VLGQGSSGVVYKVRHK------------PTGKIYALKKIHVDGDEEFRKQLLRELKTLRS 55
Query: 580 LQHRNLVRLFGCCIEQGEKISI-YEF-DIVT-DPARKDLLDWTTRV--RIIEGVAQGLLY 634
+ +V+ +G ++GE ISI E+ D + K + V I + +GL Y
Sbjct: 56 CESPYVVKCYGAFYKEGE-ISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDY 114
Query: 635 LHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPE 694
LH + +IHRD+K SN+L++S KI+DFGI++ + N VGT YMSPE
Sbjct: 115 LHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNTFVGTVTYMSPE 170
Query: 695 YALHGLFSIKSDVFSFGVLLLEILSSK 721
+S +D++S G+ LLE K
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 62/214 (28%), Positives = 105/214 (49%), Gaps = 29/214 (13%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN 572
+ + K+GEG G VYK+ +R G+EVA+K++ + Q E N
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDR------------ATGKEVAIKKMRLRK-QNKELIIN 64
Query: 573 EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTRVRIIEG----- 627
E++++ +H N+V + + E + E+ + + D++ VR+ E
Sbjct: 65 EILIMKDCKHPNIVDYYDSYLVGDELWVVMEY--MDGGSLTDIITQN-FVRMNEPQIAYV 121
Query: 628 ---VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRI 684
V QGL YLH VIHRD+K+ N+LL D + K++DFG A + +S N +
Sbjct: 122 CREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT--KEKSKRNSV 176
Query: 685 VGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEIL 718
VGT +M+PE + K D++S G++ +E+
Sbjct: 177 VGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 62/209 (29%), Positives = 106/209 (50%), Gaps = 28/209 (13%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKL 580
LG G FG VYK + W VA+K L ++ + +E +E ++A +
Sbjct: 15 LGSGAFGTVYKGV--------WIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV 66
Query: 581 QHRNLVRLFGCCI-EQGEKISIYE-----FDIVTDPA----RKDLLDWTTRVRIIEGVAQ 630
H ++VRL G C+ Q + I+ D V + + LL+W ++ A+
Sbjct: 67 DHPHVVRLLGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AK 120
Query: 631 GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGY 690
G+ YL + R++HRDL A NVL+ + + KI+DFG+A+ DE + + +
Sbjct: 121 GMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKW 177
Query: 691 MSPEYALHGLFSIKSDVFSFGVLLLEILS 719
M+ E LH +++ KSDV+S+GV + E+++
Sbjct: 178 MALESILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 8e-27
Identities = 64/219 (29%), Positives = 104/219 (47%), Gaps = 35/219 (15%)
Query: 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLS--SKSGQGLEEFKN 572
N+ + +G G FG VYK + N + G+ VA+K++S + L+
Sbjct: 1 NYQLGDLIGRGAFGVVYKGL-------NLE-----TGDFVAIKQISLEKIKEEALKSIMQ 48
Query: 573 EMMLIAKLQHRNLVRLFGCCIEQGEKISIY-EF-------DIV--TDPARKDLLDWTTRV 622
E+ L+ L+H N+V+ G IE + + I E+ I+ P + L+
Sbjct: 49 EIDLLKNLKHPNIVKYIGS-IETSDSLYIILEYAENGSLRQIIKKFGPFPESLV-----A 102
Query: 623 RIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTN 682
+ V QGL YLH+ VIHRD+KA+N+L D K++DFG+A +
Sbjct: 103 VYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS- 158
Query: 683 RIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSK 721
+VGT +M+PE S SD++S G ++E+L+
Sbjct: 159 -VVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 80/249 (32%), Positives = 114/249 (45%), Gaps = 62/249 (24%)
Query: 504 FSLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKL--LNGEE----VAVK 557
LS++ F EE LGEG FG VYK G+L N VA+K
Sbjct: 2 IPLSAV-----RFLEE--LGEGAFGKVYK-------------GELTGPNERLSATSVAIK 41
Query: 558 RLSSK-SGQGLEEFKNEMMLIAKLQHRNLVRLFGCC------------IEQGEKISIYEF 604
L + +EF+ E L++ LQH N+V L G C + G+ ++EF
Sbjct: 42 TLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGD---LHEF 98
Query: 605 DIVTDP-----------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNV 653
+ P K LD + + I +A G+ YL S +HRDL A N
Sbjct: 99 LVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNC 155
Query: 654 LLDSDMNPKISDFGIAR-TFGGD--EMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSF 710
L+ + KISDFG++R + D +QS + V +M PE L+G F+ +SD++SF
Sbjct: 156 LVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVR---WMPPEAILYGKFTTESDIWSF 212
Query: 711 GVLLLEILS 719
GV+L EI S
Sbjct: 213 GVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 83/284 (29%), Positives = 121/284 (42%), Gaps = 42/284 (14%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQ--GKLLNGEEVAVKRLSSKSGQG-LEEFKNEMMLI 577
KLG+G FG V + W GK++ VAVK L S +++F E ++
Sbjct: 2 KLGDGSFGVVRRG--------EWSTSGGKVIP---VAVKCLKSDKLSDIMDDFLKEAAIM 50
Query: 578 AKLQHRNLVRLFGCCIEQGEKISIYEF---DIVTDPARKDLLDWTTRVRIIE---GVAQG 631
L H NL+RL+G + + + E + D RKD L + + +A G
Sbjct: 51 HSLDHENLIRLYGVVLTHPLMM-VTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANG 109
Query: 632 LLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTF--GGDEMQSNTNRIVGTYG 689
+ YL R IHRDL A N+LL SD KI DFG+ R D + V +
Sbjct: 110 MRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFA 165
Query: 690 YMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAW- 748
+ +PE FS SDV+ FGV L E+ + Y + L + L K DK
Sbjct: 166 WCAPESLRTRTFSHASDVWMFGVTLWEMFT-------YGEEPWAGLSGSQILKKIDKEGE 218
Query: 749 KLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAML 792
+L P + +Y+++ + C N DRPT + L
Sbjct: 219 RLERPEACPQDIYNVMLQ-------CWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 83/298 (27%), Positives = 124/298 (41%), Gaps = 46/298 (15%)
Query: 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEE--VAVKRLSSKSGQGLE-EFK 571
N E LG G FG V+ + +G G E V VK L + L+ EF+
Sbjct: 6 NLQEITTLGRGEFGEVFLA---------KAKGIEEEGGETLVLVKALQKTKDENLQSEFR 56
Query: 572 NEMMLIAKLQHRNLVRLFGCCIEQGEKISIYE---------FDIVTDPARKDL----LDW 618
E+ + KL H+N+VRL G C E I E F T + L L
Sbjct: 57 RELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLST 116
Query: 619 TTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQ 678
+V + +A G+ +L S R +HRDL A N L+ S K+S +++ E
Sbjct: 117 KQKVALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY 173
Query: 679 SNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKK--NTRFYNTDSLTLLG 736
N ++ +++PE FS KSDV+SFGVL+ E+ + + + + L L
Sbjct: 174 KLRNALI-PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ 232
Query: 737 HAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794
+L P LY ++TR C N DRP+ E+V+ L +
Sbjct: 233 --------AGKLELPVPEGCPSRLYKLMTR-------CWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 84/297 (28%), Positives = 127/297 (42%), Gaps = 59/297 (19%)
Query: 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLS-SKSGQGLEEFKNEMMLIA 578
+LG G FG V K + K GK + VAVK L G +EF E ++A
Sbjct: 1 KELGHGNFGSVVKGVYLM------KSGKEVE---VAVKTLKQEHIAAGKKEFLREASVMA 51
Query: 579 KLQHRNLVRLFGCCIEQGEKI----------SIYEFDIVTDP--ARKDLLDWTTRVRIIE 626
+L H +VRL G C +GE + + ++ + DL + +V
Sbjct: 52 QLDHPCIVRLIGVC--KGEPLMLVMELAPLGPLLKY-LKKRREIPVSDLKELAHQV---- 104
Query: 627 GVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIART--FGGDEMQSNTNRI 684
A G+ YL +HRDL A NVLL + KISDFG++R G D ++ T
Sbjct: 105 --AMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA-- 157
Query: 685 VGTY--GYMSPEYALHGLFSIKSDVFSFGVLLLEILS--SKKNTRFYNTDSLTLLGHAWN 740
G + + +PE +G FS KSDV+S+GV L E S +K + + +L
Sbjct: 158 -GRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML----- 211
Query: 741 LWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797
+ +L P + +YS + L C + DRPT E+ + + +
Sbjct: 212 ----ESGERLPRPEECPQEIYS-------IMLSCWKYRPEDRPTFSELESTFRRDPE 257
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 109 bits (271), Expect = 2e-25
Identities = 70/314 (22%), Positives = 126/314 (40%), Gaps = 40/314 (12%)
Query: 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFK 571
++ KLGEG FG VY + +R + VA+K L+ K + +E F
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR---------------KLVALKVLAKKLESKSKEVERFL 45
Query: 572 NEMMLIAKLQH-RNLVRLFGCCIEQGEKISIYEF-------DIVTDPARKDLLDWTTRVR 623
E+ ++A L H N+V+L+ ++G + E+ D++ RK L + +
Sbjct: 46 REIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALF 105
Query: 624 IIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMN-PKISDFGIARTFGGD----EMQ 678
I+ + L YLH +IHRD+K N+LLD D K+ DFG+A+ +
Sbjct: 106 ILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIP 162
Query: 679 SNTNRIVGTYGYMSPEYALHGLF---SIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLL 735
+ + VGT GYM+PE L S SD++S G+ L E+L+ F + +
Sbjct: 163 ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGL--PPFEGEKNSSAT 220
Query: 736 GHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795
+ + + + + + + ++ +R + ++
Sbjct: 221 SQTLKIILELPT-PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279
Query: 796 IVNLPSPHQPAFSY 809
+ L
Sbjct: 280 HLKLKESDLSDLLK 293
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 61/233 (26%), Positives = 102/233 (43%), Gaps = 57/233 (24%)
Query: 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKR--LSSKSGQGLEEFKN 572
+ ++G+G FG VY V + +G+ +K LS+ S + E+ N
Sbjct: 1 KYEIIKQIGKGSFGKVYL-----VR-------RKSDGKLYVLKEIDLSNMSEKEREDALN 48
Query: 573 EMMLIAKLQHRNLVRLFGCCIEQG-----------------------EKISIYEFDIVTD 609
E+ ++ KL H N+++ + E+G E E I
Sbjct: 49 EVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQI--- 105
Query: 610 PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIA 669
LDW ++ L YLH SR +++HRD+K N+ L S+ K+ DFGI+
Sbjct: 106 ------LDWFVQL------CLALKYLH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGIS 150
Query: 670 RTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKK 722
+ + T +VGT Y+SPE + ++ KSD++S G +L E+ + K
Sbjct: 151 KVLSSTVDLAKT--VVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 28/213 (13%)
Query: 516 FSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMM 575
F KLGEG +G VYK+I K+ G+ VA+K + + L+E E+
Sbjct: 5 FDILEKLGEGSYGSVYKAI--------HKE----TGQVVAIKVVPVEED--LQEIIKEIS 50
Query: 576 LIAKLQHRNLVRLFGCCIEQGEKISIYEF-------DIVTDPARKDLLDWTTRVRIIEGV 628
++ + +V+ +G + + + E+ DI+ L I+
Sbjct: 51 ILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMK--ITNKTLTEEEIAAILYQT 108
Query: 629 AQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTY 688
+GL YLH + IHRD+KA N+LL+ + K++DFG++ + NT ++GT
Sbjct: 109 LKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTP 163
Query: 689 GYMSPEYALHGLFSIKSDVFSFGVLLLEILSSK 721
+M+PE ++ K+D++S G+ +E+ K
Sbjct: 164 FWMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 64/224 (28%), Positives = 104/224 (46%), Gaps = 37/224 (16%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEE-FKNEMMLIAKL 580
LGEG FG V+ E + + + E VAVK L + + F+ E L+
Sbjct: 13 LGEGAFGKVFLG-----ECYHLEPEN--DKELVAVKTLKETASNDARKDFEREAELLTNF 65
Query: 581 QHRNLVRLFGCCIEQGEKISIYEF----DI--------------VTDPARKDLLDWTTRV 622
QH N+V+ +G C E I ++E+ D+ + + L + +
Sbjct: 66 QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125
Query: 623 RIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTN 682
+I +A G++YL + +HRDL N L+ D+ KI DFG++R D ++
Sbjct: 126 QIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDYY 178
Query: 683 RIVGT----YGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKK 722
R+ G +M PE ++ F+ +SDV+SFGV+L EI + K
Sbjct: 179 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 67/217 (30%), Positives = 108/217 (49%), Gaps = 37/217 (17%)
Query: 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEF----KNEMM 575
++GEG +G VYK+ + GE VA+K++ ++ + E F E+
Sbjct: 5 AQIGEGTYGQVYKARNKK------------TGELVALKKIRMENEK--EGFPITAIREIK 50
Query: 576 LIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDL--LDWTTRVRIIEG------ 627
L+ KL+H N+VRL +G K SIY +V + DL L + V+ E
Sbjct: 51 LLQKLRHPNIVRLKEIVTSKG-KGSIY---MVFEYMDHDLTGLLDSPEVKFTESQIKCYM 106
Query: 628 --VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIV 685
+ +GL YLH ++HRD+K SN+L+++D K++DFG+AR + TNR++
Sbjct: 107 KQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI 163
Query: 686 GTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSK 721
T Y PE L + + D++S G +L E+ K
Sbjct: 164 -TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 84/279 (30%), Positives = 129/279 (46%), Gaps = 56/279 (20%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL 580
KLG G FG V++ + W N VAVK L + ++F E ++ KL
Sbjct: 13 KLGAGQFGEVWEGL--------WN-----NTTPVAVKTLKPGTMD-PKDFLAEAQIMKKL 58
Query: 581 QHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK-DLLDW-----------TTRVRIIEGV 628
+H L++L+ C E IY IVT+ + LL++ + + V
Sbjct: 59 RHPKLIQLYAVCT-LEE--PIY---IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQV 112
Query: 629 AQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT- 687
A G+ YL + IHRDL A NVL+ + K++DFG+AR D ++ G
Sbjct: 113 ASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAK 165
Query: 688 --YGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD 745
+ +PE AL+ FSIKSDV+SFG+LL EI++ Y + +A L + D
Sbjct: 166 FPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVT-------YGRMPYPGMTNAEVLQQVD 218
Query: 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPT 784
+ +++ P + LY + L C +E+ DRPT
Sbjct: 219 QGYRMPCPPGCPKELY-------DIMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 79/286 (27%), Positives = 122/286 (42%), Gaps = 57/286 (19%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQ 581
LG G FG V GK +VA+K + + ++F E ++ KL
Sbjct: 12 LGSGQFGVV-------------HLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLS 57
Query: 582 HRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTRVRIIEG----------VAQG 631
H NLV+L+G C +Q + E+ A LL++ + G V +
Sbjct: 58 HPNLVQLYGVCTKQRPIFIVTEY-----MANGCLLNYLRERKGKLGTEWLLDMCSDVCEA 112
Query: 632 LLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT---Y 688
+ YL IHRDL A N L+ D K+SDFG+AR D+ S+ GT
Sbjct: 113 MEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GTKFPV 165
Query: 689 GYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKN--TRFYNTDSLTLLGHAWNLWKDDK 746
+ PE + FS KSDV+SFGVL+ E+ S K RF N++ + + + L++
Sbjct: 166 KWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYR--- 222
Query: 747 AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAML 792
P + +Y+ + C E DRP ++++ L
Sbjct: 223 ------PKLAPTEVYT-------IMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 71/225 (31%), Positives = 99/225 (44%), Gaps = 25/225 (11%)
Query: 510 SAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRL-SSKSGQGLE 568
D+ + LG G FG VY+ + R + + VAVK L S S Q
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQ-------VAVKTLPESCSEQDES 54
Query: 569 EFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTD-----------PARKDLLD 617
+F E ++++K H+N+VRL G E+ + + E D P R L
Sbjct: 55 DFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLT 114
Query: 618 WTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS---DMNPKISDFGIARTFGG 674
+ VA+G YL + IHRD+ A N LL KI+DFG+AR
Sbjct: 115 MKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYR 171
Query: 675 DEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
R + +M PE L G+F+ K+DV+SFGVLL EI S
Sbjct: 172 ASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 4e-23
Identities = 68/212 (32%), Positives = 102/212 (48%), Gaps = 45/212 (21%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQ 581
+G+G FG V R G++VAVK L S + F E ++ L+
Sbjct: 14 IGKGEFGDVMLGDYR--------------GQKVAVKCLKDDST-AAQAFLAEASVMTTLR 58
Query: 582 HRNLVRLFGCCIEQGEKISIYEFDIVTDPARK-DLLDW-TTRVR-IIEG---------VA 629
H NLV+L G ++ +Y IVT+ K L+D+ +R R +I V
Sbjct: 59 HPNLVQLLGVVLQGN---PLY---IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVC 112
Query: 630 QGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTY- 688
+G+ YL + +HRDL A NVL+ D+ K+SDFG+A+ +++ + G
Sbjct: 113 EGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLP 162
Query: 689 -GYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
+ +PE FS KSDV+SFG+LL EI S
Sbjct: 163 VKWTAPEALREKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 5e-23
Identities = 78/272 (28%), Positives = 126/272 (46%), Gaps = 43/272 (15%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL 580
++G G FG V+ G L +VA+K + + E+F E ++ KL
Sbjct: 11 EIGSGQFGLVWL-------------GYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKL 56
Query: 581 QHRNLVRLFGCCIEQGEKISIYEF---DIVTD--PARKDLLDWTTRVRIIEGVAQGLLYL 635
H LV+L+G C E+ ++EF ++D A++ T + + V +G+ YL
Sbjct: 57 SHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYL 116
Query: 636 HQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT---YGYMS 692
+ VIHRDL A N L+ + K+SDFG+ R D+ S+T GT + S
Sbjct: 117 ESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSS 169
Query: 693 PEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMD 752
PE +S KSDV+SFGVL+ E+ S K Y S + + N ++L
Sbjct: 170 PEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTP--YENRSNSEVVETIN-----AGFRLYK 222
Query: 753 PTMQNEALYSMVTRYIKVALLCVQENATDRPT 784
P + ++++Y ++ C +E DRP+
Sbjct: 223 PRLASQSVYELMQH-------CWKERPEDRPS 247
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 5e-23
Identities = 31/67 (46%), Positives = 45/67 (67%), Gaps = 1/67 (1%)
Query: 337 CKTANQFKRFDDMKVPDLLDVSLNEGMNLEECGAECLNNCTCRAYAYFNLTRGGSGCLMW 396
C + F R +MK+PD ++ + L+EC CL+NC+C AYAY ++ RGGSGCL+W
Sbjct: 1 CGGGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADI-RGGSGCLIW 59
Query: 397 FGDLIDM 403
G+L+DM
Sbjct: 60 TGELVDM 66
|
Length = 66 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 28/210 (13%)
Query: 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLS-SKSGQGLEEFKNEMMLIA 578
+G G VY +I C L N E+VA+KR+ K ++E + E+ ++
Sbjct: 7 EVIGVGATAVVYAAI------C------LPNNEKVAIKRIDLEKCQTSVDELRKEVQAMS 54
Query: 579 KLQHRNLVRLFGCCIEQGEKISIYEF-------DIVTDPARKDLLDWTTRVRIIEGVAQG 631
+ H N+V+ + + E + + DI+ + LD +++ V +G
Sbjct: 55 QCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKG 114
Query: 632 LLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTF--GGDEMQSNTNRIVGTYG 689
L YLH + IHRD+KA N+LL D + KI+DFG++ + GGD + VGT
Sbjct: 115 LEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPC 171
Query: 690 YMSPE--YALHGLFSIKSDVFSFGVLLLEI 717
+M+PE +HG + K+D++SFG+ +E+
Sbjct: 172 WMAPEVMEQVHG-YDFKADIWSFGITAIEL 200
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 3e-22
Identities = 81/290 (27%), Positives = 132/290 (45%), Gaps = 45/290 (15%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNE 573
+ KLG G FG V+ G +VA+K L S E F E
Sbjct: 6 ETLKLVKKLGAGQFGEVW-------------MGYYNGHTKVAIKSLKQGS-MSPEAFLAE 51
Query: 574 MMLIAKLQHRNLVRLFGCCIEQGEKISIYEF-------DIVTDPARKDLLDWTTRVRIIE 626
L+ +LQH LVRL+ ++ I I E+ D + P L + +
Sbjct: 52 ANLMKQLQHPRLVRLYAVVTQEPIYI-ITEYMENGSLVDFLKTPEGIKL-TINKLIDMAA 109
Query: 627 GVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVG 686
+A+G+ ++ R IHRDL+A+N+L+ + KI+DFG+AR +E T R
Sbjct: 110 QIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY---TAREGA 163
Query: 687 TY--GYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD 744
+ + +PE +G F+IKSDV+SFG+LL EI++ + T+ + NL
Sbjct: 164 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQ----NL--- 216
Query: 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794
++ +++ P E LY ++ C +E +RPT + ++L+D
Sbjct: 217 ERGYRMPRPDNCPEELYELMRL-------CWKEKPEERPTFEYLRSVLED 259
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 6e-22
Identities = 67/228 (29%), Positives = 106/228 (46%), Gaps = 28/228 (12%)
Query: 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAK 579
+G+G FG V K + GK+L +E+ ++ K Q L +E+ ++ +
Sbjct: 6 ETIGKGSFGTVRKVRRK-------SDGKILVWKEIDYGNMTEKEKQQL---VSEVNILRE 55
Query: 580 LQHRNLVRLFGCCI-EQGEKISIY-EFDIVTDPARKDLLDWTTRVR-------IIEGVAQ 630
L+H N+VR + I + + I E+ D A+ L+ + R I + Q
Sbjct: 56 LKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQ--LIQKCKKERKYIEEEFIWRILTQ 113
Query: 631 GLLYLH-----QYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIV 685
LL L+ V+HRDLK +N+ LD++ N K+ DFG+A+ G D + T V
Sbjct: 114 LLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YV 171
Query: 686 GTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLT 733
GT YMSPE H + KSD++S G L+ E+ + N L
Sbjct: 172 GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLA 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 6e-22
Identities = 75/208 (36%), Positives = 102/208 (49%), Gaps = 24/208 (11%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEE-FKNEMMLIAKL 580
LGEG FG V S+ Y GE VAVK L + GQ +K E+ ++ L
Sbjct: 12 LGEGHFGKV--SLYCY------DPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL 63
Query: 581 QHRNLVRLFGCCIEQGEKIS--IYEF---DIVTDPARKDLLDWTTRVRIIEGVAQGLLYL 635
H N+V+ GCC EQG K I E+ + D K L+ + + + +G+ YL
Sbjct: 64 YHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYL 123
Query: 636 HQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTF-GGDE---MQSNTNRIVGTYGYM 691
H IHRDL A NVLLD+D KI DFG+A+ G E ++ + + V Y
Sbjct: 124 HSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY--- 177
Query: 692 SPEYALHGLFSIKSDVFSFGVLLLEILS 719
+ E FS SDV+SFGV L E+L+
Sbjct: 178 AVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 7e-22
Identities = 81/306 (26%), Positives = 136/306 (44%), Gaps = 55/306 (17%)
Query: 515 NFSEENKLGEGGFGPVY----KSIERYVE----ICNWKQGKLLNGEEVAVKRL-SSKSGQ 565
NF E KLGEG FG V+ ++ + E + +L VAVK L S
Sbjct: 8 NFVE--KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVL----VAVKVLRPDASDN 61
Query: 566 GLEEFKNEMMLIAKLQHRNLVRLFGCC---------IEQGEK------ISIYEFDIVTDP 610
E+F E+ ++++L N+ RL G C +E E + + +
Sbjct: 62 AREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLA 121
Query: 611 ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIAR 670
L ++T + + +A G+ YL L +HRDL N L+ + KI+DFG++R
Sbjct: 122 CNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
Query: 671 TFGGDEMQSNTNRIVGT----YGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRF 726
+ S+ R+ G +M+ E L G F+ KSDV++FGV L EIL+ + +
Sbjct: 179 ----NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPY 234
Query: 727 YNTDSLT---LLGHAWNLWKDDKAWKLMD-PTMQNEALYSMVTRYIKVALLCVQENATDR 782
+ LT ++ +A + ++DD + P + +Y ++ C + + DR
Sbjct: 235 ---EHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLE-------CWRRDEEDR 284
Query: 783 PTMLEV 788
PT E+
Sbjct: 285 PTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 8e-22
Identities = 75/277 (27%), Positives = 130/277 (46%), Gaps = 39/277 (14%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIA 578
++KLG G +G VY+ + WK+ VAVK L + +EEF E ++
Sbjct: 11 KHKLGGGQYGEVYEGV--------WKK----YSLTVAVKTLKEDT-MEVEEFLKEAAVMK 57
Query: 579 KLQHRNLVRLFGCCIEQGEKISIYEF-------DIVTDPARKDLLDWTTRVRIIEGVAQG 631
+++H NLV+L G C + I EF D + + + ++ + + ++
Sbjct: 58 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSA 116
Query: 632 LLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYM 691
+ YL + + IHRDL A N L+ + K++DFG++R GD ++ +
Sbjct: 117 MEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWT 172
Query: 692 SPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLM 751
+PE + FSIKSDV++FGVLL EI ++ + + D L + L +K +++
Sbjct: 173 APESLAYNKFSIKSDVWAFGVLLWEI-ATYGMSPYPGID----LSQVYELL--EKGYRME 225
Query: 752 DPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEV 788
P +Y ++ C Q N +DRP+ E+
Sbjct: 226 RPEGCPPKVY-------ELMRACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 9e-22
Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 34/208 (16%)
Query: 542 NWKQGKLL---------------NGEEVAVKR-----LSSKSGQGLEEFKNEMMLIAKLQ 581
NW++GKLL G E+AVK+ S ++ + + + E+ L+ LQ
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 582 HRNLVRLFGCCIEQGEKISIYEFDIVTDPARKD-------LLDWTTRVRIIEGVAQGLLY 634
H +V+ +GC + E +SI+ + + + KD L + TR + + +G+ Y
Sbjct: 63 HERIVQYYGC-LRDDETLSIF-MEYMPGGSVKDQLKAYGALTETVTR-KYTRQILEGVEY 119
Query: 635 LHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIV-GTYGYMSP 693
LH ++HRD+K +N+L DS N K+ DFG ++ + V GT +MSP
Sbjct: 120 LH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176
Query: 694 EYALHGLFSIKSDVFSFGVLLLEILSSK 721
E + K+DV+S G ++E+L+ K
Sbjct: 177 EVISGEGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-21
Identities = 88/291 (30%), Positives = 133/291 (45%), Gaps = 60/291 (20%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL 580
KLG G FG V+ G N +VAVK L + ++ F E L+ L
Sbjct: 13 KLGAGQFGEVW-------------MGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTL 58
Query: 581 QHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTR-----------VRIIEGVA 629
QH LVRL+ + + E I I I A+ LLD+ + +A
Sbjct: 59 QHDKLVRLYAV-VTKEEPIYI----ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIA 113
Query: 630 QGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTY- 688
+G+ Y+ R IHRDL+A+NVL+ + KI+DFG+AR +E T R +
Sbjct: 114 EGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY---TAREGAKFP 167
Query: 689 -GYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKK--NTRFYNTDSLTLLGHAWNLWKDD 745
+ +PE G F+IKSDV+SFG+LL EI++ K N+D ++ L + +
Sbjct: 168 IKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM---- 223
Query: 746 KAWKLMDPTMQN--EALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794
P M+N + LY ++ C +E A +RPT + ++L D
Sbjct: 224 -------PRMENCPDELYDIMK-------TCWKEKAEERPTFDYLQSVLDD 260
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 2e-21
Identities = 80/240 (33%), Positives = 120/240 (50%), Gaps = 49/240 (20%)
Query: 509 ISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLN---GEE---VAVKRLSSK 562
I+ +T F EE LGE FG VYK G L GE+ VA+K L K
Sbjct: 2 INLSTVRFMEE--LGEDRFGKVYK-------------GHLFGTAPGEQTQAVAIKTLKDK 46
Query: 563 SGQGL-EEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKIS----------IYEFDIVTDPA 611
+ L EEFK+E M+ ++LQH N+V L G + + + +S ++EF ++ P
Sbjct: 47 AEGPLREEFKHEAMMRSRLQHPNIVCLLGV-VTKEQPLSMIFSYCSHSDLHEFLVMRSPH 105
Query: 612 R-----------KDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMN 660
K L+ V I+ +A G+ +L S V+H+DL NVL+ +N
Sbjct: 106 SDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLN 162
Query: 661 PKISDFGIAR-TFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
KISD G+ R + D + N ++ +MSPE ++G FSI SD++S+GV+L E+ S
Sbjct: 163 VKISDLGLFREVYAADYYKLMGNSLLPIR-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 84/283 (29%), Positives = 130/283 (45%), Gaps = 46/283 (16%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN---EMMLIA 578
LG G FG VY+ +I G + VAVK L + G +E K E L++
Sbjct: 3 LGSGAFGEVYEG--TATDILGPGSGPI----RVAVKTL--RKGATDQEKKEFLKEAHLMS 54
Query: 579 KLQHRNLVRLFGCCIEQGEKISIYEF----DIVT--DPARKD-----LLDWTTRVRIIEG 627
H N+V+L G C+ + I E D+++ AR + LL + I
Sbjct: 55 NFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLD 114
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLL-----DSDMNPKISDFGIAR-TFGGDEMQSNT 681
VA+G +YL Q + IHRDL A N L+ D+D KI DFG+AR + D +
Sbjct: 115 VAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEG 171
Query: 682 NRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNL 741
++ +M+PE L G F+ +SDV+SFGVL+ EIL+ + ++ +L H
Sbjct: 172 EGLLPVR-WMAPESLLDGKFTTQSDVWSFGVLMWEILTL-GQQPYPALNNQEVLQHV--- 226
Query: 742 WKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPT 784
+L P + +Y ++T C ++ ++RPT
Sbjct: 227 ---TAGGRLQKPENCPDKIYQLMTN-------CWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 2e-21
Identities = 85/288 (29%), Positives = 135/288 (46%), Gaps = 63/288 (21%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL 580
+LG G FG V K GK +VA+K + S +EF E ++ KL
Sbjct: 11 ELGTGQFGVV-------------KYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKL 56
Query: 581 QHRNLVRLFGCCIEQGEKISIYEFDIVTD-PARKDLLDWT-------TRVRIIE---GVA 629
H LV+L+G C +Q IVT+ + LL++ +++E V
Sbjct: 57 SHEKLVQLYGVCTKQ------RPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVC 110
Query: 630 QGLLYL--HQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
+G+ YL Q+ IHRDL A N L+D K+SDFG++R DE S+ VG+
Sbjct: 111 EGMAYLESKQF-----IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGS 161
Query: 688 ---YGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKN--TRFYNTDSLTLLGHAWNLW 742
+ PE L+ FS KSDV++FGVL+ E+ S K RF N++++ + L+
Sbjct: 162 KFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLY 221
Query: 743 KDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790
+ P + +E +Y+++ C E A +RPT ++++
Sbjct: 222 R---------PHLASEKVYAIMYS-------CWHEKAEERPTFQQLLS 253
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 78/317 (24%), Positives = 131/317 (41%), Gaps = 81/317 (25%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLS--SKSGQGLEEFK 571
+ + +LG+G FG VY+ + + V VA+K ++ + + +E F
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGE-------PETRVAIKTVNENASMRERIE-FL 57
Query: 572 NEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDW------------- 618
NE ++ + ++VRL G + + E A+ DL +
Sbjct: 58 NEASVMKEFNCHHVVRLLGVVSTGQPTLVVMEL-----MAKGDLKSYLRSRRPEAENNPG 112
Query: 619 ---TTRVRIIEGVAQ---GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTF 672
T + I+ A+ G+ YL + +HRDL A N ++ D+ KI DFG+ R
Sbjct: 113 LGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR-- 167
Query: 673 GGDEMQSNTNRIVGT----YGYMSPEYALHGLFSIKSDVFSFGVLLLEI----------L 718
D +++ R G +M+PE G+F+ KSDV+SFGV+L E+ L
Sbjct: 168 --DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL 225
Query: 719 SSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMD-PTMQNEALYSMVTRYIKVALLCVQE 777
S+++ +F +D P + L ++ +C Q
Sbjct: 226 SNEEVLKFV------------------IDGGHLDLPENCPDKLL-------ELMRMCWQY 260
Query: 778 NATDRPTMLEVVAMLKD 794
N RPT LE+V+ LKD
Sbjct: 261 NPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 4e-21
Identities = 81/310 (26%), Positives = 136/310 (43%), Gaps = 69/310 (22%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEE-FKN 572
+N S LG G FG V VE + K +VAVK L + E +
Sbjct: 35 NNLSFGKTLGAGAFGKV-------VEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMS 87
Query: 573 EMMLIAKL-QHRNLVRLFGCCIEQGEKISIYEF----DIVTDPARK--------DLLDWT 619
E+ +++ L H N+V L G C G + I E+ D++ RK DLL ++
Sbjct: 88 ELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFS 147
Query: 620 TRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQS 679
+V A+G+ +L + IHRDL A NVLL KI DFG+AR ++ +
Sbjct: 148 YQV------AKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR-----DIMN 193
Query: 680 NTNRIVG-----TYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKK--------NTRF 726
++N +V +M+PE + +++ +SDV+S+G+LL EI S +++F
Sbjct: 194 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF 253
Query: 727 YNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTML 786
Y L K+ +++ P +Y ++ C + RPT
Sbjct: 254 Y------------KLIKE--GYRMAQPEHAPAEIYDIMKT-------CWDADPLKRPTFK 292
Query: 787 EVVAMLKDEI 796
++V ++ ++
Sbjct: 293 QIVQLIGKQL 302
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 6e-21
Identities = 62/220 (28%), Positives = 111/220 (50%), Gaps = 35/220 (15%)
Query: 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKR--LSSKSGQGLEEFKN 572
+F NK+G+G FG V+K + + + A+K+ LS + + EE +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRK------------ADKRVYAMKQIDLSKMNRREREEAID 48
Query: 573 EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF-------DIVT----DPARKDLLDWTTR 621
E ++AKL ++R + +++G+ + E+ ++ P +D + W
Sbjct: 49 EARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQV-WRFF 107
Query: 622 VRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNT 681
++I+ GL +LH +++HRD+K+ N+ LD+ N KI D G+A+ + +NT
Sbjct: 108 IQIL----LGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT 160
Query: 682 NRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSK 721
IVGT Y+SPE ++ KSDV++ GV+L E + K
Sbjct: 161 --IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 9e-21
Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLE-EFKN 572
+ E ++LGEG G V K C K ++ A+K +++ L+ +
Sbjct: 1 EKIVELSRLGEGAGGSVTK--------CRLKNTGMI----FALKTITTDPNPDLQKQILR 48
Query: 573 EMMLIAKLQHRNLVRLFGCCI-EQGEKISI---YEFDIVTDPARKDLLDWTTRV------ 622
E+ + + +V+ +G + E I I Y D K + R+
Sbjct: 49 ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG 108
Query: 623 RIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTN 682
+I E V +GL YLH ++IHRD+K SN+LL K+ DFG++ G+ + S
Sbjct: 109 KIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS----GELVNSLAG 161
Query: 683 RIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEI 717
GT YM+PE +SI SDV+S G+ LLE+
Sbjct: 162 TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 1e-20
Identities = 70/211 (33%), Positives = 104/211 (49%), Gaps = 43/211 (20%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL 580
+GEG FG V QG+ G++VAVK + K + F E ++ KL
Sbjct: 13 IIGEGEFGAVL-------------QGEYT-GQKVAVKNI--KCDVTAQAFLEETAVMTKL 56
Query: 581 QHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK-DLLDW-TTRVRIIEG----------V 628
H+NLVRL G + G IV + K +L+++ TR R + V
Sbjct: 57 HHKNLVRLLGVILHNG-------LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDV 109
Query: 629 AQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTY 688
A+G+ YL +++HRDL A N+L+ D K+SDFG+AR M + +++
Sbjct: 110 AEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARV---GSMGVDNSKL--PV 161
Query: 689 GYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
+ +PE H FS KSDV+S+GVLL E+ S
Sbjct: 162 KWTAPEALKHKKFSSKSDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 60/243 (24%), Positives = 95/243 (39%), Gaps = 59/243 (24%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLS-------SKSGQG 566
D+F +GEG F V + E K E A+K L K
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKE----KETNK--------EYAIKILDKRQLIKEKKVKYV 48
Query: 567 LEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK-DLLDWTTRVRII 625
E K + + H +++L+ Q E+ ++Y V + A +LL + + +
Sbjct: 49 KIE-KEVLTRLN--GHPGIIKLYYTF--QDEE-NLY---FVLEYAPNGELLQYIRKYGSL 99
Query: 626 -EGVAQ--------GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDE 676
E + L YLH +IHRDLK N+LLD DM+ KI+DFG A+ +
Sbjct: 100 DEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156
Query: 677 ------------------MQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEIL 718
+ VGT Y+SPE SD+++ G ++ ++L
Sbjct: 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQML 216
Query: 719 SSK 721
+ K
Sbjct: 217 TGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-20
Identities = 62/237 (26%), Positives = 104/237 (43%), Gaps = 45/237 (18%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEE---VAVKRLSSK-SGQGLEE 569
+N +G+G FG V+++ + LL E VAVK L + S +
Sbjct: 5 NNIEYVRDIGQGAFGRVFQA----------RAPGLLPYEPFTMVAVKMLKEEASADMQAD 54
Query: 570 FKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF------------------------- 604
F+ E L+A+ H N+V+L G C ++E+
Sbjct: 55 FQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHST 114
Query: 605 -DIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKI 663
L T ++ I + VA G+ YL S + +HRDL N L+ +M KI
Sbjct: 115 SSARKCGLNPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKI 171
Query: 664 SDFGIART-FGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
+DFG++R + D +++ N + +M PE + ++ +SDV+++GV+L EI S
Sbjct: 172 ADFGLSRNIYSADYYKASENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (227), Expect = 2e-20
Identities = 61/226 (26%), Positives = 98/226 (43%), Gaps = 44/226 (19%)
Query: 522 LGEGGFGPVY----KSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLI 577
LG+G FG V K + + K+L +++ +KR + +E E ++
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAM------KVLKKKKI-IKR------KEVEHTLTERNIL 47
Query: 578 AKLQHRNLVRLFGC------------CIEQGEKISIYEFDIVTDPARKDLLDWTTRVRII 625
+++ H +V+L GE S + R
Sbjct: 48 SRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLS-------KEGRFSEERARFYAA 100
Query: 626 EGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIV 685
E + L YLH L +I+RDLK N+LLD+D + K++DFG+A+ + ++NT
Sbjct: 101 E-IVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FC 154
Query: 686 GTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDS 731
GT Y++PE L + D +S GVLL E+L+ K FY D
Sbjct: 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK--PPFYAEDR 198
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 3e-20
Identities = 79/280 (28%), Positives = 125/280 (44%), Gaps = 39/280 (13%)
Query: 521 KLGEGGFGPVYKSIERYVEICNW--KQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIA 578
+LGEG FG V+ E N +Q K+L VAVK L S ++F+ E L+
Sbjct: 12 ELGEGAFGKVF-----LAECHNLLPEQDKML----VAVKALKEASESARQDFQREAELLT 62
Query: 579 KLQHRNLVRLFGCCIEQGEKISIYEFDIVTD---------PARKDL----------LDWT 619
LQH+++VR +G C E + ++E+ D P K L L
Sbjct: 63 VLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLG 122
Query: 620 TRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQS 679
+ I +A G++YL + L +HRDL N L+ + KI DFG++R +
Sbjct: 123 QMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR 179
Query: 680 NTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNT--RFYNTDSLTLLGH 737
R + +M PE L+ F+ +SD++SFGV+L EI + K + NT+++ +
Sbjct: 180 VGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239
Query: 738 AWNLWK----DDKAWKLMDPTMQNEALYSMVTRYIKVALL 773
L + + + +M Q E MV + I L
Sbjct: 240 GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 3e-20
Identities = 83/299 (27%), Positives = 138/299 (46%), Gaps = 52/299 (17%)
Query: 516 FSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN--- 572
F++ ++G G FG VY + + E VA+K++S Q E++++
Sbjct: 17 FTDLREIGHGSFGAVYFARDV------------RTNEVVAIKKMSYSGKQSNEKWQDIIK 64
Query: 573 EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF------DIVTDPARKDLLDWTTRVRIIE 626
E+ + +L+H N + GC + + + E+ DI+ + +K L + I
Sbjct: 65 EVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDIL-EVHKKPLQE-VEIAAICH 122
Query: 627 GVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVG 686
G QGL YLH + R IHRD+KA N+LL K++DFG A + S N VG
Sbjct: 123 GALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSA------SLVSPANSFVG 173
Query: 687 TYGYMSPEYAL---HGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWK 743
T +M+PE L G + K DV+S G+ +E L+ +K F N ++++ L H + +
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLF-NMNAMSALYH---IAQ 228
Query: 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSP 802
+D PT+ + ++ C+Q+ DRP+ E +LK V P
Sbjct: 229 NDS------PTLSSNDWSDYFRNFVD---SCLQKIPQDRPSSEE---LLKHRFVLRERP 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 5e-20
Identities = 66/210 (31%), Positives = 111/210 (52%), Gaps = 30/210 (14%)
Query: 522 LGEGGFGPVYKSIERYVEICNW-KQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAK 579
LG G FG VYK I W +G+ + VA+K L+ +G + EF +E +++A
Sbjct: 15 LGSGAFGTVYKGI--------WVPEGETVK-IPVAIKILNETTGPKANVEFMDEALIMAS 65
Query: 580 LQHRNLVRLFGCCIEQGEKISI----------YEFDIVTDPARKDLLDWTTRVRIIEGVA 629
+ H +LVRL G C+ ++ Y + + + LL+W ++ A
Sbjct: 66 MDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------A 119
Query: 630 QGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYG 689
+G++YL + R++HRDL A NVL+ S + KI+DFG+AR GDE + N +
Sbjct: 120 KGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK 176
Query: 690 YMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
+M+ E + F+ +SDV+S+GV + E+++
Sbjct: 177 WMALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 7e-20
Identities = 60/208 (28%), Positives = 95/208 (45%), Gaps = 32/208 (15%)
Query: 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVK--RLSSKSGQGLEEFKNEMM-- 575
+LG G G V K + R GK++ AVK RL K +
Sbjct: 7 GELGAGNSGVVSKVLHR-------PTGKIM-----AVKTIRLEINE----AIQKQILREL 50
Query: 576 -LIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVT--DPARKDLLDWT-TRV--RIIEGVA 629
++ K +V +G G+ E+ D K++ R+ +I V
Sbjct: 51 DILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVL 110
Query: 630 QGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYG 689
+GL YLH + ++IHRD+K SN+L++S K+ DFG++ G + S VGT
Sbjct: 111 KGLTYLH--EKHKIIHRDVKPSNILVNSRGQIKLCDFGVS----GQLVNSLAKTFVGTSS 164
Query: 690 YMSPEYALHGLFSIKSDVFSFGVLLLEI 717
YM+PE +S+KSD++S G+ L+E+
Sbjct: 165 YMAPERIQGNDYSVKSDIWSLGLSLIEL 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (225), Expect = 8e-20
Identities = 62/223 (27%), Positives = 106/223 (47%), Gaps = 44/223 (19%)
Query: 516 FSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFK---- 571
+ + KLGEG +G VYK+ ++ GE VA+K++ + E
Sbjct: 1 YEKLEKLGEGTYGVVYKARDK------------KTGEIVALKKI--RLDNEEEGIPSTAL 46
Query: 572 NEMMLIAKLQHRNLVRLFGCCIEQGEKISI----YEFDIVTDPARKDLLDWTTRVRIIEG 627
E+ L+ +L+H N+V+L I K+ + + D+ K LD +
Sbjct: 47 REISLLKELKHPNIVKLL-DVIHTERKLYLVFEYCDMDL------KKYLD-KRPGPLSPN 98
Query: 628 VAQ--------GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQS 679
+ + GL Y H + R++HRDLK N+L++ D K++DFG+AR F G +++
Sbjct: 99 LIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRT 154
Query: 680 NTNRIVGTYGYMSPEYALHGLF-SIKSDVFSFGVLLLEILSSK 721
T+ +V T Y +PE L S D++S G + E+++ K
Sbjct: 155 YTHEVV-TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 8e-20
Identities = 85/291 (29%), Positives = 141/291 (48%), Gaps = 57/291 (19%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGE-EVAVKRLSSKSGQGLEEFKNEMMLI 577
E KLG+G FG V+ W NG VA+K L + E F E ++
Sbjct: 11 EVKLGQGCFGEVWMG--------TW------NGTTRVAIKTLKPGT-MSPEAFLQEAQVM 55
Query: 578 AKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK-DLLDW-----TTRVRIIE----- 626
KL+H LV+L+ E+ IY IVT+ K LLD+ +R+ +
Sbjct: 56 KKLRHEKLVQLYAVVSEE----PIY---IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMA 108
Query: 627 -GVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIV 685
+A G+ Y+ R+ +HRDL+A+N+L+ ++ K++DFG+AR +E T R
Sbjct: 109 AQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQG 162
Query: 686 GTY--GYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWK 743
+ + +PE AL+G F+IKSDV+SFG+LL E L++K + + +L
Sbjct: 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTE-LTTKGRVPYPGMVNREVLDQV----- 216
Query: 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794
++ +++ P E+L+ ++ C ++ +RPT + A L+D
Sbjct: 217 -ERGYRMPCPPECPESLHDLM-------CQCWRKEPEERPTFEYLQAFLED 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 1e-19
Identities = 31/89 (34%), Positives = 47/89 (52%), Gaps = 10/89 (11%)
Query: 335 SDCKTANQFKRF---DDMKVPDLLDVSLNEGMNLEECGAECLNNCTCRAYAYFNLTRGGS 391
+C F D+K+PD ++ ++LEEC CL+NC+C AYAY G
Sbjct: 3 LNCGGDGSTDGFLKLPDVKLPDN-ASAIT-AISLEECREACLSNCSCTAYAY---NNGSG 57
Query: 392 GCLMWFGDLIDMRKTLANLTGQSIYLRVP 420
GCL+W G L ++R + G ++YLR+
Sbjct: 58 GCLLWNGLLNNLRS--LSSGGGTLYLRLA 84
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 1e-19
Identities = 83/313 (26%), Positives = 143/313 (45%), Gaps = 57/313 (18%)
Query: 491 AGTGKSKESWFLFFSLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLN 550
AG+ K E LFF F++ ++G G FG VY + + +
Sbjct: 6 AGSLKDPEIAELFFK----EDPEKLFTDLREIGHGSFGAVYFARD------------VRT 49
Query: 551 GEEVAVKRLSSKSGQGLEEFKN---EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIV 607
E VA+K++S Q E++++ E+ + +++H N + GC + + + E+ +
Sbjct: 50 NEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL- 108
Query: 608 TDPARKDLLDWTTR-------VRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMN 660
+ DLL+ + I G QGL YLH ++ +IHRD+KA N+LL
Sbjct: 109 --GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQ 163
Query: 661 PKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYAL---HGLFSIKSDVFSFGVLLLEI 717
K++DFG A + S N VGT +M+PE L G + K DV+S G+ +E+
Sbjct: 164 VKLADFGSA------SIASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
Query: 718 LSSKKNTRFYNTDSLTLLGH-AWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQ 776
+++ +N ++++ L H A N PT+Q+ ++ C+Q
Sbjct: 218 --AERKPPLFNMNAMSALYHIAQN----------ESPTLQSNEWSDYFRNFVDS---CLQ 262
Query: 777 ENATDRPTMLEVV 789
+ DRPT E++
Sbjct: 263 KIPQDRPTSEELL 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 30/217 (13%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLS---SKSGQGLEE 569
NF E K+G+G F VYK+I C +G VA+K++ + ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAI------CLL------DGRVVALKKVQIFEMMDAKARQD 48
Query: 570 FKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPAR--------KDLLDWTTR 621
E+ L+ +L H N+++ IE E + E D +R K L+ T
Sbjct: 49 CLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTI 108
Query: 622 VRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNT 681
+ + L ++H R++HRD+K +NV + + K+ D G+ R F +++
Sbjct: 109 WKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS 165
Query: 682 NRIVGTYGYMSPEYALHGL-FSIKSDVFSFGVLLLEI 717
+VGT YMSPE +H ++ KSD++S G LL E+
Sbjct: 166 --LVGTPYYMSPE-RIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 3e-19
Identities = 69/212 (32%), Positives = 105/212 (49%), Gaps = 30/212 (14%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQG-LEEFKNEMMLIAKL 580
LGEG FG V E+C + GE+VAVK L +SG + + K E+ ++ L
Sbjct: 12 LGEGHFGKV--------ELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 63
Query: 581 QHRNLVRLFGCCIEQGEK--ISIYEFDIVTD-----PARKDLLDWTTRVRIIEGVAQGLL 633
H N+V+ G C E G I EF P K+ ++ +++ + +G+
Sbjct: 64 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMD 123
Query: 634 YL--HQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDE----MQSNTNRIVGT 687
YL QY +HRDL A NVL++S+ KI DFG+ + D+ ++ + + V
Sbjct: 124 YLGSRQY-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFW 178
Query: 688 YGYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
Y +PE + F I SDV+SFGV L E+L+
Sbjct: 179 Y---APECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 79/296 (26%), Positives = 133/296 (44%), Gaps = 64/296 (21%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKL-LNGEE---VAVKRL-SSKSGQGLEEFKNE 573
E +G G FG V + G+L L G++ VA+K L + S + +F E
Sbjct: 9 EKVIGGGEFGEVCR-------------GRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTE 55
Query: 574 MMLIAKLQHRNLVRLFGCCI---------EQGEKISIYEFDIVTDPARKDLLDWTTRVRI 624
++ + H N++RL G E E S+ +F D V +
Sbjct: 56 ASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREND----GKFTVGQLVGM 111
Query: 625 IEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTN-- 682
+ G+A G+ YL S + +HRDL A N+L++S++ K+SDFG++R E T
Sbjct: 112 LRGIASGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGG 168
Query: 683 RIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLW 742
+I + +PE + F+ SDV+SFG+++ E++S + R Y W++
Sbjct: 169 KI--PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGE--RPY-----------WDMS 213
Query: 743 KDD------KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAML 792
D ++L P ALY ++ L C Q++ +RPT ++V+ L
Sbjct: 214 NQDVIKAVEDGYRLPPPMDCPSALY-------QLMLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-19
Identities = 85/290 (29%), Positives = 141/290 (48%), Gaps = 55/290 (18%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGE-EVAVKRLSSKSGQGL-EEFKNEMML 576
+ KLG+G FG V+ + W NG +VA+K L K G + E F E +
Sbjct: 11 DVKLGQGCFGEVW--------MGTW------NGTTKVAIKTL--KPGTMMPEAFLQEAQI 54
Query: 577 IAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTD-PARKDLLDWTTR-----------VRI 624
+ KL+H LV L+ E+ IY IVT+ + LLD+ V +
Sbjct: 55 MKKLRHDKLVPLYAVVSEE----PIY---IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDM 107
Query: 625 IEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRI 684
+A G+ Y+ R+ IHRDL+A+N+L+ ++ KI+DFG+AR +E +
Sbjct: 108 AAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAK 164
Query: 685 VGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD 744
+ +PE AL+G F+IKSDV+SFG+LL E L +K + + +L
Sbjct: 165 F-PIKWTAPEAALYGRFTIKSDVWSFGILLTE-LVTKGRVPYPGMVNREVLEQV------ 216
Query: 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794
++ +++ P E+L+ ++ LC +++ +RPT + + L+D
Sbjct: 217 ERGYRMPCPQGCPESLHELMK-------LCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 4e-19
Identities = 80/315 (25%), Positives = 143/315 (45%), Gaps = 54/315 (17%)
Query: 516 FSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN--- 572
F +++G G FG VY + + E VAVK++S Q E++++
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTN------------EVVAVKKMSYSGKQTNEKWQDIIK 70
Query: 573 EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTR-------VRII 625
E+ + +L+H N + GC +++ + E+ + + DLL+ + I
Sbjct: 71 EVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL---GSASDLLEVHKKPLQEVEIAAIT 127
Query: 626 EGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIV 685
G QGL YLH ++ IHRD+KA N+LL K++DFG A S N V
Sbjct: 128 HGALQGLAYLHSHNM---IHRDIKAGNILLTEPGQVKLADFGSA------SKSSPANSFV 178
Query: 686 GTYGYMSPEYAL---HGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLW 742
GT +M+PE L G + K DV+S G+ +E+ +++ +N ++++ L H +
Sbjct: 179 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYH---IA 233
Query: 743 KDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSP 802
++D PT+Q+ ++ C+Q+ +RP E +L+ + V P
Sbjct: 234 QNDS------PTLQSNEWTDSFRGFVD---YCLQKIPQERPASAE---LLRHDFVRRDRP 281
Query: 803 HQPAFSYVQIVERSV 817
+ +Q + +V
Sbjct: 282 ARVLIDLIQRTKDAV 296
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 5e-19
Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 36/219 (16%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQ 581
LG+G FG V E+C + + GE VAVK+L + + L +F+ E+ ++ LQ
Sbjct: 12 LGKGNFGSV--------ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQ 63
Query: 582 HRNLVRLFGCCIEQGEKISIYEFDIVTD-----------PARKDLLDWTTRVRIIEGVAQ 630
H N+V+ G C G + +V + ++ LD + + +
Sbjct: 64 HDNIVKYKGVCYSAGRR----NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICK 119
Query: 631 GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDE-----MQSNTNRIV 685
G+ YL R +HRDL N+L++S+ KI DFG+ + D+ + + I
Sbjct: 120 GMEYL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF 176
Query: 686 GTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKN 723
+ +PE FS+ SDV+SFGV+L E+ + S K+
Sbjct: 177 ----WYAPESLTESKFSVASDVWSFGVVLYELFTYSDKS 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 6e-19
Identities = 64/226 (28%), Positives = 102/226 (45%), Gaps = 44/226 (19%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRL-SSKSGQGLEEFKNEMMLIAKL 580
LGEG FG V K+ V + N VAVK L + + L + +EM ++ +
Sbjct: 20 LGEGAFGQVVKA--EAVGLDNPN-----ETSTVAVKMLKDDATEKDLSDLVSEMEMMKMI 72
Query: 581 -QHRNLVRLFGCCIEQGEKISIYEF------------------------DIVTDP--ARK 613
+H+N++ L G C ++G + E+ + +K
Sbjct: 73 GKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132
Query: 614 DLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFG 673
DL+ + +V A+G+ +L + IHRDL A NVL+ D KI+DFG+AR
Sbjct: 133 DLVSFAYQV------ARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIH 183
Query: 674 GDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
+ T +M+PE +++ +SDV+SFGVLL EI +
Sbjct: 184 HIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 6e-19
Identities = 65/219 (29%), Positives = 113/219 (51%), Gaps = 36/219 (16%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKR--LSSKSGQG-------LEEFKN 572
+G G FG VY + +GE +AVK+ L S S L+
Sbjct: 8 IGSGSFGSVYLGMNA------------SSGELMAVKQVELPSVSASSKDRKRSMLDALAR 55
Query: 573 EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDW-----TTRVR-IIE 626
E+ L+ +LQH N+V+ G ++ + ++I+ + V + LL+ T VR +
Sbjct: 56 EIALLKELQHENIVQYLGSSLDA-DHLNIF-LEYVPGGSVAALLNNYGAFEETLVRNFVR 113
Query: 627 GVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGD--EMQSNTNR- 683
+ +GL YLH +R +IHRD+K +N+L+D+ KISDFGI++ + ++N R
Sbjct: 114 QILKGLNYLH--NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARP 170
Query: 684 -IVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSK 721
+ G+ +M+PE ++ K+D++S G L++E+L+ K
Sbjct: 171 SLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 9e-19
Identities = 74/223 (33%), Positives = 110/223 (49%), Gaps = 43/223 (19%)
Query: 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGE-EVAVKRLSSKSGQGLEEF 570
++ KLG G FG V+ W NG +VAVK L + E F
Sbjct: 4 PRESLQLIKKLGNGQFGEVWMGT--------W------NGNTKVAVKTLKPGT-MSPESF 48
Query: 571 KNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK-DLLDWTTR-------- 621
E ++ KL+H LV+L+ E+ IY IVT+ K LLD+
Sbjct: 49 LEEAQIMKKLRHDKLVQLYAVVSEE----PIY---IVTEYMSKGSLLDFLKDGEGRALKL 101
Query: 622 ---VRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQ 678
V + VA G+ Y+ R+ IHRDL+++N+L+ + KI+DFG+AR +E
Sbjct: 102 PNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY- 157
Query: 679 SNTNRIVGTY--GYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
T R + + +PE AL+G F+IKSDV+SFG+LL E+++
Sbjct: 158 --TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 9e-19
Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQ 581
LG+G FG VYK+ + + L A K + +S + LE+F E+ ++++ +
Sbjct: 13 LGDGAFGKVYKAQHK--------ETGLF----AAAKIIQIESEEELEDFMVEIDILSECK 60
Query: 582 HRNLVRLFGCCIEQGEKISIYEF------DIVTDPARKDLLDWTTRVRIIEGVAQGLLYL 635
H N+V L+ + + + EF D + + L + R + + + L +L
Sbjct: 61 HPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-VCRQMLEALNFL 119
Query: 636 HQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEY 695
H + +VIHRDLKA N+LL D + K++DFG++ +Q + +GT +M+PE
Sbjct: 120 HSH---KVIHRDLKAGNILLTLDGDVKLADFGVS-AKNKSTLQKR-DTFIGTPYWMAPEV 174
Query: 696 ALHGLFS-----IKSDVFSFGVLLLEI 717
F K+D++S G+ L+E+
Sbjct: 175 VACETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 68/280 (24%), Positives = 126/280 (45%), Gaps = 42/280 (15%)
Query: 522 LGEGGFGP--VYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAK 579
LG+G FG +Y+ E L+ +EV + RLS K + NE+++++
Sbjct: 8 LGKGAFGEATLYRRTE---------DDSLVVWKEVNLTRLSEK---ERRDALNEIVILSL 55
Query: 580 LQHRNLVRLFGCCIEQGEKISIYE-------FDIVTDPARKDLLDWTTRVRIIEGVAQGL 632
LQH N++ + ++ + E +D + + L + + + + +
Sbjct: 56 LQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVR-QKGQLFEEEMVLWYLFQIVSAV 114
Query: 633 LYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMS 692
Y+H+ ++HRD+K N+ L K+ DFGI++ G + + T +VGT YMS
Sbjct: 115 SYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMS 169
Query: 693 PEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMD 752
PE ++ KSD+++ G +L E+L+ K+ F T+ L L + K +
Sbjct: 170 PELCQGVKYNFKSDIWALGCVLYELLTLKRT--FDATNPLNL------VVKIVQGNYTPV 221
Query: 753 PTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAML 792
++ + L S+V +Q++ RPT EV+
Sbjct: 222 VSVYSSELISLVHS-------LLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 67/231 (29%), Positives = 111/231 (48%), Gaps = 39/231 (16%)
Query: 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEM 574
N + +LGEG FG V+ + +C +Q K+L VAVK L S ++F E
Sbjct: 6 NIVLKRELGEGAFGKVF--LAECYNLCP-EQDKIL----VAVKTLKDASDNARKDFHREA 58
Query: 575 MLIAKLQHRNLVRLFGCCIEQGEKISIYEF---------------DIVT----DPARKDL 615
L+ LQH ++V+ +G C+E I ++E+ D V + +
Sbjct: 59 ELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAE-- 116
Query: 616 LDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGD 675
L + + I + +A G++YL + +HRDL N L+ ++ KI DFG++R D
Sbjct: 117 LTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----D 169
Query: 676 EMQSNTNRIVG----TYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKK 722
++ R+ G +M PE ++ F+ +SDV+S GV+L EI + K
Sbjct: 170 VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 39/99 (39%), Positives = 62/99 (62%), Gaps = 6/99 (6%)
Query: 623 RIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTN 682
+I V +GL YL Y+ R++HRD+K SN+L++S K+ DFG++ G+ + S +
Sbjct: 107 KIAVAVVEGLTYL--YNVHRIMHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIAD 160
Query: 683 RIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSK 721
VGT YMSPE G +++KSDV+S G+ ++E+ K
Sbjct: 161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 22/205 (10%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGL-EEFKNEMMLIAK 579
K+G+G FG VYK G L EVAVK S L +F E ++ +
Sbjct: 2 KIGKGNFGDVYK-------------GVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQ 48
Query: 580 LQHRNLVRLFGCCIEQGEKISIYEF----DIVTDPAR-KDLLDWTTRVRIIEGVAQGLLY 634
H N+V+L G C+++ + E ++T + K+ L +++ A G+ Y
Sbjct: 49 YDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEY 108
Query: 635 LHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPE 694
L + IHRDL A N L+ + KISDFG++R G + + +PE
Sbjct: 109 LESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPE 165
Query: 695 YALHGLFSIKSDVFSFGVLLLEILS 719
+G ++ +SDV+S+G+LL E S
Sbjct: 166 ALNYGRYTSESDVWSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 78/290 (26%), Positives = 134/290 (46%), Gaps = 55/290 (18%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIA 578
E KLG G FG V+ + K K VAVK + S +E F E ++
Sbjct: 11 EKKLGAGQFGEVWMATYN-------KHTK------VAVKTMKPGS-MSVEAFLAEANVMK 56
Query: 579 KLQHRNLVRLFGCCIEQG--------EKISIYEFDIVTDPARK----DLLDWTTRVRIIE 626
LQH LV+L ++ K S+ +F + +D K L+D++ ++
Sbjct: 57 TLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDF-LKSDEGSKQPLPKLIDFSAQI---- 111
Query: 627 GVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVG 686
A+G+ ++ Q + IHRDL+A+N+L+ + + KI+DFG+AR +E +
Sbjct: 112 --AEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF- 165
Query: 687 TYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTR--FYNTDSLTLLGHAWNLWKD 744
+ +PE G F+IKSDV+SFG+LL+EI++ + N + + L + + +
Sbjct: 166 PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRP 225
Query: 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794
+ E LY+++ R C + +RPT + ++L D
Sbjct: 226 ENC---------PEELYNIMMR-------CWKNRPEERPTFEYIQSVLDD 259
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 78/290 (26%), Positives = 125/290 (43%), Gaps = 63/290 (21%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL 580
+LG G FG V GK +VA+K ++ + E+F E ++ KL
Sbjct: 11 ELGSGQFGVV-------------HLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKL 56
Query: 581 QHRNLVRLFGCCIEQGEKISIYEFDIVTD----------------PARKDLLDWTTRVRI 624
H LV+L+G C +Q +Y IVT+ KD+L + +
Sbjct: 57 SHPKLVQLYGVCTQQK---PLY---IVTEFMENGCLLNYLRQRQGKLSKDML-----LSM 105
Query: 625 IEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRI 684
+ V +G+ YL + S IHRDL A N L+ S K+SDFG+ R DE S++
Sbjct: 106 CQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAK 162
Query: 685 VGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKN--TRFYNTDSLTLLGHAWNLW 742
+ PE +S KSDV+SFGVL+ E+ + K + N + + ++ + L+
Sbjct: 163 F-PVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLY 221
Query: 743 KDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAML 792
+ P + + +Y +V C E RPT E++ +
Sbjct: 222 R---------PKLASMTVY-------EVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 3e-18
Identities = 80/300 (26%), Positives = 138/300 (46%), Gaps = 31/300 (10%)
Query: 514 DNFSEENKLGEGGFGPVY----KSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLE- 568
+ + KLGEG FG V+ + +E++++ VAVK L + +
Sbjct: 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARN 64
Query: 569 EFKNEMMLIAKLQHRNLVRLFGCCI------------EQGEK---ISIYEFDIVTDPARK 613
+F E+ ++++L+ N++RL CI E G+ +S +E + A
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 614 DLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFG 673
+ ++T + + +A G+ YL S L +HRDL N L+ + KI+DFG++R
Sbjct: 125 VTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 674 GDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLT 733
+ R V +MS E L G F+ SDV++FGV L EIL+ K +
Sbjct: 182 SGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241
Query: 734 LLGHAWNLWKDD-KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAML 792
++ + ++D + L P + ++LY K+ L C + NA +RP+ E+ A L
Sbjct: 242 VIENTGEFFRDQGRQVYLPKPALCPDSLY-------KLMLSCWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-18
Identities = 57/206 (27%), Positives = 105/206 (50%), Gaps = 21/206 (10%)
Query: 516 FSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQG-LEEFKNEM 574
F++ ++G+G FG VYK I+ + E VA+K + + + +E+ + E+
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTK------------EVVAIKIIDLEEAEDEIEDIQQEI 53
Query: 575 MLIAKLQHRNLVRLFGCCIEQGEKISIYEF---DIVTDPARKDLLDWTTRVRIIEGVAQG 631
++++ + R +G ++ + I E+ D + L+ T I+ + +G
Sbjct: 54 TVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKG 113
Query: 632 LLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYM 691
L YLH R IHRD+KA+NVLL + K++DFG+A +++ NT VGT +M
Sbjct: 114 LDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWM 168
Query: 692 SPEYALHGLFSIKSDVFSFGVLLLEI 717
+PE + K+D++S G+ +E+
Sbjct: 169 APEVIKQSAYDFKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 4e-18
Identities = 76/283 (26%), Positives = 132/283 (46%), Gaps = 53/283 (18%)
Query: 516 FSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN--- 572
FS+ ++G G FG VY + + + N E VA+K++S Q E++++
Sbjct: 17 FSDLREIGHGSFGAVYFARD------------VRNSEVVAIKKMSYSGKQSNEKWQDIIK 64
Query: 573 EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTR-------VRII 625
E+ + KL+H N ++ GC + + + E+ + + DLL+ + +
Sbjct: 65 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL---GSASDLLEVHKKPLQEVEIAAVT 121
Query: 626 EGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIV 685
G QGL YLH ++ +IHRD+KA N+LL K+ DFG A + + N V
Sbjct: 122 HGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANXFV 172
Query: 686 GTYGYMSPEYAL---HGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGH-AWNL 741
GT +M+PE L G + K DV+S G+ +E+ +++ +N ++++ L H A N
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHIAQN- 229
Query: 742 WKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPT 784
P +Q+ ++ C+Q+ DRPT
Sbjct: 230 ---------ESPALQSGHWSEYFRNFVDS---CLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 5e-18
Identities = 64/215 (29%), Positives = 105/215 (48%), Gaps = 40/215 (18%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEE----VAVKRLSSKSG-QGLEEFKNEMML 576
LG G FG V+K I W + G+ VA+K + +SG Q +E + M+
Sbjct: 15 LGSGVFGTVHKGI--------W----IPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLA 62
Query: 577 IAKLQHRNLVRLFGCC-----------IEQGEKIS-IYEFDIVTDPARKDLLDWTTRVRI 624
+ L H +VRL G C G + + + DP R LL+W ++
Sbjct: 63 MGSLDHAYIVRLLGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQR--LLNWCVQI-- 118
Query: 625 IEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRI 684
A+G+ YL ++ R++HR+L A N+LL SD +I+DFG+A D+ + +
Sbjct: 119 ----AKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEH 171
Query: 685 VGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
+M+ E L G ++ +SDV+S+GV + E++S
Sbjct: 172 KTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 6e-18
Identities = 62/226 (27%), Positives = 111/226 (49%), Gaps = 49/226 (21%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVK----------RLSSKSGQGLEEFK 571
+G+G +G VY ++ + GE +AVK R S+ ++ +
Sbjct: 9 IGKGTYGRVYLAL------------NVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALR 56
Query: 572 NEMMLIAKLQHRNLVRLFGCCIEQGEK-ISIY-EF-------DIVTDPAR--KDLLDWTT 620
+E+ + L H N+V+ G E E+ +SI+ E+ + R + L+ + T
Sbjct: 57 SEIETLKDLDHLNIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFT 114
Query: 621 RVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSN 680
V +GL YLH ++HRDLKA N+L+D+D KISDFGI++ D++ N
Sbjct: 115 E-----QVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKK--SDDIYDN 164
Query: 681 --TNRIVGTYGYMSPE--YALHGLFSIKSDVFSFGVLLLEILSSKK 722
+ G+ +M+PE ++ +S K D++S G ++LE+ + ++
Sbjct: 165 DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 7e-18
Identities = 53/220 (24%), Positives = 99/220 (45%), Gaps = 43/220 (19%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNE 573
+++ ++G G +G VYK+ + GE VA+K + + G E + E
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDI------------ATGELVAIKVIKLEPGDDFEIIQQE 50
Query: 574 MMLIAKLQHRNLVRLFGC---------CIEQGEKISIYE-FDIVTDPARKDLLDWTTRVR 623
+ ++ + +H N+V FG +E S+ + + + P + + + R
Sbjct: 51 ISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCR-- 108
Query: 624 IIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIA----RTFGGDEMQS 679
+GL YLH+ IHRD+K +N+LL D + K++DFG++ T +
Sbjct: 109 ---ETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI------A 156
Query: 680 NTNRIVGTYGYMSPEYA---LHGLFSIKSDVFSFGVLLLE 716
+GT +M+PE A G + K D+++ G+ +E
Sbjct: 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 8e-18
Identities = 68/242 (28%), Positives = 114/242 (47%), Gaps = 42/242 (17%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWK--QGKLLNGEEVAVKRLSSKSGQGLEEFKNEMML 576
+ +LGEG FG V+ E N + K+L VAVK L + ++F+ E L
Sbjct: 10 KRELGEGAFGKVF-----LAECYNLSPTKDKML----VAVKALKDPTLAARKDFQREAEL 60
Query: 577 IAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTD---------PARKDLLDWTTR------ 621
+ LQH ++V+ +G C + I ++E+ D P L+D R
Sbjct: 61 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 120
Query: 622 -----VRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDE 676
+ I +A G++YL + +HRDL N L+ +++ KI DFG++R D
Sbjct: 121 GLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DV 173
Query: 677 MQSNTNRIVG----TYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSL 732
++ R+ G +M PE ++ F+ +SDV+SFGV+L EI + K F +++
Sbjct: 174 YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE 233
Query: 733 TL 734
+
Sbjct: 234 VI 235
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 63/181 (34%), Positives = 93/181 (51%), Gaps = 27/181 (14%)
Query: 551 GEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTD- 609
G +VAVK + K+ + F E ++ +L+H NLV+L G +E EK +Y IVT+
Sbjct: 29 GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE--EKGGLY---IVTEY 81
Query: 610 PARKDLLDW-TTRVRIIEG----------VAQGLLYLHQYSRLRVIHRDLKASNVLLDSD 658
A+ L+D+ +R R + G V + + YL + +HRDL A NVL+ D
Sbjct: 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSED 138
Query: 659 MNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEIL 718
K+SDFG+ + E S + + +PE FS KSDV+SFG+LL EI
Sbjct: 139 NVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY 193
Query: 719 S 719
S
Sbjct: 194 S 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 60/218 (27%), Positives = 99/218 (45%), Gaps = 41/218 (18%)
Query: 524 EGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQ-GLEEFKNEMMLIAKLQH 582
EG FG ++ I K EEV VK + + + + E L+ L H
Sbjct: 16 EGTFGRIFYGI--------LIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSH 67
Query: 583 RNLVRLFGCCIEQGEK-ISIYEFDIVTDPARKDLLDWTTRVRIIEG-------------- 627
+N++ + CIE GE +Y + +L + + R+ E
Sbjct: 68 QNILPILHVCIEDGEPPFVLYPY-----MNWGNLKLFLQQCRLGEANNPQALSTQQLVHM 122
Query: 628 ---VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIAR-TFGGDE--MQSNT 681
+A G+ YLH + VIH+D+ A N ++D ++ KI+D ++R F D + N
Sbjct: 123 AIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNE 179
Query: 682 NRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
NR V +M+ E ++ +S SDV+SFGVLL E+++
Sbjct: 180 NRPVK---WMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 53/210 (25%), Positives = 104/210 (49%), Gaps = 27/210 (12%)
Query: 516 FSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLS-SKSGQGLEEFKNEM 574
F+ +G+G FG VYK+I++ + VA+K + ++ +E+ + E+
Sbjct: 3 FTLLECIGKGSFGEVYKAIDK------------RTNQVVAIKVIDLEEAEDEIEDIQQEI 50
Query: 575 MLIAKLQHRNLVRLFGCCIEQGEKISIYEF---DIVTDPARKDLLDWTTRVRIIEGVAQG 631
+++ + + + +G ++ + I E+ D + LD T I+ V G
Sbjct: 51 QFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLG 110
Query: 632 LLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNR---IVGTY 688
L YLH+ IHRD+KA+N+LL + + K++DFG++ ++ S ++ VGT
Sbjct: 111 LEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTP 162
Query: 689 GYMSPEYALHGLFSIKSDVFSFGVLLLEIL 718
+M+PE + K+D++S G+ +E+
Sbjct: 163 FWMAPEVIKQSGYDEKADIWSLGITAIELA 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 70/230 (30%), Positives = 108/230 (46%), Gaps = 43/230 (18%)
Query: 516 FSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSS-KSGQGLEEFKNEM 574
F EE LGE FG +YK ++ + +L VA+K L + Q EF+ E
Sbjct: 9 FMEE--LGECAFGKIYKG---HLYLPGMDHAQL-----VAIKTLKDINNPQQWGEFQQEA 58
Query: 575 MLIAKLQHRNLVRLFGCC------------IEQGEKISIYEFDIVTDPAR---------- 612
L+A+L H N+V L G + QG+ ++EF I+ P
Sbjct: 59 SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGD---LHEFLIMRSPHSDVGCSSDEDG 115
Query: 613 --KDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIAR 670
K LD + I +A G+ YL + +H+DL A N+L+ ++ KISD G++R
Sbjct: 116 TVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSR 172
Query: 671 -TFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
+ D + ++ +M PE ++G FS SD++SFGV+L EI S
Sbjct: 173 EIYSADYYRVQPKSLLPIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 3e-17
Identities = 74/307 (24%), Positives = 134/307 (43%), Gaps = 55/307 (17%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNG-EEVAVKRLSSKSGQG-LEEFKNEMMLIAK 579
LGEG FG V K+ + K G VAVK L + L + +E L+ +
Sbjct: 8 LGEGEFGKVVKATAFRL--------KGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQ 59
Query: 580 LQHRNLVRLFGCCIEQGEKISIYEFD-------------------IVTDPARKDLLDWTT 620
+ H ++++L+G C + G + I E+ + +D R
Sbjct: 60 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119
Query: 621 RVRIIE---------GVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIART 671
R + +++G+ YL + ++++HRDL A NVL+ KISDFG++R
Sbjct: 120 DERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD 176
Query: 672 FGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDS 731
++ ++ +M+ E +++ +SDV+SFGVLL EI++ N Y +
Sbjct: 177 VYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP--YPGIA 234
Query: 732 LTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791
L +NL K +++ P +E +Y+++ C ++ RPT ++
Sbjct: 235 PERL---FNLLK--TGYRMERPENCSEEMYNLMLT-------CWKQEPDKRPTFADISKE 282
Query: 792 LKDEIVN 798
L+ +V
Sbjct: 283 LEKMMVK 289
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 3e-17
Identities = 63/219 (28%), Positives = 112/219 (51%), Gaps = 36/219 (16%)
Query: 516 FSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEE----VAVKRL-SSKSGQGLEEF 570
F + LG G FG VYK + W + GE+ VA+K L + S + +E
Sbjct: 9 FKKIKVLGSGAFGTVYKGL--------W----IPEGEKVKIPVAIKELREATSPKANKEI 56
Query: 571 KNEMMLIAKLQHRNLVRLFGCCIEQGEKI--SIYEFDIVTDPARKD--------LLDWTT 620
+E ++A + + ++ RL G C+ ++ + F + D R+ LL+W
Sbjct: 57 LDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 116
Query: 621 RVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSN 680
++ A+G+ YL + R++HRDL A NVL+ + + KI+DFG+A+ G DE + +
Sbjct: 117 QI------AKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYH 167
Query: 681 TNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
+M+ E LH +++ +SDV+S+GV + E+++
Sbjct: 168 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 55/215 (25%), Positives = 103/215 (47%), Gaps = 38/215 (17%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQ 581
LG G FG VY+ + N G +EV++ + +++ + E+ L++KLQ
Sbjct: 8 LGSGSFGSVYEGL-------NLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 582 HRNLVRLFGCCIEQGEKISIY--------------EFDIVTDPARKDLLDWTTRVRIIEG 627
H N+V+ G E + + I+ ++ +P ++ TR +I+ G
Sbjct: 61 HPNIVQYLGTERE-EDNLYIFLELVPGGSLAKLLKKYGSFPEP----VIRLYTR-QILLG 114
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
+ YLH R +HRD+K +N+L+D++ K++DFG+A+ S G+
Sbjct: 115 LE----YLH--DR-NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGS 164
Query: 688 YGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSK 721
+M+PE G + + +D++S G +LE+ + K
Sbjct: 165 PYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 4e-17
Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 48/217 (22%)
Query: 510 SAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRL---SSKSGQG 566
+ ++ KLGEG FG VYK+ + G VA+K++ + K G
Sbjct: 4 CSKLRDYEILGKLGEGTFGEVYKARQI------------KTGRVVALKKILMHNEKDGFP 51
Query: 567 LEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKI-----SIYEFDIVTDPARKDL--LDWT 619
+ + E+ ++ KL+H N+V L +E+ +K S+Y +VT DL L
Sbjct: 52 ITALR-EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVY---MVTPYMDHDLSGLLEN 107
Query: 620 TRVR--------IIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIART 671
V+ + + +G+ YLH+ ++HRD+KA+N+L+D+ KI+DFG+AR
Sbjct: 108 PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARP 164
Query: 672 FGGDEMQSN----------TNRIVGTYGYMSPEYALH 698
+ G TN +V T Y PE L
Sbjct: 165 YDGPPPNPKGGGGGGTRKYTNLVV-TRWYRPPELLLG 200
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 21/209 (10%)
Query: 522 LGEGGFGPVYKSIERYVEIC-NWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL 580
LG+G FG VY +C + G+ L ++V S ++ + + + E+ L+ L
Sbjct: 10 LGQGAFGRVY--------LCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61
Query: 581 QHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKD-------LLDWTTRVRIIEGVAQGLL 633
QH +V+ +GC ++ EK + + + KD L + TR + + +G+
Sbjct: 62 QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KYTRQILEGMS 120
Query: 634 YLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNR-IVGTYGYMS 692
YLH ++HRD+K +N+L DS N K+ DFG ++ M R + GT +MS
Sbjct: 121 YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMS 177
Query: 693 PEYALHGLFSIKSDVFSFGVLLLEILSSK 721
PE + K+DV+S G ++E+L+ K
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 6e-17
Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 20/201 (9%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL 580
K+GEG G V + E++ +G +VAVK + + Q E NE++++
Sbjct: 28 KIGEGSTGIVCIAREKH------------SGRQVAVKMMDLRKQQRRELLFNEVVIMRDY 75
Query: 581 QHRNLVRLFGCCIEQGEKISIYEF---DIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQ 637
QH+N+V ++ + E + EF +TD + L+ + E V Q L YLH
Sbjct: 76 QHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHS 135
Query: 638 YSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYAL 697
VIHRD+K+ ++LL D K+SDFG D + + +VGT +M+PE
Sbjct: 136 QG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVIS 190
Query: 698 HGLFSIKSDVFSFGVLLLEIL 718
+ + D++S G++++E++
Sbjct: 191 RTPYGTEVDIWSLGIMVIEMV 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 6e-17
Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 31/221 (14%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN 572
D E LG+G +G VY + + L +A+K + + + ++
Sbjct: 7 YDENGERVVLGKGTYGIVYAARD------------LSTQVRIAIKEIPERDSRYVQPLHE 54
Query: 573 EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLL--DW-------TTRVR 623
E+ L + L+HRN+V+ G E G I+ + V + LL W T +
Sbjct: 55 EIALHSYLKHRNIVQYLGSDSENGF-FKIF-MEQVPGGSLSALLRSKWGPLKDNEQTIIF 112
Query: 624 IIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP-KISDFGIARTFGGDEMQSNTN 682
+ + +GL YLH +++HRD+K NVL+++ KISDFG ++ G + T
Sbjct: 113 YTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTE 167
Query: 683 RIVGTYGYMSPEYALHGL--FSIKSDVFSFGVLLLEILSSK 721
GT YM+PE G + +D++S G ++E+ + K
Sbjct: 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 6e-17
Identities = 65/213 (30%), Positives = 109/213 (51%), Gaps = 36/213 (16%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEE----VAVKRL-SSKSGQGLEEFKNEMML 576
LG G FG VYK I W + +GE VA+K L + S + +E +E +
Sbjct: 15 LGSGAFGTVYKGI--------W----IPDGENVKIPVAIKVLRENTSPKANKEILDEAYV 62
Query: 577 IAKLQHRNLVRLFGCCIEQGEKI--SIYEFDIVTDPAR--------KDLLDWTTRVRIIE 626
+A + + RL G C+ ++ + + + D R +DLL+W ++
Sbjct: 63 MAGVGSPYVCRLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI---- 118
Query: 627 GVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVG 686
A+G+ YL + +R++HRDL A NVL+ S + KI+DFG+AR DE + + +
Sbjct: 119 --AKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV 173
Query: 687 TYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
+M+ E LH F+ +SDV+S+GV + E+++
Sbjct: 174 PIKWMALESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 9e-17
Identities = 63/227 (27%), Positives = 93/227 (40%), Gaps = 47/227 (20%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQ-GKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL 580
LG+GGFG V C K GK+ +++ KRL + G+ + NE ++ K+
Sbjct: 1 LGKGGFGEVCA--------CQVKATGKMYACKKLDKKRLKKRKGEQMA--LNEKKILEKV 50
Query: 581 QHRNLVRLFGCCIEQGEKISIYEFDIVTDPA-----------RKDLLDWTTRV----RII 625
R +V L Y F+ D + + + R I
Sbjct: 51 SSRFIVSL------------AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAI 98
Query: 626 EGVAQ---GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTN 682
AQ GL +LHQ R+++RDLK NVLLD N +ISD G+A G
Sbjct: 99 FYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIK 152
Query: 683 RIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNT 729
GT GYM+PE ++ D F+ G L E+++ + R
Sbjct: 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKE 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 9e-17
Identities = 64/213 (30%), Positives = 110/213 (51%), Gaps = 33/213 (15%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVK--RLSSKSGQGLEEFK-NEMMLI 577
K+GEG +G VYK+ ++ GE VA+K RL ++ +G+ E+ L+
Sbjct: 6 KIGEGTYGVVYKARDKL------------TGEIVALKKIRLETED-EGVPSTAIREISLL 52
Query: 578 AKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTRV----RIIEG----VA 629
+L H N+VRL + + ++EF D K +D + +I+ +
Sbjct: 53 KELNHPNIVRLLDVVHSENKLYLVFEF---LDLDLKKYMDSSPLTGLDPPLIKSYLYQLL 109
Query: 630 QGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYG 689
QG+ Y H + RV+HRDLK N+L+D + K++DFG+AR F G +++ T+ +V T
Sbjct: 110 QGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV-TLW 164
Query: 690 YMSPEYALHG-LFSIKSDVFSFGVLLLEILSSK 721
Y +PE L +S D++S G + E+++ +
Sbjct: 165 YRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-16
Identities = 66/227 (29%), Positives = 109/227 (48%), Gaps = 46/227 (20%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIA 578
E+ +GEG FG V +++ + K G +N +K +S++ +F E+ ++
Sbjct: 7 EDVIGEGNFGQVIRAMIK-------KDGLKMNAAIKMLKEFASENDH--RDFAGELEVLC 57
Query: 579 KL-QHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTRVRIIE----------- 626
KL H N++ L G C +G Y + + +LLD+ + R++E
Sbjct: 58 KLGHHPNIINLLGACENRG-----YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGT 112
Query: 627 --------------GVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTF 672
VA G+ YL S + IHRDL A NVL+ ++ KI+DFG++R
Sbjct: 113 ASTLTSQQLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR-- 167
Query: 673 GGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
G+E+ +M+ E + +++ KSDV+SFGVLL EI+S
Sbjct: 168 -GEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 65/216 (30%), Positives = 107/216 (49%), Gaps = 26/216 (12%)
Query: 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVK--RLSSKSGQGLEEFKN 572
++++ K+GEG +G VYK + G+ VA+K RL S+
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNK------------KTGQIVAMKKIRLESEEEGVPSTAIR 48
Query: 573 EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF---DI--VTDPARKD-LLDWTTRVRIIE 626
E+ L+ +LQH N+V L +++ I+EF D+ D K +D +
Sbjct: 49 EISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLY 108
Query: 627 GVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVG 686
+ QG+L+ H RV+HRDLK N+L+D+ K++DFG+AR F G ++ T+ +V
Sbjct: 109 QILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVV- 163
Query: 687 TYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSK 721
T Y +PE L +S D++S G + E+ + K
Sbjct: 164 TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-16
Identities = 53/211 (25%), Positives = 98/211 (46%), Gaps = 37/211 (17%)
Query: 542 NWKQGKLL---------------NGEEVAVKRLS----SKSGQG--LEEFKNEMMLIAKL 580
W +G+ L G +AVK+++ + S Q +E + E+ L+A+L
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 581 QHRNLVRLFGCCIEQGEKISIYEF----DIVTDPARKDLLDWTTRVRIIEGVAQGLLYLH 636
H +++R+ G E E+ + ++ + E + +GL YLH
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLH 120
Query: 637 QYSRLRVIHRDLKASNVLLDSD-MNPKISDFGIARTF-----GGDEMQSNTNRIVGTYGY 690
+ ++IHRD+K +N+L+DS +I+DFG A G E Q +++GT +
Sbjct: 121 EN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG---QLLGTIAF 174
Query: 691 MSPEYALHGLFSIKSDVFSFGVLLLEILSSK 721
M+PE + DV+S G +++E+ ++K
Sbjct: 175 MAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 64/221 (28%), Positives = 112/221 (50%), Gaps = 37/221 (16%)
Query: 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVK--RLSSKSGQGLEEFKN 572
NF + K+GEG +G VYK+ + L GE VA+K RL +++
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNK------------LTGEVVALKKIRLDTETEGVPSTAIR 48
Query: 573 EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF---DIVTDPARKDLLDWTTRVRI----- 624
E+ L+ +L H N+V+L + + ++EF D+ K +D + I
Sbjct: 49 EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL------KKFMDASPLSGIPLPLI 102
Query: 625 ---IEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNT 681
+ + QGL + H + RV+HRDLK N+L++++ K++DFG+AR F G +++ T
Sbjct: 103 KSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYT 158
Query: 682 NRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSK 721
+ +V T Y +PE L +S D++S G + E+++ +
Sbjct: 159 HEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 65/229 (28%), Positives = 104/229 (45%), Gaps = 57/229 (24%)
Query: 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN-- 572
+ + KLGEG + VYK+ ++ G VA+K++ K G+ +E K+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDK------------ETGRIVAIKKI--KLGE-RKEAKDGI 45
Query: 573 ------EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTRVRIIE 626
E+ L+ +L+H N++ L G K +I +V + DL I+
Sbjct: 46 NFTALREIKLLQELKHPNIIGLLDVF---GHKSNIN---LVFEFMETDLEKVIKDKSIVL 99
Query: 627 GVA----------QGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFG--G 674
A +GL YLH ++HRDLK +N+L+ SD K++DFG+AR+FG
Sbjct: 100 TPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156
Query: 675 DEMQSNTNRIVGTYGYMSPEYALHGLFSIKS-----DVFSFGVLLLEIL 718
+M V T Y +PE LF + D++S G + E+L
Sbjct: 157 RKMTHQ----VVTRWYRAPEL----LFGARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 3e-16
Identities = 70/222 (31%), Positives = 106/222 (47%), Gaps = 34/222 (15%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLS-SKSGQGLEEFKNEMMLIAKL 580
LGEG FG V ++ E Y + VAVK L + + + L + +EM L+ +
Sbjct: 20 LGEGCFGQVVRA-EAYGIDKSRPD----QTVTVAVKMLKDNATDKDLADLISEMELMKLI 74
Query: 581 -QHRNLVRLFGCCIEQGEKISI----------------------YEFDIVTDPARKDLLD 617
+H+N++ L G C ++G I Y FDI P ++ L
Sbjct: 75 GKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVP--EEQLS 132
Query: 618 WTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEM 677
+ V VA+G+ YL SR R IHRDL A NVL+ D KI+DFG+AR +
Sbjct: 133 FKDLVSCAYQVARGMEYLE--SR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDY 189
Query: 678 QSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
T+ +M+PE +++ +SDV+SFG+L+ EI +
Sbjct: 190 YKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 78/291 (26%), Positives = 132/291 (45%), Gaps = 42/291 (14%)
Query: 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSS---KSGQGLEEFK 571
NF E K+G G F VY++ LL+G VA+K++ + +
Sbjct: 3 NFRIEKKIGRGQFSEVYRA------------TCLLDGVPVALKKVQIFDLMDAKARADCI 50
Query: 572 NEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPAR--------KDLLDWTTRVR 623
E+ L+ +L H N+++ + IE E + E D +R K L+ T +
Sbjct: 51 KEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWK 110
Query: 624 IIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNR 683
+ L ++H SR RV+HRD+K +NV + + K+ D G+ R F +++
Sbjct: 111 YFVQLCSALEHMH--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-- 165
Query: 684 IVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWK 743
+VGT YMSPE ++ KSD++S G LL E+ + + + FY G NL+
Sbjct: 166 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ--SPFY--------GDKMNLYS 215
Query: 744 DDKAWKLMD-PTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLK 793
K + D P + ++ YS R ++ +C+ + RP + V + K
Sbjct: 216 LCKKIEQCDYPPLPSDH-YSEELR--QLVNMCINPDPEKRPDITYVYDVAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 4e-16
Identities = 62/219 (28%), Positives = 96/219 (43%), Gaps = 36/219 (16%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVK--RLSSKSGQGLEEFKNEMMLIAK 579
LGEG FG V + Q + VAVK +L + +EEF +E +
Sbjct: 7 LGEGEFGSVMEG--------QLSQDDGSQLK-VAVKTMKLDIHTYSEIEEFLSEAACMKD 57
Query: 580 LQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK--DLLDWTTRVRIIEG---------- 627
H N+++L G C E I + +V P K DL + R+
Sbjct: 58 FDHPNVMKLIGVCFEASSLQKIPK-PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLL 116
Query: 628 -----VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIART-FGGDEMQSNT 681
+A G+ YL S IHRDL A N +L DM ++DFG+++ + GD +
Sbjct: 117 KFMVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQ-- 171
Query: 682 NRIVGT-YGYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
RI +++ E +++ KSDV++FGV + EI +
Sbjct: 172 GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 4e-16
Identities = 61/230 (26%), Positives = 106/230 (46%), Gaps = 42/230 (18%)
Query: 516 FSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRL--SSKSGQGLEEFK-N 572
+ E +G G +G VYK+ K GK G+E A+K+ + G+ +
Sbjct: 2 YEIEGCIGRGTYGRVYKAK--------RKNGKD--GKEYAIKKFKGDKEQYTGISQSACR 51
Query: 573 EMMLIAKLQHRNLVRLFGCCIEQGEKISIY------EFD---IVTD---PARKDLLDWTT 620
E+ L+ +L+H N+V L +E +K S+Y E D I+ R +
Sbjct: 52 EIALLRELKHENVVSLVEVFLEHADK-SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMV 110
Query: 621 RVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP----KISDFGIARTFGGDE 676
+ ++ + G+ YLH V+HRDLK +N+L+ + KI D G+AR F
Sbjct: 111 K-SLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF-NAP 165
Query: 677 MQS--NTNRIVGTYGYMSPEYAL---HGLFSIKSDVFSFGVLLLEILSSK 721
++ + + +V T Y +PE L H +I D+++ G + E+L+ +
Sbjct: 166 LKPLADLDPVVVTIWYRAPELLLGARHYTKAI--DIWAIGCIFAELLTLE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 5e-16
Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 40/216 (18%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL- 580
+GEG +G VYK+ + K G+L VA+K + EE K E ++ K
Sbjct: 14 IGEGTYGKVYKARHK-------KTGQL-----VAIKIMDII-EDEEEEIKEEYNILRKYS 60
Query: 581 QHRNLVRLFGCCIEQGEKIS------IYEF---DIVTDPARKDLLDWTTRVR------II 625
H N+ +G I++ + + E VTD + L R++ I+
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKG-LRKKGKRLKEEWIAYIL 119
Query: 626 EGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIV 685
+GL YLH+ +VIHRD+K N+LL + K+ DFG++ + NT +
Sbjct: 120 RETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT--FI 174
Query: 686 GTYGYMSPE-----YALHGLFSIKSDVFSFGVLLLE 716
GT +M+PE + +SDV+S G+ +E
Sbjct: 175 GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 5e-16
Identities = 62/220 (28%), Positives = 102/220 (46%), Gaps = 47/220 (21%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNE 573
DNF K+GEG G V + ++ G +VAVK++ + Q E NE
Sbjct: 22 DNF---VKIGEGSTGIVCIATDKS------------TGRQVAVKKMDLRKQQRRELLFNE 66
Query: 574 MMLIAKLQHRNLVRLFGCCIEQGEKISIYEF-------DIVTDPARKDLLDWTTRVR--- 623
++++ QH N+V ++ + E + EF DIVT TR+
Sbjct: 67 VVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH----------TRMNEEQ 116
Query: 624 ---IIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSN 680
+ V + L +LH VIHRD+K+ ++LL SD K+SDFG F +
Sbjct: 117 IATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFG----FCAQVSKEV 169
Query: 681 TNR--IVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEIL 718
R +VGT +M+PE + + D++S G++++E++
Sbjct: 170 PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 5e-16
Identities = 85/294 (28%), Positives = 136/294 (46%), Gaps = 53/294 (18%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAV--------KRLSSKSGQGLEEFKNE 573
LG G FG VYK V N Q LL +E+ V KR KS + + +E
Sbjct: 8 LGSGAFGCVYK-----VRKKNNGQ-NLLALKEINVHNPAFGKDKRERDKS---IGDIVSE 58
Query: 574 MMLIAK-LQHRNLVRLFGCCIEQGEKISIYEFDIVTDPAR------KDLLDWTTRVRIIE 626
+ +I + L+H N+VR + +E +++ I I P K+ T RI
Sbjct: 59 VTIIKEQLRHPNIVRYYKTFLE-NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN 117
Query: 627 GVAQ---GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNR 683
Q L YLH+ R ++HRDL +N++L D I+DFG+A+ + ++
Sbjct: 118 IFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTS--- 172
Query: 684 IVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWK 743
+VGT Y PE + + K+DV++FG +L ++ FY+T+ L+L
Sbjct: 173 VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQM--CTLQPPFYSTNMLSL--------- 221
Query: 744 DDKAWKLMDPTMQ--NEALYS-MVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794
A K+++ + E +YS VT I C+ +A RP +++V AM+ D
Sbjct: 222 ---ATKIVEAVYEPLPEGMYSEDVTDVITS---CLTPDAEARPDIIQVSAMISD 269
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 5e-16
Identities = 57/208 (27%), Positives = 105/208 (50%), Gaps = 28/208 (13%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN--EMMLIA 578
K+GEG +G VYK+ ++ L GE VA+K++ + E+ L+
Sbjct: 6 KIGEGTYGVVYKARDK------------LTGEIVAIKKIKLRFESEGIPKTALREIKLLK 53
Query: 579 KLQHRNLVRLFGCCIEQGEKISIYEF---DI--VTDPARKDLLDWTTRVR-IIEGVAQGL 632
+L H N+++L +G+ ++EF D+ + ++ L + + ++ + + QGL
Sbjct: 54 ELNHPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPE--SLIKSYLYQLLQGL 111
Query: 633 LYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMS 692
+ H + ++HRDLK N+L++++ K++DFG+AR+FG V T Y +
Sbjct: 112 AFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSP--VRPYTHYVVTRWYRA 166
Query: 693 PEYALH-GLFSIKSDVFSFGVLLLEILS 719
PE L +S D++S G + E+LS
Sbjct: 167 PELLLGDKGYSTPVDIWSVGCIFAELLS 194
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 6e-16
Identities = 65/221 (29%), Positives = 111/221 (50%), Gaps = 34/221 (15%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLS-SKSGQGLEEFK- 571
D + + K+GEG +G VYK+ +R E +A+K++ + +G+
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTN------------ETIALKKIRLEQEDEGVPSTAI 49
Query: 572 NEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF---------DIVTDPARKDLLDWTTRV 622
E+ L+ ++QH N+VRL + ++E+ D D A+ L T
Sbjct: 50 REISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLY 109
Query: 623 RIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP-KISDFGIARTFGGDEMQSNT 681
+I+ G+A Y H + RV+HRDLK N+L+D N K++DFG+AR F G +++ T
Sbjct: 110 QILRGIA----YCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFT 161
Query: 682 NRIVGTYGYMSPEYALHGL-FSIKSDVFSFGVLLLEILSSK 721
+ +V T Y +PE L +S D++S G + E+++ K
Sbjct: 162 HEVV-TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 8e-16
Identities = 55/217 (25%), Positives = 106/217 (48%), Gaps = 20/217 (9%)
Query: 505 SLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG 564
++ S+ ++ K+G+G G VY +I+ + G+EVA+K+++ +
Sbjct: 10 TIVSVGDPKKKYTRFEKIGQGASGTVYTAID------------VATGQEVAIKQMNLQQQ 57
Query: 565 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF---DIVTDPARKDLLDWTTR 621
E NE++++ + +H N+V + E + E+ +TD + +D
Sbjct: 58 PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI 117
Query: 622 VRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNT 681
+ Q L +LH +VIHRD+K+ N+LL D + K++DFG + QS
Sbjct: 118 AAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKR 172
Query: 682 NRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEIL 718
+ +VGT +M+PE + K D++S G++ +E++
Sbjct: 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 9e-16
Identities = 88/309 (28%), Positives = 133/309 (43%), Gaps = 59/309 (19%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQ-GLEEFKNEMMLIAKL 580
LGEG FG V + E + K +VAVK L S + + L + +EM ++ +
Sbjct: 26 LGEGCFGQVVMA-----EAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 80
Query: 581 -QHRNLVRLFGCCIEQGEKISIYEF------------------DIVTDPAR--KDLLDWT 619
+H+N++ L G C + G I E+ + +P + ++ L +
Sbjct: 81 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140
Query: 620 TRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQS 679
V VA+G+ YL + + IHRDL A NVL+ D KI+DFG+AR +
Sbjct: 141 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 197
Query: 680 NTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAW 739
T +M+PE +++ +SDV+SFGVLL EI TL G +
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI--------------FTLGGSPY 243
Query: 740 ------NLWKDDKAWKLMD-PTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAML 792
L+K K MD P+ LY M+ C + RPT ++V L
Sbjct: 244 PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRD-------CWHAVPSQRPTFKQLVEDL 296
Query: 793 KDEIVNLPS 801
D I+ L S
Sbjct: 297 -DRILALTS 304
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 80/310 (25%), Positives = 131/310 (42%), Gaps = 56/310 (18%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGE---EVAVKRLS-SKSGQGLEEFKNEMML 576
+LG+G FG VY+ R ++ GE VAVK ++ S S + EF NE +
Sbjct: 13 ELGQGSFGMVYEGNAR----------DIIKGEAETRVAVKTVNESASLRERIEFLNEASV 62
Query: 577 IAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTD------PARKDLLDWTTR--------V 622
+ ++VRL G + + + E D R + + R +
Sbjct: 63 MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 122
Query: 623 RIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTN 682
++ +A G+ YL+ + +HRDL A N ++ D KI DFG+ R +
Sbjct: 123 QMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 683 RIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEI--LSSKKNTRFYNTDSLTLLGHAWN 740
+ + +M+PE G+F+ SD++SFGV+L EI L+ + N L +
Sbjct: 180 KGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY 239
Query: 741 LWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLP 800
L + D + + M+ +C Q N RPT LE+V +LKD++
Sbjct: 240 LDQPDNCPERVTDLMR----------------MCWQFNPKMRPTFLEIVNLLKDDL---- 279
Query: 801 SPHQPAFSYV 810
P+F V
Sbjct: 280 ---HPSFPEV 286
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 71/287 (24%), Positives = 121/287 (42%), Gaps = 48/287 (16%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGL-EEFKNEMMLIAK 579
+GEG FG VY+ + Y+ + + + VAVK + + + E+F E ++ +
Sbjct: 13 CIGEGQFGDVYQGV--YMS----PENEKIA---VAVKTCKNCTSPSVREKFLQEAYIMRQ 63
Query: 580 LQHRNLVRLFGCCIEQ-----------GEKISIYEFDIVTDPARKDLLDWTTRVRIIEGV 628
H ++V+L G E GE S + K LD + + +
Sbjct: 64 FDHPHIVKLIGVITENPVWIVMELAPLGELRSYLQ-------VNKYSLDLASLILYSYQL 116
Query: 629 AQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEM-QSNTNRIVGT 687
+ L YL R +HRD+ A NVL+ S K+ DFG++R + +++ ++
Sbjct: 117 STALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL--P 171
Query: 688 YGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKA 747
+M+PE F+ SDV+ FGV + EIL F + ++G +
Sbjct: 172 IKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKP-FQGVKNNDVIGRI------ENG 224
Query: 748 WKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794
+L P LYS++T+ C + + RP E+ A L D
Sbjct: 225 ERLPMPPNCPPTLYSLMTK-------CWAYDPSKRPRFTELKAQLSD 264
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 59/218 (27%), Positives = 106/218 (48%), Gaps = 36/218 (16%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRL---SSKSGQGLEEFKNEMML- 576
++GEG +G V+K+ + K G G VA+KR+ + + G L + +L
Sbjct: 8 EIGEGAYGKVFKARD-------LKNG----GRFVALKRVRVQTGEEGMPLSTIREVAVLR 56
Query: 577 -IAKLQHRNLVRLFGCC-IEQGEKISIYEFDIVTDPARKDLLDWTTRV-----------R 623
+ +H N+VRLF C + + ++ + + +V + +DL + +V
Sbjct: 57 HLETFEHPNVVRLFDVCTVSRTDRET--KLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD 114
Query: 624 IIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNR 683
++ + +GL +LH + RV+HRDLK N+L+ S K++DFG+AR + Q
Sbjct: 115 MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTS 168
Query: 684 IVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSK 721
+V T Y +PE L ++ D++S G + E+ K
Sbjct: 169 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 29/208 (13%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL 580
+LG+G FG VYK+ + G A K + +KS + LE++ E+ ++A
Sbjct: 19 ELGDGAFGKVYKAKNKE------------TGALAAAKVIETKSEEELEDYMVEIEILATC 66
Query: 581 QHRNLVRLFGCCIEQGEKISIYEF------DIVTDPARKDLLDWTTRVRIIEGVAQGLLY 634
H +V+L G G+ + EF D + + L + +V I + + L Y
Sbjct: 67 NHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-ICRQMLEALQY 125
Query: 635 LHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPE 694
LH +++IHRDLKA NVLL D + K++DFG++ + + +GT +M+PE
Sbjct: 126 LHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAK--NVKTLQRRDSFIGTPYWMAPE 180
Query: 695 YAL-----HGLFSIKSDVFSFGVLLLEI 717
+ + K+D++S G+ L+E+
Sbjct: 181 VVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 72/303 (23%), Positives = 132/303 (43%), Gaps = 69/303 (22%)
Query: 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAK 579
NK+G G FG VY ++ N G+L+ +E+ ++ K+ ++E +EM ++
Sbjct: 6 NKIGGGTFGKVYTAV-------NLDTGELMAVKEIRIQDNDPKT---IKEIADEMKVLEL 55
Query: 580 LQHRNLVRLFGCCIEQGEKISIYE--------FDIVTDPARKDLLDWT-TRV---RIIEG 627
L+H NLV+ +G + + EK+ I+ +++ +LD RV +++EG
Sbjct: 56 LKHPNLVKYYGVEVHR-EKVYIFMEYCSGGTLEELL---EHGRILDEHVIRVYTLQLLEG 111
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTF--GGDEMQSNTNRIV 685
+A YLH + ++HRD+K +N+ LD + K+ DFG A M +
Sbjct: 112 LA----YLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA 164
Query: 686 GTYGYMSPEYALHGLFSIK---SDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLW 742
GT YM+PE G +D++S G ++LE+ + K+
Sbjct: 165 GTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL--------------- 209
Query: 743 KDDKAWKLM-------DPTM-QNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794
D +++M P + + L ++ C++ + RPT E +L+
Sbjct: 210 --DNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLD---RCLESDPKKRPTASE---LLQH 261
Query: 795 EIV 797
V
Sbjct: 262 PFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 62/216 (28%), Positives = 105/216 (48%), Gaps = 31/216 (14%)
Query: 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKR--LSSKSGQGLEEFKN 572
+F KLG+G +G VYK ++R L + + A+K L S S + E+ N
Sbjct: 1 DFKVLKKLGKGSYGSVYK-VKR-----------LSDNQFYALKEVDLGSMSQKEREDAVN 48
Query: 573 EMMLIAKLQHRNLVR-----LFG---CCIEQGEKISIYEFDIVTDPARKDLLDWTTRVRI 624
E+ ++A + H N++ L G C + + I ++ L+ RI
Sbjct: 49 EIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRI 108
Query: 625 IEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSN-TNR 683
+ +GL LH+ +++HRDLK++N+LL ++ KI D GI++ ++ N
Sbjct: 109 FIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKV-----LKKNMAKT 160
Query: 684 IVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
+GT YM+PE +S KSD++S G LL E+ +
Sbjct: 161 QIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMAT 196
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 21/206 (10%)
Query: 516 FSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQG-LEEFKNEM 574
F++ K+G+G FG V+K I+ + + VA+K + + + +E+ + E+
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQ------------KVVAIKIIDLEEAEDEIEDIQQEI 53
Query: 575 MLIAKLQHRNLVRLFGCCIEQGEKISIYEF---DIVTDPARKDLLDWTTRVRIIEGVAQG 631
++++ + + +G ++ + I E+ D LD T I+ + +G
Sbjct: 54 TVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKG 113
Query: 632 LLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYM 691
L YLH + IHRD+KA+NVLL K++DFG+A + Q N VGT +M
Sbjct: 114 LDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWM 168
Query: 692 SPEYALHGLFSIKSDVFSFGVLLLEI 717
+PE + K+D++S G+ +E+
Sbjct: 169 APEVIKQSAYDSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 34/209 (16%)
Query: 542 NWKQGKLL---------------NGEEVAVKRL-----SSKSGQGLEEFKNEMMLIAKLQ 581
NW+ GKLL G E+AVK++ S ++ + + + E+ L+ L+
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 582 HRNLVRLFGCCIEQGE-KISIYEFDIVTDPARKD-------LLDWTTRVRIIEGVAQGLL 633
H +V+ +GC + E K+SI+ + + + KD L + TR R + QG+
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIF-VEYMPGGSIKDQLKAYGALTENVTR-RYTRQILQGVS 120
Query: 634 YLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQ-SNTNRIVGTYGYMS 692
YLH ++HRD+K +N+L DS N K+ DFG ++ M + + GT +MS
Sbjct: 121 YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMS 177
Query: 693 PEYALHGLFSIKSDVFSFGVLLLEILSSK 721
PE + K+DV+S ++E+L+ K
Sbjct: 178 PEVISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 63/224 (28%), Positives = 104/224 (46%), Gaps = 46/224 (20%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL- 580
+GEG FG V K+ + K G ++ +K +SK +F E+ ++ KL
Sbjct: 3 IGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLG 53
Query: 581 QHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTRVRIIE-------------- 626
H N++ L G C +G Y + + +LLD+ + R++E
Sbjct: 54 HHPNIINLLGACEHRG-----YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 108
Query: 627 -----------GVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGD 675
VA+G+ YL S+ + IHRDL A N+L+ + KI+DFG++R G
Sbjct: 109 LSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQ 162
Query: 676 EMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
E+ +M+ E + +++ SDV+S+GVLL EI+S
Sbjct: 163 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-15
Identities = 67/214 (31%), Positives = 97/214 (45%), Gaps = 34/214 (15%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQ 581
LG+GGFG V R GKL +++ KRL K +G E E ++AK+
Sbjct: 1 LGKGGFGEVSACQMR-------ATGKLYACKKLNKKRL--KKRKGYEGAMVEKRILAKVH 51
Query: 582 HRNLVRLFGCCIEQGEKIS--------------IYEFDIVTDPARKDLLDWTTRVRIIEG 627
R +V L + + IY D +P + +II
Sbjct: 52 SRFIVSL-AYAFQTKTDLCLVMTIMNGGDLRYHIYNVD-EENPGFPEPRACFYTAQII-- 107
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
GL +LHQ R+I+RDLK NVLLD+D N +ISD G+A + QS T GT
Sbjct: 108 --SGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVEL--KDGQSKTKGYAGT 160
Query: 688 YGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSK 721
G+M+PE + D F+ GV L E+++++
Sbjct: 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 64/205 (31%), Positives = 97/205 (47%), Gaps = 25/205 (12%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLE-EFKNEMMLIAKL 580
LG+G FG V+K G L + VAVK Q L+ +F +E ++ +
Sbjct: 3 LGKGNFGEVFK-------------GTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQY 49
Query: 581 QHRNLVRLFGCCIEQGEKISIYEF----DIVTDPARK-DLLDWTTRVRIIEGVAQGLLYL 635
H N+V+L G C ++ + E D ++ +K D L V+ A G+ YL
Sbjct: 50 DHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYL 109
Query: 636 HQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTF-GGDEMQSNTNRIVGTYGYMSPE 694
+ IHRDL A N L+ + KISDFG++R G S +I + +PE
Sbjct: 110 ESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAPE 164
Query: 695 YALHGLFSIKSDVFSFGVLLLEILS 719
+G +S +SDV+S+G+LL E S
Sbjct: 165 ALNYGRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 40/116 (34%), Positives = 54/116 (46%), Gaps = 10/116 (8%)
Query: 619 TTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQ 678
+ I E + L YLH +IHRD+K N+LLD + I+DF IA D +
Sbjct: 101 QVKFWICE-IVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL- 155
Query: 679 SNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTL 734
T GT GYM+PE +S+ D +S GV E L + R Y S T+
Sbjct: 156 --TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECL---RGKRPYRGHSRTI 206
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 3e-15
Identities = 56/220 (25%), Positives = 107/220 (48%), Gaps = 20/220 (9%)
Query: 505 SLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG 564
++ SI ++ K+G+G G V+ +I+ G+EVA+K+++ +
Sbjct: 10 TIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVAT------------GQEVAIKQINLQKQ 57
Query: 565 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF---DIVTDPARKDLLDWTTR 621
E NE++++ +L++ N+V + E + E+ +TD + +D
Sbjct: 58 PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQI 117
Query: 622 VRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNT 681
+ Q L +LH +VIHRD+K+ NVLL D + K++DFG + QS
Sbjct: 118 AAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE--QSKR 172
Query: 682 NRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSK 721
+ +VGT +M+PE + K D++S G++ +E++ +
Sbjct: 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-15
Identities = 63/221 (28%), Positives = 105/221 (47%), Gaps = 37/221 (16%)
Query: 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVK--RLSSKSGQGLEEFKN 572
NF + KLGEG + VYK R GE VA+K L ++ G +
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNR------------TTGEIVALKEIHLDAEEGTPSTAIR- 47
Query: 573 EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF---------DIVTDPARKDLLDWTTRVR 623
E+ L+ +L+H N+VRL + + + ++E+ D LD T
Sbjct: 48 EISLMKELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGA---LDPNTVKS 104
Query: 624 IIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNT-- 681
+ +G+ + H+ RV+HRDLK N+L++ K++DFG+AR FG + NT
Sbjct: 105 FTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFG---IPVNTFS 158
Query: 682 NRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSK 721
N +V T Y +P+ L +S D++S G ++ E+++ +
Sbjct: 159 NEVV-TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 62/218 (28%), Positives = 102/218 (46%), Gaps = 36/218 (16%)
Query: 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLS---SKSGQGLEEFK 571
NF E K+G G F VY++ C LL+ + VA+K++ + ++
Sbjct: 3 NFQIEKKIGRGQFSEVYRAT------C------LLDRKPVALKKVQIFEMMDAKARQDCV 50
Query: 572 NEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPA--------RKDLLD----WT 619
E+ L+ +L H N+++ IE E + E D + +K L+ W
Sbjct: 51 KEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWK 110
Query: 620 TRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQS 679
V++ V H +SR RV+HRD+K +NV + + K+ D G+ R F +
Sbjct: 111 YFVQLCSAVE------HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA 163
Query: 680 NTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEI 717
++ +VGT YMSPE ++ KSD++S G LL E+
Sbjct: 164 HS--LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 4e-15
Identities = 62/222 (27%), Positives = 103/222 (46%), Gaps = 27/222 (12%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQG-KLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL 580
+G G FG V+ +C K KL+ +++ V++++ + NE ++ L
Sbjct: 8 VGRGAFGIVH--------LCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLL 56
Query: 581 QHRNLVRLFGCCIEQGEKISIYEF-------DIVTDPARKDLLDWTTRVRIIEGVAQGLL 633
H N++ + +E + + E+ + + LLD T I+ Q LL
Sbjct: 57 SHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQK-RCNSLLDEDT---ILHFFVQILL 112
Query: 634 YLHQYSRLRVIHRDLKASNVLLDS-DMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMS 692
LH ++HRDLK N+LLD M KI DFGI++ +S +VGT Y+S
Sbjct: 113 ALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS---KSKAYTVVGTPCYIS 169
Query: 693 PEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTL 734
PE ++ KSD+++ G +L E+ S K+ N +L L
Sbjct: 170 PELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVL 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 77/297 (25%), Positives = 139/297 (46%), Gaps = 61/297 (20%)
Query: 517 SEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG---QGLEEFKNE 573
+++ +G G FG V++ I K+ +EVAV + K G + ++F +E
Sbjct: 8 TKQKVIGAGEFGEVFRGIL-----------KMPGRKEVAVAIKTLKPGYTEKQRQDFLSE 56
Query: 574 MMLIAKLQHRNLVRLFGCCIEQGEKISIYE-FDIVTDPARKDLLDWTTR----------- 621
++ + H N++RL G ++ ++ I+T+ LD R
Sbjct: 57 ASIMGQFSHHNIIRLEGV-------VTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL 109
Query: 622 VRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNT 681
V ++ G+A G+ YL S + +HRDL A N+L++S++ K+SDFG++R D + T
Sbjct: 110 VGMLRGIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYT 166
Query: 682 NRIVGTYG------YMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLL 735
T G + +PE + F+ SDV+SFG+++ E++S + R Y S +
Sbjct: 167 -----TSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGE--RPYWDMSNHEV 219
Query: 736 GHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAML 792
A N ++L P A+Y ++ L C Q++ RP +++V +L
Sbjct: 220 MKAIN-----DGFRLPAPMDCPSAVYQLM-------LQCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 79/296 (26%), Positives = 127/296 (42%), Gaps = 53/296 (17%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLS-SKSGQGLEEFKNEMMLIAK 579
+LG+G FG VY+ I + V K VA+K ++ + S + EF NE ++ +
Sbjct: 13 ELGQGSFGMVYEGIAKGVV-------KDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 65
Query: 580 LQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTRVR---------------- 623
++VRL G + QG+ + I+ R DL + +R
Sbjct: 66 FNCHHVVRLLGV-VSQGQPTLV----IMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120
Query: 624 ---IIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSN 680
+ +A G+ YL+ + +HRDL A N ++ D KI DFG+ R +
Sbjct: 121 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 177
Query: 681 TNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEI--LSSKKNTRFYNTDSLTLLGHA 738
+ + +MSPE G+F+ SDV+SFGV+L EI L+ + N L +
Sbjct: 178 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG 237
Query: 739 WNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794
L K D P M E + +C Q N RP+ LE+++ +K+
Sbjct: 238 GLLDKPDNC-----PDMLFELMR-----------MCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-15
Identities = 59/217 (27%), Positives = 103/217 (47%), Gaps = 20/217 (9%)
Query: 521 KLGEGGFGPVY----KSIERYVEICNWKQGKLLNGEEVAVKRLSSK-SGQGLEEFKNEMM 575
KLGEG FG V+ + + ++ + VAVK L + + +F E+
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPV--LVAVKMLRADVTKTARNDFLKEIK 69
Query: 576 LIAKLQHRNLVRLFGCCIEQGEKISIYEF----DIVTDPARKDLLDWTTRVRIIEGVA-Q 630
++++L++ N++RL G C+ I E+ D+ +++++ T I V+
Sbjct: 70 IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIA 129
Query: 631 GLLYLH-------QY-SRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTN 682
LLY+ +Y + L +HRDL N L+ + KI+DFG++R +
Sbjct: 130 NLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189
Query: 683 RIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
R V +M+ E L G F+ SDV++FGV L E+ +
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 5e-15
Identities = 55/220 (25%), Positives = 107/220 (48%), Gaps = 20/220 (9%)
Query: 505 SLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG 564
S+ S+ ++ K+G+G G VY +I+ + G+EVA+K+++ +
Sbjct: 10 SIVSVGDPKKKYTRFEKIGQGASGTVYTAID------------IATGQEVAIKQMNLQQQ 57
Query: 565 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF---DIVTDPARKDLLDWTTR 621
E NE++++ + ++ N+V + E + E+ +TD + +D
Sbjct: 58 PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI 117
Query: 622 VRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNT 681
+ Q L +LH +VIHRD+K+ N+LL D + K++DFG + QS
Sbjct: 118 AAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKR 172
Query: 682 NRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSK 721
+ +VGT +M+PE + K D++S G++ +E++ +
Sbjct: 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 5e-15
Identities = 60/222 (27%), Positives = 105/222 (47%), Gaps = 38/222 (17%)
Query: 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKR--LSSKSGQGLEEFKN 572
+ K+GEG FG +Y + + K + E +K L+ + E K
Sbjct: 1 RYEIIKKIGEGSFGKIYLA-----------KAKSDS-EHCVIKEIDLTKMPVKEKEASKK 48
Query: 573 EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF----DIVTDPARK--------DLLDWTT 620
E++L+AK++H N+V F E G + E+ D++ R+ +L W
Sbjct: 49 EVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV 108
Query: 621 RVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSD-MNPKISDFGIARTFGGDEMQS 679
+ ++ GL ++H +++HRD+K+ N+ L + M K+ DFGIAR +
Sbjct: 109 Q------ISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA 159
Query: 680 NTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSK 721
T VGT Y+SPE + ++ K+D++S G +L E+ + K
Sbjct: 160 YT--CVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 7e-15
Identities = 75/300 (25%), Positives = 136/300 (45%), Gaps = 71/300 (23%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG---QGLEEFKNEMM 575
E +G G FG E+C+ + KL E+ V + K+G + +F +E
Sbjct: 9 EKVIGAGEFG----------EVCSGRL-KLPGKREIPVAIKTLKAGYTEKQRRDFLSEAS 57
Query: 576 LIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTR-----------VRI 624
++ + H N++ L G + + + + I VT+ LD R V +
Sbjct: 58 IMGQFDHPNIIHLEGV-VTKSKPVMI-----VTEYMENGSLDAFLRKHDGQFTVIQLVGM 111
Query: 625 IEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRI 684
+ G+A G+ YL S + +HRDL A N+L++S++ K+SDFG++R D + T R
Sbjct: 112 LRGIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR- 167
Query: 685 VGTYG------YMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHA 738
G + +PE + F+ SDV+S+G+++ E++S + R Y
Sbjct: 168 ----GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE--RPY----------- 210
Query: 739 WNLWKDD------KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAML 792
W + D + ++L P AL+ ++ L C Q++ +RP ++V++L
Sbjct: 211 WEMSNQDVIKAIEEGYRLPAPMDCPAALHQLM-------LDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 7e-15
Identities = 53/220 (24%), Positives = 107/220 (48%), Gaps = 20/220 (9%)
Query: 505 SLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG 564
S+ S+ ++ K+G+G G VY +++ + G+EVA+++++ +
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMD------------VATGQEVAIRQMNLQQQ 58
Query: 565 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF---DIVTDPARKDLLDWTTR 621
E NE++++ + ++ N+V + E + E+ +TD + +D
Sbjct: 59 PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI 118
Query: 622 VRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNT 681
+ Q L +LH +VIHRD+K+ N+LL D + K++DFG + QS
Sbjct: 119 AAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKR 173
Query: 682 NRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSK 721
+ +VGT +M+PE + K D++S G++ +E++ +
Sbjct: 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 7e-15
Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 42/213 (19%)
Query: 542 NWKQGKLL---------------NGEEVAVKRL-----SSKSGQGLEEFKNEMMLIAKLQ 581
NW+ GKLL G E+AVK++ S ++ + + + E+ L+ L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 582 HRNLVRLFGCCIEQGEK-ISIYEFDIVTDPARKD-------LLDWTTRVRIIEGVAQGLL 633
H +V+ +GC + E+ +SI+ + + + KD L + TR + + +G+
Sbjct: 63 HERIVQYYGCLRDPMERTLSIF-MEHMPGGSIKDQLKSYGALTENVTR-KYTRQILEGVS 120
Query: 634 YLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIAR-----TFGGDEMQSNTNRIVGTY 688
YLH ++HRD+K +N+L DS N K+ DFG ++ G M+S + GT
Sbjct: 121 YLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS----VTGTP 173
Query: 689 GYMSPEYALHGLFSIKSDVFSFGVLLLEILSSK 721
+MSPE + K+D++S G ++E+L+ K
Sbjct: 174 YWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 7e-15
Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 27/210 (12%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIA 578
+ +LG+G FG VY ++ + +L +E+ V L+ + E L++
Sbjct: 5 QQRLGKGSFGTVYLVKDKKAV----AEERLKVLKEIPVGELNPNE---TVQANQEAQLLS 57
Query: 579 KLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTRV-----------RIIEG 627
KL H +V+ +E+ F I+T+ LD ++ E
Sbjct: 58 KLDHPAIVKFHASFLERDA------FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
Q LL +H + R++HRDLKA N+ L +++ KI DFG++R G + T GT
Sbjct: 112 FIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGT 168
Query: 688 YGYMSPEYALHGLFSIKSDVFSFGVLLLEI 717
YMSPE H + KSD++S G +L E+
Sbjct: 169 PYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 8e-15
Identities = 52/206 (25%), Positives = 104/206 (50%), Gaps = 21/206 (10%)
Query: 516 FSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQG-LEEFKNEM 574
F++ ++G+G FG V+K I+ + + VA+K + + + +E+ + E+
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQ------------QVVAIKIIDLEEAEDEIEDIQQEI 53
Query: 575 MLIAKLQHRNLVRLFGCCIEQGEKISIYEF---DIVTDPARKDLLDWTTRVRIIEGVAQG 631
++++ + + +G ++ + I E+ D R D +++ + +G
Sbjct: 54 TVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKG 113
Query: 632 LLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYM 691
L YLH + IHRD+KA+NVLL + K++DFG+A +++ NT VGT +M
Sbjct: 114 LDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWM 168
Query: 692 SPEYALHGLFSIKSDVFSFGVLLLEI 717
+PE + K+D++S G+ +E+
Sbjct: 169 APEVIQQSAYDSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 9e-15
Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 47/202 (23%)
Query: 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRL---SSKSG---QGLEEFKNE 573
K+G+G FG V+K+ + + VA+K++ + K G L E K
Sbjct: 18 AKIGQGTFGEVFKARHKK------------TKQIVALKKVLMENEKEGFPITALREIK-- 63
Query: 574 MMLIAKLQHRNLVRLFGCC-----IEQGEKISIYEFDIVTDPARKDL--------LDWTT 620
++ L+H N+V L C K S Y +V + DL + +T
Sbjct: 64 --ILQLLKHENVVNLIEICRTKATPYNRYKGSFY---LVFEFCEHDLAGLLSNKNVKFTL 118
Query: 621 RV--RIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFG---GD 675
++++ + GL Y+H R +++HRD+KA+N+L+ D K++DFG+AR F
Sbjct: 119 SEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNS 175
Query: 676 EMQSNTNRIVGTYGYMSPEYAL 697
+ TNR+V T Y PE L
Sbjct: 176 KPNRYTNRVV-TLWYRPPELLL 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 68/234 (29%), Positives = 104/234 (44%), Gaps = 42/234 (17%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQ-GLEEFKN 572
D + LGEG FG V + E + K VAVK L + + L + +
Sbjct: 15 DKLTLGKPLGEGCFGQVVMA-----EALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVS 69
Query: 573 EMMLIAKL-QHRNLVRLFGCCIEQGEKISI----------------------YEFDIVTD 609
EM ++ + +H+N++ L G C + G I Y +DI
Sbjct: 70 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARV 129
Query: 610 PAR----KDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665
P KDL+ T +V A+G+ YL + + IHRDL A NVL+ + KI+D
Sbjct: 130 PDEQMTFKDLVSCTYQV------ARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIAD 180
Query: 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
FG+AR + T +M+PE +++ +SDV+SFGVL+ EI +
Sbjct: 181 FGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 63/228 (27%), Positives = 107/228 (46%), Gaps = 48/228 (21%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQG-LEEFKNEMMLI 577
++ +GEG FG V K+ + K G ++ A+KR+ + + +F E+ ++
Sbjct: 12 QDVIGEGNFGQVLKARIK-------KDGLRMDA---AIKRMKEYASKDDHRDFAGELEVL 61
Query: 578 AKL-QHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTRVRIIE---------- 626
KL H N++ L G C +G Y + + +LLD+ + R++E
Sbjct: 62 CKLGHHPNIINLLGACEHRG-----YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 116
Query: 627 ---------------GVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIART 671
VA+G+ YL Q + IHRDL A N+L+ + KI+DFG++R
Sbjct: 117 TASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR- 172
Query: 672 FGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
G E+ +M+ E + +++ SDV+S+GVLL EI+S
Sbjct: 173 --GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 75/292 (25%), Positives = 131/292 (44%), Gaps = 59/292 (20%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEE----VAVK--RLSSKSGQGLEEFKNEMM 575
LGEG FG V + LN ++ VAVK +++ + +E+F +E +
Sbjct: 7 LGEGEFGSVMEG--------------QLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAV 52
Query: 576 LIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK--DL---------------LDW 618
+ + H N++RL G C++ E Y +V P K DL L
Sbjct: 53 CMKEFDHPNVMRLIGVCLQTVESEG-YPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPT 111
Query: 619 TTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIART-FGGDEM 677
V+ + +A G+ YL S IHRDL A N +L+ +MN ++DFG+++ + GD
Sbjct: 112 QMLVKFMTDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYY 168
Query: 678 QSNTNRIVGT-YGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLG 736
+ RI +++ E +++ KSDV+SFGV + EI +++ T + ++ +
Sbjct: 169 RQ--GRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEI-ATRGQTPYPGVENSEIYD 225
Query: 737 HAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEV 788
+ + +L P + LYS+++ C N DRP+ +
Sbjct: 226 YL------RQGNRLKQPPDCLDGLYSLMSS-------CWLLNPKDRPSFETL 264
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 54/204 (26%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL 580
K+GEG G V + E++ G++VAVK++ + Q E NE++++
Sbjct: 29 KIGEGSTGIVCIATEKH------------TGKQVAVKKMDLRKQQRRELLFNEVVIMRDY 76
Query: 581 QHRNLVRLFGCCIEQGEKISIYEF---DIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQ 637
H N+V ++ + E + EF +TD ++ + V + L YLH
Sbjct: 77 HHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHN 136
Query: 638 YSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYAL 697
VIHRD+K+ ++LL SD K+SDFG + + + +VGT +M+PE
Sbjct: 137 QG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS--LVGTPYWMAPEVIS 191
Query: 698 HGLFSIKSDVFSFGVLLLEILSSK 721
+ + D++S G++++E++ +
Sbjct: 192 RLPYGTEVDIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-14
Identities = 66/222 (29%), Positives = 100/222 (45%), Gaps = 34/222 (15%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK-SGQGLEEFKNEMMLIAKL 580
LGEG FG V + E + K VAVK L + + L + +EM ++ +
Sbjct: 20 LGEGCFGQVVMA-----EAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMI 74
Query: 581 -QHRNLVRLFGCCIEQGEKISI----------------------YEFDIVTDPARKDLLD 617
+H+N++ L G C + G + Y FD P ++ L
Sbjct: 75 GKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLP--EEQLT 132
Query: 618 WTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEM 677
+ V VA+G+ YL + + IHRDL A NVL+ D KI+DFG+AR +
Sbjct: 133 FKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDY 189
Query: 678 QSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
T +M+PE +++ +SDV+SFGVLL EI +
Sbjct: 190 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 75/304 (24%), Positives = 134/304 (44%), Gaps = 45/304 (14%)
Query: 521 KLGEGGFGPVYK-SIERYVEI------CNWKQGKLLNGEEVAVKRLSSKSGQGLE-EFKN 572
KLGEG FG V+ + ++ N ++G+ L VAVK L + + +F
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPL---LVAVKILRPDANKNARNDFLK 68
Query: 573 EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF-----------------------DIVTD 609
E+ ++++L+ N++RL G C+++ I E+ D V
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 610 PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIA 669
+ +++ + + +A G+ YL S L +HRDL N L+ ++ KI+DFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 670 RTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNT 729
R + R V +M+ E L G F+ SDV++FGV L EIL K +
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGEL 245
Query: 730 DSLTLLGHAWNLWKDD-KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEV 788
++ +A ++D + L P + LY ++ + C + +RP+ ++
Sbjct: 246 TDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQ-------CWSRDCRERPSFSDI 298
Query: 789 VAML 792
A L
Sbjct: 299 HAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 35/96 (36%), Positives = 59/96 (61%), Gaps = 6/96 (6%)
Query: 623 RIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTN 682
+I V +GL YL + + +++HRD+K SN+L++S K+ DFG++ G + S N
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMAN 156
Query: 683 RIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEIL 718
VGT YMSPE ++++SD++S G+ L+E+
Sbjct: 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMA 192
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 37/212 (17%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL 580
+LG+G FG VYK+ K+ +L A K + +KS + LE++ E+ ++A
Sbjct: 12 ELGDGAFGKVYKAQN--------KETGVL----AAAKVIDTKSEEELEDYMVEIDILASC 59
Query: 581 QHRNLVRLFGCCIEQGEKISIYEF------DIVTDPARKDLLDWTTRVRIIEGVAQGLLY 634
H N+V+L + + EF D V + L + RV + + + L Y
Sbjct: 60 DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRV-VCKQTLEALNY 118
Query: 635 LHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIA----RTFGGDEMQSNTNRIVGTYGY 690
LH+ ++IHRDLKA N+L D + K++DFG++ RT + +GT +
Sbjct: 119 LHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI------QRRDSFIGTPYW 169
Query: 691 MSPEYAL-----HGLFSIKSDVFSFGVLLLEI 717
M+PE + + K+DV+S G+ L+E+
Sbjct: 170 MAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 3e-14
Identities = 57/210 (27%), Positives = 89/210 (42%), Gaps = 37/210 (17%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEE-FKNEMMLIA 578
LG GGFG V + A+K + + G +E +E ++
Sbjct: 1 LGVGGFGRVELVKVKS------------KNRTFALKCVKKRHIVETGQQEHIFSEKEILE 48
Query: 579 KLQHRNLVRLFGCCIEQGEKISIYE----------FDIVTDPARKDLLDWTTRVRIIEGV 628
+ H +V+L+ + +K IY + I+ D D ++T R I V
Sbjct: 49 ECNHPFIVKLY--RTFKDKK-YIYMLMEYCLGGELWTILRDRGLFD--EYTARF-YIACV 102
Query: 629 AQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTY 688
YLH +I+RDLK N+LLDS+ K+ DFG A+ + T GT
Sbjct: 103 VLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTP 156
Query: 689 GYMSPEYALHGLFSIKSDVFSFGVLLLEIL 718
Y++PE L+ + D +S G+LL E+L
Sbjct: 157 EYVAPEIILNKGYDFSVDYWSLGILLYELL 186
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 67/222 (30%), Positives = 117/222 (52%), Gaps = 38/222 (17%)
Query: 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRL---SSKSGQGLEEFK 571
F + N++GEG +G VY++ + +GE VA+K++ + + G + +
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDT------------TSGEIVALKKVRMDNERDGIPISSLR 55
Query: 572 NEMMLIAKLQHRNLVRLFGCCIEQGEKI-SIYEFDIVTDPARKD---LLD------WTTR 621
E+ L+ L+H N+V L + G+ + SI+ +V + +D LLD ++
Sbjct: 56 -EITLLLNLRHPNIVELKE--VVVGKHLDSIF---LVMEYCEQDLASLLDNMPTPFSESQ 109
Query: 622 VR-IIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSN 680
V+ ++ + +GL YLH+ +IHRDLK SN+LL KI+DFG+ART+ G +
Sbjct: 110 VKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPM 165
Query: 681 TNRIVGTYGYMSPEYALHGLFSIKS-DVFSFGVLLLEILSSK 721
T ++V T Y +PE L + D+++ G +L E+L+ K
Sbjct: 166 TPKVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 61/211 (28%), Positives = 103/211 (48%), Gaps = 31/211 (14%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL 580
+LG G FG V K + + + KQ +VA+K L +++ + + + EMM A++
Sbjct: 2 ELGSGNFGCVKKGVYKMRK----KQ------IDVAIKVLKNENEKSVRD---EMMREAEI 48
Query: 581 QHR----NLVRLFGCCIEQGEKISIYEFDIVTDP------ARKDLLDWTTRVRIIEGVAQ 630
H+ +VR+ G C + E + + P +KD + + V ++ V+
Sbjct: 49 MHQLDNPYIVRMIGVC--EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSM 106
Query: 631 GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTY-- 688
G+ YL + +HRDL A NVLL + KISDFG+++ G D+ R G +
Sbjct: 107 GMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADD-SYYKARSAGKWPL 162
Query: 689 GYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
+ +PE FS +SDV+S+G+ + E S
Sbjct: 163 KWYAPECINFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 52/208 (25%), Positives = 99/208 (47%), Gaps = 33/208 (15%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQG-LEEFKNEMMLIAKL 580
+G G +G VY+ + G VA+K ++ + + + + E+ L+++L
Sbjct: 9 IGRGAYGAVYRGKH------------VPTGRVVALKIINLDTPDDDVSDIQREVALLSQL 56
Query: 581 QH---RNLVRLFGCCIEQGEKISI----YEFDIVTDPARKDLLDWTTRVRIIEGVAQGLL 633
+ N+ + +G + +G ++ I E V + + II V L
Sbjct: 57 RQSQPPNITKYYGSYL-KGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALK 115
Query: 634 YLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNR---IVGTYGY 690
Y+H+ VIHRD+KA+N+L+ + N K+ DFG+A + N+++ VGT +
Sbjct: 116 YIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAA-----LLNQNSSKRSTFVGTPYW 167
Query: 691 MSPEYALHG-LFSIKSDVFSFGVLLLEI 717
M+PE G + K+D++S G+ + E+
Sbjct: 168 MAPEVITEGKYYDTKADIWSLGITIYEM 195
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 6e-14
Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 41/217 (18%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGE----EVAVKRLSSKSG-QGLEEFKNEMML 576
+G+G FG VY G L++ + AVK L+ + + +E+F E ++
Sbjct: 3 IGKGHFGCVY-------------HGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGII 49
Query: 577 IAKLQHRNLVRLFGCCI-EQGEKISIYEF----DIVT-------DPARKDLLDWTTRVRI 624
+ H N++ L G C+ +G + + + D+ +P KDL+ + +V
Sbjct: 50 MKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQV-- 107
Query: 625 IEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRI 684
A+G+ YL + +HRDL A N +LD K++DFG+AR E S N
Sbjct: 108 ----AKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT 160
Query: 685 VGTY--GYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
+M+ E F+ KSDV+SFGVLL E+++
Sbjct: 161 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 6e-14
Identities = 50/190 (26%), Positives = 91/190 (47%), Gaps = 42/190 (22%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQG------LEEFKNEM 574
++GEG G V+K+ +R GE VA+K+++ + +G L E K
Sbjct: 7 RIGEGAHGIVFKAKDRE------------TGETVALKKVALRRLEGGIPNQALREIK--- 51
Query: 575 MLIAKLQHRNLVRL---FGCCIEQGEKISI-YEF------DIVTDPARKDLLDWTTRVRI 624
+ QH +V+L F G + E+ +++ D + L + +
Sbjct: 52 -ALQACQHPYVVKLLDVFPH----GSGFVLVMEYMPSDLSEVLRD-EERPLPEAQVK-SY 104
Query: 625 IEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRI 684
+ + +G+ Y+H ++HRDLK +N+L+ +D KI+DFG+AR F +E + +++
Sbjct: 105 MRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ- 160
Query: 685 VGTYGYMSPE 694
V T Y +PE
Sbjct: 161 VATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 9e-14
Identities = 59/220 (26%), Positives = 107/220 (48%), Gaps = 39/220 (17%)
Query: 516 FSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLS-SKSGQGLEEFK-NE 573
+ E ++GEG +G VYK+ + L G VA+K++ S +G+ E
Sbjct: 1 YEELAEIGEGAYGTVYKARD------------LNTGRFVALKKVRVPLSEEGIPLSTLRE 48
Query: 574 MMLIAKLQ---HRNLVRLFGCC--IEQGEKISIYEFDIVTDPARKDLLDWTTRV------ 622
+ L+ +L+ H N+VRL C ++ + +V + +DL + ++
Sbjct: 49 IALLKQLESFEHPNIVRLLDVCHGPRTDRELKLT---LVFEHVDQDLATYLSKCPKPGLP 105
Query: 623 -----RIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEM 677
++ + +G+ +LH + R++HRDLK N+L+ SD KI+DFG+AR + EM
Sbjct: 106 PETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIY-SFEM 161
Query: 678 QSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEI 717
+ +V T Y +PE L ++ D++S G + E+
Sbjct: 162 ALTS--VVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 1e-13
Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 42/217 (19%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN--EMMLIA 578
+LG+G FG VY + + GE VA+K++ K EE N E+ +
Sbjct: 6 QLGDGTFGSVYLARNK------------ETGELVAIKKMKKKF-YSWEECMNLREVKSLR 52
Query: 579 KLQ-HRNLVRLFGCCIEQGEKISIYEF------DIVTDPARKDLLDWTTRVR-IIEGVAQ 630
KL H N+V+L E E ++E+ ++ D K + + +R II + Q
Sbjct: 53 KLNEHPNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSE--SVIRSIIYQILQ 110
Query: 631 GLLYLHQ--YSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSN---TNRIV 685
GL ++H+ + HRDLK N+L+ KI+DFG+AR E++S T+ V
Sbjct: 111 GLAHIHKHGF-----FHRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPYTD-YV 159
Query: 686 GTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSK 721
T Y +PE L +S D+++ G ++ E+ + +
Sbjct: 160 STRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 1e-13
Identities = 69/227 (30%), Positives = 109/227 (48%), Gaps = 54/227 (23%)
Query: 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN------- 572
KLG+G +G V+K+I+R E VA+K++ + F+N
Sbjct: 13 QKLGKGAYGIVWKAIDRR------------TKEVVALKKI-------FDAFRNATDAQRT 53
Query: 573 --EMMLIAKL-QHRNLVRLFGCCIEQGEKISIY---EFDIVTD---PARKDLLDWTTRVR 623
E+M + +L H N+V+L I+ IY E+ + TD R ++L+ +
Sbjct: 54 FREIMFLQELGDHPNIVKLLNV-IKAENDKDIYLVFEY-METDLHAVIRANILEDVHKRY 111
Query: 624 IIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNR 683
I+ + + L Y+H S VIHRDLK SN+LL+SD K++DFG+AR+ E ++ N
Sbjct: 112 IMYQLLKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE-ENPENP 167
Query: 684 I----VGTYGYMSPEYALHGLFSIKS-----DVFSFGVLLLEILSSK 721
+ V T Y +PE L D++S G +L E+L K
Sbjct: 168 VLTDYVATRWYRAPEI----LLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 64/243 (26%), Positives = 109/243 (44%), Gaps = 69/243 (28%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRL---SSKSGQGLEEF 570
D F ++GEG +G VYK+ ++ GE VA+K++ + K G +
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDK------------DTGELVALKKVRLDNEKEGFPITAI 54
Query: 571 KNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTRVR------- 623
+ E+ ++ +L HRN+V L +IVTD ++D LD+
Sbjct: 55 R-EIKILRQLNHRNIVNLK---------------EIVTD--KQDALDFKKDKGAFYLVFE 96
Query: 624 ------------------------IIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDM 659
++ + +GL Y H+ + L HRD+K SN+LL++
Sbjct: 97 YMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKG 153
Query: 660 NPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYAL-HGLFSIKSDVFSFGVLLLEIL 718
K++DFG+AR + +E + TN+++ T Y PE L + DV+S G +L E+
Sbjct: 154 QIKLADFGLARLYNSEESRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELF 212
Query: 719 SSK 721
+ K
Sbjct: 213 TKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-13
Identities = 69/234 (29%), Positives = 103/234 (44%), Gaps = 56/234 (23%)
Query: 507 SSISAATDNFSE---ENKLGEGGFGPVYKSIERYVEICNWKQGKLL-------NGEEVAV 556
S +A + SE N++G G G VYK I R G+L N E+ V
Sbjct: 64 GSAPSAAKSLSELERVNRIGSGAGGTVYKVIHR-------PTGRLYALKVIYGNHED-TV 115
Query: 557 KRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF---------DIV 607
+R + E+ ++ + H N+V+ GE + EF I
Sbjct: 116 RR----------QICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIA 165
Query: 608 TDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667
+ D+ R +I+ G+A YLH R ++HRD+K SN+L++S N KI+DFG
Sbjct: 166 DEQFLADV----AR-QILSGIA----YLH---RRHIVHRDIKPSNLLINSAKNVKIADFG 213
Query: 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYA----LHGLFS-IKSDVFSFGVLLLE 716
++R + N VGT YMSPE HG + D++S GV +LE
Sbjct: 214 VSRILA--QTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 32/208 (15%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLS-SKSGQGLEEFK-NEMMLIA 578
K+GEG +G V+K+ R E VA+KR+ +G+ E+ L+
Sbjct: 7 KIGEGTYGTVFKAKNRE------------THEIVALKRVRLDDDDEGVPSSALREICLLK 54
Query: 579 KLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTRVRIIEGVAQ-------- 630
+L+H+N+VRL+ + ++E+ D K D + I + +
Sbjct: 55 ELKHKNIVRLYDVLHSDKKLTLVFEY---CDQDLKKYFD-SCNGDIDPEIVKSFMFQLLK 110
Query: 631 GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGY 690
GL + H + V+HRDLK N+L++ + K++DFG+AR F G ++ + +V T Y
Sbjct: 111 GLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAF-GIPVRCYSAEVV-TLWY 165
Query: 691 MSPEYALHG-LFSIKSDVFSFGVLLLEI 717
P+ L+S D++S G + E+
Sbjct: 166 RPPDVLFGAKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 6e-13
Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 20/211 (9%)
Query: 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAK 579
LG+G +G VY + ++ KQ +L +A ++ K L+E E+ L+
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEK----LQE---EVDLLKS 58
Query: 580 LQHRNLVRLFGCCIEQGEKISIY-EF----DIVTDPARKDLLDWTTRVRIIEGVAQGLLY 634
L+H N+V+ G C++ ISI+ EF I + R L + + + G+ Y
Sbjct: 59 LKHVNIVQYLGTCLDDN-TISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAY 117
Query: 635 LHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTF---GGDEMQSNTNRIV-GTYGY 690
LH V+HRD+K +NV+L + K+ DFG AR G SN + + GT +
Sbjct: 118 LHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174
Query: 691 MSPEYALHGLFSIKSDVFSFGVLLLEILSSK 721
M+PE + KSD++S G + E+ + K
Sbjct: 175 MAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 6e-13
Identities = 35/98 (35%), Positives = 51/98 (52%), Gaps = 9/98 (9%)
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG------IARTFGGDEMQSNT 681
+ L YLH +IHRDLK N+L+DS+ + K++DFG + R ++ +
Sbjct: 102 IVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158
Query: 682 NRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
RIVGT Y++PE L S D +S G +L E L
Sbjct: 159 KRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 8e-13
Identities = 54/209 (25%), Positives = 98/209 (46%), Gaps = 34/209 (16%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL 580
++G G +G VYK+ L GE AVK + + G + E+ ++ +
Sbjct: 16 RVGSGTYGDVYKA------------RNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKEC 63
Query: 581 QHRNLVRLFGC---------CIEQGEKISIYEFDIVTDPARKDLLDWTTRVRIIEGVAQG 631
+H N+V FG C+E S+ + VT P + + + R + QG
Sbjct: 64 KHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QG 118
Query: 632 LLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYM 691
L YLH ++ HRD+K +N+LL + + K++DFG+A + + +GT +M
Sbjct: 119 LAYLHSKGKM---HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS--FIGTPYWM 173
Query: 692 SPEYAL---HGLFSIKSDVFSFGVLLLEI 717
+PE A +G ++ D+++ G+ +E+
Sbjct: 174 APEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 1e-12
Identities = 54/212 (25%), Positives = 96/212 (45%), Gaps = 44/212 (20%)
Query: 600 SIYEFDIVTDPARKDL--LDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS 657
S D + +D LD +R VAQG+ +L + IHRD+ A NVLL
Sbjct: 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTD 247
Query: 658 DMNPKISDFGIARTFGGDEMQSNTNRIVGTYG-----YMSPEYALHGLFSIKSDVFSFGV 712
KI DFG+AR ++ +++N +V +M+PE +++++SDV+S+G+
Sbjct: 248 GRVAKICDFGLAR-----DIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 302
Query: 713 LLLEILSSKK--------NTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMV 764
LL EI S K N++FY ++ + + + D A + M+
Sbjct: 303 LLWEIFSLGKSPYPGILVNSKFYK-----MVKRGYQMSRPDFAPPEIYSIMK-------- 349
Query: 765 TRYIKVALLCVQENATDRPTMLEVVAMLKDEI 796
+C T+RPT ++ +++ ++
Sbjct: 350 --------MCWNLEPTERPTFSQISQLIQRQL 373
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 54/216 (25%), Positives = 103/216 (47%), Gaps = 34/216 (15%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNE 573
++F ++G G +G VYK+ R V GE A+K + + G+ + E
Sbjct: 9 EDFELIQRIGSGTYGDVYKA--RNVN----------TGELAAIKVIKLEPGEDFAVVQQE 56
Query: 574 MMLIAKLQHRNLVRLFGC---------CIEQGEKISIYEFDIVTDPARKDLLDWTTRVRI 624
++++ +H N+V FG C+E S+ + VT P + + + +R +
Sbjct: 57 IIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL 116
Query: 625 IEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRI 684
QGL YLH + +HRD+K +N+LL + + K++DFG++ + +
Sbjct: 117 -----QGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS--F 166
Query: 685 VGTYGYMSPEYAL---HGLFSIKSDVFSFGVLLLEI 717
+GT +M+PE A G ++ D+++ G+ +E+
Sbjct: 167 IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 2e-12
Identities = 65/233 (27%), Positives = 113/233 (48%), Gaps = 58/233 (24%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRL---SSKSGQGLEEF 570
D + + N++ EG +G VY++ ++ GE VA+K+L K G +
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDK------------KTGEIVALKKLKMEKEKEGFPITSL 52
Query: 571 KNEMMLIAKLQHRNLVRL----FGCCIEQGEKISIY------EFDIVTDPARKDLLDWTT 620
+ E+ ++ KLQH N+V + G +++ IY E D+ K L++
Sbjct: 53 R-EINILLKLQHPNIVTVKEVVVGSNLDK-----IYMVMEYVEHDL------KSLMETMK 100
Query: 621 R-----------VRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIA 669
+ ++++ GVA +LH ++HRDLK SN+LL++ KI DFG+A
Sbjct: 101 QPFLQSEVKCLMLQLLSGVA----HLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLA 153
Query: 670 RTFGGDEMQSNTNRIVGTYGYMSPEYAL-HGLFSIKSDVFSFGVLLLEILSSK 721
R + G ++ T ++V T Y +PE L +S D++S G + E+L+ K
Sbjct: 154 REY-GSPLKPYT-QLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNE 573
DNF K+GEG G V + + GKL VAVK++ + Q E NE
Sbjct: 23 DNFI---KIGEGSTGIVCIATVK-------SSGKL-----VAVKKMDLRKQQRRELLFNE 67
Query: 574 MMLIAKLQHRNLVRLFGCCIEQGEKISIYEF---DIVTDPARKDLLDWTTRVRIIEGVAQ 630
++++ QH N+V ++ + E + EF +TD ++ + V +
Sbjct: 68 VVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLK 127
Query: 631 GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGY 690
L LH VIHRD+K+ ++LL D K+SDFG + + + +VGT +
Sbjct: 128 ALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYW 182
Query: 691 MSPEYALHGLFSIKSDVFSFGVLLLEILSSK 721
M+PE + + D++S G++++E++ +
Sbjct: 183 MAPELISRLPYGPEVDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 40/216 (18%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL- 580
+G G +G VYK R+V K G+L A ++ +G EE K E+ ++ K
Sbjct: 14 VGNGTYGQVYKG--RHV-----KTGQL------AAIKVMDVTGDEEEEIKQEINMLKKYS 60
Query: 581 QHRNLVRLFGCCIEQG------EKISIYEF-------DIVTDPARKDLLD-WTTRVRIIE 626
HRN+ +G I++ + + EF D++ + L + W I
Sbjct: 61 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICR 118
Query: 627 GVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVG 686
+ +GL +LHQ+ +VIHRD+K NVLL + K+ DFG++ D N +G
Sbjct: 119 EILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIG 173
Query: 687 TYGYMSPEYAL-----HGLFSIKSDVFSFGVLLLEI 717
T +M+PE + KSD++S G+ +E+
Sbjct: 174 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 57/226 (25%), Positives = 107/226 (47%), Gaps = 33/226 (14%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL 580
K+GEG FG + + + + + GK +E+ + ++S K EE + E+ +++ +
Sbjct: 7 KIGEGSFG-------KAILVKSKEDGKQYVIKEINISKMSPKE---REESRKEVAVLSNM 56
Query: 581 QHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK------------DLLDWTTRVRIIEGV 628
+H N+V+ E G + ++ D +K +LDW ++ +
Sbjct: 57 KHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICL---- 112
Query: 629 AQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTY 688
L ++H +++HRD+K+ N+ L D K+ DFGIAR + T +GT
Sbjct: 113 --ALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART--CIGTP 165
Query: 689 GYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTL 734
Y+SPE + ++ KSD+++ G +L E+ + K N +L L
Sbjct: 166 YYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVL 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 60/224 (26%), Positives = 96/224 (42%), Gaps = 51/224 (22%)
Query: 527 FGPVYKSIERYVE-----------ICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN--- 572
FG V++ RYV+ +C+ + L G+ VA+K++ ++ F
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARD--QLTGQNVAIKKI-------MKPFSTPVL 52
Query: 573 ------EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTRVRIIE 626
E+ L+ L+H N++ L I E I VT+ DL T + +
Sbjct: 53 AKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF-----VTELLGTDLHRLLTSRPLEK 107
Query: 627 GVAQ--------GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQ 678
Q GL Y+H V+HRDLK SN+L++ + + KI DFG+AR
Sbjct: 108 QFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI-----QD 159
Query: 679 SNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSK 721
V T Y +PE L + ++ D++S G + E+L K
Sbjct: 160 PQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 36/94 (38%), Positives = 55/94 (58%), Gaps = 9/94 (9%)
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIAR--TFGGDEMQSNTNRIV 685
+A GL +LH +I+RDLK NV+LD++ + KI+DFG+ + FGG T
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK----TTRTFC 162
Query: 686 GTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
GT Y++PE + + D ++FGVLL E+L+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 196
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 69/213 (32%), Positives = 98/213 (46%), Gaps = 35/213 (16%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEE-VAVKRLSSKSGQGLEEFKNEMMLIAK 579
+LG G FG V K + K+ E+ VAVK L + + K+E++ A
Sbjct: 2 ELGSGNFGTVKKGMY-----------KMKKSEKTVAVKILKNDNND--PALKDELLREAN 48
Query: 580 ----LQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLD--WTTRVRIIEGVAQ--- 630
L + +VR+ G C + E + P K L T I E V Q
Sbjct: 49 VMQQLDNPYIVRMIGIC--EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSM 106
Query: 631 GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDE----MQSNTNRIVG 686
G+ YL + + +HRDL A NVLL + KISDFG+++ G DE +++ V
Sbjct: 107 GMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK 163
Query: 687 TYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
Y +PE + FS KSDV+SFGVL+ E S
Sbjct: 164 WY---APECMNYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 35/93 (37%), Positives = 53/93 (56%), Gaps = 9/93 (9%)
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIAR--TFGGDEMQSNTNRIV 685
+ GL +LH+ +I+RDLK NVLLDS+ + KI+DFG+ + GG T+
Sbjct: 105 IVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV----TTSTFC 157
Query: 686 GTYGYMSPEYALHGLFSIKSDVFSFGVLLLEIL 718
GT Y++PE + + D ++ GVLL E+L
Sbjct: 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 4e-12
Identities = 56/171 (32%), Positives = 83/171 (48%), Gaps = 24/171 (14%)
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTF--GGDEMQSNTNRIV 685
VA+G+ +L SR + IHRDL A N+LL + KI DFG+AR D ++ R+
Sbjct: 182 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL- 237
Query: 686 GTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD 745
+M+PE +++ +SDV+SFGVLL EI S L + + D
Sbjct: 238 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS--------------LGASPYPGVQID 282
Query: 746 KAW--KLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794
+ + +L + T Y+ Y + L C N DRPT E+V +L D
Sbjct: 283 EEFCRRLKEGTRMRAPEYATPEIY-SIMLDCWHNNPEDRPTFSELVEILGD 332
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 36/220 (16%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNE 573
D+ +LG G +G V K +AVKR+ ++ +E K
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTI------------MAVKRI--RATVNSQEQKRL 46
Query: 574 MM-LIAKLQHR---NLVRLFGCCIEQGEK-ISIYEFDIVTDPARKDLLDWTTRV------ 622
+M L ++ V +G +G+ I + D D K + D +
Sbjct: 47 LMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILG 106
Query: 623 RIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTN 682
+I + + L YLH S+L VIHRD+K SNVL++ + K+ DFGI+ G + S
Sbjct: 107 KIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS----GYLVDSVAK 160
Query: 683 RI-VGTYGYMSPEYALHGL----FSIKSDVFSFGVLLLEI 717
I G YM+PE L + +KSDV+S G+ ++E+
Sbjct: 161 TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIEL 200
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 5e-12
Identities = 60/220 (27%), Positives = 102/220 (46%), Gaps = 41/220 (18%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKL-LNGEE---VAVKRLSSK-SGQGLEEFKNE 573
E +G G FG V + G+L L G+ VA+K L S + + +F +E
Sbjct: 9 EEVIGAGEFGEVCR-------------GRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSE 55
Query: 574 MMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTR-----------V 622
++ + H N++ L G + + I EF LD R V
Sbjct: 56 ASIMGQFDHPNIIHLEGVVTKSRPVMIITEF------MENGALDSFLRQNDGQFTVIQLV 109
Query: 623 RIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTN 682
++ G+A G+ YL S + +HRDL A N+L++S++ K+SDFG++R D
Sbjct: 110 GMLRGIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYT 166
Query: 683 RIVG---TYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
+G + +PE + F+ SDV+S+G+++ E++S
Sbjct: 167 SSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 7e-12
Identities = 50/179 (27%), Positives = 76/179 (42%), Gaps = 53/179 (29%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN--------- 572
+G G +G V ++ G +VA+K++S F +
Sbjct: 8 IGSGAYGVVCSAV------------DKRTGRKVAIKKIS-------NVFDDLIDAKRILR 48
Query: 573 EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFD---IVTDPARKDL---------LDWTT 620
E+ L+ L+H N++ L S +F+ IVT+ DL L
Sbjct: 49 EIKLLRHLRHENIIGLLDILRPP----SPEDFNDVYIVTELMETDLHKVIKSPQPLT-DD 103
Query: 621 RVRIIEGVAQ---GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDE 676
++ + Q GL YLH VIHRDLK SN+L++S+ + KI DFG+AR DE
Sbjct: 104 HIQYF--LYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 7e-12
Identities = 56/221 (25%), Positives = 102/221 (46%), Gaps = 43/221 (19%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQ-GLE-EFKNEMMLIA 578
++G G +G VYK+ + + +G VA+K + ++ + GL E+ L+
Sbjct: 7 EIGVGAYGTVYKARDPH------------SGHFVALKSVRVQTNEDGLPLSTVREVALLK 54
Query: 579 KLQ---HRNLVRLFGCC----IEQGEKISIYEFDIVTDPARKDLLDWTTRV--------- 622
+L+ H N+VRL C ++ K+++ V + +DL + +V
Sbjct: 55 RLEAFDHPNIVRLMDVCATSRTDRETKVTL-----VFEHVDQDLRTYLDKVPPPGLPAET 109
Query: 623 --RIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSN 680
++ +GL +LH ++HRDLK N+L+ S K++DFG+AR + Q
Sbjct: 110 IKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMA 163
Query: 681 TNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSK 721
+V T Y +PE L ++ D++S G + E+ K
Sbjct: 164 LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 7e-12
Identities = 34/95 (35%), Positives = 53/95 (55%), Gaps = 7/95 (7%)
Query: 623 RIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTN 682
RI V +GL YL L+++HRD+K SN+L+++ K+ DFG++ + S
Sbjct: 99 RIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAK 151
Query: 683 RIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEI 717
VGT YM+PE + I SDV+S G+ +E+
Sbjct: 152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMEL 186
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 8e-12
Identities = 56/219 (25%), Positives = 99/219 (45%), Gaps = 34/219 (15%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQ 581
LG G G V+ +++ + VAVK++ Q ++ E+ +I +L
Sbjct: 13 LGCGSNGLVFSAVDSDC------------DKRVAVKKIVLTDPQSVKHALREIKIIRRLD 60
Query: 582 HRNLVRLFGCCIEQGEKI-----SIYEFD---IVTDPARKDLLDWTTRVRIIEGVA---- 629
H N+V+++ G + S+ E + IV + DL + + + E A
Sbjct: 61 HDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFM 120
Query: 630 ----QGLLYLHQYSRLRVIHRDLKASNVLLDS-DMNPKISDFGIARTFGGD-EMQSNTNR 683
+GL Y+H + V+HRDLK +NV +++ D+ KI DFG+AR + +
Sbjct: 121 YQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSE 177
Query: 684 IVGTYGYMSPEYALHGLFSIKS-DVFSFGVLLLEILSSK 721
+ T Y SP L K+ D+++ G + E+L+ K
Sbjct: 178 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 8e-12
Identities = 61/209 (29%), Positives = 92/209 (44%), Gaps = 29/209 (13%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKL-LNGEEVAVKRLSSKSGQGLE-EFKNEMMLIA 578
++G G FG V+ G+L + VAVK L+ +F E ++
Sbjct: 2 RIGRGNFGEVF-------------SGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILK 48
Query: 579 KLQHRNLVRLFGCCIEQGEKISIYEF----DIVT----DPARKDLLDWTTRVRIIEGVAQ 630
+ H N+VRL G C ++ + E D +T + R L ++++E A
Sbjct: 49 QYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPR---LKVKELIQMVENAAA 105
Query: 631 GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGY 690
G+ YL IHRDL A N L+ KISDFG++R S +
Sbjct: 106 GMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKW 162
Query: 691 MSPEYALHGLFSIKSDVFSFGVLLLEILS 719
+PE +G +S +SDV+SFG+LL E S
Sbjct: 163 TAPEALNYGRYSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 9e-12
Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 52/228 (22%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNE 573
++ + ++G G FG V K + + +G +AVKR+ S E+ +
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKP------------SGTIMAVKRIRSTVD-EKEQKRLL 50
Query: 574 MMLIAKLQHRN---LVRLFGCCIEQGEK-ISIYEFDIVTDPARKDLLDWTTRVRIIE--- 626
M L ++ + +V+ +G +G+ I + DI D K + + + I E
Sbjct: 51 MDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYE-VLKSVIPEEIL 109
Query: 627 -----GVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGI--------ARTFG 673
+ L YL + L++IHRD+K SN+LLD + N K+ DFGI A+T
Sbjct: 110 GKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKT-- 165
Query: 674 GDEMQSNTNRIVGTYGYMSPE----YALHGLFSIKSDVFSFGVLLLEI 717
R G YM+PE A G + ++SDV+S G+ L E+
Sbjct: 166 ---------RDAGCRPYMAPERIDPSARDG-YDVRSDVWSLGITLYEV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 9e-12
Identities = 35/91 (38%), Positives = 57/91 (62%), Gaps = 6/91 (6%)
Query: 627 GVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVG 686
V +GL YL + + +++HRD+K SN+L++S K+ DFG++ G + S N VG
Sbjct: 111 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVG 164
Query: 687 TYGYMSPEYALHGLFSIKSDVFSFGVLLLEI 717
T YMSPE +S++SD++S G+ L+E+
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 48/152 (31%), Positives = 80/152 (52%), Gaps = 16/152 (10%)
Query: 573 EMMLIAKLQHRNLVRLFGCCIEQGEKISIY-------EFDIVTDPARKDLLDWTTRVRII 625
E+ ++ + +V +G GE ISI D V A++ + +V I
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGE-ISICMEHMDGGSLDQVLKEAKRIPEEILGKVSI- 110
Query: 626 EGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIV 685
V +GL YL + + +++HRD+K SN+L++S K+ DFG++ G + S N V
Sbjct: 111 -AVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFV 163
Query: 686 GTYGYMSPEYALHGLFSIKSDVFSFGVLLLEI 717
GT YMSPE +S++SD++S G+ L+E+
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEL 195
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 58/220 (26%), Positives = 96/220 (43%), Gaps = 33/220 (15%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN- 572
D + + +G G +G V + + G +VA+K+LS + Q K
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKT------------GRKVAIKKLS-RPFQSAIHAKRT 61
Query: 573 --EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTRVRIIEGVAQ 630
E+ L+ + H N++ L + +VT DL + ++ + Q
Sbjct: 62 YRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQ 121
Query: 631 --------GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTN 682
GL Y+H +IHRDLK SN+ ++ D KI DFG+AR DEM
Sbjct: 122 FLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARH-TDDEMTG--- 174
Query: 683 RIVGTYGYMSPEYALHGLFSIKS-DVFSFGVLLLEILSSK 721
V T Y +PE L+ + ++ D++S G ++ E+L+ K
Sbjct: 175 -YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 2e-11
Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 45/213 (21%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSS----KSGQGLEEFKNEMMLI 577
LG G FG V + K +G+ A+K LS K Q +E NE ++
Sbjct: 9 LGTGSFGRVM--------LVRHKG----SGKYYALKILSKAKIVKLKQ-VEHVLNEKRIL 55
Query: 578 AKLQHRNLVRLFGCCIEQGEKISIY---EFDIVTDPARKDLLDWTTRV-RIIEGVAQ--- 630
++H LV L+G Q + ++Y E+ +L + R E VA+
Sbjct: 56 QSIRHPFLVNLYGS--FQDDS-NLYLVMEYVPG-----GELFSHLRKSGRFPEPVARFYA 107
Query: 631 -----GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIV 685
L YLH L +++RDLK N+LLDSD KI+DFG A+ ++ T +
Sbjct: 108 AQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLC 159
Query: 686 GTYGYMSPEYALHGLFSIKSDVFSFGVLLLEIL 718
GT Y++PE L + D ++ G+L+ E+L
Sbjct: 160 GTPEYLAPEIILSKGYGKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 4e-11
Identities = 86/388 (22%), Positives = 146/388 (37%), Gaps = 81/388 (20%)
Query: 426 KKRPLW----IVVLAALPVAILPAF-LIFYRRKKKLKEKERRTE-ASQDMLLFEINMGNM 479
+K P W L A V L AF +F R + L+ K E + ++ F+
Sbjct: 623 RKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFD------ 676
Query: 480 SRAKEFCEGDSAGTGKSKESWFLFFSLS-SISAATDNFSEENKLGEGGFGPVYKSIERYV 538
SK S S +I+ + EEN + G G YK
Sbjct: 677 ----------------SK------VSKSITINDILSSLKEENVISRGKKGASYKG----- 709
Query: 539 EICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEK 598
+ NG + VK ++ + E + + KLQH N+V+L G C +
Sbjct: 710 -------KSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLIGLCRSEKGA 758
Query: 599 ISIYEFDIVTDPARKDL------LDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASN 652
I+E K+L L W R +I G+A+ L +LH V+ +L
Sbjct: 759 YLIHE-----YIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEK 813
Query: 653 VLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGV 712
+++D P + + + + Y++PE + KSD++ FG+
Sbjct: 814 IIIDGKDEPHL-------RLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGL 866
Query: 713 LLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTM-------QNEALYSMVT 765
+L+E+L+ K +++ A + D +DP++ QNE + M
Sbjct: 867 ILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVM-- 924
Query: 766 RYIKVALLCVQENATDRPTMLEVVAMLK 793
+AL C + T RP +V+ L+
Sbjct: 925 ---NLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 35/89 (39%), Positives = 51/89 (57%), Gaps = 7/89 (7%)
Query: 631 GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIART-FGGDEMQSNTNRIVGTYG 689
GL +LH+ +I+RDLK NVLLD D + KI+DFG+ + G+ + GT
Sbjct: 108 GLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK---ASTFCGTPD 161
Query: 690 YMSPEYALHGLFSIKSDVFSFGVLLLEIL 718
Y++PE ++ D +SFGVLL E+L
Sbjct: 162 YIAPEILKGQKYNESVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 7e-11
Identities = 62/221 (28%), Positives = 104/221 (47%), Gaps = 40/221 (18%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNG--EEVAVKRLSSK--SGQGLEEFKNEMMLI 577
LG+G FG V ++ Q K +G ++VAVK L + S +EEF E +
Sbjct: 7 LGKGEFGSVREA-----------QLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACM 55
Query: 578 AKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK--DL---------------LDWTT 620
+ H N+++L G + K + +V P K DL L T
Sbjct: 56 KEFDHPNVIKLIGVSLRSRAKGRL-PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQT 114
Query: 621 RVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIART-FGGDEM-Q 678
VR + +A G+ YL S IHRDL A N +L+ +M ++DFG+++ + GD Q
Sbjct: 115 LVRFMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQ 171
Query: 679 SNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
+++ +++ E +++ SDV++FGV + EI++
Sbjct: 172 GCASKL--PVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-10
Identities = 62/228 (27%), Positives = 103/228 (45%), Gaps = 40/228 (17%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSS--KSGQGLEEFKNEMMLIAK 579
+G G +G V +I++ GE+VA+K+LS +S + E+ L+
Sbjct: 23 VGSGAYGSVCSAIDKR------------TGEKVAIKKLSRPFQSEIFAKRAYRELTLLKH 70
Query: 580 LQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTRVR-----------IIEGV 628
+QH N++ L +F +V + DL ++ ++ +
Sbjct: 71 MQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDL----QKIMGHPLSEDKVQYLVYQM 126
Query: 629 AQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTY 688
GL Y+H +IHRDLK N+ ++ D KI DFG+AR EM T +V T
Sbjct: 127 LCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARH-ADAEM---TGYVV-TR 178
Query: 689 GYMSPEYALHGLFSIKS-DVFSFGVLLLEILSSKKNTRFYNTDSLTLL 735
Y +PE L+ + ++ D++S G ++ E+L+ K T F D L L
Sbjct: 179 WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK--TLFKGKDYLDQL 224
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 1e-10
Identities = 34/93 (36%), Positives = 53/93 (56%)
Query: 630 QGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYG 689
Q LL +H +IHRD+K++N+LL S+ K+ DFG ++ + GT
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210
Query: 690 YMSPEYALHGLFSIKSDVFSFGVLLLEILSSKK 722
Y++PE +S K+D+FS GVLL E+L+ K+
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 60/222 (27%), Positives = 99/222 (44%), Gaps = 41/222 (18%)
Query: 516 FSEENKLGEGGFGPVYKSIERYVEICNWK---QGKLLNGEEVAVKRLSSKSGQGLEEFKN 572
F + LG+GGFG E+C + GK+ +++ KR+ + G+ + N
Sbjct: 2 FRQYRVLGKGGFG----------EVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LN 49
Query: 573 EMMLIAKLQHRNLVRLF-------GCCI-----EQGE-KISIYEFDIVTDPARKDLLDWT 619
E ++ K+ R +V L C+ G+ K IY + +
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVF--- 106
Query: 620 TRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQS 679
+ GL LHQ R+++RDLK N+LLD + +ISD G+A E Q+
Sbjct: 107 ----YAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV--PEGQT 157
Query: 680 NTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSK 721
R VGT GYM+PE + ++ D ++ G LL E+++ +
Sbjct: 158 IKGR-VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 34/101 (33%), Positives = 56/101 (55%), Gaps = 5/101 (4%)
Query: 621 RVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSN 680
VR+ +A+ +L L +L +I+RD+K N+LLDS+ + ++DFG+++ F +E +
Sbjct: 106 EVRVY--IAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-R 162
Query: 681 TNRIVGTYGYMSPEYALHGL--FSIKSDVFSFGVLLLEILS 719
GT YM+PE G D +S GVL E+L+
Sbjct: 163 AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 27/209 (12%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMM------ 575
LG+GGFG V V++ N GK+ +++ KRL KSG+ + + E++
Sbjct: 1 LGKGGFGEVCA-----VQVKN--TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSP 53
Query: 576 LIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTRVRIIEGVAQ---GL 632
I L + + C + ++ I R ++ R+I AQ G+
Sbjct: 54 FIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEME-----RVIHYSAQITCGI 108
Query: 633 LYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMS 692
L+LH + +++RD+K NVLLD N ++SD G+A ++ T R GT GYM+
Sbjct: 109 LHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--KTITQR-AGTNGYMA 162
Query: 693 PEYALHGLFSIKSDVFSFGVLLLEILSSK 721
PE +S D F+ G + E+++ +
Sbjct: 163 PEILKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 40/216 (18%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL- 580
+G G +G VYK R+V+ G+ A+K + + EE K E+ ++ K
Sbjct: 24 VGNGTYGQVYKG--RHVK----------TGQLAAIKVMDVTEDEE-EEIKLEINMLKKYS 70
Query: 581 QHRNLVRLFGCCIEQ---GEKISIY---EF-------DIVTDPARKDLL-DWTTRVRIIE 626
HRN+ +G I++ G ++ EF D+V + L DW I
Sbjct: 71 HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICR 128
Query: 627 GVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVG 686
+ +GL +LH + +VIHRD+K NVLL + K+ DFG++ D N +G
Sbjct: 129 EILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIG 183
Query: 687 TYGYMSPEYAL-----HGLFSIKSDVFSFGVLLLEI 717
T +M+PE + +SD++S G+ +E+
Sbjct: 184 TPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 39/92 (42%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
VA+G+ +L SR + IHRDL A N+LL + KI DFG+AR D
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 688 YGYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
+M+PE +++I+SDV+SFGVLL EI S
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 54/222 (24%), Positives = 90/222 (40%), Gaps = 41/222 (18%)
Query: 593 IEQGEKISIYEFDIVTDPARKD---------LLDWTTRVRIIEGVAQGLLYLHQYSRLRV 643
IE S Y+ + + P R L + V VA G+ +L +
Sbjct: 204 IESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFL---ASKNC 260
Query: 644 IHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSI 703
+HRDL A NVL+ KI DFG+AR D + +M+PE + L++
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT 320
Query: 704 KSDVFSFGVLLLEILS--------SKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTM 755
SDV+SFG+LL EI + N +FYN + +++ P
Sbjct: 321 LSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIK--------------RGYRMAKPAH 366
Query: 756 QNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797
++ +Y ++ + C +E RP ++V ++ D +
Sbjct: 367 ASDEIYEIMQK-------CWEEKFEIRPDFSQLVHLVGDLLT 401
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 3e-10
Identities = 28/84 (33%), Positives = 46/84 (54%), Gaps = 8/84 (9%)
Query: 338 KTANQFKRFDDMKVPDLLDVSLNEGMNLEECGAECLN-NCTCRAYAYFNLTRGGSGCLMW 396
K+ + F R + K+P + ++ +LEEC ++CLN NC+CR++ Y N G GCL+W
Sbjct: 1 KSDDCFVRLPNTKLPGFSRIVISV-ASLEECASKCLNSNCSCRSFTYNN---GTKGCLLW 56
Query: 397 -FGDLIDMRKTLANLTGQSIYLRV 419
L D R + G +Y ++
Sbjct: 57 SESSLGDARLFPSG--GVDLYEKI 78
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 3e-10
Identities = 35/97 (36%), Positives = 58/97 (59%), Gaps = 13/97 (13%)
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
VA+G+ +L + IHRDL A N+LL KI DFG+AR ++++++N +V
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----DIRNDSNYVVKG 274
Query: 688 YG-----YMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
+M+PE + +++ +SDV+S+G+LL EI S
Sbjct: 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 35/91 (38%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 632 LLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTN-RIVGTYGY 690
L YL + + VIHRD+K SN+LLD+ N K+ DFGI+ G + S R G Y
Sbjct: 127 LHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGIS----GRLVDSKAKTRSAGCAAY 180
Query: 691 MSPEY----ALHGLFSIKSDVFSFGVLLLEI 717
M+PE + + I++DV+S G+ L+E+
Sbjct: 181 MAPERIDPPDPNPKYDIRADVWSLGISLVEL 211
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 61/228 (26%), Positives = 101/228 (44%), Gaps = 45/228 (19%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKR-LSSKSGQGLEEFK- 571
D + + K+GEG +G VYK+ ++ G+ VA+K+ +G+
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKN------------TGKLVALKKTRLEMDEEGIPPTAL 48
Query: 572 NEMMLIAKLQHRN-LVRLFGCCIEQGE----KISIYEFDIVTDPARKDL----------- 615
E+ L+ L +VRL +E E K S+Y +V + DL
Sbjct: 49 REISLLQMLSESIYIVRLL--DVEHVEEKNGKPSLY---LVFEYLDSDLKKFMDSNGRGP 103
Query: 616 ---LDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP-KISDFGIART 671
L T + + +G+ + H++ V+HRDLK N+L+D KI+D G+ R
Sbjct: 104 GRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160
Query: 672 FGGDEMQSNTNRIVGTYGYMSPEYALHGL-FSIKSDVFSFGVLLLEIL 718
F ++S T+ IV T Y +PE L +S D++S G + E+
Sbjct: 161 F-SIPVKSYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 31/208 (14%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFK--NEMMLIA 578
KLGEG + VYK I R +NG+ VA+K +S K+ +G+ F E L+
Sbjct: 12 KLGEGSYATVYKGISR------------INGQLVALKVISMKTEEGVP-FTAIREASLLK 58
Query: 579 KLQHRNLVRLFGCCIEQGEKIS-IYEFDIVTDPAR------KDLLDWTTRVRIIEGVAQG 631
L+H N+V L I E ++ ++E+ + TD A+ L + R+ + + + +G
Sbjct: 59 GLKHANIVLLHDI-IHTKETLTFVFEY-MHTDLAQYMIQHPGGLHPYNVRLFMFQ-LLRG 115
Query: 632 LLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYM 691
L Y+H ++HRDLK N+L+ K++DFG+AR Q+ ++ +V T Y
Sbjct: 116 LAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARA-KSIPSQTYSSEVV-TLWYR 170
Query: 692 SPEYALHGL-FSIKSDVFSFGVLLLEIL 718
P+ L +S D++ G + +E+L
Sbjct: 171 PPDVLLGATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 65/232 (28%), Positives = 106/232 (45%), Gaps = 39/232 (16%)
Query: 506 LSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQ 565
L S+ TD + +G+G +G VYK + N K G L AVK L S
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYK-------VTNKKDGSL-----AAVKILDPISDV 61
Query: 566 GLEEFKNEMMLIAKL-QHRNLVRLFGCCIEQGEKISIYEFDIVTDPAR--------KDLL 616
EE + E ++ L H N+V+ +G + +K+ + +V + K LL
Sbjct: 62 D-EEIEAEYNILQSLPNHPNVVKFYGM-FYKADKLVGGQLWLVLELCNGGSVTELVKGLL 119
Query: 617 DWTTRVR------IIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIAR 670
R+ I+ G GL +LH R+IHRD+K +N+LL ++ K+ DFG++
Sbjct: 120 ICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSA 176
Query: 671 TFGGDEMQSNTNRIVGTYGYMSPEY-----ALHGLFSIKSDVFSFGVLLLEI 717
++ NT+ VGT +M+PE + + DV+S G+ +E+
Sbjct: 177 QLTSTRLRRNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 39/94 (41%), Positives = 57/94 (60%), Gaps = 7/94 (7%)
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTF--GGDEMQSNTNRIV 685
VA+G+ +L SR + IHRDL A N+LL + KI DFG+AR D ++ + R+
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL- 238
Query: 686 GTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
+M+PE +++ +SDV+SFGVLL EI S
Sbjct: 239 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 4e-10
Identities = 33/95 (34%), Positives = 53/95 (55%), Gaps = 9/95 (9%)
Query: 630 QGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYG 689
+GL YLH ++HRD+K N+L++S+ KI DFG+AR DE + T +V Y
Sbjct: 114 RGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169
Query: 690 YMSPEY---ALHGLFSIKSDVFSFGVLLLEILSSK 721
Y +PE + H ++ D++S G + E+L +
Sbjct: 170 YRAPEILMGSRH--YTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-10
Identities = 59/237 (24%), Positives = 102/237 (43%), Gaps = 57/237 (24%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK-SGQGL--EEFKNEMMLI 577
+G+GG G VY + Y +C VA+K++ S L + F E +
Sbjct: 9 LIGKGGMGEVYLA---YDPVC---------SRRVALKKIREDLSENPLLKKRFLREAKIA 56
Query: 578 AKLQHRNLVRLFGCCIE-----------QGEKI-----SIYEFDIVTDPARKDLLDWT-- 619
A L H +V ++ C + +G + S+++ + ++ K+L + T
Sbjct: 57 ADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLS----KELAEKTSV 112
Query: 620 -TRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDE-- 676
+ I + + Y+H S+ V+HRDLK N+LL I D+G A +E
Sbjct: 113 GAFLSIFHKICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEED 169
Query: 677 -----------MQSNTN---RIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
S+ +IVGT YM+PE L S +D+++ GV+L ++L+
Sbjct: 170 LLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-10
Identities = 49/191 (25%), Positives = 86/191 (45%), Gaps = 27/191 (14%)
Query: 551 GEEVAVKRLSSKSGQGLEE---FKNEMMLIAKLQHRNLVRLF--GCCIEQGEKISIYEF- 604
G EVA+K L + + + + F+ E L A+L H N+V L G G +++E+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 605 ------DIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLL--- 655
+++ A L R++ V L H ++HRDLK N+++
Sbjct: 62 PGRTLREVL---AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQT 115
Query: 656 DSDMNPKISDFGIARTFGG----DEMQ-SNTNRIVGTYGYMSPEYALHGLFSIKSDVFSF 710
+ K+ DFGI G D + T ++GT Y +PE + SD++++
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175
Query: 711 GVLLLEILSSK 721
G++ LE L+ +
Sbjct: 176 GLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 5e-10
Identities = 62/259 (23%), Positives = 110/259 (42%), Gaps = 61/259 (23%)
Query: 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRL--------SSKSGQGLEEFK 571
LGEG +G V K+ + L G+ VA+K++ +K Q +
Sbjct: 15 AHLGEGTYGKVEKAYD------------TLTGKIVAIKKVKIIEISNDVTKDRQLVGMCG 62
Query: 572 ------NEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDL---LDWTTRV 622
E+ ++ +++H N++ L +E ++V D DL +D R+
Sbjct: 63 IHFTTLRELKIMNEIKHENIMGLVDVYVEGDF------INLVMDIMASDLKKVVDRKIRL 116
Query: 623 R------IIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGD- 675
I+ + GL LH++ +HRDL +N+ ++S KI+DFG+AR +G
Sbjct: 117 TESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPP 173
Query: 676 ---------EMQSN---TNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSKK 722
MQ T+++V T Y +PE + + D++S G + E+L+ K
Sbjct: 174 YSDTLSKDETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK- 231
Query: 723 NTRFYNTDSLTLLGHAWNL 741
F + + LG + L
Sbjct: 232 -PLFPGENEIDQLGRIFEL 249
|
Length = 335 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 6e-10
Identities = 34/97 (35%), Positives = 55/97 (56%), Gaps = 6/97 (6%)
Query: 636 HQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEY 695
H ++R V++RDLK +N+LLD + +ISD G+A F + ++ VGT+GYM+PE
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEV 166
Query: 696 ALHGL-FSIKSDVFSFGVLLLEILSSKKNTRFYNTDS 731
G+ + +D FS G +L ++L R + T
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 6e-10
Identities = 76/284 (26%), Positives = 120/284 (42%), Gaps = 48/284 (16%)
Query: 539 EICNWKQGKLLNGE--------EVAVKRL-SSKSGQGLEEFKNEMMLIAKLQHRNLVRLF 589
EI N GK+L GE V VK L +S + F E+ +L H N+++
Sbjct: 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 590 GCCIEQGEKISIYEF--------------DIVTDPARKDLLDWTTRVRIIEGVAQGLLYL 635
G CIE + + EF +V A+KD+L R+ VA GLL+L
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVL-----QRMACEVASGLLWL 116
Query: 636 HQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEY 695
HQ IH DL N L +D++ KI D+G+A ++ + +++PE
Sbjct: 117 HQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPEL 173
Query: 696 A-------LHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAW 748
L + KS+++S GV + E L + + + + +L ++
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWE-LFTAADQPYPDLSDEQVLKQVVR----EQDI 228
Query: 749 KLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAML 792
KL P + + YS R+ +V C + T RPT EV +L
Sbjct: 229 KLPKPQLDLK--YS--DRWYEVMQFCWLDPET-RPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 6e-10
Identities = 36/89 (40%), Positives = 53/89 (59%), Gaps = 7/89 (7%)
Query: 631 GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIAR-TFGGDEMQSNTNRIVGTYG 689
GL +LH +++RDLK N+LLD+D + KI+DFG+ + GD + T GT
Sbjct: 108 GLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD---AKTCTFCGTPD 161
Query: 690 YMSPEYALHGLFSIKSDVFSFGVLLLEIL 718
Y++PE L ++ D +SFGVLL E+L
Sbjct: 162 YIAPEILLGQKYNTSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 34/94 (36%), Positives = 57/94 (60%), Gaps = 5/94 (5%)
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
++ GL +LH R +I+RDLK NV+LDS+ + KI+DFG+ + D + + T GT
Sbjct: 110 ISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT--FCGT 164
Query: 688 YGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSK 721
Y++PE + + D +++GVLL E+L+ +
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 7e-10
Identities = 63/240 (26%), Positives = 102/240 (42%), Gaps = 69/240 (28%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQ-----GLE 568
+ + +GEG +G V + + G +VA+K++S Q L
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHK------------PTGVKVAIKKISPFEHQTFCQRTLR 52
Query: 569 EFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTRVRIIEGV 628
E K ++ + +H N+ I I DI+ P+ + D V I++ +
Sbjct: 53 EIK----ILRRFKHENI-------------IGI--LDIIRPPSFESFND----VYIVQEL 89
Query: 629 ----------AQGLLYLH----QYSRLR---------VIHRDLKASNVLLDSDMNPKISD 665
Q L H Y LR V+HRDLK SN+LL+++ + KI D
Sbjct: 90 METDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICD 149
Query: 666 FGIARTFGGDEMQSNTNRI---VGTYGYMSPEYALHGLFSIKS-DVFSFGVLLLEILSSK 721
FG+AR D +T + V T Y +PE L+ K+ D++S G +L E+LS++
Sbjct: 150 FGLARI--ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-09
Identities = 40/163 (24%), Positives = 73/163 (44%), Gaps = 11/163 (6%)
Query: 573 EMMLIAKLQHRNLVRLFGCCIEQGEKISI---YEFDIVTDPARKDL-LDWTTRVRIIEGV 628
E ML+ + H +++R+ + + Y D+ T ++ L + I + +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQI 166
Query: 629 AQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTY 688
+GL YLH R+IHRD+K N+ ++ I D G A+ + GT
Sbjct: 167 LEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG---LAGTV 220
Query: 689 GYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDS 731
+PE ++ K+D++S G++L E+L+ T F + S
Sbjct: 221 ETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPS-TIFEDPPS 262
|
Length = 357 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 21/199 (10%)
Query: 551 GEEVAVKRLSS--KSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVT 608
G VAVK+LS ++ + E++L+ + H+N++ L Q + +V
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105
Query: 609 DPARKDL-------LDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP 661
+ +L LD ++ + G+ +LH +IHRDLK SN+++ SD
Sbjct: 106 ELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 162
Query: 662 KISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSK 721
KI DFG+ART + M T +V Y Y +PE L + D++S G ++ E++ K
Sbjct: 163 KILDFGLARTACTNFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGELV--K 217
Query: 722 KNTRFYNTDSLTLLGHAWN 740
+ F TD + WN
Sbjct: 218 GSVIFQGTDHID----QWN 232
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 56/212 (26%), Positives = 98/212 (46%), Gaps = 34/212 (16%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQ 581
+GEG FG R + + + + +E+ RL KS +E+ + E +L+AK++
Sbjct: 8 VGEGSFG-------RALLVQHVNSDQKYAMKEI---RLP-KSSSAVEDSRKEAVLLAKMK 56
Query: 582 HRNLVRLFGCCIEQGEKISIYEFDIVTDPARK------------DLLDWTTRVRIIEGVA 629
H N+V G + E+ D +K +L W ++ +
Sbjct: 57 HPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL----- 111
Query: 630 QGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYG 689
G+ ++H+ RV+HRD+K+ N+ L + K+ DFG AR + T VGT
Sbjct: 112 -GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPY 165
Query: 690 YMSPEYALHGLFSIKSDVFSFGVLLLEILSSK 721
Y+ PE + ++ KSD++S G +L E+ + K
Sbjct: 166 YVPPEIWENMPYNNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 37/106 (34%), Positives = 58/106 (54%), Gaps = 12/106 (11%)
Query: 636 HQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEY 695
H ++R V++RDLK +N+LLD + +ISD G+A F + ++ VGT+GYM+PE
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEV 166
Query: 696 ALHGL-FSIKSDVFSFGVLLLEILSSKKNTRFYNT------DSLTL 734
G + +D FS G +L ++L R + T D +TL
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 212
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 60/240 (25%), Positives = 106/240 (44%), Gaps = 44/240 (18%)
Query: 504 FSLSSISAATDNFSEEN-------KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAV 556
F LS + D+F + + +G+G +G V+K + + NG + AV
Sbjct: 1 FPLSGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNK------------KNGSKAAV 48
Query: 557 KRLSSKSGQGLEEFKNEMMLIAKLQ-HRNLVRLFGCCIEQGEK--------ISIYEFDIV 607
K L EE + E ++ L H N+V+ +G ++ K + + V
Sbjct: 49 KILDPIHDID-EEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSV 107
Query: 608 TDPA-----RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPK 662
TD R + ++ I+ GL +LH + IHRD+K +N+LL ++ K
Sbjct: 108 TDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVK 164
Query: 663 ISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEY-----ALHGLFSIKSDVFSFGVLLLEI 717
+ DFG++ ++ NT+ VGT +M+PE L + + DV+S G+ +E+
Sbjct: 165 LVDFGVSAQLTSTRLRRNTS--VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 35/94 (37%), Positives = 56/94 (59%), Gaps = 5/94 (5%)
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
+A GL +LH +I+RDLK NV+LDS+ + KI+DFG+ + D + + T GT
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT--FCGT 164
Query: 688 YGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSK 721
Y++PE + + D ++FGVLL E+L+ +
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
+A L +LH L +I+RDLK N+LLD + + K++DFG+++ E GT
Sbjct: 107 LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGT 161
Query: 688 YGYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
YM+PE + +D +SFGVL+ E+L+
Sbjct: 162 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT 193
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 55/222 (24%), Positives = 99/222 (44%), Gaps = 33/222 (14%)
Query: 516 FSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMM 575
F + LG+GGFG V R GK+ + + KR+ + G+ + NE
Sbjct: 2 FRQYRVLGKGGFGEVCACQVR-------ATGKMYACKRLEKKRIKKRKGESMA--LNEKQ 52
Query: 576 LIAKLQHRNLVRLF-------GCC----IEQGEKISIYEFDIVTDPARKDLLDWTTRVRI 624
++ K+ + +V L C I G + + +++ +P ++ R
Sbjct: 53 ILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNM-GNPGFEE-------ERA 104
Query: 625 IEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIA-RTFGGDEMQSNTNR 683
+ A+ L L R ++RDLK N+LLD + +ISD G+A + G+ ++
Sbjct: 105 LFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR--- 161
Query: 684 IVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTR 725
VGT GYM+PE + +++ D + G L+ E++ + R
Sbjct: 162 -VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 55/187 (29%), Positives = 89/187 (47%), Gaps = 35/187 (18%)
Query: 551 GEEVAVKRLSSKSGQGLEEFKN---------EMMLIAKLQHRNLVRLFGCCIEQGEKISI 601
G+ VA+K+LS F+N E++L+ + H+N++ L Q S+
Sbjct: 41 GQNVAIKKLS-------RPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQK---SL 90
Query: 602 YEFD---IVTDPARKDL-------LDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKAS 651
EF +V + +L LD ++ + G+ +LH +IHRDLK S
Sbjct: 91 EEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPS 147
Query: 652 NVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFG 711
N+++ SD KI DFG+ART G M T +V Y Y +PE L + D++S G
Sbjct: 148 NIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVG 204
Query: 712 VLLLEIL 718
++ E++
Sbjct: 205 CIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-09
Identities = 65/237 (27%), Positives = 108/237 (45%), Gaps = 41/237 (17%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN- 572
+ + + +G G +G V + + G VAVK+LS + Q + K
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTK------------TGLRVAVKKLS-RPFQSIIHAKRT 63
Query: 573 --EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFD---IVTDPARKDLLDWTTRVRI--- 624
E+ L+ ++H N++ L S+ EF+ +VT DL + ++
Sbjct: 64 YRELRLLKHMKHENVIGLLDVF---TPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 120
Query: 625 -----IEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQS 679
I + +GL Y+H +IHRDLK SN+ ++ D KI DFG+AR DEM
Sbjct: 121 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG 176
Query: 680 NTNRIVGTYGYMSPEYALHGL-FSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLL 735
V T Y +PE L+ + ++ D++S G ++ E+L+ + T F TD + L
Sbjct: 177 ----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQL 227
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 28/205 (13%)
Query: 539 EICNWKQGKLLNGE--------EVAVKRL-SSKSGQGLEEFKNEMMLIAKLQHRNLVRLF 589
EI N GK++ GE +V VK L S S Q +F E LQH NL++
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 590 GCCIEQGEKISIYEFDIVTDPAR-------KDLL--DWTTRVRIIEGVAQGLLYLHQYSR 640
G C E + + EF + D +L+ D TT R+ +A GLL+LH+ +
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 641 LRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYA--LH 698
IH DL N LL +D+ KI D+G++ ++ +++ +++PE +H
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 699 GLF-----SIKSDVFSFGVLLLEIL 718
G + +S+V+S GV + E+
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 35/210 (16%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFK---NEMMLI 577
++G+GG+G V + K GE VA+KR+ L E + E ++
Sbjct: 8 QVGQGGYGQV------------FLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDIL 55
Query: 578 AKLQHRNLVRLFGCCIEQGEKISIY---EF----DIVTDPARKDLL-DWTTRVRIIEGVA 629
+ LV+L + +Y E+ D T +L + R + E
Sbjct: 56 TTTKSEWLVKLL---YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFE 112
Query: 630 QGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYG 689
+ LH L IHRDLK N L+D+ + K++DFG+++ + + N +VG+
Sbjct: 113 -AVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVVGSPD 163
Query: 690 YMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
YM+PE + D +S G +L E L
Sbjct: 164 YMAPEVLRGKGYDFTVDYWSLGCMLYEFLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 60/234 (25%), Positives = 100/234 (42%), Gaps = 74/234 (31%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN--------- 572
+G G +G V + E+VA+K++++ F N
Sbjct: 13 IGRGAYGIVCSAKNS------------ETNEKVAIKKIANA-------FDNRIDAKRTLR 53
Query: 573 EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK---------DLLDWTTRVR 623
E+ L+ L H N++ + DI+ P R+ +L+D T +
Sbjct: 54 EIKLLRHLDHENVIAIK---------------DIMPPPHREAFNDVYIVYELMD-TDLHQ 97
Query: 624 IIEG---------------VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGI 668
II + +GL Y+H + V+HRDLK SN+LL+++ + KI DFG+
Sbjct: 98 IIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGL 154
Query: 669 ARTFGGDEMQSNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSK 721
ART ++ T +V T Y +PE L+ ++ DV+S G + E+L K
Sbjct: 155 ART-TSEKGDFMTEYVV-TRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 39/106 (36%), Positives = 55/106 (51%), Gaps = 9/106 (8%)
Query: 614 DLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFG 673
DLL +T +V A+G+ +L + +HRDL A NVLL KI DFG+AR
Sbjct: 238 DLLSFTYQV------ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIM 288
Query: 674 GDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
D + +M+PE L++ SDV+S+G+LL EI S
Sbjct: 289 HDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 39/217 (17%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEE--VAVKRL-SSKSGQGLEEFKNEMM 575
E LG G FG + KL + E VA+ L + S + F E +
Sbjct: 10 ERILGTGRFGEL---------CRGCL--KLPSKRELPVAIHTLRAGCSDKQRRGFLAEAL 58
Query: 576 LIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTR-----------VRI 624
+ + H N+VRL G I +G + I VT+ LD R + +
Sbjct: 59 TLGQFDHSNIVRLEGV-ITRGNTMMI-----VTEYMSNGALDSFLRKHEGQLVAGQLMGM 112
Query: 625 IEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQS--NTN 682
+ G+A G+ YL S + +H+ L A VL++SD+ KIS F R D+ ++ T
Sbjct: 113 LPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGF---RRLQEDKSEAIYTTM 166
Query: 683 RIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
+ +PE + FS SDV+SFG+++ E++S
Sbjct: 167 SGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 54/182 (29%), Positives = 89/182 (48%), Gaps = 21/182 (11%)
Query: 552 EEVAVKRLSSKSGQGLEEFKN---EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVT 608
++VAVK+LS + Q L + E+ L+ ++H N++ L + E +VT
Sbjct: 41 QKVAVKKLS-RPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVT 99
Query: 609 DPARKDLLDWTTRVRI--------IEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMN 660
+ DL + ++ I + +GL Y+H +IHRDLK SNV ++ D
Sbjct: 100 NLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCE 156
Query: 661 PKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGL-FSIKSDVFSFGVLLLEILS 719
+I DFG+AR DEM V T Y +PE L+ + ++ D++S G ++ E+L
Sbjct: 157 LRILDFGLARQ-ADDEMTG----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLK 211
Query: 720 SK 721
K
Sbjct: 212 GK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 4e-09
Identities = 58/207 (28%), Positives = 89/207 (42%), Gaps = 28/207 (13%)
Query: 522 LGEGGFGPV----YKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLI 577
LG G FG V YK I K+G ++ +EV S + + E N
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVE----SLMCEKRIFETANSER-- 60
Query: 578 AKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTRVRIIEGVAQ---GLLY 634
H LV LF C + + E+ D D + R + A GL Y
Sbjct: 61 ----HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQY 116
Query: 635 LHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIART---FGGDEMQSNTNRIVGTYGYM 691
LH+ ++++RDLK N+LLD++ KI+DFG+ + FG T+ GT ++
Sbjct: 117 LHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG-----DRTSTFCGTPEFL 168
Query: 692 SPEYALHGLFSIKSDVFSFGVLLLEIL 718
+PE ++ D + GVL+ E+L
Sbjct: 169 APEVLTETSYTRAVDWWGLGVLIYEML 195
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 34/94 (36%), Positives = 51/94 (54%), Gaps = 5/94 (5%)
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
+A L YLH+ ++HRDLK NV L K+ D GIAR ++T ++GT
Sbjct: 111 IAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGT 165
Query: 688 YGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSK 721
YMSPE + ++ KSDV++ G + E+ + K
Sbjct: 166 PYYMSPELFSNKPYNYKSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 54/215 (25%), Positives = 88/215 (40%), Gaps = 41/215 (19%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN----EMML 576
+GEG +G V K + GE VA+K+ K + E+ K E+ +
Sbjct: 8 VVGEGAYGVVLKCRNK------------ATGEIVAIKKF--KESEDDEDVKKTALREVKV 53
Query: 577 IAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDW-----------TTRVRII 625
+ +L+H N+V L +G ++E+ + LL+ R I
Sbjct: 54 LRQLRHENIVNLKEAFRRKGRLYLVFEY------VERTLLELLEASPGGLPPDAVR-SYI 106
Query: 626 EGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIV 685
+ Q + Y H +IHRD+K N+L+ K+ DFG AR T+ V
Sbjct: 107 WQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD-YV 162
Query: 686 GTYGYMSPEYALHGLFSIKS-DVFSFGVLLLEILS 719
T Y +PE + K DV++ G ++ E+L
Sbjct: 163 ATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 5e-09
Identities = 50/177 (28%), Positives = 84/177 (47%), Gaps = 15/177 (8%)
Query: 554 VAVKRLSS--KSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPA 611
VA+K+LS ++ + E++L+ + H+N++ L Q + IV +
Sbjct: 52 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 612 RKDL-------LDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664
+L LD ++ + G+ +LH +IHRDLK SN+++ SD KI
Sbjct: 112 DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKIL 168
Query: 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSK 721
DFG+ART G M T +V Y Y +PE L + D++S G ++ E++
Sbjct: 169 DFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 5e-09
Identities = 55/236 (23%), Positives = 93/236 (39%), Gaps = 65/236 (27%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG------QGL 567
+ +G G +G V +I+ +G++VA+K++ + L
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDT------------RSGKKVAIKKIPHAFDVPTLAKRTL 52
Query: 568 EEFKNEMMLIAKLQHRNLVRLFGCCI------EQGEKISIYEFDIVTDPARKDLLDWTTR 621
E K ++ +H N++ I + +Y +V D DL
Sbjct: 53 RELK----ILRHFKHDNII-----AIRDILRPPGADFKDVY---VVMDLMESDLH----- 95
Query: 622 VRIIEG---------------VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666
II + +GL Y+H + VIHRDLK SN+L++ D +I DF
Sbjct: 96 -HIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDF 151
Query: 667 GIARTFGG--DEMQSNTNRIVGTYGYMSPE--YALHGLFSIKSDVFSFGVLLLEIL 718
G+AR E + V T Y +PE +L ++ D++S G + E+L
Sbjct: 152 GMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPE-YTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 5e-09
Identities = 53/213 (24%), Positives = 95/213 (44%), Gaps = 20/213 (9%)
Query: 522 LGEGGFGPVYK-SIERYVEICNWKQGKLLNGEEVA-VKRLSSK----SGQGLEEFKNEMM 575
L G FG ++ ++ E ++G + +RL +K + + +NE++
Sbjct: 156 LPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEIL 215
Query: 576 LIAKLQHRNLVRL--------FGCCIEQGEKISIYEFDIVTDPARKDL-LDWTTRVRIIE 626
+ +L H N++++ I Q +Y F KD L TR I++
Sbjct: 216 ALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTR-AIMK 274
Query: 627 GVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVG 686
+ + Y+H ++IHRD+K N+ L+ D + DFG A F E ++ VG
Sbjct: 275 QLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPF-EKEREAFDYGWVG 330
Query: 687 TYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
T SPE + +D++S G++LL++LS
Sbjct: 331 TVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 6e-09
Identities = 35/90 (38%), Positives = 51/90 (56%), Gaps = 9/90 (10%)
Query: 631 GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIAR--TFGGDEMQSNTNRIVGTY 688
GL +LH +I+RDLK NV+LD D + KI+DFG+ + FG + + GT
Sbjct: 108 GLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG----DNRASTFCGTP 160
Query: 689 GYMSPEYALHGLFSIKSDVFSFGVLLLEIL 718
Y++PE ++ D +SFGVLL E+L
Sbjct: 161 DYIAPEILQGLKYTFSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 7e-09
Identities = 50/177 (28%), Positives = 85/177 (48%), Gaps = 15/177 (8%)
Query: 554 VAVKRLSS--KSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPA 611
VA+K+LS ++ + E++L+ + H+N++ L Q + +V +
Sbjct: 45 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 104
Query: 612 RKDL-------LDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664
+L LD ++ + G+ +LH +IHRDLK SN+++ SD KI
Sbjct: 105 DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKIL 161
Query: 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSK 721
DFG+ART G M T +V Y Y +PE L + D++S G ++ E++ K
Sbjct: 162 DFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 32/207 (15%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN----EMMLI 577
+GEG +G V K C K+ K E VA+K+ K + EE K E+ ++
Sbjct: 9 VGEGAYGVVLK--------CRHKETK----EIVAIKKF--KDSEENEEVKETTLRELKML 54
Query: 578 AKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTRV-------RIIEGVAQ 630
L+ N+V L +G+ ++E+ K++L+ + ++ + Q
Sbjct: 55 RTLKQENIVELKEAFRRRGKLYLVFEY------VEKNMLELLEEMPNGVPPEKVRSYIYQ 108
Query: 631 GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGY 690
+ +H + ++HRD+K N+L+ + K+ DFG AR + +N V T Y
Sbjct: 109 LIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNL-SEGSNANYTEYVATRWY 167
Query: 691 MSPEYALHGLFSIKSDVFSFGVLLLEI 717
SPE L + D++S G +L E+
Sbjct: 168 RSPELLLGAPYGKAVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 9e-09
Identities = 37/94 (39%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 631 GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTF--GGDEMQSNTNRIVGTY 688
GL Y+H + V+HRDLK N+L+++D KI DFG+AR F E V T
Sbjct: 117 GLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173
Query: 689 GYMSPEYALHGLFSIKS-DVFSFGVLLLEILSSK 721
Y +PE L K+ DV+S G +L E+L K
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 56/214 (26%), Positives = 90/214 (42%), Gaps = 38/214 (17%)
Query: 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN--EMMLI 577
K+GEG F V K+ R G+ A+K + K + LE+ N E+ +
Sbjct: 5 GKIGEGTFSEVLKAQSRK------------TGKYYAIKCMK-KHFKSLEQVNNLREIQAL 51
Query: 578 AKLQ-HRNLVRLFGCCIEQGEK----------ISIYEFDIVTDPARKDLLDWTTRVRIIE 626
+L H N++RL ++ +++YE RK L +
Sbjct: 52 RRLSPHPNILRLIEVLFDRKTGRLALVFELMDMNLYELI----KGRKRPLPEKRVKSYMY 107
Query: 627 GVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVG 686
+ + L ++H R + HRD+K N+L+ D K++DFG R T I
Sbjct: 108 QLLKSLDHMH---RNGIFHRDIKPENILIKDD-ILKLADFGSCRGI--YSKPPYTEYI-S 160
Query: 687 TYGYMSPEYAL-HGLFSIKSDVFSFGVLLLEILS 719
T Y +PE L G + K D+++ G + EILS
Sbjct: 161 TRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 34/102 (33%), Positives = 57/102 (55%), Gaps = 10/102 (9%)
Query: 622 VRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNT 681
VR G + +L L +L +++RD+K N+LLDS+ + ++DFG+++ F +E + T
Sbjct: 107 VRFYSG--EIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE-KERT 163
Query: 682 NRIVGTYGYMSPEY----ALHGLFSIKSDVFSFGVLLLEILS 719
GT YM+PE HG D +S G+L+ E+L+
Sbjct: 164 YSFCGTIEYMAPEIIRGKGGHGK---AVDWWSLGILIFELLT 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 56/216 (25%), Positives = 103/216 (47%), Gaps = 40/216 (18%)
Query: 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAK 579
++LG+G +G VYK + R G + +E+ ++ SK Q + E+ ++ K
Sbjct: 7 DELGKGNYGSVYKVLHR-------PTGVTMAMKEIRLELDESKFNQIIM----ELDILHK 55
Query: 580 LQHRNLVRLFGC---------CIE---QGEKISIYEFDIVTDPARKDLLDWTTRVRIIEG 627
+V +G C+E G +Y + T+ +D+L RI
Sbjct: 56 AVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVL-----RRITYA 110
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
V +GL +L + +IHRD+K +NVL++ + K+ DFG++ G+ + S +G
Sbjct: 111 VVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTNIGC 164
Query: 688 YGYMSPEY------ALHGLFSIKSDVFSFGVLLLEI 717
YM+PE + ++++SDV+S G+ +LE+
Sbjct: 165 QSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEM 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 31/217 (14%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQ 581
LG+GGFG V R GK+ +++ KR+ + G+ + NE ++ K+
Sbjct: 8 LGKGGFGEVCACQVR-------ATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVN 58
Query: 582 HRNLVRLF-------GCC----IEQGEKISIYEFDIVTDPARKDLLDWTTRVRIIEGVAQ 630
R +V L C I G + + +++ +P + R I A+
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM-GNPGFDE-------QRAIFYAAE 110
Query: 631 GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGY 690
L R R+++RDLK N+LLD + +ISD G+A E ++ R VGT GY
Sbjct: 111 LCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQI--PEGETVRGR-VGTVGY 167
Query: 691 MSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFY 727
M+PE + ++ D + G L+ E++ + R
Sbjct: 168 MAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKR 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 31/94 (32%), Positives = 54/94 (57%), Gaps = 3/94 (3%)
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
+ +L L +L +I+RD+K N+LLDS+ + ++DFG+++ F DE++ + GT
Sbjct: 111 SGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCGT 169
Query: 688 YGYMSPEYALHGL--FSIKSDVFSFGVLLLEILS 719
YM+P+ G D +S GVL+ E+L+
Sbjct: 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 6/91 (6%)
Query: 631 GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGY 690
GL LH R R+++RDLK N+LLD + +ISD G+A E ++ R VGT GY
Sbjct: 114 GLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEI--PEGETIRGR-VGTVGY 167
Query: 691 MSPEYALHGLFSIKSDVFSFGVLLLEILSSK 721
M+PE + ++ D + G L+ E++ K
Sbjct: 168 MAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 4e-08
Identities = 35/105 (33%), Positives = 53/105 (50%), Gaps = 5/105 (4%)
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
+ L++LH +I+RDLK NVLLD + + K++DFG+ + G T+ GT
Sbjct: 105 ITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKE--GIFNGKTTSTFCGT 159
Query: 688 YGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSL 732
Y++PE L+ D ++ GVLL E+L N D L
Sbjct: 160 PDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 5e-08
Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 30/203 (14%)
Query: 535 ERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFG---- 590
E V +C K G + K++ K+ G + E+ ++ + HR ++ L
Sbjct: 105 EGEVFVCT-KHG------DEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRW 157
Query: 591 ----CCIEQGEKISIYEFDIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHR 646
C + + Y+ D+ T R L + I + + L YLH +IHR
Sbjct: 158 KSTVCMV-----MPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHR 209
Query: 647 DLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYM---SPEYALHGLFSI 703
D+K N+ LD N + DFG A +T + G G + SPE +
Sbjct: 210 DVKTENIFLDEPENAVLGDFGAACKLD---AHPDTPQCYGWSGTLETNSPELLALDPYCA 266
Query: 704 KSDVFSFGVLLLEILSSKKNTRF 726
K+D++S G++L E +S K T F
Sbjct: 267 KTDIWSAGLVLFE-MSVKNVTLF 288
|
Length = 392 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 30/209 (14%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKR-LSSKSGQGLEEFK-NEMMLIA 578
+GEG +G V K C K+ G+ VA+K+ L S+ + +++ E+ ++
Sbjct: 8 LVGEGSYGMVMK--------CKHKE----TGQIVAIKKFLESEDDKMVKKIAMREIRMLK 55
Query: 579 KLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDL------LDWTTRVRIIEGVAQGL 632
+L+H NLV L + ++EF V DL LD + + + + +G+
Sbjct: 56 QLRHENLVNLIEVFRRKKRLYLVFEF--VDHTVLDDLEKYPNGLDESRVRKYLFQILRGI 113
Query: 633 LYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTF-GGDEMQSNTNRIVGTYGYM 691
+ H ++ +IHRD+K N+L+ K+ DFG ART E+ ++ V T Y
Sbjct: 114 EFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD---YVATRWYR 167
Query: 692 SPEYALHGL-FSIKSDVFSFGVLLLEILS 719
+PE + + D+++ G L+ E+L+
Sbjct: 168 APELLVGDTKYGRAVDIWAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 27/210 (12%)
Query: 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAK 579
+KLGEG + VYK + + L+ +E+ RL + G + E+ L+
Sbjct: 12 DKLGEGTYATVYKGRSKLTD-------NLVALKEI---RLEHEEGAPCTAIR-EVSLLKD 60
Query: 580 LQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTRVRIIEGVA-------QGL 632
L+H N+V L + ++E+ D K LD + V +GL
Sbjct: 61 LKHANIVTLHDIIHTEKSLTLVFEY---LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGL 117
Query: 633 LYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMS 692
Y H R +V+HRDLK N+L++ K++DFG+AR ++ +N +V T Y
Sbjct: 118 NYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARA-KSIPTKTYSNEVV-TLWYRP 172
Query: 693 PEYALHGL-FSIKSDVFSFGVLLLEILSSK 721
P+ L +S + D++ G + E+ + +
Sbjct: 173 PDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 6e-08
Identities = 33/105 (31%), Positives = 56/105 (53%), Gaps = 5/105 (4%)
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
V L++LH++ VI+RDLK N+LLD++ + K++DFG+ + G T GT
Sbjct: 105 VTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKE--GILNGVTTTTFCGT 159
Query: 688 YGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSL 732
Y++PE + D ++ GVL+ E+++ + N D L
Sbjct: 160 PDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAK 579
KLGEG + V+K + E L+ +E+ RL + G + E+ L+
Sbjct: 12 EKLGEGTYATVFKGRSKLTE-------NLVALKEI---RLEHEEGAPCTAIR-EVSLLKD 60
Query: 580 LQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTRVRIIEGVA-------QGL 632
L+H N+V L ++E+ D K +D + + V +GL
Sbjct: 61 LKHANIVTLHDIVHTDKSLTLVFEY---LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGL 117
Query: 633 LYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMS 692
Y H R +V+HRDLK N+L++ K++DFG+AR ++ +N +V T Y
Sbjct: 118 AYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARA-KSVPTKTYSNEVV-TLWYRP 172
Query: 693 PEYAL-HGLFSIKSDVFSFGVLLLEILSSK 721
P+ L +S + D++ G + E+ S +
Sbjct: 173 PDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-08
Identities = 59/233 (25%), Positives = 101/233 (43%), Gaps = 33/233 (14%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSS--KSGQGLEEFK 571
D + + ++G G +G V +++R G +VA+K+L +S +
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRR------------TGAKVAIKKLYRPFQSELFAKRAY 62
Query: 572 NEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTRVRIIEGVAQ- 630
E+ L+ ++H N++ L ++F +V DL ++ E Q
Sbjct: 63 RELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQF 122
Query: 631 -------GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNR 683
GL Y+H +IHRDLK N+ ++ D KI DFG+AR + S
Sbjct: 123 LVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTG 174
Query: 684 IVGTYGYMSPEYALHGL-FSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLL 735
V T Y +PE L+ + ++ D++S G ++ E+L+ K F D L L
Sbjct: 175 YVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK--PLFKGHDHLDQL 225
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 7e-08
Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 41/220 (18%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVK--RLSSKSGQGLEEFK 571
D++ + KLGEG + VYK + +NG+ VA+K RL + G +
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSK------------VNGKLVALKVIRLQEEEGTPFTAIR 52
Query: 572 NEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTR---------V 622
E L+ L+H N+V L + ++E+ DL + + V
Sbjct: 53 -EASLLKGLKHANIVLLHDIIHTKETLTLVFEY------VHTDLCQYMDKHPGGLHPENV 105
Query: 623 RI-IEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNT 681
++ + + +GL Y+HQ ++HRDLK N+L+ K++DFG+AR + S+T
Sbjct: 106 KLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLAR---AKSVPSHT 159
Query: 682 --NRIVGTYGYMSPEYALHGL-FSIKSDVFSFGVLLLEIL 718
N +V T Y P+ L +S D++ G + +E++
Sbjct: 160 YSNEVV-TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 9e-08
Identities = 67/254 (26%), Positives = 109/254 (42%), Gaps = 60/254 (23%)
Query: 521 KLGEGGFGPVY-KSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIA- 578
K+G G FG V+ +R E WK + S +GL+E + ++I
Sbjct: 20 KIGNGRFGEVFLVKHKRTQEFFCWK----------------AISYRGLKEREKSQLVIEV 63
Query: 579 ----KLQHRNLVRLFGCCIEQG-EKISI-YEFDIVTDPARK--------DLLDWTTRVRI 624
+L+H+N+VR + + +K+ I EF D +R ++ V I
Sbjct: 64 NVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDI 123
Query: 625 IEGVAQGLLYLHQY----SRLRVIHRDLKASNVLLDSDMN-----------------PKI 663
+ L Y H + RV+HRDLK N+ L + + KI
Sbjct: 124 TRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKI 183
Query: 664 SDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSI--KSDVFSFGVLLLEILSSK 721
DFG+++ G ++S + VGT Y SPE LH S KSD+++ G ++ E+ S K
Sbjct: 184 GDFGLSKNIG---IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
Query: 722 KNTRFYNTDSLTLL 735
T F+ ++ + L
Sbjct: 241 --TPFHKANNFSQL 252
|
Length = 1021 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 32/92 (34%), Positives = 50/92 (54%), Gaps = 11/92 (11%)
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
V G+ LHQ +IHRD+K N+L+D + K++DFG++R + VGT
Sbjct: 106 VVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSR------NGLENKKFVGT 156
Query: 688 YGYMSPEYALHGLFSIK-SDVFSFGVLLLEIL 718
Y++PE + G+ K SD +S G ++ E L
Sbjct: 157 PDYLAPE-TILGVGDDKMSDWWSLGCVIFEFL 187
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 1e-07
Identities = 34/138 (24%), Positives = 59/138 (42%), Gaps = 33/138 (23%)
Query: 614 DLLDWTTRVRIIEG------VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667
DL++ R + +A+ +L L +L IHRD+K N+L+D+D + K++DFG
Sbjct: 87 DLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFG 146
Query: 668 IARTFG-------------GDEMQSNTNR--------------IVGTYGYMSPEYALHGL 700
+ + + N VGT Y++PE
Sbjct: 147 LCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP 206
Query: 701 FSIKSDVFSFGVLLLEIL 718
+ ++ D +S GV+L E+L
Sbjct: 207 YGLECDWWSLGVILYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 34/101 (33%), Positives = 54/101 (53%), Gaps = 4/101 (3%)
Query: 619 TTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQ 678
+R R A+ L L + VI+RDLK N+LLD + + DFG+ + D+ +
Sbjct: 92 LSRARFY--TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK 149
Query: 679 SNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
+NT GT Y++PE L ++ D ++ GVLL E+L+
Sbjct: 150 TNT--FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 62/231 (26%), Positives = 101/231 (43%), Gaps = 40/231 (17%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQ 581
LG+G F ++K I R V L+ EV +K L E F ++++L
Sbjct: 3 LGQGTFTKIFKGIRREV-----GDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLS 57
Query: 582 HRNLVRLFGCCIEQGEKISIYEF------DIVTDPARKDLLDWTTRVRIIEGVAQGLLYL 635
H++LV +G C+ E I + E+ D K+L++ + ++ + + +A L +L
Sbjct: 58 HKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLK-KNKNLINISWKLEVAKQLAWALHFL 116
Query: 636 HQYSRLRVIHRDLKASNVLL-----DSDMNP---KISDFGIARTFGGDEMQSNTNRIVGT 687
+ H ++ A NVLL NP K+SD GI+ T E+ RI
Sbjct: 117 EDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEIL--LERI--- 168
Query: 688 YGYMSPEYALHGL-FSIKSDVFSFGVLLLEILS----------SKKNTRFY 727
++ PE + S+ +D +SFG L EI S S+K +FY
Sbjct: 169 -PWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY 218
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 3e-07
Identities = 36/94 (38%), Positives = 50/94 (53%), Gaps = 10/94 (10%)
Query: 644 IHRDLKASNVLLDSDMNPKISDFGIARTFGGDEM-QSNTNRIVGTYGYMSPEYAL----H 698
IHRD+K N+LLD + K++DFG + M + +T VGT Y+SPE
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT--AVGTPDYISPEVLKSQGGD 221
Query: 699 GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSL 732
G + + D +S GV L E+L +T FY DSL
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVG--DTPFY-ADSL 252
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 3e-07
Identities = 30/94 (31%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
++ L YLH+ +I+RDLK NVLLDS+ + K++D+G+ + G T+ GT
Sbjct: 105 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFCGT 159
Query: 688 YGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSK 721
Y++PE + D ++ GVL+ E+++ +
Sbjct: 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 3e-07
Identities = 61/229 (26%), Positives = 105/229 (45%), Gaps = 45/229 (19%)
Query: 518 EENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFK-NEMML 576
E K+G G +G VYK+ K GK + + A+K++ G G+ E+ L
Sbjct: 5 EGCKVGRGTYGHVYKAKR--------KDGK--DDRDYALKQIE---GTGISMSACREIAL 51
Query: 577 IAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDW------------TTRVRI 624
+ +L+H N++ L + ++ FD A DL W V++
Sbjct: 52 LRELKHPNVISLQKVFLSHADRKVWLLFDY----AEHDL--WHIIKFHRASKANKKPVQL 105
Query: 625 IEGVAQGLLY-----LHQYSRLRVIHRDLKASNVLLDSDMNP-----KISDFGIARTFGG 674
G+ + LLY +H V+HRDLK +N+L+ + P KI+D G AR F
Sbjct: 106 PRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNS 164
Query: 675 D-EMQSNTNRIVGTYGYMSPEYALHGLFSIKS-DVFSFGVLLLEILSSK 721
+ ++ + +V T+ Y +PE L K+ D+++ G + E+L+S+
Sbjct: 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-07
Identities = 29/85 (34%), Positives = 45/85 (52%), Gaps = 8/85 (9%)
Query: 634 YLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSP 693
YLH +I+RDLK N+LLD+ + K++DFG A+ ++ T + GT Y++P
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEYLAP 184
Query: 694 EYALHGLFSIKSDVFSFGVLLLEIL 718
E D ++ GVLL E +
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 4e-07
Identities = 45/186 (24%), Positives = 76/186 (40%), Gaps = 34/186 (18%)
Query: 550 NGEEVAVKR--LSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIV 607
VAVK+ L S S + L+ + E++ +LQH N++ I E + +
Sbjct: 24 TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPL--M 81
Query: 608 TDPARKDLLDWT-------TRVR-IIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDM 659
+ +DLL + I++ V L Y+H IHR +KAS++LL D
Sbjct: 82 AYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDG 138
Query: 660 NPKISDFGIARTFGGDEMQSNTNRIVGTYGY----------MSPEY---ALHGLFSIKSD 706
+S + M + R + + +SPE L G ++ KSD
Sbjct: 139 KVVLSGLRYSV-----SMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQG-YNEKSD 192
Query: 707 VFSFGV 712
++S G+
Sbjct: 193 IYSVGI 198
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 55/215 (25%), Positives = 101/215 (46%), Gaps = 40/215 (18%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKR-LSSKSGQGLEEFK-NEMMLIA 578
K+GEG +G V+K C ++ G+ VA+K+ + S+ +++ E+ ++
Sbjct: 8 KIGEGSYGVVFK--------CRNRE----TGQIVAIKKFVESEDDPVIKKIALREIRMLK 55
Query: 579 KLQHRNLVRLFGCCIE---QGEKIS-IYEFDIVTDPARKDLLDWTTR-------VRIIEG 627
+L+H NLV L IE + K+ ++E+ D + L+ R +II
Sbjct: 56 QLKHPNLVNL----IEVFRRKRKLHLVFEY---CDHTVLNELEKNPRGVPEHLIKKIIWQ 108
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTF-GGDEMQSNTNRIVG 686
Q + + H+++ IHRD+K N+L+ K+ DFG AR G + ++ V
Sbjct: 109 TLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD---YVA 162
Query: 687 TYGYMSPEYALHGL-FSIKSDVFSFGVLLLEILSS 720
T Y +PE + + DV++ G + E+L+
Sbjct: 163 TRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 35/103 (33%), Positives = 53/103 (51%), Gaps = 7/103 (6%)
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
VA + YLH L +I+RDLK N+LLDS + ++DFG+ + G E + T+ GT
Sbjct: 105 VASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKE--GVEPEETTSTFCGT 159
Query: 688 YGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTD 730
Y++PE + D + G +L E+L FY+ D
Sbjct: 160 PEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP--FYSRD 200
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 37/106 (34%), Positives = 59/106 (55%), Gaps = 10/106 (9%)
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGD-EMQSNTNRIVG 686
+A+ +L +H +L +HRD+K NVLLD + + +++DFG D +QS+ VG
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSV--AVG 165
Query: 687 TYGYMSPEY--ALH---GLFSIKSDVFSFGVLLLEILSSKKNTRFY 727
T Y+SPE A+ G + + D +S GV + E+L + T FY
Sbjct: 166 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE--TPFY 209
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 33/103 (32%), Positives = 53/103 (51%), Gaps = 6/103 (5%)
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
+ L YLH S V++RDLK N++LD D + KI+DFG+ + G + + GT
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKTFCGT 159
Query: 688 YGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTD 730
Y++PE + D + GV++ E++ + FYN D
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 7e-07
Identities = 51/162 (31%), Positives = 74/162 (45%), Gaps = 34/162 (20%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVK--RLSSKSGQGLEEFKNEMMLIA 578
KLGEG + VYK + L G+ VA+K RL + G + E L+
Sbjct: 12 KLGEGSYATVYKGRSK------------LTGQLVALKEIRLEHEEGAPFTAIR-EASLLK 58
Query: 579 KLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDL---LDWTTR------VRI-IEGV 628
L+H N+V L I +K F+ + DL +D VR+ + +
Sbjct: 59 DLKHANIVTLHD--IIHTKKTLTLVFEYL----DTDLKQYMDDCGGGLSMHNVRLFLFQL 112
Query: 629 AQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIAR 670
+GL Y HQ RV+HRDLK N+L+ K++DFG+AR
Sbjct: 113 LRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 7e-07
Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 7/103 (6%)
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
+ L YLH V++RD+K N++LD D + KI+DFG+ + D T GT
Sbjct: 104 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGT 158
Query: 688 YGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTD 730
Y++PE + D + GV++ E++ + FYN D
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 7e-07
Identities = 54/222 (24%), Positives = 95/222 (42%), Gaps = 41/222 (18%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNE 573
D+ +G G FG V+ +R E ++ K++ EV RL + + NE
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISE--HYYALKVMAIPEVI--RLKQE-----QHVHNE 51
Query: 574 MMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTD-------PARKDLLDWTTRVRIIE 626
++ ++ H ++RLF E ++ + V + T E
Sbjct: 52 KRVLKEVSHPFIIRLF--WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASE 109
Query: 627 GVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVG 686
V L YLH +++RDLK N+LLD + + K++DFG A+ +++ T + G
Sbjct: 110 IVC-ALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCG 160
Query: 687 TYGYMSPEYALHGLFSIKS-------DVFSFGVLLLEILSSK 721
T Y++PE I+S D ++ G+L+ E+L
Sbjct: 161 TPEYLAPE-------VIQSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 8e-07
Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 5/92 (5%)
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
+A L YLH L +I+RDLK N+LLDS + ++DFG+ + G E T+ GT
Sbjct: 105 IASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKE--GIEHSKTTSTFCGT 159
Query: 688 YGYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
Y++PE + D + G +L E+L
Sbjct: 160 PEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLY 191
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 8e-07
Identities = 68/278 (24%), Positives = 122/278 (43%), Gaps = 37/278 (13%)
Query: 539 EICNWKQGKLLNGE--------EVAVKRL-SSKSGQGLEEFKNEMMLIAKLQHRNLVRLF 589
EI N GK+L E V VK L ++ S + EF + LQH N+++
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 590 GCCIEQGEKISIYEF----DIVTDPARKDLLDWTTRV----RIIEGVAQGLLYLHQYSRL 641
G C+E + ++E+ D+ + +++ +++ R+ +A G+ ++H+++ L
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFL 121
Query: 642 RVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEY--ALHG 699
H DL N L SD+ K+ D+GI + ++ + +++PE HG
Sbjct: 122 ---HSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHG 178
Query: 700 -LFSIK----SDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPT 754
L + + S+V++ GV L E+ + + + +L H D+ KL P
Sbjct: 179 GLITAEQTKPSNVWALGVTLWELFENAAQP-YSHLSDREVLNHVIK----DQQVKLFKP- 232
Query: 755 MQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAML 792
Q E YS R+ +V C + R T EV +L
Sbjct: 233 -QLELPYS--ERWYEVLQFC-WLSPEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 55/212 (25%), Positives = 95/212 (44%), Gaps = 31/212 (14%)
Query: 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVK--RLSSKSGQGLEEFKNEMMLI 577
+KLGEG + V+K + L VA+K RL + G + E+ L+
Sbjct: 11 DKLGEGTYATVFKGRSK------------LTENLVALKEIRLEHEEGAPCTAIR-EVSLL 57
Query: 578 AKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTRVRIIEGVA-------Q 630
L+H N+V L + ++E+ D K LD + + V +
Sbjct: 58 KNLKHANIVTLHDIIHTERCLTLVFEY---LDSDLKQYLDNCGNLMSMHNVKIFMFQLLR 114
Query: 631 GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGY 690
GL Y H + +++HRDLK N+L++ K++DFG+AR ++ +N +V T Y
Sbjct: 115 GLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARA-KSVPTKTYSNEVV-TLWY 169
Query: 691 MSPEYALHGL-FSIKSDVFSFGVLLLEILSSK 721
P+ L +S D++ G +L E+ + +
Sbjct: 170 RPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 9e-07
Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 5/90 (5%)
Query: 629 AQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTY 688
AQ +L L +++RDLK N+LLD D K++DFG A+ + + T + GT
Sbjct: 138 AQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTP 192
Query: 689 GYMSPEYALHGLFSIKSDVFSFGVLLLEIL 718
Y++PE L+ +D ++ G+ + EIL
Sbjct: 193 EYIAPEILLNVGHGKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 30/87 (34%), Positives = 50/87 (57%), Gaps = 6/87 (6%)
Query: 632 LLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYM 691
L +LH+Y +++RDLK N+LLD+ + + DFG+++ D +NT GT Y+
Sbjct: 109 LEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT--FCGTTEYL 163
Query: 692 SPEYALHGL-FSIKSDVFSFGVLLLEI 717
+PE L ++ D +S GVL+ E+
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 29/91 (31%), Positives = 51/91 (56%), Gaps = 5/91 (5%)
Query: 631 GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGY 690
L +LH+ +I+RDLK NVLLD+D + K++D+G+ + G T+ GT Y
Sbjct: 108 ALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKE--GLGPGDTTSTFCGTPNY 162
Query: 691 MSPEYALHGLFSIKSDVFSFGVLLLEILSSK 721
++PE + D ++ GVL+ E+++ +
Sbjct: 163 IAPEILRGEEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 35/97 (36%), Positives = 48/97 (49%), Gaps = 10/97 (10%)
Query: 630 QGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIAR-TFGGDEMQSNTNRIVGTY 688
+ L Y+H + V HRDLK N+L ++D KI DFG+AR F V T
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 689 GYMSPEYALHGLFSIKS----DVFSFGVLLLEILSSK 721
Y +PE L G F K D++S G + E+L+ K
Sbjct: 171 WYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 39/111 (35%), Positives = 60/111 (54%), Gaps = 11/111 (9%)
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEM-QSNTNRIVG 686
+A+ +L + +L +HRD+K NVLLD + + +++DFG D QSN VG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNV--AVG 165
Query: 687 TYGYMSPEY--ALH---GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSL 732
T Y+SPE A+ G + + D +S GV + E+L + T FY +SL
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE--TPFY-AESL 213
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 51/278 (18%), Positives = 115/278 (41%), Gaps = 42/278 (15%)
Query: 532 KSIERYVEI------CNWKQGKLLNGEEVAVKRL---SSKSGQGLEEFKNEMMLIAKLQH 582
I++Y + N + N +EV ++ ++ +NE+ + ++
Sbjct: 18 DDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDS 77
Query: 583 RNLVRLFGCCIEQGEKIS--IYEFDIVTDPARKDLLD------WTTRVRIIEGVAQGLLY 634
N+++++G I+ + + + T +++LD + T++ + +GL
Sbjct: 78 NNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYN 137
Query: 635 LHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPE 694
L++Y+ +++L + + L+ + KI G+ + + S + V Y S +
Sbjct: 138 LYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKI-----LSSPPFKNVNFMVYFSYK 190
Query: 695 YALHGLFS---IKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLM 751
L+ +FS IK D++S GV+L EI + K F N + + + + + KL
Sbjct: 191 M-LNDIFSEYTIKDDIYSLGVVLWEIFTGK--IPFENLTTKEIYD---LIINKNNSLKL- 243
Query: 752 DPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVV 789
P + +V C ++ RP + E++
Sbjct: 244 -PLDCPLEIKCIVEA-------CTSHDSIKRPNIKEIL 273
|
Length = 283 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 28/90 (31%), Positives = 50/90 (55%)
Query: 630 QGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYG 689
Q +L L + +++HRDLK++N+ L K+ DFG ++ + + GT
Sbjct: 177 QIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPY 236
Query: 690 YMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
Y++PE +S K+D++S GV+L E+L+
Sbjct: 237 YLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 28/90 (31%), Positives = 51/90 (56%), Gaps = 5/90 (5%)
Query: 632 LLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYM 691
L +LH+ +I+RDLK NVLLD++ + K++D+G+ + G T+ GT Y+
Sbjct: 109 LNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE--GIRPGDTTSTFCGTPNYI 163
Query: 692 SPEYALHGLFSIKSDVFSFGVLLLEILSSK 721
+PE + D ++ GVL+ E+++ +
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 2e-06
Identities = 32/103 (31%), Positives = 52/103 (50%), Gaps = 7/103 (6%)
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
+ L YLH ++++RDLK N++LD D + KI+DFG+ + D T GT
Sbjct: 104 IVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGT 158
Query: 688 YGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTD 730
Y++PE + D + GV++ E++ + FYN D
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 32/102 (31%), Positives = 51/102 (50%), Gaps = 13/102 (12%)
Query: 632 LLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIAR---TFGGDEMQSNTNRIVGTY 688
L YLH V++RDLK N++LD D + KI+DFG+ + + G + GT
Sbjct: 108 LGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-----ATMKTFCGTP 159
Query: 689 GYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTD 730
Y++PE + D + GV++ E++ + FYN D
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 58/226 (25%), Positives = 107/226 (47%), Gaps = 39/226 (17%)
Query: 518 EENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFK-NEMML 576
E K+G G +G VYK+ K GK + +E A+K++ G G+ E+ L
Sbjct: 5 EGCKVGRGTYGHVYKAKR--------KDGK--DEKEYALKQIE---GTGISMSACREIAL 51
Query: 577 IAKLQHRNLVRLFGCCIEQGEK-------------ISIYEFDIVTDPARKDLLDWTTRVR 623
+ +L+H N++ L + ++ I +F + +K + + V+
Sbjct: 52 LRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVK 111
Query: 624 -IIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP-----KISDFGIARTFGGD-E 676
++ + G+ YLH V+HRDLK +N+L+ + P KI+D G AR F +
Sbjct: 112 SLLYQILDGIHYLHAN---WVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLK 167
Query: 677 MQSNTNRIVGTYGYMSPEYALHGLFSIKS-DVFSFGVLLLEILSSK 721
++ + +V T+ Y +PE L K+ D+++ G + E+L+S+
Sbjct: 168 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 5/91 (5%)
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
+A L YLH L +++RDLK N+LLDS + ++DFG+ + E T+ GT
Sbjct: 105 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNGTTSTFCGT 159
Query: 688 YGYMSPEYALHGLFSIKSDVFSFGVLLLEIL 718
Y++PE + D + G +L E+L
Sbjct: 160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 6e-06
Identities = 29/91 (31%), Positives = 46/91 (50%), Gaps = 5/91 (5%)
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
+A L YLH + +++RDLK N+LLDS + ++DFG+ + G T GT
Sbjct: 105 IASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKE--GIAQSDTTTTFCGT 159
Query: 688 YGYMSPEYALHGLFSIKSDVFSFGVLLLEIL 718
Y++PE + D + G +L E+L
Sbjct: 160 PEYLAPEVIRKQPYDNTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 7e-06
Identities = 38/108 (35%), Positives = 54/108 (50%), Gaps = 8/108 (7%)
Query: 629 AQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTY 688
A+ +L L + IHRD+K N+LLD + K++DFG + M + VGT
Sbjct: 149 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTP 207
Query: 689 GYMSPEY----ALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSL 732
Y+SPE G + + D +S GV L E+L +T FY DSL
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG--DTPFY-ADSL 252
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 9e-06
Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 9/90 (10%)
Query: 632 LLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIAR--TFGGDEMQSNTNRIVGTYG 689
L +LHQ +I+RDLK N+LLD+ + K++DFG+ + G + T+ GT
Sbjct: 113 LEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG----TVTHTFCGTIE 165
Query: 690 YMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
YM+PE + D +S G L+ ++L+
Sbjct: 166 YMAPEILMRSGHGKAVDWWSLGALMYDMLT 195
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 38/108 (35%), Positives = 54/108 (50%), Gaps = 8/108 (7%)
Query: 629 AQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTY 688
A+ +L L + +IHRD+K N+LLD + K++DFG M + VGT
Sbjct: 149 AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM-VRCDTAVGTP 207
Query: 689 GYMSPEY----ALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSL 732
Y+SPE G + + D +S GV L E+L +T FY DSL
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG--DTPFY-ADSL 252
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 30/97 (30%), Positives = 56/97 (57%), Gaps = 7/97 (7%)
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
+A+ +L +H ++ +HRD+K NVL+D + K++DFG A ++M N+ VGT
Sbjct: 108 LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-VNSKLPVGT 166
Query: 688 YGYMSPEY--ALHG----LFSIKSDVFSFGVLLLEIL 718
Y++PE ++G + ++ D +S GV+ E++
Sbjct: 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMI 203
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 42/167 (25%), Positives = 72/167 (43%), Gaps = 35/167 (20%)
Query: 632 LLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTN--------- 682
L YLH Y ++HRDLK N+L+ S + K++DFG+++ M TN
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI---GLMSLTTNLYEGHIEKD 167
Query: 683 -------RIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLL 735
++ GT Y++PE L + D ++ G++L E L F+ L
Sbjct: 168 TREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG--CVPFFGDTPEELF 225
Query: 736 GHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDR 782
G + DD W D + +A +++R + ++N +R
Sbjct: 226 GQVIS---DDIEWPEGDEALPADAQ-DLISRLL-------RQNPLER 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 5e-05
Identities = 21/54 (38%), Positives = 35/54 (64%), Gaps = 3/54 (5%)
Query: 617 DWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIAR 670
D V+ I VA L YLH++ +IHRDLK N+L+ ++ + K++DFG+++
Sbjct: 102 DEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 7e-05
Identities = 61/244 (25%), Positives = 99/244 (40%), Gaps = 66/244 (27%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSS----KSGQGLEEFKNEMMLI 577
+G G FG V R V+ K G A+K+L + Q + + E ++
Sbjct: 9 IGRGAFGEV-----RLVQ-------KKDTGHIYAMKKLRKSEMLEKEQ-VAHVRAERDIL 55
Query: 578 AKLQHRNLVRLFGCCIEQGEK--ISIYEF----DIVTDPARKDLL-DWTTRVRIIEGVAQ 630
A+ + +V+L+ Q E I E+ D++T +KD + TR I E +
Sbjct: 56 AEADNPWVVKLY--YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETI-- 111
Query: 631 GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGI------------ARTFGGDEMQ 678
L + +L IHRD+K N+LLD+ + K+SDFG+ R
Sbjct: 112 --LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPS 169
Query: 679 SNT------------------NRI------VGTYGYMSPEYALHGLFSIKSDVFSFGVLL 714
+ NR VGT Y++PE L ++ + D +S GV++
Sbjct: 170 NFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIM 229
Query: 715 LEIL 718
E+L
Sbjct: 230 YEML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 34/119 (28%), Positives = 59/119 (49%), Gaps = 10/119 (8%)
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGD-EMQSNTNRIVG 686
+A+ ++ + +L +HRD+K N+L+D + + +++DFG D +QS+ VG
Sbjct: 108 LAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV--AVG 165
Query: 687 TYGYMSPEYAL-----HGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWN 740
T Y+SPE G + + D +S GV + E+L + T FY + G N
Sbjct: 166 TPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE--TPFYAESLVETYGKIMN 222
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 38/132 (28%), Positives = 57/132 (43%), Gaps = 32/132 (24%)
Query: 615 LLDWTTR---------VRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLL---DSDMNP- 661
LLDW + +II L Y H + L ++H DLK N+L+ D+ ++P
Sbjct: 218 LLDWIMKHGPFSHRHLAQIIFQTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPV 275
Query: 662 ------------KISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFS 709
+I D G DE S T IV T Y SPE L + +D++S
Sbjct: 276 TNRALPPDPCRVRICDLGGC----CDERHSRT-AIVSTRHYRSPEVVLGLGWMYSTDMWS 330
Query: 710 FGVLLLEILSSK 721
G ++ E+ + K
Sbjct: 331 MGCIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 37/153 (24%), Positives = 67/153 (43%), Gaps = 17/153 (11%)
Query: 573 EMMLIAKLQHRNLVRLFG--------CCIEQGEKISIYEFDIVTDPARKDLLDWTTRVRI 624
E ++ + H ++++L G C I K +Y + + + D + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCY--LAAKRNIAICDI---LAI 187
Query: 625 IEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRI 684
V + + YLH+ R+IHRD+KA N+ ++ + + DFG A F D +
Sbjct: 188 ERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA-CFPVDINANKYYGW 243
Query: 685 VGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEI 717
GT +PE + D++S G++L E+
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEM 276
|
Length = 391 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 37/124 (29%), Positives = 56/124 (45%), Gaps = 33/124 (26%)
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIA-------RT--------- 671
+A+ +L + +L IHRD+K N+LLDS + K+SDFG+ RT
Sbjct: 107 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHS 166
Query: 672 ----FGGDEMQS-------NTNR------IVGTYGYMSPEYALHGLFSIKSDVFSFGVLL 714
F M S NR VGT Y++PE + ++ D +S GV++
Sbjct: 167 LPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226
Query: 715 LEIL 718
E+L
Sbjct: 227 YEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 62/247 (25%), Positives = 100/247 (40%), Gaps = 59/247 (23%)
Query: 514 DNFSEENKLGEGGFGPVY----KSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEE 569
D+F +G G FG V K + ++ +L E+VA
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVA-------------H 47
Query: 570 FKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF----DIVTDPARKDLL-DWTTRVRI 624
+ E ++ + +V++F ++ I EF D++T +KD L + T+ I
Sbjct: 48 IRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYI 107
Query: 625 IEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIA-------RT------ 671
E V L + +L IHRD+K N+LLD+ + K+SDFG+ RT
Sbjct: 108 AETV----LAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNL 163
Query: 672 -------FGGDEMQS-------NTNR------IVGTYGYMSPEYALHGLFSIKSDVFSFG 711
F M S NR VGT Y++PE + ++ D +S G
Sbjct: 164 THNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLG 223
Query: 712 VLLLEIL 718
V++ E+L
Sbjct: 224 VIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 53/216 (24%), Positives = 102/216 (47%), Gaps = 39/216 (18%)
Query: 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN-EMMLIA 578
N +G G FG VY++I C + E+VA+K++ ++KN E++++
Sbjct: 72 NIIGNGSFGVVYEAI------C------IDTSEKVAIKKVLQDP-----QYKNRELLIMK 114
Query: 579 KLQHRNLVRL----FGCCIEQGEKISIYEFDIVTDPARKDLLDWTTR-VRIIEGVAQGLL 633
L H N++ L + C ++ EK +I+ ++V + + + + R + L+
Sbjct: 115 NLNHINIIFLKDYYYTECFKKNEK-NIF-LNVVMEFIPQTVHKYMKHYARNNHALPLFLV 172
Query: 634 YLHQYSRLRVI---------HRDLKASNVLLDSDMNP-KISDFGIARTFGGDEMQSNTNR 683
L+ Y R + HRDLK N+L+D + + K+ DFG A+ Q + +
Sbjct: 173 KLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG--QRSVSY 230
Query: 684 IVGTYGYMSPEYALHGL-FSIKSDVFSFGVLLLEIL 718
I + Y +PE L ++ D++S G ++ E++
Sbjct: 231 ICSRF-YRAPELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-04
Identities = 33/136 (24%), Positives = 56/136 (41%), Gaps = 45/136 (33%)
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFG-------------- 673
+A+ L + ++ IHRD+K N+L+D D + K++DFG+ F
Sbjct: 107 IAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHI 166
Query: 674 -------------------GDEMQSNTNR------------IVGTYGYMSPEYALHGLFS 702
GD +++ R +VGT Y++PE L ++
Sbjct: 167 RQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT 226
Query: 703 IKSDVFSFGVLLLEIL 718
D +S GV+L E+L
Sbjct: 227 QLCDWWSVGVILFEML 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 6e-04
Identities = 32/119 (26%), Positives = 54/119 (45%), Gaps = 13/119 (10%)
Query: 604 FDIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP-K 662
FD++ ++ L +II + + L LH++ +IH D+K NVL D +
Sbjct: 97 FDLLK---KEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIY 150
Query: 663 ISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSK 721
+ D+G+ + G GT Y SPE + + D ++ GVL E+L+ K
Sbjct: 151 LCDYGLCKIIGTPSCYD------GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 6e-04
Identities = 31/136 (22%), Positives = 55/136 (40%), Gaps = 45/136 (33%)
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIA-------------RTFGG 674
+A+ +L + +L IHRD+K N+L+D + K+SDFG++ + G
Sbjct: 107 MAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQG 166
Query: 675 DEMQ------------------SNTNRI--------------VGTYGYMSPEYALHGLFS 702
+ S+ ++I VGT Y++PE L +
Sbjct: 167 KSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG 226
Query: 703 IKSDVFSFGVLLLEIL 718
+ D +S G ++ E L
Sbjct: 227 QECDWWSLGAIMFECL 242
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 30/116 (25%), Positives = 46/116 (39%), Gaps = 41/116 (35%)
Query: 644 IHRDLKASNVLLDSDMNPKISDFGIARTF-----------GG----------DEMQSNTN 682
IHRD+K N+L+D D + K++DFG+ F G +E
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 683 R--------------------IVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEIL 718
+VGT Y++PE L ++ D +S GV+L E+L
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 0.002
Identities = 36/136 (26%), Positives = 54/136 (39%), Gaps = 45/136 (33%)
Query: 631 GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF------------------------ 666
L YLH L +++RDLK N+LL + +SDF
Sbjct: 115 ALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171
Query: 667 ---GIARTFGGDEMQSNTNRIVGTYGYMSPEY---ALHGLFSIKSDVFSFGVLLLEIL-- 718
I +E +N VGT Y++PE HG ++ D ++ G+LL E+L
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHG-SAV--DWWTLGILLYEMLYG 228
Query: 719 ------SSKKNTRFYN 728
S++ T F N
Sbjct: 229 TTPFKGSNRDET-FSN 243
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|238649 cd01328, FSL_SPARC, Follistatin-like SPARC (secreted protein, acidic, and rich in cysteines) domain; SPARC/BM-40/osteonectin is a multifunctional glycoprotein which modulates cellular interaction with the extracellular matrix by its binding to structural matrix proteins such as collagen and vitronectin | Back alignment and domain information |
|---|
Score = 37.8 bits (88), Expect = 0.002
Identities = 18/51 (35%), Positives = 26/51 (50%), Gaps = 11/51 (21%)
Query: 289 CQNYGHCGANSICNVD--NPPKCECL--------KGFKPNSQHNQTWATTC 329
C+N+ HCGA +C VD N PKC C+ K + N+T+ + C
Sbjct: 2 CENH-HCGAGKVCEVDDENTPKCVCIDPCPEEVDDRRKVCTNDNETFDSDC 51
|
The protein it composed of an N-terminal acidic region, a follistatin (FS) domain and an EF-hand calcium binding domain. The FS domain consists of an N-terminal beta hairpin (FOLN/EGF-like domain) and a small hydrophobic core of alpha/beta structure (Kazal domain) and has five disulfide bonds and a conserved N-glycosylation site. The FSL_SPARC domain is a member of the superfamily of kazal-like proteinase inhibitors and follistatin-like proteins. Length = 86 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 30/124 (24%), Positives = 52/124 (41%), Gaps = 45/124 (36%)
Query: 640 RLRVIHRDLKASNVLLDSDMNPKISDFGIARTF----------GGDEMQSNT-------- 681
++ IHRD+K N+L+D D + K++DFG+ F GD ++ ++
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178
Query: 682 ---------------------------NRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLL 714
+ +VGT Y++PE L ++ D +S GV+L
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238
Query: 715 LEIL 718
E+L
Sbjct: 239 YEML 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.004
Identities = 59/239 (24%), Positives = 98/239 (41%), Gaps = 51/239 (21%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQ 581
LG+G F +YK + R + V +K L S + F L+++L
Sbjct: 3 LGQGTFTNIYKGVLR--VQSDLDIVGPGQEVSVVLKVLGSD-HRDSLAFFETASLMSQLS 59
Query: 582 HRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLD-WTTRVR----------IIEGVAQ 630
H++LV+L+G C+ E +V + + LD + R + + + +A
Sbjct: 60 HKHLVKLYGVCVRD-------ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLAS 112
Query: 631 GLLYLHQYSRLRVIHRDLKASNVLL---DSDMNP----KISDFGIARTFGG-DEMQSNTN 682
L YL +++H ++ N+L+ + K+SD GI T +E
Sbjct: 113 ALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE--- 166
Query: 683 RIVGTYGYMSPEYALHGLFSIKS--DVFSFGVLLLEI----------LSSKKNTRFYNT 729
RI +++PE +G S+ D +SFG LLEI LSS + RFY
Sbjct: 167 RI----PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD 221
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 840 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.98 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.98 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.98 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.98 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.98 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.98 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.98 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.98 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.98 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.98 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.98 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.98 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.98 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.98 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.98 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.98 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.98 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.98 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.98 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.98 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.98 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.98 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.98 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.97 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.97 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.96 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.96 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.95 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.95 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.95 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.95 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.94 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.94 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.94 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.92 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.92 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.89 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.89 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.79 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.78 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.78 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.75 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.75 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.73 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.71 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.71 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.7 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.69 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.68 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.61 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.61 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.6 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.59 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.57 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.55 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.54 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.53 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.53 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.5 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.49 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.45 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.43 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.41 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.35 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.34 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.19 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.14 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.14 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.08 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.04 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.96 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.95 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.85 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.84 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.75 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.73 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.72 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.66 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.55 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.53 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.46 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.4 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.38 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.27 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.26 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.15 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.05 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.02 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.01 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.98 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 97.92 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.92 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.79 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.79 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.71 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.52 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.5 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.43 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.42 | |
| PF11883 | 48 | DUF3403: Domain of unknown function (DUF3403); Int | 97.36 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.36 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.14 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.14 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.08 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.01 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.01 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.99 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.82 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.68 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.66 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.55 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.51 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.08 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 96.01 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.81 | |
| PLN02236 | 344 | choline kinase | 95.33 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 95.13 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.09 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 94.86 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 94.81 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 94.76 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 94.15 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 93.63 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 93.38 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 93.38 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-51 Score=444.19 Aligned_cols=282 Identities=43% Similarity=0.714 Sum_probs=241.8
Q ss_pred ceeecCHHHHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhh
Q 041702 500 WFLFFSLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAK 579 (840)
Q Consensus 500 ~~~~~~~~~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~ 579 (840)
....|++.++..||++|...+.||+|+||.||+| .+.++..||||++.....+..++|.+|+.++.+
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG-------------~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~ 127 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKG-------------VLSDGTVVAVKRLSSNSGQGEREFLNEVEILSR 127 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEE-------------EECCCCEEEEEEecCCCCcchhHHHHHHHHHhc
Confidence 3567999999999999999999999999999995 567889999999886544314669999999999
Q ss_pred cCCCCccceeeEeecCC-ceEEEEEeeccCCcc-----ccC-CCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCc
Q 041702 580 LQHRNLVRLFGCCIEQG-EKISIYEFDIVTDPA-----RKD-LLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASN 652 (840)
Q Consensus 580 l~H~niv~l~g~~~~~~-~~~lv~e~~~~~~~~-----~~~-~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~N 652 (840)
++|||||+|+|||.+.+ +.++||||+...... ... .++|.+|++|+.++|+||+|||+...++||||||||+|
T Consensus 128 l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssN 207 (361)
T KOG1187|consen 128 LRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSN 207 (361)
T ss_pred CCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHH
Confidence 99999999999999999 599999996443221 112 78999999999999999999999998899999999999
Q ss_pred EEecCCCCceeeccccceecCCCCcccccccc-cccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCC-C
Q 041702 653 VLLDSDMNPKISDFGIARTFGGDEMQSNTNRI-VGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNT-D 730 (840)
Q Consensus 653 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~-~ 730 (840)
||||+++++||+|||+|+..... ....... .||.+|+|||++..+..+.|+|||||||+|+||+||+++.....+ .
T Consensus 208 ILLD~~~~aKlsDFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~ 285 (361)
T KOG1187|consen 208 ILLDEDFNAKLSDFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRG 285 (361)
T ss_pred eeECCCCCEEccCccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcc
Confidence 99999999999999999765431 1111112 799999999999999999999999999999999999988776542 3
Q ss_pred CccHhHHHhhhhcccccccccCcccc-chhhH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 041702 731 SLTLLGHAWNLWKDDKAWKLMDPTMQ-NEALY-SMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEI 796 (840)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~d~~l~-~~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~ 796 (840)
...+..|++..+.+.+..+++|+.+. ..... +.+.++.+++.+|++.+|++||+|.||+++|+.+.
T Consensus 286 ~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 286 ELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred cccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 35588888888888899999999987 44443 68889999999999999999999999999997653
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=375.42 Aligned_cols=254 Identities=30% Similarity=0.478 Sum_probs=203.0
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCce-EEEEEeccCCCc--CHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEE-VAVKRLSSKSGQ--GLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~-VAvK~l~~~~~~--~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
.+...+.||+|+||+||+|.++ |+. ||||++...... ..++|.+|+.+|.+++|||||+++|+
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~--------------g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~ 107 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWR--------------GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGA 107 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeC--------------CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 3344456999999999998765 555 999999865322 25689999999999999999999999
Q ss_pred eecCC-ceEEEEEeeccCCcc------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCC-Ccee
Q 041702 592 CIEQG-EKISIYEFDIVTDPA------RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDM-NPKI 663 (840)
Q Consensus 592 ~~~~~-~~~lv~e~~~~~~~~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kL 663 (840)
|.+.. ...+|+||+...... ....+++..+++++.|||+||.|||++++ ||||||||+|||++.++ ++||
T Consensus 108 ~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI 185 (362)
T KOG0192|consen 108 CTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKI 185 (362)
T ss_pred EcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEE
Confidence 99987 799999995433211 46789999999999999999999999874 99999999999999998 9999
Q ss_pred eccccceecCCCCcccccccccccccccCccccc--cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhh
Q 041702 664 SDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYAL--HGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNL 741 (840)
Q Consensus 664 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~ 741 (840)
+|||+++...... .......||+.|||||++. ..+|+.|+|||||||+||||+||+.||+.... . +.+...
T Consensus 186 ~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--~---~~~~~v 258 (362)
T KOG0192|consen 186 ADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--V---QVASAV 258 (362)
T ss_pred CCCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--H---HHHHHH
Confidence 9999998765432 2233478999999999999 56999999999999999999999999876543 1 111111
Q ss_pred hcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCCC
Q 041702 742 WKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLP 800 (840)
Q Consensus 742 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~~ 800 (840)
... ..++..+......+..++.+||+.||+.||++.+++..|+.+.....
T Consensus 259 ~~~---------~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 259 VVG---------GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred Hhc---------CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 111 12222223355678889999999999999999999999997755443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=350.68 Aligned_cols=248 Identities=25% Similarity=0.380 Sum_probs=201.2
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC-CCcCHHHHHHHHHHHhhcCCCCccceeeEee
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK-SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCI 593 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~-~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~ 593 (840)
+.+.++.||+|..|+|||++++ .+++.+|+|++... .....+++.+|++++++.+||+||+++|.|.
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk------------~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~ 147 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHK------------PTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFY 147 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEc------------CCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEE
Confidence 3444678999999999999887 78999999999544 3345678999999999999999999999999
Q ss_pred cCC-ceEEEEEeeccCCccc----cCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 594 EQG-EKISIYEFDIVTDPAR----KDLLDWTTRVRIIEGVAQGLLYLHQ-YSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 594 ~~~-~~~lv~e~~~~~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
..+ +..++||||....... ...+++...-+|+.+|++||.|||+ ++ ||||||||+|||++..|++||||||
T Consensus 148 ~~~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFG 224 (364)
T KOG0581|consen 148 SNGEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFG 224 (364)
T ss_pred eCCceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEecccc
Confidence 999 5999999976655432 2559999999999999999999996 54 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccccc
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKA 747 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 747 (840)
.++.+... ..+..+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+...................+.
T Consensus 225 VS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~p-- 298 (364)
T KOG0581|consen 225 VSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEP-- 298 (364)
T ss_pred ccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCC--
Confidence 99887543 345689999999999999999999999999999999999999998765332222221111111110
Q ss_pred ccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 748 WKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 748 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.|.+... ...+.+.+++..||++||.+||++.|+++
T Consensus 299 ----pP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 299 ----PPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred ----CCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1222211 35667899999999999999999999874
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=364.74 Aligned_cols=246 Identities=25% Similarity=0.397 Sum_probs=204.7
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
..|...+.||+|||+.+|++++. .+|+.||+|++.+. .....+...+||+|.++|+|||||++++
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~------------~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~ 85 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDL------------DTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYH 85 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEc------------CCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeee
Confidence 57899999999999999999654 78999999999864 3455678999999999999999999999
Q ss_pred EeecCCceEEEEEeecc----CCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 591 CCIEQGEKISIYEFDIV----TDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~----~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
+|++.+..|+|.|+... .....++.+++.+...++.||+.||.|||+.+ |+|||||..|++|+++.++||+||
T Consensus 86 ~FEDs~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDF 162 (592)
T KOG0575|consen 86 FFEDSNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDF 162 (592)
T ss_pred EeecCCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEeccc
Confidence 99999999999999433 22346788999999999999999999999998 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccc
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDK 746 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 746 (840)
|||..+..+... ....+|||.|.|||++.....+..+||||+|||||-||.|++||+.... ...+......+
T Consensus 163 GLAt~le~~~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v------kety~~Ik~~~ 234 (592)
T KOG0575|consen 163 GLATQLEYDGER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV------KETYNKIKLNE 234 (592)
T ss_pred ceeeeecCcccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH------HHHHHHHHhcC
Confidence 999988654332 3357899999999999999999999999999999999999999975322 12222211111
Q ss_pred cccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHH--HHh
Q 041702 747 AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVV--AML 792 (840)
Q Consensus 747 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl--~~L 792 (840)
- ..+........+|+.++|+.||.+|||+++|+ +.+
T Consensus 235 ------Y----~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 235 ------Y----SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred ------c----ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence 0 11123445577899999999999999999999 455
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=346.13 Aligned_cols=250 Identities=24% Similarity=0.348 Sum_probs=198.5
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCc-------CHHHHHHHHHHHhhcCCCC
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQ-------GLEEFKNEMMLIAKLQHRN 584 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~-------~~~~f~~Ev~~l~~l~H~n 584 (840)
..+.|.+.+.||+|+||.|-+|.++ .+|+.||||++++.... ......+|+++|++|+|||
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~------------~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~ 237 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEK------------KTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPN 237 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEc------------ccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCC
Confidence 4567788899999999999999876 78999999999764211 1223579999999999999
Q ss_pred ccceeeEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCC--
Q 041702 585 LVRLFGCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSD-- 658 (840)
Q Consensus 585 iv~l~g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~-- 658 (840)
||++++++...+..|+|+||+.-.+ ......+.+..-..+++|++.|+.|||++| |+||||||+|||+..+
T Consensus 238 IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e 314 (475)
T KOG0615|consen 238 IVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAE 314 (475)
T ss_pred EEEEeeeeecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCc
Confidence 9999999999999999999954333 334566777788889999999999999999 9999999999999766
Q ss_pred -CCceeeccccceecCCCCcccccccccccccccCccccccCC---CCccccchhHHHHHHHHHhCCCCCCCCCCCCccH
Q 041702 659 -MNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGL---FSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTL 734 (840)
Q Consensus 659 -~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~ 734 (840)
..+||+|||+|+..++.. .+...+||+.|.|||++.+.. +..|.|+||+|||||-+|+|.+||.....+. .+
T Consensus 315 ~~llKItDFGlAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-sl 390 (475)
T KOG0615|consen 315 DCLLKITDFGLAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-SL 390 (475)
T ss_pred ceEEEecccchhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-cH
Confidence 679999999999876433 355689999999999998654 3347899999999999999999997544332 11
Q ss_pred hHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 735 LGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 735 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.... ..++ -...+..-.+..++.++++.+||..||++|||+.|+++
T Consensus 391 ~eQI----~~G~------y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 391 KEQI----LKGR------YAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred HHHH----hcCc------ccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 1110 0000 01112333466788999999999999999999999874
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=330.41 Aligned_cols=259 Identities=20% Similarity=0.303 Sum_probs=200.3
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cC-HHHHHHHHHHHhhcCCCCccceeeE
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QG-LEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~-~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
+.|+.+.++|+|+||.|||.+++ .+|+.||||++..... .. .+-.++|+++|++|+|+|+|.|+++
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk------------~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEV 69 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNK------------DTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEV 69 (396)
T ss_pred cHHhhhhccccCcceEEEEeccC------------CcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHH
Confidence 46788889999999999999887 7899999999976533 23 3446899999999999999999999
Q ss_pred eecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 592 CIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
|......++|+||....- ......++.....+++.|+++|+.|+|+++ +|||||||+||||+.++.+||||||
T Consensus 70 FrrkrklhLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFG 146 (396)
T KOG0593|consen 70 FRRKRKLHLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFG 146 (396)
T ss_pred HHhcceeEEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccch
Confidence 999999999999942211 112345778888999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCC-ccHhH--------H
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDS-LTLLG--------H 737 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~-~~~~~--------~ 737 (840)
+|+.+... ...-+..+.|..|+|||.+.+ ..|....||||.||++.||++|.+-++...+-+ ..+.. .
T Consensus 147 FAR~L~~p--gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~pr 224 (396)
T KOG0593|consen 147 FARTLSAP--GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPR 224 (396)
T ss_pred hhHhhcCC--cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHH
Confidence 99998631 122345788999999999987 789999999999999999999999887654432 11111 1
Q ss_pred Hhhhhccc-ccccccCccc-----cchhhHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 041702 738 AWNLWKDD-KAWKLMDPTM-----QNEALYSMVTRYIKVALLCVQENATDRPTMLEVV 789 (840)
Q Consensus 738 ~~~~~~~~-~~~~~~d~~l-----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 789 (840)
........ ....+.-|.. .....+.....+++++..||+.||.+|++-+|++
T Consensus 225 hq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 225 HQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred HHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 11111111 1111111111 1112233455789999999999999999999987
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=344.21 Aligned_cols=200 Identities=30% Similarity=0.489 Sum_probs=175.6
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC--CCcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK--SGQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
..+|...++||+|+||+||+|+++ .++..||||.+.+. .....+.+..|+.+|++++|||||++++
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~------------~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d 76 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHK------------KSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLD 76 (429)
T ss_pred cccceehhhccCcceEEEEEeEec------------cCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEE
Confidence 467888889999999999999877 67899999999866 4556677899999999999999999999
Q ss_pred EeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCC------CC
Q 041702 591 CCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSD------MN 660 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~------~~ 660 (840)
++..++..++||||....+ ......+++.+...++.|||.||++||+++ ||||||||+||||+.. -.
T Consensus 77 ~~~~~~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~ 153 (429)
T KOG0595|consen 77 CIEDDDFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPV 153 (429)
T ss_pred EEecCCeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCce
Confidence 9999999999999954333 345668999999999999999999999998 9999999999999765 45
Q ss_pred ceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCC
Q 041702 661 PKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTD 730 (840)
Q Consensus 661 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~ 730 (840)
+||+|||+|+.+..... ....+|++-|||||++..+.|+.|+|+||+|+|||||++|+.||+.....
T Consensus 154 LKIADFGfAR~L~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~ 220 (429)
T KOG0595|consen 154 LKIADFGFARFLQPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK 220 (429)
T ss_pred EEecccchhhhCCchhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence 79999999999875433 34578999999999999999999999999999999999999998754433
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=376.94 Aligned_cols=258 Identities=30% Similarity=0.435 Sum_probs=210.9
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcc--cCCceEEEEEeccCCCc-CHHHHHHHHHHHhhcCCCCcccee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKL--LNGEEVAVKRLSSKSGQ-GLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~--~~g~~VAvK~l~~~~~~-~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
..+....++||+|.||.||+|+-- +.. .+.+.||||.+++.... ..++|++|+++|.+|+|||||+|+
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~---------~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLl 555 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAY---------GLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLL 555 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhcc---------CCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEE
Confidence 345566689999999999998643 333 45678999999987654 778999999999999999999999
Q ss_pred eEeecCCceEEEEEeeccCCcc--------------c----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCC
Q 041702 590 GCCIEQGEKISIYEFDIVTDPA--------------R----KDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKAS 651 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~~~~--------------~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~ 651 (840)
|+|.+++..++|+||+...+.. . ...|+..+.+.|+.|||.|++||-++. +|||||..+
T Consensus 556 GVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATR 632 (774)
T KOG1026|consen 556 GVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATR 632 (774)
T ss_pred EEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhh
Confidence 9999999999999996443321 1 334888999999999999999999887 999999999
Q ss_pred cEEecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCC
Q 041702 652 NVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTD 730 (840)
Q Consensus 652 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~ 730 (840)
|+|+.++..+||+||||++.+...++........-+.+|||||.++.++||.+||||||||+|||++| |+.|+.....+
T Consensus 633 NCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~ 712 (774)
T KOG1026|consen 633 NCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ 712 (774)
T ss_pred hceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH
Confidence 99999999999999999999877776665545556789999999999999999999999999999998 66665443322
Q ss_pred CccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 731 SLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
+ +..+.+.++. -+.+...+..+.+|+..||+.+|++||+++||-..|+...+
T Consensus 713 E------VIe~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 713 E------VIECIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred H------HHHHHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 2 2222233322 23445566778999999999999999999999999998633
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=356.88 Aligned_cols=251 Identities=30% Similarity=0.444 Sum_probs=199.3
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCI 593 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~ 593 (840)
+.+...+.||+|-||.|+.|.+ .....||||.++.. ....+.|.+|+++|.+|+|+|||+++|+|.
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~-------------~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~ 271 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKW-------------NGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCT 271 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEE-------------cCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEe
Confidence 4455667899999999999754 35558999999875 344588999999999999999999999999
Q ss_pred cCCceEEEEEeeccCCc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 594 EQGEKISIYEFDIVTDP------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 594 ~~~~~~lv~e~~~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
.++..++|+||+..... .....+...+.+.++.|||+|++||++++ +|||||.++|||++++..+||+|||
T Consensus 272 ~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFG 348 (468)
T KOG0197|consen 272 KQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFG 348 (468)
T ss_pred cCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccc
Confidence 99999999999644321 34567888999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhcccc
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKDDK 746 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 746 (840)
||+...++.+.. .....-+..|.|||.+..+.++.|||||||||+||||+| |+.|++.....+
T Consensus 349 LAr~~~d~~Y~~-~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e--------------- 412 (468)
T KOG0197|consen 349 LARLIGDDEYTA-SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE--------------- 412 (468)
T ss_pred cccccCCCceee-cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH---------------
Confidence 999665544332 222234569999999999999999999999999999998 555544332111
Q ss_pred cccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 747 AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 747 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
..+.++...+-..+...+..+.+|+..||+.+|++|||++.+...|++...
T Consensus 413 v~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 413 VLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred HHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 111222222223333345567788889999999999999999999988643
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=344.79 Aligned_cols=261 Identities=23% Similarity=0.337 Sum_probs=203.8
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCcccee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
..+.|+.+++||+|.||.||||++. .+|+.||+|+++... .....-..+||.||++|.||||++|.
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~------------~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~ 182 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDL------------ETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLE 182 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeec------------ccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCccccee
Confidence 4567888899999999999999765 799999999998654 34456678999999999999999999
Q ss_pred eEeecC--CceEEEEEeeccCCc----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCcee
Q 041702 590 GCCIEQ--GEKISIYEFDIVTDP----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKI 663 (840)
Q Consensus 590 g~~~~~--~~~~lv~e~~~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL 663 (840)
+...+. +..|+|+|||.+... ...-.++..++..+++|++.||+|+|+++ |+|||||.+|||||.+|.+||
T Consensus 183 eivt~~~~~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKi 259 (560)
T KOG0600|consen 183 EIVTSKLSGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKI 259 (560)
T ss_pred eEEEecCCceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEe
Confidence 998876 789999999644322 12346889999999999999999999999 999999999999999999999
Q ss_pred eccccceecCCCCcccccccccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhh-
Q 041702 664 SDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNL- 741 (840)
Q Consensus 664 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~- 741 (840)
+|||||+.+....... .+..+.|..|+|||++.+. .|+.+.|+||.||||.||+.|++.++...+-+ .+.....+
T Consensus 260 aDFGLAr~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve--Ql~kIfklc 336 (560)
T KOG0600|consen 260 ADFGLARFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVE--QLHKIFKLC 336 (560)
T ss_pred ccccceeeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHH--HHHHHHHHh
Confidence 9999999886655433 3456779999999999875 59999999999999999999999987654322 11111111
Q ss_pred -------hccccc--ccccCcccc-----chhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 742 -------WKDDKA--WKLMDPTMQ-----NEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 742 -------~~~~~~--~~~~d~~l~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
|...++ ...+.+... .+.........++|+..+|..||.+|.|+.++++
T Consensus 337 GSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 337 GSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 111111 111111111 1112334556889999999999999999999984
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=329.39 Aligned_cols=255 Identities=26% Similarity=0.389 Sum_probs=202.5
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC--CCcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK--SGQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
..+|.++++||.|.||+||||.. +.+|..||.|.+.-. +.+..++...|+.+|++|+|||||++++
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~------------~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~ 85 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQC------------LLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYA 85 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeee------------ccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHH
Confidence 35688889999999999999954 489999999998743 3455677999999999999999999999
Q ss_pred -EeecCCc-eEEEEEeeccCC--------ccccCCCCHHHHHHHHHHHHHHHHHHHhcCC-CceecCCCCCCcEEecCCC
Q 041702 591 -CCIEQGE-KISIYEFDIVTD--------PARKDLLDWTTRVRIIEGVAQGLLYLHQYSR-LRVIHRDLKASNVLLDSDM 659 (840)
Q Consensus 591 -~~~~~~~-~~lv~e~~~~~~--------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~-~~ivHrDlkp~NILl~~~~ 659 (840)
-+.++++ .++|||+....+ ...+..+++.+.++++.|++.||.++|..-+ ..|+||||||.||+|+.+|
T Consensus 86 ~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g 165 (375)
T KOG0591|consen 86 HSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG 165 (375)
T ss_pred HhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC
Confidence 5555555 899999954444 3356789999999999999999999998321 2399999999999999999
Q ss_pred CceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHh
Q 041702 660 NPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAW 739 (840)
Q Consensus 660 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~ 739 (840)
.+||+|||+++.+.... ......+|||.||+||.+.+.+|+.|+||||+||+++||..-++||...+ +....
T Consensus 166 vvKLGDfGL~r~l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n-----~~~L~- 237 (375)
T KOG0591|consen 166 VVKLGDFGLGRFLSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN-----LLSLC- 237 (375)
T ss_pred ceeeccchhHhHhcchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc-----HHHHH-
Confidence 99999999999986543 33456899999999999999999999999999999999999999987541 11111
Q ss_pred hhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 740 NLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 740 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
...... ...+-...-.+..+.+|+..|+..||+.||+.-.+++.+...
T Consensus 238 ~KI~qg--------d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~ 285 (375)
T KOG0591|consen 238 KKIEQG--------DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSE 285 (375)
T ss_pred HHHHcC--------CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence 111111 111111244567788899999999999999976666666554
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=308.74 Aligned_cols=271 Identities=24% Similarity=0.324 Sum_probs=204.8
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC--cCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG--QGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
++|..+++||+|.||.||+|++. .+|+.||||+++.... .-.....+|++.|++++|+||+.++++
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~------------~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~ 69 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDT------------ETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDV 69 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEec------------CCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhh
Confidence 46788899999999999999765 7899999999986532 223457899999999999999999999
Q ss_pred eecCCceEEEEEeeccC----CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 592 CIEQGEKISIYEFDIVT----DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~----~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
|.+.+...+|+||+... -......+.-.++..++.++++||+|||.+. |+||||||.|+|++.+|.+||+|||
T Consensus 70 F~~~~~l~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFG 146 (318)
T KOG0659|consen 70 FPHKSNLSLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFG 146 (318)
T ss_pred ccCCCceEEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeeccc
Confidence 99999999999995322 1234456788889999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccc
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDK 746 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 746 (840)
+|+.+....... ...+.|..|+|||.+.+. .|+...|+||.|||+.||+-|.+-++...+- +.........-...
T Consensus 147 LAr~f~~p~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi--dQL~~If~~LGTP~ 222 (318)
T KOG0659|consen 147 LARFFGSPNRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI--DQLSKIFRALGTPT 222 (318)
T ss_pred chhccCCCCccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH--HHHHHHHHHcCCCC
Confidence 999986543222 223789999999998875 5999999999999999999999877654322 11111111111110
Q ss_pred ------cccccC--------ccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCCCCCCCC
Q 041702 747 ------AWKLMD--------PTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSPHQP 805 (840)
Q Consensus 747 ------~~~~~d--------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~p~~p 805 (840)
+.++.| ...............++++..++..||.+|+++.|++++ .-....|.|..|
T Consensus 223 ~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~--~yf~~~P~pt~~ 293 (318)
T KOG0659|consen 223 PDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH--PYFKSLPLPTPP 293 (318)
T ss_pred cccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc--hhhhcCCCCCCh
Confidence 111111 111111223345567999999999999999999999865 222345555444
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=330.83 Aligned_cols=240 Identities=23% Similarity=0.325 Sum_probs=196.4
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhcCCCCccce
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQHRNLVRL 588 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l 588 (840)
..++|+.++.||+|+||.||.++.+ .+++.+|+|++++. .....+..++|..+|.+++||.||++
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~------------dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l 90 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKK------------DTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKL 90 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEc------------ccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeee
Confidence 4578999999999999999999754 78999999999865 23456788999999999999999999
Q ss_pred eeEeecCCceEEEEEee----ccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 589 FGCCIEQGEKISIYEFD----IVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~~----~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
+-.|.+.+..|+|+||. +..+..+...+++....-++..|+.||.|||+.+ ||||||||+|||||++|+++|+
T Consensus 91 ~ysFQt~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~Lt 167 (357)
T KOG0598|consen 91 IYSFQTEEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLT 167 (357)
T ss_pred EEecccCCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEe
Confidence 99999999999999994 3445566778899988889999999999999999 9999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 665 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
|||+++...... ..+...+||+.|||||++.+..|+..+|.||||+++|||++|.+||...+... .......
T Consensus 168 DFgL~k~~~~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~------~~~~I~~ 239 (357)
T KOG0598|consen 168 DFGLCKEDLKDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK------MYDKILK 239 (357)
T ss_pred ccccchhcccCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH------HHHHHhc
Confidence 999998643322 23455899999999999999999999999999999999999999986543211 1111111
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCC
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRP 783 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 783 (840)
.+ + ...+.-......+++...|+.||++|.
T Consensus 240 ~k--------~-~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 240 GK--------L-PLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred Cc--------C-CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 11 0 011111334567888999999999996
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=343.28 Aligned_cols=265 Identities=26% Similarity=0.445 Sum_probs=204.3
Q ss_pred CHHHHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCC
Q 041702 505 SLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQH 582 (840)
Q Consensus 505 ~~~~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H 582 (840)
+..+++...+.+.+...||+|.||+||+|++. ..||||++.... .+..+.|++||..+++-+|
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh---------------GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH 447 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH---------------GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRH 447 (678)
T ss_pred cccccccCHHHhhccceeccccccceeecccc---------------cceEEEEEecCCCCHHHHHHHHHHHHHHhhcch
Confidence 33556666677788899999999999998765 359999998653 3467889999999999999
Q ss_pred CCccceeeEeecCCceEEEEEee----c-cCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecC
Q 041702 583 RNLVRLFGCCIEQGEKISIYEFD----I-VTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS 657 (840)
Q Consensus 583 ~niv~l~g~~~~~~~~~lv~e~~----~-~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~ 657 (840)
.||+-+.|||..... .+|..+. + ..-......++..+.++|+.||++|+.|||.++ |||||||..||+|.+
T Consensus 448 ~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~ 523 (678)
T KOG0193|consen 448 ENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHE 523 (678)
T ss_pred hhheeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEcc
Confidence 999999999998877 6666552 1 111223356778888999999999999999998 999999999999999
Q ss_pred CCCceeeccccceecCCCCcccccccccccccccCcccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccH
Q 041702 658 DMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH---GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTL 734 (840)
Q Consensus 658 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~ 734 (840)
++.+||+|||++..-..-..........|...|||||+++. .+|+..+||||||+++|||++|..|+.....+...
T Consensus 524 ~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIi- 602 (678)
T KOG0193|consen 524 DLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQII- 602 (678)
T ss_pred CCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheE-
Confidence 99999999999965433323333344567889999999864 57999999999999999999999998733332211
Q ss_pred hHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCC
Q 041702 735 LGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNL 799 (840)
Q Consensus 735 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~ 799 (840)
+..++.+...|... ......+.+.+|+..||..++++||.+.+|+..|++++..+
T Consensus 603 -------fmVGrG~l~pd~s~---~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 603 -------FMVGRGYLMPDLSK---IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred -------EEecccccCccchh---hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 11222222222221 12344567888999999999999999999999999875544
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=331.45 Aligned_cols=259 Identities=25% Similarity=0.322 Sum_probs=201.5
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHH--HHHHHHHhhcC-CCCccce
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEF--KNEMMLIAKLQ-HRNLVRL 588 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f--~~Ev~~l~~l~-H~niv~l 588 (840)
..++|...++||.|+||.||+|+. ..+++.||||+++..- ..+++. ++|++.|++|. |||||+|
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~------------~~~~~~VAIK~MK~Kf-~s~ee~~nLREvksL~kln~hpniikL 74 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKS------------KETGELVAIKKMKKKF-YSWEECMNLREVKSLRKLNPHPNIIKL 74 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeee------------cCCCceeeHHHHHhhh-ccHHHHHHHHHHHHHHhcCCCCcchhh
Confidence 457899999999999999999964 4788899999998653 234554 57999999998 9999999
Q ss_pred eeEeecCC-ceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCcee
Q 041702 589 FGCCIEQG-EKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKI 663 (840)
Q Consensus 589 ~g~~~~~~-~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL 663 (840)
.+++.+.+ ..++|||||.... ..+...+++..+..|+.||++||+|+|.+| +.||||||+|||+..+..+||
T Consensus 75 ~Evi~d~~~~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKi 151 (538)
T KOG0661|consen 75 KEVIRDNDRILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKI 151 (538)
T ss_pred HHHhhccCceEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEe
Confidence 99999988 9999999953211 123778999999999999999999999999 999999999999999999999
Q ss_pred eccccceecCCCCcccccccccccccccCccccc-cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhh
Q 041702 664 SDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYAL-HGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLW 742 (840)
Q Consensus 664 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~ 742 (840)
+|||+||.+.... .-+..+.|..|+|||++. .+.|+.+.|+|++|||++|+.+=++.|+...+-+. +-..-..+
T Consensus 152 aDFGLARev~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dq--i~KIc~VL 226 (538)
T KOG0661|consen 152 ADFGLAREVRSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQ--IYKICEVL 226 (538)
T ss_pred cccccccccccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHH--HHHHHHHh
Confidence 9999999875432 334578899999999876 56799999999999999999999998876543321 11111111
Q ss_pred cc---------ccccccc---Cccccc----hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 743 KD---------DKAWKLM---DPTMQN----EALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 743 ~~---------~~~~~~~---d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
-. ......+ -|...+ .........+++++.+|++.||.+|||++|.++.
T Consensus 227 GtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 227 GTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred CCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 00 0000111 111111 1222356778999999999999999999999864
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=320.71 Aligned_cols=259 Identities=24% Similarity=0.368 Sum_probs=203.5
Q ss_pred HHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcCCCCcccee
Q 041702 511 AATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 511 ~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
...+.|+..++||.|.-++||+|+.+ +.++.||||++..... ...+.+++|+..|+.++||||++++
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~------------p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~ 90 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCI------------PTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYH 90 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeec------------ccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEE
Confidence 35688999999999999999999654 7789999999975543 3368899999999999999999999
Q ss_pred eEeecCCceEEEEEeeccCCcc------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCcee
Q 041702 590 GCCIEQGEKISIYEFDIVTDPA------RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKI 663 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~~~~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL 663 (840)
..|..+++.++||.|+...... -...+++..+..|++++++||.|||++| .||||||+.||||+.+|.+||
T Consensus 91 ~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkL 167 (516)
T KOG0582|consen 91 CSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKL 167 (516)
T ss_pred EEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEE
Confidence 9999999999999996443321 2234888999999999999999999999 999999999999999999999
Q ss_pred eccccceecCCCCccc--ccccccccccccCcccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHh
Q 041702 664 SDFGIARTFGGDEMQS--NTNRIVGTYGYMSPEYALH--GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAW 739 (840)
Q Consensus 664 ~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~ 739 (840)
+|||.+..+....... .....+||+.|||||+++. ..|+.|+||||||++.+||.+|..||..+.+...-+..
T Consensus 168 adFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t--- 244 (516)
T KOG0582|consen 168 ADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT--- 244 (516)
T ss_pred cCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH---
Confidence 9999876554332211 1156789999999999654 45999999999999999999999998765443321110
Q ss_pred hhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 740 NLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 740 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
+ .+......-..+..+........+.+++..||+.||++|||++++++
T Consensus 245 --L-qn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 245 --L-QNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred --h-cCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 0 11111111112222333445567889999999999999999999884
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=332.92 Aligned_cols=250 Identities=24% Similarity=0.348 Sum_probs=203.1
Q ss_pred HHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhc-CCCCcc
Q 041702 511 AATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKL-QHRNLV 586 (840)
Q Consensus 511 ~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l-~H~niv 586 (840)
.-.++|...+.||+|+|++|++|+++ .+++++|||++.+. .+...+-...|-.+|.+| .||.|+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~------------~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgiv 137 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREK------------ATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIV 137 (604)
T ss_pred CChhhcchhheeccccceeEEEeeec------------CCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeE
Confidence 34578889999999999999999876 68999999999754 233345577888999999 899999
Q ss_pred ceeeEeecCCceEEEEEee----ccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCce
Q 041702 587 RLFGCCIEQGEKISIYEFD----IVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPK 662 (840)
Q Consensus 587 ~l~g~~~~~~~~~lv~e~~----~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 662 (840)
+|+--|.+....|+|+||. ++....+...+++.....++.+|+.||+|||++| ||||||||+|||||.|+++|
T Consensus 138 kLy~TFQD~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhik 214 (604)
T KOG0592|consen 138 KLYFTFQDEESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIK 214 (604)
T ss_pred EEEEEeecccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEE
Confidence 9999999999999999994 3444456678888889999999999999999999 99999999999999999999
Q ss_pred eeccccceecCCCCcc---------ccc--ccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCC
Q 041702 663 ISDFGIARTFGGDEMQ---------SNT--NRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDS 731 (840)
Q Consensus 663 L~DFGla~~~~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~ 731 (840)
|+|||.|+.+...... ... ...+||..|.+||++.....+..+|+|+||||||+|+.|++||...++.-
T Consensus 215 ITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl 294 (604)
T KOG0592|consen 215 ITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL 294 (604)
T ss_pred EeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH
Confidence 9999999988643222 111 45899999999999999999999999999999999999999997644321
Q ss_pred ccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 732 LTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
..+ ++++- .-+.+...++.+.+|+.+.|..||.+|+|.+||-+.
T Consensus 295 --iFq------------kI~~l--~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 295 --IFQ------------KIQAL--DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred --HHH------------HHHHh--cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 111 11111 112222334567789999999999999999888754
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=339.62 Aligned_cols=262 Identities=28% Similarity=0.396 Sum_probs=197.8
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhc-CCCCcccee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKL-QHRNLVRLF 589 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l-~H~niv~l~ 589 (840)
..++|++.++||+|+||.||+|.+... ....++..||||+++.... ...+.+.+|+.++.++ +||||++++
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~-------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~ 77 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGI-------DKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLL 77 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEecc-------CCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEE
Confidence 346889999999999999999864300 1224567899999975432 3346799999999999 899999999
Q ss_pred eEeecC-CceEEEEEeeccCCcc---------------------------------------------------------
Q 041702 590 GCCIEQ-GEKISIYEFDIVTDPA--------------------------------------------------------- 611 (840)
Q Consensus 590 g~~~~~-~~~~lv~e~~~~~~~~--------------------------------------------------------- 611 (840)
++|... +..+++|||....+..
T Consensus 78 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (338)
T cd05102 78 GACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGST 157 (338)
T ss_pred eEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccc
Confidence 998764 4578899984221110
Q ss_pred ---------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceecCCCCcccccc
Q 041702 612 ---------RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTN 682 (840)
Q Consensus 612 ---------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 682 (840)
....+++.+...++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++............
T Consensus 158 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~ 234 (338)
T cd05102 158 NPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 234 (338)
T ss_pred ccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhccc
Confidence 0235788899999999999999999988 9999999999999999999999999998754332222223
Q ss_pred cccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhcccccccccCccccchhhH
Q 041702 683 RIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALY 761 (840)
Q Consensus 683 ~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 761 (840)
...++..|+|||.+.+..++.++|||||||+||||++ |..|+....... ... ......... . .+.
T Consensus 235 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-~~~----~~~~~~~~~-----~----~~~ 300 (338)
T cd05102 235 SARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-EFC----QRLKDGTRM-----R----APE 300 (338)
T ss_pred CCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-HHH----HHHhcCCCC-----C----CCC
Confidence 3456789999999999999999999999999999997 999886533221 111 111111110 0 111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 762 SMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 762 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
.....+.+++.+||+.||++|||+.||++.|++++.
T Consensus 301 ~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 301 NATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 233457899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=332.88 Aligned_cols=261 Identities=24% Similarity=0.382 Sum_probs=213.1
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
++|.+.+.||+|+||.||||+.+ .+.+.||+|.+.+.. .++.+.+.+|++|+++++|||||.++++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK------------~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~es 69 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRK------------YTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLES 69 (808)
T ss_pred cchhHHHHhcCCccceeeecccc------------cceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHh
Confidence 57888899999999999999765 688999999997653 3456779999999999999999999999
Q ss_pred eecCCceEEEEEee---ccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccc
Q 041702 592 CIEQGEKISIYEFD---IVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGI 668 (840)
Q Consensus 592 ~~~~~~~~lv~e~~---~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl 668 (840)
|+...+.++|.||. +..-......+++.....|+.+++.||.|||+.+ |+|||+||+||||+..+.+|++|||+
T Consensus 70 fEt~~~~~vVte~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~ 146 (808)
T KOG0597|consen 70 FETSAHLWVVTEYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGL 146 (808)
T ss_pred hcccceEEEEehhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhh
Confidence 99999999999993 3333455677999999999999999999999988 99999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccc
Q 041702 669 ARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAW 748 (840)
Q Consensus 669 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (840)
|+...... .....+.|||.|||||...+++|+..+|.||+||||||+.+|++||-... +.+.+.....
T Consensus 147 Ar~m~~~t--~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s-----i~~Lv~~I~~----- 214 (808)
T KOG0597|consen 147 ARAMSTNT--SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS-----ITQLVKSILK----- 214 (808)
T ss_pred hhhcccCc--eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH-----HHHHHHHHhc-----
Confidence 99875432 33456789999999999999999999999999999999999999984321 1111111111
Q ss_pred cccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HhhccccCCCCCCCCCC
Q 041702 749 KLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA--MLKDEIVNLPSPHQPAF 807 (840)
Q Consensus 749 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~Le~~~~~~~~p~~p~~ 807 (840)
|+.. .+......+..++.-.|++||.+|.+-.+++. +.++.+.-...|.+|.+
T Consensus 215 ---d~v~---~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~ 269 (808)
T KOG0597|consen 215 ---DPVK---PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAF 269 (808)
T ss_pred ---CCCC---CcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhcccccccc
Confidence 1111 12255667888999999999999999999984 55665555566666665
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=323.64 Aligned_cols=254 Identities=26% Similarity=0.402 Sum_probs=195.5
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
..++...+.||+|+||.||++.+. .+|+..|||.+...+....+.+.+|+.+|.+++|||||+++|..
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~------------~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~ 83 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNK------------KTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSS 83 (313)
T ss_pred cchhhhhccccCccceEEEEEEec------------CCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcc
Confidence 345677789999999999999765 45899999998765433367799999999999999999999986
Q ss_pred ecCC--ceEEEEEeeccCCcc----ccC-CCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecC-CCCceee
Q 041702 593 IEQG--EKISIYEFDIVTDPA----RKD-LLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS-DMNPKIS 664 (840)
Q Consensus 593 ~~~~--~~~lv~e~~~~~~~~----~~~-~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kL~ 664 (840)
...+ ...+.|||....... ... .+++..+..+..||++||+|||+++ |+||||||+|||++. ++.+||+
T Consensus 84 ~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~Kla 160 (313)
T KOG0198|consen 84 SSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLA 160 (313)
T ss_pred ccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEec
Confidence 5555 588999995433322 112 6999999999999999999999998 999999999999999 7999999
Q ss_pred ccccceecCCC-CcccccccccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhh
Q 041702 665 DFGIARTFGGD-EMQSNTNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLW 742 (840)
Q Consensus 665 DFGla~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~ 742 (840)
|||+++..... ..........||+.|||||++.++ ....++|||||||+++||+||++|+... ...........
T Consensus 161 DFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~----~~~~~~~~~ig 236 (313)
T KOG0198|consen 161 DFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF----FEEAEALLLIG 236 (313)
T ss_pred cCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh----cchHHHHHHHh
Confidence 99999877641 112223457899999999999864 3446999999999999999999998643 11111111111
Q ss_pred cccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 041702 743 KDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794 (840)
Q Consensus 743 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~ 794 (840)
... ..+..+........+++.+|++.+|++|||++++++.--.
T Consensus 237 ~~~---------~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 237 RED---------SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred ccC---------CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 111 1112333355667889999999999999999999976543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=344.74 Aligned_cols=258 Identities=24% Similarity=0.382 Sum_probs=208.9
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
.....+.++||.|.||.|++|+.+ ..-.....||||.|+... +....+|+.|+.||.+++||||++|.|+
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk---------~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGV 698 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLK---------LPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGV 698 (996)
T ss_pred hhheEEEEEEecccccceeccccc---------CCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEE
Confidence 345567799999999999998765 112345679999998763 4566789999999999999999999999
Q ss_pred eecCCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 592 CIEQGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
.......++|.|||..... .....+.+.+..-++++||.|+.||-+.+ +|||||.++|||++.+..+|++||
T Consensus 699 VTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDF 775 (996)
T KOG0196|consen 699 VTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDF 775 (996)
T ss_pred EecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccc
Confidence 9999999999999644332 22345888999999999999999999998 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccc--cccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhc
Q 041702 667 GIARTFGGDEMQSNTNRIVG--TYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWK 743 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 743 (840)
|+++.++++. ....+...| +.+|.|||.+..+.+|.++|||||||++||.++ |.+|+=.+ .
T Consensus 776 GLSRvledd~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm---------------S 839 (996)
T KOG0196|consen 776 GLSRVLEDDP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM---------------S 839 (996)
T ss_pred cceeecccCC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc---------------c
Confidence 9999886655 222222222 469999999999999999999999999999886 66664211 1
Q ss_pred ccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccC
Q 041702 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVN 798 (840)
Q Consensus 744 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~ 798 (840)
+.+....++...+-..+++.+..|.+|++.|||+|..+||.+.||+..|++.+.+
T Consensus 840 NQdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 840 NQDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred hHHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 1222233444555566678888999999999999999999999999999987553
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=327.93 Aligned_cols=247 Identities=24% Similarity=0.402 Sum_probs=203.4
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCI 593 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~ 593 (840)
..|....+||+|+-|.||.|... .+++.||||++....+...+-+.+|+.+|+..+|+|||+++..+.
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~------------~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Syl 340 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKI------------STKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYL 340 (550)
T ss_pred hhhcchhhhccccccceeeeeec------------cCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhc
Confidence 45667789999999999999654 688899999998876666777899999999999999999999999
Q ss_pred cCCceEEEEEeeccC---CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccce
Q 041702 594 EQGEKISIYEFDIVT---DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIAR 670 (840)
Q Consensus 594 ~~~~~~lv~e~~~~~---~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~ 670 (840)
..++.+.||||+... +.-....+++.++..|++++++||+|||.++ |+|||||.+||||+.+|.+||+|||++.
T Consensus 341 v~deLWVVMEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFca 417 (550)
T KOG0578|consen 341 VGDELWVVMEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCA 417 (550)
T ss_pred ccceeEEEEeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeee
Confidence 999999999996433 3344556889999999999999999999999 9999999999999999999999999998
Q ss_pred ecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccccc
Q 041702 671 TFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKL 750 (840)
Q Consensus 671 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (840)
.+..... .....+|||.|||||+.....|.+|.||||||++++||+-|.+||-. +... .+..+......
T Consensus 418 qi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln--E~Pl----rAlyLIa~ng~--- 486 (550)
T KOG0578|consen 418 QISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN--ENPL----RALYLIATNGT--- 486 (550)
T ss_pred ccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC--CChH----HHHHHHhhcCC---
Confidence 8765443 33457899999999999999999999999999999999999999732 1111 11122111111
Q ss_pred cCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 751 MDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 751 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
+.+ .........+.+++.+||+.|+++||++.|+|+
T Consensus 487 --P~l--k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 487 --PKL--KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred --CCc--CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 111 223345566889999999999999999999985
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=325.15 Aligned_cols=272 Identities=24% Similarity=0.372 Sum_probs=196.5
Q ss_pred cCCcccccccCCCCccEEEeecceeehh---ccc-cCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccce
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEIC---NWK-QGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRL 588 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~---~~~-~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l 588 (840)
++|...++||+|+||.||+|.++..... ... ......+..||+|.+.... .....+|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 5788889999999999999875310000 000 0011245579999987643 2335679999999999999999999
Q ss_pred eeEeecCCceEEEEEeeccCC-----------------------ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceec
Q 041702 589 FGCCIEQGEKISIYEFDIVTD-----------------------PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIH 645 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~~~~~~-----------------------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH 645 (840)
++++.+.+..+++|||..... ......+++....+++.||+.||.|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999942211 111235788899999999999999999988 999
Q ss_pred CCCCCCcEEecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 041702 646 RDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTR 725 (840)
Q Consensus 646 rDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~ 725 (840)
|||||+|||++.++.+||+|||+++.+.............++..|+|||++.+..++.++||||||++++||+++..+.+
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999987644333233344556789999999998899999999999999999997544333
Q ss_pred CCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 041702 726 FYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794 (840)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~ 794 (840)
+........................ ...+...+..+.+++.+||+.+|++|||+.+|.+.|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTDEQVIENAGEFFRDQGRQVY------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCHHHHHHHHHHHhhhcccccc------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 3222222222222111111110000 00011223568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=357.64 Aligned_cols=261 Identities=30% Similarity=0.431 Sum_probs=206.6
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC-CCcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK-SGQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~-~~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
.++.+..+.||+|.||.||+|..+... +... ...||||.+++. +.+...+|.+|..+|++++|||||+++|+
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~------~~~~-~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv 763 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVP------GSVS-PIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGV 763 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCC------CCcc-ceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEe
Confidence 455667789999999999999765211 1111 456999999865 45677899999999999999999999999
Q ss_pred eecCCceEEEEEeeccCCcc-----------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCC
Q 041702 592 CIEQGEKISIYEFDIVTDPA-----------RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMN 660 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~ 660 (840)
|.+.+..++++|||...+.. ....+...+.+.++.|||+|+.|||+++ +|||||.++|+||++...
T Consensus 764 ~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~ 840 (1025)
T KOG1095|consen 764 CLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRV 840 (1025)
T ss_pred ecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCc
Confidence 99999999999997544322 2456888899999999999999999988 999999999999999999
Q ss_pred ceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHh
Q 041702 661 PKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAW 739 (840)
Q Consensus 661 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~ 739 (840)
+||+|||||+.+.+.++........-..+|||||.+..+.++.|+|||||||+|||++| |..|+......+ ....
T Consensus 841 VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~--v~~~-- 916 (1025)
T KOG1095|consen 841 VKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE--VLLD-- 916 (1025)
T ss_pred EEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH--HHHH--
Confidence 99999999997766665554444344569999999999999999999999999999998 566654332221 1111
Q ss_pred hhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccC
Q 041702 740 NLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVN 798 (840)
Q Consensus 740 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~ 798 (840)
....+ ++-. +...++.+.+|+..||+.+|++||++..|++.++.+...
T Consensus 917 -~~~gg---RL~~-------P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 917 -VLEGG---RLDP-------PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred -HHhCC---ccCC-------CCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 11111 2222 334455688999999999999999999999999887553
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=317.48 Aligned_cols=254 Identities=24% Similarity=0.341 Sum_probs=199.3
Q ss_pred HHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--------------CcCHHHHHHHHH
Q 041702 510 SAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--------------GQGLEEFKNEMM 575 (840)
Q Consensus 510 ~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--------------~~~~~~f~~Ev~ 575 (840)
....++|++...||+|.||.|-+|++. .+++.||||++.+.. ....++.++||.
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~------------~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIa 160 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDE------------VDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIA 160 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeec------------CCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHH
Confidence 445688999999999999999999765 789999999986531 123468999999
Q ss_pred HHhhcCCCCccceeeEeec--CCceEEEEEeeccCCcc---ccCC-CCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCC
Q 041702 576 LIAKLQHRNLVRLFGCCIE--QGEKISIYEFDIVTDPA---RKDL-LDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLK 649 (840)
Q Consensus 576 ~l~~l~H~niv~l~g~~~~--~~~~~lv~e~~~~~~~~---~~~~-l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk 649 (840)
+|++++|||||+|+.+..+ .+..|+|+||....... .... +...+..+++.++..||+|||.++ |||||||
T Consensus 161 ilKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIK 237 (576)
T KOG0585|consen 161 ILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIK 237 (576)
T ss_pred HHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccc
Confidence 9999999999999999875 46789999995433322 2223 889999999999999999999998 9999999
Q ss_pred CCcEEecCCCCceeeccccceecCCC---CcccccccccccccccCccccccCC----CCccccchhHHHHHHHHHhCCC
Q 041702 650 ASNVLLDSDMNPKISDFGIARTFGGD---EMQSNTNRIVGTYGYMSPEYALHGL----FSIKSDVFSFGVLLLEILSSKK 722 (840)
Q Consensus 650 p~NILl~~~~~~kL~DFGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDV~SlGviL~elltG~~ 722 (840)
|+|+||+++|++||+|||.+..+..+ .........+|||.|+|||...++. .+.+.||||+||+||.|+.|+.
T Consensus 238 PsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~ 317 (576)
T KOG0585|consen 238 PSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQL 317 (576)
T ss_pred hhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccC
Confidence 99999999999999999999876322 1112234578999999999887633 3567899999999999999999
Q ss_pred CCCCCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 041702 723 NTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAML 792 (840)
Q Consensus 723 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 792 (840)
||-... ...+. .+++...+.-....++.+.+.+|+.++|++||+.|.+..+|....
T Consensus 318 PF~~~~--~~~l~------------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 318 PFFDDF--ELELF------------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred Ccccch--HHHHH------------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 984321 11111 122333333333345667788999999999999999999887554
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=304.20 Aligned_cols=274 Identities=23% Similarity=0.273 Sum_probs=203.8
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC--cCHHHHHHHHHHHhhcCCCCccceee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG--QGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
.+.|+.+++|++|+||.||+|+++ .+++.||+|+++-..+ .-.-.-.+||.+|.+++|||||.+-.
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk------------~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkE 142 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDK------------KTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKE 142 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccC------------CcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEE
Confidence 456888999999999999999876 7899999999985432 11233578999999999999999998
Q ss_pred Eeec--CCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 591 CCIE--QGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 591 ~~~~--~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
+... -+..|+||||..... ....+.+...+..-++.|+++|++|||... |+|||||++|+|+...|.+||+
T Consensus 143 VVvG~~~d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKia 219 (419)
T KOG0663|consen 143 VVVGSNMDKIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIA 219 (419)
T ss_pred EEeccccceeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEec
Confidence 8764 357999999942221 112357888889999999999999999988 9999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCccccccCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhc
Q 041702 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGL-FSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWK 743 (840)
Q Consensus 665 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~ 743 (840)
|||+|+.++.. ....+..+.|..|+|||.+.+.+ |+++.|+||+|||+.||+++++.|+...+-+ .+.......-
T Consensus 220 DFGLAR~ygsp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d--Ql~~If~llG 295 (419)
T KOG0663|consen 220 DFGLAREYGSP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID--QLDKIFKLLG 295 (419)
T ss_pred ccchhhhhcCC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH--HHHHHHHHhC
Confidence 99999988643 33445678899999999998865 9999999999999999999999887654322 1111111111
Q ss_pred c-----------ccccc------ccCccccchhhHH-HHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCCCCCCCC
Q 041702 744 D-----------DKAWK------LMDPTMQNEALYS-MVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSPHQP 805 (840)
Q Consensus 744 ~-----------~~~~~------~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~p~~p 805 (840)
. -.... ..-..++..+... ..+.-.+++...|..||.+|.|++|.++. +-..+.|.|..|
T Consensus 296 tPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h--~~F~e~P~p~~P 373 (419)
T KOG0663|consen 296 TPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH--EYFRETPLPIDP 373 (419)
T ss_pred CCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc--cccccCCCCCCh
Confidence 0 00000 0000111111111 34566788889999999999999998753 334456667666
Q ss_pred CC
Q 041702 806 AF 807 (840)
Q Consensus 806 ~~ 807 (840)
.+
T Consensus 374 ~~ 375 (419)
T KOG0663|consen 374 SM 375 (419)
T ss_pred hh
Confidence 53
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=337.01 Aligned_cols=260 Identities=30% Similarity=0.442 Sum_probs=198.7
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhc-CCCCcccee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKL-QHRNLVRLF 589 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l-~H~niv~l~ 589 (840)
..++|+..+.||+|+||.||+|++... +...++..||||+++... ....+.+.+|+++++.+ +|+||++++
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~-------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~ 108 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGL-------GKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLL 108 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecC-------CcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEe
Confidence 446788999999999999999876411 234456789999997543 23346789999999999 899999999
Q ss_pred eEeecCCceEEEEEeeccCCc-----------------------------------------------------------
Q 041702 590 GCCIEQGEKISIYEFDIVTDP----------------------------------------------------------- 610 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~~~----------------------------------------------------------- 610 (840)
++|.+.+..+++|||......
T Consensus 109 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (374)
T cd05106 109 GACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS 188 (374)
T ss_pred eEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence 999999999999998421110
Q ss_pred ---------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceecCCC
Q 041702 611 ---------------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGD 675 (840)
Q Consensus 611 ---------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 675 (840)
.....+++.+.++++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~ 265 (374)
T cd05106 189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265 (374)
T ss_pred ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCC
Confidence 01134788889999999999999999988 999999999999999999999999999876443
Q ss_pred CcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhcccccccccCcc
Q 041702 676 EMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPT 754 (840)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 754 (840)
..........++..|||||++.+..++.++|||||||+++||++ |+.||....... . ........ .....+
T Consensus 266 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~----~~~~~~~~--~~~~~~- 337 (374)
T cd05106 266 SNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-K----FYKMVKRG--YQMSRP- 337 (374)
T ss_pred cceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-H----HHHHHHcc--cCccCC-
Confidence 32222223345678999999999999999999999999999997 999986433221 1 01111110 000111
Q ss_pred ccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 755 MQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 755 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
...+..+.+++.+||+.||++|||+.+|+++|+++
T Consensus 338 ------~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 338 ------DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred ------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11235678899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=313.32 Aligned_cols=266 Identities=23% Similarity=0.291 Sum_probs=201.8
Q ss_pred HHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEecc--CCCcCHHHHHHHHHHHhhcCCCCccc
Q 041702 510 SAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSS--KSGQGLEEFKNEMMLIAKLQHRNLVR 587 (840)
Q Consensus 510 ~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~--~~~~~~~~f~~Ev~~l~~l~H~niv~ 587 (840)
......|...+.||+|+||.|..|.++ .+|+.||||++.. ......++-.+|+++|+.++|+||+.
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~------------~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~ 85 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCSAKDK------------RTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIG 85 (359)
T ss_pred EeccceecccccccCcceeeEEEEEEc------------CCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcce
Confidence 345566777789999999999999876 7889999999983 34556788999999999999999999
Q ss_pred eeeEeec-----CCceEEEEEeec---cCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCC
Q 041702 588 LFGCCIE-----QGEKISIYEFDI---VTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDM 659 (840)
Q Consensus 588 l~g~~~~-----~~~~~lv~e~~~---~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~ 659 (840)
+.+.+.. -+..|+|+|++. ..-....+.|+......+++||++||.|+|+.+ ++||||||+|+|++.+.
T Consensus 86 l~di~~p~~~~~f~DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c 162 (359)
T KOG0660|consen 86 LLDIFRPPSRDKFNDVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADC 162 (359)
T ss_pred EEeecccccccccceeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCC
Confidence 9998865 467899999852 222333445888899999999999999999998 99999999999999999
Q ss_pred CceeeccccceecCCCCcccccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCC-ccHhHH
Q 041702 660 NPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDS-LTLLGH 737 (840)
Q Consensus 660 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~-~~~~~~ 737 (840)
..||+|||+|+...........+..+.|..|+|||++.. ..|+.+.||||.||||.||++|++-|++.+.-+ ..+...
T Consensus 163 ~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~ 242 (359)
T KOG0660|consen 163 DLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILE 242 (359)
T ss_pred CEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHH
Confidence 999999999999865433344467789999999998764 679999999999999999999999987654321 111100
Q ss_pred --------HhhhhcccccccccC------ccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 738 --------AWNLWKDDKAWKLMD------PTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 738 --------~~~~~~~~~~~~~~d------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.......++....+. +.-.....+......++++.+||..||.+|+|++|.++
T Consensus 243 ~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 243 LLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred hcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 001111111111111 00001112234456789999999999999999999985
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=322.09 Aligned_cols=259 Identities=26% Similarity=0.428 Sum_probs=205.5
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCc-CHHHHHHHHHHHhhcCCCCccceee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQ-GLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~-~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
+.+...+.++||+|-||.|.+.. ...+..||||+++..+.. ...+|..|+++|.+|+|||||+|+|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCe-------------veg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvG 602 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCE-------------VEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLG 602 (807)
T ss_pred chhheehhhhhcCcccceeEEEE-------------ecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEe
Confidence 34556677899999999999964 345789999999987654 4588999999999999999999999
Q ss_pred EeecCCceEEEEEeeccCCccc------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 591 CCIEQGEKISIYEFDIVTDPAR------KDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~~~~------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
+|..++...+++||+...+... ...+.-..-.+|+.||+.|++||.+.. +|||||.++|+|+|.++++||+
T Consensus 603 VC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKia 679 (807)
T KOG1094|consen 603 VCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIA 679 (807)
T ss_pred eeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEec
Confidence 9999999999999965544321 112344556789999999999999987 9999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh--CCCCCCCCCCCCccHhHHHhhhh
Q 041702 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS--SKKNTRFYNTDSLTLLGHAWNLW 742 (840)
Q Consensus 665 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt--G~~p~~~~~~~~~~~~~~~~~~~ 742 (840)
|||+++.+..+.......+.+-+.+|||||.+..++++.++|||+||++|||+++ ...|+.... +......+-.+.
T Consensus 680 dfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt--~e~vven~~~~~ 757 (807)
T KOG1094|consen 680 DFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT--DEQVVENAGEFF 757 (807)
T ss_pred CcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh--HHHHHHhhhhhc
Confidence 9999998877777777777778899999999999999999999999999999976 445554332 223333333333
Q ss_pred cccccc-cccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 743 KDDKAW-KLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 743 ~~~~~~-~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
...... -+..|.+ .+..+.+++..||..|-++||+++++...|.+.
T Consensus 758 ~~~~~~~~l~~P~~-------cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 758 RDQGRQVVLSRPPA-------CPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CCCCcceeccCCCc-------CcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 322222 2223333 345577899999999999999999999988764
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=320.09 Aligned_cols=245 Identities=23% Similarity=0.374 Sum_probs=202.6
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC-CCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK-SGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~-~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
..|+..+.||+|.||.||||.+. ..++.||+|++.-. ....+++..+|+.+|.+++|+||.+++|.+
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~------------~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsy 80 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDN------------KTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSY 80 (467)
T ss_pred cccccchhccccccceeeeeeec------------cccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhhe
Confidence 45667789999999999999876 68899999999754 445678899999999999999999999999
Q ss_pred ecCCceEEEEEeecc----CCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccc
Q 041702 593 IEQGEKISIYEFDIV----TDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGI 668 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~----~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl 668 (840)
..+....++|||... ........+++..+.-|+++++.||.|||.++ .+|||||+.|||+..+|.+||+|||.
T Consensus 81 l~g~~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgV 157 (467)
T KOG0201|consen 81 LKGTKLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGV 157 (467)
T ss_pred eecccHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecce
Confidence 999999999999432 23333444578888889999999999999998 99999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccc
Q 041702 669 ARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAW 748 (840)
Q Consensus 669 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (840)
+-.+....... ...+||+.|||||++.+..|+.|+||||||++.+||++|.+|+...++.. ..
T Consensus 158 a~ql~~~~~rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr---------------vl 220 (467)
T KOG0201|consen 158 AGQLTNTVKRR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR---------------VL 220 (467)
T ss_pred eeeeechhhcc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce---------------EE
Confidence 98876544433 56899999999999999899999999999999999999999987655422 11
Q ss_pred cccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 749 KLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 749 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.++...-.+.......+.+.+++..||..||++||++.++++
T Consensus 221 flIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 221 FLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred EeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 122222222222345666889999999999999999999884
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=334.27 Aligned_cols=259 Identities=27% Similarity=0.414 Sum_probs=196.5
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhc-CCCCccceee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKL-QHRNLVRLFG 590 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l-~H~niv~l~g 590 (840)
.++|+..++||+|+||.||+|.+... ....++..||||+++... ....+.+.+|+.++..+ +||||+++++
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~-------~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~ 106 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGL-------FKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLG 106 (375)
T ss_pred hHHeehhheecCCccceEEEEEEecc-------ccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeee
Confidence 45788899999999999999864300 122456789999997543 23456789999999999 8999999999
Q ss_pred EeecCCceEEEEEeeccCCc------------------------------------------------------------
Q 041702 591 CCIEQGEKISIYEFDIVTDP------------------------------------------------------------ 610 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~~------------------------------------------------------------ 610 (840)
+|.+.+..++||||....+.
T Consensus 107 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 186 (375)
T cd05104 107 ACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKR 186 (375)
T ss_pred eeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccc
Confidence 99999999999998421110
Q ss_pred -------------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccccee
Q 041702 611 -------------------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 611 -------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
.....+++..+.+++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 263 (375)
T cd05104 187 RSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARD 263 (375)
T ss_pred cccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCcccee
Confidence 01125788999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhcccccccc
Q 041702 672 FGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKDDKAWKL 750 (840)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (840)
..............++..|+|||.+.+..++.++|||||||+++||++ |..|+....... . ......... ..
T Consensus 264 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~----~~~~~~~~~--~~ 336 (375)
T cd05104 264 IRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-K----FYKMIKEGY--RM 336 (375)
T ss_pred ccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-H----HHHHHHhCc--cC
Confidence 654332222223345678999999999999999999999999999998 777765432211 1 111111110 00
Q ss_pred cCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 751 MDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 751 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
..+. .....+.+++.+||+.||++||++.||++.|++.
T Consensus 337 ~~~~-------~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 337 LSPE-------CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCC-------CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0111 1234578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=328.96 Aligned_cols=256 Identities=18% Similarity=0.185 Sum_probs=191.6
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
..+|++.++||+|+||.||+|.++ .+++.||+|+... ..+.+|++++++++||||+++++++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~------------~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~ 152 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDN------------KTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTF 152 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEEC------------CCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEE
Confidence 467999999999999999999765 6789999997542 4578999999999999999999999
Q ss_pred ecCCceEEEEEeecc---CCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccc
Q 041702 593 IEQGEKISIYEFDIV---TDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIA 669 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~---~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla 669 (840)
...+..++++|+... ........+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 153 ~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a 229 (391)
T PHA03212 153 TYNKFTCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAA 229 (391)
T ss_pred EECCeeEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcc
Confidence 999999999998421 11223456889999999999999999999988 999999999999999999999999999
Q ss_pred eecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCC-----ccHhHHHhhhhcc
Q 041702 670 RTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDS-----LTLLGHAWNLWKD 744 (840)
Q Consensus 670 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~-----~~~~~~~~~~~~~ 744 (840)
+...... ........||+.|+|||++.+..++.++|||||||++|||++|+.|+-...... .............
T Consensus 230 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~ 308 (391)
T PHA03212 230 CFPVDIN-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGT 308 (391)
T ss_pred ccccccc-ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcC
Confidence 7542211 112234579999999999999999999999999999999999998753221110 0000000000000
Q ss_pred c----------cccc---------ccCcccc--chhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 745 D----------KAWK---------LMDPTMQ--NEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 745 ~----------~~~~---------~~d~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
. .... ...+... ..........+.+++.+||+.||++|||++|+++
T Consensus 309 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 309 HPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred ChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0 0000 0000000 0112234567889999999999999999999984
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=322.83 Aligned_cols=243 Identities=27% Similarity=0.416 Sum_probs=192.9
Q ss_pred CcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEeecC
Q 041702 516 FSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQ 595 (840)
Q Consensus 516 f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~ 595 (840)
...++-||+|+.|.||+|+. .++.||||+++... ..+|+-|++|+||||+.+.|+|...
T Consensus 126 IsELeWlGSGaQGAVF~Grl--------------~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqs 184 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRL--------------HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQS 184 (904)
T ss_pred hhhhhhhccCcccceeeeec--------------cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCC
Confidence 34467899999999999763 48899999987432 3588999999999999999999999
Q ss_pred CceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccccee
Q 041702 596 GEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 596 ~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
--+.+||||..... ......+.-.....+..+||.|+.|||.+. |||||||.-||||..+..+||+|||.++.
T Consensus 185 PcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e 261 (904)
T KOG4721|consen 185 PCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKE 261 (904)
T ss_pred ceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHh
Confidence 99999999954433 234556777777889999999999999987 99999999999999999999999999987
Q ss_pred cCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccccccccc
Q 041702 672 FGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLM 751 (840)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (840)
..+.. ..-.+.||..|||||++.+.+.++|+|||||||||||||||..|+........ .|- ...+...+
T Consensus 262 ~~~~S---TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI-----IwG--VGsNsL~L- 330 (904)
T KOG4721|consen 262 LSDKS---TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI-----IWG--VGSNSLHL- 330 (904)
T ss_pred hhhhh---hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee-----EEe--ccCCcccc-
Confidence 65432 22347899999999999999999999999999999999999999753221110 011 11112222
Q ss_pred CccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCC
Q 041702 752 DPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNL 799 (840)
Q Consensus 752 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~ 799 (840)
..+...++-+.-|+++||+..|.+||++.+|+..|+-...++
T Consensus 331 ------pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pel 372 (904)
T KOG4721|consen 331 ------PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPEL 372 (904)
T ss_pred ------cCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHH
Confidence 223344556777888999999999999999999998654443
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=327.87 Aligned_cols=249 Identities=24% Similarity=0.359 Sum_probs=192.9
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
++|+..++||+|+||.||+|.+. .+++.||||++..... ...+.+.+|++++++++|+||+++++++
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 141 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHR------------PTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF 141 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEEC------------CCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe
Confidence 45566789999999999999754 5789999999965432 3346789999999999999999999999
Q ss_pred ecCCceEEEEEeeccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceec
Q 041702 593 IEQGEKISIYEFDIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTF 672 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~ 672 (840)
.+.+..+++|||............++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+
T Consensus 142 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~ 218 (353)
T PLN00034 142 DHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRIL 218 (353)
T ss_pred ccCCeEEEEEecCCCCcccccccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceec
Confidence 99999999999966555555556677888899999999999999988 999999999999999999999999999876
Q ss_pred CCCCcccccccccccccccCcccccc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccccc
Q 041702 673 GGDEMQSNTNRIVGTYGYMSPEYALH-----GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKA 747 (840)
Q Consensus 673 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 747 (840)
.... .......||..|+|||.+.. ...+.++|||||||++|||++|+.||......+.... .......
T Consensus 219 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~--~~~~~~~--- 291 (353)
T PLN00034 219 AQTM--DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASL--MCAICMS--- 291 (353)
T ss_pred cccc--ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHH--HHHHhcc---
Confidence 4321 12234578999999998743 2345689999999999999999999863322221111 0000000
Q ss_pred ccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 748 WKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 748 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
............+.+++.+||+.||++||++.||++.
T Consensus 292 -------~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 292 -------QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred -------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011112334568899999999999999999999864
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=325.68 Aligned_cols=246 Identities=24% Similarity=0.348 Sum_probs=196.9
Q ss_pred HHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC----CC-cCHHHHHHHHHHHhhcC-CCC
Q 041702 511 AATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK----SG-QGLEEFKNEMMLIAKLQ-HRN 584 (840)
Q Consensus 511 ~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~----~~-~~~~~f~~Ev~~l~~l~-H~n 584 (840)
....+|...+.||+|+||.|+.|.++ .+++.||||++... .. ...+.+.+|+.++++++ |||
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~------------~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~Hpn 81 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHR------------LTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPN 81 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeec------------cCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCC
Confidence 34578899999999999999999765 67899999977653 11 23456778999999998 999
Q ss_pred ccceeeEeecCCceEEEEEeecc----CCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCC-C
Q 041702 585 LVRLFGCCIEQGEKISIYEFDIV----TDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSD-M 659 (840)
Q Consensus 585 iv~l~g~~~~~~~~~lv~e~~~~----~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~-~ 659 (840)
|++++.++......++||||..- ........+.+.....++.|++.|++|+|+++ |+||||||+|||+|.+ +
T Consensus 82 I~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~ 158 (370)
T KOG0583|consen 82 IIRLLEVFATPTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEG 158 (370)
T ss_pred EeEEEEEEecCCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCC
Confidence 99999999999999999999433 22334577888999999999999999999998 9999999999999999 9
Q ss_pred CceeeccccceecCCCCcccccccccccccccCccccccCC-CC-ccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHH
Q 041702 660 NPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGL-FS-IKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGH 737 (840)
Q Consensus 660 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~ 737 (840)
++||+|||++.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||..... ..+...
T Consensus 159 ~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~--~~l~~k 234 (370)
T KOG0583|consen 159 NLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV--PNLYRK 234 (370)
T ss_pred CEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH--HHHHHH
Confidence 99999999998873 1122344578999999999999977 86 789999999999999999999875221 111111
Q ss_pred HhhhhcccccccccCccccchhhHHH-HHHHHHHHHHccccCCCCCCCHHHHH
Q 041702 738 AWNLWKDDKAWKLMDPTMQNEALYSM-VTRYIKVALLCVQENATDRPTMLEVV 789 (840)
Q Consensus 738 ~~~~~~~~~~~~~~d~~l~~~~~~~~-~~~l~~l~~~Cl~~dP~~RPs~~evl 789 (840)
..... . ..+... ...+..++.+||+.||.+|+++.+|+
T Consensus 235 ----i~~~~--------~--~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 235 ----IRKGE--------F--KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred ----HhcCC--------c--cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 11110 0 011111 55688999999999999999999999
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=318.47 Aligned_cols=240 Identities=18% Similarity=0.299 Sum_probs=188.4
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcC---HHHHHHHHHHHhhcCCCCccceeeEeec--
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQG---LEEFKNEMMLIAKLQHRNLVRLFGCCIE-- 594 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~---~~~f~~Ev~~l~~l~H~niv~l~g~~~~-- 594 (840)
..||+|++|.||+|. .+|+.||||+++...... .+.|.+|+.+|.+++||||++++|++.+
T Consensus 26 ~~i~~g~~~~v~~~~--------------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~ 91 (283)
T PHA02988 26 VLIKENDQNSIYKGI--------------FNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV 91 (283)
T ss_pred eEEeeCCceEEEEEE--------------ECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc
Confidence 579999999999975 368899999998654333 5778899999999999999999999977
Q ss_pred --CCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 595 --QGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQY-SRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 595 --~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
....+++|||..... ......+++..+.+++.+++.||.|||+. + ++||||||+|||+++++.+||+|||
T Consensus 92 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg 168 (283)
T PHA02988 92 DDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHG 168 (283)
T ss_pred cCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccc
Confidence 346789999954322 22345688999999999999999999984 5 8899999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCcccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALH--GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
+++...... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||...... ..... .....
T Consensus 169 ~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~--~~~~~---i~~~~ 238 (283)
T PHA02988 169 LEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK--EIYDL---IINKN 238 (283)
T ss_pred hHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH--HHHHH---HHhcC
Confidence 998653321 23467889999999976 68999999999999999999999998643211 11111 10111
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
. .+.. +......+.+++.+||+.||++|||+.||++.|+..
T Consensus 239 ~-----~~~~----~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 239 N-----SLKL----PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred C-----CCCC----CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 0 0111 112345688999999999999999999999999875
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=364.81 Aligned_cols=262 Identities=23% Similarity=0.363 Sum_probs=205.4
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
...|...+.||+|+||.||+|.++ .++..||||++...... ...|++++++++|||||+++|+|
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~------------~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~ 752 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSI------------KNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLC 752 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEEC------------CCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEE
Confidence 345777889999999999998654 57899999998754322 23568899999999999999999
Q ss_pred ecCCceEEEEEeeccCCccc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccccee
Q 041702 593 IEQGEKISIYEFDIVTDPAR-KDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
.+.+..++||||........ -..++|.++.+|+.||++||+|||+...++|+||||||+||+++.++.+++. ||.+..
T Consensus 753 ~~~~~~~lv~Ey~~~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~ 831 (968)
T PLN00113 753 RSEKGAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGL 831 (968)
T ss_pred EcCCCCEEEEeCCCCCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccc
Confidence 99999999999954332211 1348999999999999999999997655679999999999999999988876 666543
Q ss_pred cCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccccccccc
Q 041702 672 FGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLM 751 (840)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (840)
... .....+|+.|||||++.+..++.|+|||||||++|||+||+.|+............++............+
T Consensus 832 ~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 905 (968)
T PLN00113 832 LCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWI 905 (968)
T ss_pred ccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhhee
Confidence 321 12236789999999999999999999999999999999999998544333344444544433333444455
Q ss_pred Cccccc--hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 752 DPTMQN--EALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 752 d~~l~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
|+.+.. ....+....+.+++.+||+.+|++||+|+||++.|+++..
T Consensus 906 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 906 DPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 655533 2334566778999999999999999999999999998744
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=304.37 Aligned_cols=260 Identities=25% Similarity=0.326 Sum_probs=196.0
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC--cCHHHHHHHHHHHhhcCCCC-cccee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG--QGLEEFKNEMMLIAKLQHRN-LVRLF 589 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~--~~~~~f~~Ev~~l~~l~H~n-iv~l~ 589 (840)
...|...++||+|+||+||+|+++ .+|+.||+|+++.... .......+|+.+|++|+|+| ||+|+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~------------~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~ 77 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSK------------RTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLH 77 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEe------------cCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEE
Confidence 456777788999999999999876 6889999999986533 23456789999999999999 99999
Q ss_pred eEeecCC------ceEEEEEeecc------CCcccc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEec
Q 041702 590 GCCIEQG------EKISIYEFDIV------TDPARK-DLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLD 656 (840)
Q Consensus 590 g~~~~~~------~~~lv~e~~~~------~~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~ 656 (840)
+++...+ ..++|+||... ...... ..++-..+..++.||++||+|||+++ |+||||||.||||+
T Consensus 78 dv~~~~~~~~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~ 154 (323)
T KOG0594|consen 78 DVIHTSNNHRGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLIS 154 (323)
T ss_pred eeeeecccccccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEEC
Confidence 9998877 78899999321 111111 45666889999999999999999998 99999999999999
Q ss_pred CCCCceeeccccceecCCCCcccccccccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHh
Q 041702 657 SDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLL 735 (840)
Q Consensus 657 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~ 735 (840)
++|.+||+|||+|+.+.-.. ......++|..|+|||++.+. .|+...||||+|||+.||+++++-|+...+. +..
T Consensus 155 ~~G~lKlaDFGlAra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~--~ql 230 (323)
T KOG0594|consen 155 SSGVLKLADFGLARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI--DQL 230 (323)
T ss_pred CCCcEeeeccchHHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH--HHH
Confidence 99999999999999764221 123456789999999999887 6999999999999999999999888765442 222
Q ss_pred HHHhhhhccc--ccc---------cccCcccc-c----hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 736 GHAWNLWKDD--KAW---------KLMDPTMQ-N----EALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 736 ~~~~~~~~~~--~~~---------~~~d~~l~-~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
.......... ..+ ...-+... . ...........+++.+||+.+|.+|.|++.++++
T Consensus 231 ~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 231 FRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred HHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 2222221111 000 00000000 0 1111112468899999999999999999999875
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=317.21 Aligned_cols=261 Identities=21% Similarity=0.273 Sum_probs=196.6
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
++|++.+.||+|+||.||+|+++ .+++.||||++.... ....+.+.+|++++++++||||++++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~------------~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 68 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHK------------ETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68 (287)
T ss_pred CCceEEEEecccCCEEEEEEEEC------------CCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhh
Confidence 46888999999999999999765 578899999987542 3345678999999999999999999999
Q ss_pred eecCCceEEEEEeeccCCc----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 592 CIEQGEKISIYEFDIVTDP----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
+...+..++||||...... .....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 69 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg 145 (287)
T cd07848 69 FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFG 145 (287)
T ss_pred EecCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeecc
Confidence 9999999999999432211 12345888999999999999999999988 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccH-hHH--------H
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTL-LGH--------A 738 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~-~~~--------~ 738 (840)
++........ .......|++.|+|||++.+..++.++|||||||+++||++|+.||......+... ... .
T Consensus 146 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 224 (287)
T cd07848 146 FARNLSEGSN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQ 224 (287)
T ss_pred Cccccccccc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHH
Confidence 9987643221 12234568999999999999899999999999999999999999986533211100 000 0
Q ss_pred hhh-hcccccccccCccccc------hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 739 WNL-WKDDKAWKLMDPTMQN------EALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 739 ~~~-~~~~~~~~~~d~~l~~------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
+.. ...........+.... .........+.+++.+||+.||++|||++|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 225 MKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred HHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000 0000000000011000 111123456899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=292.41 Aligned_cols=261 Identities=21% Similarity=0.254 Sum_probs=204.9
Q ss_pred HHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCcccee
Q 041702 510 SAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 510 ~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
....++|++.++||+|||+-||.+. .+.+++.+|+|++.....++.+..++|++.-++++|||+++++
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~------------~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~ 84 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVK------------GLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLV 84 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeec------------ccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHH
Confidence 3456899999999999999999984 3578999999999888777889999999999999999999999
Q ss_pred eEeecCC-----ceEEEEEeeccCC--------ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEec
Q 041702 590 GCCIEQG-----EKISIYEFDIVTD--------PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLD 656 (840)
Q Consensus 590 g~~~~~~-----~~~lv~e~~~~~~--------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~ 656 (840)
+++..+. +.|+++.|..... ..+...+++.+.++|+.+|.+||++||+.. ++++||||||.|||+.
T Consensus 85 dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls 163 (302)
T KOG2345|consen 85 DHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLS 163 (302)
T ss_pred HHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEec
Confidence 9986544 4899998843321 234557999999999999999999999986 5799999999999999
Q ss_pred CCCCceeeccccceecCCC---Cc----ccccccccccccccCccccc---cCCCCccccchhHHHHHHHHHhCCCCCCC
Q 041702 657 SDMNPKISDFGIARTFGGD---EM----QSNTNRIVGTYGYMSPEYAL---HGLFSIKSDVFSFGVLLLEILSSKKNTRF 726 (840)
Q Consensus 657 ~~~~~kL~DFGla~~~~~~---~~----~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~SlGviL~elltG~~p~~~ 726 (840)
+.+.++|.|||.+....-. .. ...-.....|..|+|||.+. +..+++++|||||||+||+|+.|..||+.
T Consensus 164 ~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~ 243 (302)
T KOG2345|consen 164 DSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER 243 (302)
T ss_pred CCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH
Confidence 9999999999998754211 00 01112234688999999874 56789999999999999999999999864
Q ss_pred CCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 727 YNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
.......+. ..+....+.-+.....++.+.+++.+|++.||.+||++.+++..+++.
T Consensus 244 ~~~~GgSla------------LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 244 IYQQGGSLA------------LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred HhhcCCeEE------------EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 332221110 111122222222223677899999999999999999999999999875
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=314.76 Aligned_cols=246 Identities=24% Similarity=0.284 Sum_probs=192.8
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
.|+..+.||+|+||.||+|.++ .+++.||||++.... ......+.+|+.++.+++|+||++++++
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~------------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~ 68 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVR------------ATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYA 68 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEe------------cCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEE
Confidence 3677889999999999999754 678999999987532 2334568899999999999999999999
Q ss_pred eecCCceEEEEEeeccCCc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 592 CIEQGEKISIYEFDIVTDP------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
+.+.+..++++||...... .....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|
T Consensus 69 ~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~D 145 (285)
T cd05631 69 YETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISD 145 (285)
T ss_pred EccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEee
Confidence 9999999999999543322 12235889999999999999999999988 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
||++........ .....||..|+|||++.+..++.++|||||||+++||++|+.||......... .........
T Consensus 146 fg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~--~~~~~~~~~- 219 (285)
T cd05631 146 LGLAVQIPEGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR--EEVDRRVKE- 219 (285)
T ss_pred CCCcEEcCCCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH--HHHHHHhhc-
Confidence 999987543221 23456899999999999999999999999999999999999998654322110 011110000
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPT-----MLEVVA 790 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 790 (840)
. ...........+.+++.+||+.||++||+ ++++++
T Consensus 220 -------~--~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 220 -------D--QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred -------c--cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 0 00111223456788999999999999997 778775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=316.31 Aligned_cols=256 Identities=28% Similarity=0.437 Sum_probs=198.6
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
++|+..+.||+|+||.||+|.+... +.......||+|.+..... ....+|.+|+.++.+++||||+++++++
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~-------~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~ 77 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGP-------NERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVC 77 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecC-------CCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEE
Confidence 4678889999999999999875410 1123457899999875432 3346799999999999999999999999
Q ss_pred ecCCceEEEEEeeccCCc--------------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCc
Q 041702 593 IEQGEKISIYEFDIVTDP--------------------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASN 652 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~~--------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~N 652 (840)
...+..+++|||...... .....+++.+.+.++.|++.||+|||+.+ ++||||||+|
T Consensus 78 ~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~N 154 (283)
T cd05048 78 TKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARN 154 (283)
T ss_pred cCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccce
Confidence 999999999998422111 01145788999999999999999999988 9999999999
Q ss_pred EEecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCC
Q 041702 653 VLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDS 731 (840)
Q Consensus 653 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~ 731 (840)
|++++++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||+++||++ |..|+......+
T Consensus 155 il~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~ 234 (283)
T cd05048 155 CLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE 234 (283)
T ss_pred EEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 9999999999999999987644333233344566889999999998999999999999999999998 988875432211
Q ss_pred ccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 041702 732 LTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794 (840)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~ 794 (840)
. ........ ....+...+..+.+++.+||+.+|.+||++.||++.|++
T Consensus 235 --~----~~~i~~~~---------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 235 --V----IEMIRSRQ---------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred --H----HHHHHcCC---------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1 11111111 111123345678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=331.59 Aligned_cols=268 Identities=26% Similarity=0.340 Sum_probs=201.8
Q ss_pred HHHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhcCCC
Q 041702 507 SSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQHR 583 (840)
Q Consensus 507 ~~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l~H~ 583 (840)
..++..-++....++||+|+||.||+|..+..+ ......||||..+.. ......+|.+|+++|++++||
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~--------~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~ 221 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKN--------GFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHP 221 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecC--------CceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCC
Confidence 334445566667789999999999998765210 001122999998852 345678899999999999999
Q ss_pred CccceeeEeecCCceEEEEEeeccCC----ccccC-CCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCC
Q 041702 584 NLVRLFGCCIEQGEKISIYEFDIVTD----PARKD-LLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSD 658 (840)
Q Consensus 584 niv~l~g~~~~~~~~~lv~e~~~~~~----~~~~~-~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~ 658 (840)
|||+++|++....+.++|||+..-.. ..... .++..+++.++.+.|.||+|||+++ +|||||.++|+|++.+
T Consensus 222 NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~ 298 (474)
T KOG0194|consen 222 NVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKK 298 (474)
T ss_pred CEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCC
Confidence 99999999999999999999943322 22222 5999999999999999999999998 9999999999999999
Q ss_pred CCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHH
Q 041702 659 MNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGH 737 (840)
Q Consensus 659 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~ 737 (840)
+.+||+|||+++.-. ..........-+..|+|||.+....|+.++|||||||++||+++ |..|+......+
T Consensus 299 ~~vKISDFGLs~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~------ 370 (474)
T KOG0194|consen 299 GVVKISDFGLSRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE------ 370 (474)
T ss_pred CeEEeCccccccCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH------
Confidence 999999999987643 11111112234679999999999999999999999999999998 777765433221
Q ss_pred HhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCCCC
Q 041702 738 AWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPS 801 (840)
Q Consensus 738 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~ 801 (840)
+..... ....+...+...+..+..++.+||..+|++||+|.+|.+.|+.+......
T Consensus 371 v~~kI~--------~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 371 VKAKIV--------KNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred HHHHHH--------hcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 111110 00111111123345567788899999999999999999999988665543
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=323.71 Aligned_cols=243 Identities=23% Similarity=0.324 Sum_probs=200.9
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
-|+..+.||.|+-|.|-.|++. .+|+.+|||++.+.. ......+.+|+.+|+-+.|||+++++++
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~------------~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydV 80 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHA------------ETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDV 80 (786)
T ss_pred ceeccccccCCCCceehhhhcc------------cccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeee
Confidence 4566789999999999999665 899999999997652 2334568899999999999999999999
Q ss_pred eecCCceEEEEEee----ccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 592 CIEQGEKISIYEFD----IVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 592 ~~~~~~~~lv~e~~----~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
+.++.+.|+|.||+ +......+..+++.+..+++.||+.|+.|+|..+ |+||||||+|+|||..+++||+|||
T Consensus 81 we~~~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFG 157 (786)
T KOG0588|consen 81 WENKQHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFG 157 (786)
T ss_pred eccCceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccc
Confidence 99999999999994 3444557788999999999999999999999988 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCccccccCCCC-ccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccc
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFS-IKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDK 746 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 746 (840)
+|..-.++.. ....+|++.|.+||++.+.+|+ .++||||-||||+.||||+.||...+. ..++..+ ..+
T Consensus 158 MAsLe~~gkl---LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi--r~LLlKV----~~G- 227 (786)
T KOG0588|consen 158 MASLEVPGKL---LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI--RVLLLKV----QRG- 227 (786)
T ss_pred eeecccCCcc---ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH--HHHHHHH----HcC-
Confidence 9987554433 3456899999999999999985 789999999999999999999863221 1111111 111
Q ss_pred cccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 747 AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 747 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
.-+.+..+...+.+|+.+|+..||+.|.|++||++.
T Consensus 228 ---------~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 228 ---------VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred ---------cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 112234556678899999999999999999999974
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=312.34 Aligned_cols=255 Identities=22% Similarity=0.318 Sum_probs=195.9
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
.++|++.+.||+|+||.||+|.++ .....+..||+|+++.... ...+.|.+|+.++.+++||||++++++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~---------~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 74 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLK---------LPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGV 74 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEe---------cCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence 456888899999999999998654 2223567899999986532 334679999999999999999999999
Q ss_pred eecCCceEEEEEeeccCCcc-----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 592 CIEQGEKISIYEFDIVTDPA-----RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
+..++..++||||....... ....+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+||+||
T Consensus 75 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~df 151 (266)
T cd05064 75 ITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGF 151 (266)
T ss_pred EecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCC
Confidence 99999999999995332211 1346899999999999999999999988 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
|.+........ .......++..|+|||.+.+..++.++|||||||+++|+++ |+.|+...... ..... ....
T Consensus 152 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~~~~----~~~~ 224 (266)
T cd05064 152 RRLQEDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DVIKA----VEDG 224 (266)
T ss_pred cccccccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHH----HHCC
Confidence 98765422211 11112335678999999999999999999999999999875 99887543211 11111 1111
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
... ..+...+..+.+++.+||+.+|++||++++|++.|++.
T Consensus 225 --~~~-------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 225 --FRL-------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --CCC-------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 000 11122345678899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=314.35 Aligned_cols=268 Identities=28% Similarity=0.362 Sum_probs=195.9
Q ss_pred cccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcCCCCccceeeEeecC
Q 041702 517 SEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQ 595 (840)
Q Consensus 517 ~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~ 595 (840)
+..+.||+|+||.||++... .....+++.||+|.++.... ...+.|.+|++++++++||||+++++++...
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~--------~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYD--------PANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ 78 (283)
T ss_pred eeceecccCCCcEEEEeeEc--------cccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 77889999999999886432 02235688999999975432 3457799999999999999999999998764
Q ss_pred --CceEEEEEeeccCCc---cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccce
Q 041702 596 --GEKISIYEFDIVTDP---ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIAR 670 (840)
Q Consensus 596 --~~~~lv~e~~~~~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~ 670 (840)
...+++|||...... .....+++.++..++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccc
Confidence 357899998433221 12346899999999999999999999988 9999999999999999999999999998
Q ss_pred ecCCCCcccc-cccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccccccc
Q 041702 671 TFGGDEMQSN-TNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWK 749 (840)
Q Consensus 671 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (840)
.......... .....++..|+|||.+.+..++.++||||||++++||++|+.|+.........................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIE 235 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhh
Confidence 7654322111 122335667999999998899999999999999999999998875432211111111000000011111
Q ss_pred ccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 750 LMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 750 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
.++...........+..+.+++.+||+.+|++|||+++|++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 1111111112223446788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=321.24 Aligned_cols=197 Identities=25% Similarity=0.344 Sum_probs=167.9
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
.++|+..+.||+|+||.||+|.+. .++..||+|.+.... ....+++.+|++++.+++||||++++++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 71 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHK------------PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEEC------------CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEE
Confidence 468999999999999999999765 678899999987542 2334679999999999999999999999
Q ss_pred eecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 592 CIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
+...+..++||||..... ......+++..+..++.|++.||.|||+.+ .|+||||||+|||++.++.+||+|||
T Consensus 72 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg 149 (331)
T cd06649 72 FYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFG 149 (331)
T ss_pred EEECCEEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCc
Confidence 999999999999953322 123356889999999999999999999853 39999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFY 727 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~ 727 (840)
++...... ......|++.|+|||.+.+..++.++|||||||+++||++|+.|+...
T Consensus 150 ~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 150 VSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred cccccccc----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 99765332 223456899999999999999999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=323.29 Aligned_cols=262 Identities=29% Similarity=0.396 Sum_probs=197.5
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhc-CCCCcccee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKL-QHRNLVRLF 589 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l-~H~niv~l~ 589 (840)
..++|++.++||+|+||.||+|.+.. .+...+++.||+|+++.... ...+.+..|+.++.++ +|+||++++
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~-------~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~ 77 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFG-------IEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLL 77 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccc-------cccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhhee
Confidence 34679999999999999999986431 02234578999999975432 2345688899999999 899999999
Q ss_pred eEeecC-CceEEEEEeeccCCcc---------------------------------------------------------
Q 041702 590 GCCIEQ-GEKISIYEFDIVTDPA--------------------------------------------------------- 611 (840)
Q Consensus 590 g~~~~~-~~~~lv~e~~~~~~~~--------------------------------------------------------- 611 (840)
++|... ...++++||.......
T Consensus 78 ~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (337)
T cd05054 78 GACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVE 157 (337)
T ss_pred eeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcc
Confidence 988654 5677889884211100
Q ss_pred --------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceecCCCCccccccc
Q 041702 612 --------RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNR 683 (840)
Q Consensus 612 --------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 683 (840)
....++|..+.+++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...........
T Consensus 158 ~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~ 234 (337)
T cd05054 158 EDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 234 (337)
T ss_pred cchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccC
Confidence 0236889999999999999999999988 99999999999999999999999999987644332222334
Q ss_pred ccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhcccccccccCccccchhhHH
Q 041702 684 IVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYS 762 (840)
Q Consensus 684 ~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 762 (840)
..++..|+|||++.+..++.++|||||||+|+||++ |..|+......+ .+. ........ ...+..
T Consensus 235 ~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~----~~~~~~~~---------~~~~~~ 300 (337)
T cd05054 235 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFC----RRLKEGTR---------MRAPEY 300 (337)
T ss_pred CCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHH----HHHhccCC---------CCCCcc
Confidence 456778999999999999999999999999999998 988876432221 111 11111100 001112
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 763 MVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 763 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
....+.+++.+||+.+|++||++.||++.|+.++.
T Consensus 301 ~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 301 ATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 23468899999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=294.66 Aligned_cols=234 Identities=24% Similarity=0.332 Sum_probs=193.9
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhcCCCCcccee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
.++|+..+.||.|+||.|.+++++ .+|..+|+|++.+.. ....+...+|..+|+.+.||.+++++
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k------------~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~ 110 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREK------------HSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLY 110 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEc------------cCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEE
Confidence 367888899999999999999876 679999999998653 23456678999999999999999999
Q ss_pred eEeecCCceEEEEEee----ccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 590 GCCIEQGEKISIYEFD----IVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~----~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
+.|.+.+..++||||. +.....+...+++....-++.||+.||+|||+.+ |++|||||+|||||.+|.+||+|
T Consensus 111 ~t~~d~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitD 187 (355)
T KOG0616|consen 111 GTFKDNSNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITD 187 (355)
T ss_pred EeeccCCeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEe
Confidence 9999999999999994 3334455678999999999999999999999998 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
||.|+.+.+ .+...+|||.|+|||.+...++..++|.|||||++|||+.|.+||....+. . .+..+.+.
T Consensus 188 FGFAK~v~~-----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~--~----iY~KI~~~ 256 (355)
T KOG0616|consen 188 FGFAKRVSG-----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI--Q----IYEKILEG 256 (355)
T ss_pred ccceEEecC-----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH--H----HHHHHHhC
Confidence 999998753 255689999999999999999999999999999999999999998654431 1 11111111
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCC
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDR 782 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R 782 (840)
.+ ..+.-....+.+|+...|+.|-.+|
T Consensus 257 --------~v--~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 257 --------KV--KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred --------cc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 11 1222334456788888899998888
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=307.44 Aligned_cols=267 Identities=26% Similarity=0.361 Sum_probs=197.9
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhh--cCCCCccceeeE
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAK--LQHRNLVRLFGC 591 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~--l~H~niv~l~g~ 591 (840)
+..+..+.||+|.||.||||. .+++.||||++.. +..+.|++|-+|.+. ++|+||++++++
T Consensus 210 ~pl~l~eli~~Grfg~V~Kaq--------------L~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ 272 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQ--------------LDNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGA 272 (534)
T ss_pred CchhhHHHhhcCccceeehhh--------------ccCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhch
Confidence 344556789999999999975 3569999999974 345778888888775 489999999998
Q ss_pred eecCC----ceEEEEEeeccCC---ccccCCCCHHHHHHHHHHHHHHHHHHHhc------CCCceecCCCCCCcEEecCC
Q 041702 592 CIEQG----EKISIYEFDIVTD---PARKDLLDWTTRVRIIEGVAQGLLYLHQY------SRLRVIHRDLKASNVLLDSD 658 (840)
Q Consensus 592 ~~~~~----~~~lv~e~~~~~~---~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------~~~~ivHrDlkp~NILl~~~ 658 (840)
-.... +..+|++|..... ......++|....+|+..+++||+|||+. .+++|+|||||++||||.+|
T Consensus 273 ekr~t~~~~eywLVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~D 352 (534)
T KOG3653|consen 273 EKRGTADRMEYWLVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKND 352 (534)
T ss_pred hccCCccccceeEEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccC
Confidence 76665 7889999854333 34567899999999999999999999973 34679999999999999999
Q ss_pred CCceeeccccceecCCCCcccccccccccccccCccccccCC-CC-----ccccchhHHHHHHHHHhCCCCCCCCCCCC-
Q 041702 659 MNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGL-FS-----IKSDVFSFGVLLLEILSSKKNTRFYNTDS- 731 (840)
Q Consensus 659 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~ksDV~SlGviL~elltG~~p~~~~~~~~- 731 (840)
+++.|+|||+|..+..+.........+||.+|||||++.+.. +. .+.||||+|.|||||++...........+
T Consensus 353 lTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Y 432 (534)
T KOG3653|consen 353 LTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEY 432 (534)
T ss_pred CcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcc
Confidence 999999999999998776666666789999999999997653 22 35899999999999999765443211111
Q ss_pred -ccHhHHHhhhhcccccc-----cccCccccch-hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 732 -LTLLGHAWNLWKDDKAW-----KLMDPTMQNE-ALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 732 -~~~~~~~~~~~~~~~~~-----~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
..+.........-++++ +...|.+... .....+..+.+.+..||..||+.|.|+.=|-+++.++..
T Consensus 433 qlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 433 QLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred cCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 10000000000001111 1112222221 112456678999999999999999999999999888733
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=314.51 Aligned_cols=258 Identities=23% Similarity=0.347 Sum_probs=188.2
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhc---CCCCccce
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKL---QHRNLVRL 588 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l---~H~niv~l 588 (840)
++|+..+.||+|+||.||+|.+. ..+++.||||+++... ......+.+|+.+++++ +||||+++
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~-----------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~ 69 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDL-----------KNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRL 69 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEc-----------CCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceE
Confidence 46888999999999999999753 1357889999987542 22335677788877766 69999999
Q ss_pred eeEee-----cCCceEEEEEeeccC-----CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCC
Q 041702 589 FGCCI-----EQGEKISIYEFDIVT-----DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSD 658 (840)
Q Consensus 589 ~g~~~-----~~~~~~lv~e~~~~~-----~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~ 658 (840)
+++|. .....++++|+.... .......+++..+..++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 70 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~ 146 (290)
T cd07862 70 FDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSS 146 (290)
T ss_pred EEEEecccCCCCCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCC
Confidence 99985 245678999984211 0112235789999999999999999999988 9999999999999999
Q ss_pred CCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHH
Q 041702 659 MNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHA 738 (840)
Q Consensus 659 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~ 738 (840)
+.+||+|||+++..... .......||+.|+|||.+.+..++.++|||||||+++||++|++||......+ .....
T Consensus 147 ~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~--~~~~i 221 (290)
T cd07862 147 GQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGKI 221 (290)
T ss_pred CCEEEccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH--HHHHH
Confidence 99999999999876433 22334568999999999999999999999999999999999999986543221 11111
Q ss_pred hhhhc---cccc-------ccccCccc---cchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 739 WNLWK---DDKA-------WKLMDPTM---QNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 739 ~~~~~---~~~~-------~~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
..... ..+. .....+.. ...........+.+++.+||+.||++|||+.|+++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 222 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred HHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 11000 0000 00000000 00111123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=326.75 Aligned_cols=263 Identities=26% Similarity=0.366 Sum_probs=200.6
Q ss_pred HHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcC-CCCccc
Q 041702 510 SAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQ-HRNLVR 587 (840)
Q Consensus 510 ~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~-H~niv~ 587 (840)
....++|.+.++||+|+||.||+|.+... +....+..||||++..... ...+.|.+|++++.++. ||||++
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~-------~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~ 105 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGL-------SRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVN 105 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEccc-------CCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeee
Confidence 34467899999999999999999875410 1223456799999975433 33467999999999995 999999
Q ss_pred eeeEeecCCceEEEEEeeccCCc---------------------------------------------------------
Q 041702 588 LFGCCIEQGEKISIYEFDIVTDP--------------------------------------------------------- 610 (840)
Q Consensus 588 l~g~~~~~~~~~lv~e~~~~~~~--------------------------------------------------------- 610 (840)
++++|.+.+..++||||......
T Consensus 106 l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (400)
T cd05105 106 LLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADT 185 (400)
T ss_pred EEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccc
Confidence 99999999999999999421110
Q ss_pred -------------------------------------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCC
Q 041702 611 -------------------------------------------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRD 647 (840)
Q Consensus 611 -------------------------------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrD 647 (840)
.....+++..+.+++.||++||+|||+.+ |+|||
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~d 262 (400)
T cd05105 186 TQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRD 262 (400)
T ss_pred cccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCC
Confidence 00134788889999999999999999988 99999
Q ss_pred CCCCcEEecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCC
Q 041702 648 LKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRF 726 (840)
Q Consensus 648 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~ 726 (840)
|||+|||++.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||+++||++ |..|+..
T Consensus 263 ikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~ 342 (400)
T cd05105 263 LAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPG 342 (400)
T ss_pred CChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcc
Confidence 999999999999999999999987644332222334456789999999999999999999999999999997 8888754
Q ss_pred CCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 041702 727 YNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEI 796 (840)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~ 796 (840)
...+.. . ........ ...........+.+++.+||+.+|++||++.+|+++|+...
T Consensus 343 ~~~~~~-~----~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 343 MIVDST-F----YNKIKSGY---------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred cchhHH-H----HHHHhcCC---------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 322111 0 01111110 00111233456889999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=322.13 Aligned_cols=259 Identities=23% Similarity=0.303 Sum_probs=189.6
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
+|++.++||+|+||.||+|+++ .+++.||||++.... .....++.+|++++++++||||+++++++
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 68 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDT------------HTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIM 68 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEEC------------CCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceE
Confidence 4788899999999999999765 578999999987432 23345789999999999999999999988
Q ss_pred ecCC-----ceEEEEEeeccC---CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 593 IEQG-----EKISIYEFDIVT---DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 593 ~~~~-----~~~lv~e~~~~~---~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
...+ ..+++|||.... .......+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 69 ~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~ 145 (338)
T cd07859 69 LPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKIC 145 (338)
T ss_pred eccCCCCCceEEEEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEc
Confidence 6432 478999995321 1123346889999999999999999999998 9999999999999999999999
Q ss_pred ccccceecCCCCcc-cccccccccccccCcccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHh--
Q 041702 665 DFGIARTFGGDEMQ-SNTNRIVGTYGYMSPEYALH--GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAW-- 739 (840)
Q Consensus 665 DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~-- 739 (840)
|||+++........ .......||+.|+|||++.+ ..++.++|||||||+++||++|+.||....... ......
T Consensus 146 Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~--~~~~~~~~ 223 (338)
T cd07859 146 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH--QLDLITDL 223 (338)
T ss_pred cCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH--HHHHHHHH
Confidence 99999865322211 12234578999999999876 678999999999999999999999986433211 000000
Q ss_pred ---------hhhcccccccc---cCccccc---hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 740 ---------NLWKDDKAWKL---MDPTMQN---EALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 740 ---------~~~~~~~~~~~---~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
........... +.+.... .........+.+++.+||+.||++|||++|+++
T Consensus 224 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 224 LGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred hCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00000000000 0000000 001112345789999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=316.03 Aligned_cols=260 Identities=22% Similarity=0.282 Sum_probs=192.1
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
.++|...++||+|+||.||+|.++ .+++.||||++..... .....+.+|+.++++++||||++++++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 71 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSK------------VNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDI 71 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEEC------------CCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEE
Confidence 478999999999999999999765 5788999999975432 334567899999999999999999999
Q ss_pred eecCCceEEEEEeeccCC---c-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 592 CIEQGEKISIYEFDIVTD---P-ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~---~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
+...+..++||||..... . .....++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 72 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg 148 (303)
T cd07869 72 IHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFG 148 (303)
T ss_pred EecCCeEEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCC
Confidence 999999999999953211 1 12245788899999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccc
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDK 746 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 746 (840)
+++...... .......+|+.|+|||.+.+ ..++.++|||||||+++||++|+.||.........+ ...........
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~ 225 (303)
T cd07869 149 LARAKSVPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQL-ERIFLVLGTPN 225 (303)
T ss_pred cceeccCCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHH-HHHHHHhCCCC
Confidence 997643221 11233567899999998865 458899999999999999999999986532211111 11100000000
Q ss_pred --c----c--cccCcc-c---cchhhH------HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 747 --A----W--KLMDPT-M---QNEALY------SMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 747 --~----~--~~~d~~-l---~~~~~~------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
. . ...++. . ...... .....+.+++.+||+.||++|||++|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 226 EDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0 0 000000 0 000000 11245778999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=320.03 Aligned_cols=256 Identities=25% Similarity=0.370 Sum_probs=192.7
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
.+|+..+.||+|+||.||+|.+.. ........||||+++... ....++|.+|+.+++.++||||++++|+|
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~--------~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~ 78 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIP--------EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGIC 78 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEec--------CCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 568899999999999999997541 111223459999997543 34457899999999999999999999999
Q ss_pred ecCCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 593 IEQGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
... ..++++||...... .....+++...+.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 79 ~~~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG 154 (316)
T cd05108 79 LTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFG 154 (316)
T ss_pred cCC-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccc
Confidence 865 56788887433221 11345788999999999999999999988 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhcccc
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKDDK 746 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 746 (840)
+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |+.|+....... . .......
T Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~--~----~~~~~~~- 227 (316)
T cd05108 155 LAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--I----SSILEKG- 227 (316)
T ss_pred ccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--H----HHHHhCC-
Confidence 9987654332222222334678999999999999999999999999999998 888875321111 0 1111111
Q ss_pred cccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 041702 747 AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEI 796 (840)
Q Consensus 747 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~ 796 (840)
.....+ ......+.+++.+||+.+|++||++.++++.|....
T Consensus 228 -~~~~~~-------~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 228 -ERLPQP-------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred -CCCCCC-------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 001111 112345788999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=323.09 Aligned_cols=250 Identities=20% Similarity=0.305 Sum_probs=196.2
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
++|++.++||+|+||.||+|+++ .+++.||||+++... ....+.+.+|++++.+++||||+++++
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~ 68 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKK------------DTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEEC------------CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEE
Confidence 46888999999999999999765 578899999997542 234567899999999999999999999
Q ss_pred EeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 591 CCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
++.+.+..++||||..... ......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 69 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Df 145 (333)
T cd05600 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDF 145 (333)
T ss_pred EEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeC
Confidence 9999999999999943322 223456889999999999999999999998 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccc
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDK 746 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 746 (840)
|++..... ......||+.|+|||++.+..++.++|||||||+++||++|+.|+......+. .... ..+.
T Consensus 146 g~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~i-~~~~--- 214 (333)
T cd05600 146 GLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET--WENL-KYWK--- 214 (333)
T ss_pred cCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH--HHHH-Hhcc---
Confidence 99976533 23345789999999999999999999999999999999999999864332111 1100 0000
Q ss_pred cccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 747 AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 747 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
..+...............+.+++.+||+.+|++||+++++++.
T Consensus 215 --~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 215 --ETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred --ccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0011111111012334567889999999999999999999964
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=322.46 Aligned_cols=242 Identities=24% Similarity=0.321 Sum_probs=201.8
Q ss_pred HHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhc-CCCC
Q 041702 509 ISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKL-QHRN 584 (840)
Q Consensus 509 ~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l-~H~n 584 (840)
.....++|..+++||+|.||.|++|..+ .+++.+|||.+++. ....++..+.|.+|+... +||.
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k------------~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPF 430 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELK------------GTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPF 430 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEc------------CCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCe
Confidence 3445689999999999999999999765 67889999999876 356778899999999888 5999
Q ss_pred ccceeeEeecCCceEEEEEeecc---CCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCc
Q 041702 585 LVRLFGCCIEQGEKISIYEFDIV---TDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP 661 (840)
Q Consensus 585 iv~l~g~~~~~~~~~lv~e~~~~---~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 661 (840)
|+.++.+|...++.++||||..- ........+++..+.-++..|+.||.|||+++ |||||||.+|||||.+|.+
T Consensus 431 L~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~ 507 (694)
T KOG0694|consen 431 LVNLFSCFQTKEHLFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHV 507 (694)
T ss_pred EeecccccccCCeEEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcE
Confidence 99999999999999999999433 33344567899999999999999999999999 9999999999999999999
Q ss_pred eeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhh
Q 041702 662 KISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNL 741 (840)
Q Consensus 662 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~ 741 (840)
||+||||++.-... ...+...+|||.|||||++.+..|+.++|.|||||+|||||.|..||+..++++.-
T Consensus 508 kiADFGlcKe~m~~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~F-------- 577 (694)
T KOG0694|consen 508 KIADFGLCKEGMGQ--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVF-------- 577 (694)
T ss_pred EecccccccccCCC--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH--------
Confidence 99999999864322 22456789999999999999999999999999999999999999999865543311
Q ss_pred hcccccccccCccccc--hhhHHHHHHHHHHHHHccccCCCCCCCH
Q 041702 742 WKDDKAWKLMDPTMQN--EALYSMVTRYIKVALLCVQENATDRPTM 785 (840)
Q Consensus 742 ~~~~~~~~~~d~~l~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 785 (840)
|..+.. .++.-+....+.|+.++|..+|++|.-+
T Consensus 578 ----------dsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 578 ----------DSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ----------HHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 111111 1223345567889999999999999976
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=314.88 Aligned_cols=258 Identities=21% Similarity=0.273 Sum_probs=192.5
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
++|...++||+|+||.||+|.++ .+++.||+|+++... ......+.+|+.++++++||||+++++++
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 72 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSK------------LTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEEC------------CCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEE
Confidence 56888999999999999999765 578899999987543 23345788999999999999999999999
Q ss_pred ecCCceEEEEEeeccCC---c-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccc
Q 041702 593 IEQGEKISIYEFDIVTD---P-ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGI 668 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~---~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl 668 (840)
...+..++||||..... . .....+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 73 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~ 149 (288)
T cd07871 73 HTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGL 149 (288)
T ss_pred cCCCeEEEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcc
Confidence 99999999999843210 1 12335788899999999999999999988 99999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhh-----
Q 041702 669 ARTFGGDEMQSNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLW----- 742 (840)
Q Consensus 669 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~----- 742 (840)
++...... .......+++.|+|||.+.+ ..++.++|||||||+++||++|+.||......+. ........
T Consensus 150 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~ 225 (288)
T cd07871 150 ARAKSVPT--KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE--LHLIFRLLGTPTE 225 (288)
T ss_pred eeeccCCC--ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCh
Confidence 97653221 11233567899999998875 5689999999999999999999999865432211 11110000
Q ss_pred ---c----ccccccccCccccch----hhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 743 ---K----DDKAWKLMDPTMQNE----ALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 743 ---~----~~~~~~~~d~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
. .........+..... ........+.+++.+||+.||.+|||++|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 226 ETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred HHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0 000011111111100 00112345789999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=311.74 Aligned_cols=257 Identities=25% Similarity=0.412 Sum_probs=198.7
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCc-CHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQ-GLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~-~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
.++|.+.+.||+|+||.||+|.+... ....++..||||.++..... ..+.|.+|++++.+++|+||++++++
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~-------~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 76 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHL-------EPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGV 76 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccc-------cCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeE
Confidence 35688889999999999999875410 11245678999999765443 45789999999999999999999999
Q ss_pred eecCCceEEEEEeeccCC------------------ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcE
Q 041702 592 CIEQGEKISIYEFDIVTD------------------PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNV 653 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~------------------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NI 653 (840)
+...+..+++|||..... ......+++.++..++.|++.||.|||+.+ ++||||||+||
T Consensus 77 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~ni 153 (280)
T cd05049 77 CTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNC 153 (280)
T ss_pred EecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceE
Confidence 999999999999842211 122345788999999999999999999988 99999999999
Q ss_pred EecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCc
Q 041702 654 LLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSL 732 (840)
Q Consensus 654 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~ 732 (840)
+++.++.+||+|||+++...............+++.|+|||++.+..++.++||||||++++||++ |+.|+......
T Consensus 154 li~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~-- 231 (280)
T cd05049 154 LVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-- 231 (280)
T ss_pred EEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--
Confidence 999999999999999986543332222233456789999999999999999999999999999998 99887533221
Q ss_pred cHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 041702 733 TLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794 (840)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~ 794 (840)
...... ..... ..........+.+++.+||+.||++||++.||++.|++
T Consensus 232 ~~~~~~----~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 232 EVIECI----TQGRL---------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHHHH----HcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 111111 11110 01111234568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=313.57 Aligned_cols=258 Identities=26% Similarity=0.410 Sum_probs=196.2
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
.+++|+..++||+|+||.||+|.++.. .....+..||||++.... .....+|.+|+.++++++||||+++++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~-------~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~ 76 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGV-------VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 76 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccC-------CCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEE
Confidence 567899999999999999999876510 112346789999986432 233457899999999999999999999
Q ss_pred EeecCCceEEEEEeeccCCcc--------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEec
Q 041702 591 CCIEQGEKISIYEFDIVTDPA--------------RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLD 656 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~~~--------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~ 656 (840)
++.+++..++++||....... ....+++..++.++.|++.||+|||+.+ ++||||||+||+++
T Consensus 77 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~ 153 (277)
T cd05062 77 VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVA 153 (277)
T ss_pred EEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEc
Confidence 999999999999984322110 1234678889999999999999999987 99999999999999
Q ss_pred CCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHh
Q 041702 657 SDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLL 735 (840)
Q Consensus 657 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~ 735 (840)
+++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||+++||++ |..|+...... ...
T Consensus 154 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--~~~ 231 (277)
T cd05062 154 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--QVL 231 (277)
T ss_pred CCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHH
Confidence 999999999999986644332222223345778999999999999999999999999999999 67776533211 111
Q ss_pred HHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 041702 736 GHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794 (840)
Q Consensus 736 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~ 794 (840)
.......... .....+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 232 ----~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 232 ----RFVMEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred ----HHHHcCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1111111100 011223468899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=314.65 Aligned_cols=259 Identities=25% Similarity=0.378 Sum_probs=201.2
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCI 593 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~ 593 (840)
.+|...+.||+|+||.||+|.+.. .....++..+++|.+........+.|.+|++++++++|+||+++++++.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~-------~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYN-------LSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG 77 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeec-------cCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc
Confidence 457778899999999999986431 0123456789999987665555578999999999999999999999999
Q ss_pred cCCceEEEEEeeccCCc--------------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcE
Q 041702 594 EQGEKISIYEFDIVTDP--------------------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNV 653 (840)
Q Consensus 594 ~~~~~~lv~e~~~~~~~--------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NI 653 (840)
..+..++||||...... .....+++..+++++.||+.||+|||+++ |+||||||+||
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 154 (291)
T cd05094 78 DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNC 154 (291)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceE
Confidence 99999999998422111 12235889999999999999999999998 99999999999
Q ss_pred EecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCc
Q 041702 654 LLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSL 732 (840)
Q Consensus 654 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~ 732 (840)
|++.++.+||+|||++................++..|+|||.+.+..++.++||||||++++||++ |+.|+.......
T Consensus 155 l~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~- 233 (291)
T cd05094 155 LVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE- 233 (291)
T ss_pred EEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-
Confidence 999999999999999976544332222334556789999999999999999999999999999999 888875332211
Q ss_pred cHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 733 TLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
. ........... .....+..+.+++.+||+.+|++||++.+|+++|+++..
T Consensus 234 -~----~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 234 -V----IECITQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred -H----HHHHhCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 1 11111111111 111234568899999999999999999999999999844
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=308.74 Aligned_cols=256 Identities=25% Similarity=0.383 Sum_probs=197.5
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
.++|+..+.||+|+||.||+|.++ ....+...||||+++... .....+|.+|+.++.+++||||++++++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~---------~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 73 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLK---------LPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGV 73 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEc---------cCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEE
Confidence 357888999999999999999765 112245689999987543 2345679999999999999999999999
Q ss_pred eecCCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 592 CIEQGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
+.+.+..+++|||...... .....+++..+++++.|++.||+|||+.+ |+||||||+|||+++++.+||+||
T Consensus 74 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~df 150 (266)
T cd05033 74 VTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDF 150 (266)
T ss_pred EecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECcc
Confidence 9999999999998533221 11236889999999999999999999988 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
|+++.+.............++..|+|||.+.+..++.++||||||++++||++ |..|+..... .... ......
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~--~~~~----~~~~~~ 224 (266)
T cd05033 151 GLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN--QDVI----KAVEDG 224 (266)
T ss_pred chhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH--HHHH----HHHHcC
Confidence 99988752222222222345678999999999999999999999999999998 8888643211 1111 111110
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
. .. ......+..+.+++.+||+.+|++||++.||++.|+++
T Consensus 225 ~--~~-------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 225 Y--RL-------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred C--CC-------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 00 01112345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=317.70 Aligned_cols=242 Identities=21% Similarity=0.230 Sum_probs=191.9
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
++|+..++||+|+||.||+|.++ .+++.||+|++.... ....+.+.+|+.++++++||||+++++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~------------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 68 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDR------------ISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEc------------CCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHh
Confidence 46888899999999999999765 578999999986432 234567899999999999999999999
Q ss_pred EeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 591 CCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
++.+.+..+++|||..... ......+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 69 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Df 145 (291)
T cd05612 69 TEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDF 145 (291)
T ss_pred hhccCCeEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEec
Confidence 9999999999999853322 223456889999999999999999999988 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccc
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDK 746 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 746 (840)
|+++..... .....||+.|+|||.+.+..++.++|||||||+++||++|+.|+...... ... .......
T Consensus 146 g~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~--~~~----~~i~~~~ 214 (291)
T cd05612 146 GFAKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF--GIY----EKILAGK 214 (291)
T ss_pred CcchhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHH----HHHHhCC
Confidence 999865322 22356899999999999999999999999999999999999998643211 111 1111110
Q ss_pred cccccCccccchhhHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 041702 747 AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPT-----MLEVVAM 791 (840)
Q Consensus 747 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 791 (840)
.. .+......+.+++.+||+.||.+||+ ++++++.
T Consensus 215 ------~~----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 215 ------LE----FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ------cC----CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 00 11112345788999999999999995 7777643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=309.42 Aligned_cols=252 Identities=27% Similarity=0.410 Sum_probs=191.4
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCc----eEEEEEeccCCC-cCHHHHHHHHHHHhhcCCCCccce
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGE----EVAVKRLSSKSG-QGLEEFKNEMMLIAKLQHRNLVRL 588 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~----~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l 588 (840)
++|+..+.||+|+||.||+|.+. .+++ .+++|.+..... ....++..|+.++++++||||+++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~------------~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~ 74 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWI------------PEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74 (279)
T ss_pred hhceeccccCccCCcceEEEEEc------------CCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceE
Confidence 46777889999999999998653 3343 588888764322 334678889999999999999999
Q ss_pred eeEeecCCceEEEEEeeccCCcc-----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCcee
Q 041702 589 FGCCIEQGEKISIYEFDIVTDPA-----RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKI 663 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~~~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL 663 (840)
++++.. ...++++||....... ....+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.+||
T Consensus 75 ~~~~~~-~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl 150 (279)
T cd05111 75 LGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQI 150 (279)
T ss_pred EEEECC-CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEE
Confidence 999864 4567888884332221 2346889999999999999999999988 999999999999999999999
Q ss_pred eccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhh
Q 041702 664 SDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLW 742 (840)
Q Consensus 664 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 742 (840)
+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... .....
T Consensus 151 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~------~~~~~ 224 (279)
T cd05111 151 ADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE------VPDLL 224 (279)
T ss_pred cCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHH
Confidence 99999987654333223334557779999999998999999999999999999998 988875432111 11111
Q ss_pred cccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 041702 743 KDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEI 796 (840)
Q Consensus 743 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~ 796 (840)
.... ....+.. ....+.+++.+||..+|++|||+.|+++.|+.+.
T Consensus 225 ~~~~--~~~~~~~-------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 225 EKGE--RLAQPQI-------CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred HCCC--cCCCCCC-------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1111 1111111 1234677889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=321.69 Aligned_cols=238 Identities=21% Similarity=0.265 Sum_probs=187.8
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhcCCCCccceeeEeecCC
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQG 596 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~ 596 (840)
+.||+|+||.||+|.++ .+++.||||+++... .....++.+|+.++.+++||||+++++++...+
T Consensus 1 ~~lG~G~~g~Vy~~~~~------------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~ 68 (323)
T cd05571 1 KLLGKGTFGKVILVREK------------ATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHD 68 (323)
T ss_pred CeeeeCCCeEEEEEEEC------------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCC
Confidence 36999999999999765 678999999997532 234467889999999999999999999999999
Q ss_pred ceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceec
Q 041702 597 EKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTF 672 (840)
Q Consensus 597 ~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~ 672 (840)
..++||||..... ......+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 69 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~ 145 (323)
T cd05571 69 RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence 9999999953322 223456889999999999999999999998 999999999999999999999999998753
Q ss_pred CCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccccccC
Q 041702 673 GGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMD 752 (840)
Q Consensus 673 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 752 (840)
.... .......||+.|+|||.+.+..++.++|||||||+++||++|+.||...... ... .......
T Consensus 146 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--~~~----~~~~~~~------ 211 (323)
T cd05571 146 ISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLF----ELILMEE------ 211 (323)
T ss_pred ccCC--CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH--HHH----HHHHcCC------
Confidence 2211 1223457999999999999999999999999999999999999998532211 111 1111110
Q ss_pred ccccchhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041702 753 PTMQNEALYSMVTRYIKVALLCVQENATDRP-----TMLEVVA 790 (840)
Q Consensus 753 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 790 (840)
.. .+......+.+++.+||+.||++|| ++.++++
T Consensus 212 ~~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 212 IR----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CC----CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 01 1122345678899999999999999 7888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=308.27 Aligned_cols=250 Identities=27% Similarity=0.417 Sum_probs=196.5
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCI 593 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~ 593 (840)
.+|...++||+|+||.||+|.++ ..++.||+|++... ....+++.+|++++.+++||||+++++++.
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~------------~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 72 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWK------------KYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEe------------cCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEc
Confidence 45778889999999999999765 56889999998754 344678999999999999999999999999
Q ss_pred cCCceEEEEEeeccCCc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 594 EQGEKISIYEFDIVTDP------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 594 ~~~~~~lv~e~~~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
..+..+++|||...... .....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~ 149 (263)
T cd05052 73 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFG 149 (263)
T ss_pred CCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCc
Confidence 99999999998432211 12345899999999999999999999988 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhcccc
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKDDK 746 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 746 (840)
++......... .......+..|+|||.+.+..++.++||||||++++||++ |..|+...... . .+......
T Consensus 150 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~----~~~~~~~~- 221 (263)
T cd05052 150 LSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--Q----VYELLEKG- 221 (263)
T ss_pred cccccccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--H----HHHHHHCC-
Confidence 99876433221 1122234568999999999999999999999999999998 88887543211 1 11111110
Q ss_pred cccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 747 AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 747 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
.....+...+..+.+++.+||+.+|++||++.+++++|+.+
T Consensus 222 --------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 222 --------YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred --------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11111122345688899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=307.49 Aligned_cols=253 Identities=23% Similarity=0.357 Sum_probs=192.8
Q ss_pred CcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceeeEee
Q 041702 516 FSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFGCCI 593 (840)
Q Consensus 516 f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~ 593 (840)
|.+.+.||+|+||.||+|... .....+..||||+++... ....+++.+|++.+++++||||+++++++.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 71 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLS---------QDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCF 71 (273)
T ss_pred CccccccCcCCCceEEEEEEe---------cCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeec
Confidence 456789999999999998654 112235789999987542 233567999999999999999999999987
Q ss_pred cCCc------eEEEEEeeccCCc----------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecC
Q 041702 594 EQGE------KISIYEFDIVTDP----------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS 657 (840)
Q Consensus 594 ~~~~------~~lv~e~~~~~~~----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~ 657 (840)
..+. .++++||...... .....+++.....++.|++.||+|||+.+ ++||||||+||++++
T Consensus 72 ~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~ 148 (273)
T cd05035 72 EASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLRE 148 (273)
T ss_pred cCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECC
Confidence 6554 7889998432221 12346889999999999999999999988 999999999999999
Q ss_pred CCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhH
Q 041702 658 DMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLG 736 (840)
Q Consensus 658 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~ 736 (840)
++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |..|+..... .....
T Consensus 149 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--~~~~~ 226 (273)
T cd05035 149 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--HEIYD 226 (273)
T ss_pred CCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--HHHHH
Confidence 99999999999987654333222223345678999999988999999999999999999999 7777753221 11111
Q ss_pred HHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 737 HAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 737 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
. ....... ..+......+.+++.+||+.||++||++.||++.|+++
T Consensus 227 ~----~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 227 Y----LRHGNRL---------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred H----HHcCCCC---------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1 1111100 11123345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=321.92 Aligned_cols=241 Identities=22% Similarity=0.276 Sum_probs=192.2
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhcCCCCcccee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
.++|+..+.||+|+||.||+|.++ .+++.||||++.... ....+.+.+|+.++.+++||||++++
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 84 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHK------------GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMM 84 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEEC------------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEE
Confidence 367889999999999999999765 578899999987532 23456789999999999999999999
Q ss_pred eEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 590 GCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
+++.+.+..+++|||..... ......+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~D 161 (329)
T PTZ00263 85 CSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTD 161 (329)
T ss_pred EEEEcCCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEee
Confidence 99999999999999843222 223456788889999999999999999988 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .. ........
T Consensus 162 fg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--~~----~~~~i~~~ 230 (329)
T PTZ00263 162 FGFAKKVPDR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--FR----IYEKILAG 230 (329)
T ss_pred ccCceEcCCC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH--HH----HHHHHhcC
Confidence 9999876432 2235689999999999999999999999999999999999999853221 11 11111111
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCC-----HHHHH
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPT-----MLEVV 789 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl 789 (840)
+. .. +......+.+++.+||+.||++||+ +++++
T Consensus 231 ~~------~~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll 269 (329)
T PTZ00263 231 RL------KF----PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVK 269 (329)
T ss_pred Cc------CC----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 10 00 1112345778999999999999997 57766
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=306.61 Aligned_cols=250 Identities=29% Similarity=0.411 Sum_probs=195.0
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
..++|+..+.||+|++|.||+|.+. +++.||+|.++... ...++|.+|++++++++||||++++++
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~-------------~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~ 69 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWN-------------NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAV 69 (261)
T ss_pred chhheeeEEEecccCCccEEEEEec-------------CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEE
Confidence 3467888999999999999998643 45789999987543 345789999999999999999999999
Q ss_pred eecCCceEEEEEeeccCCc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 592 CIEQGEKISIYEFDIVTDP------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
+...+..+++||+...... .....+++..+.+++.|++.||.|||+.+ ++||||||+||+++.++.+||+|
T Consensus 70 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d 146 (261)
T cd05068 70 CTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVAD 146 (261)
T ss_pred EecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECC
Confidence 9999999999999422211 11246889999999999999999999988 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
||+++........ .......+..|+|||++.+..++.++||||||++++||++ |+.|+..... .... .....
T Consensus 147 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~----~~~~~ 219 (261)
T cd05068 147 FGLARVIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN--AEVL----QQVDQ 219 (261)
T ss_pred cceEEEccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH--HHHH----HHHHc
Confidence 9999877532211 1112223458999999999999999999999999999999 8888753221 1111 11111
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~ 794 (840)
. . ...........+.+++.+|++.+|++||++.++++.|++
T Consensus 220 ~--~-------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 220 G--Y-------RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred C--C-------CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0 0 001112234568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=312.20 Aligned_cols=260 Identities=25% Similarity=0.402 Sum_probs=200.5
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
.++|.+.+.||+|+||.||++.... .....++..+|+|.+........+.+.+|++++.+++||||+++++++
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~-------~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 76 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYN-------LCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVC 76 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEecc-------CCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 3578888999999999999986431 011235667999999866555567899999999999999999999999
Q ss_pred ecCCceEEEEEeeccCCc-----------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEe
Q 041702 593 IEQGEKISIYEFDIVTDP-----------------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLL 655 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~~-----------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl 655 (840)
...+..++++||...... .....+++.+++.++.|++.||+|||+.+ ++||||||+|||+
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili 153 (288)
T cd05093 77 VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLV 153 (288)
T ss_pred ecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEE
Confidence 999999999998432211 12235899999999999999999999988 9999999999999
Q ss_pred cCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccH
Q 041702 656 DSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTL 734 (840)
Q Consensus 656 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~ 734 (840)
++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |+.|+....... .
T Consensus 154 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~--~ 231 (288)
T cd05093 154 GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--V 231 (288)
T ss_pred ccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--H
Confidence 9999999999999986644332222333445778999999999999999999999999999998 888875332111 1
Q ss_pred hHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 735 LGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 735 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
. .......... .. ......+.+++.+||+.+|.+|||+.+|++.|+++..
T Consensus 232 ~----~~i~~~~~~~-----~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 232 I----ECITQGRVLQ-----RP----RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred H----HHHHcCCcCC-----CC----CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 1 1111111100 01 1123458899999999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=312.27 Aligned_cols=258 Identities=26% Similarity=0.414 Sum_probs=196.7
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcCCCCccceeeEee
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQHRNLVRLFGCCI 593 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~ 593 (840)
+|++.+.||+|+||.||+|.+... ........+|+|.+..... ...+++.+|+.++++++||||+++++.|.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~-------~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 73 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRL-------KGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS 73 (290)
T ss_pred CccccccccCcCCcceEEEEEecC-------CCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence 467788999999999999975410 1223456799999875432 33567999999999999999999999999
Q ss_pred cCCceEEEEEeeccCCc----------------------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceec
Q 041702 594 EQGEKISIYEFDIVTDP----------------------------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIH 645 (840)
Q Consensus 594 ~~~~~~lv~e~~~~~~~----------------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH 645 (840)
..+..++++||...... .....+++..++.++.|++.||+|||+.+ ++|
T Consensus 74 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH 150 (290)
T cd05045 74 QDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVH 150 (290)
T ss_pred cCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eeh
Confidence 99999999999421111 11235889999999999999999999988 999
Q ss_pred CCCCCCcEEecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCC
Q 041702 646 RDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNT 724 (840)
Q Consensus 646 rDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~ 724 (840)
|||||+|||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |+.|+
T Consensus 151 ~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~ 230 (290)
T cd05045 151 RDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 230 (290)
T ss_pred hhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCC
Confidence 99999999999999999999999986543322222233345678999999988899999999999999999998 88887
Q ss_pred CCCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 725 RFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
....+. ..+...... .....+......+.+++.+||+.+|++||+++++++.|+++..
T Consensus 231 ~~~~~~------~~~~~~~~~---------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 231 PGIAPE------RLFNLLKTG---------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred CCCCHH------HHHHHHhCC---------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 533211 111111111 0111112234568899999999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=310.48 Aligned_cols=255 Identities=27% Similarity=0.398 Sum_probs=195.0
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
++|+..++||+|+||.||+|.+.. ....++..||+|.+.... .....+|.+|++++++++||||+++++++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~--------~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 76 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYL--------PGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVV 76 (283)
T ss_pred hhceeeeeccccCCcceEEEEEec--------CCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEE
Confidence 467788999999999999986431 112457889999997543 23446799999999999999999999999
Q ss_pred ecCCceEEEEEeeccCCc---------------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCC
Q 041702 593 IEQGEKISIYEFDIVTDP---------------------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKAS 651 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~~---------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~ 651 (840)
...+..+++|||...... .....+++.+.+.++.|++.||+|||+.+ ++||||||+
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~ 153 (283)
T cd05090 77 TQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAAR 153 (283)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccc
Confidence 999999999998422111 01235788899999999999999999988 999999999
Q ss_pred cEEecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCC
Q 041702 652 NVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTD 730 (840)
Q Consensus 652 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~ 730 (840)
|||+++++.+||+|||+++...............++..|+|||++.+..++.++||||||++++||++ |..|+.....
T Consensus 154 nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~- 232 (283)
T cd05090 154 NILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN- 232 (283)
T ss_pred eEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-
Confidence 99999999999999999987644332222333445778999999988889999999999999999998 8877643221
Q ss_pred CccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 041702 731 SLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794 (840)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~ 794 (840)
.... ......... .........+.+++.+||+.+|++||++.+|++.|+.
T Consensus 233 -~~~~----~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 233 -QEVI----EMVRKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -HHHH----HHHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111 111111100 0111223467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=302.38 Aligned_cols=255 Identities=22% Similarity=0.282 Sum_probs=188.1
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
+-.|...+++|.|+||.||+|+.+ .+++.||||++-...+ .--+|+.+|+++.|||||+|+-+|
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~------------e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f 86 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLR------------ETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFF 86 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEc------------CCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEE
Confidence 345777889999999999999755 5689999999864422 113699999999999999999998
Q ss_pred ecCCce-----EEEEEeecc-------CCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCC-C
Q 041702 593 IEQGEK-----ISIYEFDIV-------TDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSD-M 659 (840)
Q Consensus 593 ~~~~~~-----~lv~e~~~~-------~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~-~ 659 (840)
....+. .+||||+.. .....+..++...+.-+..||.+||+|||+.+ |+||||||.|+|+|.+ |
T Consensus 87 ~~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg 163 (364)
T KOG0658|consen 87 SSSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTG 163 (364)
T ss_pred EecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCC
Confidence 765433 457888422 11223556777777889999999999999988 9999999999999987 8
Q ss_pred CceeeccccceecCCCCcccccccccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCC-ccHhHH
Q 041702 660 NPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDS-LTLLGH 737 (840)
Q Consensus 660 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~SlGviL~elltG~~p~~~~~~~~-~~~~~~ 737 (840)
.+||||||.|+.+..++.. .....|..|+|||.+.+. .|+.+.||||.|||+.||+-|++.|+..+..+ ......
T Consensus 164 ~LKicDFGSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik 240 (364)
T KOG0658|consen 164 VLKICDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIK 240 (364)
T ss_pred eEEeccCCcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHH
Confidence 9999999999998655432 345678999999999875 59999999999999999999999987744322 111111
Q ss_pred Hhhhhccccc-------ccccCccccch-----hhHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 041702 738 AWNLWKDDKA-------WKLMDPTMQNE-----ALYSMVTRYIKVALLCVQENATDRPTMLEVV 789 (840)
Q Consensus 738 ~~~~~~~~~~-------~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 789 (840)
..-....+++ .+.-.+.+... .........++++.++|+.+|.+|.++.|++
T Consensus 241 ~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l 304 (364)
T KOG0658|consen 241 VLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEAL 304 (364)
T ss_pred HhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHh
Confidence 1000000000 01111111111 2233456688999999999999999999988
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=312.11 Aligned_cols=256 Identities=28% Similarity=0.396 Sum_probs=194.6
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCc-CHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQ-GLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~-~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
.+|+..++||+|+||.||+|.+... .....++.||||+++..... ..+.|.+|+.++.+++||||+++++++
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~-------~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~ 77 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGT-------APGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVV 77 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecC-------CCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence 3467778999999999999875410 11234678999999855332 246689999999999999999999999
Q ss_pred ecCCceEEEEEeeccCC--------------------ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCc
Q 041702 593 IEQGEKISIYEFDIVTD--------------------PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASN 652 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~--------------------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~N 652 (840)
.+.+..++++||..... ......+++..+.+++.|++.||+|||+.+ |+||||||+|
T Consensus 78 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~N 154 (283)
T cd05091 78 TKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRN 154 (283)
T ss_pred cCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhh
Confidence 99999999999832111 112345888899999999999999999988 9999999999
Q ss_pred EEecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCC
Q 041702 653 VLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDS 731 (840)
Q Consensus 653 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~ 731 (840)
||+++++.+||+|||+++...............+++.|+|||.+.+..++.++||||||++++||++ |..|+......
T Consensus 155 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~- 233 (283)
T cd05091 155 VLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ- 233 (283)
T ss_pred eEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-
Confidence 9999999999999999887644332222334456789999999988899999999999999999998 77776432211
Q ss_pred ccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 041702 732 LTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794 (840)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~ 794 (840)
.. .......... ......+..+.+++..||+.+|++||++.+|++.|+.
T Consensus 234 -~~----~~~i~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 234 -DV----IEMIRNRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -HH----HHHHHcCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11 1111111110 1112334557899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=298.18 Aligned_cols=271 Identities=23% Similarity=0.322 Sum_probs=202.7
Q ss_pred CHHHHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhh--cCC
Q 041702 505 SLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAK--LQH 582 (840)
Q Consensus 505 ~~~~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~--l~H 582 (840)
++.......++....+.||+|.||.||+|.++ |+.||||++...+ .+.+.+|.+|.+. |+|
T Consensus 202 plLVQRTiarqI~L~e~IGkGRyGEVwrG~wr--------------Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRH 264 (513)
T KOG2052|consen 202 PLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR--------------GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRH 264 (513)
T ss_pred hhHhHHhhhheeEEEEEecCccccceeecccc--------------CCceEEEEecccc---hhhhhhHHHHHHHHHhcc
Confidence 34455677788999999999999999999876 8899999998553 3567778888775 499
Q ss_pred CCccceeeEeecCC----ceEEEEEee---ccCCccccCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCceecCCCCC
Q 041702 583 RNLVRLFGCCIEQG----EKISIYEFD---IVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQ-----YSRLRVIHRDLKA 650 (840)
Q Consensus 583 ~niv~l~g~~~~~~----~~~lv~e~~---~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-----~~~~~ivHrDlkp 650 (840)
+||+.+++.-..++ +.+||.+|. .+.+......++....++++..+|.||++||. +++|.|.|||||+
T Consensus 265 ENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKS 344 (513)
T KOG2052|consen 265 ENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKS 344 (513)
T ss_pred chhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccccc
Confidence 99999998765443 678999984 33344556788999999999999999999994 6789999999999
Q ss_pred CcEEecCCCCceeeccccceecCCC--CcccccccccccccccCccccccCC----C-C-ccccchhHHHHHHHHHhC--
Q 041702 651 SNVLLDSDMNPKISDFGIARTFGGD--EMQSNTNRIVGTYGYMSPEYALHGL----F-S-IKSDVFSFGVLLLEILSS-- 720 (840)
Q Consensus 651 ~NILl~~~~~~kL~DFGla~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~----~-~-~ksDV~SlGviL~elltG-- 720 (840)
.|||+..++.+.|+|+|+|-....+ ......+..+||.+|||||++.... + + ..+||||||.|+||+.-.
T Consensus 345 KNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~ 424 (513)
T KOG2052|consen 345 KNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCE 424 (513)
T ss_pred ccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhh
Confidence 9999999999999999999776543 3334567789999999999986532 2 1 358999999999999742
Q ss_pred --------CCCCCCCCCCCccHhHHHhhhhcccccccccCccccc-hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 721 --------KKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQN-EALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 721 --------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
+.||....+.+...... .... -.+.+.|.+.. ....+.+..+.+|+..||..+|..|-|+-.|-+.
T Consensus 425 ~ggi~eey~~Pyyd~Vp~DPs~eeM-rkVV----Cv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKt 499 (513)
T KOG2052|consen 425 SGGIVEEYQLPYYDVVPSDPSFEEM-RKVV----CVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKT 499 (513)
T ss_pred cCCEehhhcCCcccCCCCCCCHHHH-hcce----eecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHH
Confidence 23332222222211110 0000 01112222221 2334677889999999999999999999999999
Q ss_pred hhcccc
Q 041702 792 LKDEIV 797 (840)
Q Consensus 792 Le~~~~ 797 (840)
|.++.+
T Consensus 500 l~~l~~ 505 (513)
T KOG2052|consen 500 LAKLSN 505 (513)
T ss_pred HHHHhc
Confidence 988743
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=311.01 Aligned_cols=245 Identities=22% Similarity=0.275 Sum_probs=195.4
Q ss_pred HHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhcCCCCcc
Q 041702 510 SAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKLQHRNLV 586 (840)
Q Consensus 510 ~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv 586 (840)
..-.++|+.+.+||+|+||.||+|+.+ .+|+.+|+|++++.. ...++..+.|-.+|....+|.||
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk------------~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vV 204 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKK------------DTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVV 204 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEc------------cCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEE
Confidence 345689999999999999999999765 789999999998763 35567789999999999999999
Q ss_pred ceeeEeecCCceEEEEEeeccC----CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCce
Q 041702 587 RLFGCCIEQGEKISIYEFDIVT----DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPK 662 (840)
Q Consensus 587 ~l~g~~~~~~~~~lv~e~~~~~----~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 662 (840)
+|+..|.+.+..||||||..-+ .......|++.....++.+++.|++-||+.| +|||||||+|+|||..|++|
T Consensus 205 KLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiK 281 (550)
T KOG0605|consen 205 KLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIK 281 (550)
T ss_pred EEEEEecCCCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEe
Confidence 9999999999999999994333 3456778999999999999999999999999 99999999999999999999
Q ss_pred eeccccceecCC----------------------CCcc-----cc------------------cccccccccccCccccc
Q 041702 663 ISDFGIARTFGG----------------------DEMQ-----SN------------------TNRIVGTYGYMSPEYAL 697 (840)
Q Consensus 663 L~DFGla~~~~~----------------------~~~~-----~~------------------~~~~~gt~~y~aPE~~~ 697 (840)
|+||||+.-+.. .... .. ....+|||.|||||++.
T Consensus 282 LSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll 361 (550)
T KOG0605|consen 282 LSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLL 361 (550)
T ss_pred eccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHh
Confidence 999999853311 0000 00 12347999999999999
Q ss_pred cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc--HhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHcc
Q 041702 698 HGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLT--LLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCV 775 (840)
Q Consensus 698 ~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl 775 (840)
+..|+..+|.||||||+||||.|.+||....+.+.- +..|... +.-| .......+..++|.+|+
T Consensus 362 ~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~---------l~fP-----~~~~~s~eA~DLI~rll 427 (550)
T KOG0605|consen 362 GKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET---------LKFP-----EEVDLSDEAKDLITRLL 427 (550)
T ss_pred cCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh---------ccCC-----CcCcccHHHHHHHHHHh
Confidence 999999999999999999999999999765544311 1111100 0011 11112256778999999
Q ss_pred ccCCCCCCC
Q 041702 776 QENATDRPT 784 (840)
Q Consensus 776 ~~dP~~RPs 784 (840)
. ||++|.-
T Consensus 428 ~-d~~~RLG 435 (550)
T KOG0605|consen 428 C-DPENRLG 435 (550)
T ss_pred c-CHHHhcC
Confidence 8 9999986
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=312.02 Aligned_cols=249 Identities=32% Similarity=0.481 Sum_probs=186.3
Q ss_pred ccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcCCCCccceeeEeecCC
Q 041702 518 EENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQG 596 (840)
Q Consensus 518 ~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~ 596 (840)
..+.||.|.||.||+|.++. .....+..|+||.++.... ...++|.+|++.+.+++||||++++|+|.+.+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~--------~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~ 74 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQ--------KDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE 74 (259)
T ss_dssp EEEEEEEESSEEEEEEEEES--------TTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS
T ss_pred EeeEEccCCCcEEEEEEEEc--------ccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccc
Confidence 45789999999999997651 2234577899999965432 34688999999999999999999999999888
Q ss_pred ceEEEEEeeccCCc----c--ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccce
Q 041702 597 EKISIYEFDIVTDP----A--RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIAR 670 (840)
Q Consensus 597 ~~~lv~e~~~~~~~----~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~ 670 (840)
...+|+||...... . ....+++.++.+|+.||++||+|||+.+ ++|+||+++||+++.++.+||+|||++.
T Consensus 75 ~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~ 151 (259)
T PF07714_consen 75 PLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSR 151 (259)
T ss_dssp SEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGE
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccc
Confidence 99999999543222 1 2357899999999999999999999987 9999999999999999999999999998
Q ss_pred ecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhccccccc
Q 041702 671 TFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKDDKAWK 749 (840)
Q Consensus 671 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (840)
...................|+|||.+....++.++||||||+++|||++ |+.|+.... ....... . .....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~--~~~~~~~---~-~~~~~-- 223 (259)
T PF07714_consen 152 PISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD--NEEIIEK---L-KQGQR-- 223 (259)
T ss_dssp ETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC--HHHHHHH---H-HTTEE--
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccc---c-ccccc--
Confidence 8743333333334456789999999999999999999999999999999 677754331 1111111 1 11111
Q ss_pred ccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 041702 750 LMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAML 792 (840)
Q Consensus 750 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 792 (840)
...+......+.+++..||+.+|++||++.+|++.|
T Consensus 224 -------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 -------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 011112344577899999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=307.04 Aligned_cols=250 Identities=29% Similarity=0.455 Sum_probs=198.7
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
...+|+..++||+|+||.||+|.++ ++..+|+|.+.........++.+|+.++++++|+||++++++
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~-------------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 70 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWK-------------NRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAV 70 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEec-------------CCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeee
Confidence 4467888999999999999998754 378999999987665566789999999999999999999999
Q ss_pred eecCCceEEEEEeeccCC------ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 592 CIEQGEKISIYEFDIVTD------PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
+.+.+..+++|||..... ......+++..+..++.||+.||.|||+.+ ++|+||||+||++++++.+||+|
T Consensus 71 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d 147 (261)
T cd05148 71 CSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVAD 147 (261)
T ss_pred EecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEcc
Confidence 999999999999943221 112346889999999999999999999988 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
||++......... .....++..|+|||.+.+..++.++||||||+++++|++ |+.|+...... ...... ..
T Consensus 148 ~g~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~--~~~~~~----~~ 219 (261)
T cd05148 148 FGLARLIKEDVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH--EVYDQI----TA 219 (261)
T ss_pred ccchhhcCCcccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH--HHHHHH----Hh
Confidence 9999776432211 113345678999999998899999999999999999998 78887543211 111111 10
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~ 794 (840)
..........+..+.+++.+||+.+|++|||++++++.|+.
T Consensus 220 ---------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 220 ---------GYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred ---------CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 00111112334567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=311.86 Aligned_cols=262 Identities=27% Similarity=0.410 Sum_probs=199.7
Q ss_pred HHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhc-CCCCccc
Q 041702 510 SAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKL-QHRNLVR 587 (840)
Q Consensus 510 ~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l-~H~niv~ 587 (840)
....++|+..+.||+|+||.||++.++.. ........+|+|++.... .....++.+|+.++.++ +|+||++
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~-------~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~ 80 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGL-------DNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIN 80 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecC-------CCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeee
Confidence 33456788899999999999999875410 111345789999987542 23446789999999999 8999999
Q ss_pred eeeEeecCCceEEEEEeeccCC--------------------ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCC
Q 041702 588 LFGCCIEQGEKISIYEFDIVTD--------------------PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRD 647 (840)
Q Consensus 588 l~g~~~~~~~~~lv~e~~~~~~--------------------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrD 647 (840)
+++++...+..+++|||..... ......+++..+++++.|++.||.|||+.+ |+|||
T Consensus 81 ~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~d 157 (293)
T cd05053 81 LLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRD 157 (293)
T ss_pred EEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccc
Confidence 9999999999999999832111 123456889999999999999999999988 99999
Q ss_pred CCCCcEEecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCC
Q 041702 648 LKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRF 726 (840)
Q Consensus 648 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~ 726 (840)
|||+||+++.++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..|+..
T Consensus 158 lkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 237 (293)
T cd05053 158 LAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 237 (293)
T ss_pred cceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCC
Confidence 999999999999999999999987654332222233345678999999999999999999999999999998 8887653
Q ss_pred CCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 041702 727 YNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEI 796 (840)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~ 796 (840)
..... ......... ....+......+.+++.+|++.+|++|||+.|+++.|++++
T Consensus 238 ~~~~~------~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 238 IPVEE------LFKLLKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CCHHH------HHHHHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 22111 111111111 01111223456889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=301.97 Aligned_cols=253 Identities=25% Similarity=0.372 Sum_probs=198.6
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
++|++.++||+|+||.||+|++. .+++.||||.++... .....+|.+|++++++++||||+++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~------------~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 69 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCL------------LDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEe------------CCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeee
Confidence 57888999999999999999754 578999999886432 233457899999999999999999999
Q ss_pred EeecCCceEEEEEeeccCCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCce
Q 041702 591 CCIEQGEKISIYEFDIVTDP--------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPK 662 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~~--------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 662 (840)
++...+..++++||...... .....++......++.|+++||+|||+.+ ++|+||||+||+++.++.++
T Consensus 70 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~ 146 (267)
T cd08228 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVK 146 (267)
T ss_pred eEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEE
Confidence 99999999999999433221 12345788899999999999999999988 99999999999999999999
Q ss_pred eeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhh
Q 041702 663 ISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLW 742 (840)
Q Consensus 663 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~ 742 (840)
|+|||++........ ......+++.|+|||.+.+..++.++||||||++++||++|+.|+............ . .
T Consensus 147 l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~---~-~ 220 (267)
T cd08228 147 LGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQ---K-I 220 (267)
T ss_pred ECccccceeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHH---H-H
Confidence 999999987643221 122346788999999999888999999999999999999999997532221111111 1 0
Q ss_pred cccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 743 KDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 743 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
... ..+. .........+.+++.+||+.+|++||++++|++.|+.+
T Consensus 221 ~~~-----~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 221 EQC-----DYPP---LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred hcC-----CCCC---CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 100 0111 11223446688999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=304.53 Aligned_cols=251 Identities=22% Similarity=0.339 Sum_probs=196.4
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
++|+..++||+|+||.||+|.+. .+++.||+|++.... ....++|.+|++++.+++||||+++++++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~------------~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 68 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHL------------LTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEc------------CCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 35777889999999999999754 578899999987542 23346799999999999999999999999
Q ss_pred ecCCceEEEEEeeccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceec
Q 041702 593 IEQGEKISIYEFDIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTF 672 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~ 672 (840)
...+..++++||...........+++.....++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++..+
T Consensus 69 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~ 145 (279)
T cd06619 69 FVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQL 145 (279)
T ss_pred EECCEEEEEEecCCCCChHHhhcCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceec
Confidence 99999999999965544444456788899999999999999999988 999999999999999999999999999865
Q ss_pred CCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHh-HHHhhhhccccccccc
Q 041702 673 GGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLL-GHAWNLWKDDKAWKLM 751 (840)
Q Consensus 673 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 751 (840)
... ......++..|+|||.+.+..++.++||||||++++||++|+.|+........... ...........
T Consensus 146 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----- 216 (279)
T cd06619 146 VNS----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED----- 216 (279)
T ss_pred ccc----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----
Confidence 432 12335789999999999999999999999999999999999999864332221110 01111111110
Q ss_pred CccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 752 DPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 752 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
.+.+. .......+.+++.+||+.+|++||+++|+++.
T Consensus 217 ~~~~~---~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 217 PPVLP---VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCCC---CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 01110 11223457899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=317.57 Aligned_cols=239 Identities=21% Similarity=0.249 Sum_probs=186.0
Q ss_pred ccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhcCCCCccceeeEeecCCce
Q 041702 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEK 598 (840)
Q Consensus 522 lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~ 598 (840)
||+|+||.||+|.++ .+++.||+|+++.. .......+.+|+.++.+++||||+++++++.+.+..
T Consensus 1 lg~G~~g~Vy~~~~~------------~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 68 (312)
T cd05585 1 IGKGSFGKVMQVRKR------------DTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKL 68 (312)
T ss_pred CCcCCCeEEEEEEEC------------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeE
Confidence 799999999999765 57889999998753 234456788999999999999999999999999999
Q ss_pred EEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceecCC
Q 041702 599 ISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGG 674 (840)
Q Consensus 599 ~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 674 (840)
++||||..... ......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 69 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~ 145 (312)
T cd05585 69 YLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMK 145 (312)
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCcc
Confidence 99999953322 223456889999999999999999999988 99999999999999999999999999976432
Q ss_pred CCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccccccCcc
Q 041702 675 DEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPT 754 (840)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 754 (840)
.. .......||+.|+|||.+.+..++.++|||||||+++||++|+.||...... . ....... ..
T Consensus 146 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~--~---~~~~~~~-~~-------- 209 (312)
T cd05585 146 DD--DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN--E---MYRKILQ-EP-------- 209 (312)
T ss_pred CC--CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH--H---HHHHHHc-CC--------
Confidence 21 1233457899999999999999999999999999999999999998642211 1 1111111 00
Q ss_pred ccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 041702 755 MQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLK 793 (840)
Q Consensus 755 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le 793 (840)
. ..+......+.+++.+||+.||++||++.++.+.|+
T Consensus 210 ~--~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 210 L--RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred C--CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 0 111223345788999999999999986544444443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=332.61 Aligned_cols=246 Identities=19% Similarity=0.236 Sum_probs=194.1
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccC-CceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEee
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLN-GEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCI 593 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~-g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~ 593 (840)
.|...+.||+|++|.||+|.+. .+ ++.||+|.+..........+.+|+.+++.++|||||++++++.
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~------------~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~ 135 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRG------------SDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFK 135 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEc------------CCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence 4888899999999999999654 33 6789999876554444567889999999999999999999999
Q ss_pred cCCceEEEEEeeccCCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 594 EQGEKISIYEFDIVTDP--------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 594 ~~~~~~lv~e~~~~~~~--------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
..+..++||||...... .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 136 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~D 212 (478)
T PTZ00267 136 SDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGD 212 (478)
T ss_pred ECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEe
Confidence 99999999999543322 22345788899999999999999999988 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
||+++.+.............||+.|+|||++.+..++.++|||||||+++||++|+.|+..... ..... ... ..
T Consensus 213 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~--~~~~~---~~~-~~ 286 (478)
T PTZ00267 213 FGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ--REIMQ---QVL-YG 286 (478)
T ss_pred CcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--HHHHH---HHH-hC
Confidence 9999876543322233456799999999999999999999999999999999999999853221 11111 110 01
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.. ++ .+......+.+++.+||+.+|++||+++++++
T Consensus 287 ~~----~~-----~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 287 KY----DP-----FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CC----CC-----CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 00 00 11123345788999999999999999999864
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=306.44 Aligned_cols=270 Identities=23% Similarity=0.341 Sum_probs=193.9
Q ss_pred cCCcccccccCCCCccEEEeecceeehhc-c-ccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICN-W-KQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~-~-~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
++|++.++||+|+||.||++.+....... . ..........||+|+++... ....+.|.+|++++.+++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 57888999999999999998754110000 0 00001123469999987542 233467999999999999999999999
Q ss_pred EeecCCceEEEEEeeccCCc----------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEE
Q 041702 591 CCIEQGEKISIYEFDIVTDP----------------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVL 654 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~~----------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIL 654 (840)
++...+..+++|||...... .....+++..++.++.|++.||+|||+.+ ++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 99999999999998432111 11124688999999999999999999988 999999999999
Q ss_pred ecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCC--CCCCCCCCCCc
Q 041702 655 LDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSK--KNTRFYNTDSL 732 (840)
Q Consensus 655 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~--~p~~~~~~~~~ 732 (840)
++.++.+||+|||++................++..|+|||.+.+..++.++|||||||+++||+++. .|+.... ..
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~--~~ 239 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS--DE 239 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC--hH
Confidence 9999999999999998664433222233445677999999999889999999999999999999854 4443222 11
Q ss_pred cHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 041702 733 TLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794 (840)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~ 794 (840)
................... ......+..+.+++.+||+.+|++||+|.+|++.|+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 240 QVIENTGEFFRNQGRQIYL------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHHHhhhhccccccC------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 2111111111111000000 0111123568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=302.09 Aligned_cols=245 Identities=25% Similarity=0.341 Sum_probs=187.5
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceeeEeecCCce
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEK 598 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~ 598 (840)
++||+|+||.||+|.++ .+++.||+|.+.... ......|.+|++++++++||||++++++|...+..
T Consensus 1 ~~lg~g~~g~vy~~~~~------------~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 68 (252)
T cd05084 1 ERIGRGNFGEVFSGRLR------------ADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI 68 (252)
T ss_pred CccCcccCccEEEEEEe------------cCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCe
Confidence 36999999999999765 578899999886543 23456799999999999999999999999999999
Q ss_pred EEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceecC
Q 041702 599 ISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFG 673 (840)
Q Consensus 599 ~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~ 673 (840)
++|+||...... .....+++.+++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 69 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 145 (252)
T cd05084 69 YIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEE 145 (252)
T ss_pred EEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccc
Confidence 999998432211 12345889999999999999999999988 9999999999999999999999999987654
Q ss_pred CCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhcccccccccC
Q 041702 674 GDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMD 752 (840)
Q Consensus 674 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 752 (840)
.............+..|+|||.+.+..++.++||||||++++||++ |..|+....... .......
T Consensus 146 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~------~~~~~~~-------- 211 (252)
T cd05084 146 DGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ------TREAIEQ-------- 211 (252)
T ss_pred cccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH------HHHHHHc--------
Confidence 3211111111223457999999999899999999999999999998 777764322110 0011100
Q ss_pred ccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 041702 753 PTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794 (840)
Q Consensus 753 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~ 794 (840)
..........+..+.+++.+||+.+|++|||+.+|+++|+.
T Consensus 212 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 212 -GVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred -CCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 00011112234568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=318.17 Aligned_cols=239 Identities=21% Similarity=0.260 Sum_probs=188.2
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhcCCCCccceeeEeecCC
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQG 596 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~ 596 (840)
+.||+|+||.||++.++ .+++.||||++... ......++.+|++++++++||||+++++++...+
T Consensus 1 ~~lG~G~~g~Vy~~~~~------------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 68 (328)
T cd05593 1 KLLGKGTFGKVILVREK------------ASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD 68 (328)
T ss_pred CeeeeCCCEEEEEEEEC------------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC
Confidence 36999999999999765 67899999999754 2334567899999999999999999999999999
Q ss_pred ceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceec
Q 041702 597 EKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTF 672 (840)
Q Consensus 597 ~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~ 672 (840)
..++||||..... ......+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 69 ~~~lv~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~ 145 (328)
T cd05593 69 RLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (328)
T ss_pred EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccC
Confidence 9999999953222 223456889999999999999999999988 999999999999999999999999998753
Q ss_pred CCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccccccC
Q 041702 673 GGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMD 752 (840)
Q Consensus 673 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 752 (840)
.... .......||+.|+|||.+.+..++.++|||||||+++||++|+.||...... ... ...... +
T Consensus 146 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~--~~~----~~~~~~------~ 211 (328)
T cd05593 146 ITDA--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLF----ELILME------D 211 (328)
T ss_pred CCcc--cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH--HHH----HHhccC------C
Confidence 2211 1223457899999999999999999999999999999999999998543211 111 000000 0
Q ss_pred ccccchhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 041702 753 PTMQNEALYSMVTRYIKVALLCVQENATDRP-----TMLEVVAM 791 (840)
Q Consensus 753 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 791 (840)
..+ +......+.+++.+||+.||++|| ++.|+++.
T Consensus 212 ~~~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 212 IKF----PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred ccC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 111 112344578899999999999997 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=305.07 Aligned_cols=249 Identities=28% Similarity=0.418 Sum_probs=195.3
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
.++|+..++||+|+||.||+|.+ .++..||+|.+.... ...+.+.+|+.++++++|+||+++++++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-------------~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 70 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYY-------------NNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVV 70 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEe-------------cCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 36788899999999999999863 356789999987542 3457899999999999999999999999
Q ss_pred ecCCceEEEEEeeccCCc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 593 IEQGEKISIYEFDIVTDP------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
.+.+..++++|+...... .....+++.+++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+||
T Consensus 71 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df 147 (261)
T cd05072 71 TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADF 147 (261)
T ss_pred cCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCC
Confidence 999999999998532221 12345788899999999999999999987 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
|++......... ......++..|+|||++.+..++.++||||||++++||++ |+.|+...... ..... ....
T Consensus 148 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~----~~~~ 220 (261)
T cd05072 148 GLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVMSA----LQRG 220 (261)
T ss_pred ccceecCCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHHHH----HHcC
Confidence 999876543221 1223345678999999988889999999999999999998 88887542211 11111 1111
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~ 794 (840)
. .. +.....+..+.+++.+|++.+|++||+++++++.|++
T Consensus 221 ~-----~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 221 Y-----RM----PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred C-----CC----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0 00 0111233457889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=308.97 Aligned_cols=261 Identities=25% Similarity=0.350 Sum_probs=207.2
Q ss_pred HHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC-CCcCHHHHHHHHHHHhhcCCCCccc
Q 041702 509 ISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK-SGQGLEEFKNEMMLIAKLQHRNLVR 587 (840)
Q Consensus 509 ~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~-~~~~~~~f~~Ev~~l~~l~H~niv~ 587 (840)
.+...+.....++||+|-||.||+|..... .....-.||||..+.. .....+.|+.|..+|++++||||++
T Consensus 384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~--------~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIik 455 (974)
T KOG4257|consen 384 YELRRELITLKRLIGEGQFGDVYKGVYTDP--------EKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIK 455 (974)
T ss_pred ceeehhhccHHHhhcCCcccceeeeEeccc--------ccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhh
Confidence 334445566678999999999999875410 0112335999999874 3455788999999999999999999
Q ss_pred eeeEeecCCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCce
Q 041702 588 LFGCCIEQGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPK 662 (840)
Q Consensus 588 l~g~~~~~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 662 (840)
|+|+|.+ ...++|||....+.. ..+..|+......++.||..||+|||+.. +|||||..+|||+.....+|
T Consensus 456 LIGv~~e-~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVK 531 (974)
T KOG4257|consen 456 LIGVCVE-QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVK 531 (974)
T ss_pred eeeeeec-cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceee
Confidence 9999975 578999998544332 24567888888999999999999999987 99999999999999999999
Q ss_pred eeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhh
Q 041702 663 ISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNL 741 (840)
Q Consensus 663 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~ 741 (840)
|+|||+++.+.++.....+ ...-+..|||||.+.-..++.++|||-|||.+|||++ |.+||.+....+.
T Consensus 532 LaDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV--------- 601 (974)
T KOG4257|consen 532 LADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV--------- 601 (974)
T ss_pred ecccchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce---------
Confidence 9999999999877766654 3344679999999999999999999999999999986 8889876543331
Q ss_pred hcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 742 WKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 742 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
.-.++..-+...++.++..+..++.+||+.||.+||.+.|+...|+++..
T Consensus 602 ------I~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 602 ------IGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ------EEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 11222333334455666778899999999999999999999988876543
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=322.25 Aligned_cols=259 Identities=19% Similarity=0.199 Sum_probs=190.3
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
....|.+.+.||+|+||.||+|.+. ..++.||||... ...+.+|+++|++++|+|||+++++
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~------------~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~ 228 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHP------------DYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDV 228 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEEC------------CCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEE
Confidence 3567999999999999999999765 568899999643 2346789999999999999999999
Q ss_pred eecCCceEEEEEeeccCC---c-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 592 CIEQGEKISIYEFDIVTD---P-ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~---~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
+..++..+++||+..... . .....+++.+++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 229 ~~~~~~~~lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFG 305 (461)
T PHA03211 229 RVVGGLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFG 305 (461)
T ss_pred EEECCEEEEEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccC
Confidence 999999999999742111 1 11346899999999999999999999988 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCC-C-ccHhHHHhhhhccc
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTD-S-LTLLGHAWNLWKDD 745 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~-~-~~~~~~~~~~~~~~ 745 (840)
+++.+.............||..|+|||++.+..++.++|||||||+||||++|..++-..... . ..............
T Consensus 306 la~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~ 385 (461)
T PHA03211 306 AACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQA 385 (461)
T ss_pred CceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhh
Confidence 998764432222233457999999999999999999999999999999999988654221111 0 00001111111100
Q ss_pred c-----cccc----------------cCccccc---hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 746 K-----AWKL----------------MDPTMQN---EALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 746 ~-----~~~~----------------~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
. .... ..+.... .........+.+|+.+||+.||++|||+.|+++.
T Consensus 386 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 386 QVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred ccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 0000 0000000 0001122357889999999999999999999864
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=307.58 Aligned_cols=256 Identities=26% Similarity=0.399 Sum_probs=196.3
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCI 593 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~ 593 (840)
++|...++||+|+||.||+|..... ....++..+|+|.+........+.|.+|++++++++|+||+++++++.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~-------~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNL-------LPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCT 77 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecC-------CCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEe
Confidence 5677788999999999999864300 122456789999988766566678999999999999999999999999
Q ss_pred cCCceEEEEEeeccCCc-------------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEE
Q 041702 594 EQGEKISIYEFDIVTDP-------------------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVL 654 (840)
Q Consensus 594 ~~~~~~lv~e~~~~~~~-------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIL 654 (840)
..+..++++||...... .....+++..++.++.|++.||+|||+.+ ++||||||+|||
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil 154 (280)
T cd05092 78 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCL 154 (280)
T ss_pred cCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEE
Confidence 99999999998422111 11135889999999999999999999988 999999999999
Q ss_pred ecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcc
Q 041702 655 LDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLT 733 (840)
Q Consensus 655 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~ 733 (840)
+++++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||+++||++ |++|+...... .
T Consensus 155 ~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~ 232 (280)
T cd05092 155 VGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT--E 232 (280)
T ss_pred EcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH--H
Confidence 99999999999999986643332222233345678999999999999999999999999999998 88886432211 1
Q ss_pred HhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 041702 734 LLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794 (840)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~ 794 (840)
.. ........ . ..+...+..+.+++.+||+.||++||++++|++.|+.
T Consensus 233 ~~----~~~~~~~~--~-------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 233 AI----ECITQGRE--L-------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HH----HHHHcCcc--C-------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 11 00011000 0 0111223457899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=283.39 Aligned_cols=244 Identities=27% Similarity=0.357 Sum_probs=198.2
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhcCCCCccce
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKLQHRNLVRL 588 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l 588 (840)
+.++|++.+.||+|.||.||.|+.+ .++-.||+|++.+.. .+...++++|++|-+.|+||||+++
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarek------------ks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrl 87 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREK------------KSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRL 87 (281)
T ss_pred chhhccccccccCCccccEeEeeec------------cCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhh
Confidence 3478999999999999999999876 678899999997642 3445789999999999999999999
Q ss_pred eeEeecCCceEEEEEeeccC----Ccc--ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCce
Q 041702 589 FGCCIEQGEKISIYEFDIVT----DPA--RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPK 662 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~~~~~----~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 662 (840)
++||.+....|+++||.... ... ....+++.....++.|+|.||.|+|..+ +|||||||+|+|++.++..|
T Consensus 88 Y~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lk 164 (281)
T KOG0580|consen 88 YGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELK 164 (281)
T ss_pred hhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCee
Confidence 99999999999999993222 222 3455778888899999999999999987 99999999999999999999
Q ss_pred eeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhh
Q 041702 663 ISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLW 742 (840)
Q Consensus 663 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~ 742 (840)
|+|||-+..-..+ .....+||..|.+||...+...+.+.|+|++|++.+|++.|.+||+....++ .+...
T Consensus 165 iAdfGwsV~~p~~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e------tYkrI 234 (281)
T KOG0580|consen 165 IADFGWSVHAPSN----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE------TYKRI 234 (281)
T ss_pred ccCCCceeecCCC----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH------HHHHH
Confidence 9999988654321 2234689999999999999999999999999999999999999997544211 11111
Q ss_pred cccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 743 KDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 743 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.. .++.+| ........+++.+|+..+|.+|.+..||++
T Consensus 235 ~k---~~~~~p-------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 235 RK---VDLKFP-------STISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred HH---ccccCC-------cccChhHHHHHHHHhccCccccccHHHHhh
Confidence 11 111122 334456789999999999999999999875
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=322.12 Aligned_cols=263 Identities=27% Similarity=0.375 Sum_probs=198.1
Q ss_pred HHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcC-CCCccc
Q 041702 510 SAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQ-HRNLVR 587 (840)
Q Consensus 510 ~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~-H~niv~ 587 (840)
+...++|.+.++||+|+||.||+|.++.. +....+..||||+++.... ...+.+.+|+++|.++. ||||++
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~-------~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~ 105 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGL-------SHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVN 105 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCC-------CCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEE
Confidence 33456788889999999999999976510 1234567899999976432 33457899999999997 999999
Q ss_pred eeeEeecCCceEEEEEeeccCCc---------------------------------------------------------
Q 041702 588 LFGCCIEQGEKISIYEFDIVTDP--------------------------------------------------------- 610 (840)
Q Consensus 588 l~g~~~~~~~~~lv~e~~~~~~~--------------------------------------------------------- 610 (840)
++++|...+..++|+||....+.
T Consensus 106 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (401)
T cd05107 106 LLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDE 185 (401)
T ss_pred EEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcc
Confidence 99999999999999998321110
Q ss_pred ---------------------------------------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceec
Q 041702 611 ---------------------------------------------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIH 645 (840)
Q Consensus 611 ---------------------------------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH 645 (840)
.....+++...++++.||++||+|||+.+ ++|
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH 262 (401)
T cd05107 186 SADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVH 262 (401)
T ss_pred ccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCc
Confidence 11234778888999999999999999987 999
Q ss_pred CCCCCCcEEecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCC
Q 041702 646 RDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNT 724 (840)
Q Consensus 646 rDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~ 724 (840)
|||||+|||+++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||+++||++ |+.|+
T Consensus 263 rdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~ 342 (401)
T cd05107 263 RDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY 342 (401)
T ss_pred ccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCC
Confidence 99999999999999999999999986543222222223456789999999998889999999999999999998 88887
Q ss_pred CCCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 041702 725 RFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEI 796 (840)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~ 796 (840)
......+ . .......+ .....+......+.+++.+||+.+|++||++++|++.|++++
T Consensus 343 ~~~~~~~--~---~~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 343 PELPMNE--Q---FYNAIKRG---------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred CCCCchH--H---HHHHHHcC---------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 5332111 0 11111111 000111122456888999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=308.16 Aligned_cols=271 Identities=26% Similarity=0.386 Sum_probs=198.7
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhc----cccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcCCCCccc
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICN----WKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQHRNLVR 587 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~----~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~ 587 (840)
.++|++.++||+|+||.||+|.+....... ........+..||+|++..... ...++|.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 467888999999999999998764211000 0001123456799999876532 34578999999999999999999
Q ss_pred eeeEeecCCceEEEEEeeccCCc---------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCc
Q 041702 588 LFGCCIEQGEKISIYEFDIVTDP---------------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASN 652 (840)
Q Consensus 588 l~g~~~~~~~~~lv~e~~~~~~~---------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~N 652 (840)
+++++..++..++++|+...... .....+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 99999999999999998422211 11236899999999999999999999988 9999999999
Q ss_pred EEecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh--CCCCCCCCCCC
Q 041702 653 VLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS--SKKNTRFYNTD 730 (840)
Q Consensus 653 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt--G~~p~~~~~~~ 730 (840)
|+++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ +..|+... .
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~--~ 238 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL--T 238 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc--C
Confidence 9999999999999999987644333333344566789999999988899999999999999999998 45554322 1
Q ss_pred CccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 041702 731 SLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794 (840)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~ 794 (840)
..................... ......+..+.+++.+||+.||++|||+.||++.|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 239 DQQVIENAGHFFRDDGRQIYL------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred hHHHHHHHHhccccccccccC------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 222222221111111111000 1111233568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=317.14 Aligned_cols=238 Identities=20% Similarity=0.269 Sum_probs=187.3
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhcCCCCccceeeEeecCC
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQG 596 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~ 596 (840)
+.||+|+||.||++.++ .+|+.||+|+++.. .......+.+|++++.+++||||+++++++...+
T Consensus 1 ~~lG~G~~g~Vy~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~ 68 (323)
T cd05595 1 KLLGKGTFGKVILVREK------------ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD 68 (323)
T ss_pred CeeeeCCCEEEEEEEEC------------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCC
Confidence 36999999999999765 57899999999754 2234567889999999999999999999999999
Q ss_pred ceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceec
Q 041702 597 EKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTF 672 (840)
Q Consensus 597 ~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~ 672 (840)
..++||||..... ......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 69 ~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 145 (323)
T cd05595 69 RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence 9999999953332 223456899999999999999999999988 999999999999999999999999998753
Q ss_pred CCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccccccC
Q 041702 673 GGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMD 752 (840)
Q Consensus 673 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 752 (840)
.... .......||+.|+|||.+.+..++.++|||||||++|||++|+.|+...... ..... .. ...
T Consensus 146 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--~~~~~---~~-~~~------ 211 (323)
T cd05595 146 ISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--RLFEL---IL-MEE------ 211 (323)
T ss_pred cCCC--CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH--HHHHH---Hh-cCC------
Confidence 2211 1123456899999999999999999999999999999999999998543211 11110 00 000
Q ss_pred ccccchhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041702 753 PTMQNEALYSMVTRYIKVALLCVQENATDRP-----TMLEVVA 790 (840)
Q Consensus 753 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 790 (840)
..+ +......+.+++.+||+.||++|| ++.++++
T Consensus 212 ~~~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 212 IRF----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCC----CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 011 112344577899999999999998 7888774
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=313.70 Aligned_cols=197 Identities=25% Similarity=0.362 Sum_probs=166.7
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
.++|+..++||+|+||.||+|.+. .++..+|+|++.... ....+++.+|++++.+++||||++++++
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~------------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 71 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHK------------PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEEC------------CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEE
Confidence 478999999999999999999765 578899999987542 2334679999999999999999999999
Q ss_pred eecCCceEEEEEeeccCCc----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 592 CIEQGEKISIYEFDIVTDP----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
|.+.+..+++|||...... .....+++.....++.+++.||.|||+.. +|+||||||+|||++.++.+||+|||
T Consensus 72 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg 149 (333)
T cd06650 72 FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFG 149 (333)
T ss_pred EEECCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCC
Confidence 9999999999999533222 23446888899999999999999999742 39999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFY 727 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~ 727 (840)
++..+... ......|+..|+|||.+.+..++.++|||||||+++||++|+.|+...
T Consensus 150 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 150 VSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred cchhhhhh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 98765321 123356899999999999989999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=306.79 Aligned_cols=258 Identities=28% Similarity=0.398 Sum_probs=194.6
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
.+++|.+.+.||+|++|.||+|.++.. ..-..+..||+|.+.... ......|.+|+.++++++|+||+++++
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~-------~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 76 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGR-------DGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIG 76 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecC-------CCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 356788999999999999999976510 001156789999987543 233457999999999999999999999
Q ss_pred EeecCCceEEEEEeeccCCc-----------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCC
Q 041702 591 CCIEQGEKISIYEFDIVTDP-----------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDM 659 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~ 659 (840)
++.+.+..+++|||...... .....+++..+++++.||+.||+|||+.+ ++||||||+||+++.++
T Consensus 77 ~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~ 153 (277)
T cd05036 77 VSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKG 153 (277)
T ss_pred EEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccC
Confidence 99999999999998422111 11235899999999999999999999988 99999999999998765
Q ss_pred ---CceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHh
Q 041702 660 ---NPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLL 735 (840)
Q Consensus 660 ---~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~ 735 (840)
.+||+|||+++................+..|+|||++.+..++.++|||||||+++||++ |+.||...... ...
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--~~~ 231 (277)
T cd05036 154 PGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--EVM 231 (277)
T ss_pred CCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHH
Confidence 589999999987643322222222334568999999999999999999999999999997 88887532221 111
Q ss_pred HHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 041702 736 GHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794 (840)
Q Consensus 736 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~ 794 (840)
....... ....+...+..+.+++.+|++.+|++||++.+|++.|+.
T Consensus 232 ----~~~~~~~---------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 232 ----EFVTGGG---------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred ----HHHHcCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 1111100 011112234568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=318.00 Aligned_cols=261 Identities=21% Similarity=0.274 Sum_probs=200.6
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhcCCCCccce
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQHRNLVRL 588 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l 588 (840)
..++|...+.||+|+||.||+|.++ ..++..||+|++... .....+.+.+|+.++..++||||+++
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~-----------~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~ 96 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYK-----------NEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNL 96 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEE-----------CCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcce
Confidence 3467999999999999999998654 123468999998643 23345678999999999999999999
Q ss_pred eeEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 589 FGCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
++++.+.+..++||||..... ......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~ 173 (340)
T PTZ00426 97 YGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMT 173 (340)
T ss_pred EEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEe
Confidence 999999999999999953322 223456889999999999999999999998 9999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 665 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
|||+++..... .....||+.|+|||++.+..++.++|||||||+++||++|+.||..... .... .....
T Consensus 174 DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--~~~~----~~i~~ 242 (340)
T PTZ00426 174 DFGFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP--LLIY----QKILE 242 (340)
T ss_pred cCCCCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH--HHHH----HHHhc
Confidence 99999875422 2345789999999999998999999999999999999999999864321 1111 11111
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH--hhc------cccCCCCCCCCCC
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRP-----TMLEVVAM--LKD------EIVNLPSPHQPAF 807 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~--Le~------~~~~~~~p~~p~~ 807 (840)
... .+ +......+.+++.+||+.||++|+ +++++++. +++ ....++.|..|.+
T Consensus 243 ~~~--~~--------p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~ 308 (340)
T PTZ00426 243 GII--YF--------PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKY 308 (340)
T ss_pred CCC--CC--------CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCC
Confidence 100 00 111234467899999999999995 88888764 221 1224566667765
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=333.02 Aligned_cols=254 Identities=20% Similarity=0.267 Sum_probs=196.6
Q ss_pred HHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCc
Q 041702 508 SISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNL 585 (840)
Q Consensus 508 ~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~ni 585 (840)
+.....++|.+.+.||+|+||.||+|.+. .+++.||||++.... ......+.+|+.++..++|+|+
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~------------~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~i 93 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRV------------SDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSI 93 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEc------------CCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcE
Confidence 34455689999999999999999999654 678999999986542 3345678899999999999999
Q ss_pred cceeeEeecCC--------ceEEEEEeeccCCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCC
Q 041702 586 VRLFGCCIEQG--------EKISIYEFDIVTDP--------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLK 649 (840)
Q Consensus 586 v~l~g~~~~~~--------~~~lv~e~~~~~~~--------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk 649 (840)
++++..+...+ ..++||||...... .....+++.....++.|++.||.|||+.+ |+|||||
T Consensus 94 v~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLK 170 (496)
T PTZ00283 94 VKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIK 170 (496)
T ss_pred EEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCC
Confidence 99988775443 25788998433222 12346888899999999999999999988 9999999
Q ss_pred CCcEEecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCC
Q 041702 650 ASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNT 729 (840)
Q Consensus 650 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~ 729 (840)
|+|||++.++.+||+|||+++.+.............||+.|+|||.+.+..++.++|||||||+||||++|+.||.....
T Consensus 171 P~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~ 250 (496)
T PTZ00283 171 SANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM 250 (496)
T ss_pred HHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 99999999999999999999876543322333456799999999999999999999999999999999999999854221
Q ss_pred CCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 730 DSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
. ... ....... .+ ..+......+.+++.+||+.||++||++.++++.
T Consensus 251 ~--~~~----~~~~~~~----~~-----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 251 E--EVM----HKTLAGR----YD-----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred H--HHH----HHHhcCC----CC-----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1 111 1111110 00 1112234568899999999999999999999863
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=296.97 Aligned_cols=246 Identities=21% Similarity=0.368 Sum_probs=202.1
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhcCCCCccce
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQHRNLVRL 588 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l 588 (840)
...+|++.+.||+|.||.|-+|.++ ..|+.||||.+++. +++..-.+++|++||+.|+||||+.+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~------------~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~I 118 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEH------------KSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQI 118 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhc------------cCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeeh
Confidence 3457888899999999999999765 57999999999865 34556678999999999999999999
Q ss_pred eeEeecCCceEEEEEee----ccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 589 FGCCIEQGEKISIYEFD----IVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~~----~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
+.+|...+...+||||. +.........|++.+...+++||..|+.|+|.++ ++|||||.+|||||+++++||+
T Consensus 119 yEVFENkdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIA 195 (668)
T KOG0611|consen 119 YEVFENKDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIA 195 (668)
T ss_pred hhhhcCCceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeee
Confidence 99999999999999993 4455667888999999999999999999999988 9999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhc
Q 041702 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLF-SIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWK 743 (840)
Q Consensus 665 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~ 743 (840)
|||++..+..... ....+|++.|.+||++.+.+| .+..|-|||||+||-|+.|.-||...+-. .++... .
T Consensus 196 DFGLSNly~~~kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk--~lvrQI----s 266 (668)
T KOG0611|consen 196 DFGLSNLYADKKF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK--RLVRQI----S 266 (668)
T ss_pred ccchhhhhccccH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH--HHHHHh----h
Confidence 9999988765443 345789999999999999998 57899999999999999999998653211 111111 0
Q ss_pred ccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 041702 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAML 792 (840)
Q Consensus 744 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 792 (840)
. ....+|. .+....-|+.|||-.+|++|-|+.+|....
T Consensus 267 ~---GaYrEP~--------~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 267 R---GAYREPE--------TPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred c---ccccCCC--------CCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 1 1111121 223456788999999999999999998654
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=301.69 Aligned_cols=253 Identities=25% Similarity=0.383 Sum_probs=198.7
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
++|+..+.||+|++|.||+|.++ .++..+|||.+.... ....++|.+|+.+++.++||||+++++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~------------~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~ 69 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCL------------LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeec------------CCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhh
Confidence 46788899999999999999754 578999999886532 233467899999999999999999999
Q ss_pred EeecCCceEEEEEeeccCCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCce
Q 041702 591 CCIEQGEKISIYEFDIVTDP--------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPK 662 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~~--------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 662 (840)
++.+.+..+++|||...... .....+++..++.++.||++||.|||+.+ ++|+||||+||+++.++.++
T Consensus 70 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~ 146 (267)
T cd08229 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVK 146 (267)
T ss_pred eeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEE
Confidence 99999999999998432211 12456899999999999999999999988 99999999999999999999
Q ss_pred eeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhh
Q 041702 663 ISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLW 742 (840)
Q Consensus 663 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~ 742 (840)
|+|||++........ ......++..|+|||.+.+..++.++||||||++++||++|..|+.....+.......
T Consensus 147 l~dfg~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~----- 219 (267)
T cd08229 147 LGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK----- 219 (267)
T ss_pred ECcchhhhccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhh-----
Confidence 999999876643221 1223468889999999998899999999999999999999999975332211111110
Q ss_pred cccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 743 KDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 743 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
......+... .......+.+++.+||+.+|++||||.+|++++++.
T Consensus 220 ----~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 220 ----IEQCDYPPLP---SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred ----hhcCCCCCCC---cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 0011111111 123445688999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=320.14 Aligned_cols=261 Identities=19% Similarity=0.235 Sum_probs=195.5
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
..+|.+.+.||+|+||.||++..+ ....+..||+|.+... +.+.+|++++++++||||+++++++
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~----------~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~ 155 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKH----------GDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAY 155 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEc----------CCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeE
Confidence 457999999999999999998643 1235678999998643 3457899999999999999999999
Q ss_pred ecCCceEEEEEeecc---CCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccc
Q 041702 593 IEQGEKISIYEFDIV---TDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIA 669 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~---~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla 669 (840)
...+..+++||+... ........+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 156 ~~~~~~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a 232 (392)
T PHA03207 156 RWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAA 232 (392)
T ss_pred eeCCEEEEEehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccc
Confidence 999999999998421 11233467899999999999999999999988 999999999999999999999999999
Q ss_pred eecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCC-ccHhHHHhhhhcccccc
Q 041702 670 RTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDS-LTLLGHAWNLWKDDKAW 748 (840)
Q Consensus 670 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~ 748 (840)
..+.............||+.|+|||++.+..++.++|||||||++|||++|+.|+....... .................
T Consensus 233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~ 312 (392)
T PHA03207 233 CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLE 312 (392)
T ss_pred cccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccc
Confidence 87654433333445679999999999999999999999999999999999999986543322 11111111110000000
Q ss_pred -----------------cccCcccc-chh--hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 749 -----------------KLMDPTMQ-NEA--LYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 749 -----------------~~~d~~l~-~~~--~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
....+... +.. .......+.+++.+||+.||++|||+.|++..
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 313 FPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000 000 01123457789999999999999999999865
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=303.80 Aligned_cols=249 Identities=24% Similarity=0.386 Sum_probs=188.1
Q ss_pred cccccccCCCCccEEEeecceeehhccccCcccCC--ceEEEEEeccC--CCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 517 SEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNG--EEVAVKRLSSK--SGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 517 ~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g--~~VAvK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
.+.++||+|+||.||+|.+. .++ ..||+|.++.. .....+.|.+|++++.+++|+||+++++++
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~------------~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 69 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLN------------QDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVC 69 (272)
T ss_pred ccccccCcccCceEEEeEEc------------cCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 45678999999999998654 223 36999998754 234457799999999999999999999988
Q ss_pred ecC------CceEEEEEeeccCCc----------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEec
Q 041702 593 IEQ------GEKISIYEFDIVTDP----------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLD 656 (840)
Q Consensus 593 ~~~------~~~~lv~e~~~~~~~----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~ 656 (840)
... ...++++||...... .....+++.....++.|++.||+|||+.+ |+||||||+|||++
T Consensus 70 ~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~ 146 (272)
T cd05075 70 LQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLN 146 (272)
T ss_pred ccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEc
Confidence 542 246788898432221 12345889999999999999999999987 99999999999999
Q ss_pred CCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHh
Q 041702 657 SDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLL 735 (840)
Q Consensus 657 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~ 735 (840)
+++.+||+|||+++...............+++.|+|||.+.+..++.++||||||++++||++ |+.|+..... ..
T Consensus 147 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~-- 222 (272)
T cd05075 147 ENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--SE-- 222 (272)
T ss_pred CCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--HH--
Confidence 999999999999987644332222223345678999999999999999999999999999999 7777754221 11
Q ss_pred HHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 736 GHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 736 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
............ ........+.+++.+||+.+|++|||+.+|++.|+++
T Consensus 223 --~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 223 --IYDYLRQGNRLK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred --HHHHHHcCCCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111111111100 0112334578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=300.43 Aligned_cols=247 Identities=29% Similarity=0.402 Sum_probs=191.2
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCI 593 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~ 593 (840)
++|+..+.||+|+||.||+|.++ ++..+|+|.+... ....++|.+|++++++++||||+++++++.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-------------~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 69 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-------------AQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-------------cCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEc
Confidence 45788899999999999998643 4568999998643 334578999999999999999999999999
Q ss_pred cCCceEEEEEeeccCCcc-----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccc
Q 041702 594 EQGEKISIYEFDIVTDPA-----RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGI 668 (840)
Q Consensus 594 ~~~~~~lv~e~~~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl 668 (840)
+.+..+++|||....... ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 70 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~ 146 (256)
T cd05114 70 QQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGM 146 (256)
T ss_pred cCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCC
Confidence 999999999994322111 1235889999999999999999999988 99999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhccccc
Q 041702 669 ARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKDDKA 747 (840)
Q Consensus 669 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 747 (840)
++........ ......++..|+|||.+.+..++.++||||||++++||++ |+.|+..... ....... ....
T Consensus 147 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--~~~~~~i---~~~~-- 218 (256)
T cd05114 147 TRYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--YEVVEMI---SRGF-- 218 (256)
T ss_pred ccccCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH---HCCC--
Confidence 9865332211 1222345668999999988889999999999999999999 8888753321 1111111 1110
Q ss_pred ccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 041702 748 WKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLK 793 (840)
Q Consensus 748 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le 793 (840)
....+.. ....+.+++.+||+.+|++||+++++++.|.
T Consensus 219 -~~~~~~~-------~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 219 -RLYRPKL-------ASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred -CCCCCCC-------CCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1111111 2345789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=320.21 Aligned_cols=258 Identities=19% Similarity=0.267 Sum_probs=191.5
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
+|+..++||+|+||.||+|.+. .+++.||||++.... ....+++.+|+++++.++||||+++++++
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 68 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDP------------RDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDIL 68 (372)
T ss_pred CCcccceeeeCCCEEEEEEEEC------------CCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhhee
Confidence 4778899999999999999754 578999999986532 23456789999999999999999999999
Q ss_pred ecCC-----ceEEEEEeeccC---CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 593 IEQG-----EKISIYEFDIVT---DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 593 ~~~~-----~~~lv~e~~~~~---~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
...+ ..++|+||.... .......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 69 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~ 145 (372)
T cd07853 69 QPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKIC 145 (372)
T ss_pred cCCCccccceEEEEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEec
Confidence 8776 789999984321 1223456899999999999999999999988 9999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhc
Q 041702 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWK 743 (840)
Q Consensus 665 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~ 743 (840)
|||+++........ ......+++.|+|||.+.+. .++.++|||||||+++||++|+.||....... ..........
T Consensus 146 Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~g 222 (372)
T cd07853 146 DFGLARVEEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ--QLDLITDLLG 222 (372)
T ss_pred cccceeecccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH--HHHHHHHHcC
Confidence 99999875433221 22334678999999998874 47999999999999999999999986543221 1111000000
Q ss_pred cccc----------c-cccCccccc-------hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 744 DDKA----------W-KLMDPTMQN-------EALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 744 ~~~~----------~-~~~d~~l~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.... . .+....... .......+.+.+++.+||+.||++|||+.|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 223 TPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred CCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 0000 0 000000000 001112456789999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=313.92 Aligned_cols=251 Identities=21% Similarity=0.260 Sum_probs=191.9
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC----CCcCHHHHHHHHHHHhhc-CCCCcccee
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK----SGQGLEEFKNEMMLIAKL-QHRNLVRLF 589 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~----~~~~~~~f~~Ev~~l~~l-~H~niv~l~ 589 (840)
+|++.+.||+|+||.||+|++. ....+++.||+|++.+. .....+.+.+|+.++.++ +|+||++++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~ 71 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKV---------TGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLH 71 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEc---------ccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEE
Confidence 4788899999999999998754 33457899999998643 123346788999999999 599999999
Q ss_pred eEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 590 GCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
+++...+..+++|||..... ......+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 72 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~D 148 (332)
T cd05614 72 YAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTD 148 (332)
T ss_pred EEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEee
Confidence 99999999999999953322 223456889999999999999999999988 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
||+++.+..... .......||+.|+|||.+.+. .++.++|||||||+++||++|+.|+......... .........
T Consensus 149 fG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~~~~~~~~ 225 (332)
T cd05614 149 FGLSKEFLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ--SEVSRRILK 225 (332)
T ss_pred CcCCccccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH--HHHHHHHhc
Confidence 999986533221 122345789999999998865 4789999999999999999999998643322211 011110000
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRP-----TMLEVVA 790 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 790 (840)
.++.+. ......+.+++.+||+.||++|| +++++++
T Consensus 226 ------~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 ------CDPPFP----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred ------CCCCCC----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 111111 12334577899999999999999 6667764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=317.12 Aligned_cols=250 Identities=23% Similarity=0.316 Sum_probs=195.0
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
++|.+.+.||+|+||.||+|++. .+++.||||+++... ......+.+|++++..++||||+++++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~------------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~ 68 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDK------------DTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYY 68 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEEC------------CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhh
Confidence 46888999999999999999765 578999999997542 244567899999999999999999999
Q ss_pred EeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 591 CCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
++.+.+..++||||..... ......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 69 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Df 145 (350)
T cd05573 69 SFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADF 145 (350)
T ss_pred heecCCeEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecC
Confidence 9999999999999953222 122357889999999999999999999988 999999999999999999999999
Q ss_pred ccceecCCCC---------------------------cccccccccccccccCccccccCCCCccccchhHHHHHHHHHh
Q 041702 667 GIARTFGGDE---------------------------MQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719 (840)
Q Consensus 667 Gla~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt 719 (840)
|++....... .........||+.|+|||.+.+..++.++|||||||+|+||++
T Consensus 146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~ 225 (350)
T cd05573 146 GLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLY 225 (350)
T ss_pred CCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhcc
Confidence 9998664332 0012234568999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 041702 720 SKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPT-MLEVVAM 791 (840)
Q Consensus 720 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~~ 791 (840)
|+.|+....... . .......... ...+.. ......+.+++..|++ +|.+||+ ++++++.
T Consensus 226 g~~Pf~~~~~~~--~---~~~i~~~~~~--~~~p~~-----~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 226 GFPPFYSDTLQE--T---YNKIINWKES--LRFPPD-----PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCCCCCCCCHHH--H---HHHHhccCCc--ccCCCC-----CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 999986433111 0 0111110000 000000 1134567788899997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=314.16 Aligned_cols=241 Identities=23% Similarity=0.299 Sum_probs=186.9
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC----CCcCHHHHHHHHHHHhhcCCCCccceeeEeecC
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK----SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQ 595 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~----~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~ 595 (840)
++||+|+||.||+|.+. ....+++.||||+++.. .......+.+|+.+|++++||||+++++++..+
T Consensus 2 ~~lg~G~~g~V~~~~~~---------~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~ 72 (323)
T cd05584 2 KVLGKGGYGKVFQVRKV---------TGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTG 72 (323)
T ss_pred ceeeecCCeEEEEEEEc---------ccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecC
Confidence 57999999999998754 22357889999998753 223345688999999999999999999999999
Q ss_pred CceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccccee
Q 041702 596 GEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 596 ~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
+..+++|||..... ......+.+.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 149 (323)
T cd05584 73 GKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKE 149 (323)
T ss_pred CeEEEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCee
Confidence 99999999843222 223455778888899999999999999988 99999999999999999999999999875
Q ss_pred cCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccccccccc
Q 041702 672 FGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLM 751 (840)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (840)
..... .......||+.|+|||++.+..++.++|||||||+++||++|+.||...... . ...... ...
T Consensus 150 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~--~---~~~~~~-~~~----- 216 (323)
T cd05584 150 SIHEG--TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK--K---TIDKIL-KGK----- 216 (323)
T ss_pred cccCC--CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH--H---HHHHHH-cCC-----
Confidence 43222 1223456899999999999988999999999999999999999998643211 1 111111 110
Q ss_pred CccccchhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041702 752 DPTMQNEALYSMVTRYIKVALLCVQENATDRP-----TMLEVVA 790 (840)
Q Consensus 752 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 790 (840)
..+ +......+.+++.+||+.+|++|| +++++++
T Consensus 217 -~~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 217 -LNL----PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred -CCC----CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 011 112234578999999999999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=320.79 Aligned_cols=250 Identities=21% Similarity=0.289 Sum_probs=188.4
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
.|...++||+|+||.||+|+++ .+++.||||++.... ....+.+.+|++++.+++||||++++++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~------------~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~ 69 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKV------------DTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYS 69 (381)
T ss_pred CceEEEEEeecCCEEEEEEEEC------------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEE
Confidence 5788899999999999999765 578999999997542 2345678999999999999999999999
Q ss_pred eecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 592 CIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
+.+.+..++||||..... ......+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 70 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFG 146 (381)
T cd05626 70 FQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFG 146 (381)
T ss_pred EecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCc
Confidence 999999999999953322 223456888888999999999999999988 9999999999999999999999999
Q ss_pred cceecCCCCc---------------------------------------------ccccccccccccccCccccccCCCC
Q 041702 668 IARTFGGDEM---------------------------------------------QSNTNRIVGTYGYMSPEYALHGLFS 702 (840)
Q Consensus 668 la~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~ 702 (840)
+++.+..... .......+||+.|+|||.+.+..++
T Consensus 147 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~ 226 (381)
T cd05626 147 LCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT 226 (381)
T ss_pred CCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC
Confidence 9864321000 0001235799999999999999999
Q ss_pred ccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHH--ccccCCC
Q 041702 703 IKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALL--CVQENAT 780 (840)
Q Consensus 703 ~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~--Cl~~dP~ 780 (840)
.++|||||||+++||++|+.||......... ............ .........+.+++.+ |+..+|.
T Consensus 227 ~~~DiwSlG~il~elltG~~Pf~~~~~~~~~-----~~i~~~~~~~~~-------~~~~~~s~~~~dli~~ll~~~~~~~ 294 (381)
T cd05626 227 QLCDWWSVGVILFEMLVGQPPFLAPTPTETQ-----LKVINWENTLHI-------PPQVKLSPEAVDLITKLCCSAEERL 294 (381)
T ss_pred CccceeehhhHHHHHHhCCCCCcCCCHHHHH-----HHHHccccccCC-------CCCCCCCHHHHHHHHHHccCccccc
Confidence 9999999999999999999998653321111 001000000000 0001123345666666 5666777
Q ss_pred CCCCHHHHHHH
Q 041702 781 DRPTMLEVVAM 791 (840)
Q Consensus 781 ~RPs~~evl~~ 791 (840)
.||+++++++.
T Consensus 295 ~R~~~~~~l~h 305 (381)
T cd05626 295 GRNGADDIKAH 305 (381)
T ss_pred CCCCHHHHhcC
Confidence 79999999863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=304.79 Aligned_cols=257 Identities=26% Similarity=0.423 Sum_probs=197.5
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
.++|.+.+.||+|+||.||+|.++.. .....+..||+|.+..... .....|.+|+.++..++||||++++++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~-------~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~ 77 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGV-------VKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGV 77 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEecc-------CCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEE
Confidence 46788889999999999999876511 1123567899999875432 334578999999999999999999999
Q ss_pred eecCCceEEEEEeeccCCc--------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecC
Q 041702 592 CIEQGEKISIYEFDIVTDP--------------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS 657 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~~--------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~ 657 (840)
+...+..++++||...... .....+++..++.++.|++.||.|||+.+ ++||||||+|||++.
T Consensus 78 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~ 154 (277)
T cd05032 78 VSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAE 154 (277)
T ss_pred EcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcC
Confidence 9999999999998422111 12234788999999999999999999988 999999999999999
Q ss_pred CCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhH
Q 041702 658 DMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLG 736 (840)
Q Consensus 658 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~ 736 (840)
++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||++++||++ |+.|+...... ...
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~- 231 (277)
T cd05032 155 DLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--EVL- 231 (277)
T ss_pred CCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH--HHH-
Confidence 99999999999987644333222333456789999999988899999999999999999998 88887533211 111
Q ss_pred HHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 041702 737 HAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794 (840)
Q Consensus 737 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~ 794 (840)
......... .. +......+.+++.+||+.+|++|||+.++++.|++
T Consensus 232 ---~~~~~~~~~-----~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 232 ---KFVIDGGHL-----DL----PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred ---HHHhcCCCC-----CC----CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 111111111 11 11124568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=323.82 Aligned_cols=254 Identities=20% Similarity=0.249 Sum_probs=185.6
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
..++|...++||+|+||.||+|.+. .+++.||||++.... ....+|+.+|++++||||++++++
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~------------~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~ 127 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICI------------DTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDY 127 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEEC------------CCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeee
Confidence 4568999999999999999999754 578899999986432 334579999999999999999988
Q ss_pred eecC--------CceEEEEEeeccC-------CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEec
Q 041702 592 CIEQ--------GEKISIYEFDIVT-------DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLD 656 (840)
Q Consensus 592 ~~~~--------~~~~lv~e~~~~~-------~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~ 656 (840)
+... ...++||||.... .......+++.....++.||+.||+|||+.+ |+||||||+|||++
T Consensus 128 ~~~~~~~~~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~ 204 (440)
T PTZ00036 128 YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLID 204 (440)
T ss_pred EeecccccCCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEc
Confidence 6432 1356799984321 1123456889999999999999999999998 99999999999999
Q ss_pred CCC-CceeeccccceecCCCCcccccccccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccH
Q 041702 657 SDM-NPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTL 734 (840)
Q Consensus 657 ~~~-~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~ 734 (840)
.++ .+||+|||+|+.+..... .....||+.|+|||++.+. .++.++|||||||+|+||++|++||......+ .
T Consensus 205 ~~~~~vkL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--~ 279 (440)
T PTZ00036 205 PNTHTLKLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD--Q 279 (440)
T ss_pred CCCCceeeeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--H
Confidence 765 699999999987643221 2235689999999988764 68999999999999999999999986433211 1
Q ss_pred hHHHhhhhccc----------ccccccCccc-----cchhhHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 041702 735 LGHAWNLWKDD----------KAWKLMDPTM-----QNEALYSMVTRYIKVALLCVQENATDRPTMLEVV 789 (840)
Q Consensus 735 ~~~~~~~~~~~----------~~~~~~d~~l-----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 789 (840)
........... ....+.-+.. ....+......+.+++.+||+.||.+|||+.|++
T Consensus 280 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l 349 (440)
T PTZ00036 280 LVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEAL 349 (440)
T ss_pred HHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 11111100000 0000000111 1111112345688999999999999999999998
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=325.37 Aligned_cols=253 Identities=24% Similarity=0.310 Sum_probs=200.5
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcC-CCCccceee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQ-HRNLVRLFG 590 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~-H~niv~l~g 590 (840)
...++++.+.|.+|||+.||.|.+. ..|..+|+|++-..++...+..++||.+|++|+ |+|||.+++
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~------------~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yid 102 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDV------------KGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYID 102 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEec------------CCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEec
Confidence 4467788899999999999999765 444899999998778888899999999999996 999999999
Q ss_pred E-eec------CCceEEEEEeeccCC------ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecC
Q 041702 591 C-CIE------QGEKISIYEFDIVTD------PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS 657 (840)
Q Consensus 591 ~-~~~------~~~~~lv~e~~~~~~------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~ 657 (840)
. ... .-+.+|.|||..... ......|++.++++|+.++++|+++||... ++|||||||-+||||..
T Consensus 103 ss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~ 181 (738)
T KOG1989|consen 103 SSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSA 181 (738)
T ss_pred cccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcC
Confidence 3 221 135778888843211 112344999999999999999999999975 78999999999999999
Q ss_pred CCCceeeccccceecCCCCccccc-------ccccccccccCcccc---ccCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 041702 658 DMNPKISDFGIARTFGGDEMQSNT-------NRIVGTYGYMSPEYA---LHGLFSIKSDVFSFGVLLLEILSSKKNTRFY 727 (840)
Q Consensus 658 ~~~~kL~DFGla~~~~~~~~~~~~-------~~~~gt~~y~aPE~~---~~~~~~~ksDV~SlGviL~elltG~~p~~~~ 727 (840)
+++.||||||.|............ -...-|+-|+|||.+ .+.++++|+|||+|||+||-|.....||+..
T Consensus 182 ~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 182 DGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred CCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 999999999999654222111100 112358899999976 5788999999999999999999999998643
Q ss_pred CCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 728 NTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
. ...+++....-........++.+||..||+.||.+||++-||++.+-++
T Consensus 262 g------------------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l 311 (738)
T KOG1989|consen 262 G------------------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL 311 (738)
T ss_pred c------------------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence 2 1123333333333456788899999999999999999999999998776
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=309.10 Aligned_cols=262 Identities=26% Similarity=0.405 Sum_probs=198.4
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhc-CCCCcccee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKL-QHRNLVRLF 589 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l-~H~niv~l~ 589 (840)
..++|.+.+.||+|+||.||+|.+... ......++..||+|.+.... ....+++.+|+.++..+ +||||++++
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGI-----DKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEecc-----CCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchhee
Confidence 456788889999999999999864300 00122345689999987542 34457799999999999 899999999
Q ss_pred eEeecCCceEEEEEeeccCCc--------------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCC
Q 041702 590 GCCIEQGEKISIYEFDIVTDP--------------------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLK 649 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~~~--------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk 649 (840)
+++...+..+++|||...... .....+++.+++.++.||+.||.|||+.+ ++|||||
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlk 164 (304)
T cd05101 88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLA 164 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccc
Confidence 999999999999998422111 11245788999999999999999999988 9999999
Q ss_pred CCcEEecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCC
Q 041702 650 ASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYN 728 (840)
Q Consensus 650 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~ 728 (840)
|+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |..|+....
T Consensus 165 p~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 165 ARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred cceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999987654333222333445678999999998899999999999999999998 677664321
Q ss_pred CCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 041702 729 TDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEI 796 (840)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~ 796 (840)
.. . ........... .........+.+++.+||+.+|++||++.||++.|++++
T Consensus 245 ~~--~----~~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~ 297 (304)
T cd05101 245 VE--E----LFKLLKEGHRM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297 (304)
T ss_pred HH--H----HHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence 11 1 11111111100 011123456788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=310.20 Aligned_cols=262 Identities=28% Similarity=0.408 Sum_probs=197.2
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhc-CCCCccceee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKL-QHRNLVRLFG 590 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l-~H~niv~l~g 590 (840)
.++|.+.+.||+|+||.||+|.+... ..........+|+|.+.... .....++.+|++++.++ +||||+++++
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~-----~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGL-----DKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG 91 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEecc-----CCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 46799999999999999999875410 00111245679999997542 23456788999999999 7999999999
Q ss_pred EeecCCceEEEEEeeccCCc--------------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCC
Q 041702 591 CCIEQGEKISIYEFDIVTDP--------------------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKA 650 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~~--------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp 650 (840)
++...+..++++||...... .....+++.++++++.|++.||+|||+.+ ++||||||
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp 168 (307)
T cd05098 92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAA 168 (307)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccH
Confidence 99999999999998432111 11235889999999999999999999988 99999999
Q ss_pred CcEEecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCC
Q 041702 651 SNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNT 729 (840)
Q Consensus 651 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~ 729 (840)
+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||+++||++ |+.|+.....
T Consensus 169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred HheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 999999999999999999976643222222222234568999999999999999999999999999998 7777643221
Q ss_pred CCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 730 DSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
. ... ....... ....+......+.+++.+||+.+|++||+|.+|++.|+++..
T Consensus 249 ~--~~~----~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 249 E--ELF----KLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred H--HHH----HHHHcCC---------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 1 111 1111110 011112234567889999999999999999999999998744
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=302.36 Aligned_cols=270 Identities=27% Similarity=0.389 Sum_probs=194.5
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccc----cCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccce
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWK----QGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRL 588 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~----~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l 588 (840)
++|++.++||+|+||.||++.+......... .....++..||+|+++... ....++|.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 5688999999999999999854310000000 0011245579999997543 3345689999999999999999999
Q ss_pred eeEeecCCceEEEEEeeccCCc---------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcE
Q 041702 589 FGCCIEQGEKISIYEFDIVTDP---------------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNV 653 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~~~~~~~---------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NI 653 (840)
++++...+..+++|||...... .....+++.++..++.|++.||+|||+.+ ++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 9999999999999998422111 11234778899999999999999999998 99999999999
Q ss_pred EecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh--CCCCCCCCCCCC
Q 041702 654 LLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS--SKKNTRFYNTDS 731 (840)
Q Consensus 654 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt--G~~p~~~~~~~~ 731 (840)
|++.++.+||+|||+++.+.............++..|+|||...++.++.++|||||||++|||++ |..|+.....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~-- 239 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD-- 239 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh--
Confidence 999999999999999986644332222233445678999999888899999999999999999998 5556543221
Q ss_pred ccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 041702 732 LTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794 (840)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~ 794 (840)
................ ....+ .+...+..+.+++.+||+.||++||++.+|++.|++
T Consensus 240 ~~~~~~~~~~~~~~~~-~~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 EQVIENTGEFFRDQGR-QVYLP-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHHHHHhhccc-cccCC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1111111111111100 00000 111233568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=299.92 Aligned_cols=247 Identities=28% Similarity=0.397 Sum_probs=190.9
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCI 593 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~ 593 (840)
++|...+.||+|+||.||+|.+. ++..+|||.+... ....++|.+|+.++.+++||||+++++++.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-------------~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 69 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR-------------GQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec-------------CCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 45778889999999999998543 3456999998754 334578999999999999999999999999
Q ss_pred cCCceEEEEEeeccCC----c-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccc
Q 041702 594 EQGEKISIYEFDIVTD----P-ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGI 668 (840)
Q Consensus 594 ~~~~~~lv~e~~~~~~----~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl 668 (840)
+.+..+++|||..... . .....+++..+++++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||+
T Consensus 70 ~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~ 146 (256)
T cd05113 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGL 146 (256)
T ss_pred cCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCcc
Confidence 9999999999843221 1 11236899999999999999999999988 99999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhccccc
Q 041702 669 ARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKDDKA 747 (840)
Q Consensus 669 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 747 (840)
++........ ......++..|+|||.+.+..++.++||||||++++||++ |+.|+...... ..... ......
T Consensus 147 ~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~---~~~~~~- 219 (256)
T cd05113 147 SRYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--ETVEK---VSQGLR- 219 (256)
T ss_pred ceecCCCcee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHH---HhcCCC-
Confidence 9866433221 1122335678999999988889999999999999999998 88887533211 11111 111100
Q ss_pred ccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 041702 748 WKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLK 793 (840)
Q Consensus 748 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le 793 (840)
. .........+.+++.+||+.+|.+||++.+|++.|+
T Consensus 220 --~-------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 220 --L-------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --C-------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0 001112456889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=308.53 Aligned_cols=260 Identities=28% Similarity=0.408 Sum_probs=198.0
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhc-CCCCcccee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKL-QHRNLVRLF 589 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l-~H~niv~l~ 589 (840)
..++|...+.||+|+||.||+|.+.. ......+..||||+++... ....+.+.+|+++++++ +||||++++
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~-------~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 105 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYG-------LSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLL 105 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEec-------CCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEE
Confidence 34678999999999999999986420 0122356689999987543 23346799999999999 799999999
Q ss_pred eEeecCCceEEEEEeeccCCcc------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCcee
Q 041702 590 GCCIEQGEKISIYEFDIVTDPA------RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKI 663 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~~~~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL 663 (840)
+++...+..++++||....... ....+++.++..++.|++.||+|||+.+ |+|+||||+|||++.++.+||
T Consensus 106 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l 182 (302)
T cd05055 106 GACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKI 182 (302)
T ss_pred EEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEE
Confidence 9999999999999995332211 1233899999999999999999999988 999999999999999999999
Q ss_pred eccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhh
Q 041702 664 SDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLW 742 (840)
Q Consensus 664 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 742 (840)
+|||+++.+.............++..|+|||.+.+..++.++|||||||+++||++ |+.|+....... ... ...
T Consensus 183 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-~~~----~~~ 257 (302)
T cd05055 183 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-KFY----KLI 257 (302)
T ss_pred CCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-HHH----HHH
Confidence 99999986643322112223446778999999999999999999999999999998 888875432211 110 111
Q ss_pred cccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 743 KDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 743 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
... ............+.+++.+||+.+|++||++.||++.|++.
T Consensus 258 ~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 258 KEG---------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HcC---------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 111 00001112234688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=304.92 Aligned_cols=272 Identities=23% Similarity=0.334 Sum_probs=194.6
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
.++|+..+.||+|+||.||++.... -...++..||+|++........+.|.+|++++.+++||||+++++++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~--------~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 74 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDP--------LQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVC 74 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecC--------CcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEE
Confidence 3578888999999999999985320 12346889999999866555567899999999999999999999987
Q ss_pred ecC--CceEEEEEeeccCCcc-----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 593 IEQ--GEKISIYEFDIVTDPA-----RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 593 ~~~--~~~~lv~e~~~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
... ...++++||....... ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|
T Consensus 75 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~d 151 (284)
T cd05081 75 YSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGD 151 (284)
T ss_pred ccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECC
Confidence 543 4678999985322211 1345899999999999999999999988 99999999999999999999999
Q ss_pred cccceecCCCCccc-ccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhh-hhc
Q 041702 666 FGIARTFGGDEMQS-NTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWN-LWK 743 (840)
Q Consensus 666 FGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~-~~~ 743 (840)
||+++......... ......++..|+|||.+.+..++.++|||||||+++||++|..+................. ...
T Consensus 152 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd05081 152 FGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMI 231 (284)
T ss_pred CcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccc
Confidence 99998764332211 1112223456999999998899999999999999999999876643221100000000000 000
Q ss_pred ccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 744 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
.....+.+...............+.+++.+||+.+|++|||+.||++.|+.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 232 VYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0000000111111111122345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=314.24 Aligned_cols=261 Identities=21% Similarity=0.228 Sum_probs=193.0
Q ss_pred HHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC--CCcCHHHHHHHHHHHhhcCCCCccce
Q 041702 511 AATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK--SGQGLEEFKNEMMLIAKLQHRNLVRL 588 (840)
Q Consensus 511 ~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l 588 (840)
...++|+..+.||+|+||.||+|.++ .+++.||||++... ......++.+|+.++..++||||+++
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 85 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDT------------VLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISL 85 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEc------------CCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeee
Confidence 34688999999999999999999765 57899999999753 23345678899999999999999999
Q ss_pred eeEeecCC------ceEEEEEeeccCCcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCc
Q 041702 589 FGCCIEQG------EKISIYEFDIVTDPA-RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP 661 (840)
Q Consensus 589 ~g~~~~~~------~~~lv~e~~~~~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 661 (840)
++++...+ ..+++|||....... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 86 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~ 162 (359)
T cd07876 86 LNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 162 (359)
T ss_pred eeeeccCCCccccceeEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCE
Confidence 99986543 468999984322111 1234778888999999999999999998 9999999999999999999
Q ss_pred eeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhh-
Q 041702 662 KISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWN- 740 (840)
Q Consensus 662 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~- 740 (840)
||+|||+++...... ......+|+.|+|||.+.+..++.++|||||||++|||++|+.||....... .......
T Consensus 163 kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~--~~~~~~~~ 237 (359)
T cd07876 163 KILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID--QWNKVIEQ 237 (359)
T ss_pred EEecCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHh
Confidence 999999997643221 2233568999999999999999999999999999999999999986442211 0000000
Q ss_pred ------------------hhccccc------ccccCcccc---chhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 741 ------------------LWKDDKA------WKLMDPTMQ---NEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 741 ------------------~~~~~~~------~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
....... .+....-.. ..........+.+++.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 238 LGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred cCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000 000000000 00011123457899999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=300.02 Aligned_cols=246 Identities=26% Similarity=0.378 Sum_probs=187.7
Q ss_pred cccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC--cCHHHHHHHHHHHhhcCCCCccceeeEeecCCce
Q 041702 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG--QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEK 598 (840)
Q Consensus 521 ~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~ 598 (840)
+||+|+||.||+|.++ ...++..+|+|+++.... ...++|.+|+.++++++||||+++++++. .+..
T Consensus 2 ~lg~G~~g~v~~~~~~----------~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~ 70 (257)
T cd05116 2 ELGSGNFGTVKKGMYK----------MKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESW 70 (257)
T ss_pred cCCCcCCcceEEeEEe----------cCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCc
Confidence 6999999999998643 124678899999875432 33567999999999999999999999885 4567
Q ss_pred EEEEEeeccCCc----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceecCC
Q 041702 599 ISIYEFDIVTDP----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGG 674 (840)
Q Consensus 599 ~lv~e~~~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 674 (840)
+++|||...... .....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 71 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~ 147 (257)
T cd05116 71 MLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGA 147 (257)
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCC
Confidence 899998432221 23346889999999999999999999988 99999999999999999999999999987643
Q ss_pred CCccc-ccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhcccccccccC
Q 041702 675 DEMQS-NTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMD 752 (840)
Q Consensus 675 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 752 (840)
..... ......++..|+|||.+....++.++||||||++++||++ |+.|+...... ... ........
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~----~~i~~~~~----- 216 (257)
T cd05116 148 DENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVT----QMIESGER----- 216 (257)
T ss_pred CCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHH----HHHHCCCC-----
Confidence 32211 1112234578999999988889999999999999999998 89887643211 111 11111111
Q ss_pred ccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 753 PTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 753 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
...+......+.+++.+||+.||++||++.+|++.|++-
T Consensus 217 ----~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 217 ----MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred ----CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 011112345678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=305.55 Aligned_cols=261 Identities=24% Similarity=0.357 Sum_probs=196.9
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
..++|...+.||+|+||.||+|.+.. .....+..|++|++.... ....+.+.+|+.++++++||||+++++
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~--------~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~ 75 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILID--------EKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEec--------CCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 45788889999999999999987640 001236789999987542 234567899999999999999999999
Q ss_pred Eeec-CCceEEEEEeeccCCc-------c-----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecC
Q 041702 591 CCIE-QGEKISIYEFDIVTDP-------A-----RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS 657 (840)
Q Consensus 591 ~~~~-~~~~~lv~e~~~~~~~-------~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~ 657 (840)
++.+ +...++++|+...... . ....+++.+++.++.|++.||+|||+.+ ++||||||+||++++
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~ 152 (280)
T cd05043 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDE 152 (280)
T ss_pred EEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcC
Confidence 9876 4677888888432111 0 1146889999999999999999999987 999999999999999
Q ss_pred CCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhH
Q 041702 658 DMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLG 736 (840)
Q Consensus 658 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~ 736 (840)
++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||++++|+++ |+.|+..... .....
T Consensus 153 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~ 230 (280)
T cd05043 153 ELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAA 230 (280)
T ss_pred CCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHH
Confidence 99999999999986643332222223345678999999998899999999999999999999 9988753221 11111
Q ss_pred HHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccC
Q 041702 737 HAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVN 798 (840)
Q Consensus 737 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~ 798 (840)
..... ..... ....+..+.+++.+||+.+|++|||+.+|++.|+++.++
T Consensus 231 ----~~~~~--~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 231 ----YLKDG--YRLAQ-------PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred ----HHHcC--CCCCC-------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 11111 00000 111234678999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=308.67 Aligned_cols=260 Identities=21% Similarity=0.287 Sum_probs=192.0
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
++|...++||+|+||.||+|.++ .+++.||+|+++... ......+.+|+.++++++||||+++++++
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 73 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSK------------LTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73 (309)
T ss_pred CceEEEEEecccCCEEEEEEEec------------CCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEE
Confidence 57888999999999999999765 567899999987543 23345688999999999999999999999
Q ss_pred ecCCceEEEEEeeccCC---c-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccc
Q 041702 593 IEQGEKISIYEFDIVTD---P-ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGI 668 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~---~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl 668 (840)
...+..+++|||..... . .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 74 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~ 150 (309)
T cd07872 74 HTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGL 150 (309)
T ss_pred eeCCeEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcccc
Confidence 99999999999943211 1 12345788899999999999999999988 99999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCc-cHhHH--------H
Q 041702 669 ARTFGGDEMQSNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSL-TLLGH--------A 738 (840)
Q Consensus 669 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~-~~~~~--------~ 738 (840)
++....... ......+++.|+|||.+.+ ..++.++|||||||+++||++|+.||......+. ..... .
T Consensus 151 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 228 (309)
T cd07872 151 ARAKSVPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEET 228 (309)
T ss_pred ceecCCCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 976533221 1223467899999998865 5689999999999999999999999865433211 00000 0
Q ss_pred hhhhccccc-ccccCccccc----hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 739 WNLWKDDKA-WKLMDPTMQN----EALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 739 ~~~~~~~~~-~~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
|........ ...-.+.... .........+.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 229 WPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred HhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000000 0000000000 011123445789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=302.10 Aligned_cols=240 Identities=25% Similarity=0.297 Sum_probs=187.3
Q ss_pred ccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhcCCCCccceeeEeecCCce
Q 041702 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEK 598 (840)
Q Consensus 522 lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~ 598 (840)
||+|+||+||++.++ .+++.||||++.... ....+.+..|++++++++|+||+++.+++...+..
T Consensus 1 lg~G~~g~Vy~~~~~------------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~ 68 (280)
T cd05608 1 LGKGGFGEVSACQMR------------ATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDL 68 (280)
T ss_pred CCCCCceeEEEEEEc------------cCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeE
Confidence 799999999998765 678999999987532 22346788999999999999999999999999999
Q ss_pred EEEEEeeccCCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccce
Q 041702 599 ISIYEFDIVTDP--------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIAR 670 (840)
Q Consensus 599 ~lv~e~~~~~~~--------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~ 670 (840)
+++|||...... .....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 69 ~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~ 145 (280)
T cd05608 69 CLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAV 145 (280)
T ss_pred EEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccce
Confidence 999999533222 23356899999999999999999999988 9999999999999999999999999998
Q ss_pred ecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccccc
Q 041702 671 TFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKL 750 (840)
Q Consensus 671 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (840)
.+..... ......||+.|+|||.+.+..++.++|||||||+++||++|+.|+......... ...... +
T Consensus 146 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~--------~ 213 (280)
T cd05608 146 ELKDGQS--KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQR--------I 213 (280)
T ss_pred ecCCCCc--cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HHHHHh--------h
Confidence 7643322 223457899999999999999999999999999999999999998643322111 000000 0
Q ss_pred cCccccchhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041702 751 MDPTMQNEALYSMVTRYIKVALLCVQENATDRP-----TMLEVVA 790 (840)
Q Consensus 751 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 790 (840)
..... .........+.+++.+||+.||++|| +++++++
T Consensus 214 ~~~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 214 LNDSV--TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cccCC--CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 01100 11123445678999999999999999 6677774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=301.11 Aligned_cols=256 Identities=24% Similarity=0.405 Sum_probs=195.6
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
.++|+..+.||+|+||.||+|.+. ........+|+|++.... ....++|.+|++++.+++|||++++.++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 74 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILK---------MPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGV 74 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEe---------cCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEE
Confidence 457788899999999999999764 111233479999987542 3345679999999999999999999999
Q ss_pred eecCCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 592 CIEQGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
+...+..+++|||...... .....+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+||
T Consensus 75 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~df 151 (268)
T cd05063 75 VTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDF 151 (268)
T ss_pred EccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCC
Confidence 9999999999998432221 12346889999999999999999999988 999999999999999999999999
Q ss_pred ccceecCCCCccccc-ccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 667 GIARTFGGDEMQSNT-NRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 667 Gla~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
|++............ .....+..|+|||++.+..++.++|||||||++|||++ |+.|+...... ... .....
T Consensus 152 g~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--~~~----~~i~~ 225 (268)
T cd05063 152 GLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--EVM----KAIND 225 (268)
T ss_pred ccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--HHH----HHHhc
Confidence 999876433221111 11223457999999988889999999999999999997 99987543211 111 11111
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
. ............+.+++.+||+.+|++||++.+|++.|+++
T Consensus 226 ~---------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 226 G---------FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred C---------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 01111112345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=313.00 Aligned_cols=242 Identities=25% Similarity=0.338 Sum_probs=186.2
Q ss_pred CcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHH---hhcCCCCcccee
Q 041702 516 FSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLI---AKLQHRNLVRLF 589 (840)
Q Consensus 516 f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l---~~l~H~niv~l~ 589 (840)
|++.+.||+|+||.||+|.++ .+++.||||+++... ....+.+.+|++++ ++++||||++++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~------------~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~ 68 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYK------------KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLF 68 (324)
T ss_pred CeEEEEEeecCCEEEEEEEEC------------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhcee
Confidence 567789999999999999765 578999999997532 23445677777665 566899999999
Q ss_pred eEeecCCceEEEEEeeccCCc---cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 590 GCCIEQGEKISIYEFDIVTDP---ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
+++...+..++||||...... .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 69 ~~~~~~~~~~lv~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Df 145 (324)
T cd05589 69 ACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADF 145 (324)
T ss_pred eEEEcCCEEEEEEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcc
Confidence 999999999999999533221 23456899999999999999999999988 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccc
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDK 746 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 746 (840)
|+++...... .......|++.|+|||.+.+..++.++|||||||+++||++|+.|+...... .... .. ....
T Consensus 146 g~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~--~~~~---~i-~~~~ 217 (324)
T cd05589 146 GLCKEGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE--EVFD---SI-VNDE 217 (324)
T ss_pred cCCccCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH--HHHH---HH-HhCC
Confidence 9987532211 1223467899999999999999999999999999999999999998643211 1111 01 1100
Q ss_pred cccccCccccchhhHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 041702 747 AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPT-----MLEVVA 790 (840)
Q Consensus 747 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 790 (840)
... +......+.+++.+||+.||++||+ +.++++
T Consensus 218 ------~~~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 218 ------VRY----PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ------CCC----CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 001 1122445778999999999999994 555554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=307.33 Aligned_cols=253 Identities=25% Similarity=0.381 Sum_probs=192.2
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCC--ceEEEEEeccCC-CcCHHHHHHHHHHHhhc-CCCCcccee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNG--EEVAVKRLSSKS-GQGLEEFKNEMMLIAKL-QHRNLVRLF 589 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g--~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l-~H~niv~l~ 589 (840)
++|++.+.||+|+||.||+|.++ .++ ..+++|.++... ....+.|.+|+.++.++ +||||++++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~------------~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 69 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIK------------KDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69 (297)
T ss_pred ccceeeeeecCCCcceEEEEEec------------CCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheE
Confidence 57888899999999999998654 233 357889887432 23456799999999999 799999999
Q ss_pred eEeecCCceEEEEEeeccCCc--------------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCC
Q 041702 590 GCCIEQGEKISIYEFDIVTDP--------------------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLK 649 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~~~--------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk 649 (840)
+++.+.+..++++||...... .....+++..+..++.|++.||+|||+.+ |+|||||
T Consensus 70 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlk 146 (297)
T cd05089 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLA 146 (297)
T ss_pred EEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCC
Confidence 999999999999998422111 01235889999999999999999999988 9999999
Q ss_pred CCcEEecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCC
Q 041702 650 ASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYN 728 (840)
Q Consensus 650 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~ 728 (840)
|+|||+++++.+||+|||++...... ........+..|+|||.+.+..++.++|||||||+++||++ |..|+....
T Consensus 147 p~Nill~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~ 223 (297)
T cd05089 147 ARNVLVGENLASKIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT 223 (297)
T ss_pred cceEEECCCCeEEECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999999999999999998643211 11111223457999999998899999999999999999998 988875432
Q ss_pred CCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCC
Q 041702 729 TDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNL 799 (840)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~ 799 (840)
... .. ..... .............+.+++.+||+.+|.+||++++|++.|+++....
T Consensus 224 ~~~--~~----~~~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 224 CAE--LY----EKLPQ---------GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HHH--HH----HHHhc---------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 111 11 11110 0111111123356789999999999999999999999999876544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=310.22 Aligned_cols=256 Identities=26% Similarity=0.397 Sum_probs=205.3
Q ss_pred HHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccc
Q 041702 508 SISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVR 587 (840)
Q Consensus 508 ~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~ 587 (840)
+++....+....++||-|.||.||.|.|+ .-.-.||||.++.. ....++|+.|+.+|+.++|||+|+
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWK------------kyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVq 327 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWK------------KYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQ 327 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeee------------ccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHH
Confidence 34445566777899999999999999887 34567999999865 567899999999999999999999
Q ss_pred eeeEeecCCceEEEEEeeccCCc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCc
Q 041702 588 LFGCCIEQGEKISIYEFDIVTDP------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP 661 (840)
Q Consensus 588 l~g~~~~~~~~~lv~e~~~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 661 (840)
|+|+|...-.+|+|.|||...+. ..+..++-...++++.||+.|++||..+. +|||||.++|+|+.++..+
T Consensus 328 LLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiV 404 (1157)
T KOG4278|consen 328 LLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIV 404 (1157)
T ss_pred HhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceE
Confidence 99999999999999999755443 23455666677899999999999999988 9999999999999999999
Q ss_pred eeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhh
Q 041702 662 KISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWN 740 (840)
Q Consensus 662 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~ 740 (840)
||+|||+++.+..+.+... ...--...|.|||.+.-..++.|+|||+|||+||||.| |..|++.. ....++.
T Consensus 405 KvADFGLsRlMtgDTYTAH-AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi------dlSqVY~ 477 (1157)
T KOG4278|consen 405 KVADFGLSRLMTGDTYTAH-AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI------DLSQVYG 477 (1157)
T ss_pred EeeccchhhhhcCCceecc-cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc------cHHHHHH
Confidence 9999999998866544332 22233569999999999999999999999999999988 55555432 1223333
Q ss_pred hhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 741 LWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 741 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
++ +...+-+.+..+++.+.+|+..||+.+|.+||+++|+-+.+|.+
T Consensus 478 LL---------EkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 478 LL---------EKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred HH---------hccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 32 33333333444566788999999999999999999998888754
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=319.74 Aligned_cols=249 Identities=22% Similarity=0.284 Sum_probs=190.4
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
++|+..++||+|+||.||+|+++ .+++.||||++.... ......+.+|+.++..++||||+++++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~ 68 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKK------------DTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYY 68 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEEC------------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEE
Confidence 47889999999999999999765 578899999997532 234466889999999999999999999
Q ss_pred EeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 591 CCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
++.+++..++||||..... ......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 69 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Df 145 (364)
T cd05599 69 SFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDF 145 (364)
T ss_pred EEEcCCeEEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeec
Confidence 9999999999999953222 123456899999999999999999999998 999999999999999999999999
Q ss_pred ccceecCCCCccc------------------------------------ccccccccccccCccccccCCCCccccchhH
Q 041702 667 GIARTFGGDEMQS------------------------------------NTNRIVGTYGYMSPEYALHGLFSIKSDVFSF 710 (840)
Q Consensus 667 Gla~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDV~Sl 710 (840)
|++..+....... .....+||+.|+|||++.+..++.++|||||
T Consensus 146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 225 (364)
T cd05599 146 GLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSL 225 (364)
T ss_pred ccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecc
Confidence 9987653211000 0112469999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCC---HHH
Q 041702 711 GVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPT---MLE 787 (840)
Q Consensus 711 GviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~e 787 (840)
||+++||++|+.||....... .. ............ +. .....+.+.+++.+|+. +|.+|++ ++|
T Consensus 226 G~il~el~~G~~Pf~~~~~~~--~~---~~i~~~~~~~~~--~~-----~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ 292 (364)
T cd05599 226 GVIMYEMLVGYPPFCSDNPQE--TY---RKIINWKETLQF--PD-----EVPLSPEAKDLIKRLCC-EAERRLGNNGVNE 292 (364)
T ss_pred hhHHHHhhcCCCCCCCCCHHH--HH---HHHHcCCCccCC--CC-----CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHH
Confidence 999999999999986432211 11 111100000000 00 00123456778888886 9999998 888
Q ss_pred HHH
Q 041702 788 VVA 790 (840)
Q Consensus 788 vl~ 790 (840)
+++
T Consensus 293 ll~ 295 (364)
T cd05599 293 IKS 295 (364)
T ss_pred Hhc
Confidence 876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=302.04 Aligned_cols=252 Identities=25% Similarity=0.353 Sum_probs=191.3
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCC----ceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccc
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNG----EEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVR 587 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g----~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~ 587 (840)
.++|+..++||+|+||.||+|.+. .++ ..||+|+++... ....+++.+|+.++..++||||++
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~------------~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~ 73 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWI------------PDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEe------------cCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCce
Confidence 357888899999999999999754 233 358999987543 234567899999999999999999
Q ss_pred eeeEeecCCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCce
Q 041702 588 LFGCCIEQGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPK 662 (840)
Q Consensus 588 l~g~~~~~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 662 (840)
+++++... ..++++|+...... .....+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+|
T Consensus 74 ~~~~~~~~-~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~k 149 (279)
T cd05109 74 LLGICLTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVK 149 (279)
T ss_pred EEEEEcCC-CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEE
Confidence 99999754 46788887432221 11346889999999999999999999988 99999999999999999999
Q ss_pred eeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhh
Q 041702 663 ISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNL 741 (840)
Q Consensus 663 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~ 741 (840)
|+|||+++...............++..|+|||...+..++.++||||||+++|||++ |..|+..... .... ..
T Consensus 150 L~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~----~~ 223 (279)
T cd05109 150 ITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIP----DL 223 (279)
T ss_pred ECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHH----HH
Confidence 999999987643322222222334678999999999999999999999999999998 8888753221 1111 11
Q ss_pred hcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 742 WKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 742 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
....... .........+.+++.+||+.||++||++.++++.|+.+
T Consensus 224 ~~~~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 224 LEKGERL---------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred HHCCCcC---------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 1111000 01112344678899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=331.59 Aligned_cols=257 Identities=21% Similarity=0.299 Sum_probs=196.3
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC---cCHHHHHHHHHHHhhcCCCCccceee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG---QGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
++|++.++||+|+||.||+|.+. .+++.||||+++.... ...++|.+|++++++++||||+++++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~------------~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~ 69 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDP------------VCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEEC------------CCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEE
Confidence 57889999999999999999765 5688999999975422 23467999999999999999999999
Q ss_pred EeecCCceEEEEEeeccCCc---------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEe
Q 041702 591 CCIEQGEKISIYEFDIVTDP---------------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLL 655 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~~---------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl 655 (840)
++.+++..+++|||...... .....+++..+++++.||++||+|||+.+ |+||||||+|||+
T Consensus 70 v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILL 146 (932)
T PRK13184 70 ICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILL 146 (932)
T ss_pred EEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEE
Confidence 99999999999998422111 11234567788999999999999999988 9999999999999
Q ss_pred cCCCCceeeccccceecCCCCc----------------ccccccccccccccCccccccCCCCccccchhHHHHHHHHHh
Q 041702 656 DSDMNPKISDFGIARTFGGDEM----------------QSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719 (840)
Q Consensus 656 ~~~~~~kL~DFGla~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt 719 (840)
+.++.+||+|||+++....... .......+||+.|||||.+.+..++.++|||||||+++||+|
T Consensus 147 d~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLT 226 (932)
T PRK13184 147 GLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226 (932)
T ss_pred cCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHH
Confidence 9999999999999987621110 011123569999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhhccccC
Q 041702 720 SKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRP-TMLEVVAMLKDEIVN 798 (840)
Q Consensus 720 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~Le~~~~~ 798 (840)
|+.|+........... . .+.++... ....+.+..+.+++.+|++.||++|| +++++++.|+.....
T Consensus 227 G~~PF~~~~~~ki~~~----~--------~i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 227 LSFPYRRKKGRKISYR----D--------VILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred CCCCCCCcchhhhhhh----h--------hccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 9999864221111000 0 00111000 00123345678899999999999996 677888888776443
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=316.13 Aligned_cols=261 Identities=22% Similarity=0.236 Sum_probs=193.3
Q ss_pred HHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccce
Q 041702 511 AATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRL 588 (840)
Q Consensus 511 ~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l 588 (840)
...++|+..+.||+|+||.||+|.+. ..++.||||++.... ....+++.+|+.+++.++||||+++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 81 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDA------------VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEec------------CCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhce
Confidence 45689999999999999999999764 568899999997542 2344678899999999999999999
Q ss_pred eeEeecC------CceEEEEEeeccCCc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCc
Q 041702 589 FGCCIEQ------GEKISIYEFDIVTDP-ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP 661 (840)
Q Consensus 589 ~g~~~~~------~~~~lv~e~~~~~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 661 (840)
++++... ...+++|||...... .....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~ 158 (355)
T cd07874 82 LNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 158 (355)
T ss_pred eeeeeccccccccceeEEEhhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCE
Confidence 9988644 346899998432211 11234788888999999999999999988 9999999999999999999
Q ss_pred eeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHh--
Q 041702 662 KISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAW-- 739 (840)
Q Consensus 662 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~-- 739 (840)
||+|||+++...... ......+|+.|+|||.+.+..++.++|||||||+++||++|+.||....... ......
T Consensus 159 kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~ 233 (355)
T cd07874 159 KILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID--QWNKVIEQ 233 (355)
T ss_pred EEeeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHH
Confidence 999999998654322 1233568999999999999999999999999999999999999986432111 000000
Q ss_pred -----------------hhhccc-ccccccCccc-----c---chhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 740 -----------------NLWKDD-KAWKLMDPTM-----Q---NEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 740 -----------------~~~~~~-~~~~~~d~~l-----~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
...... ....+..+.. . ..........+.+++.+||+.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 234 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000 0000000000 0 00111223567899999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=304.88 Aligned_cols=271 Identities=25% Similarity=0.334 Sum_probs=196.6
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCc-CHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQ-GLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~-~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
+.|+..+.||+|+||.||+|.... ....++..||||+++..... ..++|.+|++++++++||||+++++++
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~--------~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~ 75 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDP--------LGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVC 75 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecC--------CCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeee
Confidence 456777899999999999986430 11345789999999865432 467899999999999999999999999
Q ss_pred ec--CCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 593 IE--QGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 593 ~~--~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
.. ....++++||...... .....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|
T Consensus 76 ~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~d 152 (284)
T cd05038 76 EKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISD 152 (284)
T ss_pred ecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcc
Confidence 87 5578999998432211 11225899999999999999999999988 99999999999999999999999
Q ss_pred cccceecCCCCcc-cccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 666 FGIARTFGGDEMQ-SNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 666 FGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
||++......... .......++..|+|||.+.+..++.++||||||++++||++|+.|+....................
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd05038 153 FGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIV 232 (284)
T ss_pred cccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccH
Confidence 9999877532221 111223445679999999988999999999999999999999988644322111100000000000
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
....+.+...............+.+++.+||+.+|++||+|.||+++|+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 233 TRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 000001111111111122335688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=310.83 Aligned_cols=190 Identities=22% Similarity=0.281 Sum_probs=159.5
Q ss_pred HHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 511 AATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 511 ~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
....+|++.+.||+|+||.||+|.+. .+++.||+|+.... ....|+.++++++||||+++++
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~------------~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~ 124 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKP------------GQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKD 124 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEEC------------CCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhh
Confidence 44568999999999999999999765 56788999985432 3457999999999999999999
Q ss_pred EeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 591 CCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
++.+.+..++|+|+..... ......+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 125 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~Df 201 (357)
T PHA03209 125 TLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDL 201 (357)
T ss_pred eEEeCCeeEEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecC
Confidence 9999999999999842111 112456899999999999999999999988 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCC
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNT 724 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~ 724 (840)
|+++..... .......||+.|+|||++.+..++.++|||||||++|||+++..++
T Consensus 202 G~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 202 GAAQFPVVA---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccccC---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 999753221 1223456899999999999999999999999999999999876654
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=314.74 Aligned_cols=239 Identities=21% Similarity=0.263 Sum_probs=186.9
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhcCCCCccceeeEeecCC
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQG 596 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~ 596 (840)
+.||+|+||.||+|.++ .+++.||+|++... ......++.+|++++..++||||+++++++...+
T Consensus 1 ~~lG~G~~g~V~~~~~~------------~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~ 68 (325)
T cd05594 1 KLLGKGTFGKVILVKEK------------ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD 68 (325)
T ss_pred CeeeeCCCEEEEEEEEC------------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCC
Confidence 36999999999999765 57899999999753 2234567889999999999999999999999999
Q ss_pred ceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceecCCCCCCcEEecCCCCceeecccccee
Q 041702 597 EKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQ-YSRLRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 597 ~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
..++||||..... ......+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++.
T Consensus 69 ~~~lv~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~ 145 (325)
T cd05594 69 RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKE 145 (325)
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCee
Confidence 9999999953322 2234568999999999999999999997 56 99999999999999999999999999875
Q ss_pred cCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccccccccc
Q 041702 672 FGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLM 751 (840)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (840)
..... .......||+.|+|||++.+..++.++|||||||+|+||++|+.||...... ... .......
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~--~~~----~~i~~~~----- 212 (325)
T cd05594 146 GIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLF----ELILMEE----- 212 (325)
T ss_pred cCCCC--cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH--HHH----HHHhcCC-----
Confidence 42221 1223456899999999999999999999999999999999999998543211 111 1100000
Q ss_pred CccccchhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 041702 752 DPTMQNEALYSMVTRYIKVALLCVQENATDRP-----TMLEVVAM 791 (840)
Q Consensus 752 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 791 (840)
..+ +......+.+++.+||+.||++|+ ++.++++.
T Consensus 213 -~~~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 213 -IRF----PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred -CCC----CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 011 112234577899999999999997 88888743
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=309.85 Aligned_cols=239 Identities=20% Similarity=0.281 Sum_probs=184.1
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhc-CCCCccceeeEeecC
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEQ 595 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~ 595 (840)
+.||+|+||.||+|.++ .+++.||+|+++.. .....+.+.+|+.++.++ +||||+++++++...
T Consensus 1 ~~lG~G~~g~V~~~~~~------------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~ 68 (329)
T cd05618 1 RVIGRGSYAKVLLVRLK------------KTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE 68 (329)
T ss_pred CeeeeCCCeEEEEEEEC------------CCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC
Confidence 36999999999999765 57889999999754 223445688899998877 899999999999999
Q ss_pred CceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccccee
Q 041702 596 GEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 596 ~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
+..++||||..... ......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 69 ~~~~lv~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~ 145 (329)
T cd05618 69 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE 145 (329)
T ss_pred CEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCcccc
Confidence 99999999954332 223456899999999999999999999998 99999999999999999999999999875
Q ss_pred cCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCC---ccHhHHHhhhhcccccc
Q 041702 672 FGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDS---LTLLGHAWNLWKDDKAW 748 (840)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~---~~~~~~~~~~~~~~~~~ 748 (840)
..... .......||+.|+|||++.+..++.++|||||||+++||++|+.||....... ................
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~- 222 (329)
T cd05618 146 GLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI- 222 (329)
T ss_pred ccCCC--CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-
Confidence 32211 12234578999999999999999999999999999999999999986432221 1111111111111110
Q ss_pred cccCccccchhhHHHHHHHHHHHHHccccCCCCCCCH
Q 041702 749 KLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTM 785 (840)
Q Consensus 749 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 785 (840)
. .+......+.+++.+||+.||++||++
T Consensus 223 -----~----~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 223 -----R----IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred -----C----CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 1 111233457789999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=312.11 Aligned_cols=261 Identities=28% Similarity=0.405 Sum_probs=194.1
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhc-CCCCccceee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKL-QHRNLVRLFG 590 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l-~H~niv~l~g 590 (840)
.++|+..++||+|+||.||+|.+... ....+++.||||+++.... .....+.+|+.++.++ +||||+++++
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~-------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~ 78 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGI-------DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 78 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccC-------CccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcc
Confidence 46789999999999999999975410 2345788999999975432 3345688999999999 7899999999
Q ss_pred EeecC-CceEEEEEeeccCCcc----------------------------------------------------------
Q 041702 591 CCIEQ-GEKISIYEFDIVTDPA---------------------------------------------------------- 611 (840)
Q Consensus 591 ~~~~~-~~~~lv~e~~~~~~~~---------------------------------------------------------- 611 (840)
+|... ...++++||.......
T Consensus 79 ~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (343)
T cd05103 79 ACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSL 158 (343)
T ss_pred eeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcc
Confidence 88654 4578899983211100
Q ss_pred -------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceecCCCCcc
Q 041702 612 -------------RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQ 678 (840)
Q Consensus 612 -------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 678 (840)
....+++..+.+++.||++||+|||+.+ |+||||||+|||+++++.+||+|||++.........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 235 (343)
T cd05103 159 SDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 235 (343)
T ss_pred ccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcch
Confidence 0134788888999999999999999988 999999999999999999999999999875433222
Q ss_pred cccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhcccccccccCccccc
Q 041702 679 SNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQN 757 (840)
Q Consensus 679 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 757 (840)
.......++..|+|||.+.+..++.++||||||++++||++ |..|+....... .. ........... .+
T Consensus 236 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~----~~~~~~~~~~~--~~---- 304 (343)
T cd05103 236 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EF----CRRLKEGTRMR--AP---- 304 (343)
T ss_pred hhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-HH----HHHHhccCCCC--CC----
Confidence 22223345678999999998899999999999999999997 888875432211 11 11111111000 01
Q ss_pred hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 758 EALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 758 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
......+.+++.+||+.+|++||++.||++.|+.+..
T Consensus 305 ---~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 305 ---DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred ---CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1122357889999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=296.27 Aligned_cols=253 Identities=25% Similarity=0.378 Sum_probs=199.0
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
++|+..+.||+|+||.||+|.+. .+++.||+|.++.. .....+++.+|++++++++|+|++++++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~------------~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~ 69 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICL------------LDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEc------------CCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeee
Confidence 57888999999999999999754 57899999988642 2234578999999999999999999999
Q ss_pred EeecCCceEEEEEeeccCCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCce
Q 041702 591 CCIEQGEKISIYEFDIVTDP--------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPK 662 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~~--------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 662 (840)
++...+..+++|||...... .....+++.++..++.++++||.|||+.+ ++||||||+||+++.++.++
T Consensus 70 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~ 146 (267)
T cd08224 70 SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVK 146 (267)
T ss_pred eeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEE
Confidence 99999999999999432221 22345789999999999999999999988 99999999999999999999
Q ss_pred eeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhh
Q 041702 663 ISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLW 742 (840)
Q Consensus 663 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~ 742 (840)
|+|||+++.+..... ......++..|+|||.+.+..++.++|||||||+++||++|+.|+............ ..
T Consensus 147 l~d~~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~ 220 (267)
T cd08224 147 LGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK----KI 220 (267)
T ss_pred EeccceeeeccCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHh----hh
Confidence 999999876543221 122346788999999999889999999999999999999999997533211111110 00
Q ss_pred cccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 743 KDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 743 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
.... ............+.+++.+||+.+|++||++.+|+++|+++
T Consensus 221 ~~~~--------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 221 EKCD--------YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred hcCC--------CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 0000 00011113445688999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=299.42 Aligned_cols=252 Identities=22% Similarity=0.373 Sum_probs=194.2
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
.++|+..+.||+|+||.||+|.+. .+++.||+|++........+.+.+|+.++.+++||||+++++++
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~------------~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~ 75 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNL------------HTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEEC------------CCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEE
Confidence 357888999999999999998754 57889999999765545556788999999999999999999999
Q ss_pred ecCCceEEEEEeeccCCc----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccc
Q 041702 593 IEQGEKISIYEFDIVTDP----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGI 668 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl 668 (840)
...+..++|+||...... .....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 76 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~ 152 (267)
T cd06646 76 LSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGV 152 (267)
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCcc
Confidence 999999999999432221 23456889999999999999999999988 99999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 669 ARTFGGDEMQSNTNRIVGTYGYMSPEYAL---HGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 669 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
+..+.... .......++..|+|||.+. ...++.++|||||||+++||++|+.|+......... . .....
T Consensus 153 ~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-----~-~~~~~ 224 (267)
T cd06646 153 AAKITATI--AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-----F-LMSKS 224 (267)
T ss_pred ceeecccc--cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-----e-eeecC
Confidence 98663221 1122346888999999874 455788999999999999999999987432211100 0 00000
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAML 792 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 792 (840)
....+... ........+.+++.+||+.+|++||++++|++.|
T Consensus 225 ---~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 225 ---NFQPPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ---CCCCCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00011111 1112345688999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=302.85 Aligned_cols=195 Identities=24% Similarity=0.389 Sum_probs=155.2
Q ss_pred cccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEeec--CC
Q 041702 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIE--QG 596 (840)
Q Consensus 519 ~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~--~~ 596 (840)
.++||+|+||.||+|.++ ...+++.||+|.+.... ....+.+|++++++++||||+++++++.. ..
T Consensus 6 ~~~lG~G~~g~Vy~~~~~----------~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 73 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRK----------DGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADR 73 (317)
T ss_pred ccccccCCCeEEEEEEEc----------cCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCc
Confidence 368999999999999753 12457889999987542 23567899999999999999999999864 45
Q ss_pred ceEEEEEeeccC------------CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEe----cCCCC
Q 041702 597 EKISIYEFDIVT------------DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLL----DSDMN 660 (840)
Q Consensus 597 ~~~lv~e~~~~~------------~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl----~~~~~ 660 (840)
..++++||.... .......+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.
T Consensus 74 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~ 150 (317)
T cd07868 74 KVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGR 150 (317)
T ss_pred EEEEEEeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCc
Confidence 578888883211 0112235888899999999999999999998 9999999999999 45678
Q ss_pred ceeeccccceecCCCCcc-cccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 041702 661 PKISDFGIARTFGGDEMQ-SNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYN 728 (840)
Q Consensus 661 ~kL~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~ 728 (840)
+||+|||+++.+...... .......+|+.|+|||++.+ ..++.++|||||||+++||++|++||....
T Consensus 151 ~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 151 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred EEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 999999999876433211 22334678999999999877 458999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=297.84 Aligned_cols=247 Identities=28% Similarity=0.384 Sum_probs=190.1
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCI 593 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~ 593 (840)
.+|+..+.||+|+||.||+|.++ ++..+|+|.+... ....++|.+|++++++++||||+++++++.
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-------------~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 69 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-------------GKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-------------CCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 35778889999999999998643 4567999998643 234567999999999999999999999999
Q ss_pred cCCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccc
Q 041702 594 EQGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGI 668 (840)
Q Consensus 594 ~~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl 668 (840)
+.+..++++||...... .....+++..+++++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 70 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~ 146 (256)
T cd05059 70 KQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGL 146 (256)
T ss_pred CCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCccc
Confidence 99999999998432211 11336889999999999999999999988 99999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhccccc
Q 041702 669 ARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKDDKA 747 (840)
Q Consensus 669 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 747 (840)
++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... ..... . ...
T Consensus 147 ~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~---~-~~~-- 217 (256)
T cd05059 147 ARYVLDDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--EVVES---V-SAG-- 217 (256)
T ss_pred ceeccccccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--HHHHH---H-HcC--
Confidence 9865432211 1112234458999999999999999999999999999999 78887543221 11111 1 000
Q ss_pred ccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 041702 748 WKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLK 793 (840)
Q Consensus 748 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le 793 (840)
... ..+...+..+.+++.+||+.+|++|||+.||++.|.
T Consensus 218 ---~~~----~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 218 ---YRL----YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred ---CcC----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 000 111123456889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=297.06 Aligned_cols=248 Identities=28% Similarity=0.421 Sum_probs=191.5
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
.++|++.++||+|+||.||+|.+ .++..||+|.++.... ..++|.+|+.++++++|+|++++++++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~-------------~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~ 70 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTW-------------NGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVV 70 (260)
T ss_pred hHHhhhhheeccccCceEEEEEe-------------cCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEE
Confidence 35788889999999999999854 3567799999976433 457899999999999999999999988
Q ss_pred ecCCceEEEEEeeccCCc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 593 IEQGEKISIYEFDIVTDP------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
. .+..+++|||...... .....+++.++..++.+++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 71 ~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~df 146 (260)
T cd05070 71 S-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADF 146 (260)
T ss_pred C-CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCc
Confidence 5 4568899998533221 12345889999999999999999999988 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
|++..+...... ......++..|+|||.+.+..++.++||||||++++||++ |+.|+..... ...... ....
T Consensus 147 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--~~~~~~----~~~~ 219 (260)
T cd05070 147 GLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--REVLEQ----VERG 219 (260)
T ss_pred eeeeeccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH--HHHHHH----HHcC
Confidence 999876433211 1122335668999999988899999999999999999999 8888753221 111111 1100
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~ 794 (840)
............+.+++.+|++.+|++|||+.++++.|++
T Consensus 220 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 220 ---------YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ---------CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0011112334568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=300.18 Aligned_cols=255 Identities=24% Similarity=0.379 Sum_probs=193.3
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC-CCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK-SGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~-~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
..|+..+.||+|+||.||+|.++ .....+..||||++... .....++|..|+.++++++||||+++++++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~ 74 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLK---------LPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV 74 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEe---------cCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEE
Confidence 34778899999999999999765 22223457999998754 233456899999999999999999999999
Q ss_pred ecCCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 593 IEQGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
.+++..++++||...... .....+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg 151 (269)
T cd05065 75 TKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFG 151 (269)
T ss_pred CCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCc
Confidence 999999999999432211 12345889999999999999999999988 9999999999999999999999999
Q ss_pred cceecCCCCccccccccc---ccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhc
Q 041702 668 IARTFGGDEMQSNTNRIV---GTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWK 743 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~---gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 743 (840)
++................ .+..|+|||.+.+..++.++||||||++++||++ |..|+...... ..... ..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~----i~ 225 (269)
T cd05065 152 LSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINA----IE 225 (269)
T ss_pred cccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHH----HH
Confidence 987664332211111111 2457999999999999999999999999999886 88887532211 11111 11
Q ss_pred ccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 744 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
.. ... ....+.+..+.+++.+||+.+|++||++++|++.|++.
T Consensus 226 ~~--~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 226 QD--YRL-------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred cC--CcC-------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 000 11122344578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=304.28 Aligned_cols=258 Identities=24% Similarity=0.383 Sum_probs=195.5
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcCCCCccceee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
..++|+..+.||+|+||.||+|.+... ....++..||+|++..... ...++|.+|+.++++++||||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~-------~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~ 75 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGL-------LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLG 75 (288)
T ss_pred ChHhceecccccccccccEEEEEEccc-------CCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEE
Confidence 346788999999999999999875410 0123567899999875432 33567999999999999999999999
Q ss_pred EeecCCceEEEEEeeccCC--------------------------ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCcee
Q 041702 591 CCIEQGEKISIYEFDIVTD--------------------------PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVI 644 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~--------------------------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iv 644 (840)
++..++..++++||..... ......+++..++.++.|++.||+|||+.+ ++
T Consensus 76 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~ 152 (288)
T cd05050 76 VCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FV 152 (288)
T ss_pred EEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 9999999999999832211 011234788899999999999999999988 99
Q ss_pred cCCCCCCcEEecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCC
Q 041702 645 HRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKN 723 (840)
Q Consensus 645 HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p 723 (840)
||||||+||+++.++.+||+|||++..+..............+..|+|||.+.+..++.++|||||||+++||++ |..|
T Consensus 153 H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p 232 (288)
T cd05050 153 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232 (288)
T ss_pred cccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999886543322222222344668999999998999999999999999999997 7777
Q ss_pred CCCCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 041702 724 TRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794 (840)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~ 794 (840)
+...... . ........+.. ..+......+.+++.+||+.+|++|||+.||++.|++
T Consensus 233 ~~~~~~~--~----~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 233 YYGMAHE--E----VIYYVRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred CCCCCHH--H----HHHHHhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 6432211 1 11111111111 0111234568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=297.15 Aligned_cols=249 Identities=27% Similarity=0.402 Sum_probs=192.1
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
.++|++.++||+|+||.||+|.+. +...||+|+++... ...++|.+|++++++++||||+++++++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-------------~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~ 70 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWN-------------GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV 70 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEec-------------CCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 356889999999999999998643 34569999997532 3457899999999999999999999987
Q ss_pred ecCCceEEEEEeeccCCc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 593 IEQGEKISIYEFDIVTDP------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
. .+..+++|||...... .....+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 71 ~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~df 146 (262)
T cd05071 71 S-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADF 146 (262)
T ss_pred C-CCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccC
Confidence 5 4567899998533221 12245789999999999999999999988 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
|.++.+...... ......++..|+|||...+..++.++||||||++++||++ |+.|+...... ... ......
T Consensus 147 g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~--~~~----~~~~~~ 219 (262)
T cd05071 147 GLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVL----DQVERG 219 (262)
T ss_pred Cceeeccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH--HHH----HHHhcC
Confidence 999876433221 1123345678999999988899999999999999999999 77776532211 111 111000
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
.........+..+.+++.+|++.+|++||+++++++.|++.
T Consensus 220 ---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 220 ---------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ---------CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 00011223455688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=298.37 Aligned_cols=249 Identities=24% Similarity=0.371 Sum_probs=193.1
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-----CcCHHHHHHHHHHHhhcCCCCccce
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-----GQGLEEFKNEMMLIAKLQHRNLVRL 588 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-----~~~~~~f~~Ev~~l~~l~H~niv~l 588 (840)
++|...+.||+|++|.||+|.+. .+++.||+|.+.... ....+.+.+|++++++++||||+++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~------------~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 69 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDV------------DTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69 (263)
T ss_pred CcccccceecCCCceEEEEEEEc------------CCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeee
Confidence 57888999999999999998654 568899999986432 1234578999999999999999999
Q ss_pred eeEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 589 FGCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
++++.+.+..++++|+..... ......+++..+.+++.|++.||.|||+.+ |+||||||+||++++++.+||+
T Consensus 70 ~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~ 146 (263)
T cd06625 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLG 146 (263)
T ss_pred EEEEccCCeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEe
Confidence 999999999999999943221 223346788889999999999999999988 9999999999999999999999
Q ss_pred ccccceecCCCCcccc-cccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhc
Q 041702 665 DFGIARTFGGDEMQSN-TNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWK 743 (840)
Q Consensus 665 DFGla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~ 743 (840)
|||+++.......... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+..... ... ......
T Consensus 147 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~---~~~~~~ 221 (263)
T cd06625 147 DFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA--MAA---IFKIAT 221 (263)
T ss_pred ecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch--HHH---HHHHhc
Confidence 9999976543221111 1234578899999999998999999999999999999999999753211 111 111111
Q ss_pred ccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 744 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
.. .....+......+.+++.+||+.+|++|||+.++++.
T Consensus 222 ~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 222 QP---------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred cC---------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 10 0011112234457889999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=303.68 Aligned_cols=248 Identities=21% Similarity=0.378 Sum_probs=196.5
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
..+|+..+.||+|++|.||+|++. .+++.||+|.+........+.+.+|+.++++++|+||+++++++
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~------------~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~ 86 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDV------------ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEEC------------CCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 468888899999999999999754 57889999999876555667899999999999999999999999
Q ss_pred ecCCceEEEEEeeccCC---ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccc
Q 041702 593 IEQGEKISIYEFDIVTD---PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIA 669 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~---~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla 669 (840)
..++..++||||..... ......+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 87 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~ 163 (296)
T cd06654 87 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFC 163 (296)
T ss_pred EeCCEEEEeecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccc
Confidence 99999999999953222 122345789999999999999999999988 999999999999999999999999998
Q ss_pred eecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccccccc
Q 041702 670 RTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWK 749 (840)
Q Consensus 670 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (840)
........ ......+++.|+|||.+.+..++.++|||||||+++||++|+.||........ . ....... .
T Consensus 164 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~---~~~~~~~-~-- 233 (296)
T cd06654 164 AQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--L---YLIATNG-T-- 233 (296)
T ss_pred hhcccccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--H---HHHhcCC-C--
Confidence 76533221 12234688899999999988899999999999999999999999854322110 0 0010000 0
Q ss_pred ccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 750 LMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 750 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
+.+ .........+.+++.+||+.+|++||++.+|++
T Consensus 234 ---~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 234 ---PEL--QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred ---CCC--CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 001 111233456788999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=306.34 Aligned_cols=253 Identities=25% Similarity=0.380 Sum_probs=191.9
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCc--eEEEEEeccCC-CcCHHHHHHHHHHHhhc-CCCCccce
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGE--EVAVKRLSSKS-GQGLEEFKNEMMLIAKL-QHRNLVRL 588 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~--~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l-~H~niv~l 588 (840)
.++|+..+.||+|+||.||+|.++ .++. .+|+|+++... ....++|.+|++++.++ +||||+++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~------------~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~ 73 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIK------------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEc------------cCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceE
Confidence 357888899999999999999764 3343 56888876532 33456789999999999 89999999
Q ss_pred eeEeecCCceEEEEEeeccCCc--------------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCC
Q 041702 589 FGCCIEQGEKISIYEFDIVTDP--------------------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDL 648 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~~~~~~~--------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl 648 (840)
++++.+.+..++++||...... .....+++.+++.++.||+.||+|||+.+ ++||||
T Consensus 74 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl 150 (303)
T cd05088 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDL 150 (303)
T ss_pred EEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---cccccc
Confidence 9999999999999999422111 11235789999999999999999999988 999999
Q ss_pred CCCcEEecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCC
Q 041702 649 KASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFY 727 (840)
Q Consensus 649 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~ 727 (840)
||+|||++.++.+||+|||+++..... ........+..|+|||++.+..++.++|||||||+++||+| |..|+...
T Consensus 151 kp~Nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 227 (303)
T cd05088 151 AARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 227 (303)
T ss_pred chheEEecCCCcEEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccC
Confidence 999999999999999999998643211 11112234568999999988889999999999999999998 89887533
Q ss_pred CCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccC
Q 041702 728 NTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVN 798 (840)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~ 798 (840)
... ..... .... ............+.+++.+||+.+|++||+++++++.|+.++..
T Consensus 228 ~~~--~~~~~----~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 228 TCA--ELYEK----LPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred ChH--HHHHH----HhcC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 221 11111 0000 00001112234578999999999999999999999999876443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=299.32 Aligned_cols=246 Identities=26% Similarity=0.280 Sum_probs=191.9
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
+|+..++||+|+||.||++.+. .+++.||||++.... ......+.+|+.++++++||||++++++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~------------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 68 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVR------------ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYA 68 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEc------------CCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeee
Confidence 4778899999999999998654 578999999987532 2234568899999999999999999999
Q ss_pred eecCCceEEEEEeeccCCc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 592 CIEQGEKISIYEFDIVTDP------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
+..++..+++|||...... .....+++..+..++.|+++||.|||+.+ |+||||||+||++++++.++|+|
T Consensus 69 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~D 145 (285)
T cd05605 69 YETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISD 145 (285)
T ss_pred ecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEee
Confidence 9999999999999532221 12345899999999999999999999988 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
||++........ .....|++.|+|||.+.+..++.++|||||||+++||++|+.||........ ..........
T Consensus 146 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~--~~~~~~~~~~- 219 (285)
T cd05605 146 LGLAVEIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK--REEVERRVKE- 219 (285)
T ss_pred CCCceecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH--HHHHHHHhhh-
Confidence 999987543221 1234689999999999999999999999999999999999999864322110 0011010000
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRP-----TMLEVVA 790 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 790 (840)
............+.+++.+||+.||++|| +++++++
T Consensus 220 ---------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 220 ---------DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred ---------cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 00111223455678999999999999999 7888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=301.99 Aligned_cols=256 Identities=23% Similarity=0.334 Sum_probs=186.7
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhc---CCCCcccee
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKL---QHRNLVRLF 589 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l---~H~niv~l~ 589 (840)
+|+..+.||+|+||.||+|.++ .+++.||+|.++... ......+.+|+.++.++ +||||++++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~------------~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~ 68 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDP------------HSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLM 68 (288)
T ss_pred CceEeeEEeecCCeEEEEEEEC------------CCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeee
Confidence 4788899999999999999765 678999999987542 22234567788877766 699999999
Q ss_pred eEeecC-----CceEEEEEeeccCC-----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCC
Q 041702 590 GCCIEQ-----GEKISIYEFDIVTD-----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDM 659 (840)
Q Consensus 590 g~~~~~-----~~~~lv~e~~~~~~-----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~ 659 (840)
+++... ...++++|+..... ......+++..+..++.|++.||.|||+.+ |+||||||+|||++.++
T Consensus 69 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~ 145 (288)
T cd07863 69 DVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGG 145 (288)
T ss_pred eeeccccCCCCceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCC
Confidence 998642 44788999843210 111234889999999999999999999998 99999999999999999
Q ss_pred CceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHh
Q 041702 660 NPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAW 739 (840)
Q Consensus 660 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~ 739 (840)
.+||+|||+++...... ......+|..|+|||.+.+..++.++|||||||+++||++|++||......+ ......
T Consensus 146 ~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~--~~~~~~ 220 (288)
T cd07863 146 QVKLADFGLARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGKIF 220 (288)
T ss_pred CEEECccCccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH--HHHHHH
Confidence 99999999998764322 1233567899999999999999999999999999999999999885432211 111111
Q ss_pred hhhcc---ccc-------ccccCccc---cchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 740 NLWKD---DKA-------WKLMDPTM---QNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 740 ~~~~~---~~~-------~~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
..... ... .....+.. ...........+.+++.+||+.||++|||+.|+++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 221 DLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred HHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 11000 000 00000000 01111233456789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=312.51 Aligned_cols=261 Identities=23% Similarity=0.303 Sum_probs=190.6
Q ss_pred HHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCcc
Q 041702 509 ISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLV 586 (840)
Q Consensus 509 ~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv 586 (840)
.....++|+..+.||+|+||.||+|.+. .+++.||||++.... ....+++.+|++++++++||||+
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 77 (343)
T cd07878 10 VWEVPERYQNLTPVGSGAYGSVCSAYDT------------RLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVI 77 (343)
T ss_pred HhhhhhhhhhheecccCCCeEEEEEEEC------------CCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchh
Confidence 3445688999999999999999999754 578899999987542 23346688999999999999999
Q ss_pred ceeeEeecC------CceEEEEEeecc--CCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCC
Q 041702 587 RLFGCCIEQ------GEKISIYEFDIV--TDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSD 658 (840)
Q Consensus 587 ~l~g~~~~~------~~~~lv~e~~~~--~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~ 658 (840)
++++++... ...++++++... ........+++..+..++.||+.||.|||+.+ |+||||||+|||++.+
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~ 154 (343)
T cd07878 78 GLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNED 154 (343)
T ss_pred hhhhhhcccccccccCcEEEEeecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCC
Confidence 999987543 346778877311 11223346899999999999999999999998 9999999999999999
Q ss_pred CCceeeccccceecCCCCcccccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHH
Q 041702 659 MNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGH 737 (840)
Q Consensus 659 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~ 737 (840)
+.+||+|||+++..... .....||+.|+|||.+.+ ..++.++|||||||+++||++|+.||....... ....
T Consensus 155 ~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~ 227 (343)
T cd07878 155 CELRILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID--QLKR 227 (343)
T ss_pred CCEEEcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHH
Confidence 99999999999875432 233568999999999877 568999999999999999999999986432111 0000
Q ss_pred Hhhhhcc-----------cccccccC--ccccch----hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 738 AWNLWKD-----------DKAWKLMD--PTMQNE----ALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 738 ~~~~~~~-----------~~~~~~~d--~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
....... ......+. +..... ......+.+.+++.+||+.||++|||+.|+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 228 IMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 00000000 000000 000112346799999999999999999999853
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=319.18 Aligned_cols=248 Identities=21% Similarity=0.267 Sum_probs=185.4
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
.|+..++||+|+||.||+|+++ .+++.||+|++.... ....+.+.+|++++++++||||++++++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~------------~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~ 69 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKV------------DTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYS 69 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEEC------------CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEE
Confidence 5888999999999999999765 678899999997542 2335678999999999999999999999
Q ss_pred eecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 592 CIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
+.+.+..++||||..... ......+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 70 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFG 146 (382)
T cd05625 70 FQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFG 146 (382)
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECC
Confidence 999999999999953322 223356788888999999999999999988 9999999999999999999999999
Q ss_pred cceecCCCC---------------------------------------------cccccccccccccccCccccccCCCC
Q 041702 668 IARTFGGDE---------------------------------------------MQSNTNRIVGTYGYMSPEYALHGLFS 702 (840)
Q Consensus 668 la~~~~~~~---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~ 702 (840)
++..+.... ........+||+.|+|||++.+..++
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~ 226 (382)
T cd05625 147 LCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT 226 (382)
T ss_pred CCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC
Confidence 975432100 00001234689999999999999999
Q ss_pred ccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCC
Q 041702 703 IKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDR 782 (840)
Q Consensus 703 ~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R 782 (840)
.++|||||||+|+||++|+.||........ . ........ .............+.+++.+++ .+|++|
T Consensus 227 ~~~DiwSlGvil~elltG~~Pf~~~~~~~~--~---~~i~~~~~-------~~~~p~~~~~s~~~~~li~~l~-~~p~~R 293 (382)
T cd05625 227 QLCDWWSVGVILYEMLVGQPPFLAQTPLET--Q---MKVINWQT-------SLHIPPQAKLSPEASDLIIKLC-RGPEDR 293 (382)
T ss_pred CeeeEEechHHHHHHHhCCCCCCCCCHHHH--H---HHHHccCC-------CcCCCCcccCCHHHHHHHHHHc-cCHhHc
Confidence 999999999999999999999864332111 1 00000000 0000001112334556666665 499999
Q ss_pred CC---HHHHHH
Q 041702 783 PT---MLEVVA 790 (840)
Q Consensus 783 Ps---~~evl~ 790 (840)
++ +.++++
T Consensus 294 ~~~~~~~ei~~ 304 (382)
T cd05625 294 LGKNGADEIKA 304 (382)
T ss_pred CCCCCHHHHhc
Confidence 97 777664
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=318.81 Aligned_cols=250 Identities=22% Similarity=0.261 Sum_probs=188.4
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
++|+..++||+|+||.||+|.++ .+++.||||++.... ....+.+.+|++++.+++||||+++++
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~------------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~ 68 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKK------------DTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYY 68 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEEC------------CCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 46888999999999999999755 678999999986532 234567899999999999999999999
Q ss_pred EeecCCceEEEEEeeccCCc----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 591 CCIEQGEKISIYEFDIVTDP----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
++.+.+..++||||...... .....+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 69 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~Df 145 (377)
T cd05629 69 SFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDF 145 (377)
T ss_pred EEEcCCeeEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeec
Confidence 99999999999999532221 23456788888999999999999999998 999999999999999999999999
Q ss_pred ccceecCCCCcc---------------------------------------------cccccccccccccCccccccCCC
Q 041702 667 GIARTFGGDEMQ---------------------------------------------SNTNRIVGTYGYMSPEYALHGLF 701 (840)
Q Consensus 667 Gla~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~ 701 (840)
|+++.+...... ......+||+.|+|||++.+..+
T Consensus 146 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 225 (377)
T cd05629 146 GLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY 225 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCC
Confidence 999643211000 00012469999999999999999
Q ss_pred CccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCC
Q 041702 702 SIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATD 781 (840)
Q Consensus 702 ~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~ 781 (840)
+.++|||||||+|+||++|+.||...... .... ........... +. .......+.+++.+||+ +|.+
T Consensus 226 ~~~~DiwSlGvil~elltG~~Pf~~~~~~--~~~~---~i~~~~~~~~~--p~-----~~~~s~~~~dli~~lL~-~~~~ 292 (377)
T cd05629 226 GQECDWWSLGAIMFECLIGWPPFCSENSH--ETYR---KIINWRETLYF--PD-----DIHLSVEAEDLIRRLIT-NAEN 292 (377)
T ss_pred CCceeeEecchhhhhhhcCCCCCCCCCHH--HHHH---HHHccCCccCC--CC-----CCCCCHHHHHHHHHHhc-CHhh
Confidence 99999999999999999999998643221 1111 11000000000 10 01123457788888997 6776
Q ss_pred C---CCHHHHHHH
Q 041702 782 R---PTMLEVVAM 791 (840)
Q Consensus 782 R---Ps~~evl~~ 791 (840)
| |++.|+++.
T Consensus 293 r~~r~~~~~~l~h 305 (377)
T cd05629 293 RLGRGGAHEIKSH 305 (377)
T ss_pred cCCCCCHHHHhcC
Confidence 5 588888864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=303.60 Aligned_cols=260 Identities=27% Similarity=0.416 Sum_probs=195.7
Q ss_pred HHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcCCCCcccee
Q 041702 511 AATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 511 ~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
...++|++.++||+|+||.||+|.++.. .....+..||+|.+..... ....++.+|+.++++++||||++++
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~-------~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~ 75 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDI-------IKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLL 75 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEecc-------CCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEE
Confidence 3567899999999999999999865410 1112356899999875432 2345688999999999999999999
Q ss_pred eEeecCCceEEEEEeeccCCc--------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEe
Q 041702 590 GCCIEQGEKISIYEFDIVTDP--------------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLL 655 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~~~--------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl 655 (840)
+++.+.+..+++|||...... .......+..+.+++.|++.||.|||+.+ |+||||||+|||+
T Consensus 76 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili 152 (288)
T cd05061 76 GVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMV 152 (288)
T ss_pred EEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEE
Confidence 999999999999999421110 11234567788899999999999999988 9999999999999
Q ss_pred cCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccH
Q 041702 656 DSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTL 734 (840)
Q Consensus 656 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~ 734 (840)
+.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||+++||++ |..|+...... ..
T Consensus 153 ~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~--~~ 230 (288)
T cd05061 153 AHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--QV 230 (288)
T ss_pred cCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH--HH
Confidence 9999999999999986543332222233345678999999999999999999999999999998 67776432211 11
Q ss_pred hHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 735 LGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 735 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
. ......... .........+.+++.+||+.+|++|||+.++++.|++.
T Consensus 231 ~----~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 231 L----KFVMDGGYL---------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred H----HHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 1 111111000 00112235688999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=310.65 Aligned_cols=238 Identities=24% Similarity=0.318 Sum_probs=185.9
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhc-CCCCccceeeEeecC
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEQ 595 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~ 595 (840)
++||+|+||.||+|.++ .+++.||||++... .....+.+..|.+++..+ +||||+++++++...
T Consensus 1 ~~lG~G~~g~Vy~~~~~------------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~ 68 (321)
T cd05591 1 KVLGKGSFGKVMLAELK------------GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK 68 (321)
T ss_pred CccccCCCeEEEEEEEC------------CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC
Confidence 36999999999999754 56889999999753 233456688899999876 899999999999999
Q ss_pred CceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccccee
Q 041702 596 GEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 596 ~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
+..++||||..... ......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 69 ~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~ 145 (321)
T cd05591 69 DRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKE 145 (321)
T ss_pred CeEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeeccccee
Confidence 99999999943322 223456889999999999999999999998 99999999999999999999999999876
Q ss_pred cCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccccccccc
Q 041702 672 FGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLM 751 (840)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (840)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.|+...... ..... ... .. ..
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~--~~~~~---i~~-~~---~~ 214 (321)
T cd05591 146 GILNG--VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED--DLFES---ILH-DD---VL 214 (321)
T ss_pred cccCC--ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH--HHHHH---HHc-CC---CC
Confidence 43221 1223456899999999999999999999999999999999999998643321 11111 111 10 00
Q ss_pred CccccchhhHHHHHHHHHHHHHccccCCCCCC-------CHHHHHH
Q 041702 752 DPTMQNEALYSMVTRYIKVALLCVQENATDRP-------TMLEVVA 790 (840)
Q Consensus 752 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-------s~~evl~ 790 (840)
.+ ......+.+++.+||+.||++|| +++++++
T Consensus 215 ~p-------~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 215 YP-------VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CC-------CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 11 11234577899999999999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=315.51 Aligned_cols=198 Identities=25% Similarity=0.329 Sum_probs=167.3
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
++|+..+.||+|+||.||+|.++ .+++.||||+++... ......+.+|+.++.+++|+||+++++
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~------------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~ 68 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKK------------DTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFY 68 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEEC------------CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 46888999999999999999765 578899999997532 233457889999999999999999999
Q ss_pred EeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 591 CCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
++.+.+..++||||..... ......+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 69 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DF 145 (363)
T cd05628 69 SFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDF 145 (363)
T ss_pred EEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeec
Confidence 9999999999999953322 223467899999999999999999999988 999999999999999999999999
Q ss_pred ccceecCCCCcc---------------------------------cccccccccccccCccccccCCCCccccchhHHHH
Q 041702 667 GIARTFGGDEMQ---------------------------------SNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVL 713 (840)
Q Consensus 667 Gla~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGvi 713 (840)
|+++.+...... ......+||+.|+|||++.+..++.++|||||||+
T Consensus 146 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvi 225 (363)
T cd05628 146 GLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVI 225 (363)
T ss_pred cCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHH
Confidence 998765321100 00123579999999999999999999999999999
Q ss_pred HHHHHhCCCCCCC
Q 041702 714 LLEILSSKKNTRF 726 (840)
Q Consensus 714 L~elltG~~p~~~ 726 (840)
|+||++|+.||..
T Consensus 226 l~ell~G~~Pf~~ 238 (363)
T cd05628 226 MYEMLIGYPPFCS 238 (363)
T ss_pred HHHHHhCCCCCCC
Confidence 9999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=302.54 Aligned_cols=262 Identities=25% Similarity=0.343 Sum_probs=195.2
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
+.|+..+.||+|+||.||+|... .....++..||+|.++... ....+.|.+|++++++++||||+++.+++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~--------~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 75 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYD--------PEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGIC 75 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEc--------cCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEE
Confidence 45788899999999999998632 0123568899999987543 33456799999999999999999999999
Q ss_pred ecC--CceEEEEEeeccCCcc-----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 593 IEQ--GEKISIYEFDIVTDPA-----RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 593 ~~~--~~~~lv~e~~~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
... ...+++|||....... ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|
T Consensus 76 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~d 152 (284)
T cd05079 76 TEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGD 152 (284)
T ss_pred ecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECC
Confidence 875 5678999985322221 1235899999999999999999999988 99999999999999999999999
Q ss_pred cccceecCCCCcc-cccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCC--------cc-Hh
Q 041702 666 FGIARTFGGDEMQ-SNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDS--------LT-LL 735 (840)
Q Consensus 666 FGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~--------~~-~~ 735 (840)
||+++.+...... .......++..|+|||.+.+..++.++||||||++++||++++.|........ .. ..
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd05079 153 FGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTV 232 (284)
T ss_pred CccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccH
Confidence 9999876433221 11223456778999999998899999999999999999999876542211000 00 00
Q ss_pred HHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 736 GHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 736 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
.......... .........+..+.+++.+||+.+|++||+++++++.|+++
T Consensus 233 ~~~~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 233 TRLVRVLEEG---------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHHHHcC---------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0000000000 00111122356789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=296.67 Aligned_cols=245 Identities=26% Similarity=0.383 Sum_probs=194.3
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC--CCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK--SGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
+|+..+.||+|++|.||+|.++ .+++.|++|.+... .....+++.+|++++++++||||+++++++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~------------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 68 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRK------------ADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESF 68 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEc------------CCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeee
Confidence 4677889999999999999754 57899999998643 234567899999999999999999999999
Q ss_pred ecCCceEEEEEeeccCCc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 593 IEQGEKISIYEFDIVTDP------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
.+.+..++++||...... .....+++..+.+++.+++.||.|||+.+ ++|+||||+||+++.++.+||+||
T Consensus 69 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df 145 (256)
T cd08529 69 LDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDL 145 (256)
T ss_pred ccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEccc
Confidence 999999999998432221 12356889999999999999999999987 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccc
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDK 746 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 746 (840)
|+++.+..... ......+++.|+|||+..+..++.++||||||++++||++|+.|+..... ...... .....
T Consensus 146 ~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~----~~~~~ 217 (256)
T cd08529 146 GVAKLLSDNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--GALILK----IIRGV 217 (256)
T ss_pred ccceeccCccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--HHHHHH----HHcCC
Confidence 99987644322 12334678899999999999999999999999999999999999854331 111110 00100
Q ss_pred cccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 747 AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 747 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
...........+.+++.+||+.+|++||++.++++.
T Consensus 218 ---------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 218 ---------FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ---------CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 011111344568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=287.71 Aligned_cols=245 Identities=24% Similarity=0.417 Sum_probs=202.4
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCI 593 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~ 593 (840)
+-|.++++||+|+||.||||+++ ..|+.||||.+... ..++++..|+.+|++.+.|++|+++|.+.
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~------------EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYF 98 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHR------------ESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYF 98 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHh------------ccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhc
Confidence 34677889999999999999877 78999999998754 46789999999999999999999999999
Q ss_pred cCCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccc
Q 041702 594 EQGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGI 668 (840)
Q Consensus 594 ~~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl 668 (840)
.....++||||.-.... .+++.|.+.++..|+...++||+|||... -||||||+.||||+.+|.+||+|||.
T Consensus 99 K~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGV 175 (502)
T KOG0574|consen 99 KHSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGV 175 (502)
T ss_pred cCCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccc
Confidence 99999999999544432 35678999999999999999999999987 89999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccc
Q 041702 669 ARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAW 748 (840)
Q Consensus 669 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (840)
|..+.+. ....+.+.||+-|||||++..-.|+.++||||||+...||.-|++|+...++-...+. +.
T Consensus 176 AGQLTDT--MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM-----------IP 242 (502)
T KOG0574|consen 176 AGQLTDT--MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM-----------IP 242 (502)
T ss_pred cchhhhh--HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe-----------cc
Confidence 9876432 2334568899999999999999999999999999999999999999865443221100 00
Q ss_pred cccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 749 KLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 749 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
....|.. ..+..-...+.+++.+||-+.|++|-|+-++++
T Consensus 243 T~PPPTF--~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 243 TKPPPTF--KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CCCCCCC--CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 0011122 223445677899999999999999999988765
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=300.19 Aligned_cols=258 Identities=24% Similarity=0.331 Sum_probs=190.0
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
+|+..+.||+|++|.||+|.++ .+++.||||+++... ....+.+.+|+.++.+++||||+++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~------------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 68 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNK------------KTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVL 68 (285)
T ss_pred CceEeeEecccCceEEEEEEEC------------CCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 4778889999999999999754 578899999987542 23346789999999999999999999999
Q ss_pred ecCCceEEEEEeecc------CCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 593 IEQGEKISIYEFDIV------TDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~------~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
.+++..++|+||... ........+++..+..++.||++||+|||+.+ ++||||||+||+++.++.+||+||
T Consensus 69 ~~~~~~~~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~df 145 (285)
T cd07861 69 MQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADF 145 (285)
T ss_pred eeCCeEEEEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcc
Confidence 999999999998532 11122356889999999999999999999988 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhh----
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNL---- 741 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~---- 741 (840)
|++....... .......+++.|+|||.+.+ ..++.++||||||++++||+||+.|+....... .........
T Consensus 146 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~ 222 (285)
T cd07861 146 GLARAFGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID-QLFRIFRILGTPT 222 (285)
T ss_pred cceeecCCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCC
Confidence 9997653321 11223456889999998865 457899999999999999999999886432111 000000000
Q ss_pred ---hccc----ccccccCc---cccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 742 ---WKDD----KAWKLMDP---TMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 742 ---~~~~----~~~~~~d~---~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
+... ......+. .............+.+++.+||+.||++|||+.+|++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 223 EDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000 00000000 0000011123456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=308.54 Aligned_cols=237 Identities=26% Similarity=0.317 Sum_probs=182.8
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhc-CCCCccceeeEeecC
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEQ 595 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~ 595 (840)
+.||+|+||.||+|.++ .+++.||||+++.. .....+.+..|..++..+ +||||+++++++...
T Consensus 1 ~~lG~G~~g~Vy~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~ 68 (316)
T cd05592 1 KVLGKGSFGKVMLAELK------------GTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTK 68 (316)
T ss_pred CeeeeCCCeEEEEEEEC------------CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcC
Confidence 36999999999999765 56889999999753 223445667777777654 899999999999999
Q ss_pred CceEEEEEeeccCCc----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccccee
Q 041702 596 GEKISIYEFDIVTDP----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 596 ~~~~lv~e~~~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
+..++||||...... .....+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 69 ~~~~lv~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~ 145 (316)
T cd05592 69 EHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKE 145 (316)
T ss_pred CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeE
Confidence 999999999533221 23456888999999999999999999988 99999999999999999999999999976
Q ss_pred cCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccccccccc
Q 041702 672 FGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLM 751 (840)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (840)
..... .......||+.|+|||.+.+..++.++|||||||+++||++|+.|+...... .... .. ...
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~--~~~~---~i-~~~------ 211 (316)
T cd05592 146 NMNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED--ELFD---SI-LND------ 211 (316)
T ss_pred CCCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH--HHHH---HH-HcC------
Confidence 43222 2233457899999999999999999999999999999999999998643221 1111 11 110
Q ss_pred CccccchhhHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 041702 752 DPTMQNEALYSMVTRYIKVALLCVQENATDRPTML-EVV 789 (840)
Q Consensus 752 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl 789 (840)
.+.+ +......+.+++.+||+.+|++||++. +++
T Consensus 212 ~~~~----~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 212 RPHF----PRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCC----CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 0111 112234567899999999999999876 454
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=307.75 Aligned_cols=247 Identities=25% Similarity=0.353 Sum_probs=201.8
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
.++|..+++||+|+||.++.++++ .++..+++|.+.-.. ....+...+|+.++++++|||||.+.+
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk------------~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~d 70 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHK------------SDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKD 70 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhc------------cCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeecc
Confidence 367888999999999999998766 677899999987543 334456889999999999999999999
Q ss_pred EeecCCc-eEEEEEeeccCCc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCcee
Q 041702 591 CCIEQGE-KISIYEFDIVTDP------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKI 663 (840)
Q Consensus 591 ~~~~~~~-~~lv~e~~~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL 663 (840)
.+++++. .++||+|....+. .+...++++.+.+++.|++.|+.|||++. |+|||||+.||+++.+..+||
T Consensus 71 s~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkL 147 (426)
T KOG0589|consen 71 SFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKL 147 (426)
T ss_pred chhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceee
Confidence 9999999 9999999433322 23467889999999999999999999876 999999999999999999999
Q ss_pred eccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhc
Q 041702 664 SDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWK 743 (840)
Q Consensus 664 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~ 743 (840)
.|||+|+.+.... .....++||+.||.||.+.+.+|..|+|||||||+++||++-+++|...+..... ....
T Consensus 148 gDfGlaK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li-----~ki~- 219 (426)
T KOG0589|consen 148 GDFGLAKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELI-----LKIN- 219 (426)
T ss_pred cchhhhhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHH-----HHHh-
Confidence 9999999986544 2344589999999999999999999999999999999999999998754432211 1110
Q ss_pred ccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 744 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
... ....+......+..++..|++.+|+.||++.+++.+
T Consensus 220 ----~~~-----~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 220 ----RGL-----YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ----hcc-----CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 011 112233445568889999999999999999999864
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=306.25 Aligned_cols=263 Identities=27% Similarity=0.413 Sum_probs=197.2
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhc-CCCCccceee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKL-QHRNLVRLFG 590 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l-~H~niv~l~g 590 (840)
.++|.+.++||+|+||.||+|.+... ..........+|+|+++... .....++.+|++++.++ +||||+++++
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~-----~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGI-----DKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLG 85 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeeccc-----CCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence 36788889999999999999865310 00112345679999987543 23456789999999999 6999999999
Q ss_pred EeecCCceEEEEEeeccCCc--------------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCC
Q 041702 591 CCIEQGEKISIYEFDIVTDP--------------------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKA 650 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~~--------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp 650 (840)
+|...+..++++||...... .....+++.++.+++.||+.||.|||+.+ ++||||||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp 162 (314)
T cd05099 86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAA 162 (314)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccc
Confidence 99999999999998432211 11245889999999999999999999988 99999999
Q ss_pred CcEEecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCC
Q 041702 651 SNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNT 729 (840)
Q Consensus 651 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~ 729 (840)
+|||++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |..|+.....
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred eeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987643222222222234568999999999999999999999999999999 7877643221
Q ss_pred CCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccC
Q 041702 730 DSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVN 798 (840)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~ 798 (840)
. . ........... .........+.+++.+||+.+|++||++.++++.|++....
T Consensus 243 ~--~----~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 243 E--E----LFKLLREGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred H--H----HHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 1 1 11111111110 11122234677899999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=309.74 Aligned_cols=263 Identities=27% Similarity=0.399 Sum_probs=198.0
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhc-CCCCccceee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKL-QHRNLVRLFG 590 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l-~H~niv~l~g 590 (840)
..+|.+.+.||+|+||.||+|.+...+ .........||+|.+.... ....+++.+|++++.++ +||||+++++
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~-----~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGID-----KDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLG 85 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccC-----CccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence 356888999999999999999754100 0112234579999887542 23457899999999999 8999999999
Q ss_pred EeecCCceEEEEEeeccCCc--------------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCC
Q 041702 591 CCIEQGEKISIYEFDIVTDP--------------------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKA 650 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~~--------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp 650 (840)
+|.+.+..++++||...... .....+++.++++++.|++.||+|||+.+ ++||||||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp 162 (334)
T cd05100 86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAA 162 (334)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eecccccc
Confidence 99999999999998422111 12345889999999999999999999988 99999999
Q ss_pred CcEEecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCC
Q 041702 651 SNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNT 729 (840)
Q Consensus 651 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~ 729 (840)
+|||++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |..|+.....
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 999999999999999999987654332222223344568999999999999999999999999999998 7777643221
Q ss_pred CCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccC
Q 041702 730 DSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVN 798 (840)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~ 798 (840)
. . ........... .........+.+++.+||+.+|++||++.|+++.|+++...
T Consensus 243 ~--~----~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 243 E--E----LFKLLKEGHRM---------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred H--H----HHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 1 1 11111111000 11112334688999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=313.88 Aligned_cols=238 Identities=24% Similarity=0.279 Sum_probs=185.3
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceeeEeecCCc
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGE 597 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~ 597 (840)
+.||+|+||.||++.+. ....+|+.||+|++.... .....++.+|++++.+++||||+++++++...+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 72 (318)
T cd05582 2 KVLGQGSFGKVFLVRKI---------TGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGK 72 (318)
T ss_pred ceeeeCCCEEEEEEEEe---------ccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCE
Confidence 57999999999998653 122478899999997542 2234567889999999999999999999999999
Q ss_pred eEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceecC
Q 041702 598 KISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFG 673 (840)
Q Consensus 598 ~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~ 673 (840)
.++||||..... ......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 73 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 149 (318)
T cd05582 73 LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 149 (318)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccC
Confidence 999999953222 223456899999999999999999999988 9999999999999999999999999997653
Q ss_pred CCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccccccCc
Q 041702 674 GDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDP 753 (840)
Q Consensus 674 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 753 (840)
... .......||+.|+|||.+.+..++.++|||||||+++||++|+.|+...... .... ... ....
T Consensus 150 ~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--~~~~---~i~-~~~~------ 215 (318)
T cd05582 150 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK--ETMT---MIL-KAKL------ 215 (318)
T ss_pred CCC--CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH--HHHH---HHH-cCCC------
Confidence 321 1223457899999999999888999999999999999999999998643211 1111 111 1000
Q ss_pred cccchhhHHHHHHHHHHHHHccccCCCCCCCHHH
Q 041702 754 TMQNEALYSMVTRYIKVALLCVQENATDRPTMLE 787 (840)
Q Consensus 754 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 787 (840)
.+ +......+.+++.+||+.||++||++.+
T Consensus 216 ~~----p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 GM----PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CC----CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 01 1122345778999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=313.20 Aligned_cols=248 Identities=20% Similarity=0.292 Sum_probs=191.8
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
++|...+.||+|+||.||+|.++ .+++.||+|+++... ....+.+.+|+.++..++|+||+++++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~------------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~ 68 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREK------------ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEEC------------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceee
Confidence 46888999999999999999765 678999999997542 234567889999999999999999999
Q ss_pred EeecCCceEEEEEeeccCCcc----c-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 591 CCIEQGEKISIYEFDIVTDPA----R-KDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~~~----~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
++.+.+..++||||....... . ...+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 69 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~D 145 (330)
T cd05601 69 AFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLAD 145 (330)
T ss_pred EEecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEecc
Confidence 999999999999995332211 1 246889999999999999999999988 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccc------cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHh
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYAL------HGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAW 739 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~ 739 (840)
||++..+...... ......||+.|+|||++. ...++.++|||||||+++||++|+.||....... ...
T Consensus 146 fg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-----~~~ 219 (330)
T cd05601 146 FGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK-----TYN 219 (330)
T ss_pred CCCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH-----HHH
Confidence 9999876433222 223356899999999986 4568899999999999999999999985432111 111
Q ss_pred hhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 740 NLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 740 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
............ ........+.+++..|++ +|++||+++++++
T Consensus 220 ~i~~~~~~~~~~-------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 220 NIMNFQRFLKFP-------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred HHHcCCCccCCC-------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 111111111100 011234457788889998 9999999999984
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=319.10 Aligned_cols=250 Identities=21% Similarity=0.270 Sum_probs=187.8
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
.+|++.++||+|+||.||+|+++ .+++.||||++.... ....+.+.+|+++|.+++||||+++++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~------------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~ 68 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKV------------DTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEEC------------CCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEE
Confidence 36889999999999999999765 568999999986532 234567889999999999999999999
Q ss_pred EeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 591 CCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
.+.+++..++||||..... ......++......++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 69 ~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DF 145 (376)
T cd05598 69 SFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDF 145 (376)
T ss_pred EEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeC
Confidence 9999999999999953322 223456788888899999999999999988 999999999999999999999999
Q ss_pred ccceecCCCC-----------------------------------------cccccccccccccccCccccccCCCCccc
Q 041702 667 GIARTFGGDE-----------------------------------------MQSNTNRIVGTYGYMSPEYALHGLFSIKS 705 (840)
Q Consensus 667 Gla~~~~~~~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ks 705 (840)
|+|..+.... .........||+.|||||++.+..++.++
T Consensus 146 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 225 (376)
T cd05598 146 GLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC 225 (376)
T ss_pred CCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcce
Confidence 9985331100 00001235799999999999999999999
Q ss_pred cchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCC--
Q 041702 706 DVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRP-- 783 (840)
Q Consensus 706 DV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-- 783 (840)
|||||||+|+||++|+.||......+.. . ........... + ........+.+++.+|+ .+|++|+
T Consensus 226 DiwSlGvilyell~G~~Pf~~~~~~~~~--~---~i~~~~~~~~~--~-----~~~~~s~~~~~li~~l~-~~p~~R~~~ 292 (376)
T cd05598 226 DWWSVGVILYEMLVGQPPFLADTPAETQ--L---KVINWETTLHI--P-----SQAKLSREASDLILRLC-CGAEDRLGK 292 (376)
T ss_pred eeeeccceeeehhhCCCCCCCCCHHHHH--H---HHhccCccccC--C-----CCCCCCHHHHHHHHHHh-cCHhhcCCC
Confidence 9999999999999999998654322110 0 00000000000 0 00112334566677766 4999999
Q ss_pred -CHHHHHHH
Q 041702 784 -TMLEVVAM 791 (840)
Q Consensus 784 -s~~evl~~ 791 (840)
++.|+++.
T Consensus 293 ~t~~ell~h 301 (376)
T cd05598 293 NGADEIKAH 301 (376)
T ss_pred CCHHHHhCC
Confidence 78888754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=307.55 Aligned_cols=244 Identities=19% Similarity=0.274 Sum_probs=187.8
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhc-CCCCccceeeEeecC
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEQ 595 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~ 595 (840)
+.||+|+||.||+|.++ .+++.||||+++... ....+.+..|..++.++ +||||+++++++...
T Consensus 1 ~~lG~G~~g~V~~~~~~------------~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~ 68 (329)
T cd05588 1 RVIGRGSYAKVLLVELK------------KTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE 68 (329)
T ss_pred CeEeeCCCeEEEEEEEC------------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC
Confidence 36999999999999765 578999999997532 23446688999999998 799999999999999
Q ss_pred CceEEEEEeeccCCc----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccccee
Q 041702 596 GEKISIYEFDIVTDP----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 596 ~~~~lv~e~~~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
+..++||||...... .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 69 ~~~~lv~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 145 (329)
T cd05588 69 SRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE 145 (329)
T ss_pred CEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccc
Confidence 999999999543322 23457899999999999999999999998 99999999999999999999999999874
Q ss_pred cCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCC---ccHhHHHhhhhcccccc
Q 041702 672 FGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDS---LTLLGHAWNLWKDDKAW 748 (840)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~---~~~~~~~~~~~~~~~~~ 748 (840)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ................
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~- 222 (329)
T cd05588 146 GIRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI- 222 (329)
T ss_pred cccCC--CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC-
Confidence 32111 12234578999999999999999999999999999999999999986432221 1111111111111110
Q ss_pred cccCccccchhhHHHHHHHHHHHHHccccCCCCCCC------HHHHHH
Q 041702 749 KLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPT------MLEVVA 790 (840)
Q Consensus 749 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs------~~evl~ 790 (840)
.+ +......+.+++.+||+.||++||+ ++++++
T Consensus 223 -----~~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 223 -----RI----PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred -----CC----CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 11 1122345788999999999999997 566653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=296.05 Aligned_cols=248 Identities=28% Similarity=0.396 Sum_probs=192.9
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
.++|+..++||+|+||.||+|.. .+++.||+|.+.... ...++|.+|+.++++++|+||+++++++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~-------------~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 70 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYY-------------NGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVV 70 (260)
T ss_pred hHHceeeeeeccCccceEEeeec-------------CCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEE
Confidence 46788899999999999999864 367889999987543 3457899999999999999999999986
Q ss_pred ecCCceEEEEEeeccCCc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 593 IEQGEKISIYEFDIVTDP------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
. .+..++++|+...... .....+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.++|+||
T Consensus 71 ~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~df 146 (260)
T cd05067 71 T-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADF 146 (260)
T ss_pred c-cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccC
Confidence 4 5678999998432221 12346889999999999999999999988 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
|++......... ......++..|+|||.+....++.++||||||++++||++ |+.|+..... ..... .....
T Consensus 147 g~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~----~~~~~ 219 (260)
T cd05067 147 GLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN--PEVIQ----NLERG 219 (260)
T ss_pred cceeecCCCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh--HHHHH----HHHcC
Confidence 999876532221 1122345678999999998899999999999999999999 9988753321 11111 11110
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~ 794 (840)
............+.+++.+||+.+|++||+++++++.|+.
T Consensus 220 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 220 ---------YRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ---------CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0001111223468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=297.10 Aligned_cols=250 Identities=26% Similarity=0.366 Sum_probs=185.0
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceeeEeec-CCc
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIE-QGE 597 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~-~~~ 597 (840)
+.||+|+||.||+|.+. ....+...||+|++.... ....+.+.+|+.+++.++||||+++++++.. ++.
T Consensus 1 ~~lg~g~~g~v~~~~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 71 (262)
T cd05058 1 RVIGKGHFGCVYHGTLI---------DSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGS 71 (262)
T ss_pred CcccccCCceEEEEEEe---------cCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCC
Confidence 46999999999998754 222355789999986432 3345789999999999999999999998764 556
Q ss_pred eEEEEEeeccCCcc-----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceec
Q 041702 598 KISIYEFDIVTDPA-----RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTF 672 (840)
Q Consensus 598 ~~lv~e~~~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~ 672 (840)
.++++||....... ....+.+..++.++.|+++||+|||+.+ ++||||||+|||++.++.+||+|||+++..
T Consensus 72 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~ 148 (262)
T cd05058 72 PLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDI 148 (262)
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccc
Confidence 78999985332211 1234677888999999999999999987 999999999999999999999999999765
Q ss_pred CCCCcc--cccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCC-CCCCCCCCCccHhHHHhhhhccccccc
Q 041702 673 GGDEMQ--SNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKK-NTRFYNTDSLTLLGHAWNLWKDDKAWK 749 (840)
Q Consensus 673 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (840)
...... .......++..|+|||.+.+..++.++||||||++++||++|+. |+.... ....... ..... .
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--~~~~~~~---~~~~~---~ 220 (262)
T cd05058 149 YDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD--SFDITVY---LLQGR---R 220 (262)
T ss_pred cCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHH---HhcCC---C
Confidence 432211 11123345678999999988899999999999999999999654 443211 1111111 11100 0
Q ss_pred ccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 041702 750 LMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEI 796 (840)
Q Consensus 750 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~ 796 (840)
. . .....+..+.+++.+||+.+|++||++.+|++.|+++.
T Consensus 221 ~---~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 221 L---L----QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred C---C----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 0 0 01112346889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=309.82 Aligned_cols=238 Identities=24% Similarity=0.293 Sum_probs=185.6
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhcCCC-Cccceee
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQHR-NLVRLFG 590 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l~H~-niv~l~g 590 (840)
+|+..+.||+|+||.||+|.++ .+++.||||++... .....+.+..|++++..++|+ +|+++++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~------------~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~ 68 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERK------------GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHS 68 (324)
T ss_pred CceEEEEEeeccCeEEEEEEEC------------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEE
Confidence 4778899999999999999765 56789999999753 234456788999999999765 6888999
Q ss_pred EeecCCceEEEEEeeccCCc----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 591 CCIEQGEKISIYEFDIVTDP----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
++.+.+..++||||...... .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 69 ~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Df 145 (324)
T cd05587 69 CFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADF 145 (324)
T ss_pred EEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeec
Confidence 99999999999999533222 23456889999999999999999999988 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccc
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDK 746 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 746 (840)
|+++...... .......||+.|+|||++.+..++.++|||||||+++||++|+.|+...... ..... .....
T Consensus 146 g~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~~~----i~~~~ 217 (324)
T cd05587 146 GMCKENIFGG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--ELFQS----IMEHN 217 (324)
T ss_pred CcceecCCCC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHH----HHcCC
Confidence 9987532111 1223456899999999999999999999999999999999999998643211 11111 11100
Q ss_pred cccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCH
Q 041702 747 AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTM 785 (840)
Q Consensus 747 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 785 (840)
... +......+.+++.+||+.||++||+.
T Consensus 218 ------~~~----~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 ------VSY----PKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ------CCC----CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 011 11223457889999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=315.50 Aligned_cols=253 Identities=20% Similarity=0.215 Sum_probs=193.6
Q ss_pred HHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhcCCCCccc
Q 041702 511 AATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQHRNLVR 587 (840)
Q Consensus 511 ~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~ 587 (840)
...++|+..++||+|+||.||+|.++ .+++.||+|++... .....+.+.+|+.+++.++||||++
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~------------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~ 107 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHK------------SSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQ 107 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEEC------------CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcce
Confidence 34578999999999999999999765 57889999999643 2234456889999999999999999
Q ss_pred eeeEeecCCceEEEEEeeccCC---ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 588 LFGCCIEQGEKISIYEFDIVTD---PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 588 l~g~~~~~~~~~lv~e~~~~~~---~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
+++++.+.+..++||||..... ......++......++.||+.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 108 ~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~ 184 (370)
T cd05596 108 LHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLA 184 (370)
T ss_pred EEEEEecCCEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEE
Confidence 9999999999999999953222 122345788888899999999999999988 9999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCccccccC----CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhh
Q 041702 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHG----LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWN 740 (840)
Q Consensus 665 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~ 740 (840)
|||++........ .......||+.|+|||.+.+. .++.++|||||||+|+||++|+.||...... ... ..
T Consensus 185 DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~~~---~~ 258 (370)
T cd05596 185 DFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--GTY---SK 258 (370)
T ss_pred eccceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH--HHH---HH
Confidence 9999987643221 122345799999999988653 4789999999999999999999998643211 111 11
Q ss_pred hhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 041702 741 LWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATD--RPTMLEVVAM 791 (840)
Q Consensus 741 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~ 791 (840)
.......... .........+.+++.+||+.+|.+ ||+++|+++.
T Consensus 259 i~~~~~~~~~-------~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 259 IMDHKNSLTF-------PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HHcCCCcCCC-------CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 1111100000 111123456788999999999987 9999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=309.36 Aligned_cols=233 Identities=26% Similarity=0.344 Sum_probs=183.4
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhc-CCCCccceeeEeecC
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEQ 595 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~ 595 (840)
+.||+|+||.||+|.++ .+++.||||+++.. .....+.+..|..++..+ +||||+++++++...
T Consensus 1 ~~lg~G~~g~V~~~~~~------------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 68 (320)
T cd05590 1 RVLGKGSFGKVMLARLK------------ESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTP 68 (320)
T ss_pred CeeeeCCCeEEEEEEEc------------CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcC
Confidence 36999999999999765 57889999998753 234456788899999877 699999999999999
Q ss_pred CceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccccee
Q 041702 596 GEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 596 ~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
+..++||||..... ......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 69 ~~~~iv~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~ 145 (320)
T cd05590 69 DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKE 145 (320)
T ss_pred CEEEEEEcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCee
Confidence 99999999953322 223456889999999999999999999988 99999999999999999999999999875
Q ss_pred cCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccccccccc
Q 041702 672 FGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLM 751 (840)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (840)
..... .......||+.|+|||.+.+..++.++|||||||+++||++|+.||...... ... ....... ..
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--~~~----~~i~~~~---~~ 214 (320)
T cd05590 146 GIFNG--KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED--DLF----EAILNDE---VV 214 (320)
T ss_pred cCcCC--CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--HHH----HHHhcCC---CC
Confidence 42221 1223457899999999999999999999999999999999999998643211 111 1111111 00
Q ss_pred CccccchhhHHHHHHHHHHHHHccccCCCCCCCH
Q 041702 752 DPTMQNEALYSMVTRYIKVALLCVQENATDRPTM 785 (840)
Q Consensus 752 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 785 (840)
.+ ......+.+++.+||+.||++||++
T Consensus 215 ~~-------~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 215 YP-------TWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CC-------CCCCHHHHHHHHHHcccCHHHCCCC
Confidence 01 1123457889999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=312.30 Aligned_cols=261 Identities=21% Similarity=0.243 Sum_probs=192.9
Q ss_pred HHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC--CCcCHHHHHHHHHHHhhcCCCCccce
Q 041702 511 AATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK--SGQGLEEFKNEMMLIAKLQHRNLVRL 588 (840)
Q Consensus 511 ~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l 588 (840)
...++|...+.||+|+||.||+|.+. ..++.||||++... .....+++.+|+.+++.++||||+++
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~ 88 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDA------------ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEEC------------CCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCcccc
Confidence 34678999999999999999999765 56889999999753 23345678899999999999999999
Q ss_pred eeEeecC------CceEEEEEeeccCCc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCc
Q 041702 589 FGCCIEQ------GEKISIYEFDIVTDP-ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP 661 (840)
Q Consensus 589 ~g~~~~~------~~~~lv~e~~~~~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 661 (840)
++++... ...++||||...... .....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+
T Consensus 89 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~ 165 (364)
T cd07875 89 LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 165 (364)
T ss_pred ceeecccccccccCeEEEEEeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcE
Confidence 9987543 356899998432111 11234788889999999999999999988 9999999999999999999
Q ss_pred eeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhh-
Q 041702 662 KISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWN- 740 (840)
Q Consensus 662 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~- 740 (840)
||+|||+++...... ......+|..|+|||++.+..++.++|||||||+++||++|+.||......+ .......
T Consensus 166 kL~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~~~~~~~~ 240 (364)
T cd07875 166 KILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID--QWNKVIEQ 240 (364)
T ss_pred EEEeCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHh
Confidence 999999998654322 1233568999999999999999999999999999999999999986433211 0000000
Q ss_pred ------------------hhccccc------ccccCccc---cchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 741 ------------------LWKDDKA------WKLMDPTM---QNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 741 ------------------~~~~~~~------~~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
....... ..+..... ...........+.+++.+||+.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 241 LGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred cCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000 00000000 000111123467899999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=309.40 Aligned_cols=238 Identities=25% Similarity=0.303 Sum_probs=186.3
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhc-CCCCccceee
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKL-QHRNLVRLFG 590 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l-~H~niv~l~g 590 (840)
+|...+.||+|+||.||+|.++ .+++.||||+++... ....+.+..|..++..+ +|++|+++++
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~------------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~ 68 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERK------------GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHS 68 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEEC------------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEE
Confidence 4778899999999999999765 578899999987542 23345677888888887 5899999999
Q ss_pred EeecCCceEEEEEeeccCCc----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 591 CCIEQGEKISIYEFDIVTDP----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
++...+..++||||...... .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 69 ~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~Df 145 (323)
T cd05616 69 CFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADF 145 (323)
T ss_pred EEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccC
Confidence 99999999999999533222 23456889999999999999999999988 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccc
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDK 746 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 746 (840)
|+++...... .......||+.|+|||++.+..++.++|||||||+++||++|+.|+...... .+... .....
T Consensus 146 G~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--~~~~~----i~~~~ 217 (323)
T cd05616 146 GMCKENMWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--ELFQS----IMEHN 217 (323)
T ss_pred CCceecCCCC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH--HHHHH----HHhCC
Confidence 9997543221 1223457899999999999999999999999999999999999998643221 11111 11110
Q ss_pred cccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCH
Q 041702 747 AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTM 785 (840)
Q Consensus 747 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 785 (840)
. ..+......+.+++.+||+.+|++|++.
T Consensus 218 --------~--~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 218 --------V--AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred --------C--CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 0 1112234567889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=294.68 Aligned_cols=246 Identities=25% Similarity=0.367 Sum_probs=186.4
Q ss_pred cccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcCCCCccceeeEeecCCceE
Q 041702 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKI 599 (840)
Q Consensus 521 ~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~ 599 (840)
.||+|+||.||+|.++ ....+..||+|++..... ...++|.+|+.++++++||||+++++++. .+..+
T Consensus 2 ~ig~G~~g~v~~~~~~----------~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~ 70 (257)
T cd05115 2 ELGSGNFGCVKKGVYK----------MRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALM 70 (257)
T ss_pred ccCCCCcccEEEEEEe----------cCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeE
Confidence 4899999999998654 113456799999976533 33467999999999999999999999885 45788
Q ss_pred EEEEeeccCCcc-----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceecCC
Q 041702 600 SIYEFDIVTDPA-----RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGG 674 (840)
Q Consensus 600 lv~e~~~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 674 (840)
+|+||....... ....+++..+++++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++.....
T Consensus 71 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 147 (257)
T cd05115 71 LVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGA 147 (257)
T ss_pred EEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccC
Confidence 999984322211 2456899999999999999999999988 99999999999999999999999999986543
Q ss_pred CCccc-ccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhcccccccccC
Q 041702 675 DEMQS-NTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMD 752 (840)
Q Consensus 675 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 752 (840)
..... ......++..|+|||.+.+..++.++||||||++++||++ |+.|+......+ .........
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~------ 215 (257)
T cd05115 148 DDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE------VMSFIEQGK------ 215 (257)
T ss_pred CccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH------HHHHHHCCC------
Confidence 32211 1111223578999999988889999999999999999996 998875432111 111111111
Q ss_pred ccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 753 PTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 753 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
....+......+.+++.+||+.+|++||++.+|.+.|+..
T Consensus 216 ---~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 216 ---RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 0111122345677899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=294.57 Aligned_cols=247 Identities=33% Similarity=0.471 Sum_probs=194.1
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCc-CHHHHHHHHHHHhhcCCCCccceeeEeecCCce
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQ-GLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEK 598 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~-~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~ 598 (840)
+.||+|+||.||+|.+. .....+..||+|.+...... ..+++.+|++++..++|+||+++++++...+..
T Consensus 1 ~~ig~g~~g~v~~~~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 71 (262)
T cd00192 1 KKLGEGAFGEVYKGKLK---------GKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPL 71 (262)
T ss_pred CccccCCceEEEEEEEe---------cCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCce
Confidence 46999999999999765 11134789999999865433 367899999999999999999999999999999
Q ss_pred EEEEEeeccCC----ccc---------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 599 ISIYEFDIVTD----PAR---------KDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 599 ~lv~e~~~~~~----~~~---------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
++++||..... ... ...+++..+.+++.|+++||+|||+.+ ++||||||+||++++++.+||+|
T Consensus 72 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~d 148 (262)
T cd00192 72 YLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISD 148 (262)
T ss_pred EEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcc
Confidence 99999942211 111 367899999999999999999999988 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
||.+................++..|+|||.+.+..++.++||||||++++||++ |..|+..... .... .....
T Consensus 149 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~----~~~~~ 222 (262)
T cd00192 149 FGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--EEVL----EYLRK 222 (262)
T ss_pred cccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--HHHH----HHHHc
Confidence 999987754432233344567889999999988899999999999999999999 5888764421 1111 11111
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLK 793 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le 793 (840)
.. ...........+.+++.+||+.+|++|||+.|+++.|+
T Consensus 223 ~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 223 GY---------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CC---------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 10 00111222456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=303.85 Aligned_cols=250 Identities=25% Similarity=0.351 Sum_probs=196.6
Q ss_pred HHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEecc--CCCcCHHHHHHHHHHHhhc-CCCCccc
Q 041702 511 AATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSS--KSGQGLEEFKNEMMLIAKL-QHRNLVR 587 (840)
Q Consensus 511 ~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~--~~~~~~~~f~~Ev~~l~~l-~H~niv~ 587 (840)
.....|+++++||+||.+.||++.. .+.+.+|+|++.. .+.+....|++|+..|.+| .|.+||+
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~-------------s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIq 424 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLN-------------SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQ 424 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeec-------------CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEE
Confidence 3457789999999999999999853 3567888888754 3456788899999999999 5899999
Q ss_pred eeeEeecCCceEEEEEeeccC-----CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCce
Q 041702 588 LFGCCIEQGEKISIYEFDIVT-----DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPK 662 (840)
Q Consensus 588 l~g~~~~~~~~~lv~e~~~~~-----~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 662 (840)
|++|-..++..|+|||+.... .........| .++.+..||+.++.++|+++ |||.||||.|+|+ -.|.+|
T Consensus 425 L~DYEv~d~~lYmvmE~Gd~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLl-VkG~LK 499 (677)
T KOG0596|consen 425 LYDYEVTDGYLYMVMECGDIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLL-VKGRLK 499 (677)
T ss_pred EeeeeccCceEEEEeecccccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEE-EeeeEE
Confidence 999999999999999993221 1111222334 67779999999999999998 9999999999999 678999
Q ss_pred eeccccceecCCCCcccccccccccccccCccccccC-----------CCCccccchhHHHHHHHHHhCCCCCCCCCCCC
Q 041702 663 ISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHG-----------LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDS 731 (840)
Q Consensus 663 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~ksDV~SlGviL~elltG~~p~~~~~~~~ 731 (840)
|+|||+|..+..+.........+||+.||+||.+... .++.++||||+|||||+|+.|+.||...
T Consensus 500 LIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~---- 575 (677)
T KOG0596|consen 500 LIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI---- 575 (677)
T ss_pred eeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH----
Confidence 9999999999888777777788999999999988532 2568999999999999999999997421
Q ss_pred ccHhHHHhhhhcccccccccCccccchhhHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 732 LTLLGHAWNLWKDDKAWKLMDPTMQNEALYS-MVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
...+. ++..+.+|....+++.- ....+++++..||+.||.+||+..|+|+.
T Consensus 576 ----~n~~a-----Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 576 ----INQIA-----KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ----HHHHH-----HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 11111 23445566443222211 11228999999999999999999999864
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=295.13 Aligned_cols=248 Identities=30% Similarity=0.411 Sum_probs=188.6
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcCCCCccceeeEeecCCce
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEK 598 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~ 598 (840)
++||+|+||.||+|.+. .....+..+|+|.+..... ...+++.+|+.+++++.||||+++++++. .+..
T Consensus 1 ~~ig~G~~g~v~~~~~~---------~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 70 (257)
T cd05060 1 KELGHGNFGSVVKGVYL---------MKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPL 70 (257)
T ss_pred CccCccCceeEEEeEee---------ccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCce
Confidence 47999999999998754 2222347899999986543 34567999999999999999999999876 5568
Q ss_pred EEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceecCC
Q 041702 599 ISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGG 674 (840)
Q Consensus 599 ~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 674 (840)
+++|||..... ......+++..+..++.|++.||+|||..+ ++|+||||+|||++.++.+||+|||+++....
T Consensus 71 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~ 147 (257)
T cd05060 71 MLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGA 147 (257)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeec
Confidence 89999843222 123346899999999999999999999988 99999999999999999999999999987643
Q ss_pred CCccc-ccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhcccccccccC
Q 041702 675 DEMQS-NTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMD 752 (840)
Q Consensus 675 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 752 (840)
..... ......++..|+|||.+.+..++.++||||||++++||++ |+.|+..... ...... ..... ..
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~----~~~~~--~~-- 217 (257)
T cd05060 148 GSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAM----LESGE--RL-- 217 (257)
T ss_pred CCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHH----HHcCC--cC--
Confidence 32211 1111223568999999998999999999999999999998 8988754321 111111 11111 00
Q ss_pred ccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 753 PTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 753 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
..+...+..+.+++.+||+.+|++||++.+|++.|++.
T Consensus 218 -----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 218 -----PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred -----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 11112335678999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=300.95 Aligned_cols=249 Identities=22% Similarity=0.363 Sum_probs=197.1
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
..++|+..+.||+|+||.||+|.+. .+++.||+|.+........+.+.+|+.+++.++|+||++++++
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~ 84 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDI------------ATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEEC------------CCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 3478889999999999999998654 6789999999986655556788999999999999999999999
Q ss_pred eecCCceEEEEEeeccCCc---cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccc
Q 041702 592 CIEQGEKISIYEFDIVTDP---ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGI 668 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl 668 (840)
+..++..++|+||...... .....+++.++..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+
T Consensus 85 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~ 161 (297)
T cd06656 85 YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGF 161 (297)
T ss_pred EecCCEEEEeecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCcc
Confidence 9999999999999432221 22356788999999999999999999988 99999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccc
Q 041702 669 ARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAW 748 (840)
Q Consensus 669 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (840)
+........ ......+++.|+|||.+.+..++.++|||||||++++|++|+.|+.......... ......
T Consensus 162 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~-----~~~~~~--- 231 (297)
T cd06656 162 CAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-----LIATNG--- 231 (297)
T ss_pred ceEccCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee-----eeccCC---
Confidence 976543321 1223467889999999999889999999999999999999999985432211100 000000
Q ss_pred cccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 749 KLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 749 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.+.. .........+.+++.+||+.+|++||++++|++
T Consensus 232 ---~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 232 ---TPEL--QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ---CCCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 111223445778999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=322.40 Aligned_cols=264 Identities=20% Similarity=0.257 Sum_probs=188.1
Q ss_pred HHHHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCC---
Q 041702 506 LSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQH--- 582 (840)
Q Consensus 506 ~~~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H--- 582 (840)
..++...+++|++.++||+|+||.||+|.++ ..++.||||+++... ...+++..|+.++.+++|
T Consensus 121 ~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~------------~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~ 187 (467)
T PTZ00284 121 GEDIDVSTQRFKILSLLGEGTFGKVVEAWDR------------KRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADP 187 (467)
T ss_pred CCccccCCCcEEEEEEEEeccCEEEEEEEEc------------CCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCc
Confidence 3445556789999999999999999999765 568899999997532 234556778888887755
Q ss_pred ---CCccceeeEeecC-CceEEEEEee---ccCCccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceecCCCCCCcEE
Q 041702 583 ---RNLVRLFGCCIEQ-GEKISIYEFD---IVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQY-SRLRVIHRDLKASNVL 654 (840)
Q Consensus 583 ---~niv~l~g~~~~~-~~~~lv~e~~---~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivHrDlkp~NIL 654 (840)
++++++++++... +..++|||+. ..........+++..+..|+.||+.||+|||++ + ||||||||+|||
T Consensus 188 ~~~~~i~~i~~~~~~~~~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NIL 264 (467)
T PTZ00284 188 ADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENIL 264 (467)
T ss_pred ccCcceeeeEEEEEcCCceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEE
Confidence 4588899988764 4677888763 111122345689999999999999999999974 6 999999999999
Q ss_pred ecCCC----------------CceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHH
Q 041702 655 LDSDM----------------NPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEIL 718 (840)
Q Consensus 655 l~~~~----------------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ell 718 (840)
++.++ .+||+|||.+.... .......||+.|+|||++.+..++.++|||||||+||||+
T Consensus 265 l~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~ell 339 (467)
T PTZ00284 265 METSDTVVDPVTNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELY 339 (467)
T ss_pred EecCCcccccccccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHH
Confidence 98765 48999999875432 1223467999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCC-ccHhHHH-------hh-hhcccccccc------cCccccch-----------hhHHHHHHHHHHHH
Q 041702 719 SSKKNTRFYNTDS-LTLLGHA-------WN-LWKDDKAWKL------MDPTMQNE-----------ALYSMVTRYIKVAL 772 (840)
Q Consensus 719 tG~~p~~~~~~~~-~~~~~~~-------~~-~~~~~~~~~~------~d~~l~~~-----------~~~~~~~~l~~l~~ 772 (840)
+|+.||......+ ....... +. .........+ +++..... ........+++|+.
T Consensus 340 tG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 419 (467)
T PTZ00284 340 TGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIY 419 (467)
T ss_pred hCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHH
Confidence 9999986543211 0000000 00 0000000000 00000000 00011345789999
Q ss_pred HccccCCCCCCCHHHHHH
Q 041702 773 LCVQENATDRPTMLEVVA 790 (840)
Q Consensus 773 ~Cl~~dP~~RPs~~evl~ 790 (840)
+||+.||++|||++|+++
T Consensus 420 ~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 420 GLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HhCCcChhhCCCHHHHhc
Confidence 999999999999999986
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=294.38 Aligned_cols=248 Identities=20% Similarity=0.294 Sum_probs=182.4
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEeecCCceE
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKI 599 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~ 599 (840)
+.||+|+||.||+|....................|++|.+..........|.+|+.++.+++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 36899999999998643111000000112334569999987655555668999999999999999999999999999999
Q ss_pred EEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCC-------ceeeccc
Q 041702 600 SIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMN-------PKISDFG 667 (840)
Q Consensus 600 lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~-------~kL~DFG 667 (840)
+++||...... .....+++..+++++.||++||+|||+.+ |+||||||+|||++.++. +|++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 99999532221 12345899999999999999999999988 999999999999987664 8999999
Q ss_pred cceecCCCCcccccccccccccccCccccc-cCCCCccccchhHHHHHHHHH-hCCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYAL-HGLFSIKSDVFSFGVLLLEIL-SSKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDV~SlGviL~ell-tG~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
++..... .....++..|+|||.+. +..++.++|||||||++|||+ +|+.|+......+. ..... .
T Consensus 158 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~------~~~~~-~ 224 (262)
T cd05077 158 IPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK------ERFYE-G 224 (262)
T ss_pred CCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH------HHHHh-c
Confidence 9875432 12345788999999886 567899999999999999998 47766543221110 00000 0
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLK 793 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le 793 (840)
. .. ... .....+.+++.+||+.||++||++.+|++.|+
T Consensus 225 ~-~~-----~~~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 225 Q-CM-----LVT----PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred C-cc-----CCC----CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0 00 001 11245788999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=301.30 Aligned_cols=248 Identities=22% Similarity=0.377 Sum_probs=196.2
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
..+|+..+.||.|++|.||+|.+. .+++.||+|.+........+.+.+|+.+++.++||||+++++++
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~------------~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 85 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDV------------ATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEc------------CCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeE
Confidence 356899999999999999998654 67899999999766555667899999999999999999999999
Q ss_pred ecCCceEEEEEeeccCC---ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccc
Q 041702 593 IEQGEKISIYEFDIVTD---PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIA 669 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~---~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla 669 (840)
...+..++++||..... ......+++.++..++.+++.||+|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 86 ~~~~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~ 162 (296)
T cd06655 86 LVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFC 162 (296)
T ss_pred ecCceEEEEEEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccc
Confidence 99999999999843222 122346899999999999999999999988 999999999999999999999999998
Q ss_pred eecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccccccc
Q 041702 670 RTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWK 749 (840)
Q Consensus 670 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (840)
........ ......++..|+|||.+.+..++.++|||||||+++||++|+.|+........ . ...... ...
T Consensus 163 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~--~---~~~~~~-~~~- 233 (296)
T cd06655 163 AQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--L---YLIATN-GTP- 233 (296)
T ss_pred hhcccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--H---HHHHhc-CCc-
Confidence 76543322 12234688899999999988899999999999999999999999854322110 0 000000 000
Q ss_pred ccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 750 LMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 750 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.+ .........+.+++.+||+.+|++||++.+|++
T Consensus 234 ----~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 234 ----EL--QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred ----cc--CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 00 011223345778999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=295.22 Aligned_cols=244 Identities=27% Similarity=0.385 Sum_probs=193.3
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
.++|+..+.||+|+||.||+|.. .++.||||.+..... ..+++.+|+.++.+++|+||+++++++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--------------~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~ 69 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--------------RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVV 69 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--------------cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEE
Confidence 35778889999999999999853 478899999986543 567899999999999999999999999
Q ss_pred ecCCceEEEEEeeccCCcc------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 593 IEQGEKISIYEFDIVTDPA------RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~~~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
...+..++++||....... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+||
T Consensus 70 ~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~ 146 (256)
T cd05039 70 LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDF 146 (256)
T ss_pred cCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccc
Confidence 9999999999985322211 1226899999999999999999999988 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
|.++....... ....+..|+|||.+.+..++.++||||||++++||++ |+.|+...... .+... ....
T Consensus 147 g~~~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~----~~~~ 215 (256)
T cd05039 147 GLAKEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPH----VEKG 215 (256)
T ss_pred ccccccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHH----HhcC
Confidence 99987632211 2234568999999998899999999999999999997 88887533211 11111 1110
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~ 794 (840)
. ........+..+.+++.+||+.+|++||++++++++|+.
T Consensus 216 ~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 216 Y---------RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred C---------CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 0 001112234568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=313.95 Aligned_cols=255 Identities=20% Similarity=0.227 Sum_probs=192.5
Q ss_pred HHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhcCCCCc
Q 041702 509 ISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQHRNL 585 (840)
Q Consensus 509 ~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l~H~ni 585 (840)
+....++|+..+.||+|+||.||+|.++ .+++.||+|++.+. .....+.+.+|+.+++.++||||
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~------------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~i 105 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHK------------SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV 105 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEEC------------CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCE
Confidence 3445678999999999999999999765 57889999998642 22334568899999999999999
Q ss_pred cceeeEeecCCceEEEEEeeccCC---ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCce
Q 041702 586 VRLFGCCIEQGEKISIYEFDIVTD---PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPK 662 (840)
Q Consensus 586 v~l~g~~~~~~~~~lv~e~~~~~~---~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 662 (840)
+++++++...+..++||||..... ......+++.....++.||+.||+|||+.+ |+||||||+|||+++++.+|
T Consensus 106 v~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~k 182 (370)
T cd05621 106 VQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLK 182 (370)
T ss_pred eeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEE
Confidence 999999999999999999943222 123345788889999999999999999988 99999999999999999999
Q ss_pred eeccccceecCCCCcccccccccccccccCccccccC----CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHH
Q 041702 663 ISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHG----LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHA 738 (840)
Q Consensus 663 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~ 738 (840)
|+|||++........ .......||+.|+|||.+.+. .++.++|||||||+|+||++|+.||...... ...
T Consensus 183 L~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~-----~~~ 256 (370)
T cd05621 183 LADFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV-----GTY 256 (370)
T ss_pred EEecccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH-----HHH
Confidence 999999987643221 122346799999999998754 3789999999999999999999998643211 111
Q ss_pred hhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCC--CCCCHHHHHHH
Q 041702 739 WNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENAT--DRPTMLEVVAM 791 (840)
Q Consensus 739 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~--~RPs~~evl~~ 791 (840)
............ .........+.+++..|++.++. .||++.|+++.
T Consensus 257 ~~i~~~~~~~~~-------p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 257 SKIMDHKNSLNF-------PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HHHHhCCcccCC-------CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 111111100000 11112344567788888875554 38899998865
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=307.86 Aligned_cols=238 Identities=25% Similarity=0.298 Sum_probs=186.9
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhc-CCCCccceeeEeecC
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEQ 595 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~ 595 (840)
+.||+|+||.||+|.++ .+++.||||+++.. .....+.+..|.+++..+ +||||+++++++...
T Consensus 1 ~~lG~G~~g~V~~~~~~------------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~ 68 (318)
T cd05570 1 KVLGKGSFGKVLLAELK------------GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK 68 (318)
T ss_pred CeeeeCCCeEEEEEEEC------------CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC
Confidence 36999999999999765 56889999999753 234456788899999888 799999999999999
Q ss_pred CceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccccee
Q 041702 596 GEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 596 ~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
+..++||||..... ......+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 69 ~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 145 (318)
T cd05570 69 DRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKE 145 (318)
T ss_pred CEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCee
Confidence 99999999953322 223446899999999999999999999988 99999999999999999999999999875
Q ss_pred cCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccccccccc
Q 041702 672 FGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLM 751 (840)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (840)
..... .......|++.|+|||++.+..++.++|||||||+++||++|+.||...... ... .......
T Consensus 146 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~--~~~----~~i~~~~----- 212 (318)
T cd05570 146 GILGG--VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED--ELF----QSILEDE----- 212 (318)
T ss_pred cCcCC--CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH--HHH----HHHHcCC-----
Confidence 32211 1223456899999999999999999999999999999999999998543211 111 1111110
Q ss_pred CccccchhhHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 041702 752 DPTMQNEALYSMVTRYIKVALLCVQENATDRPTM-----LEVVA 790 (840)
Q Consensus 752 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~ 790 (840)
.. .+......+.+++.+||+.||++||++ .++++
T Consensus 213 -~~----~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 213 -VR----YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred -CC----CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 00 111234467899999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=296.92 Aligned_cols=253 Identities=22% Similarity=0.326 Sum_probs=189.9
Q ss_pred CcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceeeEee
Q 041702 516 FSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFGCCI 593 (840)
Q Consensus 516 f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~ 593 (840)
|.+.+.||+|+||.||+|.++ ....+++.||||++.... ....+++.+|++++++++||||+++++++.
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 71 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLK---------SEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSL 71 (273)
T ss_pred CcchhcccCCCCCCEEeeEee---------ccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEc
Confidence 456788999999999999765 223467899999987542 234567999999999999999999999986
Q ss_pred cCCc------eEEEEEeeccCCc----------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecC
Q 041702 594 EQGE------KISIYEFDIVTDP----------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS 657 (840)
Q Consensus 594 ~~~~------~~lv~e~~~~~~~----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~ 657 (840)
..+. .+++++|...... .....+++....+++.|++.||+|||+.+ |+||||||+||+++.
T Consensus 72 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~ 148 (273)
T cd05074 72 RSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNE 148 (273)
T ss_pred cCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcC
Confidence 5432 3566776322221 11224788899999999999999999988 999999999999999
Q ss_pred CCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhH
Q 041702 658 DMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLG 736 (840)
Q Consensus 658 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~ 736 (840)
++.+||+|||+++...............+++.|++||.+.+..++.++||||||++++||++ |++|+..... .....
T Consensus 149 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~ 226 (273)
T cd05074 149 NMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYN 226 (273)
T ss_pred CCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHH
Confidence 99999999999987644332222233445678999999998899999999999999999999 7777653221 11111
Q ss_pred HHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 737 HAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 737 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
+ ....... . ........+.+++.+||+.+|++||++.++++.|+++
T Consensus 227 ~----~~~~~~~-----~----~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 227 Y----LIKGNRL-----K----QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred H----HHcCCcC-----C----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1 1111000 0 0112345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=296.40 Aligned_cols=255 Identities=23% Similarity=0.372 Sum_probs=194.3
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
.+|++.+.||+|+||.||+|.++ ..-..+..+|+|.++... ....+.|.+|+.++.+++||||+++++++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 74 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLK---------LPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV 74 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEe---------cCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 56788899999999999998754 111234579999987542 23356799999999999999999999999
Q ss_pred ecCCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 593 IEQGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
.+++..+++|||...... .....+++.+++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg 151 (267)
T cd05066 75 TKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFG 151 (267)
T ss_pred ecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCC
Confidence 999999999998533221 11245789999999999999999999988 9999999999999999999999999
Q ss_pred cceecCCCCcccc-cccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 668 IARTFGGDEMQSN-TNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 668 la~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
++..+........ .....++..|+|||.+.+..++.++||||||++++|+++ |+.|+......+ .... ..+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--~~~~----~~~~ 225 (267)
T cd05066 152 LSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--VIKA----IEEG 225 (267)
T ss_pred cccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--HHHH----HhCC
Confidence 9987643321111 112223568999999998899999999999999999886 998875432211 1111 1110
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
... ......+..+.+++.+|++.+|++||+|.++++.|+++
T Consensus 226 --~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 226 --YRL-------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --CcC-------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 000 11112345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=293.53 Aligned_cols=248 Identities=29% Similarity=0.397 Sum_probs=189.9
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcCCCCccceeeEeecCCce
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEK 598 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~ 598 (840)
++||+|++|.||+|.+. ........||||.++.... ...++|.+|++++++++||||+++++++.. ...
T Consensus 1 ~~ig~g~~~~v~~~~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~ 70 (257)
T cd05040 1 KKLGDGSFGVVRRGEWS---------TSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPL 70 (257)
T ss_pred CcCCccCcccEEeeeEe---------cCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeE
Confidence 36899999999999764 1112234699999987654 556789999999999999999999999988 889
Q ss_pred EEEEEeeccCCcc----c-c-CCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceec
Q 041702 599 ISIYEFDIVTDPA----R-K-DLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTF 672 (840)
Q Consensus 599 ~lv~e~~~~~~~~----~-~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~ 672 (840)
++++|+....... . . ..+++.....++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+
T Consensus 71 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~ 147 (257)
T cd05040 71 MMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRAL 147 (257)
T ss_pred EEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccc
Confidence 9999984322111 1 1 46899999999999999999999988 999999999999999999999999999876
Q ss_pred CCCCcc-cccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhcccccccc
Q 041702 673 GGDEMQ-SNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKDDKAWKL 750 (840)
Q Consensus 673 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (840)
...... .......++..|+|||.+.+..++.++||||||++++||++ |+.|+...... ...... ..... ..
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~---~~~~~--~~ 220 (257)
T cd05040 148 PQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS--QILKKI---DKEGE--RL 220 (257)
T ss_pred cccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHH---HhcCC--cC
Confidence 442211 11223456789999999998899999999999999999999 99987532211 111111 00000 00
Q ss_pred cCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 041702 751 MDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794 (840)
Q Consensus 751 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~ 794 (840)
......+..+.+++.+|++.+|++||++.+|++.|.+
T Consensus 221 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 257 (257)
T cd05040 221 -------ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257 (257)
T ss_pred -------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhcC
Confidence 0111234568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=295.59 Aligned_cols=252 Identities=24% Similarity=0.380 Sum_probs=192.6
Q ss_pred HHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccce
Q 041702 509 ISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRL 588 (840)
Q Consensus 509 ~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l 588 (840)
++.+++++.....||+|+||.||+|.++ .++..||+|.+........+.+.+|++++++++|+||+++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~------------~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 70 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDL------------STQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQY 70 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEec------------CCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeee
Confidence 3456777777789999999999999754 5788999999887655566789999999999999999999
Q ss_pred eeEeecCCceEEEEEeeccCCcc-----ccCCC--CHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecC-CCC
Q 041702 589 FGCCIEQGEKISIYEFDIVTDPA-----RKDLL--DWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS-DMN 660 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~~~~~~~~-----~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~ 660 (840)
++++..++..++++||....... ....+ ++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.
T Consensus 71 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~ 147 (268)
T cd06624 71 LGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGV 147 (268)
T ss_pred eeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCe
Confidence 99999999999999984322211 11234 77888899999999999999988 999999999999986 678
Q ss_pred ceeeccccceecCCCCcccccccccccccccCccccccCC--CCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHH
Q 041702 661 PKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGL--FSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHA 738 (840)
Q Consensus 661 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~ 738 (840)
+||+|||++........ ......+++.|+|||++.+.. ++.++||||||++++||++|+.|+...........
T Consensus 148 ~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~--- 222 (268)
T cd06624 148 VKISDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMF--- 222 (268)
T ss_pred EEEecchhheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHh---
Confidence 99999999876543221 122345788999999986643 78999999999999999999999754321111100
Q ss_pred hhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 739 WNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 739 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.. . .. ......+......+.+++.+||+.+|++|||+.|+++
T Consensus 223 -~~---~-~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 223 -KV---G-MF-----KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred -hh---h-hh-----ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 00 0 00 0001111223455788999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=305.57 Aligned_cols=237 Identities=23% Similarity=0.317 Sum_probs=183.9
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhc-CCCCccceeeEeecC
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEQ 595 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~ 595 (840)
+.||+|+||.||+|.++ .+++.||||+++... ....+.+..|..++..+ +||||+++++++.+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~ 68 (316)
T cd05619 1 KMLGKGSFGKVFLAELK------------GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK 68 (316)
T ss_pred CeeeeCCCEEEEEEEEC------------CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC
Confidence 36999999999999765 568899999997541 23446677888888765 999999999999999
Q ss_pred CceEEEEEeeccCCc----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccccee
Q 041702 596 GEKISIYEFDIVTDP----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 596 ~~~~lv~e~~~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
+..++||||...... .....+++.+...++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 69 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 145 (316)
T cd05619 69 ENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKE 145 (316)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceE
Confidence 999999999433222 23356889999999999999999999988 99999999999999999999999999875
Q ss_pred cCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccccccccc
Q 041702 672 FGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLM 751 (840)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (840)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.|+...... ..... ....
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~~~----i~~~------ 211 (316)
T cd05619 146 NMLGD--AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--ELFQS----IRMD------ 211 (316)
T ss_pred CCCCC--CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--HHHHH----HHhC------
Confidence 42211 1223456899999999999999999999999999999999999998643211 11111 1100
Q ss_pred CccccchhhHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 041702 752 DPTMQNEALYSMVTRYIKVALLCVQENATDRPTML-EVV 789 (840)
Q Consensus 752 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl 789 (840)
.+... ......+.+++.+||+.||++||++. ++.
T Consensus 212 ~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 212 NPCYP----RWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred CCCCC----ccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 01111 11234577899999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=297.51 Aligned_cols=242 Identities=21% Similarity=0.267 Sum_probs=185.0
Q ss_pred ccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhcCCCCccceeeEeecCCce
Q 041702 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEK 598 (840)
Q Consensus 522 lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~ 598 (840)
||+|+||.||++.++ .+|+.||+|++.... ....+.+..|++++++++||||+++++++..+...
T Consensus 1 lg~G~~g~Vy~~~~~------------~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~ 68 (277)
T cd05607 1 LGKGGFGEVCAVQVK------------NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHL 68 (277)
T ss_pred CCCCCceEEEEEEEc------------cCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeE
Confidence 799999999998765 578999999986432 12234567799999999999999999999999999
Q ss_pred EEEEEeeccCCc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceec
Q 041702 599 ISIYEFDIVTDP------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTF 672 (840)
Q Consensus 599 ~lv~e~~~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~ 672 (840)
+++|||...... .....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 69 ~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~ 145 (277)
T cd05607 69 CLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVEL 145 (277)
T ss_pred EEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeec
Confidence 999999532221 12335788999999999999999999988 999999999999999999999999999876
Q ss_pred CCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccccccC
Q 041702 673 GGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMD 752 (840)
Q Consensus 673 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 752 (840)
.... ......|+..|+|||++.+..++.++|||||||++|||++|+.|+......... ........ .
T Consensus 146 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~-~~~~~~~~-~-------- 212 (277)
T cd05607 146 KDGK---TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK-EELKRRTL-E-------- 212 (277)
T ss_pred CCCc---eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH-HHHHHHhh-c--------
Confidence 4322 122356889999999999988999999999999999999999998643221110 00000000 0
Q ss_pred ccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 041702 753 PTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAML 792 (840)
Q Consensus 753 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 792 (840)
..... ........+.+++.+||+.||++||+++|+++.+
T Consensus 213 ~~~~~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 213 DEVKF-EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred ccccc-ccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 00000 0012344578999999999999999998776443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=296.86 Aligned_cols=246 Identities=25% Similarity=0.438 Sum_probs=194.7
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
++|+..+.||.|++|.||+|++. .+++.||+|++.... ......+.+|++++++++|+||+++++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~------------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 68 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDK------------RTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSF 68 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEEC------------CCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEE
Confidence 36788899999999999999765 578999999987543 34456789999999999999999999999
Q ss_pred ecCCceEEEEEeeccCC---ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccc
Q 041702 593 IEQGEKISIYEFDIVTD---PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIA 669 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~---~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla 669 (840)
.+....++++|+..... ......+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++
T Consensus 69 ~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~ 145 (274)
T cd06609 69 LKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVS 145 (274)
T ss_pred EECCeEEEEEEeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccc
Confidence 99999999999843221 112237899999999999999999999988 999999999999999999999999999
Q ss_pred eecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccccccc
Q 041702 670 RTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWK 749 (840)
Q Consensus 670 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (840)
+...... .......+++.|+|||.+.+..++.++||||||+++|||++|+.|+....... .. ......
T Consensus 146 ~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~--~~----~~~~~~---- 213 (274)
T cd06609 146 GQLTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR--VL----FLIPKN---- 213 (274)
T ss_pred eeecccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH--HH----HHhhhc----
Confidence 8775432 12234567889999999998889999999999999999999999985433111 00 000011
Q ss_pred ccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 750 LMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 750 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
..+.+... .....+.+++.+||+.+|++||+++++++
T Consensus 214 -~~~~~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 214 -NPPSLEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred -CCCCCccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 01111111 03445788999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=306.52 Aligned_cols=242 Identities=30% Similarity=0.478 Sum_probs=194.2
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCc---CHHHHHHHHHHHhhcCCCCccceee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQ---GLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~---~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
+.|..++.||.|+||.||-|++. .+.+.||||++.-...+ .+.++..||+.|.+++|||++.+.|
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~------------~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkg 93 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDV------------RNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKG 93 (948)
T ss_pred HHHHHHHHhcCCccceeEEeecc------------CccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccc
Confidence 45777889999999999999765 78899999999765443 3567899999999999999999999
Q ss_pred EeecCCceEEEEEeeccCCc----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 591 CCIEQGEKISIYEFDIVTDP----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
+|......++||||..-... -.++++.+.++..|+.+.+.||+|||+.+ .||||||+.||||++.|.+||+||
T Consensus 94 CyLre~TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDF 170 (948)
T KOG0577|consen 94 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADF 170 (948)
T ss_pred eeeccchHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccc
Confidence 99999999999999533221 13567888899999999999999999998 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhc
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYAL---HGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWK 743 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~ 743 (840)
|.|.... ..+.++|||.|||||++. .+.|+-|+||||||++-.||.-.++|.-.++. ..-+ +....
T Consensus 171 GSAsi~~------PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA--MSAL---YHIAQ 239 (948)
T KOG0577|consen 171 GSASIMA------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSAL---YHIAQ 239 (948)
T ss_pred cchhhcC------chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH--HHHH---HHHHh
Confidence 9997653 345689999999999885 57899999999999999999999888532211 1111 11111
Q ss_pred ccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 744 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
. -.|.+.. .+-...+.+++..||++-|.+|||.+++++
T Consensus 240 N------esPtLqs---~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 240 N------ESPTLQS---NEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred c------CCCCCCC---chhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 1 1223332 344566888999999999999999987653
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=292.51 Aligned_cols=247 Identities=28% Similarity=0.424 Sum_probs=190.2
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCI 593 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~ 593 (840)
++|.+.++||+|++|.||+|.+. .+..+|+|++.... ...+.|.+|++++++++|+|++++++++.
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~-------------~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 71 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWN-------------GTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEc-------------CCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 56788889999999999998643 34569999986543 34577999999999999999999999875
Q ss_pred cCCceEEEEEeeccCCc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 594 EQGEKISIYEFDIVTDP------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 594 ~~~~~~lv~e~~~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
.+..+++|||...... .....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||
T Consensus 72 -~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg 147 (260)
T cd05069 72 -EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFG 147 (260)
T ss_pred -CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCc
Confidence 4568899998433221 12234789999999999999999999988 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhcccc
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKDDK 746 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 746 (840)
++......... ......++..|+|||...+..++.++||||||++++||++ |+.|+...... ....+ ....
T Consensus 148 ~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~----~~~~- 219 (260)
T cd05069 148 LARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--EVLEQ----VERG- 219 (260)
T ss_pred cceEccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH----HHcC-
Confidence 99876433221 1122345678999999998899999999999999999999 88887532211 11111 1110
Q ss_pred cccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 041702 747 AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794 (840)
Q Consensus 747 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~ 794 (840)
.........+..+.+++.+||+.+|++||++++|++.|++
T Consensus 220 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 220 --------YRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --------CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0001112344568899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=297.86 Aligned_cols=248 Identities=25% Similarity=0.398 Sum_probs=190.0
Q ss_pred HHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhc-CCCCcccee
Q 041702 511 AATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL-QHRNLVRLF 589 (840)
Q Consensus 511 ~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~ 589 (840)
.++..|+..+.||+|+||.||+|.+. .+++.||+|++.... .....+.+|+.++.++ +|+||++++
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~------------~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~ 69 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHV------------KTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYY 69 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEc------------CCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEe
Confidence 46678888999999999999998654 578899999987543 4456789999999999 799999999
Q ss_pred eEeecC------CceEEEEEeeccCCc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecC
Q 041702 590 GCCIEQ------GEKISIYEFDIVTDP------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS 657 (840)
Q Consensus 590 g~~~~~------~~~~lv~e~~~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~ 657 (840)
+++... ...+++|||...... .....+++..+..++.|++.||+|||+.+ |+|+||||+||++++
T Consensus 70 ~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~ 146 (272)
T cd06637 70 GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTE 146 (272)
T ss_pred eEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECC
Confidence 998753 357899999432211 12346889999999999999999999988 999999999999999
Q ss_pred CCCceeeccccceecCCCCcccccccccccccccCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCc
Q 041702 658 DMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYAL-----HGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSL 732 (840)
Q Consensus 658 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~ 732 (840)
++.+||+|||++....... .......|+..|+|||++. +..++.++|||||||++|||++|+.|+.......
T Consensus 147 ~~~~~l~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~- 223 (272)
T cd06637 147 NAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR- 223 (272)
T ss_pred CCCEEEccCCCceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-
Confidence 9999999999998654321 1223456889999999886 3468889999999999999999999975322111
Q ss_pred cHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 733 TLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
....... .. .+... .......+.+++.+||+.+|.+|||+.+|++
T Consensus 224 ----~~~~~~~-~~-----~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 224 ----ALFLIPR-NP-----APRLK---SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred ----HHHHHhc-CC-----CCCCC---CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0011111 00 01111 1122345789999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=309.79 Aligned_cols=234 Identities=22% Similarity=0.265 Sum_probs=180.4
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHH-HHhhcCCCCccceeeEeecC
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMM-LIAKLQHRNLVRLFGCCIEQ 595 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~-~l~~l~H~niv~l~g~~~~~ 595 (840)
+.||+|+||.||+|.++ .+++.||||++.... ....+++..|.. +++.++||||+++++++...
T Consensus 1 ~~lg~G~~g~V~~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~ 68 (323)
T cd05575 1 KVIGKGSFGKVLLAKHK------------ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTA 68 (323)
T ss_pred CeeeeCCCeEEEEEEEC------------CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeC
Confidence 36999999999999765 678999999997532 223345555555 56789999999999999999
Q ss_pred CceEEEEEeeccCCc----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccccee
Q 041702 596 GEKISIYEFDIVTDP----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 596 ~~~~lv~e~~~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
+..++||||...... .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 69 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 145 (323)
T cd05575 69 DKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKE 145 (323)
T ss_pred CEEEEEEcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcc
Confidence 999999999533322 23456888999999999999999999998 99999999999999999999999999875
Q ss_pred cCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccccccccc
Q 041702 672 FGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLM 751 (840)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (840)
..... .......||+.|+|||.+.+..++.++|||||||+++||++|+.||...... ... .......
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--~~~----~~i~~~~----- 212 (323)
T cd05575 146 GIEHS--KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA--EMY----DNILNKP----- 212 (323)
T ss_pred cccCC--CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH--HHH----HHHHcCC-----
Confidence 32211 2233457899999999999999999999999999999999999998643211 111 1111110
Q ss_pred CccccchhhHHHHHHHHHHHHHccccCCCCCCCHH
Q 041702 752 DPTMQNEALYSMVTRYIKVALLCVQENATDRPTML 786 (840)
Q Consensus 752 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 786 (840)
..+. ......+.+++.+||+.||++||++.
T Consensus 213 -~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 213 -LRLK----PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -CCCC----CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 0111 12245578899999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=301.15 Aligned_cols=193 Identities=24% Similarity=0.398 Sum_probs=154.6
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEeec--CCc
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIE--QGE 597 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~--~~~ 597 (840)
.+||+|+||.||+|.++ ...++..||+|.+.... ....+.+|++++++++||||+++++++.. ...
T Consensus 7 ~~lG~G~~g~Vy~~~~~----------~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 74 (317)
T cd07867 7 CKVGRGTYGHVYKAKRK----------DGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRK 74 (317)
T ss_pred eEeccCCCeeEEEEEec----------CCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCe
Confidence 57999999999999753 12356789999987542 23568899999999999999999999854 456
Q ss_pred eEEEEEeeccC------------CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEe----cCCCCc
Q 041702 598 KISIYEFDIVT------------DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLL----DSDMNP 661 (840)
Q Consensus 598 ~~lv~e~~~~~------------~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl----~~~~~~ 661 (840)
.++++||.... .......+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+
T Consensus 75 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~ 151 (317)
T cd07867 75 VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRV 151 (317)
T ss_pred EEEEEeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcE
Confidence 78899984211 0112235788899999999999999999988 9999999999999 566789
Q ss_pred eeeccccceecCCCCcc-cccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCC
Q 041702 662 KISDFGIARTFGGDEMQ-SNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFY 727 (840)
Q Consensus 662 kL~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~ 727 (840)
||+|||+++.+...... .......+|+.|+|||.+.+ ..++.++|||||||+++||+||++||...
T Consensus 152 kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 152 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred EEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 99999999876443221 12334578999999999876 45899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=291.00 Aligned_cols=245 Identities=24% Similarity=0.409 Sum_probs=195.0
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCI 593 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~ 593 (840)
++|+..+.||+|+||.||+|.++ .+++.+++|.+..... .+++.+|++++++++||||+++++++.
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~------------~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~ 68 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHK------------ETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYF 68 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEc------------CCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeee
Confidence 67888899999999999998765 4578999999975533 678999999999999999999999999
Q ss_pred cCCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccc
Q 041702 594 EQGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGI 668 (840)
Q Consensus 594 ~~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl 668 (840)
+.+..++++|+...... .....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||+
T Consensus 69 ~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~ 145 (256)
T cd06612 69 KNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGV 145 (256)
T ss_pred cCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEccccc
Confidence 99999999999432221 12456899999999999999999999988 99999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccc
Q 041702 669 ARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAW 748 (840)
Q Consensus 669 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (840)
+........ ......++..|+|||.+.+..++.++||||||++++||++|+.|+.......... . ...
T Consensus 146 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-----~-~~~---- 213 (256)
T cd06612 146 SGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-----M-IPN---- 213 (256)
T ss_pred chhcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-----h-hcc----
Confidence 987643221 2233457889999999999899999999999999999999999986432211100 0 000
Q ss_pred cccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 749 KLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 749 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
...+.. .........+.+++.+||+.+|++|||+.||++
T Consensus 214 -~~~~~~--~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 214 -KPPPTL--SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred -CCCCCC--CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 000111 111223456888999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=306.27 Aligned_cols=237 Identities=26% Similarity=0.320 Sum_probs=183.6
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhc-CCCCccceeeEeecC
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEQ 595 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~ 595 (840)
+.||+|+||.||+|.++ .+++.||+|+++... ....+.+..|..++..+ +||||+++++++.+.
T Consensus 1 ~~lg~G~~g~V~~~~~~------------~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~ 68 (316)
T cd05620 1 KVLGKGSFGKVLLAELK------------GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTK 68 (316)
T ss_pred CeeeeCCCeEEEEEEEC------------CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeC
Confidence 36999999999999765 578899999997532 23456677888888765 899999999999999
Q ss_pred CceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccccee
Q 041702 596 GEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 596 ~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
+..++||||..... ......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 69 ~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~ 145 (316)
T cd05620 69 EHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKE 145 (316)
T ss_pred CEEEEEECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCee
Confidence 99999999953322 223456888999999999999999999988 99999999999999999999999999875
Q ss_pred cCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccccccccc
Q 041702 672 FGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLM 751 (840)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (840)
..... .......||+.|+|||++.+..++.++|||||||+++||++|+.||...... .+. ......
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--~~~----~~~~~~------ 211 (316)
T cd05620 146 NVFGD--NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--ELF----ESIRVD------ 211 (316)
T ss_pred cccCC--CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHH----HHHHhC------
Confidence 32111 1223467899999999999999999999999999999999999998643211 111 111100
Q ss_pred CccccchhhHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 041702 752 DPTMQNEALYSMVTRYIKVALLCVQENATDRPTML-EVV 789 (840)
Q Consensus 752 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl 789 (840)
.+... ......+.+++.+||+.||++||++. +++
T Consensus 212 ~~~~~----~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 212 TPHYP----RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCC----CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11111 11234577899999999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=296.54 Aligned_cols=246 Identities=25% Similarity=0.381 Sum_probs=190.5
Q ss_pred CcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEeecC
Q 041702 516 FSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQ 595 (840)
Q Consensus 516 f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~ 595 (840)
|++.++||+|+||.||+|.+. .++..+++|.+........+.|.+|+++++.++||||+++++++...
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~------------~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~ 74 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNK------------ETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE 74 (282)
T ss_pred HHHHhhcccCCCeEEEEEEEC------------CCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC
Confidence 567788999999999999754 56788999999766555667899999999999999999999999999
Q ss_pred CceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccce
Q 041702 596 GEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIAR 670 (840)
Q Consensus 596 ~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~ 670 (840)
+..++++||...... .....+++..+..++.|+++||.|||+.+ ++||||||+|||++.++.+||+|||++.
T Consensus 75 ~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~ 151 (282)
T cd06643 75 NNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSA 151 (282)
T ss_pred CEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccc
Confidence 999999999432221 12356899999999999999999999988 9999999999999999999999999987
Q ss_pred ecCCCCcccccccccccccccCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 671 TFGGDEMQSNTNRIVGTYGYMSPEYAL-----HGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 671 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
...... .......++..|+|||++. +..++.++|||||||++|||++|++|+...... ... .......
T Consensus 152 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~---~~~~~~~ 224 (282)
T cd06643 152 KNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM--RVL---LKIAKSE 224 (282)
T ss_pred cccccc--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH--HHH---HHHhhcC
Confidence 653221 1223356889999999874 455788999999999999999999987543211 111 1111100
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
...+. .+......+.+++.+||+.+|.+||++.++++.
T Consensus 225 -~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 225 -PPTLA-------QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred -CCCCC-------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00011 111233467899999999999999999988743
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=309.71 Aligned_cols=195 Identities=25% Similarity=0.345 Sum_probs=165.3
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcC-C-----CCccc
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQ-H-----RNLVR 587 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~-H-----~niv~ 587 (840)
-+|.+.+.||+|+||.|-||.++ .+++.||||++++. ..-..+-..|+++|..|+ | -|+|+
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~------------~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vr 252 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDH------------KTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVR 252 (586)
T ss_pred EEEEEEEEecccccceeEEEEec------------CCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEE
Confidence 38999999999999999999876 78999999999865 334466678999999996 4 48999
Q ss_pred eeeEeecCCceEEEEEeec-----cCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCC--CC
Q 041702 588 LFGCCIEQGEKISIYEFDI-----VTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSD--MN 660 (840)
Q Consensus 588 l~g~~~~~~~~~lv~e~~~-----~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~--~~ 660 (840)
+++||...++.++|+|... +........++......|+.||+.||.+||+.+ |||+||||+||||.+- ..
T Consensus 253 m~d~F~fr~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~ 329 (586)
T KOG0667|consen 253 MLDYFYFRNHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSR 329 (586)
T ss_pred eeeccccccceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCc
Confidence 9999999999999999721 122334455889999999999999999999988 9999999999999654 47
Q ss_pred ceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCC
Q 041702 661 PKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNT 729 (840)
Q Consensus 661 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~ 729 (840)
+||+|||.|......- .....+..|+|||++.+.+|+.+.|+||||||+.||++|.+.|+..++
T Consensus 330 vKVIDFGSSc~~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 330 IKVIDFGSSCFESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred eeEEecccccccCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 9999999998754322 246778899999999999999999999999999999999888876544
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=290.71 Aligned_cols=244 Identities=26% Similarity=0.372 Sum_probs=188.2
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCc-CHHHHHHHHHHHhhcCCCCccceeeEeecCCce
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQ-GLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEK 598 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~-~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~ 598 (840)
++||+|+||.||+|.+. +++.||+|++...... ..+.|.+|++++++++|+||+++++++.+.+..
T Consensus 1 ~~lg~g~~g~v~~~~~~-------------~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 67 (251)
T cd05041 1 EKIGKGNFGDVYKGVLK-------------GNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPI 67 (251)
T ss_pred CccccCCCceEEEEEEe-------------CCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCe
Confidence 36999999999998643 3899999998765332 456899999999999999999999999999999
Q ss_pred EEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceecC
Q 041702 599 ISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFG 673 (840)
Q Consensus 599 ~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~ 673 (840)
++++|+...... .....+++.....++.+++.||+|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 68 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 144 (251)
T cd05041 68 YIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEE 144 (251)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeecccccccc
Confidence 999998432211 12345788899999999999999999988 9999999999999999999999999998654
Q ss_pred CCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhcccccccccC
Q 041702 674 GDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMD 752 (840)
Q Consensus 674 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 752 (840)
.............+..|+|||.+.+..++.++||||||++++||++ |..|+....... .. ......
T Consensus 145 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~--~~----~~~~~~------- 211 (251)
T cd05041 145 GGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ--TR----ERIESG------- 211 (251)
T ss_pred CCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH--HH----HHHhcC-------
Confidence 3222222222334567999999998899999999999999999999 777764332111 11 111100
Q ss_pred ccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 041702 753 PTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794 (840)
Q Consensus 753 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~ 794 (840)
.....+...+..+.+++.+|++.+|++||++.||++.|+.
T Consensus 212 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 212 --YRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred --CCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 0001112234568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=295.81 Aligned_cols=251 Identities=30% Similarity=0.433 Sum_probs=189.6
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceeeEeecCCce
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEK 598 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~ 598 (840)
+.||+|+||.||+|.+.... ....+++.+|||.+.... .....+|.+|+.++++++||||+++++++...+..
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~------~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDIL------GPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQ 74 (269)
T ss_pred CccccccceeEEeeeecccc------cCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCe
Confidence 36999999999998754100 001234689999986543 24467899999999999999999999999999999
Q ss_pred EEEEEeeccCCcc-----------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCC-----Cce
Q 041702 599 ISIYEFDIVTDPA-----------RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDM-----NPK 662 (840)
Q Consensus 599 ~lv~e~~~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-----~~k 662 (840)
++++||....... ....+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++ .+|
T Consensus 75 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~ 151 (269)
T cd05044 75 YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVK 151 (269)
T ss_pred EEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceE
Confidence 9999984221110 2234788999999999999999999987 99999999999999887 899
Q ss_pred eeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhh
Q 041702 663 ISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNL 741 (840)
Q Consensus 663 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~ 741 (840)
|+|||+++...............++..|+|||++.+..++.++||||||++++||++ |+.|+..... ..... .
T Consensus 152 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--~~~~~----~ 225 (269)
T cd05044 152 IGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--QEVLQ----H 225 (269)
T ss_pred ECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--HHHHH----H
Confidence 999999986643332222233445778999999999999999999999999999998 8888753221 11111 1
Q ss_pred hcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 041702 742 WKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794 (840)
Q Consensus 742 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~ 794 (840)
..... ........+..+.+++.+||+.+|++||++.+|++.|++
T Consensus 226 ~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 226 VTAGG---------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred HhcCC---------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11100 001112234567899999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=301.57 Aligned_cols=259 Identities=23% Similarity=0.337 Sum_probs=192.0
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
++|+..++||+|+||.||+|.+. .++..+|+|.+..... ...+++.+|++++.+++||||+++++++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~------------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 68 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHR------------PSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAF 68 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEc------------CCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 46888999999999999999654 5788999999875422 2345689999999999999999999999
Q ss_pred ecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 593 IEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQY-SRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
...+..++++||..... ......+++.....++.|+++||.|||+. + ++||||||+|||++.++.+||+|||
T Consensus 69 ~~~~~~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg 145 (308)
T cd06615 69 YSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFG 145 (308)
T ss_pred eeCCEEEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCC
Confidence 99999999999943222 12335688999999999999999999974 5 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccH-hHHHhhhhcccc
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTL-LGHAWNLWKDDK 746 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~-~~~~~~~~~~~~ 746 (840)
++...... ......++..|+|||.+.+..++.++||||||++++||++|+.|+.......... ............
T Consensus 146 ~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 221 (308)
T cd06615 146 VSGQLIDS----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKE 221 (308)
T ss_pred Cccccccc----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccC
Confidence 98765322 1234568899999999988889999999999999999999999975432111100 000000000000
Q ss_pred c-----------------ccccCccc---cchh-hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 747 A-----------------WKLMDPTM---QNEA-LYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 747 ~-----------------~~~~d~~l---~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
. .++.+... .+.. .......+.+++.+||+.+|++||++++|++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 222 SHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 00000000 0000 00133458899999999999999999999865
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=301.51 Aligned_cols=258 Identities=21% Similarity=0.266 Sum_probs=191.6
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
++|...++||+|+||.||+|.++ .+++.||+|.++... ......+.+|+.++++++||||+++++++
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~ 73 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSK------------LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEc------------CCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEE
Confidence 57888999999999999999765 578899999987543 33445788999999999999999999999
Q ss_pred ecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccc
Q 041702 593 IEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGI 668 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl 668 (840)
...+..++++||..... ......+++.....++.||++||+|||+.+ |+|+||||+||+++.++.+||+|||+
T Consensus 74 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~ 150 (301)
T cd07873 74 HTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGL 150 (301)
T ss_pred ecCCeEEEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcc
Confidence 99999999999943211 112345788899999999999999999988 99999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHH---------
Q 041702 669 ARTFGGDEMQSNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHA--------- 738 (840)
Q Consensus 669 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~--------- 738 (840)
+........ ......+++.|+|||.+.+ ..++.++|||||||+++||++|+.||......+ .....
T Consensus 151 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~--~~~~~~~~~~~~~~ 226 (301)
T cd07873 151 ARAKSIPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE--QLHFIFRILGTPTE 226 (301)
T ss_pred hhccCCCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCCCCh
Confidence 976432211 1223456889999998865 458899999999999999999999986543211 11000
Q ss_pred --hhhhccc-ccccccCccccch----hhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 739 --WNLWKDD-KAWKLMDPTMQNE----ALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 739 --~~~~~~~-~~~~~~d~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
|...... .....-.+..... ........+.+++.+||+.||.+|||++|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 227 ETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred hhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000 0000000111110 11123445789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=309.97 Aligned_cols=237 Identities=22% Similarity=0.278 Sum_probs=181.6
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHH-HHhhcCCCCccceeeEeecC
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMM-LIAKLQHRNLVRLFGCCIEQ 595 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~-~l~~l~H~niv~l~g~~~~~ 595 (840)
+.||+|+||.||+|.++ .+|+.||+|++... .....+++..|.. +++.++||||+++++++...
T Consensus 1 ~~lG~G~~g~V~~~~~~------------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~ 68 (325)
T cd05604 1 KVIGKGSFGKVLLAKRK------------LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTT 68 (325)
T ss_pred CceeeCCCeEEEEEEEC------------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecC
Confidence 36999999999999754 67899999999753 2233345666655 46778999999999999999
Q ss_pred CceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccccee
Q 041702 596 GEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 596 ~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
+..++||||..... ......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 69 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~ 145 (325)
T cd05604 69 EKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKE 145 (325)
T ss_pred CEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCccc
Confidence 99999999953322 223456889999999999999999999988 99999999999999999999999999875
Q ss_pred cCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccccccccc
Q 041702 672 FGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLM 751 (840)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (840)
..... .......||+.|+|||.+.+..++.++|||||||+++||++|+.||...... ... ........ .+
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~----~~~~~~~~--~~ 215 (325)
T cd05604 146 GIAQS--DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA--EMY----DNILHKPL--VL 215 (325)
T ss_pred CCCCC--CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH--HHH----HHHHcCCc--cC
Confidence 32211 1223457899999999999999999999999999999999999998643211 111 11111100 01
Q ss_pred CccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 041702 752 DPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVV 789 (840)
Q Consensus 752 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 789 (840)
.+ .....+.+++.+|++.+|++||++.+.+
T Consensus 216 ~~--------~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 216 RP--------GASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred CC--------CCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 11 1234577889999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=296.37 Aligned_cols=257 Identities=26% Similarity=0.382 Sum_probs=193.2
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
.+|+..+.||+|+||.||+|.++.. + ......||+|.+..... ...+++.+|+.++++++||||++++++|
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~-------~-~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 78 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPE-------G-EKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGIC 78 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecC-------C-CCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 5678889999999999999875410 0 11233699998875532 3456789999999999999999999999
Q ss_pred ecCCceEEEEEeeccCCcc-----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 593 IEQGEKISIYEFDIVTDPA-----RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
.. ...++++||....... ....+++..+..++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 79 ~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg 154 (279)
T cd05057 79 LS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFG 154 (279)
T ss_pred ec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCc
Confidence 87 7889999985332211 2335889999999999999999999987 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhcccc
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKDDK 746 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 746 (840)
+++.+.............++..|+|||.+....++.++||||||++++|+++ |+.|+......+ ... ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~----~~~~~~ 228 (279)
T cd05057 155 LAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE--IPD----LLEKGE 228 (279)
T ss_pred ccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH--HHH----HHhCCC
Confidence 9987653322111112223568999999988899999999999999999998 999875432211 111 111110
Q ss_pred cccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 747 AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 747 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
....+ ......+.+++.+||..+|.+||++.++++.|++...
T Consensus 229 --~~~~~-------~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 229 --RLPQP-------PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred --CCCCC-------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 01111 1122357788999999999999999999999998733
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=294.16 Aligned_cols=250 Identities=29% Similarity=0.434 Sum_probs=194.8
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
..++|.+.++||+|+||.||+|.+. +++.||||.+.... ...+++.+|+.++++++|+||++++++
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-------------~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~ 69 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-------------GTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAV 69 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-------------CCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeee
Confidence 4578889999999999999998643 45789999987543 345789999999999999999999999
Q ss_pred eecCCceEEEEEeeccCCc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 592 CIEQGEKISIYEFDIVTDP------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
+......+++||+...... .....+++.++..++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|
T Consensus 70 ~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d 146 (261)
T cd05034 70 CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIAD 146 (261)
T ss_pred eecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECc
Confidence 9998999999998432221 12246889999999999999999999988 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
||++..+...... .......+..|+|||.+.+..++.++||||||++++||++ |+.|+..... ...... ...
T Consensus 147 ~g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--~~~~~~----~~~ 219 (261)
T cd05034 147 FGLARLIEDDEYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN--REVLEQ----VER 219 (261)
T ss_pred cccceeccchhhh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH----HHc
Confidence 9999876532211 1112234568999999999899999999999999999999 8888753221 111111 100
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~ 794 (840)
. ... ..+...+..+.+++.+|++.+|++||+++++++.|+.
T Consensus 220 ~-----~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 220 G-----YRM----PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred C-----CCC----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0 000 0111124468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=304.77 Aligned_cols=239 Identities=19% Similarity=0.285 Sum_probs=185.0
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhc-CCCCccceeeEeecC
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEQ 595 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~ 595 (840)
+.||+|+||.||+|.++ .+++.||+|+++... ....+.+.+|+.++.++ +||||+++++++...
T Consensus 1 ~~lG~G~~g~V~~~~~~------------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 68 (327)
T cd05617 1 RVIGRGSYAKVLLVRLK------------KNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT 68 (327)
T ss_pred CeeeeCCCeEEEEEEEC------------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC
Confidence 36999999999999765 578899999997542 23456688999999988 699999999999999
Q ss_pred CceEEEEEeeccCCc----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccccee
Q 041702 596 GEKISIYEFDIVTDP----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 596 ~~~~lv~e~~~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
+..++||||...... .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 69 ~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~ 145 (327)
T cd05617 69 SRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKE 145 (327)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEecccccee
Confidence 999999999543322 23457899999999999999999999988 99999999999999999999999999875
Q ss_pred cCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCC-ccHhHHHhhhhcccccccc
Q 041702 672 FGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDS-LTLLGHAWNLWKDDKAWKL 750 (840)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 750 (840)
..... .......||+.|+|||++.+..++.++|||||||+|+||++|+.||....... ...............
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---- 219 (327)
T cd05617 146 GLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP---- 219 (327)
T ss_pred ccCCC--CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC----
Confidence 32211 12234678999999999999999999999999999999999999986533222 111111111111110
Q ss_pred cCccccchhhHHHHHHHHHHHHHccccCCCCCCCH
Q 041702 751 MDPTMQNEALYSMVTRYIKVALLCVQENATDRPTM 785 (840)
Q Consensus 751 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 785 (840)
. ..+......+.+++.+||+.||++||++
T Consensus 220 ----~--~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 220 ----I--RIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred ----C--CCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 0 0111223457789999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=297.54 Aligned_cols=246 Identities=25% Similarity=0.406 Sum_probs=193.1
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
+.|+..+.||+|+||.||+|.+. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 71 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDN------------RTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEc------------CCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccc
Confidence 34667788999999999998654 567899999987543 33456799999999999999999999999
Q ss_pred ecCCceEEEEEeeccCC---ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccc
Q 041702 593 IEQGEKISIYEFDIVTD---PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIA 669 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~---~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla 669 (840)
..++..++|+||..... ......+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~ 148 (277)
T cd06642 72 LKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVA 148 (277)
T ss_pred ccCCceEEEEEccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEcccccc
Confidence 99999999999953222 122356889999999999999999999987 999999999999999999999999999
Q ss_pred eecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccccccc
Q 041702 670 RTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWK 749 (840)
Q Consensus 670 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (840)
..+..... ......++..|+|||.+.+..++.++||||||++++||++|+.|+........ .. ...
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~----~~~------ 214 (277)
T cd06642 149 GQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV--LF----LIP------ 214 (277)
T ss_pred ccccCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH--Hh----hhh------
Confidence 77643221 12234578899999999998999999999999999999999998753322110 00 000
Q ss_pred ccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 750 LMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 750 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
..............+.+++.+||+.+|++||+|.+|++.
T Consensus 215 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 215 ---KNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ---cCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 000111112334567899999999999999999999973
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=301.05 Aligned_cols=251 Identities=30% Similarity=0.430 Sum_probs=189.5
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCc----eEEEEEeccCCC-cCHHHHHHHHHHHhhcCCCCccce
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGE----EVAVKRLSSKSG-QGLEEFKNEMMLIAKLQHRNLVRL 588 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~----~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l 588 (840)
++|+..+.||+|+||.||+|.+. .+++ .||+|.+..... ....++.+|+.++++++||||+++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~------------~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~ 74 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWV------------PEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74 (303)
T ss_pred hhceeccccccCCCccEEEEEEe------------cCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccE
Confidence 56777889999999999998754 2333 579998875432 234478999999999999999999
Q ss_pred eeEeecCCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCcee
Q 041702 589 FGCCIEQGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKI 663 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL 663 (840)
+++|... ...+++||...... .....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||
T Consensus 75 ~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL 150 (303)
T cd05110 75 LGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKI 150 (303)
T ss_pred EEEEcCC-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEE
Confidence 9998754 46678887433221 11235788899999999999999999988 999999999999999999999
Q ss_pred eccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhh
Q 041702 664 SDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLW 742 (840)
Q Consensus 664 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 742 (840)
+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... . .....
T Consensus 151 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~--~----~~~~~ 224 (303)
T cd05110 151 TDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR--E----IPDLL 224 (303)
T ss_pred ccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--H----HHHHH
Confidence 99999987654332222333445779999999999999999999999999999997 88887532111 1 11111
Q ss_pred cccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 743 KDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 743 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
..... ...+ ......+.+++..||..+|++||+++++++.|+.+
T Consensus 225 ~~~~~--~~~~-------~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 225 EKGER--LPQP-------PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred HCCCC--CCCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11110 0011 11234578899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=296.40 Aligned_cols=260 Identities=22% Similarity=0.319 Sum_probs=193.4
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
++|+..+.||+|++|.||+|.++ .+++.||+|++.... ....+.+.+|+.++++++||||++++++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~------------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~ 68 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNR------------ETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68 (286)
T ss_pred CceeeeeeecccCCeEEEEEEEC------------CCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeE
Confidence 46888899999999999999765 578999999986542 2334668899999999999999999999
Q ss_pred eecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 592 CIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
+...+..++++||..... ......+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 69 ~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 145 (286)
T cd07847 69 FRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFG 145 (286)
T ss_pred EeeCCEEEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccc
Confidence 999999999999953221 112345899999999999999999999988 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHh-HHH-------
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLL-GHA------- 738 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~-~~~------- 738 (840)
++........ ......++..|+|||.+.+ ..++.++||||||++++||++|+.|+......+.... ...
T Consensus 146 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 223 (286)
T cd07847 146 FARILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPR 223 (286)
T ss_pred cceecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChH
Confidence 9987644321 1223457789999999876 5588999999999999999999999864432211000 000
Q ss_pred -hhhhccccc---ccccCccccc---hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 739 -WNLWKDDKA---WKLMDPTMQN---EALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 739 -~~~~~~~~~---~~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
...+..... ....++.... .........+.+++.+||+.+|++||++.|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 224 HQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred HhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000000000 0001110000 011123466889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=294.39 Aligned_cols=244 Identities=26% Similarity=0.396 Sum_probs=184.9
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCC--ceEEEEEeccCC-CcCHHHHHHHHHHHhhc-CCCCccceeeEeecC
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNG--EEVAVKRLSSKS-GQGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEQ 595 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g--~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~ 595 (840)
+.||+|+||.||+|.+. .++ ..+|+|.++... ....+.+.+|++++.++ +||||+++++++...
T Consensus 1 ~~lg~g~~g~v~~~~~~------------~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 68 (270)
T cd05047 1 DVIGEGNFGQVLKARIK------------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 68 (270)
T ss_pred CcCCCCCCceEEEEEEc------------CCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC
Confidence 36999999999998754 234 357899887532 33456799999999999 899999999999999
Q ss_pred CceEEEEEeeccCCc--------------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEe
Q 041702 596 GEKISIYEFDIVTDP--------------------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLL 655 (840)
Q Consensus 596 ~~~~lv~e~~~~~~~--------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl 655 (840)
+..+++|||...... .....+++.++..++.|++.||+|||+.+ ++||||||+|||+
T Consensus 69 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili 145 (270)
T cd05047 69 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILV 145 (270)
T ss_pred CCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEE
Confidence 999999998422111 11235789999999999999999999987 9999999999999
Q ss_pred cCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccH
Q 041702 656 DSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTL 734 (840)
Q Consensus 656 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~ 734 (840)
++++.+||+|||++...... ........+..|+|||++....++.++||||||++++||++ |..|+...... ..
T Consensus 146 ~~~~~~kl~dfgl~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--~~ 220 (270)
T cd05047 146 GENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--EL 220 (270)
T ss_pred cCCCeEEECCCCCccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH--HH
Confidence 99999999999998632211 11111223567999999988899999999999999999997 88887532211 11
Q ss_pred hHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 041702 735 LGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEI 796 (840)
Q Consensus 735 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~ 796 (840)
... .... ............+.+++.+|++.+|.+|||+.++++.|++++
T Consensus 221 ~~~----~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 221 YEK----LPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred HHH----HhCC---------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 111 1110 000111122345789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=298.24 Aligned_cols=258 Identities=22% Similarity=0.334 Sum_probs=192.1
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC--cCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG--QGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
++|+..++||+|+||.||+|.++ .+++.||+|++..... ...+.+.+|++++++++||||++++++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~------------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 68 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHK------------ETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEEC------------CCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHh
Confidence 46888899999999999998754 4688999999865432 234678999999999999999999999
Q ss_pred eecCCceEEEEEeeccCCc----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 592 CIEQGEKISIYEFDIVTDP----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
+...+..++++||...... .....+++..++.++.||+.||+|||+.+ ++|+||+|+||++++++.+||+|||
T Consensus 69 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg 145 (286)
T cd07846 69 FRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFG 145 (286)
T ss_pred cccCCeEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeee
Confidence 9999999999999532211 12235899999999999999999999988 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcc--
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD-- 744 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~-- 744 (840)
++....... .......++..|+|||++.+ ..++.++||||||++++||++|++|+..... .............
T Consensus 146 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~--~~~~~~~~~~~~~~~ 221 (286)
T cd07846 146 FARTLAAPG--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD--IDQLYHIIKCLGNLI 221 (286)
T ss_pred eeeeccCCc--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch--HHHHHHHHHHhCCCc
Confidence 998764332 22233467889999998875 4578899999999999999999988753321 1111111100000
Q ss_pred ccccc----------ccCccccc-----hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 745 DKAWK----------LMDPTMQN-----EALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 745 ~~~~~----------~~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
..... ...+.... .........+.+++.+||+.+|++||++.++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 222 PRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000 00000000 011133566889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=291.23 Aligned_cols=250 Identities=22% Similarity=0.389 Sum_probs=196.0
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
.++|+..+.||+|+||.||+|.+. .+++.+|+|.+........+.+.+|+.++++++||||+++++++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~------------~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 69 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDI------------ATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY 69 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEec------------CCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEE
Confidence 367888999999999999999654 46788999999876555678899999999999999999999999
Q ss_pred ecCCceEEEEEeeccCCc----cc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 593 IEQGEKISIYEFDIVTDP----AR-KDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~~----~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
...+..+++|||...... .. ...+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||
T Consensus 70 ~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g 146 (262)
T cd06613 70 LRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFG 146 (262)
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccc
Confidence 999999999999432211 11 256889999999999999999999988 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCccccccC---CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALHG---LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
++..+.... .......++..|+|||.+.+. .++.++||||||++++||++|+.|+........ ......
T Consensus 147 ~~~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-----~~~~~~- 218 (262)
T cd06613 147 VSAQLTATI--AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-----LFLISK- 218 (262)
T ss_pred cchhhhhhh--hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHh-
Confidence 987654321 112235678899999998776 889999999999999999999999754321111 000000
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
. ....+.+. ........+.+++.+||+.+|.+|||+++|+.
T Consensus 219 ~---~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 219 S---NFPPPKLK--DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred c---cCCCcccc--chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 00011111 12234556889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=292.37 Aligned_cols=250 Identities=26% Similarity=0.376 Sum_probs=183.9
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcCCCCccceeeEeecCCce
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEK 598 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~ 598 (840)
+.||+|+||.||+|.+. ....+..+|+|.++.... .....|.+|+.++++++||||+++++++.+....
T Consensus 1 ~~lg~G~~g~Vy~~~~~----------~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 70 (269)
T cd05087 1 KEIGNGWFGKVILGEVN----------SGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPY 70 (269)
T ss_pred CcccccCCceEEEEEEc----------CCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCc
Confidence 36999999999998643 113456799999876532 3345789999999999999999999999999999
Q ss_pred EEEEEeeccCCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccc
Q 041702 599 ISIYEFDIVTDPA---------RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIA 669 (840)
Q Consensus 599 ~lv~e~~~~~~~~---------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla 669 (840)
++||||....... .....++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 71 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~ 147 (269)
T cd05087 71 LLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLS 147 (269)
T ss_pred EEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCcccc
Confidence 9999995322211 1234567788899999999999999988 999999999999999999999999999
Q ss_pred eecCCCCcccccccccccccccCccccccC-------CCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhh
Q 041702 670 RTFGGDEMQSNTNRIVGTYGYMSPEYALHG-------LFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNL 741 (840)
Q Consensus 670 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~ 741 (840)
+...............++..|+|||++.+. .++.++||||||++++||++ |+.|+......+ .....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--~~~~~--- 222 (269)
T cd05087 148 HNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ--VLTYT--- 222 (269)
T ss_pred ccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH--HHHHH---
Confidence 765433322223345578899999988642 35889999999999999996 998886433221 11110
Q ss_pred hcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 041702 742 WKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLK 793 (840)
Q Consensus 742 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le 793 (840)
.........++.+.. ...+.+.+++..|+ .+|++|||++||++.|+
T Consensus 223 -~~~~~~~~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 223 -VREQQLKLPKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred -hhcccCCCCCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 111111222222211 12334677888898 58999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=294.54 Aligned_cols=249 Identities=27% Similarity=0.415 Sum_probs=191.8
Q ss_pred CcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCH--HHHHHHHHHHhhcCCCCccceeeEee
Q 041702 516 FSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGL--EEFKNEMMLIAKLQHRNLVRLFGCCI 593 (840)
Q Consensus 516 f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~--~~f~~Ev~~l~~l~H~niv~l~g~~~ 593 (840)
|+..+.||+|+||+||++++. .+++.+|+|++........ ....+|+.++++++||||+++++++.
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~------------~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~ 68 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNK------------KNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQ 68 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEET------------TTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEEC------------CCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccc
Confidence 567789999999999999765 6788999999987643222 23456999999999999999999999
Q ss_pred cCCceEEEEEeeccCCc----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccc
Q 041702 594 EQGEKISIYEFDIVTDP----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIA 669 (840)
Q Consensus 594 ~~~~~~lv~e~~~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla 669 (840)
+.+..+++||+...... .....+++..+..++.||++||++||+.+ |+|+||||+||++++++.++|+|||.+
T Consensus 69 ~~~~~~~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~ 145 (260)
T PF00069_consen 69 DDNYLYIVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSS 145 (260)
T ss_dssp ESSEEEEEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccc
Confidence 99999999999544222 24677899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCCcccccccccccccccCccccc-cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccc
Q 041702 670 RTFGGDEMQSNTNRIVGTYGYMSPEYAL-HGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAW 748 (840)
Q Consensus 670 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (840)
.... ..........++..|+|||.+. +..++.++||||||+++++|++|..|+......+ ......... . .
T Consensus 146 ~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~--~~~~~~~~~-~---~ 217 (260)
T PF00069_consen 146 VKLS--ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD--QLEIIEKIL-K---R 217 (260)
T ss_dssp EEST--STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH--HHHHHHHHH-H---T
T ss_pred cccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccccchh--hhhhhhhcc-c---c
Confidence 8641 1122344567899999999998 8889999999999999999999999876431111 000000000 0 0
Q ss_pred cccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 749 KLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 749 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
. ...... ........+.+++.+||+.||++||++.++++
T Consensus 218 ~-~~~~~~--~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 218 P-LPSSSQ--QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp H-HHHHTT--SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred c-cccccc--ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000000 00011267899999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=305.36 Aligned_cols=241 Identities=25% Similarity=0.411 Sum_probs=196.8
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEeecCCceE
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKI 599 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~ 599 (840)
-+||+|.||+||.|+|+ .+...+|||.+...+....+-+.+|+.+-++|+|.|||+++|.|.+++..-
T Consensus 581 vVLGKGTYG~VYA~RD~------------~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~k 648 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDM------------DTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFK 648 (1226)
T ss_pred EEeecCceeEEEeeccc------------cceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEE
Confidence 36999999999999876 677889999999887777788999999999999999999999999999999
Q ss_pred EEEEeeccCCcc-----ccCCC--CHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEec-CCCCceeecccccee
Q 041702 600 SIYEFDIVTDPA-----RKDLL--DWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLD-SDMNPKISDFGIART 671 (840)
Q Consensus 600 lv~e~~~~~~~~-----~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~-~~~~~kL~DFGla~~ 671 (840)
+.||...-.... .-.++ ++.+.--+.+||++||.|||+.. |||||||-+|+|++ -.|.+||+|||.++.
T Consensus 649 IFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKR 725 (1226)
T KOG4279|consen 649 IFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKR 725 (1226)
T ss_pred EEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchh
Confidence 999985433322 23344 56677788999999999999988 99999999999996 568999999999987
Q ss_pred cCCCCcccccccccccccccCccccccCC--CCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccccccc
Q 041702 672 FGGDEMQSNTNRIVGTYGYMSPEYALHGL--FSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWK 749 (840)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (840)
+.. ....+....||..|||||++..++ |..++|||||||.+.||.||++||-........+. +.+
T Consensus 726 LAg--inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMF-------kVG---- 792 (1226)
T KOG4279|consen 726 LAG--INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMF-------KVG---- 792 (1226)
T ss_pred hcc--CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhh-------hhc----
Confidence 743 344566788999999999998654 89999999999999999999999865443322111 100
Q ss_pred ccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 750 LMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 750 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
--...++.+.+.......++++|..+||.+||+++++++
T Consensus 793 --myKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 793 --MYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred --ceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 011234455677788999999999999999999999984
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=292.90 Aligned_cols=246 Identities=25% Similarity=0.415 Sum_probs=190.7
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCc---------CHHHHHHHHHHHhhcCCCCc
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQ---------GLEEFKNEMMLIAKLQHRNL 585 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~---------~~~~f~~Ev~~l~~l~H~ni 585 (840)
+|.....||+|++|.||+|.+. .+++.||+|.+...... ..+.+.+|+.++++++||||
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~------------~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 68 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNA------------SSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENI 68 (267)
T ss_pred CccccceeecCCCeEEEEEEec------------CCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCe
Confidence 3566789999999999999754 56789999988654321 22568899999999999999
Q ss_pred cceeeEeecCCceEEEEEeeccCCc----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCc
Q 041702 586 VRLFGCCIEQGEKISIYEFDIVTDP----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP 661 (840)
Q Consensus 586 v~l~g~~~~~~~~~lv~e~~~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 661 (840)
+++++++.+.+..++++||...... .....+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.+
T Consensus 69 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~ 145 (267)
T cd06628 69 VQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGI 145 (267)
T ss_pred eeEEEEEEeCCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCE
Confidence 9999999999999999998432221 22356788899999999999999999988 9999999999999999999
Q ss_pred eeeccccceecCCCCccc----ccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHH
Q 041702 662 KISDFGIARTFGGDEMQS----NTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGH 737 (840)
Q Consensus 662 kL~DFGla~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~ 737 (840)
||+|||+++......... ......++..|+|||.+.+..++.++||||||++++||++|+.|+...... . .
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~---~ 220 (267)
T cd06628 146 KISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--Q---A 220 (267)
T ss_pred EecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH--H---H
Confidence 999999998765321111 112345788999999999989999999999999999999999998643211 1 1
Q ss_pred HhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 738 AWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 738 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
...... ...+. .+......+.+++.+||+.+|.+||++.||++
T Consensus 221 ~~~~~~------~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 221 IFKIGE------NASPE----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHHHhc------cCCCc----CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 111000 11111 11233456788999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=304.64 Aligned_cols=238 Identities=24% Similarity=0.314 Sum_probs=185.5
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhcC-CCCccceee
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQ-HRNLVRLFG 590 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l~-H~niv~l~g 590 (840)
+|+..+.||+|+||.||+|.++ .+++.||+|+++.. .....+.+..|+.++..+. |++|+++++
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~ 68 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERK------------GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHS 68 (323)
T ss_pred CceEEEEEEecCCeEEEEEEEC------------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheee
Confidence 4677889999999999999765 57899999999753 2334567888999998885 577888999
Q ss_pred EeecCCceEEEEEeeccCCc----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 591 CCIEQGEKISIYEFDIVTDP----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
++...+..++||||...... .....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 69 ~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Df 145 (323)
T cd05615 69 CFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADF 145 (323)
T ss_pred EEecCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEecc
Confidence 99999999999999533322 23456899999999999999999999988 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccc
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDK 746 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 746 (840)
|+++...... .......||+.|+|||++.+..++.++|||||||+++||++|+.|+...... ..... . ....
T Consensus 146 g~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~~~---i-~~~~ 217 (323)
T cd05615 146 GMCKEHMVDG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--ELFQS---I-MEHN 217 (323)
T ss_pred ccccccCCCC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHH---H-HhCC
Confidence 9987543221 1223456899999999999999999999999999999999999998643211 11111 1 1100
Q ss_pred cccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCH
Q 041702 747 AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTM 785 (840)
Q Consensus 747 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 785 (840)
. ..+......+.+++.+||+.+|.+|++.
T Consensus 218 --------~--~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 218 --------V--SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred --------C--CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 0 0111233457889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=307.10 Aligned_cols=238 Identities=21% Similarity=0.241 Sum_probs=180.3
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHH-HHhhcCCCCccceeeEeecC
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMM-LIAKLQHRNLVRLFGCCIEQ 595 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~-~l~~l~H~niv~l~g~~~~~ 595 (840)
+.||+|+||.||+|.++ .+++.||+|++.... .....++..|.. +++.++||||+++++++.+.
T Consensus 1 ~~lg~G~fg~V~~~~~~------------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~ 68 (325)
T cd05602 1 KVIGKGSFGKVLLARHK------------AEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA 68 (325)
T ss_pred CeeeeCCCeEEEEEEEC------------CCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcC
Confidence 36999999999999765 578899999987532 222344455544 56788999999999999999
Q ss_pred CceEEEEEeeccCCc----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccccee
Q 041702 596 GEKISIYEFDIVTDP----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 596 ~~~~lv~e~~~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
+..++||||...... .....+.......++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 69 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~ 145 (325)
T cd05602 69 DKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKE 145 (325)
T ss_pred CeEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcc
Confidence 999999999533222 23345777888889999999999999998 99999999999999999999999999975
Q ss_pred cCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccccccccc
Q 041702 672 FGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLM 751 (840)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (840)
..... .......||+.|+|||++.+..++.++|||||||+++||++|+.||...... .... .......
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~----~i~~~~~---- 213 (325)
T cd05602 146 NIEHN--GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--EMYD----NILNKPL---- 213 (325)
T ss_pred cccCC--CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH--HHHH----HHHhCCc----
Confidence 42211 1233457999999999999999999999999999999999999998533211 1111 1111100
Q ss_pred CccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 752 DPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 752 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.. .......+.+++.+||+.+|.+||++.+.+.
T Consensus 214 --~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 214 --QL----KPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred --CC----CCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 01 1123345778999999999999998875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=293.64 Aligned_cols=250 Identities=22% Similarity=0.383 Sum_probs=193.2
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
.++|...++||+|+||.||+|.+. .+++.||+|.++.........+.+|+.++..++||||+++++++
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~------------~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~ 75 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNV------------NTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY 75 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEc------------CCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 357888899999999999999654 57889999999766555556789999999999999999999999
Q ss_pred ecCCceEEEEEeeccCCc----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccc
Q 041702 593 IEQGEKISIYEFDIVTDP----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGI 668 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl 668 (840)
...+..++++||...... .....+++.+...++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~ 152 (267)
T cd06645 76 LRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGV 152 (267)
T ss_pred EeCCEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccee
Confidence 999999999999432222 23456889999999999999999999998 99999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 669 ARTFGGDEMQSNTNRIVGTYGYMSPEYAL---HGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 669 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
+....... .......|+..|+|||.+. ...++.++|||||||+++||++|+.|+....+.... . .... .
T Consensus 153 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~-~----~~~~-~ 224 (267)
T cd06645 153 SAQITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-F----LMTK-S 224 (267)
T ss_pred eeEccCcc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH-H----hhhc-c
Confidence 87654321 1223456899999999874 456889999999999999999999987433211110 0 0000 0
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
. ...+.... .......+.+++.+||+.+|++||++++|++
T Consensus 225 ~---~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 225 N---FQPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred C---CCCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0 00011100 0112345778999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=289.26 Aligned_cols=242 Identities=27% Similarity=0.334 Sum_probs=186.6
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcCCCCccceeeEeecCCce
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEK 598 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~ 598 (840)
++||+|+||.||+|.. .++..||+|++..... .....|.+|++++++++||||+++++++...+..
T Consensus 1 ~~ig~g~~g~vy~~~~-------------~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 67 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-------------KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPI 67 (250)
T ss_pred CccCCCCCceEEEEEe-------------cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCcc
Confidence 3699999999999753 4678999999876532 2345689999999999999999999999999999
Q ss_pred EEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceecC
Q 041702 599 ISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFG 673 (840)
Q Consensus 599 ~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~ 673 (840)
+++|||...... .....+++..+++++.+++.+|.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 68 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 144 (250)
T cd05085 68 YIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQED 144 (250)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecc
Confidence 999998432221 12345789999999999999999999988 9999999999999999999999999997643
Q ss_pred CCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhcccccccccC
Q 041702 674 GDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMD 752 (840)
Q Consensus 674 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 752 (840)
.... .......++..|+|||++.+..++.++||||||++++||++ |..|+....... .. .......
T Consensus 145 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~--~~----~~~~~~~------ 211 (250)
T cd05085 145 DGIY-SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ--AR----EQVEKGY------ 211 (250)
T ss_pred cccc-ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH--HH----HHHHcCC------
Confidence 3221 11112234568999999998899999999999999999998 888875432111 11 1111110
Q ss_pred ccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 041702 753 PTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLK 793 (840)
Q Consensus 753 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le 793 (840)
........+..+.+++.+|++.+|++||++.|++++|+
T Consensus 212 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 212 ---RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred ---CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 00111123456889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=292.08 Aligned_cols=245 Identities=22% Similarity=0.304 Sum_probs=192.6
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC-CCcCHHHHHHHHHHHhhcCCCCccceeeEee
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK-SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCI 593 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~-~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~ 593 (840)
+|+..++||+|+||.||++.+. .+++.+|+|.++.. .....+.+.+|+.++++++|+||+++++++.
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~------------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 68 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHV------------NSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFE 68 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEc------------CCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence 4778899999999999999754 57889999998643 2345678899999999999999999999999
Q ss_pred cCCceEEEEEeeccCCc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 594 EQGEKISIYEFDIVTDP------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 594 ~~~~~~lv~e~~~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
.++..++++||...... .....++....+.++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||
T Consensus 69 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg 145 (255)
T cd08219 69 ADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFG 145 (255)
T ss_pred ECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccC
Confidence 99999999999532221 12345788899999999999999999988 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccccc
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKA 747 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 747 (840)
++........ ......+++.|+|||.+.+..++.++||||||+++++|++|+.|+...... .. .... .....
T Consensus 146 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--~~---~~~~-~~~~~ 217 (255)
T cd08219 146 SARLLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK--NL---ILKV-CQGSY 217 (255)
T ss_pred cceeeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH--HH---HHHH-hcCCC
Confidence 9987643221 122356888999999999889999999999999999999999998532211 11 1111 11111
Q ss_pred ccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 748 WKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 748 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
. ..+......+.+++.+||+.||++||++.+|+..
T Consensus 218 ~---------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 218 K---------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred C---------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0 0111233457789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=290.36 Aligned_cols=243 Identities=26% Similarity=0.372 Sum_probs=188.3
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCI 593 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~ 593 (840)
++|...+.||+|+||.||++.. .+..||+|.++.. ...+.|.+|+.++++++|+|++++++++.
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--------------~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 69 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--------------RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIV 69 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--------------cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence 5788889999999999999753 4778999998643 33568999999999999999999999865
Q ss_pred -cCCceEEEEEeeccCCc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 594 -EQGEKISIYEFDIVTDP------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 594 -~~~~~~lv~e~~~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
+++..++++||...... .....+++..+++++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 70 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df 146 (256)
T cd05082 70 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDF 146 (256)
T ss_pred cCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCC
Confidence 45678999998532221 12235889999999999999999999988 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
|+++...... .....+..|+|||++.+..++.++||||||++++||++ |+.|+...... ... .. ....
T Consensus 147 g~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~--~~~---~~-~~~~ 215 (256)
T cd05082 147 GLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVV---PR-VEKG 215 (256)
T ss_pred ccceeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--HHH---HH-HhcC
Confidence 9987653221 12334568999999998899999999999999999998 88887532211 111 11 1111
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
. ........+..+.+++.+|++.+|++|||+.++++.|+++
T Consensus 216 ~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 216 Y---------KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred C---------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 0 0011122345678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=295.76 Aligned_cols=247 Identities=25% Similarity=0.389 Sum_probs=192.7
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCI 593 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~ 593 (840)
+.|++.++||+|+||.||+|.+. .+++.||+|.+........+++.+|+.++++++||||+++++++.
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~------------~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 79 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNK------------ETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEEC------------CCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEE
Confidence 67888999999999999999654 578899999998766566778999999999999999999999999
Q ss_pred cCCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccc
Q 041702 594 EQGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGI 668 (840)
Q Consensus 594 ~~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl 668 (840)
..+..++||||...... .....+++..+..++.|++.+|+|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~ 156 (292)
T cd06644 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGV 156 (292)
T ss_pred eCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCcc
Confidence 99999999999433221 12346899999999999999999999987 99999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhc
Q 041702 669 ARTFGGDEMQSNTNRIVGTYGYMSPEYAL-----HGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWK 743 (840)
Q Consensus 669 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~ 743 (840)
+....... .......+++.|+|||++. ...++.++|||||||++|||++|+.|+....... ..... .
T Consensus 157 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----~~~~~-~ 228 (292)
T cd06644 157 SAKNVKTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-----VLLKI-A 228 (292)
T ss_pred ceeccccc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH-----HHHHH-h
Confidence 87643221 1123456788999999884 3457889999999999999999999875432111 01011 0
Q ss_pred ccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 744 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
... .+.. .........+.+++.+||+.+|++||++++|++
T Consensus 229 ~~~-----~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 229 KSE-----PPTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred cCC-----CccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000 0111 011123345788999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=294.91 Aligned_cols=256 Identities=24% Similarity=0.339 Sum_probs=189.5
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
+|+..+.||+|++|.||+|++. .+++.||||++.... ....+.+.+|++++++++||||+++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~------------~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 68 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNK------------LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI 68 (284)
T ss_pred CceeeeeecCCCceEEEEEEEC------------CCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc
Confidence 4788899999999999999754 578899999987542 22346789999999999999999999999
Q ss_pred ecCCceEEEEEeeccC-----CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 593 IEQGEKISIYEFDIVT-----DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~-----~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
.+.+..++++||.... .......+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||
T Consensus 69 ~~~~~~~~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg 145 (284)
T cd07860 69 HTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFG 145 (284)
T ss_pred ccCCcEEEEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeecc
Confidence 9999999999995311 0112356889999999999999999999988 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCccccccCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccc-
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALHGL-FSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD- 745 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~- 745 (840)
++....... .......++..|+|||.+.+.. ++.++||||||++++||+||+.|+....... ... .........
T Consensus 146 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~-~~~~~~~~~~ 221 (284)
T cd07860 146 LARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLF-RIFRTLGTPD 221 (284)
T ss_pred chhhcccCc--cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHH-HHHHHhCCCC
Confidence 987653321 1122335678999999887644 6889999999999999999999986432211 110 000000000
Q ss_pred ---------------ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 746 ---------------KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 746 ---------------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.......... ..........+.+++.+||+.||++|||++++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 222 EVVWPGVTSLPDYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhhhhhhhHHHHHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000000 0011122345778999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=293.10 Aligned_cols=246 Identities=23% Similarity=0.395 Sum_probs=195.2
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
..|+..++||+|+||.||+|.+. .+++.||||.+.... ....+.+.+|+.++++++||||+++++++
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 71 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDN------------RTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEc------------cCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 35667789999999999999765 568899999987543 34456799999999999999999999999
Q ss_pred ecCCceEEEEEeeccCC---ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccc
Q 041702 593 IEQGEKISIYEFDIVTD---PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIA 669 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~---~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla 669 (840)
.+++..++||||..... ......+++.+...++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~ 148 (277)
T cd06640 72 LKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVA 148 (277)
T ss_pred EECCEEEEEEecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccc
Confidence 99999999999843221 123346788899999999999999999987 999999999999999999999999999
Q ss_pred eecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccccccc
Q 041702 670 RTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWK 749 (840)
Q Consensus 670 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (840)
..+..... ......++..|+|||.+.+..++.++||||||++++||++|+.|+......... .
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~------~--------- 211 (277)
T cd06640 149 GQLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL------F--------- 211 (277)
T ss_pred eeccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh------h---------
Confidence 87643221 223346788999999999889999999999999999999999987543221110 0
Q ss_pred ccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 750 LMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 750 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
.+...............+.+++.+||+.+|++||+++++++.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 212 LIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 001111122233455678899999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=296.63 Aligned_cols=258 Identities=24% Similarity=0.306 Sum_probs=189.7
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
+|+..+.||+|+||.||+|.++ .+|+.||+|+++... ......+.+|+.++++++||||+++++++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~------------~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~ 68 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNR------------ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVL 68 (284)
T ss_pred CceeEEEecccCCeEEEEEEEC------------CCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHh
Confidence 4778889999999999999765 578899999987532 23345688999999999999999999999
Q ss_pred ecCCceEEEEEeeccCC---c-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccc
Q 041702 593 IEQGEKISIYEFDIVTD---P-ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGI 668 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~---~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl 668 (840)
.+.+..++++||..... . .....+++.....++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 69 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~ 145 (284)
T cd07839 69 HSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGL 145 (284)
T ss_pred ccCCceEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccch
Confidence 99999999999953211 1 12346899999999999999999999988 99999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccc-
Q 041702 669 ARTFGGDEMQSNTNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDK- 746 (840)
Q Consensus 669 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~- 746 (840)
++...... .......++..|+|||.+.+. .++.++|||||||+++||++|+.|+....... ..............
T Consensus 146 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~ 222 (284)
T cd07839 146 ARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKRIFRLLGTPTE 222 (284)
T ss_pred hhccCCCC--CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH-HHHHHHHHHhCCCCh
Confidence 98654321 112234578899999988764 47999999999999999999998853222111 11100000000000
Q ss_pred -----cccccCc----ccc-----chhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 747 -----AWKLMDP----TMQ-----NEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 747 -----~~~~~d~----~l~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.....+. ... ..........+.+++.+||+.||.+|||++++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 223 ESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred HHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000000 000 0111223456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=306.01 Aligned_cols=258 Identities=20% Similarity=0.221 Sum_probs=194.0
Q ss_pred HHHHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhcCC
Q 041702 506 LSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQH 582 (840)
Q Consensus 506 ~~~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l~H 582 (840)
+.++....++|+..+.||+|+||.||+|.++ .+++.||+|++... .....+.+.+|+.+++.++|
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~------------~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~h 102 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHK------------STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEEC------------CCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCC
Confidence 3445556789999999999999999999765 67889999998642 22334568899999999999
Q ss_pred CCccceeeEeecCCceEEEEEeeccCC---ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCC
Q 041702 583 RNLVRLFGCCIEQGEKISIYEFDIVTD---PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDM 659 (840)
Q Consensus 583 ~niv~l~g~~~~~~~~~lv~e~~~~~~---~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~ 659 (840)
|||+++++++.+.+..++||||..... ......++...+..++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 103 p~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~ 179 (371)
T cd05622 103 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSG 179 (371)
T ss_pred CCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCC
Confidence 999999999999999999999953222 223345788888999999999999999998 99999999999999999
Q ss_pred CceeeccccceecCCCCcccccccccccccccCccccccC----CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHh
Q 041702 660 NPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHG----LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLL 735 (840)
Q Consensus 660 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~ 735 (840)
.+||+|||+++....... .......||+.|+|||++.+. .++.++|||||||+||||++|+.||......
T Consensus 180 ~ikL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~----- 253 (371)
T cd05622 180 HLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV----- 253 (371)
T ss_pred CEEEEeCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH-----
Confidence 999999999987643221 122346799999999998754 3789999999999999999999998643211
Q ss_pred HHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 041702 736 GHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATD--RPTMLEVVAM 791 (840)
Q Consensus 736 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~ 791 (840)
............... .........+.+++.+||+.++.+ ||+++++++.
T Consensus 254 ~~~~~i~~~~~~~~~-------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 254 GTYSKIMNHKNSLTF-------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred HHHHHHHcCCCcccC-------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 111111111111111 111223455778888999844432 7788888874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=295.12 Aligned_cols=245 Identities=23% Similarity=0.268 Sum_probs=188.8
Q ss_pred CcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 516 FSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 516 f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
|+..+.||+|+||.||+|.+. .+++.||+|.+.... ....+.+.+|++++.+++|+|++++.+++
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~------------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~ 69 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVR------------ATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY 69 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEC------------CCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE
Confidence 667789999999999998654 578999999986542 22345678999999999999999999999
Q ss_pred ecCCceEEEEEeeccCCc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 593 IEQGEKISIYEFDIVTDP------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
..++..++++||...... .....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+||
T Consensus 70 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Df 146 (285)
T cd05632 70 ETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDL 146 (285)
T ss_pred ecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecC
Confidence 999999999998533221 12336899999999999999999999988 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccc
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDK 746 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 746 (840)
|++....... ......|+..|+|||.+.+..++.++||||||++++||++|+.|+........ ...........
T Consensus 147 g~~~~~~~~~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~--~~~~~~~~~~~- 220 (285)
T cd05632 147 GLAVKIPEGE---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK--REEVDRRVLET- 220 (285)
T ss_pred CcceecCCCC---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhhhcc-
Confidence 9997653221 12234689999999999999999999999999999999999999864322111 11111100000
Q ss_pred cccccCccccchhhHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 041702 747 AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPT-----MLEVVA 790 (840)
Q Consensus 747 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 790 (840)
... ........+.+++..|++.||++||+ +.++++
T Consensus 221 -----~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 221 -----EEV----YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred -----ccc----cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 001 11123345678999999999999999 556654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=306.28 Aligned_cols=234 Identities=22% Similarity=0.256 Sum_probs=179.3
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHH-HHhhcCCCCccceeeEeecC
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMM-LIAKLQHRNLVRLFGCCIEQ 595 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~-~l~~l~H~niv~l~g~~~~~ 595 (840)
++||+|+||.||+|+++ .+++.||+|++.... .....++..|.. +++.++||||+++++++.+.
T Consensus 1 ~~lg~G~~g~Vy~~~~~------------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~ 68 (321)
T cd05603 1 KVIGKGSFGKVLLAKRK------------SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTA 68 (321)
T ss_pred CeeeeCCCEEEEEEEEC------------CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcC
Confidence 36999999999999765 578999999987532 223345555654 57889999999999999999
Q ss_pred CceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccccee
Q 041702 596 GEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 596 ~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
+..++||||..... ......++......++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 69 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 145 (321)
T cd05603 69 EKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKE 145 (321)
T ss_pred CEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCcc
Confidence 99999999953322 223456788888999999999999999988 99999999999999999999999999875
Q ss_pred cCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccccccccc
Q 041702 672 FGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLM 751 (840)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (840)
..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .. .... ....
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~---~~~i-~~~~----- 212 (321)
T cd05603 146 GVEPE--ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS--QM---YDNI-LHKP----- 212 (321)
T ss_pred CCCCC--CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH--HH---HHHH-hcCC-----
Confidence 32211 1233457899999999999999999999999999999999999998543211 11 1111 1110
Q ss_pred CccccchhhHHHHHHHHHHHHHccccCCCCCCCHH
Q 041702 752 DPTMQNEALYSMVTRYIKVALLCVQENATDRPTML 786 (840)
Q Consensus 752 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 786 (840)
. ..+......+.+++.+||+.+|++||++.
T Consensus 213 ---~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 213 ---L--QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred ---C--CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 0 01112234578899999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=305.25 Aligned_cols=249 Identities=27% Similarity=0.363 Sum_probs=193.7
Q ss_pred CcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcCCCCccceeeEeec
Q 041702 516 FSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQHRNLVRLFGCCIE 594 (840)
Q Consensus 516 f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~ 594 (840)
....++||+|.||.|++|.|. .-..+-..||||.++.... ....+|++|+.+|.+|+|+|+++|+|+..+
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt---------~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~ 182 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWT---------QPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD 182 (1039)
T ss_pred HHHHHHhcCcceeeEeecccc---------CCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc
Confidence 344578999999999998765 1122334699999987644 367899999999999999999999999887
Q ss_pred CCceEEEEEeeccCC------ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccc
Q 041702 595 QGEKISIYEFDIVTD------PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGI 668 (840)
Q Consensus 595 ~~~~~lv~e~~~~~~------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl 668 (840)
....+|+|...... ......+.......++.|||+||.||..++ +|||||..+|+||-..-.+||+|||+
T Consensus 183 -qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGL 258 (1039)
T KOG0199|consen 183 -QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGL 258 (1039)
T ss_pred -chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccc
Confidence 67888888832221 134556777788899999999999999988 99999999999999999999999999
Q ss_pred ceecCCCCccc-ccccccccccccCccccccCCCCccccchhHHHHHHHHHhC-CCCCCCCCCCCccHhHHHhhhhcccc
Q 041702 669 ARTFGGDEMQS-NTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSS-KKNTRFYNTDSLTLLGHAWNLWKDDK 746 (840)
Q Consensus 669 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~ 746 (840)
.+.+..++... ......-...|.|||.+....++.++|||+|||+||||+|+ ..|+..... . .
T Consensus 259 mRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g--~-------------q 323 (1039)
T KOG0199|consen 259 MRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG--I-------------Q 323 (1039)
T ss_pred eeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH--H-------------H
Confidence 99886654333 23333456799999999999999999999999999999985 445432211 1 1
Q ss_pred cccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 041702 747 AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAML 792 (840)
Q Consensus 747 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 792 (840)
+.+.+|..-+-..+..+.+.+++|+..||..+|++|||+..|.+.+
T Consensus 324 IL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 324 ILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred HHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 1222333333344455677899999999999999999999998443
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=293.96 Aligned_cols=261 Identities=15% Similarity=0.186 Sum_probs=178.5
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCH-----------HHHHHHHHHHhhcC
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGL-----------EEFKNEMMLIAKLQ 581 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~-----------~~f~~Ev~~l~~l~ 581 (840)
.++|.+.++||+|+||.||+|.+. +....+..+|+|+......... .....+...+..++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~---------~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~ 81 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCA---------SDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNID 81 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEc---------CCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCC
Confidence 468999999999999999999754 1112255677776433221110 11223344556678
Q ss_pred CCCccceeeEeecCCc----eEEEEEeeccC---CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEE
Q 041702 582 HRNLVRLFGCCIEQGE----KISIYEFDIVT---DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVL 654 (840)
Q Consensus 582 H~niv~l~g~~~~~~~----~~lv~e~~~~~---~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIL 654 (840)
|+|++++++++..... .++++++.... ........++.....|+.|++.||+|||+.+ |+||||||+|||
T Consensus 82 h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nil 158 (294)
T PHA02882 82 HLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIM 158 (294)
T ss_pred CCCCCcEEEeeeEecCCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence 9999999997765432 23444431111 0111223567888899999999999999988 999999999999
Q ss_pred ecCCCCceeeccccceecCCCCcc-----cccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCC
Q 041702 655 LDSDMNPKISDFGIARTFGGDEMQ-----SNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNT 729 (840)
Q Consensus 655 l~~~~~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~ 729 (840)
++.++.+||+|||+|+.+...... .......||+.|+|||.+.+..++.++|||||||+|+||++|+.||.....
T Consensus 159 l~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~ 238 (294)
T PHA02882 159 VDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH 238 (294)
T ss_pred EcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence 999999999999999876432211 112234699999999999999999999999999999999999999875532
Q ss_pred CCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 041702 730 DSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLK 793 (840)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le 793 (840)
............. ..+...... .....+.+.+++..|++.+|++||++.++++.|+
T Consensus 239 ~~~~~~~~~~~~~-----~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 239 NGNLIHAAKCDFI-----KRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred chHHHHHhHHHHH-----HHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 2211110000000 001111110 1112456888999999999999999999998874
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=289.99 Aligned_cols=249 Identities=26% Similarity=0.403 Sum_probs=193.1
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
..++|+..++||+|+||.||+|.+ ..+..+|+|.+... ....+.|.+|++++++++|+||++++++
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~-------------~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 69 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATY-------------NKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAV 69 (260)
T ss_pred cccceeEEeEecCccceEEEEEEe-------------cCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEE
Confidence 456788999999999999999853 34567999988754 2345789999999999999999999999
Q ss_pred eecCCceEEEEEeeccCCc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 592 CIEQGEKISIYEFDIVTDP------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
+.+ +..+++|||...... .....+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|
T Consensus 70 ~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d 145 (260)
T cd05073 70 VTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIAD 145 (260)
T ss_pred EcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECC
Confidence 887 778999999533221 12345788899999999999999999987 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
||++..+...... ......++..|+|||++....++.++||||||++++||++ |+.|+...... .... ....
T Consensus 146 ~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~----~~~~ 218 (260)
T cd05073 146 FGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIR----ALER 218 (260)
T ss_pred CcceeeccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--HHHH----HHhC
Confidence 9999876433221 1222345678999999998889999999999999999999 88887532211 1111 1111
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~ 794 (840)
.. ...........+.+++.+|++.+|++||++.++++.|+.
T Consensus 219 ~~---------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 219 GY---------RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CC---------CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 10 001112334568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=294.92 Aligned_cols=246 Identities=25% Similarity=0.305 Sum_probs=190.0
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
.|+..+.||+|+||.||++.++ .+++.||||.+.... ....+.+.+|+.++++++|+|++++++.
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~------------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~ 68 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVR------------ATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYA 68 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEc------------CCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEE
Confidence 3667789999999999999765 678999999987542 2233567899999999999999999999
Q ss_pred eecCCceEEEEEeeccCCc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 592 CIEQGEKISIYEFDIVTDP------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
+.+.+..+++|||...... .....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|
T Consensus 69 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~D 145 (285)
T cd05630 69 YETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISD 145 (285)
T ss_pred EecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEee
Confidence 9999999999998532221 12235888999999999999999999988 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
||++........ .....|+..|+|||.+.+..++.++||||||++++||++|+.|+......... .........
T Consensus 146 fg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~--~~~~~~~~~- 219 (285)
T cd05630 146 LGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--EEVERLVKE- 219 (285)
T ss_pred ccceeecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH--HHHHhhhhh-
Confidence 999876543221 12346899999999999999999999999999999999999998643221100 000010000
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPT-----MLEVVA 790 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 790 (840)
............+.+++.+||+.||++||| ++|+++
T Consensus 220 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 220 ---------VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred ---------hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 000111123345788999999999999999 778875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=296.19 Aligned_cols=252 Identities=24% Similarity=0.366 Sum_probs=195.9
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
.++|+..++||+|+||+||+|.+. .+++.||+|++.... ....++|.+|++++..++||||++++++
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~------------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 71 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHI------------PTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGA 71 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEc------------CCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeee
Confidence 357888899999999999998654 578899999987543 3345789999999999999999999999
Q ss_pred eecCCceEEEEEeeccCCc----cccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceecCCCCCCcEEecCCCCceeecc
Q 041702 592 CIEQGEKISIYEFDIVTDP----ARKDLLDWTTRVRIIEGVAQGLLYLHQY-SRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
+...+..++|+||...... .....+++.....++.+++.||.|||+. + ++||||||+||+++.++.++|+||
T Consensus 72 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~ 148 (284)
T cd06620 72 FLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDF 148 (284)
T ss_pred EecCCEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccC
Confidence 9999999999999543222 2234688999999999999999999973 5 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCc------cHhHHHhh
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSL------TLLGHAWN 740 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~------~~~~~~~~ 740 (840)
|++...... ......++..|+|||.+.+..++.++|||||||+++||++|+.|+........ ........
T Consensus 149 gl~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (284)
T cd06620 149 GVSGELINS----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ 224 (284)
T ss_pred Ccccchhhh----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHH
Confidence 998654221 12345689999999999888999999999999999999999999875433210 00111101
Q ss_pred hhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 041702 741 LWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAML 792 (840)
Q Consensus 741 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 792 (840)
..... .+.+. .......+.+++.+|++.||++||++.||+++.
T Consensus 225 ~~~~~------~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 225 IVQEP------PPRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred Hhhcc------CCCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 00000 01111 112345688999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=292.10 Aligned_cols=254 Identities=25% Similarity=0.368 Sum_probs=192.9
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
++|...+.||+|+||.||+|.+. ........||||...... ....+.|.+|+.++++++||||+++++++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~---------~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 76 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYM---------SPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVI 76 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEe---------cCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEE
Confidence 56788899999999999998754 111234579999987654 34456899999999999999999999998
Q ss_pred ecCCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 593 IEQGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
.. +..+++|||...... .....+++..++.++.+++.||+|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 77 ~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g 152 (270)
T cd05056 77 TE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFG 152 (270)
T ss_pred cC-CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCc
Confidence 75 567899998432221 11335899999999999999999999988 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhcccc
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKDDK 746 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 746 (840)
+++......... .....++..|+|||.+....++.++||||||++++||++ |+.||...... ..... . ....
T Consensus 153 ~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--~~~~~---~-~~~~ 225 (270)
T cd05056 153 LSRYLEDESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN--DVIGR---I-ENGE 225 (270)
T ss_pred eeeeccccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHH---H-HcCC
Confidence 998765432211 122334568999999988889999999999999999996 99987543221 11111 1 1110
Q ss_pred cccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 041702 747 AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEI 796 (840)
Q Consensus 747 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~ 796 (840)
.. .. ....+..+.+++.+|+..+|++|||+.++++.|++..
T Consensus 226 --~~---~~----~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 226 --RL---PM----PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred --cC---CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00 01 1123446888999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=274.01 Aligned_cols=250 Identities=24% Similarity=0.350 Sum_probs=196.4
Q ss_pred HHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC----Cc----CHHHHHHHHHHHhhc-C
Q 041702 511 AATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS----GQ----GLEEFKNEMMLIAKL-Q 581 (840)
Q Consensus 511 ~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~----~~----~~~~f~~Ev~~l~~l-~ 581 (840)
.-.+.|...+.||.|..++|.+..++ .+|++.|+|++.... .. -.+.-.+|+.||+++ .
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k------------~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~G 81 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHK------------ETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMG 81 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhc------------ccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcC
Confidence 34567778889999999999987655 789999999986432 11 124467799999999 6
Q ss_pred CCCccceeeEeecCCceEEEEEeecc----CCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecC
Q 041702 582 HRNLVRLFGCCIEQGEKISIYEFDIV----TDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS 657 (840)
Q Consensus 582 H~niv~l~g~~~~~~~~~lv~e~~~~----~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~ 657 (840)
||+|+++.+++..+.-.++|+|.+.. ......-.++++...+|++|+..|++|||... |+||||||+|||+|+
T Consensus 82 HP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILldd 158 (411)
T KOG0599|consen 82 HPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDD 158 (411)
T ss_pred CCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeecc
Confidence 99999999999999999999998533 33445566889999999999999999999998 999999999999999
Q ss_pred CCCceeeccccceecCCCCcccccccccccccccCccccc------cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCC
Q 041702 658 DMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYAL------HGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDS 731 (840)
Q Consensus 658 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~ 731 (840)
+.++||+|||+|..+..+.. ....+|||+|+|||.+. ...|+...|+|+.|||++.||.|.+||-. -..
T Consensus 159 n~~i~isDFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH--RkQ 233 (411)
T KOG0599|consen 159 NMNIKISDFGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH--RKQ 233 (411)
T ss_pred ccceEEeccceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH--HHH
Confidence 99999999999998876553 34578999999999874 24588999999999999999999999721 000
Q ss_pred ccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 732 LTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
. ....+..+++. ....+.-.+......+++.+||+.||.+|.|++|+++
T Consensus 234 m----lMLR~ImeGky------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 234 M----LMLRMIMEGKY------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred H----HHHHHHHhccc------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 0 01111112211 1222333456677889999999999999999999884
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=276.87 Aligned_cols=247 Identities=24% Similarity=0.368 Sum_probs=193.8
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC--CCcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK--SGQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
.+.|++.+.||+|.|+.||+..++ .+|+.+|+|++... ...+.+++.+|++|-+.|+|||||+|..
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~------------~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ 77 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHK------------TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 77 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhc------------cchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhh
Confidence 467888889999999999998655 78999999987532 3456788999999999999999999999
Q ss_pred EeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCC---CCcee
Q 041702 591 CCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSD---MNPKI 663 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~---~~~kL 663 (840)
...+.+..++|+|++.-.+ .-.+...++...-..+.||+.+|.|+|.++ |||||+||.|+||-.. --+||
T Consensus 78 ti~~~~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL 154 (355)
T KOG0033|consen 78 SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKL 154 (355)
T ss_pred hhcccceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceee
Confidence 9999999999999954332 223345666677789999999999999998 9999999999999533 35899
Q ss_pred eccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhc
Q 041702 664 SDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWK 743 (840)
Q Consensus 664 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~ 743 (840)
+|||+|..+..+ ..-...+|||+|||||++...+|+..+|||+-||||+-||.|.+||-... ...+.+.. .
T Consensus 155 ~~FGvAi~l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~--~~rlye~I----~ 225 (355)
T KOG0033|consen 155 ADFGLAIEVNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--QHRLYEQI----K 225 (355)
T ss_pred cccceEEEeCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc--HHHHHHHH----h
Confidence 999999988732 23345789999999999999999999999999999999999999985322 11111111 1
Q ss_pred ccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 041702 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVV 789 (840)
Q Consensus 744 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 789 (840)
.+ +-.+.+..-....+...+++.+||..||.+|.|+.|.+
T Consensus 226 ~g------~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 226 AG------AYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred cc------ccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence 11 01111222233445677899999999999999999876
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=297.66 Aligned_cols=263 Identities=21% Similarity=0.286 Sum_probs=191.8
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
+|+..++||+|+||.||+|.++ . ..+++.||+|.+.... ....+.+.+|+.++.+++||||++++++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~---------~-~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 70 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRK---------N-GKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEV 70 (316)
T ss_pred CceEEEEeccCCcEEEEEEEec---------C-CCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEE
Confidence 4778889999999999999765 1 0268899999998632 3445678899999999999999999999
Q ss_pred eecC--CceEEEEEeeccC-------Ccc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecC----
Q 041702 592 CIEQ--GEKISIYEFDIVT-------DPA-RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS---- 657 (840)
Q Consensus 592 ~~~~--~~~~lv~e~~~~~-------~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~---- 657 (840)
+.+. +..++|+||.... ... ....++......++.||+.||.|||+.+ |+||||||+||+++.
T Consensus 71 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~ 147 (316)
T cd07842 71 FLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPE 147 (316)
T ss_pred EeCCCCceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCc
Confidence 9988 7899999984211 011 1236788899999999999999999988 999999999999999
Q ss_pred CCCceeeccccceecCCCCc-ccccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc--
Q 041702 658 DMNPKISDFGIARTFGGDEM-QSNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLT-- 733 (840)
Q Consensus 658 ~~~~kL~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~-- 733 (840)
++.+||+|||++..+..... ........++..|+|||.+.+ ..++.++||||||++++||++|++|+.........
T Consensus 148 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~ 227 (316)
T cd07842 148 RGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSN 227 (316)
T ss_pred cceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccc
Confidence 89999999999987643322 122334567889999998776 45899999999999999999999998755433200
Q ss_pred -----HhHHHhhhhcc------------ccccc---ccC-cccc-----chhhH--HHHHHHHHHHHHccccCCCCCCCH
Q 041702 734 -----LLGHAWNLWKD------------DKAWK---LMD-PTMQ-----NEALY--SMVTRYIKVALLCVQENATDRPTM 785 (840)
Q Consensus 734 -----~~~~~~~~~~~------------~~~~~---~~d-~~l~-----~~~~~--~~~~~l~~l~~~Cl~~dP~~RPs~ 785 (840)
........+.. ..... ... .... ..... .....+.+++.+||+.||++|||+
T Consensus 228 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~ 307 (316)
T cd07842 228 PFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITA 307 (316)
T ss_pred hhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCH
Confidence 00000000000 00000 000 0000 00000 233468899999999999999999
Q ss_pred HHHHH
Q 041702 786 LEVVA 790 (840)
Q Consensus 786 ~evl~ 790 (840)
.|+++
T Consensus 308 ~eil~ 312 (316)
T cd07842 308 EEALE 312 (316)
T ss_pred HHHhc
Confidence 99975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=291.36 Aligned_cols=247 Identities=25% Similarity=0.407 Sum_probs=184.6
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-----CcCHHHHHHHHHHHhhcCCCCccce
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-----GQGLEEFKNEMMLIAKLQHRNLVRL 588 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-----~~~~~~f~~Ev~~l~~l~H~niv~l 588 (840)
.+|+..+.||+|+||.||+|.+. .++..||+|++.... ....+.+.+|+.++++++||||+++
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~------------~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 69 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDV------------DTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69 (266)
T ss_pred CCccccceecCCCCEEEEEEEEc------------CCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeE
Confidence 47888899999999999999654 568899999986432 1234568899999999999999999
Q ss_pred eeEeecC--CceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCce
Q 041702 589 FGCCIEQ--GEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPK 662 (840)
Q Consensus 589 ~g~~~~~--~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 662 (840)
++++.+. +..++++||..... ......+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+|
T Consensus 70 ~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~ 146 (266)
T cd06651 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVK 146 (266)
T ss_pred EEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEE
Confidence 9998753 56778888843221 123346889999999999999999999987 99999999999999999999
Q ss_pred eeccccceecCCCCc-ccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhh
Q 041702 663 ISDFGIARTFGGDEM-QSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNL 741 (840)
Q Consensus 663 L~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~ 741 (840)
|+|||+++....... ........++..|+|||.+.+..++.++|||||||+++||++|+.|+..... .. .....
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~--~~---~~~~~ 221 (266)
T cd06651 147 LGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA--MA---AIFKI 221 (266)
T ss_pred EccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch--HH---HHHHH
Confidence 999999976532211 1112234578899999999988899999999999999999999999853211 11 01010
Q ss_pred hcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 742 WKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 742 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
... ...+.+ +....+.+.+++ +||..+|++||+++||++
T Consensus 222 ~~~-----~~~~~~----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 222 ATQ-----PTNPQL----PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred hcC-----CCCCCC----chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 000 001111 122233344555 688889999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=290.79 Aligned_cols=249 Identities=25% Similarity=0.367 Sum_probs=180.1
Q ss_pred cccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcCCCCccceeeEeecCCceE
Q 041702 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKI 599 (840)
Q Consensus 521 ~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~ 599 (840)
+||+|+||.||+|... . ......+|+|.+..... .....|.+|+++++.++||||+++++++.+.+..+
T Consensus 2 ~lg~G~fg~v~~~~~~---------~-~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~ 71 (269)
T cd05042 2 EIGNGWFGKVLLGEAH---------R-GMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYL 71 (269)
T ss_pred cCCccCCceEEEEEEe---------c-CCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceE
Confidence 6999999999998532 1 13456799998865432 33457899999999999999999999999999999
Q ss_pred EEEEeeccCCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccce
Q 041702 600 SIYEFDIVTDPA---------RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIAR 670 (840)
Q Consensus 600 lv~e~~~~~~~~---------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~ 670 (840)
++|||....... .....++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 72 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~ 148 (269)
T cd05042 72 LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLAL 148 (269)
T ss_pred EEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEecccccc
Confidence 999995332211 1223467788899999999999999988 9999999999999999999999999987
Q ss_pred ecCCCCcccccccccccccccCccccc-------cCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhh
Q 041702 671 TFGGDEMQSNTNRIVGTYGYMSPEYAL-------HGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLW 742 (840)
Q Consensus 671 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 742 (840)
...............++..|+|||++. ...++.++|||||||+++||++ |..|+..... ...... ..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--~~~~~~---~~ 223 (269)
T cd05042 149 EQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD--EQVLKQ---VV 223 (269)
T ss_pred ccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH--HHHHHH---Hh
Confidence 543332222223345677899999864 3457889999999999999999 6777643221 111111 11
Q ss_pred cccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 041702 743 KDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLK 793 (840)
Q Consensus 743 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le 793 (840)
. .....+..+... ......+.+++..|+ .||++|||+++|++.|.
T Consensus 224 ~-~~~~~~~~~~~~----~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 224 R-EQDIKLPKPQLD----LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred h-ccCccCCCCccc----ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1 111112222222 223345667777888 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=294.00 Aligned_cols=257 Identities=24% Similarity=0.319 Sum_probs=191.2
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCc-----CHHHHHHHHHHHhhcCCCCcccee
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQ-----GLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~-----~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
+|+..+.||+|++|.||+|.++ .+++.||||+++..... ....+.+|++++.+++|+||++++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~------------~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~ 68 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDK------------ETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLL 68 (298)
T ss_pred CceeeeeeeeccccEEEEEEEC------------CCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhh
Confidence 4777889999999999999754 56889999999755322 234578899999999999999999
Q ss_pred eEeecCCceEEEEEeeccCCc----ccc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 590 GCCIEQGEKISIYEFDIVTDP----ARK-DLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~~~----~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
+++.+.+..++||||. .... ... ..+++..+.+++.||++||.|||+.+ ++|+||||+||+++.++.+||+
T Consensus 69 ~~~~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~ 144 (298)
T cd07841 69 DVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLA 144 (298)
T ss_pred heeecCCEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEc
Confidence 9999999999999996 2221 122 26899999999999999999999998 9999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhc
Q 041702 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWK 743 (840)
Q Consensus 665 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~ 743 (840)
|||++........ ......+++.|+|||.+.+ ..++.++|||||||+++||++|.+++..... ............
T Consensus 145 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~--~~~~~~~~~~~~ 220 (298)
T cd07841 145 DFGLARSFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD--IDQLGKIFEALG 220 (298)
T ss_pred cceeeeeccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc--HHHHHHHHHHcC
Confidence 9999987644321 1223356788999998865 4678999999999999999999877654322 111111111000
Q ss_pred c---------cccccccCcccc-----chhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 744 D---------DKAWKLMDPTMQ-----NEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 744 ~---------~~~~~~~d~~l~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
. ............ ..........+.+++.+||+.+|++|||++||++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 221 TPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred CCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0 000000000000 01112335678899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=294.93 Aligned_cols=250 Identities=24% Similarity=0.403 Sum_probs=191.3
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcC-CCCccceeeE
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQ-HRNLVRLFGC 591 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~-H~niv~l~g~ 591 (840)
++|...++||+|+||.||++.++ .+++.||+|++.... ......+.+|+.++.++. |+||++++++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~------------~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~ 71 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHK------------PSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEEC------------CCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeE
Confidence 35566788999999999998765 578999999987543 234567899999999996 9999999999
Q ss_pred eecCCceEEEEEeeccCC--------ccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceecCCCCCCcEEecCCCCce
Q 041702 592 CIEQGEKISIYEFDIVTD--------PARKDLLDWTTRVRIIEGVAQGLLYLHQY-SRLRVIHRDLKASNVLLDSDMNPK 662 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~--------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivHrDlkp~NILl~~~~~~k 662 (840)
+...+..++++|+..... ......+++....+++.+++.||+|||+. + ++||||||+||+++.++.+|
T Consensus 72 ~~~~~~~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~k 148 (288)
T cd06616 72 LFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIK 148 (288)
T ss_pred EecCCcEEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEE
Confidence 999999999999943211 11235688999999999999999999975 5 99999999999999999999
Q ss_pred eeccccceecCCCCcccccccccccccccCccccccC---CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHh
Q 041702 663 ISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHG---LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAW 739 (840)
Q Consensus 663 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~ 739 (840)
|+|||+++.+.... ......++..|+|||.+.+. .++.++|||||||+++||++|+.|+.... .......
T Consensus 149 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~ 221 (288)
T cd06616 149 LCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN----SVFDQLT 221 (288)
T ss_pred EeecchhHHhccCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----hHHHHHh
Confidence 99999997653321 11234578899999998766 68999999999999999999999986432 1111111
Q ss_pred hhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 740 NLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 740 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
.... ...+.+...........+.+++.+||+.+|++|||+++|++.
T Consensus 222 ~~~~------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 222 QVVK------GDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred hhcC------CCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1100 001122222223345568899999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=300.06 Aligned_cols=258 Identities=18% Similarity=0.225 Sum_probs=185.1
Q ss_pred ccccccCC--CCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceeeEee
Q 041702 518 EENKLGEG--GFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFGCCI 593 (840)
Q Consensus 518 ~~~~lG~G--~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~ 593 (840)
..++||+| +|++||++.++ .+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 69 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYK------------PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFI 69 (327)
T ss_pred hhhhccccccceEEEEEEeec------------ccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE
Confidence 35689999 67899999765 789999999997542 223456788999999999999999999999
Q ss_pred cCCceEEEEEeeccCCc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 594 EQGEKISIYEFDIVTDP------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 594 ~~~~~~lv~e~~~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
.++..++|+||...... .....+++..+.+++.|++.||+|||+.+ |+||||||+|||++.++.++++||+
T Consensus 70 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~ 146 (327)
T cd08227 70 ADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLR 146 (327)
T ss_pred ECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccc
Confidence 99999999999533221 11245889999999999999999999988 9999999999999999999999998
Q ss_pred cceecCCCCcc-----cccccccccccccCcccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhh
Q 041702 668 IARTFGGDEMQ-----SNTNRIVGTYGYMSPEYALH--GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWN 740 (840)
Q Consensus 668 la~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~ 740 (840)
.+......... .......++..|+|||++.+ ..++.++|||||||+++||++|+.||................
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 226 (327)
T cd08227 147 SNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT 226 (327)
T ss_pred hhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCC
Confidence 75443211110 01122356778999999876 468999999999999999999999986432211100000000
Q ss_pred hh---c-----c-----cccccccCc-----------------cccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 741 LW---K-----D-----DKAWKLMDP-----------------TMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 741 ~~---~-----~-----~~~~~~~d~-----------------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.. . . .......+. .............+.+++.+||+.||++|||++||++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 227 VPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred ccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00 0 0 000000000 0000111233456889999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=292.52 Aligned_cols=243 Identities=25% Similarity=0.374 Sum_probs=181.6
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEeecCCceE
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKI 599 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~ 599 (840)
+.||+|+||.||+|.++.. ..........||+|.+........++|.+|+.+++.++||||+++++++..++..+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~-----~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREV-----GDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESI 75 (258)
T ss_pred CCCCcccchhheeeeeccc-----ccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcE
Confidence 3699999999999976410 00011234569999987655555678999999999999999999999999999999
Q ss_pred EEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCC--------ceeecc
Q 041702 600 SIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMN--------PKISDF 666 (840)
Q Consensus 600 lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~--------~kL~DF 666 (840)
+||||...... .....+++..+++++.||+.||+|||+.+ |+||||||+||+++.++. +|++||
T Consensus 76 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred EEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccc
Confidence 99999533321 12335889999999999999999999988 999999999999988775 589999
Q ss_pred ccceecCCCCcccccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCC-CCCCCCCCCCccHhHHHhhhhcc
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSK-KNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~-~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
|++..... .....++..|+|||.+.+ ..++.++||||||++++||++|. .|+...... ... .....
T Consensus 153 g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~--~~~----~~~~~ 220 (258)
T cd05078 153 GISITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ--KKL----QFYED 220 (258)
T ss_pred ccccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH--HHH----HHHHc
Confidence 98865432 223457889999999886 45899999999999999999995 443321111 000 00000
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLK 793 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le 793 (840)
. ..+. ......+.+++.+||+.+|++|||++++++.|+
T Consensus 221 --~-----~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 --R-----HQLP----APKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred --c-----ccCC----CCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 0111 112245789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=291.46 Aligned_cols=247 Identities=20% Similarity=0.252 Sum_probs=180.8
Q ss_pred cccCCCCccEEEeecceeehh------------ccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccce
Q 041702 521 KLGEGGFGPVYKSIERYVEIC------------NWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRL 588 (840)
Q Consensus 521 ~lG~G~~G~Vy~a~~~~~~~~------------~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l 588 (840)
.||+|+||.||+|........ ............||+|++........++|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 699999999999875321100 00000112234699999876544445678999999999999999999
Q ss_pred eeEeecCCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCC----
Q 041702 589 FGCCIEQGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDM---- 659 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~---- 659 (840)
+++|.+....++||||...... .....+++..+++++.||++||+|||+.+ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcccC
Confidence 9999999999999999533221 12456889999999999999999999987 99999999999997654
Q ss_pred ---CceeeccccceecCCCCcccccccccccccccCcccccc-CCCCccccchhHHHHHHHHH-hCCCCCCCCCCCCccH
Q 041702 660 ---NPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEIL-SSKKNTRFYNTDSLTL 734 (840)
Q Consensus 660 ---~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~ell-tG~~p~~~~~~~~~~~ 734 (840)
.+||+|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+........
T Consensus 159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-- 230 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK-- 230 (274)
T ss_pred ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH--
Confidence 3799999998653221 12346788999998875 56899999999999999995 68888754322111
Q ss_pred hHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 041702 735 LGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLK 793 (840)
Q Consensus 735 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le 793 (840)
. ...... ..... .....+.+++.+||+.+|++||++.+|++.|.
T Consensus 231 ~----~~~~~~-------~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 E----RFYEKK-------HRLPE----PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred H----HHHHhc-------cCCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 0 000000 00111 11235788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=310.03 Aligned_cols=199 Identities=25% Similarity=0.335 Sum_probs=167.4
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
++|+..+.||+|+||.||+|.++ .+++.||||+++.. .....+.+.+|+.++.+++||||+++++
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~------------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~ 68 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKK------------DTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFY 68 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEEC------------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 46888999999999999999765 57889999999743 2334567889999999999999999999
Q ss_pred EeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 591 CCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
.+.+.+..++||||..... ......+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 69 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~Df 145 (360)
T cd05627 69 SFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDF 145 (360)
T ss_pred EEEcCCEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeec
Confidence 9999999999999953322 223456889999999999999999999998 999999999999999999999999
Q ss_pred ccceecCCCCcc---------------------------------cccccccccccccCccccccCCCCccccchhHHHH
Q 041702 667 GIARTFGGDEMQ---------------------------------SNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVL 713 (840)
Q Consensus 667 Gla~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGvi 713 (840)
|++..+...... ......+||+.|+|||++.+..++.++|||||||+
T Consensus 146 G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvi 225 (360)
T cd05627 146 GLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVI 225 (360)
T ss_pred cCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccce
Confidence 998754321100 01123579999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCC
Q 041702 714 LLEILSSKKNTRFY 727 (840)
Q Consensus 714 L~elltG~~p~~~~ 727 (840)
++||++|+.||...
T Consensus 226 lyel~tG~~Pf~~~ 239 (360)
T cd05627 226 MYEMLIGYPPFCSE 239 (360)
T ss_pred eeecccCCCCCCCC
Confidence 99999999998643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=306.35 Aligned_cols=253 Identities=26% Similarity=0.326 Sum_probs=196.7
Q ss_pred ccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC-CCcCHHHHHHHHHHHhhcCCCCccceeeEeecCC
Q 041702 518 EENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK-SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQG 596 (840)
Q Consensus 518 ~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~-~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~ 596 (840)
..++||+|+||+||||.+. +....-.-+||||++... ..+.-++|.+|+.+|.+++||||+||+|+|....
T Consensus 700 k~kvLGsgAfGtV~kGiw~--------Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~ 771 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWI--------PEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST 771 (1177)
T ss_pred hhceeccccceeEEeeeEe--------cCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch
Confidence 3468999999999998654 111112347999998765 3455688999999999999999999999998876
Q ss_pred ceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccccee
Q 041702 597 EKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 597 ~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
..+|.+++..... ..+..+.-+..+.+..|||+||.|||.+. ++||||..+|||+.+-..+||.|||+|+.
T Consensus 772 -~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~l 847 (1177)
T KOG1025|consen 772 -LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKL 847 (1177)
T ss_pred -HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhc
Confidence 6666676543322 24556778888999999999999999887 99999999999999999999999999999
Q ss_pred cCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhcccccccc
Q 041702 672 FGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKDDKAWKL 750 (840)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (840)
+..+..........-.+.|||-|.+....|+.++|||||||++||++| |..|+.....++. ...++.+
T Consensus 848 l~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI------~dlle~g----- 916 (1177)
T KOG1025|consen 848 LAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI------PDLLEKG----- 916 (1177)
T ss_pred cCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh------hHHHhcc-----
Confidence 877666555544455679999999999999999999999999999998 7777654432221 1111211
Q ss_pred cCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 751 MDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 751 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
.+-..++.....+..++.+||..|+..||+++++...+.+...
T Consensus 917 ----eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 917 ----ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred ----ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 1122233344567888899999999999999999988877643
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=289.98 Aligned_cols=249 Identities=24% Similarity=0.392 Sum_probs=191.3
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC----------CcCHHHHHHHHHHHhh-cCCC
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS----------GQGLEEFKNEMMLIAK-LQHR 583 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~----------~~~~~~f~~Ev~~l~~-l~H~ 583 (840)
+|+..+.||+|+||.||+|.+. ...++.+|+|.+.... .....++.+|+.++.+ ++||
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~-----------~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~ 69 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKK-----------NNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHP 69 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEc-----------CCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCC
Confidence 4777889999999999999765 1256889999886321 2234567889998875 6999
Q ss_pred CccceeeEeecCCceEEEEEeeccCCc--------cccCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceecCCCCCCcEE
Q 041702 584 NLVRLFGCCIEQGEKISIYEFDIVTDP--------ARKDLLDWTTRVRIIEGVAQGLLYLHQ-YSRLRVIHRDLKASNVL 654 (840)
Q Consensus 584 niv~l~g~~~~~~~~~lv~e~~~~~~~--------~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivHrDlkp~NIL 654 (840)
||+++++++.+.+..+++|||...... .....+++..+++++.|++.||.|||+ .+ ++|+||||+||+
T Consensus 70 ~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil 146 (269)
T cd08528 70 NIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIM 146 (269)
T ss_pred CeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEE
Confidence 999999999999999999998432111 234568889999999999999999996 45 999999999999
Q ss_pred ecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccH
Q 041702 655 LDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTL 734 (840)
Q Consensus 655 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~ 734 (840)
++.++.+||+|||++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+..... ...
T Consensus 147 ~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~--~~~ 221 (269)
T cd08528 147 LGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM--LSL 221 (269)
T ss_pred ECCCCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH--HHH
Confidence 9999999999999998754332 22345688899999999998899999999999999999999998743211 111
Q ss_pred hHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 041702 735 LGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794 (840)
Q Consensus 735 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~ 794 (840)
. .. ....... +. ........+.+++.+||+.||++||++.||.++|++
T Consensus 222 ~---~~-~~~~~~~----~~----~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 222 A---TK-IVEAVYE----PL----PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred H---HH-HhhccCC----cC----CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 1 00 0111100 10 011223557889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=287.63 Aligned_cols=244 Identities=25% Similarity=0.373 Sum_probs=180.4
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEeecCCceE
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKI 599 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~ 599 (840)
+.||+|+||.||+|.++..... ..........|++|.+...... ...|.+|+.++++++||||+++++++.. +..+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~--~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDL--DIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCc--cccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 3699999999999976511000 0000112246888887655333 6889999999999999999999999988 7889
Q ss_pred EEEEeeccCCcc----c-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCC-------Cceeeccc
Q 041702 600 SIYEFDIVTDPA----R-KDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDM-------NPKISDFG 667 (840)
Q Consensus 600 lv~e~~~~~~~~----~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-------~~kL~DFG 667 (840)
+++||....... . ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 999995332211 1 226889999999999999999999988 99999999999999888 79999999
Q ss_pred cceecCCCCcccccccccccccccCccccccC--CCCccccchhHHHHHHHHHhC-CCCCCCCCCCCccHhHHHhhhhcc
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALHG--LFSIKSDVFSFGVLLLEILSS-KKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDV~SlGviL~elltG-~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
++..... .....++..|+|||++.+. .++.++||||||++++||++| ..|+........ . .....
T Consensus 154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~--~----~~~~~ 221 (259)
T cd05037 154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK--E----RFYQD 221 (259)
T ss_pred ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH--H----HHHhc
Confidence 9986533 1224466789999998876 789999999999999999995 555543321110 0 00000
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLK 793 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le 793 (840)
.. ....+ ....+.+++.+||+.+|.+||++.+|++.|+
T Consensus 222 ~~--~~~~~---------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 222 QH--RLPMP---------DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CC--CCCCC---------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 00000 0156889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=295.05 Aligned_cols=259 Identities=22% Similarity=0.289 Sum_probs=195.5
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC--CCcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK--SGQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
++|+..++||+|++|.||+|.++ .+++.||||+++.. .....+.+.+|++++++++|+||++++++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~------------~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 68 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNK------------ATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeC------------CCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhhe
Confidence 36888899999999999999765 56889999998754 23345789999999999999999999999
Q ss_pred eecCCceEEEEEeeccCCc----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 592 CIEQGEKISIYEFDIVTDP----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
+..++..++++||...... .....+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||
T Consensus 69 ~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g 145 (288)
T cd07833 69 FRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFG 145 (288)
T ss_pred EEECCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeee
Confidence 9999999999999532211 12345889999999999999999999988 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhh-----
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNL----- 741 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~----- 741 (840)
++........ .......++..|+|||++.+. .++.++||||||++++||++|+.|+......+ ........
T Consensus 146 ~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~ 222 (288)
T cd07833 146 FARALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID--QLYLIQKCLGPLP 222 (288)
T ss_pred cccccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCC
Confidence 9987654332 122335678899999999888 88999999999999999999998876432211 00000000
Q ss_pred ------hcc-cccc--cccCccccc----hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 742 ------WKD-DKAW--KLMDPTMQN----EALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 742 ------~~~-~~~~--~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
+.. .... +..+..... .........+.+++.+||+.+|++||+++++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 223 PSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred HHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000 0000 000000000 011123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=293.91 Aligned_cols=261 Identities=23% Similarity=0.273 Sum_probs=190.9
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcCCCCccceee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
++++|...+.||+|+||.||+|.++ .+++.||+|++..... .....+.+|+.++++++|+||+++++
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~------------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~ 70 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISR------------INGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHD 70 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEc------------CCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEE
Confidence 4578999999999999999998755 5688999999975432 33456889999999999999999999
Q ss_pred EeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 591 CCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
++...+..++++||..... ......+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++++||+||
T Consensus 71 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Df 147 (291)
T cd07870 71 IIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADF 147 (291)
T ss_pred EEecCCeEEEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEecc
Confidence 9999999999999853211 111245678888899999999999999988 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcc-
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD- 744 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~- 744 (840)
|+++...... .......+++.|+|||.+.+. .++.++||||||++++||++|+.|+....... ......+.....
T Consensus 148 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~ 224 (291)
T cd07870 148 GLARAKSIPS--QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF-EQLEKIWTVLGVP 224 (291)
T ss_pred ccccccCCCC--CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH-HHHHHHHHHcCCC
Confidence 9997643221 112234578899999998764 57899999999999999999999986433211 111111110000
Q ss_pred -----------ccc-ccccCccccchh-----hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 745 -----------DKA-WKLMDPTMQNEA-----LYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 745 -----------~~~-~~~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.+. ............ .......+.+++.+|++.||++|||+.|++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 225 TEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000 000000000000 0011345778999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=297.23 Aligned_cols=244 Identities=25% Similarity=0.358 Sum_probs=191.0
Q ss_pred ccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEeecCCc
Q 041702 518 EENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGE 597 (840)
Q Consensus 518 ~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~ 597 (840)
...+||+|+||.||+|.+. .+++.||+|++........+.+.+|+.++..++||||+++++++..++.
T Consensus 25 ~~~~ig~g~~g~v~~~~~~------------~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~ 92 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREK------------HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEE 92 (297)
T ss_pred hhhhcCCCCceeEEEEEEc------------CCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCe
Confidence 3457999999999998654 5788999999976555556789999999999999999999999999999
Q ss_pred eEEEEEeeccCC---ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceecCC
Q 041702 598 KISIYEFDIVTD---PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGG 674 (840)
Q Consensus 598 ~~lv~e~~~~~~---~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 674 (840)
.++++||..... ......+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++..+..
T Consensus 93 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~ 169 (297)
T cd06659 93 LWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 169 (297)
T ss_pred EEEEEecCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccc
Confidence 999999843221 223356889999999999999999999988 99999999999999999999999999876543
Q ss_pred CCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccccccCcc
Q 041702 675 DEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPT 754 (840)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 754 (840)
... ......++..|+|||++.+..++.++|||||||+++||++|+.|+...... .... ....... +.
T Consensus 170 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~----~~~~~~~-----~~ 236 (297)
T cd06659 170 DVP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--QAMK----RLRDSPP-----PK 236 (297)
T ss_pred ccc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHH----HHhccCC-----CC
Confidence 221 123356889999999999889999999999999999999999997532211 1110 1111100 00
Q ss_pred ccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 755 MQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 755 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
. .........+.+++.+||+.+|++||++++|++.
T Consensus 237 ~--~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 237 L--KNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred c--cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0 0011223457789999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=287.35 Aligned_cols=247 Identities=28% Similarity=0.437 Sum_probs=190.8
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCI 593 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~ 593 (840)
.+|+..+.||+|+||.||+|.+. ++..+|+|.+... .....+|.+|++++++++|||++++++++.
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-------------~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 69 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-------------EKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-------------CCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 46777889999999999998542 4678999998754 234568999999999999999999999999
Q ss_pred cCCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccc
Q 041702 594 EQGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGI 668 (840)
Q Consensus 594 ~~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl 668 (840)
.....++++||...... .....+++..+..++.+++.||+|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 70 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~ 146 (256)
T cd05112 70 ERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGM 146 (256)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcc
Confidence 99999999998432221 11245789999999999999999999988 99999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhccccc
Q 041702 669 ARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKDDKA 747 (840)
Q Consensus 669 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 747 (840)
+......... ......++.+|+|||.+.+..++.++||||||++++||++ |+.|+..... ..... .. .. .
T Consensus 147 ~~~~~~~~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--~~~~~---~~-~~--~ 217 (256)
T cd05112 147 TRFVLDDQYT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN--SEVVE---TI-NA--G 217 (256)
T ss_pred eeecccCccc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH--HHHHH---HH-hC--C
Confidence 9865432211 1112234678999999998899999999999999999998 8888753221 11111 11 10 0
Q ss_pred ccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 041702 748 WKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLK 793 (840)
Q Consensus 748 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le 793 (840)
.....+.. ....+.+++.+||+.+|++||++.+|++.|.
T Consensus 218 ~~~~~~~~-------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 218 FRLYKPRL-------ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCCCCCCC-------CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 11112222 2356889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=287.53 Aligned_cols=245 Identities=22% Similarity=0.343 Sum_probs=194.0
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC--CCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK--SGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
+|+..+.||+|+||.||.+.+. .+++.+++|++... .....+++.+|++++++++|+||+++++++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~------------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 68 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRT------------EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHF 68 (256)
T ss_pred CceEeeEecccCCceEEEEEEc------------CCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEE
Confidence 5788899999999999998654 67889999998654 234567799999999999999999999999
Q ss_pred ecCCceEEEEEeeccCCc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 593 IEQGEKISIYEFDIVTDP------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
.+.+..+++|||...... .....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+||
T Consensus 69 ~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~ 145 (256)
T cd08221 69 MDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDF 145 (256)
T ss_pred ecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcC
Confidence 999999999999532211 11345789999999999999999999988 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccc
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDK 746 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 746 (840)
|++........ ......+++.|+|||.+.+..++.++||||||++++||++|+.|+...... . ..... ....
T Consensus 146 ~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~--~---~~~~~-~~~~ 217 (256)
T cd08221 146 GISKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL--N---LVVKI-VQGN 217 (256)
T ss_pred cceEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH--H---HHHHH-HcCC
Confidence 99987643331 223456899999999998888999999999999999999999987542211 1 11111 1111
Q ss_pred cccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 747 AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 747 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
.. .........+.+++.+||+.+|++||+++++++.
T Consensus 218 ~~---------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 218 YT---------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CC---------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 10 1112234567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=291.71 Aligned_cols=256 Identities=28% Similarity=0.379 Sum_probs=194.4
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCc-CHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQ-GLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~-~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
++|+....||+|+||.||+|+.+.. ....+.+.|++|.+...... ..++|.+|++++++++|+||+++++++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~-------~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 77 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGI-------EEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC 77 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccC-------CcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEE
Confidence 5788889999999999999976411 12235678999998754333 457899999999999999999999999
Q ss_pred ecCCceEEEEEeeccCCcc----c---------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCC
Q 041702 593 IEQGEKISIYEFDIVTDPA----R---------KDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDM 659 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~~~----~---------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~ 659 (840)
.+.+..+++|||....... . ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~ 154 (275)
T cd05046 78 REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQR 154 (275)
T ss_pred CCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCC
Confidence 9999999999994322111 1 125899999999999999999999988 99999999999999999
Q ss_pred CceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHH
Q 041702 660 NPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHA 738 (840)
Q Consensus 660 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~ 738 (840)
.+||+|||++........ .......++..|+|||.+.+...+.++||||||++++||++ |..|+..... .....
T Consensus 155 ~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~--~~~~~-- 229 (275)
T cd05046 155 EVKVSLLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD--EEVLN-- 229 (275)
T ss_pred cEEEcccccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch--HHHHH--
Confidence 999999999875432221 12233456778999999988889999999999999999999 6767643221 11111
Q ss_pred hhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 041702 739 WNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794 (840)
Q Consensus 739 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~ 794 (840)
........ . ......+..+.+++.+||+.+|++||++.|+++.|.+
T Consensus 230 --~~~~~~~~-~-------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 230 --RLQAGKLE-L-------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred --HHHcCCcC-C-------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 11111110 0 0011233468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=288.09 Aligned_cols=245 Identities=23% Similarity=0.334 Sum_probs=190.7
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
+|+..+.||+|++|.||++.++ .+++.||+|++.... ....+.+.+|++++++++|+|++++++.+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~------------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 68 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHR------------TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESW 68 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEc------------CCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeee
Confidence 4788899999999999999755 567899999986542 34456789999999999999999999987
Q ss_pred ecC-CceEEEEEeeccCCc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 593 IEQ-GEKISIYEFDIVTDP------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 593 ~~~-~~~~lv~e~~~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
... ...+++||+...... .....+++.++..++.+++.||+|||+.+ ++||||||+||+++.++.++|+|
T Consensus 69 ~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~d 145 (257)
T cd08223 69 EGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGD 145 (257)
T ss_pred cCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEec
Confidence 644 457899998432211 12346899999999999999999999998 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
||++....... .......+++.|+|||.+.+..++.++||||||++++||++|+.|+..... ........ ..
T Consensus 146 f~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-----~~~~~~~~-~~ 217 (257)
T cd08223 146 LGIARVLENQC--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-----NSLVYRII-EG 217 (257)
T ss_pred ccceEEecccC--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHH-hc
Confidence 99998764322 122345678899999999999999999999999999999999998753221 11111111 11
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
.. ..........+.+++.+|++.+|++||++.++++.
T Consensus 218 ~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 218 KL---------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CC---------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 10 11112344568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=292.26 Aligned_cols=256 Identities=23% Similarity=0.376 Sum_probs=194.4
Q ss_pred CHHHHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhc-CCC
Q 041702 505 SLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL-QHR 583 (840)
Q Consensus 505 ~~~~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l-~H~ 583 (840)
.+..+..+.++|+..+.||+|+||.||+|.+. .+++.+|+|++.... ....++.+|+.++.++ +||
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~------------~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~ 75 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNK------------KNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHP 75 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEEC------------CCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCC
Confidence 34556678899999999999999999999765 568899999986532 2346788999999999 699
Q ss_pred CccceeeEee-----cCCceEEEEEeeccCCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCC
Q 041702 584 NLVRLFGCCI-----EQGEKISIYEFDIVTDP--------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKA 650 (840)
Q Consensus 584 niv~l~g~~~-----~~~~~~lv~e~~~~~~~--------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp 650 (840)
||+++++++. .++..+++|||...... .....+++..+..++.|++.||.|||+.+ |+||||||
T Consensus 76 ~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp 152 (286)
T cd06638 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKG 152 (286)
T ss_pred CeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCH
Confidence 9999999984 34568999999532221 23356788899999999999999999987 99999999
Q ss_pred CcEEecCCCCceeeccccceecCCCCcccccccccccccccCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCC
Q 041702 651 SNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYAL-----HGLFSIKSDVFSFGVLLLEILSSKKNTR 725 (840)
Q Consensus 651 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~SlGviL~elltG~~p~~ 725 (840)
+||+++.++.+||+|||+++....... ......|++.|+|||++. +..++.++|||||||+++||++|+.|+.
T Consensus 153 ~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~ 230 (286)
T cd06638 153 NNILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA 230 (286)
T ss_pred HhEEECCCCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCC
Confidence 999999999999999999987643221 223346889999999875 3457899999999999999999999975
Q ss_pred CCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 726 FYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
....... .... .........++. .....+.+++.+||+.+|++|||+.||++.
T Consensus 231 ~~~~~~~-----~~~~-~~~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 231 DLHPMRA-----LFKI-PRNPPPTLHQPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred CCchhHH-----Hhhc-cccCCCcccCCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 4321110 0000 000000111111 123457889999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=285.50 Aligned_cols=249 Identities=23% Similarity=0.350 Sum_probs=179.1
Q ss_pred cccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceeeEeecCCceE
Q 041702 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKI 599 (840)
Q Consensus 521 ~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~ 599 (840)
+||+|+||.||+|... .......+++|.+.... ....+.|.+|+.+++.++||||++++++|......+
T Consensus 2 ~lg~G~~g~v~~~~~~----------~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 71 (268)
T cd05086 2 EIGNGWFGKVLLSEIY----------TDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYL 71 (268)
T ss_pred cCCCCcCceEEEEEEE----------cCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccE
Confidence 6999999999998532 01123457778776543 234578999999999999999999999999999999
Q ss_pred EEEEeeccCCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccccee
Q 041702 600 SIYEFDIVTDPA--------RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 600 lv~e~~~~~~~~--------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
++|||....... .....++.....++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||++..
T Consensus 72 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~ 148 (268)
T cd05086 72 LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPS 148 (268)
T ss_pred EEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccc
Confidence 999995322211 1234566777889999999999999987 99999999999999999999999999864
Q ss_pred cCCCCcccccccccccccccCcccccc-------CCCCccccchhHHHHHHHHHhC-CCCCCCCCCCCccHhHHHhhhhc
Q 041702 672 FGGDEMQSNTNRIVGTYGYMSPEYALH-------GLFSIKSDVFSFGVLLLEILSS-KKNTRFYNTDSLTLLGHAWNLWK 743 (840)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDV~SlGviL~elltG-~~p~~~~~~~~~~~~~~~~~~~~ 743 (840)
..............++..|+|||++.. ..++.++||||||++++||+++ ..|+.... ....... ..
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~--~~~~~~~---~~- 222 (268)
T cd05086 149 RYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS--DREVLNH---VI- 222 (268)
T ss_pred cCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC--HHHHHHH---HH-
Confidence 322221122234567889999998743 3457899999999999999975 55553221 1111111 11
Q ss_pred ccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 041702 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLK 793 (840)
Q Consensus 744 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le 793 (840)
.+....+.++.+... ....+.+++..|| .+|++||++++|++.|-
T Consensus 223 ~~~~~~~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 223 KDQQVKLFKPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred hhcccccCCCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 122223334433322 2345677888899 57999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=292.41 Aligned_cols=249 Identities=26% Similarity=0.397 Sum_probs=193.4
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
.++|++.++||+|+||.||+|.++ .+++.||+|.+........+.|.+|++++++++||||+++++++
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~------------~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 71 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHK------------ETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY 71 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEc------------CCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEE
Confidence 467889999999999999999754 47889999999766555667899999999999999999999999
Q ss_pred ecCCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 593 IEQGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
...+..+++|||...... .....+++.....++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g 148 (280)
T cd06611 72 FYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFG 148 (280)
T ss_pred ecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCc
Confidence 999999999999433221 11346899999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhh
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYAL-----HGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLW 742 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~ 742 (840)
++....... .......+++.|+|||.+. ...++.++||||||+++|||++|+.|+...... ... ...
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--~~~---~~~- 220 (280)
T cd06611 149 VSAKNKSTL--QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--RVL---LKI- 220 (280)
T ss_pred cchhhcccc--cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--HHH---HHH-
Confidence 987653221 1223356889999999874 345788999999999999999999997543211 111 011
Q ss_pred cccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 743 KDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 743 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
.... .+.+. ........+.+++.+||+.+|++||++.+|++.
T Consensus 221 ~~~~-----~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 221 LKSE-----PPTLD--QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred hcCC-----CCCcC--CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 1100 01110 011223457789999999999999999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-32 Score=298.12 Aligned_cols=249 Identities=25% Similarity=0.332 Sum_probs=201.5
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC---cCHHHHHHHHHHHhhcC-CCCccc
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG---QGLEEFKNEMMLIAKLQ-HRNLVR 587 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~---~~~~~f~~Ev~~l~~l~-H~niv~ 587 (840)
....|...+.||+|.||.||+++++ .+|+.+|+|.+.+... ...+.+.+|+.+|+++. |||||.
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~------------~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~ 100 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREK------------STGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQ 100 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEec------------CCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEE
Confidence 4567888899999999999999776 5699999999986543 24468999999999998 999999
Q ss_pred eeeEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCC----C
Q 041702 588 LFGCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSD----M 659 (840)
Q Consensus 588 l~g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~----~ 659 (840)
+.+.+......++|||+..-.. .... .+++.....++.||+.++.|||+.+ |+||||||+|+|+... +
T Consensus 101 l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~ 176 (382)
T KOG0032|consen 101 LKDAFEDPDSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSG 176 (382)
T ss_pred EEEEEEcCCeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCC
Confidence 9999999999999999942111 1111 3889999999999999999999988 9999999999999543 4
Q ss_pred CceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHh
Q 041702 660 NPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAW 739 (840)
Q Consensus 660 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~ 739 (840)
.+|++|||+|..... .......+||+.|+|||++...+|+.++||||+||++|.|++|.+||..........
T Consensus 177 ~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~----- 248 (382)
T KOG0032|consen 177 RIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL----- 248 (382)
T ss_pred cEEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-----
Confidence 799999999998765 234556899999999999999999999999999999999999999987554333221
Q ss_pred hhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 740 NLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 740 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
.. ... +.....+.-......+.+++..++..||..|+|+.++++.
T Consensus 249 ~i-~~~------~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 249 AI-LRG------DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HH-HcC------CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 00 011 1122233334456678889999999999999999999983
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=286.81 Aligned_cols=241 Identities=27% Similarity=0.404 Sum_probs=187.4
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCI 593 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~ 593 (840)
++|++.+.||+|+||.||++. ..++.||+|.++.. ...+.+.+|+.++.+++|||++++++++.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--------------~~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 69 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--------------YTGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVIL 69 (254)
T ss_pred HHceeeeeeccCCCCceEecc--------------cCCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEc
Confidence 457888999999999999863 35788999998653 23467999999999999999999999987
Q ss_pred cCCceEEEEEeeccCCc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 594 EQGEKISIYEFDIVTDP------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 594 ~~~~~~lv~e~~~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
.. ..+++|||...... .....+++..+++++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 70 ~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg 145 (254)
T cd05083 70 HN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFG 145 (254)
T ss_pred CC-CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCc
Confidence 65 47899998433221 12235789999999999999999999988 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhcccc
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKDDK 746 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 746 (840)
++...... ......+..|+|||.+.+..++.++||||||++++||++ |+.|+....... .. ......
T Consensus 146 ~~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~----~~~~~~- 213 (254)
T cd05083 146 LARVGSMG-----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE--VK----ECVEKG- 213 (254)
T ss_pred cceecccc-----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH--HH----HHHhCC-
Confidence 98764321 112234568999999998899999999999999999998 888875432111 11 111110
Q ss_pred cccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 041702 747 AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794 (840)
Q Consensus 747 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~ 794 (840)
.........+..+.+++.+||+.+|++||++++|++.|++
T Consensus 214 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 214 --------YRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred --------CCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 0011112234567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-32 Score=292.00 Aligned_cols=257 Identities=24% Similarity=0.374 Sum_probs=195.8
Q ss_pred cCHHHHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhc-CC
Q 041702 504 FSLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL-QH 582 (840)
Q Consensus 504 ~~~~~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l-~H 582 (840)
+.+.++..+.++|...+.||+|+||.||+|.+. .+++.+|+|++.... ...+++.+|+.++.++ +|
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~------------~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h 78 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNK------------KDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNH 78 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEEC------------CCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCC
Confidence 455667778899999999999999999998654 578899999986542 2346788999999999 89
Q ss_pred CCccceeeEeecC-----CceEEEEEeeccCCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCC
Q 041702 583 RNLVRLFGCCIEQ-----GEKISIYEFDIVTDP--------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLK 649 (840)
Q Consensus 583 ~niv~l~g~~~~~-----~~~~lv~e~~~~~~~--------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk 649 (840)
||++++++++... +..++++||...... .....+++..++.++.|++.||+|||+.+ ++|||||
T Consensus 79 ~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlk 155 (291)
T cd06639 79 PNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVK 155 (291)
T ss_pred CCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCC
Confidence 9999999998754 358999999532211 23456899999999999999999999987 9999999
Q ss_pred CCcEEecCCCCceeeccccceecCCCCcccccccccccccccCccccccC-----CCCccccchhHHHHHHHHHhCCCCC
Q 041702 650 ASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHG-----LFSIKSDVFSFGVLLLEILSSKKNT 724 (840)
Q Consensus 650 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDV~SlGviL~elltG~~p~ 724 (840)
|+||+++.++.+||+|||++........ ......++..|+|||.+... .++.++|||||||+++||++|+.|+
T Consensus 156 p~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~ 233 (291)
T cd06639 156 GNNILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233 (291)
T ss_pred HHHEEEcCCCCEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCC
Confidence 9999999999999999999886543221 12234678899999987543 3689999999999999999999997
Q ss_pred CCCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 725 RFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
....... ..... .......+.+ .......+.+++.+||+.+|++||++.|+++.
T Consensus 234 ~~~~~~~-----~~~~~-~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 234 FDMHPVK-----TLFKI-PRNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCCcHHH-----HHHHH-hcCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 5432111 01111 0011111111 11223458899999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=296.36 Aligned_cols=247 Identities=23% Similarity=0.350 Sum_probs=191.8
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEeec
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIE 594 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~ 594 (840)
.|.....||+|+||.||++.+. .++..||||++........+.+.+|+.++++++|+||+++++.+..
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~ 90 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEK------------HTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLV 90 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEEC------------CCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheec
Confidence 3344467999999999998654 5688999999876555556779999999999999999999999999
Q ss_pred CCceEEEEEeeccCC---ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccccee
Q 041702 595 QGEKISIYEFDIVTD---PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 595 ~~~~~lv~e~~~~~~---~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
++..+++|||..... ......+++.++..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++..
T Consensus 91 ~~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (292)
T cd06658 91 GDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQ 167 (292)
T ss_pred CCeEEEEEeCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhh
Confidence 999999999953322 122346889999999999999999999988 99999999999999999999999999876
Q ss_pred cCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccccccccc
Q 041702 672 FGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLM 751 (840)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (840)
..... .......++..|+|||.+.+..++.++||||||++++||++|+.|+..... ..... ... ..+
T Consensus 168 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--~~~~~----~~~-----~~~ 234 (292)
T cd06658 168 VSKEV--PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP--LQAMR----RIR-----DNL 234 (292)
T ss_pred ccccc--ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHH----HHH-----hcC
Confidence 53222 122335688999999999888999999999999999999999999753221 11110 000 011
Q ss_pred CccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 752 DPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 752 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
.+.... .......+.+++.+|++.+|++|||++++++.
T Consensus 235 ~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 235 PPRVKD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred CCcccc--ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 111111 11233457788999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=292.07 Aligned_cols=256 Identities=23% Similarity=0.322 Sum_probs=188.6
Q ss_pred CcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceeeEee
Q 041702 516 FSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFGCCI 593 (840)
Q Consensus 516 f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~ 593 (840)
|+..++||.|++|.||+|.++ .+|..||+|++.... ....+.+.+|++++++++|||++++++++.
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~------------~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~ 68 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDK------------LTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH 68 (283)
T ss_pred CchheEecCCCCeEEEEEEEc------------CCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec
Confidence 566789999999999999764 578999999987543 233467899999999999999999999999
Q ss_pred cCCceEEEEEeeccCC---c--cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccc
Q 041702 594 EQGEKISIYEFDIVTD---P--ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGI 668 (840)
Q Consensus 594 ~~~~~~lv~e~~~~~~---~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl 668 (840)
+.+..++++||..... . .....+++..+++++.|+++||+|||+.+ ++||||+|+||+++.++.+||+|||+
T Consensus 69 ~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~ 145 (283)
T cd07835 69 SENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGL 145 (283)
T ss_pred cCCeEEEEEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeeccc
Confidence 9999999999942110 1 11136899999999999999999999987 99999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhc-c--
Q 041702 669 ARTFGGDEMQSNTNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWK-D-- 744 (840)
Q Consensus 669 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~-~-- 744 (840)
++...... .......++..|+|||++.+. .++.++||||||++++||++|+.|+........ .. ....... .
T Consensus 146 ~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~-~~~~~~~~~~~ 221 (283)
T cd07835 146 ARAFGVPV--RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ-LF-RIFRTLGTPDE 221 (283)
T ss_pred ccccCCCc--cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HH-HHHHHhCCCCh
Confidence 97653221 111233568899999987664 578999999999999999999999864322110 00 0000000 0
Q ss_pred ---------ccccccc---CccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 745 ---------DKAWKLM---DPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 745 ---------~~~~~~~---d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.+..... ...............+.+++.+||+.+|++|||++|+++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 222 DVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred HHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000 000000111223356889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=291.01 Aligned_cols=246 Identities=23% Similarity=0.357 Sum_probs=186.4
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHH-HhhcCCCCccceeeE
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMML-IAKLQHRNLVRLFGC 591 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~-l~~l~H~niv~l~g~ 591 (840)
++|+..+.||+|+||.||+|.++ .+|+.||+|+++... .....++..|+.+ ++.++||||++++++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~ 68 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHV------------PTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEc------------CCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEE
Confidence 46888899999999999999765 679999999987543 2334556667765 556689999999999
Q ss_pred eecCCceEEEEEeecc-------CCccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceecCCCCCCcEEecCCCCcee
Q 041702 592 CIEQGEKISIYEFDIV-------TDPARKDLLDWTTRVRIIEGVAQGLLYLHQY-SRLRVIHRDLKASNVLLDSDMNPKI 663 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~-------~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivHrDlkp~NILl~~~~~~kL 663 (840)
+...+..++++||... ........+++..+..++.||+.||+|||++ + ++||||||+||+++.++.+||
T Consensus 69 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl 145 (283)
T cd06617 69 LFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKL 145 (283)
T ss_pred EecCCcEEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEE
Confidence 9999999999998421 1112335689999999999999999999986 5 999999999999999999999
Q ss_pred eccccceecCCCCcccccccccccccccCcccccc----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHh
Q 041702 664 SDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH----GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAW 739 (840)
Q Consensus 664 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~ 739 (840)
+|||++..+.... ......++..|+|||.+.+ ..++.++|+||||++++||++|+.|+...... .. ...
T Consensus 146 ~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~---~~~ 218 (283)
T cd06617 146 CDFGISGYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQ---QLK 218 (283)
T ss_pred eeccccccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HH---HHH
Confidence 9999998653221 1123457889999998865 45689999999999999999999997532111 01 000
Q ss_pred hhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 740 NLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 740 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
... .. ..+.+.. ......+.+++.+||+.+|++||++++|++
T Consensus 219 ~~~-~~-----~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 219 QVV-EE-----PSPQLPA---EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred HHH-hc-----CCCCCCc---cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 100 00 0111111 123456889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=289.80 Aligned_cols=252 Identities=24% Similarity=0.368 Sum_probs=190.1
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC----------cCHHHHHHHHHHHhhcCCCC
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG----------QGLEEFKNEMMLIAKLQHRN 584 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~----------~~~~~f~~Ev~~l~~l~H~n 584 (840)
+|...+.||+|+||.||+|.+. .+++.||+|.++.... ...+.+.+|+.++.+++|||
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~------------~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 69 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNV------------TTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLN 69 (272)
T ss_pred ceeecceecccCceEEEEEeec------------CCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCC
Confidence 4667789999999999998654 5788999998864211 11346889999999999999
Q ss_pred ccceeeEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCC
Q 041702 585 LVRLFGCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMN 660 (840)
Q Consensus 585 iv~l~g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~ 660 (840)
++++++++...+..++|+||..... ......+++..+..++.||+.||.|||+.+ ++||||+|+||+++.++.
T Consensus 70 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~ 146 (272)
T cd06629 70 IVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGI 146 (272)
T ss_pred cceEEEEeccCCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCe
Confidence 9999999999999999999843222 122356889999999999999999999987 999999999999999999
Q ss_pred ceeeccccceecCCCCcccccccccccccccCccccccCC--CCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHH
Q 041702 661 PKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGL--FSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHA 738 (840)
Q Consensus 661 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~ 738 (840)
+||+|||+++...............++..|+|||.+.... ++.++||||||++++|+++|+.|+..... . ...
T Consensus 147 ~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--~---~~~ 221 (272)
T cd06629 147 CKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA--I---AAM 221 (272)
T ss_pred EEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch--H---HHH
Confidence 9999999997654322222223456788999999987654 89999999999999999999999742111 1 111
Q ss_pred hhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 739 WNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 739 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
....... . .+.............+.+++.+||+.+|++||++++|++.
T Consensus 222 ~~~~~~~-~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 222 FKLGNKR-S----APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred HHhhccc-c----CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 1111110 0 1111111122345678889999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=301.82 Aligned_cols=267 Identities=22% Similarity=0.307 Sum_probs=194.9
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
+++|++.++||+|+||.||+|.+. .+++.||||++.... .....++.+|+.++++++||||++++++
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 71 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHK------------PTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDI 71 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEc------------CCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhhe
Confidence 578999999999999999999765 678999999987532 2345678899999999999999999998
Q ss_pred eecCC-----ceEEEEEeeccC--CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 592 CIEQG-----EKISIYEFDIVT--DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 592 ~~~~~-----~~~lv~e~~~~~--~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
+.... ..++++|+.... .......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+
T Consensus 72 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~ 148 (336)
T cd07849 72 IRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKIC 148 (336)
T ss_pred eecccccccceEEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEC
Confidence 76543 578889884321 1123346889999999999999999999988 9999999999999999999999
Q ss_pred ccccceecCCCCccc-ccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhh
Q 041702 665 DFGIARTFGGDEMQS-NTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLW 742 (840)
Q Consensus 665 DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~ 742 (840)
|||++.......... ......++..|+|||.+.+ ..++.++|||||||+++||++|+.|+...... ..........
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~--~~~~~~~~~~ 226 (336)
T cd07849 149 DFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL--HQLNLILGVL 226 (336)
T ss_pred cccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHc
Confidence 999998764322111 1233568899999998754 56899999999999999999999998543211 1000000000
Q ss_pred cc---cccccccC-------------cccc-chhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhccc
Q 041702 743 KD---DKAWKLMD-------------PTMQ-NEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM--LKDEI 796 (840)
Q Consensus 743 ~~---~~~~~~~d-------------~~l~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--Le~~~ 796 (840)
.. +....+.+ +... ..........+.+++.+||+.+|++|||+.|+++. ++...
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 227 GTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred CCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 00 00000000 0000 00111234568899999999999999999999976 66543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=286.92 Aligned_cols=250 Identities=33% Similarity=0.464 Sum_probs=190.7
Q ss_pred CcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCc-CHHHHHHHHHHHhhcCCCCccceeeEeec
Q 041702 516 FSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQ-GLEEFKNEMMLIAKLQHRNLVRLFGCCIE 594 (840)
Q Consensus 516 f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~-~~~~f~~Ev~~l~~l~H~niv~l~g~~~~ 594 (840)
|++.+.||.|+||.||++.+.. .....+..||+|++...... ..+.+.+|+.++.+++|+||+++++++.+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~--------~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 72 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKG--------LSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE 72 (258)
T ss_pred CcccceeccCCCcceEEEEecC--------CCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence 3456789999999999997651 00023588999999765433 56789999999999999999999999999
Q ss_pred CCceEEEEEeeccCCc----cccC-C-CCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccc
Q 041702 595 QGEKISIYEFDIVTDP----ARKD-L-LDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGI 668 (840)
Q Consensus 595 ~~~~~lv~e~~~~~~~----~~~~-~-l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl 668 (840)
.+..+++||+...... .... . +++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+
T Consensus 73 ~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~ 149 (258)
T smart00219 73 EEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGL 149 (258)
T ss_pred CCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCC
Confidence 9999999998433221 1111 2 899999999999999999999988 99999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhccccc
Q 041702 669 ARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKDDKA 747 (840)
Q Consensus 669 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 747 (840)
+............ ...+++.|+|||.+.+..++.++||||||++++||++ |+.|+..... ...... ......
T Consensus 150 ~~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--~~~~~~----~~~~~~ 222 (258)
T smart00219 150 SRDLYDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--EEVLEY----LKKGYR 222 (258)
T ss_pred ceecccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH----HhcCCC
Confidence 9876544222211 2336789999999988889999999999999999998 6777643211 111111 111110
Q ss_pred ccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 041702 748 WKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAML 792 (840)
Q Consensus 748 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 792 (840)
. .........+.+++.+|+..+|++|||+.|+++.|
T Consensus 223 ~---------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 L---------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred C---------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0 11112345688899999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.8e-32 Score=295.05 Aligned_cols=251 Identities=20% Similarity=0.259 Sum_probs=186.2
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
++|++.+.||+|+||.||++.++ .+++.||||++.+. .....+.|.+|+.++..++|+||+++++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~------------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~ 68 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMK------------NTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHY 68 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEEC------------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEE
Confidence 47888999999999999998755 57889999999742 2234566899999999999999999999
Q ss_pred EeecCCceEEEEEeeccCCc----c-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 591 CCIEQGEKISIYEFDIVTDP----A-RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~~----~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
++.+.+..++||||...... . ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 69 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~D 145 (331)
T cd05597 69 AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLAD 145 (331)
T ss_pred EEecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEE
Confidence 99999999999999432221 1 1346888899999999999999999998 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCcccccc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhh
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH-----GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWN 740 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~ 740 (840)
||++..+...... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||...... . ....
T Consensus 146 fg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~--~---~~~~ 219 (331)
T cd05597 146 FGSCLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV--E---TYGK 219 (331)
T ss_pred CCceeecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH--H---HHHH
Confidence 9999766433221 1223468999999999863 45788999999999999999999998532211 1 1111
Q ss_pred hhcccccccccCccccchhhHHHHHHHHHHHHHcccc--CCCCCCCHHHHHHH
Q 041702 741 LWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQE--NATDRPTMLEVVAM 791 (840)
Q Consensus 741 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~--dP~~RPs~~evl~~ 791 (840)
.........+ .+ ........+.+++.+|+.. ++..||+++++++.
T Consensus 220 i~~~~~~~~~-~~-----~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 220 IMNHKEHFQF-PP-----DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHcCCCcccC-CC-----ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 1111111111 00 0111334466677776644 44447898888865
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=292.38 Aligned_cols=246 Identities=22% Similarity=0.375 Sum_probs=189.7
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC-CCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK-SGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~-~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
++|+..+.||+|+||.||+|.+. .+++.||+|.+... .....+++.+|+.++.+++||||+++++++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~------------~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~ 68 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHR------------PTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEc------------CCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhe
Confidence 36788899999999999999754 57889999998754 223356799999999999999999999999
Q ss_pred ecCCceEEEEEeeccCCcc-------ccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceecCCCCCCcEEecCCCCceee
Q 041702 593 IEQGEKISIYEFDIVTDPA-------RKDLLDWTTRVRIIEGVAQGLLYLHQY-SRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
...+..++++||....... ....+++..+..++.+++.||.|||+. + |+||||||+||+++.++.+||+
T Consensus 69 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~ 145 (286)
T cd06622 69 FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLC 145 (286)
T ss_pred ecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEe
Confidence 9999999999995322211 123789999999999999999999974 5 9999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCccccccC------CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHH
Q 041702 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHG------LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHA 738 (840)
Q Consensus 665 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~ 738 (840)
|||++..+.... .....+++.|+|||.+.+. .++.++|||||||+++||++|+.|+....... .....
T Consensus 146 dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~ 219 (286)
T cd06622 146 DFGVSGNLVASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN--IFAQL 219 (286)
T ss_pred ecCCcccccCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh--HHHHH
Confidence 999987653221 2234578899999988543 35889999999999999999999985432111 11100
Q ss_pred hhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 739 WNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 739 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
....... ....+......+.+++.+||+.+|++||+++++++
T Consensus 220 -~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 220 -SAIVDGD---------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred -HHHhhcC---------CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 0000000 11122234566789999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-32 Score=291.84 Aligned_cols=249 Identities=22% Similarity=0.370 Sum_probs=196.1
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
.++|...+.||+|+||.||++.+. .+++.||+|.+........+.+.+|+.++++++||||+++++++
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~------------~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~ 85 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDV------------ATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEc------------CCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhhee
Confidence 368888999999999999998654 56788999998765555567899999999999999999999999
Q ss_pred ecCCceEEEEEeeccCCc---cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccc
Q 041702 593 IEQGEKISIYEFDIVTDP---ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIA 669 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla 669 (840)
...+..++|+||...... .....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++
T Consensus 86 ~~~~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~ 162 (293)
T cd06647 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFC 162 (293)
T ss_pred eeCCcEEEEEecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcce
Confidence 999999999998432222 12345789999999999999999999998 999999999999999999999999998
Q ss_pred eecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccccccc
Q 041702 670 RTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWK 749 (840)
Q Consensus 670 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (840)
........ ......+++.|+|||.+.+..++.++||||||+++||+++|+.||.......... ......
T Consensus 163 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~-----~~~~~~---- 231 (293)
T cd06647 163 AQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-----LIATNG---- 231 (293)
T ss_pred eccccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee-----ehhcCC----
Confidence 76543222 2233468889999999988889999999999999999999999986433211100 000000
Q ss_pred ccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 750 LMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 750 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
.+.. .........+.+++.+||+.+|++||++.++++.
T Consensus 232 --~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 232 --TPEL--QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred --CCCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0001 1112234467889999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-32 Score=312.30 Aligned_cols=275 Identities=19% Similarity=0.245 Sum_probs=180.5
Q ss_pred HHccCCcccccccCCCCccEEEeecceeehhcc-cc--CcccCCce----EEEEEeccCCCcCHHHHHHHHHHHhhcCCC
Q 041702 511 AATDNFSEENKLGEGGFGPVYKSIERYVEICNW-KQ--GKLLNGEE----VAVKRLSSKSGQGLEEFKNEMMLIAKLQHR 583 (840)
Q Consensus 511 ~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~-~~--g~~~~g~~----VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~ 583 (840)
...++|++.++||+|+||.||++..+....... .. .....+.. ++.|.+.. ......++.+|+.+|.+++||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCC
Confidence 345789999999999999999986541100000 00 00000111 11222221 122346789999999999999
Q ss_pred CccceeeEeecCCceEEEEEeeccC--------CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEe
Q 041702 584 NLVRLFGCCIEQGEKISIYEFDIVT--------DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLL 655 (840)
Q Consensus 584 niv~l~g~~~~~~~~~lv~e~~~~~--------~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl 655 (840)
||+++++++...+..++++++.... ...............|+.||+.||+|||+.+ |+||||||+|||+
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 9999999999999999998863111 1111122334567789999999999999988 9999999999999
Q ss_pred cCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCC-CCCccH
Q 041702 656 DSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYN-TDSLTL 734 (840)
Q Consensus 656 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~-~~~~~~ 734 (840)
+.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||+||||++|+.++.... ......
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 9999999999999987653322 12234579999999999999999999999999999999999875432211 111111
Q ss_pred hHHHhhhhc--ccc-------cccccCc-------cccchhh--HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 735 LGHAWNLWK--DDK-------AWKLMDP-------TMQNEAL--YSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 735 ~~~~~~~~~--~~~-------~~~~~d~-------~l~~~~~--~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
......... ... ....++. ....... ......+.+++.+||+.||++|||+.|+++
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 111100000 000 0000000 0000000 012234677889999999999999999986
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-32 Score=286.45 Aligned_cols=244 Identities=23% Similarity=0.379 Sum_probs=190.6
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-----CcCHHHHHHHHHHHhhcCCCCcccee
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-----GQGLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-----~~~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
+|+..+.||+|++|.||+|.+. .+++.|++|.+.... ....+.+.+|+.++++++|+||++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~------------~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~ 68 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNL------------DDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYL 68 (258)
T ss_pred CccccceeeecCCceEEEEEEc------------CCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchhee
Confidence 4667789999999999998654 578899999986543 22456799999999999999999999
Q ss_pred eEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 590 GCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
+++...+..++++||..... ......+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|
T Consensus 69 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d 145 (258)
T cd06632 69 GTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLAD 145 (258)
T ss_pred eeEecCCeEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcc
Confidence 99999999999999943222 122345889999999999999999999988 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGL-FSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
||++....... ......++..|+|||.+.... ++.++|+||||++++||++|+.|+..... .. ........
T Consensus 146 ~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~--~~---~~~~~~~~ 217 (258)
T cd06632 146 FGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG--VA---AVFKIGRS 217 (258)
T ss_pred Cccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH--HH---HHHHHHhc
Confidence 99988764332 223456888999999987766 89999999999999999999999754321 11 11111000
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
... ...+......+.+++.+||+.+|++||+++++++
T Consensus 218 ~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 218 KEL---------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ccC---------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 000 0111223455778999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-32 Score=287.55 Aligned_cols=250 Identities=23% Similarity=0.403 Sum_probs=192.8
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC------cCHHHHHHHHHHHhhcCCCCccce
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG------QGLEEFKNEMMLIAKLQHRNLVRL 588 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~------~~~~~f~~Ev~~l~~l~H~niv~l 588 (840)
+|+..+.||+|++|.||+|.+. .+++.||+|++..... ...+++.+|++++++++|+||+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~------------~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 68 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDV------------KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRM 68 (268)
T ss_pred CccccceecCcCceEEEEEEEc------------CCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehh
Confidence 4777889999999999998654 6788999999874321 134678999999999999999999
Q ss_pred eeEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCC-Ccee
Q 041702 589 FGCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDM-NPKI 663 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kL 663 (840)
++++.+.+..++++||..... ......+++.....++.|++.||.|||+.+ ++|+||||+||+++.++ .+||
T Consensus 69 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l 145 (268)
T cd06630 69 LGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRI 145 (268)
T ss_pred hceeccCCeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEE
Confidence 999999999999999953222 123456889999999999999999999998 99999999999998876 5899
Q ss_pred eccccceecCCCCcc--cccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhh
Q 041702 664 SDFGIARTFGGDEMQ--SNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNL 741 (840)
Q Consensus 664 ~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~ 741 (840)
+|||++......... .......++..|+|||.+.+..++.++||||||++++||++|+.|+......... ......
T Consensus 146 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~--~~~~~~ 223 (268)
T cd06630 146 ADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL--ALIFKI 223 (268)
T ss_pred cccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH--HHHHHH
Confidence 999998776433111 1123356788999999998888999999999999999999999997533221111 111000
Q ss_pred hcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 742 WKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 742 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.........+......+.+++.+|++.+|++||++.++++
T Consensus 224 ---------~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 224 ---------ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ---------hccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0001111222344566889999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=287.47 Aligned_cols=244 Identities=22% Similarity=0.346 Sum_probs=192.2
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC--CCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK--SGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
+|+..++||+|+||.||++.+. .+++.||+|++... .....+++.+|+.++++++||||+++++++
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~------------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 68 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSK------------EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF 68 (256)
T ss_pred CceEEEEeccCCceEEEEEEEc------------CCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee
Confidence 4788899999999999998754 57889999998743 233456899999999999999999999999
Q ss_pred ecCCceEEEEEeeccCCc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 593 IEQGEKISIYEFDIVTDP------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
.+.+..++++||...... .....+++.++++++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+||
T Consensus 69 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~ 145 (256)
T cd08218 69 EENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDF 145 (256)
T ss_pred cCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeec
Confidence 999999999998532221 12235788999999999999999999988 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccc
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDK 746 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 746 (840)
|++........ ......+++.|+|||++.+..++.++||||||++++||++|+.|+...... . ........ .
T Consensus 146 ~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~--~---~~~~~~~~-~ 217 (256)
T cd08218 146 GIARVLNSTVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK--N---LVLKIIRG-S 217 (256)
T ss_pred cceeecCcchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH--H---HHHHHhcC-C
Confidence 99987643221 122345788999999999999999999999999999999999987532111 1 11111110 0
Q ss_pred cccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 747 AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 747 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
. ..........+.+++.+||+.+|.+||++.+|++
T Consensus 218 ~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 218 Y---------PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred C---------CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 0 0111233456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-32 Score=290.85 Aligned_cols=259 Identities=22% Similarity=0.271 Sum_probs=189.0
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
++|+..+.||+|++|.||+|.++ .+++.||||.+..... .....+.+|++++++++|+||+++++++
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~------------~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 72 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSK------------LTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEc------------CCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEE
Confidence 67888999999999999999754 5788999999875432 2335678899999999999999999999
Q ss_pred ecCCceEEEEEeeccCC---c-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccc
Q 041702 593 IEQGEKISIYEFDIVTD---P-ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGI 668 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~---~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl 668 (840)
.+.+..++||||..... . .....+++.....++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 73 ~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 149 (291)
T cd07844 73 HTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGL 149 (291)
T ss_pred ecCCeEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECcccc
Confidence 99999999999954211 0 11235788999999999999999999988 99999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccc-
Q 041702 669 ARTFGGDEMQSNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDK- 746 (840)
Q Consensus 669 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~- 746 (840)
++....... ......++..|+|||.+.+ ..++.++||||||++++||++|+.|+....... ......+.......
T Consensus 150 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~ 226 (291)
T cd07844 150 ARAKSVPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE-DQLHKIFRVLGTPTE 226 (291)
T ss_pred ccccCCCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH-HHHHHHHHhcCCCCh
Confidence 875432111 1122346789999998875 558999999999999999999999985433111 11111111100000
Q ss_pred -c----------cc----ccCccccchhhHH--HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 747 -A----------WK----LMDPTMQNEALYS--MVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 747 -~----------~~----~~d~~l~~~~~~~--~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
. .. ...+......... ....+.+++.+||+.+|++|||+.|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 227 ETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 00 0000000000001 1256789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-32 Score=285.82 Aligned_cols=251 Identities=25% Similarity=0.420 Sum_probs=194.6
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
++|+..+.||.|+||.||+|... .++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~------------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 68 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICL------------PNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEc------------CCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEE
Confidence 46888999999999999998654 478899999997543 23567899999999999999999999999
Q ss_pred ecCCceEEEEEeeccCC-------ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 593 IEQGEKISIYEFDIVTD-------PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~-------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
...+..++++|+..... ......+++.....++.|++.||+|||+.+ ++||||||+||++++++.+||+|
T Consensus 69 ~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~d 145 (267)
T cd06610 69 VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIAD 145 (267)
T ss_pred eeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcc
Confidence 99999999999842221 111245889999999999999999999988 99999999999999999999999
Q ss_pred cccceecCCCCccc--ccccccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhh
Q 041702 666 FGIARTFGGDEMQS--NTNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLW 742 (840)
Q Consensus 666 FGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~ 742 (840)
||++..+....... ......++..|+|||.+... .++.++|||||||+++||++|+.|+........ .....
T Consensus 146 f~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-----~~~~~ 220 (267)
T cd06610 146 FGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV-----LMLTL 220 (267)
T ss_pred cchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh-----HHHHh
Confidence 99987665432221 22344688999999998876 789999999999999999999999854322110 01111
Q ss_pred cccccccccCccccchh-hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 743 KDDKAWKLMDPTMQNEA-LYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 743 ~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.. ..+...... .......+.+++.+||+.||++||++++|++
T Consensus 221 ~~------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 221 QN------DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred cC------CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 11 011111110 1234566889999999999999999999976
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=287.61 Aligned_cols=243 Identities=23% Similarity=0.317 Sum_probs=198.7
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC--CCcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK--SGQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
.-|...+.||+|.|+.|-+|++ ..+|+.||||++.+. +......+.+|++.|+-++|||||+|+.+
T Consensus 18 GLYDLekTlG~GHFAVVKLArH------------VFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEV 85 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARH------------VFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEV 85 (864)
T ss_pred eeehhhhhhcCCceehhhhhhh------------hcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeeh
Confidence 4567778999999999999865 479999999999765 33445678899999999999999999999
Q ss_pred eecCCceEEEEEeeccCC-----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEec-CCCCceeec
Q 041702 592 CIEQGEKISIYEFDIVTD-----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLD-SDMNPKISD 665 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~-----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~-~~~~~kL~D 665 (840)
.......|+|+|.....+ ......+.+....+++.||+.|+.|+|+.. +|||||||+|+.+- .-|-+||.|
T Consensus 86 iDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTD 162 (864)
T KOG4717|consen 86 IDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTD 162 (864)
T ss_pred hcccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeee
Confidence 999999999999832222 122345888899999999999999999987 99999999999774 568899999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCCCC-ccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFS-IKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
||++..+..+.. .+..+|+..|-|||++.+..|+ ++.||||||||||.|++|++||+..+..+.
T Consensus 163 FGFSNkf~PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET------------ 227 (864)
T KOG4717|consen 163 FGFSNKFQPGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET------------ 227 (864)
T ss_pred ccccccCCCcch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh------------
Confidence 999988765543 3457899999999999999986 678999999999999999999976543331
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
+..++|-.. ..+......+.+|+..||..||.+|.+.+||+.
T Consensus 228 --LTmImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 228 --LTMIMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred --hhhhhcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 112334433 234456778999999999999999999999874
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-32 Score=287.59 Aligned_cols=249 Identities=24% Similarity=0.373 Sum_probs=193.3
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
++|+..+.||+|++|.||+|.++ .+++.||+|++.... ....+++.+|++++++++||||+++++++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~------------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~ 68 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHR------------PTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEc------------CCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheee
Confidence 35777889999999999999765 578999999987653 34456799999999999999999999999
Q ss_pred ecCCceEEEEEeeccCC----ccc-cCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 593 IEQGEKISIYEFDIVTD----PAR-KDLLDWTTRVRIIEGVAQGLLYLHQ-YSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~----~~~-~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
...+..++++|+..... ... ...++.....+++.|++.||+|||+ .+ ++|+||||+||+++.++.+||+||
T Consensus 69 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~ 145 (265)
T cd06605 69 YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDF 145 (265)
T ss_pred ecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeec
Confidence 99999999999943211 111 1568889999999999999999999 77 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccc
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDK 746 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 746 (840)
|.+....... .....++..|+|||.+.+..++.++||||||+++++|++|+.|+................... ..
T Consensus 146 g~~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~ 220 (265)
T cd06605 146 GVSGQLVNSL----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN-EP 220 (265)
T ss_pred ccchhhHHHH----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc-CC
Confidence 9987653221 112567889999999999999999999999999999999999985433221111111111111 00
Q ss_pred cccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 747 AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 747 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.+.+.. ......+.+++.+||+.+|++|||+.+++.
T Consensus 221 -----~~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 221 -----PPRLPS---GKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred -----CCCCCh---hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 011111 114556889999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=323.72 Aligned_cols=251 Identities=25% Similarity=0.370 Sum_probs=189.8
Q ss_pred HHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccc
Q 041702 510 SAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVR 587 (840)
Q Consensus 510 ~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~ 587 (840)
....++|.+.++||+|+||.||+|.++ .+++.||+|.+.... ......|..|+.++.+|+|||||+
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk------------~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVr 76 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHK------------RTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVR 76 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEEC------------CCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCe
Confidence 345678999999999999999999765 578899999987532 234567999999999999999999
Q ss_pred eeeEeec--CCceEEEEEeeccCCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhcCC----CceecCCCCCCcE
Q 041702 588 LFGCCIE--QGEKISIYEFDIVTDP--------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSR----LRVIHRDLKASNV 653 (840)
Q Consensus 588 l~g~~~~--~~~~~lv~e~~~~~~~--------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~----~~ivHrDlkp~NI 653 (840)
+++++.+ .+..++||||.....+ .....+++..++.|+.||+.||.|||+.+. .+||||||||+||
T Consensus 77 l~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNI 156 (1021)
T PTZ00266 77 YIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNI 156 (1021)
T ss_pred EEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHe
Confidence 9998865 3568899999533221 123468999999999999999999998542 3499999999999
Q ss_pred EecCC-----------------CCceeeccccceecCCCCcccccccccccccccCcccccc--CCCCccccchhHHHHH
Q 041702 654 LLDSD-----------------MNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH--GLFSIKSDVFSFGVLL 714 (840)
Q Consensus 654 Ll~~~-----------------~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDV~SlGviL 714 (840)
||+.+ ..+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||||
T Consensus 157 LL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~IL 233 (1021)
T PTZ00266 157 FLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCII 233 (1021)
T ss_pred EeecCccccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHH
Confidence 99642 348999999998764322 1234578999999999864 4589999999999999
Q ss_pred HHHHhCCCCCCCCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 715 LEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 715 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
|||++|+.||...... ..+. ...... +.+. .......+.+|+..||+.+|.+||++.|+++
T Consensus 234 YELLTGk~PF~~~~~~-~qli----~~lk~~-------p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 234 YELCSGKTPFHKANNF-SQLI----SELKRG-------PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HHHHHCCCCCCcCCcH-HHHH----HHHhcC-------CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 9999999998532211 0111 111110 1110 0112345788999999999999999999983
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=287.35 Aligned_cols=247 Identities=24% Similarity=0.410 Sum_probs=189.3
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC------cCHHHHHHHHHHHhhcCCCCccce
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG------QGLEEFKNEMMLIAKLQHRNLVRL 588 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~------~~~~~f~~Ev~~l~~l~H~niv~l 588 (840)
+|...+.||+|+||.||+|.+ .+++.+|||.+..... ...+.+.+|++++++++|+||+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-------------~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 67 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-------------NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67 (265)
T ss_pred CccccceEeccCCeEEEEEEE-------------cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 467778999999999999753 4688999999864321 223568999999999999999999
Q ss_pred eeEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 589 FGCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
++++.+.+..++++||..... ......+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+
T Consensus 68 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~ 144 (265)
T cd06631 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLI 144 (265)
T ss_pred eeEeecCCeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEec
Confidence 999999999999999943222 122346788999999999999999999988 9999999999999999999999
Q ss_pred ccccceecCCCCc----ccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhh
Q 041702 665 DFGIARTFGGDEM----QSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWN 740 (840)
Q Consensus 665 DFGla~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~ 740 (840)
|||++........ ........++..|+|||.+.+..++.++||||||++++||++|+.|+........ . ..
T Consensus 145 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~--~---~~ 219 (265)
T cd06631 145 DFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA--M---FY 219 (265)
T ss_pred cchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH--H---HH
Confidence 9999876532111 1122345688999999999988899999999999999999999999853221110 0 00
Q ss_pred hhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 741 LWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 741 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
..... ...+.+ .......+.+++.+||+.+|++||++.++++
T Consensus 220 ~~~~~----~~~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 220 IGAHR----GLMPRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred hhhcc----CCCCCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000 001111 1223455788999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=287.02 Aligned_cols=247 Identities=23% Similarity=0.344 Sum_probs=187.2
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-----CcCHHHHHHHHHHHhhcCCCCccce
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-----GQGLEEFKNEMMLIAKLQHRNLVRL 588 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-----~~~~~~f~~Ev~~l~~l~H~niv~l 588 (840)
.+|+..+.||+|+||.||+|.+. .++..||||.+.... ....+.+.+|+.++++++||||+++
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~------------~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 69 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDA------------DTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEc------------CCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeE
Confidence 57888999999999999998754 578899999886321 1234578899999999999999999
Q ss_pred eeEeecC--CceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCce
Q 041702 589 FGCCIEQ--GEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPK 662 (840)
Q Consensus 589 ~g~~~~~--~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 662 (840)
++++.+. ...++++||..... ......+++....+++.|++.||+|||+.+ ++|+||||+||+++.++.+|
T Consensus 70 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~ 146 (265)
T cd06652 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVK 146 (265)
T ss_pred EeEeccCCCceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEE
Confidence 9998764 45778999843222 122345788889999999999999999988 99999999999999999999
Q ss_pred eeccccceecCCCCcc-cccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhh
Q 041702 663 ISDFGIARTFGGDEMQ-SNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNL 741 (840)
Q Consensus 663 L~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~ 741 (840)
|+|||+++........ .......++..|+|||.+.+..++.++||||||++++||++|+.|+..... .. .....
T Consensus 147 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--~~---~~~~~ 221 (265)
T cd06652 147 LGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA--MA---AIFKI 221 (265)
T ss_pred ECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch--HH---HHHHH
Confidence 9999999765322111 122334688899999999888899999999999999999999999753211 00 00010
Q ss_pred hcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 742 WKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 742 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
... ......+......+.+++.+|+. +|++||+++||++
T Consensus 222 ~~~---------~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 222 ATQ---------PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred hcC---------CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 000 01111223445567788888985 9999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-33 Score=300.44 Aligned_cols=247 Identities=25% Similarity=0.397 Sum_probs=195.4
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCI 593 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~ 593 (840)
+.|.++..||-|+||.||||..+ ..+-..|-|++.......+++|+-|++||....||+||+|++.|.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nk------------et~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy 99 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNK------------ETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYY 99 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcc------------cchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHh
Confidence 45667788999999999999765 456667888888777888999999999999999999999999999
Q ss_pred cCCceEEEEEeeccCC-----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccc
Q 041702 594 EQGEKISIYEFDIVTD-----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGI 668 (840)
Q Consensus 594 ~~~~~~lv~e~~~~~~-----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl 668 (840)
..+..+++.||..-+. ......|.+.++.-+++|++.||.|||++. |||||||+.|||++-+|.++|+|||.
T Consensus 100 ~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGV 176 (1187)
T KOG0579|consen 100 FENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGV 176 (1187)
T ss_pred ccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccc
Confidence 9999999999943222 234667899999999999999999999988 99999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhc
Q 041702 669 ARTFGGDEMQSNTNRIVGTYGYMSPEYAL-----HGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWK 743 (840)
Q Consensus 669 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~ 743 (840)
+.... ..........|||+|||||+.+ ..+|+.++||||||+.|.||..+.+|....++... ++ ...
T Consensus 177 SAKn~--~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV-ll-----Kia 248 (1187)
T KOG0579|consen 177 SAKNK--STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-LL-----KIA 248 (1187)
T ss_pred cccch--hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH-HH-----HHh
Confidence 75432 1222334678999999999764 57899999999999999999999988653322110 00 011
Q ss_pred ccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 744 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
..+ .|.+.. +..-...+.+++..||..||..||+++++++
T Consensus 249 KSe-----PPTLlq--PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 249 KSE-----PPTLLQ--PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred hcC-----CCcccC--cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 111 122221 1223445788999999999999999998874
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=295.06 Aligned_cols=248 Identities=21% Similarity=0.246 Sum_probs=192.0
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC---cCHHHHHHHHHHHhhcCCCCccceee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG---QGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
++|+..+.||+|++|.||+|.+. .+++.||+|.+..... ...+.+.+|++++.+++|+||+++++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~------------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 68 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLK------------GTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYA 68 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEc------------CCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhhee
Confidence 46888899999999999999765 4689999999976432 24567899999999999999999999
Q ss_pred EeecCCceEEEEEeeccCCc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 591 CCIEQGEKISIYEFDIVTDP------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
++.+.+..+++|||...... .....+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+
T Consensus 69 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~ 145 (316)
T cd05574 69 SFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLS 145 (316)
T ss_pred eeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEe
Confidence 99999999999998422111 12356889999999999999999999988 9999999999999999999999
Q ss_pred ccccceecCCCCcc---------------------------cccccccccccccCccccccCCCCccccchhHHHHHHHH
Q 041702 665 DFGIARTFGGDEMQ---------------------------SNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEI 717 (840)
Q Consensus 665 DFGla~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~el 717 (840)
|||++......... .......|+..|+|||.+.+..++.++||||||+++|||
T Consensus 146 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l 225 (316)
T cd05574 146 DFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEM 225 (316)
T ss_pred ecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHH
Confidence 99998754321110 011234678899999999998999999999999999999
Q ss_pred HhCCCCCCCCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCC----HHHHHH
Q 041702 718 LSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPT----MLEVVA 790 (840)
Q Consensus 718 ltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs----~~evl~ 790 (840)
++|+.|+....... .. ... .+..............+.+++.+||+.+|++||+ ++|+++
T Consensus 226 ~~g~~pf~~~~~~~--~~---~~~---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 226 LYGTTPFKGSNRDE--TF---SNI---------LKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hhCCCCCCCCchHH--HH---HHH---------hcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 99999986432211 00 011 1111111111124567889999999999999999 666654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=287.74 Aligned_cols=257 Identities=25% Similarity=0.348 Sum_probs=191.7
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcCCCCccceeeEee
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQHRNLVRLFGCCI 593 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~ 593 (840)
+|+..++||+|++|.||+|.+. .+++.||||+++.... ...+.+.+|++++++++||||+++++++.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~------------~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 68 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNR------------TTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIH 68 (284)
T ss_pred CceEeeeeccCCceEEEEEEEC------------CCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEe
Confidence 4788899999999999999765 5788999999976533 33567889999999999999999999999
Q ss_pred cCCceEEEEEeeccC------CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 594 EQGEKISIYEFDIVT------DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 594 ~~~~~~lv~e~~~~~------~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
+.+..++++||.... .......+++..+.+++.|++.||+|||+.+ ++||||||+||++++++.+||+|||
T Consensus 69 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g 145 (284)
T cd07836 69 TENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFG 145 (284)
T ss_pred eCCcEEEEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecc
Confidence 999999999995321 1111245899999999999999999999988 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhh----
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLW---- 742 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~---- 742 (840)
++........ ......++..|++||.+.+. .++.++||||||++++||++|+.|+......+ .........
T Consensus 146 ~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~ 221 (284)
T cd07836 146 LARAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED--QLLKIFRIMGTPT 221 (284)
T ss_pred hhhhhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHHHhCCCC
Confidence 9976532211 11234568899999988664 57899999999999999999999986443221 111111100
Q ss_pred -------cccccccccCcccc----chhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 743 -------KDDKAWKLMDPTMQ----NEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 743 -------~~~~~~~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
........--+... ..........+.+++.+|++.||.+||++++|++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 222 ESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000000000 0111223456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=291.00 Aligned_cols=254 Identities=24% Similarity=0.379 Sum_probs=193.1
Q ss_pred CHHHHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhc-CCC
Q 041702 505 SLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL-QHR 583 (840)
Q Consensus 505 ~~~~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l-~H~ 583 (840)
++.++..+...|+..+.||+|+||.||+|.++ .+++.+|+|++.... ....++..|+.++.++ +|+
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~------------~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~ 73 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHV------------KTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHR 73 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEc------------CCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCC
Confidence 45566667789999999999999999999764 578899999986542 3346788999999999 799
Q ss_pred CccceeeEeec------CCceEEEEEeeccCCc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCC
Q 041702 584 NLVRLFGCCIE------QGEKISIYEFDIVTDP------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKAS 651 (840)
Q Consensus 584 niv~l~g~~~~------~~~~~lv~e~~~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~ 651 (840)
||+++++++.. .+..+++|||...... .....+++..+..++.||+.||.|||+.+ |+|+||||+
T Consensus 74 ~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~ 150 (282)
T cd06636 74 NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQ 150 (282)
T ss_pred cEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHH
Confidence 99999999863 4567899999532211 12345788888999999999999999988 999999999
Q ss_pred cEEecCCCCceeeccccceecCCCCcccccccccccccccCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCC
Q 041702 652 NVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYAL-----HGLFSIKSDVFSFGVLLLEILSSKKNTRF 726 (840)
Q Consensus 652 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~SlGviL~elltG~~p~~~ 726 (840)
||++++++.+||+|||++....... .......|+..|+|||.+. +..++.++|||||||+++||++|+.|+..
T Consensus 151 nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~ 228 (282)
T cd06636 151 NVLLTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD 228 (282)
T ss_pred HEEECCCCCEEEeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccc
Confidence 9999999999999999987653211 1223456889999999875 35688899999999999999999999853
Q ss_pred CCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 727 YNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
....... .... ....+.. ........+.+++.+||+.||.+||++.|+++
T Consensus 229 ~~~~~~~-----~~~~------~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 229 MHPMRAL-----FLIP------RNPPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred cCHHhhh-----hhHh------hCCCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 3211100 0000 0000111 11123456889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-32 Score=293.95 Aligned_cols=254 Identities=19% Similarity=0.257 Sum_probs=194.5
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
++|+..+.||+|+||.||++.++ ..++.||+|.+.... ....+.+.+|++++..++||||+++++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~------------~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~ 68 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHK------------ETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFC 68 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEEC------------CCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEE
Confidence 46888899999999999999765 568899999987543 234567889999999999999999999
Q ss_pred EeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 591 CCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
.+..++..+++|||..... ......+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+||
T Consensus 69 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~df 145 (305)
T cd05609 69 SFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDF 145 (305)
T ss_pred EEecCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeC
Confidence 9999999999999853222 123356889999999999999999999988 999999999999999999999999
Q ss_pred ccceecCCCCc-------------ccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc
Q 041702 667 GIARTFGGDEM-------------QSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLT 733 (840)
Q Consensus 667 Gla~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~ 733 (840)
|+++....... ........++..|+|||.+.+..++.++||||||++++||++|+.|+...... .
T Consensus 146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~--~ 223 (305)
T cd05609 146 GLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE--E 223 (305)
T ss_pred CCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--H
Confidence 99874211100 00111245788999999999889999999999999999999999997532211 1
Q ss_pred HhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 734 LLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
.... ..... ...+... ......+.+++.+||+.+|++||++.++.+.|+..
T Consensus 224 ~~~~----~~~~~---~~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 224 LFGQ----VISDD---IEWPEGD----EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred HHHH----HHhcc---cCCCCcc----ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 1111 00000 0011111 12344578999999999999999988888888764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-32 Score=298.28 Aligned_cols=261 Identities=22% Similarity=0.320 Sum_probs=191.3
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
.++|...+.||+|+||.||+|.+. .+++.||||++.... ......+.+|+.++++++||||+++++
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~ 81 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDK------------RTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeC------------CCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhh
Confidence 478999999999999999998654 578999999987532 233456889999999999999999999
Q ss_pred EeecCC------ceEEEEEeeccCCcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCcee
Q 041702 591 CCIEQG------EKISIYEFDIVTDPA-RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKI 663 (840)
Q Consensus 591 ~~~~~~------~~~lv~e~~~~~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL 663 (840)
++.... ..++++|+....... ....+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL 158 (342)
T cd07879 82 VFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKI 158 (342)
T ss_pred eecccccCCCCceEEEEecccccCHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence 987543 458888885321111 1236889999999999999999999988 999999999999999999999
Q ss_pred eccccceecCCCCcccccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhh-
Q 041702 664 SDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNL- 741 (840)
Q Consensus 664 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~- 741 (840)
+|||+++..... .....++..|+|||.+.+ ..++.++|||||||+++||++|+.||...... .........
T Consensus 159 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~--~~~~~~~~~~ 231 (342)
T cd07879 159 LDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL--DQLTQILKVT 231 (342)
T ss_pred eeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhc
Confidence 999998764321 223467889999999876 46899999999999999999999998643211 111100000
Q ss_pred ----------hcccccccccC--ccccch----hhHHHHHHHHHHHHHccccCCCCCCCHHHHHH--Hhhcc
Q 041702 742 ----------WKDDKAWKLMD--PTMQNE----ALYSMVTRYIKVALLCVQENATDRPTMLEVVA--MLKDE 795 (840)
Q Consensus 742 ----------~~~~~~~~~~d--~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~Le~~ 795 (840)
........... +..... ........+.+++.+||+.||++||+++++++ .++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 232 GVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred CCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 00000000000 000000 00123345789999999999999999999994 36665
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=286.73 Aligned_cols=258 Identities=22% Similarity=0.316 Sum_probs=192.9
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
+|++.+.||+|++|.||+|.+. .+++.||||++.... ....+.+.+|+.++++++||||+++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~------------~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~ 68 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDR------------ETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVF 68 (286)
T ss_pred CceEEeecccCCCcEEEEEEEC------------CCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEE
Confidence 4778899999999999999754 568999999997653 33457899999999999999999999999
Q ss_pred ecCCceEEEEEeeccCCcc-----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 593 IEQGEKISIYEFDIVTDPA-----RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
...+..++|+||. ..... ....+++.++.+++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||
T Consensus 69 ~~~~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg 144 (286)
T cd07832 69 PHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFG 144 (286)
T ss_pred ecCCeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeee
Confidence 9999999999996 22211 2356899999999999999999999988 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccc-
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD- 745 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~- 745 (840)
++........ .......++..|+|||.+.+. .++.++||||||++++||++|++++..... ..............
T Consensus 145 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--~~~~~~~~~~~~~~~ 221 (286)
T cd07832 145 LARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND--IEQLAIVFRTLGTPN 221 (286)
T ss_pred ecccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH--HHHHHHHHHHcCCCC
Confidence 9987643321 112335688899999988654 468999999999999999999777643221 11111111100000
Q ss_pred -----------ccccccCcccc----chhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 746 -----------KAWKLMDPTMQ----NEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 746 -----------~~~~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
+...+..+... .....+....+.+++.+||+.+|++||+++++++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 222 EETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 01111234678899999999999999999999763
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-33 Score=303.42 Aligned_cols=237 Identities=21% Similarity=0.278 Sum_probs=178.8
Q ss_pred ccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhc---CCCCccceeeEeecC
Q 041702 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKL---QHRNLVRLFGCCIEQ 595 (840)
Q Consensus 522 lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l---~H~niv~l~g~~~~~ 595 (840)
||+|+||.||+|+++ .+++.||||++.... ......+..|..++.++ +||||+++++++.+.
T Consensus 1 lG~G~~g~Vy~~~~~------------~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~ 68 (330)
T cd05586 1 IGKGTFGQVYQVRKK------------DTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD 68 (330)
T ss_pred CCCCCceEEEEEEEC------------CCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC
Confidence 799999999999765 678999999986432 22334566677777765 699999999999999
Q ss_pred CceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccccee
Q 041702 596 GEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 596 ~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
+..++||||..... ......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 69 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~ 145 (330)
T cd05586 69 SDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKA 145 (330)
T ss_pred CeEEEEEcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcC
Confidence 99999999953322 234556889999999999999999999998 99999999999999999999999999875
Q ss_pred cCCCCcccccccccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccccc
Q 041702 672 FGGDEMQSNTNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKL 750 (840)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (840)
..... .......||+.|+|||.+.+. .++.++|||||||+++||++|+.||...... .. .........
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~--~~----~~~i~~~~~--- 214 (330)
T cd05586 146 NLTDN--KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ--QM----YRNIAFGKV--- 214 (330)
T ss_pred CCCCC--CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH--HH----HHHHHcCCC---
Confidence 43222 123345799999999998764 4899999999999999999999998542211 11 111111110
Q ss_pred cCccccchhhHHHHHHHHHHHHHccccCCCCCCC----HHHHHH
Q 041702 751 MDPTMQNEALYSMVTRYIKVALLCVQENATDRPT----MLEVVA 790 (840)
Q Consensus 751 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs----~~evl~ 790 (840)
.+.. ......+.+++.+||+.||++||+ +.++++
T Consensus 215 ---~~~~---~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 215 ---RFPK---NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred ---CCCC---ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 1111 112345678999999999999994 555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=284.12 Aligned_cols=254 Identities=24% Similarity=0.318 Sum_probs=191.8
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
++|...++||.|++|.||++.+. .+++.+|+|.+..... ...+++.+|++++++++||||++++++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~------------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 68 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLK------------NTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68 (287)
T ss_pred CceEEEEEeccCCceEEEEEEEC------------CCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEE
Confidence 46788899999999999999765 4788999999875432 3456799999999999999999999998
Q ss_pred ecC--CceEEEEEeeccCCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCce
Q 041702 593 IEQ--GEKISIYEFDIVTDP--------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPK 662 (840)
Q Consensus 593 ~~~--~~~~lv~e~~~~~~~--------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 662 (840)
.+. +..+++|||...... .....+++.....++.||+.||+|||+.+ ++|+||+|+||+++.++.+|
T Consensus 69 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~ 145 (287)
T cd06621 69 LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVK 145 (287)
T ss_pred EccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEE
Confidence 654 467899998532221 12345788899999999999999999988 99999999999999999999
Q ss_pred eeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhh
Q 041702 663 ISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLW 742 (840)
Q Consensus 663 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~ 742 (840)
|+|||++....... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+.............. ...
T Consensus 146 l~dfg~~~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~ 220 (287)
T cd06621 146 LCDFGVSGELVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELL-SYI 220 (287)
T ss_pred Eeeccccccccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHH-HHH
Confidence 99999987543221 1234567899999999999999999999999999999999999865432111111111 111
Q ss_pred cccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 743 KDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 743 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.......+ ..... ......+.+.+++.+||+.+|++|||+.||++
T Consensus 221 ~~~~~~~~-~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 221 VNMPNPEL-KDEPG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred hcCCchhh-ccCCC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 11011111 00100 00123456889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=297.76 Aligned_cols=261 Identities=21% Similarity=0.243 Sum_probs=192.9
Q ss_pred HHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC--CCcCHHHHHHHHHHHhhcCCCCccce
Q 041702 511 AATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK--SGQGLEEFKNEMMLIAKLQHRNLVRL 588 (840)
Q Consensus 511 ~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l 588 (840)
...++|+..+.||+|+||.||+|.+. .+++.||||++... .....+++.+|+.++.+++||||+++
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 80 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDT------------VTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGL 80 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEEC------------CCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcce
Confidence 35688999999999999999999765 57899999998643 22344678899999999999999999
Q ss_pred eeEeecC------CceEEEEEeeccCCcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCc
Q 041702 589 FGCCIEQ------GEKISIYEFDIVTDPA-RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP 661 (840)
Q Consensus 589 ~g~~~~~------~~~~lv~e~~~~~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 661 (840)
++++... ...++|+||....... ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+
T Consensus 81 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~ 157 (353)
T cd07850 81 LNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 157 (353)
T ss_pred eeeeccCCCccccCcEEEEEeccCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCE
Confidence 9988644 3468999985321111 1123788889999999999999999988 9999999999999999999
Q ss_pred eeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhh-
Q 041702 662 KISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWN- 740 (840)
Q Consensus 662 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~- 740 (840)
||+|||+++....... .....++..|+|||.+.+..++.++|||||||++++|++|+.||....... .......
T Consensus 158 kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~ 232 (353)
T cd07850 158 KILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID--QWNKIIEQ 232 (353)
T ss_pred EEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHh
Confidence 9999999987643221 223457889999999999999999999999999999999999986432110 0000000
Q ss_pred ------------------hhccc------ccccccCcccc----chhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 741 ------------------LWKDD------KAWKLMDPTMQ----NEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 741 ------------------~~~~~------~~~~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
..... ...++...... ..........+.+++.+||+.||++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 233 LGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred cCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 00011111100 01111235567899999999999999999999843
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-32 Score=291.20 Aligned_cols=258 Identities=23% Similarity=0.298 Sum_probs=190.8
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
++|+..+.||+|+||.||+|.++ .+++.+|+|.++... ......+.+|+.++.+++||||++++++
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~------------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~ 72 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDK------------KTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEV 72 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEEC------------CCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEE
Confidence 57888899999999999999765 568899999997543 2233467889999999999999999999
Q ss_pred eecC--CceEEEEEeeccCC---c-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 592 CIEQ--GEKISIYEFDIVTD---P-ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 592 ~~~~--~~~~lv~e~~~~~~---~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
+... +..++++||..... . .....+++.....++.||++||+|||+.+ ++|+||||+||+++.++.+||+|
T Consensus 73 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d 149 (293)
T cd07843 73 VVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICD 149 (293)
T ss_pred EEecCCCcEEEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEee
Confidence 9877 88999999853210 0 11235899999999999999999999988 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHH------
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHA------ 738 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~------ 738 (840)
||++....... .......+++.|+|||.+.+. .++.++|+||||++++||++|+.|+....... .....
T Consensus 150 ~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~ 225 (293)
T cd07843 150 FGLAREYGSPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID--QLNKIFKLLGT 225 (293)
T ss_pred cCceeeccCCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCC
Confidence 99998764432 112234578899999988764 46899999999999999999999986433211 11000
Q ss_pred -----hhhhcc------cccccccCccccchhhHH-HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 739 -----WNLWKD------DKAWKLMDPTMQNEALYS-MVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 739 -----~~~~~~------~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
|..+.. ..........+....... ..+.+.+++.+||+.+|++|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 226 PTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred CchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000 000000000111111111 3556789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=284.37 Aligned_cols=249 Identities=24% Similarity=0.423 Sum_probs=192.3
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCc--CHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQ--GLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~--~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
+|+..+.||+|+||.||+|.+. .+++.||+|.++..... ..+.+.+|+.++++++|+||+++++++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~------------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~ 68 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNL------------DTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE 68 (264)
T ss_pred CceeeeEeecCCCcEEEEEEEC------------CCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE
Confidence 4778899999999999998654 57889999998765442 567899999999999999999999999
Q ss_pred ecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccc
Q 041702 593 IEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGI 668 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl 668 (840)
...+..++++||..... ......+++..+..++.+++.||+|||+.+ ++|+||+|+||++++++.+||+|||+
T Consensus 69 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~ 145 (264)
T cd06626 69 VHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGC 145 (264)
T ss_pred ecCCEEEEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccccc
Confidence 99999999999943221 122345788999999999999999999988 99999999999999999999999999
Q ss_pred ceecCCCCcccc--cccccccccccCccccccCC---CCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhc
Q 041702 669 ARTFGGDEMQSN--TNRIVGTYGYMSPEYALHGL---FSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWK 743 (840)
Q Consensus 669 a~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~ 743 (840)
+........... .....++..|+|||++.+.. ++.++||||||++++||++|+.|+....... . .......
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-~---~~~~~~~ 221 (264)
T cd06626 146 AVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-Q---IMFHVGA 221 (264)
T ss_pred ccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-H---HHHHHhc
Confidence 987644322111 12356788999999998766 8999999999999999999999985432111 1 0111000
Q ss_pred ccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 744 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
. ..+.+.. .......+.+++.+||+.+|++||++++++.
T Consensus 222 -~-----~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 222 -G-----HKPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -C-----CCCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0 0111111 1122445778999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=291.88 Aligned_cols=244 Identities=28% Similarity=0.445 Sum_probs=189.9
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC---cCHHHHHHHHHHHhhcCCCCcccee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG---QGLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
.+.|+..+.||+|+||.||+|.+. .+++.||+|++..... ...+++.+|++++++++||||+++.
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~------------~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~ 81 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDV------------RTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEc------------CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 356888899999999999998654 5788999999865432 2335688999999999999999999
Q ss_pred eEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 590 GCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
++|...+..++|+||..... ......+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|
T Consensus 82 ~~~~~~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~d 158 (307)
T cd06607 82 GCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLAD 158 (307)
T ss_pred EEEEeCCeEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEee
Confidence 99999999999999843110 112346899999999999999999999988 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhh
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYAL---HGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLW 742 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~ 742 (840)
||++...... ....++..|+|||.+. ...++.++||||||+++|||++|+.|+...... .. .....
T Consensus 159 fg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~--~~---~~~~~ 227 (307)
T cd06607 159 FGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SA---LYHIA 227 (307)
T ss_pred cCcceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH--HH---HHHHh
Confidence 9998765322 2346788999999874 456899999999999999999999987432211 10 01110
Q ss_pred cccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 743 KDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 743 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
.. . .+.+. .......+.+++.+||+.+|++||++.+|+..
T Consensus 228 ~~-~-----~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 228 QN-D-----SPTLS---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred cC-C-----CCCCC---chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 0 01111 11234568899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-33 Score=300.94 Aligned_cols=240 Identities=23% Similarity=0.374 Sum_probs=183.1
Q ss_pred cccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC----CCcCHHHHHHHHHHHhhcCCCCccceeeEeec
Q 041702 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK----SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIE 594 (840)
Q Consensus 519 ~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~----~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~ 594 (840)
..+||+|+|-+||||.|. .+|.+||--.++.. .....++|..|+.+|+.|+||||++++.++.+
T Consensus 45 ~evLGrGafKtVYka~De------------~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d 112 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDE------------EEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVD 112 (632)
T ss_pred hhhcccccceeeeecccc------------ccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheec
Confidence 358999999999999875 56777876554322 23456899999999999999999999999988
Q ss_pred CCc--eEEEEEeeccC----CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCC-CCceeeccc
Q 041702 595 QGE--KISIYEFDIVT----DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSD-MNPKISDFG 667 (840)
Q Consensus 595 ~~~--~~lv~e~~~~~----~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kL~DFG 667 (840)
... ..+|.|.+..+ ...+...++.+....+++||++||.|||++. |||||||||.+||+|+.+ |.+||+|+|
T Consensus 113 ~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLG 191 (632)
T KOG0584|consen 113 TDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLG 191 (632)
T ss_pred CCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchh
Confidence 766 56667764322 2345567888899999999999999999986 689999999999999755 899999999
Q ss_pred cceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccccc
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKA 747 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 747 (840)
||....... ...++|||.|||||... ..|++.+||||||+.++||+|+..|+..- .-....+.....+..
T Consensus 192 LAtl~r~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC-----~n~AQIYKKV~SGiK 261 (632)
T KOG0584|consen 192 LATLLRKSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC-----TNPAQIYKKVTSGIK 261 (632)
T ss_pred HHHHhhccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh-----CCHHHHHHHHHcCCC
Confidence 998764322 23478999999999776 88999999999999999999999986421 112222222222211
Q ss_pred ccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 748 WKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 748 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
-.-+... .-..+.+++.+||.. .++|||+.|+|+
T Consensus 262 P~sl~kV--------~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 262 PAALSKV--------KDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HHHhhcc--------CCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 1100000 012467899999998 999999999984
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=286.76 Aligned_cols=245 Identities=22% Similarity=0.388 Sum_probs=191.3
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC-CCcCHHHHHHHHHHHhhcC---CCCccceee
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK-SGQGLEEFKNEMMLIAKLQ---HRNLVRLFG 590 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~-~~~~~~~f~~Ev~~l~~l~---H~niv~l~g 590 (840)
.|+..+.||+|+||.||+|.+. .+++.||+|.+... .....+++.+|+.++++++ |||++++++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~------------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~ 69 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHV------------PTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYG 69 (277)
T ss_pred hhhhhhheeccCCceEEEEEEc------------CCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEee
Confidence 4677889999999999999754 57889999998754 2345678999999999996 999999999
Q ss_pred EeecCCceEEEEEeeccCC---ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 591 CCIEQGEKISIYEFDIVTD---PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~---~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
++..+...+++|||..... ......+++.....++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||
T Consensus 70 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg 146 (277)
T cd06917 70 SYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFG 146 (277)
T ss_pred eeeeCCEEEEEEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCC
Confidence 9999999999999843221 222346889999999999999999999988 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccc
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDK 746 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 746 (840)
++....... .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.|+....... .. .....
T Consensus 147 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-----~~-~~~~~-- 216 (277)
T cd06917 147 VAALLNQNS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-----AM-MLIPK-- 216 (277)
T ss_pred ceeecCCCc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh-----hh-hcccc--
Confidence 998765433 12233468889999998865 457899999999999999999999985432111 00 00000
Q ss_pred cccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 747 AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 747 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
...+.+... .....+.+++.+||+.||++||++.++++
T Consensus 217 ---~~~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 217 ---SKPPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred ---CCCCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 011111111 13456788999999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=291.34 Aligned_cols=259 Identities=25% Similarity=0.342 Sum_probs=189.3
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC--cCHHHHHHHHHHHhhcCCCCccceee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG--QGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
.++|+..++||+|+||.||+|.++ .+++.||+|+++.... .....+.+|+.++.+++|+||+++++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 73 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDT------------TSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKE 73 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEEC------------CCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEE
Confidence 467899999999999999999765 5789999999874422 22345678999999999999999999
Q ss_pred EeecC--CceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 591 CCIEQ--GEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 591 ~~~~~--~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
++.+. +..++|+||..... ......+++.++..++.||++||+|||+.+ ++||||||+||+++.++.+||+
T Consensus 74 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~ 150 (309)
T cd07845 74 VVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIA 150 (309)
T ss_pred EEecCCCCeEEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEC
Confidence 98765 46789999843210 011356899999999999999999999998 9999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhc
Q 041702 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWK 743 (840)
Q Consensus 665 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~ 743 (840)
|||++....... .......++..|+|||.+.+ ..++.++||||||++++||++|+.|+...... ...........
T Consensus 151 dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~--~~~~~~~~~~~ 226 (309)
T cd07845 151 DFGLARTYGLPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI--EQLDLIIQLLG 226 (309)
T ss_pred ccceeeecCCcc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcC
Confidence 999998764322 11222345788999998865 55899999999999999999999998643321 11111111100
Q ss_pred c--cccc------------cccCccccc--hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 744 D--DKAW------------KLMDPTMQN--EALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 744 ~--~~~~------------~~~d~~l~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
. ...+ .+-...... .......+.+.+++.+||+.||++|||++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 227 TPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred CCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 0000 000000000 000112456788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=297.80 Aligned_cols=251 Identities=18% Similarity=0.234 Sum_probs=187.5
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
++|.+.++||+|+||.||+++++ .+++.||+|++... .....+.+.+|+.++..++|+||+++++
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~------------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~ 68 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMK------------HTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHY 68 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEEC------------CCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 47889999999999999999755 57889999998752 2233456889999999999999999999
Q ss_pred EeecCCceEEEEEeeccCCcc----c-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 591 CCIEQGEKISIYEFDIVTDPA----R-KDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~~~----~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
++.+.+..++||||....... . ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 69 ~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~D 145 (331)
T cd05624 69 AFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLAD 145 (331)
T ss_pred EEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEe
Confidence 999999999999994332211 1 356888899999999999999999988 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCcccccc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhh
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH-----GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWN 740 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~ 740 (840)
||+++........ ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||...... ... ..
T Consensus 146 fG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--~~~---~~ 219 (331)
T cd05624 146 FGSCLKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV--ETY---GK 219 (331)
T ss_pred ccceeeccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH--HHH---HH
Confidence 9999876433221 1223568999999998875 56889999999999999999999998532211 111 11
Q ss_pred hhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 041702 741 LWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATD--RPTMLEVVAM 791 (840)
Q Consensus 741 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~ 791 (840)
........ .+ +.........+.+++.+|+..++++ |++++++++.
T Consensus 220 i~~~~~~~-----~~-p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 220 IMNHEERF-----QF-PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred HHcCCCcc-----cC-CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 11110000 00 1111123456778888888765443 4678877753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-32 Score=288.57 Aligned_cols=257 Identities=23% Similarity=0.339 Sum_probs=190.9
Q ss_pred CcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceeeEee
Q 041702 516 FSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFGCCI 593 (840)
Q Consensus 516 f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~ 593 (840)
|+..++||+|++|.||+|.+. .+++.+|+|++.... ....+.+.+|++++++++|+|++++++++.
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~------------~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 68 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNK------------KTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVT 68 (287)
T ss_pred CeeeEEeccCCCeEEEEEEEC------------CCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEe
Confidence 567789999999999999754 568899999998653 334567899999999999999999999999
Q ss_pred cC--CceEEEEEeeccCC---c-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 594 EQ--GEKISIYEFDIVTD---P-ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 594 ~~--~~~~lv~e~~~~~~---~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
.. +..++++||..... . .....+++..++.++.||++||+|||+.+ ++|+||||+||++++++.+||+|||
T Consensus 69 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g 145 (287)
T cd07840 69 SKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFG 145 (287)
T ss_pred cCCCCcEEEEeccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEcccc
Confidence 88 89999999953210 1 11246889999999999999999999988 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcc--
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD-- 744 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~-- 744 (840)
++........ .......++..|+|||.+.+ ..++.++||||||++++||++|+.|+....... ...........
T Consensus 146 ~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~--~~~~~~~~~~~~~ 222 (287)
T cd07840 146 LARPYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE--QLEKIFELCGSPT 222 (287)
T ss_pred ceeeccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCc
Confidence 9987654321 11223456789999997765 468999999999999999999999986433211 11111111000
Q ss_pred -ccc--------ccccCcc--cc---chhhHH-HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 745 -DKA--------WKLMDPT--MQ---NEALYS-MVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 745 -~~~--------~~~~d~~--l~---~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
... .....+. .. ...... +...+.+++.+||+.+|++||+++++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 223 DENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000 0000000 00 001111 2567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-32 Score=288.03 Aligned_cols=245 Identities=25% Similarity=0.411 Sum_probs=191.7
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceeeEee
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFGCCI 593 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~ 593 (840)
-|+..++||+|+||.||+|.+. .+++.||||.+.... ....+.|.+|+.++.+++||||+++++++.
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~------------~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 72 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDN------------RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL 72 (277)
T ss_pred hhhhheeEeecCCeEEEEEEEC------------CCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEE
Confidence 4667788999999999998654 568899999986442 234567899999999999999999999999
Q ss_pred cCCceEEEEEeeccCC---ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccce
Q 041702 594 EQGEKISIYEFDIVTD---PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIAR 670 (840)
Q Consensus 594 ~~~~~~lv~e~~~~~~---~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~ 670 (840)
.++..++|+||..... ......+++.....++.+++.++.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 73 ~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06641 73 KDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAG 149 (277)
T ss_pred eCCeEEEEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccce
Confidence 9999999999943221 122346889999999999999999999988 9999999999999999999999999997
Q ss_pred ecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccccc
Q 041702 671 TFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKL 750 (840)
Q Consensus 671 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (840)
.+..... ......++..|+|||.+.+..++.++|||||||+++||++|..|+....... .. .. .....
T Consensus 150 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~---~~-~~~~~---- 217 (277)
T cd06641 150 QLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK--VL---FL-IPKNN---- 217 (277)
T ss_pred ecccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH--HH---HH-HhcCC----
Confidence 7643221 1223467889999999988889999999999999999999999875322111 00 00 00000
Q ss_pred cCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 751 MDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 751 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
.+. ........+.+++.+||+.+|++||+++++++.
T Consensus 218 -~~~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 218 -PPT----LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred -CCC----CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 011 112234557789999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-32 Score=285.92 Aligned_cols=248 Identities=26% Similarity=0.396 Sum_probs=191.1
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
+|+..+.||.|+||.||+|.+. .+++.||+|++.... ....+++.+|++++++++||||+++++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~------------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 68 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRK------------SDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRI 68 (265)
T ss_pred CceeeeeeccCCCeEEEEeeec------------CCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeee
Confidence 4778899999999999999765 578899999987542 33456788999999999999999999988
Q ss_pred ec--CCceEEEEEeeccCC--------ccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CCceecCCCCCCcEEecCCCC
Q 041702 593 IE--QGEKISIYEFDIVTD--------PARKDLLDWTTRVRIIEGVAQGLLYLHQYS--RLRVIHRDLKASNVLLDSDMN 660 (840)
Q Consensus 593 ~~--~~~~~lv~e~~~~~~--------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivHrDlkp~NILl~~~~~ 660 (840)
.. +...++++||..... ......+++..++.++.||++||.|||..+ ...++|+||||+||+++.++.
T Consensus 69 ~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~ 148 (265)
T cd08217 69 IDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNN 148 (265)
T ss_pred ecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCC
Confidence 64 345788999843221 122457899999999999999999999332 233999999999999999999
Q ss_pred ceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhh
Q 041702 661 PKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWN 740 (840)
Q Consensus 661 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~ 740 (840)
+||+|||++........ ......+++.|+|||.+.+..++.++||||||+++++|++|+.|+..... .... .
T Consensus 149 ~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~----~ 220 (265)
T cd08217 149 VKLGDFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ--LQLA----S 220 (265)
T ss_pred EEEecccccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH--HHHH----H
Confidence 99999999987654332 12234688999999999988899999999999999999999999864331 1111 1
Q ss_pred hhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 741 LWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 741 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
...... ...........+.+++.+|++.+|++||++.+|++.
T Consensus 221 ~~~~~~---------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 221 KIKEGK---------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHhcCC---------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 111111 111122345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-32 Score=284.90 Aligned_cols=249 Identities=25% Similarity=0.371 Sum_probs=197.1
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
++|+..+.||+|++|.||+|.++ .+++.|+||++..... ...+++.+|++++.+++|+||+++++++
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~------------~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 68 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHK------------PTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEc------------CCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 36788899999999999999765 4789999999976543 4467899999999999999999999999
Q ss_pred ecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 593 IEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQ-YSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
...+..++++||..... ......+++..+.+++.|+++||+|||+ .+ ++||||+|+||+++.++.++|+|||
T Consensus 69 ~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~ 145 (264)
T cd06623 69 YKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFG 145 (264)
T ss_pred ccCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCc
Confidence 99999999999953221 1123668999999999999999999999 87 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccccc
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKA 747 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 747 (840)
++......... .....++..|+|||.+.+..++.++||||||++++||++|+.|+....... ......... ..
T Consensus 146 ~~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~-~~-- 218 (264)
T cd06623 146 ISKVLENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS--FFELMQAIC-DG-- 218 (264)
T ss_pred cceecccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC--HHHHHHHHh-cC--
Confidence 99876433221 124567889999999999899999999999999999999999986543211 111111111 00
Q ss_pred ccccCccccchhhHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 748 WKLMDPTMQNEALYS-MVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 748 ~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
..+. .... ....+.+++.+||+.+|++||++.++++.
T Consensus 219 ---~~~~----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 219 ---PPPS----LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ---CCCC----CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0011 1112 45678899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=269.87 Aligned_cols=248 Identities=23% Similarity=0.367 Sum_probs=190.7
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcC-CCCccceeeE
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQ-HRNLVRLFGC 591 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~-H~niv~l~g~ 591 (840)
++.+.+..||.|+.|.|++++.+ .+|..+|||.+.... ..+.++++..+.++.+-+ .|.||+.+||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~r------------s~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~Gy 159 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFR------------STGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGY 159 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEc------------ccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeE
Confidence 44455677999999999999876 678999999998664 455677888888887765 8999999999
Q ss_pred eecCCceEEEEEeecc----CCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 592 CIEQGEKISIYEFDIV----TDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~----~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
|+.+....+-||.+.. ......+++++...-++...+.+||.||.++. .|+|||+||+|||+|+.|++||+|||
T Consensus 160 Fi~n~dV~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFG 237 (391)
T KOG0983|consen 160 FITNTDVFICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFG 237 (391)
T ss_pred EeeCchHHHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeeccc
Confidence 9988888888887421 11123445778777889999999999998755 59999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCcccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALH---GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
++..+-+.. ...+..|-+.|||||.+.- ..|+.++||||||+.|+||.||+.|++....+-..+. .. ..+
T Consensus 238 IsGrlvdSk---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~lt-kv---ln~ 310 (391)
T KOG0983|consen 238 ISGRLVDSK---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLT-KV---LNE 310 (391)
T ss_pred ccceeeccc---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHH-HH---Hhc
Confidence 997664332 3345678899999998863 4689999999999999999999999876443322211 11 111
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
+ .|.+.... .....+++++..||++|+.+||...++++
T Consensus 311 e------PP~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 311 E------PPLLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred C------CCCCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 1 12232211 15667899999999999999999998875
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=285.71 Aligned_cols=249 Identities=26% Similarity=0.416 Sum_probs=191.6
Q ss_pred HHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhc-CCCCcccee
Q 041702 511 AATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL-QHRNLVRLF 589 (840)
Q Consensus 511 ~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~ 589 (840)
.++++|+..+.||+|++|.||+|.++ .+++.+++|++.... ...++|.+|+.+++++ +|+||++++
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~------------~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~ 69 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHK------------KTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFY 69 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEEC------------CCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEE
Confidence 45789999999999999999999764 467899999987653 3457899999999999 799999999
Q ss_pred eEeecCC------ceEEEEEeeccCC--------ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEe
Q 041702 590 GCCIEQG------EKISIYEFDIVTD--------PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLL 655 (840)
Q Consensus 590 g~~~~~~------~~~lv~e~~~~~~--------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl 655 (840)
+++.... ..+++|||..... ......+++..+..++.|++.||.|||+.+ ++|+||+|+||++
T Consensus 70 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~ 146 (275)
T cd06608 70 GAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILL 146 (275)
T ss_pred EEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEE
Confidence 9997655 4899999843221 111356889999999999999999999988 9999999999999
Q ss_pred cCCCCceeeccccceecCCCCcccccccccccccccCcccccc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCC
Q 041702 656 DSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH-----GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTD 730 (840)
Q Consensus 656 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDV~SlGviL~elltG~~p~~~~~~~ 730 (840)
++++.+||+|||++....... .......++..|+|||.+.. ..++.++||||||++++||++|+.|+......
T Consensus 147 ~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 224 (275)
T cd06608 147 TKNAEVKLVDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM 224 (275)
T ss_pred ccCCeEEECCCccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH
Confidence 999999999999997654322 12233568889999998753 34788999999999999999999998532211
Q ss_pred CccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 731 SLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
... ..... . ..+.+. ........+.+++.+||+.||++|||+.+|++
T Consensus 225 --~~~---~~~~~-~-----~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 225 --RAL---FKIPR-N-----PPPTLK--SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred --HHH---HHhhc-c-----CCCCCC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111 01100 0 011111 11224556889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-32 Score=297.31 Aligned_cols=263 Identities=23% Similarity=0.301 Sum_probs=194.1
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC--CCcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK--SGQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
.++|...+.||+|+||.||+|.+. .+++.||||.+... ......++.+|+.++.+++|+||+++++
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 71 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNS------------ETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKD 71 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEec------------CCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHH
Confidence 467999999999999999999754 67899999998753 2334567889999999999999999999
Q ss_pred EeecC-----CceEEEEEeeccC---CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCce
Q 041702 591 CCIEQ-----GEKISIYEFDIVT---DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPK 662 (840)
Q Consensus 591 ~~~~~-----~~~~lv~e~~~~~---~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 662 (840)
++... ...++++||.... .......+++.....++.|++.||.|||+.+ ++||||||+||+++.++.+|
T Consensus 72 ~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~k 148 (337)
T cd07858 72 IMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLK 148 (337)
T ss_pred heecccccccCcEEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEE
Confidence 88654 3478999984211 1123356889999999999999999999988 99999999999999999999
Q ss_pred eeccccceecCCCCcccccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhh
Q 041702 663 ISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNL 741 (840)
Q Consensus 663 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~ 741 (840)
|+|||++....... .......++..|+|||.+.+ ..++.++||||||++++||++|+.|+....... ........
T Consensus 149 L~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~ 224 (337)
T cd07858 149 ICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH--QLKLITEL 224 (337)
T ss_pred ECcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH--HHHHHHHH
Confidence 99999998764322 11233467889999998765 568999999999999999999999986432110 00000000
Q ss_pred -----------hccccccccc-------CccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhcc
Q 041702 742 -----------WKDDKAWKLM-------DPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM--LKDE 795 (840)
Q Consensus 742 -----------~~~~~~~~~~-------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--Le~~ 795 (840)
.........+ ++... .........+.+++.+||+.+|++|||++++++. ++..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 225 LGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hCCCChHHhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0000000000 00000 0112345668899999999999999999999865 5543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-32 Score=297.60 Aligned_cols=263 Identities=27% Similarity=0.356 Sum_probs=191.9
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC--CCcCHHHHHHHHHHHhhc-CCCCccce
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK--SGQGLEEFKNEMMLIAKL-QHRNLVRL 588 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~--~~~~~~~f~~Ev~~l~~l-~H~niv~l 588 (840)
..++|+..+.||+|+||.||+|.++ .+++.+|||++... .......+.+|+.++.++ +||||+++
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~------------~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~ 72 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDR------------RTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKL 72 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEc------------CCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccce
Confidence 4578899999999999999999754 56889999998643 223445688899999999 99999999
Q ss_pred eeEeecC--CceEEEEEeeccC--CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 589 FGCCIEQ--GEKISIYEFDIVT--DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 589 ~g~~~~~--~~~~lv~e~~~~~--~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
+++|... ...++|+||.... .......+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~ 149 (337)
T cd07852 73 LNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLA 149 (337)
T ss_pred eeeeccCCCceEEEEecccccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEe
Confidence 9998654 3578999984321 1111236789999999999999999999988 9999999999999999999999
Q ss_pred ccccceecCCCCcc---cccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhh
Q 041702 665 DFGIARTFGGDEMQ---SNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWN 740 (840)
Q Consensus 665 DFGla~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~ 740 (840)
|||++......... .......++..|+|||.+.+ ..++.++||||||++++||++|+.|+....... .......
T Consensus 150 d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~--~~~~~~~ 227 (337)
T cd07852 150 DFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN--QLEKIIE 227 (337)
T ss_pred eccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHH
Confidence 99999876433221 22234568899999998765 568899999999999999999999985432211 1000000
Q ss_pred h-----------hcccccccccC----ccc--cchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 741 L-----------WKDDKAWKLMD----PTM--QNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 741 ~-----------~~~~~~~~~~d----~~l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
. +.......+++ ... ...........+.+++.+||+.+|++|||+.++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 228 VIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0 00000000110 000 001111234568899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=297.31 Aligned_cols=251 Identities=17% Similarity=0.226 Sum_probs=186.4
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
++|+..++||+|+||.||++.++ .+++.+|+|++.+. .....+.|.+|+.++..++|+||+++++
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~------------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~ 68 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLK------------NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEEC------------CCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEE
Confidence 46888999999999999998765 56789999998642 2233456889999999999999999999
Q ss_pred EeecCCceEEEEEeeccCCc----cc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 591 CCIEQGEKISIYEFDIVTDP----AR-KDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~~----~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
++.+.+..++||||...... .. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 69 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~D 145 (332)
T cd05623 69 AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLAD 145 (332)
T ss_pred EEecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEee
Confidence 99999999999999433221 11 346888899999999999999999988 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhh
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYAL-----HGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWN 740 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~ 740 (840)
||++..+..... .......||+.|+|||++. ...++.++|||||||+||||++|+.||...... . ....
T Consensus 146 fG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~--~---~~~~ 219 (332)
T cd05623 146 FGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV--E---TYGK 219 (332)
T ss_pred cchheecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH--H---HHHH
Confidence 999976533221 1223357999999999886 346889999999999999999999998533211 1 1111
Q ss_pred hhcccccccccCccccchhhHHHHHHHHHHHHHccccC--CCCCCCHHHHHHH
Q 041702 741 LWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQEN--ATDRPTMLEVVAM 791 (840)
Q Consensus 741 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~d--P~~RPs~~evl~~ 791 (840)
......... . +.........+.+++.+|+..+ +..||+++|+++.
T Consensus 220 i~~~~~~~~-----~-p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 220 IMNHKERFQ-----F-PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HhCCCcccc-----C-CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 111110000 0 0111123445677788877544 3446889888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=286.45 Aligned_cols=254 Identities=21% Similarity=0.288 Sum_probs=187.2
Q ss_pred CcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcC-CCCccceeeEee
Q 041702 516 FSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQ-HRNLVRLFGCCI 593 (840)
Q Consensus 516 f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~ 593 (840)
|+..++||+|+||.||+|.++ .+++.||+|+++... ........+|+.++.++. |+|++++++++.
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~------------~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 68 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSR------------KTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLF 68 (282)
T ss_pred CceEeeccccccceEEEEEEc------------CCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEe
Confidence 566789999999999999754 578899999987542 222334567999999985 999999999999
Q ss_pred cC--CceEEEEEeeccCC---c-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 594 EQ--GEKISIYEFDIVTD---P-ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 594 ~~--~~~~lv~e~~~~~~---~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
+. +..++|+||..... . .....+++.++..++.|++.||+|||+.+ ++||||||+||+++. +.+||+|||
T Consensus 69 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg 144 (282)
T cd07831 69 DRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFG 144 (282)
T ss_pred cCCCCcEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecc
Confidence 87 88999999853211 1 12346899999999999999999999988 999999999999999 999999999
Q ss_pred cceecCCCCcccccccccccccccCccccc-cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhh-----
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYAL-HGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNL----- 741 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~----- 741 (840)
+++....... .....++..|+|||.+. +..++.++|||||||+++||++|+.|++.....+ ........
T Consensus 145 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~--~~~~~~~~~~~~~ 219 (282)
T cd07831 145 SCRGIYSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD--QIAKIHDVLGTPD 219 (282)
T ss_pred cccccccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH--HHHHHHHHcCCCC
Confidence 9987643221 12345788999999764 4567899999999999999999999986543211 11111100
Q ss_pred ------hcccccccccCccccc----hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 742 ------WKDDKAWKLMDPTMQN----EALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 742 ------~~~~~~~~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
....+......+.... .........+.+++.+||+.+|++||+++++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 220 AEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred HHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0000000000111000 111234677999999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=287.86 Aligned_cols=258 Identities=22% Similarity=0.282 Sum_probs=188.0
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcC-CCCccceee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQ-HRNLVRLFG 590 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~-H~niv~l~g 590 (840)
++|+..+.||+|+||.||+|.++ .+++.||||++.... ......+.+|+.++.+++ ||||+++++
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~------------~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~ 68 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDK------------NTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68 (295)
T ss_pred CCceEeeEecccCCeEEEEEEEC------------CCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceee
Confidence 46888899999999999999765 578899999986542 223467889999999994 699999999
Q ss_pred EeecCCc-----eEEEEEeeccCC--------ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecC
Q 041702 591 CCIEQGE-----KISIYEFDIVTD--------PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS 657 (840)
Q Consensus 591 ~~~~~~~-----~~lv~e~~~~~~--------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~ 657 (840)
++...+. .+++|||..... ......+++..+..++.||++||.|||+.+ |+||||||+||+++.
T Consensus 69 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~ 145 (295)
T cd07837 69 VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDK 145 (295)
T ss_pred eEeecCCCCCceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEec
Confidence 9987665 799999843210 011345799999999999999999999988 999999999999998
Q ss_pred -CCCceeeccccceecCCCCcccccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHh
Q 041702 658 -DMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLL 735 (840)
Q Consensus 658 -~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~ 735 (840)
++.+||+|||+++.+..... ......+++.|+|||++.+ ..++.++||||||++++||++|..|+....... ..
T Consensus 146 ~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~ 221 (295)
T cd07837 146 QKGLLKIADLGLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--QL 221 (295)
T ss_pred CCCeEEEeecccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--HH
Confidence 88999999999986532211 1122356789999998865 457999999999999999999999886432111 11
Q ss_pred HHHhhhhccccc--c----ccc----Cccccc----hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 736 GHAWNLWKDDKA--W----KLM----DPTMQN----EALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 736 ~~~~~~~~~~~~--~----~~~----d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
............ . ... -+.... .........+.+++.+||+.||++||+++|++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 222 LHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred HHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 111110000000 0 000 000000 111234566889999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-32 Score=270.28 Aligned_cols=284 Identities=21% Similarity=0.320 Sum_probs=199.5
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccC--CceEEEEEeccCCC--cCHHHHHHHHHHHhhcCCCCccc
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLN--GEEVAVKRLSSKSG--QGLEEFKNEMMLIAKLQHRNLVR 587 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~--g~~VAvK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv~ 587 (840)
....|+....||+|.||.||||..+ ...+ ...+|||+++.... .-.....+|+.+++.++||||+.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~----------~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~ 91 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRK----------NTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVIS 91 (438)
T ss_pred HHHHhhccceecccccceeeEeeec----------cCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchh
Confidence 3456888899999999999999543 1223 34799999975422 22345789999999999999999
Q ss_pred eeeEeec-CCceEEEEEee--------ccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCC
Q 041702 588 LFGCCIE-QGEKISIYEFD--------IVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSD 658 (840)
Q Consensus 588 l~g~~~~-~~~~~lv~e~~--------~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~ 658 (840)
|..++.+ ....++++||. ........+.++-.....|+.||+.|+.|||++- |+||||||.|||+..+
T Consensus 92 Lv~Vfl~~d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgd 168 (438)
T KOG0666|consen 92 LVKVFLSHDKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGD 168 (438)
T ss_pred HHHHHhccCceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEecc
Confidence 9999987 77888999982 1122333467888899999999999999999986 9999999999999877
Q ss_pred ----CCceeeccccceecCCCCcc-cccccccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCC-
Q 041702 659 ----MNPKISDFGIARTFGGDEMQ-SNTNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDS- 731 (840)
Q Consensus 659 ----~~~kL~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~SlGviL~elltG~~p~~~~~~~~- 731 (840)
|.+||+|||+|+.+...-.. .....++.|..|+|||.+.+. .||.+.|||+.|||+.||||-.+.|.......
T Consensus 169 gperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~ 248 (438)
T KOG0666|consen 169 GPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIK 248 (438)
T ss_pred CCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcc
Confidence 89999999999988653322 244567889999999999886 49999999999999999999888775533221
Q ss_pred ------ccHhHHHhhhhcccc--cc----cccCc---------cccch-hhHH-------HHHHHHHHHHHccccCCCCC
Q 041702 732 ------LTLLGHAWNLWKDDK--AW----KLMDP---------TMQNE-ALYS-------MVTRYIKVALLCVQENATDR 782 (840)
Q Consensus 732 ------~~~~~~~~~~~~~~~--~~----~~~d~---------~l~~~-~~~~-------~~~~l~~l~~~Cl~~dP~~R 782 (840)
.+.+.......-... .+ .+.+- ..... .... -.+...+++.++|+.||.+|
T Consensus 249 ~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kR 328 (438)
T KOG0666|consen 249 TKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKR 328 (438)
T ss_pred cCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhh
Confidence 111111111110000 00 00000 00000 0000 01226789999999999999
Q ss_pred CCHHHHHHHhhccccCCCCCCCCCCccc
Q 041702 783 PTMLEVVAMLKDEIVNLPSPHQPAFSYV 810 (840)
Q Consensus 783 Ps~~evl~~Le~~~~~~~~p~~p~~~~~ 810 (840)
.|+++.++..-= .+-+.|+.|.-++.
T Consensus 329 Ita~qAleh~yF--~~d~lpp~pt~~~v 354 (438)
T KOG0666|consen 329 ITAEQALEHPYF--TEDPLPPLPTSDNV 354 (438)
T ss_pred ccHHHHhccccc--ccCCCCCCccccee
Confidence 999998765322 23344555554443
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=287.34 Aligned_cols=246 Identities=24% Similarity=0.360 Sum_probs=190.9
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEeec
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIE 594 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~ 594 (840)
.|...++||+|++|.||++.+. .+++.+++|++........+.+.+|+.++++++||||+++++++..
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~------------~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~ 87 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDK------------STGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV 87 (285)
T ss_pred hhhcceEeccCCCeEEEEEEEC------------CCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEc
Confidence 3444578999999999998654 5688999999876544556678999999999999999999999999
Q ss_pred CCceEEEEEeeccCCc---cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccccee
Q 041702 595 QGEKISIYEFDIVTDP---ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 595 ~~~~~lv~e~~~~~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
.+..++++||...... .....+++..+..++.|++.||+|||+.+ |+||||+|+||+++.++.++|+|||++..
T Consensus 88 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~ 164 (285)
T cd06648 88 GDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQ 164 (285)
T ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchh
Confidence 9999999998432221 12246888999999999999999999988 99999999999999999999999998876
Q ss_pred cCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccccccccc
Q 041702 672 FGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLM 751 (840)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (840)
...... ......|+..|+|||.+.+..++.++||||||++++||++|+.|+..... ..... ......
T Consensus 165 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~--~~~~~----~~~~~~----- 231 (285)
T cd06648 165 VSKEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP--LQAMK----RIRDNL----- 231 (285)
T ss_pred hccCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH--HHHHH----HHHhcC-----
Confidence 533221 12234688999999999988899999999999999999999998753221 11111 111110
Q ss_pred CccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 752 DPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 752 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.+... ........+.+++.+||+.+|++||++.++++
T Consensus 232 ~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 232 PPKLK--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CCCCc--ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 01111 01123456889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=282.20 Aligned_cols=244 Identities=23% Similarity=0.345 Sum_probs=190.9
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
+|+..+.||+|+||.||+|.+. .+++.+|||++.... ....+.+.+|++++++++||||+++++.+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~------------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~ 68 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRK------------ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENF 68 (256)
T ss_pred CceEEEEecccCceEEEEEEEc------------CCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeE
Confidence 4778899999999999998754 578999999987542 33467899999999999999999999999
Q ss_pred ecCCceEEEEEeeccCCc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCC-Cceeec
Q 041702 593 IEQGEKISIYEFDIVTDP------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDM-NPKISD 665 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kL~D 665 (840)
...+..++|+||...... .....+++..+.+++.+++++|+|||+.+ ++|+||||+||++++++ .+||+|
T Consensus 69 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d 145 (256)
T cd08220 69 LEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGD 145 (256)
T ss_pred ecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcc
Confidence 999999999998432221 12345789999999999999999999988 99999999999998654 579999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
||++....... ......++..|+|||.+.+..++.++||||||+++++|++|+.|+....... .... ... .
T Consensus 146 ~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~--~~~~---~~~-~ 216 (256)
T cd08220 146 FGISKILSSKS---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA--LVLK---IMS-G 216 (256)
T ss_pred CCCceecCCCc---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH--HHHH---HHh-c
Confidence 99998764332 1223567889999999998889999999999999999999999875432211 1111 100 0
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
... .........+.+++.+||+.+|++|||+.|+++.
T Consensus 217 ~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 217 TFA---------PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCC---------CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 000 0111234457899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=288.28 Aligned_cols=258 Identities=23% Similarity=0.335 Sum_probs=188.3
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
++|+..+.||+|++|.||+|.++ .+++.||+|++.... ....+.+.+|++++++++||||++++++
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~------------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 69 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDR------------VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEec------------CCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEE
Confidence 57888999999999999999754 578899999986542 2334678999999999999999999999
Q ss_pred eecCCceEEEEEeeccCC-----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecC-CCCceeec
Q 041702 592 CIEQGEKISIYEFDIVTD-----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS-DMNPKISD 665 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~-----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kL~D 665 (840)
+...+..++|+||..... ......+++.....++.||+.||+|||+.+ ++||||||+||+++. ++.+||+|
T Consensus 70 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~d 146 (294)
T PLN00009 70 VHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLAD 146 (294)
T ss_pred EecCCeEEEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcc
Confidence 999999999999953211 011122467778899999999999999987 999999999999985 45789999
Q ss_pred cccceecCCCCcccccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
||++....... .......+++.|+|||.+.+ ..++.++||||||++++||+||+.|+......+ ...........
T Consensus 147 fg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~--~~~~~~~~~~~ 222 (294)
T PLN00009 147 FGLARAFGIPV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID--ELFKIFRILGT 222 (294)
T ss_pred cccccccCCCc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCC
Confidence 99997653321 11223457889999998866 457999999999999999999999986432211 11111110000
Q ss_pred c--ccc---------cccCccccc----hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 745 D--KAW---------KLMDPTMQN----EALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 745 ~--~~~---------~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
. ..+ ....+.... .........+.+++.+|++.+|++||++.++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 223 PNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred CChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 000 000000000 011223456789999999999999999999986
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=289.73 Aligned_cols=262 Identities=21% Similarity=0.298 Sum_probs=187.9
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCcccee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
..++|+..++||+|+||.||+|.++ .+++.||||++.... ......+.+|++++++++||||++++
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~------------~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 77 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHK------------KTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 77 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEEC------------CCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceE
Confidence 3457999999999999999999765 578999999986432 22334567899999999999999999
Q ss_pred eEeecCCc--------eEEEEEeeccCC---c-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecC
Q 041702 590 GCCIEQGE--------KISIYEFDIVTD---P-ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS 657 (840)
Q Consensus 590 g~~~~~~~--------~~lv~e~~~~~~---~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~ 657 (840)
++|...+. .++++||..... . .....+++.++..++.||+.||+|||+.+ ++|+||||+||+++.
T Consensus 78 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~ 154 (310)
T cd07865 78 EICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITK 154 (310)
T ss_pred EEEecccccccCCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECC
Confidence 99876543 489999843211 1 11235889999999999999999999988 999999999999999
Q ss_pred CCCceeeccccceecCCCCcc--cccccccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccH
Q 041702 658 DMNPKISDFGIARTFGGDEMQ--SNTNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTL 734 (840)
Q Consensus 658 ~~~~kL~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~ 734 (840)
++.+||+|||++......... .......++..|+|||.+.+. .++.++||||||++++||++|+.|+....... .
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~--~ 232 (310)
T cd07865 155 DGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH--Q 232 (310)
T ss_pred CCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--H
Confidence 999999999999866432211 112234578899999988664 47899999999999999999999876433211 1
Q ss_pred hHHHhhhhc--------ccccccccC----ccccc-hhh-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 735 LGHAWNLWK--------DDKAWKLMD----PTMQN-EAL-----YSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 735 ~~~~~~~~~--------~~~~~~~~d----~~l~~-~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
......... ........+ +.... ... ......+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 233 LTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred HHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 111111000 000000000 00000 000 001245678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=277.74 Aligned_cols=248 Identities=25% Similarity=0.406 Sum_probs=196.4
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC--cCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG--QGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
+|+..+.||+|++|.||+|.++ .+++.|++|++..... ...+.+.+|+.++++++||||+++++.+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~------------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 68 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDK------------DTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSE 68 (260)
T ss_pred CceeeeEeeecCceEEEEEEEC------------CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEE
Confidence 4677889999999999999765 4788999999876542 4567899999999999999999999999
Q ss_pred ecC--CceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 593 IEQ--GEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 593 ~~~--~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
... +..++++|+..... ......+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+||
T Consensus 69 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~ 145 (260)
T cd06606 69 RDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADF 145 (260)
T ss_pred ecCCCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccc
Confidence 988 88999999842221 122337899999999999999999999987 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccc
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDK 746 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 746 (840)
|.+................++..|+|||.+.+...+.++||||||+++++|++|+.|+.... ......+....
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~--- 218 (260)
T cd06606 146 GCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG----NPMAALYKIGS--- 218 (260)
T ss_pred ccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----chHHHHHhccc---
Confidence 99988755432112334568889999999988889999999999999999999999986543 11111111111
Q ss_pred cccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 747 AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 747 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.......+......+.+++.+|++.+|++||++.++++
T Consensus 219 ------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 219 ------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11111122223566889999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=290.86 Aligned_cols=246 Identities=28% Similarity=0.448 Sum_probs=190.5
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC---cCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG---QGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
.|...+.||+|+||.||+|.+. .+++.||+|++..... ...+++.+|++++++++|||+++++++
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~------------~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 93 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDV------------RTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGC 93 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEc------------CCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3777889999999999998754 5788999999875422 234578899999999999999999999
Q ss_pred eecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 592 CIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
+.+.+..++++||..... ......+++.++..++.+++.||.|||+.+ |+||||+|+||+++.++.+||+|||
T Consensus 94 ~~~~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg 170 (317)
T cd06635 94 YLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFG 170 (317)
T ss_pred EeeCCeEEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCC
Confidence 999999999999953110 112455889999999999999999999988 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYAL---HGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
++..... .....++..|+|||++. +..++.++|||||||+++||++|+.|+..... .... ......
T Consensus 171 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--~~~~---~~~~~~ 239 (317)
T cd06635 171 SASIASP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSAL---YHIAQN 239 (317)
T ss_pred CccccCC------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH--HHHH---HHHHhc
Confidence 9875432 22346788999999874 45689999999999999999999998743211 1111 011010
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
.. +. .........+.+++.+||+.+|++||++.+|++.+-..
T Consensus 240 ~~------~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 240 ES------PT---LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred cC------CC---CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 00 00 11112344578899999999999999999999866543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=286.23 Aligned_cols=240 Identities=25% Similarity=0.326 Sum_probs=190.7
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
++|+..+.||+|+||.||+|.+. .+++.||+|++.... ....+.+.+|++++++++||||+++++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~------------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 68 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHK------------GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEc------------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceee
Confidence 46888899999999999999765 578999999986532 234567899999999999999999999
Q ss_pred EeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 591 CCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
++.+++..+++|||..... ......+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+||
T Consensus 69 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~df 145 (290)
T cd05580 69 SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDF 145 (290)
T ss_pred EEEcCCeEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeC
Confidence 9999999999999953222 223456889999999999999999999988 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccc
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDK 746 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 746 (840)
|++...... .....+++.|+|||.+.+...+.++||||||++++||++|+.|+..... .. .........
T Consensus 146 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~----~~~~~~~~~ 214 (290)
T cd05580 146 GFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--IQ----IYEKILEGK 214 (290)
T ss_pred CCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--HH----HHHHHhcCC
Confidence 999876433 2334688999999999888899999999999999999999999753321 11 111111110
Q ss_pred cccccCccccchhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHH
Q 041702 747 AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRP-----TMLEVV 789 (840)
Q Consensus 747 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl 789 (840)
..+ +......+.+++.+||+.+|.+|| +++|++
T Consensus 215 ------~~~----~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 215 ------VRF----PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred ------ccC----CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 011 112245678899999999999999 566665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=289.84 Aligned_cols=261 Identities=22% Similarity=0.278 Sum_probs=189.4
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC--cCHHHHHHHHHHHhhcCCCCccceee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG--QGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
.++|+..++||+|+||.||+|.++ .+++.||||++..... .....+.+|++++++++||||+++++
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~------------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 74 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQI------------KTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLID 74 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEEC------------CCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhh
Confidence 578999999999999999999765 5788999999865422 23356789999999999999999999
Q ss_pred EeecCC--------ceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCC
Q 041702 591 CCIEQG--------EKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSD 658 (840)
Q Consensus 591 ~~~~~~--------~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~ 658 (840)
++.+.. ..++++||..... ......+++..+..++.|+++||+|||+.+ |+|+||||+||+++++
T Consensus 75 ~~~~~~~~~~~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~ 151 (311)
T cd07866 75 MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQ 151 (311)
T ss_pred heecccccccccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCC
Confidence 876543 3588999842211 112346899999999999999999999998 9999999999999999
Q ss_pred CCceeeccccceecCCCCcc---------cccccccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCC
Q 041702 659 MNPKISDFGIARTFGGDEMQ---------SNTNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSKKNTRFYN 728 (840)
Q Consensus 659 ~~~kL~DFGla~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~SlGviL~elltG~~p~~~~~ 728 (840)
+.+||+|||+++........ .......+++.|+|||.+.+. .++.++||||||++++||++|++|+....
T Consensus 152 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~ 231 (311)
T cd07866 152 GILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKS 231 (311)
T ss_pred CCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999865432211 111234578889999987654 58999999999999999999999986433
Q ss_pred CCCccHhHHHhhhhccc---------cccc----ccCccccc---hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 729 TDSLTLLGHAWNLWKDD---------KAWK----LMDPTMQN---EALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 729 ~~~~~~~~~~~~~~~~~---------~~~~----~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
... ............ .... ........ .........+.+++.+||+.+|++|||+.|++.
T Consensus 232 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 232 DID--QLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHH--HHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 211 111111110000 0000 00000100 011122356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=293.28 Aligned_cols=261 Identities=20% Similarity=0.289 Sum_probs=192.2
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
.++|+..+.||+|++|.||+|.+. .+++.||+|++.... ....+.+.+|+.++.+++||||+++++
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~------------~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 71 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDT------------RSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRD 71 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEc------------CCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHH
Confidence 478888999999999999999754 678999999987542 234567889999999999999999999
Q ss_pred Eeec----CCceEEEEEeecc---CCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCcee
Q 041702 591 CCIE----QGEKISIYEFDIV---TDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKI 663 (840)
Q Consensus 591 ~~~~----~~~~~lv~e~~~~---~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL 663 (840)
++.. ....++|+||... ........+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||
T Consensus 72 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl 148 (334)
T cd07855 72 ILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRI 148 (334)
T ss_pred hccccCCCCceEEEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEe
Confidence 8763 3467899998421 11123455899999999999999999999988 999999999999999999999
Q ss_pred eccccceecCCCCcc--cccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhh
Q 041702 664 SDFGIARTFGGDEMQ--SNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWN 740 (840)
Q Consensus 664 ~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~ 740 (840)
+|||++......... .......++..|+|||.+.+ ..++.++||||||++++||++|+.||....... .......
T Consensus 149 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~--~~~~~~~ 226 (334)
T cd07855 149 GDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH--QLKLILS 226 (334)
T ss_pred cccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH--HHHHHHH
Confidence 999999765432211 11123568889999998765 468999999999999999999999986432211 0000000
Q ss_pred h-----------hcccccccccC---cccc---chhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 741 L-----------WKDDKAWKLMD---PTMQ---NEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 741 ~-----------~~~~~~~~~~d---~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
. ..........+ .... ..........+.+++.+||+.+|++||+++++++
T Consensus 227 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 227 VLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred HhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0 00000000000 0000 0111223567899999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=288.45 Aligned_cols=262 Identities=24% Similarity=0.314 Sum_probs=191.8
Q ss_pred HHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccce
Q 041702 511 AATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRL 588 (840)
Q Consensus 511 ~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l 588 (840)
...++|++.+.||+|+||.||+|.++ .+++.||||+++... ......+.+|++++++++||||+++
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~------------~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~ 71 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDK------------DTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNL 71 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEEC------------CCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeee
Confidence 45678999999999999999999765 568899999997543 2334578899999999999999999
Q ss_pred eeEeecCC----------ceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEE
Q 041702 589 FGCCIEQG----------EKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVL 654 (840)
Q Consensus 589 ~g~~~~~~----------~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIL 654 (840)
++++.+.. ..++++||..... ......+++..+..++.||+.||+|||+.+ |+||||||+||+
T Consensus 72 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nil 148 (302)
T cd07864 72 KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNIL 148 (302)
T ss_pred eheecCcchhhhccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence 99987655 7889999843211 111336899999999999999999999988 999999999999
Q ss_pred ecCCCCceeeccccceecCCCCcccccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc
Q 041702 655 LDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLT 733 (840)
Q Consensus 655 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~ 733 (840)
+++++.+||+|||++........ .......++..|+|||.+.+ ..++.++|||||||+++||++|++|+...... .
T Consensus 149 i~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~--~ 225 (302)
T cd07864 149 LNNKGQIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL--A 225 (302)
T ss_pred ECCCCcEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH--H
Confidence 99999999999999987643322 11122346778999998765 45789999999999999999999988643211 1
Q ss_pred HhHHHhhhhcccc-----------cccccCcc--ccc---hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 734 LLGHAWNLWKDDK-----------AWKLMDPT--MQN---EALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 734 ~~~~~~~~~~~~~-----------~~~~~d~~--l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
............. .....++. ... ......+..+.+++..||+.+|++||++++|++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 226 QLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111111100000 00000000 000 001123456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=282.19 Aligned_cols=244 Identities=24% Similarity=0.270 Sum_probs=192.4
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
+|+..+.||.|+||.||+|.+. .+++.||+|.+.... ....+.+.+|++++++++||||++++++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~------------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 68 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKR------------DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS 68 (258)
T ss_pred CceEEEEeccCCCceEEEEEEc------------cCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHh
Confidence 4788899999999999999754 578899999997542 2456789999999999999999999999
Q ss_pred eecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 592 CIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
+.+++..++++||..... ......+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||
T Consensus 69 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~ 145 (258)
T cd05578 69 FQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFN 145 (258)
T ss_pred hcCCCeEEEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecc
Confidence 999999999999853322 122347889999999999999999999988 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccccc
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKA 747 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 747 (840)
++....... ......++..|+|||.+.+..++.++|+||||+++++|++|+.|+......... ........
T Consensus 146 ~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~--- 216 (258)
T cd05578 146 IATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD---QIRAKQET--- 216 (258)
T ss_pred cccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHH---HHHHHhcc---
Confidence 988764332 223356788999999998888999999999999999999999998654332111 11111000
Q ss_pred ccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCH--HHHH
Q 041702 748 WKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTM--LEVV 789 (840)
Q Consensus 748 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~--~evl 789 (840)
.....+......+.+++.+||+.+|.+||++ +|++
T Consensus 217 -------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 217 -------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0011112234678899999999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=294.44 Aligned_cols=266 Identities=21% Similarity=0.273 Sum_probs=193.5
Q ss_pred cCHHHHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcC
Q 041702 504 FSLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQ 581 (840)
Q Consensus 504 ~~~~~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~ 581 (840)
....++...+++|...+.||+|+||.||+|.+. .+++.||+|++.... ....+.+.+|+.++.+++
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~ 74 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDT------------KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 74 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEc------------CCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcC
Confidence 445678889999999999999999999998654 578999999997532 223467889999999999
Q ss_pred CCCccceeeEeecC------CceEEEEEeec--cCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcE
Q 041702 582 HRNLVRLFGCCIEQ------GEKISIYEFDI--VTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNV 653 (840)
Q Consensus 582 H~niv~l~g~~~~~------~~~~lv~e~~~--~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NI 653 (840)
||||+++++++... ...++++++.. +........+++..+..++.|+++||+|||+.+ |+||||||+||
T Consensus 75 h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NI 151 (345)
T cd07877 75 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNL 151 (345)
T ss_pred CCcccceeeeeeecccccccccEEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHE
Confidence 99999999988643 33566666531 111112346899999999999999999999988 99999999999
Q ss_pred EecCCCCceeeccccceecCCCCcccccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCc
Q 041702 654 LLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSL 732 (840)
Q Consensus 654 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~ 732 (840)
+++.++.+||+|||+++..... .....++..|+|||.+.+ ..++.++||||||++++||++|+.|+.......
T Consensus 152 ll~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~- 225 (345)
T cd07877 152 AVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID- 225 (345)
T ss_pred EEcCCCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence 9999999999999998764321 223467889999998866 568899999999999999999999985432211
Q ss_pred cHhHHHhhhhc--cccccccc------------Cccccc---hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 733 TLLGHAWNLWK--DDKAWKLM------------DPTMQN---EALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 733 ~~~~~~~~~~~--~~~~~~~~------------d~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
.......... .......+ ...... .........+.+++.+|++.||.+||++.+++..
T Consensus 226 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 226 -QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred -HHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 1110000000 00000000 000000 0000123457899999999999999999998843
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=284.37 Aligned_cols=256 Identities=24% Similarity=0.332 Sum_probs=192.9
Q ss_pred CcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC--cCHHHHHHHHHHHhhcCCCCccceeeEee
Q 041702 516 FSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG--QGLEEFKNEMMLIAKLQHRNLVRLFGCCI 593 (840)
Q Consensus 516 f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~ 593 (840)
|+..+.||+|++|.||+|.+. .+++.+++|++..... ...+.+.+|+.++++++|+||+++++++.
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~------------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 68 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDK------------LTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFR 68 (283)
T ss_pred CccceeeecCCCceEEEEEcC------------CCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhc
Confidence 456688999999999998654 5789999999875532 24567899999999999999999999999
Q ss_pred cCCceEEEEEeeccCC---c-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccc
Q 041702 594 EQGEKISIYEFDIVTD---P-ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIA 669 (840)
Q Consensus 594 ~~~~~~lv~e~~~~~~---~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla 669 (840)
.++..++++||..... . .....+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||.+
T Consensus 69 ~~~~~~~v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~ 145 (283)
T cd05118 69 HKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLA 145 (283)
T ss_pred cCCCEEEEEeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeee
Confidence 9999999999943211 1 11246889999999999999999999988 999999999999999999999999999
Q ss_pred eecCCCCcccccccccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcc---c
Q 041702 670 RTFGGDEMQSNTNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD---D 745 (840)
Q Consensus 670 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~ 745 (840)
....... .......++..|+|||.+.+. .++.++||||||+++++|++|+.|+......+ ........... .
T Consensus 146 ~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~ 221 (283)
T cd05118 146 RSFGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID--QLFKIFRTLGTPDPE 221 (283)
T ss_pred EecCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCCCchH
Confidence 8775433 112234577899999998876 78999999999999999999998875433211 11111000000 0
Q ss_pred cccc-----------ccCccc--cchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 746 KAWK-----------LMDPTM--QNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 746 ~~~~-----------~~d~~l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.... ..+... ...........+.+++.+||+.||.+||++++++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 222 VWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000 000000 01122345667899999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=276.23 Aligned_cols=248 Identities=20% Similarity=0.230 Sum_probs=197.9
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhcCCCCcccee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
.++|+.++.||+|.-|+||++..+ .++...|+|++.+.. .....+.+.|-+||+.++||.++.|+
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~------------~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLY 143 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELR------------GTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLY 143 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEec------------CCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhh
Confidence 356778889999999999999876 456899999997653 34456788899999999999999999
Q ss_pred eEeecCCceEEEEEeeccC------CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCcee
Q 041702 590 GCCIEQGEKISIYEFDIVT------DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKI 663 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~------~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL 663 (840)
+.+...+..+++|||..-. .....+.+++..+.-++..++.||+|||..| ||+|||||+||||.++|++-|
T Consensus 144 a~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIML 220 (459)
T KOG0610|consen 144 ASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIML 220 (459)
T ss_pred heeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEe
Confidence 9999999999999995333 3345667889999999999999999999999 999999999999999999999
Q ss_pred eccccceecCC---------------------------------C-Cc--------------------cccccccccccc
Q 041702 664 SDFGIARTFGG---------------------------------D-EM--------------------QSNTNRIVGTYG 689 (840)
Q Consensus 664 ~DFGla~~~~~---------------------------------~-~~--------------------~~~~~~~~gt~~ 689 (840)
+||.|+..... . .. ...+...+||-.
T Consensus 221 sDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThE 300 (459)
T KOG0610|consen 221 SDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHE 300 (459)
T ss_pred eeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccc
Confidence 99998754311 0 00 011234679999
Q ss_pred ccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHH
Q 041702 690 YMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIK 769 (840)
Q Consensus 690 y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 769 (840)
|+|||++.+...+.++|.|+|||+|||||.|.-||...+....- ..++-..+.-......+..+.+
T Consensus 301 YlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl--------------~NIv~~~l~Fp~~~~vs~~akD 366 (459)
T KOG0610|consen 301 YLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETL--------------RNIVGQPLKFPEEPEVSSAAKD 366 (459)
T ss_pred cccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhH--------------HHHhcCCCcCCCCCcchhHHHH
Confidence 99999999999999999999999999999999999876544311 1111111211112255667899
Q ss_pred HHHHccccCCCCCCC----HHHHH
Q 041702 770 VALLCVQENATDRPT----MLEVV 789 (840)
Q Consensus 770 l~~~Cl~~dP~~RPs----~~evl 789 (840)
||.+.|.+||++|.. +.||-
T Consensus 367 LIr~LLvKdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 367 LIRKLLVKDPSKRLGSKRGAAEIK 390 (459)
T ss_pred HHHHHhccChhhhhccccchHHhh
Confidence 999999999999998 66665
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=285.56 Aligned_cols=250 Identities=24% Similarity=0.381 Sum_probs=195.1
Q ss_pred HHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCcccee
Q 041702 510 SAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 510 ~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
...++.|+..+.||+|++|.||+|.+. .+++.|++|++..... ..+.+.+|++++++++|+|+++++
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~------------~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~ 81 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDR------------ATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYY 81 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEc------------cCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEE
Confidence 346678888899999999999998754 4688999999976543 567899999999999999999999
Q ss_pred eEeecCCceEEEEEeeccCC---c-ccc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 590 GCCIEQGEKISIYEFDIVTD---P-ARK-DLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~~---~-~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
+++...+..++++||..... . ... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~ 158 (286)
T cd06614 82 DSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLA 158 (286)
T ss_pred EEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEEC
Confidence 99999999999999843211 1 112 27899999999999999999999987 9999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 665 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
|||++........ ......++..|+|||.+.+..++.++||||||++++||++|+.|+...... .... .. ..
T Consensus 159 d~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~--~~~~---~~-~~ 230 (286)
T cd06614 159 DFGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL--RALF---LI-TT 230 (286)
T ss_pred ccchhhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH--HHHH---HH-Hh
Confidence 9999865533211 122345788999999999888999999999999999999999987532211 1010 00 00
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.... ... ........+.+++.+||+.+|.+||++.+|++
T Consensus 231 ~~~~-----~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 231 KGIP-----PLK--NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred cCCC-----CCc--chhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0000 010 11123456888999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=280.74 Aligned_cols=245 Identities=24% Similarity=0.375 Sum_probs=190.5
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
+|+..+.||+|+||.||+|.++ .++..||+|.+.... ....+.+.+|+.++++++|+||+++++.+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~------------~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~ 68 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAK------------SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF 68 (257)
T ss_pred CceEEEEecCCCcceEEEEEEc------------CCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee
Confidence 4778899999999999999765 578889999986532 23456789999999999999999999999
Q ss_pred ecCCceEEEEEeeccCC------ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCC-ceeec
Q 041702 593 IEQGEKISIYEFDIVTD------PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMN-PKISD 665 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~-~kL~D 665 (840)
...+..++++||..... ......+++..+.+++.|++.||.|||+.+ ++|+||||+||++++++. +||+|
T Consensus 69 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d 145 (257)
T cd08225 69 QENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGD 145 (257)
T ss_pred ccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecc
Confidence 99999999999843221 112235789999999999999999999988 999999999999998864 69999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
||.+........ ......|++.|+|||.+.+..++.++||||||++++||++|+.|+..... ..........
T Consensus 146 ~~~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~- 217 (257)
T cd08225 146 FGIARQLNDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-----HQLVLKICQG- 217 (257)
T ss_pred cccchhccCCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHhcc-
Confidence 999977643221 12234688899999999888999999999999999999999999753221 1111111111
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
. .. .........+.+++.+|++.+|++|||+.+|++.
T Consensus 218 ~----~~-----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 218 Y----FA-----PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred c----CC-----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0 00 0111223458889999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=293.23 Aligned_cols=266 Identities=22% Similarity=0.319 Sum_probs=193.6
Q ss_pred HHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCc
Q 041702 508 SISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNL 585 (840)
Q Consensus 508 ~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~ni 585 (840)
++....++|+..+.||+|+||.||+|.+. .++..||||++.... ....+.+.+|+.++++++||||
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 76 (343)
T cd07880 9 TIWEVPDRYRDLKQVGSGAYGTVCSALDR------------RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENV 76 (343)
T ss_pred hhhccccceEEEEEeeecCCeEEEEEEEC------------CCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCc
Confidence 34556788999999999999999999754 578999999986432 2234568899999999999999
Q ss_pred cceeeEeecCC------ceEEEEEeecc--CCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecC
Q 041702 586 VRLFGCCIEQG------EKISIYEFDIV--TDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS 657 (840)
Q Consensus 586 v~l~g~~~~~~------~~~lv~e~~~~--~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~ 657 (840)
+++++++.... ..++|+|+... ........+++..+..++.||+.||+|||+.+ |+||||||+||+++.
T Consensus 77 v~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~ 153 (343)
T cd07880 77 IGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNE 153 (343)
T ss_pred cceeeeecCCccccccceEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcC
Confidence 99999987654 35788888411 11222356899999999999999999999988 999999999999999
Q ss_pred CCCceeeccccceecCCCCcccccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhH
Q 041702 658 DMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLG 736 (840)
Q Consensus 658 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~ 736 (840)
++.+||+|||++...... .....+++.|+|||.+.+ ..++.++||||||+++++|++|+.|+....... ...
T Consensus 154 ~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~--~~~ 226 (343)
T cd07880 154 DCELKILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD--QLM 226 (343)
T ss_pred CCCEEEeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHH
Confidence 999999999999765322 223457889999998876 458899999999999999999999986432110 000
Q ss_pred HHhh-----------hhcccccccccC--ccccc----hhhHHHHHHHHHHHHHccccCCCCCCCHHHHH--HHhhcc
Q 041702 737 HAWN-----------LWKDDKAWKLMD--PTMQN----EALYSMVTRYIKVALLCVQENATDRPTMLEVV--AMLKDE 795 (840)
Q Consensus 737 ~~~~-----------~~~~~~~~~~~d--~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl--~~Le~~ 795 (840)
.... ............ +.... .........+.+++.+|++.||++|||+.+++ ..++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 227 EIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred HHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 0000 000000000000 00000 01112344578999999999999999999999 444443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=275.55 Aligned_cols=245 Identities=28% Similarity=0.445 Sum_probs=193.9
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEeec
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIE 594 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~ 594 (840)
.|+..+.||+|++|.||++.+. .+++.+++|++........+++.+|++++++++|+|++++++++..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~------------~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 68 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHK------------RTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLK 68 (253)
T ss_pred CceeeeeeccCCceEEEEEEEC------------CCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence 3677789999999999998764 4788999999987655566889999999999999999999999999
Q ss_pred CCceEEEEEeeccCCcc----c-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccc
Q 041702 595 QGEKISIYEFDIVTDPA----R-KDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIA 669 (840)
Q Consensus 595 ~~~~~lv~e~~~~~~~~----~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla 669 (840)
.+..++++||....... . ...+++..+..++.|++.||.|||..+ ++||||+|+||++++++.+||+|||.+
T Consensus 69 ~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~ 145 (253)
T cd05122 69 KDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLS 145 (253)
T ss_pred CCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccc
Confidence 99999999994322211 1 147899999999999999999999987 999999999999999999999999999
Q ss_pred eecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccccccc
Q 041702 670 RTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWK 749 (840)
Q Consensus 670 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (840)
........ .....++..|+|||.+.+..++.++||||||+++++|++|+.|+......... ... .......
T Consensus 146 ~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-----~~~-~~~~~~~ 216 (253)
T cd05122 146 AQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKAL-----FKI-ATNGPPG 216 (253)
T ss_pred cccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHH-----HHH-HhcCCCC
Confidence 77644321 23456888999999998888999999999999999999999987543211100 000 0010111
Q ss_pred ccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 750 LMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 750 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
... .......+.+++.+||+.||++|||+.++++
T Consensus 217 ~~~-------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 217 LRN-------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred cCc-------ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 110 0112456888999999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=275.07 Aligned_cols=270 Identities=24% Similarity=0.330 Sum_probs=209.3
Q ss_pred cCHHHHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCC
Q 041702 504 FSLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQH 582 (840)
Q Consensus 504 ~~~~~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H 582 (840)
-.+.++.....+++....+.+|.||.||+|+++ ++.+..+.+.|-||.++... +.....|..|..++..+.|
T Consensus 274 ~r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~-------eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH 346 (563)
T KOG1024|consen 274 RRLQELTVQRCRVRLSCLLQEGTFGRIYRGIWR-------EEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASH 346 (563)
T ss_pred hhHHhhhhhhhheechhhhhcCchhheeeeeec-------ccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcC
Confidence 345667777788999999999999999999877 22445567789999988653 3456789999999999999
Q ss_pred CCccceeeEeecCC-ceEEEEEeecc------------CCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCC
Q 041702 583 RNLVRLFGCCIEQG-EKISIYEFDIV------------TDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLK 649 (840)
Q Consensus 583 ~niv~l~g~~~~~~-~~~lv~e~~~~------------~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk 649 (840)
||++.+.+++.+.. ..+.+|.+.-. .+....+.+.-.+...++.|++.|++|||.++ +||.||.
T Consensus 347 ~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiA 423 (563)
T KOG1024|consen 347 PNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIA 423 (563)
T ss_pred CCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhh
Confidence 99999999998754 45566666321 13333455667788889999999999999998 9999999
Q ss_pred CCcEEecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCC
Q 041702 650 ASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYN 728 (840)
Q Consensus 650 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~ 728 (840)
.+|++||+..++||+|-.+++.+-..++.-.......+..||+||.+.+..|+.++|||||||+||||+| |+.|+...+
T Consensus 424 aRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID 503 (563)
T KOG1024|consen 424 ARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID 503 (563)
T ss_pred hhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC
Confidence 9999999999999999999998766555444444455679999999999999999999999999999998 777754322
Q ss_pred CCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccC
Q 041702 729 TDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVN 798 (840)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~ 798 (840)
+.+. ..+..++ .++ ..+.+.++++..++..||+..|++||+++|++.-|.+...+
T Consensus 504 PfEm------~~ylkdG--yRl-------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 504 PFEM------EHYLKDG--YRL-------AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred HHHH------HHHHhcc--cee-------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 2211 1111211 112 22334566788899999999999999999999999875433
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=280.47 Aligned_cols=239 Identities=24% Similarity=0.272 Sum_probs=179.9
Q ss_pred cccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC---cCHHHHHHHHHHHhh---cCCCCccceeeEeec
Q 041702 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG---QGLEEFKNEMMLIAK---LQHRNLVRLFGCCIE 594 (840)
Q Consensus 521 ~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~---~~~~~f~~Ev~~l~~---l~H~niv~l~g~~~~ 594 (840)
.||+|+||.||+|.+. .+++.+|+|.+..... .....+.+|..++.. .+||||+.+++++..
T Consensus 1 ~lg~G~~g~Vy~~~~~------------~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 68 (279)
T cd05633 1 IIGRGGFGEVYGCRKA------------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT 68 (279)
T ss_pred CcccCCCeEEEEEEEC------------CCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec
Confidence 4899999999998754 5788999999865421 222334555544443 479999999999999
Q ss_pred CCceEEEEEeeccCCc----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccce
Q 041702 595 QGEKISIYEFDIVTDP----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIAR 670 (840)
Q Consensus 595 ~~~~~lv~e~~~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~ 670 (840)
.+..++||||...... .....+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.
T Consensus 69 ~~~~~lv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~ 145 (279)
T cd05633 69 PDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC 145 (279)
T ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcce
Confidence 9999999999533322 23456899999999999999999999988 9999999999999999999999999997
Q ss_pred ecCCCCcccccccccccccccCccccc-cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccccccc
Q 041702 671 TFGGDEMQSNTNRIVGTYGYMSPEYAL-HGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWK 749 (840)
Q Consensus 671 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (840)
...... .....|+..|+|||.+. +..++.++|||||||+++||++|+.||.............. ..
T Consensus 146 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~---~~------ 212 (279)
T cd05633 146 DFSKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TL------ 212 (279)
T ss_pred eccccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH---hh------
Confidence 653321 22346899999999886 45689999999999999999999999865432221111110 00
Q ss_pred ccCccccchhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 041702 750 LMDPTMQNEALYSMVTRYIKVALLCVQENATDRP-----TMLEVVAM 791 (840)
Q Consensus 750 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 791 (840)
..... .+......+.+++.+||+.||++|| +++|+++.
T Consensus 213 ~~~~~----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 213 TVNVE----LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cCCcC----CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 01111 1122345678899999999999999 58888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=289.78 Aligned_cols=264 Identities=24% Similarity=0.303 Sum_probs=196.6
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
+|++.+.||+|++|.||+|++. .+++.||||++.... ....+.+.+|+.+++.++|+||+++++++
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~------------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 68 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDK------------RTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDIL 68 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeC------------CCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhh
Confidence 4778899999999999999754 468899999997643 34457899999999999999999999999
Q ss_pred ecCC-----ceEEEEEeecc---CCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 593 IEQG-----EKISIYEFDIV---TDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 593 ~~~~-----~~~lv~e~~~~---~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
...+ ..++++||... ........+++..+..++.+|+.||+|||+.+ |+||||||+|||++.++.++|+
T Consensus 69 ~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~ 145 (330)
T cd07834 69 RPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKIC 145 (330)
T ss_pred cccCcccccceEEEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEc
Confidence 8775 78999998432 11122347889999999999999999999998 9999999999999999999999
Q ss_pred ccccceecCCCCcc-cccccccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhh
Q 041702 665 DFGIARTFGGDEMQ-SNTNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLW 742 (840)
Q Consensus 665 DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~ 742 (840)
|||++......... .......++..|+|||.+.+. .++.++||||||+++++|++|+.||......+ .........
T Consensus 146 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~ 223 (330)
T cd07834 146 DFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID--QLNLIVEVL 223 (330)
T ss_pred ccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHhc
Confidence 99999876543210 122334678899999999887 89999999999999999999999986543211 000000000
Q ss_pred -----------cccccccccC---ccc---cchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhcc
Q 041702 743 -----------KDDKAWKLMD---PTM---QNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM--LKDE 795 (840)
Q Consensus 743 -----------~~~~~~~~~d---~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--Le~~ 795 (840)
........+. ... ...........+.+++.+||+.+|++||+++++++. +++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 224 GTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred CCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 0000000000 000 000111235568899999999999999999999973 5543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=279.86 Aligned_cols=255 Identities=23% Similarity=0.325 Sum_probs=187.8
Q ss_pred CcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC--cCHHHHHHHHHHHhhc---CCCCccceee
Q 041702 516 FSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG--QGLEEFKNEMMLIAKL---QHRNLVRLFG 590 (840)
Q Consensus 516 f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~--~~~~~f~~Ev~~l~~l---~H~niv~l~g 590 (840)
|++.+.||+|+||.||+|.++ .+++.||+|+++.... .....+.+|+.++.++ +|+|++++++
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~------------~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~ 68 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDL------------NTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLD 68 (287)
T ss_pred CeEEEEecccCceEEEEEEEC------------CCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEE
Confidence 567789999999999999765 4688999999974422 2234577888877766 5999999999
Q ss_pred EeecCCc-----eEEEEEeeccCC---c--cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCC
Q 041702 591 CCIEQGE-----KISIYEFDIVTD---P--ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMN 660 (840)
Q Consensus 591 ~~~~~~~-----~~lv~e~~~~~~---~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~ 660 (840)
++...+. .+++||+..... . .....+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.
T Consensus 69 ~~~~~~~~~~~~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~ 145 (287)
T cd07838 69 VCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQ 145 (287)
T ss_pred EEeeccCCCCceeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCC
Confidence 9988776 889999842110 1 11235899999999999999999999988 999999999999999999
Q ss_pred ceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhh
Q 041702 661 PKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWN 740 (840)
Q Consensus 661 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~ 740 (840)
+||+|||++........ .....++..|+|||.+.+..++.++||||||++++||++|++|+......+ .......
T Consensus 146 ~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~~~~ 220 (287)
T cd07838 146 VKIADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDKIFD 220 (287)
T ss_pred EEEeccCcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHHHHH
Confidence 99999999987643321 223457889999999999999999999999999999999998876433211 1111111
Q ss_pred hhccc-c-----c----ccccCccc---cchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 741 LWKDD-K-----A----WKLMDPTM---QNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 741 ~~~~~-~-----~----~~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
..... . . ........ ...........+.+++.+||+.||++||++.++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 221 VIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred HcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000 0 0 00000000 01122344567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=278.53 Aligned_cols=239 Identities=23% Similarity=0.327 Sum_probs=186.4
Q ss_pred ccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhcCCCCccceeeEeecCCce
Q 041702 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEK 598 (840)
Q Consensus 522 lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~ 598 (840)
||.|++|.||+|.+. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..
T Consensus 1 lg~g~~~~v~~~~~~------------~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 68 (262)
T cd05572 1 LGVGGFGRVELVKVK------------SKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYI 68 (262)
T ss_pred CCCCCceEEEEEEEC------------CCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCcc
Confidence 799999999999765 468899999987542 23456799999999999999999999999999999
Q ss_pred EEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceecCC
Q 041702 599 ISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGG 674 (840)
Q Consensus 599 ~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 674 (840)
++++||..... ......+++..+..++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 69 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~ 145 (262)
T cd05572 69 YMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS 145 (262)
T ss_pred EEEEecCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCc
Confidence 99999953222 123346889999999999999999999988 99999999999999999999999999987643
Q ss_pred CCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccccccCcc
Q 041702 675 DEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPT 754 (840)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 754 (840)
.. ......++..|+|||.+.+..++.++|+||||+++|||++|+.|+.....+........ .+..
T Consensus 146 ~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------~~~~ 210 (262)
T cd05572 146 GQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDI------------LKGN 210 (262)
T ss_pred cc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHH------------hccC
Confidence 32 22334678899999999888899999999999999999999999865443221111110 0000
Q ss_pred ccchhhHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 041702 755 MQNEALYSMVTRYIKVALLCVQENATDRPT-----MLEVVA 790 (840)
Q Consensus 755 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 790 (840)
.....+......+.+++.+||+.+|++||+ ++|+++
T Consensus 211 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 211 GKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 011111222456889999999999999999 555544
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=286.06 Aligned_cols=250 Identities=22% Similarity=0.373 Sum_probs=187.8
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcC-CCCcccee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQ-HRNLVRLF 589 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~-H~niv~l~ 589 (840)
..++|+..+.||+|++|.||+|.+. .+++.||||+++.... ....++..|+.++.+.. ||||++++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~------------~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~ 80 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFK------------KTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCY 80 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEEC------------CCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhh
Confidence 3467888899999999999998754 4588999999975432 33456777888777775 99999999
Q ss_pred eEeecCCceEEEEEeeccC--C--ccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceecCCCCCCcEEecCCCCceee
Q 041702 590 GCCIEQGEKISIYEFDIVT--D--PARKDLLDWTTRVRIIEGVAQGLLYLHQY-SRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~--~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
++|.+....+++||+.... . ......+++..+.+++.||++||+|||+. + |+||||+|+||++++++.+||+
T Consensus 81 ~~~~~~~~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~ 157 (296)
T cd06618 81 GYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLC 157 (296)
T ss_pred eeeecCCeEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEEC
Confidence 9999999999999994211 0 11134688999999999999999999974 5 9999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCccccccCC----CCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhh
Q 041702 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGL----FSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWN 740 (840)
Q Consensus 665 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~ 740 (840)
|||++..+..... .....++..|+|||.+.+.. ++.++||||||++++||++|+.|+...... ..... .
T Consensus 158 dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~---~ 230 (296)
T cd06618 158 DFGISGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-FEVLT---K 230 (296)
T ss_pred ccccchhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-HHHHH---H
Confidence 9999876543221 12235778999999987553 889999999999999999999997532111 11111 1
Q ss_pred hhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 741 LWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 741 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
... ..... ... .......+.+++.+||+.||++||++.++++.
T Consensus 231 ~~~-~~~~~-----~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 231 ILQ-EEPPS-----LPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred Hhc-CCCCC-----CCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111 11100 100 00234468899999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=284.02 Aligned_cols=241 Identities=24% Similarity=0.342 Sum_probs=188.2
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEeecCCceE
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKI 599 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~ 599 (840)
.+||+|+||.||++..+ .+++.||||++........+.+.+|+.++++++|+||+++++++...+..+
T Consensus 26 ~~lg~g~~g~v~~~~~~------------~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 93 (292)
T cd06657 26 IKIGEGSTGIVCIATVK------------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELW 93 (292)
T ss_pred HHcCCCCCeEEEEEEEc------------CCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEE
Confidence 57999999999998654 578999999987655555677999999999999999999999999999999
Q ss_pred EEEEeeccC---CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceecCCCC
Q 041702 600 SIYEFDIVT---DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDE 676 (840)
Q Consensus 600 lv~e~~~~~---~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 676 (840)
++|||.... .......+++.....++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 94 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~ 170 (292)
T cd06657 94 VVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 170 (292)
T ss_pred EEEecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc
Confidence 999984222 1222345789999999999999999999988 9999999999999999999999999987654322
Q ss_pred cccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccccccCcccc
Q 041702 677 MQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQ 756 (840)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 756 (840)
.......++..|+|||.+.+..++.++||||||++++||++|+.|+...... .... .... ...+...
T Consensus 171 --~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--~~~~----~~~~-----~~~~~~~ 237 (292)
T cd06657 171 --PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMK----MIRD-----NLPPKLK 237 (292)
T ss_pred --ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHH----HHHh-----hCCcccC
Confidence 1123356789999999998888999999999999999999999997532211 1110 0000 0001110
Q ss_pred chhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 757 NEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 757 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
........+.+++.+||+.+|.+||++.+|++
T Consensus 238 --~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 238 --NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred --CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 01122345778899999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=277.40 Aligned_cols=243 Identities=25% Similarity=0.326 Sum_probs=193.6
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
+|+..++||+|+||.||++.++ .+++.+|+|++.... .....++.+|++++++++|+||+++++++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~------------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 68 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRL------------SDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF 68 (256)
T ss_pred CceEeeeecCCCceeEEEEEEC------------CCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhh
Confidence 4778899999999999998654 578899999987542 33456788999999999999999999999
Q ss_pred ecCCceEEEEEeeccCCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 593 IEQGEKISIYEFDIVTDP--------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~~--------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
.+....++++||...... .....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+
T Consensus 69 ~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~ 145 (256)
T cd08530 69 LDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIG 145 (256)
T ss_pred ccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEe
Confidence 999999999998432221 12356889999999999999999999988 9999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 665 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
|||++...... ......+++.|+|||.+.+..++.++|+||||++++||++|+.|+...... .+.. ....
T Consensus 146 d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~~~----~~~~ 215 (256)
T cd08530 146 DLGISKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--DLRY----KVQR 215 (256)
T ss_pred eccchhhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHH----HHhc
Confidence 99999876543 122345788999999999999999999999999999999999998543211 1110 0111
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
. ............+.+++.+|++.+|++||++.++++.
T Consensus 216 ~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 216 G---------KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred C---------CCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1 1111122445668899999999999999999999763
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=308.60 Aligned_cols=253 Identities=27% Similarity=0.452 Sum_probs=176.2
Q ss_pred HHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccce
Q 041702 510 SAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRL 588 (840)
Q Consensus 510 ~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l 588 (840)
..-..+|++++.||+||||.|||++++ -||+.+|||++.... ........+|+++|++|+|||||++
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNK------------lDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRY 542 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNK------------LDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRY 542 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeec------------ccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 456688999999999999999999887 799999999998653 3345668899999999999999999
Q ss_pred eeEeecCCceEEEEEe----------------------------------------e---cc------------------
Q 041702 589 FGCCIEQGEKISIYEF----------------------------------------D---IV------------------ 607 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~----------------------------------------~---~~------------------ 607 (840)
+..+.+.....-++|. + ..
T Consensus 543 ysAWVEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d 622 (1351)
T KOG1035|consen 543 YSAWVESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDD 622 (1351)
T ss_pred ehhhhccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccc
Confidence 9776543322211110 0 00
Q ss_pred --CCc---c----------------------c----cC------------------------------CC--CHHHHHHH
Q 041702 608 --TDP---A----------------------R----KD------------------------------LL--DWTTRVRI 624 (840)
Q Consensus 608 --~~~---~----------------------~----~~------------------------------~l--~~~~~~~i 624 (840)
.+. . . .+ .. .-...+++
T Consensus 623 ~dedg~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrL 702 (1351)
T KOG1035|consen 623 SDEDGRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRL 702 (1351)
T ss_pred ccccccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHH
Confidence 000 0 0 00 00 01233679
Q ss_pred HHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceecC---C-------------CCcccccccccccc
Q 041702 625 IEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFG---G-------------DEMQSNTNRIVGTY 688 (840)
Q Consensus 625 ~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~---~-------------~~~~~~~~~~~gt~ 688 (840)
+.+|+.||+|+|+.+ ||||||||.||+||++..+||+|||+|.... . .......+..+||.
T Consensus 703 FreIlEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTa 779 (1351)
T KOG1035|consen 703 FREILEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTA 779 (1351)
T ss_pred HHHHHHHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCccccccccee
Confidence 999999999999999 9999999999999999999999999998721 0 11111345678999
Q ss_pred cccCccccccC---CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHH
Q 041702 689 GYMSPEYALHG---LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVT 765 (840)
Q Consensus 689 ~y~aPE~~~~~---~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 765 (840)
-|+|||++.+. .|+.|+|+|||||||+||+. ||.... +. .......+.+.+. .+ .........
T Consensus 780 lYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--ER---a~iL~~LR~g~iP---~~---~~f~~~~~~ 845 (1351)
T KOG1035|consen 780 LYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM--ER---ASILTNLRKGSIP---EP---ADFFDPEHP 845 (1351)
T ss_pred eeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchH--HH---HHHHHhcccCCCC---CC---cccccccch
Confidence 99999998765 49999999999999999984 332111 00 0011111111111 11 111222333
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 766 RYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 766 ~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
.-..++.++++.||.+|||+.|++..
T Consensus 846 ~e~slI~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 846 EEASLIRWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred HHHHHHHHHhcCCCccCCCHHHHhhc
Confidence 44688999999999999999999754
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-31 Score=287.07 Aligned_cols=256 Identities=18% Similarity=0.264 Sum_probs=183.8
Q ss_pred ccccCC--CCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceeeEeecC
Q 041702 520 NKLGEG--GFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQ 595 (840)
Q Consensus 520 ~~lG~G--~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~ 595 (840)
..||+| +||+||+|.+. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++..+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~ 71 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHT------------PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG 71 (328)
T ss_pred HHhCCcccCceeEEEEEEc------------CCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecC
Confidence 457777 88999999754 689999999987542 23356789999999999999999999999999
Q ss_pred CceEEEEEeeccCCcc------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccc
Q 041702 596 GEKISIYEFDIVTDPA------RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIA 669 (840)
Q Consensus 596 ~~~~lv~e~~~~~~~~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla 669 (840)
+..++++||....... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++||+.+
T Consensus 72 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~ 148 (328)
T cd08226 72 SWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHL 148 (328)
T ss_pred CceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHH
Confidence 9999999995332211 1234788889999999999999999988 999999999999999999999999865
Q ss_pred eecCCCCccc-----ccccccccccccCccccccC--CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHh---
Q 041702 670 RTFGGDEMQS-----NTNRIVGTYGYMSPEYALHG--LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAW--- 739 (840)
Q Consensus 670 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~--~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~--- 739 (840)
.......... ......++..|+|||++.+. .++.++|||||||+++||++|+.|+...............
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 228 (328)
T cd08226 149 YSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPY 228 (328)
T ss_pred hhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCC
Confidence 4332111100 01112345679999998764 4789999999999999999999998643221100000000
Q ss_pred ------------hhh----------------cccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 740 ------------NLW----------------KDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 740 ------------~~~----------------~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
... .......+.+..+...........+.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 229 SPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred CCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 000 000000111112222233445677899999999999999999999973
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=285.73 Aligned_cols=246 Identities=29% Similarity=0.432 Sum_probs=189.4
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
+.|+..+.||+|+||.||+|+++ .+++.+|+|.+.... ....+++.+|++++++++|+|++++++
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~------------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 82 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDV------------RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEc------------CCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEE
Confidence 44777789999999999999764 578899999986432 223457889999999999999999999
Q ss_pred EeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 591 CCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
++...+..++|+||..... ......+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.+||+||
T Consensus 83 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~df 159 (308)
T cd06634 83 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDF 159 (308)
T ss_pred EEEcCCeeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCc
Confidence 9999999999999953111 112345789999999999999999999987 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhc
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYAL---HGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWK 743 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~ 743 (840)
|++..... .....+++.|+|||.+. ...++.++|||||||+++||++|+.|+...... .... ....
T Consensus 160 g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~---~~~~ 228 (308)
T cd06634 160 GSASIMAP------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALY---HIAQ 228 (308)
T ss_pred ccceeecC------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH--HHHH---HHhh
Confidence 99876532 12346788999999874 356889999999999999999999987432111 1010 0000
Q ss_pred ccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 041702 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794 (840)
Q Consensus 744 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~ 794 (840)
.. .+... .......+.+++.+||+.+|++||++.+|++.--.
T Consensus 229 -~~-----~~~~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~ 270 (308)
T cd06634 229 -NE-----SPALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (308)
T ss_pred -cC-----CCCcC---cccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence 00 01111 11234557889999999999999999999976443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=288.26 Aligned_cols=263 Identities=22% Similarity=0.299 Sum_probs=192.4
Q ss_pred HHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCcc
Q 041702 509 ISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLV 586 (840)
Q Consensus 509 ~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv 586 (840)
+...+++|+..+.||+|+||.||+|.+. .+++.||||++.... ....+.+.+|++++.+++||||+
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv 72 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQ------------LTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENII 72 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEEC------------CCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCee
Confidence 3457889999999999999999999654 678999999986432 23456788999999999999999
Q ss_pred ceeeEeec-CCceEEEEEeeccC--CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCcee
Q 041702 587 RLFGCCIE-QGEKISIYEFDIVT--DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKI 663 (840)
Q Consensus 587 ~l~g~~~~-~~~~~lv~e~~~~~--~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL 663 (840)
++++++.. .+..++++||.... .......+++.....++.|+++||.|||+.+ |+||||||+||++++++.+||
T Consensus 73 ~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l 149 (328)
T cd07856 73 SLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKI 149 (328)
T ss_pred eEeeeEecCCCcEEEEeehhccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEe
Confidence 99999876 56788999984211 1112345788888899999999999999988 999999999999999999999
Q ss_pred eccccceecCCCCcccccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccH-h-H----
Q 041702 664 SDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTL-L-G---- 736 (840)
Q Consensus 664 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~-~-~---- 736 (840)
+|||++...... .....++..|+|||.+.+ ..++.++||||||++++||++|+.|+.......... . .
T Consensus 150 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~ 224 (328)
T cd07856 150 CDFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGT 224 (328)
T ss_pred CccccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999998754321 123456889999998766 568999999999999999999999986543211000 0 0
Q ss_pred ---HHhhhhccccccccc-Cccccc-----hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 737 ---HAWNLWKDDKAWKLM-DPTMQN-----EALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 737 ---~~~~~~~~~~~~~~~-d~~l~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
.........+..+.+ ...... .........+.+++.+||+.+|++||++++++..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 225 PPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred CCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000000 000000 0111234578899999999999999999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=286.98 Aligned_cols=260 Identities=23% Similarity=0.322 Sum_probs=188.8
Q ss_pred cCCcc-cccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcC--------------HHHHHHHHHHHh
Q 041702 514 DNFSE-ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQG--------------LEEFKNEMMLIA 578 (840)
Q Consensus 514 ~~f~~-~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~--------------~~~f~~Ev~~l~ 578 (840)
++|.. .+.||+|+||.||+|.++ .+++.||||+++...... ...+.+|++++.
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 75 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDT------------LTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEEC------------CCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHH
Confidence 45543 467999999999999765 578899999986542211 125789999999
Q ss_pred hcCCCCccceeeEeecCCceEEEEEeeccC---CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEe
Q 041702 579 KLQHRNLVRLFGCCIEQGEKISIYEFDIVT---DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLL 655 (840)
Q Consensus 579 ~l~H~niv~l~g~~~~~~~~~lv~e~~~~~---~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl 655 (840)
+++|+||+++++++...+..+++||+.... .......+++.....++.|++.||+|||+.+ ++|+||||+||++
T Consensus 76 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill 152 (335)
T PTZ00024 76 EIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFI 152 (335)
T ss_pred hCCCcceeeeeEEEecCCcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEE
Confidence 999999999999999999999999985321 1123346888999999999999999999988 9999999999999
Q ss_pred cCCCCceeeccccceecCCCCc------------ccccccccccccccCccccccC-CCCccccchhHHHHHHHHHhCCC
Q 041702 656 DSDMNPKISDFGIARTFGGDEM------------QSNTNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSKK 722 (840)
Q Consensus 656 ~~~~~~kL~DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~SlGviL~elltG~~ 722 (840)
+.++.+||+|||+++....... ........++..|+|||.+.+. .++.++||||||++++||++|+.
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~ 232 (335)
T PTZ00024 153 NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232 (335)
T ss_pred CCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 9999999999999987642110 1111223467899999998764 47899999999999999999999
Q ss_pred CCCCCCCCCccHhHHHhhhhccccc-----------ccccCcccc---chhhHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 041702 723 NTRFYNTDSLTLLGHAWNLWKDDKA-----------WKLMDPTMQ---NEALYSMVTRYIKVALLCVQENATDRPTMLEV 788 (840)
Q Consensus 723 p~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev 788 (840)
|+...... ............... ......... ..........+.+++.+||+.+|++||+++|+
T Consensus 233 p~~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~ 310 (335)
T PTZ00024 233 LFPGENEI--DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEA 310 (335)
T ss_pred CCCCCCHH--HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHH
Confidence 98644321 111111111110000 000000000 01111234568899999999999999999999
Q ss_pred HH
Q 041702 789 VA 790 (840)
Q Consensus 789 l~ 790 (840)
+.
T Consensus 311 l~ 312 (335)
T PTZ00024 311 LK 312 (335)
T ss_pred hc
Confidence 85
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=279.03 Aligned_cols=256 Identities=21% Similarity=0.272 Sum_probs=194.4
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC----CcCHHHHHHHHHHHhhc-CCCCcccee
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS----GQGLEEFKNEMMLIAKL-QHRNLVRLF 589 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~----~~~~~~f~~Ev~~l~~l-~H~niv~l~ 589 (840)
+|+..+.||+|++|.||+|.+. +...++..||||++++.. ....+.+.+|+.++.++ +||||++++
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~---------~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~ 71 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKV---------GGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLH 71 (288)
T ss_pred CceEEEEeccCCCceEEEEEEe---------ccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhh
Confidence 3677889999999999998765 444578899999987432 23446789999999999 599999999
Q ss_pred eEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 590 GCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
+.+..++..++||||..... ......+++.....++.|++++|.|||+.+ ++||||||+||+++.++.++|+|
T Consensus 72 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~d 148 (288)
T cd05583 72 YAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTD 148 (288)
T ss_pred eeeecCCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEE
Confidence 99999999999999953222 122356888999999999999999999987 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCC--CCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGL--FSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWK 743 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~ 743 (840)
||+++.+...... ......++..|+|||.+.+.. .+.++||||||++++||++|..|+........ ..........
T Consensus 149 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-~~~~~~~~~~ 226 (288)
T cd05583 149 FGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS-QSEISRRILK 226 (288)
T ss_pred Ccccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch-HHHHHHHHHc
Confidence 9998775433211 122345788999999987655 78999999999999999999999854322111 1111111110
Q ss_pred ccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 744 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
. .+.. .......+.+++.+||+.+|++|||+.++.+.|+..
T Consensus 227 ~-------~~~~----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 227 S-------KPPF----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred c-------CCCC----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 0 0111 112234577899999999999999999998888764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=283.02 Aligned_cols=241 Identities=29% Similarity=0.469 Sum_probs=185.9
Q ss_pred CcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC---cCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 516 FSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG---QGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 516 f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
|...++||+|+||.||+|++. .+++.||+|++..... ...+.+.+|++++++++|||++++++++
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~------------~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 90 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNS------------HTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCY 90 (313)
T ss_pred hhcceeeccCCCeEEEEEEEC------------CCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence 556678999999999999754 5788999999875422 2335688999999999999999999999
Q ss_pred ecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccc
Q 041702 593 IEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGI 668 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl 668 (840)
.+.+..+++|||..... ......+++.++..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||+
T Consensus 91 ~~~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~ 167 (313)
T cd06633 91 LKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGS 167 (313)
T ss_pred EeCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCC
Confidence 99999999999852111 112346899999999999999999999988 99999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 669 ARTFGGDEMQSNTNRIVGTYGYMSPEYAL---HGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 669 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
+.... ......++..|+|||++. ...++.++||||||++++||++|..|+..... ..... .....
T Consensus 168 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~--~~~~~---~~~~~- 235 (313)
T cd06633 168 ASKSS------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALY---HIAQN- 235 (313)
T ss_pred CcccC------CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHH---HHHhc-
Confidence 86432 122456888999999874 45688999999999999999999998743321 11111 11100
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
.. +... .......+.+++.+||+.+|.+||++.+++..
T Consensus 236 ~~-----~~~~---~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 236 DS-----PTLQ---SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CC-----CCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 1111 11223457889999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=278.73 Aligned_cols=255 Identities=23% Similarity=0.268 Sum_probs=187.9
Q ss_pred CcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcC-CCCccceeeEee
Q 041702 516 FSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQ-HRNLVRLFGCCI 593 (840)
Q Consensus 516 f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~ 593 (840)
|++.+.||+|++|.||+|+++ .+++.||||++..... .......+|+..+.+++ |+||+++++++.
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~------------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 68 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNK------------ETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFR 68 (283)
T ss_pred CeeheeeccCCceEEEEEEEC------------CCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhh
Confidence 566789999999999998754 4678999999875432 22334567999999998 999999999999
Q ss_pred cCCceEEEEEeeccCC----ccc--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 594 EQGEKISIYEFDIVTD----PAR--KDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 594 ~~~~~~lv~e~~~~~~----~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
.++..+++|||. ... ... ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 69 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~ 144 (283)
T cd07830 69 ENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFG 144 (283)
T ss_pred cCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecc
Confidence 999999999985 111 111 246899999999999999999999988 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCccccc-cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhh-----
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYAL-HGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNL----- 741 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~----- 741 (840)
++........ .....++..|+|||.+. ...++.++||||||++++||++|+.|+......+. .......
T Consensus 145 ~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~--~~~~~~~~~~~~ 219 (283)
T cd07830 145 LAREIRSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ--LYKICSVLGTPT 219 (283)
T ss_pred cceeccCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHH--HHHHHHhcCCCC
Confidence 9986543221 22346788999999875 45589999999999999999999988865432111 0000000
Q ss_pred --------hcccccccccCcccc---chhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 742 --------WKDDKAWKLMDPTMQ---NEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 742 --------~~~~~~~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
.........+..... ..........+.+++.+||+.+|++||+++|++..
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 220 KQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000000000000 01111124568899999999999999999999753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=276.59 Aligned_cols=247 Identities=24% Similarity=0.349 Sum_probs=187.8
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC-----CCcCHHHHHHHHHHHhhcCCCCccce
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK-----SGQGLEEFKNEMMLIAKLQHRNLVRL 588 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~-----~~~~~~~f~~Ev~~l~~l~H~niv~l 588 (840)
.+|+..+.||+|+||.||+|.++ .++..||+|++... .......|.+|++++++++|+||+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~------------~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 69 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDA------------DTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEc------------CCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceE
Confidence 47888999999999999999765 57889999987532 12334678999999999999999999
Q ss_pred eeEeecC--CceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCce
Q 041702 589 FGCCIEQ--GEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPK 662 (840)
Q Consensus 589 ~g~~~~~--~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 662 (840)
++++.+. +..++++|+..... ......+++....+++.|++.||.|||+.+ ++|+||||+||+++.++.++
T Consensus 70 ~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~ 146 (264)
T cd06653 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVK 146 (264)
T ss_pred EEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEE
Confidence 9998764 45778999843221 123345788899999999999999999988 99999999999999999999
Q ss_pred eeccccceecCCCCcc-cccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhh
Q 041702 663 ISDFGIARTFGGDEMQ-SNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNL 741 (840)
Q Consensus 663 L~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~ 741 (840)
|+|||+++........ .......++..|+|||.+.+..++.++|||||||+++||++|+.|+..... .. .....
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~---~~~~~ 221 (264)
T cd06653 147 LGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA--MA---AIFKI 221 (264)
T ss_pred ECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH--HH---HHHHH
Confidence 9999999865321111 112235688999999999988899999999999999999999999753211 11 01010
Q ss_pred hcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 742 WKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 742 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
. ........+....+.+.+++.+|++ +|..||+..+++.
T Consensus 222 ~---------~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 222 A---------TQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred H---------cCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 0 0111112223344568889999999 5799999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=274.84 Aligned_cols=244 Identities=27% Similarity=0.412 Sum_probs=192.8
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC--cCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG--QGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
+|+..+.||+|++|.||+|.+. .+++.|++|.+..... ...+.+.+|++++.+++|+|++++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~------------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 68 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNL------------ETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSI 68 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEc------------CCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEE
Confidence 4677889999999999998654 5678999999976643 4567899999999999999999999999
Q ss_pred ecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccc
Q 041702 593 IEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGI 668 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl 668 (840)
.+.+..++++|+..... ......+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 69 ~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~ 145 (254)
T cd06627 69 ETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGV 145 (254)
T ss_pred EeCCEEEEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEecccc
Confidence 99999999999843221 122356899999999999999999999988 99999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccc
Q 041702 669 ARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAW 748 (840)
Q Consensus 669 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (840)
+......... .....++..|+|||.+.+..++.++||||||+++++|++|+.|+..... ....+.... ...
T Consensus 146 ~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~-~~~- 216 (254)
T cd06627 146 ATKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-----MAALFRIVQ-DDH- 216 (254)
T ss_pred ceecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHhc-cCC-
Confidence 9876543221 2334678899999999888899999999999999999999998753221 111111110 000
Q ss_pred cccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 749 KLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 749 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
+. ........+.+++.+||+.+|++||++.+++.
T Consensus 217 ----~~----~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 217 ----PP----LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ----CC----CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 11 11122456788999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=279.22 Aligned_cols=245 Identities=22% Similarity=0.297 Sum_probs=189.4
Q ss_pred ccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC---cCHHHHHHHHHHHhhcCCCCccceeeEeecCCce
Q 041702 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG---QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEK 598 (840)
Q Consensus 522 lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~ 598 (840)
||+|+||.||++.++ .+++.+|+|++..... ...+.+.+|++++.+++||||+++++.+..++..
T Consensus 1 lg~g~~~~vy~~~~~------------~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 68 (265)
T cd05579 1 ISKGAYGRVFLAKKK------------STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNL 68 (265)
T ss_pred CCCCCceEEEEEEEC------------CCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEE
Confidence 689999999999754 5689999999875432 4567799999999999999999999999999999
Q ss_pred EEEEEeeccCCc----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceecCC
Q 041702 599 ISIYEFDIVTDP----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGG 674 (840)
Q Consensus 599 ~lv~e~~~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 674 (840)
++++|+...... .....+++..+.+++.||+.||+|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 69 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~ 145 (265)
T cd05579 69 YLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLV 145 (265)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhccc
Confidence 999999533221 12346899999999999999999999988 99999999999999999999999999876533
Q ss_pred CCc------ccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccc
Q 041702 675 DEM------QSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAW 748 (840)
Q Consensus 675 ~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (840)
... ........++..|+|||...+...+.++||||||++++||++|+.|+....... .. ... ....
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~~---~~~-~~~~-- 217 (265)
T cd05579 146 RRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE--IF---QNI-LNGK-- 217 (265)
T ss_pred CcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH--HH---HHH-hcCC--
Confidence 211 112234567889999999988889999999999999999999999975432111 11 111 1000
Q ss_pred cccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 749 KLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 749 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
............+.+++.+||+.+|++|||+.+|.+.|+..
T Consensus 218 ------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~ 258 (265)
T cd05579 218 ------IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHP 258 (265)
T ss_pred ------cCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCc
Confidence 00000011245678999999999999999997777777653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=286.92 Aligned_cols=260 Identities=23% Similarity=0.264 Sum_probs=184.3
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhc-CCCCccceeeE
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKL-QHRNLVRLFGC 591 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l-~H~niv~l~g~ 591 (840)
+|+..+.||+|+||.||+|.+. . ..++..||+|++.... ....+.+.+|+.++.++ +||||++++++
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~---------~-~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 70 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNA---------E-TSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDM 70 (332)
T ss_pred CceEEEEccccCCeEEEEEEeC---------C-CCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeee
Confidence 4777889999999999999764 1 1127889999987532 22356788999999999 59999999997
Q ss_pred eecC----CceEEEEEeecc---CCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 592 CIEQ----GEKISIYEFDIV---TDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 592 ~~~~----~~~~lv~e~~~~---~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
+... ...++++++... ........+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 71 ~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~ 147 (332)
T cd07857 71 DIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKIC 147 (332)
T ss_pred eeeccccCCcEEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeC
Confidence 6433 346677776321 11223456889999999999999999999988 9999999999999999999999
Q ss_pred ccccceecCCCCcc--cccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhh-
Q 041702 665 DFGIARTFGGDEMQ--SNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWN- 740 (840)
Q Consensus 665 DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~- 740 (840)
|||+++.+...... .......|+..|+|||.+.+ ..++.++|||||||++++|++|+.|+....... .......
T Consensus 148 Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~--~~~~~~~~ 225 (332)
T cd07857 148 DFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD--QLNQILQV 225 (332)
T ss_pred cCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH--HHHHHHHH
Confidence 99999876432221 11234578999999998765 568999999999999999999999876432111 0000000
Q ss_pred ----------hhcccccccc---c---CccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 041702 741 ----------LWKDDKAWKL---M---DPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVV 789 (840)
Q Consensus 741 ----------~~~~~~~~~~---~---d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 789 (840)
.......... . ...............+.+++.+||+.||++|||+.+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll 290 (332)
T cd07857 226 LGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290 (332)
T ss_pred hCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 0000000000 0 00000000111235688999999999999999999987
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=274.24 Aligned_cols=245 Identities=22% Similarity=0.369 Sum_probs=194.2
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC--cCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG--QGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
+|+..+.||+|+||.||++.+. .+++.+|+|++..... ...+++.+|++++++++|||++++++.+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~------------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~ 68 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRK------------SDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESF 68 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEc------------CCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEE
Confidence 4778889999999999999764 4788999999976533 4567799999999999999999999999
Q ss_pred ecCCceEEEEEeeccCC--------ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 593 IEQGEKISIYEFDIVTD--------PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~--------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
...+..++++|+..... ......+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.+||+
T Consensus 69 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~ 145 (258)
T cd08215 69 EEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLG 145 (258)
T ss_pred ecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEEC
Confidence 99999999999843221 111367899999999999999999999988 9999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 665 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
|||++....... .......+++.|+|||.+.+..++.++||||||+++++|++|+.|+...... ... ... ..
T Consensus 146 d~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--~~~---~~~-~~ 217 (258)
T cd08215 146 DFGISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL--ELA---LKI-LK 217 (258)
T ss_pred CccceeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH--HHH---HHH-hc
Confidence 999998764432 1223356888999999999889999999999999999999999987543211 111 111 11
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
.... .+ +......+.+++.+||..+|++||++.++++.
T Consensus 218 ~~~~-----~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 218 GQYP-----PI----PSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCC-----CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1110 11 11234567889999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=289.00 Aligned_cols=262 Identities=21% Similarity=0.267 Sum_probs=188.8
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
..+|...+.||+|+||.||+|.++ .+++.||+|++........+.+.+|++++++++||||+++++++
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~------------~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~ 71 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDS------------DCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVL 71 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEEC------------CCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhh
Confidence 368899999999999999999765 67899999999776556667899999999999999999999876
Q ss_pred ecC--------------CceEEEEEeeccC--CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEec
Q 041702 593 IEQ--------------GEKISIYEFDIVT--DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLD 656 (840)
Q Consensus 593 ~~~--------------~~~~lv~e~~~~~--~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~ 656 (840)
... ...++++||.... .......+++.....++.||+.||.|||+.+ |+||||||+||+++
T Consensus 72 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~ 148 (342)
T cd07854 72 GPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFIN 148 (342)
T ss_pred cccccccccccccccccceEEEEeecccccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEc
Confidence 554 3568899985321 1112346889999999999999999999988 99999999999997
Q ss_pred C-CCCceeeccccceecCCCCccc-ccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc
Q 041702 657 S-DMNPKISDFGIARTFGGDEMQS-NTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLT 733 (840)
Q Consensus 657 ~-~~~~kL~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~ 733 (840)
. ++.+||+|||+++......... ......++..|+|||.+.+ ..++.++|||||||+++||++|+.||.........
T Consensus 149 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~ 228 (342)
T cd07854 149 TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM 228 (342)
T ss_pred CCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 4 5578999999998653321111 1123457889999997654 56889999999999999999999998643321100
Q ss_pred HhHHHhhhh--cc---ccc-----cccc----Cccc-cchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 734 LLGHAWNLW--KD---DKA-----WKLM----DPTM-QNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 734 ~~~~~~~~~--~~---~~~-----~~~~----d~~l-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
........ .. ... .... .+.. ...........+.+++.+||+.||++|||++++++
T Consensus 229 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 229 -QLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred -HHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00000000 00 000 0000 0000 00111123456889999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=277.98 Aligned_cols=256 Identities=25% Similarity=0.343 Sum_probs=190.5
Q ss_pred CcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceeeEee
Q 041702 516 FSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFGCCI 593 (840)
Q Consensus 516 f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~ 593 (840)
|+..+.||+|++|.||+|.+. .+++.||+|++.... ....+.+.+|+.++++++|+||+++++++.
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~------------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 68 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDK------------KTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIH 68 (282)
T ss_pred CeeehcccccCcceEEEeeec------------CCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhh
Confidence 456678999999999998654 568999999998653 334567889999999999999999999999
Q ss_pred cCCceEEEEEeeccCC---cccc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccc
Q 041702 594 EQGEKISIYEFDIVTD---PARK-DLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIA 669 (840)
Q Consensus 594 ~~~~~~lv~e~~~~~~---~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla 669 (840)
+.+..++++|+..... .... ..+++..+.+++.+++.||+|||+.+ |+||||+|+||++++++.+||+|||++
T Consensus 69 ~~~~~~~v~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~ 145 (282)
T cd07829 69 TERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLA 145 (282)
T ss_pred cCCceEEEecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcc
Confidence 9999999999843210 1111 46889999999999999999999988 999999999999999999999999999
Q ss_pred eecCCCCcccccccccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhh-------
Q 041702 670 RTFGGDEMQSNTNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNL------- 741 (840)
Q Consensus 670 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~------- 741 (840)
+....... ......++..|+|||.+.+. .++.++||||||++++||++|+.|+......+ ........
T Consensus 146 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 221 (282)
T cd07829 146 RAFGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID--QLFKIFQILGTPTEE 221 (282)
T ss_pred cccCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH--HHHHHHHHhCCCcHH
Confidence 87643221 12233457789999998776 78999999999999999999998875433211 11111000
Q ss_pred ----hcccc----cccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 742 ----WKDDK----AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 742 ----~~~~~----~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
..... ....................+.+++.+||+.+|++||++++|+.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 222 SWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred HHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000 00000000001111123556899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=275.93 Aligned_cols=239 Identities=25% Similarity=0.293 Sum_probs=182.7
Q ss_pred ccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhcCCCCccceeeEeecCCce
Q 041702 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEK 598 (840)
Q Consensus 522 lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~ 598 (840)
||+|+||+||+|.++ .+++.||+|.+.... ....+.+.+|++++++++||||+++++++...+..
T Consensus 1 lg~g~~g~vy~~~~~------------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 68 (277)
T cd05577 1 LGKGGFGEVCACQVK------------ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDL 68 (277)
T ss_pred CCCCCceeEEEEEEc------------CCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeE
Confidence 699999999998654 578899999986432 23345678999999999999999999999999999
Q ss_pred EEEEEeeccCCc----c--ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceec
Q 041702 599 ISIYEFDIVTDP----A--RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTF 672 (840)
Q Consensus 599 ~lv~e~~~~~~~----~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~ 672 (840)
++++||...... . ....+++..+..++.|+++||.|||+.+ ++||||+|+||+++.++.+||+|||++...
T Consensus 69 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~ 145 (277)
T cd05577 69 CLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVEL 145 (277)
T ss_pred EEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhh
Confidence 999998432211 1 1236889999999999999999999988 999999999999999999999999998765
Q ss_pred CCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccccccC
Q 041702 673 GGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMD 752 (840)
Q Consensus 673 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 752 (840)
.... ......++..|+|||.+.+..++.++||||||+++++|++|+.|+.......... ........
T Consensus 146 ~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~~~~~-------- 212 (277)
T cd05577 146 KGGK---KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE--ELKRRTLE-------- 212 (277)
T ss_pred ccCC---ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH--HHHhcccc--------
Confidence 4321 1223457889999999988889999999999999999999999986443211100 00000000
Q ss_pred ccccchhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041702 753 PTMQNEALYSMVTRYIKVALLCVQENATDRP-----TMLEVVA 790 (840)
Q Consensus 753 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 790 (840)
............+.+++.+||+.+|++|| ++.++++
T Consensus 213 --~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 213 --MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred --ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 00011122345678999999999999999 5555653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=276.71 Aligned_cols=242 Identities=21% Similarity=0.241 Sum_probs=182.9
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC---cCHHHHHHHHHHH-hhcCCCCccceeeEeecC
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG---QGLEEFKNEMMLI-AKLQHRNLVRLFGCCIEQ 595 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~---~~~~~f~~Ev~~l-~~l~H~niv~l~g~~~~~ 595 (840)
+.||+|+||.||+|.++ .+++.||||+++.... .....+..|..++ ...+|+|++++++++..+
T Consensus 2 ~~l~~g~~~~v~~a~~~------------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 69 (260)
T cd05611 2 KPISKGAFGSVYLAKKR------------STGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSK 69 (260)
T ss_pred ccCCcCCCeeEEEEEec------------CCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcC
Confidence 46999999999999764 5688999999875421 2223455555544 445899999999999999
Q ss_pred CceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccccee
Q 041702 596 GEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 596 ~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
+..++++||..... ......+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++.
T Consensus 70 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 146 (260)
T cd05611 70 DYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRN 146 (260)
T ss_pred CeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeeccccee
Confidence 99999999953322 122346889999999999999999999988 99999999999999999999999999876
Q ss_pred cCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccccccccc
Q 041702 672 FGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLM 751 (840)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (840)
... .....++..|+|||.+.+..++.++||||||++++||++|..|+...... . ..........
T Consensus 147 ~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~----~~~~~~~~~~---- 210 (260)
T cd05611 147 GLE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD--A----VFDNILSRRI---- 210 (260)
T ss_pred ccc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH--H----HHHHHHhccc----
Confidence 432 22345788999999998888999999999999999999999998543211 1 1111111100
Q ss_pred CccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 041702 752 DPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794 (840)
Q Consensus 752 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~ 794 (840)
.............+.+++.+||+.+|++||++.++.+.|+.
T Consensus 211 --~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 211 --NWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred --CCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 00111111234568899999999999999988877776654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=273.03 Aligned_cols=246 Identities=21% Similarity=0.256 Sum_probs=184.5
Q ss_pred HHHHHHccCCcccccc--cCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhc-CCC
Q 041702 507 SSISAATDNFSEENKL--GEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL-QHR 583 (840)
Q Consensus 507 ~~~~~~~~~f~~~~~l--G~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l-~H~ 583 (840)
.+.....++|.+.+.+ |+|+||.||++.++ .++..+|+|.+........ |+.....+ +||
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~------------~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~ 69 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHK------------PTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNP 69 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEc------------CCCcEEEEEEEehhhcchh-----hHHHHHHhhcCC
Confidence 3445556677777776 99999999998754 5788999999875422211 22222222 799
Q ss_pred CccceeeEeecCCceEEEEEeeccCCc----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCC
Q 041702 584 NLVRLFGCCIEQGEKISIYEFDIVTDP----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDM 659 (840)
Q Consensus 584 niv~l~g~~~~~~~~~lv~e~~~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~ 659 (840)
||+++++++...+..++||||...... .....+++.++..++.||++||.|||+.+ ++||||||+||+++.++
T Consensus 70 ~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~ 146 (267)
T PHA03390 70 NFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAK 146 (267)
T ss_pred CEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCC
Confidence 999999999999999999999432222 23347899999999999999999999988 99999999999999998
Q ss_pred -CceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHH
Q 041702 660 -NPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHA 738 (840)
Q Consensus 660 -~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~ 738 (840)
.++|+|||++...... ....++..|+|||.+.+..++.++||||||++++||++|+.|+..............
T Consensus 147 ~~~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~ 220 (267)
T PHA03390 147 DRIYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLL 220 (267)
T ss_pred CeEEEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHH
Confidence 9999999998765422 123578899999999999999999999999999999999999874332222111111
Q ss_pred hhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 041702 739 WNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPT-MLEVVA 790 (840)
Q Consensus 739 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~ 790 (840)
... . .. ..........+.+++.+||+.+|.+||+ ++|+++
T Consensus 221 ~~~--~--------~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 221 KRQ--Q--------KK--LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred Hhh--c--------cc--CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 110 0 00 0111234456889999999999999995 688874
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=289.54 Aligned_cols=258 Identities=23% Similarity=0.330 Sum_probs=191.2
Q ss_pred HHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC--CCcCHHHHHHHHHHHhhcCCCCccce
Q 041702 511 AATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK--SGQGLEEFKNEMMLIAKLQHRNLVRL 588 (840)
Q Consensus 511 ~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l 588 (840)
...++|+..+.||+|++|.||+|.+. .+++.||||++... .....+++.+|+.++++++||||+++
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~------------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 79 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDT------------KTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGL 79 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEEC------------CCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHH
Confidence 45678999999999999999999765 57889999998753 22334668889999999999999999
Q ss_pred eeEeecCCc------eEEEEEeecc--CCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCC
Q 041702 589 FGCCIEQGE------KISIYEFDIV--TDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMN 660 (840)
Q Consensus 589 ~g~~~~~~~------~~lv~e~~~~--~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~ 660 (840)
++++...+. .++|+|+... ........+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.
T Consensus 80 ~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~ 156 (343)
T cd07851 80 LDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCE 156 (343)
T ss_pred HHHhhccccccccccEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCC
Confidence 998876655 8899998421 11112346899999999999999999999988 999999999999999999
Q ss_pred ceeeccccceecCCCCcccccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHh
Q 041702 661 PKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAW 739 (840)
Q Consensus 661 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~ 739 (840)
+||+|||++...... .....++..|+|||.+.+ ..++.++|||||||+++||++|+.|+...... .......
T Consensus 157 ~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~--~~~~~i~ 229 (343)
T cd07851 157 LKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI--DQLKRIM 229 (343)
T ss_pred EEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHH
Confidence 999999999765332 223467889999998865 46889999999999999999999998643221 1111000
Q ss_pred hhh-----------cccccccccC---ccccc---hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 740 NLW-----------KDDKAWKLMD---PTMQN---EALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 740 ~~~-----------~~~~~~~~~d---~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
... ........+. ..... .........+.+++.+||+.+|++|||+.+|++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 230 NLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000 0000000000 00000 001123567889999999999999999999975
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=285.45 Aligned_cols=244 Identities=22% Similarity=0.326 Sum_probs=198.3
Q ss_pred HHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccce
Q 041702 511 AATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRL 588 (840)
Q Consensus 511 ~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l 588 (840)
.-...|.+...||+|.|+.|.+|++. .++..||||.+.+.. ......+.+|+++|..|+|||||++
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~------------~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl 120 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHI------------LTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKL 120 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEec------------CCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeee
Confidence 34567889999999999999999765 679999999998763 2334568999999999999999999
Q ss_pred eeEeecCCceEEEEEeec----cCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 589 FGCCIEQGEKISIYEFDI----VTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~~~----~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
+.+.......|+||||.. .................++.|+..|++|||+++ |+|||||++||||+.+.++||+
T Consensus 121 ~~v~~t~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIa 197 (596)
T KOG0586|consen 121 FSVIETEATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIA 197 (596)
T ss_pred eeeeeecceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeee
Confidence 999999999999999943 223334455666788889999999999999998 9999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhc
Q 041702 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLF-SIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWK 743 (840)
Q Consensus 665 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~ 743 (840)
|||++..+..... ....+|++.|.|||++.+..| .+++|+||+|++||-|+.|..||+.....+.
T Consensus 198 DfgfS~~~~~~~~---lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L----------- 263 (596)
T KOG0586|consen 198 DFGFSTFFDYGLM---LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL----------- 263 (596)
T ss_pred ccccceeeccccc---ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc-----------
Confidence 9999998864432 345789999999999998876 6889999999999999999999875432221
Q ss_pred ccccccccCccccch--hhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 744 DDKAWKLMDPTMQNE--ALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 744 ~~~~~~~~d~~l~~~--~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
-++.+... .+.-+...+-+++.++|-.+|.+|++++++.+
T Consensus 264 -------r~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 264 -------RPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred -------cchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 11111111 12223445778999999999999999999874
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=276.21 Aligned_cols=251 Identities=22% Similarity=0.286 Sum_probs=188.6
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC----CcCHHHHHHHHHHHhhc-CCCCcccee
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS----GQGLEEFKNEMMLIAKL-QHRNLVRLF 589 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~----~~~~~~f~~Ev~~l~~l-~H~niv~l~ 589 (840)
+|+..+.||+|+||.||+|.+. ....+|..||+|+++... ....+++.+|++++.++ +|+||++++
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~---------~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~ 71 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKV---------SGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH 71 (290)
T ss_pred CceeeeeeccCCcceEEEEEec---------cCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhcee
Confidence 4677889999999999998764 334578999999997532 23346788999999999 699999999
Q ss_pred eEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 590 GCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
+++..++..++++||..... ......+++.....++.|++.||.|||+.+ ++||||||+|||+++++.+||+|
T Consensus 72 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~d 148 (290)
T cd05613 72 YAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTD 148 (290)
T ss_pred eEeecCCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEee
Confidence 99999999999999953222 223456788888999999999999999988 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccccC--CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHG--LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWK 743 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~ 743 (840)
||++......... ......|+..|+|||.+.+. .++.++||||||++++||++|+.|+....... ...........
T Consensus 149 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-~~~~~~~~~~~ 226 (290)
T cd05613 149 FGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN-SQAEISRRILK 226 (290)
T ss_pred Cccceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc-cHHHHHHHhhc
Confidence 9999876433221 12235688899999998753 47889999999999999999999975432211 11111111100
Q ss_pred ccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041702 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRP-----TMLEVVA 790 (840)
Q Consensus 744 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 790 (840)
. .+ ..+......+.+++.+||+.+|++|| +++++++
T Consensus 227 ~-------~~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 227 S-------EP----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred c-------CC----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0 01 11122345678899999999999997 5555543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=277.79 Aligned_cols=246 Identities=25% Similarity=0.343 Sum_probs=192.9
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhcC-CCCcccee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQ-HRNLVRLF 589 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l~-H~niv~l~ 589 (840)
++|...+.||+|+||.||+|.++ .+++.||+|++... .....+.+.+|++++.+++ ||||++++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~------------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~ 68 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEK------------ETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLY 68 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEc------------CCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHH
Confidence 46888899999999999999765 57899999998753 2233467899999999998 99999999
Q ss_pred eEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 590 GCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
+++...+..+++||+..... ......+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|
T Consensus 69 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~d 145 (280)
T cd05581 69 YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITD 145 (280)
T ss_pred HHhcCCceEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecC
Confidence 99999999999999842222 223347899999999999999999999988 99999999999999999999999
Q ss_pred cccceecCCCCcc------------------cccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 041702 666 FGIARTFGGDEMQ------------------SNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFY 727 (840)
Q Consensus 666 FGla~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~ 727 (840)
||++......... .......++..|+|||.+.+..++.++||||||++++|+++|+.|+...
T Consensus 146 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 225 (280)
T cd05581 146 FGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS 225 (280)
T ss_pred CccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCc
Confidence 9999876433221 1223345788999999998888999999999999999999999997643
Q ss_pred CCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCH----HHHHH
Q 041702 728 NTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTM----LEVVA 790 (840)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~----~evl~ 790 (840)
.. ..... .... .....+....+.+.+++.+||+.+|++||++ +++++
T Consensus 226 ~~--~~~~~---~~~~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 226 NE--YLTFQ---KILK-----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred cH--HHHHH---HHHh-----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 31 11000 0000 0001112224568899999999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-32 Score=311.50 Aligned_cols=255 Identities=24% Similarity=0.352 Sum_probs=197.4
Q ss_pred HHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC--CCcCHHHHHHHHHHHhhcCCCCc
Q 041702 508 SISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK--SGQGLEEFKNEMMLIAKLQHRNL 585 (840)
Q Consensus 508 ~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~--~~~~~~~f~~Ev~~l~~l~H~ni 585 (840)
.+...+-++....+||.|.||.||-|. ...+|+..|+|-++.. .........+|+.++..|+|||+
T Consensus 1229 ~lsnV~~rWqrg~~Ig~G~fG~VYtav------------N~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNl 1296 (1509)
T KOG4645|consen 1229 SLSNVTFRWQRGNFIGGGTFGKVYTAV------------NLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNL 1296 (1509)
T ss_pred HhccceeeeccccccCCcceeeeEEee------------cCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccc
Confidence 345566778888999999999999984 4589999999987644 24456678899999999999999
Q ss_pred cceeeEeecCCceEEEEEeeccCCc----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCc
Q 041702 586 VRLFGCCIEQGEKISIYEFDIVTDP----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP 661 (840)
Q Consensus 586 v~l~g~~~~~~~~~lv~e~~~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 661 (840)
|+++|+-.+.+..++.|||...... ......++.....+..|++.|++|||+++ ||||||||.||+|+.+|.+
T Consensus 1297 V~YyGVEvHRekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~i 1373 (1509)
T KOG4645|consen 1297 VRYYGVEVHREKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLI 1373 (1509)
T ss_pred cccCceeecHHHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcE
Confidence 9999999999999999999432221 12233555556678899999999999999 9999999999999999999
Q ss_pred eeeccccceecCCCC--cccccccccccccccCccccccCC---CCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhH
Q 041702 662 KISDFGIARTFGGDE--MQSNTNRIVGTYGYMSPEYALHGL---FSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLG 736 (840)
Q Consensus 662 kL~DFGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~ 736 (840)
|++|||.|..+.... .........||+.|||||++.+.. ...++||||+|||++||+||++|+...+.+-.. .-
T Consensus 1374 K~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aI-My 1452 (1509)
T KOG4645|consen 1374 KYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAI-MY 1452 (1509)
T ss_pred EeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHH-Hh
Confidence 999999999886542 222334678999999999998644 567899999999999999999998644322111 11
Q ss_pred HHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 737 HAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 737 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
++ . . .-.+..+......-.+++..||+.||++|.++.|+++.
T Consensus 1453 ~V---~-~---------gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1453 HV---A-A---------GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred HH---h-c---------cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 11 0 0 11122233355666788999999999999998877654
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=274.07 Aligned_cols=238 Identities=25% Similarity=0.299 Sum_probs=179.0
Q ss_pred cccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC---cCHHHHHHHHHH---HhhcCCCCccceeeEeec
Q 041702 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG---QGLEEFKNEMML---IAKLQHRNLVRLFGCCIE 594 (840)
Q Consensus 521 ~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~---~~~~~f~~Ev~~---l~~l~H~niv~l~g~~~~ 594 (840)
.||+|+||.||+|.+. .+++.||+|.+..... .....+..|..+ ++...||||+++++++.+
T Consensus 1 ~ig~g~~g~Vy~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 68 (278)
T cd05606 1 IIGRGGFGEVYGCRKA------------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 68 (278)
T ss_pred CcccCCCeEEEEEEEe------------cCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec
Confidence 4899999999998654 5788999999875421 222334455444 344579999999999999
Q ss_pred CCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccce
Q 041702 595 QGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIAR 670 (840)
Q Consensus 595 ~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~ 670 (840)
.+..++|+||..... ......+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 69 ~~~~~~v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~ 145 (278)
T cd05606 69 PDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC 145 (278)
T ss_pred CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCcc
Confidence 999999999953222 223456899999999999999999999988 9999999999999999999999999987
Q ss_pred ecCCCCcccccccccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccccccc
Q 041702 671 TFGGDEMQSNTNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWK 749 (840)
Q Consensus 671 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (840)
.+.... .....|+..|+|||.+.++ .++.++||||||++++||++|+.|+............. ...
T Consensus 146 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~------ 212 (278)
T cd05606 146 DFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR---MTL------ 212 (278)
T ss_pred ccCccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH---Hhh------
Confidence 653221 2234689999999998754 68999999999999999999999986542222111100 000
Q ss_pred ccCccccchhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041702 750 LMDPTMQNEALYSMVTRYIKVALLCVQENATDRP-----TMLEVVA 790 (840)
Q Consensus 750 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 790 (840)
.....+ +......+.+++.+|++.+|++|| ++.++++
T Consensus 213 ~~~~~~----~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 213 TMAVEL----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred ccCCCC----CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 001111 112245688899999999999999 8989875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=305.24 Aligned_cols=264 Identities=28% Similarity=0.401 Sum_probs=197.5
Q ss_pred HHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhc-CCCCccce
Q 041702 511 AATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKL-QHRNLVRL 588 (840)
Q Consensus 511 ~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l-~H~niv~l 588 (840)
...++..+.+.||+|.||.|++|...... .+.......||||.++.... ...+.+..|+++|..+ +|+||+.+
T Consensus 293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~-----~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~l 367 (609)
T KOG0200|consen 293 IPRENLKLGKYLGEGAFGQVVKALLFGLS-----KALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNL 367 (609)
T ss_pred echhhccccceeecccccceEeEEEeecc-----cccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhh
Confidence 33444455569999999999998754111 01112356899999986533 4667899999999999 69999999
Q ss_pred eeEeecCCceEEEEEeeccCCcc------------------cc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCC
Q 041702 589 FGCCIEQGEKISIYEFDIVTDPA------------------RK--DLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDL 648 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~~~~~~~~------------------~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl 648 (840)
+|+|...+..++|.||....+.. .. ..+.....+.++.|||.|++||++.. ++||||
T Consensus 368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDL 444 (609)
T KOG0200|consen 368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDL 444 (609)
T ss_pred eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhh
Confidence 99999999999999993222110 01 24888999999999999999999987 999999
Q ss_pred CCCcEEecCCCCceeeccccceecCCCCcccccc-cccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCC
Q 041702 649 KASNVLLDSDMNPKISDFGIARTFGGDEMQSNTN-RIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRF 726 (840)
Q Consensus 649 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~ 726 (840)
.++|||+.++..+||+|||+|+............ ...-...|||||.+....|+.|+|||||||+||||+| |..|++.
T Consensus 445 AaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 445 AARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred hhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 9999999999999999999999765544433221 1113457999999999999999999999999999998 5555543
Q ss_pred CCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 041702 727 YNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEI 796 (840)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~ 796 (840)
... ...+ +...+++ .+.+.+......+.+++..||+.+|++||++.++++.++..+
T Consensus 525 ~~~-~~~l----~~~l~~G---------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 525 IPP-TEEL----LEFLKEG---------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred CCc-HHHH----HHHHhcC---------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 110 1111 1222222 222222333556788999999999999999999999999853
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-30 Score=278.22 Aligned_cols=238 Identities=20% Similarity=0.271 Sum_probs=173.5
Q ss_pred cCCceEEEEEeccC--CCcCHHHHHHHHHHHhhcCCCCccceeeEeecCCceEEEEEeeccCCc------cccCCCCHHH
Q 041702 549 LNGEEVAVKRLSSK--SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDP------ARKDLLDWTT 620 (840)
Q Consensus 549 ~~g~~VAvK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~~~~------~~~~~l~~~~ 620 (840)
.+++.||||++... .....+.+.+|++++++++|+||+++++++.+.+..+++|||...... .....+++..
T Consensus 23 ~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~ 102 (314)
T cd08216 23 PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELA 102 (314)
T ss_pred CCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHH
Confidence 47899999998754 344567899999999999999999999999999999999998532221 1123578888
Q ss_pred HHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceecCCCCc-----ccccccccccccccCccc
Q 041702 621 RVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEM-----QSNTNRIVGTYGYMSPEY 695 (840)
Q Consensus 621 ~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~ 695 (840)
...++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||.+........ ........++..|+|||.
T Consensus 103 ~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 179 (314)
T cd08216 103 IAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEV 179 (314)
T ss_pred HHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHH
Confidence 9999999999999999988 99999999999999999999999999876532211 111223456778999999
Q ss_pred ccc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhh----hc-------cccccc----ccCcc----
Q 041702 696 ALH--GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNL----WK-------DDKAWK----LMDPT---- 754 (840)
Q Consensus 696 ~~~--~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~----~~-------~~~~~~----~~d~~---- 754 (840)
+.. ..++.++|||||||+++||++|+.||........ ........ .. ...... ..++.
T Consensus 180 ~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (314)
T cd08216 180 LQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM-LLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDS 258 (314)
T ss_pred hcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccCccccccCchhhhcCCcCcccccccccchhhh
Confidence 876 3588999999999999999999999864322111 11000000 00 000000 00000
Q ss_pred ccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 755 MQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 755 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
............+.+++.+||+.||++|||++++++
T Consensus 259 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 259 VDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred hhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 011122334567889999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-32 Score=263.05 Aligned_cols=250 Identities=24% Similarity=0.384 Sum_probs=190.2
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhc-CCCCccceeeEe
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKL-QHRNLVRLFGCC 592 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l-~H~niv~l~g~~ 592 (840)
+.+.+..||.|+||+|+|-.++ ..|+..|||+++.... .+.++|+.|.+...+- +.||||+++|.+
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk------------~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~ 132 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHK------------PSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGAL 132 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcC------------ccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhh
Confidence 4445668999999999998665 7899999999986543 5667899998877665 789999999999
Q ss_pred ecCCceEEEEEeeccC--------CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 593 IEQGEKISIYEFDIVT--------DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~--------~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
...+..++-||.+... ..-....+++.-.-+|..-+.+||.||-..- .|||||+||+|||||..|.+|||
T Consensus 133 F~EGdcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLC 210 (361)
T KOG1006|consen 133 FSEGDCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLC 210 (361)
T ss_pred hcCCceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeee
Confidence 9999999999985332 1234556788877888888999999998754 59999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCcccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhh
Q 041702 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH--GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLW 742 (840)
Q Consensus 665 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~ 742 (840)
|||+...+.+. ...+.-.|-..|||||.+.. ..|+.++||||||++|+|+.||+.|++.... ...+.....
T Consensus 211 DFGIcGqLv~S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s----vfeql~~Vv 283 (361)
T KOG1006|consen 211 DFGICGQLVDS---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS----VFEQLCQVV 283 (361)
T ss_pred cccchHhHHHH---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH----HHHHHHHHH
Confidence 99998765332 12234467789999998864 3499999999999999999999999764332 222222221
Q ss_pred cccccccccCccc-cchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 743 KDDKAWKLMDPTM-QNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 743 ~~~~~~~~~d~~l-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
... . |.+ .+....+....+.+++..|+.+|.++||...++.++
T Consensus 284 ~gd-p-----p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 284 IGD-P-----PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cCC-C-----CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 111 1 111 111223355668889999999999999999988653
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=273.09 Aligned_cols=244 Identities=23% Similarity=0.276 Sum_probs=194.2
Q ss_pred HHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhcCCCCc
Q 041702 509 ISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQHRNL 585 (840)
Q Consensus 509 ~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l~H~ni 585 (840)
.....+.|+.-++||+||||.||-.+-+ .+|+.+|.|++.+. ..++....++|-.+|.+++.+.|
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvr------------aTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~Fi 247 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVR------------ATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFI 247 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEe------------cchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcE
Confidence 3444577888899999999999987655 68999999998654 24555667899999999999999
Q ss_pred cceeeEeecCCceEEEEEeeccC----Cc--cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCC
Q 041702 586 VRLFGCCIEQGEKISIYEFDIVT----DP--ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDM 659 (840)
Q Consensus 586 v~l~g~~~~~~~~~lv~e~~~~~----~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~ 659 (840)
|.+--.|...+...+|+..|--. +. .....+++...+-++.+|+.||++||... ||.|||||+|||||+.|
T Consensus 248 VslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~G 324 (591)
T KOG0986|consen 248 VSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHG 324 (591)
T ss_pred EEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCC
Confidence 99999999999999999885222 22 22347888999999999999999999988 99999999999999999
Q ss_pred CceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHh
Q 041702 660 NPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAW 739 (840)
Q Consensus 660 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~ 739 (840)
+++|+|+|+|..+.+... ....+||.+|||||++.++.|+...|.|||||+||||+.|+.||+......-
T Consensus 325 hvRISDLGLAvei~~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk------- 394 (591)
T KOG0986|consen 325 HVRISDLGLAVEIPEGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK------- 394 (591)
T ss_pred CeEeeccceEEecCCCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh-------
Confidence 999999999998865543 2345899999999999999999999999999999999999999864332110
Q ss_pred hhhcccccccccCccc---cchhhHHHHHHHHHHHHHccccCCCCCCCH
Q 041702 740 NLWKDDKAWKLMDPTM---QNEALYSMVTRYIKVALLCVQENATDRPTM 785 (840)
Q Consensus 740 ~~~~~~~~~~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 785 (840)
.+-+|.+. ..+++....+....|....|+.||++|..-
T Consensus 395 --------~eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 395 --------REEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred --------HHHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 00111111 112334455667778888999999999743
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-30 Score=269.69 Aligned_cols=243 Identities=25% Similarity=0.354 Sum_probs=184.2
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC-----CCcCHHHHHHHHHHHhhcCCCCcccee
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK-----SGQGLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~-----~~~~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
+|.+.++||+|+||.||++.+. ..+..+++|.++.. ......++..|+.++++++||||++++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 68 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDK------------KAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFH 68 (260)
T ss_pred CceeeeeecCCCCceEEEEEec------------CCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHH
Confidence 4777889999999999998764 23444555554421 123345677899999999999999999
Q ss_pred eEeecCCceEEEEEeeccCCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCc
Q 041702 590 GCCIEQGEKISIYEFDIVTDP--------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP 661 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~~~--------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 661 (840)
+++.+.+..++++||...... .....+++..++.++.|++.||.|||+.+ ++|+||||+||+++. +.+
T Consensus 69 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~ 144 (260)
T cd08222 69 ASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLL 144 (260)
T ss_pred HHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCE
Confidence 999999999999999533221 23456899999999999999999999988 999999999999975 569
Q ss_pred eeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhh
Q 041702 662 KISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNL 741 (840)
Q Consensus 662 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~ 741 (840)
||+|||++........ ......+++.|+|||.+.+..++.++|+||||+++++|++|..|+.... ........
T Consensus 145 ~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-----~~~~~~~~ 217 (260)
T cd08222 145 KIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-----FLSVVLRI 217 (260)
T ss_pred eecccCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHH
Confidence 9999999977643221 1223457889999999988889999999999999999999999875321 11111111
Q ss_pred hcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 742 WKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 742 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
. ... .+ .........+.+++.+||+.+|++||++.|+++
T Consensus 218 ~-~~~-----~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 218 V-EGP-----TP----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred H-cCC-----CC----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 0 000 11 112234456889999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-30 Score=282.93 Aligned_cols=196 Identities=28% Similarity=0.457 Sum_probs=167.5
Q ss_pred cccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceeeEeecC
Q 041702 517 SEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQ 595 (840)
Q Consensus 517 ~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~ 595 (840)
...+.||+|+||.||+++++ .+|+.||||.++... ....+...+|+++|++++|+|||++++.-.+.
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnk------------etG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~ 83 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNK------------ETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETK 83 (732)
T ss_pred eehhhhcCCccceeeeeccc------------ccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCcc
Confidence 34468999999999999876 789999999998753 34567889999999999999999999886543
Q ss_pred ------CceEEEEEee-------ccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEec--CCCC
Q 041702 596 ------GEKISIYEFD-------IVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLD--SDMN 660 (840)
Q Consensus 596 ------~~~~lv~e~~-------~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~--~~~~ 660 (840)
....++|||. .+........|++.+.+.++.++..||.|||+++ |+||||||.||++- ++|.
T Consensus 84 ~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq 160 (732)
T KOG4250|consen 84 FLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQ 160 (732)
T ss_pred ccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCc
Confidence 4678999993 4455666778999999999999999999999988 99999999999983 3343
Q ss_pred --ceeeccccceecCCCCcccccccccccccccCccccc-cCCCCccccchhHHHHHHHHHhCCCCCCCCCCC
Q 041702 661 --PKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYAL-HGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTD 730 (840)
Q Consensus 661 --~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~ 730 (840)
.||+|||.|+.++++. .....+||..|++||... ...|+..+|.|||||++||+.||..||......
T Consensus 161 ~IyKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 161 SIYKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred eEEeeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 6999999999987665 456789999999999998 488999999999999999999999999765443
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-30 Score=258.61 Aligned_cols=262 Identities=20% Similarity=0.271 Sum_probs=202.5
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhcCCCCccce
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKLQHRNLVRL 588 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l 588 (840)
..++|..+++||+|.||.|.+++.+ .+++.+|+|++++.. ..+...-..|-++|+..+||.+..|
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEK------------at~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~L 233 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREK------------ATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSL 233 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeec------------ccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHh
Confidence 4578999999999999999998765 789999999998753 3344556789999999999999999
Q ss_pred eeEeecCCceEEEEEe----eccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 589 FGCCIEQGEKISIYEF----DIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~----~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
--.|...+..++|||| .+..+......+++....-+-..|+.||.|||+++ ||.||||.+|.|||.+|++||+
T Consensus 234 KYsFQt~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKit 310 (516)
T KOG0690|consen 234 KYSFQTQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKIT 310 (516)
T ss_pred hhhhccCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEee
Confidence 9999999999999999 45566677777888877788899999999999988 9999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 665 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
|||+.+.- -.....+...+|||.|+|||++....|..+.|.|.+||++|||++|+.||...+.+..-.+...
T Consensus 311 DFGLCKE~--I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~------ 382 (516)
T KOG0690|consen 311 DFGLCKEE--IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM------ 382 (516)
T ss_pred ecccchhc--ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh------
Confidence 99998742 2222345668999999999999999999999999999999999999999854332221111000
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCC--CHHHHHHHhhc-----------cccCCCCCCCCC
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRP--TMLEVVAMLKD-----------EIVNLPSPHQPA 806 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP--s~~evl~~Le~-----------~~~~~~~p~~p~ 806 (840)
+ ++ .++....+....++.-.|.+||.+|. ...++.+..+. ..+++++|-.|.
T Consensus 383 e---d~-------kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPq 447 (516)
T KOG0690|consen 383 E---DL-------KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQ 447 (516)
T ss_pred h---hc-------cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCC
Confidence 0 00 11222333455677778899999996 23344433321 124567776675
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.5e-31 Score=276.33 Aligned_cols=237 Identities=25% Similarity=0.337 Sum_probs=190.6
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC--CCcCHHHHHHHHHHHhhcCCCCccceeeEeecCCc
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK--SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGE 597 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~ 597 (840)
+.||+|.||+||-|++| .+|+.||||++.+. .....+++++|+.||++++||.||.+--.|+..+.
T Consensus 570 evLGSGQFG~VYgg~hR------------ktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~er 637 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHR------------KTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPER 637 (888)
T ss_pred hhccCCcceeeecceec------------ccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCce
Confidence 78999999999999877 78999999999764 23455889999999999999999999999999999
Q ss_pred eEEEEEeec-----cCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCC---CCceeeccccc
Q 041702 598 KISIYEFDI-----VTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSD---MNPKISDFGIA 669 (840)
Q Consensus 598 ~~lv~e~~~-----~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~---~~~kL~DFGla 669 (840)
.+.|||... .........|++..-.-++.||+.||.|||.++ |+|+||||+||||... -++||+|||.|
T Consensus 638 vFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfA 714 (888)
T KOG4236|consen 638 VFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFA 714 (888)
T ss_pred EEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccce
Confidence 999999721 112345567888888889999999999999998 9999999999999644 46899999999
Q ss_pred eecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc-HhHHHhhhhcccccc
Q 041702 670 RTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLT-LLGHAWNLWKDDKAW 748 (840)
Q Consensus 670 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~ 748 (840)
+.+++... ...++|||.|+|||++.+..|...-|+||.|||+|--|+|..||... ++.. ..+.+
T Consensus 715 RiIgEksF---RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNA---------- 779 (888)
T KOG4236|consen 715 RIIGEKSF---RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNA---------- 779 (888)
T ss_pred eecchhhh---hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc--cchhHHhhcc----------
Confidence 99876543 34579999999999999999999999999999999999999887532 2211 11111
Q ss_pred cccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 041702 749 KLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVV 789 (840)
Q Consensus 749 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 789 (840)
..+- .+..-.+.....++++...||..-++|-+..+-+
T Consensus 780 aFMy---Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 780 AFMY---PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred cccc---CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 0111 1122234556678899999999999999887654
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-30 Score=234.81 Aligned_cols=258 Identities=24% Similarity=0.288 Sum_probs=187.8
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC--CCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK--SGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
+|...++||+|.||+||||+++ .+++.||+|+++.. ++.......+|+-+|+.++|.|||+++++.
T Consensus 3 ~ydkmekigegtygtvfkarn~------------~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvl 70 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNR------------ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL 70 (292)
T ss_pred chHHHHhhcCCcceeeEecccC------------CccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhh
Confidence 5667789999999999999776 78999999998754 334456789999999999999999999999
Q ss_pred ecCCceEEEEEeecc----CCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccc
Q 041702 593 IEQGEKISIYEFDIV----TDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGI 668 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~----~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl 668 (840)
...+...+|+||..- .-......++......++.|+++||.|.|++. +.||||||.|.||+.+|+.||+|||+
T Consensus 71 hsdkkltlvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfgl 147 (292)
T KOG0662|consen 71 HSDKKLTLVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGL 147 (292)
T ss_pred ccCceeEEeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccch
Confidence 999999999998311 11223456788888999999999999999998 99999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCccccccCC-CCccccchhHHHHHHHHHhC-CCCCCCCCCCCccHhHHHhhhh--cc
Q 041702 669 ARTFGGDEMQSNTNRIVGTYGYMSPEYALHGL-FSIKSDVFSFGVLLLEILSS-KKNTRFYNTDSLTLLGHAWNLW--KD 744 (840)
Q Consensus 669 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDV~SlGviL~elltG-~~p~~~~~~~~~~~~~~~~~~~--~~ 744 (840)
|+.++-.- ......+.|..|++|.++.+.. |+...|+||-|||+.|+... ++.|+..+.++ .+..-.+.+. .+
T Consensus 148 arafgipv--rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvdd-qlkrif~~lg~p~e 224 (292)
T KOG0662|consen 148 ARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTE 224 (292)
T ss_pred hhhcCCce--EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHH-HHHHHHHHhCCCcc
Confidence 99875321 1233456799999999998865 89999999999999999864 44454433322 1111111111 11
Q ss_pred cc---cccccCccccch---------hhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 745 DK---AWKLMDPTMQNE---------ALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 745 ~~---~~~~~d~~l~~~---------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
+. +..+.|-..-+. ..+....+=.+++.+.+.-+|.+|.++++.++
T Consensus 225 d~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 225 DQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred ccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 11 111222111111 11122222345666677779999999988765
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-30 Score=282.29 Aligned_cols=238 Identities=21% Similarity=0.239 Sum_probs=186.9
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhc-CCCCccceee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL-QHRNLVRLFG 590 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g 590 (840)
.++.|.....+|.|+|+.|-+..++ .+++..+||++.+.. .+-.+|+.++... +||||+++.+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~------------~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~ 383 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESS------------PTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHD 383 (612)
T ss_pred cchhhccccccCCCCccceeeeecc------------ccccchhheeccccc----cccccccchhhhhcCCCcceeecc
Confidence 4678888888999999999998654 789999999997652 2345677777666 7999999999
Q ss_pred EeecCCceEEEEEeeccCCcc---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEe-cCCCCceeecc
Q 041702 591 CCIEQGEKISIYEFDIVTDPA---RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLL-DSDMNPKISDF 666 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl-~~~~~~kL~DF 666 (840)
.+.++.+.++|||........ ......-..+..|+.+|+.|+.|||+++ +|||||||+|||+ ++.++++|+||
T Consensus 384 v~~~~~~~~~v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyF 460 (612)
T KOG0603|consen 384 VYEDGKEIYLVMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYF 460 (612)
T ss_pred eecCCceeeeeehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEe
Confidence 999999999999984322211 1122222677789999999999999988 9999999999999 58899999999
Q ss_pred ccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccc
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDK 746 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 746 (840)
|.++..... ....+-|..|.|||++....|++++|+||||++||+||+|+.|+.....+ ..+. ...
T Consensus 461 G~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~----~~i---- 526 (612)
T KOG0603|consen 461 GFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIH----TRI---- 526 (612)
T ss_pred chhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHH----Hhh----
Confidence 999876543 22345688999999999999999999999999999999999998643322 1111 111
Q ss_pred cccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 747 AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 747 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
..+......+....+|+.+||+.||.+||+|.++..
T Consensus 527 --------~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 527 --------QMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred --------cCCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 111122445566788999999999999999999874
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-30 Score=256.76 Aligned_cols=250 Identities=20% Similarity=0.318 Sum_probs=194.0
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhc-CCCCccceeeEeecCCce
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEQGEK 598 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~ 598 (840)
+.||+|+|+.|--++ .+.+|.++|||++.+.......+..+|++++.+. .|+||+.|+++|++....
T Consensus 84 e~LGeGAyasVqtcv------------~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~F 151 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCV------------SIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRF 151 (463)
T ss_pred HHhcCccceeeeeee------------eeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceE
Confidence 679999999998874 3579999999999988777888999999999999 599999999999999999
Q ss_pred EEEEEee----ccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCC---ceeecccccee
Q 041702 599 ISIYEFD----IVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMN---PKISDFGIART 671 (840)
Q Consensus 599 ~lv~e~~----~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~---~kL~DFGla~~ 671 (840)
|+|||.+ ++.+..+...+++.+..++.++|+.||.|||.++ |.||||||+|||-..... +||+||.+..-
T Consensus 152 YLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg 228 (463)
T KOG0607|consen 152 YLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSG 228 (463)
T ss_pred EEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccc
Confidence 9999985 4455667788999999999999999999999999 999999999999966544 79999998754
Q ss_pred cCCCC-----cccccccccccccccCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc--------
Q 041702 672 FGGDE-----MQSNTNRIVGTYGYMSPEYAL-----HGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLT-------- 733 (840)
Q Consensus 672 ~~~~~-----~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~-------- 733 (840)
+.... ........+|+..|||||+.. ...|+.++|.||||||||-||+|.+||......+-.
T Consensus 229 ~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr 308 (463)
T KOG0607|consen 229 IKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCR 308 (463)
T ss_pred cccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccH
Confidence 32211 112234567899999999763 245899999999999999999999999876654311
Q ss_pred Hh-HHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 734 LL-GHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 734 ~~-~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.- ......+.++. .+ ..++.-..+.....+++...+..++.+|.++.+++.
T Consensus 309 ~CQ~~LFesIQEGk-Ye-----FPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 309 VCQNKLFESIQEGK-YE-----FPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHHHHHHHhccC-Cc-----CChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 00 00111111111 11 111222345566778888889999999999999886
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-31 Score=255.57 Aligned_cols=263 Identities=22% Similarity=0.378 Sum_probs=189.9
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
..|....+||+|.||.||+|+.+ ..|+.||+|++.-.+ +.......+|+++|..|+|+|++.+++.
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~------------n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEi 84 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSK------------NTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhc------------CccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHH
Confidence 45666789999999999999765 678889998764322 2334567899999999999999999998
Q ss_pred eecC--------CceEEEEEe---eccCCcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCC
Q 041702 592 CIEQ--------GEKISIYEF---DIVTDPA-RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDM 659 (840)
Q Consensus 592 ~~~~--------~~~~lv~e~---~~~~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~ 659 (840)
|... ...++||.+ ++..... ....++..++.+++.++..||.|+|... |+|||+||.|+||+.++
T Consensus 85 c~tk~Tp~~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dg 161 (376)
T KOG0669|consen 85 CRTKATPTNRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDG 161 (376)
T ss_pred HhhccCCcccccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCc
Confidence 8532 346777766 2222222 2356888999999999999999999987 99999999999999999
Q ss_pred CceeeccccceecCCCCccc--ccccccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCC-ccHh
Q 041702 660 NPKISDFGIARTFGGDEMQS--NTNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDS-LTLL 735 (840)
Q Consensus 660 ~~kL~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~SlGviL~elltG~~p~~~~~~~~-~~~~ 735 (840)
.+||+|||+|+.+....... .-+..+.|..|++||.+.+. .|+++.|||.-|||+.||.|+.+.+....... ..+.
T Consensus 162 ilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~I 241 (376)
T KOG0669|consen 162 ILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLI 241 (376)
T ss_pred eEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHH
Confidence 99999999998875432211 12345679999999998875 59999999999999999999998876544332 1111
Q ss_pred --------HHHhhhhcccccccccCcc-ccc---hhhHHHHH------HHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 736 --------GHAWNLWKDDKAWKLMDPT-MQN---EALYSMVT------RYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 736 --------~~~~~~~~~~~~~~~~d~~-l~~---~~~~~~~~------~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
..+|....+-.+++-+... +.. ....+..+ ..++++.+++..||.+||++.+++..
T Consensus 242 s~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 242 SQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred HHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 1112222222222222111 111 11112222 56789999999999999999998753
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=260.64 Aligned_cols=233 Identities=25% Similarity=0.321 Sum_probs=183.2
Q ss_pred ccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC---cCHHHHHHHHHHHhhcCCCCccceeeEeecCCce
Q 041702 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG---QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEK 598 (840)
Q Consensus 522 lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~ 598 (840)
||+|+||.||++.+. .+++.+|+|++..... ...+.+..|+.++++++||||+++++.+..++..
T Consensus 1 lg~G~~~~v~~~~~~------------~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 68 (250)
T cd05123 1 LGKGSFGKVLLVRKK------------DTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKL 68 (250)
T ss_pred CCCCCceEEEEEEEC------------CCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCee
Confidence 699999999998754 4688999999875432 2456899999999999999999999999999999
Q ss_pred EEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceecCC
Q 041702 599 ISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGG 674 (840)
Q Consensus 599 ~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 674 (840)
+++||+..... ......+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 69 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~ 145 (250)
T cd05123 69 YLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSS 145 (250)
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceeccc
Confidence 99999853221 122346899999999999999999999987 99999999999999999999999999987643
Q ss_pred CCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccccccCcc
Q 041702 675 DEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPT 754 (840)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 754 (840)
.. .......++..|+|||...+...+.++|+||||++++||++|+.|+..... ...... . ... ..
T Consensus 146 ~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~~~---~-~~~------~~- 210 (250)
T cd05123 146 EG--SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--KEIYEK---I-LKD------PL- 210 (250)
T ss_pred CC--CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHH---H-hcC------CC-
Confidence 32 123345678899999999888899999999999999999999999854321 111111 0 000 00
Q ss_pred ccchhhHHHHHHHHHHHHHccccCCCCCCCHHH
Q 041702 755 MQNEALYSMVTRYIKVALLCVQENATDRPTMLE 787 (840)
Q Consensus 755 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 787 (840)
..+......+.+++.+||..||++||++.+
T Consensus 211 ---~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 211 ---RFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred ---CCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 111112456788999999999999999955
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=232.89 Aligned_cols=110 Identities=51% Similarity=0.843 Sum_probs=82.0
Q ss_pred CCcEEEeecCCCCCCCC--CceEEEecCCceEEecCCCceEEEe-cCCCCC-CCceEEEecCCCeEEEeccCCCCCCCce
Q 041702 70 PDTVVWVANRNCPILDP--HGILAINNNGNLVLLNQANGTIWSS-NMSKEA-KSPVAQLLDTGNLVLRENFSNNTSEGSY 145 (840)
Q Consensus 70 ~~tvVW~ANr~~p~~~~--~~~l~~~~~G~L~l~~~~~~~~Wss-~~~~~~-~~~~a~L~d~GNlVl~~~~~~~~~~~~~ 145 (840)
++||||+|||+.|+..+ .++|.|+.||+|+|+|..++++|++ ++.+.. ....|.|+|+|||||+| ..+++
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d------~~~~~ 74 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYD------SSGNV 74 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEE------TTSEE
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEe------ecceE
Confidence 46999999999999553 4889999999999999999999999 555444 57889999999999999 45678
Q ss_pred eEEecCCCCCcccCCCccccccccCCceeEEEeccCCCCC
Q 041702 146 LWQSFDFPSDTLLPGMKVGWDLKTGRERYLTSWRTADDPS 185 (840)
Q Consensus 146 lWqSFd~PtDtlLpg~~l~~~~~tg~~~~l~S~~s~~dps 185 (840)
|||||||||||+||||+|+.+..+|.+..++||++.+|||
T Consensus 75 lW~Sf~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 75 LWQSFDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp EEESTTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred EEeecCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 9999999999999999999988888878899999999997
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-29 Score=294.65 Aligned_cols=143 Identities=27% Similarity=0.376 Sum_probs=123.1
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhcCCCCcccee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
.++|.+.++||+|+||.||+|.+. .+++.||||+++... ....+++.+|+.++..++||||++++
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~------------~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~ 70 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKK------------NNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLY 70 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEEC------------CCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEE
Confidence 367899999999999999999764 578999999997542 22346789999999999999999999
Q ss_pred eEeecCCceEEEEEeeccCCc----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 590 GCCIEQGEKISIYEFDIVTDP----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
+++...+..++||||...... .....+++...++|+.||+.||+|||..+ |+||||||+||||+.++.+||+|
T Consensus 71 ~~~~~~~~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~D 147 (669)
T cd05610 71 YSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTD 147 (669)
T ss_pred EEEEECCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEe
Confidence 999999999999999532221 22345788899999999999999999987 99999999999999999999999
Q ss_pred cccce
Q 041702 666 FGIAR 670 (840)
Q Consensus 666 FGla~ 670 (840)
||+++
T Consensus 148 FGls~ 152 (669)
T cd05610 148 FGLSK 152 (669)
T ss_pred CCCCc
Confidence 99986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=257.72 Aligned_cols=218 Identities=17% Similarity=0.125 Sum_probs=169.4
Q ss_pred CCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEeecCCceEEEEEe
Q 041702 525 GGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF 604 (840)
Q Consensus 525 G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 604 (840)
|.+|.||+|.++ .+++.+|+|+++... .+.+|...+....||||+++++++.+.+..+++|||
T Consensus 4 g~~~~v~~~~~~------------~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 66 (237)
T cd05576 4 GVIDKVLLVMDT------------RTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQH 66 (237)
T ss_pred cccceEEEEEEc------------cCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEec
Confidence 889999999776 678999999997642 344566666667899999999999999999999999
Q ss_pred eccCCc----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceecCCCCcccc
Q 041702 605 DIVTDP----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSN 680 (840)
Q Consensus 605 ~~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 680 (840)
...... .....+++.....++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||.+......
T Consensus 67 ~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----- 138 (237)
T cd05576 67 AEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----- 138 (237)
T ss_pred CCCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----
Confidence 533221 23345899999999999999999999988 999999999999999999999999988665332
Q ss_pred cccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccccccCccccchhh
Q 041702 681 TNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEAL 760 (840)
Q Consensus 681 ~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 760 (840)
.....++..|+|||.+.+..++.++||||+|++++||++|+.++....... .. .... ..+
T Consensus 139 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------~~-----~~~~----~~~ 198 (237)
T cd05576 139 CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------NT-----HTTL----NIP 198 (237)
T ss_pred cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------cc-----cccc----CCc
Confidence 122345678999999988889999999999999999999997754211000 00 0000 011
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHH
Q 041702 761 YSMVTRYIKVALLCVQENATDRPTMLE 787 (840)
Q Consensus 761 ~~~~~~l~~l~~~Cl~~dP~~RPs~~e 787 (840)
......+.+++.+|++.||++||++.+
T Consensus 199 ~~~~~~~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 199 EWVSEEARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred ccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence 123456788999999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=274.83 Aligned_cols=255 Identities=24% Similarity=0.394 Sum_probs=203.3
Q ss_pred cCHHHHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhc-CC
Q 041702 504 FSLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL-QH 582 (840)
Q Consensus 504 ~~~~~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l-~H 582 (840)
..+..+...++.|.+.+.||.|.+|.||+++++ .+++.+|||++... ....++...|.++|+.+ .|
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~------------~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~h 75 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHV------------KTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHH 75 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeee------------ecCceeeeEeecCC-ccccHHHHHHHHHHHhccCC
Confidence 445566677889999999999999999999765 68899999998754 33447788999999988 79
Q ss_pred CCccceeeEeec-----CCceEEEEEee-------ccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCC
Q 041702 583 RNLVRLFGCCIE-----QGEKISIYEFD-------IVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKA 650 (840)
Q Consensus 583 ~niv~l~g~~~~-----~~~~~lv~e~~-------~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp 650 (840)
||++.++|++.. +++.+|||||. +..... ...+.|..+..|+..++.||.+||... ++|||||-
T Consensus 76 pnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG 151 (953)
T KOG0587|consen 76 PNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKG 151 (953)
T ss_pred CCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccC
Confidence 999999999863 57899999993 222222 778999999999999999999999987 99999999
Q ss_pred CcEEecCCCCceeeccccceecCCCCcccccccccccccccCcccccc-----CCCCccccchhHHHHHHHHHhCCCCCC
Q 041702 651 SNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH-----GLFSIKSDVFSFGVLLLEILSSKKNTR 725 (840)
Q Consensus 651 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDV~SlGviL~elltG~~p~~ 725 (840)
.||||+.++.+||+|||.+..+... ....+..+||+.|||||++.- ..|+..+|+||||++..||--|.+|+.
T Consensus 152 ~NiLLT~e~~VKLvDFGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~ 229 (953)
T KOG0587|consen 152 QNVLLTENAEVKLVDFGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLC 229 (953)
T ss_pred ceEEEeccCcEEEeeeeeeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCcc
Confidence 9999999999999999999877443 334456789999999998853 347889999999999999999999976
Q ss_pred CCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 726 FYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.+++...-+. + .-.|...-..+..-.+.+.+++..||.+|-++||++.++++
T Consensus 230 DmHPmraLF~-----------I--pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 230 DMHPMRALFL-----------I--PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred Ccchhhhhcc-----------C--CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 5443221100 0 01111111223445678999999999999999999988774
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.8e-29 Score=255.16 Aligned_cols=257 Identities=21% Similarity=0.245 Sum_probs=191.6
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcC--CCC----cc
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQ--HRN----LV 586 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~--H~n----iv 586 (840)
+++|.+...+|+|.||.|-+..++ ..+..||||+++... ...+.-+-|+++|+++. .|+ +|
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~------------~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv 154 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDR------------ETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCV 154 (415)
T ss_pred ccceehhhhhcCCcccceEEEeec------------CCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEE
Confidence 789999999999999999998776 348899999998653 33456678999999993 233 78
Q ss_pred ceeeEeecCCceEEEEEeecc-----CCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecC----
Q 041702 587 RLFGCCIEQGEKISIYEFDIV-----TDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS---- 657 (840)
Q Consensus 587 ~l~g~~~~~~~~~lv~e~~~~-----~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~---- 657 (840)
.+.++|...++..+|+|.+-. .......+++..++..|+.|++++++|||+.+ ++|-||||+|||+.+
T Consensus 155 ~m~~wFdyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~ 231 (415)
T KOG0671|consen 155 QMRDWFDYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYF 231 (415)
T ss_pred eeehhhhccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceE
Confidence 888999999999999998431 11234456788899999999999999999988 999999999999831
Q ss_pred ----------------CCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCC
Q 041702 658 ----------------DMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSK 721 (840)
Q Consensus 658 ----------------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~ 721 (840)
+..+||+|||.|..-.... ..++.|..|+|||++.+-.++..+||||+||||.|+.||.
T Consensus 232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~ 306 (415)
T KOG0671|consen 232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGE 306 (415)
T ss_pred EEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccc
Confidence 3358999999998754332 4578899999999999999999999999999999999999
Q ss_pred CCCCCCCCCC-ccHhHH--------Hhh------hhcccc-----------cccccCcccc----chhhHHHHHHHHHHH
Q 041702 722 KNTRFYNTDS-LTLLGH--------AWN------LWKDDK-----------AWKLMDPTMQ----NEALYSMVTRYIKVA 771 (840)
Q Consensus 722 ~p~~~~~~~~-~~~~~~--------~~~------~~~~~~-----------~~~~~d~~l~----~~~~~~~~~~l~~l~ 771 (840)
..|+.....+ ..+.+. ... ....++ .....++... ......+..++.+|+
T Consensus 307 ~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl 386 (415)
T KOG0671|consen 307 TLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLL 386 (415)
T ss_pred eecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHH
Confidence 8887654221 111100 000 000000 0000111000 011224556799999
Q ss_pred HHccccCCCCCCCHHHHHH
Q 041702 772 LLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 772 ~~Cl~~dP~~RPs~~evl~ 790 (840)
..||..||.+|+|+.|++.
T Consensus 387 ~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 387 RRMLEFDPARRITLREALS 405 (415)
T ss_pred HHHHccCccccccHHHHhc
Confidence 9999999999999999874
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-29 Score=256.25 Aligned_cols=238 Identities=25% Similarity=0.313 Sum_probs=189.9
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhc-CCCCccce
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKL-QHRNLVRL 588 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l-~H~niv~l 588 (840)
..+|..+.+||+|+||.|.+|..+ .+.+.+|||++++.- ....+--+.|-++|+.. +-|.++.+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerk------------gtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~ql 415 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERK------------GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQL 415 (683)
T ss_pred ecccceEEEeccCccceeeeeccc------------CcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHH
Confidence 457888899999999999998654 567889999998752 23344456777788776 56789999
Q ss_pred eeEeecCCceEEEEEee----ccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 589 FGCCIEQGEKISIYEFD----IVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~~----~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
+.++..-+..|+||||. +..+......+.+..+.-++..||-||-+||+++ ||.||||.+|||||.+|++||+
T Consensus 416 HScFQTmDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~ 492 (683)
T KOG0696|consen 416 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIA 492 (683)
T ss_pred HHHhhhhhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEee
Confidence 99999999999999993 4444555667788888899999999999999999 9999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 665 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
|||+.+.--- ....+...+|||.|+|||++.-.+|...+|.|||||+|||||.|++||+..++++ +.+.
T Consensus 493 DFGmcKEni~--~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e--lF~a------- 561 (683)
T KOG0696|consen 493 DFGMCKENIF--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--LFQA------- 561 (683)
T ss_pred eccccccccc--CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHH-------
Confidence 9999875321 1233556899999999999999999999999999999999999999987544332 2211
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCC
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRP 783 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 783 (840)
+++... .++...+.....++...|.+.|.+|.
T Consensus 562 -----I~ehnv--syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 562 -----IMEHNV--SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred -----HHHccC--cCcccccHHHHHHHHHHhhcCCcccc
Confidence 222222 33445566677888888999999996
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=245.08 Aligned_cols=249 Identities=18% Similarity=0.223 Sum_probs=187.8
Q ss_pred HHccCCccc-ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhc-CCCCccce
Q 041702 511 AATDNFSEE-NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL-QHRNLVRL 588 (840)
Q Consensus 511 ~~~~~f~~~-~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l-~H~niv~l 588 (840)
..+++|++. ++||-|-.|.|-...++ .+++.+|+|++... ...++|+++--.. .|||||.+
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k------------~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~I 120 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHK------------RTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSI 120 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEec------------cchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEe
Confidence 356666654 67999999999988766 78999999999765 4557888876665 69999999
Q ss_pred eeEeec----CCceEEEEEeeccCCc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecC-
Q 041702 589 FGCCIE----QGEKISIYEFDIVTDP------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS- 657 (840)
Q Consensus 589 ~g~~~~----~~~~~lv~e~~~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~- 657 (840)
++++.. ....++|||.+.-... .....+.+.+.-+|+.||+.|+.|||+.+ |.||||||+|+|...
T Consensus 121 idVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t 197 (400)
T KOG0604|consen 121 IDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTT 197 (400)
T ss_pred ehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecC
Confidence 999864 3457788998533221 22345888999999999999999999998 999999999999964
Q ss_pred --CCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHh
Q 041702 658 --DMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLL 735 (840)
Q Consensus 658 --~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~ 735 (840)
|..+||+|||+|+.-.. .......+-|+.|.|||++....|+...|+||+||++|-||+|.+||-........
T Consensus 198 ~~na~lKLtDfGFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais-- 272 (400)
T KOG0604|consen 198 SPNAPLKLTDFGFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-- 272 (400)
T ss_pred CCCcceEecccccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC--
Confidence 45689999999986432 22334567899999999999999999999999999999999999998654432211
Q ss_pred HHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 736 GHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 736 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.-....++.+ .-....+.-...++...+++..+|..+|.+|.|+.+++.
T Consensus 273 pgMk~rI~~g------qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 273 PGMKRRIRTG------QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred hhHHhHhhcc------CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 0011111110 011122223355677888999999999999999999874
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-28 Score=252.13 Aligned_cols=235 Identities=27% Similarity=0.367 Sum_probs=183.3
Q ss_pred CCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcC-HHHHHHHHHHHhhcCCCCccceeeEeecCCceEEEEEe
Q 041702 526 GFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQG-LEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF 604 (840)
Q Consensus 526 ~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~-~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 604 (840)
+||.||+|.+. .+++.+|+|++....... .+.+.+|++.+++++|+|++++++++......++++|+
T Consensus 1 ~~g~v~~~~~~------------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 68 (244)
T smart00220 1 SFGKVYLARDK------------KTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEY 68 (244)
T ss_pred CceEEEEEEEC------------CCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeC
Confidence 58999998754 468999999998765444 78999999999999999999999999999999999998
Q ss_pred eccCCc----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceecCCCCcccc
Q 041702 605 DIVTDP----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSN 680 (840)
Q Consensus 605 ~~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 680 (840)
...... .....+++..+..++.+++.++.|||+.+ ++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 69 ~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~ 142 (244)
T smart00220 69 CDGGDLFDLLKKRGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---L 142 (244)
T ss_pred CCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---c
Confidence 433221 11223788999999999999999999987 9999999999999999999999999998765432 2
Q ss_pred cccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccccccCccccchhh
Q 041702 681 TNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEAL 760 (840)
Q Consensus 681 ~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 760 (840)
.....++..|++||.+.+..++.++||||||+++++|++|..|+...... ... .......... . ....
T Consensus 143 ~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-~~~----~~~~~~~~~~----~---~~~~ 210 (244)
T smart00220 143 LTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-LEL----FKKIGKPKPP----F---PPPE 210 (244)
T ss_pred cccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHH----HHHHhccCCC----C---cccc
Confidence 33456788999999999888999999999999999999999887542111 111 1111110000 0 0000
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 761 YSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 761 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
......+.+++.+|+..+|++||++.++++
T Consensus 211 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 211 WKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred ccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 003456889999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-29 Score=258.37 Aligned_cols=256 Identities=24% Similarity=0.322 Sum_probs=191.2
Q ss_pred HHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC-C------CcCHHHHHHHHHHHhhcCCC
Q 041702 511 AATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK-S------GQGLEEFKNEMMLIAKLQHR 583 (840)
Q Consensus 511 ~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~-~------~~~~~~f~~Ev~~l~~l~H~ 583 (840)
...++|-.++.||+|||+.||||.|. ...+.||||+-... + ....+...+|.+|-+.|.||
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl------------~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHp 527 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDL------------TEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHP 527 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhccc------------chhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcc
Confidence 44577888999999999999999764 67889999986432 1 11234467899999999999
Q ss_pred CccceeeEee-cCCceEEEEEee----ccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEec--
Q 041702 584 NLVRLFGCCI-EQGEKISIYEFD----IVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLD-- 656 (840)
Q Consensus 584 niv~l~g~~~-~~~~~~lv~e~~----~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~-- 656 (840)
.||++++|+. +.+.++.|+||. +-+.......+++.+...|+.||+.||.||.+.. ++|||-||||.||||.
T Consensus 528 RIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~G 606 (775)
T KOG1151|consen 528 RIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNG 606 (775)
T ss_pred eeeeeeeeeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecC
Confidence 9999999986 567788899994 3334456678999999999999999999999875 7899999999999994
Q ss_pred -CCCCceeeccccceecCCCCccc-----ccccccccccccCcccccc----CCCCccccchhHHHHHHHHHhCCCCCCC
Q 041702 657 -SDMNPKISDFGIARTFGGDEMQS-----NTNRIVGTYGYMSPEYALH----GLFSIKSDVFSFGVLLLEILSSKKNTRF 726 (840)
Q Consensus 657 -~~~~~kL~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~----~~~~~ksDV~SlGviL~elltG~~p~~~ 726 (840)
..|.+||.|||+++.++++.... .+....||..|++||.+.- ..++.|+||||.|||+|+.+.|++||..
T Consensus 607 tacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGh 686 (775)
T KOG1151|consen 607 TACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGH 686 (775)
T ss_pred cccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCC
Confidence 45789999999999987665442 2455679999999998753 3489999999999999999999999864
Q ss_pred CCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 041702 727 YNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVV 789 (840)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 789 (840)
.......+. +..+...-+-.. ...+........++.+||+..-++|....++.
T Consensus 687 nqsQQdILq--------eNTIlkAtEVqF--P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 687 NQSQQDILQ--------ENTILKATEVQF--PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred chhHHHHHh--------hhchhcceeccC--CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 332221111 111110000001 11112233466788999999999998766553
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=274.83 Aligned_cols=258 Identities=19% Similarity=0.214 Sum_probs=158.6
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
..++|...++||+|+||.||+|.+.. .....+..||||++..... .+.+.+| .+....+.+++.++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~--------~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~ 197 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVN--------KQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYG 197 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcC--------CccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHh
Confidence 56889999999999999999997650 0012278999999864321 1222222 1222223333332221
Q ss_pred ------eecCCceEEEEEeeccCCcc------------------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 041702 592 ------CIEQGEKISIYEFDIVTDPA------------------------RKDLLDWTTRVRIIEGVAQGLLYLHQYSRL 641 (840)
Q Consensus 592 ------~~~~~~~~lv~e~~~~~~~~------------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~ 641 (840)
+...++.++|+||....... .........+..++.||+.||+|||+.+
T Consensus 198 ~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g-- 275 (566)
T PLN03225 198 FLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG-- 275 (566)
T ss_pred hhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--
Confidence 24567889999994221110 0001112345679999999999999988
Q ss_pred ceecCCCCCCcEEecC-CCCceeeccccceecCCCCcccccccccccccccCccccccC---------------------
Q 041702 642 RVIHRDLKASNVLLDS-DMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHG--------------------- 699 (840)
Q Consensus 642 ~ivHrDlkp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------------------- 699 (840)
|+||||||+|||++. ++.+||+|||+|+.+..... .......+++.|||||.+...
T Consensus 276 -IiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~ 353 (566)
T PLN03225 276 -IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQ 353 (566)
T ss_pred -EEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhcc
Confidence 999999999999986 57899999999986543221 223346789999999965322
Q ss_pred -CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccc----ccccccCccccch------hhHHHHHHHH
Q 041702 700 -LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD----KAWKLMDPTMQNE------ALYSMVTRYI 768 (840)
Q Consensus 700 -~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~d~~l~~~------~~~~~~~~l~ 768 (840)
.++.++|||||||+||||+++..+... ............. .....+.+....+ ..........
T Consensus 354 ~~~~~k~DVwSlGviL~el~~~~~~~~~------~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 427 (566)
T PLN03225 354 LNLPDRFDIYSAGLIFLQMAFPNLRSDS------NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGW 427 (566)
T ss_pred ccCCCCcccHHHHHHHHHHHhCcCCCch------HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHH
Confidence 234567999999999999987654321 1110000000000 0000111111000 0001122345
Q ss_pred HHHHHccccCCCCCCCHHHHHHH
Q 041702 769 KVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 769 ~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
+++.+||+.||++|||+.|+++.
T Consensus 428 dLi~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 428 ELLKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred HHHHHHccCCcccCCCHHHHhCC
Confidence 89999999999999999999863
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-28 Score=228.38 Aligned_cols=201 Identities=26% Similarity=0.355 Sum_probs=164.3
Q ss_pred HHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC-CCcCHHHHHHHHHHHhhc-CCCCcc
Q 041702 509 ISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK-SGQGLEEFKNEMMLIAKL-QHRNLV 586 (840)
Q Consensus 509 ~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~-~~~~~~~f~~Ev~~l~~l-~H~niv 586 (840)
++...+.......||+|++|.|-+-+++ ++|+..|+|+++.. +.+..++..+|+.+..+. .+|.+|
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~------------~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V 108 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHI------------QSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTV 108 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeec------------cCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEE
Confidence 4455566667788999999999887654 89999999999855 345567788899887665 799999
Q ss_pred ceeeEeecCCceEEEEEeeccC-------CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCC
Q 041702 587 RLFGCCIEQGEKISIYEFDIVT-------DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDM 659 (840)
Q Consensus 587 ~l~g~~~~~~~~~lv~e~~~~~-------~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~ 659 (840)
.++|.....+...+.||.+... -......+++...-+|+..+..||.|||++- .+||||+||+|||++.+|
T Consensus 109 ~FyGa~~regdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~G 186 (282)
T KOG0984|consen 109 HFYGALFREGDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDG 186 (282)
T ss_pred EeehhhhccccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCC
Confidence 9999999999999999985322 2334567888888999999999999999854 699999999999999999
Q ss_pred CceeeccccceecCCCCcccccccccccccccCcccccc----CCCCccccchhHHHHHHHHHhCCCCCCC
Q 041702 660 NPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH----GLFSIKSDVFSFGVLLLEILSSKKNTRF 726 (840)
Q Consensus 660 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~ksDV~SlGviL~elltG~~p~~~ 726 (840)
++|+||||++..+.+.- ..+...|-..|||||.+.. ..|+.|+||||||+.+.||.+++.|++.
T Consensus 187 qVKiCDFGIsG~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 187 QVKICDFGISGYLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred cEEEcccccceeehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 99999999998764322 1122346678999998753 3699999999999999999999999753
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-28 Score=276.24 Aligned_cols=276 Identities=20% Similarity=0.228 Sum_probs=210.6
Q ss_pred CHHHHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhcC
Q 041702 505 SLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQ 581 (840)
Q Consensus 505 ~~~~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l~ 581 (840)
...+++...++|.++++||+|+||.|..++++ .+++.+|.|++++. ......-|..|-.+|..-+
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k------------~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~n 133 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHK------------STEKVYAMKILNKWEMLKRAETACFREERDIMVFGN 133 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEee------------ccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCC
Confidence 34567777899999999999999999999876 78999999999873 3455677999999999888
Q ss_pred CCCccceeeEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecC
Q 041702 582 HRNLVRLFGCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS 657 (840)
Q Consensus 582 H~niv~l~g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~ 657 (840)
.+=|+.++-.|.+.+..|+||||+.-++ ......+++.-..-++..|..||.-||+.| +|||||||+|||||.
T Consensus 134 s~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~ 210 (1317)
T KOG0612|consen 134 SEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDK 210 (1317)
T ss_pred cHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecc
Confidence 8999999999999999999999964433 445557888888889999999999999999 999999999999999
Q ss_pred CCCceeeccccceecCCCCcccccccccccccccCccccc----c-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCc
Q 041702 658 DMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYAL----H-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSL 732 (840)
Q Consensus 658 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~ 732 (840)
.|++||+|||.+-.+..+.. ......+|||.|.+||++. + +.|.+.+|.||+||++||||.|..||...
T Consensus 211 ~GHikLADFGsClkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad----- 284 (1317)
T KOG0612|consen 211 SGHIKLADFGSCLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD----- 284 (1317)
T ss_pred cCcEeeccchhHHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH-----
Confidence 99999999999877764443 2345678999999999985 2 56999999999999999999999998431
Q ss_pred cHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH--hhc----cccCCCCCC
Q 041702 733 TLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPT---MLEVVAM--LKD----EIVNLPSPH 803 (840)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~~--Le~----~~~~~~~p~ 803 (840)
.++..........+...+.+ ..+.++...+||...+. +|+.|.. ++++-.. +++ -+.+..+|-
T Consensus 285 slveTY~KIm~hk~~l~FP~-------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~ 356 (1317)
T KOG0612|consen 285 SLVETYGKIMNHKESLSFPD-------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPV 356 (1317)
T ss_pred HHHHHHHHHhchhhhcCCCc-------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCC
Confidence 22222222222222222221 12244556667776665 7888887 7777632 222 234556666
Q ss_pred CCCCcc
Q 041702 804 QPAFSY 809 (840)
Q Consensus 804 ~p~~~~ 809 (840)
.|..++
T Consensus 357 vPevss 362 (1317)
T KOG0612|consen 357 VPEVSS 362 (1317)
T ss_pred CCcCCC
Confidence 665433
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-27 Score=263.93 Aligned_cols=267 Identities=20% Similarity=0.243 Sum_probs=174.0
Q ss_pred HccCCcccccccCCCCccEEEeecceeehh----ccccCcccCCceEEEEEeccCCCcCHHH--------------HHHH
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEIC----NWKQGKLLNGEEVAVKRLSSKSGQGLEE--------------FKNE 573 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~----~~~~g~~~~g~~VAvK~l~~~~~~~~~~--------------f~~E 573 (840)
..++|++.++||+|+||.||+|.+...+.. ...-.....++.||||++........++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999864211000 0000112356789999987543332333 3457
Q ss_pred HHHHhhcCCCCc-----cceeeEeec--------CCceEEEEEeeccCCc----------------------------cc
Q 041702 574 MMLIAKLQHRNL-----VRLFGCCIE--------QGEKISIYEFDIVTDP----------------------------AR 612 (840)
Q Consensus 574 v~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lv~e~~~~~~~----------------------------~~ 612 (840)
+.++.+++|.++ +++++||.. .+..++||||+..... ..
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777888876654 678888753 4578999999421100 01
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceecCCCCcccccccccccccccC
Q 041702 613 KDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMS 692 (840)
Q Consensus 613 ~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~a 692 (840)
...++|..+..++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||++........ .......+|+.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 223567888999999999999999987 99999999999999999999999999976543221 11122335789999
Q ss_pred ccccccCCC----------------------CccccchhHHHHHHHHHhCCC-CCCCCCCCCccH-----hHHHhhhhcc
Q 041702 693 PEYALHGLF----------------------SIKSDVFSFGVLLLEILSSKK-NTRFYNTDSLTL-----LGHAWNLWKD 744 (840)
Q Consensus 693 PE~~~~~~~----------------------~~ksDV~SlGviL~elltG~~-p~~~~~~~~~~~-----~~~~~~~~~~ 744 (840)
||.+..... ..+.||||+||+++||++|.. |+.......... ....|.....
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 998754321 234799999999999999875 443211100000 0011111111
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCC---CCCCCHHHHHH
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENA---TDRPTMLEVVA 790 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP---~~RPs~~evl~ 790 (840)
.. ..-...........+++.++|..+| .+|+|++|+++
T Consensus 459 ~~--------~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 459 QK--------YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cC--------CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 10 0011122234567788889998765 68999999975
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-27 Score=211.82 Aligned_cols=109 Identities=43% Similarity=0.944 Sum_probs=103.6
Q ss_pred EEeCCCCCceeccCCceee-ceeEEEEEecCCcEEEEEEecCCceeEEEEEccCCcEEEEEEEcCCCCeEEEEeccCCCC
Q 041702 211 ARIGPWNGFIFEDGPTFID-YLYKIILVDTEDEIYYRYESYNNLSIMMLKINPLGKIQRLLWNEGSSGWQVMFSAPGDVC 289 (840)
Q Consensus 211 ~~~g~w~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~G~l~~y~w~~~~~~W~~~~~~p~~~C 289 (840)
||+|||||..|++.|++.. ..+.+.|+++.+|.+|+|...+.+.++|++||.+|++++|.|++..++|.+.|++|.|+|
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~~p~d~C 80 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWSAPKDQC 80 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEEEecccCC
Confidence 8999999999999999985 567788899999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccCCCCCcccccCCCCcCC
Q 041702 290 QNYGHCGANSICNVDNPPKCECLKGFKPNS 319 (840)
Q Consensus 290 ~~~g~CG~~g~C~~~~~~~C~C~~GF~~~~ 319 (840)
|+|+.||+||+|+.+..+.|+|++||+|++
T Consensus 81 d~y~~CG~~g~C~~~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 81 DVYGFCGPNGICNSNNSPKCSCLPGFEPKN 110 (110)
T ss_pred CCccccCCccEeCCCCCCceECCCCcCCCc
Confidence 999999999999988889999999999975
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-28 Score=258.76 Aligned_cols=238 Identities=24% Similarity=0.286 Sum_probs=189.1
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
.+++.+..||-||||.|=++... .....+|+|++++. +....+....|-.+|.+.+.|.||+++-
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~------------~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYr 487 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVN------------SQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYR 487 (732)
T ss_pred hhhhhhhhcccCccceEEEEEec------------ccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHH
Confidence 44555668999999999987533 22234888888754 3445567889999999999999999999
Q ss_pred EeecCCceEEEEEeec----cCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 591 CCIEQGEKISIYEFDI----VTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~----~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
-|.+....|++||-.+ ..-...+..++..+..-++..++.|++|||+++ ||+|||||+|.|||.+|-+||.||
T Consensus 488 Tfrd~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDF 564 (732)
T KOG0614|consen 488 TFRDSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDF 564 (732)
T ss_pred HhccchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeeh
Confidence 9999999999988732 333455667888888889999999999999998 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhh-ccc
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLW-KDD 745 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~-~~~ 745 (840)
|+|+.+..+. .+...+|||.|.|||++.+...+.++|.||||++++|||+|.+||...++-.. ++.. ..-
T Consensus 565 GFAKki~~g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt------Yn~ILkGi 635 (732)
T KOG0614|consen 565 GFAKKIGSGR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT------YNLILKGI 635 (732)
T ss_pred hhHHHhccCC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH------HHHHHhhh
Confidence 9999986544 35668999999999999999999999999999999999999999976543321 1111 111
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCC
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPT 784 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 784 (840)
+. -..+....+...+++.+.+..+|.+|..
T Consensus 636 d~---------i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 636 DK---------IEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred hh---------hhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 11 1223344556778888888999999986
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-28 Score=239.04 Aligned_cols=261 Identities=20% Similarity=0.280 Sum_probs=183.8
Q ss_pred cccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceeeEeec
Q 041702 517 SEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIE 594 (840)
Q Consensus 517 ~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~ 594 (840)
+..+.||.|+||.||.+.|- .+|+.||+|++...- -...+++.+|+++|.-++|.|++..++....
T Consensus 56 ~PDRPIGYGAFGVVWsVTDP------------RdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQP 123 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDP------------RSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQP 123 (449)
T ss_pred CCCCcccccceeEEEeccCC------------CCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCC
Confidence 34478999999999998654 789999999987542 2345788999999999999999998887654
Q ss_pred CC-----ceEEEEEee---ccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 595 QG-----EKISIYEFD---IVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 595 ~~-----~~~lv~e~~---~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
.+ +.|.+.|.+ +..-.-..+.++-....-+++||++||+|||+.+ |.||||||.|.|++.|...||+||
T Consensus 124 ph~dfFqEiYV~TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDF 200 (449)
T KOG0664|consen 124 ANPSFFQELYVLTELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDF 200 (449)
T ss_pred CCchHHHHHHHHHHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccc
Confidence 32 344444442 2222233456777777789999999999999988 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCC-ccHhH--------
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDS-LTLLG-------- 736 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~SlGviL~elltG~~p~~~~~~~~-~~~~~-------- 736 (840)
|+|+..+.++.. ..+..+.|-.|+|||++++. .|+.+.||||.|||+.||+..+..|....+-+ .++..
T Consensus 201 GLARvee~d~~~-hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~ 279 (449)
T KOG0664|consen 201 GLARTWDQRDRL-NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQ 279 (449)
T ss_pred ccccccchhhhh-hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcH
Confidence 999986554433 34456679999999999975 59999999999999999998887776544322 11110
Q ss_pred HHhhhhcccccccccCccccc---------hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 041702 737 HAWNLWKDDKAWKLMDPTMQN---------EALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLK 793 (840)
Q Consensus 737 ~~~~~~~~~~~~~~~d~~l~~---------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le 793 (840)
.+....-++....++...... ..........+.+..+++..||.+|.+.++.+..+.
T Consensus 280 EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 280 EAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 011111111111111111110 001111223456777889999999999988886654
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7e-27 Score=234.93 Aligned_cols=244 Identities=19% Similarity=0.319 Sum_probs=192.9
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhc-CCCCccce
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKL-QHRNLVRL 588 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l-~H~niv~l 588 (840)
.++|..+.+||+|+|+.|-.++.+ .+.+.+|+|++++. ....++=.+.|-.+..+. +||.+|-+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~------------~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvgl 316 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLK------------KTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGL 316 (593)
T ss_pred cccceeeeeecCcchhhhhheehc------------ccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEeh
Confidence 467889999999999999998665 68899999999864 223344456677777766 79999999
Q ss_pred eeEeecCCceEEEEEe----eccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 589 FGCCIEQGEKISIYEF----DIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~----~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
..+|......++|.|| ++..+......|+++...-+...|..||.|||+++ ||.||||.+|+|||..|++||.
T Consensus 317 hscfqtesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghiklt 393 (593)
T KOG0695|consen 317 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLT 393 (593)
T ss_pred hhhhcccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeec
Confidence 9999999999999999 46666777888999999999999999999999999 9999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCC--ccHhHHHhhhh
Q 041702 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDS--LTLLGHAWNLW 742 (840)
Q Consensus 665 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~--~~~~~~~~~~~ 742 (840)
|+|+.+.--. ....+...+|||.|.|||++.+..|....|.|+|||+++||+.|+.||.....+. ..........
T Consensus 394 dygmcke~l~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv- 470 (593)
T KOG0695|consen 394 DYGMCKEGLG--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV- 470 (593)
T ss_pred ccchhhcCCC--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH-
Confidence 9999875321 1223556899999999999999999999999999999999999999997654332 1111111121
Q ss_pred cccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCC
Q 041702 743 KDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRP 783 (840)
Q Consensus 743 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 783 (840)
+++..++. +.....+...+++.-|.+||.+|.
T Consensus 471 -------ilekqiri--prslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 471 -------ILEKQIRI--PRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred -------Hhhhcccc--cceeehhhHHHHHHhhcCCcHHhc
Confidence 22222221 223344566778888999999985
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-27 Score=264.02 Aligned_cols=240 Identities=24% Similarity=0.382 Sum_probs=176.3
Q ss_pred CCcccccccCCCCc-cEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhc-CCCCccceeeEe
Q 041702 515 NFSEENKLGEGGFG-PVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL-QHRNLVRLFGCC 592 (840)
Q Consensus 515 ~f~~~~~lG~G~~G-~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~ 592 (840)
-|...+.+|.|..| .||+|. ..|+.||||++-.. ..+...+||..|+.- +||||||+++.-
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~--------------ye~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E 572 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGV--------------YEGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSE 572 (903)
T ss_pred eeccHHHcccCCCCcEEEEEe--------------eCCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeec
Confidence 45556789999887 467764 57899999998643 234567899999988 699999999888
Q ss_pred ecCCceEEEEEee------ccCCc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecC---C--CC
Q 041702 593 IEQGEKISIYEFD------IVTDP-ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS---D--MN 660 (840)
Q Consensus 593 ~~~~~~~lv~e~~------~~~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~---~--~~ 660 (840)
.+....|+..|.. +.... .......-...+.+..|+++||++||+.+ ||||||||.||||+. + ..
T Consensus 573 ~d~qF~YIalELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~r 649 (903)
T KOG1027|consen 573 QDRQFLYIALELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLR 649 (903)
T ss_pred cCCceEEEEehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCccee
Confidence 8888888888872 11111 11111111445678999999999999987 999999999999976 3 46
Q ss_pred ceeeccccceecCCCCccc-ccccccccccccCccccccCCCCccccchhHHHHHHHHHhC-CCCCCCCCCCCccHhHHH
Q 041702 661 PKISDFGIARTFGGDEMQS-NTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSS-KKNTRFYNTDSLTLLGHA 738 (840)
Q Consensus 661 ~kL~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG-~~p~~~~~~~~~~~~~~~ 738 (840)
++|+|||+++.+..+...- ......||.+|+|||.+....-+.++||||||||+|+.++| .+||......+.....
T Consensus 650 a~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~-- 727 (903)
T KOG1027|consen 650 AKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT-- 727 (903)
T ss_pred EEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc--
Confidence 8999999999886654322 24557799999999999999889999999999999999997 7887643332222211
Q ss_pred hhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 041702 739 WNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVV 789 (840)
Q Consensus 739 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 789 (840)
.......+.+ ..+. ...+|+.+|++.+|..||++.+|+
T Consensus 728 -----~~~~L~~L~~------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 728 -----GNYTLVHLEP------LPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred -----Cccceeeecc------CchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 1111111111 1111 467899999999999999999986
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-27 Score=226.00 Aligned_cols=257 Identities=21% Similarity=0.306 Sum_probs=191.6
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcC-CCCccceee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQ-HRNLVRLFG 590 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~-H~niv~l~g 590 (840)
..++|++.+++|+|.++.||.|+. ..+.+.++||+++.. ..+.+.+|++||..|+ ||||++|++
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~------------~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~D 100 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGIN------------ITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLD 100 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccc------------cCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhh
Confidence 467899999999999999999854 478899999999854 3467899999999996 999999999
Q ss_pred EeecC--CceEEEEEeeccCCc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCC-CCceeecc
Q 041702 591 CCIEQ--GEKISIYEFDIVTDP-ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSD-MNPKISDF 666 (840)
Q Consensus 591 ~~~~~--~~~~lv~e~~~~~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kL~DF 666 (840)
...+. ....+++|+....+. .....+....+..++.++++||.|+|+.| |+|||+||.|+++|.. -..+|+|+
T Consensus 101 iV~Dp~SktpaLiFE~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDW 177 (338)
T KOG0668|consen 101 IVKDPESKTPSLIFEYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDW 177 (338)
T ss_pred hhcCccccCchhHhhhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeec
Confidence 98764 456788888433332 23345677788889999999999999999 9999999999999865 56899999
Q ss_pred ccceecCCCCcccccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
|+|..+..... -+-.+.+..|-.||.+.. ..|+..-|+|||||+|..|+..+.||-........++.-+.-+..++
T Consensus 178 GLAEFYHp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~e 254 (338)
T KOG0668|consen 178 GLAEFYHPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDE 254 (338)
T ss_pred chHhhcCCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHH
Confidence 99998865442 233567788999998876 45899999999999999999999998554444333332221111000
Q ss_pred ------ccccccCccccc----------------hhhHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 041702 746 ------KAWKLMDPTMQN----------------EALYSMVTRYIKVALLCVQENATDRPTMLEVV 789 (840)
Q Consensus 746 ------~~~~~~d~~l~~----------------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 789 (840)
+-.-.+||.... +...-..+..++++.+.|..|-++|||+.|..
T Consensus 255 l~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam 320 (338)
T KOG0668|consen 255 LYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAM 320 (338)
T ss_pred HHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHh
Confidence 000012222111 00011235678999999999999999999875
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.94 E-value=6e-26 Score=207.58 Aligned_cols=115 Identities=43% Similarity=0.743 Sum_probs=101.4
Q ss_pred cccCCCCeEEcCCCeEEEEEecCCCCCceEEEEeeecCCCcEEEeecCCCCCCCCCceEEEecCCceEEecCCCceEEEe
Q 041702 32 TFIRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKKSPDTVVWVANRNCPILDPHGILAINNNGNLVLLNQANGTIWSS 111 (840)
Q Consensus 32 ~~l~~~~~l~S~~g~F~~gFf~~~~~~~~~lgiw~~~~~~tvVW~ANr~~p~~~~~~~l~~~~~G~L~l~~~~~~~~Wss 111 (840)
+.|+.|++|+|+++.|++|||.+......+.+|||++.+.++||.||++.| ....+.|.|+.||+|+|+|.+|.++|+|
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~~~~vW~snt~~~-~~~~~~l~l~~dGnLvl~~~~g~~vW~S 80 (116)
T cd00028 2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNP-SGSSCTLTLQSDGNLVIYDGSGTVVWSS 80 (116)
T ss_pred cCcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCCCeEEEECCCCCC-CCCCEEEEEecCCCeEEEcCCCcEEEEe
Confidence 578899999999999999999987665589999999877889999999998 4557899999999999999999999999
Q ss_pred cCCCCCCCceEEEecCCCeEEEeccCCCCCCCceeEEecCCC
Q 041702 112 NMSKEAKSPVAQLLDTGNLVLRENFSNNTSEGSYLWQSFDFP 153 (840)
Q Consensus 112 ~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~~lWqSFd~P 153 (840)
++.+......|+|+|+|||||++. .+.+||||||||
T Consensus 81 ~~~~~~~~~~~~L~ddGnlvl~~~------~~~~~W~Sf~~P 116 (116)
T cd00028 81 NTTRVNGNYVLVLLDDGNLVLYDS------DGNFLWQSFDYP 116 (116)
T ss_pred cccCCCCceEEEEeCCCCEEEECC------CCCEEEcCCCCC
Confidence 987633456789999999999983 456799999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-26 Score=247.51 Aligned_cols=209 Identities=22% Similarity=0.334 Sum_probs=170.7
Q ss_pred HHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhcCCCCc
Q 041702 509 ISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKLQHRNL 585 (840)
Q Consensus 509 ~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l~H~ni 585 (840)
-+-...-|..++.||-|+||.|.+++ +..+...+|.|.|++.+ +......+.|-.||..-..+=|
T Consensus 624 aKMdKSmFvkik~iGvGAFGeV~Lv~------------KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WV 691 (1034)
T KOG0608|consen 624 AKMDKSMFVKIKTIGVGAFGEVCLVR------------KVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWV 691 (1034)
T ss_pred hhccccceEEEeeecccccceeEEEe------------ecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcce
Confidence 33445678888999999999999984 34567789999998753 3455668899999999999999
Q ss_pred cceeeEeecCCceEEEEEee----ccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCc
Q 041702 586 VRLFGCCIEQGEKISIYEFD----IVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP 661 (840)
Q Consensus 586 v~l~g~~~~~~~~~lv~e~~----~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 661 (840)
|+|+-.|.+++.+|+||+|. .+..+-+...+++....-++..+..|+++.|..| +|||||||+|||||.+|++
T Consensus 692 VrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHI 768 (1034)
T KOG0608|consen 692 VRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHI 768 (1034)
T ss_pred EEEEEEeccCCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCce
Confidence 99999999999999999993 3333344556777777788899999999999999 9999999999999999999
Q ss_pred eeeccccceecC---------CCC------cc-------------------------cccccccccccccCccccccCCC
Q 041702 662 KISDFGIARTFG---------GDE------MQ-------------------------SNTNRIVGTYGYMSPEYALHGLF 701 (840)
Q Consensus 662 kL~DFGla~~~~---------~~~------~~-------------------------~~~~~~~gt~~y~aPE~~~~~~~ 701 (840)
||.||||..-+. .+. +. ......+||+.|+|||++....+
T Consensus 769 KLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~ 848 (1034)
T KOG0608|consen 769 KLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGY 848 (1034)
T ss_pred eeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCc
Confidence 999999985331 000 00 00123479999999999999999
Q ss_pred CccccchhHHHHHHHHHhCCCCCCCCCCCCc
Q 041702 702 SIKSDVFSFGVLLLEILSSKKNTRFYNTDSL 732 (840)
Q Consensus 702 ~~ksDV~SlGviL~elltG~~p~~~~~~~~~ 732 (840)
+..+|.||.||||+||+.|+.||....+.+.
T Consensus 849 ~q~cdwws~gvil~em~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 849 TQLCDWWSVGVILYEMLVGQPPFLADTPGET 879 (1034)
T ss_pred cccchhhHhhHHHHHHhhCCCCccCCCCCcc
Confidence 9999999999999999999999976655543
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-26 Score=230.83 Aligned_cols=261 Identities=23% Similarity=0.228 Sum_probs=191.0
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC--CCcCHHHHHHHHHHHhhcCCCCcccee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK--SGQGLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
...+|..+..+|.|.. .|-.|.|. ..++.||+|++... +....++..+|..++..++|+|+++++
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~------------v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~ 81 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQ------------VLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLL 81 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchh------------hccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeee
Confidence 4567888889999998 66666543 67899999998643 356678889999999999999999999
Q ss_pred eEeecC------CceEEEEEeeccCCcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCce
Q 041702 590 GCCIEQ------GEKISIYEFDIVTDPA-RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPK 662 (840)
Q Consensus 590 g~~~~~------~~~~lv~e~~~~~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 662 (840)
.++.-. .+.|+|||++...-.. ..-.++-.+...|..|++.|++|||+.+ |+||||||+||++..+..+|
T Consensus 82 n~ftP~~~l~~~~e~y~v~e~m~~nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lK 158 (369)
T KOG0665|consen 82 NVFTPQKTLEEFQEVYLVMELMDANLCQVILMELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLK 158 (369)
T ss_pred eccCccccHHHHHhHHHHHHhhhhHHHHHHHHhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhhee
Confidence 998643 4678899985432211 1134677788899999999999999998 99999999999999999999
Q ss_pred eeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCC------------
Q 041702 663 ISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTD------------ 730 (840)
Q Consensus 663 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~------------ 730 (840)
|.|||+|+....+ -..+-.+.|..|+|||++.+..+.+.+||||+||++.||++|+.-|+...--
T Consensus 159 i~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgt 235 (369)
T KOG0665|consen 159 ILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGT 235 (369)
T ss_pred eccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcC
Confidence 9999999875443 2334567899999999999989999999999999999999999877642110
Q ss_pred -Cc----cHhHHHhhhhcccc------ccccc-Cccccc--hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 731 -SL----TLLGHAWNLWKDDK------AWKLM-DPTMQN--EALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 731 -~~----~~~~~~~~~~~~~~------~~~~~-d~~l~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
+. .+...+....+..+ ..+++ |..... +........+.+++.+||-.+|++|.++.+++..
T Consensus 236 pd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 236 PDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred CCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 00 11111111111100 01111 111111 1111223446789999999999999999999853
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-26 Score=246.60 Aligned_cols=193 Identities=26% Similarity=0.388 Sum_probs=163.7
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--------CcCHHHHHHHHHHHhhcC---
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--------GQGLEEFKNEMMLIAKLQ--- 581 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--------~~~~~~f~~Ev~~l~~l~--- 581 (840)
..+|..++++|+|+||.|+.|.++ .+..+|+||.+.+.. ....-....|+.||..|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K------------~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~s 627 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHK------------ENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHS 627 (772)
T ss_pred cccceeeeeccccccceEEEeeec------------ccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcC
Confidence 356889999999999999999876 568899999987642 112233567999999997
Q ss_pred CCCccceeeEeecCCceEEEEEe-----eccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEec
Q 041702 582 HRNLVRLFGCCIEQGEKISIYEF-----DIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLD 656 (840)
Q Consensus 582 H~niv~l~g~~~~~~~~~lv~e~-----~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~ 656 (840)
|+||++++++|++++..|+++|. ++......+..+++.+...|++||+.|+++||+.+ |||||||-+|+.++
T Consensus 628 H~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd 704 (772)
T KOG1152|consen 628 HENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVD 704 (772)
T ss_pred ccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEe
Confidence 99999999999999999999997 33344456677899999999999999999999999 99999999999999
Q ss_pred CCCCceeeccccceecCCCCcccccccccccccccCccccccCCCC-ccccchhHHHHHHHHHhCCCCC
Q 041702 657 SDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFS-IKSDVFSFGVLLLEILSSKKNT 724 (840)
Q Consensus 657 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDV~SlGviL~elltG~~p~ 724 (840)
.+|-+||+|||.|.....+. ....+||..|.|||++.+.+|- ..-|||++|++||.++...-|+
T Consensus 705 ~~g~~klidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 705 SNGFVKLIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred cCCeEEEeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 99999999999997654332 3457899999999999999875 4579999999999998776664
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=9e-25 Score=221.71 Aligned_cols=207 Identities=35% Similarity=0.584 Sum_probs=174.1
Q ss_pred ccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCc-CHHHHHHHHHHHhhcCCCCccceeeEeecCCceEE
Q 041702 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQ-GLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKIS 600 (840)
Q Consensus 522 lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~-~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~l 600 (840)
||+|.+|.||++.+. .+++.+++|++...... ..+.+.+|++.+++++|++++++++++......++
T Consensus 1 l~~g~~~~v~~~~~~------------~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~ 68 (215)
T cd00180 1 LGEGGFGTVYLARDK------------KTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYL 68 (215)
T ss_pred CCcCCceEEEEEEec------------CCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEE
Confidence 689999999998643 35899999999865432 35789999999999999999999999999999999
Q ss_pred EEEeeccCCcc---cc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecC-CCCceeeccccceecCC
Q 041702 601 IYEFDIVTDPA---RK--DLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS-DMNPKISDFGIARTFGG 674 (840)
Q Consensus 601 v~e~~~~~~~~---~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kL~DFGla~~~~~ 674 (840)
++|+....... .. ..+++..+..++.++++++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+.....
T Consensus 69 ~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~ 145 (215)
T cd00180 69 VMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTS 145 (215)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccC
Confidence 99984321111 11 36889999999999999999999998 999999999999999 89999999999987643
Q ss_pred CCcccccccccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccccccCc
Q 041702 675 DEMQSNTNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDP 753 (840)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 753 (840)
... ......+...|++||..... ..+.++|+|++|+++++|
T Consensus 146 ~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------ 187 (215)
T cd00180 146 DKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------ 187 (215)
T ss_pred Ccc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------
Confidence 321 12334577899999998877 889999999999999998
Q ss_pred cccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 041702 754 TMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAML 792 (840)
Q Consensus 754 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 792 (840)
..+.+++..|++.+|++||++.++++.+
T Consensus 188 -----------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -----------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -----------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 4578899999999999999999998653
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.3e-26 Score=240.24 Aligned_cols=259 Identities=18% Similarity=0.216 Sum_probs=195.7
Q ss_pred HHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcC------CC
Q 041702 510 SAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQ------HR 583 (840)
Q Consensus 510 ~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~------H~ 583 (840)
+....+|.+....|+|-|++|.+|.+. .-|+.||||+++... ...+.=+.|+++|.+|+ .-
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~------------~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~ 494 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQ------------ARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKF 494 (752)
T ss_pred hhhcceeEEEeccccceeeeeeecccc------------CCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhh
Confidence 456688999999999999999999765 557799999998753 22345578999999994 35
Q ss_pred CccceeeEeecCCceEEEEEeec------cCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecC
Q 041702 584 NLVRLFGCCIEQGEKISIYEFDI------VTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS 657 (840)
Q Consensus 584 niv~l~g~~~~~~~~~lv~e~~~------~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~ 657 (840)
|.++|+-.|.+.+++++|+|... +......-.|.......++.|+..||..|-..+ |+|.||||+|||+++
T Consensus 495 Hclrl~r~F~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE 571 (752)
T KOG0670|consen 495 HCLRLFRHFKHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNE 571 (752)
T ss_pred HHHHHHHHhhhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEecc
Confidence 89999999999999999999732 222334445777788889999999999999988 999999999999987
Q ss_pred C-CCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhH
Q 041702 658 D-MNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLG 736 (840)
Q Consensus 658 ~-~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~ 736 (840)
. ..+||||||.|....++.. +-...+.-|.|||++.+-+|+...|+||.||.||||.||+..|+......+ +.
T Consensus 572 ~k~iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~M--Lr 645 (752)
T KOG0670|consen 572 SKNILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQM--LR 645 (752)
T ss_pred CcceeeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHH--HH
Confidence 6 4579999999987765443 223456689999999999999999999999999999999998876543321 11
Q ss_pred HHhh--------hhcc------------------------cc---cccccCc-----------cccchhhHHHHHHHHHH
Q 041702 737 HAWN--------LWKD------------------------DK---AWKLMDP-----------TMQNEALYSMVTRYIKV 770 (840)
Q Consensus 737 ~~~~--------~~~~------------------------~~---~~~~~d~-----------~l~~~~~~~~~~~l~~l 770 (840)
..+. +++. .. ....+.| .-.+......+.++.+|
T Consensus 646 l~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdL 725 (752)
T KOG0670|consen 646 LFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDL 725 (752)
T ss_pred HHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHH
Confidence 1000 0000 00 0011111 00112234567789999
Q ss_pred HHHccccCCCCCCCHHHHHH
Q 041702 771 ALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 771 ~~~Cl~~dP~~RPs~~evl~ 790 (840)
+..|+..||++|.|..+.|+
T Consensus 726 Ldkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 726 LDKMLILDPEKRITVNQALK 745 (752)
T ss_pred HHHHhccChhhcCCHHHHhc
Confidence 99999999999999998875
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=229.26 Aligned_cols=128 Identities=27% Similarity=0.336 Sum_probs=104.8
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcC-----C---CC
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQ-----H---RN 584 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~-----H---~n 584 (840)
..+|.+.++||.|.|++||+|.|. ++.+.||+|+.+.. +...+.-+.||++|++++ | .+
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDt------------q~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~ 143 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDT------------QNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKC 143 (590)
T ss_pred CceEEEEEeccccccceeEEEeec------------cCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCce
Confidence 368999999999999999999776 78899999999753 445567889999999993 4 35
Q ss_pred ccceeeEeec----CCceEEEEEee-----ccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEe
Q 041702 585 LVRLFGCCIE----QGEKISIYEFD-----IVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLL 655 (840)
Q Consensus 585 iv~l~g~~~~----~~~~~lv~e~~-----~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl 655 (840)
||+|+++|.. +.+.++|+|+. .+......+.++.....+|++||+.||.|||.++ .|||-||||+||||
T Consensus 144 VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 144 VVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred eeeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 9999999975 45677888872 1112234556888999999999999999999987 69999999999998
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-24 Score=196.69 Aligned_cols=113 Identities=45% Similarity=0.768 Sum_probs=98.9
Q ss_pred cccCCCCeEEcCCCeEEEEEecCCCCCceEEEEeeecCCCcEEEeecCCCCCCCCCceEEEecCCceEEecCCCceEEEe
Q 041702 32 TFIRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKKSPDTVVWVANRNCPILDPHGILAINNNGNLVLLNQANGTIWSS 111 (840)
Q Consensus 32 ~~l~~~~~l~S~~g~F~~gFf~~~~~~~~~lgiw~~~~~~tvVW~ANr~~p~~~~~~~l~~~~~G~L~l~~~~~~~~Wss 111 (840)
+.|..|++|+|+++.|++|||.+... ..+.+|||+..+.++||+|||+.|+.+ ++.|.+++||+|+|+|.+|.++|+|
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q-~dgnlV~~~~~~~~~vW~snt~~~~~~-~~~l~l~~dGnLvl~~~~g~~vW~S 79 (114)
T smart00108 2 NTLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSSRTVVWVANRDNPVSD-SCTLTLQSDGNLVLYDGDGRVVWSS 79 (114)
T ss_pred cccCCCCEEecCCCcEeeeccccCCC-CCEEEEEEECCCCcEEEECCCCCCCCC-CEEEEEeCCCCEEEEeCCCCEEEEe
Confidence 56889999999999999999998654 578999999877889999999999865 4889999999999999999999999
Q ss_pred cCCCCCCCceEEEecCCCeEEEeccCCCCCCCceeEEecCC
Q 041702 112 NMSKEAKSPVAQLLDTGNLVLRENFSNNTSEGSYLWQSFDF 152 (840)
Q Consensus 112 ~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~~lWqSFd~ 152 (840)
++........|+|+|+|||||++ ..+.+|||||||
T Consensus 80 ~t~~~~~~~~~~L~ddGnlvl~~------~~~~~~W~Sf~~ 114 (114)
T smart00108 80 NTTGANGNYVLVLLDDGNLVIYD------SDGNFLWQSFDY 114 (114)
T ss_pred cccCCCCceEEEEeCCCCEEEEC------CCCCEEeCCCCC
Confidence 98733345678999999999998 345689999997
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.7e-25 Score=242.37 Aligned_cols=249 Identities=23% Similarity=0.374 Sum_probs=192.8
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
..++|....++|+|.||.||||+++ ..++..|||+++-.......-.++|+-+++..+|||||.++|.
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~------------~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gs 80 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDK------------RSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGS 80 (829)
T ss_pred CccchhheeeecCCcccchhhhccc------------ccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhh
Confidence 4578888999999999999999876 7899999999987766667778899999999999999999999
Q ss_pred eecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 592 CIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
+...+...+.|||.--.. ......+++.++..+++..++||+|||+.+ -+|||||-.|||+++.+.+|++|||
T Consensus 81 ylr~dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfg 157 (829)
T KOG0576|consen 81 YLRRDKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFG 157 (829)
T ss_pred hhhhcCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccC
Confidence 999999999999953333 233456888999999999999999999998 8999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYAL---HGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
.+-.+.. .........||+.|||||+.. .+.|..++|||+.|+...|+---++|.-..++. .+..+...
T Consensus 158 vsaqita--ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm------r~l~LmTk 229 (829)
T KOG0576|consen 158 VSAQITA--TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM------RALFLMTK 229 (829)
T ss_pred chhhhhh--hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH------HHHHHhhc
Confidence 9876532 222334578999999999874 567999999999999999986555443211111 11111111
Q ss_pred cccccccC-ccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 041702 745 DKAWKLMD-PTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVV 789 (840)
Q Consensus 745 ~~~~~~~d-~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 789 (840)
...+ +.+.+.. .-.+.+-++++.|+..+|++||+++.++
T Consensus 230 ----S~~qpp~lkDk~--kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 230 ----SGFQPPTLKDKT--KWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred ----cCCCCCcccCCc--cchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 1111 1222221 1223466788889999999999998765
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.9e-25 Score=228.56 Aligned_cols=205 Identities=25% Similarity=0.376 Sum_probs=164.3
Q ss_pred HHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhc-CCCCcc
Q 041702 508 SISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL-QHRNLV 586 (840)
Q Consensus 508 ~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l-~H~niv 586 (840)
.+....+.|..+++||+|.|++||+|.++. .-...+.||+|.+...+ ...+..+|+++|..+ .|.||+
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~---------~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~ 98 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIE---------QDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNII 98 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhh---------hccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhh
Confidence 355566788999999999999999998762 12357789999997653 447799999999999 589999
Q ss_pred ceeeEeecCCceEEEEEeeccCCc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCC-CCceee
Q 041702 587 RLFGCCIEQGEKISIYEFDIVTDP-ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSD-MNPKIS 664 (840)
Q Consensus 587 ~l~g~~~~~~~~~lv~e~~~~~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kL~ 664 (840)
++.+++..+++..+|+||...... .....++...+..++..+++||+++|..| ||||||||+|+|.+.. +.-.|.
T Consensus 99 ~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~Lv 175 (418)
T KOG1167|consen 99 KLNGCFRNNDQVAIVLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLV 175 (418)
T ss_pred cchhhhccCCeeEEEecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEE
Confidence 999999999999999999543332 22345778899999999999999999999 9999999999999765 567899
Q ss_pred ccccceecCCCC-------------c-----------------------------ccccccccccccccCccccccC-CC
Q 041702 665 DFGIARTFGGDE-------------M-----------------------------QSNTNRIVGTYGYMSPEYALHG-LF 701 (840)
Q Consensus 665 DFGla~~~~~~~-------------~-----------------------------~~~~~~~~gt~~y~aPE~~~~~-~~ 701 (840)
|||+|....... . ........||++|+|||++... ..
T Consensus 176 DFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Q 255 (418)
T KOG1167|consen 176 DFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQ 255 (418)
T ss_pred echhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCc
Confidence 999997221000 0 0001124699999999998764 47
Q ss_pred CccccchhHHHHHHHHHhCCCCCCC
Q 041702 702 SIKSDVFSFGVLLLEILSSKKNTRF 726 (840)
Q Consensus 702 ~~ksDV~SlGviL~elltG~~p~~~ 726 (840)
++++||||-|||++-+++++.||-.
T Consensus 256 ttaiDiws~GVI~Lslls~~~PFf~ 280 (418)
T KOG1167|consen 256 TTAIDIWSAGVILLSLLSRRYPFFK 280 (418)
T ss_pred CCccceeeccceeehhhcccccccc
Confidence 8999999999999999999999843
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=216.89 Aligned_cols=194 Identities=32% Similarity=0.466 Sum_probs=162.6
Q ss_pred CcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCc-CHHHHHHHHHHHhhcCCCCccceeeEeec
Q 041702 516 FSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQ-GLEEFKNEMMLIAKLQHRNLVRLFGCCIE 594 (840)
Q Consensus 516 f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~-~~~~f~~Ev~~l~~l~H~niv~l~g~~~~ 594 (840)
|...+.||+|++|.||++.+. .+++.+|+|.+...... ..+.+.+|++.+.+++|+|++++++++..
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~------------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~ 68 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDK------------GTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFED 68 (225)
T ss_pred CceeeEeecCCCeEEEEEEEc------------CCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeec
Confidence 456688999999999998654 45789999999866544 57889999999999999999999999999
Q ss_pred CCceEEEEEeeccCCc----cccCC-CCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccc
Q 041702 595 QGEKISIYEFDIVTDP----ARKDL-LDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIA 669 (840)
Q Consensus 595 ~~~~~lv~e~~~~~~~----~~~~~-l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla 669 (840)
....++++|+...... ..... +++.....++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+
T Consensus 69 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~ 145 (225)
T smart00221 69 PEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLA 145 (225)
T ss_pred CCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCcee
Confidence 9999999998433211 11223 788999999999999999999987 999999999999999999999999999
Q ss_pred eecCCCCcccccccccccccccCcccc-ccCCCCccccchhHHHHHHHHHhCCCCCC
Q 041702 670 RTFGGDEMQSNTNRIVGTYGYMSPEYA-LHGLFSIKSDVFSFGVLLLEILSSKKNTR 725 (840)
Q Consensus 670 ~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~ksDV~SlGviL~elltG~~p~~ 725 (840)
........ .......++..|++||.+ ....++.++|||+||++++||++|+.||.
T Consensus 146 ~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 146 RFIHRDLA-ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred eEecCccc-ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 88754321 122335677899999998 67778889999999999999999999984
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.6e-24 Score=207.93 Aligned_cols=252 Identities=19% Similarity=0.307 Sum_probs=185.2
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhc-CCCCccceeeE
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL-QHRNLVRLFGC 591 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~ 591 (840)
.+.|.+.+.||+|.||.+-++.+| ++.+.+++|-+... ....++|.+|..---.| .|.||+.-+++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr------------~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~v 89 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHR------------QSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEV 89 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeecc------------CCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHH
Confidence 467888899999999999999887 78889999998765 34568899998876666 58999987765
Q ss_pred -eecCCceEEEEEeeccCCccc---cCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEec--CCCCceeec
Q 041702 592 -CIEQGEKISIYEFDIVTDPAR---KDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLD--SDMNPKISD 665 (840)
Q Consensus 592 -~~~~~~~~lv~e~~~~~~~~~---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~--~~~~~kL~D 665 (840)
|...+..++++||....+... ...+.+..-.+++.|++.|+.|+|++. +||||||.+||||- +...+||+|
T Consensus 90 aFqt~d~YvF~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcD 166 (378)
T KOG1345|consen 90 AFQTSDAYVFVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCD 166 (378)
T ss_pred HhhcCceEEEeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeee
Confidence 455677778899855544332 345777888899999999999999998 99999999999993 345899999
Q ss_pred cccceecCCCCcccccccccccccccCccccccC-----CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhh
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHG-----LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWN 740 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~ 740 (840)
||+.+..+.. .....-+..|.+||..... ...+.+|||.||+|++.+|||+.|++.....+. .-+.|.
T Consensus 167 FG~t~k~g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~--~Y~~~~ 239 (378)
T KOG1345|consen 167 FGLTRKVGTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK--PYWEWE 239 (378)
T ss_pred cccccccCce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc--hHHHHH
Confidence 9998765321 1223345689999976532 257889999999999999999999874333332 223344
Q ss_pred hhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 041702 741 LWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLK 793 (840)
Q Consensus 741 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le 793 (840)
.|..+....+ +.......++++++-.+-+..+|++|=-..++.++..
T Consensus 240 ~w~~rk~~~~------P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 240 QWLKRKNPAL------PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred HHhcccCccC------chhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 4444333211 1112234556777888899999999955555555544
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.2e-24 Score=259.19 Aligned_cols=192 Identities=17% Similarity=0.224 Sum_probs=130.1
Q ss_pred hcCC-CCccceeeEe-------ecCCceEEEEEeeccC---Cc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecC
Q 041702 579 KLQH-RNLVRLFGCC-------IEQGEKISIYEFDIVT---DP-ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHR 646 (840)
Q Consensus 579 ~l~H-~niv~l~g~~-------~~~~~~~lv~e~~~~~---~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHr 646 (840)
.++| +||++++++| .+.+..+.++|+.... .. .....+++.+++.++.||++||+|||+++ |+||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---IvHr 104 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG---IVVH 104 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC---eeec
Confidence 4556 5888888887 2334556667763111 11 12345899999999999999999999988 9999
Q ss_pred CCCCCcEEecC-------------------CCCceeeccccceecCCCCc--------------ccccccccccccccCc
Q 041702 647 DLKASNVLLDS-------------------DMNPKISDFGIARTFGGDEM--------------QSNTNRIVGTYGYMSP 693 (840)
Q Consensus 647 Dlkp~NILl~~-------------------~~~~kL~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~aP 693 (840)
||||+||||+. ++.+||+|||+++....... ........||+.||||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 99999999954 45567777777654321000 0001124578899999
Q ss_pred cccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHH
Q 041702 694 EYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALL 773 (840)
Q Consensus 694 E~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~ 773 (840)
|++.+..++.++|||||||+||||++|.+|+.... .... . ... ..+.+.. .........++.+
T Consensus 185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----~~~~---~-~~~----~~~~~~~-----~~~~~~~~~~~~~ 247 (793)
T PLN00181 185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----RTMS---S-LRH----RVLPPQI-----LLNWPKEASFCLW 247 (793)
T ss_pred hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----HHHH---H-HHH----hhcChhh-----hhcCHHHHHHHHH
Confidence 99999999999999999999999999887743110 0000 0 000 0111111 1112335678889
Q ss_pred ccccCCCCCCCHHHHHH
Q 041702 774 CVQENATDRPTMLEVVA 790 (840)
Q Consensus 774 Cl~~dP~~RPs~~evl~ 790 (840)
||+.+|.+||+|.||++
T Consensus 248 ~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 248 LLHPEPSCRPSMSELLQ 264 (793)
T ss_pred hCCCChhhCcChHHHhh
Confidence 99999999999999985
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-22 Score=199.69 Aligned_cols=157 Identities=20% Similarity=0.134 Sum_probs=118.0
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceecCCCCcccccccccccccccC
Q 041702 613 KDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMS 692 (840)
Q Consensus 613 ~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~a 692 (840)
...+++.++..|+.||++||+|||+.+ ||+|||++.++.+|+ ||+++...... ..||+.|||
T Consensus 11 ~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~-------~~g~~~y~a 72 (176)
T smart00750 11 GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ-------SRVDPYFMA 72 (176)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc-------CCCcccccC
Confidence 346899999999999999999999875 999999999999999 99998754321 257899999
Q ss_pred ccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHH--HHHHH
Q 041702 693 PEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVT--RYIKV 770 (840)
Q Consensus 693 PE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~--~l~~l 770 (840)
||++.+..++.++|||||||++|||++|+.|+.............. ..... .++... ........ .+.++
T Consensus 73 PE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~-~~~~~------~~~~~~-~~~~~~~~~~~~~~~ 144 (176)
T smart00750 73 PEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILL-NGMPA------DDPRDR-SNLESVSAARSFADF 144 (176)
T ss_pred hHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHH-HHhcc------CCcccc-ccHHHHHhhhhHHHH
Confidence 9999999999999999999999999999999754322111111110 00000 001000 11122222 58999
Q ss_pred HHHccccCCCCCCCHHHHHHHhhcc
Q 041702 771 ALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 771 ~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
+.+||+.+|++||++.|+++.+...
T Consensus 145 i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 145 MRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHHhcccccccCHHHHHHHHHHH
Confidence 9999999999999999999988764
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.5e-21 Score=209.20 Aligned_cols=180 Identities=18% Similarity=0.152 Sum_probs=132.5
Q ss_pred HHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-----CcCHHHHHHHHHHHhhcCCC
Q 041702 509 ISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-----GQGLEEFKNEMMLIAKLQHR 583 (840)
Q Consensus 509 ~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-----~~~~~~f~~Ev~~l~~l~H~ 583 (840)
.....++|...+.||+|+||.||+|+++ ..+++.||||++.... ....+.|.+|+++|.+++|+
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~-----------~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~ 81 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFA-----------GDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGI 81 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEc-----------CCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCC
Confidence 3456688999999999999999999754 1257778999875331 12345699999999999999
Q ss_pred CccceeeEeecCCceEEEEEeeccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCC-CCCcEEecCCCCce
Q 041702 584 NLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDL-KASNVLLDSDMNPK 662 (840)
Q Consensus 584 niv~l~g~~~~~~~~~lv~e~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl-kp~NILl~~~~~~k 662 (840)
|++..+.. .+..++||||..-....... . .....++.+++++|.|||+.+ |+|||| ||+|||++.++.+|
T Consensus 82 ~iv~~l~~---~~~~~LVmE~~~G~~L~~~~--~-~~~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ik 152 (365)
T PRK09188 82 GVVPQLLA---TGKDGLVRGWTEGVPLHLAR--P-HGDPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAA 152 (365)
T ss_pred CCCcEEEE---cCCcEEEEEccCCCCHHHhC--c-cchHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEE
Confidence 99853322 25689999995322221111 1 112568899999999999988 999999 99999999999999
Q ss_pred eeccccceecCCCCcccc------cccccccccccCccccccCC------CCccccch
Q 041702 663 ISDFGIARTFGGDEMQSN------TNRIVGTYGYMSPEYALHGL------FSIKSDVF 708 (840)
Q Consensus 663 L~DFGla~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~------~~~ksDV~ 708 (840)
|+|||+|+.+........ .....+++.|+|||.+.... .+..+|-|
T Consensus 153 LiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 153 VIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred EEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 999999998755332111 13566888999999886432 33446666
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.5e-19 Score=197.00 Aligned_cols=259 Identities=22% Similarity=0.246 Sum_probs=186.0
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccC-CceEEEEEeccCCCcCHHHHHHHHHHHhhcCC----CCcccee
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLN-GEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQH----RNLVRLF 589 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~-g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H----~niv~l~ 589 (840)
+|.+.++||+|+||.||+|.+. .+ ...+|+|............+..|+.++..+.+ +++.+++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~------------~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~ 86 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDK------------SEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLL 86 (322)
T ss_pred ceEEeeeccccCCceEEEEEec------------CCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEE
Confidence 8999999999999999999764 22 46788888776533333378899999999973 5899999
Q ss_pred eEe-ecCCceEEEEEeec-----cCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCC-----
Q 041702 590 GCC-IEQGEKISIYEFDI-----VTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSD----- 658 (840)
Q Consensus 590 g~~-~~~~~~~lv~e~~~-----~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~----- 658 (840)
+.. ......++||+..- +........++..+.++|+.|++.+|++||+.+ ++||||||.|+++...
T Consensus 87 ~~G~~~~~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~ 163 (322)
T KOG1164|consen 87 DHGRSTEDFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEV 163 (322)
T ss_pred EeccCCCceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCccc
Confidence 888 47778899988721 111111467899999999999999999999999 9999999999999765
Q ss_pred CCceeeccccce--ecCCCCc----cc-c-cccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCC
Q 041702 659 MNPKISDFGIAR--TFGGDEM----QS-N-TNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTD 730 (840)
Q Consensus 659 ~~~kL~DFGla~--~~~~~~~----~~-~-~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~ 730 (840)
..+.|.|||+++ .+..... .. . .....||..|.+++.+.+...+.+.|+||++.++.|++.|..|++.....
T Consensus 164 ~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~ 243 (322)
T KOG1164|consen 164 RTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMT 243 (322)
T ss_pred ceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccccc
Confidence 358999999998 4322221 11 1 22355999999999999999999999999999999999999887544322
Q ss_pred CccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCC
Q 041702 731 SLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNL 799 (840)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~ 799 (840)
.. ........ ....... . .. ..+..+.++...+-..+..++|....+...|++.....
T Consensus 244 ~~--~~~~~~~~----~~~~~~~-~-~~---~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 244 DL--KSKFEKDP----RKLLTDR-F-GD---LKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred ch--HHHHHHHh----hhhcccc-c-cC---CChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 21 11100000 0011111 1 11 11223444555555589999999999999988765543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.2e-19 Score=179.18 Aligned_cols=271 Identities=18% Similarity=0.228 Sum_probs=195.0
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhc-CCCCccceeeE
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL-QHRNLVRLFGC 591 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~ 591 (840)
.-+|.+.++||+|.||.++.|. .+.+++.||||.-...+ ..-++..|.+..+.| ..++|...+-+
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~------------Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYF 92 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGK------------NLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYF 92 (449)
T ss_pred cccceeccccccCcceeeeccc------------ccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeee
Confidence 4579999999999999999984 45899999999865443 335678888888888 46899999888
Q ss_pred eecCCceEEEEEee-----ccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCC-----Cc
Q 041702 592 CIEQGEKISIYEFD-----IVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDM-----NP 661 (840)
Q Consensus 592 ~~~~~~~~lv~e~~-----~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-----~~ 661 (840)
-.++-+-.+|+|.. .+.+. -...++.++...|+.|++.-++|+|++. +|.|||||+|+||...+ .+
T Consensus 93 GqeG~~NiLVidLLGPSLEDLFD~-CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~I 168 (449)
T KOG1165|consen 93 GQEGKYNILVIDLLGPSLEDLFDL-CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVI 168 (449)
T ss_pred ccccchhhhhhhhhCcCHHHHHHH-hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceE
Confidence 88888888888872 11111 1345778899999999999999999998 99999999999996443 47
Q ss_pred eeeccccceecCCCCccc-----ccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhH
Q 041702 662 KISDFGIARTFGGDEMQS-----NTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLG 736 (840)
Q Consensus 662 kL~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~ 736 (840)
.|+|||+|+.+.+..+.. ......||.+||+-.-+.+...+.+.|+-|||-++++.|-|..|+.....+...
T Consensus 169 hiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK--- 245 (449)
T KOG1165|consen 169 HIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK--- 245 (449)
T ss_pred EEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchH---
Confidence 899999999876544332 234567999999999999999999999999999999999999999865544321
Q ss_pred HHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCCCCCCCCCCcc
Q 041702 737 HAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSPHQPAFSY 809 (840)
Q Consensus 737 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~p~~p~~~~ 809 (840)
..+..+-+.+...- ........+.++..-+.-.-..+-.+-|..+-+...+.+.+..+..-..-.|+|
T Consensus 246 ~kYeKIGe~Kr~T~-----i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW 313 (449)
T KOG1165|consen 246 EKYEKIGETKRSTP-----IEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDW 313 (449)
T ss_pred HHHHHhccccccCC-----HHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccccc
Confidence 11121111111100 011111223333334444444678888998877777776666655544444444
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.6e-19 Score=172.73 Aligned_cols=272 Identities=18% Similarity=0.232 Sum_probs=199.0
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCC-CCccceee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQH-RNLVRLFG 590 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H-~niv~l~g 590 (840)
...+|..+++||+|+||.+|.|.. +.+|+.||||.-+..... .++.-|.++...|+| ..|..+..
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~------------i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~ 78 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGIS------------ITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRH 78 (341)
T ss_pred eccceEEEEeecCCchhheeeeee------------ccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhh
Confidence 456899999999999999999954 478999999997765433 467789999999976 68999999
Q ss_pred EeecCCceEEEEEee-----ccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCC---CCce
Q 041702 591 CCIEQGEKISIYEFD-----IVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSD---MNPK 662 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~-----~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~---~~~k 662 (840)
|..+.+...+||+.. .+... -...++..+.+-++-|++.-++|+|.++ +|||||||+|+|..-+ ..+.
T Consensus 79 y~~e~~ynvlVMdLLGPsLEdLfnf-C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~ 154 (341)
T KOG1163|consen 79 YGTEKDYNVLVMDLLGPSLEDLFNF-CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLY 154 (341)
T ss_pred hccccccceeeeeccCccHHHHHHH-HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEE
Confidence 999999999999972 11111 1235677888999999999999999998 9999999999999644 4688
Q ss_pred eeccccceecCCCCccc-----ccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHH
Q 041702 663 ISDFGIARTFGGDEMQS-----NTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGH 737 (840)
Q Consensus 663 L~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~ 737 (840)
|+|||+|+.+.+..... ......||.+|.+-..+.+-..+.+.|+-|+|.+|....-|..|++......- ..
T Consensus 155 LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk---~Q 231 (341)
T KOG1163|consen 155 LIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK---KQ 231 (341)
T ss_pred EEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH---HH
Confidence 99999999875543322 23456799999999888888889999999999999999999999876543321 11
Q ss_pred HhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCCCCCCCCCCcc
Q 041702 738 AWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSPHQPAFSY 809 (840)
Q Consensus 738 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~p~~p~~~~ 809 (840)
.++...+.++... -..++. ..+.++.-.+..|-..--++-|...-+.+.+.-....+.....--|+|
T Consensus 232 KyEkI~EkK~s~~-ie~LC~----G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW 298 (341)
T KOG1163|consen 232 KYEKISEKKMSTP-IEVLCK----GFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDW 298 (341)
T ss_pred HHHHHHHhhcCCC-HHHHhC----CCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeH
Confidence 1222222221111 111111 223445666777888888999998888877776655554443333433
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.1e-18 Score=185.12 Aligned_cols=255 Identities=26% Similarity=0.369 Sum_probs=186.8
Q ss_pred CcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCc---CHHHHHHHHHHHhhcCCC-CccceeeE
Q 041702 516 FSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQ---GLEEFKNEMMLIAKLQHR-NLVRLFGC 591 (840)
Q Consensus 516 f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~---~~~~f~~Ev~~l~~l~H~-niv~l~g~ 591 (840)
|.....||.|+||.||++.+. ..+++|.+...... ....|.+|+.++..+.|+ +++++.++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---------------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~ 66 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---------------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDF 66 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---------------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEE
Confidence 566788999999999998532 78999999765432 367899999999999988 79999999
Q ss_pred eecCCceEEEEEeeccCCcc---cc----CCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCC-Ccee
Q 041702 592 CIEQGEKISIYEFDIVTDPA---RK----DLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDM-NPKI 663 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~~~---~~----~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kL 663 (840)
+...+..++++++....... .. ..+.......++.|++.++.|+|+.+ ++|||+||+||+++..+ .+++
T Consensus 67 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l 143 (384)
T COG0515 67 FQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKL 143 (384)
T ss_pred EecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEE
Confidence 97777778999984322211 11 26788889999999999999999998 99999999999999998 7999
Q ss_pred eccccceecCCCCccc----ccccccccccccCcccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhH
Q 041702 664 SDFGIARTFGGDEMQS----NTNRIVGTYGYMSPEYALH---GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLG 736 (840)
Q Consensus 664 ~DFGla~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~ 736 (840)
+|||+++.+....... ......|+..|+|||.+.+ .......|+||+|++++++++|..|+...... ....
T Consensus 144 ~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~--~~~~ 221 (384)
T COG0515 144 IDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS--SATS 221 (384)
T ss_pred eccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc--ccHH
Confidence 9999998665433221 2356789999999999987 57899999999999999999999995544321 0001
Q ss_pred HHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 737 HAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 737 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
............ .................+.+++..|+..+|..|.++.+....
T Consensus 222 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 222 QTLKIILELPTP-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHHHHHHhcCCc-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 111111111100 000001000002223457788888999999999998877754
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.3e-20 Score=211.03 Aligned_cols=251 Identities=19% Similarity=0.222 Sum_probs=180.6
Q ss_pred ccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEecc---CCC---cCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 518 EENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSS---KSG---QGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 518 ~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~---~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
..+.+|.|.+|.|+.+... ......+.|..+. ... .....+..|+.+-..++|||++..+..
T Consensus 322 ~~~~~g~ga~g~~~~~~~~------------~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~ 389 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRR------------SDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDI 389 (601)
T ss_pred ccceeeecccCceEEEEec------------CCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHH
Confidence 4578999999988776543 2233333333221 111 111225567777788899999998888
Q ss_pred eecCCceEEEEEeecc---CCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccc
Q 041702 592 CIEQGEKISIYEFDIV---TDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGI 668 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~---~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl 668 (840)
+.+.......|||... ........+.-.++..++.|++.|+.|||+.+ |.|||||++|+++..++.+||+|||.
T Consensus 390 ~~~~~~~~~~mE~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~ 466 (601)
T KOG0590|consen 390 VQEIDGILQSMEYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGA 466 (601)
T ss_pred HhhcccchhhhhcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCc
Confidence 8877777777888433 22222336788888999999999999999999 99999999999999999999999999
Q ss_pred ceecCCCCcc--cccccccccccccCccccccCCCCcc-ccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 669 ARTFGGDEMQ--SNTNRIVGTYGYMSPEYALHGLFSIK-SDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 669 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k-sDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
+..+...... ......+|+..|+|||.+.+..|++. .||||.|+++..|++|+.|+......+..........
T Consensus 467 ~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~---- 542 (601)
T KOG0590|consen 467 ASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSD---- 542 (601)
T ss_pred ceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcccc----
Confidence 9877544332 44556789999999999999999865 6999999999999999999876655443321111000
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
+ .-...-.......++.+...++.++|+.+|.+|.||++|++
T Consensus 543 --~-~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 543 --Q-RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred --c-cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0 00011111233455667788999999999999999999985
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1e-19 Score=178.94 Aligned_cols=241 Identities=18% Similarity=0.280 Sum_probs=177.7
Q ss_pred cccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceeeEeecCC
Q 041702 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQG 596 (840)
Q Consensus 519 ~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~ 596 (840)
.-+|.+...|..|+|++. |..+++|++.... ..-.++|..|.-.|+-+.||||+.++|.|....
T Consensus 195 ~tkl~e~hsgelwrgrwq--------------gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnspp 260 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ--------------GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPP 260 (448)
T ss_pred hhhhccCCCccccccccc--------------CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCC
Confidence 346888999999997654 5567778776432 223367999999999999999999999999999
Q ss_pred ceEEEEEeeccCC------ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccce
Q 041702 597 EKISIYEFDIVTD------PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIAR 670 (840)
Q Consensus 597 ~~~lv~e~~~~~~------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~ 670 (840)
+..++..|+.... ....-.++-.+..+++.+||+|++|||+..+ -|.---|.+..+++|++.+++|+=-. ++
T Consensus 261 nlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad-~k 338 (448)
T KOG0195|consen 261 NLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMAD-TK 338 (448)
T ss_pred CceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheeccc-ce
Confidence 9999988864432 2223346778899999999999999999763 23344789999999999998875211 11
Q ss_pred ecCCCCcccccccccccccccCccccccCCC---CccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccccc
Q 041702 671 TFGGDEMQSNTNRIVGTYGYMSPEYALHGLF---SIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKA 747 (840)
Q Consensus 671 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 747 (840)
. .-......-.|.||+||.+...+- -.++|+|||.++||||.|...||....+-+..+.
T Consensus 339 f------sfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk------------ 400 (448)
T KOG0195|consen 339 F------SFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK------------ 400 (448)
T ss_pred e------eeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh------------
Confidence 0 001112334679999999887653 3678999999999999999999876554432211
Q ss_pred ccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 748 WKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 748 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
+.-..++...++.....+.+++.-|+..||.+||.+..|+-.||+.
T Consensus 401 --ialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 401 --IALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred --hhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 1122333444455566788888899999999999999999999986
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.4e-18 Score=173.95 Aligned_cols=172 Identities=13% Similarity=0.116 Sum_probs=129.2
Q ss_pred HHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHH---H------HHHHHHHHhhcC
Q 041702 511 AATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLE---E------FKNEMMLIAKLQ 581 (840)
Q Consensus 511 ~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~---~------f~~Ev~~l~~l~ 581 (840)
-..++|+..++||.|+||.||++. .++..+|||.+++......+ . |.+|+..+.+++
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~--------------~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~ 93 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLID--------------TDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVR 93 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEe--------------cCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHH
Confidence 346899999999999999999853 13667999999765332222 2 689999999999
Q ss_pred CCCccceeeEeecC--------CceEEEEEeeccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcE
Q 041702 582 HRNLVRLFGCCIEQ--------GEKISIYEFDIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNV 653 (840)
Q Consensus 582 H~niv~l~g~~~~~--------~~~~lv~e~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NI 653 (840)
|++|..+..++... +..+++|||..-........++ .....+++.+|..+|+.+ ++|||+||+||
T Consensus 94 ~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~~~----~~~~~~i~~~l~~lH~~g---i~H~Dikp~Ni 166 (232)
T PRK10359 94 SEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPEIS----EDVKAKIKASIESLHQHG---MVSGDPHKGNF 166 (232)
T ss_pred HCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhhcc----HHHHHHHHHHHHHHHHcC---CccCCCChHHE
Confidence 99999999886643 3578999995433322222222 235669999999999998 99999999999
Q ss_pred EecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHH
Q 041702 654 LLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEIL 718 (840)
Q Consensus 654 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ell 718 (840)
+++.++ ++|+|||........... ..+.....+..++|+||||+.+....
T Consensus 167 li~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 167 IVSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999988 999999988654221110 11445566778999999999997764
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1e-18 Score=200.87 Aligned_cols=248 Identities=18% Similarity=0.226 Sum_probs=173.5
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHh--hcCCCCccceeeE
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIA--KLQHRNLVRLFGC 591 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~--~l~H~niv~l~g~ 591 (840)
.+...+.||++.|=.|.+|+++ .|. |+||++-+.. ....+.|.++++-++ .++|||.+.+.-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-------------eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~ 89 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-------------EGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKV 89 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-------------Cce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHH
Confidence 5667789999999999998764 444 9999987654 456677777666555 3489999998877
Q ss_pred eecCCceEEEEEee---ccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccc
Q 041702 592 CIEQGEKISIYEFD---IVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGI 668 (840)
Q Consensus 592 ~~~~~~~~lv~e~~---~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl 668 (840)
-......|+|-+|. +......+..+...+.+.|+.|+++||.-+|..+ |+|||||.+||||+.-+-+.|+||..
T Consensus 90 ~~t~kAAylvRqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAs 166 (1431)
T KOG1240|consen 90 LVTDKAAYLVRQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFAS 166 (1431)
T ss_pred HHhhHHHHHHHHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccc
Confidence 66666677776663 3444556667778889999999999999999998 99999999999999999999999987
Q ss_pred ceec--CCCCccc---ccccccccccccCcccccc----------CC-CCccccchhHHHHHHHHHhC-CCCCCCCCCCC
Q 041702 669 ARTF--GGDEMQS---NTNRIVGTYGYMSPEYALH----------GL-FSIKSDVFSFGVLLLEILSS-KKNTRFYNTDS 731 (840)
Q Consensus 669 a~~~--~~~~~~~---~~~~~~gt~~y~aPE~~~~----------~~-~~~ksDV~SlGviL~elltG-~~p~~~~~~~~ 731 (840)
-+.. .++.... .......-..|.|||.+-. .+ .+++-||||+||++.||++- +++|...
T Consensus 167 FKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS---- 242 (1431)
T KOG1240|consen 167 FKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS---- 242 (1431)
T ss_pred cCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----
Confidence 6543 1111111 1111122348999997643 12 67889999999999999984 6666421
Q ss_pred ccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 041702 732 LTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794 (840)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~ 794 (840)
.+. +++.........++ ..+. -..+.+++..|++.||++|.++++.++.-.+
T Consensus 243 -QL~--aYr~~~~~~~e~~L-e~Ie-------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 243 -QLL--AYRSGNADDPEQLL-EKIE-------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred -HHH--hHhccCccCHHHHH-HhCc-------CccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 111 11111000000000 0111 1146788999999999999999999988444
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.4e-17 Score=166.62 Aligned_cols=135 Identities=20% Similarity=0.172 Sum_probs=102.3
Q ss_pred cccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCc--C-------HHHH-----------------HH
Q 041702 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQ--G-------LEEF-----------------KN 572 (840)
Q Consensus 519 ~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~--~-------~~~f-----------------~~ 572 (840)
...||+|++|.||+|.+ .+|+.||||+++..... . ..+| ..
T Consensus 2 ~~~ig~G~~~~Vy~a~~-------------~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 68 (190)
T cd05147 2 NGCISTGKEANVYHATT-------------ANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEK 68 (190)
T ss_pred CCccccccceEEEEEEC-------------CCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHH
Confidence 35799999999999853 37999999999754211 1 1223 34
Q ss_pred HHHHHhhcCCCCccceeeEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHH-HhcCCCceecCC
Q 041702 573 EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYL-HQYSRLRVIHRD 647 (840)
Q Consensus 573 Ev~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~ivHrD 647 (840)
|++.+.++.|+++.....+.. ...++||||..... ......++..+..+++.|++.+|.|| |+.+ |+|||
T Consensus 69 E~~~l~~l~~~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrD 143 (190)
T cd05147 69 EMRNLKRLVTAGIPCPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR---LVHAD 143 (190)
T ss_pred HHHHHHHHHHCCCCCCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 999999998888755443322 23489999953221 12335688889999999999999999 6777 99999
Q ss_pred CCCCcEEecCCCCceeeccccceec
Q 041702 648 LKASNVLLDSDMNPKISDFGIARTF 672 (840)
Q Consensus 648 lkp~NILl~~~~~~kL~DFGla~~~ 672 (840)
|||+|||++ ++.++|+|||+|...
T Consensus 144 lkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 144 LSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCHHHEEEE-CCcEEEEEccccccC
Confidence 999999998 578999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.3e-17 Score=173.62 Aligned_cols=228 Identities=18% Similarity=0.238 Sum_probs=144.3
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhcCC---------
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKLQH--------- 582 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l~H--------- 582 (840)
.+...+.||.|+++.||.+.+. .+++++|||++.... ....+++++|.-.+..+.+
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~------------~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~ 80 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDV------------ETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYR 80 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEET------------TTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHH
T ss_pred EEEEccccccCCceEEEEEEEc------------cCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHH
Confidence 4456688999999999999765 789999999875432 3456788888877766433
Q ss_pred -CCccceeeEee-cCC----------ce------EEEEEee---c------cC-CccccCCCCHHHHHHHHHHHHHHHHH
Q 041702 583 -RNLVRLFGCCI-EQG----------EK------ISIYEFD---I------VT-DPARKDLLDWTTRVRIIEGVAQGLLY 634 (840)
Q Consensus 583 -~niv~l~g~~~-~~~----------~~------~lv~e~~---~------~~-~~~~~~~l~~~~~~~i~~~ia~~L~y 634 (840)
-.++..++... .+. .. +++|+-. + +. .......+....++.+..|+++.+++
T Consensus 81 ~~r~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~ 160 (288)
T PF14531_consen 81 HLRFLVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVAN 160 (288)
T ss_dssp HH-B---SEEEEETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHH
T ss_pred hceEEeeeEEEEEcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHH
Confidence 22333233221 111 11 2333321 0 00 00011234455667888999999999
Q ss_pred HHhcCCCceecCCCCCCcEEecCCCCceeeccccceecCCCCcccccccccccccccCcccccc--------CCCCcccc
Q 041702 635 LHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH--------GLFSIKSD 706 (840)
Q Consensus 635 LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksD 706 (840)
||+.+ ++|+||||+|++++++|.++|+||+.....+.... ....+..|.+||.... -.++.+.|
T Consensus 161 Lh~~G---lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~-----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~D 232 (288)
T PF14531_consen 161 LHSYG---LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR-----CSEFPVAFTPPELESCAGQFGQNNAPYTFATD 232 (288)
T ss_dssp HHHTT---EEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEE-----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHH
T ss_pred Hhhcc---eEecccceeeEEEcCCCCEEEcChHHHeecCceee-----ccCCCcccCChhhhhhhcccCcccceeeeccC
Confidence 99999 99999999999999999999999998876532111 0234578999997643 24789999
Q ss_pred chhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCC
Q 041702 707 VFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDR 782 (840)
Q Consensus 707 V~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R 782 (840)
.|+||+++|.|.+++.|+........... ....+. +.++.+..|+..+|+.+|++|
T Consensus 233 aW~LG~~ly~lWC~~lPf~~~~~~~~~~~-------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 233 AWQLGITLYSLWCGRLPFGLSSPEADPEW-------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHHHHHHSS-STCCCGGGSTSGG-------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHHHHHHHccCCCCCCCccccccc-------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999999999999999865432221100 112333 667788899999999999988
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.4e-17 Score=161.91 Aligned_cols=136 Identities=21% Similarity=0.210 Sum_probs=105.6
Q ss_pred cccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCc---------------------C-----HHHHHH
Q 041702 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQ---------------------G-----LEEFKN 572 (840)
Q Consensus 519 ~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~---------------------~-----~~~f~~ 572 (840)
...||+|++|.||+|.+ .+|+.||||+++..... . ...+..
T Consensus 2 ~~~ig~G~~~~Vy~a~~-------------~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 68 (190)
T cd05145 2 NGCISTGKEANVYHART-------------GDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEK 68 (190)
T ss_pred CceeecCCCcEEEEEEc-------------CCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHH
Confidence 36899999999999853 27999999998764211 0 122467
Q ss_pred HHHHHhhcCCCCccceeeEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceecCC
Q 041702 573 EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQ-YSRLRVIHRD 647 (840)
Q Consensus 573 Ev~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivHrD 647 (840)
|.+.+.++.|+++.....+... ..++||||..... ......++.....+++.|++.++.+||+ .+ |+|||
T Consensus 69 E~~~l~~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrD 143 (190)
T cd05145 69 EFRNLKRLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGD 143 (190)
T ss_pred HHHHHHHHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCC
Confidence 9999999999988655554433 3489999953221 1223456778889999999999999999 87 99999
Q ss_pred CCCCcEEecCCCCceeeccccceecC
Q 041702 648 LKASNVLLDSDMNPKISDFGIARTFG 673 (840)
Q Consensus 648 lkp~NILl~~~~~~kL~DFGla~~~~ 673 (840)
|||+|||++ ++.++|+|||++....
T Consensus 144 lkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 144 LSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred CChhhEEEE-CCCEEEEEcccceecC
Confidence 999999998 8999999999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.8e-17 Score=179.81 Aligned_cols=212 Identities=23% Similarity=0.333 Sum_probs=154.5
Q ss_pred HhhcCCCCccceeeEeecCCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCC
Q 041702 577 IAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKAS 651 (840)
Q Consensus 577 l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~ 651 (840)
|+.+.|.|+.+++|.+.++...+.|.+|...... .....++|.-+..++++|++||+|||... -..|+.|+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeeccc
Confidence 4678999999999999999999999999433221 13456889999999999999999999854 2399999999
Q ss_pred cEEecCCCCceeeccccceecCCCCcccccccccccccccCccccccC-------CCCccccchhHHHHHHHHHhCCCCC
Q 041702 652 NVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHG-------LFSIKSDVFSFGVLLLEILSSKKNT 724 (840)
Q Consensus 652 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~ksDV~SlGviL~elltG~~p~ 724 (840)
|+++|....+||+|||+.................-...|.|||.+.+. ..+.+.||||||++++||++.+.|+
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999998776431111111112234589999988763 2477899999999999999999998
Q ss_pred CCCCCCCc--cHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 725 RFYNTDSL--TLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 725 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
........ ++... ... .....+.|.+... .+....+..++..||..+|++||++++|-..++....
T Consensus 159 ~~~~~~~~~~eii~~----~~~-~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILR----VKK-GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccccccCChHHHHHH----HHh-cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 76433332 22211 111 1112222332211 1344468899999999999999999999999887633
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.5e-16 Score=155.79 Aligned_cols=183 Identities=16% Similarity=0.105 Sum_probs=132.9
Q ss_pred ccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCc----CHHHHHHHHHHHhhcC-CCCccceeeEe
Q 041702 518 EENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQ----GLEEFKNEMMLIAKLQ-HRNLVRLFGCC 592 (840)
Q Consensus 518 ~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~----~~~~f~~Ev~~l~~l~-H~niv~l~g~~ 592 (840)
+...|++|+||+||.+. ..+.+++.+.+.....- ....|.+|+++|++|+ |+++++++++
T Consensus 6 ~~~~l~~~~f~~v~~~~--------------~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~- 70 (218)
T PRK12274 6 VNEPLKSDTFGRILLVR--------------GGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW- 70 (218)
T ss_pred cceeecCCCcceEEEee--------------cCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE-
Confidence 44689999999999863 36788888888654321 1235899999999995 5889999886
Q ss_pred ecCCceEEEEEeeccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCC-CCCcEEecCCCCceeecccccee
Q 041702 593 IEQGEKISIYEFDIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDL-KASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl-kp~NILl~~~~~~kL~DFGla~~ 671 (840)
+..+++|||..-..... .... ....++.|++.+|+++|+.+ |+|||| ||.|||++.++.++|+|||+|..
T Consensus 71 ---~~~~lvmeyI~G~~L~~--~~~~-~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~ 141 (218)
T PRK12274 71 ---DGRHLDRSYLAGAAMYQ--RPPR-GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVR 141 (218)
T ss_pred ---cCEEEEEeeecCccHHh--hhhh-hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCcee
Confidence 45689999843222211 1111 22467889999999999998 999999 79999999999999999999986
Q ss_pred cCCCCcc------cc-----cccccccccccCccccccC-CCC-ccccchhHHHHHHHHHhCCCCC
Q 041702 672 FGGDEMQ------SN-----TNRIVGTYGYMSPEYALHG-LFS-IKSDVFSFGVLLLEILSSKKNT 724 (840)
Q Consensus 672 ~~~~~~~------~~-----~~~~~gt~~y~aPE~~~~~-~~~-~ksDV~SlGviL~elltG~~p~ 724 (840)
....... .. ......++.|++|+...-. ..+ ...+.++-|.-+|.++|++.+.
T Consensus 142 ~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 142 GNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred cCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 5443210 00 1112357788888744321 223 5679999999999999999774
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.6e-17 Score=183.01 Aligned_cols=225 Identities=24% Similarity=0.299 Sum_probs=168.9
Q ss_pred cccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC--cCHHHHHHHHHHHhhcC-CCCccceeeEeecCCc
Q 041702 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG--QGLEEFKNEMMLIAKLQ-HRNLVRLFGCCIEQGE 597 (840)
Q Consensus 521 ~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~--~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~ 597 (840)
.+|+|.||.|++++-. +....|..+|.|.+++... ........|..++..++ ||.+|++...+.....
T Consensus 1 vlg~g~~gkvfLvrk~---------~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~k 71 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKA---------GGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGK 71 (612)
T ss_pred CCCcCCCcchHHHHHh---------ccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccc
Confidence 3799999999987533 3335677889998876532 11125667888888886 9999999999999999
Q ss_pred eEEEEEee----ccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceecC
Q 041702 598 KISIYEFD----IVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFG 673 (840)
Q Consensus 598 ~~lv~e~~----~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~ 673 (840)
.+++.++. ..................+...++-+++++|+.+ |+|||+|++||+++.+|++|+.|||+++..-
T Consensus 72 l~l~ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v 148 (612)
T KOG0603|consen 72 LYLILDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAV 148 (612)
T ss_pred hhHhhhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhH
Confidence 99999883 3333444455666666778889999999999998 9999999999999999999999999998754
Q ss_pred CCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccccccCc
Q 041702 674 GDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDP 753 (840)
Q Consensus 674 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 753 (840)
.... .+||..|||||++. ....++|.||||++++||+||-.||.. +... .++..
T Consensus 149 ~~~~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------~~~~------------~Il~~ 202 (612)
T KOG0603|consen 149 KEKI------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------DTMK------------RILKA 202 (612)
T ss_pred hhhh------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------HHHH------------HHhhh
Confidence 3222 28899999999987 677899999999999999999999864 1110 01110
Q ss_pred cccchhhHHHHHHHHHHHHHccccCCCCCCCH
Q 041702 754 TMQNEALYSMVTRYIKVALLCVQENATDRPTM 785 (840)
Q Consensus 754 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 785 (840)
....+.+......++...+...+|.+|--.
T Consensus 203 --~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 203 --ELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred --ccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 112233444455566667778888888755
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.3e-15 Score=151.99 Aligned_cols=133 Identities=21% Similarity=0.262 Sum_probs=96.6
Q ss_pred cccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhc-----CCCCccceeeE
Q 041702 517 SEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL-----QHRNLVRLFGC 591 (840)
Q Consensus 517 ~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l-----~H~niv~l~g~ 591 (840)
.....||+|+||.||. +. .++.. +||++........+++.+|++++.++ .||||++++|+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp------------~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~ 69 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HP------------EDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGT 69 (210)
T ss_pred CCcceecCCCceEEEE--CC------------CCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEE
Confidence 3456899999999996 22 23444 69998765455567899999999999 57999999999
Q ss_pred eecCC---c-eEEEEEeec--cCC---ccccCCCCHHHHHHHHHHHHHHH-HHHHhcCCCceecCCCCCCcEEecCC---
Q 041702 592 CIEQG---E-KISIYEFDI--VTD---PARKDLLDWTTRVRIIEGVAQGL-LYLHQYSRLRVIHRDLKASNVLLDSD--- 658 (840)
Q Consensus 592 ~~~~~---~-~~lv~e~~~--~~~---~~~~~~l~~~~~~~i~~~ia~~L-~yLH~~~~~~ivHrDlkp~NILl~~~--- 658 (840)
+..+. . ..+|+||+- ... ......+++. ..++.+++.++ +|||+++ |+||||||+|||++..
T Consensus 70 ~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~ 144 (210)
T PRK10345 70 VETDCGTGYVYDVIADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISES 144 (210)
T ss_pred EEeCCCCeEEEEEEecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCC
Confidence 98874 2 225677721 111 1112234444 35678888887 9999998 9999999999999743
Q ss_pred -CCceeeccccc
Q 041702 659 -MNPKISDFGIA 669 (840)
Q Consensus 659 -~~~kL~DFGla 669 (840)
..++|+||+-+
T Consensus 145 ~~~~~LiDg~G~ 156 (210)
T PRK10345 145 EVIPVVCDNIGE 156 (210)
T ss_pred CCcEEEEECCCC
Confidence 47999994443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.61 E-value=2e-15 Score=178.13 Aligned_cols=250 Identities=18% Similarity=0.232 Sum_probs=175.6
Q ss_pred HHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcC---CCC
Q 041702 508 SISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQ---HRN 584 (840)
Q Consensus 508 ~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~---H~n 584 (840)
+.+.-...|.+.+.||+|+||+||+|.+. +|+.||+|+-+.... -+|.--.+++.+|+ -+-
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~-------------~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~ 755 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHS-------------NGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPS 755 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecC-------------CCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcc
Confidence 44556678999999999999999998653 499999999765432 23443444555555 234
Q ss_pred ccceeeEeecCCceEEEEEee----ccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecC---
Q 041702 585 LVRLFGCCIEQGEKISIYEFD----IVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS--- 657 (840)
Q Consensus 585 iv~l~g~~~~~~~~~lv~e~~----~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~--- 657 (840)
|..+...+.-.+.-++|.||. ++......+.++|...+-++.|+++.+++||..+ |||+||||+|.||..
T Consensus 756 ~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~ 832 (974)
T KOG1166|consen 756 IMHISSAHVFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREIC 832 (974)
T ss_pred hHHHHHHHccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccC
Confidence 555555566678889999983 3333446778999999999999999999999998 999999999999932
Q ss_pred ----CCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc
Q 041702 658 ----DMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLT 733 (840)
Q Consensus 658 ----~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~ 733 (840)
.-.++|+|||.+-.+.--.........++|-.+--+|...|.+++..+|.|.|.-+++-||.|+..-
T Consensus 833 ~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q--------- 903 (974)
T KOG1166|consen 833 ADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME--------- 903 (974)
T ss_pred CCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH---------
Confidence 3358999999996653222223345677899999999999999999999999999999999998431
Q ss_pred HhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 734 LLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
...+..+ .++..+..-...++-. ++...+|..|-..=|...++...|++.+.
T Consensus 904 --------~~~g~~~-~~~~~~~Ry~~~~~W~---~~F~~lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 904 --------VKNGSSW-MVKTNFPRYWKRDMWN---KFFDLLLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred --------hcCCcce-eccccchhhhhHHHHH---HHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence 1111111 1122222212222222 33334555566666777788888877654
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.60 E-value=7.3e-16 Score=124.74 Aligned_cols=66 Identities=47% Similarity=1.153 Sum_probs=58.5
Q ss_pred ccCCCceeEeecccCCCcccccccccCChhHHHHHhhcccceeeeeccccccCCccceeecccchhh
Q 041702 337 CKTANQFKRFDDMKVPDLLDVSLNEGMNLEECGAECLNNCTCRAYAYFNLTRGGSGCLMWFGDLIDM 403 (840)
Q Consensus 337 C~~~~~f~~~~~~~~p~~~~~~~~~~~s~e~C~~~Cl~nCsC~a~~y~~~~~~g~~C~~w~~~l~~~ 403 (840)
|+.+++|.++++|++|++.......+.++++|+..|++||||+||+|.++. ++++|.+|+++|+|+
T Consensus 1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~-~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLS-GGGGCLLWYGDLVDL 66 (66)
T ss_pred CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccC-CCCEEEEEcCEeecC
Confidence 556789999999999999877766779999999999999999999997665 677999999999874
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=3.4e-15 Score=154.87 Aligned_cols=196 Identities=20% Similarity=0.210 Sum_probs=126.6
Q ss_pred CCCCccceeeEeecC---------------------------CceEEEEEee--ccCCccccCCCCHHHHHHHHHHHHHH
Q 041702 581 QHRNLVRLFGCCIEQ---------------------------GEKISIYEFD--IVTDPARKDLLDWTTRVRIIEGVAQG 631 (840)
Q Consensus 581 ~H~niv~l~g~~~~~---------------------------~~~~lv~e~~--~~~~~~~~~~l~~~~~~~i~~~ia~~ 631 (840)
+|||||+++++|.+. ...|+||.-. .+....-....+...+.-|+.|+++|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~~s~r~~~~~laQlLEa 353 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRHRSYRTGRVILAQLLEA 353 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCCCchHHHHHHHHHHHHH
Confidence 599999999887532 2344444321 11111222345556677799999999
Q ss_pred HHHHHhcCCCceecCCCCCCcEEe--cCCC--CceeeccccceecCCCCcc----cccccccccccccCccccccCC---
Q 041702 632 LLYLHQYSRLRVIHRDLKASNVLL--DSDM--NPKISDFGIARTFGGDEMQ----SNTNRIVGTYGYMSPEYALHGL--- 700 (840)
Q Consensus 632 L~yLH~~~~~~ivHrDlkp~NILl--~~~~--~~kL~DFGla~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~--- 700 (840)
+.|||.++ |.|||+|++|||+ |+|. ...|+|||++-.-...... ...-...|...-||||+....+
T Consensus 354 v~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~ 430 (598)
T KOG4158|consen 354 VTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPN 430 (598)
T ss_pred HHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCc
Confidence 99999999 9999999999999 3443 3589999987543221111 1111234677899999886433
Q ss_pred ---CCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHcccc
Q 041702 701 ---FSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQE 777 (840)
Q Consensus 701 ---~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~ 777 (840)
--.|+|.|+.|.+.||+++..-||-...+...+... .++---|.+ +...+..+.+++...|+.
T Consensus 431 avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~----------Yqe~qLPal----p~~vpp~~rqlV~~lL~r 496 (598)
T KOG4158|consen 431 AVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT----------YQESQLPAL----PSRVPPVARQLVFDLLKR 496 (598)
T ss_pred eeeccchhhhhhhhhhHHHHhccCCcccccchheechhh----------hhhhhCCCC----cccCChHHHHHHHHHhcC
Confidence 236899999999999999988887542221111110 011111222 223344577889999999
Q ss_pred CCCCCCCHHHHHHHhh
Q 041702 778 NATDRPTMLEVVAMLK 793 (840)
Q Consensus 778 dP~~RPs~~evl~~Le 793 (840)
||++||+..=....|.
T Consensus 497 ~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 497 DPSKRVSPNIAANVLN 512 (598)
T ss_pred CccccCCccHHHhHHH
Confidence 9999998765555544
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.6e-14 Score=149.58 Aligned_cols=147 Identities=15% Similarity=0.104 Sum_probs=107.7
Q ss_pred HHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCc----------------------
Q 041702 508 SISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQ---------------------- 565 (840)
Q Consensus 508 ~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~---------------------- 565 (840)
.+..-...|.+.+.||+|++|.||+|.+. ..+|+.||||+++.....
T Consensus 22 ~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~-----------~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (237)
T smart00090 22 SLLNRGILSAIGGCISTGKEANVYHALDF-----------DGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPR 90 (237)
T ss_pred HHHhcCchHHhCCeeccCcceeEEEEEec-----------CCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHH
Confidence 34444456888899999999999998621 257899999998754210
Q ss_pred --CHHHHHHHHHHHhhcCCC--CccceeeEeecCCceEEEEEeeccCCc----cccCCCCHHHHHHHHHHHHHHHHHHHh
Q 041702 566 --GLEEFKNEMMLIAKLQHR--NLVRLFGCCIEQGEKISIYEFDIVTDP----ARKDLLDWTTRVRIIEGVAQGLLYLHQ 637 (840)
Q Consensus 566 --~~~~f~~Ev~~l~~l~H~--niv~l~g~~~~~~~~~lv~e~~~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~ 637 (840)
....+..|+.++.++.|. .+.+++++ ...++||||...... .....+...+...++.||+.+|++||+
T Consensus 91 ~~~~~~~~~E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~ 166 (237)
T smart00090 91 KLVRLWAEKEFRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYK 166 (237)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHh
Confidence 012357899999999763 34455543 245899999433211 122334555667899999999999998
Q ss_pred cCCCceecCCCCCCcEEecCCCCceeeccccceec
Q 041702 638 YSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTF 672 (840)
Q Consensus 638 ~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~ 672 (840)
.+ .|+||||||+||+++ ++.++|+|||.+...
T Consensus 167 ~g--~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 167 EG--ELVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred cC--CEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 76 499999999999999 889999999998754
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.2e-14 Score=143.95 Aligned_cols=147 Identities=17% Similarity=0.173 Sum_probs=108.6
Q ss_pred HHHHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCc--------------------
Q 041702 506 LSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQ-------------------- 565 (840)
Q Consensus 506 ~~~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~-------------------- 565 (840)
+.++......|...+.||+|+||.||++.. .+|+.||||+++.....
T Consensus 7 ~~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~-------------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 73 (198)
T cd05144 7 LHTLVKRGVVESLGNQIGVGKESDVYLALD-------------PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWL 73 (198)
T ss_pred HHHHHHcCchhhcCCccccCcceEEEEEEc-------------CCCCEEEEEEEecccchhhhhcchHHHHhccccchhH
Confidence 445555555688889999999999999753 37899999987643210
Q ss_pred --CHHHHHHHHHHHhhcCCCC--ccceeeEeecCCceEEEEEeeccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 041702 566 --GLEEFKNEMMLIAKLQHRN--LVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRL 641 (840)
Q Consensus 566 --~~~~f~~Ev~~l~~l~H~n--iv~l~g~~~~~~~~~lv~e~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~ 641 (840)
....+..|..++.++.|++ +++.++ .+..+++||+......... ........++.+++.++.++|+.+
T Consensus 74 ~~~~~~~~~E~~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~--~~~~~~~~~~~~i~~~l~~lh~~g-- 145 (198)
T cd05144 74 YLSRLAAQKEFAALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRV--RVLEDPEEVLDEILEEIVKAYKHG-- 145 (198)
T ss_pred HHhHHHHHHHHHHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhc--cccccHHHHHHHHHHHHHHHHHCC--
Confidence 1123678999999998874 445544 2456899998543222111 111345678999999999999987
Q ss_pred ceecCCCCCCcEEecCCCCceeeccccceecCC
Q 041702 642 RVIHRDLKASNVLLDSDMNPKISDFGIARTFGG 674 (840)
Q Consensus 642 ~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 674 (840)
|+||||||+||++++++.++|+|||++..+..
T Consensus 146 -i~H~Dl~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 146 -IIHGDLSEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred -CCcCCCCcccEEEcCCCcEEEEECCccccCCC
Confidence 99999999999999999999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.54 E-value=2.1e-15 Score=163.36 Aligned_cols=155 Identities=26% Similarity=0.385 Sum_probs=111.7
Q ss_pred CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceecCCCC----cccccccc
Q 041702 609 DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDE----MQSNTNRI 684 (840)
Q Consensus 609 ~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~----~~~~~~~~ 684 (840)
........++...+.++.|++.|++| ++ .+|+|+||.||+...+..+||.|||+........ ........
T Consensus 349 rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~ 422 (516)
T KOG1033|consen 349 RRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQ 422 (516)
T ss_pred CCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhc
Confidence 34445567788889999999999999 55 9999999999999999999999999987765544 22234567
Q ss_pred cccccccCccccccCCCCccccchhHHHHHHHHHhCC-CCCCCCCCCCccHhHHHhhhhcccccccccCccccchhhHHH
Q 041702 685 VGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSK-KNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSM 763 (840)
Q Consensus 685 ~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 763 (840)
+||..||+||.+.+..|+.|+||||||+||+|++.-- -.++ .. .-..++-|..+.+....+.
T Consensus 423 ~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e--------------r~---~t~~d~r~g~ip~~~~~d~ 485 (516)
T KOG1033|consen 423 VGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE--------------RI---ATLTDIRDGIIPPEFLQDY 485 (516)
T ss_pred ccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH--------------HH---HhhhhhhcCCCChHHhhcC
Confidence 8999999999999999999999999999999998621 1100 00 0011111222222222222
Q ss_pred HHHHHHHHHHccccCCCCCCCHHH
Q 041702 764 VTRYIKVALLCVQENATDRPTMLE 787 (840)
Q Consensus 764 ~~~l~~l~~~Cl~~dP~~RPs~~e 787 (840)
+. =..++.+++...|.+||++.+
T Consensus 486 p~-e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 486 PE-EYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred cH-HHHHHHHhcCCCcccCchHHH
Confidence 22 246778899999999995443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.53 E-value=3.9e-14 Score=144.84 Aligned_cols=133 Identities=17% Similarity=0.168 Sum_probs=105.0
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCc--------CHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQ--------GLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~--------~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
+.||+|++|.||+|.+ +|..|+||+....... ...++.+|++++..++|++++....+
T Consensus 2 ~~l~~G~~~~vy~~~~--------------~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~ 67 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--------------LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVY 67 (211)
T ss_pred cccccCceEEEEEEee--------------CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEE
Confidence 5799999999999752 5778999986543211 12468899999999999999988888
Q ss_pred eecCCceEEEEEeeccCCcccc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccce
Q 041702 592 CIEQGEKISIYEFDIVTDPARK-DLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIAR 670 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~ 670 (840)
+...+..+++|||......... ....+ .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||++.
T Consensus 68 ~~~~~~~~lv~e~~~G~~L~~~~~~~~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~ 142 (211)
T PRK14879 68 FVDPENFIIVMEYIEGEPLKDLINSNGM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAE 142 (211)
T ss_pred EEeCCCCEEEEEEeCCcCHHHHHHhccH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCccc
Confidence 8888889999999532221110 01112 67899999999999999988 99999999999999 7899999999886
Q ss_pred e
Q 041702 671 T 671 (840)
Q Consensus 671 ~ 671 (840)
.
T Consensus 143 ~ 143 (211)
T PRK14879 143 F 143 (211)
T ss_pred C
Confidence 4
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.53 E-value=3.3e-15 Score=172.39 Aligned_cols=218 Identities=21% Similarity=0.289 Sum_probs=143.3
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
...+|..++.|..|+||.||.++++ ...+..|.|+ .+.+- -.++ ++.....|.+| |=
T Consensus 81 ~e~df~~IklisngAygavylvrh~------------~trqrfa~ki-Nkq~l----ilRn---ilt~a~npfvv---gD 137 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHK------------ETRQRFAMKI-NKQNL----ILRN---ILTFAGNPFVV---GD 137 (1205)
T ss_pred CccccceeEeeccCCCCceeeeecc------------ccccchhhcc-cccch----hhhc---cccccCCccee---ch
Confidence 3468888999999999999999776 5677888843 32210 0011 22222334333 11
Q ss_pred eecCCceEEEEEeeccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccccee
Q 041702 592 CIEQGEKISIYEFDIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
|. .....-..++ .+++.+++|||+.+ |+|||+||+|.+|+.-|++|+.|||+.+.
T Consensus 138 c~--------------tllk~~g~lP--------vdmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~ 192 (1205)
T KOG0606|consen 138 CA--------------TLLKNIGPLP--------VDMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKK 192 (1205)
T ss_pred hh--------------hhcccCCCCc--------chhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhh
Confidence 10 0001111122 23388999999998 99999999999999999999999999875
Q ss_pred cCCC--------Cc-----ccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHH
Q 041702 672 FGGD--------EM-----QSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHA 738 (840)
Q Consensus 672 ~~~~--------~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~ 738 (840)
.... .. +-....++||+.|+|||++....|...+|.|++|+|+||.+-|+.||....+++ +....
T Consensus 193 GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee--lfg~v 270 (1205)
T KOG0606|consen 193 GLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE--LFGQV 270 (1205)
T ss_pred hhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH--HHhhh
Confidence 4211 00 111245689999999999999999999999999999999999999986554433 22222
Q ss_pred hhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 739 WNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 739 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
... ...-++..........+++.+.|+.+|..|--....++
T Consensus 271 isd-----------~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~e 311 (1205)
T KOG0606|consen 271 ISD-----------DIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALE 311 (1205)
T ss_pred hhh-----------hccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhh
Confidence 110 00011111222344677888899999999974433333
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.2e-13 Score=139.93 Aligned_cols=130 Identities=18% Similarity=0.256 Sum_probs=99.9
Q ss_pred cccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-c-------CHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-Q-------GLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 521 ~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~-------~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
.||+|++|.||+|. .++..|++|+...... . ..+++.+|++++..++|+++.....++
T Consensus 1 ~ig~G~~~~vy~~~--------------~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~ 66 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--------------FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYD 66 (199)
T ss_pred CCCCCceEEEEEee--------------cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEE
Confidence 48999999999975 3567899998654321 1 135678999999999998877766677
Q ss_pred ecCCceEEEEEeeccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccccee
Q 041702 593 IEQGEKISIYEFDIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
...+..+++||+........ .+.... ..++.+++.+|.+||+.+ ++|+|++|+||+++ ++.++++|||++..
T Consensus 67 ~~~~~~~lv~e~~~g~~l~~--~~~~~~-~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 67 VDPDNKTIVMEYIEGKPLKD--VIEEGN-DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EECCCCEEEEEEECCccHHH--HHhhcH-HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 77778899999943222111 111111 178999999999999988 99999999999999 89999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.49 E-value=5.1e-14 Score=164.15 Aligned_cols=139 Identities=17% Similarity=0.230 Sum_probs=105.6
Q ss_pred HHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEe-ccCCC-------cCHHHHHHHHHHHhhcCC
Q 041702 511 AATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRL-SSKSG-------QGLEEFKNEMMLIAKLQH 582 (840)
Q Consensus 511 ~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l-~~~~~-------~~~~~f~~Ev~~l~~l~H 582 (840)
.....|...++||+|+||.||++.+. +..+++|+. .+... ...+++.+|++++.+++|
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~--------------~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 395 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYL--------------GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARR 395 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeec--------------CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcc
Confidence 33455566789999999999997532 333444432 21111 123568999999999999
Q ss_pred CCccceeeEeecCCceEEEEEeeccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCce
Q 041702 583 RNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPK 662 (840)
Q Consensus 583 ~niv~l~g~~~~~~~~~lv~e~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 662 (840)
++++....++...+..++||||........ . +..+..++.+++.+|.|||+.+ ++||||||+|||+ .++.++
T Consensus 396 ~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~--~--l~~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~ 467 (535)
T PRK09605 396 AGVPTPVIYDVDPEEKTIVMEYIGGKDLKD--V--LEGNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLY 467 (535)
T ss_pred cCCCeeEEEEEeCCCCEEEEEecCCCcHHH--H--HHHHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEE
Confidence 999998888888888899999953322211 1 1146789999999999999988 9999999999999 678999
Q ss_pred eecccccee
Q 041702 663 ISDFGIART 671 (840)
Q Consensus 663 L~DFGla~~ 671 (840)
|+|||+++.
T Consensus 468 liDFGla~~ 476 (535)
T PRK09605 468 LIDFGLGKY 476 (535)
T ss_pred EEeCccccc
Confidence 999999975
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.45 E-value=7e-13 Score=127.18 Aligned_cols=135 Identities=21% Similarity=0.177 Sum_probs=110.5
Q ss_pred ccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCC--CCccceeeEeecC
Q 041702 518 EENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQH--RNLVRLFGCCIEQ 595 (840)
Q Consensus 518 ~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H--~niv~l~g~~~~~ 595 (840)
+.+.||+|.++.||++.. ++..+++|....... ...+.+|+.++..++| .++++++++....
T Consensus 2 ~~~~i~~g~~~~v~~~~~--------------~~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~ 65 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGT--------------KDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESD 65 (155)
T ss_pred cceecccccccceEEEEe--------------cCCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC
Confidence 346899999999999863 236899999865433 5679999999999976 5899999999888
Q ss_pred CceEEEEEeeccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccccee
Q 041702 596 GEKISIYEFDIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 596 ~~~~lv~e~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
+..++++|+........ ++......++.+++.+|++||......++|+|++|+||++++.+.++++|||.+..
T Consensus 66 ~~~~~v~e~~~g~~~~~---~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 66 GWSYLLMEWIEGETLDE---VSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CccEEEEEecCCeeccc---CCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 89999999843222211 16677888999999999999986545699999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.43 E-value=6.5e-13 Score=133.02 Aligned_cols=134 Identities=20% Similarity=0.219 Sum_probs=93.9
Q ss_pred cccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCc--CHHH----------------------HHHHH
Q 041702 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQ--GLEE----------------------FKNEM 574 (840)
Q Consensus 519 ~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~--~~~~----------------------f~~Ev 574 (840)
.+.||+|+||.||+|.+ .+++.||||+++..... .... ...|.
T Consensus 2 ~~~lg~G~~g~Vy~a~~-------------~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~ 68 (187)
T cd05119 2 GGPIGTGKEADVYLALD-------------GDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEF 68 (187)
T ss_pred CcccccccceeEEEEEC-------------CCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHH
Confidence 36799999999999853 26889999998753211 1111 13566
Q ss_pred HHHhhcCCC--CccceeeEeecCCceEEEEEeeccCCcc---ccCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceecCCC
Q 041702 575 MLIAKLQHR--NLVRLFGCCIEQGEKISIYEFDIVTDPA---RKDLLDWTTRVRIIEGVAQGLLYLHQ-YSRLRVIHRDL 648 (840)
Q Consensus 575 ~~l~~l~H~--niv~l~g~~~~~~~~~lv~e~~~~~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivHrDl 648 (840)
..+.++.+. .+.+.+++ ...+++|||....... ...........+++.+++.++.++|. .+ |+||||
T Consensus 69 ~~l~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl 141 (187)
T cd05119 69 RNLKRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLYREAG---LVHGDL 141 (187)
T ss_pred HHHHHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHhhccC---cCcCCC
Confidence 666666443 34455443 2468999995432111 01111115678899999999999998 76 999999
Q ss_pred CCCcEEecCCCCceeeccccceecC
Q 041702 649 KASNVLLDSDMNPKISDFGIARTFG 673 (840)
Q Consensus 649 kp~NILl~~~~~~kL~DFGla~~~~ 673 (840)
||+||+++ ++.++|+|||.+....
T Consensus 142 ~p~Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 142 SEYNILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred ChhhEEEE-CCcEEEEECccccccc
Confidence 99999999 9999999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.6e-14 Score=164.71 Aligned_cols=251 Identities=21% Similarity=0.257 Sum_probs=180.2
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcC-CCCccceee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQ-HRNLVRLFG 590 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~-H~niv~l~g 590 (840)
..|...+.||+|+|+.|-.+... ......+|+|.+.... ....+....|..+-..+. |+|++++++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~-----------~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~ 88 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNS-----------RDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIE 88 (601)
T ss_pred ccccccccccccccchhhhhhhc-----------CCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCC
Confidence 45666677999999999876432 2344567777776543 223344455777777776 999999999
Q ss_pred EeecCCceEEEEEeeccCCccc------cCCCCHHHHHHHHHHHHHHHHHHH-hcCCCceecCCCCCCcEEecCCC-Cce
Q 041702 591 CCIEQGEKISIYEFDIVTDPAR------KDLLDWTTRVRIIEGVAQGLLYLH-QYSRLRVIHRDLKASNVLLDSDM-NPK 662 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~~~~------~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~ivHrDlkp~NILl~~~~-~~k 662 (840)
...+.+..++..++........ ....+....-.++.|+..++.|+| ..+ +.||||||+|.+++..+ ..|
T Consensus 89 ~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~ 165 (601)
T KOG0590|consen 89 PSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALK 165 (601)
T ss_pred ccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCccc
Confidence 9999999999999832221111 114455666779999999999999 777 99999999999999999 999
Q ss_pred eeccccceecCC-CCcccccccccc-cccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHh
Q 041702 663 ISDFGIARTFGG-DEMQSNTNRIVG-TYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAW 739 (840)
Q Consensus 663 L~DFGla~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~ 739 (840)
++|||+|..+.. ...........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+............+.
T Consensus 166 ~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~- 244 (601)
T KOG0590|consen 166 IADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWK- 244 (601)
T ss_pred CCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeec-
Confidence 999999988766 444445556678 9999999998885 457788999999999999999999766544432211111
Q ss_pred hhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 041702 740 NLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVV 789 (840)
Q Consensus 740 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 789 (840)
+.+ ................++..+++..+|..|.+.+++.
T Consensus 245 ----~~~------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 245 ----SNK------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ----ccc------cccccCccccCChhhhhcccccccCCchhcccccccc
Confidence 111 0000111223344566778888889999999988764
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.35 E-value=3.1e-12 Score=132.78 Aligned_cols=131 Identities=21% Similarity=0.198 Sum_probs=95.8
Q ss_pred cccc-CCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-------------CcCHHHHHHHHHHHhhcCCCCc
Q 041702 520 NKLG-EGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-------------GQGLEEFKNEMMLIAKLQHRNL 585 (840)
Q Consensus 520 ~~lG-~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-------------~~~~~~f~~Ev~~l~~l~H~ni 585 (840)
..|| .||.|+||++. .++..++||++.... .....++.+|++++.+|+|++|
T Consensus 37 ~~lg~~~g~gtv~~v~--------------~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi 102 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQ--------------TPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGL 102 (239)
T ss_pred ceeecCCCCccEEEEE--------------eCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCC
Confidence 4687 88999999874 247789999885321 1233568899999999998875
Q ss_pred --cceeeEeecCCc----eEEEEEeecc-CCc---cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEe
Q 041702 586 --VRLFGCCIEQGE----KISIYEFDIV-TDP---ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLL 655 (840)
Q Consensus 586 --v~l~g~~~~~~~----~~lv~e~~~~-~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl 655 (840)
++.+++...... .++|+|+..- ... .....++. ..+.+|+.+|.+||+.+ |+||||||.|||+
T Consensus 103 ~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~----~~~~~i~~~l~~lH~~G---I~HrDlkp~NILv 175 (239)
T PRK01723 103 PVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEAPLSE----EQWQAIGQLIARFHDAG---VYHADLNAHNILL 175 (239)
T ss_pred CCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcCCCCH----HHHHHHHHHHHHHHHCC---CCCCCCCchhEEE
Confidence 777777544322 2488887432 111 11122332 34678999999999998 9999999999999
Q ss_pred cCCCCceeecccccee
Q 041702 656 DSDMNPKISDFGIART 671 (840)
Q Consensus 656 ~~~~~~kL~DFGla~~ 671 (840)
+.++.++|+|||.+..
T Consensus 176 ~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 176 DPDGKFWLIDFDRGEL 191 (239)
T ss_pred cCCCCEEEEECCCccc
Confidence 9999999999999875
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.7e-12 Score=108.40 Aligned_cols=71 Identities=21% Similarity=0.404 Sum_probs=60.2
Q ss_pred ccCCCceeEeecccCCCcccccccccCChhHHHHHhhc---ccceeeeeccccccCCccceeecccc-hhhhhhcccCCc
Q 041702 337 CKTANQFKRFDDMKVPDLLDVSLNEGMNLEECGAECLN---NCTCRAYAYFNLTRGGSGCLMWFGDL-IDMRKTLANLTG 412 (840)
Q Consensus 337 C~~~~~f~~~~~~~~p~~~~~~~~~~~s~e~C~~~Cl~---nCsC~a~~y~~~~~~g~~C~~w~~~l-~~~~~~~~~~~~ 412 (840)
|...++|.++.++++|++.. +++++|++.|++ ||||+||+|.+. +.||.+|++++ .+++... ..+
T Consensus 5 ~~~~g~fl~~~~~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~~~---~~gC~~W~~~l~~d~~~~~--~~g 73 (80)
T cd00129 5 CKSAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAKA---RKQCLWFPFNSMSGVRKEF--SHG 73 (80)
T ss_pred eecCCeEEEeecccCCcccc------cCHHHHHHHHhcCCCCCCceeeeccCC---CCCeEEecCcchhhHHhcc--CCC
Confidence 34456899999999998764 689999999999 999999999653 35899999999 9998774 458
Q ss_pred ceeeee
Q 041702 413 QSIYLR 418 (840)
Q Consensus 413 ~~lylr 418 (840)
.++|+|
T Consensus 74 ~~Ly~r 79 (80)
T cd00129 74 FDLYEN 79 (80)
T ss_pred ceeEeE
Confidence 899987
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.5e-11 Score=104.25 Aligned_cols=80 Identities=40% Similarity=0.854 Sum_probs=63.6
Q ss_pred CCCccCC---CceeEeecccCCCcccccccccCChhHHHHHhhcccceeeeeccccccCCccceeecccchhhhhhcccC
Q 041702 334 LSDCKTA---NQFKRFDDMKVPDLLDVSLNEGMNLEECGAECLNNCTCRAYAYFNLTRGGSGCLMWFGDLIDMRKTLANL 410 (840)
Q Consensus 334 ~~~C~~~---~~f~~~~~~~~p~~~~~~~~~~~s~e~C~~~Cl~nCsC~a~~y~~~~~~g~~C~~w~~~l~~~~~~~~~~ 410 (840)
+++|... ..|..+.++++|+..... .++++++|++.|++||+|+||+|.+ ++.+|.+|.+.+.+.+... .
T Consensus 2 ~~~C~~~~~~~~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~~---~~~~C~~~~~~~~~~~~~~--~ 74 (84)
T cd01098 2 PLNCGGDGSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN---GSGGCLLWNGLLNNLRSLS--S 74 (84)
T ss_pred CcccCCCCCCCEEEEeCCeeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeecC---CCCeEEEEeceecceEeec--C
Confidence 3567544 589999999999876433 7789999999999999999999964 3568999999998866532 3
Q ss_pred Ccceeeeecc
Q 041702 411 TGQSIYLRVP 420 (840)
Q Consensus 411 ~~~~lylrvp 420 (840)
.+..+|||++
T Consensus 75 ~~~~~yiKv~ 84 (84)
T cd01098 75 GGGTLYLRLA 84 (84)
T ss_pred CCcEEEEEeC
Confidence 3578999985
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.14 E-value=6.9e-11 Score=131.22 Aligned_cols=246 Identities=22% Similarity=0.248 Sum_probs=170.2
Q ss_pred cCCcccccccC--CCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC--cCHHHHHHHHHHHhhc-CCCCccce
Q 041702 514 DNFSEENKLGE--GGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG--QGLEEFKNEMMLIAKL-QHRNLVRL 588 (840)
Q Consensus 514 ~~f~~~~~lG~--G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~--~~~~~f~~Ev~~l~~l-~H~niv~l 588 (840)
..|.....+|. |.+|.||.+.- +.-.++..+|+|+-+.... ....+=.+|+....++ .|+|.++.
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~----------~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~ 183 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRC----------TNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRD 183 (524)
T ss_pred hhcccccccccCCCCCceeecccC----------CcccCCcccccccccCCCCCccccccccchhhcccccCcccccccc
Confidence 44556678999 99999999754 1136888999998543322 2223335676666677 59999999
Q ss_pred eeEeecCCceEEEEEeeccC---C-ccccCCCCHHHHHHHHHHHHH----HHHHHHhcCCCceecCCCCCCcEEecCC-C
Q 041702 589 FGCCIEQGEKISIYEFDIVT---D-PARKDLLDWTTRVRIIEGVAQ----GLLYLHQYSRLRVIHRDLKASNVLLDSD-M 659 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~~~~~---~-~~~~~~l~~~~~~~i~~~ia~----~L~yLH~~~~~~ivHrDlkp~NILl~~~-~ 659 (840)
...++..+..++-.|..... . ......++......+..+... ||.++|... ++|-|+||.||++..+ .
T Consensus 184 ~~~~e~~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~ 260 (524)
T KOG0601|consen 184 SPAWEGSGILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWT 260 (524)
T ss_pred CcccccCCcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccc
Confidence 99999999999998883211 1 111223555566667777777 999999988 9999999999999999 8
Q ss_pred CceeeccccceecCCCCccc---ccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhH
Q 041702 660 NPKISDFGIARTFGGDEMQS---NTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLG 736 (840)
Q Consensus 660 ~~kL~DFGla~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~ 736 (840)
..++.|||+...+....... ...+..|...|++||. ....++.+.|+|++|.+.+|..++...........
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~-~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~----- 334 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKEL-LNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS----- 334 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhh-hccccchHhhhcchhhhhHhhHhhcccccCCCCCC-----
Confidence 89999999999887654322 2233467889999995 46678899999999999999998876543221111
Q ss_pred HHhhhhcccccccccCcc-ccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 041702 737 HAWNLWKDDKAWKLMDPT-MQNEALYSMVTRYIKVALLCVQENATDRPTMLEVV 789 (840)
Q Consensus 737 ~~~~~~~~~~~~~~~d~~-l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 789 (840)
|. .+++. +..++......++...+..+++.+|..|++.+.+.
T Consensus 335 --W~---------~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 335 --WS---------QLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred --cc---------ccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 11 11111 11122112222344477789999999999876654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.5e-10 Score=130.70 Aligned_cols=142 Identities=21% Similarity=0.208 Sum_probs=93.9
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcC---------------------------
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQG--------------------------- 566 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~--------------------------- 566 (840)
..|.. +.||+|++|.||+|+ +.+|+.||||+.+......
T Consensus 118 ~~fd~-~plasaSigQVh~A~-------------l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~ 183 (437)
T TIGR01982 118 AEFEE-KPLAAASIAQVHRAR-------------LVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRP 183 (437)
T ss_pred hhCCC-cceeeeehhheEEEE-------------ecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCH
Confidence 34443 689999999999975 3479999999986542100
Q ss_pred -------------HHHHHHHHHHHhhcC-----CCCccceeeEeecCCceEEEEEeeccCCcccc---CCCCHHHHHHHH
Q 041702 567 -------------LEEFKNEMMLIAKLQ-----HRNLVRLFGCCIEQGEKISIYEFDIVTDPARK---DLLDWTTRVRII 625 (840)
Q Consensus 567 -------------~~~f~~Ev~~l~~l~-----H~niv~l~g~~~~~~~~~lv~e~~~~~~~~~~---~~l~~~~~~~i~ 625 (840)
.-+|.+|++.+.+++ ++++.-..-|.......+++|||..-...... .... ..+.+++
T Consensus 184 ~~~~~e~~~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~-~~~~~ia 262 (437)
T TIGR01982 184 TEVVKEFEKTLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG-LDRKALA 262 (437)
T ss_pred HHHHHHHHHHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC-CCHHHHH
Confidence 013556666666652 33332222222334568999999532222111 0001 1345677
Q ss_pred HHHHH-HHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceecC
Q 041702 626 EGVAQ-GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFG 673 (840)
Q Consensus 626 ~~ia~-~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~ 673 (840)
..++. .+..+|..+ ++|+|+||.||+++.++.++|+|||++..+.
T Consensus 263 ~~~~~~~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 263 ENLARSFLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHHHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 77766 478889887 9999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.08 E-value=6.4e-10 Score=109.33 Aligned_cols=130 Identities=22% Similarity=0.149 Sum_probs=93.6
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCcc-ceeeEeecCCce
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLV-RLFGCCIEQGEK 598 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv-~l~g~~~~~~~~ 598 (840)
+.|+.|.++.||++.. .+..|++|....... ....+..|++++..+.+.+++ +++.+. .+..
T Consensus 4 ~~l~~G~~~~vy~~~~--------------~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~ 66 (170)
T cd05151 4 SPLKGGMTNKNYRVEV--------------ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETG 66 (170)
T ss_pred eecCCcccCceEEEEE--------------CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCC
Confidence 5789999999999742 377899999765432 234578999999999765544 555443 3345
Q ss_pred EEEEEeeccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CCceecCCCCCCcEEecCCCCceeecccccee
Q 041702 599 ISIYEFDIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYS--RLRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 599 ~lv~e~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
++|||+..-....... .....++.+++++|+.||..+ +..++|+|++|.||+++ ++.++++|||.+..
T Consensus 67 ~lv~e~i~G~~l~~~~----~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 67 VLITEFIEGSELLTED----FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred eEEEEecCCCcccccc----ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 8999994333222111 112346789999999999876 33469999999999998 67899999998754
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1e-10 Score=119.46 Aligned_cols=197 Identities=16% Similarity=0.189 Sum_probs=125.2
Q ss_pred HHHHhhcCCCCccceeeEeecCC-----ceEEEEEeeccCCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 041702 574 MMLIAKLQHRNLVRLFGCCIEQG-----EKISIYEFDIVTDPA--------RKDLLDWTTRVRIIEGVAQGLLYLHQYSR 640 (840)
Q Consensus 574 v~~l~~l~H~niv~l~g~~~~~~-----~~~lv~e~~~~~~~~--------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ 640 (840)
..-|-++-|.|||+++.|+.+.. +..++.||+...... ....+....-.+++-||+.||.|||+..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~- 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD- 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence 44455667999999999986543 456777885333221 2234555566789999999999999975
Q ss_pred CceecCCCCCCcEEecCCCCceeeccccceecCC---CCcccccccccccccccCccccccCCCCccccchhHHHHHHHH
Q 041702 641 LRVIHRDLKASNVLLDSDMNPKISDFGIARTFGG---DEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEI 717 (840)
Q Consensus 641 ~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~el 717 (840)
++|+|+++..+.|++..++-+|+.--- -..... .........-.+-++|.+||+=.....+.++|||+||+..+||
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~a-p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CccccCCcchhheeecCCceEEecccC-ccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 789999999999999999988874311 111110 0011112223456799999988777888999999999999999
Q ss_pred HhCCCCCCCCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 718 LSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 718 ltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.-+..-... .+........ ..+....+...+ -...+.+|++.+|..||+|.+++.
T Consensus 276 ailEiq~tn--seS~~~~ee~-----ia~~i~~len~l-----------qr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 276 AILEIQSTN--SESKVEVEEN-----IANVIIGLENGL-----------QRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HHheeccCC--Ccceeehhhh-----hhhheeeccCcc-----------ccCcCcccccCCCCCCcchhhhhc
Confidence 876532110 0000000000 000000111111 124556799999999999998764
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=2.6e-09 Score=119.81 Aligned_cols=166 Identities=15% Similarity=0.166 Sum_probs=121.0
Q ss_pred ccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEeecCCceEEEEEeeccCCccccCCCCHHHHHHHHHH
Q 041702 548 LLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTRVRIIEG 627 (840)
Q Consensus 548 ~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~~~~~~~~~l~~~~~~~i~~~ 627 (840)
..++.+|.|...+.......+...+-++.|+.++||||++++....+.+..|+|.|-..-..... +.+........+.|
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~Pl~~~l-k~l~~~~v~~Gl~q 112 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRPLETVL-KELGKEEVCLGLFQ 112 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccccHHHHH-HHhHHHHHHHHHHH
Confidence 36788999999887655334567888999999999999999999999999999999732111000 01223444567899
Q ss_pred HHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccc
Q 041702 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDV 707 (840)
Q Consensus 628 ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV 707 (840)
|++||.|||+.+ .++|++|.-..|++++.|+.||++|.++........ ......---.|..|+.+.... ...|.
T Consensus 113 Il~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~s~D~ 186 (690)
T KOG1243|consen 113 ILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--WSIDS 186 (690)
T ss_pred HHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--cchhh
Confidence 999999999766 499999999999999999999999998865432221 000111112456666432222 45699
Q ss_pred hhHHHHHHHHHhC
Q 041702 708 FSFGVLLLEILSS 720 (840)
Q Consensus 708 ~SlGviL~elltG 720 (840)
|-||++++|++.|
T Consensus 187 ~~Lg~li~el~ng 199 (690)
T KOG1243|consen 187 WGLGCLIEELFNG 199 (690)
T ss_pred hhHHHHHHHHhCc
Confidence 9999999999998
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.95 E-value=5.5e-09 Score=103.74 Aligned_cols=139 Identities=14% Similarity=0.071 Sum_probs=96.0
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC------------C---------cC-HHHHH----HH
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS------------G---------QG-LEEFK----NE 573 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~------------~---------~~-~~~f~----~E 573 (840)
..||.|--+.||.|..... ......+..+|||+.+... . .. .+.+. +|
T Consensus 3 g~i~~GKEa~V~~~~~~~~------~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE 76 (197)
T cd05146 3 GCISTGKESVVLHANGGSN------ETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKE 76 (197)
T ss_pred CccccCcceEEEEEecCcc------cccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHH
Confidence 4799999999999863200 0001246799999875321 0 01 22333 89
Q ss_pred HHHHhhcCC--CCccceeeEeecCCceEEEEEeeccC----CccccCCCCHHHHHHHHHHHHHHHHHH-HhcCCCceecC
Q 041702 574 MMLIAKLQH--RNLVRLFGCCIEQGEKISIYEFDIVT----DPARKDLLDWTTRVRIIEGVAQGLLYL-HQYSRLRVIHR 646 (840)
Q Consensus 574 v~~l~~l~H--~niv~l~g~~~~~~~~~lv~e~~~~~----~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~ivHr 646 (840)
++.|.++.. -++++++++ ...++||||..-. .......++..+..++..+++.+|..| |..+ |+|+
T Consensus 77 ~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHG 149 (197)
T cd05146 77 MHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHA 149 (197)
T ss_pred HHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 999999953 567777765 5678999994221 111122344455677889999999999 7777 9999
Q ss_pred CCCCCcEEecCCCCceeeccccceec
Q 041702 647 DLKASNVLLDSDMNPKISDFGIARTF 672 (840)
Q Consensus 647 Dlkp~NILl~~~~~~kL~DFGla~~~ 672 (840)
||++.|||++ ++.+.|+|||.+-..
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCceeC
Confidence 9999999996 578999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.7e-09 Score=118.76 Aligned_cols=245 Identities=18% Similarity=0.169 Sum_probs=165.2
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHH--HHHHHHHHhhc-CCCCccce
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEE--FKNEMMLIAKL-QHRNLVRL 588 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~--f~~Ev~~l~~l-~H~niv~l 588 (840)
...+|..+..||.|.|+.|++..- ...++..+++|.+.+.......+ -..|+-+...+ .|.++++.
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~-----------r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~ 331 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSK-----------RPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGK 331 (524)
T ss_pred ecCCcceeEEccCCccccceeeee-----------cCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCC
Confidence 456788899999999999998642 23678899999887653322222 23466666555 68999998
Q ss_pred eeEeecCCceEEEEEeeccCCc----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCC-CCcee
Q 041702 589 FGCCIEQGEKISIYEFDIVTDP----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSD-MNPKI 663 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~~~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kL 663 (840)
...+...++.++=-||...... .....++...++++..|++.++.++|+.. ++|+|+||+||++..+ +..++
T Consensus 332 ~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~ 408 (524)
T KOG0601|consen 332 NSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKL 408 (524)
T ss_pred CCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhc
Confidence 8888877777776666322111 22334666778889999999999999887 9999999999999886 78899
Q ss_pred eccccceecCCCCccccccccccccccc--CccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhh
Q 041702 664 SDFGIARTFGGDEMQSNTNRIVGTYGYM--SPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNL 741 (840)
Q Consensus 664 ~DFGla~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~ 741 (840)
.|||.+..+.-. .. ......+++ +|+......+..+.|++|||.-+.|.+++..-.+... +
T Consensus 409 ~~~~~~t~~~~~----~~-~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-------~----- 471 (524)
T KOG0601|consen 409 GDFGCWTRLAFS----SG-VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-------Q----- 471 (524)
T ss_pred ccccccccccee----cc-cccccccccccchhhccccccccccccccccccccccccCcccCcccc-------c-----
Confidence 999998642111 11 112233444 5555667788999999999999999998875422100 0
Q ss_pred hcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 041702 742 WKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794 (840)
Q Consensus 742 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~ 794 (840)
...+..... ... ......+..++..++..++..||.+.++....+-
T Consensus 472 -----~~~i~~~~~-p~~-~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 472 -----SLTIRSGDT-PNL-PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred -----ceeeecccc-cCC-CchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 000111101 000 1111445566777889999999998887665443
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.84 E-value=9.4e-09 Score=117.45 Aligned_cols=147 Identities=18% Similarity=0.141 Sum_probs=89.3
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCc--------------------------
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQ-------------------------- 565 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~-------------------------- 565 (840)
....|+. +.||+|++|.||+|+.+ .+|+.||||++++....
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~------------~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l 184 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLK------------DNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRL 184 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEEC------------CCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccC
Confidence 3455776 78999999999998754 34999999999754110
Q ss_pred C--------H------HHHHHHHHHHhhcC----CCCccceeeEee-cCCceEEEEEeeccCCccccCCCCH--HHHHHH
Q 041702 566 G--------L------EEFKNEMMLIAKLQ----HRNLVRLFGCCI-EQGEKISIYEFDIVTDPARKDLLDW--TTRVRI 624 (840)
Q Consensus 566 ~--------~------~~f~~Ev~~l~~l~----H~niv~l~g~~~-~~~~~~lv~e~~~~~~~~~~~~l~~--~~~~~i 624 (840)
. . -+|.+|+..+.+++ +.+.+.+=.++. -..+.++||||..-........+.- ..+..+
T Consensus 185 ~~~~~v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~l 264 (537)
T PRK04750 185 KPREVVAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLL 264 (537)
T ss_pred CHHHHHHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHH
Confidence 0 0 12455555555552 333333333332 2467889999953332211100100 011223
Q ss_pred HHHHHHH-HHHHHhcCCCceecCCCCCCcEEecCCC----CceeeccccceecCC
Q 041702 625 IEGVAQG-LLYLHQYSRLRVIHRDLKASNVLLDSDM----NPKISDFGIARTFGG 674 (840)
Q Consensus 625 ~~~ia~~-L~yLH~~~~~~ivHrDlkp~NILl~~~~----~~kL~DFGla~~~~~ 674 (840)
+...+.. +.-++..+ ++|+|+||.||+++.++ .+++.|||++..+..
T Consensus 265 a~~~v~~~~~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 265 AERGVEVFFTQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHHHHHHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3222222 23334556 99999999999999988 999999999987754
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.75 E-value=8.2e-08 Score=98.67 Aligned_cols=139 Identities=17% Similarity=0.199 Sum_probs=104.3
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcCC--CCccceeeEeecCC
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQH--RNLVRLFGCCIEQG 596 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~H--~niv~l~g~~~~~~ 596 (840)
+.|+.|..+.||++.. .+|+.+++|....... ....++..|++++..+++ .++.+++.+..+..
T Consensus 4 ~~l~~G~~n~~~~v~~-------------~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~ 70 (223)
T cd05154 4 RQLSGGQSNLTYLLTA-------------GGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS 70 (223)
T ss_pred eecCCCccceEEEEEe-------------cCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC
Confidence 5689999999999753 2367899999765432 245678999999999975 45678888877643
Q ss_pred ---ceEEEEEeeccCCcccc---CCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------
Q 041702 597 ---EKISIYEFDIVTDPARK---DLLDWTTRVRIIEGVAQGLLYLHQYS------------------------------- 639 (840)
Q Consensus 597 ---~~~lv~e~~~~~~~~~~---~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------------- 639 (840)
..+++||+..-...... ..++..++..++.+++++|..||+..
T Consensus 71 ~~~~~~~v~e~i~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (223)
T cd05154 71 VLGTPFYVMERVDGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASR 150 (223)
T ss_pred ccCCceEEEEEeCCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhc
Confidence 56899999532222211 34677888889999999999999521
Q ss_pred ----------------------CCceecCCCCCCcEEecC--CCCceeecccccee
Q 041702 640 ----------------------RLRVIHRDLKASNVLLDS--DMNPKISDFGIART 671 (840)
Q Consensus 640 ----------------------~~~ivHrDlkp~NILl~~--~~~~kL~DFGla~~ 671 (840)
+..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 151 TDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred ccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 244799999999999998 56689999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=3.3e-07 Score=97.26 Aligned_cols=180 Identities=17% Similarity=0.125 Sum_probs=115.9
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceecCCCCcccccccccccccccC
Q 041702 613 KDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMS 692 (840)
Q Consensus 613 ~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~a 692 (840)
....+|.-.++.++.++.+.+.||..| .+-+|+.++|+|+.+++.+.|.|-..-.....+ ......+|...|.+
T Consensus 111 ~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng---~~~~cpVg~~eftP 184 (637)
T COG4248 111 YPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQINANG---TLHLCPVGVSEFTP 184 (637)
T ss_pred CCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceeeccCC---ceEecccCccccCC
Confidence 345789999999999999999999999 899999999999999999999985543332111 22334678999999
Q ss_pred ccccc-----cCCCCccccchhHHHHHHHHHhC-CCCCCCCCCC-----CccHhHHHhhhhcccccccccCccccchhhH
Q 041702 693 PEYAL-----HGLFSIKSDVFSFGVLLLEILSS-KKNTRFYNTD-----SLTLLGHAWNLWKDDKAWKLMDPTMQNEALY 761 (840)
Q Consensus 693 PE~~~-----~~~~~~ksDV~SlGviL~elltG-~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 761 (840)
||... +..-+...|.|.|||+++++|.| ++|+...... ..+.......+....+...-..+.-......
T Consensus 185 PElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~ 264 (637)
T COG4248 185 PELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLS 264 (637)
T ss_pred HHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChh
Confidence 99654 34467889999999999999988 8887553211 1110000000000011110111111111122
Q ss_pred HHHHHHHHHHHHccccC--CCCCCCHHHHHHHhhccccC
Q 041702 762 SMVTRYIKVALLCVQEN--ATDRPTMLEVVAMLKDEIVN 798 (840)
Q Consensus 762 ~~~~~l~~l~~~Cl~~d--P~~RPs~~evl~~Le~~~~~ 798 (840)
-....+..+-.+|+..- +.-|||++--+..|...-.+
T Consensus 265 ~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 265 MLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred hcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 23445556666787543 56899999888777654333
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.9e-07 Score=101.64 Aligned_cols=163 Identities=19% Similarity=0.254 Sum_probs=123.2
Q ss_pred CccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEee----cCCceEEEE
Q 041702 527 FGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCI----EQGEKISIY 602 (840)
Q Consensus 527 ~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~----~~~~~~lv~ 602 (840)
-.+.||+... .+|..|++|++.....+....-..-+++++++.|+|+|++..++. .....++||
T Consensus 289 ~~Ttyk~~s~------------~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvY 356 (655)
T KOG3741|consen 289 SITTYKATSN------------VDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVY 356 (655)
T ss_pred cceeEeeeec------------cCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEE
Confidence 3678998654 789999999995443333333455688999999999999998876 345677888
Q ss_pred Eeec--------c------------CCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCce
Q 041702 603 EFDI--------V------------TDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPK 662 (840)
Q Consensus 603 e~~~--------~------------~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 662 (840)
+|.. . ........+++...+.++.|+..||.++|+.| +.-+-|.+++||++.+.+++
T Consensus 357 DYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIr 433 (655)
T KOG3741|consen 357 DYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIR 433 (655)
T ss_pred ecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEE
Confidence 8721 1 11223445778899999999999999999998 88899999999999999999
Q ss_pred eeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCC
Q 041702 663 ISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKN 723 (840)
Q Consensus 663 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p 723 (840)
|+..|....+..+.... + .--.+-|.=.||.+++.|.||...
T Consensus 434 iS~C~i~Dvl~~d~~~~----------------l---e~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 434 ISGCGIMDVLQEDPTEP----------------L---ESQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred EecccceeeecCCCCcc----------------h---hHHhhhhHHHHHHHHHHHhhcccc
Confidence 99999887765443111 1 012456888999999999999754
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.1e-07 Score=91.25 Aligned_cols=131 Identities=20% Similarity=0.257 Sum_probs=94.2
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEE-eccCCC-------cCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKR-LSSKSG-------QGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~-l~~~~~-------~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
..+++|+-+.+|.+.+ -|..+++|. +++.-. -..++-.+|+++|.+++--.|...+=|
T Consensus 2 ~~i~~GAEa~i~~~~~--------------~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~ 67 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--------------LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVY 67 (204)
T ss_pred chhhCCcceeEEeeec--------------cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEE
Confidence 3588999999998632 244466664 332211 123467889999999987777777777
Q ss_pred eecCCceEEEEEeeccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccccee
Q 041702 592 CIEQGEKISIYEFDIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
..+.+...++|||..-.. .+..+. ..+..++..+-.-+.-||..+ |+|+||.++||++.... +.++||||+..
T Consensus 68 dvD~~~~~I~me~I~G~~--lkd~l~-~~~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 68 DVDPDNGLIVMEYIEGEL--LKDALE-EARPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEcCCCCEEEEEEeCChh--HHHHHH-hcchHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 888889999999932111 110111 114578888999999999998 99999999999996655 99999999874
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=2.3e-08 Score=116.89 Aligned_cols=247 Identities=18% Similarity=0.183 Sum_probs=157.6
Q ss_pred HHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhcCCCCccc
Q 041702 511 AATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQHRNLVR 587 (840)
Q Consensus 511 ~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~ 587 (840)
...+.|.+.+.+.+|.++.++.+.-+ ..|...++|..... .....+....+-.++-..+||-+++
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa------------~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~ 868 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPA------------GSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVR 868 (1205)
T ss_pred CCCccceecccccCCCCcccccCCcc------------ccccccchhhhccchhhccccccccCCccCccccCCCCceec
Confidence 45677888889999999999987543 33444444443322 1122333344444444445666776
Q ss_pred eeeEeecCCceEEEEEeecc----CCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCcee
Q 041702 588 LFGCCIEQGEKISIYEFDIV----TDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKI 663 (840)
Q Consensus 588 l~g~~~~~~~~~lv~e~~~~----~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL 663 (840)
..--+......++++++.-. .........+..-....+..+..+++|||... +.|+|++|.|+|...++..++
T Consensus 869 ~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l 945 (1205)
T KOG0606|consen 869 SFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPL 945 (1205)
T ss_pred ccCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCccc
Confidence 65555566778888887311 11111223444444456677888999999876 899999999999999999999
Q ss_pred eccccceecCC---------------------CC----cc----cccccccccccccCccccccCCCCccccchhHHHHH
Q 041702 664 SDFGIARTFGG---------------------DE----MQ----SNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLL 714 (840)
Q Consensus 664 ~DFGla~~~~~---------------------~~----~~----~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL 714 (840)
+|||....... .. .. .......+|+.|.+||...+......+|.|++|+++
T Consensus 946 ~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l 1025 (1205)
T KOG0606|consen 946 TDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCL 1025 (1205)
T ss_pred CccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhh
Confidence 99985433211 00 00 012345689999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCCccHhHHHhhhhcccccccccCcccc-chhhHHHHHHHHHHHHHccccCCCCCCCHH
Q 041702 715 LEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQ-NEALYSMVTRYIKVALLCVQENATDRPTML 786 (840)
Q Consensus 715 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 786 (840)
+|.++|.+|+....+.... . .++..... .....+......+++...+..+|.+|-.|.
T Consensus 1026 ~e~l~g~pp~na~tpq~~f------~--------ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1026 FEVLTGIPPFNAETPQQIF------E--------NILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhhcCCCCCCCcchhhhh------h--------ccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9999999998654433211 0 01110000 011112233455666667788899998766
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.53 E-value=4.2e-07 Score=86.61 Aligned_cols=137 Identities=23% Similarity=0.242 Sum_probs=98.2
Q ss_pred ccccccCCCCccEEEeecceeehhccccCcccCCceEEEEE-eccCC-------CcCHHHHHHHHHHHhhcCCCCcccee
Q 041702 518 EENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKR-LSSKS-------GQGLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 518 ~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~-l~~~~-------~~~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
....|-+|+-+.|+++. ..|+...||. +.+.- .-...+.++|+++|.+++--.|.-..
T Consensus 11 ~l~likQGAEArv~~~~--------------~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~ 76 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGS--------------FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPR 76 (229)
T ss_pred cceeeeccceeeEeeec--------------cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCce
Confidence 45678999999999975 3577777774 33221 12346789999999999876777666
Q ss_pred eEeecCCceEEEEEeeccCCcc-------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCC--
Q 041702 590 GCCIEQGEKISIYEFDIVTDPA-------RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMN-- 660 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~-- 660 (840)
-++.+...-.++|||..-.... ......-.....++..|-..+.-||..+ |+|+||..+||+|..++.
T Consensus 77 l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~ 153 (229)
T KOG3087|consen 77 LIFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQI 153 (229)
T ss_pred EEEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcC
Confidence 6777888888999983211000 0111111222678899999999999998 999999999999976653
Q ss_pred -ceeecccccee
Q 041702 661 -PKISDFGIART 671 (840)
Q Consensus 661 -~kL~DFGla~~ 671 (840)
+.|+|||++..
T Consensus 154 ~~~lIdfgls~~ 165 (229)
T KOG3087|consen 154 TPILIDFGLSSV 165 (229)
T ss_pred ceEEEeecchhc
Confidence 58999999854
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.46 E-value=9.6e-07 Score=87.47 Aligned_cols=96 Identities=20% Similarity=0.248 Sum_probs=63.7
Q ss_pred HHHHHHHHHhhcCCC--CccceeeEeecCCceEEEEEeeccCCcccc----CCCCHHHHHHHHHHHHHHHHH-HHhcCCC
Q 041702 569 EFKNEMMLIAKLQHR--NLVRLFGCCIEQGEKISIYEFDIVTDPARK----DLLDWTTRVRIIEGVAQGLLY-LHQYSRL 641 (840)
Q Consensus 569 ~f~~Ev~~l~~l~H~--niv~l~g~~~~~~~~~lv~e~~~~~~~~~~----~~l~~~~~~~i~~~ia~~L~y-LH~~~~~ 641 (840)
...+|.+.|.++... ++++++.+- ...+||||......... ..++......++.+++..+.. +|..+
T Consensus 54 ~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~g-- 127 (188)
T PF01163_consen 54 WAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKAG-- 127 (188)
T ss_dssp HHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCTT--
T ss_pred HHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhcC--
Confidence 467899999999765 577777552 45799999541111111 111134566788888886666 56777
Q ss_pred ceecCCCCCCcEEecCCCCceeeccccceec
Q 041702 642 RVIHRDLKASNVLLDSDMNPKISDFGIARTF 672 (840)
Q Consensus 642 ~ivHrDlkp~NILl~~~~~~kL~DFGla~~~ 672 (840)
|+|+||.+.|||++++ .+.|+|||.+...
T Consensus 128 -ivHGDLs~~NIlv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 128 -IVHGDLSEYNILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp -EEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred -ceecCCChhhEEeecc-eEEEEecCcceec
Confidence 9999999999999887 9999999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.40 E-value=1.2e-06 Score=79.82 Aligned_cols=88 Identities=26% Similarity=0.352 Sum_probs=62.7
Q ss_pred eEEEecCCceEEecCC-CceEEEecCCCCCC-CceEEEecCCCeEEEeccCCCCCCCceeEEecCCCCCcccCCCccccc
Q 041702 89 ILAINNNGNLVLLNQA-NGTIWSSNMSKEAK-SPVAQLLDTGNLVLRENFSNNTSEGSYLWQSFDFPSDTLLPGMKVGWD 166 (840)
Q Consensus 89 ~l~~~~~G~L~l~~~~-~~~~Wss~~~~~~~-~~~a~L~d~GNlVl~~~~~~~~~~~~~lWqSFd~PtDtlLpg~~l~~~ 166 (840)
.+.+..||+||+++.. +.++|++++..... ...+.|.++|||||++. .+.++|+| +|-
T Consensus 23 ~~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~------~g~~vW~S-----~t~--------- 82 (114)
T smart00108 23 TLIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDG------DGRVVWSS-----NTT--------- 82 (114)
T ss_pred ccCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeC------CCCEEEEe-----ccc---------
Confidence 3456689999999875 58999999864432 36789999999999983 34568886 111
Q ss_pred cccCCceeEEEeccCCCCCCCceEEeecCCCCcEEEEEcCCeeeEEeC
Q 041702 167 LKTGRERYLTSWRTADDPSPGKFTYRLDIHVLPQIFLYKGSLKLARIG 214 (840)
Q Consensus 167 ~~tg~~~~l~S~~s~~dps~G~~~l~~~~~~~~~~~~~~~~~~~~~~g 214 (840)
...|.+.+.|+++|..+++-.++ .+.|.+.
T Consensus 83 -----------------~~~~~~~~~L~ddGnlvl~~~~~-~~~W~Sf 112 (114)
T smart00108 83 -----------------GANGNYVLVLLDDGNLVIYDSDG-NFLWQSF 112 (114)
T ss_pred -----------------CCCCceEEEEeCCCCEEEECCCC-CEEeCCC
Confidence 12467899999999987754333 4677653
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=8.7e-08 Score=108.16 Aligned_cols=151 Identities=19% Similarity=0.290 Sum_probs=98.7
Q ss_pred HHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceecCCCCc------ccc-cccccccccccCccccc
Q 041702 625 IEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEM------QSN-TNRIVGTYGYMSPEYAL 697 (840)
Q Consensus 625 ~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~------~~~-~~~~~gt~~y~aPE~~~ 697 (840)
+.+++.|+.|+|.. ..+||++|.|++|.++..+..||+.|+.+........ ... ..-..-...|.|||++.
T Consensus 105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 34555999999974 4699999999999999999999999998765433111 000 11122456899999999
Q ss_pred cCCCCccccchhHHHHHHHHHhCCCC-CCCCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccc
Q 041702 698 HGLFSIKSDVFSFGVLLLEILSSKKN-TRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQ 776 (840)
Q Consensus 698 ~~~~~~ksDV~SlGviL~elltG~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~ 776 (840)
+...+.++|+||+|++++-+..|..+ +......... .. .. ...+.... ....+.+.++.+=+.+.+.
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~---~~-~~-------~~~~~~~~-~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY---SF-SR-------NLLNAGAF-GYSNNLPSELRESLKKLLN 250 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchh---hh-hh-------cccccccc-cccccCcHHHHHHHHHHhc
Confidence 98899999999999999999944443 3322111100 00 00 00011110 1112344456666677889
Q ss_pred cCCCCCCCHHHHH
Q 041702 777 ENATDRPTMLEVV 789 (840)
Q Consensus 777 ~dP~~RPs~~evl 789 (840)
.++.-||++.++.
T Consensus 251 ~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 251 GDSAVRPTLDLLL 263 (700)
T ss_pred CCcccCcchhhhh
Confidence 9999999777654
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.27 E-value=2.9e-06 Score=77.48 Aligned_cols=87 Identities=21% Similarity=0.279 Sum_probs=62.3
Q ss_pred EEEec-CCceEEecCC-CceEEEecCCCC-CCCceEEEecCCCeEEEeccCCCCCCCceeEEecCCCCCcccCCCccccc
Q 041702 90 LAINN-NGNLVLLNQA-NGTIWSSNMSKE-AKSPVAQLLDTGNLVLRENFSNNTSEGSYLWQSFDFPSDTLLPGMKVGWD 166 (840)
Q Consensus 90 l~~~~-~G~L~l~~~~-~~~~Wss~~~~~-~~~~~a~L~d~GNlVl~~~~~~~~~~~~~lWqSFd~PtDtlLpg~~l~~~ 166 (840)
+.+.. ||+||+++.. +.++|++|+... .....+.|.++|||||+|. ++.++|+|=-
T Consensus 24 ~~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~------~g~~vW~S~~--------------- 82 (116)
T cd00028 24 LIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDG------SGTVVWSSNT--------------- 82 (116)
T ss_pred CCCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcC------CCcEEEEecc---------------
Confidence 44555 9999999765 589999998653 3355789999999999983 3456888521
Q ss_pred cccCCceeEEEeccCCCCCCCceEEeecCCCCcEEEEEcCCeeeEEeC
Q 041702 167 LKTGRERYLTSWRTADDPSPGKFTYRLDIHVLPQIFLYKGSLKLARIG 214 (840)
Q Consensus 167 ~~tg~~~~l~S~~s~~dps~G~~~l~~~~~~~~~~~~~~~~~~~~~~g 214 (840)
....+.+.+.|+++|...++-.+ ..+.|.+.
T Consensus 83 ----------------~~~~~~~~~~L~ddGnlvl~~~~-~~~~W~Sf 113 (116)
T cd00028 83 ----------------TRVNGNYVLVLLDDGNLVLYDSD-GNFLWQSF 113 (116)
T ss_pred ----------------cCCCCceEEEEeCCCCEEEECCC-CCEEEcCC
Confidence 11246789999999987776443 35577764
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.26 E-value=3.2e-06 Score=88.93 Aligned_cols=120 Identities=18% Similarity=0.098 Sum_probs=84.8
Q ss_pred cCCceEEEEEeccCCC-----------cCHHHHHHHHHHHhhcCCCC--ccceeeEeec-----CCceEEEEEeeccC-C
Q 041702 549 LNGEEVAVKRLSSKSG-----------QGLEEFKNEMMLIAKLQHRN--LVRLFGCCIE-----QGEKISIYEFDIVT-D 609 (840)
Q Consensus 549 ~~g~~VAvK~l~~~~~-----------~~~~~f~~Ev~~l~~l~H~n--iv~l~g~~~~-----~~~~~lv~e~~~~~-~ 609 (840)
.+|+.+.||+...... .....+.+|.+.+.++...+ .++++++... ....++|+|+.... .
T Consensus 43 ~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~s 122 (268)
T PRK15123 43 LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTIS 122 (268)
T ss_pred ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCcc
Confidence 3577899997753321 11124889999999995444 4455666643 23578999983221 1
Q ss_pred ---cc---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecC-------CCCceeecccccee
Q 041702 610 ---PA---RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS-------DMNPKISDFGIART 671 (840)
Q Consensus 610 ---~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-------~~~~kL~DFGla~~ 671 (840)
.. .....+...+..++.+++..+.-||..+ |+|+|++++|||++. +..+.|+||+.++.
T Consensus 123 L~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 123 LEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 10 0223445667789999999999999999 999999999999975 46789999998853
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.3e-05 Score=81.81 Aligned_cols=147 Identities=18% Similarity=0.187 Sum_probs=99.3
Q ss_pred cCHHHHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--------------------
Q 041702 504 FSLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-------------------- 563 (840)
Q Consensus 504 ~~~~~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-------------------- 563 (840)
..+..+.....-..+.++||.|--+.||.|.+ +.|.++|||.-+...
T Consensus 81 LAL~~l~~r~~ve~iG~~IGvGKEsdVY~~~~-------------~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~s 147 (304)
T COG0478 81 LALHALVKRGIVEAIGTKIGVGKESDVYVAID-------------PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGS 147 (304)
T ss_pred HHHHHHHHcChHHhhccccccCccceEEEEEC-------------CCCCEEEEEEeecCchhhhhhcchhhhhccccCcc
Confidence 34444444444456668999999999999753 479999999643210
Q ss_pred C--cCHHHHHHHHHHHhhcCCC--CccceeeEeecCCceEEEEEeeccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 041702 564 G--QGLEEFKNEMMLIAKLQHR--NLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYS 639 (840)
Q Consensus 564 ~--~~~~~f~~Ev~~l~~l~H~--niv~l~g~~~~~~~~~lv~e~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~ 639 (840)
. -......+|.++|.+|.-. .+.+.+++ +...+|||+..-....... ++-...-.|+..|+.-+.-+-..|
T Consensus 148 Wl~~sRl~A~rEf~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r-~~~en~~~il~~il~~~~~~~~~G 222 (304)
T COG0478 148 WLYVSRLAAEREFEALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR-LDVENPDEILDKILEEVRKAYRRG 222 (304)
T ss_pred hhhhHHHHHHHHHHHHHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc-CcccCHHHHHHHHHHHHHHHHHcC
Confidence 0 1223467899999999654 77777765 4567899983222222111 133444455556666555555666
Q ss_pred CCceecCCCCCCcEEecCCCCceeecccccee
Q 041702 640 RLRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 640 ~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
+||+|+++-||++++||.+.++||-.+..
T Consensus 223 ---iVHGDlSefNIlV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 223 ---IVHGDLSEFNILVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred ---ccccCCchheEEEecCCCEEEEeCccccc
Confidence 99999999999999999999999976644
|
|
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.05 E-value=8.5e-06 Score=68.43 Aligned_cols=72 Identities=38% Similarity=0.795 Sum_probs=52.5
Q ss_pred CceeEeecccCCCcccccccccCChhHHHHHhhc-ccceeeeeccccccCCccceeec-ccchhhhhhcccCCcceeeee
Q 041702 341 NQFKRFDDMKVPDLLDVSLNEGMNLEECGAECLN-NCTCRAYAYFNLTRGGSGCLMWF-GDLIDMRKTLANLTGQSIYLR 418 (840)
Q Consensus 341 ~~f~~~~~~~~p~~~~~~~~~~~s~e~C~~~Cl~-nCsC~a~~y~~~~~~g~~C~~w~-~~l~~~~~~~~~~~~~~lylr 418 (840)
..|.+++++.+++..... ....++++|++.|++ +|+|.||.|.+ ++.+|.+|. +.+.+..... ..+.++|.+
T Consensus 4 ~~f~~~~~~~l~~~~~~~-~~~~s~~~C~~~C~~~~~~C~s~~y~~---~~~~C~l~~~~~~~~~~~~~--~~~~~~y~~ 77 (78)
T smart00473 4 DCFVRLPNTKLPGFSRIV-ISVASLEECASKCLNSNCSCRSFTYNN---GTKGCLLWSESSLGDARLFP--SGGVDLYEK 77 (78)
T ss_pred ceeEEecCccCCCCccee-EcCCCHHHHHHHhCCCCCceEEEEEcC---CCCEEEEeeCCccccceecc--cCCceeEEe
Confidence 458899999999664432 456799999999999 99999999954 355899999 6666665221 334455543
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.02 E-value=6e-05 Score=75.20 Aligned_cols=134 Identities=15% Similarity=0.124 Sum_probs=93.4
Q ss_pred cccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC------CcCHHHHHHHHHHHhhcCC--CCccceeeEe
Q 041702 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS------GQGLEEFKNEMMLIAKLQH--RNLVRLFGCC 592 (840)
Q Consensus 521 ~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~------~~~~~~f~~Ev~~l~~l~H--~niv~l~g~~ 592 (840)
--|+||.+.|++.. .+|+.+-+|+-...- +.+...|.+|+..|.+|.. -.+++++.+.
T Consensus 25 N~~rgG~SgV~r~~--------------~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~ 90 (216)
T PRK09902 25 NYRRNGMSGVQCVE--------------RNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGE 90 (216)
T ss_pred CcCCCCcceEEEEE--------------eCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceee
Confidence 35778999999853 245578899865221 3356789999999999953 3355555222
Q ss_pred ecC----CceEEEEEeec----cCCccc---cCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCC-
Q 041702 593 IEQ----GEKISIYEFDI----VTDPAR---KDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMN- 660 (840)
Q Consensus 593 ~~~----~~~~lv~e~~~----~~~~~~---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~- 660 (840)
... -..++|.|-.. +..... ....+...+..++.++++.+.-||+.+ +.|+|+.+.||+++.++.
T Consensus 91 ~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~ 167 (216)
T PRK09902 91 AVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKA 167 (216)
T ss_pred eeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCe
Confidence 221 23567777411 111111 223466677899999999999999998 999999999999986677
Q ss_pred -ceeecccccee
Q 041702 661 -PKISDFGIART 671 (840)
Q Consensus 661 -~kL~DFGla~~ 671 (840)
++++||.-++.
T Consensus 168 ~v~lIDlEk~r~ 179 (216)
T PRK09902 168 EAGFLDLEKSRR 179 (216)
T ss_pred eEEEEEhhccch
Confidence 89999987654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.01 E-value=3.7e-05 Score=78.05 Aligned_cols=120 Identities=23% Similarity=0.163 Sum_probs=83.9
Q ss_pred CCceEEEEEeccCC-------CcCHHHHHHHHHHHhhcCC--CCccceeeEeecCC----ceEEEEEeeccC-C----cc
Q 041702 550 NGEEVAVKRLSSKS-------GQGLEEFKNEMMLIAKLQH--RNLVRLFGCCIEQG----EKISIYEFDIVT-D----PA 611 (840)
Q Consensus 550 ~g~~VAvK~l~~~~-------~~~~~~f~~Ev~~l~~l~H--~niv~l~g~~~~~~----~~~lv~e~~~~~-~----~~ 611 (840)
.++.+-+|.+.... .-...+..+|...+.+|.. -..++.+++..... ..++|+|+..-. . ..
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 45556666543211 1234578899999998853 45667777776533 347778872111 1 11
Q ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCC---Cceeeccccceec
Q 041702 612 RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDM---NPKISDFGIARTF 672 (840)
Q Consensus 612 ~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~---~~kL~DFGla~~~ 672 (840)
.....+...+..++.+++..++-||..+ |+|+|+++.|||++.+. .+.|+||+.++..
T Consensus 111 ~~~~~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 111 QWEQLDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred hhcccchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 1112456677889999999999999999 99999999999999887 8999999987753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.98 E-value=1.8e-05 Score=90.11 Aligned_cols=143 Identities=20% Similarity=0.245 Sum_probs=89.8
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCc--------------------------
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQ-------------------------- 565 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~-------------------------- 565 (840)
....|+. +.|+.++-|.||+|+ +.+|+.||||+.++.-..
T Consensus 124 ~F~eF~~-~PiAsASIaQVH~A~-------------L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l 189 (517)
T COG0661 124 LFSEFEP-EPIASASIAQVHRAV-------------LKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRL 189 (517)
T ss_pred HHHHcCC-CchhhhhHhhheeEE-------------ecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccC
Confidence 3344544 689999999999976 457999999997653211
Q ss_pred CH--------------HHHHHHHHHHhhcC-----CCCccceeeEeecCCceEEEEEeecc---CCc--cccCCCCHHHH
Q 041702 566 GL--------------EEFKNEMMLIAKLQ-----HRNLVRLFGCCIEQGEKISIYEFDIV---TDP--ARKDLLDWTTR 621 (840)
Q Consensus 566 ~~--------------~~f~~Ev~~l~~l~-----H~niv~l~g~~~~~~~~~lv~e~~~~---~~~--~~~~~l~~~~~ 621 (840)
.. -+|.+|..-+.+++ .+++.-..=|..-.+...++|||..- .+. .....++ +
T Consensus 190 ~~~~vv~e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d---~ 266 (517)
T COG0661 190 DLVEVVDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGID---R 266 (517)
T ss_pred ChHHHHHHHHHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCC---H
Confidence 00 02455555555552 34433333334446788999999422 111 1112233 3
Q ss_pred HHHHHHHHHH-HHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceecCC
Q 041702 622 VRIIEGVAQG-LLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGG 674 (840)
Q Consensus 622 ~~i~~~ia~~-L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 674 (840)
..|+..++++ +..+-..+ ++|.|..|.||+++.++.+.+.|||+...+.+
T Consensus 267 k~ia~~~~~~f~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 267 KELAELLVRAFLRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHHHHHHHHHHHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 3444444443 22222345 99999999999999999999999999987654
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00011 Score=66.76 Aligned_cols=100 Identities=26% Similarity=0.399 Sum_probs=64.7
Q ss_pred CeEEcCCCeEEEEEecCCCCCceEEEEeeecCCCcEEEee-cCCCCCCCCCceEEEecCCceEEecCCCceEEEecCCCC
Q 041702 38 EKLVSPSQRFELGFFSPGNSKNRYLGVWYKKSPDTVVWVA-NRNCPILDPHGILAINNNGNLVLLNQANGTIWSSNMSKE 116 (840)
Q Consensus 38 ~~l~S~~g~F~~gFf~~~~~~~~~lgiw~~~~~~tvVW~A-Nr~~p~~~~~~~l~~~~~G~L~l~~~~~~~~Wss~~~~~ 116 (840)
+.+.+.+|.+.|-|...|+ |-|. + ...+++|.. +...... ..+.+.|..||||||+|..+.++|++...
T Consensus 12 ~p~~~~s~~~~L~l~~dGn-----Lvl~-~-~~~~~iWss~~t~~~~~-~~~~~~L~~~GNlvl~d~~~~~lW~Sf~~-- 81 (114)
T PF01453_consen 12 SPLTSSSGNYTLILQSDGN-----LVLY-D-SNGSVIWSSNNTSGRGN-SGCYLVLQDDGNLVLYDSSGNVLWQSFDY-- 81 (114)
T ss_dssp EEEEECETTEEEEEETTSE-----EEEE-E-TTTEEEEE--S-TTSS--SSEEEEEETTSEEEEEETTSEEEEESTTS--
T ss_pred cccccccccccceECCCCe-----EEEE-c-CCCCEEEEecccCCccc-cCeEEEEeCCCCEEEEeecceEEEeecCC--
Confidence 4555555888888887764 3332 2 235679999 4333321 46889999999999999999999999432
Q ss_pred CCCceEEEec--CCCeEEEeccCCCCCCCceeEEecCCCC
Q 041702 117 AKSPVAQLLD--TGNLVLRENFSNNTSEGSYLWQSFDFPS 154 (840)
Q Consensus 117 ~~~~~a~L~d--~GNlVl~~~~~~~~~~~~~lWqSFd~Pt 154 (840)
........++ .||++ +. ....+.|.|=+.|+
T Consensus 82 ptdt~L~~q~l~~~~~~-~~------~~~~~sw~s~~dps 114 (114)
T PF01453_consen 82 PTDTLLPGQKLGDGNVT-GK------NDSLTSWSSNTDPS 114 (114)
T ss_dssp SS-EEEEEET--TSEEE-EE------STSSEEEESS----
T ss_pred CccEEEeccCcccCCCc-cc------cceEEeECCCCCCC
Confidence 2345567777 88888 65 22356898877664
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00013 Score=75.09 Aligned_cols=133 Identities=20% Similarity=0.131 Sum_probs=85.4
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCC--ccceeeEeecCCc
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRN--LVRLFGCCIEQGE 597 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~n--iv~l~g~~~~~~~ 597 (840)
.+||+|..+.||+. .+..+++|...... ......+|.+++..+..-. +.+.+++....+.
T Consensus 7 ~~i~~G~t~~~y~~----------------~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~ 68 (226)
T TIGR02172 7 TQTGEGGNGESYTH----------------KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGR 68 (226)
T ss_pred eeecCCCCcceeEe----------------cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCe
Confidence 47999999999983 24467788876532 3456789999999996443 5778888877778
Q ss_pred eEEEEEeeccCC-ccccCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 041702 598 KISIYEFDIVTD-PARKDLLDWTTRVRIIEGVAQGLLYLHQ--------------------------------------- 637 (840)
Q Consensus 598 ~~lv~e~~~~~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~--------------------------------------- 637 (840)
..++||+..-.. .......+......++.++++.+.-||+
T Consensus 69 ~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~ 148 (226)
T TIGR02172 69 LGLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKE 148 (226)
T ss_pred eeeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHh
Confidence 888998822210 0000011112222233333333333332
Q ss_pred -cCCCceecCCCCCCcEEecCCCCceeecccccee
Q 041702 638 -YSRLRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 638 -~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
...+.++|+|+.|.||++++++ +.|+||+.+..
T Consensus 149 ~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 149 VPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCCCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 1123478999999999999888 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.79 E-value=8.5e-05 Score=73.95 Aligned_cols=98 Identities=19% Similarity=0.170 Sum_probs=79.5
Q ss_pred HHHHHHHhhcCC-CCccceeeEeecCCceEEEEEeeccCC-------ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCc
Q 041702 571 KNEMMLIAKLQH-RNLVRLFGCCIEQGEKISIYEFDIVTD-------PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLR 642 (840)
Q Consensus 571 ~~Ev~~l~~l~H-~niv~l~g~~~~~~~~~lv~e~~~~~~-------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ 642 (840)
..|..+|..+++ +++++++|+|- .+++.|+..... ......-+|..|.+|+.++++.+++|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358889999976 69999999993 366778744321 223345789999999999999999999865556
Q ss_pred eecCCCCCCcEEecCCCCceeeccccceec
Q 041702 643 VIHRDLKASNVLLDSDMNPKISDFGIARTF 672 (840)
Q Consensus 643 ivHrDlkp~NILl~~~~~~kL~DFGla~~~ 672 (840)
+...|++++|+-+++++++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 889999999999999999999999887554
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.79 E-value=5.7e-06 Score=92.60 Aligned_cols=185 Identities=16% Similarity=0.079 Sum_probs=128.8
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCC-ccceee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRN-LVRLFG 590 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~n-iv~l~g 590 (840)
.++-+...+.+++++++.+||.+.. . .+...++.+... ....-++++|.+++||| .++.++
T Consensus 240 k~kws~~fh~fvK~altknpKkRpt------------a-eklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~ 301 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPT------------A-EKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLE 301 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCC------------h-hhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccc
Confidence 4445555567899999999997543 1 122224444322 45567899999999999 666666
Q ss_pred EeecCCceEEEEEeeccC-Cccc-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 591 CCIEQGEKISIYEFDIVT-DPAR-----KDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~-~~~~-----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
-+.......+.+++.... +... ...+...+...+.+.-+++++|||+.. -+|+| ||+..+ +..|..
T Consensus 302 d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~ 373 (829)
T KOG0576|consen 302 DYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLL 373 (829)
T ss_pred cCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccc
Confidence 666666666667763222 1111 112233344556777788999999864 58998 777755 778999
Q ss_pred ccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 041702 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTR 725 (840)
Q Consensus 665 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~ 725 (840)
||+.+..+.+.. ..+...+|+.++|||...+..+..+.|+|++|+-..++--|-+|..
T Consensus 374 ~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 374 DFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cccCCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 999988765433 3445678999999999999999999999999998777777766643
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00036 Score=70.72 Aligned_cols=148 Identities=19% Similarity=0.201 Sum_probs=95.1
Q ss_pred CHHHHHHHccCCcccc---cccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCc----------------
Q 041702 505 SLSSISAATDNFSEEN---KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQ---------------- 565 (840)
Q Consensus 505 ~~~~~~~~~~~f~~~~---~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~---------------- 565 (840)
++..+....++..+.. .|+.|--+.||+|.. .++..+|||+++.....
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~-------------~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~ 102 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAET-------------GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRN 102 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeecc-------------CCCceEEEEEEehhhhhhhhHHHHHhcChhhhc
Confidence 3444444444444333 466777889999742 46889999998643211
Q ss_pred ---CHHH-----HHHHHHHHhhcC--CCCccceeeEeecCCceEEEEEeeccCC---cc-ccCCCCHHHHHHHHHHHHHH
Q 041702 566 ---GLEE-----FKNEMMLIAKLQ--HRNLVRLFGCCIEQGEKISIYEFDIVTD---PA-RKDLLDWTTRVRIIEGVAQG 631 (840)
Q Consensus 566 ---~~~~-----f~~Ev~~l~~l~--H~niv~l~g~~~~~~~~~lv~e~~~~~~---~~-~~~~l~~~~~~~i~~~ia~~ 631 (840)
..++ ..+|+.-|.++. +-.+.+.+++. +-.+||||..... .. ..-.+...+...+..++++.
T Consensus 103 ~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~ 178 (268)
T COG1718 103 SRSNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEY 178 (268)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHH
Confidence 1111 245777777773 45566666554 4579999932221 11 11112222566677888888
Q ss_pred HHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceec
Q 041702 632 LLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTF 672 (840)
Q Consensus 632 L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~ 672 (840)
+.-|-... .+||+||+.=|||+. ++.+.|+|||.|-..
T Consensus 179 ~~~l~~~a--~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 179 MRRLYKEA--GLVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred HHHHHHhc--CcccccchhhheEEE-CCeEEEEECcccccc
Confidence 88887632 399999999999998 899999999988654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00094 Score=69.76 Aligned_cols=67 Identities=15% Similarity=0.115 Sum_probs=47.2
Q ss_pred cccCCCC-ccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcC-CCCccceeeEeecCCce
Q 041702 521 KLGEGGF-GPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQ-HRNLVRLFGCCIEQGEK 598 (840)
Q Consensus 521 ~lG~G~~-G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~~ 598 (840)
.|-.|.. ..||+.. .++..+.||+..... ..++.+|++++..+. +--+.+++++....+..
T Consensus 5 ~~~~g~~~~~v~~~~--------------~~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~ 67 (244)
T cd05150 5 RVTEGQSGATVYRLD--------------GKNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRA 67 (244)
T ss_pred ecCCCCCcCeEEEEc--------------CCCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCcc
Confidence 3455555 7889863 124678888876442 346778999998883 45567788887777778
Q ss_pred EEEEEe
Q 041702 599 ISIYEF 604 (840)
Q Consensus 599 ~lv~e~ 604 (840)
++|||+
T Consensus 68 ~lv~e~ 73 (244)
T cd05150 68 WLLTSA 73 (244)
T ss_pred EEEEEe
Confidence 899998
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0015 Score=65.40 Aligned_cols=132 Identities=14% Similarity=0.205 Sum_probs=89.7
Q ss_pred cccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC----------------CcCHHHHHHHHHHHhhcC-
Q 041702 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS----------------GQGLEEFKNEMMLIAKLQ- 581 (840)
Q Consensus 519 ~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~----------------~~~~~~f~~Ev~~l~~l~- 581 (840)
...||+|+.-.||.= +++....||+..... ....+++.+|+.-...+.
T Consensus 6 ~~~i~~G~~R~cy~H---------------P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~ 70 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH---------------PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSL 70 (199)
T ss_pred CcccccCCCceEEEC---------------CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhh
Confidence 457999999999972 567788999987654 223567788887776665
Q ss_pred -----CCCccceeeEeecCCceEEEEEeeccCCccccCCCCHHHH-----HHHHHHHHHHHHHHHhcCCCceecCCCCCC
Q 041702 582 -----HRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTR-----VRIIEGVAQGLLYLHQYSRLRVIHRDLKAS 651 (840)
Q Consensus 582 -----H~niv~l~g~~~~~~~~~lv~e~~~~~~~~~~~~l~~~~~-----~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~ 651 (840)
+.+|.+++|+...+....+|+|...-.+......|.+..+ ..+...+-.-..||-+.. |+.+||+|.
T Consensus 71 ~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~~~~~~L~~f~~~l~~~~---Iv~~dl~~~ 147 (199)
T PF10707_consen 71 RRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTEELRQALDEFKRYLLDHH---IVIRDLNPH 147 (199)
T ss_pred ccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccHHHHHHHHHHHHHHHHcC---CeecCCCcc
Confidence 8899999999999999999999843333222222221111 123333344456666665 999999999
Q ss_pred cEEecCCC----Cceeec-ccc
Q 041702 652 NVLLDSDM----NPKISD-FGI 668 (840)
Q Consensus 652 NILl~~~~----~~kL~D-FGl 668 (840)
||++..+. .+.|+| ||-
T Consensus 148 NIv~~~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 148 NIVVQRRDSGEFRLVLIDGLGE 169 (199)
T ss_pred cEEEEecCCCceEEEEEeCCCC
Confidence 99996442 466776 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.00061 Score=70.27 Aligned_cols=70 Identities=16% Similarity=0.240 Sum_probs=47.7
Q ss_pred cccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCC--CccceeeEeecC-
Q 041702 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHR--NLVRLFGCCIEQ- 595 (840)
Q Consensus 519 ~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~--niv~l~g~~~~~- 595 (840)
++.|+.|..+.||++.. ++..+++|..... .....+.+|+.++..+... .+.+++.+....
T Consensus 2 i~~l~~G~~n~~~~v~~--------------~~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~ 65 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTT--------------DDGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDE 65 (239)
T ss_dssp EEEEEESSSSEEEEEEE--------------TTSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETE
T ss_pred CccCCCCCeeeEEEEEE--------------CCcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeeccccc
Confidence 35789999999999742 2358999997654 3456788999999988533 466777655332
Q ss_pred --CceEEEEEe
Q 041702 596 --GEKISIYEF 604 (840)
Q Consensus 596 --~~~~lv~e~ 604 (840)
...+++|++
T Consensus 66 ~~~~~~~~~~~ 76 (239)
T PF01636_consen 66 FNGFPYLLMEY 76 (239)
T ss_dssp ETSEEEEEEEE
T ss_pred ccccceEEEEE
Confidence 345778887
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0012 Score=65.51 Aligned_cols=125 Identities=24% Similarity=0.342 Sum_probs=89.4
Q ss_pred cCCcccccccCCCC-ccEEEeecceeehhccccCcccCCceEEEEEeccC---C---------C---------cCHHHHH
Q 041702 514 DNFSEENKLGEGGF-GPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---S---------G---------QGLEEFK 571 (840)
Q Consensus 514 ~~f~~~~~lG~G~~-G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~---------~---------~~~~~f~ 571 (840)
.+++.++.||.|.. |.|||+. .+|+.+|+|.++.- . . ....-|.
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~--------------I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~ 102 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVE--------------IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFN 102 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEE--------------ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHH
Confidence 78899999999999 9999985 46889999994321 0 0 1223588
Q ss_pred HHHHHHhhcC---CCCc--cceeeEeecCC------------------ceEEEEEeeccCCccccCCCCHHHHHHHHHHH
Q 041702 572 NEMMLIAKLQ---HRNL--VRLFGCCIEQG------------------EKISIYEFDIVTDPARKDLLDWTTRVRIIEGV 628 (840)
Q Consensus 572 ~Ev~~l~~l~---H~ni--v~l~g~~~~~~------------------~~~lv~e~~~~~~~~~~~~l~~~~~~~i~~~i 628 (840)
.|.+..++|+ +.++ |+.+||..-.. ...+|.||..... ....+-+.+|
T Consensus 103 ~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~~~~~ 173 (207)
T PF13095_consen 103 CECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRDIPQM 173 (207)
T ss_pred HHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhHHHHH
Confidence 9999999885 4466 99999974221 1234555421111 2234456788
Q ss_pred HHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccc
Q 041702 629 AQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIA 669 (840)
Q Consensus 629 a~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla 669 (840)
.+-|..+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 174 ~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 174 LRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 88899999988 999999999975 4589999864
|
|
| >PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.00015 Score=53.80 Aligned_cols=40 Identities=33% Similarity=0.532 Sum_probs=34.9
Q ss_pred cCCCCCCCCCCccceeeehhhhcccccc-----cccccccceeeeccCC
Q 041702 797 VNLPSPHQPAFSYVQIVERSVLLANINA-----EASLGNCLTLSVVDAR 840 (840)
Q Consensus 797 ~~~~~p~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~ 840 (840)
..||.|++|.| +.+|.....+++. ...+.|+||+++++||
T Consensus 4 ~~LP~PKqPgF----~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R 48 (48)
T PF11883_consen 4 ATLPQPKQPGF----FTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR 48 (48)
T ss_pred ccCCCCCCCCE----EeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence 57999999999 9999988877653 4589999999999999
|
; GO: 0004674 protein serine/threonine kinase activity |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0017 Score=65.17 Aligned_cols=138 Identities=13% Similarity=0.127 Sum_probs=84.6
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHH---------HHHHHHHhhcCC
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEF---------KNEMMLIAKLQH 582 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f---------~~Ev~~l~~l~H 582 (840)
...+|...+++-......|.+-. .+|+.+.+|..+.......+.| .+++..+.+++.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIe--------------i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~ 94 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIE--------------IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRN 94 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEE--------------ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHH
Confidence 34567766777666666666532 4788999998876543222222 234444444432
Q ss_pred ---CCccceeeEee-----cCCceEEEEEeeccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEE
Q 041702 583 ---RNLVRLFGCCI-----EQGEKISIYEFDIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVL 654 (840)
Q Consensus 583 ---~niv~l~g~~~-----~~~~~~lv~e~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIL 654 (840)
-....++.+.. -....+++|||..-........++. .+...++.++.-||+.| +.|+|..|+|++
T Consensus 95 ~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFl 167 (229)
T PF06176_consen 95 EGFTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIEDIDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFL 167 (229)
T ss_pred cCccccccceeeeeeeeccceeEEEEEEEEecCeecccchhcCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEE
Confidence 22333232222 2234567899843333222222322 35567788899999999 999999999999
Q ss_pred ecCCCCceeecccccee
Q 041702 655 LDSDMNPKISDFGIART 671 (840)
Q Consensus 655 l~~~~~~kL~DFGla~~ 671 (840)
++.+ .++++||+..+.
T Consensus 168 v~~~-~i~iID~~~k~~ 183 (229)
T PF06176_consen 168 VSNN-GIRIIDTQGKRM 183 (229)
T ss_pred EECC-cEEEEECccccc
Confidence 9854 499999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0037 Score=64.90 Aligned_cols=31 Identities=26% Similarity=0.352 Sum_probs=25.8
Q ss_pred CceecCCCCCCcEEecCCCCceeecccccee
Q 041702 641 LRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 641 ~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
+.++|+|+.+.|||++.+...-|+||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 4489999999999998765567999998753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0053 Score=75.71 Aligned_cols=76 Identities=14% Similarity=0.297 Sum_probs=52.8
Q ss_pred cccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcC-CCCc--cceeeEeec
Q 041702 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQ-HRNL--VRLFGCCIE 594 (840)
Q Consensus 519 ~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~-H~ni--v~l~g~~~~ 594 (840)
...|+.|.+..+|+.... +. .....+++|+..... ......+.+|+++|+.+. |.++ .+++++|.+
T Consensus 43 v~~l~gG~sn~ty~l~~~---------~~-~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d 112 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVG---------NG-GSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTD 112 (822)
T ss_pred EEEeCCCCcCceEEEEEC---------CC-CcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecC
Confidence 467899999999986432 00 011467788765432 123457899999999995 6664 788888876
Q ss_pred C---CceEEEEEe
Q 041702 595 Q---GEKISIYEF 604 (840)
Q Consensus 595 ~---~~~~lv~e~ 604 (840)
. +..++|||+
T Consensus 113 ~~v~G~~flVME~ 125 (822)
T PLN02876 113 ASVIGTAFYIMEY 125 (822)
T ss_pred CCcCCCceEEEEe
Confidence 4 467899999
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0012 Score=75.22 Aligned_cols=140 Identities=16% Similarity=0.206 Sum_probs=86.1
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCc--------------------------
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQ-------------------------- 565 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~-------------------------- 565 (840)
....|.. +.||..+.|.||+|+. .+|+.||||+-++.-+.
T Consensus 160 if~~f~~-~piaaASlaQVhrA~L-------------~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~ 225 (538)
T KOG1235|consen 160 IFSEFDE-EPIAAASLAQVHRARL-------------KNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLV 225 (538)
T ss_pred HHHhcCc-chhhhcchhheEEEEe-------------cCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchh
Confidence 3344443 5799999999999864 46999999986543111
Q ss_pred -----------CHHHHHHHHHHHhhc----CCCC------ccceeeEeecCCceEEEEEeeccCCccc-----cCCCCHH
Q 041702 566 -----------GLEEFKNEMMLIAKL----QHRN------LVRLFGCCIEQGEKISIYEFDIVTDPAR-----KDLLDWT 619 (840)
Q Consensus 566 -----------~~~~f~~Ev~~l~~l----~H~n------iv~l~g~~~~~~~~~lv~e~~~~~~~~~-----~~~l~~~ 619 (840)
..-+|.+|++-..++ .|-+ |.+++ ......+.++|||+.-..... ...++-.
T Consensus 226 ~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~ 303 (538)
T KOG1235|consen 226 WLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAIDKRGISPH 303 (538)
T ss_pred hHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHHHHcCCCHH
Confidence 011366666655554 3555 33332 223467899999953322221 1223322
Q ss_pred HHHHHHHHHHHHHHHH-HhcCCCceecCCCCCCcEEecC----CCCceeeccccceecC
Q 041702 620 TRVRIIEGVAQGLLYL-HQYSRLRVIHRDLKASNVLLDS----DMNPKISDFGIARTFG 673 (840)
Q Consensus 620 ~~~~i~~~ia~~L~yL-H~~~~~~ivHrDlkp~NILl~~----~~~~kL~DFGla~~~~ 673 (840)
.|+..+.++...+ -..| ++|+|=.|.||++.. ++++.+-|||+...+.
T Consensus 304 ---~i~~~l~~~~~~qIf~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 304 ---DILNKLVEAYLEQIFKTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred ---HHHHHHHHHHHHHHHhcC---CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 3444444432222 1233 999999999999984 6789999999987654
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.004 Score=59.86 Aligned_cols=127 Identities=21% Similarity=0.191 Sum_probs=82.5
Q ss_pred cccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCcc-ceeeEeecC
Q 041702 517 SEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLV-RLFGCCIEQ 595 (840)
Q Consensus 517 ~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv-~l~g~~~~~ 595 (840)
...+.|++|.+|.||++.++ |..+|+|+-+..+ ....+..|+++|..+.-.++- +++.|-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~--------------~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg--- 85 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR--------------GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG--- 85 (201)
T ss_pred hhhhhhhcccccEEEEeecc--------------CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec---
Confidence 44578999999999998654 5689999876543 347799999999999876654 344443
Q ss_pred CceEEEEEeeccCCccccCCCCHHH--HHHHHHHHHHHHHHHHhcCCCceecCCCC-CCcEEecCCCCceeecccccee
Q 041702 596 GEKISIYEFDIVTDPARKDLLDWTT--RVRIIEGVAQGLLYLHQYSRLRVIHRDLK-ASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 596 ~~~~lv~e~~~~~~~~~~~~l~~~~--~~~i~~~ia~~L~yLH~~~~~~ivHrDlk-p~NILl~~~~~~kL~DFGla~~ 671 (840)
+..+.|||..-. ....|.. -.+-+..++..---|-..+ |-|+.|. |..++|-.+..+.|+||..|..
T Consensus 86 -~~~i~me~i~G~-----~L~~~~~~~~rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 86 -EDFIRMEYIDGR-----PLGKLEIGGDRKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred -hhhhhhhhhcCc-----chhhhhhcccHHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 223447772111 1111222 1334445555544455555 8899884 5555555666999999999874
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.012 Score=63.20 Aligned_cols=73 Identities=12% Similarity=0.151 Sum_probs=52.1
Q ss_pred CcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCC---CCccceeeEe
Q 041702 516 FSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQH---RNLVRLFGCC 592 (840)
Q Consensus 516 f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H---~niv~l~g~~ 592 (840)
....+.||.|..+.||+... .++ .+.+|..+. ......|.+|.+.|+.|.. -.+++++++|
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~-------------~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~ 79 (297)
T PRK10593 16 LSRVECISEQPYAALWALYD-------------SQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVM 79 (297)
T ss_pred hheeeecCCccceeEEEEEc-------------CCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEe
Confidence 34456799999999998531 223 566677443 1133689999999999953 4688899888
Q ss_pred ec---CCceEEEEEe
Q 041702 593 IE---QGEKISIYEF 604 (840)
Q Consensus 593 ~~---~~~~~lv~e~ 604 (840)
.. .+..++|||+
T Consensus 80 ~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 80 THEQSPGPDVLLLER 94 (297)
T ss_pred ccCCcCCCeEEEEec
Confidence 54 3668999998
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0086 Score=66.51 Aligned_cols=70 Identities=16% Similarity=0.269 Sum_probs=50.2
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCC-ceEEEEEeccC------C-CcCHHHHHHHHHHHhhcC---CCCccce
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNG-EEVAVKRLSSK------S-GQGLEEFKNEMMLIAKLQ---HRNLVRL 588 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g-~~VAvK~l~~~------~-~~~~~~f~~Ev~~l~~l~---H~niv~l 588 (840)
+.||.|.+..||++.+ .+| +.|+||.-... . ....+++..|.+.|..+. -.+++++
T Consensus 32 ~elggGn~N~VyrV~~-------------~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV 98 (401)
T PRK09550 32 REIGDGNLNLVFRVSD-------------TEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKV 98 (401)
T ss_pred eEcCCCceEEEEEEEe-------------CCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeE
Confidence 5799999999999753 244 58999985421 1 235678888999998873 2457777
Q ss_pred eeEeecCCceEEEEEe
Q 041702 589 FGCCIEQGEKISIYEF 604 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~ 604 (840)
+.+ +.+..++|||+
T Consensus 99 ~~~--D~~~~~lVME~ 112 (401)
T PRK09550 99 YHY--DEELAVTVMED 112 (401)
T ss_pred EEE--CCCCCEEEEec
Confidence 776 34567899998
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.012 Score=61.88 Aligned_cols=132 Identities=14% Similarity=0.012 Sum_probs=72.6
Q ss_pred cccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCc-cceeeEeecCCceE
Q 041702 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNL-VRLFGCCIEQGEKI 599 (840)
Q Consensus 521 ~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~ni-v~l~g~~~~~~~~~ 599 (840)
.+..|-...+|+.. .++..+++|+.........-...+|.++++.+....+ .++++.+. ..
T Consensus 3 ~~~~G~tn~~y~~~--------------~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~ 64 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--------------HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HW 64 (256)
T ss_pred cCCCcCcCCeEEEE--------------eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CE
Confidence 35567778899853 3566788887654322211246789999999964433 44554432 36
Q ss_pred EEEEeeccCCcc-------------------------ccCCCCHHHH-HHHHHH---------HHHHHHHHHhc-----C
Q 041702 600 SIYEFDIVTDPA-------------------------RKDLLDWTTR-VRIIEG---------VAQGLLYLHQY-----S 639 (840)
Q Consensus 600 lv~e~~~~~~~~-------------------------~~~~l~~~~~-~~i~~~---------ia~~L~yLH~~-----~ 639 (840)
+|+|+..-.... ....++...+ .....+ +...+..+-.. .
T Consensus 65 ~v~e~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (256)
T TIGR02721 65 LLVEWLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPL 144 (256)
T ss_pred EEEEeccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCC
Confidence 888882111100 0011111111 011101 11112222111 1
Q ss_pred CCceecCCCCCCcEEecCCCCceeecccccee
Q 041702 640 RLRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 640 ~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
+..++|+|+.|.||++++++ +.|+||..|..
T Consensus 145 ~~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 145 PLAPLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CCeeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 23589999999999999877 78999998754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.0025 Score=76.85 Aligned_cols=193 Identities=19% Similarity=0.214 Sum_probs=125.7
Q ss_pred HHHHHHHHHhhcCCCCccceeeEeecCCceEEEEEe--------eccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 041702 569 EFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF--------DIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSR 640 (840)
Q Consensus 569 ~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lv~e~--------~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ 640 (840)
...-|...+.++.|+|++.+++|-.+.....++++- ...........++..+.+.+..++.+||+|+|+..
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~- 306 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS- 306 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc-
Confidence 345577788889999999999987665443322221 12223334456777888889999999999999875
Q ss_pred CceecCCCCCC---cEEecCCCCceee--ccccceecCCCCcccccccccccccccCccccccCCCCc--cccchhHHHH
Q 041702 641 LRVIHRDLKAS---NVLLDSDMNPKIS--DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSI--KSDVFSFGVL 713 (840)
Q Consensus 641 ~~ivHrDlkp~---NILl~~~~~~kL~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--ksDV~SlGvi 713 (840)
..|.-|..+ +-..+.++...++ ||+..+.+....... ...-+..+-+||.......+. +.|+|.+|..
T Consensus 307 --l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 307 --LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred --cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHHHHH
Confidence 556555544 4455666667766 888887664432211 123345677888776665544 4799999999
Q ss_pred HHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 041702 714 LLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAML 792 (840)
Q Consensus 714 L~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 792 (840)
+..+..|..+...... ...+++.... ..+.+....|+..++++|+++.+++...
T Consensus 382 ~~~~~~~~~i~~~~~~-----------------~~~~l~~~~~--------~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSAV-----------------PVSLLDVLST--------SELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred HhhhhhcCcccccccc-----------------hhhhhccccc--------hhhhhhhhhhcchhhhhccchhhhhhch
Confidence 9999988765321100 0001111110 0355667779999999999999998654
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.019 Score=61.86 Aligned_cols=135 Identities=21% Similarity=0.161 Sum_probs=79.8
Q ss_pred cccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCC--CccceeeE-----
Q 041702 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHR--NLVRLFGC----- 591 (840)
Q Consensus 519 ~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~--niv~l~g~----- 591 (840)
.+.|..|....+|+.. .++..+++|+... ...++...|++++..+.+. .+++++..
T Consensus 19 i~~i~~G~~n~~y~v~--------------~~~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~ 81 (296)
T cd05153 19 FEGISAGIENTNYFVT--------------TDSGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEY 81 (296)
T ss_pred eecccCccccceEEEE--------------eCCCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcE
Confidence 4567788878999863 2345788898764 2345677888888888543 34555432
Q ss_pred -eecCCceEEEEEeeccCCc-----------------------------cccCCCCHHHHH----------HHHHHHHHH
Q 041702 592 -CIEQGEKISIYEFDIVTDP-----------------------------ARKDLLDWTTRV----------RIIEGVAQG 631 (840)
Q Consensus 592 -~~~~~~~~lv~e~~~~~~~-----------------------------~~~~~l~~~~~~----------~i~~~ia~~ 631 (840)
....+..+.++++..-... .......|.... .....+..+
T Consensus 82 ~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 161 (296)
T cd05153 82 LSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADE 161 (296)
T ss_pred eeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHH
Confidence 1223456788887211000 000112222211 011223344
Q ss_pred HHHHHh----cCCCceecCCCCCCcEEecCCCCceeeccccce
Q 041702 632 LLYLHQ----YSRLRVIHRDLKASNVLLDSDMNPKISDFGIAR 670 (840)
Q Consensus 632 L~yLH~----~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~ 670 (840)
+.++.. ..+..++|+|+.|.|||++++..+.|+||+.+.
T Consensus 162 ~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 162 LARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred HHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 455543 123459999999999999988777899999874
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.011 Score=63.08 Aligned_cols=72 Identities=17% Similarity=0.223 Sum_probs=49.2
Q ss_pred CcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcC---CCCccceeeEe
Q 041702 516 FSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQ---HRNLVRLFGCC 592 (840)
Q Consensus 516 f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~---H~niv~l~g~~ 592 (840)
.+..+.|+.|....+|+.. .+++.+.||.-.. .....|..|.+-|+.|. --.+++.+++.
T Consensus 19 i~~~~~v~GG~i~~a~~~~--------------~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G 81 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--------------TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWG 81 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--------------TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEE
T ss_pred eeeeEecCCCChhheEEEE--------------CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEE
Confidence 3445678888889999853 4688899998762 23367899999998883 34688899998
Q ss_pred ecCCceEEEEEe
Q 041702 593 IEQGEKISIYEF 604 (840)
Q Consensus 593 ~~~~~~~lv~e~ 604 (840)
...+..++++|+
T Consensus 82 ~~~~~~fLlle~ 93 (288)
T PF03881_consen 82 EYDDDAFLLLEF 93 (288)
T ss_dssp E-SSCCEEEEE-
T ss_pred eecCCceEEEEe
Confidence 888888999998
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.026 Score=58.42 Aligned_cols=32 Identities=22% Similarity=0.345 Sum_probs=27.2
Q ss_pred CCceecCCCCCCcEEecC-CCCceeecccccee
Q 041702 640 RLRVIHRDLKASNVLLDS-DMNPKISDFGIART 671 (840)
Q Consensus 640 ~~~ivHrDlkp~NILl~~-~~~~kL~DFGla~~ 671 (840)
+..++|+|+.+.|||++. ++.+.|+||..|..
T Consensus 169 ~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 169 PIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred CEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 345999999999999998 57899999987753
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.11 Score=56.67 Aligned_cols=31 Identities=39% Similarity=0.407 Sum_probs=26.0
Q ss_pred CCceecCCCCCCcEEecCCCCceeeccccce
Q 041702 640 RLRVIHRDLKASNVLLDSDMNPKISDFGIAR 670 (840)
Q Consensus 640 ~~~ivHrDlkp~NILl~~~~~~kL~DFGla~ 670 (840)
+..++|+|+.|.|||++.+...-|+||+.+.
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 3459999999999999866556899999874
|
|
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.007 Score=50.06 Aligned_cols=48 Identities=17% Similarity=0.295 Sum_probs=32.9
Q ss_pred ecccCCCcccccccccCChhHHHHHhhcccceeeeeccccccCCccceeecc
Q 041702 347 DDMKVPDLLDVSLNEGMNLEECGAECLNNCTCRAYAYFNLTRGGSGCLMWFG 398 (840)
Q Consensus 347 ~~~~~p~~~~~~~~~~~s~e~C~~~Cl~nCsC~a~~y~~~~~~g~~C~~w~~ 398 (840)
.++.++...... ....+.++|++.|+.+|+|.||.|.. +...|.++.+
T Consensus 10 ~~~~~~g~d~~~-~~~~s~~~Cq~~C~~~~~C~afT~~~---~~~~C~lk~~ 57 (73)
T cd01100 10 SNVDFRGGDLST-VFASSAEQCQAACTADPGCLAFTYNT---KSKKCFLKSS 57 (73)
T ss_pred CCCccccCCcce-eecCCHHHHHHHcCCCCCceEEEEEC---CCCeEEcccC
Confidence 445555433222 23568899999999999999999953 2347887664
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.81 E-value=0.15 Score=55.26 Aligned_cols=136 Identities=23% Similarity=0.208 Sum_probs=76.8
Q ss_pred cccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCC--CccceeeEe----
Q 041702 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHR--NLVRLFGCC---- 592 (840)
Q Consensus 519 ~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~--niv~l~g~~---- 592 (840)
...++.|....+|++. .++..+++|+..... ..++...|++++..|... .+++++...
T Consensus 27 i~~~~~G~~n~~y~v~--------------t~~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~ 90 (307)
T TIGR00938 27 LKGIAEGVENSNYLLT--------------TDVGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQ 90 (307)
T ss_pred ccccCCccccceEEEE--------------eCCCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCe
Confidence 4567777778999863 123357788775421 235566778888777432 244544321
Q ss_pred --ecCCceEEEEEeeccC-------------------------Cc--ccc---CCCCHHHHH------------HHHHHH
Q 041702 593 --IEQGEKISIYEFDIVT-------------------------DP--ARK---DLLDWTTRV------------RIIEGV 628 (840)
Q Consensus 593 --~~~~~~~lv~e~~~~~-------------------------~~--~~~---~~l~~~~~~------------~i~~~i 628 (840)
...+..++++++..-. .. ... ..-.|.... .....+
T Consensus 91 ~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l 170 (307)
T TIGR00938 91 LSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAEL 170 (307)
T ss_pred ehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHH
Confidence 2245567888871000 00 000 011121110 011223
Q ss_pred HHHHHHHHh----cCCCceecCCCCCCcEEecCCCCceeeccccce
Q 041702 629 AQGLLYLHQ----YSRLRVIHRDLKASNVLLDSDMNPKISDFGIAR 670 (840)
Q Consensus 629 a~~L~yLH~----~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~ 670 (840)
.+.++++.. .-+..++|+|+.+.||+++.++...|+||+.+.
T Consensus 171 ~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 171 DKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 345555543 223569999999999999988777899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.33 E-value=0.15 Score=56.06 Aligned_cols=31 Identities=26% Similarity=0.423 Sum_probs=26.5
Q ss_pred CceecCCCCCCcEEecC-CCCceeecccccee
Q 041702 641 LRVIHRDLKASNVLLDS-DMNPKISDFGIART 671 (840)
Q Consensus 641 ~~ivHrDlkp~NILl~~-~~~~kL~DFGla~~ 671 (840)
..++|+|+++.|||+++ ++.+.|+||..|..
T Consensus 200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 200 IGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred ceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 45899999999999986 46799999988753
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.13 E-value=0.11 Score=55.94 Aligned_cols=33 Identities=30% Similarity=0.355 Sum_probs=28.2
Q ss_pred CCCceecCCCCCCcEEecCC----CCceeecccccee
Q 041702 639 SRLRVIHRDLKASNVLLDSD----MNPKISDFGIART 671 (840)
Q Consensus 639 ~~~~ivHrDlkp~NILl~~~----~~~kL~DFGla~~ 671 (840)
.+..++|+|+.+.|||++++ +.++|+||..|..
T Consensus 177 ~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 177 SPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred CCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 44569999999999999985 8899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.09 E-value=0.036 Score=58.35 Aligned_cols=141 Identities=16% Similarity=0.145 Sum_probs=89.6
Q ss_pred HHHHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC-----------------CC---c
Q 041702 506 LSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK-----------------SG---Q 565 (840)
Q Consensus 506 ~~~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~-----------------~~---~ 565 (840)
+..+.....-++..++||-|.-+-||.+-+ ..|++.++|.-+.. .. .
T Consensus 84 lktL~~R~~v~svGnqIGVGKESDIY~v~d-------------~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWl 150 (465)
T KOG2268|consen 84 LKTLSNRGSVESVGNQIGVGKESDIYVVAD-------------EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWL 150 (465)
T ss_pred HHHHHhcchhhhhccccccccccceEEEec-------------CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchh
Confidence 334444444567789999999999999754 46888888842210 01 1
Q ss_pred CH--HHHHHHHHHHhhcC-C-CCccceeeEeecCCceEEEEEeeccCCcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 041702 566 GL--EEFKNEMMLIAKLQ-H-RNLVRLFGCCIEQGEKISIYEFDIVTDPA-RKDLLDWTTRVRIIEGVAQGLLYLHQYSR 640 (840)
Q Consensus 566 ~~--~~f~~Ev~~l~~l~-H-~niv~l~g~~~~~~~~~lv~e~~~~~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ 640 (840)
.+ -...+|+..|+.|. | --+.+.++++ ...+|||+....... ..+..+. -.+...+..-+--|..+|
T Consensus 151 yLSRlaa~kEfafmkaL~e~gfpVPkpiD~~----RH~Vvmelv~g~Pl~~v~~v~d~---~~ly~~lm~~Iv~la~~G- 222 (465)
T KOG2268|consen 151 YLSRLAATKEFAFMKALYERGFPVPKPIDHN----RHCVVMELVDGYPLRQVRHVEDP---PTLYDDLMGLIVRLANHG- 222 (465)
T ss_pred hhHHHHHHHHHHHHHHHHHcCCCCCCccccc----ceeeHHHhhcccceeeeeecCCh---HHHHHHHHHHHHHHHHcC-
Confidence 11 13467888888884 3 3466666554 446777762211111 1112222 334444555566677777
Q ss_pred CceecCCCCCCcEEecCCCCceeeccccc
Q 041702 641 LRVIHRDLKASNVLLDSDMNPKISDFGIA 669 (840)
Q Consensus 641 ~~ivHrDlkp~NILl~~~~~~kL~DFGla 669 (840)
+||+|..-=||++++++.++++||-..
T Consensus 223 --lIHgDFNEFNimv~dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 223 --LIHGDFNEFNIMVKDDDKIVVIDFPQM 249 (465)
T ss_pred --ceecccchheeEEecCCCEEEeechHh
Confidence 999999999999999999999999754
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=94.86 E-value=0.2 Score=53.32 Aligned_cols=31 Identities=26% Similarity=0.501 Sum_probs=25.7
Q ss_pred CceecCCCCCCcEEecCCCC-ceeecccccee
Q 041702 641 LRVIHRDLKASNVLLDSDMN-PKISDFGIART 671 (840)
Q Consensus 641 ~~ivHrDlkp~NILl~~~~~-~kL~DFGla~~ 671 (840)
+.++|+|+++.|||+++++. .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 34899999999999987555 46999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.81 E-value=0.13 Score=55.14 Aligned_cols=135 Identities=19% Similarity=0.196 Sum_probs=88.9
Q ss_pred cccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-------C--cCHHH-----------------HHH
Q 041702 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-------G--QGLEE-----------------FKN 572 (840)
Q Consensus 519 ~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-------~--~~~~~-----------------f~~ 572 (840)
...|..|--+.||.|.. .+|..+|||+++... . .+.-+ ...
T Consensus 149 nGCiSTGKEANVYHat~-------------~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEK 215 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATE-------------EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEK 215 (520)
T ss_pred ccccccCccceeEeeec-------------CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHH
Confidence 35688899999999753 588889999875310 0 01111 234
Q ss_pred HHHHHhhcCCCCccceeeEeecCCceEEEEEeec----cCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCC
Q 041702 573 EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDI----VTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDL 648 (840)
Q Consensus 573 Ev~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~----~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl 648 (840)
|++-|.+|+...|...--... ...+|||+|.- .........++......+-.+++.-+.-|-+.+ ++||.||
T Consensus 216 E~RNLkRl~~aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADL 291 (520)
T KOG2270|consen 216 EMRNLKRLNNAGIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADL 291 (520)
T ss_pred HHHHHHHHHhcCCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccch
Confidence 777777775444432211111 23478999832 112223344666677777888888888888777 5999999
Q ss_pred CCCcEEecCCCCceeecccccee
Q 041702 649 KASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 649 kp~NILl~~~~~~kL~DFGla~~ 671 (840)
.--|+|+ .+|.+.|+|-+.+..
T Consensus 292 SEfN~Ly-hdG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 292 SEFNLLY-HDGKLYIIDVSQSVE 313 (520)
T ss_pred hhhhheE-ECCEEEEEEcccccc
Confidence 9999998 678899999887643
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.76 E-value=0.41 Score=51.52 Aligned_cols=31 Identities=19% Similarity=0.417 Sum_probs=28.2
Q ss_pred CceecCCCCCCcEEecCCCCceeecccccee
Q 041702 641 LRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 641 ~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
+.++|+|+.+.||+++.+.-+-|.||+++..
T Consensus 198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred ceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 4599999999999999998899999999865
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=94.15 E-value=0.26 Score=53.75 Aligned_cols=70 Identities=14% Similarity=0.216 Sum_probs=44.2
Q ss_pred cccCCCCccEEEeecceeehhccccCcccCCceEEEEEecc-------CCCcCHHHHHHHHHHHhhcC--CC-Cccceee
Q 041702 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSS-------KSGQGLEEFKNEMMLIAKLQ--HR-NLVRLFG 590 (840)
Q Consensus 521 ~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~-------~~~~~~~~f~~Ev~~l~~l~--H~-niv~l~g 590 (840)
.||-|....||++.+. ..++.|+||.-.. .-.-..++-.-|.+.|.... -| .+++++.
T Consensus 2 EigdGnlN~VfrV~~~------------~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~ 69 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQ------------EGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH 69 (370)
T ss_pred cCCCCceEEEEEEEcC------------CCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE
Confidence 5799999999997532 1235799996431 11344566677888887663 34 3555544
Q ss_pred EeecCCceEEEEEe
Q 041702 591 CCIEQGEKISIYEF 604 (840)
Q Consensus 591 ~~~~~~~~~lv~e~ 604 (840)
| +.+...++||+
T Consensus 70 ~--D~e~~~~vMEd 81 (370)
T TIGR01767 70 F--DTEMAVTVMED 81 (370)
T ss_pred E--ccccceehHhh
Confidence 3 45566688887
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=93.63 E-value=0.49 Score=51.76 Aligned_cols=31 Identities=23% Similarity=0.342 Sum_probs=26.1
Q ss_pred CceecCCCCCCcEEecC-CCCceeecccccee
Q 041702 641 LRVIHRDLKASNVLLDS-DMNPKISDFGIART 671 (840)
Q Consensus 641 ~~ivHrDlkp~NILl~~-~~~~kL~DFGla~~ 671 (840)
..++|+|+.+.|||+++ ++.++++||..|..
T Consensus 182 ~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 182 VVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred eEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 34789999999999975 57899999998753
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=93.38 E-value=0.23 Score=50.50 Aligned_cols=30 Identities=33% Similarity=0.486 Sum_probs=21.5
Q ss_pred ceecCCCCCCcEEe-cCCCCceeecccccee
Q 041702 642 RVIHRDLKASNVLL-DSDMNPKISDFGIART 671 (840)
Q Consensus 642 ~ivHrDlkp~NILl-~~~~~~kL~DFGla~~ 671 (840)
.++|+||.+.|||+ +.++.++|+||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 48899999999999 8899999999998854
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=93.38 E-value=0.5 Score=52.58 Aligned_cols=70 Identities=10% Similarity=0.097 Sum_probs=47.1
Q ss_pred cccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC----C---cCHHHHHHHHHHHhhcC---CCCccce
Q 041702 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS----G---QGLEEFKNEMMLIAKLQ---HRNLVRL 588 (840)
Q Consensus 519 ~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~----~---~~~~~f~~Ev~~l~~l~---H~niv~l 588 (840)
.+.||-|..-.||+..+ .+..++||+-.... . ...++-..|++.|..+. ..+++++
T Consensus 37 ~~eiggGn~N~VyrV~~--------------~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkV 102 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS--------------SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEV 102 (418)
T ss_pred EEEcCCCceeeEEEEEc--------------CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeE
Confidence 35789999999999642 24568999855211 1 23455556677776663 3578889
Q ss_pred eeEeecCCceEEEEEe
Q 041702 589 FGCCIEQGEKISIYEF 604 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~ 604 (840)
+.++. +..+++||+
T Consensus 103 y~~de--d~~vlvME~ 116 (418)
T PLN02756 103 YHFDR--TMALIGMRY 116 (418)
T ss_pred EEECC--CCCEEEEee
Confidence 98887 456778887
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 840 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 9e-47 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-45 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-33 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-33 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-32 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-31 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-31 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-30 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 8e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 9e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-19 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-18 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-18 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-18 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-18 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-18 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-18 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-18 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-17 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-17 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-17 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-17 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-17 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-17 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-17 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-16 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-16 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-16 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-16 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-16 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-16 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-16 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-16 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-16 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-16 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-16 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-16 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-16 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-16 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-16 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-16 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-16 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-16 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-16 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-16 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-16 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-16 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 8e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-16 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-16 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-15 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-15 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-15 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-15 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-15 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-15 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-15 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-15 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-15 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-15 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-15 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-15 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-15 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-15 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-15 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-15 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-15 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-15 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-15 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-15 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-15 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-15 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-15 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-14 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-14 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-14 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-14 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-14 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-14 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-14 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-14 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-14 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-14 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-14 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-14 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 7e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-13 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-13 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-13 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 9e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 9e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 9e-13 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-12 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-12 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-12 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-12 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-12 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-12 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 6e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 9e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-11 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-11 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-11 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 8e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 9e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-10 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 7e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 8e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 8e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 8e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 8e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 8e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 8e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 8e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 9e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 9e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 9e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 9e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 9e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 9e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 8e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 9e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 9e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 6e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 7e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 9e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 8e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 8e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 9e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 9e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 9e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-05 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-05 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 4e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 5e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 6e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 8e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 9e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-04 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-04 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-04 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-04 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-04 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 8e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 371 bits (955), Expect = e-122
Identities = 117/305 (38%), Positives = 171/305 (56%), Gaps = 28/305 (9%)
Query: 504 FSLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS 563
FSL + A+DNFS +N LG GGFG VYK G+L +G VAVKRL +
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYK-------------GRLADGTLVAVKRLKEER 66
Query: 564 GQGLE-EFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF--------DIVTDPARKD 614
QG E +F+ E+ +I+ HRNL+RL G C+ E++ +Y + + P +
Sbjct: 67 TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP 126
Query: 615 LLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGG 674
LDW R RI G A+GL YLH + ++IHRD+KA+N+LLD + + DFG+A+
Sbjct: 127 PLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-- 184
Query: 675 DEMQSN-TNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNT---RFYNTD 730
D ++ T + GT G+++PEY G S K+DVF +GV+LLE+++ ++ R N D
Sbjct: 185 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 244
Query: 731 SLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790
+ LL L K+ K L+D +Q V + I+VALLC Q + +RP M EVV
Sbjct: 245 DVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 304
Query: 791 MLKDE 795
ML+ +
Sbjct: 305 MLEGD 309
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 370 bits (952), Expect = e-122
Identities = 100/310 (32%), Positives = 150/310 (48%), Gaps = 42/310 (13%)
Query: 504 FSLSSISAATDNFSEE------NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVK 557
FS + T+NF E NK+GEGGFG VYK G +N VAVK
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYK-------------G-YVNNTTVAVK 60
Query: 558 RLSS----KSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF-------DI 606
+L++ + + ++F E+ ++AK QH NLV L G + + +Y + D
Sbjct: 61 KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 607 VTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666
++ L W R +I +G A G+ +LH+ IHRD+K++N+LLD KISDF
Sbjct: 121 LSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDF 177
Query: 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRF 726
G+AR T+RIVGT YM+PE L G + KSD++SFGV+LLEI++
Sbjct: 178 GLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDE 236
Query: 727 YNTDSLTLLGHAWNLWKDDKAW-KLMDPTMQNEALYSM--VTRYIKVALLCVQENATDRP 783
+ + LL + ++K +D M + V VA C+ E RP
Sbjct: 237 -HREPQLLLDIKEEIEDEEKTIEDYIDKKMND---ADSTSVEAMYSVASQCLHEKKNKRP 292
Query: 784 TMLEVVAMLK 793
+ +V +L+
Sbjct: 293 DIKKVQQLLQ 302
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 330 bits (849), Expect = e-107
Identities = 99/337 (29%), Positives = 167/337 (49%), Gaps = 39/337 (11%)
Query: 476 MGNMSRAKEFCEGDSAGTGKSKESWFLFFSLSSISAATDNFSEENKLGEGGFGPVYKSIE 535
MG+ D+ + L + AT+NF + +G G FG VYK
Sbjct: 1 MGSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYK--- 57
Query: 536 RYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQ 595
G L +G +VA+KR + +S QG+EEF+ E+ ++ +H +LV L G C E+
Sbjct: 58 ----------GVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107
Query: 596 GEKISIYEF-------------DIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLR 642
E I IY++ D+ T + W R+ I G A+GL YLH +
Sbjct: 108 NEMILIYKYMENGNLKRHLYGSDLPTMS-----MSWEQRLEICIGAARGLHYLHTRA--- 159
Query: 643 VIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFS 702
+IHRD+K+ N+LLD + PKI+DFGI++ + + + GT GY+ PEY + G +
Sbjct: 160 IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLT 219
Query: 703 IKSDVFSFGVLLLEILSSKKNTRFYN-TDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALY 761
KSDV+SFGV+L E+L ++ + + L A + + +++DP + ++
Sbjct: 220 EKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADK--I 277
Query: 762 SM--VTRYIKVALLCVQENATDRPTMLEVVAMLKDEI 796
+ ++ A+ C+ ++ DRP+M +V+ L+ +
Sbjct: 278 RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 258 bits (660), Expect = 2e-79
Identities = 61/319 (19%), Positives = 119/319 (37%), Gaps = 45/319 (14%)
Query: 504 FSLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS 563
++ + G FG V+K+ L E VAVK +
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQ--------------LLNEYVAVKIFPIQD 59
Query: 564 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIE----QGEKISIYEF---DIVTDPARKDLL 616
Q + + E+ + ++H N+++ G + I F ++D + +++
Sbjct: 60 KQS-WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVV 118
Query: 617 DWTTRVRIIEGVAQGLLYLHQ-------YSRLRVIHRDLKASNVLLDSDMNPKISDFGIA 669
W I E +A+GL YLH+ + + HRD+K+ NVLL +++ I+DFG+A
Sbjct: 119 SWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178
Query: 670 RTFGGDEMQSNTNRIVGTYGYMSPEYALHGL-----FSIKSDVFSFGVLLLEILSSKKNT 724
F + +T+ VGT YM+PE + ++ D+++ G++L E+ S
Sbjct: 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA 238
Query: 725 RFYNTDSLTLLGHAWNLWKDDK--------AWKLMDPTMQNEALYSMVTR-YIKVALLCV 775
+ + + + K P +++ + C
Sbjct: 239 DGPVDEYMLPF--EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECW 296
Query: 776 QENATDRPTMLEVVAMLKD 794
+A R + V +
Sbjct: 297 DHDAEARLSAGCVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 1e-66
Identities = 69/346 (19%), Positives = 116/346 (33%), Gaps = 60/346 (17%)
Query: 502 LFFSLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSS 561
+ + S S DN +G G +G VYK G L + VAVK S
Sbjct: 1 MEAAASEPSLDLDNLKLLELIGRGRYGAVYK-------------GSL-DERPVAVKVFSF 46
Query: 562 KSGQGLEEFKNE--MMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVT---------DP 610
+ Q F NE + + ++H N+ R E+ +V
Sbjct: 47 ANRQ---NFINEKNIYRVPLMEHDNIARFIVGDER-VTADGRMEYLLVMEYYPNGSLXKY 102
Query: 611 ARKDLLDWTTRVRIIEGVAQGLLYLHQ------YSRLRVIHRDLKASNVLLDSDMNPKIS 664
DW + R+ V +GL YLH + + + HRDL + NVL+ +D IS
Sbjct: 103 LSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162
Query: 665 DFGIARTFGG------DEMQSNTNRIVGTYGYMSPEYALHGLFSI--------KSDVFSF 710
DFG++ G E + VGT YM+PE L G ++ + D+++
Sbjct: 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEV-LEGAVNLRDXESALKQVDMYAL 221
Query: 711 GVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMD--------PTMQNE--AL 760
G++ EI + + + + + P
Sbjct: 222 GLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKEN 281
Query: 761 YSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSPHQPA 806
V + C ++A R T + + ++ +
Sbjct: 282 SLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVS 327
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 3e-55
Identities = 68/301 (22%), Positives = 131/301 (43%), Gaps = 46/301 (15%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNE 573
E +G G FG V K+ W+ ++VA+K++ +S + F E
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAK--------WR------AKDVAIKQI--ESESERKAFIVE 51
Query: 574 MMLIAKLQHRNLVRLFGCCIEQGEKISI-YEF-------DIVTDPARKDLLDWTTRVRII 625
+ ++++ H N+V+L+G C+ + + E+ +++ +
Sbjct: 52 LRQLSRVNHPNIVKLYGACLN---PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWC 108
Query: 626 EGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMN-PKISDFGIARTFGGDEMQSNTNRI 684
+QG+ YLH +IHRDLK N+LL + KI DFG A ++Q++
Sbjct: 109 LQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNN 163
Query: 685 VGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD 744
G+ +M+PE +S K DVFS+G++L E+++ +K ++ W +
Sbjct: 164 KGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK---PFDEIGGPAFRIMWAVHNG 220
Query: 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSPHQ 804
+ + + S++TR C ++ + RP+M E+V ++ + P +
Sbjct: 221 ---TRPPLIKNLPKPIESLMTR-------CWSKDPSQRPSMEEIVKIMTHLMRYFPGADE 270
Query: 805 P 805
P
Sbjct: 271 P 271
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 4e-53
Identities = 70/319 (21%), Positives = 134/319 (42%), Gaps = 70/319 (21%)
Query: 515 NFSE---ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK--SGQGLEE 569
+ + + K+G G FG V+++ W G +VAVK L + + + E
Sbjct: 35 PWCDLNIKEKIGAGSFGTVHRAE--------WH------GSDVAVKILMEQDFHAERVNE 80
Query: 570 FKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF-------DIVTDPARKDLLDWTTRV 622
F E+ ++ +L+H N+V G + + E+ ++ ++ LD R+
Sbjct: 81 FLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRL 140
Query: 623 RIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTN 682
+ VA+G+ YLH ++HR+LK+ N+L+D K+ DFG++R + S +
Sbjct: 141 SMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA 199
Query: 683 RIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLW 742
GT +M+PE + KSDV+SFGV+L E+ + +
Sbjct: 200 --AGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ--------------------- 236
Query: 743 KDDKAWKLMDPTMQNEALYSMVTRYI----------KVALL---CVQENATDRPTMLEVV 789
+ W ++P Q + ++ + +VA + C RP+ ++
Sbjct: 237 ---QPWGNLNP-AQ--VVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIM 290
Query: 790 AMLKD-EIVNLPSPHQPAF 807
+L+ +P P++
Sbjct: 291 DLLRPLIKSAVPPPNRSDL 309
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 2e-52
Identities = 65/331 (19%), Positives = 123/331 (37%), Gaps = 74/331 (22%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIA 578
LG+G FG K ++ GE + +K L + F E+ ++
Sbjct: 15 GEVLGKGCFGQAIKVT--------HRE----TGEVMVMKELIRFDEETQRTFLKEVKVMR 62
Query: 579 KLQHRNLVRLFGCCIEQGEKISIY-EF-------DIVTDPARKDLLDWTTRVRIIEGVAQ 630
L+H N+++ G + ++++ E+ I+ + W+ RV + +A
Sbjct: 63 CLEHPNVLKFIGVLY-KDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIAS 119
Query: 631 GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNR------- 683
G+ YLH + +IHRDL + N L+ + N ++DFG+AR ++ Q R
Sbjct: 120 GMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDR 176
Query: 684 -----IVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHA 738
+VG +M+PE + K DVFSFG++L EI+
Sbjct: 177 KKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRV----------------- 219
Query: 739 WNLWKDDKAWKLMDPT-----MQNEALYSMV------TRYIKVALLCVQENATDRPTMLE 787
A P + + + + C + RP+ ++
Sbjct: 220 -------NADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVK 272
Query: 788 VVAMLKDEIVNLPSPHQPAFSYVQIVERSVL 818
+ L+ + + H P ++ ++R
Sbjct: 273 LEHWLET-LRMHLAGHLPLGPQLEQLDRGFW 302
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 2e-51
Identities = 59/306 (19%), Positives = 128/306 (41%), Gaps = 63/306 (20%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQG------- 566
+ E ++G+GGFG V+K + + VA+K L +G
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGR--------LVK----DKSVVAIKSLILGDSEGETEMIEK 66
Query: 567 LEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTD-----------PARKDL 615
+EF+ E+ +++ L H N+V+L+G +V + +
Sbjct: 67 FQEFQREVFIMSNLNHPNIVKLYGLMHNP--------PRMVMEFVPCGDLYHRLLDKAHP 118
Query: 616 LDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS-----DMNPKISDFGIAR 670
+ W+ ++R++ +A G+ Y+ ++HRDL++ N+ L S + K++DFG+++
Sbjct: 119 IKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177
Query: 671 TFGGDEMQSNTNRIVGTYGYMSPE--YALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYN 728
+ + + ++G + +M+PE A ++ K+D +SF ++L IL+ + +
Sbjct: 178 -----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE---GPF- 228
Query: 729 TDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEV 788
D + + ++ + P L +++ C + RP +
Sbjct: 229 -DEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIEL-------CWSGDPKKRPHFSYI 280
Query: 789 VAMLKD 794
V L +
Sbjct: 281 VKELSE 286
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 4e-51
Identities = 79/304 (25%), Positives = 124/304 (40%), Gaps = 62/304 (20%)
Query: 515 NFSE---ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRL----SSKSGQGL 567
+F+E E +G GGFG VY++ W G+EVAVK Q +
Sbjct: 5 DFAELTLEEIIGIGGFGKVYRAF--------W------IGDEVAVKAARHDPDEDISQTI 50
Query: 568 EEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVT---------DPARKDLLDW 618
E + E L A L+H N++ L G C+++ +V +
Sbjct: 51 ENVRQEAKLFAMLKHPNIIALRGVCLKEPN------LCLVMEFARGGPLNRVLSGKRIPP 104
Query: 619 TTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP--------KISDFGIAR 670
V +A+G+ YLH + + +IHRDLK+SN+L+ + KI+DFG+AR
Sbjct: 105 DILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164
Query: 671 TFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTD 730
+ S G Y +M+PE +FS SDV+S+GVLL E+L+ + F D
Sbjct: 165 EWHRTTKMSAA----GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE--VPFRGID 218
Query: 731 SLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790
L + L P+ E ++ C + RP+ ++
Sbjct: 219 GLAVAYGVAM-----NKLALPIPSTCPEPFAKLMED-------CWNPDPHSRPSFTNILD 266
Query: 791 MLKD 794
L
Sbjct: 267 QLTT 270
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 1e-49
Identities = 65/311 (20%), Positives = 126/311 (40%), Gaps = 79/311 (25%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRL--SSKSGQGLEEFK 571
+ ++G G FG VYK W +VAVK L ++ + Q L+ FK
Sbjct: 24 GQITVGQRIGSGSFGTVYKGK--------WHG-------DVAVKMLNVTAPTPQQLQAFK 68
Query: 572 NEMMLIAKLQHRNLVRLFGCCIEQGEKISIY-EF-------DIVTDPARKDLLDWTTRVR 623
NE+ ++ K +H N++ G +++I ++ + K + +
Sbjct: 69 NEVGVLRKTRHVNILLFMGYSTA--PQLAIVTQWCEGSSLYHHLHASETK--FEMKKLID 124
Query: 624 IIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNR 683
I A+G+ YLH +IHRDLK++N+ L D KI DFG+A +
Sbjct: 125 IARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQ 181
Query: 684 IVGTYGYMSPE---YALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWN 740
+ G+ +M+PE +S +SDV++FG++L E+++ +
Sbjct: 182 LSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ------------------- 222
Query: 741 LWKDDKAWKLMDPTMQNEALYSMVTR-----------------YIKVALLCVQENATDRP 783
+ ++ + + MV R ++ C+++ +RP
Sbjct: 223 -----LPYSNINNR---DQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERP 274
Query: 784 TMLEVVAMLKD 794
+ ++A +++
Sbjct: 275 SFPRILAEIEE 285
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 6e-47
Identities = 57/314 (18%), Positives = 109/314 (34%), Gaps = 88/314 (28%)
Query: 515 NFSE---ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK--SGQGLEE 569
+F + KL E G ++K W+ G ++ VK L + S + +
Sbjct: 8 DFKQLNFLTKLNENHSGELWKGR--------WQ------GNDIVVKVLKVRDWSTRKSRD 53
Query: 570 FKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTD------------PARKDLLD 617
F E + H N++ + G C ++T ++D
Sbjct: 54 FNEECPRLRIFSHPNVLPVLGACQSPPAP----HPTLITHWMPYGSLYNVLHEGTNFVVD 109
Query: 618 WTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEM 677
+ V+ +A+G+ +LH L + L + +V++D DM +IS + +F
Sbjct: 110 QSQAVKFALDMARGMAFLHTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF----- 163
Query: 678 QSNTNRIVGTYGYMSPEYALHG----LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLT 733
QS + +++PE AL +D++SF VLL E++ TR
Sbjct: 164 QSPGR--MYAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELV-----TR-------- 207
Query: 734 LLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTR-------------YIKVALLCVQENAT 780
+ + + E + K+ +C+ E+
Sbjct: 208 -----------EVPFADLSNM---EIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPA 253
Query: 781 DRPTMLEVVAMLKD 794
RP +V +L+
Sbjct: 254 KRPKFDMIVPILEK 267
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 3e-46
Identities = 64/320 (20%), Positives = 118/320 (36%), Gaps = 69/320 (21%)
Query: 515 NFSE---ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK--SGQGLEE 569
F + +G+G FG VY W EVA++ + + + L+
Sbjct: 31 PFEQLEIGELIGKGRFGQVYHGR--------WHG-------EVAIRLIDIERDNEDQLKA 75
Query: 570 FKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTD-----------PARKDLLDW 618
FK E+M + +H N+V G C+ I+T K +LD
Sbjct: 76 FKREVMAYRQTRHENVVLFMGACMSPP------HLAIITSLCKGRTLYSVVRDAKIVLDV 129
Query: 619 TTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQ 678
+I + + +G+ YLH ++H+DLK+ NV D + I+DFG+ G +
Sbjct: 130 NKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG 185
Query: 679 SNTNRI---VGTYGYMSPE---------YALHGLFSIKSDVFSFGVLLLEILSSKKNTRF 726
+++ G +++PE FS SDVF+ G + E+ + + F
Sbjct: 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE--WPF 243
Query: 727 YNTDSLTLLGHAWNLWKDDKAWKLMDPTMQ-NEALYSMVTRYIKVALLCVQENATDRPTM 785
+ + +W+ K + + + ++ C +RPT
Sbjct: 244 KTQPAEAI------IWQMGTGMKPNLSQIGMGKEISDILLF-------CWAFEQEERPTF 290
Query: 786 LEVVAMLKDEIVNLPSPHQP 805
+++ ML+ P
Sbjct: 291 TKLMDMLEKLPKRNRRLSHP 310
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-44
Identities = 61/307 (19%), Positives = 116/307 (37%), Gaps = 51/307 (16%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNE--MML 576
+G+G +G V++ +W GE VAVK SS + + + E +
Sbjct: 13 LECVGKGRYGEVWR--------GSW------QGENVAVKIFSS---RDEKSWFRETELYN 55
Query: 577 IAKLQHRNLVRLFGCCIEQGEKISIYEFDIVT---------DPARKDLLDWTTRVRIIEG 627
L+H N++ + + + ++T D + LD + +RI+
Sbjct: 56 TVMLRHENILGFIASDMTSRHSST--QLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLS 113
Query: 628 VAQGLLYLH-----QYSRLRVIHRDLKASNVLLDSDMNPKISDFGIAR--TFGGDEMQSN 680
+A GL +LH + + HRDLK+ N+L+ + I+D G+A + +++
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVG 173
Query: 681 TNRIVGTYGYMSPE------YALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNT----- 729
N VGT YM+PE + D+++FG++L E+ +
Sbjct: 174 NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233
Query: 730 DSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALL--CVQENATDRPTMLE 787
+ ++ + P + N + L+ C +N + R T L
Sbjct: 234 YDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLA-KLMKECWYQNPSARLTALR 292
Query: 788 VVAMLKD 794
+ L
Sbjct: 293 IKKTLTK 299
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-44
Identities = 65/306 (21%), Positives = 115/306 (37%), Gaps = 49/306 (16%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNE--MML 576
++G+G +G V+ GK GE+VAVK + + E +
Sbjct: 42 VKQIGKGRYGEVWM-------------GKW-RGEKVAVKVFFT---TEEASWFRETEIYQ 84
Query: 577 IAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPA---------RKDLLDWTTRVRIIEG 627
++H N++ I+ S + ++TD + LD + +++
Sbjct: 85 TVLMRHENILGFIAADIK--GTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYS 142
Query: 628 VAQGLLYLH-----QYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTF--GGDEMQSN 680
GL +LH + + HRDLK+ N+L+ + I+D G+A F +E+
Sbjct: 143 SVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIP 202
Query: 681 TNRIVGTYGYMSPE------YALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNT----- 729
N VGT YM PE H I +D++SFG++L E+ +
Sbjct: 203 PNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262
Query: 730 DSLTLLGHAWNLWKDDKAWKLMDPTM-QNEALYSMVTRYIKVALLCVQENATDRPTMLEV 788
L ++ ++ K + P+ + + + K+ C N R T L V
Sbjct: 263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRV 322
Query: 789 VAMLKD 794
L
Sbjct: 323 KKTLAK 328
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-42
Identities = 65/311 (20%), Positives = 122/311 (39%), Gaps = 72/311 (23%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIA 578
+LG+G FG V C + + GE VAVK+L + + L +F+ E+ ++
Sbjct: 15 LQQLGKGNFGSVEM--------CRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 66
Query: 579 KLQHRNLVRLFGCCIEQGEKISIYEFDIVTD-----------PARKDLLDWTTRVRIIEG 627
LQH N+V+ G C G + ++ ++ + K+ +D ++
Sbjct: 67 SLQHDNIVKYKGVCYSAGRR-NLK---LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 122
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
+ +G+ YL R IHRDL N+L++++ KI DFG+ + D+
Sbjct: 123 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK---------EF 170
Query: 688 YG----------YMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGH 737
+ + +PE FS+ SDV+SFGV+L E+ + + ++ + + ++G
Sbjct: 171 FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG- 229
Query: 738 AWNLWKDDKAWKLMDPTMQNEALYSMVTR--------------YIKVALLCVQENATDRP 783
M L ++ Y + C N RP
Sbjct: 230 -----------NDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIY-MIMTECWNNNVNQRP 277
Query: 784 TMLEVVAMLKD 794
+ ++ +
Sbjct: 278 SFRDLALRVDQ 288
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 4e-42
Identities = 66/322 (20%), Positives = 118/322 (36%), Gaps = 67/322 (20%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIA 578
++LG+G FG V C + G VAVK+L +F+ E+ ++
Sbjct: 28 ISQLGKGNFGSVEL--------CRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 79
Query: 579 KLQHRNLVRLFGCCIEQGEKISIYEFDIVTD-----------PARKDLLDWTTRVRIIEG 627
L +V+ G G + S+ +V + + LD + +
Sbjct: 80 ALHSDFIVKYRGVSYGPGRQ-SLR---LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ 135
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
+ +G+ YL R +HRDL A N+L++S+ + KI+DFG+A+ D+ +V
Sbjct: 136 ICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----VVRE 188
Query: 688 YG-----YMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHA--WN 740
G + +PE +FS +SDV+SFGV+L E+ +
Sbjct: 189 PGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT---------------YCDKSCSP 233
Query: 741 LWKDDKAWKLMDPTMQNEALYSMVTR--------------YIKVALLCVQENATDRPTML 786
+ + L ++ + ++ LC + DRP+
Sbjct: 234 SAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVH-ELMKLCWAPSPQDRPSFS 292
Query: 787 EVVAMLKDEIVNLPSPHQPAFS 808
+ L AF+
Sbjct: 293 ALGPQLDMLWSGSRGCETHAFT 314
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 4e-42
Identities = 67/306 (21%), Positives = 123/306 (40%), Gaps = 62/306 (20%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIA 578
+LG+G FG V C + + GE VAVK+L + + L +F+ E+ ++
Sbjct: 46 LQQLGKGNFGSVEM--------CRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 97
Query: 579 KLQHRNLVRLFGCCIEQGEKISIYEFDIVTD-----------PARKDLLDWTTRVRIIEG 627
LQH N+V+ G C G + ++ ++ + K+ +D ++
Sbjct: 98 SLQHDNIVKYKGVCYSAGRR-NLK---LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 153
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
+ +G+ YL R IHRDL N+L++++ KI DFG+ + D+ V
Sbjct: 154 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY----KVKE 206
Query: 688 YG-----YMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLW 742
G + +PE FS+ SDV+SFGV+L E+ + + ++ + + ++G
Sbjct: 207 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG------ 260
Query: 743 KDDKAWKLMDPTMQNEALYSMVTR--------------YIKVALLCVQENATDRPTMLEV 788
M L ++ Y + C N RP+ ++
Sbjct: 261 ------NDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIY-MIMTECWNNNVNQRPSFRDL 313
Query: 789 VAMLKD 794
+
Sbjct: 314 ALRVDQ 319
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 5e-42
Identities = 62/322 (19%), Positives = 108/322 (33%), Gaps = 81/322 (25%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNE--MML 576
+ +G+G FG V++ GEEVAVK SS + + E +
Sbjct: 47 QESIGKGRFGEVWRGK--------------WRGEEVAVKIFSS---REERSWFREAEIYQ 89
Query: 577 IAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPA---------RKDLLDWTTRVRIIEG 627
L+H N++ + + + +V+D + + +++
Sbjct: 90 TVMLRHENILGFIAADNKDNGTWT--QLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALS 147
Query: 628 VAQGLLYLHQ-----YSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTF--GGDEMQSN 680
A GL +LH + + HRDLK+ N+L+ + I+D G+A D +
Sbjct: 148 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 207
Query: 681 TNRIVGTYGYMSPE------YALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTL 734
N VGT YM+PE H ++D+++ G++ EI + L
Sbjct: 208 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267
Query: 735 LGHAW----------------------NLWKDDKAWKLMDPTMQNEALYSMVTRYIKVAL 772
N W+ +A ++M M+
Sbjct: 268 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRE--------------- 312
Query: 773 LCVQENATDRPTMLEVVAMLKD 794
C N R T L + L
Sbjct: 313 -CWYANGAARLTALRIKKTLSQ 333
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-40
Identities = 77/307 (25%), Positives = 123/307 (40%), Gaps = 66/307 (21%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLI 577
LGEG FG V + GE VAVK L + +G Q +K E+ ++
Sbjct: 36 IRDLGEGHFGKVSL--------YCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDIL 87
Query: 578 AKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPA---------RKDLLDWTTRVRIIEGV 628
L H ++++ GCC + G S+ +V + + + + + +
Sbjct: 88 RTLYHEHIIKYKGCCEDAGAA-SLQ---LVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQI 143
Query: 629 AQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDE----MQSNTN-- 682
+G+ YLH IHRDL A NVLLD+D KI DFG+A+ ++ + +
Sbjct: 144 CEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 200
Query: 683 -RIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNL 741
+ +PE F SDV+SFGV L E+L+ +++ T L L+G A
Sbjct: 201 VF------WYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ-- 252
Query: 742 WKDDKAWKLMDPTMQNEALYSMVTR--------------YIKVALLCVQENATDRPTMLE 787
M L ++ R Y + C + A+ RPT
Sbjct: 253 -----------GQMTVLRLTELLERGERLPRPDKCPAEVY-HLMKNCWETEASFRPTFEN 300
Query: 788 VVAMLKD 794
++ +LK
Sbjct: 301 LIPILKT 307
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 8e-40
Identities = 66/315 (20%), Positives = 119/315 (37%), Gaps = 70/315 (22%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKN 572
LGEG FG V C + GE+VAVK L +SG + + K
Sbjct: 21 RFLKRIRDLGEGHFGKVEL--------CRYDPEGDNTGEQVAVKSLKPESGGNHIADLKK 72
Query: 573 EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTD-----------PARKDLLDWTTR 621
E+ ++ L H N+V+ G C E G I ++ + P K+ ++ +
Sbjct: 73 EIEILRNLYHENIVKYKGICTEDGGN-GIK---LIMEFLPSGSLKEYLPKNKNKINLKQQ 128
Query: 622 VRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNT 681
++ + +G+ YL + +HRDL A NVL++S+ KI DFG+ + ++++
Sbjct: 129 LKYAVQICKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTK-----AIETDK 180
Query: 682 NRIVGTYG------YMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLL 735
+ +PE + F I SDV+SFGV L E+L+
Sbjct: 181 EYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT---------------Y 225
Query: 736 GHAWNLWKDDKAWKLMDP--TMQNEALYSMVTR--------------YIKVALLCVQENA 779
+ + + M L + + Y ++ C +
Sbjct: 226 CDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVY-QLMRKCWEFQP 284
Query: 780 TDRPTMLEVVAMLKD 794
++R + ++ +
Sbjct: 285 SNRTSFQNLIEGFEA 299
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 5e-39
Identities = 67/295 (22%), Positives = 115/295 (38%), Gaps = 51/295 (17%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRL-SSKSGQGLEEFKN 572
++ ++G G FG V+ + VAVK + +F
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGR--------LRADNT----LVAVKSCRETLPPDLKAKFLQ 161
Query: 573 EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK-DLLD----------WTTR 621
E ++ + H N+VRL G C ++ IY IV + + D L T
Sbjct: 162 EARILKQYSHPNIVRLIGVCTQKQ---PIY---IVMELVQGGDFLTFLRTEGARLRVKTL 215
Query: 622 VRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNT 681
++++ A G+ YL IHRDL A N L+ KISDFG++R ++
Sbjct: 216 LQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASG 272
Query: 682 NRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKN--TRFYNTDSLTLLGHAW 739
+ +PE +G +S +SDV+SFG+LL E S + N + +
Sbjct: 273 GLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV---- 328
Query: 740 NLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794
+K +L P + +A++ ++ + C RP+ + L+
Sbjct: 329 -----EKGGRLPCPELCPDAVFRLMEQ-------CWAYEPGQRPSFSTIYQELQS 371
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 8e-38
Identities = 82/302 (27%), Positives = 138/302 (45%), Gaps = 55/302 (18%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIA 578
E KLG+G FG V+ G VA+K L + E F E ++
Sbjct: 189 EVKLGQGCFGEVWM-------------GTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMK 234
Query: 579 KLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK-DLLD-----------WTTRVRIIE 626
KL+H LV+L+ E+ IY IVT+ K LLD V +
Sbjct: 235 KLRHEKLVQLYAVVSEEP----IY---IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 287
Query: 627 GVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVG 686
+A G+ Y+ R+ +HRDL+A+N+L+ ++ K++DFG+AR +E +
Sbjct: 288 QIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF- 343
Query: 687 TYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKN--TRFYNTDSLTLLGHAWNLWKD 744
+ +PE AL+G F+IKSDV+SFG+LL E+ + + N + L +
Sbjct: 344 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV--------- 394
Query: 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSPHQ 804
++ +++ P E+L+ ++ + C ++ +RPT + A L+D + +Q
Sbjct: 395 ERGYRMPCPPECPESLHDLMCQ-------CWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 447
Query: 805 PA 806
P
Sbjct: 448 PG 449
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 9e-38
Identities = 82/302 (27%), Positives = 138/302 (45%), Gaps = 55/302 (18%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIA 578
E KLG+G FG V+ G VA+K L + E F E ++
Sbjct: 272 EVKLGQGCFGEVWM-------------GTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMK 317
Query: 579 KLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK-DLLD-----------WTTRVRIIE 626
KL+H LV+L+ E+ IY IVT+ K LLD V +
Sbjct: 318 KLRHEKLVQLYAVVSEEP----IY---IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 370
Query: 627 GVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVG 686
+A G+ Y+ R+ +HRDL+A+N+L+ ++ K++DFG+AR +E +
Sbjct: 371 QIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF- 426
Query: 687 TYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKN--TRFYNTDSLTLLGHAWNLWKD 744
+ +PE AL+G F+IKSDV+SFG+LL E+ + + N + L +
Sbjct: 427 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV--------- 477
Query: 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSPHQ 804
++ +++ P E+L+ ++ + C ++ +RPT + A L+D + +Q
Sbjct: 478 ERGYRMPCPPECPESLHDLMCQ-------CWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 530
Query: 805 PA 806
P
Sbjct: 531 PG 532
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 63/297 (21%), Positives = 116/297 (39%), Gaps = 64/297 (21%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNE 573
+F E +G GGFG V+K+ R ++G+ +KR+ + E+ + E
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHR------------IDGKTYVIKRVKYNN----EKAERE 54
Query: 574 MMLIAKLQHRNLVRLFGCCIEQGEKISIYEFD----------IVTDPA-RKDLLDWTTR- 621
+ +AKL H N+V GC + I + + L W +
Sbjct: 55 VKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 114
Query: 622 ----------VRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIART 671
+ + E + +G+ Y+H ++I+RDLK SN+ L KI DFG+ +
Sbjct: 115 RGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTS 171
Query: 672 FGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDS 731
D R GT YMSPE + + D+++ G++L E+L + T
Sbjct: 172 LKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD--TAFETS- 225
Query: 732 LTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEV 788
+ D + + + ++ +++ + + + DRP E+
Sbjct: 226 --------KFFTDLRDGII--SDIFDKKEKTLLQK-------LLSKKPEDRPNTSEI 265
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 83/308 (26%), Positives = 133/308 (43%), Gaps = 69/308 (22%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQ-GLEEFKNEMMLI 577
+LG G FG V+ G +VAVK L K G + F E L+
Sbjct: 18 VERLGAGQFGEVWM-------------GYYNGHTKVAVKSL--KQGSMSPDAFLAEANLM 62
Query: 578 AKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK-DLLDW-----------TTRVRII 625
+LQH+ LVRL+ ++ IY I+T+ L+D+ + +
Sbjct: 63 KQLQHQRLVRLYAVVTQEP----IY---IITEYMENGSLVDFLKTPSGIKLTINKLLDMA 115
Query: 626 EGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIV 685
+A+G+ ++ IHRDL+A+N+L+ ++ KI+DFG+AR +E +
Sbjct: 116 AQIAEGMAFI---EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE---- 168
Query: 686 GT---YGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKN--TRFYNTDSLTLLGHAWN 740
G + +PE +G F+IKSDV+SFG+LL EI++ + N + + L +
Sbjct: 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR 228
Query: 741 LWKDDKAWKLMDPTMQN--EALYS-MVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797
+ N E LY M LC +E DRPT + ++L+D
Sbjct: 229 M-----------VRPDNCPEELYQLM--------RLCWKERPEDRPTFDYLRSVLEDFFT 269
Query: 798 NLPSPHQP 805
+QP
Sbjct: 270 ATEGQYQP 277
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 71/327 (21%), Positives = 121/327 (37%), Gaps = 68/327 (20%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLS-SKSGQGLEEFKN 572
+F LG GGFG V+++ + ++ A+KR+ E+
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNK------------VDDCNYAIKRIRLPNRELAREKVMR 52
Query: 573 EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFD------IVTDPA-RKDLLDW------- 618
E+ +AKL+H +VR F +E+ + I +++L DW
Sbjct: 53 EVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTI 112
Query: 619 -----TTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFG 673
+ + I +A+ + +LH ++HRDLK SN+ D K+ DFG+
Sbjct: 113 EERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD 169
Query: 674 GDEMQSNT----------NRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKN 723
DE + VGT YMSPE +S K D+FS G++L E+L
Sbjct: 170 QDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL----- 224
Query: 724 TRFYNTDSLTLLGHAWNLWKDDKAWKLM-DPTMQNEALYSMVTRYIKVALLCVQENATDR 782
F D + K T + Y MV + + +R
Sbjct: 225 YPFSTQMERVR------TLTDVRNLKFPPLFTQKYPCEYVMVQD-------MLSPSPMER 271
Query: 783 PTMLEVVAMLKDEIV-NLPSPHQPAFS 808
P + + +++ + +L P +
Sbjct: 272 PEAINI---IENAVFEDLDFPGKTVLR 295
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 73/323 (22%), Positives = 121/323 (37%), Gaps = 86/323 (26%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGE-EVAVKRLSSKSGQGLEEFKNEMMLI 577
+ +LGEG FG V+ + VAVK L + ++F+ E L+
Sbjct: 20 KRELGEGAFGKVFL--------AECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELL 71
Query: 578 AKLQHRNLVRLFGCCIEQGEKISIYEF--------------------DIVTDPARKDLLD 617
LQH ++V+ +G C + I ++E+ K L
Sbjct: 72 TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131
Query: 618 WTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEM 677
+ + I +A G++YL + +HRDL N L+ +++ KI DFG++R D
Sbjct: 132 LSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVY 184
Query: 678 QSNTNRIVGTYG-----YMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSL 732
++ R VG + +M PE ++ F+ +SDV+SFGV+L EI +
Sbjct: 185 STDYYR-VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT------------- 230
Query: 733 TLLGHA-WNLWKDDKAWKLMDPTMQNEALYSMVTR--------------YIKVALLCVQE 777
G W + N + +T+ Y V L C Q
Sbjct: 231 --YGKQPW-------------FQLSNTEVIECITQGRVLERPRVCPKEVY-DVMLGCWQR 274
Query: 778 NATDRPTMLEVVAMLKDEIVNLP 800
R + E+ +L P
Sbjct: 275 EPQQRLNIKEIYKILHALGKATP 297
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-37
Identities = 77/291 (26%), Positives = 127/291 (43%), Gaps = 55/291 (18%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQ-GLEEFKNEMMLI 577
++KLG G +G VY+ WK+ VAVK L K +EEF E ++
Sbjct: 225 KHKLGGGQYGEVYE--------GVWKK----YSLTVAVKTL--KEDTMEVEEFLKEAAVM 270
Query: 578 AKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK-DLLD-----------WTTRVRII 625
+++H NLV+L G C + Y I+T+ +LLD + +
Sbjct: 271 KEIKHPNLVQLLGVCTREP---PFY---IITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 324
Query: 626 EGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIV 685
++ + YL + IHR+L A N L+ + K++DFG++R GD ++
Sbjct: 325 TQISSAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 381
Query: 686 GTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKN--TRFYNTDSLTLLGHAWNLWK 743
+ +PE + FSIKSDV++FGVLL EI + + + LL
Sbjct: 382 -PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-------- 432
Query: 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794
+K +++ P E +Y ++ C Q N +DRP+ E+ +
Sbjct: 433 -EKDYRMERPEGCPEKVYELM-------RACWQWNPSDRPSFAEIHQAFET 475
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 5e-37
Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 40/218 (18%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRL-SSKSGQGLEEFKNEMMLI 577
LG G FG VYK + W VA+K L + S + +E +E ++
Sbjct: 20 IKVLGSGAFGTVYKGL--------WIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 578 AKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPA-----------RKDLLDWTTRVRIIE 626
A + + ++ RL G C+ ++ ++T KD + +
Sbjct: 72 ASVDNPHVCRLLGICLTS----TVQ---LITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 124
Query: 627 GVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVG 686
+A+G+ YL R++HRDL A NVL+ + + KI+DFG+A+ G +E + +
Sbjct: 125 QIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG--- 178
Query: 687 TYG-----YMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
G +M+ E LH +++ +SDV+S+GV + E+++
Sbjct: 179 --GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 5e-37
Identities = 76/296 (25%), Positives = 119/296 (40%), Gaps = 71/296 (23%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIA 578
+G+G FG V G G +VAVK + K+ + F E ++
Sbjct: 198 LQTIGKGEFGDVML-------------GDY-RGNKVAVKCI--KNDATAQAFLAEASVMT 241
Query: 579 KLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK-DLLDW-----------TTRVRIIE 626
+L+H NLV+L G +E+ +Y IVT+ K L+D+ ++
Sbjct: 242 QLRHSNLVQLLGVIVEEKG--GLY---IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL 296
Query: 627 GVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVG 686
V + + YL +HRDL A NVL+ D K+SDFG+ +
Sbjct: 297 DVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASST 342
Query: 687 TYG------YMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKN--TRFYNTDSLTLLGHA 738
+ +PE FS KSDV+SFG+LL EI S + R D + +
Sbjct: 343 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV--- 399
Query: 739 WNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794
+K +K+ P A+Y ++ C +A RPT L++ L+
Sbjct: 400 ------EKGYKMDAPDGCPPAVYDVMKN-------CWHLDAATRPTFLQLREQLEH 442
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-37
Identities = 76/296 (25%), Positives = 127/296 (42%), Gaps = 65/296 (21%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLI 577
++KLG G +G VY+ WK+ L VAVK L K +EEF E ++
Sbjct: 18 KHKLGGGQYGEVYE--------GVWKKYSL----TVAVKTL--KEDTMEVEEFLKEAAVM 63
Query: 578 AKLQHRNLVRLFGCCIEQGEKISIYEFDIVTD------------PARKDLLDWTTRVRII 625
+++H NLV+L G C + Y I+T+ + + + +
Sbjct: 64 KEIKHPNLVQLLGVCTREP---PFY---IITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 117
Query: 626 EGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTN--- 682
++ + YL + IHRDL A N L+ + K++DFG++R GD ++
Sbjct: 118 TQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 683 --RIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKN--TRFYNTDSLTLLGHA 738
+ + +PE + FSIKSDV++FGVLL EI + + + LL
Sbjct: 175 PIK------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL--- 225
Query: 739 WNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794
+K +++ P E +Y ++ C Q N +DRP+ E+ +
Sbjct: 226 ------EKDYRMERPEGCPEKVYELMRA-------CWQWNPSDRPSFAEIHQAFET 268
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 7e-37
Identities = 75/296 (25%), Positives = 120/296 (40%), Gaps = 71/296 (23%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIA 578
+G+G FG V G G +VAVK + K+ + F E ++
Sbjct: 26 LQTIGKGEFGDVML-------------GDY-RGNKVAVKCI--KNDATAQAFLAEASVMT 69
Query: 579 KLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK-DLLD-----------WTTRVRIIE 626
+L+H NLV+L G +E+ +Y IVT+ K L+D ++
Sbjct: 70 QLRHSNLVQLLGVIVEEKG--GLY---IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL 124
Query: 627 GVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVG 686
V + + YL +HRDL A NVL+ D K+SDFG+ + + +
Sbjct: 125 DVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASST------- 170
Query: 687 TYG------YMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKN--TRFYNTDSLTLLGHA 738
+ +PE FS KSDV+SFG+LL EI S + R D + +
Sbjct: 171 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV--- 227
Query: 739 WNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794
+K +K+ P A+Y ++ C +A RP+ L++ L+
Sbjct: 228 ------EKGYKMDAPDGCPPAVYEVMKN-------CWHLDAAMRPSFLQLREQLEH 270
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 7e-37
Identities = 58/224 (25%), Positives = 93/224 (41%), Gaps = 52/224 (23%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLI 577
LG G FG V+K W V +K + KSG Q + + M+ I
Sbjct: 18 LKVLGSGVFGTVHK--------GVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAI 69
Query: 578 AKLQHRNLVRLFGCCIEQGEKISIYEFDIVT-----------------DPARKDLLDWTT 620
L H ++VRL G C S+ +VT + LL+W
Sbjct: 70 GSLDHAHIVRLLGLCPGS----SLQ---LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV 122
Query: 621 RVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSN 680
+A+G+ YL ++HR+L A NVLL S +++DFG+A D+ Q
Sbjct: 123 ------QIAKGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLL 173
Query: 681 TNRIVGTYG-----YMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
+ +M+ E G ++ +SDV+S+GV + E+++
Sbjct: 174 YSE-----AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 7e-37
Identities = 81/293 (27%), Positives = 128/293 (43%), Gaps = 61/293 (20%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLI 577
++G G FG V+ G LN ++VA+K + + G E+F E ++
Sbjct: 13 VQEIGSGQFGLVHL-------------GYWLNKDKVAIKTI--REGAMSEEDFIEEAEVM 57
Query: 578 AKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK-DLLDW----------TTRVRIIE 626
KL H LV+L+G C+EQ I +VT+ L D+ T + +
Sbjct: 58 MKLSHPKLVQLYGVCLEQA---PIC---LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCL 111
Query: 627 GVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVG 686
V +G+ YL VIHRDL A N L+ + K+SDFG+ R D+ S+T G
Sbjct: 112 DVCEGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----G 164
Query: 687 T---YGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKN--TRFYNTDSLTLLGHAWNL 741
T + SPE +S KSDV+SFGVL+ E+ S K N++ + +
Sbjct: 165 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI------ 218
Query: 742 WKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794
++L P + + +Y ++ C +E DRP ++ L +
Sbjct: 219 ---STGFRLYKPRLASTHVYQIMNH-------CWRERPEDRPAFSRLLRQLAE 261
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 73/320 (22%), Positives = 120/320 (37%), Gaps = 72/320 (22%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGE-EVAVKRLSSKSGQGLEEFKNEMMLI 577
+ +LGEG FG V+ + VAVK L S ++F+ E L+
Sbjct: 46 KWELGEGAFGKVFL--------AECHNLLPEQDKMLVAVKALKEASESARQDFQREAELL 97
Query: 578 AKLQHRNLVRLFGCCIEQGEKISIYEF-------------------DIVTDPARKDLLDW 618
LQH+++VR FG C E + ++E+ + L
Sbjct: 98 TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157
Query: 619 TTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQ 678
+ + VA G++YL + L +HRDL N L+ + KI DFG++R D
Sbjct: 158 GQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYS 210
Query: 679 SNTNRIVGTYG-----YMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLT 733
++ R VG +M PE L+ F+ +SDV+SFGV+L EI +
Sbjct: 211 TDYYR-VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT-------------- 255
Query: 734 LLG-------HAWNLWKDDKAWKLMDPTMQ-NEALYSMVTRYIKVALLCVQENATDRPTM 785
G + ++ +Y+++ C Q R ++
Sbjct: 256 -YGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRG-------CWQREPQQRHSI 307
Query: 786 LEVVAMLKDEIVNLPSPHQP 805
+V A L + P +
Sbjct: 308 KDVHARL-QALAQAPPVYLD 326
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 65/319 (20%), Positives = 116/319 (36%), Gaps = 70/319 (21%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRL--SSKSGQGLEEFKNEMML 576
LG+G FG V + K + + +VAVK L + +EEF E
Sbjct: 28 GRMLGKGEFGSVRE--------AQLK-QEDGSFVKVAVKMLKADIIASSDIEEFLREAAC 78
Query: 577 IAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK-DLLDWTTRVRIIEG-------- 627
+ + H ++ +L G + K + ++ + DL + RI E
Sbjct: 79 MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQT 138
Query: 628 -------VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSN 680
+A G+ YL S IHRDL A N +L DM ++DFG++R +
Sbjct: 139 LVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR----KIYSGD 191
Query: 681 TNRIVGTYG-----YMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLL 735
R G +++ E L+++ SDV++FGV + EI++
Sbjct: 192 YYR-QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT---------------R 235
Query: 736 G-------HAWNLWKDDKAWKLMD-PTMQNEALYSMVTRYIKVALLCVQENATDRPTMLE 787
G ++ + P E +Y ++ + C + RP+
Sbjct: 236 GQTPYAGIENAEIYNYLIGGNRLKQPPECMEEVYDLMYQ-------CWSADPKQRPSFTC 288
Query: 788 VVAMLKDEIVNLPSPHQPA 806
+ L++ + +L
Sbjct: 289 LRMELENILGHLSVLSTSQ 307
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-36
Identities = 81/306 (26%), Positives = 136/306 (44%), Gaps = 67/306 (21%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLI 577
E KLG G FG V+ +VAVK + K G +E F E ++
Sbjct: 193 EKKLGAGQFGEVWM-------------ATYNKHTKVAVKTM--KPGSMSVEAFLAEANVM 237
Query: 578 AKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK-DLLD-----------WTTRVRII 625
LQH LV+L ++ IY I+T+ K LLD +
Sbjct: 238 KTLQHDKLVKLHAVVTKE----PIY---IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS 290
Query: 626 EGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIV 685
+A+G+ ++ + IHRDL+A+N+L+ + + KI+DFG+AR +E +
Sbjct: 291 AQIAEGMAFI---EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE---- 343
Query: 686 GT---YGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKN--TRFYNTDSLTLLGHAWN 740
G + +PE G F+IKSDV+SFG+LL+EI++ + N + + L
Sbjct: 344 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL----- 398
Query: 741 LWKDDKAWKLMDPTMQN--EALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVN 798
++ +++ P +N E LY+++ R C + +RPT + ++L D
Sbjct: 399 ----ERGYRM--PRPENCPEELYNIMMR-------CWKNRPEERPTFEYIQSVLDDFYTA 445
Query: 799 LPSPHQ 804
S ++
Sbjct: 446 TESQYE 451
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-36
Identities = 63/218 (28%), Positives = 90/218 (41%), Gaps = 38/218 (17%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRL---SSKSGQGLEEFKNEMM 575
KLG+G FG V + W VAVK L + +++F E+
Sbjct: 23 LEKLGDGSFGVVRRGE--------WD-APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 73
Query: 576 LIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK-DLLDW----------TTRVRI 624
+ L HRNL+RL+G + + +VT+ A LLD T R
Sbjct: 74 AMHSLDHRNLIRLYGVVLTP----PMK---MVTELAPLGSLLDRLRKHQGHFLLGTLSRY 126
Query: 625 IEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRI 684
VA+G+ YL R IHRDL A N+LL + KI DFG+ R ++
Sbjct: 127 AVQVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE- 182
Query: 685 VGT---YGYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
+ + +PE FS SD + FGV L E+ +
Sbjct: 183 -HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-36
Identities = 55/237 (23%), Positives = 93/237 (39%), Gaps = 47/237 (19%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN 572
+F E LG+G FG V K+ L+ A+K++ + L +
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNA------------LDSRYYAIKKIRHTEEK-LSTILS 51
Query: 573 EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFD-------IVTDPARK-DLLDWTTR--- 621
E+ML+A L H+ +VR + +E+ + I + L D
Sbjct: 52 EVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENL 111
Query: 622 -------VRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTF-- 672
R+ + + L Y+H +IHRDLK N+ +D N KI DFG+A+
Sbjct: 112 NQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHR 168
Query: 673 ----------GGDEMQSNTNRIVGTYGYMSPE-YALHGLFSIKSDVFSFGVLLLEIL 718
N +GT Y++ E G ++ K D++S G++ E++
Sbjct: 169 SLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 8e-36
Identities = 76/318 (23%), Positives = 121/318 (38%), Gaps = 87/318 (27%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGE-EVAVKRLSSK-SGQGLEEFKNEMML 576
+LGE FG VYK + VA+K L K G EEF++E ML
Sbjct: 14 MEELGEDRFGKVYK--------GHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAML 65
Query: 577 IAKLQHRNLVRLFGCCIEQGEKISIYEF--------------------DIVTDPARKDLL 616
A+LQH N+V L G + I+ + D K L
Sbjct: 66 RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125
Query: 617 DWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDE 676
+ V ++ +A G+ YL S V+H+DL NVL+ +N KISD G+ R +
Sbjct: 126 EPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR----EV 178
Query: 677 MQSNTNRIVGTYG-----YMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDS 731
++ ++ +M+PE ++G FSI SD++S+GV+L E+ S
Sbjct: 179 YAADYYKL-LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS------------ 225
Query: 732 LTLLGHA-WNLWKDDKAWKLMDPTMQNEALYSMVTR--------------YIKVALLCVQ 776
G + N+ + M+ Y + + C
Sbjct: 226 ---YGLQPY-------------CGYSNQDVVEMIRNRQVLPCPDDCPAWVY-ALMIECWN 268
Query: 777 ENATDRPTMLEVVAMLKD 794
E + RP ++ + L+
Sbjct: 269 EFPSRRPRFKDIHSRLRA 286
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 8e-36
Identities = 69/309 (22%), Positives = 121/309 (39%), Gaps = 65/309 (21%)
Query: 518 EENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRL-SSKSGQGLEEFKNEMML 576
+ +LG G FG V + + ++ K +VA+K L EE E +
Sbjct: 14 ADIELGCGNFGSVRQGV--------YRMRK--KQIDVAIKVLKQGTEKADTEEMMREAQI 63
Query: 577 IAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK-DLLD----------WTTRVRII 625
+ +L + +VRL G C + ++ +V + A L + ++
Sbjct: 64 MHQLDNPYIVRLIGVCQAE----ALM---LVMEMAGGGPLHKFLVGKREEIPVSNVAELL 116
Query: 626 EGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIV 685
V+ G+ YL +HRDL A NVLL + KISDFG+++ G D+ +
Sbjct: 117 HQVSMGMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD-----SYYT 168
Query: 686 GTYG------YMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFY----NTDSLTLL 735
+ +PE FS +SDV+S+GV + E LS + Y + + +
Sbjct: 169 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS--YGQKPYKKMKGPEVMAFI 226
Query: 736 GHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795
++ ++ P LY++++ C DRP L V ++
Sbjct: 227 ---------EQGKRMECPPECPPELYALMSD-------CWIYKWEDRPDFLTVEQRMRAC 270
Query: 796 IVNLPSPHQ 804
+L S +
Sbjct: 271 YYSLASKVE 279
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 75/295 (25%), Positives = 124/295 (42%), Gaps = 65/295 (22%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLI 577
+LG G FG V GK +VAVK + K G +EF E +
Sbjct: 13 LKELGSGQFGVVKL-------------GKWKGQYDVAVKMI--KEGSMSEDEFFQEAQTM 57
Query: 578 AKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK-DLLDW----------TTRVRIIE 626
KL H LV+ +G C ++ IY IVT+ LL++ + + +
Sbjct: 58 MKLSHPKLVKFYGVCSKEY---PIY---IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCY 111
Query: 627 GVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVG 686
V +G+ +L + IHRDL A N L+D D+ K+SDFG+ R D+ S+ G
Sbjct: 112 DVCEGMAFL---ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV----G 164
Query: 687 T---YGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKN--TRFYNTDSLTLLGHAWNL 741
T + +PE + +S KSDV++FG+L+ E+ S K + N++ + + L
Sbjct: 165 TKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL 224
Query: 742 WKDDKAWKLMDPTMQN--EALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794
+ +Y ++ C E RPT ++++ ++
Sbjct: 225 -----------YRPHLASDTIYQIMYS-------CWHELPEKRPTFQQLLSSIEP 261
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 77/302 (25%), Positives = 130/302 (43%), Gaps = 66/302 (21%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLI 577
+LG G FG V GK +VA+K + K G +EF E ++
Sbjct: 29 LKELGTGQFGVVKY-------------GKWRGQYDVAIKMI--KEGSMSEDEFIEEAKVM 73
Query: 578 AKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK-DLLDW----------TTRVRIIE 626
L H LV+L+G C +Q I+ I+T+ LL++ + + +
Sbjct: 74 MNLSHEKLVQLYGVCTKQR---PIF---IITEYMANGCLLNYLREMRHRFQTQQLLEMCK 127
Query: 627 GVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVG 686
V + + YL + +HRDL A N L++ K+SDFG++R DE S+ G
Sbjct: 128 DVCEAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV----G 180
Query: 687 T---YGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKN--TRFYNTDSLTLLGHAWNL 741
+ + PE ++ FS KSD+++FGVL+ EI S K RF N+++ + L
Sbjct: 181 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL 240
Query: 742 WKDDKAWKLMDPTMQN--EALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNL 799
E +Y+++ C E A +RPT +++ + ++++
Sbjct: 241 -----------YRPHLASEKVYTIMYS-------CWHEKADERPTFKILLSNI-LDVMDE 281
Query: 800 PS 801
S
Sbjct: 282 ES 283
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 71/304 (23%), Positives = 119/304 (39%), Gaps = 61/304 (20%)
Query: 518 EENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRL--SSKSGQGLEEFKNEMM 575
E+ +LG G FG V K ++ K + VAVK L + +E E
Sbjct: 21 EDKELGSGNFGTVKKGY--------YQMKK--VVKTVAVKILKNEANDPALKDELLAEAN 70
Query: 576 LIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK-DLLD---------WTTRVRII 625
++ +L + +VR+ G C + S +V + A L + ++
Sbjct: 71 VMQQLDNPYIVRMIGICEAE----SWM---LVMEMAELGPLNKYLQQNRHVKDKNIIELV 123
Query: 626 EGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIV 685
V+ G+ YL +HRDL A NVLL + KISDFG+++ DE N
Sbjct: 124 HQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-----NYYK 175
Query: 686 GTYG------YMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKN--TRFYNTDSLTLLGH 737
+ +PE + FS KSDV+SFGVL+ E S + ++ +L
Sbjct: 176 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-- 233
Query: 738 AWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797
+K ++ P +Y ++ C + +RP V L++
Sbjct: 234 -------EKGERMGCPAGCPREMYDLMNL-------CWTYDVENRPGFAAVELRLRNYYY 279
Query: 798 NLPS 801
++ +
Sbjct: 280 DVVN 283
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 78/347 (22%), Positives = 149/347 (42%), Gaps = 77/347 (22%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRL-SSKSGQGLEEFKN 572
F + LG G FG VYK + W VA+K L + S + +E +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGL--------WIPEGEKVKIPVAIKELREATSPKANKEILD 66
Query: 573 EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPA-----------RKDLLDWTTR 621
E ++A + + ++ RL G C+ ++ ++T KD +
Sbjct: 67 EAYVMASVDNPHVCRLLGICLTS----TVQ---LITQLMPFGCLLDYVREHKDNIGSQYL 119
Query: 622 VRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNT 681
+ +A+G+ YL R++HRDL A NVL+ + + KI+DFG+A+ G +E + +
Sbjct: 120 LNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 682 NRIVGTYG-----YMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFY----NTDSL 732
G +M+ E LH +++ +SDV+S+GV + E+++ ++ Y ++
Sbjct: 177 EG-----GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT--FGSKPYDGIPASEIS 229
Query: 733 TLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAML 792
++L +K +L P + +Y ++ + C +A RP E++
Sbjct: 230 SIL---------EKGERLPQPPICTIDVYMIMVK-------CWMIDADSRPKFRELIIEF 273
Query: 793 --------------KDEIVNLPSPHQPAFSYVQIVERSVLLANINAE 825
DE ++LPSP F Y +++ + ++A+
Sbjct: 274 SKMARDPQRYLVIQGDERMHLPSPTDSNF-YRALMDEEDMDDVVDAD 319
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 69/314 (21%), Positives = 114/314 (36%), Gaps = 75/314 (23%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEE--VAVKRL-SSKSGQGLEEFKNEMM 575
+G G FG VY +G++ AVK L + +F E +
Sbjct: 30 NEVIGRGHFGCVYH--------GTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGI 78
Query: 576 LIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK-DLLDW----------TTRVRI 624
++ H N++ L G C+ + V + DL ++ +
Sbjct: 79 IMKDFSHPNVLSLLGICLRSEGSPLV-----VLPYMKHGDLRNFIRNETHNPTVKDLIGF 133
Query: 625 IEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRI 684
VA+G+ YL + + +HRDL A N +LD K++DFG+AR D +
Sbjct: 134 GLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSV 186
Query: 685 VGTYG------YMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFY---------NT 729
G +M+ E F+ KSDV+SFGVLL E+++
Sbjct: 187 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT-------RGAPPYPDVNTF 239
Query: 730 DSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVV 789
D L + +L+ P + LY ++ + C A RP+ E+V
Sbjct: 240 DITVYL---------LQGRRLLQPEYCPDPLYEVMLK-------CWHPKAEMRPSFSELV 283
Query: 790 AMLKDEIVNLPSPH 803
+ + H
Sbjct: 284 SRISAIFSTFIGEH 297
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-35
Identities = 74/331 (22%), Positives = 127/331 (38%), Gaps = 82/331 (24%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK-SGQGLEEFKN 572
D + LGEG FG V + ++ K VAVK L + + L + +
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPK-----EAVTVAVKMLKDDATEKDLSDLVS 89
Query: 573 EMMLIAKL-QHRNLVRLFGCCIEQGEKISIYEF--------------------DIVTDPA 611
EM ++ + +H+N++ L G C + G I E+ +
Sbjct: 90 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 612 RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIART 671
++ + + V +A+G+ YL + + IHRDL A NVL+ + KI+DFG+AR
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR- 205
Query: 672 FGGDEMQSNTNRIVGTYG-----YMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRF 726
++ + T G +M+PE +++ +SDV+SFGVL+ EI
Sbjct: 206 ----DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI--------- 252
Query: 727 YNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTR--------------YIKVAL 772
TL G + P + E L+ ++ Y +
Sbjct: 253 -----FTLGGSPY-------------PGIPVEELFKLLKEGHRMDKPANCTNELY-MMMR 293
Query: 773 LCVQENATDRPTMLEVVAMLKDEIVNLPSPH 803
C + RPT ++V L + +
Sbjct: 294 DCWHAVPSQRPTFKQLVEDLDRILTLTTNEE 324
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-35
Identities = 73/318 (22%), Positives = 120/318 (37%), Gaps = 91/318 (28%)
Query: 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGE-EVAVKRLSSK-SGQGLEEFKNEMMLI 577
+LG+G FG VY+ K E VA+K ++ S + EF NE ++
Sbjct: 31 RELGQGSFGMVYE--------GVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 578 AKLQHRNLVRLFGCCIEQGEKISIYEF--------------------DIVTDPARKDLLD 617
+ ++VRL G + + I E ++ P+ ++
Sbjct: 83 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 618 WTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEM 677
+A G+ YL + + +HRDL A N ++ D KI DFG+ R ++
Sbjct: 143 MAG------EIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-----DI 188
Query: 678 QSNTNRIVGTYGY-----MSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSL 732
G G MSPE G+F+ SDV+SFGV+L EI
Sbjct: 189 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI--------------A 234
Query: 733 TLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTR--------------YIKVALLCVQEN 778
TL + + NE + V + ++ +C Q N
Sbjct: 235 TLAEQPY-------------QGLSNEQVLRFVMEGGLLDKPDNCPDMLF-ELMRMCWQYN 280
Query: 779 ATDRPTMLEVVAMLKDEI 796
RP+ LE+++ +K+E+
Sbjct: 281 PKMRPSFLEIISSIKEEM 298
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 6e-35
Identities = 70/313 (22%), Positives = 122/313 (38%), Gaps = 71/313 (22%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRL--SSKSGQGLEEFKNEMML 576
LGEG FG V + N K + +VAVK + + S + +EEF +E
Sbjct: 39 GKILGEGEFGSVME--------GNLK-QEDGTSLKVAVKTMKLDNSSQREIEEFLSEAAC 89
Query: 577 IAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK-DLLDW---------------TT 620
+ H N++RL G CI + I + ++ + DL + T
Sbjct: 90 MKDFSHPNVIRLLGVCI-EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQT 148
Query: 621 RVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSN 680
++ + +A G+ YL S +HRDL A N +L DM ++DFG+++ +
Sbjct: 149 LLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK----KIYSGD 201
Query: 681 TNRIVGTYG-----YMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLL 735
R G +++ E +++ KSDV++FGV + EI +
Sbjct: 202 YYR-QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT---------------R 245
Query: 736 G-------HAWNLWKDDKAWKLMD-PTMQNEALYSMVTRYIKVALLCVQENATDRPTMLE 787
G ++ + P + LY ++ C + + DRPT
Sbjct: 246 GMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYS-------CWRTDPLDRPTFSV 298
Query: 788 VVAMLKDEIVNLP 800
+ L+ + +LP
Sbjct: 299 LRLQLEKLLESLP 311
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 6e-35
Identities = 75/322 (23%), Positives = 125/322 (38%), Gaps = 82/322 (25%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK-SGQGLEEFKN 572
D + LGEG FG V + E + K VAVK L + + L + +
Sbjct: 81 DKLTLGKPLGEGCFGQVVMA-----EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVS 135
Query: 573 EMMLIAKL-QHRNLVRLFGCCIEQGEKISIYEF--------------------DIVTDPA 611
EM ++ + +H+N++ L G C + G I E+ +
Sbjct: 136 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 195
Query: 612 RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIART 671
++ + + V +A+G+ YL + + IHRDL A NVL+ + KI+DFG+AR
Sbjct: 196 PEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR- 251
Query: 672 FGGDEMQSNTNRIVGTYG-----YMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRF 726
++ + T G +M+PE +++ +SDV+SFGVL+ EI
Sbjct: 252 ----DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI--------- 298
Query: 727 YNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTR--------------YIKVAL 772
TL G + P + E L+ ++ Y +
Sbjct: 299 -----FTLGGSPY-------------PGIPVEELFKLLKEGHRMDKPANCTNELY-MMMR 339
Query: 773 LCVQENATDRPTMLEVVAMLKD 794
C + RPT ++V L
Sbjct: 340 DCWHAVPSQRPTFKQLVEDLDR 361
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 73/317 (23%), Positives = 121/317 (38%), Gaps = 66/317 (20%)
Query: 518 EENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRL-SSKSGQGLEEFKNEMML 576
+ +G+G FG VY + + N + A+K L Q +E F E +L
Sbjct: 25 SDRVIGKGHFGVVYH--------GEYI-DQAQNRIQCAIKSLSRITEMQQVEAFLREGLL 75
Query: 577 IAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK-DLLDW----------TTRVRII 625
+ L H N++ L G + + ++ DLL + +
Sbjct: 76 MRGLNHPNVLALIGIMLPPEG--LPH---VLLPYMCHGDLLQFIRSPQRNPTVKDLISFG 130
Query: 626 EGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIV 685
VA+G+ YL + + +HRDL A N +LD K++DFG+AR D + +
Sbjct: 131 LQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLAR----DILDREYYSVQ 183
Query: 686 GTYG------YMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKN--TRFYNTDSLTLLGH 737
+ + E F+ KSDV+SFGVLL E+L+ D L
Sbjct: 184 QHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ 243
Query: 738 AWNLWKDDKAWKLMDPTMQN--EALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795
L P + ++LY ++ + C + + RPT +V ++
Sbjct: 244 GRRL-----------PQPEYCPDSLYQVMQQ-------CWEADPAVRPTFRVLVGEVEQI 285
Query: 796 IVNLPSPHQPAFSYVQI 812
+ L H YVQ+
Sbjct: 286 VSALLGDH-----YVQL 297
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 70/307 (22%), Positives = 129/307 (42%), Gaps = 72/307 (23%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRL-SSKSGQGLEEFKNEMMLI 577
+ +G G FG VYK + K VA+K L + + + +F E ++
Sbjct: 49 QKVIGAGEFGEVYKGM--------LKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIM 100
Query: 578 AKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK-DLLDW----------TTRVRIIE 626
+ H N++RL G + + I+T+ L + V ++
Sbjct: 101 GQFSHHNIIRLEGVISKYK---PMM---IITEYMENGALDKFLREKDGEFSVLQLVGMLR 154
Query: 627 GVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVG 686
G+A G+ YL + + +HRDL A N+L++S++ K+SDFG++R D + T
Sbjct: 155 GIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT----- 206
Query: 687 TYG------YMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHA-- 738
T G + +PE + F+ SDV+SFG+++ E+++ G
Sbjct: 207 TSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT---------------YGERPY 251
Query: 739 WNLWKDDKAWKLMD-----PTMQN--EALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791
W + + K ++ PT + A+Y ++ + C Q+ RP ++V++
Sbjct: 252 WE-LSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQ-------CWQQERARRPKFADIVSI 303
Query: 792 LKDEIVN 798
L I
Sbjct: 304 LDKLIRA 310
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 77/312 (24%), Positives = 125/312 (40%), Gaps = 61/312 (19%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRL-SSKSGQGLEEFKN 572
+N LG G FG V ++ + +VAVK L S+ E +
Sbjct: 46 NNLQFGKTLGAGAFGKVVEAT--AFGLGKED-----AVLKVAVKMLKSTAHADEKEALMS 98
Query: 573 EMMLIAKL-QHRNLVRLFGCCIEQGEKISIYEF------------------DIVTDPARK 613
E+ +++ L QH N+V L G C G + I E+
Sbjct: 99 ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158
Query: 614 DLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFG 673
+ VAQG+ +L + IHRD+ A NVLL + KI DFG+AR
Sbjct: 159 STASTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR--- 212
Query: 674 GDEMQSNTNRIVGTYG-----YMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKN---TR 725
++ +++N IV +M+PE +++++SDV+S+G+LL EI S N
Sbjct: 213 --DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI 270
Query: 726 FYNTDSLTLLGHAWNLWKDDKAWKLMD-PTMQNEALYSMVTRYIKVALLCVQENATDRPT 784
N+ L+ K M P + +YS++ C T RPT
Sbjct: 271 LVNSKFYKLV----------KDGYQMAQPAFAPKNIYSIMQA-------CWALEPTHRPT 313
Query: 785 MLEVVAMLKDEI 796
++ + L+++
Sbjct: 314 FQQICSFLQEQA 325
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 70/310 (22%), Positives = 113/310 (36%), Gaps = 70/310 (22%)
Query: 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGE-EVAVKRL-SSKSGQGLEEFKNEMMLI 577
LG G FG V + + VAVK L + +E+ ++
Sbjct: 33 KPLGRGAFGQVIE--------ADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 84
Query: 578 AKL-QHRNLVRLFGCCIEQGEKISI---------------------YEFDIVTDPARKDL 615
+ H N+V L G C + G + + + + + KD
Sbjct: 85 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 616 LDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGD 675
L + VA+G+ +L + + IHRDL A N+LL KI DFG+AR
Sbjct: 145 LTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR----- 196
Query: 676 EMQSNTNRIVGTYG-----YMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKN---TRFY 727
++ + + + +M+PE +++I+SDV+SFGVLL EI S +
Sbjct: 197 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256
Query: 728 NTDSLTLL--GHAWNLWKDDKAWKLMD-PTMQNEALYSMVTRYIKVALLCVQENATDRPT 784
+ + L G M P +Y + C + RPT
Sbjct: 257 DEEFCRRLKEGT------------RMRAPDYTTPEMYQTMLD-------CWHGEPSQRPT 297
Query: 785 MLEVVAMLKD 794
E+V L +
Sbjct: 298 FSELVEHLGN 307
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 69/316 (21%), Positives = 116/316 (36%), Gaps = 85/316 (26%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGE-EVAVKRL-SSKSGQGLEEFKNEMML 576
+GEG FG V++ I + + N VA+K + S E+F E +
Sbjct: 20 GRCIGEGQFGDVHQGI--------YMSPE--NPALAVAIKTCKNCTSDSVREKFLQEALT 69
Query: 577 IAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK-DLLDW----------TTRVRII 625
+ + H ++V+L G E ++ I+ + +L + + +
Sbjct: 70 MRQFDHPHIVKLIGVITEN----PVW---IIMELCTLGELRSFLQVRKYSLDLASLILYA 122
Query: 626 EGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIV 685
++ L YL R +HRD+ A NVL+ S+ K+ DFG++R
Sbjct: 123 YQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST--------- 170
Query: 686 GTYGY------------MSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFY----NT 729
Y M+PE F+ SDV+ FGV + EIL + + N
Sbjct: 171 ----YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM--HGVKPFQGVKNN 224
Query: 730 DSLTLLGHAWNLWKDDKAWKLMDPTMQN--EALYSMVTRYIKVALLCVQENATDRPTMLE 787
D + + + L P N LYS++T+ C + + RP E
Sbjct: 225 DVIGRIENGERL-----------PMPPNCPPTLYSLMTK-------CWAYDPSRRPRFTE 266
Query: 788 VVAMLKDEIVNLPSPH 803
+ A L I+
Sbjct: 267 LKAQL-STILEEEKAQ 281
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 4e-34
Identities = 85/338 (25%), Positives = 133/338 (39%), Gaps = 95/338 (28%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRL-SSKSGQGLEEFKNEMMLI 577
LGEG FG V + E + K +VAVK L S + + L + +EM ++
Sbjct: 74 GKPLGEGAFGQVVLA-----EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 578 AKL-QHRNLVRLFGCCIEQGEKISIYEF--------------------------DIVTDP 610
+ +H+N++ L G C + G I E+ +
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 611 ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIAR 670
+ KDL+ +V A+G+ YL + + IHRDL A NVL+ D KI+DFG+AR
Sbjct: 189 SSKDLVSCAYQV------ARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239
Query: 671 TFGGDEMQSNTNRIVGTYG-----YMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTR 725
++ T G +M+PE +++ +SDV+SFGVLL EI
Sbjct: 240 -----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI-------- 286
Query: 726 FYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTR--------------YIKVA 771
TL G + P + E L+ ++ Y +
Sbjct: 287 ------FTLGGSPY-------------PGVPVEELFKLLKEGHRMDKPSNCTNELY-MMM 326
Query: 772 LLCVQENATDRPTMLEVVAMLKDEIVNLPSPHQPAFSY 809
C + RPT ++V L D IV L S + + +
Sbjct: 327 RDCWHAVPSQRPTFKQLVEDL-DRIVALTSNQEMGYYH 363
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 5e-34
Identities = 72/336 (21%), Positives = 127/336 (37%), Gaps = 97/336 (28%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGE-EVAVKRL-SSKSGQGLEEFK 571
N LGEG FG V K K G VAVK L + S L +
Sbjct: 23 KNLVLGKTLGEGEFGKVVK--------ATAFHLKGRAGYTTVAVKMLKENASPSELRDLL 74
Query: 572 NEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF--------------------------- 604
+E ++ ++ H ++++L+G C + G + I E+
Sbjct: 75 SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 605 -DIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKI 663
D + L + ++QG+ YL + ++++HRDL A N+L+ KI
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKI 191
Query: 664 SDFGIAR-TFGGDEMQSNTN-----RIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEI 717
SDFG++R + D + + +M+ E +++ +SDV+SFGVLL EI
Sbjct: 192 SDFGLSRDVYEEDSYVKRSQGRIPVK------WMAIESLFDHIYTTQSDVWSFGVLLWEI 245
Query: 718 LSSKKNTRFYNTDSLTLLGHA-WNLWKDDKAWKLMDPTMQNEALYSMVTR---------- 766
++ LG + P + E L++++
Sbjct: 246 VT---------------LGGNPY-------------PGIPPERLFNLLKTGHRMERPDNC 277
Query: 767 ----YIKVALLCVQENATDRPTMLEVVAMLKDEIVN 798
Y ++ L C ++ RP ++ L+ +V
Sbjct: 278 SEEMY-RLMLQCWKQEPDKRPVFADISKDLEKMMVK 312
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-34
Identities = 59/220 (26%), Positives = 96/220 (43%), Gaps = 43/220 (19%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGE-EVAVKRL-SSKSGQGLEEFKNEMML 576
E +G G G V + + VA+K L + + + +F +E +
Sbjct: 54 EKIIGSGDSGEVCYGR--------LRVPG--QRDVPVAIKALKAGYTERQRRDFLSEASI 103
Query: 577 IAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK-DLLDW----------TTRVRII 625
+ + H N++RL G IVT+ L + V ++
Sbjct: 104 MGQFDHPNIIRLEGVVTRGR---LAM---IVTEYMENGSLDTFLRTHDGQFTIMQLVGML 157
Query: 626 EGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIV 685
GV G+ YL S L +HRDL A NVL+DS++ K+SDFG++R ++ + +
Sbjct: 158 RGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSR-----VLEDDPDAAY 209
Query: 686 GTYG------YMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
T G + +PE FS SDV+SFGV++ E+L+
Sbjct: 210 TTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-34
Identities = 66/330 (20%), Positives = 122/330 (36%), Gaps = 60/330 (18%)
Query: 502 LFFSLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSS 561
L+F + ++ KLGEGGF V + +G A+KR+
Sbjct: 17 LYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLH------------DGHFYALKRILC 64
Query: 562 KSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPA-RKDLLDWTT 620
Q EE + E + H N++RL C+ + + +E ++ R L +
Sbjct: 65 HEQQDREEAQREADMHRLFNHPNILRLVAYCLRERG--AKHEAWLLLPFFKRGTLWNEIE 122
Query: 621 RV-------------RIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667
R+ ++ G+ +GL +H HRDLK +N+LL + P + D G
Sbjct: 123 RLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLG 179
Query: 668 IART-----FGGDEMQSNTNRI--VGTYGYMSPE---YALHGLFSIKSDVFSFGVLLLEI 717
G + + + T Y +PE H + ++DV+S G +L +
Sbjct: 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAM 239
Query: 718 LSSKK--NTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCV 775
+ + + F DS+ L + + AL+ ++ +
Sbjct: 240 MFGEGPYDMVFQKGDSVAL--------AVQNQLSIPQSPRHSSALWQLLNS-------MM 284
Query: 776 QENATDRPTMLEVVAMLKDEIVNLPSPHQP 805
+ RP + +++ L E + P+P Q
Sbjct: 285 TVDPHQRPHIPLLLSQL--EALQPPAPGQH 312
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-34
Identities = 70/308 (22%), Positives = 111/308 (36%), Gaps = 86/308 (27%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRL-SSKSGQGLEEFKNEMMLI 577
LGEG FG VY+ + + VAVK + E+F +E +++
Sbjct: 17 NRILGEGFFGEVYEGV--------YT-NHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIM 67
Query: 578 AKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK-DLLDW----------TTRVRIIE 626
L H ++V+L G E+ + I+ + +L + T V
Sbjct: 68 KNLDHPHIVKLIGIIEEE----PTW---IIMELYPYGELGHYLERNKNSLKVLTLVLYSL 120
Query: 627 GVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVG 686
+ + + YL + +HRD+ N+L+ S K+ DFG++R ++
Sbjct: 121 QICKAMAYL---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED---------- 167
Query: 687 TYGY------------MSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTL 734
Y MSPE F+ SDV+ F V + EILS
Sbjct: 168 ---YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS--------------- 209
Query: 735 LGHA--WNLWKDDKAWKLMD----PTMQN--EALYSMVTRYIKVALLCVQENATDRPTML 786
G + L D L P LY+++TR C + +DRP
Sbjct: 210 FGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTR-------CWDYDPSDRPRFT 262
Query: 787 EVVAMLKD 794
E+V L D
Sbjct: 263 ELVCSLSD 270
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-34
Identities = 52/222 (23%), Positives = 94/222 (42%), Gaps = 37/222 (16%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVK--RLSSKSGQGLEEFK 571
+ + K+GEG FG +G + +K +S S + EE +
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTE------------DGRQYVIKEINISRMSSKEREESR 71
Query: 572 NEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTD------------PARKDLLDWT 619
E+ ++A ++H N+V+ E G +Y IV D + L
Sbjct: 72 REVAVLANMKHPNIVQYRESFEENGS---LY---IVMDYCEGGDLFKRINAQKGVLFQED 125
Query: 620 TRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQS 679
+ + L ++H +++HRD+K+ N+ L D ++ DFGIAR +
Sbjct: 126 QILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA 182
Query: 680 NTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSK 721
+GT Y+SPE + ++ KSD+++ G +L E+ + K
Sbjct: 183 RA--CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLK 222
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 7e-34
Identities = 70/328 (21%), Positives = 119/328 (36%), Gaps = 98/328 (29%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEE---VAVKRL-SSKSGQGLEEFKNEM 574
++ +GEG FG V K ++ A+KR+ S +F E+
Sbjct: 30 QDVIGEGNFGQVLK-------------ARIKKDGLRMDAAIKRMKEYASKDDHRDFAGEL 76
Query: 575 MLIAKL-QHRNLVRLFGCCIEQGEKISIYEF--------------------DIVTDPARK 613
++ KL H N++ L G C +G E+ +
Sbjct: 77 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 136
Query: 614 DLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFG 673
L + VA+G+ YL S+ + IHRDL A N+L+ + KI+DFG++R G
Sbjct: 137 STLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--G 191
Query: 674 GDEMQSNTN-----RIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYN 728
+ T R +M+ E + +++ SDV+S+GVLL EI+S
Sbjct: 192 QEVYVKKTMGRLPVR------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS--------- 236
Query: 729 TDSLTLLGHA-WNLWKDDKAWKLMDPTMQNEALYSMVTR--------------YIKVALL 773
LG + M LY + + Y +
Sbjct: 237 ------LGGTPY-------------CGMTCAELYEKLPQGYRLEKPLNCDDEVY-DLMRQ 276
Query: 774 CVQENATDRPTMLEVVAMLKDEIVNLPS 801
C +E +RP+ +++ L + +
Sbjct: 277 CWREKPYERPSFAQILVSLNRMLEERKT 304
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 9e-34
Identities = 67/310 (21%), Positives = 124/310 (40%), Gaps = 65/310 (20%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRL-SSKSGQGLEEFKNEMMLI 577
+ +LG G FG V + + ++ K +VA+K L EE E ++
Sbjct: 341 DIELGCGNFGSVRQGV--------YRMRK--KQIDVAIKVLKQGTEKADTEEMMREAQIM 390
Query: 578 AKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPA-----------RKDLLDWTTRVRIIE 626
+L + +VRL G C + ++ +V + A +++ + + ++
Sbjct: 391 HQLDNPYIVRLIGVCQAE----ALM---LVMEMAGGGPLHKFLVGKREEIPVSNVAELLH 443
Query: 627 GVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVG 686
V+ G+ YL +HR+L A NVLL + KISDFG+++ G D+ +
Sbjct: 444 QVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD-----SYYTA 495
Query: 687 TYG------YMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFY----NTDSLTLLG 736
+ +PE FS +SDV+S+GV + E LS + Y + + +
Sbjct: 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS--YGQKPYKKMKGPEVMAFI- 552
Query: 737 HAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEI 796
++ ++ P LY++++ C DRP L V ++
Sbjct: 553 --------EQGKRMECPPECPPELYALMSD-------CWIYKWEDRPDFLTVEQRMRACY 597
Query: 797 VNLPSPHQPA 806
+L S +
Sbjct: 598 YSLASKVEGG 607
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 9e-34
Identities = 71/320 (22%), Positives = 121/320 (37%), Gaps = 67/320 (20%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEE--VAVKRL-SSKSGQGLEEFKNEMM 575
+G G FG VY +G++ AVK L + +F E +
Sbjct: 94 NEVIGRGHFGCVYH--------GTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGI 142
Query: 576 LIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK-DLLDW----------TTRVRI 624
++ H N++ L G C+ + V + DL ++ +
Sbjct: 143 IMKDFSHPNVLSLLGICLRSEGSPLV-----VLPYMKHGDLRNFIRNETHNPTVKDLIGF 197
Query: 625 IEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRI 684
VA+G+ +L + + +HRDL A N +LD K++DFG+AR D + +
Sbjct: 198 GLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEFDSV 250
Query: 685 VGTYG------YMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFY----NTDSLTL 734
G +M+ E F+ KSDV+SFGVLL E+++ + Y D
Sbjct: 251 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVY 308
Query: 735 LGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794
L + +L+ P + LY ++ + C A RP+ E+V+ +
Sbjct: 309 L---------LQGRRLLQPEYCPDPLYEVMLK-------CWHPKAEMRPSFSELVSRISA 352
Query: 795 EIVNLPSPH--QPAFSYVQI 812
H +YV +
Sbjct: 353 IFSTFIGEHYVHVNATYVNV 372
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 66/326 (20%), Positives = 111/326 (34%), Gaps = 95/326 (29%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGE-EVAVKRLSSK-SGQGLEEFKNEMML 576
+GEG FG V++ VAVK L + S +F+ E L
Sbjct: 52 VRDIGEGAFGRVFQ--------ARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 103
Query: 577 IAKLQHRNLVRLFGCCIEQGEKISIYEF----------------------------DIVT 608
+A+ + N+V+L G C ++E+
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 609 DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGI 668
L ++ I VA G+ YL S + +HRDL N L+ +M KI+DFG+
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGL 220
Query: 669 ARTFGGDEMQSNTNRIVGTYGY-----MSPEYALHGLFSIKSDVFSFGVLLLEILSSKKN 723
+R + ++ + M PE + ++ +SDV+++GV+L EI S
Sbjct: 221 SR----NIYSADYYK-ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS---- 271
Query: 724 TRFYNTDSLTLLGHA-WNLWKDDKAWKLMDPTMQNEALYSMVTR--------------YI 768
G + M +E + V Y
Sbjct: 272 -----------YGLQPY-------------YGMAHEEVIYYVRDGNILACPENCPLELY- 306
Query: 769 KVALLCVQENATDRPTMLEVVAMLKD 794
+ LC + DRP+ + +L+
Sbjct: 307 NLMRLCWSKLPADRPSFCSIHRILQR 332
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 76/326 (23%), Positives = 119/326 (36%), Gaps = 84/326 (25%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGE-EVAVKRLSSK-SGQGLEEFKNEMML 576
LG G FG VY+ +VAVK L S Q +F E ++
Sbjct: 35 IRGLGHGAFGEVYE--------GQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 86
Query: 577 IAKLQHRNLVRLFGCCIEQGEKISIYEF-----------DIVTDPARKDLLDWTTRVRII 625
I+K H+N+VR G ++ + + E + P++ L + +
Sbjct: 87 ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146
Query: 626 EGVAQGLLYLHQYSRLRVIHRDLKASNVLLD---SDMNPKISDFGIARTFGGDEMQSNTN 682
+A G YL IHRD+ A N LL KI DFG+AR D +++
Sbjct: 147 RDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYY 199
Query: 683 RIVGTYGY-----MSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGH 737
R G M PE + G+F+ K+D +SFGVLL EI +L
Sbjct: 200 R-KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI--------------FSLGYM 244
Query: 738 AWNLWKDDKAWKLMDPTMQNEALYSMVTR--------------YIKVALLCVQENATDRP 783
+ P+ N+ + VT Y ++ C Q DRP
Sbjct: 245 PY-------------PSKSNQEVLEFVTSGGRMDPPKNCPGPVY-RIMTQCWQHQPEDRP 290
Query: 784 TMLEVVAMLKD-----EIVNLPSPHQ 804
++ ++ +++N P +
Sbjct: 291 NFAIILERIEYCTQDPDVINTALPIE 316
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 72/337 (21%), Positives = 130/337 (38%), Gaps = 86/337 (25%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGE-EVAVKRL-SSKSGQGLEEFK 571
+ S LG G FG V + + VAVK L S E
Sbjct: 23 NRLSFGKTLGAGAFGKVVE--------ATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM 74
Query: 572 NEMMLIAKL-QHRNLVRLFGCCIEQGEKISIYEF-------------------------- 604
+E+ +++ L H N+V L G C G + I E+
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 605 --DIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPK 662
D +DLL ++ +V A+G+ +L + IHRDL A N+LL K
Sbjct: 135 MEDDELALDLEDLLSFSYQV------AKGMAFL---ASKNCIHRDLAARNILLTHGRITK 185
Query: 663 ISDFGIARTFGGDEMQSNTNRIVGTYG-----YMSPEYALHGLFSIKSDVFSFGVLLLEI 717
I DFG+AR ++++++N +V +M+PE + +++ +SDV+S+G+ L E+
Sbjct: 186 ICDFGLAR-----DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 240
Query: 718 LSSKKN---TRFYNTDSLTLLGHAWNLWKDDKAWKLMD-PTMQNEALYSMVTRYIKVALL 773
S + ++ ++ K M P +Y ++
Sbjct: 241 FSLGSSPYPGMPVDSKFYKMI----------KEGFRMLSPEHAPAEMYDIMKT------- 283
Query: 774 CVQENATDRPTMLEVVAMLKDEIVNLPSPHQPAFSYV 810
C + RPT ++V +++ +I + +++
Sbjct: 284 CWDADPLKRPTFKQIVQLIEKQI-------SESTNHI 313
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-32
Identities = 74/324 (22%), Positives = 115/324 (35%), Gaps = 84/324 (25%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGE-EVAVKRLSSK-SGQGLEEFKNEMML 576
LG G FG VY+ +VAVK L S Q +F E ++
Sbjct: 76 IRGLGHGAFGEVYE--------GQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 127
Query: 577 IAKLQHRNLVRLFGCCIEQGEKISIYEF-----------DIVTDPARKDLLDWTTRVRII 625
I+K H+N+VR G ++ + + E + P++ L + +
Sbjct: 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187
Query: 626 EGVAQGLLYLHQYSRLRVIHRDLKASNVLLD---SDMNPKISDFGIARTFGGDEMQSNTN 682
+A G YL IHRD+ A N LL KI DFG+AR ++
Sbjct: 188 RDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRAGY 239
Query: 683 RIVGTYGY-----MSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGH 737
G M PE + G+F+ K+D +SFGVLL EI +L
Sbjct: 240 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI--------------FSLGYM 285
Query: 738 AWNLWKDDKAWKLMDPTMQNEALYSMVTR--------------YIKVALLCVQENATDRP 783
+ P+ N+ + VT Y ++ C Q DRP
Sbjct: 286 PY-------------PSKSNQEVLEFVTSGGRMDPPKNCPGPVY-RIMTQCWQHQPEDRP 331
Query: 784 TMLEVVAMLKD-----EIVNLPSP 802
++ ++ +++N P
Sbjct: 332 NFAIILERIEYCTQDPDVINTALP 355
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 36/224 (16%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVK--RLSSKSGQGLEEFK 571
+++ +G G +G K + +G+ + K S + +
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKS------------DGKILVWKELDYGSMTEAEKQMLV 53
Query: 572 NEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK-DLLDWTTR--------- 621
+E+ L+ +L+H N+VR + I++ ++Y IV + DL T+
Sbjct: 54 SEVNLLRELKHPNIVRYYDRIIDRTNT-TLY---IVMEYCEGGDLASVITKGTKERQYLD 109
Query: 622 ----VRIIEGVAQGLLYLHQ--YSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGD 675
+R++ + L H+ V+HRDLK +NV LD N K+ DFG+AR D
Sbjct: 110 EEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD 169
Query: 676 EMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
+ T VGT YMSPE ++ KSD++S G LL E+ +
Sbjct: 170 TSFAKT--FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 45/229 (19%), Positives = 85/229 (37%), Gaps = 56/229 (24%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGE---EVAVKRLSSKSGQGLEEFKNEMM 575
LG+G F ++K + ++ EV +K L E F
Sbjct: 13 NESLGQGTFTKIFKGV--------RREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAAS 64
Query: 576 LIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK-DLLDW----------TTRVRI 624
+++KL H++LV +G C+ E +V + + L + ++ +
Sbjct: 65 MMSKLSHKHLVLNYGVCVCGDE---NI---LVQEFVKFGSLDTYLKKNKNCINILWKLEV 118
Query: 625 IEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP--------KISDFGIARTFGGDE 676
+ +A + +L +IH ++ A N+LL + + K+SD GI+ T +
Sbjct: 119 AKQLAAAMHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175
Query: 677 MQSNTNRIVGTYGY-----MSPEYALHG-LFSIKSDVFSFGVLLLEILS 719
+ PE + ++ +D +SFG L EI S
Sbjct: 176 -----------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 30/220 (13%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRL---SSKSGQGLEEF 570
NF E K+G G F VY++ +G VA+K++ + +
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLL------------DGVPVALKKVQIFDLMDAKARADC 79
Query: 571 KNEMMLIAKLQHRNLVRLFGCCIEQGEKISIY-EF--------DIVTDPARKDLLDWTTR 621
E+ L+ +L H N+++ + IE +++I E I +K L+ T
Sbjct: 80 IKEIDLLKQLNHPNVIKYYASFIEDN-ELNIVLELADAGDLSRMIKHFKKQKRLIPERTV 138
Query: 622 VRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNT 681
+ + L ++H RV+HRD+K +NV + + K+ D G+ R F +++
Sbjct: 139 WKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS 195
Query: 682 NRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSK 721
+VGT YMSPE ++ KSD++S G LL E+ + +
Sbjct: 196 --LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 233
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-32
Identities = 51/226 (22%), Positives = 82/226 (36%), Gaps = 38/226 (16%)
Query: 510 SAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVK--RLSSKSGQGL 567
S +F ++LG G +G V+K + +G AVK + +
Sbjct: 53 SFFQQSFQRLSRLGHGSYGEVFKVRSK------------EDGRLYAVKRSMSPFRGPKDR 100
Query: 568 EEFKNEMMLIAKL-QHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTRV---- 622
E+ K+ QH VRL E G +Y + T+ L
Sbjct: 101 ARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI---LY---LQTELCGPSLQQHCEAWGASL 154
Query: 623 ------RIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDE 676
+ L +LH ++H D+K +N+ L K+ DFG+ G
Sbjct: 155 PEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211
Query: 677 MQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKK 722
G YM+PE L G + +DVFS G+ +LE+ + +
Sbjct: 212 A---GEVQEGDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNME 253
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 8e-32
Identities = 55/219 (25%), Positives = 94/219 (42%), Gaps = 41/219 (18%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRL-SSKSGQGLEEFKNEMMLI 577
+ +G G FG V K VA+K L + + +F E ++
Sbjct: 50 DKVVGAGEFGEVCSGR--------LK-LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 578 AKLQHRNLVRLFGCCIEQGEKISIYEFDIVTD-----------PARKDLLDWTTRVRIIE 626
+ H N++RL G + + IVT+ V ++
Sbjct: 101 GQFDHPNIIRLEGVVTKSK---PVM---IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 154
Query: 627 GVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVG 686
G+A G+ YL S + +HRDL A N+L++S++ K+SDFG+ R ++ +
Sbjct: 155 GIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGR-----VLEDDPEAAYT 206
Query: 687 TYG------YMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
T G + SPE + F+ SDV+S+G++L E++S
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 8e-32
Identities = 53/229 (23%), Positives = 88/229 (38%), Gaps = 43/229 (18%)
Query: 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKR--LSSKSGQGLEEFKN 572
+S ++G GG V++ + A+K L Q L+ ++N
Sbjct: 29 IYSILKQIGSGGSSKVFQ-------------VLNEKKQIYAIKYVNLEEADNQTLDSYRN 75
Query: 573 EMMLIAKLQHRNL--VRLFGCCIEQGEKISI---YE----FDIVTDPARKDLLDWTTRVR 623
E+ + KLQ + +RL+ + I + + +K +D R
Sbjct: 76 EIAYLNKLQQHSDKIIRLYDY-EITDQYIYMVMECGNIDLNSWLK---KKKSIDPWERKS 131
Query: 624 IIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNR 683
+ + + + +HQ+ ++H DLK +N L+ D K+ DFGIA D +
Sbjct: 132 YWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDS 187
Query: 684 IVGTYGYMSPE-----------YALHGLFSIKSDVFSFGVLLLEILSSK 721
VGT YM PE S KSDV+S G +L + K
Sbjct: 188 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-31
Identities = 69/301 (22%), Positives = 117/301 (38%), Gaps = 64/301 (21%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGE-EVAVKRL-SSKSGQGLEEFKNEMML 576
+GEG FG V++ I + + N VA+K + S E+F E +
Sbjct: 395 GRCIGEGQFGDVHQGI--------YMSPE--NPAMAVAIKTCKNCTSDSVREKFLQEALT 444
Query: 577 IAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPA-----------RKDLLDWTTRVRII 625
+ + H ++V+L G E ++ I+ + RK LD + +
Sbjct: 445 MRQFDHPHIVKLIGVITEN----PVW---IIMELCTLGELRSFLQVRKFSLDLASLILYA 497
Query: 626 EGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIV 685
++ L YL R +HRD+ A NVL+ S+ K+ DFG++R + +
Sbjct: 498 YQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 554
Query: 686 GTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHA--WNLWK 743
+M+PE F+ SDV+ FGV + EIL G +
Sbjct: 555 -PIKWMAPESINFRRFTSASDVWMFGVCMWEILM---------------HGVKPFQGVKN 598
Query: 744 DDKAWKLMD----PTMQN--EALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797
+D ++ + P N LYS++T+ C + + RP E+ A L +
Sbjct: 599 NDVIGRIENGERLPMPPNCPPTLYSLMTK-------CWAYDPSRRPRFTELKAQLSTILE 651
Query: 798 N 798
Sbjct: 652 E 652
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 56/226 (24%), Positives = 87/226 (38%), Gaps = 47/226 (20%)
Query: 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKR--LSSKSGQGLEEFKNEMMLI 577
++G GG V++ + A+K L Q L+ ++NE+ +
Sbjct: 15 KQIGSGGSSKVFQ-------------VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 61
Query: 578 AKLQHRNL--VRLFGCCIEQGEKISIYEFDIVTDPARKDLLDW---------TTRVRIIE 626
KLQ + +RL+ I IY +V + DL W R +
Sbjct: 62 NKLQQHSDKIIRLYDYEITDQY---IY---MVMECGNIDLNSWLKKKKSIDPWERKSYWK 115
Query: 627 GVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVG 686
+ + + +HQ+ ++H DLK +N L+ D K+ DFGIA D + VG
Sbjct: 116 NMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVG 171
Query: 687 TYGYMSPE-----------YALHGLFSIKSDVFSFGVLLLEILSSK 721
T YM PE S KSDV+S G +L + K
Sbjct: 172 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-31
Identities = 57/257 (22%), Positives = 94/257 (36%), Gaps = 43/257 (16%)
Query: 487 EGDSAGTGKSKESWFLFFSLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQG 546
DS G + + IS +S ++G GG V++
Sbjct: 29 HMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQ-------------V 75
Query: 547 KLLNGEEVAVKR--LSSKSGQGLEEFKNEMMLIAKLQHRNL--VRLFGCCIEQGEKISI- 601
+ A+K L Q L+ ++NE+ + KLQ + +RL+ + I +
Sbjct: 76 LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY-EITDQYIYMV 134
Query: 602 --YE----FDIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLL 655
+ +K +D R + + + + +HQ+ ++H DLK +N L+
Sbjct: 135 MECGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLI 188
Query: 656 DSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPE-----------YALHGLFSIK 704
D K+ DFGIA D + VG YM PE S K
Sbjct: 189 V-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPK 247
Query: 705 SDVFSFGVLLLEILSSK 721
SDV+S G +L + K
Sbjct: 248 SDVWSLGCILYYMTYGK 264
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-31
Identities = 73/326 (22%), Positives = 117/326 (35%), Gaps = 86/326 (26%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGE-EVAVKRL-SSKSGQGLEEFKNEMML 576
LG G FG V +VAVK L E +E+ +
Sbjct: 50 GKVLGSGAFGKVMN--------ATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKM 101
Query: 577 IAKL-QHRNLVRLFGCCIEQGEKISIYEF------------------------------- 604
+ +L H N+V L G C G I+E+
Sbjct: 102 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161
Query: 605 --DIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPK 662
+ + +DLL + +V A+G+ +L +HRDL A NVL+ K
Sbjct: 162 EEEDLNVLTFEDLLCFAYQV------AKGMEFL---EFKSCVHRDLAARNVLVTHGKVVK 212
Query: 663 ISDFGIAR-TFGGDEMQSNTN-----RIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLE 716
I DFG+AR N + +M+PE G+++IKSDV+S+G+LL E
Sbjct: 213 ICDFGLARDIMSDSNYVVRGNARLPVK------WMAPESLFEGIYTIKSDVWSYGILLWE 266
Query: 717 ILSSKKN---TRFYNTDSLTLLGHAWNLWKDDKAWKLMD-PTMQNEALYSMVTRYIKVAL 772
I S N + + L+ + MD P E +Y ++
Sbjct: 267 IFSLGVNPYPGIPVDANFYKLI----------QNGFKMDQPFYATEEIYIIMQS------ 310
Query: 773 LCVQENATDRPTMLEVVAMLKDEIVN 798
C ++ RP+ + + L ++ +
Sbjct: 311 -CWAFDSRKRPSFPNLTSFLGCQLAD 335
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-31
Identities = 57/212 (26%), Positives = 100/212 (47%), Gaps = 37/212 (17%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLS---SKSGQGLEEFKNEMMLI 577
KLG GG VY + + +LN +VA+K + + + L+ F+ E+
Sbjct: 18 KLGGGGMSTVYLAEDT-----------ILN-IKVAIKAIFIPPREKEETLKRFEREVHNS 65
Query: 578 AKLQHRNLVRLFGCCIEQGEKISIY----EF-------DIVTDPARKDLLDWTTRVRIIE 626
++L H+N+V + + E+ Y E+ + + L T +
Sbjct: 66 SQLSHQNIVSMI----DVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTN 118
Query: 627 GVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVG 686
+ G+ + H +R++HRD+K N+L+DS+ KI DFGIA+ + + TN ++G
Sbjct: 119 QILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-TQTNHVLG 174
Query: 687 TYGYMSPEYALHGLFSIKSDVFSFGVLLLEIL 718
T Y SPE A +D++S G++L E+L
Sbjct: 175 TVQYFSPEQAKGEATDECTDIYSIGIVLYEML 206
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 47/219 (21%), Positives = 79/219 (36%), Gaps = 47/219 (21%)
Query: 519 ENKLGEGGFGPVYK----SIERYVEICNWKQGKLLNGE----EVAVKRLSSKSGQGLEEF 570
+G GG G VY+ ER V + KL++ V R
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVAL------KLMSETLSSDPVFRTR-----------M 81
Query: 571 KNEMMLIAKLQHRNLVRLFGCCIEQGEKISIY----EF-------DIVTDPARKDLLDWT 619
+ E +LQ ++V + + GE ++ L
Sbjct: 82 QREARTAGRLQEPHVVPIH----DFGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPP 134
Query: 620 TRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQS 679
V I+ + L H HRD+K N+L+ +D + DFGIA +++ +
Sbjct: 135 RAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL-T 190
Query: 680 NTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEIL 718
VGT YM+PE + ++D+++ +L E L
Sbjct: 191 QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECL 229
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 45/237 (18%), Positives = 93/237 (39%), Gaps = 42/237 (17%)
Query: 506 LSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLS-SKSG 564
+ S S + + + LG+G V++ + G+ A+K +
Sbjct: 1 MGSQSTSNHLWLLSDILGQGATANVFRGRHK------------KTGDLFAIKVFNNISFL 48
Query: 565 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIY---E-------FDIVTDPARKD 614
+ ++ E ++ KL H+N+V+LF E+ E + ++ +P+
Sbjct: 49 RPVDVQMREFEVLKKLNHKNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAY 107
Query: 615 LLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLL----DSDMNPKISDFGIAR 670
L + + ++ V G+ +L + ++HR++K N++ D K++DFG AR
Sbjct: 108 GLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164
Query: 671 TFGGDEMQSNTNRIVGTYGYMSPE--------YALHGLFSIKSDVFSFGVLLLEILS 719
DE + + GT Y+ P+ + D++S GV +
Sbjct: 165 ELEDDEQFVS---LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 5e-30
Identities = 39/211 (18%), Positives = 78/211 (36%), Gaps = 40/211 (18%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEE-FKNEMMLIAK 579
+ GG G +Y +++R +NG V +K L + E +A+
Sbjct: 87 CIAHGGLGWIYLALDR-----------NVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAE 135
Query: 580 LQHRNLVRL--FGCCIEQGEKISIY---EF-------DIVTDPARKDLLDWTTRVRIIEG 627
+ H ++V++ F ++ Y E+ L + +
Sbjct: 136 VVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLE 190
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
+ L YLH + +++ DLK N++L + K+ D G + GT
Sbjct: 191 ILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGT 240
Query: 688 YGYMSPEYALHGLFSIKSDVFSFGVLLLEIL 718
G+ +PE G ++ +D+++ G L +
Sbjct: 241 PGFQAPEIVRTGP-TVATDIYTVGRTLAALT 270
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 5e-30
Identities = 54/228 (23%), Positives = 92/228 (40%), Gaps = 41/228 (17%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIA 578
L EGGF VY+ + + +G E A+KRL S + E+ +
Sbjct: 33 RRVLAEGGFAFVYE-----AQ-------DVGSGREYALKRLLSNEEEKNRAIIQEVCFMK 80
Query: 579 KLQ-HRNLVRLFGCCIEQGEKI--SIYEFDIVTDPARKDLLDWTTRVR------------ 623
KL H N+V+ E+ EF ++T+ + L+++ ++
Sbjct: 81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK 140
Query: 624 IIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNR 683
I + + ++H + +IHRDLK N+LL + K+ DFG A T S + +
Sbjct: 141 IFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQ 199
Query: 684 I----------VGTYGYMSPE-YALHGLFSI--KSDVFSFGVLLLEIL 718
T Y +PE L+ F I K D+++ G +L +
Sbjct: 200 RRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLC 247
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 36/226 (15%)
Query: 508 SISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGL 567
S+ D+ +LG G +G V K +G+ +AVKR+ +
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHV------------PSGQIMAVKRIRATVNS-- 46
Query: 568 EEFKNEMM----LIAKLQHRNLVRLFGCCIEQGEKISIY-EF-DIVTDPARKDLLDWTTR 621
+E K +M + + V +G +G+ + I E D D K ++D
Sbjct: 47 QEQKRLLMDLDISMRTVDCPFTVTFYGALFREGD-VWICMELMDTSLDKFYKQVIDKGQT 105
Query: 622 V------RIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGD 675
+ +I + + L +LH S+L VIHRD+K SNVL+++ K+ DFGI+ D
Sbjct: 106 IPEDILGKIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VD 162
Query: 676 EMQSNTNRIVGTYGYMSPE----YALHGLFSIKSDVFSFGVLLLEI 717
++ + + G YM+PE +S+KSD++S G+ ++E+
Sbjct: 163 DVAKDID--AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 206
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 53/218 (24%), Positives = 85/218 (38%), Gaps = 43/218 (19%)
Query: 521 KLGEGGFGPVYK----SIERYVEICNWKQGKLLNGE----EVAVKRLSSKSGQGLEEFKN 572
LG GG V+ R V + K+L + R F+
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAV------KVLRADLARDPSFYLR-----------FRR 61
Query: 573 EMMLIAKLQHRNLVRLFGCCIEQGEKISIY----EF-------DIVTDPARKDLLDWTTR 621
E A L H +V ++ + + E+ DIV +
Sbjct: 62 EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRA 118
Query: 622 VRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQ-SN 680
+ +I Q L + H + +IHRD+K +N+++ + K+ DFGIAR +
Sbjct: 119 IEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 175
Query: 681 TNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEIL 718
T ++GT Y+SPE A +SDV+S G +L E+L
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVL 213
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 53/211 (25%), Positives = 93/211 (44%), Gaps = 29/211 (13%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQ 581
LG+G +G VY + N +A+K + + + + E+ L L+
Sbjct: 30 LGKGTYGIVYAGR-------DLS-----NQVRIAIKEIPERDSRYSQPLHEEIALHKHLK 77
Query: 582 HRNLVRLFGCCIEQGEKISIY-EF-------DIVTDPARKDLLDWTTRVRIIEGVAQGLL 633
H+N+V+ G E I I+ E ++ + T + + +GL
Sbjct: 78 HKNIVQYLGSFSE-NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLK 136
Query: 634 YLHQYSRLRVIHRDLKASNVLLDSDM-NPKISDFGIARTFGGDEMQSNTNRIVGTYGYMS 692
YLH +++HRD+K NVL+++ KISDFG ++ G + T GT YM+
Sbjct: 137 YLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMA 191
Query: 693 PEYALHGL--FSIKSDVFSFGVLLLEILSSK 721
PE G + +D++S G ++E+ + K
Sbjct: 192 PEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 2e-29
Identities = 54/248 (21%), Positives = 98/248 (39%), Gaps = 45/248 (18%)
Query: 492 GTGKSKESWFLFFSLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNG 551
G+ S E S + +F ++ LG G G + +G +
Sbjct: 2 GSSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVY------------RGMF-DN 48
Query: 552 EEVAVKRLSSKSGQGLEEFKNEM-MLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDP 610
+VAVKR+ + E+ +L +H N++R F C E+ + Y I +
Sbjct: 49 RDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYF--CTEKDRQ-FQY---IAIEL 99
Query: 611 ARKDLLDWTTR----------VRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLL----- 655
L ++ + + +++ GL +LH L ++HRDLK N+L+
Sbjct: 100 CAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNA 156
Query: 656 DSDMNPKISDFGIARTFGGDE-MQSNTNRIVGTYGYMSPEY---ALHGLFSIKSDVFSFG 711
+ ISDFG+ + S + + GT G+++PE + D+FS G
Sbjct: 157 HGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAG 216
Query: 712 VLLLEILS 719
+ ++S
Sbjct: 217 CVFYYVIS 224
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-29
Identities = 45/237 (18%), Positives = 92/237 (38%), Gaps = 42/237 (17%)
Query: 506 LSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLS-SKSG 564
+ S S + + + LG+G V++ + G+ A+K +
Sbjct: 1 MGSQSTSNHLWLLSDILGQGATANVFRGRHK------------KTGDLFAIKVFNNISFL 48
Query: 565 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIY---E-------FDIVTDPARKD 614
+ ++ E ++ KL H+N+V+LF E+ E + ++ +P+
Sbjct: 49 RPVDVQMREFEVLKKLNHKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAY 107
Query: 615 LLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLL----DSDMNPKISDFGIAR 670
L + + ++ V G+ +L + ++HR++K N++ D K++DFG AR
Sbjct: 108 GLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164
Query: 671 TFGGDEMQSNTNRIVGTYGYMSPE--------YALHGLFSIKSDVFSFGVLLLEILS 719
DE + GT Y+ P+ + D++S GV +
Sbjct: 165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 54/217 (24%), Positives = 105/217 (48%), Gaps = 23/217 (10%)
Query: 506 LSSISAATD---NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK 562
L SI + D ++ K+G+G G VY +++ G+EVA+++++ +
Sbjct: 9 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVA------------TGQEVAIRQMNLQ 56
Query: 563 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF---DIVTDPARKDLLDWT 619
E NE++++ + ++ N+V + E + E+ +TD + +D
Sbjct: 57 QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG 116
Query: 620 TRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQS 679
+ Q L +LH +VIHRD+K+ N+LL D + K++DFG ++ +
Sbjct: 117 QIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173
Query: 680 NTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLE 716
+T +VGT +M+PE + K D++S G++ +E
Sbjct: 174 ST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIE 208
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 20/207 (9%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN 572
K+GEG G V + E++ +G +VAVK + + Q E N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKH------------SGRQVAVKMMDLRKQQRRELLFN 91
Query: 573 EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF---DIVTDPARKDLLDWTTRVRIIEGVA 629
E++++ QH N+V ++ + E + EF +TD + L+ + E V
Sbjct: 92 EVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVL 151
Query: 630 QGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYG 689
Q L YLH VIHRD+K+ ++LL D K+SDFG D + + +VGT
Sbjct: 152 QALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPY 206
Query: 690 YMSPEYALHGLFSIKSDVFSFGVLLLE 716
+M+PE L++ + D++S G++++E
Sbjct: 207 WMAPEVISRSLYATEVDIWSLGIMVIE 233
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 60/247 (24%), Positives = 106/247 (42%), Gaps = 35/247 (14%)
Query: 482 AKEFCEGDSAGTGKSKESWFLFFSLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEIC 541
K+ E + + + FL D+F + ++LG G G V+K +
Sbjct: 1 GKKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHK----- 55
Query: 542 NWKQGKLLNGEEVAVKRLSSKSGQGLEEFK---NEMMLIAKLQHRNLVRLFGCCIEQGEK 598
+G +A K + + E+ ++ + +V +G GE
Sbjct: 56 -------PSGLVMARKLIHLEIKP--AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE- 105
Query: 599 ISIY-EF-------DIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKA 650
ISI E ++ R + ++ V +GL YL + +++HRD+K
Sbjct: 106 ISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKP 160
Query: 651 SNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSF 710
SN+L++S K+ DFG++ G + S N VGT YMSPE +S++SD++S
Sbjct: 161 SNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSM 216
Query: 711 GVLLLEI 717
G+ L+E+
Sbjct: 217 GLSLVEM 223
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 56/212 (26%), Positives = 89/212 (41%), Gaps = 34/212 (16%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLS----SKSGQGLEEFKNEMMLI 577
LG+GGF ++ + E A K + K Q E+ E+ +
Sbjct: 49 LGKGGFAKCFEISD------------ADTKEVFAGKIVPKSLLLKPHQ-REKMSMEISIH 95
Query: 578 AKLQHRNLVRLFGCCIEQGEKI-SIYE-------FDIVTDPARKDLLDWTTRVRIIEGVA 629
L H+++V G E + + + E ++ RK L + R + +
Sbjct: 96 RSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHK--RRKALTEPEAR-YYLRQIV 151
Query: 630 QGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYG 689
G YLH+ RVIHRDLK N+ L+ D+ KI DFG+A D + + GT
Sbjct: 152 LGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPN 206
Query: 690 YMSPEYALHGLFSIKSDVFSFGVLLLEILSSK 721
Y++PE S + DV+S G ++ +L K
Sbjct: 207 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 49/215 (22%), Positives = 88/215 (40%), Gaps = 35/215 (16%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVK--RLSSKSGQGLEEFKNEMMLIA 578
++G G F VYK ++ EVA + + + FK E ++
Sbjct: 33 EIGRGSFKTVYKGLDTE------------TTVEVAWCELQDRKLTKSERQRFKEEAEMLK 80
Query: 579 KLQHRNLVRLFGCCI---EQGEKISIY-EF-------DIVTDPARKDLLDWTTRVRIIEG 627
LQH N+VR + + + I + E + R ++
Sbjct: 81 GLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQ 137
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDS-DMNPKISDFGIARTFGGDEMQSNTNRIVG 686
+ +GL +LH +IHRDLK N+ + + KI D G+A ++ ++G
Sbjct: 138 ILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIG 192
Query: 687 TYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSK 721
T +M+PE + DV++FG+ +LE+ +S+
Sbjct: 193 TPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSE 226
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 2e-28
Identities = 57/212 (26%), Positives = 89/212 (41%), Gaps = 34/212 (16%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLS----SKSGQGLEEFKNEMMLI 577
LG+GGF ++ + E A K + K Q E+ E+ +
Sbjct: 23 LGKGGFAKCFEISD------------ADTKEVFAGKIVPKSLLLKPHQ-REKMSMEISIH 69
Query: 578 AKLQHRNLVRLFGCCIEQGEKI-SIYE-------FDIVTDPARKDLLDWTTRVRIIEGVA 629
L H+++V G E + + + E ++ RK L + R + +
Sbjct: 70 RSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHK--RRKALTEPEAR-YYLRQIV 125
Query: 630 QGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYG 689
G YLH R RVIHRDLK N+ L+ D+ KI DFG+A D + + GT
Sbjct: 126 LGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPN 180
Query: 690 YMSPEYALHGLFSIKSDVFSFGVLLLEILSSK 721
Y++PE S + DV+S G ++ +L K
Sbjct: 181 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 55/228 (24%), Positives = 95/228 (41%), Gaps = 38/228 (16%)
Query: 507 SSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQG 566
+ + ++G G FG V++ + G + AVK++
Sbjct: 51 YEYREEVHWMTHQPRVGRGSFGEVHRMKD------------KQTGFQCAVKKVR------ 92
Query: 567 LEEFK-NEMMLIAKLQHRNLVRLFGCCIEQGEKISIY-EF-------DIVTDPARKDLLD 617
LE F+ E++ A L +V L+G E G ++I+ E ++ + L
Sbjct: 93 LEVFRVEELVACAGLSSPRIVPLYGAVRE-GPWVNIFMELLEGGSLGQLIK---QMGCLP 148
Query: 618 WTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP-KISDFGIARTFGGDE 676
+ + +GL YLH R++H D+KA NVLL SD + + DFG A D
Sbjct: 149 EDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205
Query: 677 MQSNTNR---IVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSK 721
+ + I GT +M+PE + K D++S ++L +L+
Sbjct: 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 55/216 (25%), Positives = 100/216 (46%), Gaps = 31/216 (14%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN 572
+ + +LG+G FG VYK+ + G A K + +KS + LE++
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNK------------ETGALAAAKVIETKSEEELEDYIV 65
Query: 573 EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF-------DIVTDPARKDLLDWTTRVRII 625
E+ ++A H +V+L G G+ + EF I+ + R L +
Sbjct: 66 EIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVVC 123
Query: 626 EGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIV 685
+ + L +LH R+IHRDLKA NVL+ + + +++DFG++ + ++ +
Sbjct: 124 RQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FI 178
Query: 686 GTYGYMSPEYALHGLFS-----IKSDVFSFGVLLLE 716
GT +M+PE + K+D++S G+ L+E
Sbjct: 179 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIE 214
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-27
Identities = 53/225 (23%), Positives = 93/225 (41%), Gaps = 37/225 (16%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEE-FK 571
+ + +LG GGFG V + I + GE+VA+K+ + E +
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQ------------DTGEQVAIKQCRQELSPKNRERWC 60
Query: 572 NEMMLIAKLQHRNLVRLFGCCIEQGEKISIYE--------------FDIVTDPARKDLLD 617
E+ ++ KL H N+V + +K++ + + L
Sbjct: 61 LEIQIMKKLNHPNVVSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLK 119
Query: 618 WTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS---DMNPKISDFGIARTFGG 674
++ ++ L YLH+ R+IHRDLK N++L + KI D G A+
Sbjct: 120 EGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ 176
Query: 675 DEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
E+ + VGT Y++PE +++ D +SFG L E ++
Sbjct: 177 GELCTE---FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECIT 218
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 59/221 (26%), Positives = 106/221 (47%), Gaps = 31/221 (14%)
Query: 506 LSSISAATD---NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK 562
L S F KLGEG +G VYK+I + G+ VA+K++ +
Sbjct: 18 LDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHK------------ETGQIVAIKQVPVE 65
Query: 563 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF-------DIVTDPARKDL 615
L+E E+ ++ + ++V+ +G + + + E+ DI+ R
Sbjct: 66 --SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIR--LRNKT 121
Query: 616 LDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGD 675
L I++ +GL YLH +R IHRD+KA N+LL+++ + K++DFG+A
Sbjct: 122 LTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178
Query: 676 EMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLE 716
+ NT ++GT +M+PE ++ +D++S G+ +E
Sbjct: 179 MAKRNT--VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIE 217
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 26/253 (10%), Positives = 56/253 (22%), Gaps = 61/253 (24%)
Query: 507 SSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---S 563
S +S L G V+ + E+ A+K + S
Sbjct: 55 SLLSQGERKLKLVEPLRVGDRSVVFLVRDV------------ERLEDFALKVFTMGAENS 102
Query: 564 GQGLEEFKNEMMLIAKLQHRNLVRLFGCC--------------------IEQGEKISIYE 603
LE A+L + + ++
Sbjct: 103 RSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVAN 162
Query: 604 FDIVTDPARKDL----------------LDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRD 647
+ ++ A DL + + + L ++H
Sbjct: 163 YLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGH 219
Query: 648 LKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHG--LFSIKS 705
N+ + D + D G + Y E+ F+
Sbjct: 220 FTPDNLFIMPDGRLMLGDVSALWKVG-----TRGPASSVPVTYAPREFLNASTATFTHAL 274
Query: 706 DVFSFGVLLLEIL 718
+ + G+ + +
Sbjct: 275 NAWQLGLSIYRVW 287
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 56/244 (22%), Positives = 97/244 (39%), Gaps = 40/244 (16%)
Query: 491 AGTGKSKESWFLFFSLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLN 550
+ K++ +L A ++ ++G G G V+K R
Sbjct: 2 SSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRK------------T 49
Query: 551 GEEVAVKRLSSKSGQGLEEFKNEMM----LIAKLQHRNLVRLFGCCIEQGEKISIY-EF- 604
G +AVK++ + EE K +M ++ +V+ FG I + I E
Sbjct: 50 GHVIAVKQMRRSGNK--EENKRILMDLDVVLKSHDCPYIVQCFGTFITNT-DVFIAMELM 106
Query: 605 DIVTDPARKDLLDWTTRV------RIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSD 658
+ K + ++ + + L YL + VIHRD+K SN+LLD
Sbjct: 107 GTCAE---KLKKRMQGPIPERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDER 161
Query: 659 MNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPE-----YALHGLFSIKSDVFSFGVL 713
K+ DFGI+ D+ + + G YM+PE + I++DV+S G+
Sbjct: 162 GQIKLCDFGISGRL-VDDKAKDRS--AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGIS 218
Query: 714 LLEI 717
L+E+
Sbjct: 219 LVEL 222
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 55/209 (26%), Positives = 103/209 (49%), Gaps = 21/209 (10%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQG-LEEFK 571
+ F++ K+G+G FG V+K I+ + VA+K + + + +E+ +
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDN------------RTQKVVAIKIIDLEEAEDEIEDIQ 68
Query: 572 NEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF---DIVTDPARKDLLDWTTRVRIIEGV 628
E+ ++++ + + +G ++ + I E+ D LD T I+ +
Sbjct: 69 QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREI 128
Query: 629 AQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTY 688
+GL YLH + IHRD+KA+NVLL K++DFG+A +++ NT VGT
Sbjct: 129 LKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTP 183
Query: 689 GYMSPEYALHGLFSIKSDVFSFGVLLLEI 717
+M+PE + K+D++S G+ +E+
Sbjct: 184 FWMAPEVIKQSAYDSKADIWSLGITAIEL 212
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 55/228 (24%), Positives = 95/228 (41%), Gaps = 37/228 (16%)
Query: 507 SSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQG 566
++ + ++G G +G V K + + +G+ +AVKR+ S +
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHK------------PSGQIMAVKRIRSTVDE- 61
Query: 567 LEEFKNEMM----LIAKLQHRNLVRLFGCCIEQGEKISIY-EF-DIVTDPARKDLLDWTT 620
+E K +M ++ +V+ +G +G I E D K +
Sbjct: 62 -KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG-DCWICMELMSTSFDKFYKYVYSVLD 119
Query: 621 RV-------RIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFG 673
V +I + L +L L++IHRD+K SN+LLD N K+ DFGI+
Sbjct: 120 DVIPEEILGKITLATVKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177
Query: 674 GDEMQSNTNRIVGTYGYMSPE----YALHGLFSIKSDVFSFGVLLLEI 717
++ G YM+PE A + ++SDV+S G+ L E+
Sbjct: 178 DSIAKTRD---AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYEL 222
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-26
Identities = 58/248 (23%), Positives = 103/248 (41%), Gaps = 53/248 (21%)
Query: 492 GTGKSKESWFLFFSLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNG 551
G ++ F+ + ++ + KLG G +G V ++ +
Sbjct: 18 GDLQATPGMFITSKKGHL---SEMYQRVKKLGSGAYGEVLLCRDK------------VTH 62
Query: 552 EEVAVKRLSSK--SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTD 609
E A+K + S + E+ ++ L H N+++L+ ++ + Y +V +
Sbjct: 63 VERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKR---NYY---LVME 116
Query: 610 PAR-KDLLDWTTRVRIIEG--------------VAQGLLYLHQYSRLRVIHRDLKASNVL 654
+ +L D II V G+ YLH+ ++HRDLK N+L
Sbjct: 117 CYKGGELFD-----EIIHRMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLL 168
Query: 655 LDS---DMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFG 711
L+S D KI DFG++ F + +GT Y++PE L + K DV+S G
Sbjct: 169 LESKEKDALIKIVDFGLSAVFENQKKM---KERLGTAYYIAPE-VLRKKYDEKCDVWSIG 224
Query: 712 VLLLEILS 719
V+L +L+
Sbjct: 225 VILFILLA 232
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 52/250 (20%), Positives = 94/250 (37%), Gaps = 56/250 (22%)
Query: 505 SLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKR--LSSK 562
++ S T F E K+G G FG V+K ++R L+G A+KR
Sbjct: 2 AMGMKSRYTTEFHELEKIGSGEFGSVFKCVKR------------LDGCIYAIKRSKKPLA 49
Query: 563 SGQGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEQGEKISIY-EF-------DIVTDPARK 613
+ E+ A L QH ++VR F E + + I E+ D +++ R
Sbjct: 50 GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE-DDHMLIQNEYCNGGSLADAISENYRI 108
Query: 614 -DLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP----------- 661
++ V +GL Y+H + ++H D+K SN+ + P
Sbjct: 109 MSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165
Query: 662 --------KISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFS--IKSDVFSFG 711
KI D G S+ G +++ E L ++ K+D+F+
Sbjct: 166 WASNKVMFKIGDLGHVTRI------SSPQVEEGDSRFLANE-VLQENYTHLPKADIFALA 218
Query: 712 VLLLEILSSK 721
+ ++ ++
Sbjct: 219 LTVVCAAGAE 228
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-26
Identities = 58/243 (23%), Positives = 93/243 (38%), Gaps = 58/243 (23%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNE 573
+ E LG G G V QG G VAVKR+ + E
Sbjct: 15 NLVVSEKILGYGSSGTVVF------------QGSF-QGRPVAVKRMLIDF---CDIALME 58
Query: 574 M-MLIAKLQHRNLVRLFGCCIEQGEKISIY---E------FDIVTDPARKDLLDWTTR-- 621
+ +L H N++R + C E ++ +Y E D+V D +
Sbjct: 59 IKLLTESDDHPNVIRYY--CSETTDR-FLYIALELCNLNLQDLVESKNVSDENLKLQKEY 115
Query: 622 --VRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS-------------DMNPKISDF 666
+ ++ +A G+ +LH L++IHRDLK N+L+ + ++ ISDF
Sbjct: 116 NPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172
Query: 667 GIARTFGGDE--MQSNTNRIVGTYGYMSPEYALHGLFSI-------KSDVFSFGVLLLEI 717
G+ + + ++N N GT G+ +PE D+FS G + I
Sbjct: 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYI 232
Query: 718 LSS 720
LS
Sbjct: 233 LSK 235
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-26
Identities = 64/227 (28%), Positives = 101/227 (44%), Gaps = 50/227 (22%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK--SGQGLEEF 570
+ ++ LG+G FG V K +R + +E AVK ++ +
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDR------------ITQQEYAVKVINKASAKNKDTSTI 68
Query: 571 KNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPAR-KDLLDWTTRVRIIEG-- 627
E+ L+ KL H N+++LF + S Y IV + +L D II+
Sbjct: 69 LREVELLKKLDHPNIMKLFEILEDSS---SFY---IVGELYTGGELFD-----EIIKRKR 117
Query: 628 ------------VAQGLLYLHQYSRLRVIHRDLKASNVLLDS---DMNPKISDFGIARTF 672
V G+ Y+H+ ++HRDLK N+LL+S D + KI DFG++ F
Sbjct: 118 FSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174
Query: 673 GGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
+ +GT Y++PE L G + K DV+S GV+L +LS
Sbjct: 175 QQNTKM---KDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLS 217
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 59/226 (26%), Positives = 102/226 (45%), Gaps = 37/226 (16%)
Query: 507 SSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLS----SK 562
+ I ++F N LG+G F VY++ G EVA+K + K
Sbjct: 4 TCIGEKIEDFKVGNLLGKGSFAGVYRAESI------------HTGLEVAIKMIDKKAMYK 51
Query: 563 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKI----------SIYEFDIVTDPAR 612
+G ++ +NE+ + +L+H +++ L+ E + + + +
Sbjct: 52 AGM-VQRVQNEVKIHCQLKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRY-LKN--RV 106
Query: 613 KDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTF 672
K + R + + G+LYLH + ++HRDL SN+LL +MN KI+DFG+A
Sbjct: 107 KPFSENEAR-HFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQL 162
Query: 673 GGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEIL 718
+ T + GT Y+SPE A ++SDV+S G + +L
Sbjct: 163 KMPHEKHYT--LCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLL 206
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 37/217 (17%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLS-SKSGQGLEEFK 571
D F + KLG G FG V+ ER +G E +K ++ +S +E+ +
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEER------------SSGLERVIKTINKDRSQVPMEQIE 68
Query: 572 NEMMLIAKLQHRNLVRLFGCCIEQGEKISIY---------E-FD-IVTDPARKDLLDWTT 620
E+ ++ L H N++++F E + ++Y E + IV+ AR L
Sbjct: 69 AEIEVLKSLDHPNIIKIFEV-FE--DYHNMYIVMETCEGGELLERIVSAQARGKALSEGY 125
Query: 621 RVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS---DMNPKISDFGIARTFGGDEM 677
+++ + L Y H V+H+DLK N+L KI DFG+A F DE
Sbjct: 126 VAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH 182
Query: 678 QSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLL 714
+N GT YM+PE + K D++S GV++
Sbjct: 183 STN---AAGTALYMAPE-VFKRDVTFKCDIWSAGVVM 215
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-26
Identities = 69/253 (27%), Positives = 111/253 (43%), Gaps = 54/253 (21%)
Query: 488 GDSAGTGKSKESWFLFFSLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGK 547
G + F+ S + +D + + LG+G FG V ++
Sbjct: 3 GSMMDHLHATPGMFVQHSTAIF---SDRYKGQRVLGKGSFGEVILCKDK----------- 48
Query: 548 LLNGEEVAVKRLS---SKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF 604
+ G+E AVK +S K E E+ L+ +L H N+++L+ E +K Y
Sbjct: 49 -ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-E--DKGYFY-- 102
Query: 605 DIVTDPAR-KDLLDWTTRVRIIEG--------------VAQGLLYLHQYSRLRVIHRDLK 649
+V + +L D II V G+ Y+H+ +++HRDLK
Sbjct: 103 -LVGEVYTGGELFD-----EIISRKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLK 153
Query: 650 ASNVLLDS---DMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSD 706
N+LL+S D N +I DFG++ F + +GT Y++PE LHG + K D
Sbjct: 154 PENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDKIGTAYYIAPE-VLHGTYDEKCD 209
Query: 707 VFSFGVLLLEILS 719
V+S GV+L +LS
Sbjct: 210 VWSTGVILYILLS 222
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 6e-26
Identities = 28/242 (11%), Positives = 65/242 (26%), Gaps = 61/242 (25%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSS---KSGQGLEEFKNEMMLIA 578
LG+ ++ ++ GE V +++ K E++ +
Sbjct: 86 LGQEDPYAYLEATDQ------------ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLR 133
Query: 579 KLQH----------------RNLVRLFGCC-----IEQGEKISIYEFDIVTDPARKDLLD 617
L+ +LV+ + + + + +L
Sbjct: 134 LLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQT 193
Query: 618 ----------------WTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP 661
R+++ V + L LH ++H L+ +++LD
Sbjct: 194 FGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGV 250
Query: 662 KISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYAL-----HGLFSIKSDVFSFGVLLLE 716
++ F G S R + L + D ++ G+ +
Sbjct: 251 FLTGFEHLVRD-GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309
Query: 717 IL 718
I
Sbjct: 310 IW 311
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 62/222 (27%), Positives = 98/222 (44%), Gaps = 50/222 (22%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK--SGQGLEEF 570
+ ++ LG+G FG V K +R + +E AVK ++ +
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDR------------ITQQEYAVKVINKASAKNKDTSTI 68
Query: 571 KNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPAR-KDLLDWTTRVRIIEG-- 627
E+ L+ KL H N+++LF + S Y IV + +L D II+
Sbjct: 69 LREVELLKKLDHPNIMKLFEILEDSS---SFY---IVGELYTGGELFD-----EIIKRKR 117
Query: 628 ------------VAQGLLYLHQYSRLRVIHRDLKASNVLLDS---DMNPKISDFGIARTF 672
V G+ Y+H+ ++HRDLK N+LL+S D + KI DFG++ F
Sbjct: 118 FSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174
Query: 673 GGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLL 714
+ +GT Y++PE L G + K DV+S GV+L
Sbjct: 175 QQNTK---MKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 8e-26
Identities = 46/212 (21%), Positives = 85/212 (40%), Gaps = 31/212 (14%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN 572
D + +LG G FG V++ +E+ G K +++ KN
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEK------------ATGRVFVAKFINTPYPLDKYTVKN 97
Query: 573 EMMLIAKLQHRNLVRLFGCCIEQGEKISIYE-------FD-IVTDPARKDLLDWTTRVRI 624
E+ ++ +L H L+ L ++ E + I E FD I A + +
Sbjct: 98 EISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA---AEDYKMSEAEVINY 154
Query: 625 IEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP--KISDFGIARTFGGDEMQSNTN 682
+ +GL ++H+ ++H D+K N++ ++ KI DFG+A DE+
Sbjct: 155 MRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV-- 209
Query: 683 RIVGTYGYMSPEYALHGLFSIKSDVFSFGVLL 714
T + +PE +D+++ GVL
Sbjct: 210 -TTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 56/271 (20%), Positives = 89/271 (32%), Gaps = 72/271 (26%)
Query: 514 DNFSEENKLGEGGFGPVYK-------------------------SIERYVEI-------- 540
+F +G GGFG V++ + R V+
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 541 ----------CNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFG 590
++ + E + + I ++ + G
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 591 CCIEQGEKISIYEFDIVTDPARK-DLLDWTTR------------VRIIEGVAQGLLYLHQ 637
K+ +Y I RK +L DW R + I +A+ + +LH
Sbjct: 126 QLQPSSPKVYLY---IQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS 182
Query: 638 YSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTN----------RIVGT 687
++HRDLK SN+ D K+ DFG+ DE + VGT
Sbjct: 183 ---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239
Query: 688 YGYMSPEYALHGLFSIKSDVFSFGVLLLEIL 718
YMSPE +S K D+FS G++L E+L
Sbjct: 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 55/220 (25%), Positives = 94/220 (42%), Gaps = 48/220 (21%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN 572
++ EN +G G +G V ++++ A K++ + ++ FK
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQK------------GTRIRRAAKKIPKYFVEDVDRFKQ 55
Query: 573 EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPAR-KDLLDWTTRVRIIEG---- 627
E+ ++ L H N++RL+ E + IY +V + +L + R++
Sbjct: 56 EIEIMKSLDHPNIIRLYE-TFE--DNTDIY---LVMELCTGGELFE-----RVVHKRVFR 104
Query: 628 ----------VAQGLLYLHQYSRLRVIHRDLKASNVLLDS---DMNPKISDFGIARTFGG 674
V + Y H+ L V HRDLK N L + D K+ DFG+A F
Sbjct: 105 ESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161
Query: 675 DEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLL 714
+M VGT Y+SP+ L GL+ + D +S GV++
Sbjct: 162 GKMMRT---KVGTPYYVSPQ-VLEGLYGPECDEWSAGVMM 197
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 52/219 (23%), Positives = 85/219 (38%), Gaps = 46/219 (21%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN 572
F LG G F V+ +R L G+ A+K + +N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQR------------LTGKLFALKCIKKSPAFRDSSLEN 55
Query: 573 EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFD----IVTDPAR-KDLLDWTTR------ 621
E+ ++ K++H N+V L IYE +V +L D
Sbjct: 56 EIAVLKKIKHENIVTLED----------IYESTTHYYLVMQLVSGGELFDRILERGVYTE 105
Query: 622 ---VRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS---DMNPKISDFGIARTFGGD 675
+I+ V + YLH+ ++HRDLK N+L + + I+DFG+++
Sbjct: 106 KDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162
Query: 676 EMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLL 714
M + GT GY++PE +S D +S GV+
Sbjct: 163 IMST----ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 44/212 (20%), Positives = 81/212 (38%), Gaps = 32/212 (15%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN 572
+ + LG G FG V++ +E + + K + G K
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVET------------SSKKTYMAKFVK-VKGTDQVLVKK 50
Query: 573 EMMLIAKLQHRNLVRLFGCCIEQGEKISIYE-------FD-IVTDPARKDLLDWTTRVRI 624
E+ ++ +HRN++ L E + I+E F+ I L+ V
Sbjct: 51 EISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSY 107
Query: 625 IEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP--KISDFGIARTFGGDEMQSNTN 682
+ V + L +LH + H D++ N++ + + KI +FG AR +
Sbjct: 108 VHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-- 162
Query: 683 RIVGTYGYMSPEYALHGLFSIKSDVFSFGVLL 714
+ Y +PE H + S +D++S G L+
Sbjct: 163 -LFTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-25
Identities = 47/232 (20%), Positives = 86/232 (37%), Gaps = 36/232 (15%)
Query: 505 SLSSISAATDNFSEENKLGEG--GFGPVYKSIERYVEICNWKQGKLLNGEEVAVKR--LS 560
+SS + +G+G V + + GE V V+R L
Sbjct: 16 GMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYK------------PTGEYVTVRRINLE 63
Query: 561 SKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF-------DIVTDPARK 613
+ S + + + E+ + H N+V I E + F D++
Sbjct: 64 ACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLIC-THFM 122
Query: 614 DLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFG 673
D ++ I++GV + L Y+H + +HR +KAS++L+ D +S +
Sbjct: 123 DGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179
Query: 674 GDEMQSNT-----NRIVGTYGYMSPE---YALHGLFSIKSDVFSFGVLLLEI 717
+ V ++SPE L G + KSD++S G+ E+
Sbjct: 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQG-YDAKSDIYSVGITACEL 230
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-25
Identities = 59/256 (23%), Positives = 104/256 (40%), Gaps = 64/256 (25%)
Query: 495 KSKESWFLFFSLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEV 554
++ I +++ + KLG G +G V E+ E
Sbjct: 20 AINPGMYVRKKEGKI---GESYFKVRKLGSGAYGEVLLCKEK------------NGHSEK 64
Query: 555 AVKRLS-------------SKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISI 601
A+K + + EE NE+ L+ L H N+++LF ++
Sbjct: 65 AIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKK---YF 121
Query: 602 YEFDIVTDPAR-KDLLDWTTRVRIIEG--------------VAQGLLYLHQYSRLRVIHR 646
Y +VT+ +L + +II + G+ YLH+ ++HR
Sbjct: 122 Y---LVTEFYEGGELFE-----QIINRHKFDECDAANIMKQILSGICYLHK---HNIVHR 170
Query: 647 DLKASNVLLDS---DMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSI 703
D+K N+LL++ +N KI DFG++ F D + +GT Y++PE L ++
Sbjct: 171 DIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD---RLGTAYYIAPE-VLKKKYNE 226
Query: 704 KSDVFSFGVLLLEILS 719
K DV+S GV++ +L
Sbjct: 227 KCDVWSCGVIMYILLC 242
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-25
Identities = 50/211 (23%), Positives = 86/211 (40%), Gaps = 29/211 (13%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN 572
D++ +LG G FG V++ ER G A K + + E +
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTER------------ATGNNFAAKFVMTPHESDKETVRK 203
Query: 573 EMMLIAKLQHRNLVRLFGCCIEQGEKISIYE-------FDIVTDPARKDLLDWTTRVRII 625
E+ ++ L+H LV L + E + IYE F+ V D + + V +
Sbjct: 204 EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYM 261
Query: 626 EGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP--KISDFGIARTFGGDEMQSNTNR 683
V +GL ++H+ +H DLK N++ + + K+ DFG+ + +
Sbjct: 262 RQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKV 315
Query: 684 IVGTYGYMSPEYALHGLFSIKSDVFSFGVLL 714
GT + +PE A +D++S GVL
Sbjct: 316 TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-24
Identities = 53/210 (25%), Positives = 96/210 (45%), Gaps = 31/210 (14%)
Query: 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEM 574
S+ LG G FG V+K E G ++A K + ++ + EE KNE+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEET------------ATGLKLAAKIIKTRGMKDKEEVKNEI 137
Query: 575 MLIAKLQHRNLVRLFGCCIEQGEKISIYE-------FD-IVTDPARKDLLDWTTRVRIIE 626
++ +L H NL++L+ + + + + E FD I+ L + ++
Sbjct: 138 SVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRII---DESYNLTELDTILFMK 194
Query: 627 GVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP--KISDFGIARTFGGDEMQSNTNRI 684
+ +G+ ++HQ + ++H DLK N+L + KI DFG+AR + E
Sbjct: 195 QICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV---N 248
Query: 685 VGTYGYMSPEYALHGLFSIKSDVFSFGVLL 714
GT +++PE + S +D++S GV+
Sbjct: 249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 59/220 (26%), Positives = 96/220 (43%), Gaps = 42/220 (19%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLS----SKSGQGLEE 569
++F LG+G FG VY + E+ + +A+K L K+G +
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREK------------QSKFILALKVLFKAQLEKAGV-EHQ 55
Query: 570 FKNEMMLIAKLQHRNLVRLFGCCIEQGEKI-SIYE-------FDIVTDPARKDLLDWTTR 621
+ E+ + + L+H N++RL+G ++ I E + + + T
Sbjct: 56 LRREVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTA 112
Query: 622 VRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNT 681
I +A L Y H RVIHRD+K N+LL S KI+DFG + + + +
Sbjct: 113 -TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPS 161
Query: 682 NR---IVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEIL 718
+R + GT Y+ PE + K D++S GVL E L
Sbjct: 162 SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL 201
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 35/217 (16%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLS---SKSGQGLEE 569
FS+ ++G G FG VY + + N E VA+K++S +S + ++
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVR------------NSEVVAIKKMSYSGKQSNEKWQD 100
Query: 570 FKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF------DIVTDPARKDLLDWTTRVR 623
E+ + KL+H N ++ GC + + + E+ D++ K L
Sbjct: 101 IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAA 158
Query: 624 IIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNR 683
+ G QGL YLH +IHRD+KA N+LL K+ DFG A +N+
Sbjct: 159 VTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA----PANS-- 209
Query: 684 IVGTYGYMSPEYALH---GLFSIKSDVFSFGVLLLEI 717
VGT +M+PE L G + K DV+S G+ +E+
Sbjct: 210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 246
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-24
Identities = 54/229 (23%), Positives = 85/229 (37%), Gaps = 55/229 (24%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVK-----RLSSKSGQGL 567
D + +G+G F V + I R G++ AVK + +S G
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINR------------ETGQQFAVKIVDVAKFTSSPGLST 70
Query: 568 EEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK-DLLDWTTRVRIIE 626
E+ K E + L+H ++V L G +Y +V + DL I++
Sbjct: 71 EDLKREASICHMLKHPHIVELLETYSSDG---MLY---MVFEFMDGADLCF-----EIVK 119
Query: 627 G------------------VAQGLLYLHQYSRLRVIHRDLKASNVLLDS---DMNPKISD 665
+ + L Y H +IHRD+K VLL S K+
Sbjct: 120 RADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGG 176
Query: 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLL 714
FG+A G + + VGT +M+PE + DV+ GV+L
Sbjct: 177 FGVAIQLGESGLVAGG--RVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 60/232 (25%), Positives = 98/232 (42%), Gaps = 36/232 (15%)
Query: 504 FSLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS 563
LS++ F +G G +G VYK G+ A+K +
Sbjct: 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHV------------KTGQLAAIKVMDVT- 60
Query: 564 GQGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEQGEKISIYEFDIVTD----PARKDLLDW 618
G EE K E+ ++ K HRN+ +G I++ + +V + + DL+
Sbjct: 61 GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN 120
Query: 619 TTRVRIIEG--------VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIAR 670
T + E + +GL +LHQ +VIHRD+K NVLL + K+ DFG++
Sbjct: 121 TKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSA 177
Query: 671 TFGGDEMQSNTNRIVGTYGYMSPEYALHGLFS-----IKSDVFSFGVLLLEI 717
+ NT +GT +M+PE KSD++S G+ +E+
Sbjct: 178 QLDRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 227
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 7e-24
Identities = 55/221 (24%), Positives = 99/221 (44%), Gaps = 32/221 (14%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLS-SKSGQGLEEFKN 572
D++ + +G G V + E+VA+KR++ K ++E
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCA------------PKKEKVAIKRINLEKCQTSMDELLK 62
Query: 573 EMMLIAKLQHRNLVRLFGCCIEQ------------GEKISIYEFDIVTDPARKDLLDWTT 620
E+ +++ H N+V + + + G + I + + + +LD +T
Sbjct: 63 EIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 122
Query: 621 RVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIA---RTFGGDEM 677
I+ V +GL YLH + IHRD+KA N+LL D + +I+DFG++ T G
Sbjct: 123 IATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITR 179
Query: 678 QSNTNRIVGTYGYMSPEYALHGL-FSIKSDVFSFGVLLLEI 717
VGT +M+PE + K+D++SFG+ +E+
Sbjct: 180 NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIEL 220
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 28/235 (11%), Positives = 67/235 (28%), Gaps = 30/235 (12%)
Query: 507 SSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQG 566
+ + + LGEG F VY++ + N ++ +K +
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQG-------DLNDAKNKQKFVLKVQKPANPWE 110
Query: 567 LEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYE-------FDIV--TDPARKDLLD 617
M + ++ + + Q + + E + + + ++
Sbjct: 111 FYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMP 170
Query: 618 WTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLL-----------DSDMNPKISDF 666
+ + + +H +IH D+K N +L D + D
Sbjct: 171 QGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDL 227
Query: 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSK 721
G + + T G+ E + ++ + D F + +L
Sbjct: 228 GQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-23
Identities = 59/258 (22%), Positives = 97/258 (37%), Gaps = 55/258 (21%)
Query: 487 EGDSAGTGKSKESWFLFFSLSS--ISAATDNFSEE----NKLGEGGFGPVYKSIERYVEI 540
S+ F+FF L+ S +E LG G G V + ER
Sbjct: 102 NNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFER---- 157
Query: 541 CNWKQGKLLNGEEVAVKRLS--------SKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592
++VA++ +S ++ + E+ ++ KL H ++++
Sbjct: 158 --------KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF 209
Query: 593 IEQGEKISIYEFDIVTDPAR-KDLLDW-TTRVRIIEGVA--------QGLLYLHQYSRLR 642
+ Y IV + +L D R+ E + YLH+
Sbjct: 210 ----DAEDYY---IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE---NG 259
Query: 643 VIHRDLKASNVLLDS---DMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPE---YA 696
+IHRDLK NVLL S D KI+DFG ++ G + + GT Y++PE
Sbjct: 260 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSV 316
Query: 697 LHGLFSIKSDVFSFGVLL 714
++ D +S GV+L
Sbjct: 317 GTAGYNRAVDCWSLGVIL 334
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 42/197 (21%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN- 572
+NF + K+GEG +G VYK+ + L GE VA+K++ L+
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNK------------LTGEVVALKKIR------LDTETEG 44
Query: 573 -------EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTRVRII 625
E+ L+ +L H N+V+L + + ++EF + D K +D + I
Sbjct: 45 VPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQD--LKKFMDASALTGIP 101
Query: 626 EGVA--------QGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEM 677
+ QGL + H + RV+HRDLK N+L++++ K++DFG+AR F G +
Sbjct: 102 LPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPV 157
Query: 678 QSNTNRIVGTYGYMSPE 694
++ T+ +V T Y +PE
Sbjct: 158 RTYTHEVV-TLWYRAPE 173
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 4e-23
Identities = 56/226 (24%), Positives = 94/226 (41%), Gaps = 53/226 (23%)
Query: 513 TDNFSEE----NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK--SGQG 566
+ FS+ +LG+G F V + + + G E A K +++K S +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHK------------TTGLEFAAKIINTKKLSARD 48
Query: 567 LEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK-DLLDWTTRVRII 625
++ + E + KLQH N+VRL E+ Y +V D +L + I+
Sbjct: 49 FQKLEREARICRKLQHPNIVRLHDSIQEES---FHY---LVFDLVTGGELFE-----DIV 97
Query: 626 EG--------------VAQGLLYLHQYSRLRVIHRDLKASNVLLDS---DMNPKISDFGI 668
+ + + Y H ++HR+LK N+LL S K++DFG+
Sbjct: 98 AREFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGL 154
Query: 669 ARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLL 714
A E + GT GY+SPE +S D+++ GV+L
Sbjct: 155 AIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 99.5 bits (249), Expect = 4e-23
Identities = 58/230 (25%), Positives = 104/230 (45%), Gaps = 52/230 (22%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN- 572
+ + K+GEG +G V+K+ R E VA+KR+ L++
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNR------------ETHEIVALKRVR------LDDDDEG 43
Query: 573 -------EMMLIAKLQHRNLVRLFGCCIEQGEKISIY---EFDIVTDPARKDLLDWTTRV 622
E+ L+ +L+H+N+VRL + +K + EF D K D +
Sbjct: 44 VPSSALREICLLKELKHKNIVRLH--DVLHSDK-KLTLVFEF-CDQD--LKKYFD-SCNG 96
Query: 623 RIIEGVA--------QGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGG 674
+ + +GL + H V+HRDLK N+L++ + K+++FG+AR F G
Sbjct: 97 DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-G 152
Query: 675 DEMQSNTNRIVGTYGYMSPEYALHG--LFSIKSDVFSFGVLLLEILSSKK 722
++ + +V T Y P+ L G L+S D++S G + E+ ++ +
Sbjct: 153 IPVRCYSAEVV-TLWYRPPD-VLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 46/225 (20%), Positives = 88/225 (39%), Gaps = 43/225 (19%)
Query: 521 KLGEGGFGPVY--KSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQG-------LEEFK 571
L +G F + + ++ + K + KR +KS ++FK
Sbjct: 38 TLNQGKFNKIILCEKDNKFYAL------KKYEKSLLEKKRDFTKSNNDKISIKSKYDDFK 91
Query: 572 NEMMLIAKLQHRNLVRLFGCC------------IEQGEKIS-IYEFDIVTDPARKDLLDW 618
NE+ +I +++ + G +E + F ++ +
Sbjct: 92 NELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQ 151
Query: 619 TTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQ 678
+ II+ V Y+H + + HRD+K SN+L+D + K+SDFG + +++
Sbjct: 152 VIK-CIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK 208
Query: 679 SNTNRIVGTYGYMSPE-----YALHGLFSIKSDVFSFGVLLLEIL 718
GTY +M PE + +G K D++S G+ L +
Sbjct: 209 G----SRGTYEFMPPEFFSNESSYNGA---KVDIWSLGICLYVMF 246
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-23
Identities = 60/240 (25%), Positives = 105/240 (43%), Gaps = 42/240 (17%)
Query: 490 SAGTGKSKESWFLFFSLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLL 549
+ G + S F+ + + +DN+ + +LG+G F V + + +
Sbjct: 8 TGGQQMGRGSEFMMNASTKF---SDNYDVKEELGKGAFSVVRRCVHK------------T 52
Query: 550 NGEEVAVKRLSSK--SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIV 607
G E A K +++K S + ++ + E + KLQH N+VRL I+ E+ Y +V
Sbjct: 53 TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS-IQ--EESFHY---LV 106
Query: 608 TDPARK-DLLDWTTRV---------RIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS 657
D +L + I+ + + + Y H ++HR+LK N+LL S
Sbjct: 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLAS 163
Query: 658 ---DMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLL 714
K++DFG+A E + GT GY+SPE +S D+++ GV+L
Sbjct: 164 KAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 9e-23
Identities = 56/219 (25%), Positives = 96/219 (43%), Gaps = 38/219 (17%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVK-----RLSSK-SGQG 566
D++ +LG G F V K ++ G+E A K RLSS G
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQK------------GTGKEYAAKFIKKRRLSSSRRGVS 51
Query: 567 LEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYE-------FDIVTDPARKDLLDWT 619
EE + E+ ++ +++H N++ L + + + I E FD + + K+ L
Sbjct: 52 REEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE---KESLTED 108
Query: 620 TRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP----KISDFGIARTFGGD 675
+ ++ + G+ YLH R+ H DLK N++L P K+ DFGIA
Sbjct: 109 EATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG 165
Query: 676 EMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLL 714
N I GT +++PE + +++D++S GV+
Sbjct: 166 NEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 100 bits (249), Expect = 9e-23
Identities = 30/249 (12%), Positives = 74/249 (29%), Gaps = 72/249 (28%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSS---KSGQGLEEFKNEMMLIA 578
LG+ ++ ++ GE V +++ K E++ +
Sbjct: 81 LGQEDPYAYLEATDQ------------ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLR 128
Query: 579 KLQ-------------------------HRNLVRLFG----------CCIEQGEKISIYE 603
L+ + ++R+ + + ++
Sbjct: 129 LLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQT 188
Query: 604 F--DIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP 661
F +++ + L R+++ V + L LH Y ++H L+ +++LD
Sbjct: 189 FGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGV 245
Query: 662 KISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH-----------GLFSIKSDVFSF 710
++ F G + G+ PE L + D ++
Sbjct: 246 FLTGFEHLVRDG------ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWAL 299
Query: 711 GVLLLEILS 719
G+++ I
Sbjct: 300 GLVIYWIWC 308
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-22
Identities = 54/220 (24%), Positives = 93/220 (42%), Gaps = 40/220 (18%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVK------RLSSKSGQG 566
D + +LG G F V K E+ G E A K +S+ G
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREK------------STGLEYAAKFIKKRQSRASRRGVC 58
Query: 567 LEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYE-------FDIVTDPARKDLLDWT 619
EE + E+ ++ ++ H N++ L + + + I E FD + K+ L
Sbjct: 59 REEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQ---KESLSEE 115
Query: 620 TRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP----KISDFGIARTFG-G 674
I+ + G+ YLH ++ H DLK N++L P K+ DFG+A G
Sbjct: 116 EATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 675 DEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLL 714
E ++ I GT +++PE + +++D++S GV+
Sbjct: 173 VEFKN----IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 58/235 (24%), Positives = 96/235 (40%), Gaps = 54/235 (22%)
Query: 510 SAATDNFSEE----NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQ 565
S +T F E LG G V + I + +E AVK + G
Sbjct: 9 SHSTHGFYENYEPKEILGRGVSSVVRRCIHK------------PTCKEYAVKIIDVTGGG 56
Query: 566 GL---------EEFKNEMMLIAKL-QHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK-D 614
E E+ ++ K+ H N+++L E + +V D +K +
Sbjct: 57 SFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY-E--TNTFFF---LVFDLMKKGE 110
Query: 615 LLDWTTRV---------RIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665
L D+ T +I+ + + + LH+ L ++HRDLK N+LLD DMN K++D
Sbjct: 111 LFDYLTEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTD 167
Query: 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPE------YALHGLFSIKSDVFSFGVLL 714
FG + E + GT Y++PE H + + D++S GV++
Sbjct: 168 FGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 3e-22
Identities = 54/197 (27%), Positives = 94/197 (47%), Gaps = 44/197 (22%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN- 572
+ + + K+GEG +G VYK+ + G VA+KR+ L+
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDS-------------QGRIVALKRIR------LDAEDEG 61
Query: 573 -------EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTRVRII 625
E+ L+ +L H N+V L + ++EF + D K +LD + +
Sbjct: 62 IPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF-MEKD--LKKVLD-ENKTGLQ 117
Query: 626 EGVA--------QGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEM 677
+ +G+ + HQ+ R++HRDLK N+L++SD K++DFG+AR F G +
Sbjct: 118 DSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPV 173
Query: 678 QSNTNRIVGTYGYMSPE 694
+S T+ +V T Y +P+
Sbjct: 174 RSYTHEVV-TLWYRAPD 189
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-22
Identities = 50/227 (22%), Positives = 93/227 (40%), Gaps = 49/227 (21%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQG------ 566
+ ++ +G G V + + R G E AVK + + +
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHR------------ATGHEFAVKIMEVTAERLSPEQLE 140
Query: 567 --LEEFKNEMMLIAKL-QHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK-DLLDWTTRV 622
E + E ++ ++ H +++ L E ++ +V D RK +L D+ T
Sbjct: 141 EVREATRRETHILRQVAGHPHIITLIDSY-E--SSSFMF---LVFDLMRKGELFDYLTEK 194
Query: 623 ---------RIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFG 673
I+ + + + +LH ++HRDLK N+LLD +M ++SDFG +
Sbjct: 195 VALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251
Query: 674 GDEMQSNTNRIVGTYGYMSPE------YALHGLFSIKSDVFSFGVLL 714
E + GT GY++PE H + + D+++ GV+L
Sbjct: 252 PGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 3e-22
Identities = 54/283 (19%), Positives = 96/283 (33%), Gaps = 75/283 (26%)
Query: 493 TGKSKESWFLFFSLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGE 552
+ + +F SL + + + +G+G +G V +IE
Sbjct: 8 SSGRENLYFQGGSLLEL---QKKYHLKGAIGQGSYGVVRVAIEN------------QTRA 52
Query: 553 EVAVK-----RLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGC------------CIEQ 595
A+K ++ + + +E K E+ L+ KL H N+ RL+
Sbjct: 53 IRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHG 112
Query: 596 GE---KISIYEFDIVTDPARKDLLDWTTRV-----------------------------R 623
G K++++ D A +
Sbjct: 113 GHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISN 172
Query: 624 IIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSD--MNPKISDFGIARTFGGDEMQSNT 681
I+ + L YLH + HRD+K N L ++ K+ DFG+++ F
Sbjct: 173 IMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYY 229
Query: 682 --NRIVGTYGYMSPEYALHGL---FSIKSDVFSFGVLLLEILS 719
GT +++PE L+ + K D +S GVLL +L
Sbjct: 230 GMTTKAGTPYFVAPE-VLNTTNESYGPKCDAWSAGVLLHLLLM 271
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 62/239 (25%), Positives = 97/239 (40%), Gaps = 75/239 (31%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLS------------------SKS 563
+G+G +G V + + A+K LS ++
Sbjct: 21 IGKGSYGVVKLAY------------NENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRP 68
Query: 564 GQGLEEFKNEMML-----IA---KLQHRNLVRLFGCCIEQGEKISIY---E-------FD 605
G + IA KL H N+V+L ++ + +Y E +
Sbjct: 69 APGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPVME 127
Query: 606 IVT------DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDM 659
+ T D AR D +I+G+ YLH ++IHRD+K SN+L+ D
Sbjct: 128 VPTLKPLSEDQARFYFQD------LIKGIE----YLH---YQKIIHRDIKPSNLLVGEDG 174
Query: 660 NPKISDFGIARTF-GGDEMQSNTNRIVGTYGYMSPE--YALHGLFS-IKSDVFSFGVLL 714
+ KI+DFG++ F G D + SNT VGT +M+PE +FS DV++ GV L
Sbjct: 175 HIKIADFGVSNEFKGSDALLSNT---VGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 4e-22
Identities = 53/219 (24%), Positives = 90/219 (41%), Gaps = 38/219 (17%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVK------RLSSKSGQG 566
D + +LG G F V K E+ G E A K +S+ G
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREK------------STGLEYAAKFIKKRQSRASRRGVS 58
Query: 567 LEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYE-------FDIVTDPARKDLLDWT 619
EE + E+ ++ ++ H N++ L + + + I E FD + K+ L
Sbjct: 59 REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQ---KESLSEE 115
Query: 620 TRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP----KISDFGIARTFGGD 675
I+ + G+ YLH ++ H DLK N++L P K+ DFG+A
Sbjct: 116 EATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 676 EMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLL 714
N I GT +++PE + +++D++S GV+
Sbjct: 173 VEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 4e-22
Identities = 55/219 (25%), Positives = 94/219 (42%), Gaps = 38/219 (17%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRL------SSKSGQG 566
D + +LG G F V K E+ G + A K + SS+ G
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREK------------STGLQYAAKFIKKRRTKSSRRGVS 57
Query: 567 LEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYE-------FDIVTDPARKDLLDWT 619
E+ + E+ ++ ++QH N++ L + + I I E FD + + K+ L
Sbjct: 58 REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEE 114
Query: 620 TRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP----KISDFGIARTFGGD 675
++ + G+ YLH L++ H DLK N++L P KI DFG+A
Sbjct: 115 EATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 171
Query: 676 EMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLL 714
N I GT +++PE + +++D++S GV+
Sbjct: 172 NEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 4e-22
Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 38/217 (17%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEE--F 570
T+ + +LG+G F V + ++ L G+E A +++K +
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKV------------LAGQEYAAMIINTKKLSARDHQKL 57
Query: 571 KNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK-DLLDWTTR-------- 621
+ E + L+H N+VRL E+G Y ++ D +L +
Sbjct: 58 EREARICRLLKHPNIVRLHDSISEEG---HHY---LIFDLVTGGELFEDIVAREYYSEAD 111
Query: 622 -VRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS---DMNPKISDFGIARTFGGDEM 677
I+ + + +L+ HQ + V+HR+LK N+LL S K++DFG+A G+
Sbjct: 112 ASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE-- 166
Query: 678 QSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLL 714
Q GT GY+SPE + D+++ GV+L
Sbjct: 167 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 7e-22
Identities = 55/220 (25%), Positives = 93/220 (42%), Gaps = 42/220 (19%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLS----SKSGQGLEE 569
D+F LG+G FG VY + E+ N +A+K L K G +
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREK------------QNKFIMALKVLFKSQLEKEGV-EHQ 60
Query: 570 FKNEMMLIAKLQHRNLVRLFGCCIEQGEKI-SIYE-------FDIVTDPARKDLLDWTTR 621
+ E+ + + L+H N++R++ ++I + E + + R + +
Sbjct: 61 LRREIEIQSHLRHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKELQKHGR--FDEQRSA 117
Query: 622 VRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNT 681
+E +A L Y H +VIHRD+K N+L+ KI+DFG + + + +
Sbjct: 118 -TFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWS-------VHAPS 166
Query: 682 NR---IVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEIL 718
R + GT Y+ PE K D++ GVL E L
Sbjct: 167 LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFL 206
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 1e-21
Identities = 53/204 (25%), Positives = 93/204 (45%), Gaps = 47/204 (23%)
Query: 511 AATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVK--RLSSKSG---Q 565
+++ F + KLG G + VYK + + G VA+K +L S+ G
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNK------------TTGVYVALKEVKLDSEEGTPST 49
Query: 566 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF---DIVTDPARKDLLDWTTRV 622
+ E L+ +L+H N+VRL+ + + ++EF D+ K +D T
Sbjct: 50 AIREIS----LMKELKHENIVRLYDVIHTENKLTLVFEFMDNDL------KKYMDSRTVG 99
Query: 623 RIIEGVA------------QGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIAR 670
G+ QGL + H+ +++HRDLK N+L++ K+ DFG+AR
Sbjct: 100 NTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLAR 156
Query: 671 TFGGDEMQSNTNRIVGTYGYMSPE 694
F G + + ++ +V T Y +P+
Sbjct: 157 AF-GIPVNTFSSEVV-TLWYRAPD 178
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 54/226 (23%), Positives = 86/226 (38%), Gaps = 49/226 (21%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEE--- 569
D + LG G G V + ER ++VA+K +S +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFER------------KTCKKVAIKIISKRKFAIGSAREA 56
Query: 570 -----FKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK-DLLDW-TTRV 622
+ E+ ++ KL H ++++ + Y IV + +L D
Sbjct: 57 DPALNVETEIEILKKLNHPCIIKIKNFF----DAEDYY---IVLELMEGGELFDKVVGNK 109
Query: 623 RIIEGVA--------QGLLYLHQYSRLRVIHRDLKASNVLLDS---DMNPKISDFGIART 671
R+ E + YLH +IHRDLK NVLL S D KI+DFG ++
Sbjct: 110 RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166
Query: 672 FGGDEMQSNTNRIVGTYGYMSPE---YALHGLFSIKSDVFSFGVLL 714
G + + GT Y++PE ++ D +S GV+L
Sbjct: 167 LGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 2e-21
Identities = 54/197 (27%), Positives = 90/197 (45%), Gaps = 44/197 (22%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN- 572
+ + K+GEG +G VYK+ GE A+K++ LE+
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-------------YGETFALKKIR------LEKEDEG 42
Query: 573 -------EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTRVRII 625
E+ ++ +L+H N+V+L+ + + ++E + D K LLD +
Sbjct: 43 IPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH-LDQD--LKKLLD-VCEGGLE 98
Query: 626 EGVA--------QGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEM 677
A G+ Y H RV+HRDLK N+L++ + KI+DFG+AR F G +
Sbjct: 99 SVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPV 154
Query: 678 QSNTNRIVGTYGYMSPE 694
+ T+ IV T Y +P+
Sbjct: 155 RKYTHEIV-TLWYRAPD 170
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 4e-21
Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 47/205 (22%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN- 572
+ + K+G+G FG V+K+ R G++VA+K++ +E K
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRK------------TGQKVALKKVL------MENEKEG 58
Query: 573 -------EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDI--VTDPARKDL---LDWTT 620
E+ ++ L+H N+V L C + + + I V D DL L
Sbjct: 59 FPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS-NV 117
Query: 621 RVRIIEGVA--------QGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTF 672
V+ GL Y+H+ +++HRD+KA+NVL+ D K++DFG+AR F
Sbjct: 118 LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAF 174
Query: 673 G---GDEMQSNTNRIVGTYGYMSPE 694
+ TNR+V T Y PE
Sbjct: 175 SLAKNSQPNRYTNRVV-TLWYRPPE 198
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 5e-21
Identities = 56/221 (25%), Positives = 90/221 (40%), Gaps = 48/221 (21%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLS----SKSGQGLEEFKNEMMLI 577
LGEG +G V + ++ AVK L + G K E+ L+
Sbjct: 13 LGEGSYGKVKEVLD------------SETLCRRAVKILKKKKLRRIPNGEANVKKEIQLL 60
Query: 578 AKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPAR---KDLLDWTTRVRIIEGVAQ---- 630
+L+H+N+++L + EK +Y +V + +++LD R A
Sbjct: 61 RRLRHKNVIQLVDV-LYNEEKQKMY---MVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFC 116
Query: 631 ----GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIA---RTFGGDEMQSNTNR 683
GL YLH ++H+D+K N+LL + KIS G+A F D+ +
Sbjct: 117 QLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS-- 171
Query: 684 IVGTYGYMSPEYAL-----HGLFSIKSDVFSFGVLLLEILS 719
G+ + PE A G K D++S GV L I +
Sbjct: 172 -QGSPAFQPPEIANGLDTFSGF---KVDIWSAGVTLYNITT 208
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 7e-21
Identities = 50/223 (22%), Positives = 93/223 (41%), Gaps = 43/223 (19%)
Query: 513 TDNFSE-----ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVK--RLSSKSGQ 565
+NF+ +LG G F V + I + G+E A K + +
Sbjct: 23 MENFNNFYILTSKELGRGKFAVVRQCISK------------STGQEYAAKFLKKRRRGQD 70
Query: 566 GLEEFKNEMMLIAKLQHR-NLVRLFGCCIEQGEKISIYE-------FDIVTDPARKDLLD 617
E +E+ ++ + ++ L E I I E F + +
Sbjct: 71 CRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLP---ELAEM 127
Query: 618 WTTR--VRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLL---DSDMNPKISDFGIARTF 672
+ +R+I+ + +G+ YLHQ ++H DLK N+LL + KI DFG++R
Sbjct: 128 VSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184
Query: 673 G-GDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLL 714
G E++ I+GT Y++PE + + +D+++ G++
Sbjct: 185 GHACELRE----IMGTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 8e-21
Identities = 54/200 (27%), Positives = 96/200 (48%), Gaps = 46/200 (23%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVK--RLSSKSGQGLEEFK 571
+ + + LGEG F VYK+ ++ + VA+K +L + E K
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDK------------NTNQIVAIKKIKLGHR-----SEAK 52
Query: 572 N--------EMMLIAKLQHRNLVRLFGCCIEQGEKIS-IYEFDIVTDPARKDLLDWTTRV 622
+ E+ L+ +L H N++ L IS +++F + TD + ++ +
Sbjct: 53 DGINRTALREIKLLQELSHPNIIGLLD-AFGHKSNISLVFDF-METD--LEVIIK-DNSL 107
Query: 623 RIIEGVA--------QGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGG 674
+ QGL YLHQ+ ++HRDLK +N+LLD + K++DFG+A++F G
Sbjct: 108 VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-G 163
Query: 675 DEMQSNTNRIVGTYGYMSPE 694
++ T+++V T Y +PE
Sbjct: 164 SPNRAYTHQVV-TRWYRAPE 182
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 1e-20
Identities = 45/225 (20%), Positives = 85/225 (37%), Gaps = 54/225 (24%)
Query: 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVK--------RLSSKSGQG 566
+S + LG G FG V+ ++++ +EV VK
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDK------------EKNKEVVVKFIKKEKVLEDCWIEDPK 72
Query: 567 LEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK--DLLDW-TTRVR 623
L + E+ ++++++H N++++ E + +V + DL + R
Sbjct: 73 LGKVTLEIAILSRVEHANIIKVLDI-FE--NQGFFQ---LVMEKHGSGLDLFAFIDRHPR 126
Query: 624 IIEGVA--------QGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGD 675
+ E +A + YL +IHRD+K N+++ D K+ DFG A
Sbjct: 127 LDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG 183
Query: 676 EMQSNTNRIVGTYGYMSPEYALHGLFSIKS------DVFSFGVLL 714
++ GT Y +PE + +++S GV L
Sbjct: 184 KLFYTF---CGTIEYCAPE-----VLMGNPYRGPELEMWSLGVTL 220
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-20
Identities = 55/197 (27%), Positives = 84/197 (42%), Gaps = 44/197 (22%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVK--RLSSKSG---QGLE 568
+ + + +KLGEG + VYK + L VA+K RL + G +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSK------------LTDNLVALKEIRLEHEEGAPCTAIR 49
Query: 569 EFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIY---EFDIVTDPARKDLLDWTTRVRII 625
E L+ L+H N+V L I EK S+ E+ + D K LD I
Sbjct: 50 EVS----LLKDLKHANIVTLH--DIIHTEK-SLTLVFEY-LDKD--LKQYLD-DCGNIIN 98
Query: 626 EGVA--------QGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEM 677
+GL Y H+ +V+HRDLK N+L++ K++DFG+AR
Sbjct: 99 MHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPT 154
Query: 678 QSNTNRIVGTYGYMSPE 694
++ N +V T Y P+
Sbjct: 155 KTYDNEVV-TLWYRPPD 170
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-20
Identities = 58/205 (28%), Positives = 85/205 (41%), Gaps = 55/205 (26%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN- 572
D + KLGEG +G VYK+I+ + E VA+KR+ LE +
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDT------------VTNETVAIKRIR------LEHEEEG 75
Query: 573 -------EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF---DIVTDPARKDLLDWTTRV 622
E+ L+ +LQHRN++ L I+E+ D+ K +D
Sbjct: 76 VPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDL------KKYMD--KNP 127
Query: 623 RIIEGVA--------QGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP-----KISDFGIA 669
+ V G+ + H R +HRDLK N+LL KI DFG+A
Sbjct: 128 DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184
Query: 670 RTFGGDEMQSNTNRIVGTYGYMSPE 694
R F G ++ T+ I+ T Y PE
Sbjct: 185 RAF-GIPIRQFTHEII-TLWYRPPE 207
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 58/237 (24%), Positives = 95/237 (40%), Gaps = 50/237 (21%)
Query: 510 SAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRL---SSKSGQG 566
S AT + ++G G +G VYK+ + +G VA+K + + G G
Sbjct: 5 SMATSRYEPVAEIGVGAYGTVYKARDP------------HSGHFVALKSVRVPNGGGGGG 52
Query: 567 ------LEEFKNEMMLIAKLQHRNLVRLFGCCI--EQGEKISIY---EF---DIVTDPAR 612
+ E L +H N+VRL C +I + E D+
Sbjct: 53 GLPISTVREVALLRRL-EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDL------ 105
Query: 613 KDLLDWTTRVRIIEGVA--------QGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664
+ LD + +GL +LH ++HRDLK N+L+ S K++
Sbjct: 106 RTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLA 162
Query: 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSK 721
DFG+AR + + T +V T Y +PE L ++ D++S G + E+ K
Sbjct: 163 DFGLARIYSYQ--MALTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 49/220 (22%), Positives = 91/220 (41%), Gaps = 49/220 (22%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN 572
+D F E++LG G VY+ ++ + A+K L + + +
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQK------------GTQKPYALKVLKKTVDK--KIVRT 97
Query: 573 EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPAR-KDLLDWTTRVRIIEG---- 627
E+ ++ +L H N+++L E I +V + +L D RI+E
Sbjct: 98 EIGVLLRLSHPNIIKLKEIF-E--TPTEIS---LVLELVTGGELFD-----RIVEKGYYS 146
Query: 628 ----------VAQGLLYLHQYSRLRVIHRDLKASNVLL---DSDMNPKISDFGIARTFGG 674
+ + + YLH+ ++HRDLK N+L D KI+DFG+++
Sbjct: 147 ERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203
Query: 675 DEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLL 714
+ + GT GY +PE + + D++S G++
Sbjct: 204 QVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 3e-20
Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 47/212 (22%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLS-SKSGQGLEEFKNEMMLIAKL 580
LGEG +G V ++ R + E VAVK + ++ E K E+ + L
Sbjct: 15 LGEGAYGEVQLAVNR------------VTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 581 QHRNLVRLFGCCIEQGEKISI---Y----E-FD-IVTDPARKDLLDWTTRV---RIIEGV 628
H N+V+ +G +G + Y E FD I + + + +++ GV
Sbjct: 63 NHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGV 118
Query: 629 AQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTY 688
YLH + + HRD+K N+LLD N KISDFG+A F + + N++ GT
Sbjct: 119 V----YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 689 GYMSPE------YALHGLFSIKSDVFSFGVLL 714
Y++PE + H DV+S G++L
Sbjct: 172 PYVAPELLKRREF--HAE---PVDVWSCGIVL 198
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 55/246 (22%), Positives = 87/246 (35%), Gaps = 72/246 (29%)
Query: 511 AATDNFSE---------ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSS 561
+TD+FS E+ LGEG V I +E AVK +
Sbjct: 1 GSTDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLI------------TSQEYAVKIIEK 48
Query: 562 KSGQGLEEFKNEMMLIAKLQ-HRNLVRLFGCCIEQGEKISIYE----FDIVTDPARK-DL 615
+ G E+ ++ + Q HRN++ L +E F +V + R +
Sbjct: 49 QPGHIRSRVFREVEMLYQCQGHRNVLELIE----------FFEEEDRFYLVFEKMRGGSI 98
Query: 616 LDWTTRVRIIE--------------GVAQGLLYLHQYSRLRVIHRDLKASNVLL---DSD 658
L I + VA L +LH + HRDLK N+L +
Sbjct: 99 LS-----HIHKRRHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQV 150
Query: 659 MNPKISDFGIARTFGGDEMQSNTNR-----IVGTYGYMSPE-----YALHGLFSIKSDVF 708
KI DF + + S + G+ YM+PE ++ + D++
Sbjct: 151 SPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLW 210
Query: 709 SFGVLL 714
S GV+L
Sbjct: 211 SLGVIL 216
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 5e-20
Identities = 56/235 (23%), Positives = 97/235 (41%), Gaps = 56/235 (23%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN- 572
+ ++GEG +G V+K+ + G VA+KR+ ++ +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDL-----------KNGGRFVALKRVR------VQTGEEG 53
Query: 573 -------EMMLIAKLQ---HRNLVRLFGCCI--EQGEKISIY---EF---DIVTDPARKD 614
E+ ++ L+ H N+VRLF C + + E D+
Sbjct: 54 MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDL------TT 107
Query: 615 LLDWTTRVRIIEGVA--------QGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666
LD + +GL +LH + RV+HRDLK N+L+ S K++DF
Sbjct: 108 YLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 164
Query: 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSK 721
G+AR + + T+ +V T Y +PE L ++ D++S G + E+ K
Sbjct: 165 GLARIYSFQ--MALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 7e-20
Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 49/212 (23%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGK-LLNGEEVAVKRL--SSKSGQGLEEFKNEMMLIA 578
+G+G F V K + +L G EVA+K + + + L++ E+ ++
Sbjct: 23 IGKGNFAKV-------------KLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMK 69
Query: 579 KLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK-DLLDW-TTRVRIIEGVAQ------ 630
L H N+V+LF IE + +Y ++ + A ++ D+ R+ E A+
Sbjct: 70 ILNHPNIVKLFE-VIETEKT--LY---LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI 123
Query: 631 --GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTY 688
+ Y H + R++HRDLKA N+LLD+DMN KI+DFG + F G
Sbjct: 124 VSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF---CGAP 177
Query: 689 GYMSPEYALHGLFS------IKSDVFSFGVLL 714
Y +PE LF + DV+S GV+L
Sbjct: 178 PYAAPE-----LFQGKKYDGPEVDVWSLGVIL 204
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 7e-20
Identities = 46/196 (23%), Positives = 76/196 (38%), Gaps = 41/196 (20%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN- 572
+ + +GEG +G V K + G VA+K+ + K
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNK------------DTGRIVAIKKF--LESDDDKMVKKI 70
Query: 573 ---EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF---DIVTDPARKDLLDWTTRVRIIE 626
E+ L+ +L+H NLV L C ++ ++EF I D L+ +
Sbjct: 71 AMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTI------LDDLE-LFPNGLDY 123
Query: 627 GVA--------QGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQ 678
V G+ + H + +IHRD+K N+L+ K+ DFG ART +
Sbjct: 124 QVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGE 179
Query: 679 SNTNRIVGTYGYMSPE 694
+ + T Y +PE
Sbjct: 180 VYDDEVA-TRWYRAPE 194
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 9e-20
Identities = 50/216 (23%), Positives = 84/216 (38%), Gaps = 40/216 (18%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN 572
TD + + +G G + + I + E AVK + EE
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHK------------ATNMEFAVKIIDKSKRDPTEE--- 65
Query: 573 EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK-DLLDWTTR---------V 622
+L+ QH N++ L + +Y +VT+ + +LLD R
Sbjct: 66 IEILLRYGQHPNIITLKDVYDDGK---YVY---VVTELMKGGELLDKILRQKFFSEREAS 119
Query: 623 RIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP----KISDFGIARTFGGDEMQ 678
++ + + + YLH V+HRDLK SN+L + +I DFG A+ +
Sbjct: 120 AVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176
Query: 679 SNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLL 714
T T +++PE + D++S GVLL
Sbjct: 177 LMT--PCYTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 47/212 (22%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLS-SKSGQGLEEFKNEMMLIAKL 580
LGEG +G V ++ R + E VAVK + ++ E K E+ + L
Sbjct: 15 LGEGAYGEVQLAVNR------------VTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 581 QHRNLVRLFGCCIEQGEKISI---Y----E-FD-IVTDPARKDLLDWTTRV---RIIEGV 628
H N+V+ +G +G + Y E FD I + + + +++ GV
Sbjct: 63 NHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGV 118
Query: 629 AQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTY 688
YLH + + HRD+K N+LLD N KISDFG+A F + + N++ GT
Sbjct: 119 V----YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 689 GYMSPE------YALHGLFSIKSDVFSFGVLL 714
Y++PE + H DV+S G++L
Sbjct: 172 PYVAPELLKRREF--HAE---PVDVWSCGIVL 198
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 1e-19
Identities = 48/210 (22%), Positives = 87/210 (41%), Gaps = 53/210 (25%)
Query: 514 DNFSEEN-KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLS----SKSGQGLE 568
D F E K+G G +G VYK+ + + + ++ A+K++ S S
Sbjct: 20 DLFEYEGCKVGRGTYGHVYKAKRKDGK----------DDKDYALKQIEGTGISMSACR-- 67
Query: 569 EFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDL---LDWTTRVRII 625
E+ L+ +L+H N++ L + ++ ++ ++ D A DL + + +
Sbjct: 68 ----EIALLRELKHPNVISLQKVFLSHADR-KVW---LLFDYAEHDLWHIIKFHRASKAN 119
Query: 626 EGVA---------------QGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP----KISDF 666
+ G+ YLH V+HRDLK +N+L+ + KI+D
Sbjct: 120 KKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM 176
Query: 667 GIARTFG--GDEMQSNTNRIVGTYGYMSPE 694
G AR F + +V T+ Y +PE
Sbjct: 177 GFARLFNSPLKPLADLDPVVV-TFWYRAPE 205
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 1e-19
Identities = 43/194 (22%), Positives = 77/194 (39%), Gaps = 37/194 (19%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN- 572
+ + + K+GEG +G V+K R G+ VA+K+ E
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNR------------DTGQIVAIKKF------LESEDDPV 44
Query: 573 -------EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF---DI--VTDPARKDLLDWTT 620
E+ ++ +L+H NLV L + ++E+ + D ++ + +
Sbjct: 45 IKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLV 104
Query: 621 RVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSN 680
+ I Q + + H++ IHRD+K N+L+ K+ DFG AR
Sbjct: 105 K-SITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYY 159
Query: 681 TNRIVGTYGYMSPE 694
+ + T Y SPE
Sbjct: 160 DDEVA-TRWYRSPE 172
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 49/227 (21%), Positives = 85/227 (37%), Gaps = 50/227 (22%)
Query: 507 SSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQG 566
S D ++ LGEG F K + + + + AVK +S +
Sbjct: 4 SPFYQHYDLDLKDKPLGEGSFSICRKCVHKK------------SNQAFAVKIISKRM--- 48
Query: 567 LEEFKNEMMLIAKLQ-HRNLVRLFGCCIEQGEKISIYEFDIVTDPARK-DLLDWTTRVRI 624
+ E+ + + H N+V+L +Q + +V + +L + RI
Sbjct: 49 EANTQKEITALKLCEGHPNIVKLHEVFHDQL---HTF---LVMELLNGGELFE-----RI 97
Query: 625 IE--------------GVAQGLLYLHQYSRLRVIHRDLKASNVLL---DSDMNPKISDFG 667
+ + + ++H + V+HRDLK N+L + ++ KI DFG
Sbjct: 98 KKKKHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFG 154
Query: 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLL 714
AR D T T Y +PE + D++S GV+L
Sbjct: 155 FARLKPPDNQPLKT--PCFTLHYAAPELLNQNGYDESCDLWSLGVIL 199
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 41/218 (18%), Positives = 77/218 (35%), Gaps = 54/218 (24%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIA 578
+ LG G G V + R G++ A+K L + + E+
Sbjct: 34 KQVLGLGVNGKVLECFHRR------------TGQKCALKLLYDS-----PKARQEVDHHW 76
Query: 579 KLQ-HRNLVRLFGCCIEQGE-KISIYEFDIVTDPAR-KDLLDWTTRVRIIEG-------- 627
+ ++V + K + I+ + +L RI E
Sbjct: 77 QASGGPHIVCILDVYENMHHGKRCLL---IIMECMEGGELFS-----RIQERGDQAFTER 128
Query: 628 --------VAQGLLYLHQYSRLRVIHRDLKASNVLL---DSDMNPKISDFGIARTFGGDE 676
+ + +LH + HRD+K N+L + D K++DFG A+ +
Sbjct: 129 EAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA 185
Query: 677 MQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLL 714
+Q+ T Y++PE + D++S GV++
Sbjct: 186 LQT----PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 2e-19
Identities = 49/197 (24%), Positives = 82/197 (41%), Gaps = 48/197 (24%)
Query: 613 KDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTF 672
+ L+ ++ +V A+G+ +L + + IHRDL A N+LL KI DFG+AR
Sbjct: 193 EHLICYSFQV------AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-- 241
Query: 673 GGDEMQSNTNRIVGTYG-----YMSPEYALHGLFSIKSDVFSFGVLLLEILSS------- 720
++ + + + +M+PE +++I+SDV+SFGVLL EI S
Sbjct: 242 ---DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 298
Query: 721 -KKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENA 779
K + F G ++ P +Y + C
Sbjct: 299 VKIDEEFCR---RLKEGT-----------RMRAPDYTTPEMYQTMLD-------CWHGEP 337
Query: 780 TDRPTMLEVVAMLKDEI 796
+ RPT E+V L + +
Sbjct: 338 SQRPTFSELVEHLGNLL 354
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 36/172 (20%), Positives = 57/172 (33%), Gaps = 17/172 (9%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQ-GKLLNGEEVAVKRLSSKSGQG-LEEFK 571
D LG G FG V + + K VAVK L +
Sbjct: 22 DRLKLGKPLGRGAFGQVIE--------ADAFGIDKTATCRTVAVKMLKEGATHSEHRALM 73
Query: 572 NEM-MLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLD--WTTRVRIIEGV 628
+E+ +LI H N+V L G C + G + + IV +L + R +
Sbjct: 74 SELKILIHIGHHLNVVNLLGACTKPGGPLMV----IVEFCKFGNLSTYLRSKRNEFVPYK 129
Query: 629 AQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSN 680
+G + + I DLK + S + S F ++ E +
Sbjct: 130 TKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 181
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-18
Identities = 52/232 (22%), Positives = 95/232 (40%), Gaps = 54/232 (23%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN 572
++ +G G FG V++ KL+ +EVA+K++ + FKN
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQ-------------AKLVESDEVAIKKVLQD-----KRFKN 80
Query: 573 -EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTRVRIIEGVA-- 629
E+ ++ ++H N+V L G+K ++V + + T R A
Sbjct: 81 RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL-----EYVP-ETVYRASRHYAKL 134
Query: 630 -----------------QGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP-KISDFGIART 671
+ L Y+H + + HRD+K N+LLD K+ DFG A+
Sbjct: 135 KQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191
Query: 672 FGGDEMQSNTNRIVGTYGYMSPEYALHG--LFSIKSDVFSFGVLLLEILSSK 721
+ N + I Y Y +PE + G ++ D++S G ++ E++ +
Sbjct: 192 L--IAGEPNVSYICSRY-YRAPE-LIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 2e-18
Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 53/232 (22%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN 572
++++ +G G FG VY++ +GE VA+K++ + FKN
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLC------------DSGELVAIKKVLQD-----KRFKN 95
Query: 573 -EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTRVRIIEGVA-- 629
E+ ++ KL H N+VRL GEK ++V D + T R+ +
Sbjct: 96 RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL-----DYVP-ETVYRVARHYSRA 149
Query: 630 -----------------QGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP-KISDFGIART 671
+ L Y+H + HRD+K N+LLD D K+ DFG A+
Sbjct: 150 KQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206
Query: 672 FGGDEMQSNTNRIVGTYGYMSPEYALHG--LFSIKSDVFSFGVLLLEILSSK 721
E N + I Y Y +PE + G ++ DV+S G +L E+L +
Sbjct: 207 LVRGE--PNVSYICSRY-YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 46/216 (21%), Positives = 76/216 (35%), Gaps = 48/216 (22%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRL------SSKSGQGLEEFKNE-- 573
LG+GGFG V+ + +VA+K + E
Sbjct: 39 LGKGGFGTVFAGHRL------------TDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVA 86
Query: 574 --MMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK--DLLDW-TTRVRIIEGV 628
+ A H ++RL E + +V + DL D+ T + + EG
Sbjct: 87 LLWKVGAGGGHPGVIRLLDW-FET--QEGFM---LVLERPLPAQDLFDYITEKGPLGEGP 140
Query: 629 A--------QGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP-KISDFGIARTFGGDEMQS 679
+ + + H V+HRD+K N+L+D K+ DFG +
Sbjct: 141 SRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD 197
Query: 680 NTNRIVGTYGYMSPEYALHGLFS-IKSDVFSFGVLL 714
GT Y PE+ + + + V+S G+LL
Sbjct: 198 ----FDGTRVYSPPEWISRHQYHALPATVWSLGILL 229
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 4e-18
Identities = 58/241 (24%), Positives = 90/241 (37%), Gaps = 65/241 (26%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKR-LSSKSGQGLEEFK 571
D F E G+G FG V E+ G VA+K+ + F+
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEK------------STGMSVAIKKVIQDPR------FR 63
Query: 572 N----EMMLIAKLQHRNLVRLFGCCIEQGEKIS--IYEFDIVTDPARKDLLDWTTRVRII 625
N M +A L H N+V+L GE+ IY ++V + + T R
Sbjct: 64 NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY-LNVVM-----EYVP-DTLHRCC 116
Query: 626 EGVAQ-------------------GLLYLHQYSRLRVIHRDLKASNVLLD-SDMNPKISD 665
+ + LH S + V HRD+K NVL++ +D K+ D
Sbjct: 117 RNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCD 175
Query: 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKS-----DVFSFGVLLLEILSS 720
FG A+ E N I Y Y +PE +F + D++S G + E++
Sbjct: 176 FGSAKKLSPSE--PNVAYICSRY-YRAPEL----IFGNQHYTTAVDIWSVGCIFAEMMLG 228
Query: 721 K 721
+
Sbjct: 229 E 229
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 9e-18
Identities = 49/214 (22%), Positives = 81/214 (37%), Gaps = 46/214 (21%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRL------SSKSGQGLEEFKNEMM 575
LG GGFG VY I + VA+K + E++
Sbjct: 51 LGSGGFGSVYSGIRV------------SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 98
Query: 576 LIAKLQHR--NLVRLFGCCIEQGEKISIYEFDIVTDPAR--KDLLDW-TTRVRIIEGVA- 629
L+ K+ ++RL E+ S ++ + +DL D+ T R + E +A
Sbjct: 99 LLKKVSSGFSGVIRLLDW-FER--PDSFV---LILERPEPVQDLFDFITERGALQEELAR 152
Query: 630 -------QGLLYLHQYSRLRVIHRDLKASNVLLDSD-MNPKISDFGIARTFGGDEMQSNT 681
+ + + H V+HRD+K N+L+D + K+ DFG
Sbjct: 153 SFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-- 207
Query: 682 NRIVGTYGYMSPEYALHGLFS-IKSDVFSFGVLL 714
GT Y PE+ + + + V+S G+LL
Sbjct: 208 --FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 239
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 1e-17
Identities = 42/236 (17%), Positives = 83/236 (35%), Gaps = 60/236 (25%)
Query: 507 SSISAATDNFSEE-----NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSS 561
S + + ++ LG G G V + + E+ A+K L
Sbjct: 50 SGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKR------------TQEKFALKMLQD 97
Query: 562 KSGQGLEEFKNEMMLIAKLQ-HRNLVRLFGCCIEQ-GEKISIYEFDIVTDPAR-KDLLDW 618
+ + E+ L + ++VR+ + + IV + +L
Sbjct: 98 C-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL---IVMECLDGGELFS- 148
Query: 619 TTRVRIIEG----------------VAQGLLYLHQYSRLRVIHRDLKASNVLLDS---DM 659
RI + + + + YLH + + HRD+K N+L S +
Sbjct: 149 ----RIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNA 201
Query: 660 NPKISDFGIARTF-GGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLL 714
K++DFG A+ + + + T Y++PE + D++S GV++
Sbjct: 202 ILKLTDFGFAKETTSHNSLTT----PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 58/212 (27%), Positives = 90/212 (42%), Gaps = 48/212 (22%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVK---RLSSKSGQGLEEFKNEMMLIA 578
LG G FG V L G +VAVK R +S + + K E+ +
Sbjct: 19 LGVGTFGKVKIGEH------------QLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK 66
Query: 579 KLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK-DLLDW-TTRVRIIEGVAQ------ 630
+H ++++L+ I + +V + +L D+ R+ E A+
Sbjct: 67 LFRHPHIIKLYQ-VIST--PTDFF---MVMEYVSGGELFDYICKHGRVEEMEARRLFQQI 120
Query: 631 --GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTY 688
+ Y H R V+HRDLK NVLLD+ MN KI+DFG++ E + G+
Sbjct: 121 LSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSP 174
Query: 689 GYMSPE------YALHGLFSIKSDVFSFGVLL 714
Y +PE Y G + D++S GV+L
Sbjct: 175 NYAAPEVISGRLY--AGP---EVDIWSCGVIL 201
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 5e-17
Identities = 53/211 (25%), Positives = 90/211 (42%), Gaps = 47/211 (22%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVK---RLSSKSGQGLEEFKNEMMLIA 578
LGEG FG V + ++VA+K R K + E+ +
Sbjct: 17 LGEGSFGKVKLATHY------------KTQQKVALKFISRQLLKKSDMHMRVEREISYLK 64
Query: 579 KLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDW-TTRVRIIEGVAQ------- 630
L+H ++++L+ I I +V + A +L D+ + R+ E +
Sbjct: 65 LLRHPHIIKLYD-VITTPTD--IV---MVIEYAGGELFDYIVEKKRMTEDEGRRFFQQII 118
Query: 631 -GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYG 689
+ Y H R +++HRDLK N+LLD ++N KI+DFG++ + G+
Sbjct: 119 CAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS---CGSPN 172
Query: 690 YMSPE------YALHGLFSIKSDVFSFGVLL 714
Y +PE Y G + DV+S G++L
Sbjct: 173 YAAPEVINGKLY--AGP---EVDVWSCGIVL 198
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 9e-17
Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 36/212 (16%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLS----SKSGQGLEEFKNEMMLI 577
LGEG F V + E E A+K L K + + E ++
Sbjct: 38 LGEGSFSTVVLARELA------------TSREYAIKILEKRHIIKENK-VPYVTRERDVM 84
Query: 578 AKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARK-DLLDWTTRVRII-EGVAQ----- 630
++L H V+L+ Q ++ +Y A+ +LL + ++ E +
Sbjct: 85 SRLDHPFFVKLYFTF--QDDE-KLY---FGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 138
Query: 631 ---GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
L YLH +IHRDLK N+LL+ DM+ +I+DFG A+ + Q+ N VGT
Sbjct: 139 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195
Query: 688 YGYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
Y+SPE SD+++ G ++ ++++
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVA 227
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 1e-16
Identities = 62/214 (28%), Positives = 92/214 (42%), Gaps = 52/214 (24%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVK---RLSSKSGQGLEEFKNEMMLIA 578
LG G FG V L G +VAVK R +S + + + E+ +
Sbjct: 24 LGVGTFGKVKVGKHE------------LTGHKVAVKILNRQKIRSLDVVGKIRREIQNLK 71
Query: 579 KLQHRNLVRLFGCCIEQGEKISI---Y----E-FD-IVTDPARKDLLDWTTRV---RIIE 626
+H ++++L+ I I + Y E FD I L + +R +I+
Sbjct: 72 LFRHPHIIKLYQV-ISTPSDIFMVMEYVSGGELFDYIC---KNGRLDEKESRRLFQQILS 127
Query: 627 GVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVG 686
GV Y H R V+HRDLK NVLLD+ MN KI+DFG++ E + G
Sbjct: 128 GVD----YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CG 177
Query: 687 TYGYMSPE------YALHGLFSIKSDVFSFGVLL 714
+ Y +PE YA + D++S GV+L
Sbjct: 178 SPNYAAPEVISGRLYA-----GPEVDIWSSGVIL 206
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 3e-16
Identities = 53/226 (23%), Positives = 92/226 (40%), Gaps = 43/226 (19%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN 572
+ +G G G V + + + VA+K+LS F+N
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDA------------VLDRNVAIKKLS-------RPFQN 101
Query: 573 ---------EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPA--------RKDL 615
E++L+ + H+N++ L Q + +V + + +L
Sbjct: 102 QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL 161
Query: 616 LDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGD 675
+ + + G+ +LH +IHRDLK SN+++ SD KI DFG+ART G
Sbjct: 162 DHERMSYLLYQML-CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 217
Query: 676 EMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSK 721
M + V T Y +PE L + D++S G ++ E++ K
Sbjct: 218 FMMTPY---VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 3e-16
Identities = 57/215 (26%), Positives = 85/215 (39%), Gaps = 56/215 (26%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQ 581
+G G FG ++ L E VAVK + + E + E++ L+
Sbjct: 28 IGSGNFGVARLMRDK------------LTKELVAVKYI-ERGAAIDENVQREIINHRSLR 74
Query: 582 HRNLVRLFGCCIEQGEKIS----IYEFDIVTDPARK-DLLDW-TTRVRIIEGVAQ----- 630
H N+VR E I + I+ + A +L + R E A+
Sbjct: 75 HPNIVRFK-------EVILTPTHLA---IIMEYASGGELYERICNAGRFSEDEARFFFQQ 124
Query: 631 ---GLLYLHQYSRLRVIHRDLKASNVLLDSD--MNPKISDFGIARTFGGDEMQSNTNRIV 685
G+ Y H +++ HRDLK N LLD KI DFG +++ +T V
Sbjct: 125 LLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---V 178
Query: 686 GTYGYMSPE------YALHGLFSIKSDVFSFGVLL 714
GT Y++PE Y G +DV+S GV L
Sbjct: 179 GTPAYIAPEVLLRQEYD--GK---IADVWSCGVTL 208
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 6e-16
Identities = 59/218 (27%), Positives = 89/218 (40%), Gaps = 32/218 (14%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEF 570
D F + LG GGFG V+ + G+ A K+L+ K +G +
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKA------------TGKLYACKKLNKKRLKKRKGYQGA 232
Query: 571 KNEMMLIAKLQHRNLVRLFGCCIEQGEKIS-IYE--------FDIVTDPARKDLLDWTTR 621
E ++AK+ R +V L E + + + I R
Sbjct: 233 MVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPR 290
Query: 622 VRI-IEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSN 680
+ GL +LHQ +I+RDLK NVLLD D N +ISD G+A + ++
Sbjct: 291 AIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK 347
Query: 681 TNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEIL 718
GT G+M+PE L + D F+ GV L E++
Sbjct: 348 G--YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMI 383
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 55/225 (24%), Positives = 92/225 (40%), Gaps = 41/225 (18%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN 572
+ +G G G V + + + VA+K+LS F+N
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDA------------ILERNVAIKKLS-------RPFQN 64
Query: 573 ---------EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDL-------L 616
E++L+ + H+N++ L Q + IV + +L L
Sbjct: 65 QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMEL 124
Query: 617 DWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDE 676
D ++ + G+ +LH +IHRDLK SN+++ SD KI DFG+ART G
Sbjct: 125 DHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181
Query: 677 MQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSK 721
M + V T Y +PE L + D++S G ++ E++
Sbjct: 182 MMTPY---VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 2e-15
Identities = 43/213 (20%), Positives = 85/213 (39%), Gaps = 59/213 (27%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN 572
D + + +G G +G V ++ ++ L VA+K++ F++
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDK------------LEKRVVAIKKIL-------RVFED 92
Query: 573 ---------EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFD---IVTDPARKDLLDWTT 620
E+ ++ +L H ++V++ I + + +FD +V + A D
Sbjct: 93 LIDCKRILREIAILNRLNHDHVVKVLDIVIPK----DVEKFDELYVVLEIADSDFK---- 144
Query: 621 RVRIIEG---------------VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665
++ + G+ Y+H S ++HRDLK +N L++ D + K+ D
Sbjct: 145 --KLFRTPVYLTELHIKTLLYNLLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCD 199
Query: 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH 698
FG+ART E ++ I M+ H
Sbjct: 200 FGLARTVDYPENGNSQLPISPREDDMNLVTFPH 232
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 4e-15
Identities = 60/227 (26%), Positives = 99/227 (43%), Gaps = 46/227 (20%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN 572
+ +G G +G V +I++ +GE+VA+K+LS F++
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDK------------RSGEKVAIKKLS-------RPFQS 63
Query: 573 ---------EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTRVR 623
E++L+ +QH N++ L + Y+F +V + DL ++
Sbjct: 64 EIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQK-IMGLK 122
Query: 624 IIEGVAQ--------GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGD 675
E Q GL Y+H V+HRDLK N+ ++ D KI DFG+AR
Sbjct: 123 FSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHA-DA 178
Query: 676 EMQSNTNRIVGTYGYMSPEYAL-HGLFSIKSDVFSFGVLLLEILSSK 721
EM T V T Y +PE L ++ D++S G ++ E+L+ K
Sbjct: 179 EM---TGY-VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 4e-15
Identities = 34/92 (36%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
+ GL ++H V++RDLK +N+LLD + +ISD G+A F + + VGT
Sbjct: 301 IILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGT 353
Query: 688 YGYMSPEYALHGLFSIKS-DVFSFGVLLLEIL 718
+GYM+PE G+ S D FS G +L ++L
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 7e-15
Identities = 44/257 (17%), Positives = 89/257 (34%), Gaps = 71/257 (27%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN 572
+ +S LG G FG V + + +G+ A+K++ +KN
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDI------------ESGKRFALKKVLQDP-----RYKN 48
Query: 573 -EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDW------------- 618
E+ ++ L H N+++L G++ +
Sbjct: 49 RELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPS 108
Query: 619 -------------TTRVRIIEGVAQ-------------------GLLYLHQYSRLRVIHR 646
T ++++ + + ++H L + HR
Sbjct: 109 QNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHR 165
Query: 647 DLKASNVLLDSDMNP-KISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHG-LFSIK 704
D+K N+L++S N K+ DFG A+ + + I + Y +PE L ++
Sbjct: 166 DIKPQNLLVNSKDNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPELMLGATEYTPS 222
Query: 705 SDVFSFGVLLLEILSSK 721
D++S G + E++ K
Sbjct: 223 IDLWSIGCVFGELILGK 239
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 8e-15
Identities = 22/205 (10%), Positives = 61/205 (29%), Gaps = 53/205 (25%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG---QGLEEFKNEMMLI 577
G +++++ L +VA+ + + L+E + + +
Sbjct: 38 FHGGVPPLQFWQALDT----------AL--DRQVALTFVDPQGVLPDDVLQETLSRTLRL 85
Query: 578 AKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLD----WTTRVRIIEGVAQGLL 633
+++ + R+ + + + E+ + + +++ D +R ++ +A
Sbjct: 86 SRIDKPGVARVLDVVHTRAGGLVVAEW--IRGGSLQEVADTSPSPVGAIRAMQSLAAAAD 143
Query: 634 YLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSP 693
H R V S V + D + ++ M
Sbjct: 144 AAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPD 178
Query: 694 EYALHGLFSIKSDVFSFGVLLLEIL 718
+ + D+ G L +L
Sbjct: 179 A-------NPQDDIRGIGASLYALL 196
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 9e-15
Identities = 59/219 (26%), Positives = 91/219 (41%), Gaps = 37/219 (16%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEF 570
+ F + LG+GGFG V R G+ A K+L K +G
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRA------------TGKMYACKKLEKKRIKKRKGEAMA 231
Query: 571 KNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDL---LDWTTRVRIIEG 627
NE ++ K+ R +V L E + + ++T DL + + E
Sbjct: 232 LNEKQILEKVNSRFVVSLA-YAYETKDAL----CLVLTLMNGGDLKFHIYHMGQAGFPEA 286
Query: 628 VAQ--------GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQS 679
A GL LH R R+++RDLK N+LLD + +ISD G+A +
Sbjct: 287 RAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-- 341
Query: 680 NTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEIL 718
VGT GYM+PE + ++ D ++ G LL E++
Sbjct: 342 -IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMI 379
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 55/243 (22%), Positives = 96/243 (39%), Gaps = 64/243 (26%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN 572
+ + LG GG G V+ +++ + VA+K++ +
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDN------------DCDKRVAIKKIV---------LTD 48
Query: 573 ---------EMMLIAKLQHRNLVRLF-----GCCIEQGEKISIYEFD---IVTDPARKDL 615
E+ +I +L H N+V++F + S+ E + IV + DL
Sbjct: 49 PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDL 108
Query: 616 LDWTTRVRIIEGVAQGLLYLHQ----YSRLR---------VIHRDLKASNVLLDS-DMNP 661
++E LL H Y LR V+HRDLK +N+ +++ D+
Sbjct: 109 A------NVLE--QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVL 160
Query: 662 KISDFGIARTFGGDEMQSN--TNRIVGTYGYMSPEYALHGL-FSIKSDVFSFGVLLLEIL 718
KI DFG+AR + +V T Y SP L ++ D+++ G + E+L
Sbjct: 161 KIGDFGLARIMDPHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML 219
Query: 719 SSK 721
+ K
Sbjct: 220 TGK 222
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 50/224 (22%), Positives = 91/224 (40%), Gaps = 43/224 (19%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN 572
D++ KLG G + V+++I N E+V VK L + + K
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINI------------TNNEKVVVKILKPVKKK---KIKR 79
Query: 573 EMMLIAKLQ-HRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTRVRI---IEGV 628
E+ ++ L+ N++ L + + F+ V + K L T I + +
Sbjct: 80 EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEI 139
Query: 629 AQGLLYLHQYSRLRVIHRDLKASNVLLDSD-MNPKISDFGIARTFGGDEMQSNTNRIVGT 687
+ L Y H S ++HRD+K NV++D + ++ D+G+A Q R+
Sbjct: 140 LKALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASR 194
Query: 688 YGYMSPE---------YALHGLFSIKSDVFSFGVLLLEILSSKK 722
Y + PE Y+L D++S G +L ++ K+
Sbjct: 195 Y-FKGPELLVDYQMYDYSL--------DMWSLGCMLASMIFRKE 229
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 50/239 (20%), Positives = 91/239 (38%), Gaps = 58/239 (24%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEE--F 570
++ + + G +G V ++ G VA+KR+ + G
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDS-------------EGIPVAIKRVFNTVSDGRTVNIL 67
Query: 571 KN---------EMMLIAKLQHRNLVRLFGCCI--EQGEKISIYEFDIVTDPARKDLLDWT 619
+ E+ L+ H N++ L + E+ +Y +VT+ R DL
Sbjct: 68 SDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLY---LVTELMRTDL---- 120
Query: 620 TRVRIIEG----------------VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKI 663
++I + GL LH+ V+HRDL N+LL + + I
Sbjct: 121 --AQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITI 175
Query: 664 SDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYAL-HGLFSIKSDVFSFGVLLLEILSSK 721
DF +AR D +++ V Y +PE + F+ D++S G ++ E+ + K
Sbjct: 176 CDFNLAREDTADANKTHY---VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 5e-14
Identities = 59/238 (24%), Positives = 103/238 (43%), Gaps = 63/238 (26%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN 572
++ + +GEG +G V + + LN VA+K++S F++
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDN------------LNKVRVAIKKISP--------FEH 65
Query: 573 ---------EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFD---IVTDPARKDLLDWTT 620
E+ ++ + +H N++ + +I + IV D DL
Sbjct: 66 QTYCQRTLREIKILLRFRHENIIGINDIIRAP----TIEQMKDVYIVQDLMETDLY---- 117
Query: 621 RVRIIEG-----------VAQ---GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666
++++ + Q GL Y+H S V+HRDLK SN+LL++ + KI DF
Sbjct: 118 --KLLKTQHLSNDHICYFLYQILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDF 172
Query: 667 GIARTFGGDEMQSN--TNRIVGTYGYMSPEYAL-HGLFSIKSDVFSFGVLLLEILSSK 721
G+AR D + T V T Y +PE L ++ D++S G +L E+LS++
Sbjct: 173 GLARVADPDHDHTGFLTEY-VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 6e-14
Identities = 53/227 (23%), Positives = 93/227 (40%), Gaps = 45/227 (19%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN 572
+ + +G G +G V +++ G +VA+K+L F++
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDG------------RTGAKVAIKKLY-------RPFQS 64
Query: 573 ---------EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDL-------- 615
E+ L+ ++H N++ L +F +V DL
Sbjct: 65 ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK 124
Query: 616 LDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGD 675
L ++ + +GL Y+H +IHRDLK N+ ++ D KI DFG+AR
Sbjct: 125 LGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA-DS 180
Query: 676 EMQSNTNRIVGTYGYMSPEYAL-HGLFSIKSDVFSFGVLLLEILSSK 721
EM T V T Y +PE L ++ D++S G ++ E+++ K
Sbjct: 181 EM---TGY-VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 57/244 (23%), Positives = 97/244 (39%), Gaps = 68/244 (27%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN 572
+ +F ++ LGEG +G V + + GE VA+K++ F
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHK------------PTGEIVAIKKIEP--------FDK 49
Query: 573 ---------EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFD---IVTDPARKDLLDWTT 620
E+ ++ +H N++ +F S F+ I+ + + DL
Sbjct: 50 PLFALRTLREIKILKHFKHENIITIFNIQRPD----SFENFNEVYIIQELMQTDLH---- 101
Query: 621 RVRIIEG-----------VAQ---GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666
R+I + Q + LH + VIHRDLK SN+L++S+ + K+ DF
Sbjct: 102 --RVISTQMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDF 156
Query: 667 GIARTFGGDEMQSNTNRI--------VGTYGYMSPEYAL-HGLFSIKSDVFSFGVLLLEI 717
G+AR ++ V T Y +PE L +S DV+S G +L E+
Sbjct: 157 GLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216
Query: 718 LSSK 721
+
Sbjct: 217 FLRR 220
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 57/233 (24%), Positives = 95/233 (40%), Gaps = 57/233 (24%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN 572
+ + + +G G +G V + + G VAVK+LS F++
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDT------------KTGLRVAVKKLS-------RPFQS 68
Query: 573 ---------EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTRVR 623
E+ L+ ++H N++ L + +VT DL
Sbjct: 69 IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL------NN 122
Query: 624 IIEG--------------VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIA 669
I++ + +GL Y+H +IHRDLK SN+ ++ D KI DFG+A
Sbjct: 123 IVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179
Query: 670 RTFGGDEMQSNTNRIVGTYGYMSPEYAL-HGLFSIKSDVFSFGVLLLEILSSK 721
R DEM T V T Y +PE L ++ D++S G ++ E+L+ +
Sbjct: 180 RHT-ADEM---TGY-VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 3e-13
Identities = 44/214 (20%), Positives = 85/214 (39%), Gaps = 59/214 (27%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN 572
DN+ ++ +G G +G VY + ++ + VA+K+++ F++
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDK------------NTEKNVAIKKVNR-------MFED 65
Query: 573 ---------EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFD---IVTDPARKDLLDWTT 620
E+ ++ +L+ ++RL+ I + +FD IV + A DL
Sbjct: 66 LIDCKRILREITILNRLKSDYIIRLYDLIIPD----DLLKFDELYIVLEIADSDLK---- 117
Query: 621 RVRIIEGVAQ---------------GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665
++ + G ++H +IHRDLK +N LL+ D + K+ D
Sbjct: 118 --KLFKTPIFLTEEHIKTILYNLLLGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCD 172
Query: 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHG 699
FG+ART ++ + N + L
Sbjct: 173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKK 206
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 32/97 (32%), Positives = 46/97 (47%), Gaps = 15/97 (15%)
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
+ L YL R+IHRD+K N+LLD + I+DF IA + + GT
Sbjct: 124 LVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGT 177
Query: 688 YGYMSPE------YALHGLFSIKSDVFSFGVLLLEIL 718
YM+PE A + F++ D +S GV E+L
Sbjct: 178 KPYMAPEMFSSRKGAGYS-FAV--DWWSLGVTAYELL 211
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 34/171 (19%), Positives = 60/171 (35%), Gaps = 50/171 (29%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL 580
LG G G V + + E+ A+K L + + E+ L +
Sbjct: 25 VLGLGINGKVLQIFNKR------------TQEKFALKMLQDC-----PKARREVELHWRA 67
Query: 581 -QHRNLVRLFGCC-IEQGEKISIYEFDIVTDPAR-KDLLDWTTRVRIIEG---------- 627
Q ++VR+ + + IV + +L RI +
Sbjct: 68 SQCPHIVRIVDVYENLYAGRKCLL---IVMECLDGGELFS-----RIQDRGDQAFTEREA 119
Query: 628 ------VAQGLLYLHQYSRLRVIHRDLKASNVLLDS---DMNPKISDFGIA 669
+ + + YLH + + HRD+K N+L S + K++DFG A
Sbjct: 120 SEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 2e-12
Identities = 27/124 (21%), Positives = 44/124 (35%), Gaps = 20/124 (16%)
Query: 26 DSITPATFIRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKKSPDTVVWVANRNCPILD 85
+S++ + G L + L N V Y VW +N
Sbjct: 2 NSLSSPNSLFTGHSL-EVGPSYRLIMQGDCNF------VLYDS--GKPVWASNTGGLGSG 52
Query: 86 PHGILAINNNGNLVLLNQANGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSEGSY 145
L +NNGNLV+ +Q+N IW + + + V L N+V+ G
Sbjct: 53 CRLTL--HNNGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIY---------GPV 101
Query: 146 LWQS 149
+W +
Sbjct: 102 VWAT 105
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 2e-12
Identities = 23/127 (18%), Positives = 46/127 (36%), Gaps = 20/127 (15%)
Query: 26 DSITPATFIRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKKSPDTVVWVANRNCPILD 85
+ +T + G+ L + N V Y T VW +N
Sbjct: 2 NLLTNGEGLYAGQSLDVE--PYHFIMQEDCNL------VLYDH--STSVWASNTGILGKK 51
Query: 86 PHGILAINNNGNLVLLNQANGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSEGSY 145
+ ++GN V+ + ++W+S+ + + V L + GN+V+ GS
Sbjct: 52 GC-KAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIY---------GSD 101
Query: 146 LWQSFDF 152
+W + +
Sbjct: 102 IWSTGTY 108
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 9e-12
Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 56/206 (27%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN 572
+ KLG+G +G V+KSI+R GE VAVK++ + F+N
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDR------------RTGEVVAVKKIF-------DAFQN 48
Query: 573 ---------EMMLIAKLQ-HRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTRV 622
E+M++ +L H N+V L ++ +Y +V D DL
Sbjct: 49 STDAQRTFREIMILTELSGHENIVNLLNVLRADNDR-DVY---LVFDYMETDLH------ 98
Query: 623 RIIEG-----------VAQ---GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGI 668
+I V Q + YLH S ++HRD+K SN+LL+++ + K++DFG+
Sbjct: 99 AVIRANILEPVHKQYVVYQLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGL 155
Query: 669 ARTFGGDEMQSNTNRIVGTYGYMSPE 694
+R+F +N + + +
Sbjct: 156 SRSFVNIRRVTNNIPLSINENTENFD 181
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 31/108 (28%), Positives = 52/108 (48%), Gaps = 11/108 (10%)
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
+ + +HQ L +HRD+K N+L+D + + +++DFG D ++ VGT
Sbjct: 184 MVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ-SSVAVGT 239
Query: 688 YGYMSPE-----YALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTD 730
Y+SPE G + + D +S GV + E+L + T FY
Sbjct: 240 PDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE--TPFYAES 285
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 35/139 (25%), Positives = 61/139 (43%), Gaps = 14/139 (10%)
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
+ + +H+ L +HRD+K N+LLD + +++DFG D + VGT
Sbjct: 171 IVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT-VRSLVAVGT 226
Query: 688 YGYMSPE-------YALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWN 740
Y+SPE G + + D ++ GV E+ + T FY + G +
Sbjct: 227 PDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ--TPFYADSTAETYGKIVH 284
Query: 741 LWKDDKAWKLMDPTMQNEA 759
+K+ + L+D + EA
Sbjct: 285 -YKEHLSLPLVDEGVPEEA 302
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 60/238 (25%), Positives = 97/238 (40%), Gaps = 50/238 (21%)
Query: 514 DNFSEENKLGEGGFGPVY----KSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEE 569
+++ +G G FG V KS + + KLL+ E+ +KR
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAM------KLLSKFEM-IKR------SDSAF 115
Query: 570 FKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTD-PARKDLLDWTTRVRIIEGV 628
F E ++A +V+LF Q ++ +Y +V + DL++ + + E
Sbjct: 116 FWEERDIMAFANSPWVVQLFYAF--QDDR-YLY---MVMEYMPGGDLVNLMSNYDVPEKW 169
Query: 629 AQ--------GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSN 680
A+ L +H + IHRD+K N+LLD + K++DFG + M
Sbjct: 170 ARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR- 225
Query: 681 TNRIVGTYGYMSPE-------YALHGLFSIKS-DVFSFGVLLLEILSSKKNTRFYNTD 730
+ VGT Y+SPE +G + D +S GV L E+L T FY
Sbjct: 226 CDTAVGTPDYISPEVLKSQGGDGYYG----RECDWWSVGVFLYEMLVGD--TPFYADS 277
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 34/103 (33%), Positives = 52/103 (50%), Gaps = 6/103 (5%)
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
+ L YLH S V++RDLK N++LD D + KI+DFG+ + D T GT
Sbjct: 257 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGT 312
Query: 688 YGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTD 730
Y++PE + D + GV++ E++ + FYN D
Sbjct: 313 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 353
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.7 bits (154), Expect = 7e-11
Identities = 38/212 (17%), Positives = 61/212 (28%), Gaps = 66/212 (31%)
Query: 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRL--------SSKS 563
T+ K+GEG FG V+++I + VA+K + +
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTI--------------ADHTPVAIKIIAIEGPDLVNGSH 63
Query: 564 GQGLEEFKNEMMLIAKLQ---------HRNLVRLFGCCIEQGEKIS-------------- 600
+ EE E+++ +L + L QG
Sbjct: 64 QKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKG 123
Query: 601 ----------------IYEFD---IVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRL 641
+ EF+ I + R L T I+ + L L
Sbjct: 124 SANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SL 181
Query: 642 RVIHRDLKASNVLLDSDMNPKISDFGIARTFG 673
R HRDL NVLL K+ ++
Sbjct: 182 RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSST 213
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 7e-11
Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 7/103 (6%)
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
+ L YLH V++RD+K N++LD D + KI+DFG+ + D T GT
Sbjct: 114 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGT 168
Query: 688 YGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTD 730
Y++PE + D + GV++ E++ + FYN D
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 209
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 8e-11
Identities = 23/125 (18%), Positives = 46/125 (36%), Gaps = 19/125 (15%)
Query: 25 ADSITPATFIRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKKSPDTVVWVANRNCPIL 84
+D + + G L + + N V Y + VW + N
Sbjct: 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCNL------VLYDN--NRAVWASGTNGKAS 50
Query: 85 DPHGILAINNNGNLVLLNQANGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSEGS 144
L + N+GNLV+ + + IW+SN +++ + L N+V+ + +
Sbjct: 51 GCV--LKMQNDGNLVIYS-GSRAIWASNTNRQNGNYYLILQRDRNVVIY------DNSNN 101
Query: 145 YLWQS 149
+W +
Sbjct: 102 AIWAT 106
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 62.9 bits (154), Expect = 1e-10
Identities = 28/88 (31%), Positives = 48/88 (54%), Gaps = 5/88 (5%)
Query: 631 GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGY 690
L +LHQ +I+RDLK N++L+ + K++DFG+ + D ++T GT Y
Sbjct: 133 ALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEY 187
Query: 691 MSPEYALHGLFSIKSDVFSFGVLLLEIL 718
M+PE + + D +S G L+ ++L
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDML 215
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 1e-10
Identities = 32/95 (33%), Positives = 56/95 (58%), Gaps = 11/95 (11%)
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
++ L YLH+ +I+RDLK NVLLDS+ + K++D+G+ + ++T GT
Sbjct: 119 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGT 173
Query: 688 YGYMSPE---YALHGLFSIKSDVFSFGVLLLEILS 719
Y++PE +G FS+ D ++ GVL+ E+++
Sbjct: 174 PNYIAPEILRGEDYG-FSV--DWWALGVLMFEMMA 205
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 1e-10
Identities = 33/91 (36%), Positives = 54/91 (59%), Gaps = 5/91 (5%)
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
+A L +LH L +I+RDLK N+LLD + + K++DFG+++ E ++ + GT
Sbjct: 135 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGT 189
Query: 688 YGYMSPEYALHGLFSIKSDVFSFGVLLLEIL 718
YM+PE + +D +SFGVL+ E+L
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEML 220
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 1e-10
Identities = 32/95 (33%), Positives = 53/95 (55%), Gaps = 13/95 (13%)
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
+ L++LH +I+RDLK NVLLD + + K++DFG+ + + + + T GT
Sbjct: 133 IISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGT 187
Query: 688 YGYMSPE---YALHGLFSIKS-DVFSFGVLLLEIL 718
Y++PE L+G + D ++ GVLL E+L
Sbjct: 188 PDYIAPEILQEMLYG----PAVDWWAMGVLLYEML 218
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 32/95 (33%), Positives = 56/95 (58%), Gaps = 11/95 (11%)
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
++ L YLH+ +I+RDLK NVLLDS+ + K++D+G+ + ++T GT
Sbjct: 162 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGT 216
Query: 688 YGYMSPE---YALHGLFSIKSDVFSFGVLLLEILS 719
Y++PE +G FS+ D ++ GVL+ E+++
Sbjct: 217 PNYIAPEILRGEDYG-FSV--DWWALGVLMFEMMA 248
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 64.1 bits (155), Expect = 2e-10
Identities = 102/674 (15%), Positives = 187/674 (27%), Gaps = 194/674 (28%)
Query: 221 FEDGPTFIDYLYKIILVDTEDEIYYRYESY-------NNLS------IMMLKINPLGKIQ 267
FE G Y YK IL ED ++ + LS I+M K + +
Sbjct: 9 FETGE--HQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSK-DAVSGTL 65
Query: 268 RLLW---NEGSSGWQVMFSAPGDVCQ-NYGHCGANSICNVDNPPKCECLKGFKPNSQHNQ 323
RL W ++ Q +V + NY + I P + Q ++
Sbjct: 66 RLFWTLLSKQEEMVQKFV---EEVLRINYKFL-MSPIKTEQRQPS---MMTRMYIEQRDR 118
Query: 324 TWATTCVRSHLSDCKTANQFKRFDDMKVP-----DLLDVSLNE----------GMNLEEC 368
+ N + F V L +L E G+
Sbjct: 119 LY---------------NDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVL--GS 161
Query: 369 GAECLNNCTCRAYAYFNLTRGGSGCLMW--FGDLIDMRKTLANLTGQSIYLRVPASEPGK 426
G + C +Y + + W + L L Q + ++
Sbjct: 162 GKTWVALDVCLSYK---VQCKMDFKIFWLNLKNCNSPETVLEML--QKLLYQI------- 209
Query: 427 KRPLWIVVLAALPVAILPAFLIFYRRKKKLKEKERRTEASQDMLL-------------FE 473
P W L I ++ LK K ++ LL F
Sbjct: 210 -DPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY-----ENCLLVLLNVQNAKAWNAFN 263
Query: 474 I--------------NMGNMSRAKEFCEGDSAGTGKSKESWFLFFSLSSISAATDNFSEE 519
+ + + + + T E L L + + E
Sbjct: 264 LSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLL--LKYLDCRPQDLPRE 321
Query: 520 NKLGEGGFGPVYKSI--ERYVE-ICNWKQGKLLNGEEVAVKRLSSKSGQGLE--EFKN-- 572
P SI E + + W K +N ++ + + S LE E++
Sbjct: 322 VLTT----NPRRLSIIAESIRDGLATWDNWKHVNCDK--LTTIIESSLNVLEPAEYRKMF 375
Query: 573 EMMLI----AKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTRVRIIEGV 628
+ + + A + L ++ + I +V + L++ +
Sbjct: 376 DRLSVFPPSAHIPTILLSLIW------FDVIKSDVMVVVNKLHKYSLVE--------KQP 421
Query: 629 AQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD-FGIARTFGGDEMQSNTNRIVGT 687
+ + + I+ +LK + + ++ I D + I +TF D++
Sbjct: 422 KESTISIPS------IYLELKV-KLENEYALHRSIVDHYNIPKTFDSDDLIPPYLD---Q 471
Query: 688 YGYMSPEYALHGLFSI----KSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWK 743
Y Y + H L +I + +F L L K + AWN
Sbjct: 472 YFY---SHIGHHLKNIEHPERMTLFRMVFLDFRFLEQK----------IRHDSTAWN--- 515
Query: 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSP- 802
A + T+Q Y YI C + +R ++ + LP
Sbjct: 516 ---ASGSILNTLQQLKFYK---PYI-----CDNDPKYER--------LVNAILDFLPKIE 556
Query: 803 ----HQPAFSYVQI 812
++I
Sbjct: 557 ENLICSKYTDLLRI 570
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 59.5 bits (143), Expect = 4e-09
Identities = 62/362 (17%), Positives = 101/362 (27%), Gaps = 112/362 (30%)
Query: 67 KKSPDTVVWVANRNCPILDPHGILAINNNGNLVLLNQANGTIWSSNMSKEAKSPVAQLLD 126
K + W+ +NC P +L + L+ N T S + S + +
Sbjct: 178 CKMDFKIFWLNLKNC--NSPETVLEMLQK--LLYQIDPNWTSRSDHSS-----NIKLRIH 228
Query: 127 TGNLVLRENFSNNTSEGSYL----------WQSFDFPSDTLLPGMKVGWDLKTGRERYLT 176
+ LR + E L W +F+ LL T R + +T
Sbjct: 229 SIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILL----------TTRFKQVT 278
Query: 177 SWRTA--------DDPSPGKFTYR---------LDIHV--LPQIFLYKGS-LKLARIGPW 216
+ +A D S T LD LP+ L + +L+ I
Sbjct: 279 DFLSAATTTHISLDHHSMT-LTPDEVKSLLLKYLDCRPQDLPREVL-TTNPRRLSIIAE- 335
Query: 217 NGFIFEDGPTFIDY--------LYKIIL--VDTEDEIYYRYESYNNLSIMM--LKINPLG 264
DG D L II ++ + YR + ++ LS+ I P
Sbjct: 336 ---SIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYR-KMFDRLSVFPPSAHI-PTI 390
Query: 265 KIQRLLWNEGSSGWQVMFSAPGDVCQNYG------------------------------H 294
+ L+W + VM + Y H
Sbjct: 391 LLS-LIWFDVIKS-DVMVVV--NKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALH 446
Query: 295 CGANSICNVDNPPKCECLKGFKPNSQHNQTWATTCVRSHLSDCKTANQFKRFDDMKVPDL 354
SI + N PK P + + HL + + + F +
Sbjct: 447 ---RSIVDHYNIPKTFDSDDLIPPYLDQY-FYSHIGH-HLKNIEHPERMTLFRMV----F 497
Query: 355 LD 356
LD
Sbjct: 498 LD 499
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.4 bits (135), Expect = 4e-08
Identities = 52/326 (15%), Positives = 100/326 (30%), Gaps = 91/326 (27%)
Query: 568 EEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDW--------- 618
EE + ++++K +RLF + + E++ + +F V + R + +
Sbjct: 49 EEIDH--IIMSKDAVSGTLRLFWTLLSKQEEM-VQKF--VEEVLRINY-KFLMSPIKTEQ 102
Query: 619 ----------------------------TTRVRIIEGVAQGLLYLHQYSRLRVIHRDL-- 648
+R++ + Q LL L + +I L
Sbjct: 103 RQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNV-LIDGVLGS 161
Query: 649 -K---ASNVLLDSDMNPKISDFGIA-RTFGGD-------EMQSNTNRIVGTYGYMSPEYA 696
K A +V L + K+ DF I EM + P +
Sbjct: 162 GKTWVALDVCLSYKVQCKM-DFKIFWLNLKNCNSPETVLEMLQKL------LYQIDPNWT 214
Query: 697 --LHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPT 754
+IK + S L +L SK L +L + N AW + +
Sbjct: 215 SRSDHSSNIKLRIHSIQAELRRLLKSKPYEN-----CLLVLLNVQNAK----AWNAFNLS 265
Query: 755 MQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSPHQPAFSYVQIVE 814
+ L + TR+ +V T + + DE+ +L + ++
Sbjct: 266 CK--IL--LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSL-------LL--KYLD 312
Query: 815 RSVLLANINAEASLGNCLTLSVVDAR 840
++ E N LS++
Sbjct: 313 CRP--QDLPREVLTTNPRRLSIIAES 336
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 2e-10
Identities = 34/91 (37%), Positives = 53/91 (58%), Gaps = 5/91 (5%)
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
+A GL +L +I+RDLK NV+LDS+ + KI+DFG+ + D + + T GT
Sbjct: 130 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGT 184
Query: 688 YGYMSPEYALHGLFSIKSDVFSFGVLLLEIL 718
Y++PE + + D ++FGVLL E+L
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 215
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 63.5 bits (154), Expect = 2e-10
Identities = 34/91 (37%), Positives = 53/91 (58%), Gaps = 5/91 (5%)
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
+A GL +L +I+RDLK NV+LDS+ + KI+DFG+ + D + + T GT
Sbjct: 451 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGT 505
Query: 688 YGYMSPEYALHGLFSIKSDVFSFGVLLLEIL 718
Y++PE + + D ++FGVLL E+L
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 536
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 5/91 (5%)
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
+A L YLH L +++RDLK N+LLDS + ++DFG+ + ++T GT
Sbjct: 148 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGT 202
Query: 688 YGYMSPEYALHGLFSIKSDVFSFGVLLLEIL 718
Y++PE + D + G +L E+L
Sbjct: 203 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEML 233
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 3e-10
Identities = 21/124 (16%), Positives = 39/124 (31%), Gaps = 21/124 (16%)
Query: 26 DSITPATFIRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKKSPDTVVWVANRNCPILD 85
+ + + L + + L + N V Y+ +W +N +
Sbjct: 3 NVLLSGQTLHADHSLQAG--AYTLTIQNKCNL------VKYQN--GRQIWASNTDRR--G 50
Query: 86 PHGILAINNNGNLVLLNQANGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSEGSY 145
L + ++GNLV+ + N +W S + L G V+ G
Sbjct: 51 SGCRLTLLSDGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVIY---------GPV 101
Query: 146 LWQS 149
LW
Sbjct: 102 LWSL 105
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 47/236 (19%), Positives = 88/236 (37%), Gaps = 68/236 (28%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG---QGLEEFK------ 571
KLG G F V+ + + ++N VA+K + +E K
Sbjct: 26 KLGWGHFSTVWLAKD------------MVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVN 73
Query: 572 -NEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFD----------IVTDPARKDLLDW-- 618
+ + ++++L F+ +V + ++LL
Sbjct: 74 DADNTKEDSMGANHILKLLDH------------FNHKGPNGVHVVMVFEVLGENLLALIK 121
Query: 619 --------TTRVR-IIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP------KI 663
V+ I + + GL Y+H R +IH D+K NVL++ +P KI
Sbjct: 122 KYEHRGIPLIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKI 179
Query: 664 SDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS 719
+D G A + + + + T Y SPE L + +D++S L+ E+++
Sbjct: 180 ADLGNA-CWYDEHYTN----SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT 230
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 4e-10
Identities = 35/91 (38%), Positives = 54/91 (59%), Gaps = 5/91 (5%)
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
+ GL +LH +++RDLK N+LLD D + KI+DFG+ + + ++NT GT
Sbjct: 127 IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGT 181
Query: 688 YGYMSPEYALHGLFSIKSDVFSFGVLLLEIL 718
Y++PE L ++ D +SFGVLL E+L
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEML 212
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 32/91 (35%), Positives = 51/91 (56%), Gaps = 8/91 (8%)
Query: 631 GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGY 690
L +LH+ L +I+RD+K N+LLDS+ + ++DFG+++ F DE + GT Y
Sbjct: 171 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGTIEY 226
Query: 691 MSPE---YALHGLFSIKSDVFSFGVLLLEIL 718
M+P+ G D +S GVL+ E+L
Sbjct: 227 MAPDIVRGGDSG-HDKAVDWWSLGVLMYELL 256
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 5e-10
Identities = 27/96 (28%), Positives = 48/96 (50%), Gaps = 16/96 (16%)
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
+ YLH +I+RDLK N+L+D +++DFG A+ ++ T + GT
Sbjct: 150 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGT 201
Query: 688 YGYMSPEYAL---HGLFSIKS-DVFSFGVLLLEILS 719
++PE L + K+ D ++ GVL+ E+ +
Sbjct: 202 PEALAPEIILSKGYN----KAVDWWALGVLIYEMAA 233
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 7e-10
Identities = 24/138 (17%), Positives = 43/138 (31%), Gaps = 29/138 (21%)
Query: 23 LAADSITPATFIRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKKSPDTVVWVANRNCP 82
L + + + L + F+L N V Y + + R+C
Sbjct: 1 LGTNYLLSGQTLDTEGHLKN--GDFDLVMQDDCNL------VLYNGNWQSNTANNGRDC- 51
Query: 83 ILDPHGILAINNNGNLVLLNQANGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSE 142
L + + G LV+ N T+W S + A + G LV+
Sbjct: 52 ------KLTLTDYGELVIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVV---------F 96
Query: 143 GSYLWQSFDFPSDTLLPG 160
G +++ D + G
Sbjct: 97 GPSVFK-----IDPWVRG 109
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 7e-10
Identities = 28/124 (22%), Positives = 46/124 (37%), Gaps = 21/124 (16%)
Query: 26 DSITPATFIRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKKSPDTVVWVANRNCPILD 85
+ + + GE L + R+ N V Y D +W N D
Sbjct: 2 NILYSGETLSPGEFL--NNGRYVFIMQEDCNL------VLYDV--DKPIWATNTGGL--D 49
Query: 86 PHGILAINNNGNLVLLNQANGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSEGSY 145
L++ ++GNLV+ + N IW+SN E + V L N+V+ G+
Sbjct: 50 RRCHLSMQSDGNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIY---------GTA 100
Query: 146 LWQS 149
W +
Sbjct: 101 RWAT 104
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 9e-10
Identities = 20/111 (18%), Positives = 39/111 (35%), Gaps = 19/111 (17%)
Query: 39 KLVSPSQRFELGFFSPGNSKNRYLGVWYKKSPDTVVWVANRNCPILDPHGILAINNNGNL 98
+++ + + + N V Y + +W N + +G L
Sbjct: 24 EILFGTHVYRFIMQTDCNL------VLYDN--NNPIWATNTGGL--GNGCRAVLQPDGVL 73
Query: 99 VLLNQANGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSEGSYLWQS 149
V++ N T+W S ++ +A V L N+V+ G LW +
Sbjct: 74 VVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIY---------GDALWAT 115
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 2e-09
Identities = 35/96 (36%), Positives = 52/96 (54%), Gaps = 16/96 (16%)
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
V L YLH +I+RDLK N+LLD + + KI+DFG A+ + T + GT
Sbjct: 115 VCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGT 166
Query: 688 YGYMSPEYAL---HGLFSIKS-DVFSFGVLLLEILS 719
Y++PE + KS D +SFG+L+ E+L+
Sbjct: 167 PDYIAPEVVSTKPYN----KSIDWWSFGILIYEMLA 198
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 2e-09
Identities = 19/109 (17%), Positives = 38/109 (34%), Gaps = 10/109 (9%)
Query: 24 AADSITPATFIRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKKSPDTVVWVANRNCPI 83
+ + + + D +L + + + L N V K S +VW
Sbjct: 5 VRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCNL------VLTKGSKTNIVW--ESGTSG 54
Query: 84 LDPHGILAINNNGNLVLLNQANGTIWSSNMSKEAKSPVAQLLDTGNLVL 132
H + + ++G L + + T++ SN + V L G V+
Sbjct: 55 RGQHCFMRLGHSGELDITDDRLNTVFVSNTVGQEGDYVLILQINGQAVV 103
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 39/206 (18%), Positives = 72/206 (34%), Gaps = 52/206 (25%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL 580
+G+GGFG +Y + + VK S +G E K
Sbjct: 42 PIGQGGFGCIY-------LADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 581 QHRNLVRL-------------FGCCIEQGEKISIYEFDIVTD---PARKDLLDWTTR--- 621
Q + +R G + G+ Y F ++ D + + + +
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKS---YRF-MIMDRFGSDLQKIYEANAKRFS 150
Query: 622 --------VRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKI--SDFGIART 671
+RI+ L Y+H++ +H D+KASN+LL+ ++ D+G+A
Sbjct: 151 RKTVLQLSLRIL----DILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203
Query: 672 F----GGDEMQSNTNR-IVGTYGYMS 692
+ ++ R GT + S
Sbjct: 204 YCPEGVHKAYAADPKRCHDGTIEFTS 229
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 2e-08
Identities = 23/112 (20%), Positives = 36/112 (32%), Gaps = 13/112 (11%)
Query: 21 FSLAADSITPATFIRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKKSPDTVVWVANRN 80
+ + + +L + +L N V Y W N
Sbjct: 2 IPFTNNLLFSGQVLYGDGRLTAK--NHQLVMQGDCNL------VLYGGKY---GW--QSN 48
Query: 81 CPILDPHGILAINNNGNLVLLNQANGTIWSSNMSKEAKSPVAQLLDTGNLVL 132
H L +N+ G L++ + TIWSS S + V L D G V+
Sbjct: 49 THGNGEHCFLRLNHKGELIIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVI 100
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 39.5 bits (92), Expect = 5e-04
Identities = 13/72 (18%), Positives = 25/72 (34%), Gaps = 8/72 (11%)
Query: 78 NRNCPILDPHGILAINNNGNLVLLNQANGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFS 137
+ + + L + + NLVL W SN + +L G L+++
Sbjct: 16 YGDGRLTAKNHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIK---- 69
Query: 138 NNTSEGSYLWQS 149
+ +W S
Sbjct: 70 --DDDFKTIWSS 79
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 30/203 (14%), Positives = 67/203 (33%), Gaps = 42/203 (20%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIA 578
++ G +Y++ ++ ++K L +K G+ E
Sbjct: 47 KSFQTRDNQGILYEAAP----TSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAK 101
Query: 579 KLQHRNLVRLFGC-------CIEQGEKISIYEFDIVTD---PARKDLLDWTTR------- 621
LQ +L+ C+ G Y F +V + + LD + +
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRF-LVLPSLGRSLQSALDVSPKHVLSERS 160
Query: 622 -----VRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKI--SDFGIARTF-- 672
R++ L +LH+ +H ++ A N+ +D + ++ + +G A +
Sbjct: 161 VLQVACRLL----DALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP 213
Query: 673 GGDEMQSNTNR---IVGTYGYMS 692
G + G ++S
Sbjct: 214 SGKHVAYVEGSRSPHEGDLEFIS 236
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 49/225 (21%), Positives = 80/225 (35%), Gaps = 62/225 (27%)
Query: 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG---QGLEEFKNEMML 576
+ +G+G FG V K+ + E VA+K + +K Q E + L
Sbjct: 60 SLIGKGSFGQVVKAY------------DRVEQEWVAIKIIKNKKAFLNQAQIEVR----L 103
Query: 577 IAKLQHR------NLVRLFGCCIEQGEKISIYEFD------IVTDPARKDLLDW------ 618
+ + +V L F +V + +L D
Sbjct: 104 LELMNKHDTEMKYYIVHLKRH------------FMFRNHLCLVFEMLSYNLYDLLRNTNF 151
Query: 619 ----TTRVRII-EGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP--KISDFGIART 671
R + + LL+L L +IH DLK N+LL + KI DFG +
Sbjct: 152 RGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-C 209
Query: 672 FGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLE 716
G + + + Y SPE L + + D++S G +L+E
Sbjct: 210 QLGQRIYQ----YIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVE 250
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 4e-07
Identities = 47/228 (20%), Positives = 83/228 (36%), Gaps = 72/228 (31%)
Query: 522 LGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG---QGLEEFKNEMMLIA 578
+G+G FG V K+ + VA+K + ++ Q EE + ++
Sbjct: 105 IGKGSFGQVVKAY------------DHKVHQHVALKMVRNEKRFHRQAAEEIR----ILE 148
Query: 579 KLQHR------NLVRLFGCCIEQGEKISIYEFD------IVTDPARKDLLDW-------- 618
L+ + N++ + F + + +L +
Sbjct: 149 HLRKQDKDNTMNVIHMLEN------------FTFRNHICMTFELLSMNLYELIKKNKFQG 196
Query: 619 --TTRVRII-EGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP--KISDFGIARTFG 673
VR + Q L LH + R+IH DLK N+LL K+ DFG + +
Sbjct: 197 FSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-CY- 251
Query: 674 GDEMQSNTNRIVGTY----GYMSPEYALHGLFSIKSDVFSFGVLLLEI 717
++ V TY Y +PE L + + D++S G +L E+
Sbjct: 252 -------EHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAEL 292
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 50.8 bits (120), Expect = 6e-07
Identities = 33/169 (19%), Positives = 55/169 (32%), Gaps = 21/169 (12%)
Query: 22 SLAADSITPATFIRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKKSPDTVVWVANRNC 81
+ + + G+ L+SP+QRF+L GN V VWVAN
Sbjct: 11 GVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDGNL------VIQDNGA--TVWVANEQQ 62
Query: 82 PI------LDPHGILAINNNGNLVLLNQANGTIWSS-----NMSKEAKSPVAQLLDTGNL 130
P + LA L + + +W + + + L D GN+
Sbjct: 63 PFSSTIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNI 122
Query: 131 VLRENFSNNTSEGSYLWQSFDFPSDTLLPGMK--VGWDLKTGRERYLTS 177
VL ++ + + S L PG + G G + +
Sbjct: 123 VLVDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVVYGAGASKLVFQ 171
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 43.1 bits (100), Expect = 2e-04
Identities = 18/92 (19%), Positives = 29/92 (31%), Gaps = 13/92 (14%)
Query: 64 VWYKKSPDTVVWVANRNCPILDPHGILAINNNGNLVLLNQANGTIWSSNMSKEAKSPVAQ 123
V Y + W A +GNLV+ N +W S+ A + V +
Sbjct: 177 VAYGPN-GAATWNAGTQGK---GAVRAVFQGDGNLVVYGAGNAVLWHSHTGGHASA-VLR 231
Query: 124 LLDTGNLVLRENFSNNTSEGSYLWQSFDFPSD 155
L G++ + +W F F
Sbjct: 232 LQANGSIAI---LDEKP-----VWARFGFQPT 255
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 34/176 (19%), Positives = 57/176 (32%), Gaps = 67/176 (38%)
Query: 606 IVTDPARKDLLDWTTR----------VR-IIEGVAQGLLYLHQYSRLRVIHRDLKASNVL 654
+V + LL W + V+ II+ V QGL YLH ++ R+IH D+K N+L
Sbjct: 122 MVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH--TKCRIIHTDIKPENIL 179
Query: 655 L-------------------------------------------------DSDMNPKISD 665
L + KI+D
Sbjct: 180 LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIAD 239
Query: 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSK 721
G A + + T Y S E + ++ +D++S + E+ +
Sbjct: 240 LGNAC-WVHKHFTE----DIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGD 290
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 40/195 (20%), Positives = 75/195 (38%), Gaps = 50/195 (25%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL 580
K+G G FG +Y + EEVA+K + K+ E + L
Sbjct: 14 KIGSGSFGEIYLGTN------------IQTNEEVAIKLENVKTKHPQ--LLYESKIYRIL 59
Query: 581 QHRNLV-RLFGCCIEQGEKISIYEFDIVTD---PARKDLLDWTTR-------VRIIEGVA 629
Q + + +E + +V D P+ +DL ++ +R + + + +
Sbjct: 60 QGGTGIPNVRWFGVEGDYNV------LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 113
Query: 630 QGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPK---ISDFGIARTFGGDEMQSNTNR--- 683
+ ++H S +HRD+K N L+ I DFG+A+ + ++T++
Sbjct: 114 NRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY----RDTSTHQHIP 166
Query: 684 ------IVGTYGYMS 692
+ GT Y S
Sbjct: 167 YRENKNLTGTARYAS 181
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 41/195 (21%), Positives = 75/195 (38%), Gaps = 50/195 (25%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL 580
K+G G FG +Y + + GEEVA+K K+ E + +
Sbjct: 16 KIGSGSFGDIYLGTD------------IAAGEEVAIKLECVKTKHPQ--LHIESKIYKMM 61
Query: 581 QH-RNLVRLFGCCIEQGEKISIYEFDIVTD---PARKDLLDWTTR-------VRIIEGVA 629
Q + + C E + +V + P+ +DL ++ +R + + + +
Sbjct: 62 QGGVGIPTIRWCGAEGDYNV------MVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMI 115
Query: 630 QGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPK---ISDFGIARTFGGDEMQSNTNR--- 683
+ Y+H + IHRD+K N L+ I DFG+A+ + + T++
Sbjct: 116 SRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY----RDARTHQHIP 168
Query: 684 ------IVGTYGYMS 692
+ GT Y S
Sbjct: 169 YRENKNLTGTARYAS 183
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 49.1 bits (116), Expect = 2e-06
Identities = 21/86 (24%), Positives = 30/86 (34%), Gaps = 13/86 (15%)
Query: 64 VWYKKSPDTVVWVANRNCPILDPHGILAINNNGNLVLLNQANGTIWSSNMSKEAKSPVAQ 123
V + D VW N +L NG + +L N +W+S S+ A V
Sbjct: 163 VLFD--RDDRVWSTNTAGKGTGCRAVL--QPNGRMDVLTNQNIAVWTSGNSRSAGRYVFV 218
Query: 124 LLDTGNLVLRENFSNNTSEGSYLWQS 149
L NL + G LW +
Sbjct: 219 LQPDRNLAIY---------GGALWTT 235
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 40/205 (19%), Positives = 79/205 (38%), Gaps = 54/205 (26%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVK--RLSSKSGQGLEEFK 571
++ ++GEG FG +++ LLN ++VA+K S + Q +E++
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTN------------LLNNQQVAIKFEPRRSDAPQLRDEYR 57
Query: 572 NEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTD---PARKDLLDWTTR------- 621
+L + ++ E + +V D P+ +DLLD R
Sbjct: 58 TYKLLAGC---TGIPNVYYFGQEGLHNV------LVIDLLGPSLEDLLDLCGRKFSVKTV 108
Query: 622 VRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPK-----ISDFGIARTFGGDE 676
+ + + +H+ S +++RD+K N L+ + + DFG+ + +
Sbjct: 109 AMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY---- 161
Query: 677 MQSNTNR---------IVGTYGYMS 692
T + + GT YMS
Sbjct: 162 RDPVTKQHIPYREKKNLSGTARYMS 186
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 40/202 (19%), Positives = 67/202 (33%), Gaps = 50/202 (24%)
Query: 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEM 574
NF K+G G FG + L E VA+K KS +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKN------------LYTNEYVAIKLEPMKSRAPQLHLEYRF 57
Query: 575 MLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTD---PARKDLLDWTTR-------VRI 624
+ +++ +V + P+ +DL D R + I
Sbjct: 58 YKQLG-SGDGIPQVYYFGPCGKYNA------MVLELLGPSLEDLFDLCDRTFSLKTVLMI 110
Query: 625 IEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPK-----ISDFGIARTFGGDEMQS 679
+ + Y+H + +I+RD+K N L+ N I DF +A+ + +
Sbjct: 111 AIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY----IDP 163
Query: 680 NTNR---------IVGTYGYMS 692
T + + GT YMS
Sbjct: 164 ETKKHIPYREHKSLTGTARYMS 185
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 47/242 (19%), Positives = 81/242 (33%), Gaps = 82/242 (33%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG---QGLEEFKNEMMLI 577
LGEG FG V + ++ +VA+K + + E ++
Sbjct: 26 NLGEGTFGKVVECLDH-----------ARGKSQVALKIIRNVGKYREAARLEIN----VL 70
Query: 578 AKLQHR------NLVRLFGCCIEQGEKISIYEFD------IVTDPARKDLLDW------- 618
K++ + V + F+ I + K+ ++
Sbjct: 71 KKIKEKDKENKFLCVLMSDW------------FNFHGHMCIAFELLGKNTFEFLKENNFQ 118
Query: 619 ---TTRVRII-EGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP------------- 661
VR + + L +LH ++ H DLK N+L +
Sbjct: 119 PYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175
Query: 662 ------KISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGL-FSIKSDVFSFGVLL 714
+++DFG A TF + + IV T Y PE L L ++ DV+S G +L
Sbjct: 176 VKNTSIRVADFGSA-TFDHEHHTT----IVATRHYRPPEVIL-ELGWAQPCDVWSIGCIL 229
Query: 715 LE 716
E
Sbjct: 230 FE 231
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 38/204 (18%), Positives = 72/204 (35%), Gaps = 51/204 (25%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVA---VKRLSSKSGQGLEEFKNEMMLI 577
K+G GGFG +Y + E+ A VK ++G E K +
Sbjct: 44 KIGSGGFGLIYLAF------------PTNKPEKDARHVVKVEYQENGPLFSELKFYQRVA 91
Query: 578 AKLQHRNLVRL-------------FGCCIEQGEKISIYEFDIVTD---PARKDLLDWT-- 619
K + + G +G Y F +V + + +
Sbjct: 92 KKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRS---YRF-MVMERLGIDLQKISGQNGT 147
Query: 620 ----TRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKI--SDFGIARTF- 672
T +++ + L Y+H+ +H D+KA+N+LL ++ +D+G++ +
Sbjct: 148 FKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYC 204
Query: 673 ---GGDEMQSNTNR-IVGTYGYMS 692
+ Q N + GT + S
Sbjct: 205 PNGNHKQYQENPRKGHNGTIEFTS 228
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 53/247 (21%), Positives = 84/247 (34%), Gaps = 88/247 (35%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG---QGLEEFKNEMMLI 577
K+G+G FG V N + AVK + + E ++
Sbjct: 42 KMGDGTFGRVLLCQHID------------NKKYYAVKVVRNIKKYTRSAKIEAD----IL 85
Query: 578 AKLQHR-----NLVRLFGCCIEQGEKISIYEFD------IVTDPARKDLLDW-------- 618
K+Q+ N+V+ G F ++ +P L +
Sbjct: 86 KKIQNDDINNNNIVKYHGK------------FMYYDHMCLIFEPLGPSLYEIITRNNYNG 133
Query: 619 --TTRVR-IIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP-------------- 661
++ + + L YL ++ + H DLK N+LLD
Sbjct: 134 FHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK 190
Query: 662 -----------KISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGL-FSIKSDVFS 709
K+ DFG A TF D S I+ T Y +PE L L + + SD++S
Sbjct: 191 IQIYRTKSTGIKLIDFGCA-TFKSDYHGS----IINTRQYRAPEVIL-NLGWDVSSDMWS 244
Query: 710 FGVLLLE 716
FG +L E
Sbjct: 245 FGCVLAE 251
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 49/242 (20%), Positives = 80/242 (33%), Gaps = 82/242 (33%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG---QGLEEFKNEMMLI 577
LGEG FG V + I+ G VAVK + + E + ++
Sbjct: 21 TLGEGAFGKVVECIDHKA-----------GGRHVAVKIVKNVDRYCEAARSEIQ----VL 65
Query: 578 AKLQHR------NLVRLFGCCIEQGEKISIYEFD------IVTDPARKDLLDW------- 618
L V++ F+ IV + D+
Sbjct: 66 EHLNTTDPNSTFRCVQMLEW------------FEHHGHICIVFELLGLSTYDFIKENGFL 113
Query: 619 ---TTRVRII-EGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP------------- 661
+R + + + + +LH ++ H DLK N+L
Sbjct: 114 PFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170
Query: 662 ------KISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGL-FSIKSDVFSFGVLL 714
K+ DFG A T+ + + +V T Y +PE L L +S DV+S G +L
Sbjct: 171 LINPDIKVVDFGSA-TYDDEHHST----LVSTRHYRAPEVIL-ALGWSQPCDVWSIGCIL 224
Query: 715 LE 716
+E
Sbjct: 225 IE 226
|
| >1ob1_C Major merozoite surface protein; immune system, immunoglobulin/complex, immunoglobulin, antib fragment, MSP1-19, EGF-like domain; 2.90A {Plasmodium falciparum} SCOP: g.3.11.4 g.3.11.4 PDB: 1cej_A 2flg_A Length = 99 | Back alignment and structure |
|---|
Score = 39.0 bits (90), Expect = 7e-04
Identities = 14/57 (24%), Positives = 20/57 (35%), Gaps = 10/57 (17%)
Query: 287 DVCQNYGHCGANSIC--NVDNPPKCECLKGFKPNSQHNQTWATTCVRSHLSDCKTAN 341
C C NS C ++D +C+CL +K CV + C N
Sbjct: 5 HQCVK-KQCPQNSGCFRHLDEREECKCLLNYKQEG-------DKCVENPNPTCNENN 53
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 39.0 bits (91), Expect = 7e-04
Identities = 12/67 (17%), Positives = 23/67 (34%), Gaps = 5/67 (7%)
Query: 89 ILAINNNGNLVLLNQANGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSEGSYLWQ 148
+ + NLVL N + SN +L + G L + S N++ +++
Sbjct: 23 AFVMQGDCNLVLYN--EAGGFQSNTHGRGVDCTLRLNNRGQLEI---HSANSNTPVWVYP 77
Query: 149 SFDFPSD 155
Sbjct: 78 RSVNTVR 84
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 840 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.98 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.91 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.87 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.85 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.85 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.84 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.81 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.81 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.8 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.76 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.71 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.68 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.68 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.64 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.64 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.64 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.58 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.56 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.53 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.49 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.31 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.24 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.24 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.11 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.05 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.05 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.05 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.86 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.79 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.72 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.53 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.47 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.02 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.99 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.95 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.76 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.76 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.6 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.55 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.19 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.19 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.12 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.74 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.47 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.29 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.02 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 95.97 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 95.83 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.8 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.31 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 94.63 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 94.47 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 93.78 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.99 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 91.11 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 87.27 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 84.41 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-50 Score=435.44 Aligned_cols=259 Identities=27% Similarity=0.393 Sum_probs=198.1
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCI 593 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~ 593 (840)
++|...++||+|+||.||+|+++.. ....+++.||||+++.......++|.+|+++|++++|||||+++|+|.
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~-------~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 113 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNL-------LPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCT 113 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSS-------CC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred HHeEEEEEEccCCCcEEEEEEECCc-------ccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 5677889999999999999976510 122468899999998776666788999999999999999999999999
Q ss_pred cCCceEEEEEeeccCCc-------------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEE
Q 041702 594 EQGEKISIYEFDIVTDP-------------------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVL 654 (840)
Q Consensus 594 ~~~~~~lv~e~~~~~~~-------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIL 654 (840)
+.+..++||||....+. .....++|.++++|+.|||+||+|||+.+ ||||||||+|||
T Consensus 114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NIL 190 (329)
T 4aoj_A 114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCL 190 (329)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEE
Confidence 99999999999533221 12346999999999999999999999987 999999999999
Q ss_pred ecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcc
Q 041702 655 LDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLT 733 (840)
Q Consensus 655 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~ 733 (840)
|++++.+||+|||+|+.+.............||+.|||||++.+..++.++|||||||+||||+| |+.||...... .
T Consensus 191 l~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~--~ 268 (329)
T 4aoj_A 191 VGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT--E 268 (329)
T ss_dssp EETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH--H
T ss_pred ECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH--H
Confidence 99999999999999998765544444556789999999999999999999999999999999999 89998643211 1
Q ss_pred HhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 734 LLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
.. .....+.. . +.+...++.+.+|+.+||+.||++||||+||++.|+.+..
T Consensus 269 ~~----~~i~~g~~--~-------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 269 AI----DCITQGRE--L-------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HH----HHHHHTCC--C-------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HH----HHHHcCCC--C-------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 11 11111110 1 1112234568899999999999999999999999998744
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=431.69 Aligned_cols=260 Identities=25% Similarity=0.395 Sum_probs=206.7
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCI 593 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~ 593 (840)
++|.+.++||+|+||.||+|.++.. ....++..||||+++.......++|.+|+++|++++|||||+++|+|.
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~-------~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 85 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNL-------CPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV 85 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSC-------C----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCc-------ccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence 5688889999999999999976410 122468899999998766666788999999999999999999999999
Q ss_pred cCCceEEEEEeeccCCc-----------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEec
Q 041702 594 EQGEKISIYEFDIVTDP-----------------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLD 656 (840)
Q Consensus 594 ~~~~~~lv~e~~~~~~~-----------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~ 656 (840)
+++..++||||....+. .....++|.++++|+.||+.||+|||+++ |+||||||+||||+
T Consensus 86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~ 162 (299)
T 4asz_A 86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVG 162 (299)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEEC
Confidence 99999999999543322 22357999999999999999999999988 99999999999999
Q ss_pred CCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHh
Q 041702 657 SDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLL 735 (840)
Q Consensus 657 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~ 735 (840)
+++.+||+|||+|+...............||+.|||||++.+..++.|+|||||||+||||+| |+.||...... .+.
T Consensus 163 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~--~~~ 240 (299)
T 4asz_A 163 ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--EVI 240 (299)
T ss_dssp GGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHH
T ss_pred CCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHH
Confidence 999999999999987755444444455679999999999999999999999999999999999 89998643321 111
Q ss_pred HHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccC
Q 041702 736 GHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVN 798 (840)
Q Consensus 736 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~ 798 (840)
.....+... ..+...++.+.+++.+||+.||++||||+||++.|+++...
T Consensus 241 ----~~i~~~~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 241 ----ECITQGRVL---------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp ----HHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHHHcCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 111111111 11122345688999999999999999999999999987443
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=427.33 Aligned_cols=257 Identities=28% Similarity=0.391 Sum_probs=203.0
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
.+++..++||+|+||.||+|..+.. ....+++.||||+++... ....++|.+|+.+|++++|||||+++|+|
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~-------~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~ 98 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGP-------APGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVV 98 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC--------------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCC-------ccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEE
Confidence 3456678999999999999975410 123467899999997653 34567899999999999999999999999
Q ss_pred ecCCceEEEEEeeccCCc--------------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCc
Q 041702 593 IEQGEKISIYEFDIVTDP--------------------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASN 652 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~~--------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~N 652 (840)
.+.+..++||||....+. .....++|.++++|+.|||+||+|||+++ ||||||||+|
T Consensus 99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~N 175 (308)
T 4gt4_A 99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRN 175 (308)
T ss_dssp CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccc
Confidence 999999999999532221 12356999999999999999999999988 9999999999
Q ss_pred EEecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCC
Q 041702 653 VLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDS 731 (840)
Q Consensus 653 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~ 731 (840)
|||++++++||+|||+|+.+.............||+.|||||++.++.++.++|||||||+||||+| |+.||.....
T Consensus 176 ILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~-- 253 (308)
T 4gt4_A 176 VLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-- 253 (308)
T ss_dssp EEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH--
T ss_pred eEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH--
Confidence 9999999999999999987755444444556789999999999999999999999999999999999 8889864332
Q ss_pred ccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 732 LTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
..+. .....+... +.+...+..+.+|+.+||+.||++||||+||++.|+..
T Consensus 254 ~~~~----~~i~~~~~~---------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 254 QDVV----EMIRNRQVL---------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHH----HHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHH----HHHHcCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1111 111111111 11223345688999999999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=416.08 Aligned_cols=259 Identities=23% Similarity=0.383 Sum_probs=196.0
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCcccee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
..+++...++||+|+||+||+|+++ ..||||+++... ....++|.+|+++|++++|||||+++
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~---------------~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~ 98 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWH---------------GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFM 98 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESS---------------SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEEC---------------CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 3467888899999999999998643 259999987542 34457899999999999999999999
Q ss_pred eEeecCCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 590 GCCIEQGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
|+|.+ +..++||||....+. .....++|.++++|+.|||+||+|||+++ ||||||||+||||++++++||+
T Consensus 99 g~~~~-~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~ 174 (307)
T 3omv_A 99 GYMTK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIG 174 (307)
T ss_dssp EEECS-SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEEC
T ss_pred EEEEC-CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEe
Confidence 99865 568999999544332 12356999999999999999999999987 9999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCcccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhh
Q 041702 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH---GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNL 741 (840)
Q Consensus 665 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~ 741 (840)
|||+|+...............||+.|||||++.+ .+|+.++|||||||+||||+||+.||....... ... ..
T Consensus 175 DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~--~~~---~~ 249 (307)
T 3omv_A 175 DFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD--QII---FM 249 (307)
T ss_dssp CCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHH---HH
T ss_pred eccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH--HHH---HH
Confidence 9999987755444444556789999999999863 469999999999999999999999986433211 111 11
Q ss_pred hcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCC
Q 041702 742 WKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNL 799 (840)
Q Consensus 742 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~ 799 (840)
.... ...+.+ .......++.+.+++.+||+.||++||||.||++.|+.+...+
T Consensus 250 ~~~~----~~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 250 VGRG----YASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp HHTT----CCCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred HhcC----CCCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 1111 111111 1112233456889999999999999999999999999874444
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=412.78 Aligned_cols=247 Identities=24% Similarity=0.352 Sum_probs=202.4
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCI 593 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~ 593 (840)
+.|+..++||+|+||.||+|+++ .+|+.||||++........+.+.+|+++|++++|||||++++++.
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~------------~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~ 141 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVR------------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEET------------TTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEEC------------CCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 56899999999999999999876 689999999998766666788999999999999999999999999
Q ss_pred cCCceEEEEEeeccC---CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccce
Q 041702 594 EQGEKISIYEFDIVT---DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIAR 670 (840)
Q Consensus 594 ~~~~~~lv~e~~~~~---~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~ 670 (840)
+.+..++||||.... .......+++.++..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+
T Consensus 142 ~~~~~~ivmEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~ 218 (346)
T 4fih_A 142 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCA 218 (346)
T ss_dssp ETTEEEEEECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred ECCEEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCce
Confidence 999999999994322 2223457999999999999999999999998 9999999999999999999999999999
Q ss_pred ecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccccc
Q 041702 671 TFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKL 750 (840)
Q Consensus 671 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (840)
.+..... .....+||+.|||||++.+..|+.++|||||||+||||++|+.||..... .... ......
T Consensus 219 ~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~----~~i~~~----- 285 (346)
T 4fih_A 219 QVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAM----KMIRDN----- 285 (346)
T ss_dssp ECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHH----HHHHHS-----
T ss_pred ecCCCCC--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHH----HHHHcC-----
Confidence 8754322 23457899999999999999999999999999999999999999864321 1111 111111
Q ss_pred cCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 751 MDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 751 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
..+.+. ........+.+++.+||+.||++|||++|+++
T Consensus 286 ~~~~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 286 LPPRLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp SCCCCS--CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCC--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111111 11233456789999999999999999999875
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=412.34 Aligned_cols=255 Identities=22% Similarity=0.252 Sum_probs=202.0
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
.+.|...++||+|+||.||+|+++ .+|+.||||+++... .+.+|+.+|++++|||||++++++
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~------------~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~ 119 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDK------------QTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAV 119 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEET------------TTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEEC------------CCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEE
Confidence 456888899999999999999876 689999999997542 225799999999999999999999
Q ss_pred ecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCC-Cceeeccc
Q 041702 593 IEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDM-NPKISDFG 667 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kL~DFG 667 (840)
.+.+..++||||....+ ......+++.++..++.||+.||+|||+++ ||||||||+||||+.++ .+||+|||
T Consensus 120 ~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFG 196 (336)
T 4g3f_A 120 REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFG 196 (336)
T ss_dssp EETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCT
T ss_pred EECCEEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCC
Confidence 99999999999954332 234567999999999999999999999998 99999999999999997 69999999
Q ss_pred cceecCCCCccc---ccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 668 IARTFGGDEMQS---NTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 668 la~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
+|+.+..+.... .....+||+.|||||++.+..|+.++|||||||+||||+||+.||......... ... ...
T Consensus 197 la~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~--~~i---~~~ 271 (336)
T 4g3f_A 197 HALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC--LKI---ASE 271 (336)
T ss_dssp TCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH--HHH---HHS
T ss_pred CCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH--HHH---HcC
Confidence 999875443221 223467999999999999999999999999999999999999999754433321 111 111
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCCC
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLP 800 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~~ 800 (840)
... ....+......+.+++.+||+.||++|||+.|+++.|...+.++.
T Consensus 272 ~~~--------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 272 PPP--------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp CCG--------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred CCC--------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 100 001122334567889999999999999999999999987655443
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=418.74 Aligned_cols=270 Identities=28% Similarity=0.372 Sum_probs=211.9
Q ss_pred cCHHHHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcCC
Q 041702 504 FSLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQH 582 (840)
Q Consensus 504 ~~~~~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~H 582 (840)
+...+++...++|++.++||+|+||.||+|.++. .+....++.||||++..... ...++|.+|+++|.+++|
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~-------~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~h 126 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFG-------IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 126 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEET-------SSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCC
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcC-------CCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCC
Confidence 3445566677899999999999999999997651 12345667899999976533 345679999999999965
Q ss_pred -CCccceeeEeecC-CceEEEEEeeccCCc--------------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 041702 583 -RNLVRLFGCCIEQ-GEKISIYEFDIVTDP--------------------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSR 640 (840)
Q Consensus 583 -~niv~l~g~~~~~-~~~~lv~e~~~~~~~--------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ 640 (840)
||||+++|+|.+. +..++||||....+. .....++|.+++.++.|||+||+|||+++
T Consensus 127 hpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~- 205 (353)
T 4ase_A 127 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK- 205 (353)
T ss_dssp CTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred CCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC-
Confidence 8999999999764 568999999422111 12356899999999999999999999998
Q ss_pred CceecCCCCCCcEEecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-
Q 041702 641 LRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS- 719 (840)
Q Consensus 641 ~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt- 719 (840)
||||||||+||||++++.+||+|||+|+.+..+..........||+.|||||++.+..|+.++|||||||+||||+|
T Consensus 206 --iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~ 283 (353)
T 4ase_A 206 --CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 283 (353)
T ss_dssp --CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred --eecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhC
Confidence 99999999999999999999999999998765554445556789999999999999999999999999999999998
Q ss_pred CCCCCCCCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 720 SKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 720 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
|+.||....... .+. .....+.. + ..+...++.+.+++.+||+.||++|||++||++.|++++.
T Consensus 284 G~~Pf~~~~~~~-~~~----~~i~~g~~-----~----~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 284 GASPYPGVKIDE-EFC----RRLKEGTR-----M----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp SCCSSTTCCCSH-HHH----HHHHHTCC-----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHH-HHH----HHHHcCCC-----C----CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 899986543221 111 11111111 1 1111224467889999999999999999999999988754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=412.22 Aligned_cols=246 Identities=22% Similarity=0.358 Sum_probs=193.6
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
.++|+++++||+|+||.||+|+++ .+|+.||||++.... ....++|.+|+++|++|+|||||++++
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~------------~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~ 90 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKST------------EDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90 (350)
T ss_dssp CCCEEEEEEC------CEEEEEET------------TTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEEC------------CCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEE
Confidence 368999999999999999999766 689999999997542 234578999999999999999999999
Q ss_pred EeecCCceEEEEEeeccCCc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 591 CCIEQGEKISIYEFDIVTDP------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
++.+.+..++||||....+. .....+++.+...|+.||+.||+|||+++ |+||||||+||||+.++.+||+
T Consensus 91 ~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~ 167 (350)
T 4b9d_A 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLG 167 (350)
T ss_dssp EEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEEC
T ss_pred EEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEc
Confidence 99999999999999543332 12345788899999999999999999998 9999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 665 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
|||+|+.+.... ......+||+.|||||++.+..|+.++|||||||+||||++|+.||...... .+. .... .
T Consensus 168 DFGla~~~~~~~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~--~~~---~~i~-~ 239 (350)
T 4b9d_A 168 DFGIARVLNSTV--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK--NLV---LKII-S 239 (350)
T ss_dssp STTEESCCCHHH--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHH---HHHH-H
T ss_pred ccccceeecCCc--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHH---HHHH-c
Confidence 999998764321 1234567999999999999999999999999999999999999998643211 111 1111 1
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
... +.. .......+.+++.+||+.||++|||++|+++
T Consensus 240 ~~~-----~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 240 GSF-----PPV----SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp TCC-----CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCC-----CCC----CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111 011 1123456789999999999999999999985
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=404.84 Aligned_cols=245 Identities=23% Similarity=0.300 Sum_probs=202.8
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
++|++.++||+|+||.||+|+++ .+++.||||++.+. .....+.+.+|+++|++++|||||++++
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~------------~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~ 99 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLAREL------------ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 99 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET------------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred cccEEEEEEecccCeEEEEEEEC------------CCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 57999999999999999999876 68999999999753 2455688999999999999999999999
Q ss_pred EeecCCceEEEEEeecc----CCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 591 CCIEQGEKISIYEFDIV----TDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~----~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
++.+.+..++||||... ........+++.+...++.||+.||+|||+++ |+||||||+||||+.++.+||+||
T Consensus 100 ~~~~~~~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DF 176 (311)
T 4aw0_A 100 TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDF 176 (311)
T ss_dssp EEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred EEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEc
Confidence 99999999999999432 22334567999999999999999999999998 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccc
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDK 746 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 746 (840)
|+|+.+............+||+.|||||++.+..|+.++|||||||+||||++|+.||...+. ..+.... ...+
T Consensus 177 Gla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i----~~~~ 250 (311)
T 4aw0_A 177 GTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--GLIFAKI----IKLE 250 (311)
T ss_dssp TTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHH----HHTC
T ss_pred CCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHH----HcCC
Confidence 999988655444455667899999999999999999999999999999999999999964321 1111111 1111
Q ss_pred cccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 041702 747 AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVV 789 (840)
Q Consensus 747 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 789 (840)
..+. ....+.+.+++.+||+.||++|||++|++
T Consensus 251 ------~~~p----~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 251 ------YDFP----EKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp ------CCCC----TTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred ------CCCC----cccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 0111 12234578899999999999999999864
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=404.90 Aligned_cols=265 Identities=21% Similarity=0.265 Sum_probs=195.1
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCI 593 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~ 593 (840)
++|.+.++||+|+||.||+|++ +|+.||||+++.... ....+..|+..+.+++|||||+++|+|.
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--------------~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~ 67 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--------------RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADN 67 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--------------TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--------------CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEE
Confidence 4577889999999999999853 478999999975422 1223445677778899999999999998
Q ss_pred cCC----ceEEEEEeeccCCc---cccCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCceecCCCCCCcEEecCCCCc
Q 041702 594 EQG----EKISIYEFDIVTDP---ARKDLLDWTTRVRIIEGVAQGLLYLHQYS-----RLRVIHRDLKASNVLLDSDMNP 661 (840)
Q Consensus 594 ~~~----~~~lv~e~~~~~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivHrDlkp~NILl~~~~~~ 661 (840)
+.+ ..++||||+...+. .....++|..+.+++.|+++||+|||++. .++|+||||||+||||+.++++
T Consensus 68 ~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~ 147 (303)
T 3hmm_A 68 KDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 147 (303)
T ss_dssp EECSSSEEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred ecCCCceEEEEEecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCE
Confidence 764 57999999643332 23567999999999999999999999861 3359999999999999999999
Q ss_pred eeeccccceecCCCCcc--cccccccccccccCccccccC------CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc
Q 041702 662 KISDFGIARTFGGDEMQ--SNTNRIVGTYGYMSPEYALHG------LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLT 733 (840)
Q Consensus 662 kL~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~ 733 (840)
||+|||+|+........ ......+||+.|||||++.+. .++.|+|||||||+||||+||++|+.........
T Consensus 148 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p 227 (303)
T 3hmm_A 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227 (303)
T ss_dssp EECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred EEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc
Confidence 99999999877543322 223456799999999998764 3678999999999999999998876443222110
Q ss_pred H---------hHHHhhhhcccccccccCccccch-hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 734 L---------LGHAWNLWKDDKAWKLMDPTMQNE-ALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 734 ~---------~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
. ......... ...++|.+... ...+.+..+.+|+.+||+.||++||||.||++.|+++..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~----~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 228 YYDLVPSDPSVEEMRKVVC----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp TTTTSCSSCCHHHHHHHHT----TSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chhcccccchHHHHHHHHh----cccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 0 001111111 11223333222 223456778999999999999999999999999988643
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=392.79 Aligned_cols=243 Identities=23% Similarity=0.368 Sum_probs=184.7
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
++|++.+.||+|+||.||+|+++ .+|+.||||++.+.. ....+++.+|+++|++++|||||++++
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~------------~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~ 80 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHT------------TTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECT------------TTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEEC------------CCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEE
Confidence 68999999999999999999765 689999999997542 344678999999999999999999999
Q ss_pred EeecCCceEEEEEee---ccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 591 CCIEQGEKISIYEFD---IVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~---~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
++.+.+..++||||. ..........+++.+...++.||+.||+|||+++ |+||||||+|||++.++++||+|||
T Consensus 81 ~~~~~~~~~ivmEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFG 157 (275)
T 3hyh_A 81 VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFG 157 (275)
T ss_dssp EEECSSEEEEEEECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSS
T ss_pred EEEECCEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecC
Confidence 999999999999994 2222234567999999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccc
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLF-SIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDK 746 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 746 (840)
+|+...... .....+||+.|||||++.+..+ +.++|||||||+||||+||+.||..... ..+... .....
T Consensus 158 la~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~--~~~~~~----i~~~~ 228 (275)
T 3hyh_A 158 LSNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI--PVLFKN----ISNGV 228 (275)
T ss_dssp CC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHH----HHHTC
T ss_pred CCeecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH--HHHHHH----HHcCC
Confidence 998764332 2234689999999999998886 5799999999999999999999864221 111111 11111
Q ss_pred cccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 747 AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 747 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
..+. ....+.+.+++.+||+.||++|||++|+++
T Consensus 229 ------~~~p----~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 229 ------YTLP----KFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ------CCCC----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ------CCCC----CCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0111 112345788999999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=413.28 Aligned_cols=248 Identities=25% Similarity=0.355 Sum_probs=203.1
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
.+.|+..++||+|+||.||+|+++ .+|+.||||++........+.+.+|+.+|++++|||||++++++
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~------------~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~ 217 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVR------------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 217 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEET------------TTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEEC------------CCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEE
Confidence 357999999999999999999876 68999999999877666778899999999999999999999999
Q ss_pred ecCCceEEEEEeecc---CCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccc
Q 041702 593 IEQGEKISIYEFDIV---TDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIA 669 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~---~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla 669 (840)
.+.+..++||||... .+......+++.++..|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|
T Consensus 218 ~~~~~~~iVmEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla 294 (423)
T 4fie_A 218 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFC 294 (423)
T ss_dssp EETTEEEEEEECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTC
T ss_pred EECCEEEEEEeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccc
Confidence 999999999999432 22234456999999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccccccc
Q 041702 670 RTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWK 749 (840)
Q Consensus 670 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (840)
+.+..... .....+||+.|||||++.+..|+.++|||||||+||||++|+.||..... .... ......
T Consensus 295 ~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~----~~i~~~---- 362 (423)
T 4fie_A 295 AQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAM----KMIRDN---- 362 (423)
T ss_dssp EECCSSCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHH----HHHHHS----
T ss_pred eECCCCCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHH----HHHHcC----
Confidence 98754322 23457899999999999999999999999999999999999999854221 1111 111111
Q ss_pred ccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 750 LMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 750 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
..+.+. ........+.+++.+||+.||++|||++|+++
T Consensus 363 -~~~~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 363 -LPPRLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp -CCCCCS--CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CCCCCc--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 011111 11123456788999999999999999999875
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=397.02 Aligned_cols=243 Identities=22% Similarity=0.348 Sum_probs=189.1
Q ss_pred cccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceeeEeec
Q 041702 517 SEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIE 594 (840)
Q Consensus 517 ~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~ 594 (840)
+..++||+|+||.||+|.++ .+++.||||++.... ....++|.+|+++|++++|||||+++++|..
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~------------~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~ 96 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDT------------ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWES 96 (290)
T ss_dssp EEEEEEEECSSEEEEEEEET------------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEEC------------CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEee
Confidence 55678999999999999876 678999999997542 3345779999999999999999999999865
Q ss_pred ----CCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecC-CCCceeec
Q 041702 595 ----QGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS-DMNPKISD 665 (840)
Q Consensus 595 ----~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kL~D 665 (840)
.+..++||||....+ ......+++..+..++.||+.||+|||+++ ++|+||||||+||||+. ++.+||+|
T Consensus 97 ~~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~D 175 (290)
T 3fpq_A 97 TVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGD 175 (290)
T ss_dssp EETTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECC
T ss_pred ccCCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEe
Confidence 345799999954333 234567999999999999999999999875 35999999999999984 79999999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
||+|+..... .....+||+.|||||++.+ .|+.++|||||||+||||+||+.||...... .. ........
T Consensus 176 FGla~~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-~~----~~~~i~~~ 245 (290)
T 3fpq_A 176 LGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-AQ----IYRRVTSG 245 (290)
T ss_dssp TTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-HH----HHHHHTTT
T ss_pred CcCCEeCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-HH----HHHHHHcC
Confidence 9999864322 2345689999999998865 6999999999999999999999998532211 11 11111111
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.. + ........+.+.+++.+||+.||++|||++|+++
T Consensus 246 ~~-----~---~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 246 VK-----P---ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CC-----C---GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CC-----C---CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 10 1 0111112345788999999999999999999975
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=394.88 Aligned_cols=247 Identities=23% Similarity=0.268 Sum_probs=189.8
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
++|++.+.||+|+||.||+|++. ....+++.||||++++.. .....++.+|+++|++++|||||+++++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~---------~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~ 94 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKI---------SGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYA 94 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEEC---------SSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEc---------cCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEE
Confidence 67999999999999999999764 223468899999997542 2234578999999999999999999999
Q ss_pred eecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 592 CIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
+.+.+..++||||....+ ......+++.+...++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFG 171 (304)
T 3ubd_A 95 FQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFG 171 (304)
T ss_dssp EEETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSE
T ss_pred EEECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccc
Confidence 999999999999953332 234567999999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccccc
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKA 747 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 747 (840)
+|+...... ......+||+.|||||++.+..|+.++|||||||+||||+||+.||...... .+... .....
T Consensus 172 la~~~~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~--~~~~~----i~~~~- 242 (304)
T 3ubd_A 172 LSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK--ETMTM----ILKAK- 242 (304)
T ss_dssp EEEC-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH----HHHCC-
T ss_pred cceeccCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH--HHHHH----HHcCC-
Confidence 998754322 2234568999999999999999999999999999999999999998643211 11111 11111
Q ss_pred ccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 041702 748 WKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTM-----LEVVA 790 (840)
Q Consensus 748 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~ 790 (840)
... +......+.+++.+||+.||++|||+ +|+++
T Consensus 243 -----~~~----p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 243 -----LGM----PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp -----CCC----CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred -----CCC----CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 011 11234457889999999999999984 56653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=385.95 Aligned_cols=245 Identities=24% Similarity=0.374 Sum_probs=179.3
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
++|++.+.||+|+||.||+|+++ .+|+.||||+++.... ...+++.+|+++|++++|||||++++++
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~------------~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~ 72 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNK------------VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEET------------TTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhCEEeeEEecCCCeEEEEEEEC------------CCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 45889999999999999999776 6889999999975433 3456799999999999999999999999
Q ss_pred ecCCc------------eEEEEEeeccCCc-------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcE
Q 041702 593 IEQGE------------KISIYEFDIVTDP-------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNV 653 (840)
Q Consensus 593 ~~~~~------------~~lv~e~~~~~~~-------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NI 653 (840)
.+.+. .++||||....+. ......++...+.|+.||+.||+|||+++ |+||||||+||
T Consensus 73 ~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NI 149 (299)
T 4g31_A 73 LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNI 149 (299)
T ss_dssp EEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred EecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHe
Confidence 76553 6899999533221 12233556778899999999999999998 99999999999
Q ss_pred EecCCCCceeeccccceecCCCCccc----------ccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCC
Q 041702 654 LLDSDMNPKISDFGIARTFGGDEMQS----------NTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKN 723 (840)
Q Consensus 654 Ll~~~~~~kL~DFGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p 723 (840)
||+.++.+||+|||+|+.+....... .....+||+.|||||++.+..|+.++|||||||+||||++ |
T Consensus 150 Ll~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---P 226 (299)
T 4g31_A 150 FFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---P 226 (299)
T ss_dssp EECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---C
T ss_pred EECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---C
Confidence 99999999999999998875432211 1234579999999999999999999999999999999996 5
Q ss_pred CCCCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 724 TRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
|... ..... ....... ... +.......+.+.+++.+||+.||++|||+.|+++
T Consensus 227 f~~~----~~~~~-~~~~~~~--------~~~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 227 FSTQ----MERVR-TLTDVRN--------LKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp CSSH----HHHHH-HHHHHHT--------TCC-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCc----cHHHH-HHHHHhc--------CCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 4311 01010 0011111 111 1222334455678999999999999999999986
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=370.60 Aligned_cols=232 Identities=19% Similarity=0.204 Sum_probs=181.3
Q ss_pred hhcccCcCCCCcccCCCCeEEcCCCeEEEEEecCCCCCceEEEEeeecCCCcEEEeecCCCCCCCC----CceEEEecCC
Q 041702 21 FSLAADSITPATFIRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKKSPDTVVWVANRNCPILDP----HGILAINNNG 96 (840)
Q Consensus 21 ~~~~~~~~~~~~~l~~~~~l~S~~g~F~~gFf~~~~~~~~~lgiw~~~~~~tvVW~ANr~~p~~~~----~~~l~~~~~G 96 (840)
++++.|+|++|++|++|++|+||+|.|+||||.++ ++|| |+ ..+ |||+|||++|+.++ +++|+|+.||
T Consensus 10 ~~~~~~~l~~g~~l~~~~~l~S~~g~F~lgf~~~~---~~~l---y~-~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~~G 81 (276)
T 3m7h_A 10 NGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDG---NLVI---QD-NGA-TVWVANEQQPFSSTIPLRNKKAPLAFYV 81 (276)
T ss_dssp CCTTSSEECTTEEBCTTCEEECTTSSEEEEECTTS---CEEE---EE-TTE-EEEECSTTSTTEEEEECCCTTCCSEEEE
T ss_pred ccccCCEecCCCEecCCCEEEcCCCcEEEEEECCC---CeEE---EC-CCC-eEEECCCCCCcCCcccccceEEEEeCCC
Confidence 45688999999999999999999999999999543 5677 77 336 99999999999875 7899999999
Q ss_pred ceEE--ecCCCceEEEecCCCC-----CCCceEEEecCCCeEEEeccCCCCCCCceeEEecCCCCCcccCCCcccccccc
Q 041702 97 NLVL--LNQANGTIWSSNMSKE-----AKSPVAQLLDTGNLVLRENFSNNTSEGSYLWQSFDFPSDTLLPGMKVGWDLKT 169 (840)
Q Consensus 97 ~L~l--~~~~~~~~Wss~~~~~-----~~~~~a~L~d~GNlVl~~~~~~~~~~~~~lWqSFd~PtDtlLpg~~l~~~~~t 169 (840)
+|+| .|++|.+||+|+++.. ..++.|+|+|+|||||+| +.+|||| |||||||||||++.++++
T Consensus 82 ~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~--------~~~lWqS--~ptdtlLpg~~~~~~l~~ 151 (276)
T 3m7h_A 82 QYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD--------SLALWNG--TPAIPLVPGAIDSLLLAP 151 (276)
T ss_dssp SSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE--------EEEEEES--CTTSCCCCSCTTCEEECS
T ss_pred cEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC--------CceeeCc--cccccccccccccccccc
Confidence 9999 7888999999997652 235689999999999997 2579999 999999999999999998
Q ss_pred CCceeEEEeccCCCCCCCceEEeecCCCCcEEEEEc-CCeeeEEeCCCCCceeccCCceee-ceeEEEEEecCC-cEEEE
Q 041702 170 GRERYLTSWRTADDPSPGKFTYRLDIHVLPQIFLYK-GSLKLARIGPWNGFIFEDGPTFID-YLYKIILVDTED-EIYYR 246 (840)
Q Consensus 170 g~~~~l~S~~s~~dps~G~~~l~~~~~~~~~~~~~~-~~~~~~~~g~w~~~~~~~~~~~~~-~~~~~~~~~~~~-~~~~~ 246 (840)
|.. | ++.+||++|.|++.++++|. +++++ ++.+||++|+|++.. ..+.. ....+.+.++.+ ..+++
T Consensus 152 g~~--L---~S~~dps~G~fsl~l~~dGn--lvLy~~~~~~yW~Sgt~~~~~----~~l~l~~dGnLvl~d~~~~~vWsS 220 (276)
T 3m7h_A 152 GSE--L---VQGVVYGAGASKLVFQGDGN--LVAYGPNGAATWNAGTQGKGA----VRAVFQGDGNLVVYGAGNAVLWHS 220 (276)
T ss_dssp SEE--E---CTTCEEEETTEEEEECTTSC--EEEECTTSSEEEECCCTTTTC----CEEEECTTSCEEEECTTSCEEEEC
T ss_pred Ccc--c---ccCCCCCCceEEEeecCCce--EEEEeCCCeEEEECCCCCCcc----EEEEEcCCCeEEEEeCCCcEEEEe
Confidence 876 5 67899999999999999995 44455 469999999997532 11111 112233444433 33333
Q ss_pred EEecCCceeEEEEEccCCcEEEEEEEcCCCCeEEEEeccC
Q 041702 247 YESYNNLSIMMLKINPLGKIQRLLWNEGSSGWQVMFSAPG 286 (840)
Q Consensus 247 ~~~~~~~~~~~l~l~~~G~l~~y~w~~~~~~W~~~~~~p~ 286 (840)
++. .....|++|+.||++++|.| ...|...+..|.
T Consensus 221 ~t~--~~~~~rl~Ld~dGnLvly~~---~~~Wqsf~~~P~ 255 (276)
T 3m7h_A 221 HTG--GHASAVLRLQANGSIAILDE---KPVWARFGFQPT 255 (276)
T ss_dssp SCT--TCTTCEEEECTTSCEEEEEE---EEEEESSSCCTT
T ss_pred cCC--CCCCEEEEEcCCccEEEEcC---CCeEEccCccCC
Confidence 322 22357999999999999998 235665555553
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=388.84 Aligned_cols=261 Identities=20% Similarity=0.259 Sum_probs=195.9
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC--cCHHHHHHHHHHHhhcCCCCccceee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG--QGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
.++|++.++||+|+||.||+|+++ .+|+.||||+++.... ...+++.+|+++|++++|||||++++
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~------------~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 120 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRR------------LTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKD 120 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEET------------TTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CCCeEEEEEEecccCeEEEEEEEC------------CCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEee
Confidence 468999999999999999999876 6899999999975432 33467899999999999999999999
Q ss_pred Eeec------CCceEEEEEeec---cCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCc
Q 041702 591 CCIE------QGEKISIYEFDI---VTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP 661 (840)
Q Consensus 591 ~~~~------~~~~~lv~e~~~---~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 661 (840)
++.. .+..++||||.. .........+++.++..++.||+.||+|||+++ ||||||||+|||++.++.+
T Consensus 121 ~~~~~~~~~~~~~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~ 197 (398)
T 4b99_A 121 ILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCEL 197 (398)
T ss_dssp ECCCSSCTTTCCCEEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCE
T ss_pred eeecccccccCCEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCE
Confidence 8753 467899999942 112234567999999999999999999999998 9999999999999999999
Q ss_pred eeeccccceecCCCCc--ccccccccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHH
Q 041702 662 KISDFGIARTFGGDEM--QSNTNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHA 738 (840)
Q Consensus 662 kL~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~ 738 (840)
||+|||+|+.+..... .......+||+.|||||++.+. .++.++||||+||+++||++|++||...... ......
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~--~~l~~I 275 (398)
T 4b99_A 198 KIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV--HQLQLI 275 (398)
T ss_dssp EECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH--HHHHHH
T ss_pred EEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH--HHHHHH
Confidence 9999999987643321 2233457899999999998875 5699999999999999999999999654321 111111
Q ss_pred hhhhcccc--ccc------------ccCccccc---hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 739 WNLWKDDK--AWK------------LMDPTMQN---EALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 739 ~~~~~~~~--~~~------------~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
........ ... .+.+.... .........+.+|+.+||+.||++|||++|+++
T Consensus 276 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 276 MMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp HHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 11100000 000 00000000 001122456789999999999999999999885
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=370.32 Aligned_cols=278 Identities=33% Similarity=0.563 Sum_probs=230.9
Q ss_pred cCHHHHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCC
Q 041702 504 FSLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHR 583 (840)
Q Consensus 504 ~~~~~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~ 583 (840)
+++.++..++++|+..+.||+|+||.||+|.+ .+++.||||++........++|.+|++++++++||
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-------------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 95 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-------------RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHP 95 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEEC-------------TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEE-------------CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCC
Confidence 44556677889999999999999999999864 36889999999877666678899999999999999
Q ss_pred CccceeeEeecCCceEEEEEeeccCCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEe
Q 041702 584 NLVRLFGCCIEQGEKISIYEFDIVTDP--------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLL 655 (840)
Q Consensus 584 niv~l~g~~~~~~~~~lv~e~~~~~~~--------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl 655 (840)
||+++++++.+.+..++||||...... .....+++..+++++.||+.||+|||+.+ |+||||||+|||+
T Consensus 96 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~ 172 (321)
T 2qkw_B 96 HLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILL 172 (321)
T ss_dssp TBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEE
T ss_pred CEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEE
Confidence 999999999999999999999432211 11235899999999999999999999988 9999999999999
Q ss_pred cCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCC-ccH
Q 041702 656 DSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDS-LTL 734 (840)
Q Consensus 656 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~-~~~ 734 (840)
+.++.+||+|||+++...............||+.|+|||.+.+..++.++||||||++++||++|+.|+....+.. ...
T Consensus 173 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~ 252 (321)
T 2qkw_B 173 DENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252 (321)
T ss_dssp CTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCH
T ss_pred CCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHH
Confidence 9999999999999987654333333345568999999999999999999999999999999999999987655443 333
Q ss_pred hHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 735 LGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 735 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
..+.............+++.+......+....+.+++.+||+.||++|||+.||++.|+.+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 253 AEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp HHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 333333444455566677777666677888899999999999999999999999999998743
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=375.09 Aligned_cols=205 Identities=21% Similarity=0.314 Sum_probs=169.6
Q ss_pred HHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhc-CCCCcc
Q 041702 508 SISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL-QHRNLV 586 (840)
Q Consensus 508 ~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l-~H~niv 586 (840)
.+....++|++.++||+|+||.||+|+++ ....+++.||||++... ....++.+|+++|.++ +|||||
T Consensus 15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~---------~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv 83 (361)
T 4f9c_A 15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQ---------LQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVM 83 (361)
T ss_dssp HSGGGGGTCEEEEEEEECSSEEEEEEEEE---------BTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBC
T ss_pred hcCCccCcEEEEEEEecccCcEEEEEEEc---------ccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCc
Confidence 34456788999999999999999999865 33456789999998754 3456789999999998 699999
Q ss_pred ceeeEeecCCceEEEEEeeccCCc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCC-CCceee
Q 041702 587 RLFGCCIEQGEKISIYEFDIVTDP-ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSD-MNPKIS 664 (840)
Q Consensus 587 ~l~g~~~~~~~~~lv~e~~~~~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kL~ 664 (840)
++++++.+.+..++||||....+. .....+++.+...++.||+.||+|||+++ |+||||||+|||++.+ +.+||+
T Consensus 84 ~l~~~~~~~~~~~lvmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~ 160 (361)
T 4f9c_A 84 GVKYCFRKNDHVVIAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALV 160 (361)
T ss_dssp CCSEEEEETTEEEEEEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEEC
T ss_pred eEEEEEEECCEEEEEEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEEC
Confidence 999999999999999999543322 12245899999999999999999999998 9999999999999877 799999
Q ss_pred ccccceecCCCCcc--------------------------cccccccccccccCccccccC-CCCccccchhHHHHHHHH
Q 041702 665 DFGIARTFGGDEMQ--------------------------SNTNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEI 717 (840)
Q Consensus 665 DFGla~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~SlGviL~el 717 (840)
|||+|+........ ......+||+.|||||++.+. .++.++||||+||+++||
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~el 240 (361)
T 4f9c_A 161 DFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSL 240 (361)
T ss_dssp CCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHH
T ss_pred cCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHH
Confidence 99999876433211 112335799999999999876 489999999999999999
Q ss_pred HhCCCCCCC
Q 041702 718 LSSKKNTRF 726 (840)
Q Consensus 718 ltG~~p~~~ 726 (840)
++|+.||..
T Consensus 241 l~G~~Pf~~ 249 (361)
T 4f9c_A 241 LSGRYPFYK 249 (361)
T ss_dssp HHTCSSSSC
T ss_pred HHCCCCCCC
Confidence 999999854
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=364.24 Aligned_cols=281 Identities=40% Similarity=0.645 Sum_probs=232.7
Q ss_pred eeecCHHHHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhh
Q 041702 501 FLFFSLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAK 579 (840)
Q Consensus 501 ~~~~~~~~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~ 579 (840)
+..|++.++....++|+..+.||+|+||.||+|.+ .+++.||||++..... ....+|.+|++++.+
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-------------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~ 83 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRL-------------ADGTLVAVKRLKEERTQGGELQFQTEVEMISM 83 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECC-------------SSSCCEEEEECCC-----CCCHHHHHHHGGGT
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEe-------------cCCCEEEEEEeccccCchHHHHHHHHHHHHHh
Confidence 56789999999999999999999999999999853 3688999999976532 334579999999999
Q ss_pred cCCCCccceeeEeecCCceEEEEEeeccC--------CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCC
Q 041702 580 LQHRNLVRLFGCCIEQGEKISIYEFDIVT--------DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKAS 651 (840)
Q Consensus 580 l~H~niv~l~g~~~~~~~~~lv~e~~~~~--------~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~ 651 (840)
++||||+++++++...+..++||||.... .......+++..+..++.|++.||+|||+...++|+||||||+
T Consensus 84 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~ 163 (326)
T 3uim_A 84 AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAA 163 (326)
T ss_dssp CCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGG
T ss_pred ccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchh
Confidence 99999999999999999999999994322 1223445999999999999999999999982223999999999
Q ss_pred cEEecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCC---C
Q 041702 652 NVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFY---N 728 (840)
Q Consensus 652 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~---~ 728 (840)
|||++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++||||||++++||++|+.|+... .
T Consensus 164 Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 242 (326)
T 3uim_A 164 NILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 242 (326)
T ss_dssp GEEECTTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTT
T ss_pred hEEECCCCCEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccccc
Confidence 99999999999999999987653332 2233456999999999999999999999999999999999999998632 2
Q ss_pred CCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 729 TDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
........+............+.+..+......+....+.+++.+||+.||++|||+.||++.|++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 243 DDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred ccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 2233444455555556666677777777777788889999999999999999999999999999975
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=387.93 Aligned_cols=248 Identities=24% Similarity=0.335 Sum_probs=201.6
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
.++|++.++||+|+||.||+|+++ .+|+.||||++........+.+.+|+++|++++|||||++++++
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~------------~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 223 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTER------------ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEET------------TTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEEC------------CCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 368999999999999999999876 68999999999876555567899999999999999999999999
Q ss_pred ecCCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCC--CCceeec
Q 041702 593 IEQGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSD--MNPKISD 665 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~--~~~kL~D 665 (840)
.+.+..++||||....+. .....+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|
T Consensus 224 ~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~D 300 (573)
T 3uto_A 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLID 300 (573)
T ss_dssp ECSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECC
T ss_pred EECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEee
Confidence 999999999999543322 12346889999999999999999999998 9999999999999854 8999999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
||+|+.+..... ....+||+.|||||++.+..|+.++|||||||+||||++|+.||...... ...... ...
T Consensus 301 FG~a~~~~~~~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~--~~~~~i----~~~ 371 (573)
T 3uto_A 301 FGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--ETLRNV----KSC 371 (573)
T ss_dssp CSSCEECCTTSE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHH----HTT
T ss_pred ccceeEccCCCc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHHH----HhC
Confidence 999998754432 33467999999999999999999999999999999999999998643221 111111 110
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
+............+.+.+|+.+||+.||++|||+.|+++
T Consensus 372 ------~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 372 ------DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp ------CCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ------CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011111112233456789999999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=381.99 Aligned_cols=246 Identities=24% Similarity=0.274 Sum_probs=193.6
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHH---HHHHHhhcCCCCcc
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKN---EMMLIAKLQHRNLV 586 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~---Ev~~l~~l~H~niv 586 (840)
.++|++.++||+|+||.||+|+++ .+|+.||||++.+. .......+.+ ++.++..++|||||
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~------------~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV 255 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKA------------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET------------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBC
T ss_pred hHHeEEEEEEecccCeEEEEEEEC------------CCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEe
Confidence 478999999999999999999876 68999999999643 1233333444 46677778999999
Q ss_pred ceeeEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCce
Q 041702 587 RLFGCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPK 662 (840)
Q Consensus 587 ~l~g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 662 (840)
++++++.+.+..++||||....+ ......+++.....++.||+.||+|||+++ ||||||||+||||+.+|++|
T Consensus 256 ~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vK 332 (689)
T 3v5w_A 256 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVR 332 (689)
T ss_dssp CEEEEEECSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEE
T ss_pred EEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEE
Confidence 99999999999999999954333 334567999999999999999999999998 99999999999999999999
Q ss_pred eeccccceecCCCCcccccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhh
Q 041702 663 ISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNL 741 (840)
Q Consensus 663 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~ 741 (840)
|+|||+|+.+.... ....+||+.|||||++.+ ..|+.++|||||||+||||++|+.||......+.... ...
T Consensus 333 L~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i---~~~ 405 (689)
T 3v5w_A 333 ISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---DRM 405 (689)
T ss_dssp ECCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHH---HHH
T ss_pred ecccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHh
Confidence 99999998875432 345689999999999974 5799999999999999999999999975443322111 011
Q ss_pred hcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 041702 742 WKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPT-----MLEVVA 790 (840)
Q Consensus 742 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 790 (840)
..... ... +......+.+++.+||+.||++|++ ++||++
T Consensus 406 i~~~~------~~~----p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 406 TLTMA------VEL----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp HHHCC------CCC----CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred hcCCC------CCC----CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 00000 011 1123455789999999999999998 577763
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=346.43 Aligned_cols=276 Identities=35% Similarity=0.535 Sum_probs=219.5
Q ss_pred eeecCHHHHHHHccCCccc------ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC----CcCHHHH
Q 041702 501 FLFFSLSSISAATDNFSEE------NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS----GQGLEEF 570 (840)
Q Consensus 501 ~~~~~~~~~~~~~~~f~~~------~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~----~~~~~~f 570 (840)
+..|++.++..++++|... ++||+|+||.||+|.+ +++.||||++.... ....+.|
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--------------~~~~vavK~~~~~~~~~~~~~~~~~ 77 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--------------NNTTVAVKKLAAMVDITTEELKQQF 77 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--------------SSCEEEEEEECCCTTSCTTTHHHHH
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--------------CCceEEEEEEecccCcchHHHHHHH
Confidence 5679999999999999988 8899999999999852 57899999987532 2335679
Q ss_pred HHHHHHHhhcCCCCccceeeEeecCCceEEEEEeeccCC-------ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCce
Q 041702 571 KNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTD-------PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRV 643 (840)
Q Consensus 571 ~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~~~-------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i 643 (840)
.+|+.++++++||||+++++++.+.+..+++||+..... ......+++..+..++.||+.||+|||+.+ |
T Consensus 78 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i 154 (307)
T 2nru_A 78 DQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---H 154 (307)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---e
Confidence 999999999999999999999999999999999943221 223456899999999999999999999998 9
Q ss_pred ecCCCCCCcEEecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCC
Q 041702 644 IHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKN 723 (840)
Q Consensus 644 vHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p 723 (840)
+||||||+||+++.++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||++++||++|+.|
T Consensus 155 ~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p 233 (307)
T 2nru_A 155 IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPA 233 (307)
T ss_dssp ECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCS
T ss_pred ecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCC
Confidence 9999999999999999999999999987654433333445679999999998765 589999999999999999999999
Q ss_pred CCCCCCCCccHhHHHhhhh-cccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 041702 724 TRFYNTDSLTLLGHAWNLW-KDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEI 796 (840)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~ 796 (840)
+......... ........ ........+++.+. .........+.+++.+||+.||++|||+.+|++.|+++.
T Consensus 234 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 234 VDEHREPQLL-LDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp BCTTBSSSBT-THHHHHHHTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred cccCcchHHH-HHHHHHhhhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 8765443321 11111111 11112223333332 234566778999999999999999999999999999863
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=353.60 Aligned_cols=259 Identities=24% Similarity=0.411 Sum_probs=205.5
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
.++|...++||+|+||.||+|.++ .+++.||+|++........+.|.+|++++.+++||||+++++++
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~------------~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 76 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHR------------ETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEET------------TTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEEC------------CCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEE
Confidence 467888999999999999999765 67899999999776666678899999999999999999999999
Q ss_pred ecCCceEEEEEeeccCCcc-----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 593 IEQGEKISIYEFDIVTDPA-----RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
.+.+..++||||....... ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg 153 (310)
T 3s95_A 77 YKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFG 153 (310)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCT
T ss_pred ecCCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecc
Confidence 9999999999995332221 2456899999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCCccc------------ccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHh
Q 041702 668 IARTFGGDEMQS------------NTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLL 735 (840)
Q Consensus 668 la~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~ 735 (840)
+++......... ......||+.|+|||.+.+..++.++||||||++++||++|..|+...........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~ 233 (310)
T 3s95_A 154 LARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG 233 (310)
T ss_dssp TCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS
T ss_pred cceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh
Confidence 998764432211 11145799999999999999999999999999999999999998765433221111
Q ss_pred HHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCC
Q 041702 736 GHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNL 799 (840)
Q Consensus 736 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~ 799 (840)
..... ..+... +...+..+.+++.+||+.||++|||+.++++.|+.+...+
T Consensus 234 ~~~~~---------~~~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 234 LNVRG---------FLDRYC----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp BCHHH---------HHHHTC----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hhhhc---------cccccC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 00000 000000 1112345788999999999999999999999999875554
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=345.91 Aligned_cols=249 Identities=21% Similarity=0.372 Sum_probs=201.1
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
..++|+..++||+|+||.||+|.++ .+++.||||++........+.+.+|+.++++++||||++++++
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 85 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDV------------ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBT------------TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEEC------------CCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEE
Confidence 3468999999999999999999765 6789999999987666667889999999999999999999999
Q ss_pred eecCCceEEEEEeeccCC---ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccc
Q 041702 592 CIEQGEKISIYEFDIVTD---PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGI 668 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~---~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl 668 (840)
+...+..++||||..... ......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 86 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~ 162 (297)
T 3fxz_A 86 YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGF 162 (297)
T ss_dssp EEETTEEEEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTT
T ss_pred EEECCEEEEEEECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCC
Confidence 999999999999953222 223446899999999999999999999998 99999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccc
Q 041702 669 ARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAW 748 (840)
Q Consensus 669 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (840)
+........ ......||+.|+|||.+.+..++.++||||||++++||++|+.||....... ......... .
T Consensus 163 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~~~~~~-~- 233 (297)
T 3fxz_A 163 CAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-----ALYLIATNG-T- 233 (297)
T ss_dssp CEECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHHHHC-S-
T ss_pred ceecCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhCC-C-
Confidence 987654332 2334679999999999999999999999999999999999999985432111 111111110 0
Q ss_pred cccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 749 KLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 749 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
+.+ .........+.+++.+||+.||++|||++|+++
T Consensus 234 ----~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 234 ----PEL--QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp ----CCC--SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----CCC--CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 001 011223455788999999999999999999975
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=357.27 Aligned_cols=263 Identities=26% Similarity=0.405 Sum_probs=206.2
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhc-CCCCcccee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKL-QHRNLVRLF 589 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l-~H~niv~l~ 589 (840)
..++|.+.+.||+|+||.||+|.+... ......++..||||+++... ....+++.+|+.+++++ +||||++++
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~-----~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 153 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGI-----DKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL 153 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETC-----STTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecc-----cCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 347899999999999999999975410 01223467789999997653 23456799999999999 899999999
Q ss_pred eEeecCCceEEEEEeeccCCc--------------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCC
Q 041702 590 GCCIEQGEKISIYEFDIVTDP--------------------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLK 649 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~~~--------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk 649 (840)
++|.+.+..++||||...... .....+++.+++.++.||+.||+|||+.+ |+|||||
T Consensus 154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlk 230 (370)
T 2psq_A 154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLA 230 (370)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCC
T ss_pred EEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccc
Confidence 999999999999999422111 11245889999999999999999999998 9999999
Q ss_pred CCcEEecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCC
Q 041702 650 ASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYN 728 (840)
Q Consensus 650 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~ 728 (840)
|+|||++.++.+||+|||+++.+.............+|+.|+|||.+.+..++.++|||||||++|||++ |+.|+....
T Consensus 231 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 231 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp GGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999999999999999999998765444334445567889999999999999999999999999999999 998886433
Q ss_pred CCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 729 TDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
... +.. ....... ...+......+.+++.+||+.||++||++.|+++.|+.++.
T Consensus 311 ~~~--~~~----~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 311 VEE--LFK----LLKEGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp GGG--HHH----HHHTTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHH--HHH----HHhcCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 211 111 1111110 01112234468889999999999999999999999998754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=350.47 Aligned_cols=263 Identities=25% Similarity=0.378 Sum_probs=193.8
Q ss_pred HHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC--cCHHHHHHHHHHHhhcCCCCccc
Q 041702 510 SAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG--QGLEEFKNEMMLIAKLQHRNLVR 587 (840)
Q Consensus 510 ~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv~ 587 (840)
....++|++.++||+|+||.||+|.+ +++.||||++..... ...++|.+|++++++++||||++
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~--------------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~ 98 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEW--------------HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE--------------TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cCChhHceeeeEeecCCCeEEEEEEE--------------CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEee
Confidence 34457899999999999999999853 478899999976532 33467999999999999999999
Q ss_pred eeeEeecCCceEEEEEeeccCCc-------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCC
Q 041702 588 LFGCCIEQGEKISIYEFDIVTDP-------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMN 660 (840)
Q Consensus 588 l~g~~~~~~~~~lv~e~~~~~~~-------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~ 660 (840)
+++++.+.+..++||||...... .....+++..++.++.||+.||+|||+.+ ++|+||||||+|||++.++.
T Consensus 99 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~ 177 (309)
T 3p86_A 99 FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYT 177 (309)
T ss_dssp EEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCC
T ss_pred EEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCc
Confidence 99999999999999999533221 11223899999999999999999999875 35999999999999999999
Q ss_pred ceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhh
Q 041702 661 PKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWN 740 (840)
Q Consensus 661 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~ 740 (840)
+||+|||+++...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ... .
T Consensus 178 ~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~--~~~---~ 250 (309)
T 3p86_A 178 VKVCDFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ--VVA---A 250 (309)
T ss_dssp EEECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH--HHH---H
T ss_pred EEECCCCCCccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH---H
Confidence 9999999998653322 12334678999999999999999999999999999999999999986432211 111 0
Q ss_pred hhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCCCCCC
Q 041702 741 LWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSPH 803 (840)
Q Consensus 741 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~p~ 803 (840)
...... .... +......+.+++.+||+.||++|||+++|++.|+.......+|+
T Consensus 251 ~~~~~~-----~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~ 304 (309)
T 3p86_A 251 VGFKCK-----RLEI----PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304 (309)
T ss_dssp HHHSCC-----CCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC------
T ss_pred HHhcCC-----CCCC----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCC
Confidence 000000 0011 11223457889999999999999999999999999877654443
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=345.03 Aligned_cols=259 Identities=25% Similarity=0.359 Sum_probs=207.4
Q ss_pred ecCHHHHHHHccC----------CcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHH
Q 041702 503 FFSLSSISAATDN----------FSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN 572 (840)
Q Consensus 503 ~~~~~~~~~~~~~----------f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~ 572 (840)
.++.++++.+++. |...++||+|+||.||+|.++ .+|+.||||++........+.+.+
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~------------~~g~~vavK~~~~~~~~~~~~~~~ 91 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREK------------HSGRQVAVKMMDLRKQQRRELLFN 91 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEET------------TTCCEEEEEEEETTTCCSHHHHHH
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEEC------------CCCcEEEEEEEeccchhHHHHHHH
Confidence 4777888887764 777789999999999999754 578999999998776677788999
Q ss_pred HHHHHhhcCCCCccceeeEeecCCceEEEEEeeccC---CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCC
Q 041702 573 EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVT---DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLK 649 (840)
Q Consensus 573 Ev~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~~---~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk 649 (840)
|+.++++++||||+++++++...+..++||||.... .......+++..+..++.||+.||+|||+.+ |+|||||
T Consensus 92 E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlk 168 (321)
T 2c30_A 92 EVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIK 168 (321)
T ss_dssp HHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred HHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCC
Confidence 999999999999999999999999999999994322 1223456899999999999999999999988 9999999
Q ss_pred CCcEEecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCC
Q 041702 650 ASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNT 729 (840)
Q Consensus 650 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~ 729 (840)
|+|||++.++.+||+|||++........ ......||+.|+|||.+.+..++.++||||||++++||++|+.|+.....
T Consensus 169 p~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~ 246 (321)
T 2c30_A 169 SDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP 246 (321)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred HHHEEECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999999999999999987654322 22346799999999999999999999999999999999999999854321
Q ss_pred CCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 730 DSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
.... ...... ..+.+.. .......+.+++.+||+.||++|||++|+++.
T Consensus 247 --~~~~----~~~~~~-----~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 247 --VQAM----KRLRDS-----PPPKLKN--SHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp --HHHH----HHHHHS-----SCCCCTT--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --HHHH----HHHhcC-----CCCCcCc--cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111 111111 1111111 11233457889999999999999999999863
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=349.80 Aligned_cols=264 Identities=22% Similarity=0.288 Sum_probs=202.6
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
..++|+..++||+|+||.||+|.+ .++.||||++.... .....+..|+.++.+++||||++++++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~--------------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~ 86 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQL--------------LNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGA 86 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEE--------------TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEE
T ss_pred chhhchhhheecccCceEEEEEEE--------------CCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcce
Confidence 347899999999999999999863 36899999997543 234556779999999999999999999
Q ss_pred eecCCc----eEEEEEeeccCC---ccccCCCCHHHHHHHHHHHHHHHHHHHhc----------CCCceecCCCCCCcEE
Q 041702 592 CIEQGE----KISIYEFDIVTD---PARKDLLDWTTRVRIIEGVAQGLLYLHQY----------SRLRVIHRDLKASNVL 654 (840)
Q Consensus 592 ~~~~~~----~~lv~e~~~~~~---~~~~~~l~~~~~~~i~~~ia~~L~yLH~~----------~~~~ivHrDlkp~NIL 654 (840)
+..... .++||||..... ......+++..+..++.||+.||+|||+. + |+||||||+|||
T Consensus 87 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nil 163 (322)
T 3soc_A 87 EKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVL 163 (322)
T ss_dssp EEEECSSSEEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEE
T ss_pred eccCCCCCceEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEE
Confidence 987554 699999953322 22345689999999999999999999987 6 999999999999
Q ss_pred ecCCCCceeeccccceecCCCCcccccccccccccccCccccccC-----CCCccccchhHHHHHHHHHhCCCCCCCCCC
Q 041702 655 LDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHG-----LFSIKSDVFSFGVLLLEILSSKKNTRFYNT 729 (840)
Q Consensus 655 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDV~SlGviL~elltG~~p~~~~~~ 729 (840)
++.++.+||+|||+++.+.............||+.|+|||.+.+. .++.++|||||||++|||++|+.||.....
T Consensus 164 l~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 243 (322)
T 3soc_A 164 LKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243 (322)
T ss_dssp ECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCC
T ss_pred ECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcc
Confidence 999999999999999887655444444556799999999998863 466789999999999999999999876443
Q ss_pred CCccHhHH----------HhhhhcccccccccCccccch-hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 730 DSLTLLGH----------AWNLWKDDKAWKLMDPTMQNE-ALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 730 ~~~~~~~~----------~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
........ ....... ....+.+... ........+.+++.+||+.||++|||+.||++.|+.+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 244 EYMLPFEEEIGQHPSLEDMQEVVVH----KKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTT----SCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhccchhhhhccCCchhhhhhhhhc----ccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 32111100 0000001 1111222111 122445678999999999999999999999999998643
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=351.99 Aligned_cols=253 Identities=25% Similarity=0.386 Sum_probs=192.1
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCc----eEEEEEeccC-CCcCHHHHHHHHHHHhhcCCCCccc
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGE----EVAVKRLSSK-SGQGLEEFKNEMMLIAKLQHRNLVR 587 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~----~VAvK~l~~~-~~~~~~~f~~Ev~~l~~l~H~niv~ 587 (840)
.++|+..++||+|+||.||+|.+. .+++ .||+|.+... .....++|.+|+.++++++||||++
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~------------~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 81 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWI------------PEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEC------------C----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCC
T ss_pred HHHcccceEEeeCCCeEEEEEEEc------------CCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeE
Confidence 367899999999999999999764 2333 4688988654 3356688999999999999999999
Q ss_pred eeeEeecCCceEEEEEeeccCCcc-----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCce
Q 041702 588 LFGCCIEQGEKISIYEFDIVTDPA-----RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPK 662 (840)
Q Consensus 588 l~g~~~~~~~~~lv~e~~~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 662 (840)
++++|.+.+ .++++|+....... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 82 ~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~k 157 (327)
T 3poz_A 82 LLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVK 157 (327)
T ss_dssp EEEEEESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEE
T ss_pred EEEEEecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEE
Confidence 999998765 67788874332221 2456899999999999999999999998 99999999999999999999
Q ss_pred eeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhh
Q 041702 663 ISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNL 741 (840)
Q Consensus 663 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~ 741 (840)
|+|||+++...............+|+.|+|||.+.+..++.++|||||||+++||++ |+.|+....... ... .
T Consensus 158 l~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~----~ 231 (327)
T 3poz_A 158 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISS----I 231 (327)
T ss_dssp ECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHH----H
T ss_pred EccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH--HHH----H
Confidence 999999988765544444445567889999999999999999999999999999999 999986433221 111 1
Q ss_pred hcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 041702 742 WKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEI 796 (840)
Q Consensus 742 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~ 796 (840)
..... ...........+.+++.+||+.||++||++.||++.|+.+.
T Consensus 232 ~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 232 LEKGE---------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp HHTTC---------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred HHcCC---------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11110 00111122345788999999999999999999999998764
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=345.09 Aligned_cols=251 Identities=25% Similarity=0.369 Sum_probs=197.7
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
.++|++.+.||+|+||.||+|.++ .+++.||||++.... ....+.+.+|+.++++++||||++++++
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~------------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 73 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNR------------VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEET------------TTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEEC------------CCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 468999999999999999999765 678999999996543 2334678999999999999999999999
Q ss_pred eecCCceEEEEEeec----cCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 592 CIEQGEKISIYEFDI----VTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~----~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
+.+.+..++||||.. .........+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 74 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg 150 (323)
T 3tki_A 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFG 150 (323)
T ss_dssp EECSSEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred EecCCeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEee
Confidence 999999999999942 222334456899999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccc
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLF-SIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDK 746 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 746 (840)
+++.+.............||+.|+|||.+.+..+ +.++|||||||+++||++|+.||............. ....
T Consensus 151 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~-----~~~~ 225 (323)
T 3tki_A 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-----KEKK 225 (323)
T ss_dssp TCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHH-----HTTC
T ss_pred ccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH-----hccc
Confidence 9987654333333445679999999999988775 789999999999999999999987544332221111 1110
Q ss_pred cccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 747 AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 747 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
. .. .........+.+++.+||+.||++|||++|+++.
T Consensus 226 ~--~~------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 226 T--YL------NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp T--TS------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred c--cC------CccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0 00 1112234457789999999999999999998753
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=343.43 Aligned_cols=263 Identities=19% Similarity=0.172 Sum_probs=205.5
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhc-CCCCccceeeE
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL-QHRNLVRLFGC 591 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~ 591 (840)
.++|+..+.||+|+||.||+|.+. .+++.||||++..... .+++.+|+++++++ +||||++++++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~ 73 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNL------------YTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYF 73 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEET------------TTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEEC------------CCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEE
Confidence 468999999999999999999754 6789999999875432 35689999999999 99999999999
Q ss_pred eecCCceEEEEEeeccCCcc-----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCC-----c
Q 041702 592 CIEQGEKISIYEFDIVTDPA-----RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMN-----P 661 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~-----~ 661 (840)
+...+..++|||+. ..... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +
T Consensus 74 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~ 149 (330)
T 2izr_A 74 GPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVI 149 (330)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSE
T ss_pred EecCCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceE
Confidence 99999999999995 22111 1457999999999999999999999998 999999999999998887 9
Q ss_pred eeeccccceecCCCCccc-----ccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhH
Q 041702 662 KISDFGIARTFGGDEMQS-----NTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLG 736 (840)
Q Consensus 662 kL~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~ 736 (840)
||+|||+++.+....... ......||+.|+|||.+.+..++.++|||||||+++||++|+.||............
T Consensus 150 kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~ 229 (330)
T 2izr_A 150 HIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERY 229 (330)
T ss_dssp EECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHH
T ss_pred EEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHH
Confidence 999999998765433211 124567999999999999999999999999999999999999999765433321110
Q ss_pred HHhhhhcccccccccCccccchh-hHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCCCCCC
Q 041702 737 HAWNLWKDDKAWKLMDPTMQNEA-LYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSPH 803 (840)
Q Consensus 737 ~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~p~ 803 (840)
.. ...... ...... ....+ .+.+++..||+.||.+||++++|++.|+++......+.
T Consensus 230 ~~---i~~~~~------~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~ 287 (330)
T 2izr_A 230 QK---IGDTKR------ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMF 287 (330)
T ss_dssp HH---HHHHHH------HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCC
T ss_pred HH---HHhhhc------cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCC
Confidence 00 000000 000000 00112 68899999999999999999999999998766554433
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=335.10 Aligned_cols=272 Identities=15% Similarity=0.185 Sum_probs=213.4
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhc-CCCCccceee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL-QHRNLVRLFG 590 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g 590 (840)
..++|+..+.||+|+||.||+|.+. .+++.||||++.... ..+.+.+|+.++.++ +|+|++++++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~ 73 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNL------------LNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYY 73 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEET------------TTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEEC------------CCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEe
Confidence 3468999999999999999999754 678999999987543 335689999999999 8999999999
Q ss_pred EeecCCceEEEEEeeccCCcc-----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCC-----
Q 041702 591 CCIEQGEKISIYEFDIVTDPA-----RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMN----- 660 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~----- 660 (840)
++.+.+..++|||+. ..... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 74 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~ 149 (298)
T 1csn_A 74 FGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANM 149 (298)
T ss_dssp EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTC
T ss_pred ecCCCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCe
Confidence 999999999999995 22111 1345899999999999999999999988 999999999999987776
Q ss_pred ceeeccccceecCCCCcc-----cccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc-H
Q 041702 661 PKISDFGIARTFGGDEMQ-----SNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLT-L 734 (840)
Q Consensus 661 ~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~-~ 734 (840)
+||+|||+++........ .......||+.|+|||.+.+..++.++||||||++++||++|+.||......... .
T Consensus 150 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 229 (298)
T 1csn_A 150 IYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK 229 (298)
T ss_dssp EEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH
T ss_pred EEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHH
Confidence 999999999887543321 1234567999999999999999999999999999999999999998765433321 1
Q ss_pred hHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCCCCCCCCCCccc
Q 041702 735 LGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSPHQPAFSYV 810 (840)
Q Consensus 735 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~p~~p~~~~~ 810 (840)
........... .........++.+.+++.+||+.||++||++++|++.|+++..++.....-.|+|.
T Consensus 230 ~~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~ 296 (298)
T 1csn_A 230 YERIGEKKQST---------PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWN 296 (298)
T ss_dssp HHHHHHHHHHS---------CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGG
T ss_pred HHHHHhhccCc---------cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccC
Confidence 11110000000 00011112345688999999999999999999999999999888776666666653
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=355.80 Aligned_cols=270 Identities=28% Similarity=0.366 Sum_probs=208.7
Q ss_pred cCHHHHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhc-C
Q 041702 504 FSLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKL-Q 581 (840)
Q Consensus 504 ~~~~~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l-~ 581 (840)
+...+++...++|++.++||+|+||.||+|.+.. .....+++.||||+++.... ...++|.+|++++.++ +
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~-------~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~ 84 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFG-------IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 84 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEES-------SSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCC
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEecc-------ccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcC
Confidence 4566677788999999999999999999997541 01346788999999976432 3346799999999999 8
Q ss_pred CCCccceeeEeecCCc-eEEEEEeeccCC-------cc------------------------------------------
Q 041702 582 HRNLVRLFGCCIEQGE-KISIYEFDIVTD-------PA------------------------------------------ 611 (840)
Q Consensus 582 H~niv~l~g~~~~~~~-~~lv~e~~~~~~-------~~------------------------------------------ 611 (840)
||||+++++++.+.+. .++||||..... ..
T Consensus 85 hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (359)
T 3vhe_A 85 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSAS 164 (359)
T ss_dssp CTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------
T ss_pred CcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccc
Confidence 9999999999987654 899999832100 00
Q ss_pred ---------------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccce
Q 041702 612 ---------------------RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIAR 670 (840)
Q Consensus 612 ---------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~ 670 (840)
....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 241 (359)
T 3vhe_A 165 SGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLAR 241 (359)
T ss_dssp -------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGS
T ss_pred cccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEecccee
Confidence 0122889999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhccccccc
Q 041702 671 TFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKDDKAWK 749 (840)
Q Consensus 671 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (840)
...............||+.|+|||.+.+..++.++||||||++++||++ |+.|+......... . .........
T Consensus 242 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-~----~~~~~~~~~- 315 (359)
T 3vhe_A 242 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-C----RRLKEGTRM- 315 (359)
T ss_dssp CTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH-H----HHHHHTCCC-
T ss_pred eecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH-H----HHHHcCCCC-
Confidence 7755444344455678999999999999999999999999999999998 99998654322211 1 111111100
Q ss_pred ccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 750 LMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 750 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
.. +......+.+++.+||+.||++|||++||++.|+++..
T Consensus 316 ----~~----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 316 ----RA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp ----CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 01 11123457889999999999999999999999998743
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=348.34 Aligned_cols=260 Identities=24% Similarity=0.351 Sum_probs=201.5
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
.++|++.+.||+|+||.||+|.++ ..-..+..||||+++... ....++|.+|+.++.+++||||++++++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 118 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLR---------VPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGV 118 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEEC---------CTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEe---------cCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 467889999999999999999765 222345679999997642 3345679999999999999999999999
Q ss_pred eecCCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 592 CIEQGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
+.+.+..++||||...... .....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Df 195 (325)
T 3kul_A 119 VTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDF 195 (325)
T ss_dssp ECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred EEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCC
Confidence 9999999999999533221 12346899999999999999999999998 999999999999999999999999
Q ss_pred ccceecCCCCccc-ccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 667 GIARTFGGDEMQS-NTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 667 Gla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
|+++......... ......+|+.|+|||.+.+..++.++||||||++++||++ |+.|+...... ..... ...
T Consensus 196 g~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~----~~~ 269 (325)
T 3kul_A 196 GLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR--DVISS----VEE 269 (325)
T ss_dssp SSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHHH----HHT
T ss_pred CcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--HHHHH----HHc
Confidence 9998875432211 2223446778999999999999999999999999999999 99997543211 11111 111
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCC
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNL 799 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~ 799 (840)
. ............+.+++.+||+.||++|||+.+|++.|+.+....
T Consensus 270 ~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 270 G---------YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp T---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred C---------CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 1 000111123456889999999999999999999999999985543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=342.83 Aligned_cols=268 Identities=24% Similarity=0.352 Sum_probs=199.5
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
.++|+..++||+|+||.||+|+.. .....+++.||||++........++|.+|++++.+++||||+++++++
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 80 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYD--------PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 80 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEC--------TTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred HHHhhhhheeeccCCEEEEEEEEe--------cccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 478899999999999999998632 012357899999999876656667899999999999999999999998
Q ss_pred ecC--CceEEEEEeeccCCcc-----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 593 IEQ--GEKISIYEFDIVTDPA-----RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 593 ~~~--~~~~lv~e~~~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
... ...++||||....... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 81 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~D 157 (295)
T 3ugc_A 81 YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGD 157 (295)
T ss_dssp CHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC
T ss_pred ecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEcc
Confidence 654 5589999995332211 1335899999999999999999999988 99999999999999999999999
Q ss_pred cccceecCCCCcc-cccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCC----------CccH
Q 041702 666 FGIARTFGGDEMQ-SNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTD----------SLTL 734 (840)
Q Consensus 666 FGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~----------~~~~ 734 (840)
||+++........ .......++..|+|||.+.+..++.++||||||++++||++|..|+...... ....
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~ 237 (295)
T 3ugc_A 158 FGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 237 (295)
T ss_dssp CCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHH
T ss_pred CcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchh
Confidence 9999876543221 2223345778899999999999999999999999999999999887532110 0000
Q ss_pred hHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCCC
Q 041702 735 LGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLP 800 (840)
Q Consensus 735 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~~ 800 (840)
......... .......+...+..+.+++.+||+.||++|||++||++.|+.+..+++
T Consensus 238 ~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~ 294 (295)
T 3ugc_A 238 VFHLIELLK---------NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294 (295)
T ss_dssp HHHHHHHHH---------TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred HHHHHHHHh---------ccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence 000001110 111111122334568899999999999999999999999999866553
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=357.78 Aligned_cols=255 Identities=24% Similarity=0.334 Sum_probs=201.6
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcCCCCccceee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
..++|...++||+|+||.||+|.++ .+++.||||+++.... ...++|.+|+++|++++||||+++++
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~------------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 179 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLR------------ADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET------------TTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEe------------cCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 4578899999999999999999765 5789999999975432 23457899999999999999999999
Q ss_pred EeecCCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 591 CCIEQGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
++...+..++||||...... .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 180 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~D 256 (377)
T 3cbl_A 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISD 256 (377)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred EEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECc
Confidence 99999999999999543321 12345899999999999999999999998 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.|+...... . .......
T Consensus 257 fG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--~----~~~~~~~ 330 (377)
T 3cbl_A 257 FGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ--Q----TREFVEK 330 (377)
T ss_dssp GGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH--H----HHHHHHT
T ss_pred CCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--H----HHHHHHc
Confidence 999987644332222223346778999999999999999999999999999998 88887643211 1 1111111
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEI 796 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~ 796 (840)
.. ....+ ...+..+.+++.+||+.||++|||+++|++.|+++.
T Consensus 331 ~~--~~~~~-------~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 331 GG--RLPCP-------ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp TC--CCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC--CCCCC-------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 11 01111 122345788999999999999999999999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=353.30 Aligned_cols=260 Identities=26% Similarity=0.366 Sum_probs=199.9
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
.++|+..++||+|+||.||+|.+... ....+++.||||+++... .....++.+|+.++.+++||||++++++
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~-------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 142 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGM-------PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGV 142 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC------------CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccC-------CCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 46789999999999999999975410 123568899999997542 3445679999999999999999999999
Q ss_pred eecCCceEEEEEeeccCC-----------ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCC-
Q 041702 592 CIEQGEKISIYEFDIVTD-----------PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDM- 659 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~-----------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~- 659 (840)
+.+.+..++||||..... ......+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~ 219 (367)
T 3l9p_A 143 SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGP 219 (367)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSST
T ss_pred EecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCC
Confidence 999999999999942211 122345899999999999999999999998 99999999999999555
Q ss_pred --CceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhH
Q 041702 660 --NPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLG 736 (840)
Q Consensus 660 --~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~ 736 (840)
.+||+|||+++.+.............+|+.|+|||.+.+..++.++|||||||+++||++ |+.|+...... ...
T Consensus 220 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~--~~~- 296 (367)
T 3l9p_A 220 GRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EVL- 296 (367)
T ss_dssp TCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHH-
T ss_pred CceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHH-
Confidence 599999999986543333333445668999999999999999999999999999999998 98888643211 111
Q ss_pred HHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 737 HAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 737 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
........ ..........+.+++.+||+.||++|||+.+|++.|+....
T Consensus 297 ---~~i~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 297 ---EFVTSGGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp ---HHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHHcCCC---------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 11111110 00111223457889999999999999999999999987643
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=336.25 Aligned_cols=247 Identities=23% Similarity=0.325 Sum_probs=190.5
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC--------------------------cC
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG--------------------------QG 566 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~--------------------------~~ 566 (840)
.++|+..+.||+|+||.||+|.++ .+++.||||++..... ..
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~------------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 79 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNE------------NDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEET------------TTTEEEEEEEEECC------------------------------
T ss_pred ecceEEEeEEeecCCEEEEEEEEC------------CCCcEEEEEEeehhhhhhhcccccccccccccccccccccccch
Confidence 478999999999999999999765 6789999999865421 12
Q ss_pred HHHHHHHHHHHhhcCCCCccceeeEeec--CCceEEEEEeec---cCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 041702 567 LEEFKNEMMLIAKLQHRNLVRLFGCCIE--QGEKISIYEFDI---VTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRL 641 (840)
Q Consensus 567 ~~~f~~Ev~~l~~l~H~niv~l~g~~~~--~~~~~lv~e~~~---~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~ 641 (840)
.+++.+|++++++++||||+++++++.+ .+..++||||.. +........+++..+..++.||+.||+|||+.+
T Consensus 80 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-- 157 (298)
T 2zv2_A 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQK-- 157 (298)
T ss_dssp -CHHHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 4678999999999999999999999986 567899999942 333344567999999999999999999999998
Q ss_pred ceecCCCCCCcEEecCCCCceeeccccceecCCCCcccccccccccccccCccccccCC---CCccccchhHHHHHHHHH
Q 041702 642 RVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGL---FSIKSDVFSFGVLLLEIL 718 (840)
Q Consensus 642 ~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDV~SlGviL~ell 718 (840)
|+||||||+|||++.++.+||+|||+++....... ......||+.|+|||.+.+.. ++.++|||||||+++||+
T Consensus 158 -ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~ 234 (298)
T 2zv2_A 158 -IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFV 234 (298)
T ss_dssp -EECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHH
T ss_pred -eeccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHH
Confidence 99999999999999999999999999987654322 223457999999999987765 478899999999999999
Q ss_pred hCCCCCCCCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 719 SSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 719 tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
+|+.||..... .... ........ ...+ .......+.+++.+||+.||++|||+.|+++
T Consensus 235 ~g~~pf~~~~~--~~~~----~~~~~~~~-~~~~-------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 235 FGQCPFMDERI--MCLH----SKIKSQAL-EFPD-------QPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HSSCSSCCSSH--HHHH----HHHHHCCC-CCCS-------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HCCCCCCCccH--HHHH----HHHhcccC-CCCC-------ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 99999853221 1111 11111100 0000 0122345789999999999999999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=337.58 Aligned_cols=259 Identities=22% Similarity=0.320 Sum_probs=195.4
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC--cCHHHHHHHHHHHhhcCCCCcccee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG--QGLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
..++|+..++||+|+||.||+|.+. +++.||||++..... ...+.+.+|++++++++||||++++
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~-------------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 85 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDS-------------QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLI 85 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEET-------------TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEEC-------------CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeee
Confidence 4578999999999999999998753 588999999975432 2346789999999999999999999
Q ss_pred eEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 590 GCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
+++.+.+..++||||..... ......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~D 162 (311)
T 3niz_A 86 DVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLAD 162 (311)
T ss_dssp EEECCSSCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECC
T ss_pred eEEccCCEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEcc
Confidence 99999999999999943210 112345899999999999999999999998 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
||+++...... .......+|+.|+|||.+.+ ..++.++|||||||+++||++|+.||......+. ..........
T Consensus 163 fg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i~~~~~~ 238 (311)
T 3niz_A 163 FGLARAFGIPV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ--LPKIFSILGT 238 (311)
T ss_dssp CTTCEETTSCC--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH--HHHHHHHHCC
T ss_pred CcCceecCCCc--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHHCC
Confidence 99998764322 12234578999999999876 5689999999999999999999999876544331 1111111110
Q ss_pred cc----------------cccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 745 DK----------------AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 745 ~~----------------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.. .....+..............+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 239 PNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp CCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00 00001111101111223456789999999999999999999986
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=337.94 Aligned_cols=259 Identities=24% Similarity=0.364 Sum_probs=199.7
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC---cCHHHHHHHHHHHhhcCCCCcccee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG---QGLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
.++|++.+.||+|+||.||+|.+. .+++.||+|++..... ...++|.+|+.++.+++||||++++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~ 77 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDT------------ILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEET------------TTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEE
T ss_pred hccEEEEEEEccCCCEEEEEEEEC------------CCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEE
Confidence 468999999999999999999765 6789999999865432 3346799999999999999999999
Q ss_pred eEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 590 GCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
+++.+.+..++||||..... ......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 78 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~D 154 (294)
T 4eqm_A 78 DVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFD 154 (294)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECC
T ss_pred EeeeeCCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEe
Confidence 99999999999999953322 223456899999999999999999999998 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
||+++....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .........
T Consensus 155 fg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-----~~~~~~~~~ 228 (294)
T 4eqm_A 155 FGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS-----IAIKHIQDS 228 (294)
T ss_dssp CSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH-----HHHHHHSSC
T ss_pred CCCccccccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHhhcc
Confidence 999987643322 22334679999999999999999999999999999999999999986432111 111111110
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhhccccC
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRP-TMLEVVAMLKDEIVN 798 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~Le~~~~~ 798 (840)
.+..........+..+.+++.+||+.||++|| +++++.+.|+.....
T Consensus 229 ------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 229 ------VPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp ------CCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred ------CCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 01111111123345688999999999999999 999999999987443
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=347.07 Aligned_cols=247 Identities=25% Similarity=0.342 Sum_probs=198.4
Q ss_pred HHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccce
Q 041702 511 AATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRL 588 (840)
Q Consensus 511 ~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l 588 (840)
...++|+..+.||+|+||.||+|.++ .+|+.||||++.... ....+++.+|++++++++||||+++
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l 79 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHI------------LTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEET------------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEEC------------CCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeE
Confidence 34578999999999999999999765 688999999997542 2345678999999999999999999
Q ss_pred eeEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 589 FGCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
++++...+..++||||..... ......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 80 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~ 156 (328)
T 3fe3_A 80 FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIA 156 (328)
T ss_dssp EEEEECSSEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred EEEEEECCEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEe
Confidence 999999999999999953322 223467899999999999999999999998 9999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCccccccCCCC-ccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhc
Q 041702 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFS-IKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWK 743 (840)
Q Consensus 665 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~ 743 (840)
|||+++...... ......||+.|+|||.+.+..++ .++|||||||+++||++|+.||....... +. ....
T Consensus 157 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~----~~i~ 227 (328)
T 3fe3_A 157 DFGFSNEFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE--LR----ERVL 227 (328)
T ss_dssp STTCCGGGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH----HHHH
T ss_pred eccCceecCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH--HH----HHHH
Confidence 999998764332 23446799999999999988875 79999999999999999999986432111 11 1111
Q ss_pred ccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 744 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
.... .. +......+.+++.+||+.||++|||++|+++.
T Consensus 228 ~~~~------~~----p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 228 RGKY------RI----PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HCCC------CC----CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred hCCC------CC----CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1100 01 11123457889999999999999999999863
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=353.00 Aligned_cols=273 Identities=27% Similarity=0.378 Sum_probs=210.2
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhc-CCCCcccee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKL-QHRNLVRLF 589 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l-~H~niv~l~ 589 (840)
..++|.+.++||+|+||.||+|.+... .......+..||||++.... ....+++.+|++++.++ +||||++++
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~-----~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 141 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGL-----DKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLL 141 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETS-----STTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred chhheEeeeEEecCCCeEEEEEEEccc-----cccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence 457899999999999999999976410 01122455789999997653 23457799999999999 999999999
Q ss_pred eEeecCCceEEEEEeeccCCc--------------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCC
Q 041702 590 GCCIEQGEKISIYEFDIVTDP--------------------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLK 649 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~~~--------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk 649 (840)
+++...+..++||||...... .....+++.++++++.||+.||+|||+.+ |+|||||
T Consensus 142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlk 218 (382)
T 3tt0_A 142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLA 218 (382)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCC
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCC
Confidence 999999999999999422111 11245899999999999999999999998 9999999
Q ss_pred CCcEEecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCC
Q 041702 650 ASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYN 728 (840)
Q Consensus 650 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~ 728 (840)
|+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||+++||++ |+.|+....
T Consensus 219 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 219 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp GGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999987765444344445667899999999999999999999999999999999 998875432
Q ss_pred CCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCCCCCCCCCC
Q 041702 729 TDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSPHQPAF 807 (840)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~p~~p~~ 807 (840)
.. . ........... ..+......+.+++.+||+.||++|||++||++.|+.+.........+.+
T Consensus 299 ~~--~----~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~ 362 (382)
T 3tt0_A 299 VE--E----LFKLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYY 362 (382)
T ss_dssp HH--H----HHHHHHTTCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC----
T ss_pred HH--H----HHHHHHcCCCC---------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCCC
Confidence 11 1 11111111100 01112234588899999999999999999999999998766655544443
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=352.17 Aligned_cols=258 Identities=24% Similarity=0.371 Sum_probs=189.9
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
.++|++.+.||+|+||.||+|+++ ....++..||||+++... ....++|.+|+.++++++||||++++++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 114 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLK---------LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGV 114 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CB---------CTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEe---------cCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 468899999999999999998754 222467789999997542 3345679999999999999999999999
Q ss_pred eecCCceEEEEEeeccCCcc-----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 592 CIEQGEKISIYEFDIVTDPA-----RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
+.+.+..++||||....... ....+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 115 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Df 191 (373)
T 2qol_A 115 VTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDF 191 (373)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC
T ss_pred EeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcC
Confidence 99999999999995322211 2346899999999999999999999998 999999999999999999999999
Q ss_pred ccceecCCCCccc-ccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 667 GIARTFGGDEMQS-NTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 667 Gla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
|+++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+...... ... .....
T Consensus 192 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~--~~~----~~i~~ 265 (373)
T 2qol_A 192 GLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--DVI----KAVDE 265 (373)
T ss_dssp ----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH--HHH----HHHHT
T ss_pred ccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHH----HHHHc
Confidence 9998765432211 1222345778999999999999999999999999999998 99987543211 111 11111
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
. .........+..+.+++.+||+.||++||++.+|++.|+.+..
T Consensus 266 ~---------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 266 G---------YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp T---------EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C---------CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 1 0011112234568899999999999999999999999998754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=333.74 Aligned_cols=259 Identities=24% Similarity=0.295 Sum_probs=196.2
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC--cCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG--QGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
++|+..++||+|+||.||+|.++ .+++.||||++..... ...+.+.+|+.++++++||||++++++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 69 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNR------------ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEET------------TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEEC------------CCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeE
Confidence 57899999999999999999765 6789999999975432 334778999999999999999999999
Q ss_pred eecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 592 CIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
+.+.+..++||||..... ......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 70 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg 146 (292)
T 3o0g_A 70 LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFG 146 (292)
T ss_dssp EEETTEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred EEeCCEEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence 999999999999943211 112456899999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCccccccCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccc
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALHGL-FSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDK 746 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 746 (840)
+++...... .......||+.|+|||.+.+.. ++.++|||||||+++||++|+.|+-..... ...............
T Consensus 147 ~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~-~~~~~~i~~~~~~~~ 223 (292)
T 3o0g_A 147 LARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQLKRIFRLLGTPT 223 (292)
T ss_dssp TCEECCSCC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH-HHHHHHHHHHHCCCC
T ss_pred cceecCCcc--ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH-HHHHHHHHHHhCCCC
Confidence 998764322 2233457899999999998766 899999999999999999998885322211 111111111111000
Q ss_pred c------ccccC---------ccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 747 A------WKLMD---------PTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 747 ~------~~~~d---------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
. ....+ ..............+.+++.+||+.||++|||++|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 224 EEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0 00000 00001111234456789999999999999999999986
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=346.67 Aligned_cols=263 Identities=23% Similarity=0.329 Sum_probs=187.1
Q ss_pred HHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC--CCcCHHHHHHHHHHHhhcCCCCccc
Q 041702 510 SAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK--SGQGLEEFKNEMMLIAKLQHRNLVR 587 (840)
Q Consensus 510 ~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~ 587 (840)
....++|+..+.||+|+||.||+|.++ ..-.....||||+++.. .....++|.+|++++++++||||++
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 89 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLK---------QEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC----------------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred ccChhHeEEeceecccCCeEEEEEEEc---------ccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceeh
Confidence 345678999999999999999999765 11112238999999764 3345678999999999999999999
Q ss_pred eeeEeecCCce------EEEEEeeccCCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCC
Q 041702 588 LFGCCIEQGEK------ISIYEFDIVTDPA----------RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKAS 651 (840)
Q Consensus 588 l~g~~~~~~~~------~lv~e~~~~~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~ 651 (840)
+++++...+.. ++++||....... ....+++..+..++.||+.||+|||+.+ |+||||||+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~ 166 (323)
T 3qup_A 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAAR 166 (323)
T ss_dssp CCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred hhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcc
Confidence 99999887665 8999984332211 1225899999999999999999999998 999999999
Q ss_pred cEEecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCC
Q 041702 652 NVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTD 730 (840)
Q Consensus 652 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~ 730 (840)
|||++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||++++||++ |+.|+......
T Consensus 167 NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~ 246 (323)
T 3qup_A 167 NCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA 246 (323)
T ss_dssp GEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred eEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH
Confidence 99999999999999999987655443333344557889999999999999999999999999999999 88887643322
Q ss_pred CccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCC
Q 041702 731 SLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNL 799 (840)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~ 799 (840)
. .... ...... ..........+.+++.+||+.||++|||+.++++.|++++...
T Consensus 247 ~--~~~~----~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 247 E--IYNY----LIGGNR---------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp G--HHHH----HHTTCC---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred H--HHHH----HhcCCC---------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 1 1111 111110 0111123346889999999999999999999999999986654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=349.02 Aligned_cols=268 Identities=24% Similarity=0.360 Sum_probs=206.2
Q ss_pred HHHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcCCCCc
Q 041702 507 SSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQHRNL 585 (840)
Q Consensus 507 ~~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~H~ni 585 (840)
.++....++|...+.||+|+||.||+|.++.. ....+++.||||+++.... ...++|.+|+.++.+++||||
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~-------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~i 112 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGL-------LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETS-------STTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTB
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCc-------CCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCE
Confidence 34445678999999999999999999976510 1124568999999986532 335679999999999999999
Q ss_pred cceeeEeecCCceEEEEEeeccCCcc----------------------------ccCCCCHHHHHHHHHHHHHHHHHHHh
Q 041702 586 VRLFGCCIEQGEKISIYEFDIVTDPA----------------------------RKDLLDWTTRVRIIEGVAQGLLYLHQ 637 (840)
Q Consensus 586 v~l~g~~~~~~~~~lv~e~~~~~~~~----------------------------~~~~l~~~~~~~i~~~ia~~L~yLH~ 637 (840)
+++++++.+.+..++||||....... ....+++.+++.++.||+.||+|||+
T Consensus 113 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~ 192 (343)
T 1luf_A 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE 192 (343)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 99999999999999999984221110 12568999999999999999999999
Q ss_pred cCCCceecCCCCCCcEEecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHH
Q 041702 638 YSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEI 717 (840)
Q Consensus 638 ~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~el 717 (840)
.+ |+||||||+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||
T Consensus 193 ~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el 269 (343)
T 1luf_A 193 RK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 269 (343)
T ss_dssp TT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred CC---eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHH
Confidence 98 999999999999999999999999999876543333333455688999999999999999999999999999999
Q ss_pred Hh-CCCCCCCCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 041702 718 LS-SKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEI 796 (840)
Q Consensus 718 lt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~ 796 (840)
++ |+.|+...... ... ......... ..+......+.+++.+||+.||++||++.+|++.|+++.
T Consensus 270 ~t~g~~p~~~~~~~--~~~----~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~ 334 (343)
T 1luf_A 270 FSYGLQPYYGMAHE--EVI----YYVRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 334 (343)
T ss_dssp HTTTCCTTTTSCHH--HHH----HHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HhcCCCcCCCCChH--HHH----HHHhCCCcC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence 99 99887543211 111 111111111 011123346888999999999999999999999999985
Q ss_pred cCC
Q 041702 797 VNL 799 (840)
Q Consensus 797 ~~~ 799 (840)
...
T Consensus 335 ~~~ 337 (343)
T 1luf_A 335 ERA 337 (343)
T ss_dssp C--
T ss_pred hhh
Confidence 543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=342.89 Aligned_cols=284 Identities=17% Similarity=0.175 Sum_probs=207.6
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCc-----------CHHHHHHHHHHHhhc
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQ-----------GLEEFKNEMMLIAKL 580 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~-----------~~~~f~~Ev~~l~~l 580 (840)
..++|.+.++||+|+||.||+|.++. ......++.||||++...... ....+..|+..+..+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-------~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l 105 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNS-------SESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKL 105 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECC-------SSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecC-------ccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhc
Confidence 45689999999999999999997651 122345789999998754311 112344566667777
Q ss_pred CCCCccceeeEeecC----CceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCC
Q 041702 581 QHRNLVRLFGCCIEQ----GEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKAS 651 (840)
Q Consensus 581 ~H~niv~l~g~~~~~----~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~ 651 (840)
+||||+++++++... ...++||||. .... .....+++..++.|+.||+.||+|||+.+ |+||||||+
T Consensus 106 ~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~ 181 (364)
T 3op5_A 106 KYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKAS 181 (364)
T ss_dssp SCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG
T ss_pred cCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHH
Confidence 899999999999875 4479999995 2111 12356999999999999999999999998 999999999
Q ss_pred cEEec--CCCCceeeccccceecCCCCccc-----ccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCC
Q 041702 652 NVLLD--SDMNPKISDFGIARTFGGDEMQS-----NTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNT 724 (840)
Q Consensus 652 NILl~--~~~~~kL~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~ 724 (840)
|||++ .++.+||+|||+++.+....... ......||+.|+|||.+.+..++.++|||||||+||||++|+.||
T Consensus 182 Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf 261 (364)
T 3op5_A 182 NLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPW 261 (364)
T ss_dssp GEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999 88999999999998765432211 113445999999999999999999999999999999999999998
Q ss_pred CCCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCCCCCCC
Q 041702 725 RFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSPHQ 804 (840)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~p~~ 804 (840)
......... ....... .......++++.+.. ...+..+.+++..||+.+|++||++.+|++.|+++...+..+..
T Consensus 262 ~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~ 336 (364)
T 3op5_A 262 EDNLKDPKY-VRDSKIR-YRENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDD 336 (364)
T ss_dssp GGGTTCHHH-HHHHHHH-HHHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCC
T ss_pred cccccCHHH-HHHHHHH-hhhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcC
Confidence 753322211 1111100 011111222222111 11245688899999999999999999999999999888877776
Q ss_pred CCCccce
Q 041702 805 PAFSYVQ 811 (840)
Q Consensus 805 p~~~~~~ 811 (840)
..+++..
T Consensus 337 ~~~dw~~ 343 (364)
T 3op5_A 337 GKLDLSV 343 (364)
T ss_dssp CCCCC--
T ss_pred CccceEe
Confidence 6665543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=341.70 Aligned_cols=268 Identities=23% Similarity=0.351 Sum_probs=195.4
Q ss_pred HHHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCC
Q 041702 507 SSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRN 584 (840)
Q Consensus 507 ~~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~n 584 (840)
.++....++|...+.||+|+||.||+|.+. ....+++.||||+++... ....++|.+|+.++.+++|||
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 97 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLK---------QEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEE---------CTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTT
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEe---------ccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCC
Confidence 344456688999999999999999999765 333456789999997543 234567999999999999999
Q ss_pred ccceeeEeecCCc-----eEEEEEeeccCCc----------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCC
Q 041702 585 LVRLFGCCIEQGE-----KISIYEFDIVTDP----------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLK 649 (840)
Q Consensus 585 iv~l~g~~~~~~~-----~~lv~e~~~~~~~----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk 649 (840)
|+++++++.+.+. .++++||...... .....+++..++.++.||+.||.|||+.+ |+|||||
T Consensus 98 iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dik 174 (313)
T 3brb_A 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLA 174 (313)
T ss_dssp BCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCS
T ss_pred eeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 9999999987654 4899998432211 23456899999999999999999999988 9999999
Q ss_pred CCcEEecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCC
Q 041702 650 ASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYN 728 (840)
Q Consensus 650 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~ 728 (840)
|+|||++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||++++||++ |+.|+....
T Consensus 175 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 254 (313)
T 3brb_A 175 ARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ 254 (313)
T ss_dssp GGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 9999999999999999999987654433333344567889999999999999999999999999999999 888875433
Q ss_pred CCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCCCC
Q 041702 729 TDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPS 801 (840)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~ 801 (840)
... ..... ..... + ..+......+.+++.+||+.||++|||+.++++.|+++...+|.
T Consensus 255 ~~~--~~~~~----~~~~~-----~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp~ 312 (313)
T 3brb_A 255 NHE--MYDYL----LHGHR-----L----KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPD 312 (313)
T ss_dssp GGG--HHHHH----HTTCC-----C----CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred HHH--HHHHH----HcCCC-----C----CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 221 11111 11100 0 11122335688999999999999999999999999998777753
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=333.63 Aligned_cols=259 Identities=25% Similarity=0.316 Sum_probs=195.8
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhh--cCCCCcccee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAK--LQHRNLVRLF 589 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~--l~H~niv~l~ 589 (840)
..++|+..+.||+|+||.||+|.+ +++.||||++... ..+.+..|.+++.. ++||||++++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--------------~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~ 68 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--------------QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFI 68 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--------------TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--------------CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEE
Confidence 357899999999999999999853 5889999999753 34567777777776 7999999999
Q ss_pred eEeecC----CceEEEEEeeccCC---ccccCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCceecCCCCCCcEE
Q 041702 590 GCCIEQ----GEKISIYEFDIVTD---PARKDLLDWTTRVRIIEGVAQGLLYLH--------QYSRLRVIHRDLKASNVL 654 (840)
Q Consensus 590 g~~~~~----~~~~lv~e~~~~~~---~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~ivHrDlkp~NIL 654 (840)
+++... +..++||||..... ......+++..+++++.||+.||+||| +.+ |+||||||+|||
T Consensus 69 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nil 145 (301)
T 3q4u_A 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNIL 145 (301)
T ss_dssp EEEEEEETTEEEEEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEE
T ss_pred EeeccccCCCceeEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEE
Confidence 997653 45789999843322 223456899999999999999999999 666 999999999999
Q ss_pred ecCCCCceeeccccceecCCCCccc--ccccccccccccCccccccC------CCCccccchhHHHHHHHHHhC------
Q 041702 655 LDSDMNPKISDFGIARTFGGDEMQS--NTNRIVGTYGYMSPEYALHG------LFSIKSDVFSFGVLLLEILSS------ 720 (840)
Q Consensus 655 l~~~~~~kL~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~ksDV~SlGviL~elltG------ 720 (840)
++.++.+||+|||+++......... ......||+.|+|||.+.+. .++.++|||||||++|||++|
T Consensus 146 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~ 225 (301)
T 3q4u_A 146 VKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI 225 (301)
T ss_dssp ECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred EcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccc
Confidence 9999999999999998764433221 12345799999999999876 456799999999999999999
Q ss_pred ----CCCCCCCCCCCccHhHHHhhhhcccccccccCccccc-hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 721 ----KKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQN-EALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 721 ----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
+.|+..................... ..+.... .........+.+++.+||+.||++|||+.||++.|+++
T Consensus 226 ~~~~~~pf~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 226 VEDYKPPFYDVVPNDPSFEDMRKVVCVDQ-----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CCCCCCTTTTTSCSSCCHHHHHHHHTTSC-----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccccccccCCCCcchhhhhHHHhccC-----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 7776544333322211111111111 1111111 12334667899999999999999999999999999875
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=343.38 Aligned_cols=249 Identities=22% Similarity=0.294 Sum_probs=198.9
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC------cCHHHHHHHHHHHhhcCCCCc
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG------QGLEEFKNEMMLIAKLQHRNL 585 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~------~~~~~f~~Ev~~l~~l~H~ni 585 (840)
..+.|.+.+.||+|+||.||+|.++ .+|+.||||++..... ...+.+.+|+.+|.+++||||
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~------------~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnI 77 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREK------------STGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEET------------TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTB
T ss_pred hhhceEEeeEEeeCcCEEEEEEEEC------------CCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCC
Confidence 4578999999999999999999765 6789999999976432 235789999999999999999
Q ss_pred cceeeEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCC--
Q 041702 586 VRLFGCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDM-- 659 (840)
Q Consensus 586 v~l~g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-- 659 (840)
+++++++.+.+..++||||..... ......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 78 v~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~ 154 (361)
T 2yab_A 78 ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIP 154 (361)
T ss_dssp CCEEEEEECSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSS
T ss_pred CcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCC
Confidence 999999999999999999953222 223456899999999999999999999998 99999999999998877
Q ss_pred --CceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHH
Q 041702 660 --NPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGH 737 (840)
Q Consensus 660 --~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~ 737 (840)
.+||+|||++..+.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....
T Consensus 155 ~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~--~~~~~ 229 (361)
T 2yab_A 155 IPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLAN 229 (361)
T ss_dssp SCCEEECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHH
T ss_pred ccCEEEEecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH
Confidence 79999999998865432 223467999999999999999999999999999999999999998543211 11111
Q ss_pred HhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 738 AWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 738 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.... ...............+.+++.+||+.||++|||+.|+++
T Consensus 230 ----i~~~------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 230 ----ITAV------SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp ----HHTT------CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----HHhc------CCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1110 001111111233456789999999999999999999884
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=359.39 Aligned_cols=254 Identities=27% Similarity=0.409 Sum_probs=204.2
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
..++|...++||+|+||.||+|.++ .++..||||+++.. ....++|.+|+.+|++++||||++++++
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~------------~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~ 284 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWK------------KYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGV 284 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEG------------GGTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEc------------CCCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 4567889999999999999999765 46889999999764 3457889999999999999999999999
Q ss_pred eecCCceEEEEEeeccCCc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 592 CIEQGEKISIYEFDIVTDP------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
|.+.+..++||||...... .....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 285 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~D 361 (495)
T 1opk_A 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVAD 361 (495)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECC
T ss_pred EecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEee
Confidence 9999999999999543221 12345889999999999999999999998 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
||+++....... .......++..|+|||.+.+..++.++|||||||+||||++ |+.|+....... .. .....
T Consensus 362 FG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~--~~----~~~~~ 434 (495)
T 1opk_A 362 FGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VY----ELLEK 434 (495)
T ss_dssp TTCEECCTTCCE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HH----HHHHT
T ss_pred cccceeccCCce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH--HH----HHHHc
Confidence 999987654322 22233456789999999999999999999999999999999 888886433221 11 11111
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
. .....+...+..+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus 435 ~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 435 D---------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp T---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred C---------CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 1 1111112234568889999999999999999999999998753
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=344.26 Aligned_cols=263 Identities=25% Similarity=0.396 Sum_probs=206.1
Q ss_pred HHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCcccee
Q 041702 511 AATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 511 ~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
...++|.+.+.||+|+||.||+|.+... ....+++.||||++.... ....+++.+|++++++++||||++++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 92 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHL-------KGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLY 92 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETG-------GGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred cchhheeeeeeecccCCeeEEEEEEecc-------CcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEE
Confidence 3567899999999999999999976410 112456899999997543 23457799999999999999999999
Q ss_pred eEeecCCceEEEEEeeccCCcc----------------------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 041702 590 GCCIEQGEKISIYEFDIVTDPA----------------------------RKDLLDWTTRVRIIEGVAQGLLYLHQYSRL 641 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~~~~----------------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~ 641 (840)
+++.+.+..++||||....... ....+++.++++++.||+.||+|||+.+
T Consensus 93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-- 170 (314)
T 2ivs_A 93 GACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK-- 170 (314)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred EEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 9999999999999994321110 1234889999999999999999999998
Q ss_pred ceecCCCCCCcEEecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-C
Q 041702 642 RVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-S 720 (840)
Q Consensus 642 ~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G 720 (840)
|+||||||+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||++++||++ |
T Consensus 171 -ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 249 (314)
T 2ivs_A 171 -LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 249 (314)
T ss_dssp -EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred -CcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999988755443333444567889999999999999999999999999999999 9
Q ss_pred CCCCCCCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccC
Q 041702 721 KKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVN 798 (840)
Q Consensus 721 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~ 798 (840)
+.|+....... .. ........ . .........+.+++.+||+.||++||++.+|++.|+++..+
T Consensus 250 ~~p~~~~~~~~--~~----~~~~~~~~-----~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 250 GNPYPGIPPER--LF----NLLKTGHR-----M----ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp CCSSTTCCGGG--HH----HHHHTTCC-----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCCCCHHH--HH----HHhhcCCc-----C----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 99886433221 11 11111110 0 11112345688999999999999999999999999987543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=342.36 Aligned_cols=254 Identities=24% Similarity=0.360 Sum_probs=196.0
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCc----eEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccc
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGE----EVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVR 587 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~----~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~ 587 (840)
.++|+..+.||+|+||.||+|.++ .+++ .||+|.+.... ....+++.+|+.++.+++||||++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~------------~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 79 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWI------------PEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEEC------------CTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCC
T ss_pred HhHceeeeeeeecCCceEEEEEEc------------CCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCe
Confidence 367889999999999999999765 3344 48888886443 344567889999999999999999
Q ss_pred eeeEeecCCceEEEEEeeccCCcc-----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCce
Q 041702 588 LFGCCIEQGEKISIYEFDIVTDPA-----RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPK 662 (840)
Q Consensus 588 l~g~~~~~~~~~lv~e~~~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 662 (840)
+++++. .+..++|+||....... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 80 ~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~k 155 (325)
T 3kex_A 80 LLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQ 155 (325)
T ss_dssp EEEEEC-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEE
T ss_pred EEEEEc-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEE
Confidence 999986 56788999985432221 1346889999999999999999999998 99999999999999999999
Q ss_pred eeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhh
Q 041702 663 ISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNL 741 (840)
Q Consensus 663 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~ 741 (840)
|+|||+++.+.............+|..|+|||.+.+..++.++||||||+++|||++ |+.|+....... ....
T Consensus 156 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~---- 229 (325)
T 3kex_A 156 VADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE--VPDL---- 229 (325)
T ss_dssp ECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH--HHHH----
T ss_pred ECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH--HHHH----
Confidence 999999998765544444455678889999999999999999999999999999999 999986543222 1111
Q ss_pred hcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 742 WKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 742 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
..... ....+.. ....+.+++.+||+.||++||++.+|++.|+.+..
T Consensus 230 ~~~~~--~~~~~~~-------~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 230 LEKGE--RLAQPQI-------CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp HHTTC--BCCCCTT-------BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred HHcCC--CCCCCCc-------CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11110 0111111 12246788999999999999999999999988643
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=340.99 Aligned_cols=244 Identities=21% Similarity=0.312 Sum_probs=196.2
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhcCCCCcccee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
.++|.+.+.||+|+||.||+|.+. .+++.||||++... .....+.+.+|+.+++.++||||++++
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~ 75 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHY------------KTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEET------------TTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEEC------------CCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 468999999999999999999765 67899999998643 223456899999999999999999999
Q ss_pred eEeecCCceEEEEEeec---cCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 590 GCCIEQGEKISIYEFDI---VTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~---~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
+++...+..++||||.. .........+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 76 ~~~~~~~~~~lv~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DF 152 (336)
T 3h4j_B 76 DVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADF 152 (336)
T ss_dssp EEEECSSEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCS
T ss_pred EEEEeCCEEEEEEECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEe
Confidence 99999999999999941 111223467899999999999999999999998 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLF-SIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
|++........ .....||+.|+|||.+.+..+ +.++|||||||+++||++|+.||.........
T Consensus 153 G~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~------------ 217 (336)
T 3h4j_B 153 GLSNIMTDGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF------------ 217 (336)
T ss_dssp SCTBTTTTSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB------------
T ss_pred ccceeccCCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH------------
Confidence 99987644322 234579999999999988776 78999999999999999999998653322211
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
..+.... ...+......+.+++.+||+.||.+|||++|+++
T Consensus 218 ---~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 218 ---KKVNSCV-YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp ---CCCCSSC-CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred ---HHHHcCC-CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 0000000 0011122345788999999999999999999985
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=340.97 Aligned_cols=245 Identities=20% Similarity=0.264 Sum_probs=197.7
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhcCCCCcccee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
.++|+..+.||+|+||.||+|+++ .+++.||||++++. .....+.+.+|++++.+++||||++++
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~ 71 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREK------------ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET------------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEEC------------CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceE
Confidence 367999999999999999999765 67899999999754 345667899999999999999999999
Q ss_pred eEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 590 GCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
+++...+..++||||..... ......+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 72 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~D 148 (337)
T 1o6l_A 72 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITD 148 (337)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECC
T ss_pred EEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEee
Confidence 99999999999999953322 223457899999999999999999999998 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
||+++...... .......||+.|+|||.+.+..++.++|||||||+++||++|+.||..... ..+. ......
T Consensus 149 FG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~----~~i~~~ 220 (337)
T 1o6l_A 149 FGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLF----ELILME 220 (337)
T ss_dssp CTTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH----HHHHHC
T ss_pred ccchhhcccCC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH--HHHH----HHHHcC
Confidence 99998643222 123456799999999999999999999999999999999999999854321 1111 111111
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRP-----TMLEVVA 790 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 790 (840)
. ... +......+.+++.+||+.||++|| +++||++
T Consensus 221 ~------~~~----p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 221 E------IRF----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp C------CCC----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred C------CCC----CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 0 011 112234578899999999999999 8999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=340.53 Aligned_cols=264 Identities=26% Similarity=0.377 Sum_probs=206.1
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhc-CCCCcccee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKL-QHRNLVRLF 589 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l-~H~niv~l~ 589 (840)
..++|+..+.||+|+||.||+|.+... ....+++.||||++..... ...+.+.+|+.++.++ +||||++++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 93 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGL-------IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLL 93 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESS-------SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeec-------cccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEE
Confidence 457899999999999999999975300 1235678999999976533 3457799999999999 999999999
Q ss_pred eEeecCCceEEEEEeeccCCc----------------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCC
Q 041702 590 GCCIEQGEKISIYEFDIVTDP----------------------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRD 647 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~~~----------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrD 647 (840)
+++...+..++||||...... .....+++..+++++.||+.||+|||+.+ |+|||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~d 170 (313)
T 1t46_A 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRD 170 (313)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCC
Confidence 999999999999999421110 11225899999999999999999999998 99999
Q ss_pred CCCCcEEecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCC
Q 041702 648 LKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRF 726 (840)
Q Consensus 648 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~ 726 (840)
|||+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||++++||++ |+.|+..
T Consensus 171 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 250 (313)
T 1t46_A 171 LAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250 (313)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred CccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 999999999999999999999988765443333445567889999999999999999999999999999999 9988865
Q ss_pred CCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCC
Q 041702 727 YNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNL 799 (840)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~ 799 (840)
...... .. ...... . .. .........+.+++.+||+.||++|||+.||++.|++.+.+.
T Consensus 251 ~~~~~~-~~----~~~~~~-~----~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 251 MPVDSK-FY----KMIKEG-F----RM----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp CCSSHH-HH----HHHHHT-C----CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred ccchhH-HH----HHhccC-C----CC----CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 432211 11 111110 0 00 011122346788999999999999999999999999876554
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=331.44 Aligned_cols=252 Identities=28% Similarity=0.427 Sum_probs=200.2
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
.++|+..+.||+|+||.||+|.+. +++.||||++... ....+++.+|++++.+++||||+++++++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-------------~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 74 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-------------NKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVC 74 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-------------TTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhhceeeheecCCCccEEEEEEec-------------CCCeEEEEEeccc-ccCHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 467899999999999999998653 5778999999864 33457899999999999999999999999
Q ss_pred ecCCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 593 IEQGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
.+.+..++||||...... .....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg 151 (269)
T 4hcu_A 75 LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFG 151 (269)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTT
T ss_pred ecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccc
Confidence 999999999999533221 12345899999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhcccc
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKDDK 746 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 746 (840)
+++....... .......+|+.|+|||.+.+..++.++||||||++++||++ |+.|+...... ..... ....
T Consensus 152 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~--~~~~~----~~~~- 223 (269)
T 4hcu_A 152 MTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVED----ISTG- 223 (269)
T ss_dssp GGGGBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHH----HHTT-
T ss_pred cccccccccc-ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH--HHHHH----HhcC-
Confidence 9987643321 22234456788999999999999999999999999999999 89887543211 11111 1111
Q ss_pred cccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 747 AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 747 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
.....+. .....+.+++.+||+.||++|||++|+++.|+++.+
T Consensus 224 -~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 224 -FRLYKPR-------LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp -CCCCCCT-------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -ccCCCCC-------cCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 0111111 123457889999999999999999999999998743
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=331.56 Aligned_cols=251 Identities=29% Similarity=0.444 Sum_probs=188.1
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC----CcCHHHHHHHHHHHhhcCCCCccce
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS----GQGLEEFKNEMMLIAKLQHRNLVRL 588 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~----~~~~~~f~~Ev~~l~~l~H~niv~l 588 (840)
.++|+..+.||+|+||.||+|.+ .++.||||+++... ....+.+.+|++++++++||||+++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~--------------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 71 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW--------------IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE--------------TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred hhheeeeeeeccCCCeEEEEEEE--------------cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 46889999999999999999863 37889999987542 2345789999999999999999999
Q ss_pred eeEeecCCceEEEEEeecc---CCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecC--------
Q 041702 589 FGCCIEQGEKISIYEFDIV---TDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS-------- 657 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~~~~---~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-------- 657 (840)
++++.+.+..++||||... ........+++..+..++.|++.||+|||+.+..+|+||||||+|||++.
T Consensus 72 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~ 151 (271)
T 3dtc_A 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLS 151 (271)
T ss_dssp EEEECCC--CEEEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCS
T ss_pred EEEEecCCceEEEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccccccc
Confidence 9999999999999999422 12223457899999999999999999999987666999999999999986
Q ss_pred CCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHH
Q 041702 658 DMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGH 737 (840)
Q Consensus 658 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~ 737 (840)
++.+||+|||++....... .....||+.|+|||.+.+..++.++||||||++++||++|+.|+....... .
T Consensus 152 ~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~ 222 (271)
T 3dtc_A 152 NKILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA-----V 222 (271)
T ss_dssp SCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH-----H
T ss_pred CcceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----H
Confidence 6789999999998654322 223568999999999999999999999999999999999999986432111 1
Q ss_pred HhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 738 AWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 738 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
........ . .. .........+.+++.+||+.||++|||+.|+++.|+++
T Consensus 223 ~~~~~~~~-~----~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 223 AYGVAMNK-L----AL----PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HHHHHTSC-C----CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred HHhhhcCC-C----CC----CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 11111110 0 01 11112234688999999999999999999999999863
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=337.56 Aligned_cols=249 Identities=22% Similarity=0.315 Sum_probs=198.2
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC------cCHHHHHHHHHHHhhcCCCCc
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG------QGLEEFKNEMMLIAKLQHRNL 585 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~------~~~~~f~~Ev~~l~~l~H~ni 585 (840)
..++|...+.||+|+||.||+|.++ .+++.||||++..... ...+++.+|+.++.+++||||
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~------------~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i 76 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREK------------STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEET------------TTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTB
T ss_pred cccceEeceEEeeCCCeEEEEEEEC------------CCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCC
Confidence 3467899999999999999999765 6789999999875432 246789999999999999999
Q ss_pred cceeeEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCC--
Q 041702 586 VRLFGCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDM-- 659 (840)
Q Consensus 586 v~l~g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-- 659 (840)
+++++++.+.+..++||||..... ......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 77 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~ 153 (326)
T 2y0a_A 77 ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVP 153 (326)
T ss_dssp CCEEEEEECSSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSS
T ss_pred CcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCC
Confidence 999999999999999999943222 123456899999999999999999999998 99999999999999887
Q ss_pred --CceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHH
Q 041702 660 --NPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGH 737 (840)
Q Consensus 660 --~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~ 737 (840)
.+||+|||+++...... ......||+.|+|||.+.+..++.++|||||||+++||++|+.||...... .....
T Consensus 154 ~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~ 228 (326)
T 2y0a_A 154 KPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLAN 228 (326)
T ss_dssp SCCEEECCCTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHH
T ss_pred CCCEEEEECCCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--HHHHH
Confidence 79999999998875332 223457999999999999999999999999999999999999998543211 11111
Q ss_pred HhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 738 AWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 738 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
. ... ...............+.+++.+||+.||++|||+.|+++
T Consensus 229 ~----~~~------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 229 V----SAV------NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp H----HHT------CCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred H----Hhc------CCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 000 011111111223456789999999999999999999986
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=317.35 Aligned_cols=217 Identities=13% Similarity=0.146 Sum_probs=170.3
Q ss_pred cccCcCCCCcccCCCCeEEcCCCeEEEEEecCCCCCceEEEEeeecCCCcEEEeecCCCCCCCCCceEEEecCCceEEec
Q 041702 23 LAADSITPATFIRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKKSPDTVVWVANRNCPILDPHGILAINNNGNLVLLN 102 (840)
Q Consensus 23 ~~~~~~~~~~~l~~~~~l~S~~g~F~~gFf~~~~~~~~~lgiw~~~~~~tvVW~ANr~~p~~~~~~~l~~~~~G~L~l~~ 102 (840)
++.|+|.+|++|.+|++| ++|.|+|||+.+++ +.+ |.. +|+||+|||+.| ++++|+|+.||||||+|
T Consensus 6 ~~~~~i~~g~~L~~g~~l--~~g~f~l~f~~~gn-----l~l-y~~--~~~vW~an~~~~---~~~~l~l~~dGnLvl~d 72 (236)
T 1dlp_A 6 GLSHEGSHPQTLHAAQSL--ELSSFRFTMQSDCN-----LVL-FDS--DVRVWASNTAGA---TGCRAVLQSDGLLVILT 72 (236)
T ss_dssp CSSSSSCSCSCCCTTCEE--CSTTEEEEECTTSC-----EEE-EES--SSEEECCCCCSC---SCCBCCBCSSSCBCCBC
T ss_pred eccceeCCCCEECCCCEE--EcCCEEEEECCCCc-----EEE-EEC--CEEEEECCCCCC---CCeEEEEcCCCcEEEEc
Confidence 577999999999999999 59999999997765 233 433 799999999988 57899999999999999
Q ss_pred CCCceEEEecCCCCCCCceEEEecCCCeEEEeccCCCCCCCceeEEecCCCCCcc-cCCCcccccc-ccCC-----ceeE
Q 041702 103 QANGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSEGSYLWQSFDFPSDTL-LPGMKVGWDL-KTGR-----ERYL 175 (840)
Q Consensus 103 ~~~~~~Wss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~~lWqSFd~PtDtl-Lpg~~l~~~~-~tg~-----~~~l 175 (840)
++|.+||+|++........|+|+|+|||||++. ++||||||||||+ |||| +.|. .+|+ ++.|
T Consensus 73 ~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~~---------~~W~S~~~p~~t~~lp~~--g~d~L~~gq~~~~~~~~L 141 (236)
T 1dlp_A 73 AQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGP---------GLWDSGTSNKGSVVVANN--GNSILYSTQGNDNHPQTL 141 (236)
T ss_dssp TTTCCSCCCCCCCCSSCCEEEECSSSCEEEECS---------EEEECSCCCSSCCCCSSC--CCEECCCC--CCCCCCEE
T ss_pred CCCcEEEeCCccccCCcEEEEEeCCCCEEEecC---------CEEECCCCCCcccccCCc--cceEEecCCcCCCccceE
Confidence 999999999986544456799999999999961 6999999999888 6775 5565 5665 5677
Q ss_pred EEeccCCCCCCCceEEeecCCCCcEEEEEcCCeeeEEeCCCCCceeccCCceeeceeEEEEEecCCcEEEEEEecCCcee
Q 041702 176 TSWRTADDPSPGKFTYRLDIHVLPQIFLYKGSLKLARIGPWNGFIFEDGPTFIDYLYKIILVDTEDEIYYRYESYNNLSI 255 (840)
Q Consensus 176 ~S~~s~~dps~G~~~l~~~~~~~~~~~~~~~~~~~~~~g~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (840)
+| .+||++|.|++.++++| +++++++..+||++++|++. +...+.+.....-+.+..+.++.++.|..... ..
T Consensus 142 ~s---~~d~s~G~~~l~l~~dG--~LvL~~~~~~~W~s~~~~~~-~~~~~~L~~~Gnl~ly~~~~~~vw~s~~~~~~-~~ 214 (236)
T 1dlp_A 142 HA---TQSLQLSPYRLSMETDC--NLVLFDRDDRVWSTNTAGKG-TGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSA-GR 214 (236)
T ss_dssp CS---SCCCBCSSCEEEEETTT--EEEEEBTTBCCSCCCCCSSC-SSCEEEEETTTEEEEEETTTEEEEECCCCCSS-SC
T ss_pred Ec---CcEeecCcEEEEECCCC--cEEEEcCCEeEEeCCCcCCC-CceEEEECCCCcEEEEeCCCcEEEEeCCCCCC-CC
Confidence 74 78999999999999999 67788888999999999754 55555655332222222233445555544433 46
Q ss_pred EEEEEccCCcEEEEE
Q 041702 256 MMLKINPLGKIQRLL 270 (840)
Q Consensus 256 ~~l~l~~~G~l~~y~ 270 (840)
+|++|+.||++++|.
T Consensus 215 ~rl~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 215 YVFVLQPDRNLAIYG 229 (236)
T ss_dssp CEEEECSSSCEEEEC
T ss_pred EEEEEcCCCcEEEeC
Confidence 899999999999984
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=341.07 Aligned_cols=242 Identities=23% Similarity=0.270 Sum_probs=187.9
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC--cCHHHHHHHHHHHhhc-CCCCcccee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG--QGLEEFKNEMMLIAKL-QHRNLVRLF 589 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~--~~~~~f~~Ev~~l~~l-~H~niv~l~ 589 (840)
.++|+..++||+|+||+||+|.++ .+++.||||++..... ....++..|+..+.++ +||||++++
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~------------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~ 123 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSK------------EDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEET------------TTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhheeeeheeccCCCeEEEEEEEC------------CCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEE
Confidence 367999999999999999999765 6799999999865432 2334566677666666 899999999
Q ss_pred eEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 590 GCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
++|.+.+..++|||+..... ......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 124 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~D 200 (311)
T 3p1a_A 124 QAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGD 200 (311)
T ss_dssp EEEEETTEEEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECC
T ss_pred EEEEeCCEEEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEcc
Confidence 99999999999999952110 112346999999999999999999999988 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
||++....... ......||+.|+|||++.+ .++.++|||||||+++||++|..++... . .+.....
T Consensus 201 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~-----~----~~~~~~~- 266 (311)
T 3p1a_A 201 FGLLVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG-----E----GWQQLRQ- 266 (311)
T ss_dssp CTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH-----H----HHHHHTT-
T ss_pred ceeeeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc-----c----HHHHHhc-
Confidence 99998764332 2234568999999998876 7999999999999999999997765321 0 1111111
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
..............+.+++.+||+.||++|||++|+++
T Consensus 267 -------~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 267 -------GYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp -------TCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -------cCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11111222234567889999999999999999999986
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=338.25 Aligned_cols=246 Identities=24% Similarity=0.359 Sum_probs=189.4
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
.++|+..+.||+|+||.||+|+++ .+++.||||+++... ....+.+.+|++++++++||||++++++
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~------------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 72 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNK------------VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEET------------TTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEE
T ss_pred hhcCceeeEecCCCCeEEEEEEEc------------CCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 467899999999999999999765 578999999997543 3345789999999999999999999999
Q ss_pred eecCCc---------------------------------------------------------eEEEEEeeccCC-----
Q 041702 592 CIEQGE---------------------------------------------------------KISIYEFDIVTD----- 609 (840)
Q Consensus 592 ~~~~~~---------------------------------------------------------~~lv~e~~~~~~----- 609 (840)
+.+.+. .+++|||.....
T Consensus 73 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 152 (332)
T 3qd2_B 73 WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWM 152 (332)
T ss_dssp EEECCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHH
T ss_pred EEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHH
Confidence 876543 789999843222
Q ss_pred --ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceecCCCCcc---------
Q 041702 610 --PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQ--------- 678 (840)
Q Consensus 610 --~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~--------- 678 (840)
.......++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 153 ~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~ 229 (332)
T 3qd2_B 153 NRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 229 (332)
T ss_dssp HTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC------------
T ss_pred hcccCccchhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccc
Confidence 122234567778999999999999999998 999999999999999999999999999887544211
Q ss_pred -cccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccccccCccccc
Q 041702 679 -SNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQN 757 (840)
Q Consensus 679 -~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 757 (840)
.......||+.|+|||.+.+..++.++||||||++++||++|..|+. ... ....... . ...+
T Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~-------~~~-~~~~~~~--------~-~~~~ 292 (332)
T 3qd2_B 230 YATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-------ERV-RIITDVR--------N-LKFP 292 (332)
T ss_dssp --CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH-------HHH-HHHHHHH--------T-TCCC
T ss_pred cccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh-------HHH-HHHHHhh--------c-cCCC
Confidence 12234579999999999999999999999999999999999876531 000 0000000 0 0112
Q ss_pred hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 758 EALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 758 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.........+.+++.+||+.||++|||++|+++
T Consensus 293 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 293 LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred cccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 223344556789999999999999999999986
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=342.76 Aligned_cols=254 Identities=25% Similarity=0.377 Sum_probs=190.3
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCc----eEEEEEeccC-CCcCHHHHHHHHHHHhhcCCCCccc
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGE----EVAVKRLSSK-SGQGLEEFKNEMMLIAKLQHRNLVR 587 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~----~VAvK~l~~~-~~~~~~~f~~Ev~~l~~l~H~niv~ 587 (840)
.++|+..++||+|+||.||+|.++ .+++ .||+|.+... .....+++.+|+.++.+++||||++
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~------------~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~ 81 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWI------------PEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEEC------------CTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCC
T ss_pred HhHceEEEEeeeCCCeEEEEEEEc------------CCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeE
Confidence 468999999999999999999765 3344 4688887644 3456788999999999999999999
Q ss_pred eeeEeecCCceEEEEEeeccCCcc-----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCce
Q 041702 588 LFGCCIEQGEKISIYEFDIVTDPA-----RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPK 662 (840)
Q Consensus 588 l~g~~~~~~~~~lv~e~~~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 662 (840)
+++++...+ .++++|+....... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 82 ~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~k 157 (327)
T 3lzb_A 82 LLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVK 157 (327)
T ss_dssp CCEEEESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEE
T ss_pred EEEEEecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEE
Confidence 999998765 67777774332211 2356899999999999999999999998 99999999999999999999
Q ss_pred eeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhh
Q 041702 663 ISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNL 741 (840)
Q Consensus 663 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~ 741 (840)
|+|||+++...............+|+.|+|||.+.+..++.++||||||++++||++ |+.|+....... ... .
T Consensus 158 L~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~----~ 231 (327)
T 3lzb_A 158 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISS----I 231 (327)
T ss_dssp ECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHH----H
T ss_pred EccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHH----H
Confidence 999999987754443333444557889999999999999999999999999999999 999986443222 111 1
Q ss_pred hcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 742 WKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 742 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
..... ...........+.+++.+||+.||++||++.|+++.|+++..
T Consensus 232 ~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 232 LEKGE---------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HHTTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred HHcCC---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11110 001111223457889999999999999999999999998754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=344.14 Aligned_cols=250 Identities=24% Similarity=0.348 Sum_probs=187.5
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCC--CCccc
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQH--RNLVR 587 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H--~niv~ 587 (840)
..++|++.+.||+|+||.||+|.+. +++.||||++.... ....+.|.+|+.+|.+++| |||++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~-------------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~ 73 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNE-------------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 73 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECT-------------TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCC
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeC-------------CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEE
Confidence 3567999999999999999998643 58899999987542 2345779999999999976 99999
Q ss_pred eeeEeecCCceEEEEEee---ccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 588 LFGCCIEQGEKISIYEFD---IVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 588 l~g~~~~~~~~~lv~e~~---~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
+++++...+..++|||+. +.........+++.++..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~ 149 (343)
T 3dbq_A 74 LYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLI 149 (343)
T ss_dssp EEEEEECSSEEEEEECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEEC
T ss_pred EeeeEeeCCEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEe
Confidence 999999999999999972 1112233457899999999999999999999998 99999999999996 6789999
Q ss_pred ccccceecCCCCcccccccccccccccCcccccc-----------CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc
Q 041702 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH-----------GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLT 733 (840)
Q Consensus 665 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~ 733 (840)
|||+++.+.............||+.|+|||++.+ ..++.++|||||||+++||++|+.||......
T Consensus 150 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--- 226 (343)
T 3dbq_A 150 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--- 226 (343)
T ss_dssp CCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH---
T ss_pred ecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH---
Confidence 9999987755443333445679999999999865 67899999999999999999999998532211
Q ss_pred HhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 734 LLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
....... +++......+......+.+++.+||+.||++|||+.|+++.
T Consensus 227 -~~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 227 -ISKLHAI---------IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp -HHHHHHH---------HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -HHHHHHH---------hcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1111111 11111111111112457889999999999999999999853
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=331.32 Aligned_cols=264 Identities=20% Similarity=0.269 Sum_probs=203.4
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
.++|.+.++||+|+||.||+|.++ .+++.||||++.... ....+.+.+|++++++++||||++++++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 75 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHK------------KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEET------------TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEEC------------CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEE
Confidence 367899999999999999999765 578999999997543 3456789999999999999999999999
Q ss_pred eecCC--ceEEEEEeeccCC-------ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEe----cCC
Q 041702 592 CIEQG--EKISIYEFDIVTD-------PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLL----DSD 658 (840)
Q Consensus 592 ~~~~~--~~~lv~e~~~~~~-------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl----~~~ 658 (840)
+...+ ..++||||..... ......+++.+++.++.||+.||+|||+.+ |+||||||+|||+ +.+
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~ 152 (319)
T 4euu_A 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQ 152 (319)
T ss_dssp EECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSC
T ss_pred eecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCC
Confidence 98765 6789999843221 122234899999999999999999999998 9999999999999 788
Q ss_pred CCceeeccccceecCCCCcccccccccccccccCccccc--------cCCCCccccchhHHHHHHHHHhCCCCCCCCCCC
Q 041702 659 MNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYAL--------HGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTD 730 (840)
Q Consensus 659 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~ 730 (840)
+.+||+|||+++....... .....||+.|+|||.+. +..++.++|||||||++|||++|+.||......
T Consensus 153 ~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 229 (319)
T 4euu_A 153 SVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229 (319)
T ss_dssp EEEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCG
T ss_pred ceEEEccCCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc
Confidence 8899999999988754332 23456899999999886 578999999999999999999999998654332
Q ss_pred CccHhHHHhhhhcccc---cc---ccc--------CccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 731 SLTLLGHAWNLWKDDK---AW---KLM--------DPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 731 ~~~~~~~~~~~~~~~~---~~---~~~--------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
.... ........... .. ... +..............+.+++.+||+.||++|||++|+++...+.
T Consensus 230 ~~~~-~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 230 RRNK-EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp GGCH-HHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred chhH-HHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 2111 11111111100 00 000 00111133456677889999999999999999999999998875
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=326.81 Aligned_cols=251 Identities=25% Similarity=0.475 Sum_probs=195.6
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCc-------CHHHHHHHHHHHhhcCCCCc
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQ-------GLEEFKNEMMLIAKLQHRNL 585 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~-------~~~~f~~Ev~~l~~l~H~ni 585 (840)
.++|+..+.||+|+||.||+|.++ .+++.||||++...... ..++|.+|+.++.+++||||
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 85 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLV------------KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEET------------TTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTB
T ss_pred hccceehhccccCCceeEEEEEEc------------CCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCc
Confidence 478999999999999999999765 57899999998754322 22679999999999999999
Q ss_pred cceeeEeecCCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCC
Q 041702 586 VRLFGCCIEQGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMN 660 (840)
Q Consensus 586 v~l~g~~~~~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~ 660 (840)
+++++++.+.. ++||||...... .....+++..+..++.|++.||+|||+.+ .+|+||||||+|||++.++.
T Consensus 86 ~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~ 162 (287)
T 4f0f_A 86 VKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDE 162 (287)
T ss_dssp CCEEEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCT
T ss_pred hhhheeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCC
Confidence 99999986654 789999532221 23456899999999999999999999875 34999999999999988876
Q ss_pred -----ceeeccccceecCCCCcccccccccccccccCccccc--cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc
Q 041702 661 -----PKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYAL--HGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLT 733 (840)
Q Consensus 661 -----~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~ 733 (840)
+||+|||+++.... ......||+.|+|||.+. ...++.++||||||++++||++|+.||.........
T Consensus 163 ~~~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 237 (287)
T 4f0f_A 163 NAPVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK 237 (287)
T ss_dssp TCSCCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH
T ss_pred CCceeEEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH
Confidence 99999999975432 233457899999999983 556889999999999999999999998654433222
Q ss_pred HhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 734 LLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
...... ... ..+.. .......+.+++.+||+.||++|||++||++.|+++
T Consensus 238 ~~~~~~----~~~----~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 238 FINMIR----EEG----LRPTI----PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHHHH----HSC----CCCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HHHHHh----ccC----CCCCC----CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 111111 111 11111 122345688999999999999999999999999863
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=344.38 Aligned_cols=266 Identities=27% Similarity=0.395 Sum_probs=202.8
Q ss_pred HHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhc-CCCCccce
Q 041702 511 AATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKL-QHRNLVRL 588 (840)
Q Consensus 511 ~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l-~H~niv~l 588 (840)
...++|...+.||+|+||.||+|.+.. .....++..||||++.... ....+.+.+|+.++.++ +||||+++
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 114 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYG-------ISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNL 114 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEES-------CSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cCHHHceeeeeecCCCCceeEEeeeec-------cccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence 356889999999999999999997641 0123467789999997542 34567899999999999 89999999
Q ss_pred eeEeecCCceEEEEEeeccCCcc---------------------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 041702 589 FGCCIEQGEKISIYEFDIVTDPA---------------------------RKDLLDWTTRVRIIEGVAQGLLYLHQYSRL 641 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~~~~~~~~---------------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~ 641 (840)
++++...+..++||||....... ....+++..++.++.||+.||+|||+.+
T Consensus 115 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-- 192 (344)
T 1rjb_A 115 LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-- 192 (344)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred EEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 99999999999999984221110 1134789999999999999999999998
Q ss_pred ceecCCCCCCcEEecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-C
Q 041702 642 RVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-S 720 (840)
Q Consensus 642 ~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G 720 (840)
|+||||||+|||++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||++++||+| |
T Consensus 193 -ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 271 (344)
T 1rjb_A 193 -CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 271 (344)
T ss_dssp -EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred -cccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCC
Confidence 99999999999999999999999999987654443333445667889999999999999999999999999999998 9
Q ss_pred CCCCCCCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCCC
Q 041702 721 KKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLP 800 (840)
Q Consensus 721 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~~ 800 (840)
+.|+....... ... ....... .. ..+......+.+++.+||+.||++|||+.+|++.|+......+
T Consensus 272 ~~p~~~~~~~~-~~~----~~~~~~~-----~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 272 VNPYPGIPVDA-NFY----KLIQNGF-----KM----DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp CCSSTTCCCSH-HHH----HHHHTTC-----CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred CCCcccCCcHH-HHH----HHHhcCC-----CC----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 99986543221 111 1111110 00 1111224568889999999999999999999999999866543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=334.44 Aligned_cols=259 Identities=25% Similarity=0.438 Sum_probs=194.9
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
.++|+..+.||+|+||.||+|.+ .++.||||++... ...+.|.+|++++++++||||+++++++
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~--------------~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 70 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW--------------RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGAC 70 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--------------TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBC
T ss_pred HhHeeeeeEeecCCCceEEEEEE--------------CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence 36788899999999999999863 3678999999643 3457899999999999999999999998
Q ss_pred ecCCceEEEEEeeccCC-------ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCC-ceee
Q 041702 593 IEQGEKISIYEFDIVTD-------PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMN-PKIS 664 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~-------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~-~kL~ 664 (840)
. +..++||||..... ......+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+
T Consensus 71 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~ 148 (307)
T 2eva_A 71 L--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKIC 148 (307)
T ss_dssp T--TTTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEEC
T ss_pred c--CCcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEc
Confidence 7 45899999943221 112234788899999999999999999943234999999999999998887 7999
Q ss_pred ccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 665 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
|||++...... .....||+.|+|||.+.+..++.++||||||++++||++|+.|+.......... .+.....
T Consensus 149 Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~---~~~~~~~ 220 (307)
T 2eva_A 149 DFGTACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI---MWAVHNG 220 (307)
T ss_dssp CCCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHH---HHHHHTT
T ss_pred ccccccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHH---HHHHhcC
Confidence 99999765322 223468999999999999999999999999999999999999986433221111 1111111
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCCCCCCCCCC
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSPHQPAF 807 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~p~~p~~ 807 (840)
. .+.. .......+.+++.+||+.||++|||+++|++.|+.+....+.+..|..
T Consensus 221 -~-----~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~~ 273 (307)
T 2eva_A 221 -T-----RPPL----IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQ 273 (307)
T ss_dssp -C-----CCCC----BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCCC
T ss_pred -C-----CCCc----ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCccc
Confidence 0 0111 112234578899999999999999999999999998777776666653
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=328.19 Aligned_cols=253 Identities=25% Similarity=0.378 Sum_probs=200.9
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
..++|+..+.||+|+||.||+|.++ ++..||||+++... ...+++.+|++++.+++||||++++++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-------------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~ 71 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-------------GQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGV 71 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-------------TTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred chhheeeeeeeccCCCceEEEEEec-------------CceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 3578899999999999999998643 56789999997643 345789999999999999999999999
Q ss_pred eecCCceEEEEEeeccCCcc-----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 592 CIEQGEKISIYEFDIVTDPA-----RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
+.+.+..++|||+....... ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 72 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Df 148 (268)
T 3sxs_A 72 CSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDF 148 (268)
T ss_dssp ECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCT
T ss_pred EccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccC
Confidence 99999999999995332211 2345899999999999999999999998 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
|++......... ......+|+.|+|||.+.+..++.++||||||++++||++ |+.|+....... .. ... ...
T Consensus 149 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~---~~~-~~~ 221 (268)
T 3sxs_A 149 GMTRYVLDDQYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE--VV---LKV-SQG 221 (268)
T ss_dssp TCEEECCTTCEE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HH---HHH-HTT
T ss_pred ccceecchhhhh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH--HH---HHH-HcC
Confidence 999876544322 2233456778999999999899999999999999999999 998875432211 11 111 110
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
.....+.. ....+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 222 --~~~~~~~~-------~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 222 --HRLYRPHL-------ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp --CCCCCCTT-------SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred --CCCCCCCc-------ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 01111111 13457889999999999999999999999998743
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=345.86 Aligned_cols=280 Identities=22% Similarity=0.275 Sum_probs=203.5
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
.++|+..+.||+|+||.||+|.++ .....+++.||||++........+.+.+|++++++++||||+++++++
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 93 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYD--------PLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVS 93 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEC--------TTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEec--------cCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEE
Confidence 368899999999999999998632 012367899999999876655667899999999999999999999998
Q ss_pred e--cCCceEEEEEeeccCCcc-----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 593 I--EQGEKISIYEFDIVTDPA-----RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 593 ~--~~~~~~lv~e~~~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
. +.+..++||||....... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~D 170 (327)
T 3lxl_A 94 YGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIAD 170 (327)
T ss_dssp ECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECC
T ss_pred ecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcc
Confidence 7 456688999985322211 1345899999999999999999999998 99999999999999999999999
Q ss_pred cccceecCCCCcc-cccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 666 FGIARTFGGDEMQ-SNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 666 FGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
||++......... .......+|+.|+|||.+.+..++.++||||||++++||++|+.|+....................
T Consensus 171 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 250 (327)
T 3lxl_A 171 FGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL 250 (327)
T ss_dssp GGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHH
T ss_pred cccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccH
Confidence 9999887543322 223345678899999999999999999999999999999999998753221100000000000000
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCCCCCC
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSPH 803 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~p~ 803 (840)
......+...............+.+++.+||+.||++|||++||++.|+.++.......
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 309 (327)
T 3lxl_A 251 SRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCE 309 (327)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--------
T ss_pred HHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCcc
Confidence 00000111111111122334568899999999999999999999999998866554333
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=354.90 Aligned_cols=260 Identities=27% Similarity=0.413 Sum_probs=199.2
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
..++|+..++||+|+||.||+|.++ ++..||||+++... ...++|.+|+++|++++||||++++++
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~-------------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~ 247 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWN-------------GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV 247 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-------------TTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ChhHceeeeeecCCCCeEEEEEEEC-------------CCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 4577899999999999999998654 45679999998643 456789999999999999999999999
Q ss_pred eecCCceEEEEEeeccCCc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 592 CIEQGEKISIYEFDIVTDP------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
+.+ +..++||||...... .....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 248 ~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~D 323 (452)
T 1fmk_A 248 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVAD 323 (452)
T ss_dssp ECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECC
T ss_pred EcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECC
Confidence 876 778999999533221 12345899999999999999999999998 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
||+++....... .......++..|+|||.+.+..++.++|||||||+||||++ |+.|+...... .... ....
T Consensus 324 fG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--~~~~----~i~~ 396 (452)
T 1fmk_A 324 FGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLD----QVER 396 (452)
T ss_dssp CCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHH----HHHT
T ss_pred CccceecCCCce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH--HHHH----HHHc
Confidence 999987654322 12223456789999999999999999999999999999999 89887643211 1111 1111
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCCCCCCCC
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSPHQP 805 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~p~~p 805 (840)
. ... ..+...+..+.+++.+||+.||++|||+++|++.|+......+++.+|
T Consensus 397 ~--~~~-------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~~~ 448 (452)
T 1fmk_A 397 G--YRM-------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 448 (452)
T ss_dssp T--CCC-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred C--CCC-------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCccccc
Confidence 1 000 111223456888999999999999999999999999987766555444
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=335.47 Aligned_cols=259 Identities=24% Similarity=0.358 Sum_probs=182.5
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
.++|+..++||+|+||.||+|.++ .+++.||||+++... ....+.+.+|++++++++||||++++++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 71 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNK------------TTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDV 71 (317)
T ss_dssp ---------------CEEEEEECS------------SSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEEC------------CCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEE
Confidence 467899999999999999999765 578999999997543 3345789999999999999999999999
Q ss_pred eecCCceEEEEEeeccC---------CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCce
Q 041702 592 CIEQGEKISIYEFDIVT---------DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPK 662 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~---------~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 662 (840)
+...+..++||||.... .......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 72 ~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~k 148 (317)
T 2pmi_A 72 IHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLK 148 (317)
T ss_dssp ECCTTEEEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEE
T ss_pred EEECCeEEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEE
Confidence 99999999999994311 0111245889999999999999999999998 99999999999999999999
Q ss_pred eeccccceecCCCCcccccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhh
Q 041702 663 ISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNL 741 (840)
Q Consensus 663 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~ 741 (840)
|+|||+++...... .......+|+.|+|||.+.+ ..++.++|||||||+++||++|+.||......+ ........
T Consensus 149 l~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~ 224 (317)
T 2pmi_A 149 LGDFGLARAFGIPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE--QLKLIFDI 224 (317)
T ss_dssp ECCCSSCEETTSCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHH
T ss_pred ECcCccceecCCCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHH
Confidence 99999998764322 12234578999999999876 468999999999999999999999986543211 11111111
Q ss_pred hccc--ccc----c--ccCccc------------cchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 742 WKDD--KAW----K--LMDPTM------------QNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 742 ~~~~--~~~----~--~~d~~l------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.... ..+ . ...+.. ...........+.+++.+||+.||++|||++|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 225 MGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp HCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0000 000 0 000000 00000122346889999999999999999999875
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=338.72 Aligned_cols=248 Identities=24% Similarity=0.320 Sum_probs=196.5
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC-----CCcCHHHHHHHHHHHhhcCCCCccc
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK-----SGQGLEEFKNEMMLIAKLQHRNLVR 587 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~-----~~~~~~~f~~Ev~~l~~l~H~niv~ 587 (840)
.+.|++.+.||+|+||.||+|.++ .+++.||||++... .....+.+.+|+.++.+++||||++
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~------------~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~ 90 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINR------------ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET------------TTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccceEEeeEEeeCCCEEEEEEEEC------------CCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCc
Confidence 467999999999999999999765 67899999998632 2235678999999999999999999
Q ss_pred eeeEeecCCceEEEEEeeccCCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCC
Q 041702 588 LFGCCIEQGEKISIYEFDIVTDP--------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDM 659 (840)
Q Consensus 588 l~g~~~~~~~~~lv~e~~~~~~~--------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~ 659 (840)
+++++.+.+..++||||...... .....+++..+..++.||+.||+|||+++ |+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~ 167 (351)
T 3c0i_A 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKE 167 (351)
T ss_dssp EEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSS
T ss_pred EEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCC
Confidence 99999999999999999543222 12235889999999999999999999998 99999999999998765
Q ss_pred C---ceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhH
Q 041702 660 N---PKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLG 736 (840)
Q Consensus 660 ~---~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~ 736 (840)
. +||+|||+++....... ......||+.|+|||.+.+..++.++|||||||+++||++|+.||.... ....
T Consensus 168 ~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~- 241 (351)
T 3c0i_A 168 NSAPVKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK---ERLF- 241 (351)
T ss_dssp TTCCEEECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH---HHHH-
T ss_pred CCCcEEEecCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH---HHHH-
Confidence 5 99999999988754322 2334579999999999999999999999999999999999999986421 1111
Q ss_pred HHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 737 HAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 737 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
........ .............+.+++.+||+.||++|||+.|+++
T Consensus 242 ---~~i~~~~~------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 242 ---EGIIKGKY------KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp ---HHHHHTCC------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---HHHHcCCC------CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11111100 0111111123456889999999999999999999985
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=329.64 Aligned_cols=257 Identities=22% Similarity=0.333 Sum_probs=190.9
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
++|+..++||+|+||.||+|.+ .+++.||||++.... ....+.+.+|++++++++||||++++++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-------------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 68 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-------------NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-------------TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-------------CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeE
Confidence 5789999999999999999864 368899999997542 2345789999999999999999999999
Q ss_pred eecCCceEEEEEeeccC---Cc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 592 CIEQGEKISIYEFDIVT---DP-ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~---~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
+...+..++|||+.... .. .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 69 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 145 (288)
T 1ob3_A 69 IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFG 145 (288)
T ss_dssp EECSSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTT
T ss_pred EccCCeEEEEEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECc
Confidence 99999999999994221 00 12346889999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccc
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDK 746 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 746 (840)
+++...... .......+|+.|+|||.+.+. .++.++|||||||+++||++|+.||...... ..............
T Consensus 146 ~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~ 221 (288)
T 1ob3_A 146 LARAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA--DQLMRIFRILGTPN 221 (288)
T ss_dssp HHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCC
T ss_pred cccccCccc--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHHCCCC
Confidence 998764321 122345689999999998764 5899999999999999999999998643221 11111111110000
Q ss_pred c--------ccccCcccc-------chhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 747 A--------WKLMDPTMQ-------NEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 747 ~--------~~~~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
. ....++... ..........+.+++.+||+.||++|||++|+++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 222 SKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 000011100 0111223456789999999999999999999975
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=338.65 Aligned_cols=264 Identities=24% Similarity=0.342 Sum_probs=199.9
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC-CCcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK-SGQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~-~~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
.+.|+..++||+|+||.||+|++. .....+++.||||++... .....+++.+|++++.+++||||++++++
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 91 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYD--------PEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGI 91 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEC--------TTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhhhhhhccCCCCceEEEEEEEc--------cccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeE
Confidence 356888999999999999998632 013367899999999754 33556889999999999999999999999
Q ss_pred eecC--CceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 592 CIEQ--GEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 592 ~~~~--~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
+.+. +..++||||...... .....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 92 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~ 168 (302)
T 4e5w_A 92 CTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIG 168 (302)
T ss_dssp EEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEEC
T ss_pred EecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEEC
Confidence 9876 668899998533221 22356899999999999999999999998 9999999999999999999999
Q ss_pred ccccceecCCCCcc-cccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCC--------CC-ccH
Q 041702 665 DFGIARTFGGDEMQ-SNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNT--------DS-LTL 734 (840)
Q Consensus 665 DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~--------~~-~~~ 734 (840)
|||++......... .......+|..|+|||.+.+..++.++||||||++++||++|+.|+..... .. ...
T Consensus 169 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (302)
T 4e5w_A 169 DFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMT 248 (302)
T ss_dssp CCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGH
T ss_pred cccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccC
Confidence 99999887544322 223345688899999999999999999999999999999999987532110 00 000
Q ss_pred hHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 041702 735 LGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEI 796 (840)
Q Consensus 735 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~ 796 (840)
......... ..............+.+++.+||+.||++|||+.++++.|+.++
T Consensus 249 ~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 249 VTRLVNTLK---------EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHHH---------TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHh---------ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 000000000 00111111233456889999999999999999999999999764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=342.58 Aligned_cols=246 Identities=19% Similarity=0.275 Sum_probs=192.6
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhc-CCCCccce
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKL-QHRNLVRL 588 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l-~H~niv~l 588 (840)
.++|+..++||+|+||.||+|+++ .+++.||||++++.. ....+.+.+|..++.++ +||||+++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~------------~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l 118 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLK------------KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET------------TTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEEC------------CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCee
Confidence 468999999999999999999765 678999999997542 33445688999999987 89999999
Q ss_pred eeEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 589 FGCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
++++.+.+..++||||..... ......+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+
T Consensus 119 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~ 195 (396)
T 4dc2_A 119 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLT 195 (396)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEEC
T ss_pred EEEEEECCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEe
Confidence 999999999999999953322 233467999999999999999999999998 9999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCc---cHhHHHhhh
Q 041702 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSL---TLLGHAWNL 741 (840)
Q Consensus 665 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~---~~~~~~~~~ 741 (840)
|||+++...... ......+||+.|+|||++.+..++.++|||||||+++||++|+.||......+. .........
T Consensus 196 DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~ 273 (396)
T 4dc2_A 196 DYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 273 (396)
T ss_dssp CCTTCBCCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHH
T ss_pred ecceeeecccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHH
Confidence 999998632221 223456899999999999999999999999999999999999999965432211 001111111
Q ss_pred hcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCH
Q 041702 742 WKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTM 785 (840)
Q Consensus 742 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 785 (840)
..... ..+ +......+.+++.+||+.||++||++
T Consensus 274 i~~~~------~~~----p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 274 ILEKQ------IRI----PRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HHHCC------CCC----CTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred Hhccc------cCC----CCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 11110 011 11234457899999999999999996
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=356.00 Aligned_cols=256 Identities=26% Similarity=0.405 Sum_probs=201.9
Q ss_pred HHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCcccee
Q 041702 510 SAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 510 ~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
+...++|...++||+|+||.||+|.++ ++..||||+++... ...++|.+|+++|++++||||++++
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-------------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~ 249 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYN-------------KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLH 249 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEET-------------TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred eechHHeEEEEEcccCCceEEEEEEEC-------------CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEE
Confidence 345678999999999999999998643 57789999998643 4678999999999999999999999
Q ss_pred eEeecCCceEEEEEeeccCCcc------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCcee
Q 041702 590 GCCIEQGEKISIYEFDIVTDPA------RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKI 663 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~~~~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL 663 (840)
+++. .+..++||||....... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 250 ~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl 325 (454)
T 1qcf_A 250 AVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKI 325 (454)
T ss_dssp EEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEE
T ss_pred EEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEE
Confidence 9986 66789999995332221 1236888999999999999999999998 999999999999999999999
Q ss_pred eccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhh
Q 041702 664 SDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLW 742 (840)
Q Consensus 664 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 742 (840)
+|||+++....... .......+|..|+|||.+....++.++|||||||+||||++ |+.|+...... .... ..
T Consensus 326 ~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~--~~~~----~i 398 (454)
T 1qcf_A 326 ADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIR----AL 398 (454)
T ss_dssp CSTTGGGGBCCHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHH----HH
T ss_pred eeCCCceEcCCCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH--HHHH----HH
Confidence 99999987643221 11223446789999999999999999999999999999999 99998643211 1111 11
Q ss_pred cccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCC
Q 041702 743 KDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNL 799 (840)
Q Consensus 743 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~ 799 (840)
... ..+.. +...+..+.+++.+||+.||++|||+++|++.|++.....
T Consensus 399 ~~~--~~~~~-------~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 399 ERG--YRMPR-------PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp HHT--CCCCC-------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred HcC--CCCCC-------CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 111 01111 1123456889999999999999999999999999986544
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=337.52 Aligned_cols=267 Identities=17% Similarity=0.207 Sum_probs=194.9
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCc-----------CHHHHHHHHHHHhhcC
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQ-----------GLEEFKNEMMLIAKLQ 581 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~-----------~~~~f~~Ev~~l~~l~ 581 (840)
.++|.+.+.||+|+||.||+|.++ ....++..||||++...... ..+.+.+|+.++..++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~ 106 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPT---------NKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLD 106 (345)
T ss_dssp SCEEEEEEEC------CEEEEEES---------SSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCS
T ss_pred CceEEEEeeEeecCCeEEEEEEec---------CCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhcccc
Confidence 468999999999999999999865 22236789999998754321 2235778889999999
Q ss_pred CCCccceeeEeec----CCceEEEEEee---ccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEE
Q 041702 582 HRNLVRLFGCCIE----QGEKISIYEFD---IVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVL 654 (840)
Q Consensus 582 H~niv~l~g~~~~----~~~~~lv~e~~---~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIL 654 (840)
||||+++++++.. .+..++|||+. +.........+++.+++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 107 h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 183 (345)
T 2v62_A 107 YLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLL 183 (345)
T ss_dssp CCCCCCEEEEEEEESSSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred ccCcceeecccccccCCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEE
Confidence 9999999999988 77899999995 1111222337899999999999999999999998 999999999999
Q ss_pred ecCCC--CceeeccccceecCCCCcc-----cccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 041702 655 LDSDM--NPKISDFGIARTFGGDEMQ-----SNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFY 727 (840)
Q Consensus 655 l~~~~--~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~ 727 (840)
++.++ .+||+|||+++.+...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 184 l~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 263 (345)
T 2v62_A 184 LGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQN 263 (345)
T ss_dssp EESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGG
T ss_pred EccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 99887 9999999999876433211 1123457999999999999999999999999999999999999998643
Q ss_pred CCCCccHhHHHhhhhcccccccccCccccch-hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 728 NTDSLTLLGHAWNLWKDDKAWKLMDPTMQNE-ALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
.............. .. .+...+... .....+..+.+++.+||+.||++||++++|++.|+....
T Consensus 264 ~~~~~~~~~~~~~~-~~-----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 264 LKDPVAVQTAKTNL-LD-----ELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp TTCHHHHHHHHHHH-HH-----TTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred ccccHHHHHHHHhh-cc-----cccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 22221111111010 00 000000000 000234568899999999999999999999999998743
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=334.89 Aligned_cols=247 Identities=22% Similarity=0.313 Sum_probs=197.7
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
.++|.+.+.||+|+||.||+|.++ .+++.||+|.+... ....+.+.+|+.++.+++||||+++++++
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~------------~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 70 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVET------------SSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESF 70 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET------------TTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEEC------------CCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEE
Confidence 478999999999999999999765 67899999999754 23456789999999999999999999999
Q ss_pred ecCCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecC--CCCceeec
Q 041702 593 IEQGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS--DMNPKISD 665 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~--~~~~kL~D 665 (840)
.+.+..++||||...... .....+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|
T Consensus 71 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~D 147 (321)
T 1tki_A 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIE 147 (321)
T ss_dssp EETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECC
T ss_pred ecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEE
Confidence 999999999999533221 12236899999999999999999999998 999999999999987 78999999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
||+++.+.... ......||+.|+|||.+.+..++.++|||||||+++||++|+.||...... ..... ... .
T Consensus 148 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~---i~~-~ 218 (321)
T 1tki_A 148 FGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--QIIEN---IMN-A 218 (321)
T ss_dssp CTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHH---HHH-T
T ss_pred CCCCeECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH--HHHHH---HHc-C
Confidence 99998875432 223457899999999999988999999999999999999999998643211 11111 110 0
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
. ..............+.+++.+||+.||++|||+.|+++
T Consensus 219 ~------~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 219 E------YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp C------CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C------CCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 00111111233556889999999999999999999996
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=331.87 Aligned_cols=259 Identities=24% Similarity=0.338 Sum_probs=192.1
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-----CcCHHHHHHHHHHHhhcC---CC
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-----GQGLEEFKNEMMLIAKLQ---HR 583 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-----~~~~~~f~~Ev~~l~~l~---H~ 583 (840)
..++|++.++||+|+||.||+|+++ .+++.||||++.... ......+.+|+.++++++ ||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ 74 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDP------------HSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECT------------TTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCT
T ss_pred cccceEEEEEEecCCCeEEEEEEEC------------CCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCC
Confidence 4679999999999999999999765 678999999987432 222457788888888775 99
Q ss_pred CccceeeEeecCC-----ceEEEEEeeccC---C--ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcE
Q 041702 584 NLVRLFGCCIEQG-----EKISIYEFDIVT---D--PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNV 653 (840)
Q Consensus 584 niv~l~g~~~~~~-----~~~lv~e~~~~~---~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NI 653 (840)
||+++++++.... ..+++||+.... . ......+++..+..++.||+.||+|||+.+ |+||||||+||
T Consensus 75 niv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Ni 151 (308)
T 3g33_A 75 NVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENI 151 (308)
T ss_dssp TBCCEEEEEEECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTE
T ss_pred CeEEeeeeeeccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHE
Confidence 9999999998765 478899984211 0 111233899999999999999999999998 99999999999
Q ss_pred EecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc
Q 041702 654 LLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLT 733 (840)
Q Consensus 654 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~ 733 (840)
|++.++.+||+|||+++...... ......||+.|+|||.+.+..++.++|||||||+++||++|+.||...... .
T Consensus 152 l~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~ 226 (308)
T 3g33_A 152 LVTSGGTVKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA--D 226 (308)
T ss_dssp EECTTSCEEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH--H
T ss_pred EEcCCCCEEEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--H
Confidence 99999999999999998664322 234467899999999999999999999999999999999999998643321 1
Q ss_pred HhHHHhhhhcccccc------c----ccCcc---ccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 734 LLGHAWNLWKDDKAW------K----LMDPT---MQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 734 ~~~~~~~~~~~~~~~------~----~~d~~---l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
............... . ...+. .......+....+.+++.+||+.||++|||+.|+++
T Consensus 227 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 227 QLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 111111111000000 0 00000 000111233466889999999999999999999975
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=325.83 Aligned_cols=270 Identities=18% Similarity=0.222 Sum_probs=202.7
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
..++|+..+.||+|+||.||+|.++ .+++.||||++..... .+++.+|++++.+++|++++..+++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~ 72 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDI------------AAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRW 72 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEET------------TTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEc------------CCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeee
Confidence 4578999999999999999999765 6789999998765432 2468999999999998887776666
Q ss_pred e-ecCCceEEEEEeeccCCcc-----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEe---cCCCCce
Q 041702 592 C-IEQGEKISIYEFDIVTDPA-----RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLL---DSDMNPK 662 (840)
Q Consensus 592 ~-~~~~~~~lv~e~~~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl---~~~~~~k 662 (840)
+ .+.+..+++||+. ..... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+|
T Consensus 73 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~k 148 (296)
T 4hgt_A 73 CGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVY 148 (296)
T ss_dssp EEEETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEE
T ss_pred ecCCCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEE
Confidence 5 5667789999995 21111 2456899999999999999999999998 9999999999999 7899999
Q ss_pred eeccccceecCCCCcc-----cccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCc-cHhH
Q 041702 663 ISDFGIARTFGGDEMQ-----SNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSL-TLLG 736 (840)
Q Consensus 663 L~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~-~~~~ 736 (840)
|+|||+++........ .......||+.|+|||.+.+..++.++|||||||+++||++|+.||........ ....
T Consensus 149 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 228 (296)
T 4hgt_A 149 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 228 (296)
T ss_dssp ECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHH
T ss_pred EecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhh
Confidence 9999999887544321 122356789999999999999999999999999999999999999976443331 1111
Q ss_pred HHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCCCCCCCCCCc
Q 041702 737 HAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSPHQPAFS 808 (840)
Q Consensus 737 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~p~~p~~~ 808 (840)
......... + ........+..+.+++.+||+.||++|||+++|++.|+++..+...+..-.++
T Consensus 229 ~~~~~~~~~-------~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~d 291 (296)
T 4hgt_A 229 RISEKKMST-------P--IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFD 291 (296)
T ss_dssp HHHHHHHHS-------C--HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCG
T ss_pred hhhcccccc-------h--hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccc
Confidence 110100000 0 00001122456889999999999999999999999999987766554433333
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=336.70 Aligned_cols=260 Identities=23% Similarity=0.296 Sum_probs=190.5
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC---cCHHHHHHHHHHHhhcCCCCcccee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG---QGLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
.++|++.+.||+|+||.||+|.++ .+++.||||++..... ...++|.+|+.++.+++||||++++
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 78 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDL------------RDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET------------TTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEEC------------CCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEE
Confidence 478999999999999999999765 6789999999976532 2345789999999999999999999
Q ss_pred eEeecCCce----EEEEEeeccC----CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCc
Q 041702 590 GCCIEQGEK----ISIYEFDIVT----DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP 661 (840)
Q Consensus 590 g~~~~~~~~----~lv~e~~~~~----~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 661 (840)
+++...+.. ++||||.... .......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~ 155 (311)
T 3ork_A 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAV 155 (311)
T ss_dssp EEEEEEETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCE
T ss_pred EeeeccCCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCE
Confidence 998876544 8999984221 1223456899999999999999999999998 9999999999999999999
Q ss_pred eeeccccceecCCCCcc-cccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhh
Q 041702 662 KISDFGIARTFGGDEMQ-SNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWN 740 (840)
Q Consensus 662 kL~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~ 740 (840)
||+|||+++.+...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ....
T Consensus 156 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-----~~~~ 230 (311)
T 3ork_A 156 KVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-----VAYQ 230 (311)
T ss_dssp EECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHH
T ss_pred EEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-----HHHH
Confidence 99999999876543221 22334578999999999999999999999999999999999999986432111 1111
Q ss_pred hhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHH-HHHHhhccccCC
Q 041702 741 LWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLE-VVAMLKDEIVNL 799 (840)
Q Consensus 741 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e-vl~~Le~~~~~~ 799 (840)
...... .............+.+++.+||+.||++||++.+ +.+.|.......
T Consensus 231 ~~~~~~-------~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~ 283 (311)
T 3ork_A 231 HVREDP-------IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGE 283 (311)
T ss_dssp HHHCCC-------CCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTC
T ss_pred HhcCCC-------CCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCC
Confidence 111110 0000111123456889999999999999996555 446666553333
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=330.80 Aligned_cols=253 Identities=26% Similarity=0.389 Sum_probs=197.8
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
..++|+..+.||+|+||.||+|.++ ++..||||++... ....+++.+|++++.+++||||++++++
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~-------------~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 87 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWR-------------GQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGV 87 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEET-------------TTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEc-------------CCCeEEEEEecCC-CCCHHHHHHHHHHHhcCCCCCEeeEEEE
Confidence 4578999999999999999998643 5778999999865 3345789999999999999999999999
Q ss_pred eecCCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 592 CIEQGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
+.+.+..++||||...... .....+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Df 164 (283)
T 3gen_A 88 CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDF 164 (283)
T ss_dssp ECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECST
T ss_pred EecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccc
Confidence 9999999999999532221 11356899999999999999999999998 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
|+++....... .......+|+.|+|||.+.+..++.++||||||++++||++ |+.|+...... .... .. ...
T Consensus 165 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--~~~~---~~-~~~ 237 (283)
T 3gen_A 165 GLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAE---HI-AQG 237 (283)
T ss_dssp TGGGGBCCHHH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHH---HH-HTT
T ss_pred ccccccccccc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh--HHHH---HH-hcc
Confidence 99987643321 12233456788999999999999999999999999999998 99998643211 1111 11 110
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
.....+. ...+.+.+++.+||+.||++|||++++++.|+++..
T Consensus 238 --~~~~~~~-------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 238 --LRLYRPH-------LASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp --CCCCCCT-------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --cCCCCCC-------cCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 0011111 113457889999999999999999999999988643
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=334.36 Aligned_cols=255 Identities=27% Similarity=0.402 Sum_probs=204.2
Q ss_pred HHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 511 AATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 511 ~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
...++|+..+.||+|+||.||+|.++ .++..||||++... ....+++.+|++++++++||||+++++
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~------------~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~ 76 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWK------------KYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLG 76 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEG------------GGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEec------------CCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 45678999999999999999999765 56889999999754 344678999999999999999999999
Q ss_pred EeecCCceEEEEEeeccCC------ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 591 CCIEQGEKISIYEFDIVTD------PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
++.+.+..++|||+..... ......+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+
T Consensus 77 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~ 153 (288)
T 3kfa_A 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVA 153 (288)
T ss_dssp EECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEEC
T ss_pred EEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEc
Confidence 9999999999999843211 112345899999999999999999999998 9999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhc
Q 041702 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWK 743 (840)
Q Consensus 665 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 743 (840)
|||++........ .......+|+.|+|||.+.+..++.++||||||++++||++ |+.|+....... .... ..
T Consensus 154 Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~--~~~~----~~ 226 (288)
T 3kfa_A 154 DFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYEL----LE 226 (288)
T ss_dssp CCCGGGTSCSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHH----HH
T ss_pred cCccceeccCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH----Hh
Confidence 9999987654332 22334557889999999999999999999999999999999 888876433221 1111 11
Q ss_pred ccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 744 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
.. .....+......+.+++.+||+.||++|||+++|++.|+....
T Consensus 227 ~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 227 KD---------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp TT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cc---------CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 10 0011112233568899999999999999999999999988644
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=344.75 Aligned_cols=277 Identities=26% Similarity=0.342 Sum_probs=202.1
Q ss_pred CcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcCCCCccceeeEeec
Q 041702 516 FSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQHRNLVRLFGCCIE 594 (840)
Q Consensus 516 f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~ 594 (840)
|+..++||+|+||.||++..+ .....+++.||||++..... ...+.|.+|++++++++||||+++++++.+
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~--------~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYD--------PTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCED 104 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEEC--------SCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred HhhhheecCCCCeEEEEEEEc--------cCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEec
Confidence 488999999999999887533 12335789999999986532 345679999999999999999999999987
Q ss_pred C--CceEEEEEeeccC---CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccc
Q 041702 595 Q--GEKISIYEFDIVT---DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIA 669 (840)
Q Consensus 595 ~--~~~~lv~e~~~~~---~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla 669 (840)
. ...++||||.... .......+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 105 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a 181 (318)
T 3lxp_A 105 AGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLA 181 (318)
T ss_dssp TTTTEEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred CCCceEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccc
Confidence 4 5678999985322 2223445899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCCcc-cccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccc
Q 041702 670 RTFGGDEMQ-SNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAW 748 (840)
Q Consensus 670 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (840)
......... .......+|..|+|||.+.+..++.++||||||++++||++|+.|+........................
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (318)
T 3lxp_A 182 KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT 261 (318)
T ss_dssp EECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHH
T ss_pred ccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHH
Confidence 887543322 2233456788999999999999999999999999999999999987532111000000000000000011
Q ss_pred cccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCCCCCC
Q 041702 749 KLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSPH 803 (840)
Q Consensus 749 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~p~ 803 (840)
+.++..............+.+++.+||+.||++|||+.|+++.|+.+.+++..+.
T Consensus 262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~ 316 (318)
T 3lxp_A 262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQA 316 (318)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC--
T ss_pred HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCC
Confidence 1111111111222334568899999999999999999999999998876654443
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=339.29 Aligned_cols=247 Identities=21% Similarity=0.300 Sum_probs=197.0
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhcCCCCcccee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
.++|.+.+.||+|+||.||+|.++ .+++.||+|++... .....+.+.+|+++|.+++|||||+++
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~------------~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~ 81 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKN------------DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEET------------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEEC------------CCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 467999999999999999999765 67899999998653 245567899999999999999999999
Q ss_pred eEeecCCceEEEEEeeccC----CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 590 GCCIEQGEKISIYEFDIVT----DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~----~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
+++.+.+..++||||.... .......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 82 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~D 158 (384)
T 4fr4_A 82 YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITD 158 (384)
T ss_dssp EEEECSSEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred EEEEeCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEec
Confidence 9999999999999994222 2223456899999999999999999999998 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCcccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhh
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH---GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLW 742 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~ 742 (840)
||+++.+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.............. .
T Consensus 159 FG~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~---~ 232 (384)
T 4fr4_A 159 FNIAAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT---F 232 (384)
T ss_dssp CTTCEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH---H
T ss_pred cceeeeccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH---H
Confidence 99998765332 2345679999999999864 4589999999999999999999999865443332111111 0
Q ss_pred cccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 041702 743 KDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPT-MLEVVA 790 (840)
Q Consensus 743 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~ 790 (840)
.... . ..+......+.+++.+||+.||++||+ +++|++
T Consensus 233 ~~~~------~----~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 233 ETTV------V----TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHCC------C----CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred hhcc------c----CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0000 0 011122456889999999999999998 677664
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=324.47 Aligned_cols=272 Identities=18% Similarity=0.220 Sum_probs=208.7
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
..++|+..+.||+|+||.||+|++. .+++.||||++..... .+++.+|+.++.+++|++++..+.+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~ 72 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDI------------AAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRW 72 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEET------------TTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEc------------CCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCcccc
Confidence 3578999999999999999999764 6789999999875433 3579999999999999887666665
Q ss_pred e-ecCCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEe---cCCCCce
Q 041702 592 C-IEQGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLL---DSDMNPK 662 (840)
Q Consensus 592 ~-~~~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl---~~~~~~k 662 (840)
+ .+.+..+++|||. .... .....+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+|
T Consensus 73 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~k 148 (296)
T 3uzp_A 73 CGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVY 148 (296)
T ss_dssp EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEE
T ss_pred ccCCCCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEE
Confidence 5 5667789999995 2111 12456899999999999999999999998 9999999999999 5889999
Q ss_pred eeccccceecCCCCccc-----ccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCC-ccHhH
Q 041702 663 ISDFGIARTFGGDEMQS-----NTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDS-LTLLG 736 (840)
Q Consensus 663 L~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~-~~~~~ 736 (840)
|+|||+++......... ......||+.|+|||.+.+..++.++|||||||+++||++|+.||....... .....
T Consensus 149 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 228 (296)
T 3uzp_A 149 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 228 (296)
T ss_dssp ECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHH
T ss_pred EeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhh
Confidence 99999998875443211 2245679999999999999999999999999999999999999987644332 11111
Q ss_pred HHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCCCCCCCCCCccc
Q 041702 737 HAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSPHQPAFSYV 810 (840)
Q Consensus 737 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~p~~p~~~~~ 810 (840)
......... + ........+..+.+++.+||+.||++|||+++|++.|+++......+..-.|+|.
T Consensus 229 ~~~~~~~~~-------~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~ 293 (296)
T 3uzp_A 229 RISEKKMST-------P--IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN 293 (296)
T ss_dssp HHHHHHHHS-------C--HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGG
T ss_pred hhcccccCC-------c--hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccccccccc
Confidence 111100000 0 0001112345688999999999999999999999999998877766655555553
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=323.23 Aligned_cols=251 Identities=25% Similarity=0.370 Sum_probs=198.8
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
..++|+..+.||+|+||.||+|.++ .+++.||||++.... ....+.+.+|+.++++++||||+++++
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 72 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNR------------VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEET------------TTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEEC------------CCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeee
Confidence 3467899999999999999999765 578999999997543 234578999999999999999999999
Q ss_pred EeecCCceEEEEEeec----cCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 591 CCIEQGEKISIYEFDI----VTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~----~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
++.+.+..++|+|+.. .........+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 73 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 149 (276)
T 2yex_A 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDF 149 (276)
T ss_dssp EEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred EEEcCCEEEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeC
Confidence 9999999999999942 222233456899999999999999999999998 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLF-SIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
|++................||+.|+|||.+.+..+ +.++||||||++++||++|+.|+............. ...
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-----~~~ 224 (276)
T 2yex_A 150 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-----KEK 224 (276)
T ss_dssp TTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHH-----HTT
T ss_pred CCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHh-----hhc
Confidence 99987643332233345678999999999987775 789999999999999999999987544332221111 111
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.. .. .........+.+++.+||+.||++|||++|+++
T Consensus 225 ~~--~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 225 KT--YL------NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp CT--TS------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cc--cc------CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 00 00 011123445788999999999999999999875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=345.85 Aligned_cols=264 Identities=23% Similarity=0.333 Sum_probs=186.9
Q ss_pred HHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC--CCcCHHHHHHHHHHHhhcC-CCCccc
Q 041702 511 AATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK--SGQGLEEFKNEMMLIAKLQ-HRNLVR 587 (840)
Q Consensus 511 ~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~--~~~~~~~f~~Ev~~l~~l~-H~niv~ 587 (840)
...++|+..++||+|+||.||+|.++ .+++.||||++... .....+++.+|+.++.++. ||||++
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~------------~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~ 73 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDR------------RTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVN 73 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEET------------TTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEEC------------CCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCe
Confidence 45688999999999999999999765 67899999998654 2234567889999999997 999999
Q ss_pred eeeEeecCC--ceEEEEEeecc--CCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCcee
Q 041702 588 LFGCCIEQG--EKISIYEFDIV--TDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKI 663 (840)
Q Consensus 588 l~g~~~~~~--~~~lv~e~~~~--~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL 663 (840)
+++++...+ ..++||||... ........+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 74 l~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl 150 (388)
T 3oz6_A 74 LLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKV 150 (388)
T ss_dssp EEEEEECTTSSCEEEEEECCSEEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred eeeEEecCCCCEEEEEecccCcCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEe
Confidence 999997544 68999999531 11122357889999999999999999999998 999999999999999999999
Q ss_pred eccccceecCCCCc-------------------ccccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCC
Q 041702 664 SDFGIARTFGGDEM-------------------QSNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKN 723 (840)
Q Consensus 664 ~DFGla~~~~~~~~-------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p 723 (840)
+|||+|+.+..... .......+||+.|+|||++.+ ..++.++|||||||+++||++|++|
T Consensus 151 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~p 230 (388)
T 3oz6_A 151 ADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPI 230 (388)
T ss_dssp CCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCC
Confidence 99999987643110 112234579999999999886 6799999999999999999999999
Q ss_pred CCCCCCCCccHhHHHhhhhccccc---cccc------------------Cccccchhh------------HHHHHHHHHH
Q 041702 724 TRFYNTDSLTLLGHAWNLWKDDKA---WKLM------------------DPTMQNEAL------------YSMVTRYIKV 770 (840)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~------------------d~~l~~~~~------------~~~~~~l~~l 770 (840)
|....... .............. ..+. ......... ......+.++
T Consensus 231 f~~~~~~~--~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 308 (388)
T 3oz6_A 231 FPGSSTMN--QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDL 308 (388)
T ss_dssp CCCSSHHH--HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHH
T ss_pred CCCCCHHH--HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHH
Confidence 86543211 11111110000000 0000 000000000 0123468899
Q ss_pred HHHccccCCCCCCCHHHHHHH
Q 041702 771 ALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 771 ~~~Cl~~dP~~RPs~~evl~~ 791 (840)
+.+||+.||++|||++|+++.
T Consensus 309 l~~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 309 LDKLLQFNPNKRISANDALKH 329 (388)
T ss_dssp HHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHhhccCcccCCCHHHHhCC
Confidence 999999999999999999865
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=346.91 Aligned_cols=249 Identities=24% Similarity=0.333 Sum_probs=187.7
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcC--CCCccce
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQ--HRNLVRL 588 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~--H~niv~l 588 (840)
.++|++.+.||+|+||.||+|.+. +++.||||++.... ....++|.+|+.+|.+++ ||||+++
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~-------------~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~ 121 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNE-------------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT-------------TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred CCceEEEEEEccCCCeEEEEEEcC-------------CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEE
Confidence 356999999999999999998653 48899999997542 334578999999999996 5999999
Q ss_pred eeEeecCCceEEEEEeec---cCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 589 FGCCIEQGEKISIYEFDI---VTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~~~---~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
++++...+..++|||+.. .........+++.++..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|
T Consensus 122 ~~~~~~~~~~~lv~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~D 197 (390)
T 2zmd_A 122 YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLID 197 (390)
T ss_dssp EEEEECSSEEEEEEECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECC
T ss_pred EEEEecCCEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEe
Confidence 999999999999999721 111223457889999999999999999999988 99999999999995 58999999
Q ss_pred cccceecCCCCcccccccccccccccCcccccc-----------CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccH
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH-----------GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTL 734 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~ 734 (840)
||+++.+.............||+.|+|||++.+ ..++.++|||||||+||||++|+.||......
T Consensus 198 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---- 273 (390)
T 2zmd_A 198 FGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---- 273 (390)
T ss_dssp CSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH----
T ss_pred cCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH----
Confidence 999987754433333445679999999999865 46899999999999999999999998532211
Q ss_pred hHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 735 LGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 735 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
........ ++......+......+.+++.+||+.||++|||+.||++.
T Consensus 274 ~~~~~~~~---------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 274 ISKLHAII---------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHHHHHHH---------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHh---------CccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 11111111 1111100111113457889999999999999999999853
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=349.99 Aligned_cols=259 Identities=21% Similarity=0.239 Sum_probs=192.1
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC--CCcCHHHHHHHHHHHhhcCCCCcccee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK--SGQGLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
..++|+..++||+|+||.||+|.++ .+++.||||++... .....+++.+|+.+|++++||||++++
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~------------~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~ 127 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDA------------VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEET------------TTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred ecCCeEEEEEeecCCCeEEEEEEEC------------CCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 3578999999999999999999765 67899999999754 233457789999999999999999999
Q ss_pred eEeecC------CceEEEEEeeccCCc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCce
Q 041702 590 GCCIEQ------GEKISIYEFDIVTDP-ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPK 662 (840)
Q Consensus 590 g~~~~~------~~~~lv~e~~~~~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 662 (840)
+++... ...++||||...... .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 128 ~~~~~~~~~~~~~~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~k 204 (464)
T 3ttj_A 128 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK 204 (464)
T ss_dssp EEECSCCSTTTCCEEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEE
T ss_pred EEEccCCccccCCeEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEE
Confidence 999654 356999999432111 11234889999999999999999999998 99999999999999999999
Q ss_pred eeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhh-
Q 041702 663 ISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNL- 741 (840)
Q Consensus 663 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~- 741 (840)
|+|||+|+...... .....+||+.|+|||++.+..++.++|||||||+|+||++|+.||......+ ........
T Consensus 205 l~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~--~~~~i~~~l 279 (464)
T 3ttj_A 205 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID--QWNKVIEQL 279 (464)
T ss_dssp ECCCCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHH
T ss_pred EEEEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhc
Confidence 99999998764322 2344679999999999999999999999999999999999999986533111 11110000
Q ss_pred ------------------hcccc------cccccCccc---cchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 742 ------------------WKDDK------AWKLMDPTM---QNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 742 ------------------~~~~~------~~~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
..... ........+ ...........+.+++.+||+.||++|||++|+++
T Consensus 280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 280 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp CSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000 000000000 01112233567899999999999999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=331.10 Aligned_cols=263 Identities=25% Similarity=0.321 Sum_probs=200.1
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcCCCCccceeeEee
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQHRNLVRLFGCCI 593 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~ 593 (840)
.|...++||+|+||.||+|.+. ....++..||+|++..... ...+.|.+|+.++++++||||+++++++.
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 92 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYI---------DQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIML 92 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEE---------CSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEC
T ss_pred EEccCceeccCCCceEEEEEEe---------cCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEe
Confidence 4566689999999999999764 2334455899999976433 34578999999999999999999999998
Q ss_pred cCCce-EEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 594 EQGEK-ISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 594 ~~~~~-~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
+.+.. ++++|+...... .....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 93 ~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg 169 (298)
T 3pls_A 93 PPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFG 169 (298)
T ss_dssp CSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTT
T ss_pred cCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCC
Confidence 76665 899998432221 12356889999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCCc--ccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 668 IARTFGGDEM--QSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 668 la~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
+++....... ........+|+.|+|||.+.+..++.++||||||++++||++|+.|+.... ......... ...
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~-~~~~~~~~~----~~~ 244 (298)
T 3pls_A 170 LARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI-DPFDLTHFL----AQG 244 (298)
T ss_dssp SSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-CGGGHHHHH----HTT
T ss_pred CcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC-CHHHHHHHh----hcC
Confidence 9986644321 122334567899999999999999999999999999999999666542211 111111111 111
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCCCCCC
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSPH 803 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~p~ 803 (840)
.. . .........+.+++.+||+.||++|||++++++.|+++...+....
T Consensus 245 ~~--~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~ 293 (298)
T 3pls_A 245 RR--L-------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293 (298)
T ss_dssp CC--C-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred CC--C-------CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence 00 0 0011123458899999999999999999999999999877765443
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=338.80 Aligned_cols=250 Identities=22% Similarity=0.253 Sum_probs=187.1
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
..++|...++||+|+||.||+|+++ .+++.||||++.... ...+.+.+|+.++++++||||++++++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~------------~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~ 84 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDK------------LTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEV 84 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEET------------TTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEEC------------CCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 3578999999999999999999765 678999999997643 334778999999999999999999999
Q ss_pred eecCCceEEEEEeeccCCc----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCC--ceeec
Q 041702 592 CIEQGEKISIYEFDIVTDP----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMN--PKISD 665 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~--~kL~D 665 (840)
+...+..++||||...... .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|
T Consensus 85 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~D 161 (361)
T 3uc3_A 85 ILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICD 161 (361)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECC
T ss_pred EeeCCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEee
Confidence 9999999999999533222 23456899999999999999999999998 999999999999987765 99999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCCCCcc-ccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIK-SDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
||+++..... .......||+.|+|||.+.+..++.+ +|||||||+++||++|+.||......... .........
T Consensus 162 fg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-~~~~~~~~~- 236 (361)
T 3uc3_A 162 FGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY-RKTIQRILS- 236 (361)
T ss_dssp CCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH-HHHHHHHHT-
T ss_pred cCcccccccc---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH-HHHHHHHhc-
Confidence 9999753222 12234579999999999988887666 89999999999999999998754433211 111111110
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
. .............+.+++.+||+.||++|||+.|+++
T Consensus 237 ~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 237 V--------KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp T--------CCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred C--------CCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 0 0000001112345789999999999999999999985
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=332.31 Aligned_cols=257 Identities=24% Similarity=0.326 Sum_probs=188.3
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
..++|+..+.||+|+||.||+|.+. .....+..||||++.... ....+.|.+|+.++++++||||+++++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 83 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYM---------SPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG 83 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEC---------CC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEe---------cCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEE
Confidence 4578999999999999999999765 222356789999987643 234567999999999999999999999
Q ss_pred EeecCCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 591 CCIEQGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
++. .+..++||||...... .....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 84 ~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~D 159 (281)
T 1mp8_A 84 VIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGD 159 (281)
T ss_dssp EEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC
T ss_pred EEc-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECc
Confidence 984 5678899998432111 12336899999999999999999999998 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
||+++........ ......+|+.|+|||.+.+..++.++||||||++++||++ |+.||...... ...... ..
T Consensus 160 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~--~~~~~i----~~ 232 (281)
T 1mp8_A 160 FGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRI----EN 232 (281)
T ss_dssp --------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHH----HT
T ss_pred cccccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH--HHHHHH----Hc
Confidence 9999876543221 2233456789999999999999999999999999999997 88888643322 111111 11
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
... ... .......+.+++.+||+.||++|||+.||++.|+++..
T Consensus 233 ~~~-----~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 233 GER-----LPM----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp TCC-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCC-----CCC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 100 001 11234567889999999999999999999999998744
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=342.37 Aligned_cols=262 Identities=23% Similarity=0.249 Sum_probs=185.8
Q ss_pred HHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcC-CCCcccee
Q 041702 511 AATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQ-HRNLVRLF 589 (840)
Q Consensus 511 ~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~-H~niv~l~ 589 (840)
....+|++.++||+|+||.||+|.++ .+++.||||++........+.+.+|+.++.++. ||||++++
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~ 92 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDV------------GSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEET------------TTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEE
T ss_pred ccCceEEEEEEEccCCceEEEEEEEC------------CCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcc
Confidence 34568999999999999999999765 578999999997665555678999999999996 99999999
Q ss_pred eEee--------cCCceEEEEEeecc------CCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEe
Q 041702 590 GCCI--------EQGEKISIYEFDIV------TDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLL 655 (840)
Q Consensus 590 g~~~--------~~~~~~lv~e~~~~------~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl 655 (840)
+++. .....++++|+... ........+++..++.++.||+.||+|||+.+ ++|+||||||+|||+
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~ 171 (337)
T 3ll6_A 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLL 171 (337)
T ss_dssp EEEEECTTTSTTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEE
T ss_pred ccccccccccccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEE
Confidence 9994 33447889998421 11123456999999999999999999999875 359999999999999
Q ss_pred cCCCCceeeccccceecCCCCccc----------ccccccccccccCcccc---ccCCCCccccchhHHHHHHHHHhCCC
Q 041702 656 DSDMNPKISDFGIARTFGGDEMQS----------NTNRIVGTYGYMSPEYA---LHGLFSIKSDVFSFGVLLLEILSSKK 722 (840)
Q Consensus 656 ~~~~~~kL~DFGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~ksDV~SlGviL~elltG~~ 722 (840)
+.++.+||+|||+++......... ......||+.|+|||.+ .+..++.++||||||++++||++|+.
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~ 251 (337)
T 3ll6_A 172 SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH 251 (337)
T ss_dssp CTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSC
T ss_pred CCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCC
Confidence 999999999999998765432211 11234589999999998 56778999999999999999999999
Q ss_pred CCCCCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCCCCC
Q 041702 723 NTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSP 802 (840)
Q Consensus 723 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~p 802 (840)
|+........ . . ... ....+ ......+.+++.+||+.||++|||+.|+++.|+.+....+.+
T Consensus 252 p~~~~~~~~~--~-------~-~~~-~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~ 313 (337)
T 3ll6_A 252 PFEDGAKLRI--V-------N-GKY-SIPPH-------DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN 313 (337)
T ss_dssp CC----------------------C-CCCTT-------CCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCC
T ss_pred CCcchhHHHh--h-------c-Ccc-cCCcc-------cccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCC
Confidence 9853221110 0 0 000 00000 111123678899999999999999999999999886654433
Q ss_pred C
Q 041702 803 H 803 (840)
Q Consensus 803 ~ 803 (840)
.
T Consensus 314 ~ 314 (337)
T 3ll6_A 314 P 314 (337)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=348.69 Aligned_cols=251 Identities=23% Similarity=0.329 Sum_probs=196.9
Q ss_pred HHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccce
Q 041702 511 AATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRL 588 (840)
Q Consensus 511 ~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l 588 (840)
...++|+..++||+|+||.||+|.++ .+|+.||+|++.... ....+.+.+|++++++++||||+++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~------------~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l 75 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKV------------LAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRL 75 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEET------------TTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEEC------------CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeE
Confidence 34578999999999999999999765 689999999997543 2334678999999999999999999
Q ss_pred eeEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEec---CCCCc
Q 041702 589 FGCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLD---SDMNP 661 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~---~~~~~ 661 (840)
++++.+.+..++||||..... ......+++..+..++.||+.||+|||+.+ |+||||||+|||++ .++.+
T Consensus 76 ~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~v 152 (444)
T 3soa_A 76 HDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAV 152 (444)
T ss_dssp EEEEECSSEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCE
T ss_pred EEEEEECCEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcE
Confidence 999999999999999953322 234467899999999999999999999998 99999999999998 46789
Q ss_pred eeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhh
Q 041702 662 KISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNL 741 (840)
Q Consensus 662 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~ 741 (840)
||+|||++........ ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ..... .
T Consensus 153 kL~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~--~~~~~----~ 224 (444)
T 3soa_A 153 KLADFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ--HRLYQ----Q 224 (444)
T ss_dssp EECCCSSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHH----H
T ss_pred EEccCceeEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH--HHHHH----H
Confidence 9999999987654322 22346799999999999999999999999999999999999999853221 11111 1
Q ss_pred hcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 742 WKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 742 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
...... .... .........+.+++.+||+.||++|||+.|+++
T Consensus 225 i~~~~~-~~~~-----~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 225 IKAGAY-DFPS-----PEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp HHHTCC-CCCT-----TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhCCC-CCCc-----cccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 111110 0111 111123456789999999999999999999986
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=348.81 Aligned_cols=246 Identities=26% Similarity=0.372 Sum_probs=195.7
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
..++|+..++||+|+||.||+|.+ .++.||||+++... ..++|.+|+++|++++||||++++++
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~--------------~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~ 254 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDY--------------RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGV 254 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--------------TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEe--------------cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEE
Confidence 457889999999999999999853 36799999998643 45789999999999999999999999
Q ss_pred eecCC-ceEEEEEeeccCCcc------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 592 CIEQG-EKISIYEFDIVTDPA------RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 592 ~~~~~-~~~lv~e~~~~~~~~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
+.+.+ ..++||||....... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 255 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~ 331 (450)
T 1k9a_A 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVS 331 (450)
T ss_dssp EECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEEC
T ss_pred EEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEe
Confidence 87765 789999995332211 1234789999999999999999999998 9999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhc
Q 041702 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWK 743 (840)
Q Consensus 665 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 743 (840)
|||+++..... .....+++.|+|||.+.+..++.++|||||||+||||++ |+.|+......+ ..... .
T Consensus 332 DfG~a~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i----~ 400 (450)
T 1k9a_A 332 DFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRV----E 400 (450)
T ss_dssp CCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--HHHHH----H
T ss_pred eCCCccccccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH----H
Confidence 99999864322 122356889999999999999999999999999999998 999986543322 11111 1
Q ss_pred ccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 041702 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEI 796 (840)
Q Consensus 744 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~ 796 (840)
.+. .+ ..+...+..+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 401 ~~~--~~-------~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 401 KGY--KM-------DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp TTC--CC-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCC--CC-------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 110 01 111223456888999999999999999999999999864
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=340.64 Aligned_cols=251 Identities=23% Similarity=0.351 Sum_probs=197.6
Q ss_pred HHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccce
Q 041702 511 AATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRL 588 (840)
Q Consensus 511 ~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l 588 (840)
...++|...+.||+|+||.||+|.++ .+++.||||++.... ....+.+.+|+.++++++||||+++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~------------~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~ 93 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHK------------TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 93 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEET------------TTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEEC------------CCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 34578999999999999999999765 678999999997543 2345678999999999999999999
Q ss_pred eeEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCC---Cc
Q 041702 589 FGCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDM---NP 661 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~---~~ 661 (840)
++++.+.+..++||||..... ......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+
T Consensus 94 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~ 170 (362)
T 2bdw_A 94 HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAV 170 (362)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCE
T ss_pred EEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCE
Confidence 999999999999999943322 223456899999999999999999999998 99999999999998654 59
Q ss_pred eeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhh
Q 041702 662 KISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNL 741 (840)
Q Consensus 662 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~ 741 (840)
||+|||++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.. .
T Consensus 171 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--~~~~~----~ 241 (362)
T 2bdw_A 171 KLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLYA----Q 241 (362)
T ss_dssp EECCCTTCBCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH----H
T ss_pred EEeecCcceEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHH----H
Confidence 999999998765332 22346799999999999999999999999999999999999999854321 11111 1
Q ss_pred hcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 742 WKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 742 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
...... .. ...........+.+++.+||+.||++||++.|+++.
T Consensus 242 i~~~~~-~~-----~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 242 IKAGAY-DY-----PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHHTCC-CC-----CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHhCCC-CC-----CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111100 00 011111234567899999999999999999999853
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=339.44 Aligned_cols=264 Identities=28% Similarity=0.411 Sum_probs=203.6
Q ss_pred HHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhc-CCCCccc
Q 041702 510 SAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKL-QHRNLVR 587 (840)
Q Consensus 510 ~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l-~H~niv~ 587 (840)
+...++|...+.||+|+||.||+|.+.. .+.......||||++..... ...+.+.+|+.++.++ +||||++
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-------~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~ 114 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFG-------LGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVN 114 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETT-------CSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecC-------CCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeee
Confidence 3456889999999999999999997651 12223456899999976532 3456799999999999 8999999
Q ss_pred eeeEeecCCceEEEEEeeccCCcc------------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCC
Q 041702 588 LFGCCIEQGEKISIYEFDIVTDPA------------------RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLK 649 (840)
Q Consensus 588 l~g~~~~~~~~~lv~e~~~~~~~~------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk 649 (840)
+++++.+.+..++||||....... ....+++..++.++.||+.||+|||+.+ |+|||||
T Consensus 115 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 191 (333)
T 2i1m_A 115 LLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVA 191 (333)
T ss_dssp EEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCS
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcc
Confidence 999999999999999994221110 1345789999999999999999999998 9999999
Q ss_pred CCcEEecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCC
Q 041702 650 ASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYN 728 (840)
Q Consensus 650 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~ 728 (840)
|+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||++++||++ |..|+....
T Consensus 192 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 271 (333)
T 2i1m_A 192 ARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 271 (333)
T ss_dssp GGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred cceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence 9999999999999999999987654433333344567889999999999999999999999999999999 888876433
Q ss_pred CCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 729 TDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
.... .. ...... .....+. .....+.+++.+||+.||.+|||+.||++.|++...
T Consensus 272 ~~~~-~~----~~~~~~--~~~~~~~-------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 272 VNSK-FY----KLVKDG--YQMAQPA-------FAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp SSHH-HH----HHHHHT--CCCCCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhHH-HH----HHHhcC--CCCCCCC-------CCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 2211 11 111110 0001111 123457889999999999999999999999987643
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=335.14 Aligned_cols=270 Identities=28% Similarity=0.374 Sum_probs=207.4
Q ss_pred cCHHHHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhc-C
Q 041702 504 FSLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKL-Q 581 (840)
Q Consensus 504 ~~~~~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l-~ 581 (840)
+...+.....++|++.+.||+|+||.||+|.+... ....+++.||||++..... ...+.+.+|++++.++ +
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~ 89 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI-------DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESS-------SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCC
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecC-------CccccceEEEEEecccCCCcHHHHHHHHHHHHHHhccc
Confidence 34455666778999999999999999999975410 1345788999999976533 3346799999999999 7
Q ss_pred CCCccceeeEeecCC-ceEEEEEeeccCCc----c----------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 041702 582 HRNLVRLFGCCIEQG-EKISIYEFDIVTDP----A----------------RKDLLDWTTRVRIIEGVAQGLLYLHQYSR 640 (840)
Q Consensus 582 H~niv~l~g~~~~~~-~~~lv~e~~~~~~~----~----------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ 640 (840)
||||+++++++...+ ..++++||...... . ....+++..+..++.||+.||.|||+.+
T Consensus 90 hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~- 168 (316)
T 2xir_A 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK- 168 (316)
T ss_dssp CTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred CCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 999999999988755 48999998321110 0 0223789999999999999999999998
Q ss_pred CceecCCCCCCcEEecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-
Q 041702 641 LRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS- 719 (840)
Q Consensus 641 ~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt- 719 (840)
|+||||||+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||++++||++
T Consensus 169 --i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~ 246 (316)
T 2xir_A 169 --CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 246 (316)
T ss_dssp --CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred --cccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhC
Confidence 99999999999999999999999999987755443333445668899999999999999999999999999999998
Q ss_pred CCCCCCCCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 720 SKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 720 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
|+.|+........ .. ........ ... .......+.+++.+||+.||++|||+.||++.|+.++.
T Consensus 247 g~~p~~~~~~~~~-~~----~~~~~~~~-----~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 247 GASPYPGVKIDEE-FC----RRLKEGTR-----MRA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp SCCSSTTCCCSHH-HH----HHHHHTCC-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCcccchhHH-HH----HHhccCcc-----CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 9998865432211 11 11111110 001 11123457889999999999999999999999998754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=335.31 Aligned_cols=240 Identities=21% Similarity=0.329 Sum_probs=195.5
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC--------cCHHHHHHHHHHHhhcCCC
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG--------QGLEEFKNEMMLIAKLQHR 583 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~--------~~~~~f~~Ev~~l~~l~H~ 583 (840)
..++|+..+.||+|+||.||+|.++ .+++.||||++..... ...+.+.+|+.++.+++||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~------------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 89 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDK------------EKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEET------------TTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCT
T ss_pred cccceEEEeEEEecCCEEEEEEEEC------------CCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCC
Confidence 4578999999999999999999765 6789999999976421 2345788999999999999
Q ss_pred CccceeeEeecCCceEEEEEeeccC-----CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCC
Q 041702 584 NLVRLFGCCIEQGEKISIYEFDIVT-----DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSD 658 (840)
Q Consensus 584 niv~l~g~~~~~~~~~lv~e~~~~~-----~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~ 658 (840)
||+++++++.+.+..++|||+.... .......+++..+..|+.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 90 ~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~ 166 (335)
T 3dls_A 90 NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAED 166 (335)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTT
T ss_pred CEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCC
Confidence 9999999999999999999984322 1223446899999999999999999999998 9999999999999999
Q ss_pred CCceeeccccceecCCCCcccccccccccccccCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHH
Q 041702 659 MNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLF-SIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGH 737 (840)
Q Consensus 659 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~ 737 (840)
+.+||+|||+++....... .....||+.|+|||.+.+..+ +.++||||||++++||++|+.||......
T Consensus 167 ~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------- 236 (335)
T 3dls_A 167 FTIKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------- 236 (335)
T ss_dssp SCEEECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-------
T ss_pred CcEEEeecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-------
Confidence 9999999999987654332 234578999999999988887 88999999999999999999998531100
Q ss_pred HhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 738 AWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 738 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
......+. ......+.+++.+||+.||++|||++++++.
T Consensus 237 ---------~~~~~~~~------~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 ---------VEAAIHPP------YLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ---------TTTCCCCS------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ---------HhhccCCC------cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000 1123457889999999999999999999874
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=351.05 Aligned_cols=193 Identities=25% Similarity=0.388 Sum_probs=149.1
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
.++|++.++||+|+||.||+|+++ .+++.||||++.... ....+++.+|+++|.+++||||+++++
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~------------~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 119 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDK------------LEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLD 119 (458)
T ss_dssp CTTEEECCC-------CEEEEEEC------------C--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CCCeEEeeEeeecCCeEEEEEEEC------------CCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEE
Confidence 478999999999999999999765 578999999997542 234567999999999999999999999
Q ss_pred EeecC-----CceEEEEEeec---cCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCce
Q 041702 591 CCIEQ-----GEKISIYEFDI---VTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPK 662 (840)
Q Consensus 591 ~~~~~-----~~~~lv~e~~~---~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 662 (840)
++... +..++|||+.. .........+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+|
T Consensus 120 ~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~k 196 (458)
T 3rp9_A 120 IVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVK 196 (458)
T ss_dssp ECCCSCTTTCCCEEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEE
T ss_pred EEecCCcccCceEEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEe
Confidence 99543 56899999832 111223456899999999999999999999998 99999999999999999999
Q ss_pred eeccccceecCCCCcc-------------------------cccccccccccccCcccc-ccCCCCccccchhHHHHHHH
Q 041702 663 ISDFGIARTFGGDEMQ-------------------------SNTNRIVGTYGYMSPEYA-LHGLFSIKSDVFSFGVLLLE 716 (840)
Q Consensus 663 L~DFGla~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~ksDV~SlGviL~e 716 (840)
|+|||+|+........ ......+||+.|+|||++ .+..++.++|||||||+|+|
T Consensus 197 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~e 276 (458)
T 3rp9_A 197 VCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAE 276 (458)
T ss_dssp ECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHH
T ss_pred ecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHH
Confidence 9999999876432110 122345789999999976 46679999999999999999
Q ss_pred HHhC
Q 041702 717 ILSS 720 (840)
Q Consensus 717 lltG 720 (840)
|++|
T Consensus 277 lltg 280 (458)
T 3rp9_A 277 LLNM 280 (458)
T ss_dssp HHTT
T ss_pred HHHh
Confidence 9994
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=337.79 Aligned_cols=266 Identities=25% Similarity=0.406 Sum_probs=206.2
Q ss_pred HHHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcCCCCc
Q 041702 507 SSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQHRNL 585 (840)
Q Consensus 507 ~~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~H~ni 585 (840)
.+++...++|+..+.||+|+||.||+|.++.. ....+++.||||++..... ....+|.+|++++++++||||
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-------~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 90 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGV-------VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEE-------ETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTB
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCc-------cCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCE
Confidence 34455678999999999999999999976511 1123578899999975432 334579999999999999999
Q ss_pred cceeeEeecCCceEEEEEeeccCCcc--------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCC
Q 041702 586 VRLFGCCIEQGEKISIYEFDIVTDPA--------------RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKAS 651 (840)
Q Consensus 586 v~l~g~~~~~~~~~lv~e~~~~~~~~--------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~ 651 (840)
+++++++.+.+..++|||+....... ....+++..+++++.||+.||+|||+.+ |+||||||+
T Consensus 91 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~ 167 (322)
T 1p4o_A 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAAR 167 (322)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGG
T ss_pred eeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccc
Confidence 99999999999999999994322111 1145689999999999999999999998 999999999
Q ss_pred cEEecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCC
Q 041702 652 NVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTD 730 (840)
Q Consensus 652 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~ 730 (840)
|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||++++||++ |+.|+......
T Consensus 168 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 247 (322)
T 1p4o_A 168 NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 247 (322)
T ss_dssp GEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH
T ss_pred eEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH
Confidence 99999999999999999987654433333344567889999999999999999999999999999999 78887543211
Q ss_pred CccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 731 SLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
... ......... .........+.+++.+||+.||++|||+.|+++.|++...
T Consensus 248 --~~~----~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 248 --QVL----RFVMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp --HHH----HHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred --HHH----HHHHcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 111 111111110 0111233457889999999999999999999999998744
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=328.01 Aligned_cols=257 Identities=25% Similarity=0.434 Sum_probs=185.6
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCcccee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
..++|++.++||+|+||.||+|.+. ..||||+++... ....+.|.+|++++++++||||++++
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~---------------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH---------------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS---------------SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc---------------CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEE
Confidence 4578999999999999999998543 359999997543 23456799999999999999999999
Q ss_pred eEeecCCceEEEEEeeccCC-----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 590 GCCIEQGEKISIYEFDIVTD-----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~~-----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
+++ ..+..++||||..... ......+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 87 ~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~ 162 (289)
T 3og7_A 87 GYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIG 162 (289)
T ss_dssp EEE-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEEC
T ss_pred eec-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEc
Confidence 975 4566889999842211 122456899999999999999999999998 9999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhh
Q 041702 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYAL---HGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNL 741 (840)
Q Consensus 665 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~ 741 (840)
|||++................||+.|+|||.+. +..++.++||||||++++||++|+.|+....... ... ..
T Consensus 163 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~----~~ 237 (289)
T 3og7_A 163 DFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-QII----EM 237 (289)
T ss_dssp CCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH-HHH----HH
T ss_pred cceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH-HHH----HH
Confidence 999998665433333334567899999999986 6678999999999999999999999986433211 111 11
Q ss_pred hcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 742 WKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 742 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
...... .+.. .......+..+.+++.+||+.||++|||+.++++.|+++..
T Consensus 238 ~~~~~~----~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 238 VGRGSL----SPDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp HHHTSC----CCCT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred hccccc----Ccch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 111111 0110 00111234568899999999999999999999999998743
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=342.47 Aligned_cols=246 Identities=26% Similarity=0.323 Sum_probs=192.6
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhc-CCCCccc
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKL-QHRNLVR 587 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l-~H~niv~ 587 (840)
..++|+..++||+|+||.||+|+++ .+++.||||++++. .....+.+.+|.+++..+ +||||++
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~------------~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~ 88 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVK------------ETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEET------------TTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCC
T ss_pred chhheEEEEEEeeCCCEEEEEEEEc------------CCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceee
Confidence 4578999999999999999999765 67899999999753 234567789999999998 7999999
Q ss_pred eeeEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCcee
Q 041702 588 LFGCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKI 663 (840)
Q Consensus 588 l~g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL 663 (840)
+++++.+.+..++||||..... ......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 89 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL 165 (353)
T 3txo_A 89 LFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKL 165 (353)
T ss_dssp EEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEE
T ss_pred EEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEE
Confidence 9999999999999999953322 233467999999999999999999999998 999999999999999999999
Q ss_pred eccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhc
Q 041702 664 SDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWK 743 (840)
Q Consensus 664 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~ 743 (840)
+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+... ..
T Consensus 166 ~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--~~~~~----i~ 237 (353)
T 3txo_A 166 ADFGMCKEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED--DLFEA----IL 237 (353)
T ss_dssp CCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH----HH
T ss_pred ccccceeecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH--HHHHH----HH
Confidence 9999998643222 2234567999999999999999999999999999999999999998643221 11111 11
Q ss_pred ccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 041702 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTM------LEVVA 790 (840)
Q Consensus 744 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~ 790 (840)
... . .. +......+.+++.+||+.||++||++ +||++
T Consensus 238 ~~~---~---~~----p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 238 NDE---V---VY----PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HCC---C---CC----CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred cCC---C---CC----CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 110 0 01 11123457889999999999999998 66664
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=329.76 Aligned_cols=259 Identities=22% Similarity=0.280 Sum_probs=191.5
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC--cCHHHHHHHHHHHhhcCCCCccceee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG--QGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
.++|+..++||+|+||.||+|.++ .+++.||||++..... ...+.+.+|++++.+++||||+++++
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 69 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNR------------DTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEET------------TTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeC------------CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhh
Confidence 367999999999999999999765 5789999999865432 22466889999999999999999999
Q ss_pred EeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 591 CCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
++.+.+..++||||..... ......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 70 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Df 146 (311)
T 4agu_A 70 VFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDF 146 (311)
T ss_dssp EEEETTEEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eeecCCeEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeC
Confidence 9999999999999943211 122456899999999999999999999998 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhh----
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNL---- 741 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~---- 741 (840)
|++........ ......||+.|+|||.+.+ ..++.++||||||++++||++|+.|+......+. .......
T Consensus 147 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~ 222 (311)
T 4agu_A 147 GFARLLTGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ--LYLIRKTLGDL 222 (311)
T ss_dssp TTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCSC
T ss_pred CCchhccCccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhccc
Confidence 99987643221 2234578999999999876 6789999999999999999999999865432211 1100000
Q ss_pred -------hcccc---cccccCccccc---hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 742 -------WKDDK---AWKLMDPTMQN---EALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 742 -------~~~~~---~~~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
..... ...+.++.... .........+.+++.+||+.||++|||++|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 223 IPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp CHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000 00111111100 011233456889999999999999999999985
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=341.29 Aligned_cols=265 Identities=26% Similarity=0.397 Sum_probs=203.5
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhc-CCCCcccee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKL-QHRNLVRLF 589 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l-~H~niv~l~ 589 (840)
..++|...+.||+|+||.||+|.+... ......+++.||||++.... ....+++.+|++++.++ +||||++++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 107 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGI-----DKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL 107 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTC-----STTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccc-----cccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEE
Confidence 457899999999999999999976410 01123467889999997543 23456799999999999 899999999
Q ss_pred eEeecCCceEEEEEeeccCCc--------------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCC
Q 041702 590 GCCIEQGEKISIYEFDIVTDP--------------------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLK 649 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~~~--------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk 649 (840)
+++...+..++||||...... .....+++..++.++.||+.||+|||+.+ |+|||||
T Consensus 108 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlk 184 (334)
T 2pvf_A 108 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLA 184 (334)
T ss_dssp EEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCS
T ss_pred EEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCc
Confidence 999999999999999422111 01234889999999999999999999998 9999999
Q ss_pred CCcEEecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCC
Q 041702 650 ASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYN 728 (840)
Q Consensus 650 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~ 728 (840)
|+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||++++||++ |+.|+....
T Consensus 185 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 185 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp GGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 9999999999999999999988765443333444567889999999999999999999999999999999 998875432
Q ss_pred CCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCC
Q 041702 729 TDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNL 799 (840)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~ 799 (840)
.. ... ........ ... .......+.+++.+||+.||++|||+.||++.|+++....
T Consensus 265 ~~--~~~----~~~~~~~~-----~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 265 VE--ELF----KLLKEGHR-----MDK----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp HH--HHH----HHHHHTCC-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HH--HHH----HHHhcCCC-----CCC----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 11 111 11111110 001 1122345788999999999999999999999999876543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=338.02 Aligned_cols=244 Identities=24% Similarity=0.343 Sum_probs=189.0
Q ss_pred cccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEeecCC
Q 041702 517 SEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQG 596 (840)
Q Consensus 517 ~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~ 596 (840)
...+.||+|+||.||+|.++ .+|+.||||+++.......++|.+|++++.+++||||+++++++.+.+
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~------------~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 159 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEET------------ATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKN 159 (373)
T ss_dssp EEEEECC-----CEEEEEET------------TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ecceEEecCcCEEEEEEEEc------------CCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 33578999999999999765 678999999998765555678999999999999999999999999999
Q ss_pred ceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEe--cCCCCceeeccccc
Q 041702 597 EKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLL--DSDMNPKISDFGIA 669 (840)
Q Consensus 597 ~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl--~~~~~~kL~DFGla 669 (840)
..++||||...... .....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 160 ~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a 236 (373)
T 2x4f_A 160 DIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLA 236 (373)
T ss_dssp EEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSC
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCc
Confidence 99999999533221 12346899999999999999999999998 9999999999999 56788999999999
Q ss_pred eecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccccccc
Q 041702 670 RTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWK 749 (840)
Q Consensus 670 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (840)
+.+..... .....||+.|+|||++.+..++.++|||||||+++||++|+.||...... ...... .... ..
T Consensus 237 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~~~~i---~~~~--~~ 306 (373)
T 2x4f_A 237 RRYKPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA--ETLNNI---LACR--WD 306 (373)
T ss_dssp EECCTTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHH---HHTC--CC
T ss_pred eecCCccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH---Hhcc--CC
Confidence 88754322 23346999999999999999999999999999999999999998643211 111111 1100 00
Q ss_pred ccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 750 LMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 750 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
............+.+++.+||+.||++|||+.|+++
T Consensus 307 -----~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 307 -----LEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp -----SCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----CChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 111111223456889999999999999999999986
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=340.78 Aligned_cols=249 Identities=22% Similarity=0.326 Sum_probs=197.9
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
.++|++.+.||+|+||.||+|.++ .+++.||+|++..........+.+|+++|.+++||||+++++++
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~------------~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~ 117 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEK------------ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEET------------TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEEC------------CCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEE
Confidence 468999999999999999999765 57899999999865544556799999999999999999999999
Q ss_pred ecCCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecC--CCCceeec
Q 041702 593 IEQGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS--DMNPKISD 665 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~--~~~~kL~D 665 (840)
.+.+..++||||...... .....+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|
T Consensus 118 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~D 194 (387)
T 1kob_A 118 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIID 194 (387)
T ss_dssp ECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECC
T ss_pred EeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEe
Confidence 999999999999532221 12236899999999999999999999998 999999999999974 47799999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
||+++....... .....||+.|+|||++.+..++.++|||||||+++||++|+.||..... ....... .. .
T Consensus 195 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--~~~~~~i---~~-~ 265 (387)
T 1kob_A 195 FGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--LETLQNV---KR-C 265 (387)
T ss_dssp CTTCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHHH---HH-C
T ss_pred cccceecCCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH--HHHHHHH---Hh-C
Confidence 999988754332 2335789999999999999999999999999999999999999864321 1111111 00 0
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
. . ..++ .........+.+++.+||+.||++|||+.|+++.
T Consensus 266 ~-~-~~~~----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 266 D-W-EFDE----DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp C-C-CCCS----STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred C-C-CCCc----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0 0 0111 1111234567899999999999999999999863
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=337.19 Aligned_cols=249 Identities=20% Similarity=0.281 Sum_probs=181.8
Q ss_pred HHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 511 AATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 511 ~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
...++|++.+.||+|+||.||+|.++ .+++.||||++.... ..+.+.+|++++.+++||||+++++
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~------------~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~ 115 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQK------------GTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKE 115 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEET------------TTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEEC------------CCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceee
Confidence 35678999999999999999999765 568899999997643 3467889999999999999999999
Q ss_pred EeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecC---CCCcee
Q 041702 591 CCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS---DMNPKI 663 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kL 663 (840)
++.+.+..++||||..... ......+++.++..++.||+.||.|||+.+ |+||||||+|||++. ++.+||
T Consensus 116 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl 192 (349)
T 2w4o_A 116 IFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKI 192 (349)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEE
T ss_pred eEecCCeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEE
Confidence 9999999999999953222 223456899999999999999999999998 999999999999975 889999
Q ss_pred eccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhc
Q 041702 664 SDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWK 743 (840)
Q Consensus 664 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~ 743 (840)
+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.|+........ .. ....
T Consensus 193 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~----~~i~ 264 (349)
T 2w4o_A 193 ADFGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF-MF----RRIL 264 (349)
T ss_dssp CCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH-HH----HHHH
T ss_pred ccCccccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH-HH----HHHH
Confidence 9999998764322 22345789999999999999999999999999999999999999854322110 11 1111
Q ss_pred ccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 744 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.... ... ..........+.+++.+||+.||++|||+.|+++
T Consensus 265 ~~~~-~~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 265 NCEY-YFI-----SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TTCC-CCC-----TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hCCC-ccC-----CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1110 001 1111223456789999999999999999999986
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=341.02 Aligned_cols=265 Identities=18% Similarity=0.241 Sum_probs=196.7
Q ss_pred HccCCcccccccCC--CCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccc
Q 041702 512 ATDNFSEENKLGEG--GFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVR 587 (840)
Q Consensus 512 ~~~~f~~~~~lG~G--~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~ 587 (840)
..++|++.++||+| +||.||+|+++ .+++.||||++.... ....+.+.+|+.++++++|||||+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~------------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 90 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYK------------PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEET------------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEc------------CCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCc
Confidence 45789999999999 99999999765 579999999997543 233467889999999999999999
Q ss_pred eeeEeecCCceEEEEEeeccCCcc------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCc
Q 041702 588 LFGCCIEQGEKISIYEFDIVTDPA------RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP 661 (840)
Q Consensus 588 l~g~~~~~~~~~lv~e~~~~~~~~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 661 (840)
+++++.+.+..++||||....... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~ 167 (389)
T 3gni_B 91 YRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKV 167 (389)
T ss_dssp EEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCE
T ss_pred EeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCE
Confidence 999999999999999995332211 1256899999999999999999999998 9999999999999999999
Q ss_pred eeeccccceecCCCCc-----ccccccccccccccCcccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccH
Q 041702 662 KISDFGIARTFGGDEM-----QSNTNRIVGTYGYMSPEYALH--GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTL 734 (840)
Q Consensus 662 kL~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~ 734 (840)
||+|||.+........ ........||+.|+|||.+.+ ..++.++|||||||+++||++|+.||..........
T Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 247 (389)
T 3gni_B 168 YLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL 247 (389)
T ss_dssp EECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH
T ss_pred EEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 9999999875432211 111233478999999999987 679999999999999999999999986543332111
Q ss_pred hHHHhhh---hc-----ccc-------------cccccC---cc------ccchhhHHHHHHHHHHHHHccccCCCCCCC
Q 041702 735 LGHAWNL---WK-----DDK-------------AWKLMD---PT------MQNEALYSMVTRYIKVALLCVQENATDRPT 784 (840)
Q Consensus 735 ~~~~~~~---~~-----~~~-------------~~~~~d---~~------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 784 (840)
....... .. ... ....+. +. ............+.+++.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 327 (389)
T 3gni_B 248 EKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPS 327 (389)
T ss_dssp HC--------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCC
T ss_pred HHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCC
Confidence 0000000 00 000 000000 00 000111223456889999999999999999
Q ss_pred HHHHHHH
Q 041702 785 MLEVVAM 791 (840)
Q Consensus 785 ~~evl~~ 791 (840)
++|+++.
T Consensus 328 a~ell~h 334 (389)
T 3gni_B 328 ASTLLNH 334 (389)
T ss_dssp HHHHTTS
T ss_pred HHHHhcC
Confidence 9999853
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-37 Score=324.31 Aligned_cols=248 Identities=21% Similarity=0.331 Sum_probs=198.6
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
..++|++.+.||+|+||.||+|.++ .++..||+|++........+++.+|++++++++||||++++++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 74 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQK------------GTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 74 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEET------------TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeC------------CCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 4567999999999999999999765 5688999999987666678899999999999999999999999
Q ss_pred eecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEe---cCCCCceee
Q 041702 592 CIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLL---DSDMNPKIS 664 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl---~~~~~~kL~ 664 (840)
+.+.+..++||||..... ......+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+
T Consensus 75 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~ 151 (277)
T 3f3z_A 75 FEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLI 151 (277)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEEC
T ss_pred EecCCeEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEE
Confidence 999999999999953322 223456899999999999999999999998 9999999999999 788999999
Q ss_pred ccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 665 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
|||++....... ......||+.|+|||.+.+. ++.++||||||++++||++|+.|+...... ... .....
T Consensus 152 Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~----~~~~~ 221 (277)
T 3f3z_A 152 DFGLAARFKPGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS--EVM----LKIRE 221 (277)
T ss_dssp CCTTCEECCTTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH----HHHHH
T ss_pred ecccceeccCcc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH--HHH----HHHHh
Confidence 999998765433 22345689999999988654 999999999999999999999998643211 111 11111
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.. ..............+.+++.+||+.||++|||+.++++
T Consensus 222 ~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 222 GT------FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp CC------CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CC------CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 00111111123456889999999999999999999984
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=332.57 Aligned_cols=257 Identities=20% Similarity=0.250 Sum_probs=196.9
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
..++|+..+.||+|+||.||+|.++ .+++.||||++........+.+.+|++++++++||||++++++
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 94 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGL------------HDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEET------------TTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEec------------CCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 4578999999999999999999765 5789999999976655566789999999999999999999999
Q ss_pred ee----cCCceEEEEEeeccCCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCC
Q 041702 592 CI----EQGEKISIYEFDIVTDP--------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDM 659 (840)
Q Consensus 592 ~~----~~~~~~lv~e~~~~~~~--------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~ 659 (840)
+. ..+..++|+||...... .....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 95 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~ 171 (317)
T 2buj_A 95 CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEG 171 (317)
T ss_dssp EEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTS
T ss_pred EEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCC
Confidence 97 34578899998533221 12456899999999999999999999998 99999999999999999
Q ss_pred CceeeccccceecCCCCccc-------ccccccccccccCccccccCC---CCccccchhHHHHHHHHHhCCCCCCCCCC
Q 041702 660 NPKISDFGIARTFGGDEMQS-------NTNRIVGTYGYMSPEYALHGL---FSIKSDVFSFGVLLLEILSSKKNTRFYNT 729 (840)
Q Consensus 660 ~~kL~DFGla~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~ksDV~SlGviL~elltG~~p~~~~~~ 729 (840)
.+||+|||++.......... ......||+.|+|||.+.+.. ++.++||||||++++||++|+.|+.....
T Consensus 172 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 251 (317)
T 2buj_A 172 QPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQ 251 (317)
T ss_dssp CEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHH
T ss_pred CEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhc
Confidence 99999999987653211100 112345799999999987654 78999999999999999999999753211
Q ss_pred CCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 041702 730 DSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEI 796 (840)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~ 796 (840)
......... .. .... .........+.+++.+||+.||++|||+++|++.|+.+.
T Consensus 252 ~~~~~~~~~----~~--~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 252 KGDSVALAV----QN--QLSI-------PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp TTSCHHHHH----HC--C--C-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred ccchhhHHh----hc--cCCC-------CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 111111100 00 0000 001122346889999999999999999999999999873
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=334.71 Aligned_cols=263 Identities=22% Similarity=0.277 Sum_probs=188.2
Q ss_pred HHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC--cCHHHHHHHHHHHhhcCCCCcc
Q 041702 509 ISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG--QGLEEFKNEMMLIAKLQHRNLV 586 (840)
Q Consensus 509 ~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv 586 (840)
.....++|+..++||+|+||.||+|.++ .+++.||||+++.... ...+.+.+|++++++++||||+
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 96 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDT------------VTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNII 96 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEET------------TTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBC
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEEC------------CCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcc
Confidence 3456688999999999999999999765 6789999999975432 3346788999999999999999
Q ss_pred ceeeEeecCCceEEEEEeecc---CCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEec-----CC
Q 041702 587 RLFGCCIEQGEKISIYEFDIV---TDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLD-----SD 658 (840)
Q Consensus 587 ~l~g~~~~~~~~~lv~e~~~~---~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~-----~~ 658 (840)
++++++.+.+..++||||... ........+++..+..++.||+.||+|||+.+ |+||||||+|||++ .+
T Consensus 97 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~ 173 (329)
T 3gbz_A 97 ELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASET 173 (329)
T ss_dssp CEEEEEEETTEEEEEEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----C
T ss_pred eEEEEEecCCEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCcc
Confidence 999999999999999999431 11223456899999999999999999999998 99999999999994 45
Q ss_pred CCceeeccccceecCCCCcccccccccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHH
Q 041702 659 MNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGH 737 (840)
Q Consensus 659 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~ 737 (840)
+.+||+|||+++.+.... .......+|+.|+|||.+.+. .++.++|||||||+++||++|+.||......+ ....
T Consensus 174 ~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~ 249 (329)
T 3gbz_A 174 PVLKIGDFGLARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID--QLFK 249 (329)
T ss_dssp CEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH
T ss_pred ceEEECcCCCccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH--HHHH
Confidence 559999999998764322 122345689999999999874 48999999999999999999999986433211 1111
Q ss_pred Hhhhhcccc----------------cccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 738 AWNLWKDDK----------------AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 738 ~~~~~~~~~----------------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
......... ........+...........+.+++.+||+.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 250 IFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp HHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 111100000 00000001111111113456789999999999999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=327.15 Aligned_cols=259 Identities=27% Similarity=0.401 Sum_probs=199.6
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
..++|+..+.||+|+||.||+|.+. ++..||||++... ....+.|.+|++++++++||||++++++
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-------------~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 76 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN-------------GHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAV 76 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-------------TTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc-------------CCcEEEEEEecCC-cccHHHHHHHHHHHHhCCCcCcceEEEE
Confidence 4578999999999999999998643 5678999999754 3456889999999999999999999999
Q ss_pred eecCCceEEEEEeeccCCc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 592 CIEQGEKISIYEFDIVTDP------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
+. .+..++|||+...... .....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 77 ~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~D 152 (279)
T 1qpc_A 77 VT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIAD 152 (279)
T ss_dssp EC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECC
T ss_pred Ec-CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECC
Confidence 86 4568899998432221 11226899999999999999999999998 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
||++........ .......++..|+|||.+.+..++.++||||||++++||++ |+.|+...... .... ....
T Consensus 153 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~----~~~~ 225 (279)
T 1qpc_A 153 FGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQ----NLER 225 (279)
T ss_dssp CTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHH----HHHT
T ss_pred CcccccccCccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH--HHHH----HHhc
Confidence 999987754332 12233456789999999998899999999999999999999 88887543211 1111 1111
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCCCCCCC
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSPHQ 804 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~p~~ 804 (840)
. ..... .......+.+++.+||+.||++|||+.++++.|++.........+
T Consensus 226 ~--~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~ 276 (279)
T 1qpc_A 226 G--YRMVR-------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQ 276 (279)
T ss_dssp T--CCCCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-----
T ss_pred c--cCCCC-------cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCCCC
Confidence 1 00001 112235688999999999999999999999999988666544433
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=348.76 Aligned_cols=259 Identities=17% Similarity=0.231 Sum_probs=200.9
Q ss_pred CHHHHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhcC
Q 041702 505 SLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQ 581 (840)
Q Consensus 505 ~~~~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l~ 581 (840)
.+.++....++|+..++||+|+||.||+|+++ .+++.||||++.+. .....+.+.+|+.++.+++
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~------------~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~ 132 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLK------------NADKVFAMKILNKWEMLKRAETACFREERDVLVNGD 132 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEET------------TTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSC
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEc------------CCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCC
Confidence 34566667889999999999999999999765 57899999999752 2233456899999999999
Q ss_pred CCCccceeeEeecCCceEEEEEeeccCCc----c-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEec
Q 041702 582 HRNLVRLFGCCIEQGEKISIYEFDIVTDP----A-RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLD 656 (840)
Q Consensus 582 H~niv~l~g~~~~~~~~~lv~e~~~~~~~----~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~ 656 (840)
||||++++++|.+.+..++||||...... . ....+++..+..++.||+.||+|||+.+ |+||||||+||||+
T Consensus 133 hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~ 209 (437)
T 4aw2_A 133 SKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMD 209 (437)
T ss_dssp TTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred CCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEc
Confidence 99999999999999999999999533221 1 1357899999999999999999999998 99999999999999
Q ss_pred CCCCceeeccccceecCCCCcccccccccccccccCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCC
Q 041702 657 SDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYAL-----HGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDS 731 (840)
Q Consensus 657 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~ 731 (840)
.++.+||+|||+++....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||......
T Consensus 210 ~~g~vkL~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~- 287 (437)
T 4aw2_A 210 MNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV- 287 (437)
T ss_dssp TTSCEEECCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-
T ss_pred CCCCEEEcchhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh-
Confidence 999999999999987654332 2233467999999999987 567999999999999999999999998643211
Q ss_pred ccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCC--CCCHHHHHH
Q 041702 732 LTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATD--RPTMLEVVA 790 (840)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~ 790 (840)
...... ..... ...-+.. .......+.+++.+||+.+|++ ||+++|+++
T Consensus 288 -~~~~~i---~~~~~--~~~~p~~----~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 288 -ETYGKI---MNHKE--RFQFPTQ----VTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp -HHHHHH---HTHHH--HCCCCSS----CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred -HHHHhh---hhccc--cccCCcc----cccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 111111 10000 0000111 0112345788999999888887 999999985
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=331.58 Aligned_cols=242 Identities=23% Similarity=0.309 Sum_probs=196.1
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhcCCCCcccee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
.++|+..+.||+|+||.||+|+++ .+|+.||+|+++.. .....+.+.+|+.+++.++||||++++
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~------------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~ 72 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSR------------HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 72 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET------------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEEC------------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEe
Confidence 367899999999999999999765 67899999999753 234567889999999999999999999
Q ss_pred eEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 590 GCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
+++.+.+..++||||..... ......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 73 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~D 149 (318)
T 1fot_A 73 GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITD 149 (318)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECC
T ss_pred EEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEee
Confidence 99999999999999943222 223456899999999999999999999988 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
||+++..... .....||+.|+|||.+.+..++.++|||||||+++||++|+.||..... .... ..... .
T Consensus 150 fg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~---~~i~~-~ 218 (318)
T 1fot_A 150 FGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT--MKTY---EKILN-A 218 (318)
T ss_dssp CSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--HHHH---HHHHH-C
T ss_pred cCcceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHHH---HHHHh-C
Confidence 9999875432 2346799999999999999999999999999999999999999854321 1111 11111 1
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRP-----TMLEVVA 790 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 790 (840)
. .... ......+.+++.+||+.||++|| +++||++
T Consensus 219 ~------~~~p----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 219 E------LRFP----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp C------CCCC----TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred C------CCCC----CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 1 0111 12234578899999999999999 8888883
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=333.10 Aligned_cols=246 Identities=20% Similarity=0.272 Sum_probs=192.4
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC---cCHHHHHHHHHHHhhc-CCCCccce
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG---QGLEEFKNEMMLIAKL-QHRNLVRL 588 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~---~~~~~f~~Ev~~l~~l-~H~niv~l 588 (840)
.++|+..+.||+|+||.||+|+++ .+++.||||++..... ...+.+.+|+.++.++ +||||+++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~------------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l 75 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLK------------KTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET------------TTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred hhheEEEEEEEecCCeEEEEEEEC------------CCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeE
Confidence 367899999999999999999765 6789999999976432 2345688999999988 89999999
Q ss_pred eeEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 589 FGCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
++++.+.+..++||||..... ......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 76 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~ 152 (345)
T 3a8x_A 76 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLT 152 (345)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEEC
T ss_pred EEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEE
Confidence 999999999999999953322 223457899999999999999999999998 9999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCc---cHhHHHhhh
Q 041702 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSL---TLLGHAWNL 741 (840)
Q Consensus 665 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~---~~~~~~~~~ 741 (840)
|||+++...... .......||+.|+|||.+.+..++.++|||||||+++||++|+.||........ .........
T Consensus 153 DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 230 (345)
T 3a8x_A 153 DYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 230 (345)
T ss_dssp CGGGCBCSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHH
T ss_pred eccccccccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHH
Confidence 999998643221 223456799999999999999999999999999999999999999865322211 001111111
Q ss_pred hcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCH
Q 041702 742 WKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTM 785 (840)
Q Consensus 742 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 785 (840)
..... ..+ +......+.+++.+||+.||++||++
T Consensus 231 i~~~~------~~~----p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 231 ILEKQ------IRI----PRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HHHCC------CCC----CTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred HHcCC------CCC----CCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 11111 011 11234457889999999999999996
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=339.92 Aligned_cols=244 Identities=29% Similarity=0.457 Sum_probs=193.1
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC---cCHHHHHHHHHHHhhcCCCCcccee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG---QGLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
.+.|+..+.||+|+||.||+|.+. .+++.||||++..... ...++|.+|++++++++||||++++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 120 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDV------------RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET------------TTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEc------------cCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 356889999999999999999754 6789999999975432 2345789999999999999999999
Q ss_pred eEeecCCceEEEEEeeccC---C-ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 590 GCCIEQGEKISIYEFDIVT---D-PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~---~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
+++...+..++||||.... . ......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 121 ~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~D 197 (348)
T 1u5q_A 121 GCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGD 197 (348)
T ss_dssp EEEEETTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECC
T ss_pred EEEEECCeEEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEee
Confidence 9999999999999995211 0 112456899999999999999999999998 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhh
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYAL---HGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLW 742 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~ 742 (840)
||+++.... .....||+.|+|||.+. +..++.++|||||||+++||++|+.|+..... ........
T Consensus 198 fG~a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~-----~~~~~~~~ 266 (348)
T 1u5q_A 198 FGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYHIA 266 (348)
T ss_dssp CTTCBSSSS------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHH
T ss_pred ccCceecCC------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHH
Confidence 999986542 23457899999999884 56799999999999999999999999753321 11111111
Q ss_pred cccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 743 KDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 743 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
... .+.... ......+.+++.+||+.||++|||++++++.
T Consensus 267 ~~~------~~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 267 QNE------SPALQS---GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp HSC------CCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred hcC------CCCCCC---CCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 111 011111 1123457789999999999999999999753
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=340.18 Aligned_cols=262 Identities=25% Similarity=0.349 Sum_probs=189.8
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
..|...+.||+|+||.||+|.+. ..-..+..||||.++... ....++|.+|+.++++++||||++++++|
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~ 159 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLL---------DNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC 159 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEE---------ETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEE---------CCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 34677789999999999998754 111234579999997543 34467899999999999999999999997
Q ss_pred ec-CCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 593 IE-QGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 593 ~~-~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
.+ .+..++||||...... .....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 160 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DF 236 (373)
T 3c1x_A 160 LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADF 236 (373)
T ss_dssp CCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC
T ss_pred EcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeec
Confidence 65 4578999999533221 12345788999999999999999999998 999999999999999999999999
Q ss_pred ccceecCCCCccc--ccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhc
Q 041702 667 GIARTFGGDEMQS--NTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWK 743 (840)
Q Consensus 667 Gla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 743 (840)
|+++.+....... ......+|+.|+|||.+.+..++.++||||||+++|||++ |.+|+......+ ..... .
T Consensus 237 G~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~--~~~~~----~ 310 (373)
T 3c1x_A 237 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYL----L 310 (373)
T ss_dssp ---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC--HHHHH----H
T ss_pred cccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH--HHHHH----H
Confidence 9998764332211 2233457789999999999999999999999999999999 566665433222 11111 1
Q ss_pred ccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCCCCC
Q 041702 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSP 802 (840)
Q Consensus 744 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~p 802 (840)
... ....+. ..+..+.+++.+||+.||++|||++||++.|+.+...+...
T Consensus 311 ~~~--~~~~p~-------~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 311 QGR--RLLQPE-------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp TTC--CCCCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred cCC--CCCCCC-------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 111 111111 12345788999999999999999999999999987766533
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=334.83 Aligned_cols=256 Identities=20% Similarity=0.257 Sum_probs=193.5
Q ss_pred HHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC-----CCcCHHHHHHHHHHHhhcCC
Q 041702 508 SISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK-----SGQGLEEFKNEMMLIAKLQH 582 (840)
Q Consensus 508 ~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~-----~~~~~~~f~~Ev~~l~~l~H 582 (840)
++....++|+..+.||+|+||.||+|.++ .+++.||||++... .....+++.+|++++++++|
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 87 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIEN------------QTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEET------------TTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEEC------------CCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCC
Confidence 35677889999999999999999999765 67889999998643 23456789999999999999
Q ss_pred CCccceeeEeecCCceEEEEEeeccCCcc--------------------------------------------ccCCCCH
Q 041702 583 RNLVRLFGCCIEQGEKISIYEFDIVTDPA--------------------------------------------RKDLLDW 618 (840)
Q Consensus 583 ~niv~l~g~~~~~~~~~lv~e~~~~~~~~--------------------------------------------~~~~l~~ 618 (840)
|||+++++++.+.+..++||||....... ....+++
T Consensus 88 pniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (345)
T 3hko_A 88 PNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQRE 167 (345)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHH
T ss_pred CCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccH
Confidence 99999999999999999999994221110 0112346
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCC--CceeeccccceecCCCCc--ccccccccccccccCcc
Q 041702 619 TTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDM--NPKISDFGIARTFGGDEM--QSNTNRIVGTYGYMSPE 694 (840)
Q Consensus 619 ~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~--~~kL~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE 694 (840)
..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++.+..... ........||+.|+|||
T Consensus 168 ~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE 244 (345)
T 3hko_A 168 KLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE 244 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHH
T ss_pred HHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCch
Confidence 677889999999999999998 99999999999998776 899999999987643221 11234567999999999
Q ss_pred cccc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHH
Q 041702 695 YALH--GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVAL 772 (840)
Q Consensus 695 ~~~~--~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~ 772 (840)
.+.+ ..++.++||||||++++||++|+.||......+ . ......... . ............+.+++.
T Consensus 245 ~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~---~~~~~~~~~--~-----~~~~~~~~~~~~~~~li~ 312 (345)
T 3hko_A 245 VLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDAD--T---ISQVLNKKL--C-----FENPNYNVLSPLARDLLS 312 (345)
T ss_dssp HHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--H---HHHHHHCCC--C-----TTSGGGGGSCHHHHHHHH
T ss_pred hhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHH--H---HHHHHhccc--c-----cCCcccccCCHHHHHHHH
Confidence 9875 678999999999999999999999986433211 1 111111110 0 011111123456789999
Q ss_pred HccccCCCCCCCHHHHHH
Q 041702 773 LCVQENATDRPTMLEVVA 790 (840)
Q Consensus 773 ~Cl~~dP~~RPs~~evl~ 790 (840)
+||+.||++||++.|+++
T Consensus 313 ~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 313 NLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHSCSCTTTSCCHHHHHH
T ss_pred HHcCCChhHCCCHHHHhc
Confidence 999999999999999986
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=330.60 Aligned_cols=257 Identities=20% Similarity=0.263 Sum_probs=192.4
Q ss_pred ccCCccc-ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhc-CCCCccceee
Q 041702 513 TDNFSEE-NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL-QHRNLVRLFG 590 (840)
Q Consensus 513 ~~~f~~~-~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g 590 (840)
.+.|.+. +.||+|+||.||+|.++ .+++.||||++........+++.+|++++.++ +||||+++++
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~------------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~ 78 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINL------------ITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECS------------SSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEc------------CCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEE
Confidence 3567774 78999999999999765 67899999999876666778899999999995 7999999999
Q ss_pred EeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCC---cee
Q 041702 591 CCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMN---PKI 663 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~---~kL 663 (840)
++.+.+..++||||..... ......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||
T Consensus 79 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl 155 (316)
T 2ac3_A 79 FFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKI 155 (316)
T ss_dssp EEEETTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEE
T ss_pred EEeeCCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEE
Confidence 9999999999999953222 223456899999999999999999999998 999999999999998776 999
Q ss_pred eccccceecCCCCc-----ccccccccccccccCcccccc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc
Q 041702 664 SDFGIARTFGGDEM-----QSNTNRIVGTYGYMSPEYALH-----GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLT 733 (840)
Q Consensus 664 ~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~ 733 (840)
+|||++........ ........||+.|+|||.+.+ ..++.++|||||||+++||++|+.||......+..
T Consensus 156 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 235 (316)
T 2ac3_A 156 CDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG 235 (316)
T ss_dssp CCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSC
T ss_pred EEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccc
Confidence 99999976542211 111223568999999999875 56899999999999999999999998765433210
Q ss_pred H---------hHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 734 L---------LGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 734 ~---------~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
. ............ ..............+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~i~~~~------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 236 WDRGEACPACQNMLFESIQEGK------YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp C----CCHHHHHHHHHHHHHCC------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccccccchhHHHHHHHHHhccC------cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 0 000001111110 00111111123456889999999999999999999987
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=328.82 Aligned_cols=261 Identities=25% Similarity=0.354 Sum_probs=191.8
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhcCCCCcccee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
.++|++.+.||+|+||.||+|.+. .+++.||||++.... ....+++.+|+.++++++||||++++
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~------------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 98 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACL------------LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEET------------TTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred ccceEEEEeecCCCCceEEEEEEc------------CCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 467999999999999999999754 578999999997532 23456789999999999999999999
Q ss_pred eEeecCCceEEEEEeeccCCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCc
Q 041702 590 GCCIEQGEKISIYEFDIVTDP--------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP 661 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~~~--------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 661 (840)
+++.+.+..+++||+...... .....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~ 175 (310)
T 2wqm_A 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVV 175 (310)
T ss_dssp EEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCE
T ss_pred EEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCE
Confidence 999999999999999433221 12456889999999999999999999998 9999999999999999999
Q ss_pred eeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhh
Q 041702 662 KISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNL 741 (840)
Q Consensus 662 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~ 741 (840)
||+|||++........ ......|++.|+|||.+.+..++.++||||||++++||++|+.|+............ .
T Consensus 176 kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~----~ 249 (310)
T 2wqm_A 176 KLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK----K 249 (310)
T ss_dssp EECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHH----H
T ss_pred EEEeccceeeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHH----H
Confidence 9999999987643221 223456899999999999999999999999999999999999998543222111111 1
Q ss_pred hcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCCCCC
Q 041702 742 WKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSP 802 (840)
Q Consensus 742 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~p 802 (840)
....... ... .......+.+++.+||+.||++|||+.+|++.|+++......|
T Consensus 250 ~~~~~~~-----~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~ 302 (310)
T 2wqm_A 250 IEQCDYP-----PLP---SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302 (310)
T ss_dssp HHTTCSC-----CCC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred hhcccCC-----CCc---ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence 1111110 110 1122345788999999999999999999999999875554433
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=337.38 Aligned_cols=247 Identities=23% Similarity=0.311 Sum_probs=196.6
Q ss_pred HHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhc-CCCCc
Q 041702 510 SAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKL-QHRNL 585 (840)
Q Consensus 510 ~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l-~H~ni 585 (840)
....++|...+.||+|+||.||+|+++ .+++.||||+++... ....+.+..|..++.++ +||||
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~i 80 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFK------------KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 80 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEET------------TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTB
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEEC------------CCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCC
Confidence 446689999999999999999999765 578999999997542 34567789999999987 99999
Q ss_pred cceeeEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCc
Q 041702 586 VRLFGCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP 661 (840)
Q Consensus 586 v~l~g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 661 (840)
+++++++.+.+..++||||..... ......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 81 v~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~v 157 (345)
T 1xjd_A 81 THMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHI 157 (345)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCE
T ss_pred CcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCE
Confidence 999999999999999999953322 223457899999999999999999999998 9999999999999999999
Q ss_pred eeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhh
Q 041702 662 KISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNL 741 (840)
Q Consensus 662 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~ 741 (840)
||+|||+++...... .......||+.|+|||++.+..++.++|||||||+++||++|+.||...... .+.. .
T Consensus 158 kL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~----~ 229 (345)
T 1xjd_A 158 KIADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--ELFH----S 229 (345)
T ss_dssp EECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH----H
T ss_pred EEeEChhhhhcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH--HHHH----H
Confidence 999999998643222 2234567999999999999999999999999999999999999998643211 1111 1
Q ss_pred hcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 041702 742 WKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTML-EVV 789 (840)
Q Consensus 742 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl 789 (840)
..... +... ......+.+++.+||+.||++||++. +|+
T Consensus 230 i~~~~------~~~p----~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 230 IRMDN------PFYP----RWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp HHHCC------CCCC----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred HHhCC------CCCC----cccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 11110 1111 11234578899999999999999997 665
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=339.77 Aligned_cols=250 Identities=23% Similarity=0.294 Sum_probs=186.6
Q ss_pred HHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--------CcCHHHHHHHHHHHhhcCC
Q 041702 511 AATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--------GQGLEEFKNEMMLIAKLQH 582 (840)
Q Consensus 511 ~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--------~~~~~~f~~Ev~~l~~l~H 582 (840)
...++|...+.||+|+||.||+|.++ .+++.||||++.... ......+.+|+++|++++|
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~------------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 199 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFER------------KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEET------------TTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCC
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEEC------------CCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCC
Confidence 45689999999999999999999765 678999999987531 1223468999999999999
Q ss_pred CCccceeeEeecCCceEEEEEeeccC----CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCC
Q 041702 583 RNLVRLFGCCIEQGEKISIYEFDIVT----DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSD 658 (840)
Q Consensus 583 ~niv~l~g~~~~~~~~~lv~e~~~~~----~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~ 658 (840)
|||+++++++. .+..++||||.... .......+++..+..++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 200 pniv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~ 275 (419)
T 3i6u_A 200 PCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQ 275 (419)
T ss_dssp TTBCCCCEEEE-SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSS
T ss_pred CCEeeEEEEEe-cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecC
Confidence 99999999975 45689999995332 2234567899999999999999999999998 9999999999999754
Q ss_pred C---CceeeccccceecCCCCcccccccccccccccCcccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCc
Q 041702 659 M---NPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH---GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSL 732 (840)
Q Consensus 659 ~---~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~ 732 (840)
+ .+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||+++||++|+.||........
T Consensus 276 ~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~ 352 (419)
T 3i6u_A 276 EEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS 352 (419)
T ss_dssp SSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC
T ss_pred CCcceEEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH
Confidence 4 59999999998764322 2334679999999999863 6788999999999999999999999865332221
Q ss_pred cHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 733 TLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
+.... ..... .............+.+++.+||+.||++|||++|+++
T Consensus 353 -~~~~i----~~~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 353 -LKDQI----TSGKY------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp -HHHHH----HTTCC------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -HHHHH----hcCCC------CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 11111 00000 0111111233556889999999999999999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=327.28 Aligned_cols=271 Identities=22% Similarity=0.283 Sum_probs=197.9
Q ss_pred HHHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhc--CCCC
Q 041702 507 SSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL--QHRN 584 (840)
Q Consensus 507 ~~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l--~H~n 584 (840)
.......++|++.++||+|+||.||+|.+ .++.||||++... ....+..|.+++..+ +|||
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--------------~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~ 92 (337)
T 3mdy_A 30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKW--------------RGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHEN 92 (337)
T ss_dssp HHHTTHHHHCEEEEEEEEETTEEEEEEEE--------------TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTT
T ss_pred ccccccccceEEEeEeecCCCeEEEEEEE--------------CCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCC
Confidence 34445668999999999999999999863 3789999998643 234555666666554 9999
Q ss_pred ccceeeEeecC----CceEEEEEeeccCC---ccccCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCceecCCCCCCc
Q 041702 585 LVRLFGCCIEQ----GEKISIYEFDIVTD---PARKDLLDWTTRVRIIEGVAQGLLYLHQYS-----RLRVIHRDLKASN 652 (840)
Q Consensus 585 iv~l~g~~~~~----~~~~lv~e~~~~~~---~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivHrDlkp~N 652 (840)
|+++++++... +..++||||..... ......+++..++.++.|++.||+|||+.. ..+|+||||||+|
T Consensus 93 i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~N 172 (337)
T 3mdy_A 93 ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKN 172 (337)
T ss_dssp BCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGG
T ss_pred eeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHH
Confidence 99999999887 77899999953322 223456899999999999999999999871 1139999999999
Q ss_pred EEecCCCCceeeccccceecCCCCccc--ccccccccccccCccccccCCCCcc------ccchhHHHHHHHHHhC----
Q 041702 653 VLLDSDMNPKISDFGIARTFGGDEMQS--NTNRIVGTYGYMSPEYALHGLFSIK------SDVFSFGVLLLEILSS---- 720 (840)
Q Consensus 653 ILl~~~~~~kL~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k------sDV~SlGviL~elltG---- 720 (840)
||++.++.+||+|||+++.+....... ......||+.|+|||.+.+...+.+ +|||||||++|||++|
T Consensus 173 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~ 252 (337)
T 3mdy_A 173 ILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG 252 (337)
T ss_dssp EEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred EEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcc
Confidence 999999999999999998764433221 1234579999999999988776665 9999999999999999
Q ss_pred ------CCCCCCCCCCCccHhHHHhhhhcccccccccCccccch-hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 041702 721 ------KKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNE-ALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLK 793 (840)
Q Consensus 721 ------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le 793 (840)
+.|+............. ...... ....+..... ........+.+++.+||+.||++|||+.||++.|+
T Consensus 253 ~~~~~~~~p~~~~~~~~~~~~~~-~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 327 (337)
T 3mdy_A 253 GIVEEYQLPYHDLVPSDPSYEDM-REIVCI----KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327 (337)
T ss_dssp TBCCCCCCTTTTTSCSSCCHHHH-HHHHTT----SCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred cccccccccHhhhcCCCCchhhh-HHHHhh----hccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHH
Confidence 55544333222211111 111111 1111222111 12356778999999999999999999999999999
Q ss_pred ccccCC
Q 041702 794 DEIVNL 799 (840)
Q Consensus 794 ~~~~~~ 799 (840)
.+....
T Consensus 328 ~l~~~~ 333 (337)
T 3mdy_A 328 KMSESQ 333 (337)
T ss_dssp HHHHTT
T ss_pred HHHhhc
Confidence 875543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=324.13 Aligned_cols=261 Identities=20% Similarity=0.226 Sum_probs=191.8
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCc---CHHHHHHHHHHHhhcCCCCccce
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQ---GLEEFKNEMMLIAKLQHRNLVRL 588 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~---~~~~f~~Ev~~l~~l~H~niv~l 588 (840)
..++|.+.+.||+|+||.||+|.++ .+++.||||++...... ..+++.+|+.++.+++||||+++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~ 99 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDT------------VRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEET------------TTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEc------------CCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 4578999999999999999999765 57899999999754322 24679999999999999999999
Q ss_pred eeEeecCCceEEEEEeeccC----CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 589 FGCCIEQGEKISIYEFDIVT----DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~~~~~----~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
++++...+..++++|+.... .......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 100 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~ 176 (309)
T 2h34_A 100 HDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLV 176 (309)
T ss_dssp EEEEEETTEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred EEEEeeCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEe
Confidence 99999999999999994221 1223456899999999999999999999998 9999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 665 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
|||++........ .......|++.|+|||.+.+..++.++||||||++++||++|+.||...... ........
T Consensus 177 Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~ 249 (309)
T 2h34_A 177 DFGIASATTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS------VMGAHINQ 249 (309)
T ss_dssp SCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH------HHHHHHHS
T ss_pred cCccCcccccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH------HHHHHhcc
Confidence 9999987643322 1223456899999999999999999999999999999999999998643211 11111111
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhhccccCCCC
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRP-TMLEVVAMLKDEIVNLPS 801 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~Le~~~~~~~~ 801 (840)
. . ..+ .......+..+.+++.+||+.||++|| +++++++.|+..+.....
T Consensus 250 ~-~---~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~ 300 (309)
T 2h34_A 250 A-I---PRP---STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ 300 (309)
T ss_dssp C-C---CCG---GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred C-C---CCc---cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence 0 0 000 011122334578899999999999999 999999999988655533
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=335.12 Aligned_cols=242 Identities=21% Similarity=0.263 Sum_probs=196.6
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhcCCCCcccee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
.++|+..+.||+|+||.||+|+++ .+++.||||++... .....+.+.+|++++.+++||||++++
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~------------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 107 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHK------------ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET------------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEEC------------CCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 368999999999999999999765 57899999999653 234567899999999999999999999
Q ss_pred eEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 590 GCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
+++.+.+..++||||..... ......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 108 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~D 184 (350)
T 1rdq_E 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTD 184 (350)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred EEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcc
Confidence 99999999999999953222 223456899999999999999999999998 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
||+++..... .....||+.|+|||.+.+..++.++|||||||+++||++|+.||..... .... ......
T Consensus 185 Fg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~----~~i~~~ 253 (350)
T 1rdq_E 185 FGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--IQIY----EKIVSG 253 (350)
T ss_dssp CTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH----HHHHHC
T ss_pred cccceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH--HHHH----HHHHcC
Confidence 9999876432 2346799999999999999999999999999999999999999864321 1111 111111
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPT-----MLEVVA 790 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 790 (840)
.. ... ......+.+++.+||+.||++||+ ++||++
T Consensus 254 ~~------~~p----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 254 KV------RFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CC------CCC----TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CC------CCC----CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 10 111 122345789999999999999998 788874
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=345.05 Aligned_cols=273 Identities=19% Similarity=0.224 Sum_probs=207.6
Q ss_pred HHHHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhcCC
Q 041702 506 LSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQH 582 (840)
Q Consensus 506 ~~~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l~H 582 (840)
+.++....++|...++||+|+||.||+|+++ .+++.||+|++++. .....+.+.+|+.++..++|
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~------------~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~h 128 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHK------------STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEET------------TTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEEC------------CCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCC
Confidence 3455667789999999999999999999765 57899999999752 22344668999999999999
Q ss_pred CCccceeeEeecCCceEEEEEeeccC---CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCC
Q 041702 583 RNLVRLFGCCIEQGEKISIYEFDIVT---DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDM 659 (840)
Q Consensus 583 ~niv~l~g~~~~~~~~~lv~e~~~~~---~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~ 659 (840)
|||+++++++.+.+..++||||.... .......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 129 p~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g 205 (410)
T 3v8s_A 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSG 205 (410)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTS
T ss_pred CCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCC
Confidence 99999999999999999999994221 1223446899999999999999999999998 99999999999999999
Q ss_pred CceeeccccceecCCCCcccccccccccccccCccccccCC----CCccccchhHHHHHHHHHhCCCCCCCCCCCCccHh
Q 041702 660 NPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGL----FSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLL 735 (840)
Q Consensus 660 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~ 735 (840)
.+||+|||+++....... ......+||+.|+|||++.+.. ++.++|||||||+||||++|+.||...... ...
T Consensus 206 ~ikL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~~~ 282 (410)
T 3v8s_A 206 HLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--GTY 282 (410)
T ss_dssp CEEECCCTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHH
T ss_pred CEEEeccceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh--hHH
Confidence 999999999987654332 1234568999999999998765 889999999999999999999998643211 111
Q ss_pred HHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH--hhcc------ccCCCCCCCC
Q 041702 736 GHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATD--RPTMLEVVAM--LKDE------IVNLPSPHQP 805 (840)
Q Consensus 736 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~--Le~~------~~~~~~p~~p 805 (840)
... ..........+ .......+.+++.+||+.+|.+ ||+++||++. ++++ ..++++|-.|
T Consensus 283 ~~i---~~~~~~~~~p~-------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~~~~~~~~p~~p 352 (410)
T 3v8s_A 283 SKI---MNHKNSLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVP 352 (410)
T ss_dssp HHH---HTHHHHCCCCT-------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCSTTGGGSCCSCCC
T ss_pred HHH---HhccccccCCC-------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHHhhcccCCCCCC
Confidence 111 11000000000 0122345788999999988988 9999999953 2221 2345566556
Q ss_pred C
Q 041702 806 A 806 (840)
Q Consensus 806 ~ 806 (840)
.
T Consensus 353 ~ 353 (410)
T 3v8s_A 353 D 353 (410)
T ss_dssp C
T ss_pred c
Confidence 5
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=356.98 Aligned_cols=258 Identities=26% Similarity=0.397 Sum_probs=201.9
Q ss_pred HHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 511 AATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 511 ~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
...++|++.++||+|+||.||+|.++ ++..||||+++... ...++|.+|+++|++++||||+++++
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~-------------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~ 329 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWN-------------GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA 329 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-------------TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cchhhhhhheecccCCCeEEEEEEEC-------------CCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 34578899999999999999998654 45679999998653 45678999999999999999999999
Q ss_pred EeecCCceEEEEEeeccCCc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 591 CCIEQGEKISIYEFDIVTDP------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
++.+ +..++||||...... .....+++.+++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 330 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~ 405 (535)
T 2h8h_A 330 VVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVA 405 (535)
T ss_dssp EECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEEC
T ss_pred EEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEc
Confidence 9876 778999999432111 12345899999999999999999999998 9999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhc
Q 041702 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWK 743 (840)
Q Consensus 665 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 743 (840)
|||+++....... .......++..|+|||.+.+..++.++|||||||+||||++ |+.|+...... .... ...
T Consensus 406 DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~--~~~~----~i~ 478 (535)
T 2h8h_A 406 DFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLD----QVE 478 (535)
T ss_dssp CTTSTTTCCCHHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH--HHHH----HHH
T ss_pred ccccceecCCCce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHH----HHH
Confidence 9999987643221 11223456789999999999999999999999999999999 88887543211 1111 111
Q ss_pred ccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCCCCC
Q 041702 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSP 802 (840)
Q Consensus 744 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~p 802 (840)
... .+ .........+.+|+.+||+.||++|||+++|++.|+.+.......
T Consensus 479 ~~~--~~-------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~ 528 (535)
T 2h8h_A 479 RGY--RM-------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 528 (535)
T ss_dssp TTC--CC-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCS
T ss_pred cCC--CC-------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCcc
Confidence 110 00 111123456788999999999999999999999999986655443
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=328.74 Aligned_cols=255 Identities=22% Similarity=0.333 Sum_probs=195.1
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
.++|...+.||+|+||.||+|.++.... .....+..||+|++........++|.+|++++++++||||+++++++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGD-----YGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVC 81 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECG-----GGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccc-----cccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 4678899999999999999998761100 00112367999999876666778899999999999999999999999
Q ss_pred ecCCceEEEEEeeccCCcc-----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCC-------
Q 041702 593 IEQGEKISIYEFDIVTDPA-----RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMN------- 660 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~------- 660 (840)
.+.+..++||||....... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccc
Confidence 9999999999995322211 2234899999999999999999999998 999999999999998887
Q ss_pred -ceeeccccceecCCCCcccccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHH
Q 041702 661 -PKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHA 738 (840)
Q Consensus 661 -~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~ 738 (840)
+||+|||++..... .....+|+.|+|||.+.+ ..++.++||||||++++||++|..|+...... .. .
T Consensus 159 ~~kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-~~-~--- 227 (289)
T 4fvq_A 159 FIKLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-QR-K--- 227 (289)
T ss_dssp EEEECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-HH-H---
T ss_pred eeeeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch-HH-H---
Confidence 99999999865432 223457889999999987 67999999999999999999966553221111 01 0
Q ss_pred hhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 739 WNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 739 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
....... ..+.... ...+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 228 ~~~~~~~---~~~~~~~--------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 228 LQFYEDR---HQLPAPK--------AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HHHHHTT---CCCCCCS--------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred HHHhhcc---CCCCCCC--------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 0111100 0011111 2347789999999999999999999999998754
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=325.74 Aligned_cols=256 Identities=26% Similarity=0.364 Sum_probs=196.2
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
..++|...+.||+|+||.||+|.+. .....+..||||++.... ....++|.+|+.++++++||||+++++
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 80 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYT---------NHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIG 80 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEE---------CTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEE
T ss_pred cccceEEEEEEEecCCeeEEEeEEc---------CCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 4578999999999999999999765 233455679999997653 234578999999999999999999999
Q ss_pred EeecCCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 591 CCIEQGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
++.+ +..+++||+...... .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 81 ~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~D 156 (281)
T 3cc6_A 81 IIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGD 156 (281)
T ss_dssp EECS-SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECC
T ss_pred EEcC-CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCc
Confidence 9865 456899998432221 12345899999999999999999999998 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
||++......... ......+|+.|+|||.+.+..++.++||||||++++||++ |+.|+....... ..... ..
T Consensus 157 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--~~~~~----~~ 229 (281)
T 3cc6_A 157 FGLSRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--VIGVL----EK 229 (281)
T ss_dssp CCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--HHHHH----HH
T ss_pred cCCCccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH--HHHHH----hc
Confidence 9999876443221 1233456889999999999999999999999999999998 999986433222 11111 11
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEI 796 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~ 796 (840)
... ...+ ....+.+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 230 ~~~--~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 230 GDR--LPKP-------DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp TCC--CCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCC--CCCC-------CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 000 0011 112345788999999999999999999999998763
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=343.03 Aligned_cols=249 Identities=25% Similarity=0.386 Sum_probs=198.9
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhcCCCCcccee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
.++|.+.+.||+|+||.||+|.++ .+|+.||||++... .....+.+.+|+.+++.++||||++++
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~------------~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~ 82 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHE------------LTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEET------------TTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEEC------------CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 468999999999999999999765 67999999999753 223467899999999999999999999
Q ss_pred eEeecCCceEEEEEeecc----CCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 590 GCCIEQGEKISIYEFDIV----TDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~----~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
+++...+..++||||... ........+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 83 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~D 159 (476)
T 2y94_A 83 QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIAD 159 (476)
T ss_dssp EEEECSSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred EEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEe
Confidence 999999999999999421 11223456899999999999999999999998 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLF-SIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
||+++....... .....||+.|+|||.+.+..+ +.++|||||||+++||++|+.||...... .+... ...
T Consensus 160 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--~~~~~----i~~ 230 (476)
T 2y94_A 160 FGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP--TLFKK----ICD 230 (476)
T ss_dssp CSSCEECCTTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH--HHHHH----HHT
T ss_pred ccchhhcccccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH--HHHHH----Hhc
Confidence 999988654322 234579999999999988776 68999999999999999999998643211 11111 111
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH--Hhhcc
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA--MLKDE 795 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~Le~~ 795 (840)
... ..+ ......+.+++.+||+.||++|||++||++ .+...
T Consensus 231 ~~~---~~p-------~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 231 GIF---YTP-------QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp TCC---CCC-------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred CCc---CCC-------ccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 100 001 112345788999999999999999999996 45543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=332.45 Aligned_cols=259 Identities=23% Similarity=0.325 Sum_probs=192.4
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC--cCHHHHHHHHHHHhhcCCCCccceee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG--QGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
.++|+..+.||+|+||.||+|.++ .+++.||||++..... ...+.+.+|+.++.+++||||+++++
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 91 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNK------------DTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEET------------TTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEEC------------CCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEE
Confidence 468999999999999999999765 5789999999865432 23456889999999999999999999
Q ss_pred EeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 591 CCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
++.+.+..++||||..... ......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 92 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Df 168 (331)
T 4aaa_A 92 VCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDF 168 (331)
T ss_dssp EEEETTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC
T ss_pred EeecCCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeC
Confidence 9999999999999942211 122456899999999999999999999998 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhh-----
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWN----- 740 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~----- 740 (840)
|+++....... ......||+.|+|||.+.+. .++.++||||||++++||++|+.||......+ .......
T Consensus 169 g~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~ 244 (331)
T 4aaa_A 169 GFARTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID--QLYHIMMCLGNL 244 (331)
T ss_dssp TTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSC
T ss_pred CCceeecCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHHHhCCC
Confidence 99987643221 22345689999999998875 78999999999999999999999986543211 1111000
Q ss_pred ------hhcc------cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 741 ------LWKD------DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 741 ------~~~~------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.+.. .....+..............+.+.+++.+||+.||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 245 IPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000 0001111111111111234567899999999999999999999875
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=337.27 Aligned_cols=205 Identities=26% Similarity=0.292 Sum_probs=173.7
Q ss_pred eeecCHHHHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhc
Q 041702 501 FLFFSLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL 580 (840)
Q Consensus 501 ~~~~~~~~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l 580 (840)
...+++.+.....++|.+.++||+|+||.||+|.++ .+++.||||+++.. ....+.+..|+.++.++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~------------~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l 88 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHI------------DNKKYYAVKVVRNI-KKYTRSAKIEADILKKI 88 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEET------------TTCCEEEEEEECSC-HHHHHHHHHHHHHHHHT
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEEC------------CCCeEEEEEEeccc-hhhhhhhHHHHHHHHHh
Confidence 334566666677899999999999999999999765 57899999999743 23446788899999999
Q ss_pred C-----CCCccceeeEeecCCceEEEEEeeccCCc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCC
Q 041702 581 Q-----HRNLVRLFGCCIEQGEKISIYEFDIVTDP------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLK 649 (840)
Q Consensus 581 ~-----H~niv~l~g~~~~~~~~~lv~e~~~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk 649 (840)
+ ||||+++++++...+..++|||+. .... .....+++..+..++.||+.||+|||+.+ |+|||||
T Consensus 89 ~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlk 164 (360)
T 3llt_A 89 QNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLK 164 (360)
T ss_dssp CCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCS
T ss_pred cccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCC
Confidence 6 999999999999999999999984 1111 11234889999999999999999999998 9999999
Q ss_pred CCcEEecC-------------------------CCCceeeccccceecCCCCcccccccccccccccCccccccCCCCcc
Q 041702 650 ASNVLLDS-------------------------DMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIK 704 (840)
Q Consensus 650 p~NILl~~-------------------------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k 704 (840)
|+|||++. ++.+||+|||+++..... .....||+.|+|||.+.+..++.+
T Consensus 165 p~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~ 239 (360)
T 3llt_A 165 PENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVS 239 (360)
T ss_dssp GGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTT
T ss_pred cccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCc
Confidence 99999975 789999999999875432 234578999999999999999999
Q ss_pred ccchhHHHHHHHHHhCCCCCCCC
Q 041702 705 SDVFSFGVLLLEILSSKKNTRFY 727 (840)
Q Consensus 705 sDV~SlGviL~elltG~~p~~~~ 727 (840)
+|||||||+++||++|+.||...
T Consensus 240 ~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 240 SDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cchHHHHHHHHHHHHCCCCCCCC
Confidence 99999999999999999998653
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=325.56 Aligned_cols=262 Identities=25% Similarity=0.353 Sum_probs=196.6
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
..+|+..++||+|+||.||+|.+. ........||+|++..... ...++|.+|+.++++++||||++++++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 94 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLL---------DNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGI 94 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC--------------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred ceehhhcceeeecCCceEEEEEEe---------cCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeE
Confidence 356888899999999999999754 2223445799999976432 345779999999999999999999998
Q ss_pred ee-cCCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 592 CI-EQGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 592 ~~-~~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
+. ..+..+++|||...... .....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 95 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~D 171 (298)
T 3f66_A 95 CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVAD 171 (298)
T ss_dssp ECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECS
T ss_pred EEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECc
Confidence 65 45678899999533221 12455789999999999999999999998 99999999999999999999999
Q ss_pred cccceecCCCCcc--cccccccccccccCccccccCCCCccccchhHHHHHHHHHhCC-CCCCCCCCCCccHhHHHhhhh
Q 041702 666 FGIARTFGGDEMQ--SNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSK-KNTRFYNTDSLTLLGHAWNLW 742 (840)
Q Consensus 666 FGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~-~p~~~~~~~~~~~~~~~~~~~ 742 (840)
||+++........ .......+|+.|+|||.+.+..++.++||||||++++||++|. +|+......+ ..... .
T Consensus 172 fg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~--~~~~~---~ 246 (298)
T 3f66_A 172 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYL---L 246 (298)
T ss_dssp CGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT--HHHHH---H
T ss_pred ccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH--HHHHH---h
Confidence 9999876543321 1223456788999999999999999999999999999999954 4544332222 11111 0
Q ss_pred cccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCCCC
Q 041702 743 KDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPS 801 (840)
Q Consensus 743 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~ 801 (840)
. .. ....+. .....+.+++.+||+.||++|||++|+++.|+++...+..
T Consensus 247 ~-~~--~~~~~~-------~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 247 Q-GR--RLLQPE-------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp T-TC--CCCCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred c-CC--CCCCCc-------cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 0 00 011111 1234578899999999999999999999999998776644
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=335.21 Aligned_cols=279 Identities=12% Similarity=0.112 Sum_probs=204.2
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccc-----
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVR----- 587 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~----- 587 (840)
.++|.+.+.||+|+||.||+|.++... ......+++.||||++... +.+.+|++++.+++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~----~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~ 111 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTL----TCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKL 111 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC---------------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCc----cccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhh
Confidence 468999999999999999999865100 0000115889999999754 57899999999999999988
Q ss_pred ----------eeeEeec-CCceEEEEEeeccCCc----cc--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCC
Q 041702 588 ----------LFGCCIE-QGEKISIYEFDIVTDP----AR--KDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKA 650 (840)
Q Consensus 588 ----------l~g~~~~-~~~~~lv~e~~~~~~~----~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp 650 (840)
+++++.. .+..++||||. .... .. ...+++..++.++.||+.||+|||+.+ |+||||||
T Consensus 112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp 187 (352)
T 2jii_A 112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTA 187 (352)
T ss_dssp TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCG
T ss_pred ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCH
Confidence 5677766 67889999984 2111 11 367999999999999999999999998 99999999
Q ss_pred CcEEecCCC--CceeeccccceecCCCCccc-----ccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCC
Q 041702 651 SNVLLDSDM--NPKISDFGIARTFGGDEMQS-----NTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKN 723 (840)
Q Consensus 651 ~NILl~~~~--~~kL~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p 723 (840)
+|||++.++ .+||+|||+++.+....... ......||+.|+|||.+.+..++.++||||||++|+||++|+.|
T Consensus 188 ~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 267 (352)
T 2jii_A 188 ENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267 (352)
T ss_dssp GGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred HHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999998 89999999998765332111 12335799999999999999999999999999999999999999
Q ss_pred CCCCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCCCCCC
Q 041702 724 TRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSPH 803 (840)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~p~ 803 (840)
|.................. .....+.+..... ......+.+++.+||+.||++|||+++|++.|+++..+.....
T Consensus 268 f~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~ 342 (352)
T 2jii_A 268 WTNCLPNTEDIMKQKQKFV--DKPGPFVGPCGHW---IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSP 342 (352)
T ss_dssp TGGGTTCHHHHHHHHHHHH--HSCCCEECTTSCE---ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCT
T ss_pred cccCCcCHHHHHHHHHhcc--CChhhhhhhcccc---CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCc
Confidence 8755433222221111111 1111111111100 0123558889999999999999999999999999887766554
Q ss_pred CCCCcc
Q 041702 804 QPAFSY 809 (840)
Q Consensus 804 ~p~~~~ 809 (840)
...+++
T Consensus 343 ~~~~dw 348 (352)
T 2jii_A 343 YDPIGL 348 (352)
T ss_dssp TSCCCC
T ss_pred CccccC
Confidence 444433
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=335.90 Aligned_cols=267 Identities=20% Similarity=0.277 Sum_probs=204.8
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
.++|.+.++||+|+||.||+|.++ .+++.||||++.... ....+.+.+|++++++++||||++++++
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 75 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHK------------KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEET------------TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEEC------------CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEe
Confidence 467899999999999999999765 578999999997543 3456788999999999999999999999
Q ss_pred eecCC--ceEEEEEeec-------cCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEe----cCC
Q 041702 592 CIEQG--EKISIYEFDI-------VTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLL----DSD 658 (840)
Q Consensus 592 ~~~~~--~~~lv~e~~~-------~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl----~~~ 658 (840)
+.+.+ ..++||||.. +........+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.+
T Consensus 76 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~ 152 (396)
T 4eut_A 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQ 152 (396)
T ss_dssp EECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSC
T ss_pred eccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCc
Confidence 98765 6799999842 222222334899999999999999999999998 9999999999999 777
Q ss_pred CCceeeccccceecCCCCcccccccccccccccCcccccc--------CCCCccccchhHHHHHHHHHhCCCCCCCCCCC
Q 041702 659 MNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH--------GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTD 730 (840)
Q Consensus 659 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDV~SlGviL~elltG~~p~~~~~~~ 730 (840)
+.+||+|||+++...... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......
T Consensus 153 ~~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~ 229 (396)
T 4eut_A 153 SVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229 (396)
T ss_dssp EEEEECCGGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCT
T ss_pred eeEEEecCCCceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcc
Confidence 889999999998765432 2234568999999998865 56788999999999999999999998654432
Q ss_pred CccHhHHHhhhhccccc--c----ccc--------CccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 041702 731 SLTLLGHAWNLWKDDKA--W----KLM--------DPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEI 796 (840)
Q Consensus 731 ~~~~~~~~~~~~~~~~~--~----~~~--------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~ 796 (840)
..... ........... . ... +..............+.+++.+||+.||++||++.|+++.+++++
T Consensus 230 ~~~~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il 308 (396)
T 4eut_A 230 RRNKE-VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (396)
T ss_dssp TTCHH-HHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred cchHH-HHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence 21111 11111111100 0 000 001111233566778899999999999999999999999998875
Q ss_pred cC
Q 041702 797 VN 798 (840)
Q Consensus 797 ~~ 798 (840)
..
T Consensus 309 ~~ 310 (396)
T 4eut_A 309 HR 310 (396)
T ss_dssp TC
T ss_pred hc
Confidence 53
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=331.28 Aligned_cols=248 Identities=23% Similarity=0.295 Sum_probs=186.0
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC----CcCHHHHHHHHHHHhhcCCCCccce
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS----GQGLEEFKNEMMLIAKLQHRNLVRL 588 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~----~~~~~~f~~Ev~~l~~l~H~niv~l 588 (840)
.++|+..+.||+|+||.||+|++. ....+++.||||+++... ......+.+|+.++++++||||+++
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~ 86 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKV---------TGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDL 86 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEC---------SSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCE
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEe---------ccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccce
Confidence 468999999999999999998754 223578999999997642 2345668899999999999999999
Q ss_pred eeEeecCCceEEEEEeeccC----CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 589 FGCCIEQGEKISIYEFDIVT----DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~~~~~----~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
++++...+..++||||.... .......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 87 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~ 163 (327)
T 3a62_A 87 IYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLT 163 (327)
T ss_dssp EEEEECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEEC
T ss_pred eEEEEcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEE
Confidence 99999999999999994221 1223456889999999999999999999998 9999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 665 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
|||+++...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ..... ...
T Consensus 164 Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~---i~~- 235 (327)
T 3a62_A 164 DFGLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK--KTIDK---ILK- 235 (327)
T ss_dssp CCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHH---HHH-
T ss_pred eCCcccccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH--HHHHH---HHh-
Confidence 999997643222 1233457999999999999999999999999999999999999998643211 11111 111
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRP-----TMLEVVA 790 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 790 (840)
.. ..+. ......+.+++.+||+.||++|| +++|+++
T Consensus 236 ~~------~~~p----~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 236 CK------LNLP----PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp TC------CCCC----TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred CC------CCCC----CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 00 0111 12234578899999999999999 6777764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=329.45 Aligned_cols=249 Identities=22% Similarity=0.298 Sum_probs=197.9
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC------cCHHHHHHHHHHHhhcCCCCc
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG------QGLEEFKNEMMLIAKLQHRNL 585 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~------~~~~~f~~Ev~~l~~l~H~ni 585 (840)
..++|++.+.||+|+||.||+|.++ .+++.||||++..... ...+++.+|+.++.+++||||
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 77 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREK------------STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEET------------TTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTB
T ss_pred hhccEEEeeEeeecCCEEEEEEEEC------------CCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCc
Confidence 3567999999999999999999765 5789999999975432 246789999999999999999
Q ss_pred cceeeEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCC--
Q 041702 586 VRLFGCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDM-- 659 (840)
Q Consensus 586 v~l~g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-- 659 (840)
+++++++.+.+..++||||..... ......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 78 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~ 154 (321)
T 2a2a_A 78 ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIP 154 (321)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSS
T ss_pred ceEEEEEecCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCC
Confidence 999999999999999999943222 123456889999999999999999999998 99999999999999888
Q ss_pred --CceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHH
Q 041702 660 --NPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGH 737 (840)
Q Consensus 660 --~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~ 737 (840)
.+||+|||++....... ......||+.|+|||.+.+..++.++||||||++++||++|+.|+...... .....
T Consensus 155 ~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~ 229 (321)
T 2a2a_A 155 IPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLAN 229 (321)
T ss_dssp SCCEEECCCTTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHH
T ss_pred cCCEEEccCccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH--HHHHH
Confidence 79999999998765432 223456899999999999999999999999999999999999998543211 11111
Q ss_pred HhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 738 AWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 738 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.... ...............+.+++.+||+.||++|||+.|+++
T Consensus 230 ----i~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 230 ----ITSV------SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp ----HHTT------CCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred ----HHhc------ccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000 001111111223456889999999999999999999986
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=322.51 Aligned_cols=248 Identities=23% Similarity=0.380 Sum_probs=196.3
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
.++|++.+.||+|+||.||+|.++ .+++.||+|++.... ....+++.+|+.++++++||||+++++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 72 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHK------------TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEET------------TTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEc------------CCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEE
Confidence 578999999999999999999765 678999999997542 234567899999999999999999999
Q ss_pred EeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCC---cee
Q 041702 591 CCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMN---PKI 663 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~---~kL 663 (840)
++.+.+..+++||+..... ......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||
T Consensus 73 ~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl 149 (284)
T 3kk8_A 73 SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKL 149 (284)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEE
T ss_pred EEEcCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEE
Confidence 9999999999999953322 223466899999999999999999999998 999999999999987665 999
Q ss_pred eccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhc
Q 041702 664 SDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWK 743 (840)
Q Consensus 664 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~ 743 (840)
+|||++........ .....||+.|+|||.+.+..++.++||||||++++||++|+.|+...... ..... ..
T Consensus 150 ~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~----~~ 220 (284)
T 3kk8_A 150 ADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYAQ----IK 220 (284)
T ss_dssp CCCTTCEECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH----HH
T ss_pred eeceeeEEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh--HHHHH----HH
Confidence 99999987653322 23457899999999999999999999999999999999999998542211 11111 11
Q ss_pred ccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 744 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
... .....+ ........+.+++.+||+.||++|||++|+++
T Consensus 221 ~~~-~~~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 221 AGA-YDYPSP-----EWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp HTC-CCCCTT-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hcc-ccCCch-----hhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 110 000111 11122345788999999999999999999986
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=331.27 Aligned_cols=245 Identities=22% Similarity=0.255 Sum_probs=173.0
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcC-CCCccceeeEeecCCce
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQ-HRNLVRLFGCCIEQGEK 598 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~~ 598 (840)
++||+|+||.||+|.++ .+++.||||++... ....+.+|+.++.++. ||||+++++++.+.+..
T Consensus 17 ~~lG~G~~g~V~~~~~~------------~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~ 81 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHK------------KSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHT 81 (325)
T ss_dssp CCSEEETTEEEEEEEET------------TTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CccccCCCeEEEEEEEC------------CCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEE
Confidence 78999999999999765 67899999999743 3467889999999997 99999999999999999
Q ss_pred EEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCC---Cceeecccccee
Q 041702 599 ISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDM---NPKISDFGIART 671 (840)
Q Consensus 599 ~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~---~~kL~DFGla~~ 671 (840)
++||||..... ......+++.++..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++.
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 82 FLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp EEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred EEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 99999953322 233467899999999999999999999998 99999999999997765 799999999987
Q ss_pred cCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCc-cHhHHHhhhhcccccccc
Q 041702 672 FGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSL-TLLGHAWNLWKDDKAWKL 750 (840)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 750 (840)
...... ......||+.|+|||.+.+..++.++||||||++++||++|+.||........ ..............
T Consensus 159 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~---- 232 (325)
T 3kn6_A 159 KPPDNQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD---- 232 (325)
T ss_dssp CCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTC----
T ss_pred cCCCCC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCC----
Confidence 643322 22345689999999999999999999999999999999999999875433211 11111111111111
Q ss_pred cCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 751 MDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 751 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
..............+.+++.+||+.||++|||++|+++
T Consensus 233 --~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 233 --FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp --CCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred --CCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 11112222334567889999999999999999999873
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=328.01 Aligned_cols=260 Identities=21% Similarity=0.304 Sum_probs=194.0
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
.++|+..++||+|+||.||+|.++ .+++.||||++.... ......+.+|++++.+++||||+++++
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 83 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHR------------KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 83 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEET------------TTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceeEEEEEecCCCcEEEEEEEC------------CCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhh
Confidence 468999999999999999999765 678999999986543 234567899999999999999999999
Q ss_pred Eeec--------CCceEEEEEeecc---CC-ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCC
Q 041702 591 CCIE--------QGEKISIYEFDIV---TD-PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSD 658 (840)
Q Consensus 591 ~~~~--------~~~~~lv~e~~~~---~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~ 658 (840)
++.. .+..++||||... .. ......+++.++..++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 84 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~ 160 (351)
T 3mi9_A 84 ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRD 160 (351)
T ss_dssp EEEEC--------CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTT
T ss_pred eeeccccccccCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCC
Confidence 9987 4568999999431 11 112245899999999999999999999998 9999999999999999
Q ss_pred CCceeeccccceecCCCCcc--cccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHh
Q 041702 659 MNPKISDFGIARTFGGDEMQ--SNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLL 735 (840)
Q Consensus 659 ~~~kL~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~ 735 (840)
+.+||+|||+++.+...... .......||+.|+|||.+.+ ..++.++|||||||+++||++|+.|+....... ..
T Consensus 161 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~ 238 (351)
T 3mi9_A 161 GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH--QL 238 (351)
T ss_dssp SCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HH
T ss_pred CCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH--HH
Confidence 99999999999876532221 22344578999999998876 458999999999999999999999986533211 11
Q ss_pred HHHhhhhcc-----------ccccc---ccCccccchhhHH-----HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 736 GHAWNLWKD-----------DKAWK---LMDPTMQNEALYS-----MVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 736 ~~~~~~~~~-----------~~~~~---~~d~~l~~~~~~~-----~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
......... ..... ...... ...... ....+.+++.+||+.||++|||++|+++
T Consensus 239 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 239 ALISQLCGSITPEVWPNVDNYELYEKLELVKGQK-RKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp HHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCC-CCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhCCCChhhccccccchhhcccccccccc-cCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 111111000 00000 000000 000011 1345789999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=332.02 Aligned_cols=261 Identities=26% Similarity=0.359 Sum_probs=194.6
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
..++|...+.||+|+||.||+|.+... ....+++.||||++.... .....++.+|+.++.+++||||+++++
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 100 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGM-------PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIG 100 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC---------------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCC-------CCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEE
Confidence 357899999999999999999975410 123578899999997542 344567999999999999999999999
Q ss_pred EeecCCceEEEEEeeccC-----------CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecC--
Q 041702 591 CCIEQGEKISIYEFDIVT-----------DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS-- 657 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~-----------~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-- 657 (840)
++.+.+..++||||.... .......+++..++.++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 101 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~ 177 (327)
T 2yfx_A 101 VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPG 177 (327)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSS
T ss_pred EEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCC
Confidence 999999999999994211 1112245889999999999999999999998 999999999999984
Q ss_pred -CCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHh
Q 041702 658 -DMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLL 735 (840)
Q Consensus 658 -~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~ 735 (840)
+..+||+|||++................+|+.|+|||.+.+..++.++||||||++++||++ |+.|+...... ...
T Consensus 178 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~ 255 (327)
T 2yfx_A 178 PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EVL 255 (327)
T ss_dssp TTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHH
T ss_pred CcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH--HHH
Confidence 44699999999986644433333445568899999999999999999999999999999998 88887543211 111
Q ss_pred HHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 736 GHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 736 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
........ .. ........+.+++.+||+.||++||++.+|++.|+....
T Consensus 256 ----~~~~~~~~-----~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 256 ----EFVTSGGR-----MD----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp ----HHHHTTCC-----CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHHhcCCC-----CC----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 11111110 00 111223467889999999999999999999999987643
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=326.76 Aligned_cols=261 Identities=26% Similarity=0.381 Sum_probs=201.2
Q ss_pred ccCCcccc-cccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 513 TDNFSEEN-KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 513 ~~~f~~~~-~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
.++|.+.+ .||+|+||.||+|.++ ...++..||||+++... ....+++.+|++++.+++||||+++++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~----------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 77 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYR----------MRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC-------------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred HHHhhhhhccccccCceeEEEeEec----------cCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEE
Confidence 35566666 8999999999998753 12367889999998653 234677999999999999999999999
Q ss_pred EeecCCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 591 CCIEQGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
++ +.+..++|||+...... .....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 78 ~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~D 153 (287)
T 1u59_A 78 VC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISD 153 (287)
T ss_dssp EE-ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECC
T ss_pred Ee-cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECc
Confidence 99 56678999998422111 13456899999999999999999999998 99999999999999999999999
Q ss_pred cccceecCCCCcc-cccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhc
Q 041702 666 FGIARTFGGDEMQ-SNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWK 743 (840)
Q Consensus 666 FGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 743 (840)
||++......... .......+|+.|+|||.+.+..++.++||||||++++||++ |+.|+...... .... ...
T Consensus 154 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~----~i~ 227 (287)
T 1u59_A 154 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMA----FIE 227 (287)
T ss_dssp CTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHH----HHH
T ss_pred ccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--HHHH----HHh
Confidence 9999887543322 22233456889999999998899999999999999999998 99998643321 1111 111
Q ss_pred ccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCCCCC
Q 041702 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSP 802 (840)
Q Consensus 744 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~p 802 (840)
.... + ..+......+.+++.+||+.||++||++.+|++.|+.+......+
T Consensus 228 ~~~~-----~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 228 QGKR-----M----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277 (287)
T ss_dssp TTCC-----C----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred cCCc-----C----CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence 1110 1 111223456889999999999999999999999999886655444
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=349.58 Aligned_cols=246 Identities=20% Similarity=0.250 Sum_probs=187.2
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhcCCCCccce
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQHRNLVRL 588 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l 588 (840)
..++|+..++||+|+||.||+|.++ .+++.||||++... .......+.+|++++++++||||+++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l 213 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEK------------ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 213 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET------------TTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEc------------CCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeE
Confidence 3478999999999999999999765 67999999999753 33445678899999999999999999
Q ss_pred eeEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceecCCCCCCcEEecCCCCcee
Q 041702 589 FGCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQ-YSRLRVIHRDLKASNVLLDSDMNPKI 663 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivHrDlkp~NILl~~~~~~kL 663 (840)
++++...+..++||||..... ......+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.+||
T Consensus 214 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl 290 (446)
T 4ejn_A 214 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKI 290 (446)
T ss_dssp EEEEEETTEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEE
T ss_pred EEEEeeCCEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEE
Confidence 999999999999999953322 2334678999999999999999999998 77 999999999999999999999
Q ss_pred eccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhc
Q 041702 664 SDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWK 743 (840)
Q Consensus 664 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~ 743 (840)
+|||+++...... .......||+.|+|||++.+..++.++|||||||+|+||++|+.||...... .+... ..
T Consensus 291 ~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~----i~ 362 (446)
T 4ejn_A 291 TDFGLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFEL----IL 362 (446)
T ss_dssp CCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH----HH
T ss_pred ccCCCceeccCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--HHHHH----HH
Confidence 9999998643222 2234467999999999999999999999999999999999999998543211 11111 11
Q ss_pred ccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041702 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRP-----TMLEVVA 790 (840)
Q Consensus 744 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 790 (840)
... ... +......+.+++.+||+.||++|| +++|+++
T Consensus 363 ~~~------~~~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 363 MEE------IRF----PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp HCC------CCC----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred hCC------CCC----CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 110 001 111234578899999999999999 9999985
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=332.48 Aligned_cols=263 Identities=19% Similarity=0.269 Sum_probs=190.3
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
++|...++||+|+||.||+|.++ .+++.||||++..... .....+.+|++++++++||||+++++++
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~------------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 69 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSK------------LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEET------------TTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEEC------------CCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEE
Confidence 57899999999999999999765 5789999999975432 2223566899999999999999999999
Q ss_pred ecCCceEEEEEeeccC---C-ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccc
Q 041702 593 IEQGEKISIYEFDIVT---D-PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGI 668 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~---~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl 668 (840)
...+..++||||.... . ......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 70 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~ 146 (324)
T 3mtl_A 70 HTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGL 146 (324)
T ss_dssp ECSSCEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSE
T ss_pred eeCCEEEEEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcc
Confidence 9999999999994311 0 112346889999999999999999999998 99999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccc-
Q 041702 669 ARTFGGDEMQSNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDK- 746 (840)
Q Consensus 669 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~- 746 (840)
++...... .......||+.|+|||.+.+ ..++.++|||||||+++||++|+.||......+ .............
T Consensus 147 a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~~~~~ 222 (324)
T 3mtl_A 147 ARAKSIPT--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE--QLHFIFRILGTPTE 222 (324)
T ss_dssp EECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCT
T ss_pred cccccCCc--cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCh
Confidence 98654322 12234568999999999876 568999999999999999999999986543221 1111111110000
Q ss_pred --ccccc---------Ccccc----chhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH--Hhhcc
Q 041702 747 --AWKLM---------DPTMQ----NEALYSMVTRYIKVALLCVQENATDRPTMLEVVA--MLKDE 795 (840)
Q Consensus 747 --~~~~~---------d~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~Le~~ 795 (840)
..... .+... ..........+.+++.+||+.||++|||++|+++ .+.+.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 223 ETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288 (324)
T ss_dssp TTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred HhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence 00000 00000 0111123456789999999999999999999986 45544
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-36 Score=340.44 Aligned_cols=260 Identities=19% Similarity=0.237 Sum_probs=201.6
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCC-CCccceeeE
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQH-RNLVRLFGC 591 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H-~niv~l~g~ 591 (840)
.++|.+.++||+|+||.||+|.+. .+++.||||++..... .+++.+|++++..++| ++++.+..+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~------------~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~ 71 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNI------------QTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWF 71 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEET------------TTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEEC------------CCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEE
Confidence 478999999999999999999764 6789999999875432 3568999999999977 566677777
Q ss_pred eecCCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEe---cCCCCcee
Q 041702 592 CIEQGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLL---DSDMNPKI 663 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl---~~~~~~kL 663 (840)
+.+.+..++||||. .... .....+++.+++.|+.||+.||+|||+.+ |+||||||+|||| +.++.+||
T Consensus 72 ~~~~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL 147 (483)
T 3sv0_A 72 GVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYI 147 (483)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEE
T ss_pred EeeCCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEE
Confidence 78888899999995 1111 11456999999999999999999999998 9999999999999 68899999
Q ss_pred eccccceecCCCCcc-----cccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc-HhHH
Q 041702 664 SDFGIARTFGGDEMQ-----SNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLT-LLGH 737 (840)
Q Consensus 664 ~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~-~~~~ 737 (840)
+|||+++.+...... .......||+.|+|||.+.+..++.++|||||||+||||++|+.||......... ....
T Consensus 148 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 227 (483)
T 3sv0_A 148 IDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 227 (483)
T ss_dssp CCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHH
T ss_pred EeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHH
Confidence 999999887544321 1223567999999999999999999999999999999999999998765443311 1111
Q ss_pred HhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCC
Q 041702 738 AWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNL 799 (840)
Q Consensus 738 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~ 799 (840)
... ......+ ..........+.+++..||+.+|++||++.+|+++|+++....
T Consensus 228 i~~----~~~~~~~-----~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 228 ISE----KKVATSI-----EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp HHH----HHHHSCH-----HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred Hhh----ccccccH-----HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 100 0000000 0111122456889999999999999999999999999875543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=334.47 Aligned_cols=261 Identities=21% Similarity=0.297 Sum_probs=191.0
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCcccee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
..++|+..+.||+|+||.||+|.++ .+|+.||||++.... ....+++.+|++++++++||||++++
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~ 90 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDG------------RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEET------------TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCS
T ss_pred ecceEEEeEEeeecCCeEEEEEEEC------------CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCce
Confidence 3578999999999999999999765 678999999996542 23356789999999999999999999
Q ss_pred eEeecCC------ceEEEEEeec--cCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCc
Q 041702 590 GCCIEQG------EKISIYEFDI--VTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP 661 (840)
Q Consensus 590 g~~~~~~------~~~lv~e~~~--~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 661 (840)
+++...+ ..++|||+.. +........+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 91 ~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~ 167 (367)
T 1cm8_A 91 DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCEL 167 (367)
T ss_dssp EEECSCSSTTTCCCCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCE
T ss_pred eeEecCCccccCceEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCE
Confidence 9997663 4599999941 111222356899999999999999999999998 9999999999999999999
Q ss_pred eeeccccceecCCCCcccccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhh
Q 041702 662 KISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWN 740 (840)
Q Consensus 662 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~ 740 (840)
||+|||+++..... .....+|+.|+|||.+.+ ..++.++|||||||+++||++|+.||...... ........
T Consensus 168 kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~l~~i~~ 240 (367)
T 1cm8_A 168 KILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL--DQLKEIMK 240 (367)
T ss_dssp EECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH
T ss_pred EEEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHH
Confidence 99999999875432 234578999999999887 67999999999999999999999998643321 11111110
Q ss_pred hhcc-----------ccc-------ccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH--Hhhcc
Q 041702 741 LWKD-----------DKA-------WKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA--MLKDE 795 (840)
Q Consensus 741 ~~~~-----------~~~-------~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~Le~~ 795 (840)
.... ... ........ ..........+.+++.+||+.||++|||++|+++ .+++.
T Consensus 241 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 241 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp HHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 0000 000 00000000 0111223456889999999999999999999987 35443
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=323.00 Aligned_cols=244 Identities=26% Similarity=0.355 Sum_probs=192.7
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhcCCCCccce
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQHRNLVRL 588 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l 588 (840)
+.++|++.+.||+|+||.||+|.++ .+++.||||++... .....+.+.+|+.++++++||||+++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 74 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREK------------QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET------------TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEc------------cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcch
Confidence 4578999999999999999999765 67889999998643 22345779999999999999999999
Q ss_pred eeEeecCCceEEEEEeeccC----CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 589 FGCCIEQGEKISIYEFDIVT----DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~~~~~----~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
++++.+.+..++||||.... .......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 75 ~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~ 151 (279)
T 3fdn_A 75 YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIA 151 (279)
T ss_dssp EEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEEC
T ss_pred hheEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEE
Confidence 99999999999999984321 1223456899999999999999999999988 9999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 665 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
|||++....... .....||+.|+|||.+.+..++.++||||||++++||++|+.|+...... ... .....
T Consensus 152 Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~----~~~~~ 221 (279)
T 3fdn_A 152 DFGWSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--ETY----KRISR 221 (279)
T ss_dssp SCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHH----HHHHH
T ss_pred eccccccCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH--HHH----HHHHh
Confidence 999986543222 23457899999999999999999999999999999999999998643211 111 11000
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
. ..... ......+.+++.+||+.||++|||++||++
T Consensus 222 ~------~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 222 V------EFTFP----DFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp T------CCCCC----TTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred C------CCCCC----CcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0 00111 112345778999999999999999999995
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=321.02 Aligned_cols=252 Identities=28% Similarity=0.427 Sum_probs=199.2
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
.++|+..+.||+|+||.||+|.+. +++.||+|++.... ...+++.+|++++.+++||||+++++++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-------------~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 72 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-------------NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVC 72 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-------------TTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhheeeeeEecCCCceeEEEEEec-------------CCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 467889999999999999998643 57789999998653 3457899999999999999999999999
Q ss_pred ecCCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 593 IEQGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
.+.+..+++||+...... .....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 73 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg 149 (267)
T 3t9t_A 73 LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFG 149 (267)
T ss_dssp CSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTT
T ss_pred ccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccc
Confidence 999999999999532221 12345899999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhcccc
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKDDK 746 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 746 (840)
++........ .......+++.|+|||.+.+..++.++||||||++++||++ |+.|+...... .... .. ...
T Consensus 150 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~---~i-~~~- 221 (267)
T 3t9t_A 150 MTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVE---DI-STG- 221 (267)
T ss_dssp GGGGBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHH---HH-HTT-
T ss_pred cccccccccc-cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH--HHHH---HH-hcC-
Confidence 9987643221 12233457789999999999999999999999999999999 88887542211 1111 11 111
Q ss_pred cccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 747 AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 747 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
.....+. .....+.+++.+||+.||++||+++++++.|+++.+
T Consensus 222 -~~~~~~~-------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 222 -FRLYKPR-------LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp -CCCCCCT-------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CcCCCCc-------cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0011111 123457889999999999999999999999998743
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=341.68 Aligned_cols=198 Identities=25% Similarity=0.395 Sum_probs=161.9
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCcccee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
..++|.+.+.||+|+||.||+|.++ .+++.||||++.... ....+++.+|+++|++++||||++++
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~------------~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~ 91 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDK------------NTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLY 91 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEET------------TTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ecCCEEEEEEEeecCCEEEEEEEEC------------CCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEE
Confidence 3578999999999999999999765 678999999997542 23456799999999999999999999
Q ss_pred eEeecC-----CceEEEEEeecc---CCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCc
Q 041702 590 GCCIEQ-----GEKISIYEFDIV---TDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP 661 (840)
Q Consensus 590 g~~~~~-----~~~~lv~e~~~~---~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 661 (840)
+++... +..++|||+... ........+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~ 168 (432)
T 3n9x_A 92 DLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSV 168 (432)
T ss_dssp EECCCSCTTTCCCEEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCE
T ss_pred EEEecCCCCcCCeEEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCE
Confidence 999776 578999998421 11223456899999999999999999999998 9999999999999999999
Q ss_pred eeeccccceecCCCCcc--------------------cccccccccccccCcccc-ccCCCCccccchhHHHHHHHHHhC
Q 041702 662 KISDFGIARTFGGDEMQ--------------------SNTNRIVGTYGYMSPEYA-LHGLFSIKSDVFSFGVLLLEILSS 720 (840)
Q Consensus 662 kL~DFGla~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~ksDV~SlGviL~elltG 720 (840)
||+|||+|+........ ......+||+.|+|||++ ....++.++|||||||+|+||++|
T Consensus 169 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g 248 (432)
T 3n9x_A 169 KVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM 248 (432)
T ss_dssp EECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTT
T ss_pred EEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhc
Confidence 99999999886543211 123456799999999986 566799999999999999999986
Q ss_pred CCCC
Q 041702 721 KKNT 724 (840)
Q Consensus 721 ~~p~ 724 (840)
..|+
T Consensus 249 ~~p~ 252 (432)
T 3n9x_A 249 LQSH 252 (432)
T ss_dssp CTTT
T ss_pred cccc
Confidence 5544
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=330.30 Aligned_cols=263 Identities=22% Similarity=0.281 Sum_probs=190.5
Q ss_pred HHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-----cCHHHHHHHHHHHhhcCCCC
Q 041702 510 SAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-----QGLEEFKNEMMLIAKLQHRN 584 (840)
Q Consensus 510 ~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-----~~~~~f~~Ev~~l~~l~H~n 584 (840)
....++|...+.||+|+||.||+|.++ .+++.||||++..... ...+.+.+|++++.+++|||
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~------------~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 73 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDK------------NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN 73 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECS------------SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEEC------------CCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCC
Confidence 445688999999999999999999765 5789999999975321 12357889999999999999
Q ss_pred ccceeeEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCC
Q 041702 585 LVRLFGCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMN 660 (840)
Q Consensus 585 iv~l~g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~ 660 (840)
|+++++++.+.+..++||||..... ......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.
T Consensus 74 iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~ 150 (346)
T 1ua2_A 74 IIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGV 150 (346)
T ss_dssp BCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCC
T ss_pred CCeEEEEEeeCCceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCC
Confidence 9999999999999999999943210 112345888999999999999999999998 999999999999999999
Q ss_pred ceeeccccceecCCCCcccccccccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHh
Q 041702 661 PKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAW 739 (840)
Q Consensus 661 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~ 739 (840)
+||+|||+++.+.... .......+|+.|+|||.+.+. .++.++|||||||+++||++|.+|+...... .......
T Consensus 151 ~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~--~~~~~i~ 226 (346)
T 1ua2_A 151 LKLADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL--DQLTRIF 226 (346)
T ss_dssp EEECCCGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHH
T ss_pred EEEEecccceeccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--HHHHHHH
Confidence 9999999998764322 122345789999999998764 5899999999999999999999987643221 1111111
Q ss_pred hhhcccccc------cccC---ccccc-----hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 740 NLWKDDKAW------KLMD---PTMQN-----EALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 740 ~~~~~~~~~------~~~d---~~l~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
......... .+.+ ..... .........+.+++.+||+.||++|||++|+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 227 ETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp HHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 111000000 0000 00000 0112234568899999999999999999999864
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=326.06 Aligned_cols=259 Identities=25% Similarity=0.347 Sum_probs=197.7
Q ss_pred HccCCcccc-cccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC--cCHHHHHHHHHHHhhcCCCCccce
Q 041702 512 ATDNFSEEN-KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG--QGLEEFKNEMMLIAKLQHRNLVRL 588 (840)
Q Consensus 512 ~~~~f~~~~-~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv~l 588 (840)
..++|.+.+ .||+|+||.||+|.++ ...+++.||||+++.... ...++|.+|++++.+++||||+++
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~----------~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 83 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQ----------MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEE----------CSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred cchhhhhccCccccccCeeeEeeeec----------CCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 346788777 9999999999998543 124578999999976532 235789999999999999999999
Q ss_pred eeEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 589 FGCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
++++ +.+..++|+|+..... ......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~ 159 (291)
T 1xbb_A 84 IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKIS 159 (291)
T ss_dssp EEEE-ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEEC
T ss_pred EEEE-CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEc
Confidence 9999 6678899999942211 223456899999999999999999999998 9999999999999999999999
Q ss_pred ccccceecCCCCccc-ccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhh
Q 041702 665 DFGIARTFGGDEMQS-NTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLW 742 (840)
Q Consensus 665 DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 742 (840)
|||++.......... ......+++.|+|||.+.+..++.++||||||++++||++ |+.|+...... .. ....
T Consensus 160 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~----~~~~ 233 (291)
T 1xbb_A 160 DFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EV----TAML 233 (291)
T ss_dssp CCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HH----HHHH
T ss_pred cCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HH----HHHH
Confidence 999998775433221 2223446789999999998889999999999999999999 99998643221 11 1111
Q ss_pred cccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCC
Q 041702 743 KDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNL 799 (840)
Q Consensus 743 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~ 799 (840)
..... + ..+......+.+++.+||+.||++||++.+|++.|++.....
T Consensus 234 ~~~~~-----~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 234 EKGER-----M----GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp HTTCC-----C----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HcCCC-----C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 11110 1 111223456889999999999999999999999999875543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=333.56 Aligned_cols=246 Identities=24% Similarity=0.276 Sum_probs=195.8
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhc-CCCCccc
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKL-QHRNLVR 587 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l-~H~niv~ 587 (840)
..++|+..+.||+|+||.||+|+++ .+++.||||+++.. .....+.+.+|..++..+ +||||++
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~------------~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~ 85 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERK------------GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 85 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEET------------TEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCC
T ss_pred chHHcEEEEEEeeCCCEEEEEEEEC------------CCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEee
Confidence 4578999999999999999999765 56889999999754 234567889999999988 8999999
Q ss_pred eeeEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCcee
Q 041702 588 LFGCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKI 663 (840)
Q Consensus 588 l~g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL 663 (840)
+++++.+.+..++||||..... ......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 86 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL 162 (353)
T 2i0e_A 86 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKI 162 (353)
T ss_dssp EEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEE
T ss_pred EEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEE
Confidence 9999999999999999953322 223457899999999999999999999998 999999999999999999999
Q ss_pred eccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhc
Q 041702 664 SDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWK 743 (840)
Q Consensus 664 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~ 743 (840)
+|||+++...... .......||+.|+|||++.+..++.++|||||||+++||++|+.||..... ..+... ..
T Consensus 163 ~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--~~~~~~----i~ 234 (353)
T 2i0e_A 163 ADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DELFQS----IM 234 (353)
T ss_dssp CCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHH----HH
T ss_pred EeCCcccccccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH--HHHHHH----HH
Confidence 9999998643222 223456799999999999999999999999999999999999999864321 111111 11
Q ss_pred ccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 041702 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPT-----MLEVVA 790 (840)
Q Consensus 744 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 790 (840)
.... .. +......+.+++.+||+.||++||+ +++|++
T Consensus 235 ~~~~------~~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 235 EHNV------AY----PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp HCCC------CC----CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred hCCC------CC----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1110 01 1123456788999999999999995 466653
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=328.15 Aligned_cols=269 Identities=21% Similarity=0.287 Sum_probs=204.2
Q ss_pred CHHHHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhh--cCC
Q 041702 505 SLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAK--LQH 582 (840)
Q Consensus 505 ~~~~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~--l~H 582 (840)
++.......++|...+.||+|+||.||+|.+ +++.||||++... ..+.+.+|++++.. ++|
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--------------~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h 95 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW--------------RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRH 95 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE--------------TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCC
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEE--------------cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCC
Confidence 3444566678999999999999999999853 4789999999643 34678889999987 799
Q ss_pred CCccceeeEeecCC----ceEEEEEeeccCC---ccccCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCceecCC
Q 041702 583 RNLVRLFGCCIEQG----EKISIYEFDIVTD---PARKDLLDWTTRVRIIEGVAQGLLYLH--------QYSRLRVIHRD 647 (840)
Q Consensus 583 ~niv~l~g~~~~~~----~~~lv~e~~~~~~---~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~ivHrD 647 (840)
|||+++++++...+ ..++||||..... ......+++..+++++.|++.||+||| +.+ |+|||
T Consensus 96 ~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~D 172 (342)
T 1b6c_B 96 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRD 172 (342)
T ss_dssp TTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSC
T ss_pred CcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCC
Confidence 99999999998876 7899999943322 223456899999999999999999999 666 99999
Q ss_pred CCCCcEEecCCCCceeeccccceecCCCCccc--ccccccccccccCccccccCC------CCccccchhHHHHHHHHHh
Q 041702 648 LKASNVLLDSDMNPKISDFGIARTFGGDEMQS--NTNRIVGTYGYMSPEYALHGL------FSIKSDVFSFGVLLLEILS 719 (840)
Q Consensus 648 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~ksDV~SlGviL~ellt 719 (840)
|||+|||++.++.+||+|||++.......... ......||+.|+|||.+.+.. ++.++||||||++++||++
T Consensus 173 lkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~t 252 (342)
T 1b6c_B 173 LKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 252 (342)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHh
Confidence 99999999999999999999998765433211 234457999999999987753 3478999999999999999
Q ss_pred C----------CCCCCCCCCCCccHhHHHhhhhcccccccccCccccch-hhHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 041702 720 S----------KKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNE-ALYSMVTRYIKVALLCVQENATDRPTMLEV 788 (840)
Q Consensus 720 G----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev 788 (840)
| +.|+.............. ...... ...+.+... ...+....+.+++.+||+.||++|||+.||
T Consensus 253 g~~~~~~~~~~~~p~~~~~~~~~~~~~~~-~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i 327 (342)
T 1b6c_B 253 RCSIGGIHEDYQLPYYDLVPSDPSVEEMR-KVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 327 (342)
T ss_dssp TBCBTTBCCCCCCTTTTTSCSSCCHHHHH-HHHTTS----CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred ccCcCCcccccccCccccCcCcccHHHHH-HHHHHH----HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHH
Confidence 9 556544333222211111 111111 112222211 223566789999999999999999999999
Q ss_pred HHHhhccccC
Q 041702 789 VAMLKDEIVN 798 (840)
Q Consensus 789 l~~Le~~~~~ 798 (840)
++.|+.+..+
T Consensus 328 ~~~L~~i~~~ 337 (342)
T 1b6c_B 328 KKTLSQLSQQ 337 (342)
T ss_dssp HHHHHHHHHT
T ss_pred HHHHHHHHHH
Confidence 9999987554
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=356.62 Aligned_cols=257 Identities=26% Similarity=0.378 Sum_probs=195.2
Q ss_pred cCCcccc-cccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 514 DNFSEEN-KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 514 ~~f~~~~-~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
+++...+ +||+|+||.||+|.++ ...++..||||+++... ....++|.+|+++|++++|||||+++++
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~----------~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~ 404 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYR----------MRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 404 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEE----------CSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEe----------cCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 3444444 7999999999998754 11356789999998653 3467889999999999999999999999
Q ss_pred eecCCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 592 CIEQGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
|.. +..++||||...... .....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 405 ~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DF 480 (613)
T 2ozo_A 405 CQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDF 480 (613)
T ss_dssp EES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCC
T ss_pred ecc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeec
Confidence 976 668999999533221 12456899999999999999999999998 999999999999999999999999
Q ss_pred ccceecCCCCcc-cccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 667 GIARTFGGDEMQ-SNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 667 Gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
|+++.+...... .......+|+.|+|||++.+..++.++|||||||+||||++ |+.|+...... .... ....
T Consensus 481 Gla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~----~i~~ 554 (613)
T 2ozo_A 481 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMA----FIEQ 554 (613)
T ss_dssp STTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--HHHH----HHHT
T ss_pred cCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHH----HHHc
Confidence 999876433221 11222345689999999999999999999999999999998 99998654322 1111 1111
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCC
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNL 799 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~ 799 (840)
... ...+...+..+.+++.+||+.||++||++.+|++.|+.....+
T Consensus 555 ~~~---------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 555 GKR---------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp TCC---------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCC---------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 110 1111223456889999999999999999999999999875544
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=329.09 Aligned_cols=257 Identities=22% Similarity=0.305 Sum_probs=180.1
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCcccee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
..++|+..+.||+|+||.||+|.+. .+|+.||||++.... ....+++.+|++++++++||||++++
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 94 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDT------------KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEET------------TTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred CCCceEEeeEEeecCCeEEEEEEEC------------CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 4578999999999999999999765 678999999997542 23456788999999999999999999
Q ss_pred eEeecC------CceEEEEEee--ccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCc
Q 041702 590 GCCIEQ------GEKISIYEFD--IVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP 661 (840)
Q Consensus 590 g~~~~~------~~~~lv~e~~--~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 661 (840)
+++... ...++++|+. .+........+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 95 ~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~ 171 (367)
T 2fst_X 95 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCEL 171 (367)
T ss_dssp EEECSCSSGGGCCCCEEEEECCCEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCE
T ss_pred EEEecCCccccCCeEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCE
Confidence 998654 5678999984 2222233457899999999999999999999998 9999999999999999999
Q ss_pred eeeccccceecCCCCcccccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhh
Q 041702 662 KISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWN 740 (840)
Q Consensus 662 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~ 740 (840)
||+|||+++..... .....||+.|+|||.+.+ ..++.++|||||||+++||++|+.||...... ........
T Consensus 172 kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~l~~i~~ 244 (367)
T 2fst_X 172 KILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI--DQLKLILR 244 (367)
T ss_dssp EECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHH
T ss_pred EEeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHH
Confidence 99999999875422 234578999999999887 67999999999999999999999998653321 11111111
Q ss_pred hhccc-----------ccccccC--cccc----chhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 741 LWKDD-----------KAWKLMD--PTMQ----NEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 741 ~~~~~-----------~~~~~~d--~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
..... .....+. +... ..........+.+++.+||+.||++|||++|+++
T Consensus 245 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 245 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 10000 0000000 0000 0011122456889999999999999999999985
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=322.05 Aligned_cols=247 Identities=23% Similarity=0.354 Sum_probs=189.7
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
..++|...++||+|+||.||+|.++ .++..||+|++.... ....+++.+|++++++++||||+++++
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 87 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEER------------SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEET------------TTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEc------------cCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHH
Confidence 3467999999999999999999765 578999999997653 345788999999999999999999999
Q ss_pred EeecCCceEEEEEeeccCCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEe---cCCC
Q 041702 591 CCIEQGEKISIYEFDIVTDP--------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLL---DSDM 659 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~~--------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl---~~~~ 659 (840)
++.+.+..++||||...... .....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~ 164 (285)
T 3is5_A 88 VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHS 164 (285)
T ss_dssp EEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTC
T ss_pred heecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCC
Confidence 99999999999999533221 12367899999999999999999999998 9999999999999 4567
Q ss_pred CceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHh
Q 041702 660 NPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAW 739 (840)
Q Consensus 660 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~ 739 (840)
.+||+|||++....... ......||+.|+|||.+. ..++.++||||||++++||++|+.||....... ....
T Consensus 165 ~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~--~~~~-- 236 (285)
T 3is5_A 165 PIKIIDFGLAELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE--VQQK-- 236 (285)
T ss_dssp CEEECCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH--
T ss_pred CEEEEeeecceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH--HHhh--
Confidence 89999999998764332 223456899999999875 568999999999999999999999986432111 1100
Q ss_pred hhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 740 NLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 740 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.......... .. ....+.+.+++.+||+.||++|||+.||++
T Consensus 237 -~~~~~~~~~~-~~-------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 237 -ATYKEPNYAV-EC-------RPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -HHHCCCCCCC----------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred -hccCCccccc-cc-------CcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000000000 00 012345778999999999999999999985
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=319.13 Aligned_cols=246 Identities=25% Similarity=0.385 Sum_probs=175.0
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhcCCCCccce
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQHRNLVRL 588 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l 588 (840)
..++|.+.+.||+|+||.||+|.+. .+++.||||++... .....+++.+|+.++.+++||||+++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~------------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 76 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESI------------HTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEET------------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCE
T ss_pred ccccceeeeeecCCCceEEEEEEEc------------cCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeE
Confidence 3467999999999999999999754 57899999999643 23345789999999999999999999
Q ss_pred eeEeecCCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCcee
Q 041702 589 FGCCIEQGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKI 663 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL 663 (840)
++++.+.+..++++|+...... .....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||
T Consensus 77 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl 153 (278)
T 3cok_A 77 YNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKI 153 (278)
T ss_dssp EEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEE
T ss_pred EEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEE
Confidence 9999999999999999422111 12256899999999999999999999998 999999999999999999999
Q ss_pred eccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhc
Q 041702 664 SDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWK 743 (840)
Q Consensus 664 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~ 743 (840)
+|||++........ ......||+.|+|||.+.+..++.++||||||++++||++|+.|+......... . ...
T Consensus 154 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~----~~~ 225 (278)
T 3cok_A 154 ADFGLATQLKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL--N----KVV 225 (278)
T ss_dssp CCCTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CC
T ss_pred EeecceeeccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH--H----HHh
Confidence 99999987643221 122456899999999999999999999999999999999999998654322110 0 000
Q ss_pred ccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 744 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
..+.... ......+.+++.+||+.||++|||++++++
T Consensus 226 ------~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 226 ------LADYEMP----SFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ------SSCCCCC----TTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ------hcccCCc----cccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 0001111 112345788999999999999999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=330.62 Aligned_cols=259 Identities=24% Similarity=0.388 Sum_probs=192.5
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
.++|...+.||+|+||.||+|.++. .....+..||||+++.... ....+|.+|+.++.+++||||++++++
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~--------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 114 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKT--------SSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGV 114 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC-----------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEec--------CCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 4677888999999999999997651 0112345799999975432 345679999999999999999999999
Q ss_pred eecCCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 592 CIEQGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
+.+.+..++|||+...... .....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 115 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Df 191 (333)
T 1mqb_A 115 ISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDF 191 (333)
T ss_dssp ECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC
T ss_pred EecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCC
Confidence 9999999999999422111 12356899999999999999999999998 999999999999999999999999
Q ss_pred ccceecCCCCccc-ccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 667 GIARTFGGDEMQS-NTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 667 Gla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
|+++......... ......+|+.|+|||.+.+..++.++||||||++++||++ |+.|+..... .... .....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--~~~~----~~~~~ 265 (333)
T 1mqb_A 192 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVM----KAIND 265 (333)
T ss_dssp CC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHH----HHHHT
T ss_pred CcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH--HHHH----HHHHC
Confidence 9998765432211 1223346789999999999999999999999999999999 9998853321 1111 11111
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
.. .. .........+.+++.+||+.||++||++.+|++.|+++..
T Consensus 266 ~~--~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 266 GF--RL-------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp TC--CC-------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CC--cC-------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 10 00 0111234567899999999999999999999999998654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=321.77 Aligned_cols=248 Identities=19% Similarity=0.305 Sum_probs=193.2
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
.++|...+.||+|+||.||+|.+ .++.||||++.... ....++|.+|+.++++++||||+++++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~--------------~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 74 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW--------------QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE--------------TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE--------------CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEE
Confidence 46789999999999999999864 37889999997653 234567999999999999999999999
Q ss_pred EeecC--CceEEEEEeeccCCc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCce
Q 041702 591 CCIEQ--GEKISIYEFDIVTDP------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPK 662 (840)
Q Consensus 591 ~~~~~--~~~~lv~e~~~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 662 (840)
++.+. +..+++|||...... .....+++..+..++.||+.||+|||+.+ .+|+||||||+|||++.++.+|
T Consensus 75 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~ 153 (271)
T 3kmu_A 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTAR 153 (271)
T ss_dssp EECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEE
T ss_pred EEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCccee
Confidence 99887 788999999532221 11225899999999999999999999865 3599999999999999999999
Q ss_pred eeccccceecCCCCcccccccccccccccCccccccCCCCc---cccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHh
Q 041702 663 ISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSI---KSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAW 739 (840)
Q Consensus 663 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~ 739 (840)
|+|||++.... .....||+.|+|||.+.+..++. ++||||||++++||++|+.|+....... ...
T Consensus 154 l~~~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~ 221 (271)
T 3kmu_A 154 ISMADVKFSFQ-------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME-----IGM 221 (271)
T ss_dssp EEGGGSCCTTS-------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH-----HHH
T ss_pred EEeccceeeec-------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH-----HHH
Confidence 99998875432 22346899999999998765544 7999999999999999999986432111 111
Q ss_pred hhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 041702 740 NLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEI 796 (840)
Q Consensus 740 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~ 796 (840)
...... ..+.. +......+.+++.+||+.||++|||++|+++.|+++.
T Consensus 222 ~~~~~~-----~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 222 KVALEG-----LRPTI----PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp HHHHSC-----CCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HHHhcC-----CCCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 111111 01111 1123445889999999999999999999999999874
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=320.68 Aligned_cols=248 Identities=21% Similarity=0.296 Sum_probs=194.5
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC------cCHHHHHHHHHHHhhcCCCCcc
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG------QGLEEFKNEMMLIAKLQHRNLV 586 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~------~~~~~f~~Ev~~l~~l~H~niv 586 (840)
.++|+..+.||+|+||.||+|.++ .+++.||||++..... ...+.|.+|+.++.+++||||+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 71 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQK------------GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET------------TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBC
T ss_pred hhhhhhHHhhcccCceEEEEEEEc------------CCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCee
Confidence 357899999999999999999765 5789999999875421 2467899999999999999999
Q ss_pred ceeeEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCC---
Q 041702 587 RLFGCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDM--- 659 (840)
Q Consensus 587 ~l~g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~--- 659 (840)
++++++.+.+..++|||+..... ......+++..+..++.||+.||+|||+.+ |+||||||+||+++.++
T Consensus 72 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~ 148 (283)
T 3bhy_A 72 TLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPN 148 (283)
T ss_dssp CEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSS
T ss_pred ehhheecCCCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCC
Confidence 99999999999999999953222 123457899999999999999999999998 99999999999998877
Q ss_pred -CceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHH
Q 041702 660 -NPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHA 738 (840)
Q Consensus 660 -~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~ 738 (840)
.+||+|||++........ .....+++.|+|||.+.+..++.++||||||++++||++|+.|+...... ...
T Consensus 149 ~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~--- 220 (283)
T 3bhy_A 149 PRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ--ETL--- 220 (283)
T ss_dssp CCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHH---
T ss_pred CceEEEecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH--HHH---
Confidence 899999999987643321 23456899999999999999999999999999999999999998643211 111
Q ss_pred hhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 739 WNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 739 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
...... ...............+.+++.+||+.||++|||+.|+++
T Consensus 221 -~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 221 -TNISAV------NYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp -HHHHTT------CCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -HHhHhc------ccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 111100 011111112233456889999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=323.94 Aligned_cols=247 Identities=25% Similarity=0.422 Sum_probs=198.4
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
.+.|...+.||+|+||.||+|.+. .+++.||||++.... ....+.+.+|+.++.+++||||++++++
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 88 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDN------------RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEET------------TTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEEC------------CCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 467899999999999999999754 578999999997553 3456889999999999999999999999
Q ss_pred eecCCceEEEEEeecc---CCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccc
Q 041702 592 CIEQGEKISIYEFDIV---TDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGI 668 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~---~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl 668 (840)
+.+.+..++||||... ........+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~ 165 (303)
T 3a7i_A 89 YLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGV 165 (303)
T ss_dssp EEETTEEEEEEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EecCCeEEEEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeeccc
Confidence 9999999999999421 22223456899999999999999999999998 99999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccc
Q 041702 669 ARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAW 748 (840)
Q Consensus 669 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (840)
+........ ......||+.|+|||.+.+..++.++||||||++++||++|+.|+...... .... . .....
T Consensus 166 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~---~-~~~~~-- 235 (303)
T 3a7i_A 166 AGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM--KVLF---L-IPKNN-- 235 (303)
T ss_dssp CEECBTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHH---H-HHHSC--
T ss_pred ceecCcccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH--HHHH---H-hhcCC--
Confidence 987654322 223457899999999999999999999999999999999999997543211 1110 0 01110
Q ss_pred cccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 749 KLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 749 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
.+.+.. .....+.+++.+||+.||++|||+.||++.
T Consensus 236 ---~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 236 ---PPTLEG----NYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp ---CCCCCS----SCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ---CCCCcc----ccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 111111 123457889999999999999999999863
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=342.08 Aligned_cols=259 Identities=18% Similarity=0.223 Sum_probs=199.7
Q ss_pred cCHHHHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhc
Q 041702 504 FSLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKL 580 (840)
Q Consensus 504 ~~~~~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l 580 (840)
+.+.++....++|+..++||+|+||.||+|+++ .+++.||||++++.. ....+.+.+|..++.++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~------------~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~ 118 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMK------------QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG 118 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEET------------TTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEEC------------CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc
Confidence 345566667899999999999999999999765 679999999997531 23345689999999999
Q ss_pred CCCCccceeeEeecCCceEEEEEeeccCCc----cc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEe
Q 041702 581 QHRNLVRLFGCCIEQGEKISIYEFDIVTDP----AR-KDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLL 655 (840)
Q Consensus 581 ~H~niv~l~g~~~~~~~~~lv~e~~~~~~~----~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl 655 (840)
+||||+++++++.+.+..++||||...... .. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 119 ~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl 195 (412)
T 2vd5_A 119 DRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILL 195 (412)
T ss_dssp CTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred CCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeee
Confidence 999999999999999999999999533221 11 247899999999999999999999998 9999999999999
Q ss_pred cCCCCceeeccccceecCCCCcccccccccccccccCccccc-------cCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 041702 656 DSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYAL-------HGLFSIKSDVFSFGVLLLEILSSKKNTRFYN 728 (840)
Q Consensus 656 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~ksDV~SlGviL~elltG~~p~~~~~ 728 (840)
+.++++||+|||+++....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus 196 d~~g~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 274 (412)
T 2vd5_A 196 DRCGHIRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS 274 (412)
T ss_dssp CTTSCEEECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cCCCCEEEeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC
Confidence 9999999999999987654332 1223467999999999987 3568999999999999999999999986432
Q ss_pred CCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCC---CCHHHHHH
Q 041702 729 TDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDR---PTMLEVVA 790 (840)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ps~~evl~ 790 (840)
.. ........ ... ....+. ........+.+++.+||+ +|++| |+++||++
T Consensus 275 ~~--~~~~~i~~---~~~--~~~~p~----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 275 TA--ETYGKIVH---YKE--HLSLPL----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HH--HHHHHHHT---HHH--HCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HH--HHHHHHHh---ccc--CcCCCc----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 11 11111100 000 000011 111234568899999999 99998 58888874
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=341.98 Aligned_cols=238 Identities=14% Similarity=0.170 Sum_probs=179.7
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHH---HHHhhcCCCCc
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEM---MLIAKLQHRNL 585 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev---~~l~~l~H~ni 585 (840)
..++|...+.||+|+||.||+|.++ .+|+.||||++... .....+.|.+|+ +++++++||||
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~------------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpni 138 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQ------------ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-------------CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHH
T ss_pred CCceEEEcceeecCCCEEEEEEEEC------------CCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHH
Confidence 4578899999999999999999765 57899999999743 234457899999 55556689999
Q ss_pred ccee-------eEeecCC-----------------ceEEEEEeecc---CCccc-------cCCCCHHHHHHHHHHHHHH
Q 041702 586 VRLF-------GCCIEQG-----------------EKISIYEFDIV---TDPAR-------KDLLDWTTRVRIIEGVAQG 631 (840)
Q Consensus 586 v~l~-------g~~~~~~-----------------~~~lv~e~~~~---~~~~~-------~~~l~~~~~~~i~~~ia~~ 631 (840)
|+++ +++...+ ..+++|||... ..... ...+++..++.|+.||+.|
T Consensus 139 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~a 218 (377)
T 3byv_A 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRL 218 (377)
T ss_dssp HHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHH
T ss_pred HHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHH
Confidence 9998 5555443 27788888411 00011 1223358888999999999
Q ss_pred HHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceecCCCCcccccccccccccccCccccccC-----------C
Q 041702 632 LLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHG-----------L 700 (840)
Q Consensus 632 L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~ 700 (840)
|+|||+.+ |+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .
T Consensus 219 L~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~ 289 (377)
T 3byv_A 219 LASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTL 289 (377)
T ss_dssp HHHHHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEE
T ss_pred HHHHHhCC---eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhccccccccccccccc
Confidence 99999998 99999999999999999999999999986432 2234567 999999999887 8
Q ss_pred CCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCC
Q 041702 701 FSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENAT 780 (840)
Q Consensus 701 ~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~ 780 (840)
++.++|||||||+||||++|+.||......... ..+.. .. ......+.+++.+||+.||+
T Consensus 290 ~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~--------------~~~~~-~~-----~~~~~~~~~li~~~L~~dp~ 349 (377)
T 3byv_A 290 MTFSFDAWALGLVIYWIWCADLPITKDAALGGS--------------EWIFR-SC-----KNIPQPVRALLEGFLRYPKE 349 (377)
T ss_dssp CCHHHHHHHHHHHHHHHHHSSCCC------CCS--------------GGGGS-SC-----CCCCHHHHHHHHHHTCSSGG
T ss_pred CChhhhHHHHHHHHHHHHHCCCCCcccccccch--------------hhhhh-hc-----cCCCHHHHHHHHHHcCCCch
Confidence 999999999999999999999998643322110 00000 00 11234578899999999999
Q ss_pred CCCCHHHHHH
Q 041702 781 DRPTMLEVVA 790 (840)
Q Consensus 781 ~RPs~~evl~ 790 (840)
+|||+.|+++
T Consensus 350 ~Rpt~~e~l~ 359 (377)
T 3byv_A 350 DRLLPLQAME 359 (377)
T ss_dssp GCCCHHHHHT
T ss_pred hCCCHHHHhh
Confidence 9999999985
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-36 Score=319.76 Aligned_cols=247 Identities=24% Similarity=0.373 Sum_probs=188.9
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCI 593 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~ 593 (840)
+.|.....||+|+||.||+|.+. .+++.||||++........+.+.+|+.++++++||||+++++++.
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 89 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDL------------SNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEET------------TTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEEC------------CCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEE
Confidence 44555668999999999999765 578899999998766666788999999999999999999999999
Q ss_pred cCCceEEEEEeeccCC-------ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecC-CCCceeec
Q 041702 594 EQGEKISIYEFDIVTD-------PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS-DMNPKISD 665 (840)
Q Consensus 594 ~~~~~~lv~e~~~~~~-------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kL~D 665 (840)
+.+..++|+|+..... ......+++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~D 166 (295)
T 2clq_A 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISD 166 (295)
T ss_dssp ETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECC
T ss_pred eCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEee
Confidence 9999999999842111 111234678888999999999999999998 999999999999987 89999999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCC--CCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGL--FSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWK 743 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~ 743 (840)
||++....... .......||+.|+|||.+.+.. ++.++||||||++++||++|+.|+............. ...
T Consensus 167 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~- 241 (295)
T 2clq_A 167 FGTSKRLAGIN--PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV--GMF- 241 (295)
T ss_dssp TTTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHH--HHH-
T ss_pred cccccccCCCC--CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhh--ccc-
Confidence 99998764322 1223457899999999987654 8899999999999999999999985332111110000 000
Q ss_pred ccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 744 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
...+.+. ......+.+++.+||+.||++||+++++++
T Consensus 242 ------~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 242 ------KVHPEIP----ESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp ------CCCCCCC----TTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ------ccccccc----ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0111111 123346788999999999999999999975
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=328.78 Aligned_cols=257 Identities=13% Similarity=0.135 Sum_probs=200.1
Q ss_pred HHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcC---CCCcc
Q 041702 510 SAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQ---HRNLV 586 (840)
Q Consensus 510 ~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~---H~niv 586 (840)
+...++|.+.++||+|+||.||+|.++.. ....+++.||||++... ...++..|++++.+++ |+||+
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~-------~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv 130 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDL-------NDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFM 130 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC--------------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBC
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCC-------cccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhh
Confidence 34568899999999999999999964310 12467899999999754 4567888888888886 99999
Q ss_pred ceeeEeecCCceEEEEEeeccCCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecC
Q 041702 587 RLFGCCIEQGEKISIYEFDIVTDPA---------RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS 657 (840)
Q Consensus 587 ~l~g~~~~~~~~~lv~e~~~~~~~~---------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~ 657 (840)
++++++...+..++||||....... ....+++..++.|+.||+.||+|||+.+ |+||||||+|||++.
T Consensus 131 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~ 207 (365)
T 3e7e_A 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGN 207 (365)
T ss_dssp CEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECG
T ss_pred hhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecc
Confidence 9999999999999999995332211 2456999999999999999999999988 999999999999998
Q ss_pred -----------CCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 041702 658 -----------DMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRF 726 (840)
Q Consensus 658 -----------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~ 726 (840)
++.+||+|||+|+.+.............||+.|+|||++.+..++.++|||||||++|||++|+.|+..
T Consensus 208 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 208 GFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp GGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred cccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence 899999999999876433333334556799999999999999999999999999999999999999743
Q ss_pred CCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCC-CCHHHHHHHhhccccCC
Q 041702 727 YNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDR-PTMLEVVAMLKDEIVNL 799 (840)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R-Ps~~evl~~Le~~~~~~ 799 (840)
....... +...+.... ..+.+.+++..|++.+|.+| |+++++.+.|++.+...
T Consensus 288 ~~~~~~~-----------------~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 288 NEGGECK-----------------PEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp EETTEEE-----------------ECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred CCCCcee-----------------echhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 2211100 111111111 13346678888999999999 58899999999876543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=325.63 Aligned_cols=248 Identities=23% Similarity=0.339 Sum_probs=180.5
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC--cCHHHHHHHHHHHhhcCCCCcccee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG--QGLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
..++|+..+.||+|+||.||+|.++ .+++.||||++..... ...+.+.++...++.++||||++++
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~ 72 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHV------------PSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET------------TTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEec------------CCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEe
Confidence 4578999999999999999999765 6789999999975422 2223345555668888999999999
Q ss_pred eEeecCCceEEEEEeeccC-------CccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceecCCCCCCcEEecCCCCc
Q 041702 590 GCCIEQGEKISIYEFDIVT-------DPARKDLLDWTTRVRIIEGVAQGLLYLHQY-SRLRVIHRDLKASNVLLDSDMNP 661 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~-------~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivHrDlkp~NILl~~~~~~ 661 (840)
+++.+.+..++||||.... .......+++..+..++.||+.||+|||++ + |+||||||+|||++.++.+
T Consensus 73 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~ 149 (290)
T 3fme_A 73 GALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQV 149 (290)
T ss_dssp EEEECSSSEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCE
T ss_pred eeeeccCCEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCE
Confidence 9999999999999995321 112345799999999999999999999998 7 9999999999999999999
Q ss_pred eeeccccceecCCCCcccccccccccccccCcccc----ccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHH
Q 041702 662 KISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYA----LHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGH 737 (840)
Q Consensus 662 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~ 737 (840)
||+|||++........ .....||+.|+|||.+ .+..++.++||||||++++||++|+.|+.........
T Consensus 150 kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---- 222 (290)
T 3fme_A 150 KMCDFGISGYLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ---- 222 (290)
T ss_dssp EBCCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH----
T ss_pred EEeecCCccccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH----
Confidence 9999999987643321 2234689999999996 5667899999999999999999999998643221111
Q ss_pred HhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 738 AWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 738 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
........ . +... .......+.+++.+||+.||++|||+.|+++
T Consensus 223 ~~~~~~~~-~-----~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 223 LKQVVEEP-S-----PQLP---ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHHHHHSC-C-----CCCC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHhccC-C-----CCcc---cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 11111111 0 0111 1122345789999999999999999999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=319.58 Aligned_cols=248 Identities=23% Similarity=0.296 Sum_probs=197.9
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhcCCCCcccee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
.++|...+.||+|+||.||+|.+. .+++.||||++... .....+++.+|++++.+++||||++++
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 80 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREK------------QNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET------------TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred hhhceeeheecCCCCeEEEEEEEc------------CCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEE
Confidence 367999999999999999999765 57889999998643 233457899999999999999999999
Q ss_pred eEeecCCceEEEEEeeccC----CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 590 GCCIEQGEKISIYEFDIVT----DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~----~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
+++.+.+..++++|+.... .......+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 81 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~D 157 (284)
T 2vgo_A 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIAD 157 (284)
T ss_dssp EEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECC
T ss_pred EEEEcCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEec
Confidence 9999999999999994221 1223456899999999999999999999988 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
||++....... .....|++.|+|||.+.+..++.++||||||++++||++|+.|+...... ... ......
T Consensus 158 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~----~~~~~~ 227 (284)
T 2vgo_A 158 FGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT--ETH----RRIVNV 227 (284)
T ss_dssp CTTCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHH----HHHHTT
T ss_pred ccccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh--HHH----HHHhcc
Confidence 99997654322 23456899999999999999999999999999999999999998643211 111 111110
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH--Hhhcc
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA--MLKDE 795 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~Le~~ 795 (840)
+.... ......+.+++.+||+.||++||+++++++ .++..
T Consensus 228 ------~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 228 ------DLKFP----PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp ------CCCCC----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred ------ccCCC----CcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 01111 122345788999999999999999999985 55544
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-36 Score=331.94 Aligned_cols=258 Identities=22% Similarity=0.237 Sum_probs=187.4
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
.++|+..+.||+|+||.||+|.++ .+++.||||++.... ....+++.+|+.++++++||||+++++
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~------------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 91 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDA------------ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN 91 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEET------------TTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hhheeEeeeeEecCCEEEEEEEEC------------CCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEE
Confidence 478999999999999999999765 578999999997542 234567899999999999999999999
Q ss_pred EeecCC------ceEEEEEeeccCCc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCcee
Q 041702 591 CCIEQG------EKISIYEFDIVTDP-ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKI 663 (840)
Q Consensus 591 ~~~~~~------~~~lv~e~~~~~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL 663 (840)
++...+ ..++||||...... .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl 168 (371)
T 2xrw_A 92 VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKI 168 (371)
T ss_dssp EECSCCSTTTCCEEEEEEECCSEEHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred eeccccccccccceEEEEEcCCCCHHHHHhhccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEE
Confidence 997665 67999999432100 01245889999999999999999999998 999999999999999999999
Q ss_pred eccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhh--
Q 041702 664 SDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNL-- 741 (840)
Q Consensus 664 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~-- 741 (840)
+|||+++...... ......||+.|+|||.+.+..++.++|||||||+++||++|+.||...... .........
T Consensus 169 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~~ 243 (371)
T 2xrw_A 169 LDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI--DQWNKVIEQLG 243 (371)
T ss_dssp CCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHC-CC
T ss_pred EEeeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhC
Confidence 9999998764322 223457899999999999999999999999999999999999998653221 100000000
Q ss_pred -----------------hcccc------cccccCccc---cchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 742 -----------------WKDDK------AWKLMDPTM---QNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 742 -----------------~~~~~------~~~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
..... ......... ...........+.+++.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 244 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp CCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 00000 000000000 01122334667899999999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=331.45 Aligned_cols=262 Identities=22% Similarity=0.298 Sum_probs=196.2
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcCCCCccceee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
..++|+..+.||+|+||.||+|.+. .+++.||||++..... ...+++.+|++++.+++||||+++++
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 92 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDN------------LNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 92 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEET------------TTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCE
T ss_pred ccccEEEEEEeecCCCeEEEEEEEC------------CCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcccee
Confidence 3568999999999999999999765 5789999999975432 33467999999999999999999999
Q ss_pred EeecC-----CceEEEEEeecc--CCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCcee
Q 041702 591 CCIEQ-----GEKISIYEFDIV--TDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKI 663 (840)
Q Consensus 591 ~~~~~-----~~~~lv~e~~~~--~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL 663 (840)
++... ...++|+|+... ........+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 93 ~~~~~~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl 169 (364)
T 3qyz_A 93 IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKI 169 (364)
T ss_dssp EECCSSTTTCCCEEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred EEecCCccccceEEEEEcccCcCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEE
Confidence 99755 468899998431 11123456899999999999999999999998 999999999999999999999
Q ss_pred eccccceecCCCCccc-ccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhh
Q 041702 664 SDFGIARTFGGDEMQS-NTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNL 741 (840)
Q Consensus 664 ~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~ 741 (840)
+|||+++......... ......||+.|+|||.+.+ ..++.++|||||||+++||++|+.||......+ ........
T Consensus 170 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~i~~~ 247 (364)
T 3qyz_A 170 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD--QLNHILGI 247 (364)
T ss_dssp CCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG--HHHHHHHH
T ss_pred EeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH--HHHHHHHH
Confidence 9999998765332211 1244579999999998654 558999999999999999999999986543322 11111110
Q ss_pred hccccc---------------ccccCcccc--chhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 742 WKDDKA---------------WKLMDPTMQ--NEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 742 ~~~~~~---------------~~~~d~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
...... .....+... ..........+.+++.+||+.||++|||++|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 248 LGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 000000000 0011123456889999999999999999999985
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=328.02 Aligned_cols=253 Identities=25% Similarity=0.381 Sum_probs=195.2
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCce--EEEEEeccC-CCcCHHHHHHHHHHHhhc-CCCCcccee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEE--VAVKRLSSK-SGQGLEEFKNEMMLIAKL-QHRNLVRLF 589 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~--VAvK~l~~~-~~~~~~~f~~Ev~~l~~l-~H~niv~l~ 589 (840)
++|+..+.||+|+||.||+|+++ .++.. ||||++... .....+++.+|++++.++ +||||++++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~------------~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 92 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIK------------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEE------------ETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEE
T ss_pred HHccceeeeecCCCceEEEEEEc------------cCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhc
Confidence 67999999999999999999765 45664 599998753 234557799999999999 999999999
Q ss_pred eEeecCCceEEEEEeeccCCc--------------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCC
Q 041702 590 GCCIEQGEKISIYEFDIVTDP--------------------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLK 649 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~~~--------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk 649 (840)
+++.+.+..++|||+...... .....+++..++.++.||+.||+|||+.+ |+|||||
T Consensus 93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlk 169 (327)
T 1fvr_A 93 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLA 169 (327)
T ss_dssp EEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCS
T ss_pred eeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCc
Confidence 999999999999999422111 12246899999999999999999999998 9999999
Q ss_pred CCcEEecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCC
Q 041702 650 ASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYN 728 (840)
Q Consensus 650 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~ 728 (840)
|+|||++.++.+||+|||+++.... ........+++.|+|||.+.+..++.++||||||++++||++ |+.|+....
T Consensus 170 p~NIl~~~~~~~kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~ 246 (327)
T 1fvr_A 170 ARNILVGENYVAKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 246 (327)
T ss_dssp GGGEEECGGGCEEECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cceEEEcCCCeEEEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc
Confidence 9999999999999999999974321 112233456889999999998899999999999999999998 999985432
Q ss_pred CCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCC
Q 041702 729 TDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNL 799 (840)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~ 799 (840)
.. .. ........ .. .........+.+++.+||+.||++|||++|+++.|+.+..+.
T Consensus 247 ~~--~~----~~~~~~~~-----~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 247 CA--EL----YEKLPQGY-----RL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp HH--HH----HHHGGGTC-----CC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HH--HH----HHHhhcCC-----CC----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 11 11 11111110 00 111122356889999999999999999999999999876654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=328.50 Aligned_cols=265 Identities=24% Similarity=0.349 Sum_probs=200.8
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
.++|+..+.||+|+||.||+|... .....+++.||||++........++|.+|++++++++||||+++++++
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 111 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYD--------PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 111 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEEC--------TTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred HHHceeeeeeccCCCeEEEEEEec--------cccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 467889999999999999998632 012357899999999876666667899999999999999999999998
Q ss_pred ecCC--ceEEEEEeeccCCcc-----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 593 IEQG--EKISIYEFDIVTDPA-----RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 593 ~~~~--~~~lv~e~~~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
...+ ..++|+|+....... ....+++..+++++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 112 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~D 188 (326)
T 2w1i_A 112 YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGD 188 (326)
T ss_dssp CC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECC
T ss_pred EecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEec
Confidence 7654 678999984322211 1245899999999999999999999988 99999999999999999999999
Q ss_pred cccceecCCCCccc-ccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCC---------CCcc-H
Q 041702 666 FGIARTFGGDEMQS-NTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNT---------DSLT-L 734 (840)
Q Consensus 666 FGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~---------~~~~-~ 734 (840)
||++.......... ......++..|+|||.+.+..++.++||||||++++||++|+.|+..... .... .
T Consensus 189 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 268 (326)
T 2w1i_A 189 FGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 268 (326)
T ss_dssp CTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHH
T ss_pred CcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhh
Confidence 99998875443221 12334567789999999998999999999999999999999988643210 0000 0
Q ss_pred hHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 735 LGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 735 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
......... ...........+..+.+++.+||+.||++|||+.||++.|+.+..
T Consensus 269 ~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 269 VFHLIELLK---------NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HHHHHHHHH---------TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhh---------cCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 000001110 000111112234568899999999999999999999999998744
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=335.55 Aligned_cols=245 Identities=21% Similarity=0.241 Sum_probs=185.0
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHH-HhhcCCCCccc
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMML-IAKLQHRNLVR 587 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~-l~~l~H~niv~ 587 (840)
..++|+..+.||+|+||.||+|+++ .+++.||||++++.. ....+.+.+|..+ ++.++||||++
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~------------~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~ 103 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHK------------AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEET------------TTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCC
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEc------------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 3468999999999999999999765 578999999997543 2334567778777 57789999999
Q ss_pred eeeEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCcee
Q 041702 588 LFGCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKI 663 (840)
Q Consensus 588 l~g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL 663 (840)
+++++.+.+..++||||..... ......+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 104 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL 180 (373)
T 2r5t_A 104 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVL 180 (373)
T ss_dssp EEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEE
T ss_pred EEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEE
Confidence 9999999999999999953322 223456889999999999999999999998 999999999999999999999
Q ss_pred eccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhc
Q 041702 664 SDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWK 743 (840)
Q Consensus 664 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~ 743 (840)
+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ....
T Consensus 181 ~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--~~~----~~i~ 252 (373)
T 2r5t_A 181 TDFGLCKENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--EMY----DNIL 252 (373)
T ss_dssp CCCCBCGGGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH--HHH----HHHH
T ss_pred eeCccccccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH--HHH----HHHH
Confidence 9999998643221 2234567999999999999999999999999999999999999998543211 111 1111
Q ss_pred ccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 041702 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVV 789 (840)
Q Consensus 744 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 789 (840)
.... .+. ......+.+++.+||+.||++||++.+.+
T Consensus 253 ~~~~------~~~----~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 253 NKPL------QLK----PNITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp HSCC------CCC----SSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred hccc------CCC----CCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 1110 011 11234578899999999999999986433
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=314.98 Aligned_cols=245 Identities=27% Similarity=0.407 Sum_probs=195.2
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
..++|+..+.||+|+||.||+|.++ .+++.||||++.... +.+.+|++++.+++||||++++++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~ 72 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHR------------IDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGC 72 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEET------------TTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEE
T ss_pred hccccceeeeeccCCceEEEEEEEc------------CCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeee
Confidence 4567999999999999999999765 578999999997543 567899999999999999999998
Q ss_pred eec----------------CCceEEEEEeeccCCc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCC
Q 041702 592 CIE----------------QGEKISIYEFDIVTDP------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLK 649 (840)
Q Consensus 592 ~~~----------------~~~~~lv~e~~~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk 649 (840)
+.. ....++||||...... .....+++..+..++.||+.||.|||+.+ |+|||||
T Consensus 73 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlk 149 (284)
T 2a19_B 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLK 149 (284)
T ss_dssp EEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCS
T ss_pred EeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCC
Confidence 864 4457899998433221 12356899999999999999999999998 9999999
Q ss_pred CCcEEecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCC
Q 041702 650 ASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNT 729 (840)
Q Consensus 650 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~ 729 (840)
|+|||++.++.+||+|||++........ .....||+.|+|||.+.+..++.++||||||++++||++|..|+..
T Consensus 150 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~--- 223 (284)
T 2a19_B 150 PSNIFLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE--- 223 (284)
T ss_dssp GGGEEEEETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH---
T ss_pred HHHEEEcCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh---
Confidence 9999999999999999999987754322 2345689999999999999999999999999999999999987521
Q ss_pred CCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccC
Q 041702 730 DSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVN 798 (840)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~ 798 (840)
........... .+.. .....+.+++.+||+.||++|||+.|+++.|+.....
T Consensus 224 -----~~~~~~~~~~~--------~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 224 -----TSKFFTDLRDG--------IISD----IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp -----HHHHHHHHHTT--------CCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred -----HHHHHHHhhcc--------cccc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 00111111111 1111 1223467899999999999999999999999987443
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=330.89 Aligned_cols=263 Identities=21% Similarity=0.229 Sum_probs=187.2
Q ss_pred HHHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCcc
Q 041702 507 SSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLV 586 (840)
Q Consensus 507 ~~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv 586 (840)
.+.....++|++.+.||+|+||.||+|.++ .+++.||||++.... ....++.+|++.+..++||||+
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv 82 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEK------------STGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIV 82 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEET------------TTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBC
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEEC------------CCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcc
Confidence 355677899999999999999999999765 578999999986543 3345778899999999999999
Q ss_pred ceeeEeecCCc-------eEEEEEeeccC-------CccccCCCCHHHHHHHHHHHHHHHHHHH--hcCCCceecCCCCC
Q 041702 587 RLFGCCIEQGE-------KISIYEFDIVT-------DPARKDLLDWTTRVRIIEGVAQGLLYLH--QYSRLRVIHRDLKA 650 (840)
Q Consensus 587 ~l~g~~~~~~~-------~~lv~e~~~~~-------~~~~~~~l~~~~~~~i~~~ia~~L~yLH--~~~~~~ivHrDlkp 650 (840)
++++++...+. .++||||.... .......+++..+..++.|++.||.||| +.+ |+||||||
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp 159 (360)
T 3e3p_A 83 QLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKP 159 (360)
T ss_dssp CEEEEEEEECSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCG
T ss_pred cHHHhhhccccccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCH
Confidence 99999976544 78899984321 1124556888999999999999999999 777 99999999
Q ss_pred CcEEecC-CCCceeeccccceecCCCCcccccccccccccccCccccccCC-CCccccchhHHHHHHHHHhCCCCCCCCC
Q 041702 651 SNVLLDS-DMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGL-FSIKSDVFSFGVLLLEILSSKKNTRFYN 728 (840)
Q Consensus 651 ~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDV~SlGviL~elltG~~p~~~~~ 728 (840)
+|||++. ++.+||+|||+++....... .....||+.|+|||.+.+.. ++.++|||||||+++||++|+.||....
T Consensus 160 ~NIll~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 236 (360)
T 3e3p_A 160 HNVLVNEADGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN 236 (360)
T ss_dssp GGEEEETTTTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHEEEeCCCCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC
Confidence 9999997 89999999999987654322 23456899999999987654 8999999999999999999999986533
Q ss_pred CCCccHhHHHhhhhccc------------ccccccCcc------ccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 729 TDSLTLLGHAWNLWKDD------------KAWKLMDPT------MQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 729 ~~~~~~~~~~~~~~~~~------------~~~~~~d~~------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
... ............ ......+.. ............+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 237 SAG--QLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHH--HHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred hHH--HHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 211 111111100000 000000000 000111123567899999999999999999999985
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=359.17 Aligned_cols=249 Identities=26% Similarity=0.342 Sum_probs=190.8
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceeeEeecCCc
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGE 597 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~ 597 (840)
++||+|+||.||+|.++ ....++.||||+++... ....++|.+|+++|.+++|||||+++++|. .+.
T Consensus 375 ~~LG~G~fG~Vy~~~~~----------~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~ 443 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQ----------MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AES 443 (635)
T ss_dssp EEEEECSSEEEEEEEEE----------CSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSS
T ss_pred CEeccCCCEEEEEEEEc----------CCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCC
Confidence 47999999999998643 12457889999997643 234678999999999999999999999996 456
Q ss_pred eEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceecC
Q 041702 598 KISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFG 673 (840)
Q Consensus 598 ~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~ 673 (840)
.++||||..... ......+++..++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 444 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 520 (635)
T 4fl3_A 444 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALR 520 (635)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTT
T ss_pred EEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccc
Confidence 889999943221 233457899999999999999999999998 9999999999999999999999999998775
Q ss_pred CCCcc-cccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhccccccccc
Q 041702 674 GDEMQ-SNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLM 751 (840)
Q Consensus 674 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (840)
..... .......+|+.|+|||++.+..++.++|||||||+|+||++ |+.|+......+ ..........
T Consensus 521 ~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~------~~~~i~~~~~---- 590 (635)
T 4fl3_A 521 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE------VTAMLEKGER---- 590 (635)
T ss_dssp C-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHHHTTCC----
T ss_pred cCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCC----
Confidence 43321 22233456789999999999999999999999999999998 999986432211 1111111110
Q ss_pred CccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 752 DPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 752 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
...+...+..+.+++.+||+.||++||++++|++.|++...
T Consensus 591 -----~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 591 -----MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11112234568899999999999999999999999998654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-36 Score=332.35 Aligned_cols=257 Identities=18% Similarity=0.203 Sum_probs=188.9
Q ss_pred HHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCcccee
Q 041702 510 SAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 510 ~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
+...++|+..+.||+|+||.||+|.++ .+++.||||++..... ...+|++++++++||||++++
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~------------~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~ 66 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDI------------ESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLV 66 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEET------------TTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEE
T ss_pred ccccceEEEEEEEEeccCEEEEEEEEC------------CCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchh
Confidence 456789999999999999999999765 6789999999875432 234799999999999999999
Q ss_pred eEeecC--------------------------------------CceEEEEEeeccC-------CccccCCCCHHHHHHH
Q 041702 590 GCCIEQ--------------------------------------GEKISIYEFDIVT-------DPARKDLLDWTTRVRI 624 (840)
Q Consensus 590 g~~~~~--------------------------------------~~~~lv~e~~~~~-------~~~~~~~l~~~~~~~i 624 (840)
+++... ...++||||.... .......+++..+..+
T Consensus 67 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i 146 (383)
T 3eb0_A 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIY 146 (383)
T ss_dssp EEEEEC-------------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHH
T ss_pred heeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHH
Confidence 998543 2377899984321 1123467999999999
Q ss_pred HHHHHHHHHHHHhcCCCceecCCCCCCcEEec-CCCCceeeccccceecCCCCcccccccccccccccCccccccC-CCC
Q 041702 625 IEGVAQGLLYLHQYSRLRVIHRDLKASNVLLD-SDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHG-LFS 702 (840)
Q Consensus 625 ~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~ 702 (840)
+.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+|+.+..... .....+|+.|+|||.+.+. .++
T Consensus 147 ~~qi~~aL~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~ 220 (383)
T 3eb0_A 147 IYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYT 220 (383)
T ss_dssp HHHHHHHHHHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCC
T ss_pred HHHHHHHHHHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCC
Confidence 999999999999988 99999999999998 688999999999987644332 2345689999999998875 489
Q ss_pred ccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcc----------cccccc-----cCccccchhhHHHHHHH
Q 041702 703 IKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD----------DKAWKL-----MDPTMQNEALYSMVTRY 767 (840)
Q Consensus 703 ~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~----------~~~~~~-----~d~~l~~~~~~~~~~~l 767 (840)
.++|||||||+++||++|+.||......+ ........... ...... ................+
T Consensus 221 ~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (383)
T 3eb0_A 221 PSIDLWSIGCVFGELILGKPLFSGETSID--QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLA 298 (383)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHH
T ss_pred cchhhhhHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHH
Confidence 99999999999999999999986533211 11111110000 000000 00000111112234568
Q ss_pred HHHHHHccccCCCCCCCHHHHHH
Q 041702 768 IKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 768 ~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.+++.+||+.||++|||+.|+++
T Consensus 299 ~~li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 299 IDLLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHHHccCChhhCCCHHHHhc
Confidence 89999999999999999999983
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=330.02 Aligned_cols=249 Identities=20% Similarity=0.258 Sum_probs=193.0
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhc-CCCCccceee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL-QHRNLVRLFG 590 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g 590 (840)
..++|+..+.||+|+||.||+|.++ .+++.||||++..... .+.+|++++.++ +||||+++++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~------------~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~ 83 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHK------------ATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKD 83 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEET------------TTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEEC------------CCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEE
Confidence 4578999999999999999999765 6789999999976532 346788999888 7999999999
Q ss_pred EeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCC-C---Cce
Q 041702 591 CCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSD-M---NPK 662 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~-~---~~k 662 (840)
++.+.+..++||||..... ......+++..+..++.||+.||+|||+.+ |+||||||+|||+..+ + .+|
T Consensus 84 ~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~k 160 (342)
T 2qr7_A 84 VYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIR 160 (342)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEE
T ss_pred EEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEE
Confidence 9999999999999953222 223456899999999999999999999998 9999999999998543 3 499
Q ss_pred eeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhh
Q 041702 663 ISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLW 742 (840)
Q Consensus 663 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~ 742 (840)
|+|||+++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........... ....
T Consensus 161 l~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~---~~~i 235 (342)
T 2qr7_A 161 ICDFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI---LARI 235 (342)
T ss_dssp ECCCTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHH---HHHH
T ss_pred EEECCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHH---HHHH
Confidence 999999987644322 22345789999999999888899999999999999999999999865332221111 1111
Q ss_pred cccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 743 KDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 743 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
..... .............+.+++.+||+.||++||++.|+++
T Consensus 236 ~~~~~------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 236 GSGKF------SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp HHCCC------CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ccCCc------ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11111 0111111223456788999999999999999999885
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=322.89 Aligned_cols=257 Identities=26% Similarity=0.350 Sum_probs=188.8
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhcCCCCcccee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
.++|+..+.||+|+||.||+|.+. .....+..||||+++... ....++|.+|++++.+++||||++++
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 87 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWD---------APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLY 87 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEE---------CTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhHeeeeeeecCCCceeEEEEEec---------cCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEE
Confidence 468999999999999999998754 111233479999987542 33457899999999999999999999
Q ss_pred eEeecCCceEEEEEeeccCCcc-----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 590 GCCIEQGEKISIYEFDIVTDPA-----RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
+++...+ .++++|+....... ....+++..+.+++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 88 ~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~ 163 (291)
T 1u46_A 88 GVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIG 163 (291)
T ss_dssp EEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEEC
T ss_pred EEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEc
Confidence 9998765 88999984332211 1346889999999999999999999998 9999999999999999999999
Q ss_pred ccccceecCCCCcc-cccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhh
Q 041702 665 DFGIARTFGGDEMQ-SNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLW 742 (840)
Q Consensus 665 DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 742 (840)
|||++......... .......+|..|+|||.+.+..++.++||||||++++||++ |+.|+...... ... ....
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~---~~~~ 238 (291)
T 1u46_A 164 DFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QIL---HKID 238 (291)
T ss_dssp CCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHH---HHHH
T ss_pred cccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH--HHH---HHHH
Confidence 99999887543322 12234557889999999998889999999999999999999 99998543211 111 1111
Q ss_pred cccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 041702 743 KDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEI 796 (840)
Q Consensus 743 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~ 796 (840)
..... . .........+.+++.+||+.||++|||+.++++.|+++.
T Consensus 239 ~~~~~-----~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 239 KEGER-----L----PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp TSCCC-----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ccCCC-----C----CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 11100 0 011123456889999999999999999999999999873
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=322.62 Aligned_cols=248 Identities=20% Similarity=0.289 Sum_probs=194.3
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
..++|...+.||+|+||.||+|.++ .+++.||||++........+.+.+|+.++.+++||||++++++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 74 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQR------------LTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEET------------TTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEEC------------CCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhh
Confidence 4568899999999999999999765 5789999999986654455779999999999999999999999
Q ss_pred eecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEe---cCCCCceee
Q 041702 592 CIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLL---DSDMNPKIS 664 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl---~~~~~~kL~ 664 (840)
+.+.+..++++|+..... ......+++..+..++.|++.||.|||+.+ |+||||||+||++ +.++.+||+
T Consensus 75 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~ 151 (304)
T 2jam_A 75 YESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMIT 151 (304)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBC
T ss_pred cccCCEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEc
Confidence 999999999999953222 223456899999999999999999999998 9999999999999 788999999
Q ss_pred ccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 665 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
|||++...... ......||+.|+|||.+.+..++.++||||||++++||++|+.|+..... ..... ....
T Consensus 152 Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~----~i~~ 221 (304)
T 2jam_A 152 DFGLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE--SKLFE----KIKE 221 (304)
T ss_dssp SCSTTCCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHH----HHHH
T ss_pred cCCcceecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHH----HHHc
Confidence 99999764322 12335689999999999999999999999999999999999999854321 11111 1111
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
... . .. ..........+.+++.+||+.||++|||++|+++
T Consensus 222 ~~~-~-~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 222 GYY-E-FE----SPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp CCC-C-CC----TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCC-C-CC----ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 100 0 00 1111223456889999999999999999999985
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-36 Score=321.49 Aligned_cols=248 Identities=21% Similarity=0.260 Sum_probs=192.0
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC----CcCHHHHHHHHHHHhhcCCCCccc
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS----GQGLEEFKNEMMLIAKLQHRNLVR 587 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~----~~~~~~f~~Ev~~l~~l~H~niv~ 587 (840)
..++|.+.+.||+|+||.||+|.+. .+++.||||++.... ....+.+.+|++++++++||||++
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~------------~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 70 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDS------------ETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBT------------TTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cccceeEeeEEecCCCeEEEEEEEC------------CCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeE
Confidence 3478999999999999999999765 678999999997532 234578999999999999999999
Q ss_pred eeeEee--cCCceEEEEEeeccC-----CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCC
Q 041702 588 LFGCCI--EQGEKISIYEFDIVT-----DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMN 660 (840)
Q Consensus 588 l~g~~~--~~~~~~lv~e~~~~~-----~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~ 660 (840)
+++++. +.+..++||||.... .......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 71 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~ 147 (305)
T 2wtk_C 71 LVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGT 147 (305)
T ss_dssp EEEEEECC---CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred EEEEEEcCCCCeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCc
Confidence 999984 456789999994321 1112456899999999999999999999998 999999999999999999
Q ss_pred ceeeccccceecCCCCcccccccccccccccCccccccCC--CCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHH
Q 041702 661 PKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGL--FSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHA 738 (840)
Q Consensus 661 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~ 738 (840)
+||+|||++................||+.|+|||.+.+.. ++.++||||||++++||++|+.|+...... . .
T Consensus 148 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~----~ 221 (305)
T 2wtk_C 148 LKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY--K----L 221 (305)
T ss_dssp EEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH--H----H
T ss_pred EEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH--H----H
Confidence 9999999998875433333344567899999999987644 478999999999999999999998642211 1 1
Q ss_pred hhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 739 WNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 739 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
......... ... ......+.+++.+||+.||++|||++|+++
T Consensus 222 ~~~i~~~~~------~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 222 FENIGKGSY------AIP----GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp HHHHHHCCC------CCC----SSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHhcCCC------CCC----CccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111111100 111 112345778999999999999999999995
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=324.48 Aligned_cols=257 Identities=20% Similarity=0.267 Sum_probs=194.4
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcC-CCCccceeeE
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQ-HRNLVRLFGC 591 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~-H~niv~l~g~ 591 (840)
.++|++.++||+|+||.||+|.++ .+++.||||++... ..+.+.+|++++.+++ ||||++++++
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~ 99 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINI------------TNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADI 99 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET------------TTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEEC------------CCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeee
Confidence 478999999999999999999765 67899999999743 4578999999999997 9999999999
Q ss_pred eec--CCceEEEEEeeccCCcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCC-Cceeeccc
Q 041702 592 CIE--QGEKISIYEFDIVTDPA-RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDM-NPKISDFG 667 (840)
Q Consensus 592 ~~~--~~~~~lv~e~~~~~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kL~DFG 667 (840)
+.+ ....+++||+....... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 100 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg 176 (330)
T 3nsz_A 100 VKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWG 176 (330)
T ss_dssp EECTTTCCEEEEEECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCT
T ss_pred eccCCCCceEEEEeccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCC
Confidence 987 66789999985433221 2235889999999999999999999998 99999999999999777 89999999
Q ss_pred cceecCCCCcccccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHh-------
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAW------- 739 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~------- 739 (840)
+++....... .....+|+.|+|||.+.+ ..++.++|||||||+++||++|+.|+.........+.....
T Consensus 177 ~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~ 253 (330)
T 3nsz_A 177 LAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 253 (330)
T ss_dssp TCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHH
T ss_pred CceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchh
Confidence 9987654332 234578999999999887 67999999999999999999999998533222111111000
Q ss_pred -hhhcccc--------------cccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 740 -NLWKDDK--------------AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 740 -~~~~~~~--------------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
....... ....................+.+++.+||+.||++|||++|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 254 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000 00000000111111223566889999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=320.53 Aligned_cols=249 Identities=23% Similarity=0.374 Sum_probs=190.4
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
..++|++.+.||+|+||.||+|.++ .+++.||+|++........+++.+|++++.+++||||++++++
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~------------~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 84 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNK------------ETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEET------------TTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEc------------CCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeee
Confidence 4578999999999999999999765 5789999999987766778899999999999999999999999
Q ss_pred eecCCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 592 CIEQGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
+...+..++|+|+...... .....+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+||
T Consensus 85 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Df 161 (302)
T 2j7t_A 85 YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADF 161 (302)
T ss_dssp EECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCC
T ss_pred eeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEEC
Confidence 9999999999999432211 12356899999999999999999999998 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCcccc-----ccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhh
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYA-----LHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNL 741 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~ 741 (840)
|++...... ........||+.|+|||.+ .+..++.++||||||++++||++|+.|+...... .. ....
T Consensus 162 g~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~---~~~~ 234 (302)
T 2j7t_A 162 GVSAKNLKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RV---LLKI 234 (302)
T ss_dssp HHHHHHHHH--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HH---HHHH
T ss_pred CCCcccccc--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH--HH---HHHH
Confidence 997543211 1112335689999999988 3677899999999999999999999998643211 11 1111
Q ss_pred hcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 742 WKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 742 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
... ...... ........+.+++.+||+.||++|||++++++
T Consensus 235 ~~~-~~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 235 AKS-DPPTLL-------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp HHS-CCCCCS-------SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred hcc-CCcccC-------CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 111 100011 11122345788999999999999999999875
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=336.55 Aligned_cols=254 Identities=24% Similarity=0.278 Sum_probs=187.4
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
..+|+..+.||+|+||.||+|+++ .+++.||||++.... +.+.+|+++|++++||||+++++++
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~------------~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~ 116 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLC------------DSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFF 116 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEET------------TTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEEC------------CCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEE
Confidence 346888999999999999999765 578999999986542 2345799999999999999999998
Q ss_pred ecCC------ceEEEEEeeccC-------CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCC-
Q 041702 593 IEQG------EKISIYEFDIVT-------DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSD- 658 (840)
Q Consensus 593 ~~~~------~~~lv~e~~~~~-------~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~- 658 (840)
...+ ..++||||.... .......+++..+..++.||++||+|||+.+ |+||||||+|||++.+
T Consensus 117 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~ 193 (420)
T 1j1b_A 117 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDT 193 (420)
T ss_dssp EEEETTTTEEEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTT
T ss_pred eccCCCCcceeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCC
Confidence 6432 256788884221 0123467899999999999999999999988 9999999999999965
Q ss_pred CCceeeccccceecCCCCcccccccccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHH
Q 041702 659 MNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGH 737 (840)
Q Consensus 659 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~ 737 (840)
+.+||+|||+++.+..... .....||+.|+|||++.+. .++.++|||||||+|+||++|+.||...... .....
T Consensus 194 ~~~kl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~--~~l~~ 268 (420)
T 1j1b_A 194 AVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV--DQLVE 268 (420)
T ss_dssp TEEEECCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH
T ss_pred CeEEeccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHH
Confidence 5689999999987644322 2345789999999998765 7999999999999999999999998653321 11111
Q ss_pred Hhhhhc----------ccccccccCccccch-----hhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 738 AWNLWK----------DDKAWKLMDPTMQNE-----ALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 738 ~~~~~~----------~~~~~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
...... .....+...+.+... ........+.+|+.+||+.||++|||+.|+++
T Consensus 269 i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 269 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 111000 000111111111110 11123456889999999999999999999985
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=323.32 Aligned_cols=260 Identities=25% Similarity=0.372 Sum_probs=177.1
Q ss_pred HHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccce
Q 041702 510 SAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRL 588 (840)
Q Consensus 510 ~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l 588 (840)
....++|.+.+.||+|+||.||+|.+. .+++.||||++.... ....+++.+|+.++.+++||||+++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 78 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCA------------PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSY 78 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----------------CEEEEECCC----------------CCCCCCCTTBCCE
T ss_pred ccchhhhhhhheeccccceEEEEEEEC------------CCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeE
Confidence 345689999999999999999999754 578899999987543 3445778999999999999999999
Q ss_pred eeEeecCCceEEEEEeeccCC------------ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEec
Q 041702 589 FGCCIEQGEKISIYEFDIVTD------------PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLD 656 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~~~~~~------------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~ 656 (840)
++++...+..++||||..... ......+++..+..++.||+.||.|||+.+ |+||||||+||+++
T Consensus 79 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~ 155 (303)
T 2vwi_A 79 YTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLG 155 (303)
T ss_dssp EEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEC
T ss_pred EEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEc
Confidence 999999999999999943221 112456899999999999999999999998 99999999999999
Q ss_pred CCCCceeeccccceecCCCCc---ccccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCc
Q 041702 657 SDMNPKISDFGIARTFGGDEM---QSNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSL 732 (840)
Q Consensus 657 ~~~~~kL~DFGla~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~ 732 (840)
.++.+||+|||++........ ........||+.|+|||.+.+ ..++.++||||||++++||++|+.|+........
T Consensus 156 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 235 (303)
T 2vwi_A 156 EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV 235 (303)
T ss_dssp TTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH
T ss_pred CCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH
Confidence 999999999999976643221 112234568999999999876 5689999999999999999999999865432211
Q ss_pred cHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 733 TLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.................++... ......+.+++.+||+.||++|||+.++++
T Consensus 236 --~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 236 --LMLTLQNDPPSLETGVQDKEML----KKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp --HHHHHTSSCCCTTC-----CCC----CCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --HHHHhccCCCccccccccchhh----hhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 1100000000000000111111 122345788999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=330.40 Aligned_cols=266 Identities=18% Similarity=0.235 Sum_probs=191.9
Q ss_pred cCHHHHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCc-----------CHHHHHH
Q 041702 504 FSLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQ-----------GLEEFKN 572 (840)
Q Consensus 504 ~~~~~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~-----------~~~~f~~ 572 (840)
..+.++....++|...+.||+|+||.||+|.+. +++.||||++...... ..+++.+
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~ 78 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDS-------------EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECT-------------TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHH
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECC-------------CCCeEEEEeccccCCccchhhhhhhhhHHHHHHH
Confidence 446788899999999999999999999998653 4889999998653221 1377999
Q ss_pred HHHHHhhcCCCCccceeeEeecC-----CceEEEEEeeccC---C-ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCce
Q 041702 573 EMMLIAKLQHRNLVRLFGCCIEQ-----GEKISIYEFDIVT---D-PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRV 643 (840)
Q Consensus 573 Ev~~l~~l~H~niv~l~g~~~~~-----~~~~lv~e~~~~~---~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i 643 (840)
|++++.+++||||+++++++... ...++|||+.... . ......+++..+..++.||+.||.|||+.+ |
T Consensus 79 E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i 155 (362)
T 3pg1_A 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---V 155 (362)
T ss_dssp HHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc---C
Confidence 99999999999999999999543 3579999994211 0 112346899999999999999999999998 9
Q ss_pred ecCCCCCCcEEecCCCCceeeccccceecCCCCcccccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCC
Q 041702 644 IHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKK 722 (840)
Q Consensus 644 vHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~ 722 (840)
+||||||+|||++.++.+||+|||+++...... ......+|+.|+|||.+.+ ..++.++|||||||+++||++|+.
T Consensus 156 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~ 232 (362)
T 3pg1_A 156 VHRDLHPGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232 (362)
T ss_dssp CCCCCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSC
T ss_pred EecCCChHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCC
Confidence 999999999999999999999999997543322 2334578999999999877 679999999999999999999999
Q ss_pred CCCCCCCCCccHhHHHhhhhcccc------------------cccccCccccchhhHHHHHHHHHHHHHccccCCCCCCC
Q 041702 723 NTRFYNTDSLTLLGHAWNLWKDDK------------------AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPT 784 (840)
Q Consensus 723 p~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 784 (840)
|+...... .............. ....................+.+++.+||+.||++|||
T Consensus 233 pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 310 (362)
T 3pg1_A 233 LFRGSTFY--NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIS 310 (362)
T ss_dssp SCCCSSHH--HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCCCCHH--HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCC
Confidence 98653311 11111111000000 00000000001111223456889999999999999999
Q ss_pred HHHHHH
Q 041702 785 MLEVVA 790 (840)
Q Consensus 785 ~~evl~ 790 (840)
++|+++
T Consensus 311 ~~ell~ 316 (362)
T 3pg1_A 311 TEQALR 316 (362)
T ss_dssp HHHHHT
T ss_pred HHHHHc
Confidence 999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=319.16 Aligned_cols=246 Identities=26% Similarity=0.357 Sum_probs=187.1
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
..++|+..+.||+|+||.||+|.+ .++.||||+++.. ...++|.+|++++.+++||||++++++
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~--------------~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~ 82 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY--------------RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGV 82 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--------------TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEE
T ss_pred ChhhceEEeEEecCCCceEEEEEE--------------cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 357899999999999999999853 4789999999754 345789999999999999999999999
Q ss_pred eecC-CceEEEEEeeccCCc----c--ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 592 CIEQ-GEKISIYEFDIVTDP----A--RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 592 ~~~~-~~~~lv~e~~~~~~~----~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
+.+. +..++|+|+...... . ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~ 159 (278)
T 1byg_A 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVS 159 (278)
T ss_dssp ECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEEC
T ss_pred EEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEe
Confidence 7654 478999998422111 1 1123788999999999999999999998 9999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhc
Q 041702 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWK 743 (840)
Q Consensus 665 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 743 (840)
|||++...... .....+++.|+|||.+.+..++.++||||||++++||++ |+.|+...... .... ...
T Consensus 160 Dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~~----~~~ 228 (278)
T 1byg_A 160 DFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVP----RVE 228 (278)
T ss_dssp CCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHH----HHT
T ss_pred ecccccccccc-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHHH----HHh
Confidence 99999765332 123356889999999999999999999999999999998 99887643221 1111 111
Q ss_pred ccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 041702 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEI 796 (840)
Q Consensus 744 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~ 796 (840)
... .. .........+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 229 ~~~-----~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 229 KGY-----KM----DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp TTC-----CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCC-----CC----CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 110 01 111223456888999999999999999999999999863
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=329.18 Aligned_cols=246 Identities=18% Similarity=0.232 Sum_probs=183.1
Q ss_pred ccCCccc-ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhc-CCCCccceee
Q 041702 513 TDNFSEE-NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL-QHRNLVRLFG 590 (840)
Q Consensus 513 ~~~f~~~-~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g 590 (840)
.++|... ++||+|+||.||+|.++ .+++.||||++... ..+.+|+.++.++ +||||+++++
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~------------~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~ 122 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNK------------RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVD 122 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEET------------TTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEE
T ss_pred cccceeccceeeeccCeEEEEEEEC------------CCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeE
Confidence 3566665 68999999999999765 67899999999642 5678899988554 8999999999
Q ss_pred Eeec----CCceEEEEEeeccCC----c--cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecC---
Q 041702 591 CCIE----QGEKISIYEFDIVTD----P--ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS--- 657 (840)
Q Consensus 591 ~~~~----~~~~~lv~e~~~~~~----~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~--- 657 (840)
++.. .+..++||||..... . .....+++..+..|+.||+.||.|||+.+ |+||||||+|||++.
T Consensus 123 ~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~ 199 (400)
T 1nxk_A 123 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRP 199 (400)
T ss_dssp EEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSST
T ss_pred EEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCC
Confidence 9875 567899999942211 1 11235899999999999999999999988 999999999999998
Q ss_pred CCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc--Hh
Q 041702 658 DMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLT--LL 735 (840)
Q Consensus 658 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~--~~ 735 (840)
++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||......... ..
T Consensus 200 ~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~ 276 (400)
T 1nxk_A 200 NAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 276 (400)
T ss_dssp TCCEEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHH
T ss_pred CccEEEEecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHH
Confidence 7899999999998764322 223467899999999999999999999999999999999999998654433211 11
Q ss_pred HHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 736 GHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 736 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
... ..... .... .........+.+++.+||+.||++|||+.||++.
T Consensus 277 ~~i----~~~~~-~~~~-----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 277 TRI----RMGQY-EFPN-----PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp HHH----HHTCC-CCCT-----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHH----HcCcc-cCCC-----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 111 00000 0000 0111234568899999999999999999999863
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=341.47 Aligned_cols=249 Identities=23% Similarity=0.288 Sum_probs=198.4
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhcCCCCccce
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQHRNLVRL 588 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l 588 (840)
..++|...+.||+|+||.||+|.++ .+|+.||||++... .....+.+.+|+++|.+++||||+++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~------------~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l 249 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVR------------ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET------------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccceEEEEEEeeCCCEEEEEEEEC------------CCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeE
Confidence 4577999999999999999999765 67999999999653 23456778999999999999999999
Q ss_pred eeEeecCCceEEEEEeeccCCc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCce
Q 041702 589 FGCCIEQGEKISIYEFDIVTDP------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPK 662 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~~~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 662 (840)
++++.+.+..++||||...... .....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+|
T Consensus 250 ~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vK 326 (576)
T 2acx_A 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIR 326 (576)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEE
T ss_pred EEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeE
Confidence 9999999999999999533221 11234899999999999999999999998 99999999999999999999
Q ss_pred eeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhh
Q 041702 663 ISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLW 742 (840)
Q Consensus 663 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~ 742 (840)
|+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......... .......
T Consensus 327 L~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~--~~i~~~i 401 (576)
T 2acx_A 327 ISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--EEVERLV 401 (576)
T ss_dssp ECCCTTCEECCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH--HHHHHHH
T ss_pred EEecccceecccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH--HHHHHHh
Confidence 999999988754332 23457999999999999999999999999999999999999998754332211 1111111
Q ss_pred cccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041702 743 KDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRP-----TMLEVVA 790 (840)
Q Consensus 743 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 790 (840)
.... ... +......+.+++.+||+.||++|| +++||++
T Consensus 402 ~~~~------~~~----p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 402 KEVP------EEY----SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp HHCC------CCC----CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred hccc------ccC----CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 1100 011 112345678999999999999999 6788874
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=329.73 Aligned_cols=258 Identities=21% Similarity=0.283 Sum_probs=191.8
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC--cCHHHHHHHHHHHhhcCCCCcccee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG--QGLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
..++|...+.||+|+||.||+|.++ .+++.||||++..... ...+++.+|+.++++++||||++++
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 107 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDK------------RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 107 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEET------------TTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred ccccEEEEeEEecCCCeEEEEEEEC------------CCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhh
Confidence 4578999999999999999999765 6789999999976432 2356789999999999999999999
Q ss_pred eEeecCCce------EEEEEeeccCC-ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCce
Q 041702 590 GCCIEQGEK------ISIYEFDIVTD-PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPK 662 (840)
Q Consensus 590 g~~~~~~~~------~lv~e~~~~~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 662 (840)
+++...+.. ++|||+..... ......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 108 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~k 184 (371)
T 4exu_A 108 DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELK 184 (371)
T ss_dssp EEECSCSSSTTCCCCEEEEECCCEEHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEE
T ss_pred hheeccCCcccceeEEEEEccccccHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEE
Confidence 999887765 99999843110 011334899999999999999999999998 99999999999999999999
Q ss_pred eeccccceecCCCCcccccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhh
Q 041702 663 ISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNL 741 (840)
Q Consensus 663 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~ 741 (840)
|+|||+++..... .....||+.|+|||.+.+ ..++.++|||||||+++||++|+.||...... .........
T Consensus 185 L~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~ 257 (371)
T 4exu_A 185 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL--DQLTQILKV 257 (371)
T ss_dssp ECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHH
T ss_pred EEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHH
Confidence 9999999865322 234578999999999887 77999999999999999999999998643211 111111110
Q ss_pred hccc--cc-------------ccccCcccc--chhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 742 WKDD--KA-------------WKLMDPTMQ--NEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 742 ~~~~--~~-------------~~~~d~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
.... .. ..+...... ..........+.+++.+||+.||++|||++|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 258 TGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0000 00 000000000 00111234668899999999999999999999853
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=334.17 Aligned_cols=250 Identities=11% Similarity=0.051 Sum_probs=175.5
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC---cCHHHHHHHHHHHhhc--CCCCccc
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG---QGLEEFKNEMMLIAKL--QHRNLVR 587 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~---~~~~~f~~Ev~~l~~l--~H~niv~ 587 (840)
..+|...++||+|+||.||+|.++ .+++.||||++..... ...+.+.+|+.++..+ +||||++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~------------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~ 128 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDV------------ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEET------------TTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-------
T ss_pred ceeeeeeeeccCCCCEEEEEEEEC------------CCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhh
Confidence 456889999999999999999765 6789999999987532 3355678886555555 6999887
Q ss_pred ee-------eEeecC-----------------CceEEEEEeeccCCcc-----ccCCCCHHHH------HHHHHHHHHHH
Q 041702 588 LF-------GCCIEQ-----------------GEKISIYEFDIVTDPA-----RKDLLDWTTR------VRIIEGVAQGL 632 (840)
Q Consensus 588 l~-------g~~~~~-----------------~~~~lv~e~~~~~~~~-----~~~~l~~~~~------~~i~~~ia~~L 632 (840)
++ +++... ...++||||.. .+.. ....+.+..+ ..++.||+.||
T Consensus 129 ~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL 207 (371)
T 3q60_A 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLA 207 (371)
T ss_dssp ---CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred hceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHH
Confidence 55 444332 33799999843 1111 1224566666 78889999999
Q ss_pred HHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceecCCCCcccccccccccccccCcccccc--CCCCccccchhH
Q 041702 633 LYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH--GLFSIKSDVFSF 710 (840)
Q Consensus 633 ~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDV~Sl 710 (840)
+|||+++ |+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||.+.+ ..++.++|||||
T Consensus 208 ~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSl 279 (371)
T 3q60_A 208 ANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQL 279 (371)
T ss_dssp HHHHHTT---EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHH
T ss_pred HHHHHCC---CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHH
Confidence 9999998 999999999999999999999999999876421 113456799999999987 679999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 711 GVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 711 GviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
||+||||++|+.||........... ........................+.+++.+||+.||++|||+.|+++
T Consensus 280 G~il~elltg~~Pf~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 280 GLSIYRVWCLFLPFGLVTPGIKGSW-------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp HHHHHHHHHSSCSTTBCCTTCTTCC-------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred HHHHHHHHhCCCCCCCcCcccccch-------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9999999999999876543321100 000000011111111111233456889999999999999999999974
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=323.58 Aligned_cols=254 Identities=22% Similarity=0.331 Sum_probs=195.5
Q ss_pred HHHHHHccCCccc-ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhc-CC
Q 041702 507 SSISAATDNFSEE-NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKL-QH 582 (840)
Q Consensus 507 ~~~~~~~~~f~~~-~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l-~H 582 (840)
...+...+.|.+. ++||+|+||.||+|.++ .+++.||||++.... .....++.+|+.++.++ +|
T Consensus 21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~------------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~ 88 (327)
T 3lm5_A 21 QSMENFNNFYILTSKELGRGKFAVVRQCISK------------STGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSC 88 (327)
T ss_dssp BCHHHHHHHEEEEEEEEEEETTEEEEEEEET------------TTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTC
T ss_pred HHHHhhhhEEeeccceeCCCCCeEEEEEEEC------------CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCC
Confidence 3445566777777 88999999999999765 678999999997542 34567899999999999 56
Q ss_pred CCccceeeEeecCCceEEEEEeeccC---C---ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEec
Q 041702 583 RNLVRLFGCCIEQGEKISIYEFDIVT---D---PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLD 656 (840)
Q Consensus 583 ~niv~l~g~~~~~~~~~lv~e~~~~~---~---~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~ 656 (840)
|||+++++++.+.+..++||||.... . ......+++..+..++.||+.||+|||+.+ |+||||||+|||++
T Consensus 89 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~ 165 (327)
T 3lm5_A 89 PRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLS 165 (327)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEES
T ss_pred CCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEe
Confidence 99999999999999999999994221 1 122356899999999999999999999998 99999999999998
Q ss_pred C---CCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc
Q 041702 657 S---DMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLT 733 (840)
Q Consensus 657 ~---~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~ 733 (840)
. ++.+||+|||+++...... ......||+.|+|||.+.+..++.++||||||++++||++|+.|+.......
T Consensus 166 ~~~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-- 240 (327)
T 3lm5_A 166 SIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE-- 240 (327)
T ss_dssp CBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--
T ss_pred cCCCCCcEEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--
Confidence 8 7899999999998764332 1234579999999999999999999999999999999999999985432211
Q ss_pred HhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 734 LLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
....... . ...............+.+++.+||+.||++|||++|+++
T Consensus 241 ~~~~i~~----~------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 241 TYLNISQ----V------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp HHHHHHH----T------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHHh----c------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 1100000 0 001111111223455788999999999999999999985
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=331.30 Aligned_cols=265 Identities=24% Similarity=0.332 Sum_probs=190.3
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHH--HhhcCCCCcccee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMML--IAKLQHRNLVRLF 589 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~--l~~l~H~niv~l~ 589 (840)
..++|+..+.||+|+||.||+|. .+++.||||++.... ...+..|.++ +..++||||++++
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~--------------~~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~ 73 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGS--------------LDERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFI 73 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEE--------------ETTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEE
T ss_pred ChHHhheeeecccCCCeEEEEEE--------------ECCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhhe
Confidence 34789999999999999999985 257899999997542 3445555544 4568999999999
Q ss_pred eEeec-----CCceEEEEEeeccCC---ccccCCCCHHHHHHHHHHHHHHHHHHHhc---------CCCceecCCCCCCc
Q 041702 590 GCCIE-----QGEKISIYEFDIVTD---PARKDLLDWTTRVRIIEGVAQGLLYLHQY---------SRLRVIHRDLKASN 652 (840)
Q Consensus 590 g~~~~-----~~~~~lv~e~~~~~~---~~~~~~l~~~~~~~i~~~ia~~L~yLH~~---------~~~~ivHrDlkp~N 652 (840)
+++.. ....++||||..... .......++..+.+++.||+.||+|||+. + |+||||||+|
T Consensus 74 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~N 150 (336)
T 3g2f_A 74 VGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRN 150 (336)
T ss_dssp EEEEEECTTSCEEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGG
T ss_pred ecccccccCCCceEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccce
Confidence 86532 235689999953322 22344568999999999999999999998 6 9999999999
Q ss_pred EEecCCCCceeeccccceecCCCCc------ccccccccccccccCcccccc-------CCCCccccchhHHHHHHHHHh
Q 041702 653 VLLDSDMNPKISDFGIARTFGGDEM------QSNTNRIVGTYGYMSPEYALH-------GLFSIKSDVFSFGVLLLEILS 719 (840)
Q Consensus 653 ILl~~~~~~kL~DFGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDV~SlGviL~ellt 719 (840)
||++.++.+||+|||+++.+..... ........||+.|+|||.+.+ ..++.++|||||||++|||++
T Consensus 151 ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~ 230 (336)
T 3g2f_A 151 VLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230 (336)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHh
Confidence 9999999999999999987654321 112234569999999999886 456789999999999999999
Q ss_pred CCCCCCCCCCCCccHhH------------HHhhhhcccccccccCccccc--hhhHHHHHHHHHHHHHccccCCCCCCCH
Q 041702 720 SKKNTRFYNTDSLTLLG------------HAWNLWKDDKAWKLMDPTMQN--EALYSMVTRYIKVALLCVQENATDRPTM 785 (840)
Q Consensus 720 G~~p~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 785 (840)
|+.|+............ .......... ..+.+.. .........+.+++.+||+.||++|||+
T Consensus 231 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 306 (336)
T 3g2f_A 231 RCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREK----QRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTA 306 (336)
T ss_dssp TBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSC----CCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCH
T ss_pred cCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccc----cCCCCCcccccccchHHHHHHHHHHHhcCChhhCcch
Confidence 97765332221110000 0000000000 1111111 1112356679999999999999999999
Q ss_pred HHHHHHhhccccCCC
Q 041702 786 LEVVAMLKDEIVNLP 800 (840)
Q Consensus 786 ~evl~~Le~~~~~~~ 800 (840)
+||++.|+++.....
T Consensus 307 ~e~l~~L~~ll~~~~ 321 (336)
T 3g2f_A 307 QXAEERMAELMMIWE 321 (336)
T ss_dssp HHHHHHHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHH
Confidence 999999998765543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-36 Score=329.63 Aligned_cols=259 Identities=22% Similarity=0.312 Sum_probs=194.2
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
.++|+..++||+|+||.||+|.++ .+++.||+|++.... ....+.+.+|+.++.+++||||++++++
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 99 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHK------------PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 99 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET------------TTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEEC------------CCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEE
Confidence 467999999999999999999765 678999999997653 2345679999999999999999999999
Q ss_pred eecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceecCCCCCCcEEecCCCCceeecc
Q 041702 592 CIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQY-SRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
+...+..++||||..... ......+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+||
T Consensus 100 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Df 176 (360)
T 3eqc_A 100 FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDF 176 (360)
T ss_dssp EEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCC
T ss_pred EEECCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEEC
Confidence 999999999999953322 12345689999999999999999999985 7 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHH--------
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHA-------- 738 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~-------- 738 (840)
|++...... ......||+.|+|||.+.+..++.++||||||++++||++|+.||..............
T Consensus 177 g~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 252 (360)
T 3eqc_A 177 GVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 252 (360)
T ss_dssp CCCHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------
T ss_pred CCCcccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCC
Confidence 998754221 22345789999999999999999999999999999999999999865332111000000
Q ss_pred --hhhhcc--------------cccccccC----ccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 739 --WNLWKD--------------DKAWKLMD----PTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 739 --~~~~~~--------------~~~~~~~d----~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
...... ....+.++ ..............+.+++.+||+.||++|||++|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 253 TPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ---------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000000 00000000 00000000112446889999999999999999999985
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=321.99 Aligned_cols=246 Identities=23% Similarity=0.328 Sum_probs=196.8
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhcCCCCccce
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKLQHRNLVRL 588 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l 588 (840)
..++|...+.||+|+||.||+|.++ .+++.||+|++.... ....+.+.+|+.++++++||||+++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~------------~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 80 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDA------------DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEET------------TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred cccceEEEEEEeecCCEEEEEEEEC------------CCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeee
Confidence 3467899999999999999999765 578899999987542 2345678999999999999999999
Q ss_pred eeEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 589 FGCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
++++.+.+..++++|+..... ......+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~ 157 (294)
T 2rku_A 81 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIG 157 (294)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEEC
T ss_pred eeeeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEE
Confidence 999999999999999953222 123457899999999999999999999998 9999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 665 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
|||++........ ......||+.|+|||.+.+..++.++||||||++++||++|+.|+......+ .......
T Consensus 158 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~ 229 (294)
T 2rku_A 158 DFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TYLRIKK 229 (294)
T ss_dssp CCTTCEECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHT
T ss_pred eccCceecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHhh
Confidence 9999987643221 2234568999999999999999999999999999999999999986432111 1111111
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.. ..+. ......+.+++.+||+.||++|||++|+++
T Consensus 230 ~~------~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 230 NE------YSIP----KHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp TC------CCCC----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cc------CCCc----cccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 10 0011 112345778999999999999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=339.54 Aligned_cols=244 Identities=25% Similarity=0.311 Sum_probs=194.6
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhcCCCCcccee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
.++|...+.||+|+||.||+|+++ .+|+.||||++.+. .....+.+.+|++++.+++||||++++
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~------------~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~ 251 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMK------------ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEET------------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEC------------CCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 477899999999999999999765 67899999999753 234567899999999999999999999
Q ss_pred eEeecCCceEEEEEeeccCCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCc
Q 041702 590 GCCIEQGEKISIYEFDIVTDP--------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP 661 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~~~--------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 661 (840)
+++...+..++||||...... .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 252 ~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~v 328 (543)
T 3c4z_A 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNV 328 (543)
T ss_dssp EEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCE
T ss_pred EEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCE
Confidence 999999999999999532221 12346899999999999999999999998 9999999999999999999
Q ss_pred eeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhh
Q 041702 662 KISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNL 741 (840)
Q Consensus 662 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~ 741 (840)
||+|||+++.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... . .....
T Consensus 329 kL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~-~-~~~~~ 404 (543)
T 3c4z_A 329 RISDLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN-K-ELKQR 404 (543)
T ss_dssp EECCCTTCEECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH-H-HHHHH
T ss_pred EEeecceeeeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH-H-HHHHH
Confidence 9999999987654332 223457999999999999999999999999999999999999998754322111 1 11111
Q ss_pred hcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCH
Q 041702 742 WKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTM 785 (840)
Q Consensus 742 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 785 (840)
..... .. .+......+.+++.+||+.||++||++
T Consensus 405 i~~~~------~~----~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 405 VLEQA------VT----YPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp HHHCC------CC----CCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred Hhhcc------cC----CCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 11100 00 111234567889999999999999975
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=329.15 Aligned_cols=255 Identities=21% Similarity=0.280 Sum_probs=196.5
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC----CcCHHHHHHHHHHHhhc-CCCCccc
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS----GQGLEEFKNEMMLIAKL-QHRNLVR 587 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~----~~~~~~f~~Ev~~l~~l-~H~niv~ 587 (840)
.++|++.++||+|+||.||+|++. ....+++.||||+++... ....+.+.+|++++.++ +||||++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~ 123 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKI---------SGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVT 123 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEEC---------SSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCC
T ss_pred ccceEEEEEeccCCCEEEEEEEEc---------ccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeE
Confidence 468999999999999999999764 223578999999987532 23456788999999999 6999999
Q ss_pred eeeEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCcee
Q 041702 588 LFGCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKI 663 (840)
Q Consensus 588 l~g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL 663 (840)
+++++...+..++||||..... ......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 124 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl 200 (355)
T 1vzo_A 124 LHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVL 200 (355)
T ss_dssp EEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEE
T ss_pred EEEEEeeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEE
Confidence 9999999999999999953322 223456899999999999999999999998 999999999999999999999
Q ss_pred eccccceecCCCCcccccccccccccccCcccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhh
Q 041702 664 SDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH--GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNL 741 (840)
Q Consensus 664 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~ 741 (840)
+|||+++.+..... .......||+.|+|||++.+ ..++.++|||||||+|+||++|+.||......... .......
T Consensus 201 ~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~ 278 (355)
T 1vzo_A 201 TDFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ-AEISRRI 278 (355)
T ss_dssp SCSSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH-HHHHHHH
T ss_pred eeCCCCeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH-HHHHHHH
Confidence 99999987643222 22334679999999999986 34789999999999999999999998754433211 1111111
Q ss_pred hcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHh
Q 041702 742 WKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRP-----TMLEVVAML 792 (840)
Q Consensus 742 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L 792 (840)
... .+.. +......+.+++.+||+.||++|| +++|+++..
T Consensus 279 ~~~-------~~~~----~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 279 LKS-------EPPY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp HHC-------CCCC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred hcc-------CCCC----CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 100 0111 122334578899999999999999 899998643
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=333.44 Aligned_cols=257 Identities=21% Similarity=0.199 Sum_probs=196.2
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcC--------CCC
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQ--------HRN 584 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~--------H~n 584 (840)
.++|.+.++||+|+||.||+|++. .+++.||||++... ....+.+.+|++++++++ |+|
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~ 102 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDI------------QGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREM 102 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET------------TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGG
T ss_pred CCeEEEEEEeeecCCeeEEEEEec------------CCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcce
Confidence 478999999999999999999765 67899999999753 334577899999999995 788
Q ss_pred ccceeeEee----cCCceEEEEEeeccCC---c--cccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceecCCCCCCcEE
Q 041702 585 LVRLFGCCI----EQGEKISIYEFDIVTD---P--ARKDLLDWTTRVRIIEGVAQGLLYLHQY-SRLRVIHRDLKASNVL 654 (840)
Q Consensus 585 iv~l~g~~~----~~~~~~lv~e~~~~~~---~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivHrDlkp~NIL 654 (840)
|+++++++. .....++|||+..... . .....+++..+..++.||+.||+|||++ + |+||||||+|||
T Consensus 103 iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIl 179 (397)
T 1wak_A 103 VVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENIL 179 (397)
T ss_dssp BCCEEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEE
T ss_pred eeeeecceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHee
Confidence 999999987 5667899999842111 1 1224689999999999999999999998 7 999999999999
Q ss_pred ecCCC-------------------------------------------------CceeeccccceecCCCCccccccccc
Q 041702 655 LDSDM-------------------------------------------------NPKISDFGIARTFGGDEMQSNTNRIV 685 (840)
Q Consensus 655 l~~~~-------------------------------------------------~~kL~DFGla~~~~~~~~~~~~~~~~ 685 (840)
++.++ .+||+|||++...... .....
T Consensus 180 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~ 254 (397)
T 1wak_A 180 LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDI 254 (397)
T ss_dssp ECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCC
T ss_pred EeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCC
Confidence 99775 8999999999876432 23457
Q ss_pred ccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccH----hHHHhhhhcc-----------------
Q 041702 686 GTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTL----LGHAWNLWKD----------------- 744 (840)
Q Consensus 686 gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~----~~~~~~~~~~----------------- 744 (840)
||+.|+|||++.+..++.++|||||||+|+||++|+.||.......... ..........
T Consensus 255 gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 334 (397)
T 1wak_A 255 QTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFT 334 (397)
T ss_dssp SCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBC
T ss_pred CCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccC
Confidence 8999999999999999999999999999999999999997654433211 1111000000
Q ss_pred --cccccccCccc---------cchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 745 --DKAWKLMDPTM---------QNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 745 --~~~~~~~d~~l---------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.....+.+... ...........+.+++.+||+.||++|||++||++
T Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 335 KKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp TTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00000000000 00123456678999999999999999999999985
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-36 Score=323.90 Aligned_cols=261 Identities=21% Similarity=0.303 Sum_probs=187.7
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
.++|...+.||+|+||.||+|.++ .+++.||||++........+++.+|++++++++||||+++++++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 77 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDN------------DCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEIL 77 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEET------------TTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CCceeEEEEeccCCCeEEEEEEEC------------CCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEec
Confidence 478999999999999999999765 57899999999876556677899999999999999999999987
Q ss_pred e--------------cCCceEEEEEeecc--CCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEec
Q 041702 593 I--------------EQGEKISIYEFDIV--TDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLD 656 (840)
Q Consensus 593 ~--------------~~~~~~lv~e~~~~--~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~ 656 (840)
. +.+..++||||... ........+++..+..++.||+.||+|||+.+ |+||||||+|||++
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~ 154 (320)
T 2i6l_A 78 GPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFIN 154 (320)
T ss_dssp CTTSCBCCC----CCSCSEEEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEE
T ss_pred cccccccccccccccccCceeEEeeccCCCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEc
Confidence 4 44678999998421 11122456889999999999999999999998 99999999999997
Q ss_pred -CCCCceeeccccceecCCCCc-ccccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc
Q 041702 657 -SDMNPKISDFGIARTFGGDEM-QSNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLT 733 (840)
Q Consensus 657 -~~~~~kL~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~ 733 (840)
+++.+||+|||+++....... ........+|+.|+|||.+.+ ..++.++||||||++++||++|+.||...... .
T Consensus 155 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~ 232 (320)
T 2i6l_A 155 TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL--E 232 (320)
T ss_dssp TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--H
T ss_pred CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH--H
Confidence 567899999999987643221 112234567899999998865 67999999999999999999999998654321 1
Q ss_pred HhHHHhhhhc---ccccccc------------cCcccc-chhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 734 LLGHAWNLWK---DDKAWKL------------MDPTMQ-NEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 734 ~~~~~~~~~~---~~~~~~~------------~d~~l~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.......... .....++ ..+... ..........+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 233 QMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 1111100000 0000000 000000 0111123566889999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=340.14 Aligned_cols=249 Identities=25% Similarity=0.361 Sum_probs=195.3
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC--CCcCHHHHHHHHHHHhhcCCCCcccee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK--SGQGLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
..++|++.++||+|+||.||+|.++ .+++.||||++... .....+.+.+|++++++++||||++++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~------------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 87 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDR------------ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEET------------TTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEEC------------CCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4578999999999999999999765 67899999998643 234567899999999999999999999
Q ss_pred eEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEec---CCCCce
Q 041702 590 GCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLD---SDMNPK 662 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~---~~~~~k 662 (840)
+++.+.+..++|+||..... ......+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+|
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~k 164 (486)
T 3mwu_A 88 EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIK 164 (486)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEE
T ss_pred EEEEcCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEE
Confidence 99999999999999953322 223467899999999999999999999998 99999999999995 456799
Q ss_pred eeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhh
Q 041702 663 ISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLW 742 (840)
Q Consensus 663 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~ 742 (840)
|+|||+++.+.... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||...... ......
T Consensus 165 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i---- 234 (486)
T 3mwu_A 165 IIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--DILKRV---- 234 (486)
T ss_dssp ECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH----
T ss_pred EEECCcCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH----
Confidence 99999998764332 2234579999999998875 5999999999999999999999998643211 111111
Q ss_pred cccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 743 KDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 743 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
..... .............+.+++.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 235 ETGKY------AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp HHTCC------CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred HhCCC------CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11100 00011112234567899999999999999999999863
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=328.56 Aligned_cols=246 Identities=23% Similarity=0.332 Sum_probs=197.1
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhcCCCCccce
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKLQHRNLVRL 588 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l 588 (840)
..++|...+.||+|+||.||+|.+. .+++.||+|++.... ....+.+.+|+.++++++||||+++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~------------~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 106 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDA------------DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEET------------TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEEC------------CCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 3578999999999999999999765 578899999987542 2345678999999999999999999
Q ss_pred eeEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 589 FGCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
++++.+.+..++||||..... ......+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 107 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~ 183 (335)
T 2owb_A 107 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIG 183 (335)
T ss_dssp EEEEECSSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEEC
T ss_pred EEEEecCCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEe
Confidence 999999999999999953222 123457899999999999999999999998 9999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 665 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
|||++........ ......||+.|+|||.+.+..++.++||||||++++||++|+.|+......+ .......
T Consensus 184 Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~ 255 (335)
T 2owb_A 184 DFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TYLRIKK 255 (335)
T ss_dssp CCTTCEECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHH
T ss_pred eccCceecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH------HHHHHhc
Confidence 9999987643222 2234578999999999999999999999999999999999999986432111 0111111
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.. ..+.. .....+.+++.+||+.||++|||++|+++
T Consensus 256 ~~------~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 256 NE------YSIPK----HINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp TC------CCCCT----TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CC------CCCCc----cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 10 01111 12345778999999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=330.85 Aligned_cols=262 Identities=22% Similarity=0.334 Sum_probs=175.7
Q ss_pred cCCcc-cccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 514 DNFSE-ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 514 ~~f~~-~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
+.|.. .++||+|+||.||+|+++ ...+++.||||++.... ..+.+.+|+.+|++++||||+++++++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~----------~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~ 87 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRK----------DGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVF 87 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEES----------SSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEc----------cCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEE
Confidence 44554 357999999999999753 12467899999997542 336789999999999999999999999
Q ss_pred ec--CCceEEEEEeeccC------------CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEe---
Q 041702 593 IE--QGEKISIYEFDIVT------------DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLL--- 655 (840)
Q Consensus 593 ~~--~~~~~lv~e~~~~~------------~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl--- 655 (840)
.. ....++||||.... .......+++..+..|+.||+.||+|||+.+ |+||||||+|||+
T Consensus 88 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~ 164 (405)
T 3rgf_A 88 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGE 164 (405)
T ss_dssp EETTTTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCS
T ss_pred ecCCCCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecC
Confidence 54 67889999983211 0111224899999999999999999999998 9999999999999
Q ss_pred -cCCCCceeeccccceecCCCCc-ccccccccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCC-
Q 041702 656 -DSDMNPKISDFGIARTFGGDEM-QSNTNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDS- 731 (840)
Q Consensus 656 -~~~~~~kL~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~SlGviL~elltG~~p~~~~~~~~- 731 (840)
+.++.+||+|||+++.+..... ........||+.|+|||++.+. .++.++|||||||+|+||++|+.||.....+.
T Consensus 165 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 244 (405)
T 3rgf_A 165 GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 244 (405)
T ss_dssp STTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC----
T ss_pred CCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccc
Confidence 7789999999999987653221 1223456789999999999874 58999999999999999999999996543321
Q ss_pred ------ccHhHHHhhhhccc--cccccc--------------CccccchhhH--------HHHHHHHHHHHHccccCCCC
Q 041702 732 ------LTLLGHAWNLWKDD--KAWKLM--------------DPTMQNEALY--------SMVTRYIKVALLCVQENATD 781 (840)
Q Consensus 732 ------~~~~~~~~~~~~~~--~~~~~~--------------d~~l~~~~~~--------~~~~~l~~l~~~Cl~~dP~~ 781 (840)
.............. ..+..+ .......... .....+.+|+.+||+.||++
T Consensus 245 ~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~ 324 (405)
T 3rgf_A 245 TSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIK 324 (405)
T ss_dssp --CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGG
T ss_pred ccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCccc
Confidence 01111111110000 000000 0000000000 01345789999999999999
Q ss_pred CCCHHHHHH
Q 041702 782 RPTMLEVVA 790 (840)
Q Consensus 782 RPs~~evl~ 790 (840)
|||++|+++
T Consensus 325 R~ta~e~L~ 333 (405)
T 3rgf_A 325 RITSEQAMQ 333 (405)
T ss_dssp SCCHHHHHT
T ss_pred CCCHHHHhc
Confidence 999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=320.65 Aligned_cols=249 Identities=23% Similarity=0.298 Sum_probs=189.8
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--------CcCHHHHHHHHHHHhhcCCC
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--------GQGLEEFKNEMMLIAKLQHR 583 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--------~~~~~~f~~Ev~~l~~l~H~ 583 (840)
..++|.+.+.||+|+||.||+|.++ .+++.||||++.... ......+.+|++++.+++||
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 75 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFER------------KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEET------------TTTEEEEEEEECC---------------CHHHHHHHHHHCCCT
T ss_pred hhhceeEeeEEecCCCEEEEEEEEc------------CCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCC
Confidence 4568999999999999999999765 578999999986532 12334689999999999999
Q ss_pred CccceeeEeecCCceEEEEEeeccC----CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCC
Q 041702 584 NLVRLFGCCIEQGEKISIYEFDIVT----DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDM 659 (840)
Q Consensus 584 niv~l~g~~~~~~~~~lv~e~~~~~----~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~ 659 (840)
||+++++++...+ .++||||.... .......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 76 ~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~ 151 (322)
T 2ycf_A 76 CIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQE 151 (322)
T ss_dssp TBCCEEEEEESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSS
T ss_pred CCceEeeEEcCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCC
Confidence 9999999987654 89999994221 1223457899999999999999999999998 99999999999998766
Q ss_pred C---ceeeccccceecCCCCcccccccccccccccCccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc
Q 041702 660 N---PKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYAL---HGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLT 733 (840)
Q Consensus 660 ~---~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~ 733 (840)
. +||+|||+++...... ......||+.|+|||.+. ...++.++||||||++++||++|+.|+........
T Consensus 152 ~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~- 227 (322)
T 2ycf_A 152 EDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS- 227 (322)
T ss_dssp SSCCEEECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC-
T ss_pred CCCeEEEccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH-
Confidence 5 9999999998764322 123456899999999874 56789999999999999999999999865433221
Q ss_pred HhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 734 LLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
+.... ..... ...+.........+.+++.+||+.||++||++.++++
T Consensus 228 ~~~~~----~~~~~------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 228 LKDQI----TSGKY------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHHH----HHTCC------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHH----HhCcc------ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 11111 00000 0111111223456889999999999999999999884
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=337.36 Aligned_cols=195 Identities=20% Similarity=0.261 Sum_probs=165.5
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhc------CCCCc
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL------QHRNL 585 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l------~H~ni 585 (840)
...+|++.++||+|+||.||+|.+. .+++.||||+++.. ....+++.+|++++..+ +|+||
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~------------~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~i 161 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDH------------KVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNV 161 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEET------------TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCB
T ss_pred ccCcEEEEEEcccCccEEEEEEEEC------------CCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCE
Confidence 4567999999999999999999765 57899999999754 23346788899998888 56799
Q ss_pred cceeeEeecCCceEEEEEeeccCC-----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCC
Q 041702 586 VRLFGCCIEQGEKISIYEFDIVTD-----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMN 660 (840)
Q Consensus 586 v~l~g~~~~~~~~~lv~e~~~~~~-----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~ 660 (840)
+++++++...+..++|||+..... ......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 162 v~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~ 238 (429)
T 3kvw_A 162 IHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGR 238 (429)
T ss_dssp CCEEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTS
T ss_pred EEEEeecccCCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCC
Confidence 999999999999999999953110 112234899999999999999999999998 999999999999999987
Q ss_pred --ceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 041702 661 --PKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFY 727 (840)
Q Consensus 661 --~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~ 727 (840)
+||+|||++...... .....||+.|+|||++.+..++.++|||||||+|+||++|++||...
T Consensus 239 ~~vkL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 239 SGIKVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp CCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cceEEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 999999999765322 23457899999999999999999999999999999999999998654
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=327.38 Aligned_cols=257 Identities=25% Similarity=0.338 Sum_probs=189.2
Q ss_pred cCHHHHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcC
Q 041702 504 FSLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQ 581 (840)
Q Consensus 504 ~~~~~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~ 581 (840)
+.+.++....++|++.+.||+|+||.||+|.+. +++.||||++.... ....+++.+|++++.+++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-------------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~ 84 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-------------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 84 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECT-------------TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHG
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-------------CCcEEEEEEeccccccccchHHHHHHHHHHHhcc
Confidence 334444556788999999999999999998653 58899999997542 234578999999999997
Q ss_pred --CCCccceeeEeecCCceEEEEEeec---cCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEec
Q 041702 582 --HRNLVRLFGCCIEQGEKISIYEFDI---VTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLD 656 (840)
Q Consensus 582 --H~niv~l~g~~~~~~~~~lv~e~~~---~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~ 656 (840)
||||+++++++.+.+..+++||+.. .........+++..+..++.||+.||.|||+.+ |+||||||+|||++
T Consensus 85 ~~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~ 161 (313)
T 3cek_A 85 QHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV 161 (313)
T ss_dssp GGCTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE
T ss_pred ccCCceEEEEEEeecCCEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEE
Confidence 5999999999999999999999621 111223457899999999999999999999998 99999999999996
Q ss_pred CCCCceeeccccceecCCCCcccccccccccccccCcccccc-----------CCCCccccchhHHHHHHHHHhCCCCCC
Q 041702 657 SDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH-----------GLFSIKSDVFSFGVLLLEILSSKKNTR 725 (840)
Q Consensus 657 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDV~SlGviL~elltG~~p~~ 725 (840)
++.+||+|||+++...............||+.|+|||.+.+ ..++.++||||||++++||++|+.|+.
T Consensus 162 -~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 240 (313)
T 3cek_A 162 -DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 240 (313)
T ss_dssp -TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred -CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchh
Confidence 48999999999987654433333345578999999999875 478899999999999999999999985
Q ss_pred CCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 726 FYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
..... ........ ++......+......+.+++.+||+.||++||+++|+++
T Consensus 241 ~~~~~----~~~~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 241 QIINQ----ISKLHAII---------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp TCCSH----HHHHHHHH---------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hHHHH----HHHHHHHH---------hcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 43211 11111111 111111111111345788999999999999999999985
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=321.97 Aligned_cols=255 Identities=25% Similarity=0.351 Sum_probs=194.2
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCcccee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
..++|+..+.||+|+||.||+|.++ .+++.||+|++.... ....+.+.+|++++++++||||++++
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 71 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRK------------SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEET------------TTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred chhheeeehhccCCCCcEEEEEEEC------------CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEE
Confidence 3578999999999999999999765 578999999997543 23456799999999999999999999
Q ss_pred eEeec--CCceEEEEEeeccCC--------ccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CCceecCCCCCCcEEecC
Q 041702 590 GCCIE--QGEKISIYEFDIVTD--------PARKDLLDWTTRVRIIEGVAQGLLYLHQYS--RLRVIHRDLKASNVLLDS 657 (840)
Q Consensus 590 g~~~~--~~~~~lv~e~~~~~~--------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivHrDlkp~NILl~~ 657 (840)
+++.+ .+..++||||..... ......+++..++.++.|++.||+|||+.+ ..+|+||||||+|||++.
T Consensus 72 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~ 151 (279)
T 2w5a_A 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG 151 (279)
T ss_dssp EEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECS
T ss_pred EEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcC
Confidence 98854 677899999942211 112345899999999999999999999976 234999999999999999
Q ss_pred CCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHH
Q 041702 658 DMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGH 737 (840)
Q Consensus 658 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~ 737 (840)
++.+||+|||+++....... ......||+.|+|||.+.+..++.++||||||++++||++|+.|+...... ...
T Consensus 152 ~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~-- 225 (279)
T 2w5a_A 152 KQNVKLGDFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--ELA-- 225 (279)
T ss_dssp SSCEEECCCCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH--
T ss_pred CCCEEEecCchheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH--HHH--
Confidence 99999999999987643221 122356899999999999999999999999999999999999998643211 111
Q ss_pred HhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 738 AWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 738 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
......... .+ +......+.+++.+||+.||++||++.||++.+...
T Consensus 226 --~~i~~~~~~-----~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 226 --GKIREGKFR-----RI----PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp --HHHHHTCCC-----CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred --HHHhhcccc-----cC----CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 111111110 11 112335688999999999999999999999876543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=316.72 Aligned_cols=248 Identities=24% Similarity=0.412 Sum_probs=191.4
Q ss_pred HHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 511 AATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 511 ~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
...++|+..+.||+|+||.||+|.++ .+++.||||++... ...+++.+|+.++.+++||||+++++
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~------------~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~ 91 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHK------------ETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYG 91 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEET------------TTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEEC------------CCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEE
Confidence 34578999999999999999999765 57899999999764 34578999999999999999999999
Q ss_pred EeecCCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 591 CCIEQGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
++...+..++|+||...... .....+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d 168 (314)
T 3com_A 92 SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLAD 168 (314)
T ss_dssp EEEETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECC
T ss_pred EEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEee
Confidence 99999999999999422111 12457899999999999999999999998 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
||++........ ......||+.|+|||.+.+..++.++||||||++++||++|+.|+...... ........ .
T Consensus 169 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~-~ 240 (314)
T 3com_A 169 FGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM-----RAIFMIPT-N 240 (314)
T ss_dssp CTTCEECBTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHHHH-S
T ss_pred cccchhhhhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHhc-C
Confidence 999987643321 223457899999999999999999999999999999999999998643211 11111101 1
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.. +... ........+.+++.+||+.||++|||+.++++
T Consensus 241 ~~-----~~~~--~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 241 PP-----PTFR--KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp CC-----CCCS--SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CC-----cccC--CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00 0110 11122346788999999999999999999975
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=339.84 Aligned_cols=248 Identities=22% Similarity=0.338 Sum_probs=191.6
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCcccee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
..++|+..++||+|+||.||+|.++ .++..||||++.... ....+.+.+|+.++++++||||++++
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~------------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 102 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDK------------VTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEET------------TTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEEC------------CCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 3467999999999999999999765 678999999997543 34467899999999999999999999
Q ss_pred eEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCC---CCce
Q 041702 590 GCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSD---MNPK 662 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~---~~~k 662 (840)
+++.+.+..++||||..... ......+++..+..++.||+.||+|||+.+ |+||||||+|||++.. +.+|
T Consensus 103 ~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~k 179 (494)
T 3lij_A 103 DFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIK 179 (494)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEE
T ss_pred EEEEeCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEE
Confidence 99999999999999953322 223457899999999999999999999998 9999999999999764 4599
Q ss_pred eeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhh
Q 041702 663 ISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLW 742 (840)
Q Consensus 663 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~ 742 (840)
|+|||++..+.... ......||+.|+|||++. ..++.++|||||||++|||++|+.||...... ..... .
T Consensus 180 l~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~----i 249 (494)
T 3lij_A 180 IVDFGLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ--EILRK----V 249 (494)
T ss_dssp ECCCTTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH----H
T ss_pred EEECCCCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH----H
Confidence 99999998765432 233457999999999876 56999999999999999999999998643221 11111 1
Q ss_pred cccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 743 KDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 743 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
..... .. ...........+.+++.+||+.||++|||+.|+++
T Consensus 250 ~~~~~-~~-----~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 250 EKGKY-TF-----DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp HHTCC-CC-----CSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhCCC-CC-----CchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 11100 00 01111123456789999999999999999999984
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=316.95 Aligned_cols=240 Identities=22% Similarity=0.356 Sum_probs=188.9
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhc-CCCCccce
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKL-QHRNLVRL 588 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l-~H~niv~l 588 (840)
..++|+..+.||+|+||.||+|.++ .+++.||||++.... .....++.+|+..+.++ +||||+++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~ 76 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKR------------LDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEET------------TTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEc------------CCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeee
Confidence 4578999999999999999999765 578999999997542 33456789999999999 99999999
Q ss_pred eeEeecCCceEEEEEeeccCCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCC--
Q 041702 589 FGCCIEQGEKISIYEFDIVTDPA--------RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSD-- 658 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~~~~~~~~--------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~-- 658 (840)
++++.+.+..++||||....... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 77 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~ 153 (289)
T 1x8b_A 77 FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSI 153 (289)
T ss_dssp EEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----
T ss_pred eeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCC
Confidence 99999999999999995332211 1256899999999999999999999998 9999999999999844
Q ss_pred -----------------CCceeeccccceecCCCCcccccccccccccccCccccccC-CCCccccchhHHHHHHHHHhC
Q 041702 659 -----------------MNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSS 720 (840)
Q Consensus 659 -----------------~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~SlGviL~elltG 720 (840)
..+||+|||++....... ...||+.|+|||.+.+. .++.++||||||++++||++|
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~ 227 (289)
T 1x8b_A 154 PNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA 227 (289)
T ss_dssp ----------------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTC
T ss_pred CcccccccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcC
Confidence 478999999998764322 24589999999998876 567899999999999999999
Q ss_pred CCCCCCCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 721 KKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 721 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.+++... .. +........ +.+. ......+.+++.+||+.||++|||+.|+++
T Consensus 228 ~~~~~~~-----~~----~~~~~~~~~-----~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 228 EPLPRNG-----DQ----WHEIRQGRL-----PRIP----QVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp CCCCSSS-----HH----HHHHHTTCC-----CCCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCcch-----hH----HHHHHcCCC-----CCCC----cccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 8765321 11 111111111 1111 122345788999999999999999999875
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=325.00 Aligned_cols=255 Identities=19% Similarity=0.320 Sum_probs=198.3
Q ss_pred HHHHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCc--------CHHHHHHHHHHH
Q 041702 506 LSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQ--------GLEEFKNEMMLI 577 (840)
Q Consensus 506 ~~~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~--------~~~~f~~Ev~~l 577 (840)
........++|.+.+.||+|+||.||+|.++ .+|+.||||++...... ..+.+.+|+.++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~------------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l 153 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHR------------ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEET------------TTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHH
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEEC------------CCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHH
Confidence 3444556678999999999999999999764 57899999998754321 145688999999
Q ss_pred hhc-CCCCccceeeEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCc
Q 041702 578 AKL-QHRNLVRLFGCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASN 652 (840)
Q Consensus 578 ~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~N 652 (840)
.++ +||||+++++++...+..++||||..... ......+++..+..++.||+.||.|||+.+ |+||||||+|
T Consensus 154 ~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~N 230 (365)
T 2y7j_A 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPEN 230 (365)
T ss_dssp HHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred HHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHH
Confidence 999 79999999999999999999999953322 123457899999999999999999999998 9999999999
Q ss_pred EEecCCCCceeeccccceecCCCCcccccccccccccccCcccccc------CCCCccccchhHHHHHHHHHhCCCCCCC
Q 041702 653 VLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH------GLFSIKSDVFSFGVLLLEILSSKKNTRF 726 (840)
Q Consensus 653 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDV~SlGviL~elltG~~p~~~ 726 (840)
||++.++.+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 231 Il~~~~~~ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 307 (365)
T 2y7j_A 231 ILLDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH 307 (365)
T ss_dssp EEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EEECCCCCEEEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC
Confidence 999999999999999998765432 2234679999999998863 3688999999999999999999999853
Q ss_pred CCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 727 YNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
... ..... ....... .............+.+++.+||+.||++|||++|+++
T Consensus 308 ~~~--~~~~~----~i~~~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 308 RRQ--ILMLR----MIMEGQY------QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp SSH--HHHHH----HHHHTCC------CCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCH--HHHHH----HHHhCCC------CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 221 11111 1111100 0000011122455889999999999999999999986
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=316.26 Aligned_cols=246 Identities=22% Similarity=0.343 Sum_probs=189.0
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
+.|...+.||+|+||.||+|.+. .++..||+|++.... ....+.+.+|+.++++++||||++++++
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~------------~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 93 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDT------------ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEET------------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEec------------CCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeee
Confidence 45778889999999999999765 678899999987542 3345679999999999999999999999
Q ss_pred eec----CCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEec-CCCCce
Q 041702 592 CIE----QGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLD-SDMNPK 662 (840)
Q Consensus 592 ~~~----~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~-~~~~~k 662 (840)
+.. ....++||||..... ......+++..+..++.||+.||.|||+.+ .+|+||||||+|||++ .++.+|
T Consensus 94 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~k 172 (290)
T 1t4h_A 94 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVK 172 (290)
T ss_dssp EEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEE
T ss_pred eccccCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEE
Confidence 875 355789999843222 123367899999999999999999999875 3599999999999997 789999
Q ss_pred eeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhh
Q 041702 663 ISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLW 742 (840)
Q Consensus 663 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~ 742 (840)
|+|||++...... ......||+.|+|||.+. ..++.++||||||++++||++|+.|+....... . .....
T Consensus 173 l~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~----~~~~~ 242 (290)
T 1t4h_A 173 IGDLGLATLKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA-Q----IYRRV 242 (290)
T ss_dssp ECCTTGGGGCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-H----HHHHH
T ss_pred EeeCCCccccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH-H----HHHHH
Confidence 9999999754332 223456899999999876 459999999999999999999999985432111 1 11111
Q ss_pred cccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 743 KDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 743 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
..... + ..........+.+++.+||+.||++|||++||++
T Consensus 243 ~~~~~-----~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 243 TSGVK-----P---ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp TTTCC-----C---GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccCC-----c---cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11100 0 0111112245889999999999999999999985
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=350.67 Aligned_cols=247 Identities=24% Similarity=0.272 Sum_probs=197.6
Q ss_pred HHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhc-CCCCcc
Q 041702 511 AATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKL-QHRNLV 586 (840)
Q Consensus 511 ~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l-~H~niv 586 (840)
...++|+..++||+|+||.||+|.++ .+++.||||++++. .....+.+..|..++..+ +||||+
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~------------~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~ 405 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERK------------GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 405 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEES------------SSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBC
T ss_pred ccccceEEEEEEccCCCEEEEEEEEC------------CCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEE
Confidence 34678999999999999999999765 57899999999753 234567889999999988 799999
Q ss_pred ceeeEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCce
Q 041702 587 RLFGCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPK 662 (840)
Q Consensus 587 ~l~g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 662 (840)
++++++.+.+..++||||..... ......+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+|
T Consensus 406 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ik 482 (674)
T 3pfq_A 406 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIK 482 (674)
T ss_dssp CEEEECBCSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEE
T ss_pred EEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEE
Confidence 99999999999999999953322 223457999999999999999999999998 99999999999999999999
Q ss_pred eeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhh
Q 041702 663 ISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLW 742 (840)
Q Consensus 663 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~ 742 (840)
|+|||+++...... .......||+.|+|||++.+..++.++|||||||+||||++|+.||..... ..+.. ..
T Consensus 483 L~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~--~~~~~----~i 554 (674)
T 3pfq_A 483 IADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DELFQ----SI 554 (674)
T ss_dssp ECCCTTCEECCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH----HH
T ss_pred EeecceeeccccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH--HHHHH----HH
Confidence 99999998643322 223456899999999999999999999999999999999999999864321 11111 11
Q ss_pred cccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 041702 743 KDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTM-----LEVVA 790 (840)
Q Consensus 743 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~ 790 (840)
.... + ..+......+.+|+.+||+.||++||++ +||++
T Consensus 555 ~~~~--------~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 555 MEHN--------V--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp HSSC--------C--CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred HhCC--------C--CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1111 0 0111234568899999999999999997 66653
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=342.08 Aligned_cols=248 Identities=25% Similarity=0.376 Sum_probs=196.9
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhcCCCCccce
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKLQHRNLVRL 588 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l~H~niv~l 588 (840)
..++|+..++||+|+||.||+|.++ .+++.||||++.... ....+.+.+|+.++++++||||+++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 91 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDK------------ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEET------------TTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCE
T ss_pred ccCceEEeeEEecCCCEEEEEEEEC------------CCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcE
Confidence 3467999999999999999999765 678999999996542 3457889999999999999999999
Q ss_pred eeEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEe---cCCCCc
Q 041702 589 FGCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLL---DSDMNP 661 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl---~~~~~~ 661 (840)
++++.+.+..++|+|+..... ......+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~ 168 (484)
T 3nyv_A 92 YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANI 168 (484)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCE
T ss_pred EEEEEeCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcE
Confidence 999999999999999843222 223467899999999999999999999998 9999999999999 567899
Q ss_pred eeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhh
Q 041702 662 KISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNL 741 (840)
Q Consensus 662 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~ 741 (840)
||+|||+++.+.... ......||+.|+|||.+.+ .++.++|||||||++|||++|+.||...... .....
T Consensus 169 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~---- 238 (484)
T 3nyv_A 169 RIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY--DILKK---- 238 (484)
T ss_dssp EECCTTHHHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH----
T ss_pred EEEeeeeeEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH--HHHHH----
Confidence 999999998765432 2234579999999998866 6999999999999999999999998643211 11111
Q ss_pred hcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 742 WKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 742 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
...... .............+.+++.+||+.||++|||+.|+++
T Consensus 239 i~~~~~------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 239 VEKGKY------TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp HHHCCC------CCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHcCCC------CCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 111110 0001111223456789999999999999999999984
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=327.24 Aligned_cols=262 Identities=23% Similarity=0.277 Sum_probs=193.2
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcCCCCccceee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
..++|...+.||+|+||.||+|.++ .+++.||||++..... ....++.+|++++++++||||+++++
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 76 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHK------------PTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFN 76 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEET------------TTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccceEEeeEEcCCCCeEEEEEEEC------------CCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeee
Confidence 3578999999999999999999765 5789999999975432 33467889999999999999999999
Q ss_pred EeecC-----CceEEEEEeecc--CCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCcee
Q 041702 591 CCIEQ-----GEKISIYEFDIV--TDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKI 663 (840)
Q Consensus 591 ~~~~~-----~~~~lv~e~~~~--~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL 663 (840)
++... +..++++|+... ........+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 77 ~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl 153 (353)
T 2b9h_A 77 IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKV 153 (353)
T ss_dssp ECCCSCSTTCCCEEEEECCCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEE
T ss_pred eecccccCccceEEEEEeccCccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEE
Confidence 98754 678999998421 11112356899999999999999999999998 999999999999999999999
Q ss_pred eccccceecCCCCccc--------ccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccH
Q 041702 664 SDFGIARTFGGDEMQS--------NTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTL 734 (840)
Q Consensus 664 ~DFGla~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~ 734 (840)
+|||+++......... ......||+.|+|||.+.+ ..++.++|||||||+++||++|+.||....... .
T Consensus 154 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~ 231 (353)
T 2b9h_A 154 CDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH--Q 231 (353)
T ss_dssp CCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--H
T ss_pred EecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH--H
Confidence 9999998765332111 1223568999999998764 779999999999999999999999986543111 0
Q ss_pred hHHHhhhhcccc----ccc------------cc--CccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 735 LGHAWNLWKDDK----AWK------------LM--DPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 735 ~~~~~~~~~~~~----~~~------------~~--d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
............ ... +. ...............+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 232 LLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 100100000000 000 00 000000111233456889999999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=329.54 Aligned_cols=253 Identities=19% Similarity=0.243 Sum_probs=187.2
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
..+|...++||+|+||.||+|++. .+..||+|++..... ...+|++++++++||||+++++++
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~-------------~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~ 101 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLV-------------ESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFF 101 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEET-------------TTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEEC-------------CCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEE
Confidence 457999999999999999998754 344589998865422 224799999999999999999999
Q ss_pred ecCCc------eEEEEEeeccC-------CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEec-CC
Q 041702 593 IEQGE------KISIYEFDIVT-------DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLD-SD 658 (840)
Q Consensus 593 ~~~~~------~~lv~e~~~~~-------~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~-~~ 658 (840)
...+. .++||||.... .......+++..+..++.||+.||+|||+.+ |+||||||+|||++ .+
T Consensus 102 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~ 178 (394)
T 4e7w_A 102 YSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPS 178 (394)
T ss_dssp EEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTT
T ss_pred EecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCC
Confidence 76544 77999984221 1122567899999999999999999999998 99999999999999 78
Q ss_pred CCceeeccccceecCCCCcccccccccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHH
Q 041702 659 MNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGH 737 (840)
Q Consensus 659 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~ 737 (840)
+.+||+|||+++....... .....+|+.|+|||.+.+. .++.++|||||||+++||++|+.||......+ ....
T Consensus 179 ~~~kL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~l~~ 253 (394)
T 4e7w_A 179 GVLKLIDFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID--QLVE 253 (394)
T ss_dssp TEEEECCCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH
T ss_pred CcEEEeeCCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH
Confidence 9999999999987644332 2345789999999998765 58999999999999999999999986543211 1111
Q ss_pred Hhhhhc----------ccccccccCccccc-----hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 738 AWNLWK----------DDKAWKLMDPTMQN-----EALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 738 ~~~~~~----------~~~~~~~~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
...... ........-+.... .........+.+++.+||+.||++|||+.|+++
T Consensus 254 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 254 IIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 111000 00000000011110 111123456889999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=338.26 Aligned_cols=248 Identities=25% Similarity=0.350 Sum_probs=194.2
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-------------cCHHHHHHHHHHHh
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-------------QGLEEFKNEMMLIA 578 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-------------~~~~~f~~Ev~~l~ 578 (840)
..++|.+.++||+|+||.||+|.++ .+++.||||++..... ...+++.+|+.+++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~------------~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 101 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEK------------NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEET------------TTCCEEEEEEEEC----------------CTHHHHHHHHHHHH
T ss_pred cccceEEEeEecccCCeEEEEEEEC------------CCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHH
Confidence 4678999999999999999999765 5789999999875421 34578999999999
Q ss_pred hcCCCCccceeeEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEE
Q 041702 579 KLQHRNLVRLFGCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVL 654 (840)
Q Consensus 579 ~l~H~niv~l~g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIL 654 (840)
+++||||+++++++.+.+..++||||..... ......+++..+..++.||+.||+|||+.+ |+||||||+|||
T Consensus 102 ~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil 178 (504)
T 3q5i_A 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENIL 178 (504)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred hCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEE
Confidence 9999999999999999999999999953322 223467899999999999999999999998 999999999999
Q ss_pred ecCCC---CceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCC
Q 041702 655 LDSDM---NPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDS 731 (840)
Q Consensus 655 l~~~~---~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~ 731 (840)
++.++ .+||+|||++..+.... ......||+.|+|||.+. ..++.++|||||||+++||++|+.||......
T Consensus 179 ~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~- 253 (504)
T 3q5i_A 179 LENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ- 253 (504)
T ss_dssp ESSTTCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-
T ss_pred EecCCCCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 98776 69999999998775432 223457999999999876 56999999999999999999999998643221
Q ss_pred ccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 732 LTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
..... ...... .............+.+++.+||+.||++|||++|+++
T Consensus 254 -~~~~~----i~~~~~------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 254 -DIIKK----VEKGKY------YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp -HHHHH----HHHCCC------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -HHHHH----HHcCCC------CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 11111 111100 0011111223456889999999999999999999984
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=319.50 Aligned_cols=267 Identities=23% Similarity=0.357 Sum_probs=191.4
Q ss_pred HHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCc
Q 041702 508 SISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNL 585 (840)
Q Consensus 508 ~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~ni 585 (840)
+.....++|+..+.||+|+||.||+|.++ ..||+|++.... ....+.|.+|+.++.+++||||
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~---------------~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 91 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWH---------------GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENV 91 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSSSEEEEEEES---------------SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTB
T ss_pred cccCCHHHeEEeeEeccCCceEEEEEEEc---------------CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCE
Confidence 34445688999999999999999998643 259999987542 3345678899999999999999
Q ss_pred cceeeEeecCCceEEEEEeeccCC-----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCC
Q 041702 586 VRLFGCCIEQGEKISIYEFDIVTD-----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMN 660 (840)
Q Consensus 586 v~l~g~~~~~~~~~lv~e~~~~~~-----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~ 660 (840)
+++++++.+.+..++++|+..... ......+++..+..++.||+.||+|||+.+ |+||||||+|||++ ++.
T Consensus 92 v~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~ 167 (319)
T 2y4i_B 92 VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGK 167 (319)
T ss_dssp CCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---C
T ss_pred eEEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCC
Confidence 999999999999999999942111 112346899999999999999999999998 99999999999998 689
Q ss_pred ceeeccccceecCCCC---cccccccccccccccCcccccc---------CCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 041702 661 PKISDFGIARTFGGDE---MQSNTNRIVGTYGYMSPEYALH---------GLFSIKSDVFSFGVLLLEILSSKKNTRFYN 728 (840)
Q Consensus 661 ~kL~DFGla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~ksDV~SlGviL~elltG~~p~~~~~ 728 (840)
+||+|||++....... .........||+.|+|||.+.+ ..++.++||||||++++||++|+.|+....
T Consensus 168 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 247 (319)
T 2y4i_B 168 VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP 247 (319)
T ss_dssp CEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC
T ss_pred EEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999987653221 1122234568999999998864 457899999999999999999999986432
Q ss_pred CCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCCCCCCCCCC
Q 041702 729 TDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSPHQPAF 807 (840)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~p~~p~~ 807 (840)
.. .. .... ........... .....+.+++.+||+.||++|||+.+|+++|+.+.........|..
T Consensus 248 ~~--~~---~~~~-~~~~~~~~~~~--------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~ 312 (319)
T 2y4i_B 248 AE--AI---IWQM-GTGMKPNLSQI--------GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGH 312 (319)
T ss_dssp HH--HH---HHHH-HTTCCCCCCCS--------SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------------
T ss_pred HH--HH---HHHh-ccCCCCCCCcC--------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCcc
Confidence 11 11 1111 11111111111 1223477899999999999999999999999998776655555543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-35 Score=322.10 Aligned_cols=255 Identities=21% Similarity=0.281 Sum_probs=190.0
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC--cCHHHHHHHHHHHhhcCCCCccceee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG--QGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
.++|...+.||+|+||.||+|.++ .+|+.||||++..... ...+++.+|+.++++++||||+++++
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 90 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDK------------RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLD 90 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEET------------TTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred CceEEEeeeEecCCCeEEEEEEEC------------CCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhh
Confidence 478999999999999999999765 6789999999975432 23467899999999999999999999
Q ss_pred EeecCCc------eEEEEEeeccCC-ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCcee
Q 041702 591 CCIEQGE------KISIYEFDIVTD-PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKI 663 (840)
Q Consensus 591 ~~~~~~~------~~lv~e~~~~~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL 663 (840)
++...+. .+++||+..... ......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 91 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl 167 (353)
T 3coi_A 91 VFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKI 167 (353)
T ss_dssp EECSCSSGGGCCCCEEEEECCSEEGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEE
T ss_pred eEecccccccceeEEEEeccccCCHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEE
Confidence 9987654 499999843110 011235899999999999999999999998 999999999999999999999
Q ss_pred eccccceecCCCCcccccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhh
Q 041702 664 SDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLW 742 (840)
Q Consensus 664 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~ 742 (840)
+|||+++..... .....+|+.|+|||.+.+ ..++.++||||||++++||++|+.||...... ..........
T Consensus 168 ~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~~~i~~~~ 240 (353)
T 3coi_A 168 LDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL--DQLTQILKVT 240 (353)
T ss_dssp CSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH--HHHHHHHHHH
T ss_pred eecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHh
Confidence 999999765322 234578999999999887 67899999999999999999999998653321 1111111000
Q ss_pred cc-----------c-------ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 743 KD-----------D-------KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 743 ~~-----------~-------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.. . .......+.. ..........+.+++.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 241 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp CBCCHHHHTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCCCHHHHHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 0 0000000000 0111233556889999999999999999999985
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=313.03 Aligned_cols=245 Identities=23% Similarity=0.361 Sum_probs=187.6
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhcCCCCccce
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQHRNLVRL 588 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l 588 (840)
..++|.+.+.||+|+||.||+|.++ .+++.||||++... .....+.+.+|+.++++++||||+++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 76 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQ------------LTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEET------------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCE
T ss_pred eeccEEEEeeecCCCCeEEEEEEEC------------CCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEE
Confidence 3478999999999999999999764 57899999998643 23456789999999999999999999
Q ss_pred eeEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 589 FGCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
++++.+.+..++|+|+..... ......+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+
T Consensus 77 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~ 153 (276)
T 2h6d_A 77 YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIA 153 (276)
T ss_dssp EEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEEC
T ss_pred EEEEecCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEe
Confidence 999999999999999943222 123456899999999999999999999998 9999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhc
Q 041702 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLF-SIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWK 743 (840)
Q Consensus 665 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~ 743 (840)
|||++........ .....+++.|+|||.+.+..+ +.++||||||++++||++|+.|+..... ... .....
T Consensus 154 dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~----~~~~~ 224 (276)
T 2h6d_A 154 DFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV--PTL----FKKIR 224 (276)
T ss_dssp CCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHH----HHHHH
T ss_pred ecccccccCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH--HHH----HHHhh
Confidence 9999987644321 234568999999999988765 6899999999999999999999854221 111 11111
Q ss_pred ccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 744 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.... ... ......+.+++.+||+.||++|||++||++
T Consensus 225 ~~~~------~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 225 GGVF------YIP----EYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp HCCC------CCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCcc------cCc----hhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 1100 011 112345778999999999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=323.32 Aligned_cols=255 Identities=25% Similarity=0.391 Sum_probs=189.8
Q ss_pred cCHHHHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhc-CC
Q 041702 504 FSLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL-QH 582 (840)
Q Consensus 504 ~~~~~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l-~H 582 (840)
+.+.++....++|+..+.||+|+||.||+|.+. .+++.||||++.... ...+++.+|+.++.++ +|
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~------------~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h 80 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHV------------KTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHH 80 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEET------------TTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCS
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEEC------------CCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCC
Confidence 344455567889999999999999999999764 578999999997543 3457899999999999 89
Q ss_pred CCccceeeEeec------CCceEEEEEeeccCC------ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCC
Q 041702 583 RNLVRLFGCCIE------QGEKISIYEFDIVTD------PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKA 650 (840)
Q Consensus 583 ~niv~l~g~~~~------~~~~~lv~e~~~~~~------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp 650 (840)
|||+++++++.. .+..++||||..... ......+++..+..++.||+.||+|||+.+ |+||||||
T Consensus 81 ~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp 157 (326)
T 2x7f_A 81 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKG 157 (326)
T ss_dssp TTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSG
T ss_pred CCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcH
Confidence 999999999987 467899999842211 112356889999999999999999999998 99999999
Q ss_pred CcEEecCCCCceeeccccceecCCCCcccccccccccccccCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCC
Q 041702 651 SNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYAL-----HGLFSIKSDVFSFGVLLLEILSSKKNTR 725 (840)
Q Consensus 651 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~SlGviL~elltG~~p~~ 725 (840)
+|||++.++.+||+|||++....... .......||+.|+|||.+. +..++.++||||||++++||++|+.|+.
T Consensus 158 ~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 235 (326)
T 2x7f_A 158 QNVLLTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 235 (326)
T ss_dssp GGEEECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTT
T ss_pred HHEEEcCCCCEEEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999998764321 1223456899999999987 5678999999999999999999999985
Q ss_pred CCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 726 FYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
..... ........ ........ ......+.+++.+||+.||++||+++++++
T Consensus 236 ~~~~~-----~~~~~~~~-~~~~~~~~--------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 236 DMHPM-----RALFLIPR-NPAPRLKS--------KKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp TSCHH-----HHHHHHHH-SCCCCCSC--------SCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCcHH-----HHHHHhhc-CccccCCc--------cccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 33211 11111111 11111111 112345788999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=321.16 Aligned_cols=251 Identities=23% Similarity=0.389 Sum_probs=172.8
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHH-HHhhcCCCCcccee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMM-LIAKLQHRNLVRLF 589 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~-~l~~l~H~niv~l~ 589 (840)
..++|...+.||+|+||.||+|.++ .+++.||||++..... ....++..|+. +++.++||||++++
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~ 87 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHK------------PSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFY 87 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEET------------TTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEc------------CCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeee
Confidence 3478899999999999999999765 5789999999976432 33445666666 77778999999999
Q ss_pred eEeecCCceEEEEEeeccC--C------ccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceecCCCCCCcEEecCCCC
Q 041702 590 GCCIEQGEKISIYEFDIVT--D------PARKDLLDWTTRVRIIEGVAQGLLYLHQY-SRLRVIHRDLKASNVLLDSDMN 660 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~--~------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivHrDlkp~NILl~~~~~ 660 (840)
+++...+..++||||.... . ......+++..+.+++.|++.||.|||+. + |+||||||+|||++.++.
T Consensus 88 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~ 164 (327)
T 3aln_A 88 GALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGN 164 (327)
T ss_dssp EEEECSSEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTE
T ss_pred eEEEeCCceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCC
Confidence 9999999999999994321 0 01246789999999999999999999998 7 999999999999999999
Q ss_pred ceeeccccceecCCCCcccccccccccccccCcccc----ccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhH
Q 041702 661 PKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYA----LHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLG 736 (840)
Q Consensus 661 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~ 736 (840)
+||+|||+++...... ......||+.|+|||.+ .+..++.++||||||++++||++|+.|+.........
T Consensus 165 ~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--- 238 (327)
T 3aln_A 165 IKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ--- 238 (327)
T ss_dssp EEECCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------
T ss_pred EEEccCCCceeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH---
Confidence 9999999998764322 12234689999999998 4667899999999999999999999998643221110
Q ss_pred HHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 737 HAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 737 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.... ... ..+.+...........+.+++.+||+.||++|||+.+|++
T Consensus 239 -~~~~-~~~-----~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 239 -LTQV-VKG-----DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp --CCC-CCS-----CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -HHHH-hcC-----CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 0000 000 0111111111123456889999999999999999999974
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-35 Score=313.66 Aligned_cols=250 Identities=22% Similarity=0.319 Sum_probs=195.4
Q ss_pred HHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC---------cCHHHHHHHHHHHhhcC
Q 041702 511 AATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG---------QGLEEFKNEMMLIAKLQ 581 (840)
Q Consensus 511 ~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~---------~~~~~f~~Ev~~l~~l~ 581 (840)
...++|...+.||+|+||.||+|.++ .+++.||||++..... ...+.+.+|++++.++.
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 81 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHK------------PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEET------------TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHT
T ss_pred chhhccceeeeecCCCceEEEEEEEc------------CcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhc
Confidence 34578999999999999999999765 5789999999975431 12456889999999995
Q ss_pred -CCCccceeeEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEec
Q 041702 582 -HRNLVRLFGCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLD 656 (840)
Q Consensus 582 -H~niv~l~g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~ 656 (840)
||||+++++++...+..++|||+..... ......+++..+..++.||+.||+|||+.+ |+||||||+||+++
T Consensus 82 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~ 158 (298)
T 1phk_A 82 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLD 158 (298)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC
T ss_pred CCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEc
Confidence 9999999999999999999999953222 123457899999999999999999999998 99999999999999
Q ss_pred CCCCceeeccccceecCCCCcccccccccccccccCccccc------cCCCCccccchhHHHHHHHHHhCCCCCCCCCCC
Q 041702 657 SDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYAL------HGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTD 730 (840)
Q Consensus 657 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~ 730 (840)
.++.+||+|||++....... ......+++.|+|||.+. ...++.++||||||++++||++|+.|+.....
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~- 234 (298)
T 1phk_A 159 DDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ- 234 (298)
T ss_dssp TTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-
T ss_pred CCCcEEEecccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH-
Confidence 99999999999998765432 223456899999999885 45689999999999999999999999854321
Q ss_pred CccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 731 SLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.... ........ .. ...........+.+++.+||+.||++|||+.|+++
T Consensus 235 -~~~~----~~~~~~~~-~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 235 -MLML----RMIMSGNY-QF-----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp -HHHH----HHHHHTCC-CC-----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred -HHHH----HHHhcCCc-cc-----CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1111 11111110 00 01111223456889999999999999999999975
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=318.50 Aligned_cols=252 Identities=20% Similarity=0.309 Sum_probs=194.1
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcC-----------------HHHHHHHHH
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQG-----------------LEEFKNEMM 575 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~-----------------~~~f~~Ev~ 575 (840)
.++|.+.+.||+|+||.||+|.+ +++.||||++....... .+.|.+|+.
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--------------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 95 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--------------DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--------------TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHH
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--------------CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHH
Confidence 57899999999999999999852 68999999987532111 178999999
Q ss_pred HHhhcCCCCccceeeEeecCCceEEEEEeeccCC----------ccc--cCCCCHHHHHHHHHHHHHHHHHHHh-cCCCc
Q 041702 576 LIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTD----------PAR--KDLLDWTTRVRIIEGVAQGLLYLHQ-YSRLR 642 (840)
Q Consensus 576 ~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~~~----------~~~--~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ 642 (840)
++.+++||||+++++++.+.+..++||||..... ... ...+++..+..++.||+.||.|||+ .+
T Consensus 96 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--- 172 (348)
T 2pml_X 96 IITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--- 172 (348)
T ss_dssp HHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---
T ss_pred HHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---
Confidence 9999999999999999999999999999943211 111 5678999999999999999999999 87
Q ss_pred eecCCCCCCcEEecCCCCceeeccccceecCCCCcccccccccccccccCccccccC-CCCc-cccchhHHHHHHHHHhC
Q 041702 643 VIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHG-LFSI-KSDVFSFGVLLLEILSS 720 (840)
Q Consensus 643 ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-ksDV~SlGviL~elltG 720 (840)
|+||||||+|||++.++.+||+|||++...... ......||+.|+|||.+.+. .++. ++||||||++++||++|
T Consensus 173 i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g 248 (348)
T 2pml_X 173 ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN 248 (348)
T ss_dssp EECCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHS
T ss_pred EeecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhC
Confidence 999999999999999999999999999876433 23345789999999999887 6766 99999999999999999
Q ss_pred CCCCCCCCCCCccHhHHHhhhhccccccc------ccCc---cccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 721 KKNTRFYNTDSLTLLGHAWNLWKDDKAWK------LMDP---TMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 721 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~~d~---~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
+.|+....... ..... ........ ...+ .............+.+++.+||+.||++|||++|+++
T Consensus 249 ~~pf~~~~~~~-~~~~~----i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 249 VVPFSLKISLV-ELFNN----IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp SCSSCCSSCSH-HHHHH----HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCCCCCCcHH-HHHHH----HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 99986543311 11111 11111000 0000 0000011233456889999999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-35 Score=316.85 Aligned_cols=261 Identities=23% Similarity=0.315 Sum_probs=193.6
Q ss_pred HHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhc---CCCCc
Q 041702 511 AATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKL---QHRNL 585 (840)
Q Consensus 511 ~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l---~H~ni 585 (840)
.+.++|++.+.||+|+||.||+|.+. ..+++.||||++.... ......+.+|+.+++++ +||||
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i 76 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDL-----------KNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 76 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEET-----------TTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTB
T ss_pred CchhceeeeeeecccccEEEEEEEec-----------CCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCe
Confidence 35688999999999999999999753 2468899999987432 22345677888888777 89999
Q ss_pred cceeeEee-----cCCceEEEEEeeccCC-----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEe
Q 041702 586 VRLFGCCI-----EQGEKISIYEFDIVTD-----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLL 655 (840)
Q Consensus 586 v~l~g~~~-----~~~~~~lv~e~~~~~~-----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl 655 (840)
+++++++. .....++|+|+..... ......+++..+..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 77 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili 153 (326)
T 1blx_A 77 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILV 153 (326)
T ss_dssp CCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred EeeeeeeeecccCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEE
Confidence 99999997 5667889999843110 011234889999999999999999999998 9999999999999
Q ss_pred cCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHh
Q 041702 656 DSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLL 735 (840)
Q Consensus 656 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~ 735 (840)
+.++.+||+|||+++...... ......||+.|+|||.+.+..++.++||||||++++||++|+.||...... ...
T Consensus 154 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~ 228 (326)
T 1blx_A 154 TSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV--DQL 228 (326)
T ss_dssp CTTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHH
T ss_pred cCCCCEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH--HHH
Confidence 999999999999998754221 233457899999999999999999999999999999999999998643321 111
Q ss_pred HHHhhhhccc---ccc-------ccc---CccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 736 GHAWNLWKDD---KAW-------KLM---DPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 736 ~~~~~~~~~~---~~~-------~~~---d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.......... ... ... ...............+.+++.+||+.||++|||+.|+++
T Consensus 229 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 229 GKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp HHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1111110000 000 000 000001111233456789999999999999999999984
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=348.80 Aligned_cols=259 Identities=24% Similarity=0.320 Sum_probs=197.5
Q ss_pred HHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcCCCCccce
Q 041702 510 SAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQHRNLVRL 588 (840)
Q Consensus 510 ~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l 588 (840)
....++|...+.||+|+||.||+|.++ .....+..||||++..... ...++|.+|+.++++++||||+++
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l 456 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYM---------SPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEEC---------CSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEe---------cCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 344578999999999999999999765 2233567899999875432 334779999999999999999999
Q ss_pred eeEeecCCceEEEEEeeccCCcc-----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCcee
Q 041702 589 FGCCIEQGEKISIYEFDIVTDPA-----RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKI 663 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~~~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL 663 (840)
++++. .+..++||||....... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 457 ~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL 532 (656)
T 2j0j_A 457 IGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKL 532 (656)
T ss_dssp EEEEC-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEE
T ss_pred EEEEe-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEE
Confidence 99985 46789999995332221 2335899999999999999999999998 999999999999999999999
Q ss_pred eccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhh
Q 041702 664 SDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLW 742 (840)
Q Consensus 664 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 742 (840)
+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||...... ..... .
T Consensus 533 ~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--~~~~~----i 605 (656)
T 2j0j_A 533 GDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGR----I 605 (656)
T ss_dssp CCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHH----H
T ss_pred EecCCCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--HHHHH----H
Confidence 999999876443221 2233456789999999999999999999999999999997 88887643211 11111 1
Q ss_pred cccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 743 KDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 743 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
..... ... +...+..+.+++.+||+.||++|||+.+|++.|+.++.
T Consensus 606 ~~~~~-----~~~----~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 606 ENGER-----LPM----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp HHTCC-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCCC-----CCC----CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 11100 001 11234567889999999999999999999999998643
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-35 Score=317.96 Aligned_cols=256 Identities=20% Similarity=0.253 Sum_probs=192.8
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCC------cc
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRN------LV 586 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~n------iv 586 (840)
.++|++.+.||+|+||.||+|.+. ..+++.||||+++.. ....+.+.+|++++.+++|+| ++
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~ 80 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDH-----------KAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCV 80 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEET-----------TTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBC
T ss_pred cCceEEEEEEecCCCeEEEEEEec-----------CCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeE
Confidence 468999999999999999999752 257889999999754 234567899999999997654 99
Q ss_pred ceeeEeecCCceEEEEEeeccC---Cc--cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecC----
Q 041702 587 RLFGCCIEQGEKISIYEFDIVT---DP--ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS---- 657 (840)
Q Consensus 587 ~l~g~~~~~~~~~lv~e~~~~~---~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~---- 657 (840)
++++++...+..++|||+.... .. .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~ 157 (339)
T 1z57_A 81 QMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYT 157 (339)
T ss_dssp CEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEE
T ss_pred eeecccccCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccc
Confidence 9999999999999999995111 01 11235789999999999999999999998 999999999999987
Q ss_pred ---------------CCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCC
Q 041702 658 ---------------DMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKK 722 (840)
Q Consensus 658 ---------------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~ 722 (840)
++.+||+|||+++..... .....||+.|+|||.+.+..++.++||||||++++||++|+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 232 (339)
T 1z57_A 158 EAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFT 232 (339)
T ss_dssp EEEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCC
Confidence 678999999999875322 234578999999999999999999999999999999999999
Q ss_pred CCCCCCCCCccHhHHHhhhhcc--------cccccc---------------------cCccc-cchhhHHHHHHHHHHHH
Q 041702 723 NTRFYNTDSLTLLGHAWNLWKD--------DKAWKL---------------------MDPTM-QNEALYSMVTRYIKVAL 772 (840)
Q Consensus 723 p~~~~~~~~~~~~~~~~~~~~~--------~~~~~~---------------------~d~~l-~~~~~~~~~~~l~~l~~ 772 (840)
|+......+ ........... ...... ..+.. .........+.+.+++.
T Consensus 233 pf~~~~~~~--~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 310 (339)
T 1z57_A 233 VFPTHDSKE--HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQ 310 (339)
T ss_dssp SCCCSCHHH--HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHH
T ss_pred CCCCCChHH--HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHH
Confidence 986543221 11100000000 000000 00000 00011234567899999
Q ss_pred HccccCCCCCCCHHHHHH
Q 041702 773 LCVQENATDRPTMLEVVA 790 (840)
Q Consensus 773 ~Cl~~dP~~RPs~~evl~ 790 (840)
+||+.||++|||++||++
T Consensus 311 ~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 311 KMLEYDPAKRITLREALK 328 (339)
T ss_dssp HHTCSSTTTSCCHHHHTT
T ss_pred HHhCcCcccccCHHHHhc
Confidence 999999999999999974
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=308.59 Aligned_cols=250 Identities=25% Similarity=0.347 Sum_probs=195.2
Q ss_pred HHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC--CCcCHHHHHHHHHHHhhcCCCCccc
Q 041702 510 SAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK--SGQGLEEFKNEMMLIAKLQHRNLVR 587 (840)
Q Consensus 510 ~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~ 587 (840)
....++|++.+.||+|+||.||+|.++ .+++.||||++... .....+.+.+|++++++++||||++
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~------------~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 85 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDR------------ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEET------------TTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCC
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEc------------CCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccE
Confidence 345578999999999999999999765 57899999998654 2345788999999999999999999
Q ss_pred eeeEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCC---CC
Q 041702 588 LFGCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSD---MN 660 (840)
Q Consensus 588 l~g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~---~~ 660 (840)
+++++.+.+..++++|+..... ......+++..+..++.||+.||.|||+.+ |+||||||+||+++.+ +.
T Consensus 86 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~ 162 (287)
T 2wei_A 86 LFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCD 162 (287)
T ss_dssp EEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCC
T ss_pred EEEEEeCCCeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCccc
Confidence 9999999999999999843222 223457899999999999999999999998 9999999999999764 46
Q ss_pred ceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhh
Q 041702 661 PKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWN 740 (840)
Q Consensus 661 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~ 740 (840)
+||+|||++........ .....+|+.|+|||.+.+ .++.++||||||++++||++|+.|+...... ... .
T Consensus 163 ~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~----~ 232 (287)
T 2wei_A 163 IKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--DIL----K 232 (287)
T ss_dssp EEECSTTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH----H
T ss_pred EEEeccCcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH--HHH----H
Confidence 99999999987643321 223468999999998865 4899999999999999999999998643211 111 1
Q ss_pred hhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 741 LWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 741 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
........ ............+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 233 RVETGKYA------FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp HHHHCCCC------CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHcCCCC------CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 11111100 000111123456789999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=320.81 Aligned_cols=243 Identities=21% Similarity=0.306 Sum_probs=192.2
Q ss_pred HHHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC------cCHHHHHHHHHHHhhc
Q 041702 507 SSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG------QGLEEFKNEMMLIAKL 580 (840)
Q Consensus 507 ~~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~------~~~~~f~~Ev~~l~~l 580 (840)
.+.....++|++.+.||+|+||.||+|.+. .+++.||||++..... ...+++.+|+.++.++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 103 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRV------------SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEET------------TTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHH
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEEC------------CCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhh
Confidence 344556788999999999999999999754 6789999999975432 1335688899999999
Q ss_pred C--CCCccceeeEeecCCceEEEEEeecc-----CCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcE
Q 041702 581 Q--HRNLVRLFGCCIEQGEKISIYEFDIV-----TDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNV 653 (840)
Q Consensus 581 ~--H~niv~l~g~~~~~~~~~lv~e~~~~-----~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NI 653 (840)
+ |+||+++++++...+..++++|+... ........+++..+..++.||+.||+|||+.+ |+||||||+||
T Consensus 104 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NI 180 (320)
T 3a99_A 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENI 180 (320)
T ss_dssp CSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGE
T ss_pred ccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHE
Confidence 6 59999999999999999999998421 11223467899999999999999999999998 99999999999
Q ss_pred Eec-CCCCceeeccccceecCCCCcccccccccccccccCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCC
Q 041702 654 LLD-SDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLF-SIKSDVFSFGVLLLEILSSKKNTRFYNTDS 731 (840)
Q Consensus 654 Ll~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~SlGviL~elltG~~p~~~~~~~~ 731 (840)
|++ +++.+||+|||+++...... .....||+.|+|||.+.+..+ +.++||||||++++||++|+.|+....
T Consensus 181 ll~~~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--- 253 (320)
T 3a99_A 181 LIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--- 253 (320)
T ss_dssp EEETTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---
T ss_pred EEeCCCCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh---
Confidence 999 78999999999998765332 233568999999999987776 688999999999999999999975311
Q ss_pred ccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 732 LTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
. ..... ..... .....+.+++.+||+.||++|||++||++
T Consensus 254 -~-------~~~~~---~~~~~--------~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 254 -E-------IIRGQ---VFFRQ--------RVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp -H-------HHHCC---CCCSS--------CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -h-------hhccc---ccccc--------cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00000 00111 12345788999999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=317.30 Aligned_cols=242 Identities=20% Similarity=0.290 Sum_probs=182.6
Q ss_pred HHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC------cCHHHHHHHHHHHhhc-
Q 041702 508 SISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG------QGLEEFKNEMMLIAKL- 580 (840)
Q Consensus 508 ~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~------~~~~~f~~Ev~~l~~l- 580 (840)
+.+...++|+..+.||+|+||.||+|.++ .+++.||||++..... .....+.+|+.++.++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 92 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRL------------TDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECT------------TTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHH
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEc------------cCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhc
Confidence 34456688999999999999999999764 5789999999975432 2234567899999999
Q ss_pred ---CCCCccceeeEeecCCceEEEEEee-c----cCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCc
Q 041702 581 ---QHRNLVRLFGCCIEQGEKISIYEFD-I----VTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASN 652 (840)
Q Consensus 581 ---~H~niv~l~g~~~~~~~~~lv~e~~-~----~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~N 652 (840)
+||||+++++++...+..++++|+. . .........+++..+..++.||+.||+|||+.+ |+||||||+|
T Consensus 93 ~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~N 169 (312)
T 2iwi_A 93 AGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDEN 169 (312)
T ss_dssp SSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGG
T ss_pred ccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhh
Confidence 8999999999999999999999972 1 111223456899999999999999999999998 9999999999
Q ss_pred EEec-CCCCceeeccccceecCCCCcccccccccccccccCccccccCCCC-ccccchhHHHHHHHHHhCCCCCCCCCCC
Q 041702 653 VLLD-SDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFS-IKSDVFSFGVLLLEILSSKKNTRFYNTD 730 (840)
Q Consensus 653 ILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDV~SlGviL~elltG~~p~~~~~~~ 730 (840)
|+++ .++.+||+|||++....... .....||+.|+|||.+.+..+. .++||||||++++||++|+.|+....
T Consensus 170 il~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-- 243 (312)
T 2iwi_A 170 ILIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-- 243 (312)
T ss_dssp EEEETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--
T ss_pred EEEeCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--
Confidence 9999 88999999999998775432 2345689999999998877764 58999999999999999999975311
Q ss_pred CccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 731 SLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
. . .. .. .... ......+.+++.+||+.||++|||++|+++
T Consensus 244 --~----~---~~-~~------~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 244 --E----I---LE-AE------LHFP----AHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp --H----H---HH-TC------CCCC----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --H----H---hh-hc------cCCc----ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0 00 00 0011 112345788999999999999999999997
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=318.75 Aligned_cols=198 Identities=24% Similarity=0.328 Sum_probs=164.1
Q ss_pred HHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcC-CC-----C
Q 041702 511 AATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQ-HR-----N 584 (840)
Q Consensus 511 ~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~-H~-----n 584 (840)
...++|++.++||+|+||.||+|.++ .+++.||||+++.. ....+++..|++++..++ |+ +
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~------------~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~ 117 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDR------------VEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYY 117 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEET------------TTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGG
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEc------------CCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhccccccee
Confidence 45689999999999999999999765 57899999999753 233567888999999885 55 4
Q ss_pred ccceeeEeecCCceEEEEEeeccCC-----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEec--C
Q 041702 585 LVRLFGCCIEQGEKISIYEFDIVTD-----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLD--S 657 (840)
Q Consensus 585 iv~l~g~~~~~~~~~lv~e~~~~~~-----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~--~ 657 (840)
|+++++++...+..++|||+..... ......+++..+..++.||+.||.|||++. .+|+||||||+|||++ .
T Consensus 118 iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~ 196 (382)
T 2vx3_A 118 IVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPK 196 (382)
T ss_dssp BCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTT
T ss_pred EEEeeeeeccCCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCC
Confidence 9999999999999999999953210 011245899999999999999999999521 2399999999999994 5
Q ss_pred CCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 041702 658 DMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFY 727 (840)
Q Consensus 658 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~ 727 (840)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||+++||++|+.||...
T Consensus 197 ~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 197 RSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp SCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCcEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 788999999999876432 23457899999999999999999999999999999999999998754
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=309.88 Aligned_cols=249 Identities=22% Similarity=0.331 Sum_probs=182.2
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
..++|+..+.||+|+||.||+|.+. .+++.||||++... ....+.+.+|+.++++++||||++++++
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 70 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNA------------LDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAA 70 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEET------------TTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccccchhhheeccCCcEEEEEEEEc------------CCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHH
Confidence 3467899999999999999999764 57899999999653 3345779999999999999999999999
Q ss_pred eec-------------CCceEEEEEeeccCCcc-----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcE
Q 041702 592 CIE-------------QGEKISIYEFDIVTDPA-----RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNV 653 (840)
Q Consensus 592 ~~~-------------~~~~~lv~e~~~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NI 653 (840)
+.+ .+..++||||....... ....+++..+..++.||+.||+|||+.+ |+||||||+||
T Consensus 71 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Ni 147 (303)
T 1zy4_A 71 WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNI 147 (303)
T ss_dssp EEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred HHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhE
Confidence 865 45678999984322211 2335678889999999999999999998 99999999999
Q ss_pred EecCCCCceeeccccceecCCCCc------------ccccccccccccccCccccccC-CCCccccchhHHHHHHHHHhC
Q 041702 654 LLDSDMNPKISDFGIARTFGGDEM------------QSNTNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSS 720 (840)
Q Consensus 654 Ll~~~~~~kL~DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~SlGviL~elltG 720 (840)
|++.++.+||+|||++........ ........||+.|+|||.+.+. .++.++||||||++++||++
T Consensus 148 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~- 226 (303)
T 1zy4_A 148 FIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY- 226 (303)
T ss_dssp EECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS-
T ss_pred EEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh-
Confidence 999999999999999987643210 1122345689999999998864 68999999999999999998
Q ss_pred CCCCCCCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 721 KKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 721 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
|+.... . ........... ...............+.+++.+||+.||++|||+.++++
T Consensus 227 --p~~~~~----~-~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 227 --PFSTGM----E-RVNILKKLRSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp --CCSSHH----H-HHHHHHHHHST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --ccCCch----h-HHHHHHhcccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 322100 0 00011111110 111111122233455788999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=312.44 Aligned_cols=249 Identities=22% Similarity=0.376 Sum_probs=174.7
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-c-CHHHHHHHHHHHhhcCCCCcccee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-Q-GLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~-~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
..++|+..+.||+|+||.||+|.++ .+++.||||++..... . ..+.+.++..++..++||||++++
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 90 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFR------------KTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCF 90 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEET------------TTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred hhccccccceeeecCCeeEEEEEEe------------cCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEE
Confidence 4578999999999999999999765 5789999999976532 1 223345555678888999999999
Q ss_pred eEeecCCceEEEEEeecc--CC--ccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceecCCCCCCcEEecCCCCceee
Q 041702 590 GCCIEQGEKISIYEFDIV--TD--PARKDLLDWTTRVRIIEGVAQGLLYLHQY-SRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~--~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
+++.+.+..++|||+... .. ......+++..+..++.||+.||.|||+. + |+||||||+|||++.++.+||+
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~ 167 (318)
T 2dyl_A 91 GTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLC 167 (318)
T ss_dssp EEEECSSEEEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEEC
T ss_pred EEEecCCcEEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEE
Confidence 999999999999999411 00 11235689999999999999999999985 7 9999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHh
Q 041702 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYAL-----HGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAW 739 (840)
Q Consensus 665 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~ 739 (840)
|||++....... ......+|+.|+|||.+. ...++.++||||||++++||++|+.|+....... ....
T Consensus 168 dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~--- 240 (318)
T 2dyl_A 168 DFGISGRLVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF-EVLT--- 240 (318)
T ss_dssp CCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH-HHHH---
T ss_pred ECCCchhccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH-HHHH---
Confidence 999997664322 123456899999999984 5668999999999999999999999986422111 1111
Q ss_pred hhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 740 NLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 740 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
...... . +.... .......+.+++.+||+.||++||++++|++
T Consensus 241 ~~~~~~-~-----~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 241 KVLQEE-P-----PLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp HHHHSC-C-----CCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHhccC-C-----CCCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 111111 0 00000 0112345788999999999999999999985
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=319.49 Aligned_cols=257 Identities=19% Similarity=0.241 Sum_probs=189.6
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcC-----------
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQ----------- 581 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~----------- 581 (840)
.++|.+.+.||+|+||.||+|.++ .+++.||||++... ....+.+.+|++++.+++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~ 84 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDM------------VNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMG 84 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET------------TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHH
T ss_pred CCeEEEEEeeeecCCeEEEEEEec------------CCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccc
Confidence 468999999999999999999765 67899999999743 233567899999999886
Q ss_pred CCCccceeeEeecCC----ceEEEEEeecc---CC--ccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceecCCCCCC
Q 041702 582 HRNLVRLFGCCIEQG----EKISIYEFDIV---TD--PARKDLLDWTTRVRIIEGVAQGLLYLHQY-SRLRVIHRDLKAS 651 (840)
Q Consensus 582 H~niv~l~g~~~~~~----~~~lv~e~~~~---~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivHrDlkp~ 651 (840)
||||+++++++...+ ..+++||+... .. ......+++..+..++.||+.||+|||++ + |+||||||+
T Consensus 85 ~~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~ 161 (373)
T 1q8y_A 85 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPE 161 (373)
T ss_dssp HTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGG
T ss_pred cchHHHHHHHhhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChH
Confidence 899999999998654 67888887311 00 11234589999999999999999999997 7 999999999
Q ss_pred cEEec------CCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 041702 652 NVLLD------SDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTR 725 (840)
Q Consensus 652 NILl~------~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~ 725 (840)
|||++ ..+.+||+|||++...... .....||+.|+|||.+.+..++.++|||||||+++||++|+.||.
T Consensus 162 NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 236 (373)
T 1q8y_A 162 NVLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 236 (373)
T ss_dssp GEEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred HeEEeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 99994 3447999999999876432 234578999999999999999999999999999999999999987
Q ss_pred CCCCCCc----cHhHHHhhhhc------------------ccccccccCc-cc---------cchhhHHHHHHHHHHHHH
Q 041702 726 FYNTDSL----TLLGHAWNLWK------------------DDKAWKLMDP-TM---------QNEALYSMVTRYIKVALL 773 (840)
Q Consensus 726 ~~~~~~~----~~~~~~~~~~~------------------~~~~~~~~d~-~l---------~~~~~~~~~~~l~~l~~~ 773 (840)
....... ........... .......+.. .. ...........+.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 316 (373)
T 1q8y_A 237 PDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 316 (373)
T ss_dssp --------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGG
T ss_pred CCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHH
Confidence 5442211 11111110000 0000000000 00 011234567789999999
Q ss_pred ccccCCCCCCCHHHHHH
Q 041702 774 CVQENATDRPTMLEVVA 790 (840)
Q Consensus 774 Cl~~dP~~RPs~~evl~ 790 (840)
||+.||++|||++||++
T Consensus 317 ~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 317 MLQLDPRKRADAGGLVN 333 (373)
T ss_dssp GGCSSTTTCBCHHHHHT
T ss_pred HhccCccccCCHHHHhh
Confidence 99999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=323.53 Aligned_cols=247 Identities=24% Similarity=0.317 Sum_probs=176.8
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhc-CCCCccceeeEe
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL-QHRNLVRLFGCC 592 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~ 592 (840)
+.|...++||+|+||+||.+. ..+|+.||||++... ..+.+.+|++++.++ +||||+++++++
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~-------------~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~ 78 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQG-------------SFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSE 78 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEE-------------ESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred heeeccCeEeeCCCeEEEEEE-------------EECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEE
Confidence 445566889999999998642 246899999998653 246788999999987 899999999999
Q ss_pred ecCCceEEEEEeecc------CC-cccc---CCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCC----
Q 041702 593 IEQGEKISIYEFDIV------TD-PARK---DLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSD---- 658 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~------~~-~~~~---~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~---- 658 (840)
.+.+..++|||+... .. .... ....+..++.++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 79 ~~~~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~ 155 (434)
T 2rio_A 79 TTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFT 155 (434)
T ss_dssp ECSSEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHH
T ss_pred ecCCeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccc
Confidence 999999999999421 00 0000 11234456789999999999999998 9999999999999754
Q ss_pred ---------CCceeeccccceecCCCCcc--cccccccccccccCcccccc-------CCCCccccchhHHHHHHHHHh-
Q 041702 659 ---------MNPKISDFGIARTFGGDEMQ--SNTNRIVGTYGYMSPEYALH-------GLFSIKSDVFSFGVLLLEILS- 719 (840)
Q Consensus 659 ---------~~~kL~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDV~SlGviL~ellt- 719 (840)
+.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||+++||++
T Consensus 156 ~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~ 235 (434)
T 2rio_A 156 ADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235 (434)
T ss_dssp SCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhC
Confidence 47999999999987543321 12234679999999999875 678999999999999999999
Q ss_pred CCCCCCCCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 720 SKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 720 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
|+.|+........ ....... .. +.............+.+++.+||+.||++|||+.||++
T Consensus 236 g~~Pf~~~~~~~~-------~i~~~~~--~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 236 GKHPFGDKYSRES-------NIIRGIF--SL--DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp SCCTTCSTTTHHH-------HHHHTCC--CC--CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCCCchhhHH-------HHhcCCC--Cc--ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 8988753221110 0101000 00 11111122345677899999999999999999999985
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=315.73 Aligned_cols=256 Identities=19% Similarity=0.223 Sum_probs=192.0
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCC------cc
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRN------LV 586 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~n------iv 586 (840)
.++|++.+.||+|+||.||+|.++ ..+++.||||+++.. ....+.+.+|+.++++++|++ ++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~ 85 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDH-----------ARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCV 85 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEET-----------TTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBC
T ss_pred cccEEEEEEeeccCCeEEEEEEec-----------CCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEE
Confidence 478999999999999999999764 123478999999753 234567889999999997765 89
Q ss_pred ceeeEeecCCceEEEEEeeccCC---c--cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEe------
Q 041702 587 RLFGCCIEQGEKISIYEFDIVTD---P--ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLL------ 655 (840)
Q Consensus 587 ~l~g~~~~~~~~~lv~e~~~~~~---~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl------ 655 (840)
.+++++...+..++|||+..... . .....+++..+..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~ 162 (355)
T 2eu9_A 86 LMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFE 162 (355)
T ss_dssp CEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEE
T ss_pred EeeeeeeeCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccc
Confidence 99999999999999999942111 1 11246899999999999999999999988 9999999999999
Q ss_pred -------------cCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCC
Q 041702 656 -------------DSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKK 722 (840)
Q Consensus 656 -------------~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~ 722 (840)
+.++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||+++||++|+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 237 (355)
T 2eu9_A 163 TLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFT 237 (355)
T ss_dssp EEECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccccccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCC
Confidence 67889999999999875322 234578999999999999999999999999999999999999
Q ss_pred CCCCCCCCCccHhHHHhhhhcc--------cccccc-------cCcc-------------c--cchhhHHHHHHHHHHHH
Q 041702 723 NTRFYNTDSLTLLGHAWNLWKD--------DKAWKL-------MDPT-------------M--QNEALYSMVTRYIKVAL 772 (840)
Q Consensus 723 p~~~~~~~~~~~~~~~~~~~~~--------~~~~~~-------~d~~-------------l--~~~~~~~~~~~l~~l~~ 772 (840)
||....... ........... ...... .+.. + ...........+.+++.
T Consensus 238 pf~~~~~~~--~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 315 (355)
T 2eu9_A 238 LFQTHENRE--HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMR 315 (355)
T ss_dssp SCCCSSHHH--HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHH
T ss_pred CCCCCCHHH--HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHH
Confidence 986533211 11110000000 000000 0000 0 00011233557889999
Q ss_pred HccccCCCCCCCHHHHHH
Q 041702 773 LCVQENATDRPTMLEVVA 790 (840)
Q Consensus 773 ~Cl~~dP~~RPs~~evl~ 790 (840)
+||+.||++|||++|+++
T Consensus 316 ~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 316 RMLEFDPAQRITLAEALL 333 (355)
T ss_dssp HHTCSSTTTSCCHHHHTT
T ss_pred HHhcCChhhCcCHHHHhc
Confidence 999999999999999974
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=309.79 Aligned_cols=252 Identities=18% Similarity=0.223 Sum_probs=166.3
Q ss_pred HccCCcccc-cccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHH-HHHhhcCCCCcccee
Q 041702 512 ATDNFSEEN-KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEM-MLIAKLQHRNLVRLF 589 (840)
Q Consensus 512 ~~~~f~~~~-~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev-~~l~~l~H~niv~l~ 589 (840)
..++|.+.+ .||+|+||.||+|.++ .+++.||||++... ....+|+ ..+..++||||++++
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~------------~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~ 88 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHR------------RTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCIL 88 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEET------------TTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEEC------------CCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHH
Confidence 457888855 6999999999999765 67899999999653 2233333 345667999999999
Q ss_pred eEeec----CCceEEEEEeeccCCc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecC--
Q 041702 590 GCCIE----QGEKISIYEFDIVTDP------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS-- 657 (840)
Q Consensus 590 g~~~~----~~~~~lv~e~~~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-- 657 (840)
+++.. .+..++||||...... .....+++.++..++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 89 ~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~ 165 (336)
T 3fhr_A 89 DVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKE 165 (336)
T ss_dssp EEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSS
T ss_pred HHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecC
Confidence 99876 4458899998422111 12246899999999999999999999998 999999999999976
Q ss_pred -CCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhH
Q 041702 658 -DMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLG 736 (840)
Q Consensus 658 -~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~ 736 (840)
++.+||+|||+++...... .....+|+.|+|||.+.+..++.++||||||++++||++|+.|+...........
T Consensus 166 ~~~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~- 240 (336)
T 3fhr_A 166 KDAVLKLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG- 240 (336)
T ss_dssp TTCCEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred CCceEEEeccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh-
Confidence 4559999999998754322 2345689999999999888999999999999999999999999864433221100
Q ss_pred HHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH--Hhhcc
Q 041702 737 HAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA--MLKDE 795 (840)
Q Consensus 737 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~Le~~ 795 (840)
....... ................+.+++.+||+.||++|||++|+++ .+.+.
T Consensus 241 -~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 241 -MKRRIRL------GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp -----------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred -HHHhhhc------cccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 0000000 0000111111223456889999999999999999999997 55543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=319.65 Aligned_cols=247 Identities=20% Similarity=0.275 Sum_probs=176.7
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhc-CCCCccceee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL-QHRNLVRLFG 590 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g 590 (840)
...+|...++||+|+||+||.. ...+++.||||++.... .+.+.+|+++|+++ +|||||++++
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~-------------~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~ 85 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYR-------------GMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFC 85 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEE-------------EESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEE
T ss_pred ccEEEecCCeeecCcCEEEEEE-------------EEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEE
Confidence 3456888999999999996642 12478999999997532 24467899999999 8999999999
Q ss_pred EeecCCceEEEEEeeccC---Cc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecC-----CCCc
Q 041702 591 CCIEQGEKISIYEFDIVT---DP-ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS-----DMNP 661 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~---~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-----~~~~ 661 (840)
++.+.+..++|||+.... .. .....+.+..+..++.||+.||+|||+.+ |+||||||+|||++. ...+
T Consensus 86 ~~~~~~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~ 162 (432)
T 3p23_A 86 TEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKA 162 (432)
T ss_dssp EEEETTEEEEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCE
T ss_pred EEecCCEEEEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeE
Confidence 999999999999994210 00 11123445567889999999999999998 999999999999953 2357
Q ss_pred eeeccccceecCCCCcc-cccccccccccccCccccc---cCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhH
Q 041702 662 KISDFGIARTFGGDEMQ-SNTNRIVGTYGYMSPEYAL---HGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLG 736 (840)
Q Consensus 662 kL~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~ 736 (840)
||+|||+++........ .......||+.|+|||++. ...++.++|||||||+++||++ |..|+....... .
T Consensus 163 kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~---~- 238 (432)
T 3p23_A 163 MISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ---A- 238 (432)
T ss_dssp EECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH---H-
T ss_pred EEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH---H-
Confidence 89999999876543211 2234467999999999987 4567889999999999999999 888874321111 0
Q ss_pred HHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 737 HAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 737 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
... .......... ........+.+++.+||+.||++|||++||++
T Consensus 239 --~~~-~~~~~~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 239 --NIL-LGACSLDCLH------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp --HHH-TTCCCCTTSC------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --HHH-hccCCccccC------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 001 1110000011 11223445778999999999999999999983
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-33 Score=332.17 Aligned_cols=238 Identities=19% Similarity=0.334 Sum_probs=188.9
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
.++|++.++||+|+||.||+|.++ ..+++.||||++.... ....+.|.+|++++.+++||||++++++
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~-----------~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 147 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDR-----------NVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNF 147 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEG-----------GGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEc-----------CCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeee
Confidence 478999999999999999999765 1368899999987543 2345678999999999999999999999
Q ss_pred eecCCc-----eEEEEEeec---cCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCcee
Q 041702 592 CIEQGE-----KISIYEFDI---VTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKI 663 (840)
Q Consensus 592 ~~~~~~-----~~lv~e~~~---~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL 663 (840)
+.+.+. .++||||.. +... ....+++.+++.|+.||+.||.|||+++ |+||||||+|||++.+ .+||
T Consensus 148 ~~~~~~~~~~~~~lv~E~~~g~~L~~~-~~~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl 222 (681)
T 2pzi_A 148 VEHTDRHGDPVGYIVMEYVGGQSLKRS-KGQKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKL 222 (681)
T ss_dssp EEEECTTSCEEEEEEEECCCCEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEE
T ss_pred EeecCCCCCceeEEEEEeCCCCcHHHH-HhCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEE
Confidence 988766 699999942 2221 2237899999999999999999999998 9999999999999885 8999
Q ss_pred eccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhc
Q 041702 664 SDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWK 743 (840)
Q Consensus 664 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~ 743 (840)
+|||+++..... ....||+.|+|||++.+.. +.++|||||||+|+||++|.+|+.......
T Consensus 223 ~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~------------ 283 (681)
T 2pzi_A 223 IDLGAVSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG------------ 283 (681)
T ss_dssp CCCTTCEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS------------
T ss_pred EecccchhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc------------
Confidence 999999876432 3457999999999987654 899999999999999999988764211110
Q ss_pred ccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhhcc
Q 041702 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRP-TMLEVVAMLKDE 795 (840)
Q Consensus 744 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~Le~~ 795 (840)
+. ...........+.+++.+||+.||++|| +++++.+.|...
T Consensus 284 ------~~----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 284 ------LP----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp ------CC----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ------cc----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 00 0111223345688999999999999999 566676666654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=326.75 Aligned_cols=253 Identities=23% Similarity=0.284 Sum_probs=186.8
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC-CCcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK-SGQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~-~~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
.++|++.++||+|+||.||+|.++ .+|+.||||+++.. .....++|.+|++++.+++||||++++++
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~------------~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v 80 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQ------------DTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCT------------TTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEEC
T ss_pred CCCeEEEEEEeeCCCeEEEEEEEC------------CCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeee
Confidence 478999999999999999998764 67899999998754 23345679999999999999999999999
Q ss_pred eec------CCceEEEEEeeccCC-------ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCC
Q 041702 592 CIE------QGEKISIYEFDIVTD-------PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSD 658 (840)
Q Consensus 592 ~~~------~~~~~lv~e~~~~~~-------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~ 658 (840)
+.. .+..++||||..... ......+++..+..++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 81 ~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~ 157 (676)
T 3qa8_A 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPG 157 (676)
T ss_dssp CTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECC
T ss_pred ecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecC
Confidence 765 677899999953221 122335889999999999999999999988 9999999999999977
Q ss_pred CC---ceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHh
Q 041702 659 MN---PKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLL 735 (840)
Q Consensus 659 ~~---~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~ 735 (840)
+. +||+|||++........ .....||+.|+|||.+.+..++.++||||||++++||++|+.||...... .
T Consensus 158 g~~~~vKL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~----~ 230 (676)
T 3qa8_A 158 PQRLIHKIIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP----V 230 (676)
T ss_dssp SSSCEEEECSCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH----H
T ss_pred CCceeEEEcccccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch----h
Confidence 65 89999999987654322 23467899999999999999999999999999999999999998542110 0
Q ss_pred HHHhhh--------hccccccc--ccCcc--ccchhhHHHHHHHHHHHHHccccCCCCCCCHHH
Q 041702 736 GHAWNL--------WKDDKAWK--LMDPT--MQNEALYSMVTRYIKVALLCVQENATDRPTMLE 787 (840)
Q Consensus 736 ~~~~~~--------~~~~~~~~--~~d~~--l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 787 (840)
.+.... ........ ..... ............+.+++.+||+.||++|||++|
T Consensus 231 ~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 231 QWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp HSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 000000 00000000 00000 011122335667889999999999999999977
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=316.79 Aligned_cols=238 Identities=14% Similarity=0.169 Sum_probs=172.5
Q ss_pred HHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhcCC-CCcc
Q 041702 511 AATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKLQH-RNLV 586 (840)
Q Consensus 511 ~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l~H-~niv 586 (840)
..+..|...+.||+|+||.||+|.+. .+|+.||||++.... ....+.|.+|+.++..++| +|..
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~------------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~ 142 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQ------------ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQK 142 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEET------------TTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHH
T ss_pred CCceeEEEecccccCCCEEEEEEEec------------CCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHH
Confidence 34566888899999999999999765 678999999988432 2346889999999999987 3322
Q ss_pred ceee---------Ee------------ec-----CCceEEEEEeec--cCC--------ccccCCCCHHHHHHHHHHHHH
Q 041702 587 RLFG---------CC------------IE-----QGEKISIYEFDI--VTD--------PARKDLLDWTTRVRIIEGVAQ 630 (840)
Q Consensus 587 ~l~g---------~~------------~~-----~~~~~lv~e~~~--~~~--------~~~~~~l~~~~~~~i~~~ia~ 630 (840)
.... .+ .. ....+++|+... +.. ......+++..++.|+.||++
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~ 222 (413)
T 3dzo_A 143 QAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIR 222 (413)
T ss_dssp HHHHHTCBCCCCEEEECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHH
T ss_pred HHHHhcccccchhhcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHH
Confidence 2111 11 11 112344554411 000 112345778899999999999
Q ss_pred HHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceecCCCCcccccccccccccccCcccc----------ccCC
Q 041702 631 GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYA----------LHGL 700 (840)
Q Consensus 631 ~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~ 700 (840)
||+|||+.+ |+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..
T Consensus 223 aL~~LH~~~---iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~ 293 (413)
T 3dzo_A 223 LLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTL 293 (413)
T ss_dssp HHHHHHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEE
T ss_pred HHHHHHhCC---cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcC
Confidence 999999998 999999999999999999999999999875432 334567 999999998 5556
Q ss_pred CCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCC
Q 041702 701 FSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENAT 780 (840)
Q Consensus 701 ~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~ 780 (840)
++.++|||||||+||||++|+.||......... ..++... . ..++.+.+++.+||+.||+
T Consensus 294 ~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~--------------~~~~~~~--~----~~~~~~~~li~~~l~~dP~ 353 (413)
T 3dzo_A 294 MTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS--------------EWIFRSC--K----NIPQPVRALLEGFLRYPKE 353 (413)
T ss_dssp ECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCS--------------GGGGSSC--C----CCCHHHHHHHHHHTCSSGG
T ss_pred CCchhhHHHHHHHHHHHHHCCCCCCCcchhhhH--------------HHHHhhc--c----cCCHHHHHHHHHHccCChh
Confidence 889999999999999999999998643321110 0011100 0 1235688999999999999
Q ss_pred CCCCHHHHH
Q 041702 781 DRPTMLEVV 789 (840)
Q Consensus 781 ~RPs~~evl 789 (840)
+||++.+++
T Consensus 354 ~Rpt~~~~l 362 (413)
T 3dzo_A 354 DRLLPLQAM 362 (413)
T ss_dssp GSCCHHHHT
T ss_pred hCcCHHHHH
Confidence 999976664
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.98 E-value=3.1e-32 Score=291.10 Aligned_cols=228 Identities=12% Similarity=0.045 Sum_probs=176.3
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCc---CHHHHHHHHHHHhhcCCCCcccee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQ---GLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~---~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
.++|++.+.||+|+||.||+|.+. .+++.||||++...... ..++|.+|+.++.+++||||++++
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~------------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~ 97 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDT------------ALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEET------------TTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEec------------CCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceee
Confidence 467999999999999999999765 57899999999865332 246799999999999999999999
Q ss_pred eEeecCCceEEEEEeecc---CCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 590 GCCIEQGEKISIYEFDIV---TDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~---~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
+++.+.+..++||||... ....... ....+..+|+.||+.||+|||+.+ |+||||||+|||++.++.+||+++
T Consensus 98 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~ 173 (286)
T 3uqc_A 98 DVVHTRAGGLVVAEWIRGGSLQEVADTS-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYP 173 (286)
T ss_dssp EEEEETTEEEEEEECCCEEEHHHHHTTC-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSC
T ss_pred EEEEECCcEEEEEEecCCCCHHHHHhcC-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEec
Confidence 999999999999999321 1111122 355578899999999999999998 999999999999999999999854
Q ss_pred ccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccc
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDK 746 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 746 (840)
+ |++ +++.++|||||||+||||++|+.||...........
T Consensus 174 ~----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~----------- 213 (286)
T 3uqc_A 174 A----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP----------- 213 (286)
T ss_dssp C----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE-----------
T ss_pred c----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH-----------
Confidence 3 333 368999999999999999999999875443221100
Q ss_pred cccccCcccc--chhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 747 AWKLMDPTMQ--NEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 747 ~~~~~d~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
....+..... ..........+.+++.+||+.||++| |+.|+++.|+.+..
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 214 AERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp CCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred HHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 0000000000 01112334568899999999999999 99999999998643
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-32 Score=298.07 Aligned_cols=239 Identities=17% Similarity=0.196 Sum_probs=178.4
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--------CcCHHHHHHHHHHHhhcC---
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--------GQGLEEFKNEMMLIAKLQ--- 581 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--------~~~~~~f~~Ev~~l~~l~--- 581 (840)
.++|+..++||+|+||.||+|++ +++.||||++.... ....+.+.+|+.++++++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--------------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~ 84 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--------------DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLS 84 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--------------TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGG
T ss_pred cccchheeeecccCceEEEEEEe--------------CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhh
Confidence 46788999999999999999863 47899999997542 234578999999999986
Q ss_pred ------CCCccceeeEe-----------------ec-------------CCceEEEEEeeccC---CccccCCCCHHHHH
Q 041702 582 ------HRNLVRLFGCC-----------------IE-------------QGEKISIYEFDIVT---DPARKDLLDWTTRV 622 (840)
Q Consensus 582 ------H~niv~l~g~~-----------------~~-------------~~~~~lv~e~~~~~---~~~~~~~l~~~~~~ 622 (840)
||||+++.+.+ .+ .+..++||||.... .......+++..+.
T Consensus 85 ~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~ 164 (336)
T 2vuw_A 85 GEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAK 164 (336)
T ss_dssp GCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHH
T ss_pred ccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHH
Confidence 66666665553 33 68899999994322 22233668999999
Q ss_pred HHHHHHHHHHHHHH-hcCCCceecCCCCCCcEEecCCC--------------------CceeeccccceecCCCCccccc
Q 041702 623 RIIEGVAQGLLYLH-QYSRLRVIHRDLKASNVLLDSDM--------------------NPKISDFGIARTFGGDEMQSNT 681 (840)
Q Consensus 623 ~i~~~ia~~L~yLH-~~~~~~ivHrDlkp~NILl~~~~--------------------~~kL~DFGla~~~~~~~~~~~~ 681 (840)
.++.||+.||+||| +.+ |+||||||+|||++.++ .+||+|||+|+....
T Consensus 165 ~i~~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------- 234 (336)
T 2vuw_A 165 SILHQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------- 234 (336)
T ss_dssp HHHHHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------
T ss_pred HHHHHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------
Confidence 99999999999999 888 99999999999999887 899999999987643
Q ss_pred ccccccccccCccccccCCCCccccchhHHHH-HHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccccccCccccchhh
Q 041702 682 NRIVGTYGYMSPEYALHGLFSIKSDVFSFGVL-LLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEAL 760 (840)
Q Consensus 682 ~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGvi-L~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 760 (840)
....||+.|||||++.+.. +.++||||||++ .+++++|..|+... ............. ............
T Consensus 235 ~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~-----~~~~~~~~~~~~~---~~~~~~~~~~~~ 305 (336)
T 2vuw_A 235 GIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV-----LWLHYLTDKMLKQ---MTFKTKCNTPAM 305 (336)
T ss_dssp TEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH-----HHHHHHHHHHHHT---CCCSSCCCSHHH
T ss_pred CcEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch-----hhhhHHHHhhhhh---hccCcccchhhh
Confidence 2347999999999998776 899999998777 77888898886310 0000000000000 011112222344
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 041702 761 YSMVTRYIKVALLCVQENATDRPTMLEVV 789 (840)
Q Consensus 761 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 789 (840)
......+.+++.+||+.| |++|++
T Consensus 306 ~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 306 KQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred hhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 567788999999999966 888887
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=286.30 Aligned_cols=231 Identities=18% Similarity=0.246 Sum_probs=172.4
Q ss_pred ccCCccc-ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHH-hhcCCCCccceee
Q 041702 513 TDNFSEE-NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLI-AKLQHRNLVRLFG 590 (840)
Q Consensus 513 ~~~f~~~-~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l-~~l~H~niv~l~g 590 (840)
.++|... +.||+|+||.||+|.++ .+++.||||++... ..+.+|+.++ +.++||||+++++
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~------------~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~ 78 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNK------------RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVD 78 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEET------------TTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEc------------CCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHh
Confidence 4567776 77999999999999765 57899999999643 5788899988 5559999999999
Q ss_pred Eeec----CCceEEEEEeeccCCc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecC---
Q 041702 591 CCIE----QGEKISIYEFDIVTDP------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS--- 657 (840)
Q Consensus 591 ~~~~----~~~~~lv~e~~~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~--- 657 (840)
++.. .+..++||||...... .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 155 (299)
T 3m2w_A 79 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRP 155 (299)
T ss_dssp EEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSST
T ss_pred hhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCC
Confidence 9876 6778999998433221 11236899999999999999999999998 999999999999998
Q ss_pred CCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHH
Q 041702 658 DMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGH 737 (840)
Q Consensus 658 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~ 737 (840)
++.+||+|||++.... +..++.++|||||||+++||++|+.||..........
T Consensus 156 ~~~~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~--- 208 (299)
T 3m2w_A 156 NAILKLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--- 208 (299)
T ss_dssp TCCEEECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C---
T ss_pred CCcEEEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH---
Confidence 7889999999987542 2346789999999999999999999986433221100
Q ss_pred HhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH--Hhhcc
Q 041702 738 AWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA--MLKDE 795 (840)
Q Consensus 738 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~Le~~ 795 (840)
.. ......................+.+++.+||+.||++|||++|+++ .+.+.
T Consensus 209 --~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 209 --GM---KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp --CS---CCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred --HH---HHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 00 0000000011111111234566889999999999999999999996 44443
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6.9e-26 Score=263.95 Aligned_cols=181 Identities=16% Similarity=0.082 Sum_probs=122.6
Q ss_pred cccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC----------CcCHHHHHHHHHHHhhc-CCCCcccee
Q 041702 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS----------GQGLEEFKNEMMLIAKL-QHRNLVRLF 589 (840)
Q Consensus 521 ~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~----------~~~~~~f~~Ev~~l~~l-~H~niv~l~ 589 (840)
..+.|++|.+..++.. ..|+.+|||++.... +...++|.+|+++|+++ .|+||++++
T Consensus 241 ~~~~~~~~~h~~~rr~------------~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~ 308 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRY------------FFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVL 308 (569)
T ss_dssp C-C--------CCEEE------------EECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEE
T ss_pred ccccCCcccccccccc------------cccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEE
Confidence 4677777777766443 568999999997542 12346799999999999 799999999
Q ss_pred eEeecCCceEEEEEeec----cCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 590 GCCIEQGEKISIYEFDI----VTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~----~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
+++.+.+..|+||||.. .........++.. +|+.||+.||+|||+++ ||||||||+||||+.++++||+|
T Consensus 309 ~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~D 382 (569)
T 4azs_A 309 AHGENAQSGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLID 382 (569)
T ss_dssp EEEECSSEEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECC
T ss_pred EEEEECCEEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEee
Confidence 99999999999999932 1112233445543 58999999999999999 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCC
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKK 722 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~ 722 (840)
||+|+....... .....+||+.|||||++.+ .+..++|+||+|++++++.++..
T Consensus 383 FGlAr~~~~~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 383 FGSIVTTPQDCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp CTTEESCC---C--CSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred cccCeeCCCCCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 999987654332 2345689999999998875 46778999999999988866543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=6.2e-23 Score=237.72 Aligned_cols=185 Identities=16% Similarity=0.146 Sum_probs=138.7
Q ss_pred cccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCc--------CHHHHHHHHHHHhhcCCCCccce
Q 041702 517 SEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQ--------GLEEFKNEMMLIAKLQHRNLVRL 588 (840)
Q Consensus 517 ~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~--------~~~~f~~Ev~~l~~l~H~niv~l 588 (840)
...++||+|+||.||+|. ..++.+++|+....... ..++|.+|++++++++||||+++
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--------------~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~ 404 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--------------YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAP 404 (540)
T ss_dssp ---------CCEEEEEEE--------------CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCC
T ss_pred CCCCEEeeCCCEEEEEEE--------------ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCce
Confidence 345789999999999984 35788999986543211 13458999999999999999988
Q ss_pred eeEeecCCceEEEEEeeccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccc
Q 041702 589 FGCCIEQGEKISIYEFDIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGI 668 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl 668 (840)
..++...+..++||||....+... .+.. +..++.||++||+|||+++ |+||||||+|||++. ++||+|||+
T Consensus 405 ~~~~~~~~~~~lVmE~~~ggsL~~--~l~~--~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGl 475 (540)
T 3en9_A 405 YIFDVDLDNKRIMMSYINGKLAKD--VIED--NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGL 475 (540)
T ss_dssp CEEEEETTTTEEEEECCCSEEHHH--HSTT--CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTT
T ss_pred EEEEEeCCccEEEEECCCCCCHHH--HHHH--HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECcc
Confidence 888888888999999943221111 1111 5689999999999999998 999999999999998 999999999
Q ss_pred ceecCCCCccc-----ccccccccccccCcccccc--CCCCccccchhHHHHHHHHHhCCCCC
Q 041702 669 ARTFGGDEMQS-----NTNRIVGTYGYMSPEYALH--GLFSIKSDVFSFGVLLLEILSSKKNT 724 (840)
Q Consensus 669 a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~ksDV~SlGviL~elltG~~p~ 724 (840)
++......... ......||+.|||||++.. ..|+.+.|+||..+-.++.+.++.++
T Consensus 476 a~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 476 GKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 99875432211 1235679999999999987 66888999999999999888776554
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.85 E-value=7.4e-21 Score=168.67 Aligned_cols=104 Identities=16% Similarity=0.351 Sum_probs=90.7
Q ss_pred CcCCCCcccCCCCeEEcCCCeEEEEEecCCCCCceEEEEeeecCCCcEEEeecCCCCCCCCCceEEEecCCceEEecCCC
Q 041702 26 DSITPATFIRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKKSPDTVVWVANRNCPILDPHGILAINNNGNLVLLNQAN 105 (840)
Q Consensus 26 ~~~~~~~~l~~~~~l~S~~g~F~~gFf~~~~~~~~~lgiw~~~~~~tvVW~ANr~~p~~~~~~~l~~~~~G~L~l~~~~~ 105 (840)
|+|.+||.|.+|++|+| |.|.|.|...++ |.++. ..++||+|||+.|..+ .+.|+|+.||||||+|+++
T Consensus 2 n~L~~g~~L~~g~~L~s--g~y~l~~q~DgN-----Lvly~---~~~~vW~ant~~~~~~-~~~L~l~~dGnLvL~d~~~ 70 (105)
T 4h3o_A 2 NILDNNEGLYAGQSLDV--EPYHFIMQDDCN-----LVLYD---HSTSTWASNTEIGGKS-GCSAVLQSDGNFVVYDSSG 70 (105)
T ss_dssp CEECTTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE---TTEEEEECCCCCTTCC-SCEEEECTTSCEEEECTTC
T ss_pred CCcCCCCEEcCCCEEEE--CCEEEEECCCCe-----EEEEE---CCEEEEEecCCCCCCc-cEEEEEeCCccEEEECCCc
Confidence 68999999999999998 789999988775 55553 3689999999999754 6789999999999999999
Q ss_pred ceEEEecCCCCCCCceEEEecCCCeEEEeccCCCCCCCceeEEe
Q 041702 106 GTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSEGSYLWQS 149 (840)
Q Consensus 106 ~~~Wss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~~lWqS 149 (840)
.+||+|+++.......|+|+|+|||||++. +||||
T Consensus 71 ~~vWss~t~~~~~~~~l~L~ddGNlVly~~---------~~W~S 105 (105)
T 4h3o_A 71 RSLWASHSTRGSGNYILILQDDGNVIIYGS---------DIWST 105 (105)
T ss_dssp CEEEECCCCCCSSCEEEEECTTSCEEEEES---------EEEEC
T ss_pred EEEEEecCCCCCCCEEEEEeCCCeEEEECC---------cEecC
Confidence 999999987666567899999999999972 49998
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.85 E-value=1.1e-20 Score=171.62 Aligned_cols=108 Identities=20% Similarity=0.324 Sum_probs=94.6
Q ss_pred cccCcCCCCcccCCCCeEE--cCCCeEEEEEecCCCCCceEEEEeeecCCCcEEEeecCCCCCCCCCceEEEecCCceEE
Q 041702 23 LAADSITPATFIRDGEKLV--SPSQRFELGFFSPGNSKNRYLGVWYKKSPDTVVWVANRNCPILDPHGILAINNNGNLVL 100 (840)
Q Consensus 23 ~~~~~~~~~~~l~~~~~l~--S~~g~F~~gFf~~~~~~~~~lgiw~~~~~~tvVW~ANr~~p~~~~~~~l~~~~~G~L~l 100 (840)
++.++|.+|++|.+|++|+ |++|.|+|+|+.+|+ + +||++ .++||+|||+.| +.++.|+|..||||||
T Consensus 6 ~~~~~l~~g~~L~~g~~l~~~S~~g~~~L~~~~dgn-----l-vly~~--~~~vW~sn~~~~--~~~~~l~l~~dGNLVl 75 (119)
T 1b2p_A 6 SKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCN-----L-VLYDN--NNPIWATNTGGL--GNGCRAVLQPDGVLVV 75 (119)
T ss_dssp CSCSSSCCCCEEETTCEEEEEETTEEEEEEECTTSC-----E-EEEET--TEEEEECCCTTS--CSSCEEEECTTSCEEE
T ss_pred ecCcccCCCCEEcCCCEEEEeCCCCCEEEEEecCCC-----E-EEEEC--CEEEEeCCCccC--CCceEEEEccCCEEEE
Confidence 5789999999999999999 999999999999875 2 57876 799999999877 4468999999999999
Q ss_pred ecCCCceEEEecCCCCCCCceEEEecCCCeEEEeccCCCCCCCceeEEe
Q 041702 101 LNQANGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSEGSYLWQS 149 (840)
Q Consensus 101 ~~~~~~~~Wss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~~lWqS 149 (840)
+|.++.++|+|++........++|+|+|||||++. ++|||
T Consensus 76 ~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~~---------~~W~S 115 (119)
T 1b2p_A 76 ITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYGD---------ALWAT 115 (119)
T ss_dssp ECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEES---------EEEEC
T ss_pred EeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEECc---------cEeCC
Confidence 99999999999976544456789999999999971 59997
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.6e-20 Score=168.51 Aligned_cols=110 Identities=25% Similarity=0.410 Sum_probs=95.0
Q ss_pred cCcCCCCcccCCCCeEEcCCCeEEEEEecCCCCCceEEEEeeecCCCcEEEeecCCCCCCCCCceEEEecCCceEEecCC
Q 041702 25 ADSITPATFIRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKKSPDTVVWVANRNCPILDPHGILAINNNGNLVLLNQA 104 (840)
Q Consensus 25 ~~~~~~~~~l~~~~~l~S~~g~F~~gFf~~~~~~~~~lgiw~~~~~~tvVW~ANr~~p~~~~~~~l~~~~~G~L~l~~~~ 104 (840)
+|+|.+||.|.+|++|+ ++|.|+|+|+..|+ | ++|+ ..++||.||++.| +.++.++|..||||||+|.+
T Consensus 1 ~d~l~~g~~L~~g~~l~-~~~~~~l~~~~dGn-----l-vl~~--~~~~vW~sn~~~~--~~~~~l~l~~dGNLVl~~~~ 69 (110)
T 3a0c_A 1 VNSLSSPNSLFTGHSLE-VGPSYRLIMQGDCN-----F-VLYD--SGKPVWASNTGGL--GSGCRLTLHNNGNLVIYDQS 69 (110)
T ss_dssp CCEEETTCEECTTCEEE-ETTTEEEEECTTSC-----E-EEEE--TTEEEEECCCTTS--CSSCEEEECTTSCEEEECTT
T ss_pred CCEeCCCCEECCCCEEE-ECCCEEEEEcCCCc-----E-EEEE--CCEEEEECCCCCC--CCcEEEEEeCCCCEEEECCC
Confidence 47899999999999999 99999999998876 2 6776 4799999999876 34678999999999999999
Q ss_pred CceEEEecCCCCCCCceEEEecCCCeEEEeccCCCCCCCceeEEecCCCC
Q 041702 105 NGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSEGSYLWQSFDFPS 154 (840)
Q Consensus 105 ~~~~Wss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~~lWqSFd~Pt 154 (840)
|.++|+|++........++|+|+|||||++. ++||||+||.
T Consensus 70 ~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~~---------~~W~S~~~~~ 110 (110)
T 3a0c_A 70 NRVIWQTKTNGKEDHYVLVLQQDRNVVIYGP---------VVWATGSGPA 110 (110)
T ss_dssp CCEEEECCCCCSSSCCEEEECTTSCEEEECS---------EEEECSCCC-
T ss_pred CcEEEecCCCCCCCCEEEEEeCCccEEEECC---------CEecCCCcCC
Confidence 9999999977554455789999999999862 5999999983
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=2.3e-20 Score=198.11 Aligned_cols=156 Identities=17% Similarity=0.129 Sum_probs=121.0
Q ss_pred cCHHHHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC------------------c
Q 041702 504 FSLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG------------------Q 565 (840)
Q Consensus 504 ~~~~~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~------------------~ 565 (840)
..+..+......|...+.||+|+||.||+|.+ .+|+.||||+++.... .
T Consensus 80 ~~l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-------------~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~ 146 (282)
T 1zar_A 80 YSLHRLVRSGKVDAIGKLMGEGKESAVFNCYS-------------EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVL 146 (282)
T ss_dssp HHHHHHHHTTSCSEEEEEEEECSSEEEEEEEE-------------TTTEEEEEEEECC------CCCC-------CHHHH
T ss_pred HHHHHHHhCCeEEEecCEeccCCCceEEEEEe-------------CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHH
Confidence 44556666777888889999999999999853 4789999999964321 1
Q ss_pred CHHHHHHHHHHHhhcCCCCccceeeEeecCCceEEEEEeeccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceec
Q 041702 566 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIH 645 (840)
Q Consensus 566 ~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH 645 (840)
....+.+|+.++.+++ | +++.+++. .+..++||||........ +.......++.||+.||.|||+.+ |+|
T Consensus 147 ~~~~~~~E~~~l~~l~--~-~~v~~~~~-~~~~~lvmE~~~g~~L~~---l~~~~~~~i~~qi~~~l~~lH~~g---iiH 216 (282)
T 1zar_A 147 AIRSARNEFRALQKLQ--G-LAVPKVYA-WEGNAVLMELIDAKELYR---VRVENPDEVLDMILEEVAKFYHRG---IVH 216 (282)
T ss_dssp HHHHHHHHHHHHHHTT--T-SSSCCEEE-EETTEEEEECCCCEEGGG---CCCSCHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHHHHHHHHHHHhcc--C-CCcCeEEe-ccceEEEEEecCCCcHHH---cchhhHHHHHHHHHHHHHHHHHCC---CEe
Confidence 2456899999999999 5 66666554 356799999953322222 333556689999999999999998 999
Q ss_pred CCCCCCcEEecCCCCceeeccccceecCCCCcccccccccccccccCcccccc
Q 041702 646 RDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH 698 (840)
Q Consensus 646 rDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 698 (840)
|||||+|||++ ++.+||+|||+|+.. ..++|||++..
T Consensus 217 rDlkp~NILl~-~~~vkl~DFG~a~~~---------------~~~~a~e~l~r 253 (282)
T 1zar_A 217 GDLSQYNVLVS-EEGIWIIDFPQSVEV---------------GEEGWREILER 253 (282)
T ss_dssp SCCSTTSEEEE-TTEEEECCCTTCEET---------------TSTTHHHHHHH
T ss_pred CCCCHHHEEEE-CCcEEEEECCCCeEC---------------CCCCHHHHHHH
Confidence 99999999999 999999999998742 35788997743
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=1.3e-19 Score=164.22 Aligned_cols=110 Identities=18% Similarity=0.305 Sum_probs=93.4
Q ss_pred cCcCCCCcccCCCCeEEcCCCeEEEEEecCCCCCceEEEEeeecCCCcEEEeecCCCCCCCCCceEEEecCCceEEecCC
Q 041702 25 ADSITPATFIRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKKSPDTVVWVANRNCPILDPHGILAINNNGNLVLLNQA 104 (840)
Q Consensus 25 ~~~~~~~~~l~~~~~l~S~~g~F~~gFf~~~~~~~~~lgiw~~~~~~tvVW~ANr~~p~~~~~~~l~~~~~G~L~l~~~~ 104 (840)
.|+|.+||+|.+|++|+ +|.|+|+|+.+|+- ++|+ ..++||+||++.| +.++.|+|+.||||||+|.+
T Consensus 2 ~dtl~~gq~L~~g~~L~--~g~~~L~~~~dgnl------vly~--~~~~vW~sn~~~~--~~~~~l~l~~~GnLvl~d~~ 69 (115)
T 2dpf_A 2 DNVLLSGQTLHADHSLQ--AGAYTLTIQNKCNL------VKYQ--NGRQIWASNTDRR--GSGCRLTLLSDGNLVIYDHN 69 (115)
T ss_dssp CCEEETTCEEETTEEEE--ETTEEEEECTTSCE------EEEE--TTEEEEECSCTTS--CSSCEEEECTTSCEEEECTT
T ss_pred CCEeCCCCEECCCCEEE--CCCEEEEEcCCCcE------EEEe--CCEEEEeCCCCCC--CCceEEEECCCCcEEEECCC
Confidence 58999999999999998 89999999877752 2355 4789999999988 34689999999999999998
Q ss_pred CceEEEecCCCCCCCceEEEecCCCeEEEeccCCCCCCCceeEEecCCCCC
Q 041702 105 NGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSEGSYLWQSFDFPSD 155 (840)
Q Consensus 105 ~~~~Wss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~~lWqSFd~PtD 155 (840)
+.++|+|++........++|+|+|||||++. ++||||.+++.
T Consensus 70 ~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~~---------~~W~S~~~~~~ 111 (115)
T 2dpf_A 70 NNDVWGSACWGDNGKYALVLQKDGRFVIYGP---------VLWSLGPNGCR 111 (115)
T ss_dssp CCEEEECCCCCSSSCCEEEECTTSCEEEECS---------EEECSSTTCBC
T ss_pred ceEEEEcCCCCCCCCEEEEEeCCCeEEEECC---------CEEECCCCCCc
Confidence 9999999987544456799999999999961 59999998764
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.80 E-value=2.5e-19 Score=161.51 Aligned_cols=110 Identities=22% Similarity=0.418 Sum_probs=92.5
Q ss_pred cCcCCCCcccCCCCeEEcCCCeEEEEEecCCCCCceEEEEeeecCCCcEEEeecCCCCCCCCCceEEEecCCceEEecCC
Q 041702 25 ADSITPATFIRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKKSPDTVVWVANRNCPILDPHGILAINNNGNLVLLNQA 104 (840)
Q Consensus 25 ~~~~~~~~~l~~~~~l~S~~g~F~~gFf~~~~~~~~~lgiw~~~~~~tvVW~ANr~~p~~~~~~~l~~~~~G~L~l~~~~ 104 (840)
+|+|.+||+|.+|++| ++|.|+|+|+.+|+- ++|++ .++||+||++.+ +.++.|+|..||||||+| +
T Consensus 1 tdtl~~gq~L~~g~~L--~~~~~~L~~~~dgnl------vl~~~--~~~vW~sn~~~~--~~~~~l~l~~~GNLvl~d-~ 67 (112)
T 1xd5_A 1 SDRLNSGHQLDTGGSL--AEGGYLFIIQNDCNL------VLYDN--NRAVWASGTNGK--ASGCVLKMQNDGNLVIYS-G 67 (112)
T ss_dssp CCEEETTEEECTTCEE--EETTEEEEECTTSCE------EEEET--TEEEEECCCTTS--CSSEEEEECTTSCEEEEE-T
T ss_pred CCCCCCCCEECCCCEE--eCCCEEEEEcCCCcE------EEEEC--CEEEEeCCCcCC--CCCEEEEEeCCCCEEEEc-C
Confidence 4899999999999999 589999999998862 35765 789999999864 446899999999999999 8
Q ss_pred CceEEEecCCCCCCCceEEEecCCCeEEEeccCCCCCCCceeEEecCCC
Q 041702 105 NGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSEGSYLWQSFDFP 153 (840)
Q Consensus 105 ~~~~Wss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~~lWqSFd~P 153 (840)
+.++|+|++........++|+++|||||++. .+.++||||++.
T Consensus 68 ~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~------~~~~~W~S~~~~ 110 (112)
T 1xd5_A 68 SRAIWASNTNRQNGNYYLILQRDRNVVIYDN------SNNAIWATHTNV 110 (112)
T ss_dssp TEEEEECCCCCSCCCCEEEECTTSCEEEECT------TSCEEEECCCCC
T ss_pred CEEEEECCccCCCCCEEEEEeCCCcEEEECC------CCceEEECCCcc
Confidence 8999999876544456799999999999972 245799999985
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=2.6e-18 Score=153.83 Aligned_cols=104 Identities=26% Similarity=0.395 Sum_probs=87.6
Q ss_pred CcCCCCcccCCCCeEEcCCCeEEEEEecCCCCCceEEEEeeecCCCcEEEeecCCCCCCCCCceEEEecCCceEEecCCC
Q 041702 26 DSITPATFIRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKKSPDTVVWVANRNCPILDPHGILAINNNGNLVLLNQAN 105 (840)
Q Consensus 26 ~~~~~~~~l~~~~~l~S~~g~F~~gFf~~~~~~~~~lgiw~~~~~~tvVW~ANr~~p~~~~~~~l~~~~~G~L~l~~~~~ 105 (840)
++|.|||+|.+|++|+ +|.|.|+|+..|+ |- .|.. .++||.+|++.+ +.++.|+|..||||||+|.++
T Consensus 2 ntL~~gq~L~~g~~L~--~g~~~L~~q~dGn-----Lv-ly~~--~~~vW~snt~~~--~~~~~l~l~~dGNLvl~~~~~ 69 (109)
T 3dzw_A 2 NILYSGETLSPGEFLN--NGRYVFIMQEDCN-----LV-LYDV--DKPIWATNTGGL--DRRCHLSMQSDGNLVVYSPRN 69 (109)
T ss_dssp CEEETTEEECTTCEEE--ETTEEEEECTTSC-----EE-EEET--TEEEEECCCTTS--SSSCEEEECTTSCEEEECTTS
T ss_pred CCcCCCCEeCCCCEEE--CCCEEEEEcCCCc-----EE-EEeC--CEEEEECCcccC--CCCEEEEEeCCCCEEEECCCC
Confidence 6899999999999997 7999999988875 22 2554 689999999876 446899999999999999989
Q ss_pred ceEEEecCCCCCCCceEEEecCCCeEEEeccCCCCCCCceeEEec
Q 041702 106 GTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSEGSYLWQSF 150 (840)
Q Consensus 106 ~~~Wss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~~lWqSF 150 (840)
.++|++++........|+|+|+|||||++. ++|||=
T Consensus 70 ~~~W~S~t~~~~~~~~~~L~ddGNlvly~~---------~~W~s~ 105 (109)
T 3dzw_A 70 NPIWASNTGGENGNYVCVLQKDRNVVIYGT---------ARWATG 105 (109)
T ss_dssp CEEEECCCCCSSSCEEEEECTTSCEEEEES---------CCCCCC
T ss_pred CEEEECCCCCCCCCEEEEEeCCCEEEEECC---------CEEeCC
Confidence 999999987554446799999999999982 499973
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.71 E-value=3.1e-17 Score=146.79 Aligned_cols=106 Identities=22% Similarity=0.336 Sum_probs=86.8
Q ss_pred hcccCcCCCCcccCCCCeEEcCCCeEEEEEecCCCCCceEEEEeeecCCCcEEEeecCCCCCCCCCceEEEecCCceEEe
Q 041702 22 SLAADSITPATFIRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKKSPDTVVWVANRNCPILDPHGILAINNNGNLVLL 101 (840)
Q Consensus 22 ~~~~~~~~~~~~l~~~~~l~S~~g~F~~gFf~~~~~~~~~lgiw~~~~~~tvVW~ANr~~p~~~~~~~l~~~~~G~L~l~ 101 (840)
.++.|+|.|||.|..|+.|+|. .|.|-|...|+ |.+ |.. ++||.+|++.. +.++.|+|..||||||+
T Consensus 3 ~~~~dtL~~gq~L~~g~~L~sg--~~~L~~q~dGn-----Lvl-~~~---~~vW~snt~~~--~~~~~l~l~~dGNLvl~ 69 (110)
T 3r0e_B 3 PFTNNLLFSGQVLYGDGRLTAK--NHQLVMQGDCN-----LVL-YGG---KYGWQSNTHGN--GEHCFLRLNHKGELIIK 69 (110)
T ss_dssp CCBTTEEETTCEEETTEEEECS--SCEEEECTTSC-----EEE-ECS---SSCEECCCTTS--SSSCEEEECTTSCEEEE
T ss_pred ccccCEECCCCEecCCCEEEeC--CEEEEEcCCCe-----EEE-ECC---eEEEECCCcCC--CcCEEEEEeCCCcEEEE
Confidence 3688999999999999999984 58887766554 444 543 58999999863 34579999999999999
Q ss_pred cCCCceEEEecCCCCCCCceEEEecCCCeEEEeccCCCCCCCceeEEe
Q 041702 102 NQANGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSEGSYLWQS 149 (840)
Q Consensus 102 ~~~~~~~Wss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~~lWqS 149 (840)
|.++.++|++++........|+|+|+|||||++ .++|+|
T Consensus 70 d~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~---------~~~W~t 108 (110)
T 3r0e_B 70 DDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYG---------PAIFET 108 (110)
T ss_dssp CTTCCEEEECCCCCSSSCCEEEECTTSCEEEEC---------SEEEES
T ss_pred eCCCCEEEEcCCcCCCCCEEEEEcCCccEEEec---------CCEecC
Confidence 999999999998654444679999999999997 259986
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=4.3e-17 Score=170.73 Aligned_cols=141 Identities=16% Similarity=0.134 Sum_probs=104.3
Q ss_pred HHccCCcccccccCCCCccEEEeecceeehhccccCcccCCce--EEEEEeccCCCc-----------------------
Q 041702 511 AATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEE--VAVKRLSSKSGQ----------------------- 565 (840)
Q Consensus 511 ~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~--VAvK~l~~~~~~----------------------- 565 (840)
....-|.+.+.||+|+||.||+|.+. .+|+. ||||+++.....
T Consensus 44 ~~~~~~~i~~~ig~G~~g~Vy~a~~~------------~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 111 (258)
T 1zth_A 44 AKGYITAMGGVISTGKEANVFYADGV------------FDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKE 111 (258)
T ss_dssp HTTSEEEEEEEEEECSSEEEEEEEEE------------ETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHH
T ss_pred hCCCchhhCCEEeecceEEEEEEEEc------------CCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHH
Confidence 33334677889999999999998653 46888 999997543111
Q ss_pred -CHHHHHHHHHHHhhcCCCCc--cceeeEeecCCceEEEEEeeccC-----Cccc-cCCCCHHHHHHHHHHHHHHHHHHH
Q 041702 566 -GLEEFKNEMMLIAKLQHRNL--VRLFGCCIEQGEKISIYEFDIVT-----DPAR-KDLLDWTTRVRIIEGVAQGLLYLH 636 (840)
Q Consensus 566 -~~~~f~~Ev~~l~~l~H~ni--v~l~g~~~~~~~~~lv~e~~~~~-----~~~~-~~~l~~~~~~~i~~~ia~~L~yLH 636 (840)
....+.+|+.+|.+++|+++ +.++++ +..++||||.... .... ....++.....++.|++.+|.|||
T Consensus 112 ~~~~~~~~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH 187 (258)
T 1zth_A 112 KVFIWTEKEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLY 187 (258)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHH
Confidence 01368899999999998864 444432 4678999996211 1110 011224567889999999999999
Q ss_pred -hcCCCceecCCCCCCcEEecCCCCceeeccccceec
Q 041702 637 -QYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTF 672 (840)
Q Consensus 637 -~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~ 672 (840)
+.+ |+||||||+|||++. .++|+|||+|...
T Consensus 188 ~~~g---ivHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 188 QEAE---LVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp HTSC---EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HHCC---EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 887 999999999999988 9999999999764
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.68 E-value=3e-16 Score=141.20 Aligned_cols=108 Identities=19% Similarity=0.304 Sum_probs=89.5
Q ss_pred cccCcCCCCcccCCCCeEEcCCCeEEEEEecCCCCCceEEEEeeecCCCcEEEeecCCCCCCCCCceEEEecCCceEEec
Q 041702 23 LAADSITPATFIRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKKSPDTVVWVANRNCPILDPHGILAINNNGNLVLLN 102 (840)
Q Consensus 23 ~~~~~~~~~~~l~~~~~l~S~~g~F~~gFf~~~~~~~~~lgiw~~~~~~tvVW~ANr~~p~~~~~~~l~~~~~G~L~l~~ 102 (840)
.+.|+|.+||.|..|+.|.+ |.|.|-|...|+ |.++ .....++||.+|+..+ +.++.|+|..||||||+|
T Consensus 4 ~~~~tL~~gq~L~~g~~L~~--g~~~L~~q~dGN-----LvL~-~~~~~~~vWssnt~~~--~~~~~l~l~~dGNLVl~d 73 (113)
T 3mez_B 4 RVRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCN-----LVLT-KGSKTNIVWESGTSGR--GQHCFMRLGHSGELDITD 73 (113)
T ss_dssp CCSSEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEE-ETTTTEEEEECCCTTS--CSSCEEEECTTSCEEEEC
T ss_pred ccCCEeCCCCEECCCCEeEc--CCEEEEEcCCCE-----EEEE-ECCCCEEEEECCcccC--CcCEEEEEeCCCcEEEEC
Confidence 46789999999999999975 889999987765 5554 3224789999999876 346789999999999999
Q ss_pred CCCceEEEecCCCCCCCceEEEecCCCeEEEeccCCCCCCCceeEEe
Q 041702 103 QANGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSEGSYLWQS 149 (840)
Q Consensus 103 ~~~~~~Wss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~~lWqS 149 (840)
.++.++|++++........|+|+|+|||||++ .++|+|
T Consensus 74 ~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~---------~~~W~s 111 (113)
T 3mez_B 74 DRLNTVFVSNTVGQEGDYVLILQINGQAVVYG---------PAVWST 111 (113)
T ss_dssp TTSCEEEECSCCCSSSCCEEEECTTSCEEEEC---------SEEEES
T ss_pred CCCCEEEECCCcCCCCCEEEEEcCCceEEEec---------CCEecC
Confidence 99999999998654445689999999999996 259997
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.64 E-value=6.9e-16 Score=137.75 Aligned_cols=109 Identities=20% Similarity=0.320 Sum_probs=88.6
Q ss_pred cccCcCCCCcccCCCCeEEcCCCeEEEEEecCCCCCceEEEEeeecCCCcEEEeecCCCCCCCCCceEEEecCCceEEec
Q 041702 23 LAADSITPATFIRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKKSPDTVVWVANRNCPILDPHGILAINNNGNLVLLN 102 (840)
Q Consensus 23 ~~~~~~~~~~~l~~~~~l~S~~g~F~~gFf~~~~~~~~~lgiw~~~~~~tvVW~ANr~~p~~~~~~~l~~~~~G~L~l~~ 102 (840)
+|.|+|.|||.|..|+.| .+|.|.|.|...|+- -+ |.. +|.+|+..+ +.++.|+|+.||||||+|
T Consensus 1 ~~~dtL~~gq~L~~g~~L--~~g~~~L~~q~dGNL-----vl-~~~-----~Wssnt~~~--~~~~~l~l~~dGnLvl~d 65 (109)
T 3r0e_A 1 LGTNYLLSGQTLDTEGHL--KNGDFDLVMQDDCNL-----VL-YNG-----NWQSNTANN--GRDCKLTLTDYGELVIKN 65 (109)
T ss_dssp CCCSEEETTCEECTTCEE--EETTEEEEECTTSCE-----EE-ETT-----TEECCCTTS--CSSCEEEECTTSCEEEEC
T ss_pred CccCCcCCCCCcCCCCEe--ECCCEEEEEecCCeE-----EE-EeC-----eEEcCCCCC--CCcEEEEEcCCCeEEEEe
Confidence 478999999999999999 579999999877752 22 321 699998865 346899999999999999
Q ss_pred CCCceEEEecCCCCCCCceEEEecCCCeEEEeccCCCCCCCceeEEecCCCCCcccCC
Q 041702 103 QANGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSEGSYLWQSFDFPSDTLLPG 160 (840)
Q Consensus 103 ~~~~~~Wss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~~lWqSFd~PtDtlLpg 160 (840)
.++.++|++++........|+|+|+|||||++ .++|+| .|.+||
T Consensus 66 ~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~---------~~~W~s-----~t~~~~ 109 (109)
T 3r0e_A 66 GDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG---------PSVFKI-----DPWVRG 109 (109)
T ss_dssp TTSCEEEECCCCCSSSCCEEEEETTTEEEEEC---------SEEEEE-----CTTSCC
T ss_pred CCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe---------cCEECC-----CCccCC
Confidence 99999999998654445679999999999996 359996 555554
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=7.6e-16 Score=137.91 Aligned_cols=89 Identities=20% Similarity=0.357 Sum_probs=73.9
Q ss_pred CCceEEEecCCceEEecCCCceEEEecCCCCCCCceEEEecCCCeEEEeccCCCCCCCceeEEecCCCCCcccCCCcccc
Q 041702 86 PHGILAINNNGNLVLLNQANGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSEGSYLWQSFDFPSDTLLPGMKVGW 165 (840)
Q Consensus 86 ~~~~l~~~~~G~L~l~~~~~~~~Wss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~~lWqSFd~PtDtlLpg~~l~~ 165 (840)
...+|.|+.||||||+| .+.+||++++........++|+|+|||||+|. .+.++||||
T Consensus 20 ~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~------~~~~~W~S~--------------- 77 (110)
T 3a0c_A 20 PSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQ------SNRVIWQTK--------------- 77 (110)
T ss_dssp TTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECT------TCCEEEECC---------------
T ss_pred CCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECC------CCcEEEecC---------------
Confidence 36789999999999999 48999999987555456899999999999983 346799999
Q ss_pred ccccCCceeEEEeccCCCCCCCceEEeecCCCCcEEEEEcCCeeeEEeCCC
Q 041702 166 DLKTGRERYLTSWRTADDPSPGKFTYRLDIHVLPQIFLYKGSLKLARIGPW 216 (840)
Q Consensus 166 ~~~tg~~~~l~S~~s~~dps~G~~~l~~~~~~~~~~~~~~~~~~~~~~g~w 216 (840)
+++++|.|++.++++|. ++++++ +||+++++
T Consensus 78 ----------------t~~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~ 108 (110)
T 3a0c_A 78 ----------------TNGKEDHYVLVLQQDRN--VVIYGP--VVWATGSG 108 (110)
T ss_dssp ----------------CCCSSSCCEEEECTTSC--EEEECS--EEEECSCC
T ss_pred ----------------CCCCCCCEEEEEeCCcc--EEEECC--CEecCCCc
Confidence 24567899999999998 455665 89999875
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.64 E-value=8.4e-16 Score=138.37 Aligned_cols=96 Identities=22% Similarity=0.383 Sum_probs=78.2
Q ss_pred CCCCCCceEEEecCCceEEecCCCceEEEecCCCCCCCceEEEecCCCeEEEeccCCCCCCCceeEEecCCCCCcccCCC
Q 041702 82 PILDPHGILAINNNGNLVLLNQANGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSEGSYLWQSFDFPSDTLLPGM 161 (840)
Q Consensus 82 p~~~~~~~l~~~~~G~L~l~~~~~~~~Wss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~~lWqSFd~PtDtlLpg~ 161 (840)
|+.+...+|.|+.||+|+|++. +.+||++++......+.|+|+|+|||||+| + +.++||||+
T Consensus 15 ~L~~~~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d--~-----~~~~W~S~~---------- 76 (112)
T 1xd5_A 15 SLAEGGYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS--G-----SRAIWASNT---------- 76 (112)
T ss_dssp EEEETTEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE--T-----TEEEEECCC----------
T ss_pred EEeCCCEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc--C-----CEEEEECCc----------
Confidence 3434568899999999999988 889999998754445789999999999997 2 247999994
Q ss_pred ccccccccCCceeEEEeccCCCCCCCceEEeecCCCCcEEEEEc-CCeeeEEeCCCCC
Q 041702 162 KVGWDLKTGRERYLTSWRTADDPSPGKFTYRLDIHVLPQIFLYK-GSLKLARIGPWNG 218 (840)
Q Consensus 162 ~l~~~~~tg~~~~l~S~~s~~dps~G~~~l~~~~~~~~~~~~~~-~~~~~~~~g~w~~ 218 (840)
+|++|.|++.++++|. +++++ +..+||++++|+|
T Consensus 77 ---------------------~~~~g~~~l~l~~dGn--lvl~~~~~~~~W~S~~~~g 111 (112)
T 1xd5_A 77 ---------------------NRQNGNYYLILQRDRN--VVIYDNSNNAIWATHTNVG 111 (112)
T ss_dssp ---------------------CCSCCCCEEEECTTSC--EEEECTTSCEEEECCCCCC
T ss_pred ---------------------cCCCCCEEEEEeCCCc--EEEECCCCceEEECCCccC
Confidence 4567899999999998 44555 5689999999986
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.58 E-value=7.4e-15 Score=133.18 Aligned_cols=87 Identities=24% Similarity=0.305 Sum_probs=72.3
Q ss_pred CceEEEecCCceEEecCCCceEEEecCCCCCCCceEEEecCCCeEEEeccCCCCCCCceeEEecCCCCCcccCCCccccc
Q 041702 87 HGILAINNNGNLVLLNQANGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSEGSYLWQSFDFPSDTLLPGMKVGWD 166 (840)
Q Consensus 87 ~~~l~~~~~G~L~l~~~~~~~~Wss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~~lWqSFd~PtDtlLpg~~l~~~ 166 (840)
..+|.+..||+|+|++. +.+||++++........|+|+|+|||||+| ..++++||||
T Consensus 31 ~~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d------~~~~~lW~S~---------------- 87 (119)
T 1b2p_A 31 VYRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVIT------NENVTVWQSP---------------- 87 (119)
T ss_dssp EEEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEEC------TTCCEEEECS----------------
T ss_pred CEEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEe------CCCcEEEcCC----------------
Confidence 46799999999999987 899999998755545789999999999998 3456899999
Q ss_pred cccCCceeEEEeccCCCCCCCceEEeecCCCCcEEEEEcCCeeeEEeCC
Q 041702 167 LKTGRERYLTSWRTADDPSPGKFTYRLDIHVLPQIFLYKGSLKLARIGP 215 (840)
Q Consensus 167 ~~tg~~~~l~S~~s~~dps~G~~~l~~~~~~~~~~~~~~~~~~~~~~g~ 215 (840)
+||++|.|++.++++|. +++++ .+||++|+
T Consensus 88 ---------------~~~~~g~~~l~l~~~Gn--lvl~~--~~~W~Sg~ 117 (119)
T 1b2p_A 88 ---------------VAGKAGHYVLVLQPDRN--VVIYG--DALWATQT 117 (119)
T ss_dssp ---------------CCCCSSCEEEEECTTSC--EEEEE--SEEEECCC
T ss_pred ---------------CCCCCCCEEEEEECCCc--EEEEC--ccEeCCCC
Confidence 35678999999999998 44555 38999986
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=1.4e-14 Score=130.89 Aligned_cols=91 Identities=27% Similarity=0.403 Sum_probs=74.9
Q ss_pred CceEEEecCCceEEecCCCceEEEecCCCCCCCceEEEecCCCeEEEeccCCCCCCCceeEEecCCCCCcccCCCccccc
Q 041702 87 HGILAINNNGNLVLLNQANGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSEGSYLWQSFDFPSDTLLPGMKVGWD 166 (840)
Q Consensus 87 ~~~l~~~~~G~L~l~~~~~~~~Wss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~~lWqSFd~PtDtlLpg~~l~~~ 166 (840)
...|.+..||||+|++ .+.++|++++.....++.++|+++|||||+|. .+.++|||||+
T Consensus 21 ~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~------~~~~vW~S~~~-------------- 79 (115)
T 2dpf_A 21 AYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDH------NNNDVWGSACW-------------- 79 (115)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECT------TCCEEEECCCC--------------
T ss_pred CEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECC------CceEEEEcCCC--------------
Confidence 5779999999999998 58899999987554456899999999999983 34679999997
Q ss_pred cccCCceeEEEeccCCCCCCCceEEeecCCCCcEEEEEcCCeeeEEeCCCCCc
Q 041702 167 LKTGRERYLTSWRTADDPSPGKFTYRLDIHVLPQIFLYKGSLKLARIGPWNGF 219 (840)
Q Consensus 167 ~~tg~~~~l~S~~s~~dps~G~~~l~~~~~~~~~~~~~~~~~~~~~~g~w~~~ 219 (840)
+++|.|++.++++|. ++++++ +||++++|...
T Consensus 80 -----------------~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~~~ 111 (115)
T 2dpf_A 80 -----------------GDNGKYALVLQKDGR--FVIYGP--VLWSLGPNGCR 111 (115)
T ss_dssp -----------------CSSSCCEEEECTTSC--EEEECS--EEECSSTTCBC
T ss_pred -----------------CCCCCEEEEEeCCCe--EEEECC--CEEECCCCCCc
Confidence 345789999999998 555665 89999999643
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.53 E-value=8.3e-15 Score=159.55 Aligned_cols=148 Identities=14% Similarity=0.180 Sum_probs=99.3
Q ss_pred CHHHHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC--------------cCHHHH
Q 041702 505 SLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG--------------QGLEEF 570 (840)
Q Consensus 505 ~~~~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~--------------~~~~~f 570 (840)
.+..+.....-|++.++||+|++|.||+|.+ .+|+.||||+++.... ......
T Consensus 86 AL~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d-------------~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~ 152 (397)
T 4gyi_A 86 ALHTHAARKDVYSVGSRIGVGKESDIMIVAD-------------EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSW 152 (397)
T ss_dssp HHHHHHHTTSCSEEEEEEEECSSEEEEEEEC-------------TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHH
T ss_pred HHHHHHHCCCEEEecCEeeeCCceEEEEEEC-------------CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccH
Confidence 3444555555599999999999999999864 3689999998763210 111122
Q ss_pred H--------HHHHHHhhcCCCCccceeeEeecCCceEEEEEeeccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCc
Q 041702 571 K--------NEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLR 642 (840)
Q Consensus 571 ~--------~Ev~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ 642 (840)
+ +|...|.++.+.++....-+. ....++||||.. ...............++.||+.+|.|||+.+
T Consensus 153 ~~~~rl~A~kE~~nL~rL~~~gv~vp~p~~--~~~~~LVME~i~--G~~L~~l~~~~~~~~l~~qll~~l~~lH~~g--- 225 (397)
T 4gyi_A 153 MYLSRLAAIKEFAFMKALYEEGFPVPEPIA--QSRHTIVMSLVD--ALPMRQVSSVPDPASLYADLIALILRLAKHG--- 225 (397)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCSCCCEEE--EETTEEEEECCS--CEEGGGCCCCSCHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCCeeee--ccCceEEEEecC--CccHhhhcccHHHHHHHHHHHHHHHHHHHCC---
Confidence 2 345555555444332211111 123479999942 1222223333455678999999999999988
Q ss_pred eecCCCCCCcEEecCCCC----------ceeeccccceec
Q 041702 643 VIHRDLKASNVLLDSDMN----------PKISDFGIARTF 672 (840)
Q Consensus 643 ivHrDlkp~NILl~~~~~----------~kL~DFGla~~~ 672 (840)
||||||||.|||+++++. +.|+||+.+-..
T Consensus 226 IVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 226 LIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 999999999999988774 889999987653
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.49 E-value=9.2e-14 Score=124.36 Aligned_cols=103 Identities=16% Similarity=0.234 Sum_probs=81.9
Q ss_pred cCcCCCCcccCCCCeEEcCCCeEEEEEecCCCCCceEEEEeeecCCCcEEEeecCCCCCCCCCceEEEecCCceEEecCC
Q 041702 25 ADSITPATFIRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKKSPDTVVWVANRNCPILDPHGILAINNNGNLVLLNQA 104 (840)
Q Consensus 25 ~~~~~~~~~l~~~~~l~S~~g~F~~gFf~~~~~~~~~lgiw~~~~~~tvVW~ANr~~p~~~~~~~l~~~~~G~L~l~~~~ 104 (840)
.|+|.|||.|..|+.|. +|.|.|.|...|+ |.+ |.. .. ||.+|+..+ +.++.|+|..||||||+|.+
T Consensus 2 ~~~l~~gq~L~~g~~L~--~g~~~L~~q~dGn-----Lvl-~~~--~~-vW~snt~~~--~~~~~l~l~~dGNLVl~~~~ 68 (111)
T 3mez_A 2 NNVLLTGDVIHTDNQLS--YESAAFVMQGDCN-----LVL-YNE--AG-GFQSNTHGR--GVDCTLRLNNRGQLEIHSAN 68 (111)
T ss_dssp TTEEETTCEECTTCEEE--ETTEEEEECTTSC-----EEE-ECS--SC-CEECCCTTS--CSSCEEEECTTSCEEEECSS
T ss_pred cCEeCCCCEeCCCCEEe--cCCEEEEEccCCe-----EEE-ECC--CC-EEECCcccC--CcCEEEEEcCCCcEEEEeCC
Confidence 57899999999999994 7899999987765 333 432 23 999999876 34689999999999999988
Q ss_pred Cc-eEEEecCCC--CCCCceEEEecCCCeEEEeccCCCCCCCceeEEe
Q 041702 105 NG-TIWSSNMSK--EAKSPVAQLLDTGNLVLRENFSNNTSEGSYLWQS 149 (840)
Q Consensus 105 ~~-~~Wss~~~~--~~~~~~a~L~d~GNlVl~~~~~~~~~~~~~lWqS 149 (840)
+. ++|+|++.. ......+.|+|+|||||++ .++|+|
T Consensus 69 ~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~---------~~~W~s 107 (111)
T 3mez_A 69 SNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG---------PAIWST 107 (111)
T ss_dssp CSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC---------SEEEEC
T ss_pred CCEEEEEeccccCCCCcCEEEEECCCCeEEEec---------cCEEcc
Confidence 76 599999642 2234578999999999996 359997
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.31 E-value=7.7e-12 Score=112.29 Aligned_cols=95 Identities=17% Similarity=0.258 Sum_probs=72.8
Q ss_pred CCCCCCCCceEEEecCCceEEecC-CCceEEEecCCCCCCCceEEEecCCCeEEEeccCCCCCCCceeEEecCCCCCccc
Q 041702 80 NCPILDPHGILAINNNGNLVLLNQ-ANGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSEGSYLWQSFDFPSDTLL 158 (840)
Q Consensus 80 ~~p~~~~~~~l~~~~~G~L~l~~~-~~~~~Wss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~~lWqSFd~PtDtlL 158 (840)
+.|+.+...+|.++.||||||++. .+.++|++++........++|+|+|||||+|. .+.++|||=.+
T Consensus 18 g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~------~~~~iW~S~t~------ 85 (113)
T 3mez_B 18 NAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDD------RLNTVFVSNTV------ 85 (113)
T ss_dssp TCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECT------TSCEEEECSCC------
T ss_pred CCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECC------CCCEEEECCCc------
Confidence 445555578899999999999998 58999999987554456899999999999983 34579986221
Q ss_pred CCCccccccccCCceeEEEeccCCCCCCCceEEeecCCCCcEEEEEcCCeeeEEeCC
Q 041702 159 PGMKVGWDLKTGRERYLTSWRTADDPSPGKFTYRLDIHVLPQIFLYKGSLKLARIGP 215 (840)
Q Consensus 159 pg~~l~~~~~tg~~~~l~S~~s~~dps~G~~~l~~~~~~~~~~~~~~~~~~~~~~g~ 215 (840)
-..|.|.+.++.+|...++ + .+.|.+|+
T Consensus 86 -------------------------~~~~~~~~~L~~dGnlvly--~--~~~W~s~~ 113 (113)
T 3mez_B 86 -------------------------GQEGDYVLILQINGQAVVY--G--PAVWSTAA 113 (113)
T ss_dssp -------------------------CSSSCCEEEECTTSCEEEE--C--SEEEESCC
T ss_pred -------------------------CCCCCEEEEEcCCceEEEe--c--CCEecCCC
Confidence 0135689999999987765 3 57898875
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.24 E-value=2.7e-11 Score=108.30 Aligned_cols=94 Identities=17% Similarity=0.190 Sum_probs=70.8
Q ss_pred CCCCCCceEEEecCCceEEecCCCceEEEecCCCCCCCceEEEecCCCeEEEeccCCCCCCCceeEEecCCCCCcccCCC
Q 041702 82 PILDPHGILAINNNGNLVLLNQANGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSEGSYLWQSFDFPSDTLLPGM 161 (840)
Q Consensus 82 p~~~~~~~l~~~~~G~L~l~~~~~~~~Wss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~~lWqSFd~PtDtlLpg~ 161 (840)
++.+....|.++.||||||++..+ +|++++........++|+|+|||||++... ..++|||.-+
T Consensus 16 ~L~~g~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~~-----~~~vW~S~t~--------- 79 (111)
T 3mez_A 16 QLSYESAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSANS-----NTPVWVYPRS--------- 79 (111)
T ss_dssp EEEETTEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSSC-----SSCSEEESSS---------
T ss_pred EEecCCEEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCCC-----CEEEEEeccc---------
Confidence 333446789999999999999876 999998765445789999999999998421 1249998721
Q ss_pred ccccccccCCceeEEEeccCCCCCCCceEEeecCCCCcEEEEEcCCeeeEEeCC
Q 041702 162 KVGWDLKTGRERYLTSWRTADDPSPGKFTYRLDIHVLPQIFLYKGSLKLARIGP 215 (840)
Q Consensus 162 ~l~~~~~tg~~~~l~S~~s~~dps~G~~~l~~~~~~~~~~~~~~~~~~~~~~g~ 215 (840)
.....|.|.+.++.+|...++ + .++|.+++
T Consensus 80 --------------------~~~~~~~~~l~Lq~dGNlvly--~--~~~W~s~t 109 (111)
T 3mez_A 80 --------------------VNTVRGNYAATLGPDQHVTIY--G--PAIWSTPA 109 (111)
T ss_dssp --------------------CCCCSSCCEEEECTTSCEEEE--C--SEEEECCC
T ss_pred --------------------cCCCCcCEEEEECCCCeEEEe--c--cCEEccCC
Confidence 011347899999999987765 3 67898875
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=1.9e-11 Score=127.67 Aligned_cols=113 Identities=22% Similarity=0.399 Sum_probs=87.4
Q ss_pred cccCcCCCCcc----cCCCCeEEcCCCeEEEEEecCC--CCCceEEEEeeecCCCcEEEeecCCCCCCCCCceEEEecCC
Q 041702 23 LAADSITPATF----IRDGEKLVSPSQRFELGFFSPG--NSKNRYLGVWYKKSPDTVVWVANRNCPILDPHGILAINNNG 96 (840)
Q Consensus 23 ~~~~~~~~~~~----l~~~~~l~S~~g~F~~gFf~~~--~~~~~~lgiw~~~~~~tvVW~ANr~~p~~~~~~~l~~~~~G 96 (840)
-.+|++.||+. |..|+.|+|+ ..++-|+|... ...+.+ + |.+ ..+++|.+++..+ +. ..|.++.+|
T Consensus 134 ~ptdtlLpg~~~~~~l~~g~~L~S~-~dps~G~fsl~l~~dGnlv--L-y~~-~~~~yW~Sgt~~~--~~-~~l~l~~dG 205 (276)
T 3m7h_A 134 TPAIPLVPGAIDSLLLAPGSELVQG-VVYGAGASKLVFQGDGNLV--A-YGP-NGAATWNAGTQGK--GA-VRAVFQGDG 205 (276)
T ss_dssp CTTSCCCCSCTTCEEECSSEEECTT-CEEEETTEEEEECTTSCEE--E-ECT-TSSEEEECCCTTT--TC-CEEEECTTS
T ss_pred ccccccccccccccccccCcccccC-CCCCCceEEEeecCCceEE--E-EeC-CCeEEEECCCCCC--cc-EEEEEcCCC
Confidence 36799999999 8899999764 56676666532 222333 3 322 3689999999876 32 789999999
Q ss_pred ceEEecCCCceEEEecCCCCCCCceEEEecCCCeEEEeccCCCCCCCceeEEecCC
Q 041702 97 NLVLLNQANGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSEGSYLWQSFDF 152 (840)
Q Consensus 97 ~L~l~~~~~~~~Wss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~~lWqSFd~ 152 (840)
+|+++|.++.++|++++.... ..+|+|+++|||||++. .++||||||
T Consensus 206 nLvl~d~~~~~vWsS~t~~~~-~~rl~Ld~dGnLvly~~--------~~~Wqsf~~ 252 (276)
T 3m7h_A 206 NLVVYGAGNAVLWHSHTGGHA-SAVLRLQANGSIAILDE--------KPVWARFGF 252 (276)
T ss_dssp CEEEECTTSCEEEECSCTTCT-TCEEEECTTSCEEEEEE--------EEEEESSSC
T ss_pred eEEEEeCCCcEEEEecCCCCC-CEEEEEcCCccEEEEcC--------CCeEEccCc
Confidence 999999988999999976443 47899999999999973 369999996
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.11 E-value=2.5e-10 Score=101.74 Aligned_cols=87 Identities=18% Similarity=0.311 Sum_probs=66.7
Q ss_pred CCceEEEecCCceEEecCCCceEEEecCCCCCCCceEEEecCCCeEEEeccCCCCCCCceeEEecCCCCCcccCCCcccc
Q 041702 86 PHGILAINNNGNLVLLNQANGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSEGSYLWQSFDFPSDTLLPGMKVGW 165 (840)
Q Consensus 86 ~~~~l~~~~~G~L~l~~~~~~~~Wss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~~lWqSFd~PtDtlLpg~~l~~ 165 (840)
....|.++.||||||++. .++|++++........++|+|+|||||+|. .+.++|||-.+-
T Consensus 24 g~~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~------~~~~iW~S~t~~------------ 83 (110)
T 3r0e_B 24 KNHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDD------DFKTIWSSRSSS------------ 83 (110)
T ss_dssp SSCEEEECTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECT------TCCEEEECCCCC------------
T ss_pred CCEEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeC------CCCEEEEcCCcC------------
Confidence 357899999999999887 599999987654456899999999999983 345799974310
Q ss_pred ccccCCceeEEEeccCCCCCCCceEEeecCCCCcEEEEEcCCeeeEEeCC
Q 041702 166 DLKTGRERYLTSWRTADDPSPGKFTYRLDIHVLPQIFLYKGSLKLARIGP 215 (840)
Q Consensus 166 ~~~tg~~~~l~S~~s~~dps~G~~~l~~~~~~~~~~~~~~~~~~~~~~g~ 215 (840)
..|.|.+.++.+|...++ + .+.|.+|+
T Consensus 84 -------------------~~~~~~~~L~~dGNlvly--~--~~~W~t~~ 110 (110)
T 3r0e_B 84 -------------------KQGEYVLILQDDGFGVIY--G--PAIFETSS 110 (110)
T ss_dssp -------------------SSSCCEEEECTTSCEEEE--C--SEEEESCC
T ss_pred -------------------CCCCEEEEEcCCccEEEe--c--CCEecCCC
Confidence 134588999999987765 4 47888763
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.05 E-value=6.6e-10 Score=99.04 Aligned_cols=87 Identities=20% Similarity=0.292 Sum_probs=66.9
Q ss_pred CceEEEecCCceEEecCCCceEEEecCCCCCCCceEEEecCCCeEEEeccCCCCCCCceeEEecCCCCCcccCCCccccc
Q 041702 87 HGILAINNNGNLVLLNQANGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSEGSYLWQSFDFPSDTLLPGMKVGWD 166 (840)
Q Consensus 87 ~~~l~~~~~G~L~l~~~~~~~~Wss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~~lWqSFd~PtDtlLpg~~l~~~ 166 (840)
...|.++.||||||++. +.++|++++........+.|+|+|||||+|. .+.++|||....
T Consensus 20 ~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~------~~~~~W~S~t~~------------- 79 (109)
T 3dzw_A 20 RYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSP------RNNPIWASNTGG------------- 79 (109)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECT------TSCEEEECCCCC-------------
T ss_pred CEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECC------CCCEEEECCCCC-------------
Confidence 57899999999999988 7899999987554456899999999999983 345799875321
Q ss_pred cccCCceeEEEeccCCCCCCCceEEeecCCCCcEEEEEcCCeeeEEeCC
Q 041702 167 LKTGRERYLTSWRTADDPSPGKFTYRLDIHVLPQIFLYKGSLKLARIGP 215 (840)
Q Consensus 167 ~~tg~~~~l~S~~s~~dps~G~~~l~~~~~~~~~~~~~~~~~~~~~~g~ 215 (840)
..+.|.+.++.+|...++ +. +.|.+|.
T Consensus 80 ------------------~~~~~~~~L~ddGNlvly--~~--~~W~s~t 106 (109)
T 3dzw_A 80 ------------------ENGNYVCVLQKDRNVVIY--GT--ARWATGT 106 (109)
T ss_dssp ------------------SSSCEEEEECTTSCEEEE--ES--CCCCCCC
T ss_pred ------------------CCCCEEEEEeCCCEEEEE--CC--CEEeCCC
Confidence 124688999999987765 32 6777664
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.05 E-value=3.5e-10 Score=100.68 Aligned_cols=91 Identities=25% Similarity=0.444 Sum_probs=68.8
Q ss_pred CCCCCCCceEEEecCCceEEecCCCceEEEecCCCCCCCceEEEecCCCeEEEeccCCCCCCCceeEEecCCCCCcccCC
Q 041702 81 CPILDPHGILAINNNGNLVLLNQANGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSEGSYLWQSFDFPSDTLLPG 160 (840)
Q Consensus 81 ~p~~~~~~~l~~~~~G~L~l~~~~~~~~Wss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~~lWqSFd~PtDtlLpg 160 (840)
.|+.+....|.++.||||||+++ +|++++........++|+++|||||+|. .+.++|+|- |
T Consensus 16 ~~L~~g~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~------~~~~vWss~-----t---- 76 (109)
T 3r0e_A 16 GHLKNGDFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNG------DGSTVWKSG-----A---- 76 (109)
T ss_dssp CEEEETTEEEEECTTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECT------TSCEEEECC-----C----
T ss_pred CEeECCCEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeC------CCCEEEcCC-----C----
Confidence 34444567899999999999985 7999987655457889999999999983 335688742 1
Q ss_pred CccccccccCCceeEEEeccCCCCCCCceEEeecCCCCcEEEEEcCCeeeEEeCCC
Q 041702 161 MKVGWDLKTGRERYLTSWRTADDPSPGKFTYRLDIHVLPQIFLYKGSLKLARIGPW 216 (840)
Q Consensus 161 ~~l~~~~~tg~~~~l~S~~s~~dps~G~~~l~~~~~~~~~~~~~~~~~~~~~~g~w 216 (840)
....+.|.+.++++|...++ + .+.|.+++|
T Consensus 77 ----------------------~~~~~~~~~~L~~dGNlvly--~--~~~W~s~t~ 106 (109)
T 3r0e_A 77 ----------------------QSVKGNYAAVVHPDGRLVVF--G--PSVFKIDPW 106 (109)
T ss_dssp ----------------------CCSSSCCEEEEETTTEEEEE--C--SEEEEECTT
T ss_pred ----------------------cCCCcCEEEEEcCCCeEEEE--e--cCEECCCCc
Confidence 01235689999999986665 3 688999987
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.05 E-value=7.3e-10 Score=115.77 Aligned_cols=147 Identities=16% Similarity=0.111 Sum_probs=109.9
Q ss_pred HHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcC-CCCccce
Q 041702 510 SAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQ-HRNLVRL 588 (840)
Q Consensus 510 ~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~-H~niv~l 588 (840)
......|+....++.|+.+.||++. ..++.+++|+..........++.+|+++++.+. |.++.++
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~--------------~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v 75 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLV--------------GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKV 75 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEE--------------CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCE
T ss_pred HHHhccceeEeeccCCCCCeEEEEE--------------CCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeE
Confidence 4455678888889999999999974 236789999987532233457899999999994 6788899
Q ss_pred eeEeecCCceEEEEEeeccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------
Q 041702 589 FGCCIEQGEKISIYEFDIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYS----------------------------- 639 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~----------------------------- 639 (840)
++++...+..++|||+..-...... ..+......++.+++++|..||+..
T Consensus 76 ~~~~~~~~~~~lv~e~i~G~~l~~~-~~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (263)
T 3tm0_A 76 LHFERHDGWSNLLMSEADGVLCSEE-YEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD 154 (263)
T ss_dssp EEEEEETTEEEEEEECCSSEEHHHH-CCTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCS
T ss_pred EEEEecCCceEEEEEecCCeehhhc-cCCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccc
Confidence 9999988899999999322111111 1122344578999999999999811
Q ss_pred ---------------------------CCceecCCCCCCcEEecCCCCceeecccccee
Q 041702 640 ---------------------------RLRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 640 ---------------------------~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
+..++|+|++|.|||++++..+.|+||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13489999999999998765567999998753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.86 E-value=3.8e-09 Score=109.89 Aligned_cols=139 Identities=15% Similarity=0.094 Sum_probs=98.8
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCC--ccceee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRN--LVRLFG 590 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~n--iv~l~g 590 (840)
...+......+.|..+.||++. ..+|+.+++|+.... ....+.+|+.+++.+.+.+ +.++++
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~-------------~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~ 82 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLS-------------AQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLD 82 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEE-------------CTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEE
T ss_pred cCCCceEecccCCCCceEEEEe-------------cCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEE
Confidence 3445543333455669999963 235778999997643 2356889999999996544 567899
Q ss_pred EeecCCceEEEEEeeccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------
Q 041702 591 CCIEQGEKISIYEFDIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYS------------------------------- 639 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------------- 639 (840)
+....+..+++||+..-.... .+......++.++++.|..||+..
T Consensus 83 ~~~~~~~~~~v~e~i~G~~l~----~~~~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (264)
T 1nd4_A 83 VVTEAGRDWLLLGEVPGQDLL----SSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDL 158 (264)
T ss_dssp EEECSSCEEEEEECCSSEETT----TSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSC
T ss_pred eccCCCCCEEEEEecCCcccC----cCcCCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhh
Confidence 888888899999984222111 111223478889999999999743
Q ss_pred ------------------------CCceecCCCCCCcEEecCCCCceeecccccee
Q 041702 640 ------------------------RLRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 640 ------------------------~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
+..++|+|++|.|||++++..++|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 159 DEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998776677999998754
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.79 E-value=2.1e-08 Score=88.33 Aligned_cols=78 Identities=26% Similarity=0.401 Sum_probs=59.9
Q ss_pred CceEEEecCCceEEecCCCceEEEecCCCCC-CCceEEEecCCCeEEEeccCCCCCCCceeEEecCCCCCcccCCCcccc
Q 041702 87 HGILAINNNGNLVLLNQANGTIWSSNMSKEA-KSPVAQLLDTGNLVLRENFSNNTSEGSYLWQSFDFPSDTLLPGMKVGW 165 (840)
Q Consensus 87 ~~~l~~~~~G~L~l~~~~~~~~Wss~~~~~~-~~~~a~L~d~GNlVl~~~~~~~~~~~~~lWqSFd~PtDtlLpg~~l~~ 165 (840)
.-+|.+..||||||++. +.+||++++.... ....+.|.++|||||+| ..++++|.|-
T Consensus 20 ~y~l~~q~DgNLvly~~-~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d------~~~~~vWss~--------------- 77 (105)
T 4h3o_A 20 PYHFIMQDDCNLVLYDH-STSTWASNTEIGGKSGCSAVLQSDGNFVVYD------SSGRSLWASH--------------- 77 (105)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCCCTTCCSCEEEECTTSCEEEEC------TTCCEEEECC---------------
T ss_pred CEEEEECCCCeEEEEEC-CEEEEEecCCCCCCccEEEEEeCCccEEEEC------CCcEEEEEec---------------
Confidence 35799999999999985 6899999986543 34678999999999998 3446788751
Q ss_pred ccccCCceeEEEeccCCCCCCCceEEeecCCCCcEEE
Q 041702 166 DLKTGRERYLTSWRTADDPSPGKFTYRLDIHVLPQIF 202 (840)
Q Consensus 166 ~~~tg~~~~l~S~~s~~dps~G~~~l~~~~~~~~~~~ 202 (840)
+....+.|.+.++++|...++
T Consensus 78 ----------------t~~~~~~~~l~L~ddGNlVly 98 (105)
T 4h3o_A 78 ----------------STRGSGNYILILQDDGNVIIY 98 (105)
T ss_dssp ----------------CCCCSSCEEEEECTTSCEEEE
T ss_pred ----------------CCCCCCCEEEEEeCCCeEEEE
Confidence 112346789999999987664
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.72 E-value=6.8e-08 Score=105.76 Aligned_cols=140 Identities=13% Similarity=0.247 Sum_probs=102.5
Q ss_pred ccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEec--cCC-CcCHHHHHHHHHHHhhcC--CCCccceeeEe
Q 041702 518 EENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLS--SKS-GQGLEEFKNEMMLIAKLQ--HRNLVRLFGCC 592 (840)
Q Consensus 518 ~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~--~~~-~~~~~~f~~Ev~~l~~l~--H~niv~l~g~~ 592 (840)
..+.|+.|.++.||++.. .+..+++|+.. ... ......+.+|+.+++.+. +..+++++.++
T Consensus 42 ~~~~l~~G~sn~~y~v~~--------------~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~ 107 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVT--------------PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALC 107 (359)
T ss_dssp EEEECCC-CCSCEEEEEC--------------SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEE
T ss_pred eEEEcCCcccceEEEEEE--------------CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEEC
Confidence 356899999999999742 34678888876 322 123457889999999996 45688999998
Q ss_pred ecC---CceEEEEEeeccCCc--cccCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------
Q 041702 593 IEQ---GEKISIYEFDIVTDP--ARKDLLDWTTRVRIIEGVAQGLLYLHQYS---------------------------- 639 (840)
Q Consensus 593 ~~~---~~~~lv~e~~~~~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~---------------------------- 639 (840)
.+. +..++|||+..-... .....++..++..++.++++.|+.||+..
T Consensus 108 ~~~~~~g~~~~vme~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (359)
T 3dxp_A 108 EDESVIGRAFYIMEFVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYK 187 (359)
T ss_dssp CCTTTTSSCEEEEECCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHH
T ss_pred CCCCccCCeEEEEEecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHH
Confidence 776 458999999432221 12234677888999999999999999731
Q ss_pred ---------------------------CCceecCCCCCCcEEecCCCC--ceeecccccee
Q 041702 640 ---------------------------RLRVIHRDLKASNVLLDSDMN--PKISDFGIART 671 (840)
Q Consensus 640 ---------------------------~~~ivHrDlkp~NILl~~~~~--~kL~DFGla~~ 671 (840)
+..++|+|+++.|||++.++. +.|+||+.+..
T Consensus 188 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 188 LSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997754 58999999865
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.53 E-value=1.8e-07 Score=95.65 Aligned_cols=86 Identities=23% Similarity=0.351 Sum_probs=66.1
Q ss_pred CceEEEecCCceEEecCCCceEEEecCCCCCCCceEEEecCCCeEEEeccCCCCCCCceeEEecCCCCCcccCCCccccc
Q 041702 87 HGILAINNNGNLVLLNQANGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSEGSYLWQSFDFPSDTLLPGMKVGWD 166 (840)
Q Consensus 87 ~~~l~~~~~G~L~l~~~~~~~~Wss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~~lWqSFd~PtDtlLpg~~l~~~ 166 (840)
.-+|.++.+|+|+|.+.+ .++|++++.+......++|.++||||+++. .+.++||||.+
T Consensus 151 ~~~l~l~~dG~LvL~~~~-~~~W~s~~~~~~~~~~~~L~~~Gnl~ly~~------~~~~vw~s~~~-------------- 209 (236)
T 1dlp_A 151 PYRLSMETDCNLVLFDRD-DRVWSTNTAGKGTGCRAVLQPNGRMDVLTN------QNIAVWTSGNS-------------- 209 (236)
T ss_dssp SCEEEEETTTEEEEEBTT-BCCSCCCCCSSCSSCEEEEETTTEEEEEET------TTEEEEECCCC--------------
T ss_pred cEEEEECCCCcEEEEcCC-EeEEeCCCcCCCCceEEEECCCCcEEEEeC------CCcEEEEeCCC--------------
Confidence 567999999999999874 689999876544456789999999999983 33579999943
Q ss_pred cccCCceeEEEeccCCCCCCCceEEeecCCCCcEEEEEcCCeeeEEeC
Q 041702 167 LKTGRERYLTSWRTADDPSPGKFTYRLDIHVLPQIFLYKGSLKLARIG 214 (840)
Q Consensus 167 ~~tg~~~~l~S~~s~~dps~G~~~l~~~~~~~~~~~~~~~~~~~~~~g 214 (840)
| ++|.|++.+|++|..+++ . ..||.+|
T Consensus 210 -----------~------~~~~~rl~Ld~dG~l~ly--~--~~~W~sg 236 (236)
T 1dlp_A 210 -----------R------SAGRYVFVLQPDRNLAIY--G--GALWTTG 236 (236)
T ss_dssp -----------C------SSSCCEEEECSSSCEEEE--C--CCCCBC-
T ss_pred -----------C------CCCCEEEEEcCCCcEEEe--C--CCCccCC
Confidence 1 236789999999987765 3 3788765
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.47 E-value=9.6e-08 Score=101.97 Aligned_cols=183 Identities=16% Similarity=0.167 Sum_probs=115.2
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhc-CCCC--ccceeeEeecCC
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL-QHRN--LVRLFGCCIEQG 596 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l-~H~n--iv~l~g~~~~~~ 596 (840)
+.++.|....||++ +..+++|+.... .....+.+|+++|+.+ .+.. +.+++......+
T Consensus 26 ~~~~~G~~n~v~~v-----------------~~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~ 86 (304)
T 3sg8_A 26 EISGEGNDCIAYEI-----------------NRDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSE 86 (304)
T ss_dssp CEEEECSSEEEEES-----------------TTSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCS
T ss_pred EecCCCCcceEEEE-----------------CCEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCC
Confidence 46899999999984 146889986532 3346789999999988 3433 455555544333
Q ss_pred ---ceEEEEEeeccCCcc--ccCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------
Q 041702 597 ---EKISIYEFDIVTDPA--RKDLLDWTTRVRIIEGVAQGLLYLHQYS-------------------------------- 639 (840)
Q Consensus 597 ---~~~lv~e~~~~~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~-------------------------------- 639 (840)
..++||++..-.... ....++..++..++.++++.|+.||+..
T Consensus 87 ~~~~~~~vm~~i~G~~l~~~~~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (304)
T 3sg8_A 87 TYQMSFAGFTKIKGVPLTPLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELK 166 (304)
T ss_dssp SCSCSCEEEECCCCEECCHHHHHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSC
T ss_pred CCCcceEEEcccCCeECCccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCC
Confidence 347788883211111 1234566778889999999999999621
Q ss_pred -----------------------CCceecCCCCCCcEEecC--CCCceeeccccceecCCCCcccccc------------
Q 041702 640 -----------------------RLRVIHRDLKASNVLLDS--DMNPKISDFGIARTFGGDEMQSNTN------------ 682 (840)
Q Consensus 640 -----------------------~~~ivHrDlkp~NILl~~--~~~~kL~DFGla~~~~~~~~~~~~~------------ 682 (840)
++.++|+|++|.||++++ ...+.|+||+.+..-..........
T Consensus 167 ~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~ 246 (304)
T 3sg8_A 167 GPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVS 246 (304)
T ss_dssp HHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHH
T ss_pred cccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHH
Confidence 235899999999999988 4567899999987542210000000
Q ss_pred cccccccccC-ccccccCCCCccccchhHHHHHHHHHhCCCC
Q 041702 683 RIVGTYGYMS-PEYALHGLFSIKSDVFSFGVLLLEILSSKKN 723 (840)
Q Consensus 683 ~~~gt~~y~a-PE~~~~~~~~~ksDV~SlGviL~elltG~~p 723 (840)
......+... |+.... .....+.|+++.+++++.+|..+
T Consensus 247 ~~l~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~ 286 (304)
T 3sg8_A 247 KILNHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMD 286 (304)
T ss_dssp HHHHHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHH
T ss_pred HHHHHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHH
Confidence 0000011112 222111 12236899999999999999865
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.95 E-value=1.8e-05 Score=82.54 Aligned_cols=136 Identities=16% Similarity=0.091 Sum_probs=92.1
Q ss_pred cccCCCCc-cEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcC-CCCccceeeEeecCCce
Q 041702 521 KLGEGGFG-PVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQ-HRNLVRLFGCCIEQGEK 598 (840)
Q Consensus 521 ~lG~G~~G-~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~~ 598 (840)
.+..|..+ .||+.... .++..+++|+-... ...++.+|...|+.+. +-.+.++++++.+.+..
T Consensus 31 ~~~~G~S~~~v~rl~~~------------~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~ 95 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGK------------PNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDA 95 (272)
T ss_dssp EEECSSSSCEEEEEECC------------TTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred EccCCCcCCeEEEEEec------------CCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeE
Confidence 45555555 58986432 45678999986533 3457889999999884 44578899999999999
Q ss_pred EEEEEeeccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 041702 599 ISIYEFDIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYS--------------------------------------- 639 (840)
Q Consensus 599 ~lv~e~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--------------------------------------- 639 (840)
++|||+..-................+..+++..|.-||...
T Consensus 96 ~lvme~l~G~~~~~~~~~~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (272)
T 4gkh_A 96 WLLTTAIPGKTAFQVLEEYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWP 175 (272)
T ss_dssp EEEEECCCSEEHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCC
T ss_pred EEEEEeeCCccccccccCCHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchH
Confidence 99999832111110001112334456677777777777421
Q ss_pred ----------------CCceecCCCCCCcEEecCCCCceeecccccee
Q 041702 640 ----------------RLRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 640 ----------------~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
++.++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 176 ~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 176 VEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12279999999999999877777999998754
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.76 E-value=9.7e-05 Score=78.55 Aligned_cols=133 Identities=22% Similarity=0.177 Sum_probs=91.4
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCC---CccceeeEee-cC
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHR---NLVRLFGCCI-EQ 595 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~---niv~l~g~~~-~~ 595 (840)
+.++.|....||+. +..+++|+-.. ......+.+|+++|..+.+. .+.+.+.++. ..
T Consensus 25 ~~l~~G~~n~v~~v-----------------g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~ 85 (306)
T 3tdw_A 25 ESLGEGFRNYAILV-----------------NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSD 85 (306)
T ss_dssp EEEEECSSEEEEEE-----------------TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTT
T ss_pred eecCCCcceeEEEE-----------------CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCC
Confidence 46788888899983 45688888532 22346789999999999652 3667777774 45
Q ss_pred CceEEEEEeeccCCcc--ccCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------
Q 041702 596 GEKISIYEFDIVTDPA--RKDLLDWTTRVRIIEGVAQGLLYLHQY----------------------------------- 638 (840)
Q Consensus 596 ~~~~lv~e~~~~~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~----------------------------------- 638 (840)
+..+++||+..-.... ....++..++..++.++++.|+.||+.
T Consensus 86 g~~~~v~e~i~G~~l~~~~~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~ 165 (306)
T 3tdw_A 86 GNPFVGYRKVQGQILGEDGMAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLD 165 (306)
T ss_dssp SCEEEEEECCCSEECHHHHHTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSC
T ss_pred CceEEEEeccCCeECchhhhhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccc
Confidence 5678999983211111 112345556667777777777777753
Q ss_pred ----------------------CCCceecCCCCCCcEEecC---CCCc-eeecccccee
Q 041702 639 ----------------------SRLRVIHRDLKASNVLLDS---DMNP-KISDFGIART 671 (840)
Q Consensus 639 ----------------------~~~~ivHrDlkp~NILl~~---~~~~-kL~DFGla~~ 671 (840)
.++.++|+|+++.|||++. ++.+ .|+||+.+..
T Consensus 166 ~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 166 ESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred hhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2234699999999999987 4554 7999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00019 Score=77.91 Aligned_cols=147 Identities=10% Similarity=0.054 Sum_probs=87.6
Q ss_pred cccc-cCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC---CcCHHHHHHHHHHHhhcC-C--CCccceeeE
Q 041702 519 ENKL-GEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS---GQGLEEFKNEMMLIAKLQ-H--RNLVRLFGC 591 (840)
Q Consensus 519 ~~~l-G~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~---~~~~~~f~~Ev~~l~~l~-H--~niv~l~g~ 591 (840)
.+.| +.|....+|+....... ....+++.+++|+..... ......+.+|+.+++.+. + ..+.+++++
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~------~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~ 98 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQ------DGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWI 98 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEE------TTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEE
T ss_pred EEECCCCCccceEEEEEEeccc------CCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEE
Confidence 3567 78888999986421000 000026678899865432 112356889999999884 3 367888888
Q ss_pred eecC---CceEEEEEeeccCCcccc----------CCCCHHHHHHHHHHHHHHHHHHHh---------------------
Q 041702 592 CIEQ---GEKISIYEFDIVTDPARK----------DLLDWTTRVRIIEGVAQGLLYLHQ--------------------- 637 (840)
Q Consensus 592 ~~~~---~~~~lv~e~~~~~~~~~~----------~~l~~~~~~~i~~~ia~~L~yLH~--------------------- 637 (840)
+.+. +..+++||+..-...... ..++..++..++.++++.|.-||+
T Consensus 99 ~~~~~~~g~~~~v~e~l~G~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~La~LH~~~~~~~~l~~~~~~~~~~~~~ 178 (357)
T 3ats_A 99 ETTGDVLGTPFFLMDYVEGVVPPDVMPYTFGDNWFADAPAERQRQLQDATVAALATLHSIPNAQNTFSFLTQGRTSDTTL 178 (357)
T ss_dssp ECSSTTTSSCEEEEECCCCBCCCBTTBGGGSCSTTTTSCHHHHHHHHHHHHHHHHHHTTCSSHHHHTGGGC-----CCHH
T ss_pred ccCCCccCCceEEEEecCCCChhhcCcccccccccCCCCHHHHHHHHHHHHHHHHHHhCCCCccCChhhccCCCCCCchH
Confidence 7665 356889998321111100 012223333334444444433332
Q ss_pred ---------------------------------c-------CCCceecCCCCCCcEEecCCCCceeecccccee
Q 041702 638 ---------------------------------Y-------SRLRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 638 ---------------------------------~-------~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
. .+..++|+|+.+.|||++++..+.|+||+.+..
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 179 HRHFNWVRSWYDFAVEGIGRSPLLERTFEWLQSHWPDDAAAREPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp HHHHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHTCCHHHHHSCCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred HHHHHHHHHHHHhhccCCCCChHHHHHHHHHHHhCCCcccCCCceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 1 135689999999999998644578999998854
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.55 E-value=8.2e-05 Score=82.25 Aligned_cols=72 Identities=11% Similarity=0.218 Sum_probs=47.6
Q ss_pred cccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-------cCHHHHHHHHHHHhhcCC--C-Cccce
Q 041702 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-------QGLEEFKNEMMLIAKLQH--R-NLVRL 588 (840)
Q Consensus 519 ~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-------~~~~~f~~Ev~~l~~l~H--~-niv~l 588 (840)
.+.||.|..+.||++... .+++.++||....... ...+++..|.+++..+.+ + .+.++
T Consensus 35 ~~~lg~G~~n~vyrv~~~------------~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~ 102 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQ------------EHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRV 102 (397)
T ss_dssp EEECCSSSSEEEEEEEC----------------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCE
T ss_pred EEECCCCceEEEEEEEEC------------CCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeE
Confidence 457999999999998533 2467899998653211 234567889999988843 3 34456
Q ss_pred eeEeecCCceEEEEEe
Q 041702 589 FGCCIEQGEKISIYEF 604 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~ 604 (840)
+.+ +.+..++|||+
T Consensus 103 ~~~--d~~~~~lvmE~ 116 (397)
T 2olc_A 103 FYS--DTEMAVTVMED 116 (397)
T ss_dssp EEE--ETTTTEEEECC
T ss_pred EEE--cCCccEEEEEe
Confidence 644 34556899998
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0024 Score=67.74 Aligned_cols=70 Identities=21% Similarity=0.181 Sum_probs=55.9
Q ss_pred ccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcC---CCCccceeeEeec
Q 041702 518 EENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQ---HRNLVRLFGCCIE 594 (840)
Q Consensus 518 ~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~---H~niv~l~g~~~~ 594 (840)
..+.|+.|....+|+.. .++..+++|+.... ....|..|++.|+.|. ...++++++++..
T Consensus 40 ~~~~l~gG~~n~~y~v~--------------~~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~ 102 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIN--------------DEVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNS 102 (312)
T ss_dssp EEEEECCSSSSEEEEEE--------------SSSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC
T ss_pred eeEEeCCccceeeeEEE--------------ECCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec
Confidence 34679999999999963 24678889987643 3567899999999884 3578899999888
Q ss_pred CCceEEEEEe
Q 041702 595 QGEKISIYEF 604 (840)
Q Consensus 595 ~~~~~lv~e~ 604 (840)
.+..++|||+
T Consensus 103 ~g~~~lvme~ 112 (312)
T 3jr1_A 103 QGHSFLLLEA 112 (312)
T ss_dssp SSEEEEEEEC
T ss_pred CCceEEEEEe
Confidence 8889999998
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0029 Score=67.79 Aligned_cols=44 Identities=18% Similarity=0.079 Sum_probs=34.3
Q ss_pred HHHHHHHHHh----------cCCCceecCCCCCCcEEecCCCCceeecccccee
Q 041702 628 VAQGLLYLHQ----------YSRLRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 628 ia~~L~yLH~----------~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
+.+++.+|+. ..+..++|+|+++.|||++.++.+.|+||+.+..
T Consensus 199 ~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 199 GLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 3446667763 1245699999999999998888999999998753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.12 E-value=0.00071 Score=71.05 Aligned_cols=74 Identities=16% Similarity=0.176 Sum_probs=54.2
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCC---CCccceee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQH---RNLVRLFG 590 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H---~niv~l~g 590 (840)
..+.....+|.|..+.||+.. +.+|+.|.+|+-..........|..|++.|+.|.- -.++++++
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~-------------l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~ 81 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVE-------------LADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAG 81 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEE-------------ETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEE
T ss_pred CCeEEEEecCCCCCeEEEEEE-------------ECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEe
Confidence 455666789999999999963 46899999998775544445678999999998842 23555665
Q ss_pred EeecCCceEEEEEe
Q 041702 591 CCIEQGEKISIYEF 604 (840)
Q Consensus 591 ~~~~~~~~~lv~e~ 604 (840)
+. ..+++||+
T Consensus 82 ~~----~~~lv~e~ 91 (288)
T 3f7w_A 82 WD----DRTLAMEW 91 (288)
T ss_dssp EE----TTEEEEEC
T ss_pred cc----CceEEEEe
Confidence 42 34788887
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0072 Score=67.04 Aligned_cols=78 Identities=12% Similarity=0.105 Sum_probs=48.2
Q ss_pred CCceecCCCCCCcEEecCCCCceeeccccceecCCCCcccccccccc--cccccCccccccC---CCCccccchhHHHHH
Q 041702 640 RLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVG--TYGYMSPEYALHG---LFSIKSDVFSFGVLL 714 (840)
Q Consensus 640 ~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~ksDV~SlGviL 714 (840)
+..++|+|+++.|||++.++ ++|+||+.+..-... ........ ...|.+|+..... .-....++......+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~---~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG---FDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH---HHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH---HHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 45699999999999998776 999999988753210 00000111 1346666654311 112235566888888
Q ss_pred HHHHhCC
Q 041702 715 LEILSSK 721 (840)
Q Consensus 715 ~elltG~ 721 (840)
|+.++++
T Consensus 307 ~~~y~~~ 313 (420)
T 2pyw_A 307 WNLFNKR 313 (420)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 8887653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.47 E-value=0.016 Score=61.57 Aligned_cols=152 Identities=14% Similarity=0.114 Sum_probs=81.6
Q ss_pred cCHHHHHHHccCCcc-----cccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHh
Q 041702 504 FSLSSISAATDNFSE-----ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIA 578 (840)
Q Consensus 504 ~~~~~~~~~~~~f~~-----~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~ 578 (840)
++..++......|.. .+.|+.|....+|+... ++..+++|+.... ...+++..|+.++.
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~--------------~~g~~vlk~~~~~--~~~~~l~~e~~~l~ 70 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHT--------------TKDPLILTLYEKR--VEKNDLPFFLGLMQ 70 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEE--------------SSCCEEEEEECC-----CCHHHHHHHHHH
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEe--------------CCccEEEEEeCCC--CCHHHHHHHHHHHH
Confidence 344455555555543 34567788888998631 2336889988752 12346677888888
Q ss_pred hcCCCC--ccceeeE------eecCCceEEEEEeeccC-------------------------Ccccc-----CCCCHHH
Q 041702 579 KLQHRN--LVRLFGC------CIEQGEKISIYEFDIVT-------------------------DPARK-----DLLDWTT 620 (840)
Q Consensus 579 ~l~H~n--iv~l~g~------~~~~~~~~lv~e~~~~~-------------------------~~~~~-----~~l~~~~ 620 (840)
.+...+ +.+++.. ....+..++++++..-. ..... ....|..
T Consensus 71 ~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~ 150 (322)
T 2ppq_A 71 HLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKV 150 (322)
T ss_dssp HHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHH
T ss_pred HHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHH
Confidence 774222 3444421 12235567888872100 00000 0011322
Q ss_pred HHH------------HHHHHHHHHHHHHhc----CCCceecCCCCCCcEEecCCCCceeecccccee
Q 041702 621 RVR------------IIEGVAQGLLYLHQY----SRLRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 621 ~~~------------i~~~ia~~L~yLH~~----~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
... +...+...+++++.. .+..++|+|+.+.|||++.+..+.|+||+.+..
T Consensus 151 ~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 151 LWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 110 111244455666532 234599999999999998776568999997753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.29 E-value=0.012 Score=61.84 Aligned_cols=126 Identities=11% Similarity=0.068 Sum_probs=79.3
Q ss_pred cccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCc-cceeeEeecCCc
Q 041702 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNL-VRLFGCCIEQGE 597 (840)
Q Consensus 519 ~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~ni-v~l~g~~~~~~~ 597 (840)
.+.|+.|....+|+. +.+++|+....... .....+|+.+++.+...++ .++++++ .+.
T Consensus 23 i~~l~gG~tN~~~~~------------------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~ 81 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------------------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PAT 81 (301)
T ss_dssp CEEEESCSSEEEEEE------------------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTT
T ss_pred eeEcCCcccccccee------------------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCC
Confidence 567888999999983 45888887653222 1234678888888743333 4666553 334
Q ss_pred eEEEEEeeccCCccccCCCCHHHH---HHHHHHHHHHHHHHHhcC-----------------------------------
Q 041702 598 KISIYEFDIVTDPARKDLLDWTTR---VRIIEGVAQGLLYLHQYS----------------------------------- 639 (840)
Q Consensus 598 ~~lv~e~~~~~~~~~~~~l~~~~~---~~i~~~ia~~L~yLH~~~----------------------------------- 639 (840)
.++++||.. ....++.... ..+..++++.|+-||+..
T Consensus 82 ~~~v~e~i~-----~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 156 (301)
T 3dxq_A 82 GVMVTRYIA-----GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVV 156 (301)
T ss_dssp CCEEEECCT-----TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHH
T ss_pred CEEEEeecC-----CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHH
Confidence 578888840 1112222211 225566666666666532
Q ss_pred ---------------CCceecCCCCCCcEEecCCCCceeecccccee
Q 041702 640 ---------------RLRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 640 ---------------~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
+..++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 157 ~~~~~l~~~l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 157 REAGGVRSALAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp HHHHHHHHHHHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 223799999999999 5677889999998764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.02 E-value=0.036 Score=61.98 Aligned_cols=68 Identities=13% Similarity=0.123 Sum_probs=42.0
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCc-cceeeEeecCCce
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNL-VRLFGCCIEQGEK 598 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~ni-v~l~g~~~~~~~~ 598 (840)
+.|+.|-...+|++... ..+..+++|+........ -.-.+|..++..|...++ .++++.+. +
T Consensus 114 ~~lsgG~tN~~y~v~~~------------~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~-~--- 176 (458)
T 2qg7_A 114 QIINGGITNILIKVKDM------------SKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT-N--- 176 (458)
T ss_dssp EEECC--CEEEEEEEET------------TTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET-T---
T ss_pred EEcCCCeEeEEEEEEEC------------CCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC-C---
Confidence 56888888899996421 124778899875432221 122689999999965554 56777763 2
Q ss_pred EEEEEe
Q 041702 599 ISIYEF 604 (840)
Q Consensus 599 ~lv~e~ 604 (840)
.+|+||
T Consensus 177 G~v~e~ 182 (458)
T 2qg7_A 177 GRIEEF 182 (458)
T ss_dssp EEEEEC
T ss_pred eEEEEe
Confidence 358888
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=95.97 E-value=0.014 Score=64.83 Aligned_cols=74 Identities=12% Similarity=0.113 Sum_probs=45.0
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCc-cceeeEeecCCce
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNL-VRLFGCCIEQGEK 598 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~ni-v~l~g~~~~~~~~ 598 (840)
+.|+.|-...+|++.... .......+++.+++|+.... ...+.+..|..++..+...++ +++++.+.+
T Consensus 79 ~~l~gG~tN~~y~v~~~~-----~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~---- 147 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSE-----VYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG---- 147 (429)
T ss_dssp EEECCCTTEEEEEEEECT-----TSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEeCCCcccceEEEEeCC-----CccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence 568888888999974210 00000012568899988432 122567789999998853333 677776543
Q ss_pred EEEEEe
Q 041702 599 ISIYEF 604 (840)
Q Consensus 599 ~lv~e~ 604 (840)
.+++||
T Consensus 148 g~v~e~ 153 (429)
T 1nw1_A 148 GRLEEY 153 (429)
T ss_dssp EEEECC
T ss_pred CEEEEE
Confidence 277887
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.83 E-value=0.095 Score=55.54 Aligned_cols=70 Identities=13% Similarity=0.061 Sum_probs=44.2
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCC--CCccceeeE-----e
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQH--RNLVRLFGC-----C 592 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H--~niv~l~g~-----~ 592 (840)
..|+ |....||++. ..+|+.+++|+..... ...+++..|..++..+.. -.+++++.. .
T Consensus 32 ~~l~-g~~n~~y~v~-------------~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~ 96 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQ-------------DEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLL 96 (328)
T ss_dssp EEEC-CSSSEEEEEC-------------CTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCE
T ss_pred Eeec-CcccceEEEE-------------cCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEE
Confidence 3466 7778899853 2356689999986431 245678889998888842 234555543 1
Q ss_pred ecCCceEEEEEe
Q 041702 593 IEQGEKISIYEF 604 (840)
Q Consensus 593 ~~~~~~~lv~e~ 604 (840)
...+..++++++
T Consensus 97 ~~~g~~~~l~~~ 108 (328)
T 1zyl_A 97 NHQGFYFAVFPS 108 (328)
T ss_dssp EETTEEEEEEEC
T ss_pred EECCEEEEEEEe
Confidence 123455678887
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.80 E-value=0.042 Score=59.74 Aligned_cols=142 Identities=16% Similarity=0.134 Sum_probs=76.9
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcC-CCCccceeeEeecCCce
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQ-HRNLVRLFGCCIEQGEK 598 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~~ 598 (840)
+.|..|-...+|++.... -.+..-.+++.+++|+.... ......+.+|.++++.|. +.-..++++++.+
T Consensus 56 ~~lsGG~TN~~y~v~~~~-----~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~---- 125 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPD-----HLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE---- 125 (379)
T ss_dssp EEC-----CCEEEEECCT-----TSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----
T ss_pred EEcCCcccccEEEEEeCC-----CccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----
Confidence 467777788899864310 00000113578999986432 234567789999999884 3334667776654
Q ss_pred EEEEEeecc---C-----------------------CccccCCCC--HHHHHHHHHHHH-------------------HH
Q 041702 599 ISIYEFDIV---T-----------------------DPARKDLLD--WTTRVRIIEGVA-------------------QG 631 (840)
Q Consensus 599 ~lv~e~~~~---~-----------------------~~~~~~~l~--~~~~~~i~~~ia-------------------~~ 631 (840)
.+|+||..- . ......... |.+..++..++. +.
T Consensus 126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~ 205 (379)
T 3feg_A 126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE 205 (379)
T ss_dssp EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence 288888210 0 000011111 233333333221 12
Q ss_pred HHHHH----h-cCCCceecCCCCCCcEEecCC----CCceeecccccee
Q 041702 632 LLYLH----Q-YSRLRVIHRDLKASNVLLDSD----MNPKISDFGIART 671 (840)
Q Consensus 632 L~yLH----~-~~~~~ivHrDlkp~NILl~~~----~~~kL~DFGla~~ 671 (840)
+..|. . ..+..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 33332 2 123458999999999999876 7899999998754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.31 E-value=0.056 Score=53.09 Aligned_cols=92 Identities=10% Similarity=0.028 Sum_probs=58.3
Q ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceecCCCCccccccccccccccc
Q 041702 612 RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYM 691 (840)
Q Consensus 612 ~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~ 691 (840)
...++++.+.+.++.|.+++|.-+-... .+ ..+=+.|..|+|..+|.+.+.+ ..+. .....+.
T Consensus 42 ~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------~~~~~~~ 104 (229)
T 2yle_A 42 YNQPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD--------------AGEPPPV 104 (229)
T ss_dssp HTSCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C------------------------
T ss_pred cCCCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc--------------ccccCCC
Confidence 3567999999999999999987762211 01 1223356899999999988764 1111 1122566
Q ss_pred CccccccCCCCccccchhHHHHHHHHHhCC
Q 041702 692 SPEYALHGLFSIKSDVFSFGVLLLEILSSK 721 (840)
Q Consensus 692 aPE~~~~~~~~~ksDV~SlGviL~elltG~ 721 (840)
|||... ...+.+.=|||||++||..+--.
T Consensus 105 ~pe~~~-~~~te~~~IysLG~tLY~ALDyg 133 (229)
T 2yle_A 105 AGKLGY-SQCMETEVIESLGIIIYKALDYG 133 (229)
T ss_dssp --CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred Chhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence 888653 45567888999999999988543
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=94.63 E-value=0.098 Score=55.65 Aligned_cols=32 Identities=28% Similarity=0.428 Sum_probs=27.4
Q ss_pred CCceecCCCCCCcEEecCC----CCceeecccccee
Q 041702 640 RLRVIHRDLKASNVLLDSD----MNPKISDFGIART 671 (840)
Q Consensus 640 ~~~ivHrDlkp~NILl~~~----~~~kL~DFGla~~ 671 (840)
+..++|+|+.+.|||++.+ ..+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 4569999999999999875 6789999998865
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=94.47 E-value=0.087 Score=57.01 Aligned_cols=30 Identities=20% Similarity=0.378 Sum_probs=24.7
Q ss_pred CceecCCCCCCcEEecCCCCceeecccccee
Q 041702 641 LRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 641 ~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
..++|+|+++.|||++.+. +.|+||..+..
T Consensus 212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp EEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred eEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 4589999999999997654 89999988753
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=93.78 E-value=0.21 Score=53.28 Aligned_cols=32 Identities=25% Similarity=0.358 Sum_probs=28.0
Q ss_pred CCceecCCCCCCcEEecCCCCceeecccccee
Q 041702 640 RLRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 640 ~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
+..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 35699999999999999888899999987754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=91.11 E-value=0.58 Score=51.48 Aligned_cols=30 Identities=27% Similarity=0.470 Sum_probs=26.4
Q ss_pred CceecCCCCCCcEEecCCCCceeecccccee
Q 041702 641 LRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 641 ~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
..++|+|+.+.||+ +.++.+.|+||..|..
T Consensus 262 ~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 262 LVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 45899999999999 7888999999998854
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=87.27 E-value=19 Score=36.43 Aligned_cols=87 Identities=13% Similarity=0.221 Sum_probs=51.1
Q ss_pred EEEEeeecCCCcEEEeecCCCC--CC----CCCceEEEecCCceEEecCCCceEEEecCCCCCCCceEEEecCCCeEEEe
Q 041702 61 YLGVWYKKSPDTVVWVANRNCP--IL----DPHGILAINNNGNLVLLNQANGTIWSSNMSKEAKSPVAQLLDTGNLVLRE 134 (840)
Q Consensus 61 ~lgiw~~~~~~tvVW~ANr~~p--~~----~~~~~l~~~~~G~L~l~~~~~~~~Wss~~~~~~~~~~a~L~d~GNlVl~~ 134 (840)
.+.|| +....+++|...+..+ +. .+++.+-++.++.+..+|.+|..+|............+..+.+||+++-+
T Consensus 16 ~v~~~-d~~tG~~~w~~~~~~~~~~~~~~~~pdG~ilvs~~~~V~~~d~~G~~~W~~~~~~~~~~~~~~~~~dG~~lv~~ 94 (276)
T 3no2_A 16 KIAII-NKDTKEIVWEYPLEKGWECNSVAATKAGEILFSYSKGAKMITRDGRELWNIAAPAGCEMQTARILPDGNALVAW 94 (276)
T ss_dssp EEEEE-ETTTTEEEEEEECCTTCCCCEEEECTTSCEEEECBSEEEEECTTSCEEEEEECCTTCEEEEEEECTTSCEEEEE
T ss_pred EEEEE-ECCCCeEEEEeCCCccCCCcCeEECCCCCEEEeCCCCEEEECCCCCEEEEEcCCCCccccccEECCCCCEEEEe
Confidence 45555 3224678899887642 11 12344444555556667788999999876422222346788899998876
Q ss_pred cc-CCC----CCCCceeEE
Q 041702 135 NF-SNN----TSEGSYLWQ 148 (840)
Q Consensus 135 ~~-~~~----~~~~~~lWq 148 (840)
.. +.. ..+++.+|+
T Consensus 95 ~~~~~~v~~vd~~Gk~l~~ 113 (276)
T 3no2_A 95 CGHPSTILEVNMKGEVLSK 113 (276)
T ss_dssp ESTTEEEEEECTTSCEEEE
T ss_pred cCCCCEEEEEeCCCCEEEE
Confidence 42 110 134566776
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=84.41 E-value=0.78 Score=32.40 Aligned_cols=13 Identities=8% Similarity=0.324 Sum_probs=4.9
Q ss_pred HHHHHhhhhhhhc
Q 041702 442 ILPAFLIFYRRKK 454 (840)
Q Consensus 442 l~~~~~~~~~~~~ 454 (840)
++++.++++.||+
T Consensus 26 ii~~~~~~~~RRr 38 (44)
T 2ks1_B 26 VVALGIGLFMRRR 38 (44)
T ss_dssp HHHHHHHHHHHTT
T ss_pred HHHHHHHHHhhhh
Confidence 3333333333333
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 840 | ||||
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-60 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-59 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-58 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 9e-57 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 9e-57 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-56 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-56 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-56 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-55 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-55 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-54 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-54 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 9e-54 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-53 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-53 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-53 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-53 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-53 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-52 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-51 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-51 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-51 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-51 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-50 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-49 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-49 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-49 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-48 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-47 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-43 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-42 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-40 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-39 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-39 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-39 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-39 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-38 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-38 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-38 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-38 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-37 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-36 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-36 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 8e-36 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-35 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-35 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-35 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-34 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-33 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-33 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-32 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-31 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-29 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-29 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-28 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-28 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-26 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-24 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 2e-22 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-22 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 1e-14 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 2e-13 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 3e-13 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 9e-13 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 5e-08 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 1e-07 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 2e-60
Identities = 74/286 (25%), Positives = 125/286 (43%), Gaps = 37/286 (12%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNE 573
+ ++G G FG V+ G LN ++VA+K + + E+F E
Sbjct: 5 SELTFVQEIGSGQFGLVHL-------------GYWLNKDKVAIKTIR-EGAMSEEDFIEE 50
Query: 574 MMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTD-----PARKDLLDWTTRVRIIEGV 628
++ KL H LV+L+G C+EQ ++EF ++ L T + + V
Sbjct: 51 AEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV 110
Query: 629 AQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTY 688
+G+ YL + VIHRDL A N L+ + K+SDFG+ R D+ +++
Sbjct: 111 CEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPV 166
Query: 689 GYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAW 748
+ SPE +S KSDV+SFGVL+ E+ S K ++S + +
Sbjct: 167 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-------EVVEDISTGF 219
Query: 749 KLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794
+L P + + +Y ++ C +E DRP ++ L +
Sbjct: 220 RLYKPRLASTHVY-------QIMNHCWKERPEDRPAFSRLLRQLAE 258
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 2e-60
Identities = 63/297 (21%), Positives = 123/297 (41%), Gaps = 39/297 (13%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNE 573
+ ++G G FG VYK GK V + +++ + Q L+ FKNE
Sbjct: 8 GQITVGQRIGSGSFGTVYK-------------GKWHGDVAVKMLNVTAPTPQQLQAFKNE 54
Query: 574 MMLIAKLQHRNLVRLFGCCIEQGEKISIYEF-------DIVTDPARKDLLDWTTRVRIIE 626
+ ++ K +H N++ G I + ++ + K + + I
Sbjct: 55 VGVLRKTRHVNILLFMGYSTAPQLAI-VTQWCEGSSLYHHLHIIETK--FEMIKLIDIAR 111
Query: 627 GVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVG 686
AQG+ YLH +IHRDLK++N+ L D+ KI DFG+A ++ G
Sbjct: 112 QTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSG 168
Query: 687 TYGYMSPEYALH---GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWK 743
+ +M+PE +S +SDV++FG++L E+++ + + N ++ +
Sbjct: 169 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP--YSNINNRDQIIFMVGRGY 226
Query: 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLP 800
+ ++ C+++ +RP +++A ++ +LP
Sbjct: 227 LSPDLSKVRSNCPKAM--------KRLMAECLKKKRDERPLFPQILASIELLARSLP 275
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 4e-59
Identities = 75/298 (25%), Positives = 132/298 (44%), Gaps = 37/298 (12%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNE 573
++ E KLG+G FG V+ G VA+K L E F E
Sbjct: 17 ESLRLEVKLGQGCFGEVWM-------------GTWNGTTRVAIKTLK-PGTMSPEAFLQE 62
Query: 574 MMLIAKLQHRNLVRLFGCCIEQG-----EKISIYEFDIVTDPARKDLLDWTTRVRIIEGV 628
++ KL+H LV+L+ E+ E +S L V + +
Sbjct: 63 AQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI 122
Query: 629 AQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTY 688
A G+ Y+ + +HRDL+A+N+L+ ++ K++DFG+AR +E +
Sbjct: 123 ASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPI 178
Query: 689 GYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAW 748
+ +PE AL+G F+IKSDV+SFG+LL E+ + + Y + L + ++ +
Sbjct: 179 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR--VPYPGMVNREV-----LDQVERGY 231
Query: 749 KLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSPHQPA 806
++ P E+L+ ++ + C ++ +RPT + A L+D + +QP
Sbjct: 232 RMPCPPECPESLHDLMCQ-------CWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 2e-58
Identities = 74/287 (25%), Positives = 130/287 (45%), Gaps = 39/287 (13%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNE 573
+ +LG G FG V+ G +VAVK L + + F E
Sbjct: 13 ETLKLVERLGAGQFGEVWM-------------GYYNGHTKVAVKSLK-QGSMSPDAFLAE 58
Query: 574 MMLIAKLQHRNLVRLFGCCIEQGEKISIYEF------DIVTDPARKDLLDWTTRVRIIEG 627
L+ +LQH+ LVRL+ ++ I I E+ L + +
Sbjct: 59 ANLMKQLQHQRLVRLYAVVTQEPIYI-ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
+A+G+ ++ + IHRDL+A+N+L+ ++ KI+DFG+AR +E +
Sbjct: 118 IAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFP 173
Query: 688 YGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKA 747
+ +PE +G F+IKSDV+SFG+LL EI++ + Y + + + ++
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR--IPYPGMTNPEV-----IQNLERG 226
Query: 748 WKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794
++++ P E LY ++ LC +E DRPT + ++L+D
Sbjct: 227 YRMVRPDNCPEELY-------QLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 9e-57
Identities = 62/295 (21%), Positives = 124/295 (42%), Gaps = 33/295 (11%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQG-LEEFKN 572
+ + +G G FG VYK K VA+K L + + +F
Sbjct: 7 SCVTRQKVIGAGEFGEVYK--------GMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLG 58
Query: 573 EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPA-----RKDLLDWTTRVRIIEG 627
E ++ + H N++RL G + + I E+ + V ++ G
Sbjct: 59 EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 118
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNT-NRIVG 686
+A G+ YL + +HRDL A N+L++S++ K+SDFG++R D + T +
Sbjct: 119 IAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175
Query: 687 TYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDK 746
+ +PE + F+ SDV+SFG+++ E+++ + + + +
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGE--------------RPYWELSNHE 221
Query: 747 AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPS 801
K ++ + + ++ + C Q+ RP ++V++L D+++ P
Sbjct: 222 VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL-DKLIRAPD 275
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 9e-57
Identities = 70/286 (24%), Positives = 119/286 (41%), Gaps = 37/286 (12%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNE 573
+ + +LG G FG V GK +VA+K + + +EF E
Sbjct: 4 KDLTFLKELGTGQFGVVKY-------------GKWRGQYDVAIKMIK-EGSMSEDEFIEE 49
Query: 574 MMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTD-----PARKDLLDWTTRVRIIEGV 628
++ L H LV+L+G C +Q I E+ + + + + V
Sbjct: 50 AKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 109
Query: 629 AQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTY 688
+ + YL + +HRDL A N L++ K+SDFG++R DE S+
Sbjct: 110 CEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG-SKFPV 165
Query: 689 GYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAW 748
+ PE ++ FS KSD+++FGVL+ EI S K Y + ++ +
Sbjct: 166 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK--MPYERFT-----NSETAEHIAQGL 218
Query: 749 KLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794
+L P + +E +Y + C E A +RPT +++ + D
Sbjct: 219 RLYRPHLASEKVY-------TIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (495), Expect = 1e-56
Identities = 60/301 (19%), Positives = 110/301 (36%), Gaps = 41/301 (13%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIA 578
+ +G+G FG V++ GEEVAVK SS+ + + E+
Sbjct: 8 QESIGKGRFGEVWRGK--------------WRGEEVAVKIFSSREERS-WFREAEIYQTV 52
Query: 579 KLQHRNLVRLFGCCIEQGEKIS----IYEFDI---VTDPARKDLLDWTTRVRIIEGVAQG 631
L+H N++ + + + ++ + D + + +++ A G
Sbjct: 53 MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASG 112
Query: 632 LLYLHQ-----YSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTF--GGDEMQSNTNRI 684
L +LH + + HRDLK+ N+L+ + I+D G+A D + N
Sbjct: 113 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR 172
Query: 685 VGTYGYMSPEYAL------HGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDS-----LT 733
VGT YM+PE H ++D+++ G++ EI + L
Sbjct: 173 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232
Query: 734 LLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYI-KVALLCVQENATDRPTMLEVVAML 792
+ + + + P + N R + K+ C N R T L + L
Sbjct: 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292
Query: 793 K 793
Sbjct: 293 S 293
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 193 bits (491), Expect = 3e-56
Identities = 66/316 (20%), Positives = 126/316 (39%), Gaps = 45/316 (14%)
Query: 504 FSLSSISAATDNFSEE---------NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEV 554
F+ + A F++E +G G FG V + GK V
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLK-------LPGK--REIFV 57
Query: 555 AVKRL-SSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTD---- 609
A+K L S + + +F +E ++ + H N++ L G + + I EF
Sbjct: 58 AIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF 117
Query: 610 -PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGI 668
V ++ G+A G+ YL +HRDL A N+L++S++ K+SDFG+
Sbjct: 118 LRQNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGL 174
Query: 669 ARTFGGDEMQSNTNRIVG---TYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTR 725
+R D +G + +PE + F+ SDV+S+G+++ E++S +
Sbjct: 175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE--- 231
Query: 726 FYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTM 785
+ + ++ + + ++ L C Q++ RP
Sbjct: 232 -----------RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKF 280
Query: 786 LEVVAMLKDEIVNLPS 801
++V L D+++ P+
Sbjct: 281 GQIVNTL-DKMIRNPN 295
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 193 bits (490), Expect = 3e-56
Identities = 70/287 (24%), Positives = 123/287 (42%), Gaps = 37/287 (12%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNE 573
+ + ++KLG G +G VY+ + + VAVK L + + +EEF E
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWK------------KYSLTVAVKTLKEDTME-VEEFLKE 63
Query: 574 MMLIAKLQHRNLVRLFGCCIEQGEKISIYEF------DIVTDPARKDLLDWTTRVRIIEG 627
++ +++H NLV+L G C + I EF + + + +
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 123
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
++ + YL + IHRDL A N L+ + K++DFG++R GD ++
Sbjct: 124 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFP 179
Query: 688 YGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKA 747
+ +PE + FSIKSDV++FGVLL EI + Y L +
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM--SPYPGIDL------------SQV 225
Query: 748 WKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794
++L++ + E + ++ C Q N +DRP+ E+ +
Sbjct: 226 YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 1e-55
Identities = 73/314 (23%), Positives = 132/314 (42%), Gaps = 44/314 (14%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLS-SKSGQGLEEFKN 572
F + LG G FG VYK W VA+K L + S + +E +
Sbjct: 9 TEFKKIKVLGSGAFGTVYK--------GLWIPEGEKVKIPVAIKELREATSPKANKEILD 60
Query: 573 EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFD----IVTDPARKDLLDWTTRVRIIEGV 628
E ++A + + ++ RL G C+ ++ + KD + + +
Sbjct: 61 EAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120
Query: 629 AQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTY 688
A+G+ YL R++HRDL A NVL+ + + KI+DFG+A+ G +E + +
Sbjct: 121 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 689 GYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAW 748
+M+ E LH +++ +SDV+S+GV + E+++ + Y+ + + +K
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGS--KPYDGIPASEI-----SSILEKGE 230
Query: 749 KLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLK--------------D 794
+L P + +Y + + C +A RP E++ D
Sbjct: 231 RLPQPPICTIDVY-------MIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGD 283
Query: 795 EIVNLPSPHQPAFS 808
E ++LPSP F
Sbjct: 284 ERMHLPSPTDSNFY 297
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 5e-55
Identities = 59/310 (19%), Positives = 113/310 (36%), Gaps = 51/310 (16%)
Query: 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGL-EEF 570
D+F + ++LG G G V+K + +G +A K + + + +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHK------------PSGLVMARKLIHLEIKPAIRNQI 51
Query: 571 KNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF----DIVTDPARKDLLDWTTRVRIIE 626
E+ ++ + +V +G GE E + + + ++
Sbjct: 52 IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI 111
Query: 627 GVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVG 686
V +GL YL + +++HRD+K SN+L++S K+ DFG++ + S N VG
Sbjct: 112 AVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVG 165
Query: 687 TYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSK--------------KNTRFYNTDSL 732
T YMSPE +S++SD++S G+ L+E+ + + +
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225
Query: 733 TLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALL--------------CVQEN 778
T P M L + L C+ +N
Sbjct: 226 TPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN 285
Query: 779 ATDRPTMLEV 788
+R + ++
Sbjct: 286 PAERADLKQL 295
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 1e-54
Identities = 69/291 (23%), Positives = 121/291 (41%), Gaps = 38/291 (13%)
Query: 518 EENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQG--LEEFKNEMM 575
E+ +LG G FG V K ++ K+ + VAVK L +++ +E E
Sbjct: 11 EDKELGSGNFGTVKK--------GYYQMKKV--VKTVAVKILKNEANDPALKDELLAEAN 60
Query: 576 LIAKLQHRNLVRLFGCCIEQGEKISIYEF----DIVTDPARKDLLDWTTRVRIIEGVAQG 631
++ +L + +VR+ G C E + + E + + + + ++ V+ G
Sbjct: 61 VMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG 119
Query: 632 LLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTN-RIVGTYGY 690
+ YL + +HRDL A NVLL + KISDFG+++ DE +
Sbjct: 120 MKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 176
Query: 691 MSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKL 750
+PE + FS KSDV+SFGVL+ E S + + + +K ++
Sbjct: 177 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQ-KPYRGMKGSEV------TAMLEKGERM 229
Query: 751 MDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD---EIVN 798
P +Y ++ C + +RP V L++ ++VN
Sbjct: 230 GCPAGCPREMYDLMNL-------CWTYDVENRPGFAAVELRLRNYYYDVVN 273
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 9e-54
Identities = 67/306 (21%), Positives = 118/306 (38%), Gaps = 40/306 (13%)
Query: 512 ATDNFS-EENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQG-LEE 569
DN + +LG G FG V + + R +VA+K L + + EE
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYR----------MRKKQIDVAIKVLKQGTEKADTEE 55
Query: 570 FKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF-------DIVTDPARKDLLDWTTRV 622
E ++ +L + +VRL G C + + + E + +++ + +
Sbjct: 56 MMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVA 112
Query: 623 RIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSN-T 681
++ V+ G+ YL + +HRDL A NVLL + KISDFG+++ G D+
Sbjct: 113 ELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 169
Query: 682 NRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNL 741
+ + +PE FS +SDV+S+GV + E LS + +
Sbjct: 170 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ--------------KPYKK 215
Query: 742 WKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPS 801
K + ++ + E + C DRP L V ++ +L S
Sbjct: 216 MKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 275
Query: 802 PHQPAF 807
+
Sbjct: 276 KVEGHH 281
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 9e-54
Identities = 73/312 (23%), Positives = 120/312 (38%), Gaps = 42/312 (13%)
Query: 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQG-LEEFKNE 573
+F+E +G G FG VY AVK L+ + G + +F E
Sbjct: 30 HFNE--VIGRGHFGCVYH--------GTLLDNDG-KKIHCAVKSLNRITDIGEVSQFLTE 78
Query: 574 MMLIAKLQHRNLVRLFGCCIE-QGEKISIYEFDIVTD-----PARKDLLDWTTRVRIIEG 627
+++ H N++ L G C+ +G + + + D +
Sbjct: 79 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 138
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNR--IV 685
VA+G+ + + +HRDL A N +LD K++DFG+AR E S N+
Sbjct: 139 VAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 195
Query: 686 GTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD 745
+M+ E F+ KSDV+SFGVLL E+++ Y + +
Sbjct: 196 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA--PPYPDVNTFDI-----TVYLL 248
Query: 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSPHQP 805
+ +L+ P + LY +V L C A RP+ E+V+ + H
Sbjct: 249 QGRRLLQPEYCPDPLY-------EVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH-- 299
Query: 806 AFSYVQIVERSV 817
YV + V
Sbjct: 300 ---YVHVNATYV 308
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 1e-53
Identities = 73/289 (25%), Positives = 120/289 (41%), Gaps = 47/289 (16%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNE 573
+G+G FG V G +VAVK + + + + F E
Sbjct: 7 KELKLLQTIGKGEFGDVMLGD--------------YRGNKVAVKCIKNDATA--QAFLAE 50
Query: 574 MMLIAKLQHRNLVRLFGCCIEQGEKISI-YEF-------DIVTDPARKDLLDWTTRVRII 625
++ +L+H NLV+L G +E+ + I E+ D + R +L ++
Sbjct: 51 ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFS 109
Query: 626 EGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIV 685
V + + YL +HRDL A NVL+ D K+SDFG+ + E S +
Sbjct: 110 LDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGK 161
Query: 686 GTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD 745
+ +PE FS KSDV+SFG+LL EI S + Y L + + + +
Sbjct: 162 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR--VPYPRIPLKDV-----VPRVE 214
Query: 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794
K +K+ P A+Y ++ C +A RP+ L++ L+
Sbjct: 215 KGYKMDAPDGCPPAVYEVMKN-------CWHLDAAMRPSFLQLREQLEH 256
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 1e-53
Identities = 68/307 (22%), Positives = 113/307 (36%), Gaps = 47/307 (15%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQG-LEEFKN 572
+ S LG G FG V ++ K VAVK L + E +
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAY-------GLIKSDAAMTVAVKMLKPSAHLTEREALMS 75
Query: 573 EMMLIAKL-QHRNLVRLFGCCIEQGEKISIYEF----------------------DIVTD 609
E+ +++ L H N+V L G C G + I E+
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 610 PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIA 669
+ LD + VA+G+ +L IHRDL A N+LL KI DFG+A
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLA 192
Query: 670 RTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNT 729
R D +M+PE + +++ +SDV+S+G+ L E+ S +
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS------ 246
Query: 730 DSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVV 789
+ D K +K++ + + + C + RPT ++V
Sbjct: 247 -------PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299
Query: 790 AMLKDEI 796
+++ +I
Sbjct: 300 QLIEKQI 306
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 185 bits (472), Expect = 2e-53
Identities = 72/287 (25%), Positives = 122/287 (42%), Gaps = 45/287 (15%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQG---LEE 569
FS+ ++G G FG VY + + N E VA+K++S Q ++
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVR------------NSEVVAIKKMSYSGKQSNEKWQD 61
Query: 570 FKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF----DIVTDPARKDLLDWTTRVRII 625
E+ + KL+H N ++ GC + + + E+ K L +
Sbjct: 62 IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVT 121
Query: 626 EGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIV 685
G QGL YLH +IHRD+KA N+LL K+ DFG A + N V
Sbjct: 122 HGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFV 172
Query: 686 GTYGYMSPEYAL---HGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLW 742
GT +M+PE L G + K DV+S G+ +E+ K +N ++++ L +++
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK--PPLFNMNAMSAL---YHIA 227
Query: 743 KDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVV 789
+++ + +E + V C+Q+ DRPT ++
Sbjct: 228 QNE--SPALQSGHWSEYFRNFVDS-------CLQKIPQDRPTSEVLL 265
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 4e-53
Identities = 67/281 (23%), Positives = 117/281 (41%), Gaps = 34/281 (12%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLS-SKSGQGLEEFKN 572
+++ LGEG +G V ++ R E VAVK + ++ E K
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRV------------TEEAVAVKIVDMKRAVDCPENIKK 52
Query: 573 EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPA----RKDLLDWTTRVRIIEGV 628
E+ + L H N+V+ +G E + E+ + + R +
Sbjct: 53 EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 112
Query: 629 AQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTY 688
G++YLH + + HRD+K N+LLD N KISDFG+A F + + N++ GT
Sbjct: 113 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 169
Query: 689 GYMSPEYALHGLF-SIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKA 747
Y++PE F + DV+S G++L +L+ + +DS
Sbjct: 170 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW-DQPSDSCQEYSDWKEKKTYLNP 228
Query: 748 WKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEV 788
WK +D A +++ + + EN + R T+ ++
Sbjct: 229 WKKIDS-----APLALLHK-------ILVENPSARITIPDI 257
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 5e-53
Identities = 70/312 (22%), Positives = 116/312 (37%), Gaps = 52/312 (16%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQG-LEEFKN 572
+N LG G FG V + K +VAVK L K+ E +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAY-------GISKTGVSIQVAVKMLKEKADSSEREALMS 89
Query: 573 EMMLIAKL-QHRNLVRLFGCCIEQGEKISIYEF--------------------------- 604
E+ ++ +L H N+V L G C G I+E+
Sbjct: 90 ELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQ 149
Query: 605 DIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664
+ + ++L + + VA+G+ +L +HRDL A NVL+ KI
Sbjct: 150 KRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKIC 206
Query: 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNT 724
DFG+AR D +M+PE G+++IKSDV+S+G+LL EI S N
Sbjct: 207 DFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 266
Query: 725 RFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPT 784
+ +KL+ + + + + C ++ RP+
Sbjct: 267 -YPGIPVDANF------------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPS 313
Query: 785 MLEVVAMLKDEI 796
+ + L ++
Sbjct: 314 FPNLTSFLGCQL 325
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 182 bits (462), Expect = 3e-52
Identities = 64/318 (20%), Positives = 115/318 (36%), Gaps = 53/318 (16%)
Query: 505 SLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLS-SKS 563
L S+ +N +GEG FG V+++ VAVK L S
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAP-------GLLPYEPFTMVAVKMLKEEAS 56
Query: 564 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF------------------- 604
+F+ E L+A+ + N+V+L G C ++E+
Sbjct: 57 ADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVC 116
Query: 605 ---------DIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLL 655
L ++ I VA G+ YL + + +HRDL N L+
Sbjct: 117 SLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLV 173
Query: 656 DSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLL 715
+M KI+DFG++R + +M PE + ++ +SDV+++GV+L
Sbjct: 174 GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLW 233
Query: 716 EILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCV 775
EI S + + ++ + + D + + + LC
Sbjct: 234 EIFSYGLQ-------------PYYGMAHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCW 279
Query: 776 QENATDRPTMLEVVAMLK 793
+ DRP+ + +L+
Sbjct: 280 SKLPADRPSFCSIHRILQ 297
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 3e-51
Identities = 63/287 (21%), Positives = 126/287 (43%), Gaps = 33/287 (11%)
Query: 505 SLSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG 564
S+ S+ ++ K+G+G G VY +++ G+EVA+++++ +
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDV------------ATGQEVAIRQMNLQQQ 58
Query: 565 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF---DIVTDPARKDLLDWTTR 621
E NE++++ + ++ N+V + E + E+ +TD + +D
Sbjct: 59 PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI 118
Query: 622 VRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNT 681
+ Q L +LH +VIHRD+K+ N+LL D + K++DFG QS
Sbjct: 119 AAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKR 173
Query: 682 NRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNL 741
+ +VGT +M+PE + K D++S G++ +E++ + + N + L L L
Sbjct: 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP--YLNENPLRAL----YL 227
Query: 742 WKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEV 788
+ +L +P + + R C+ + R + E+
Sbjct: 228 IATNGTPELQNPEKLSAIFRDFLNR-------CLDMDVEKRGSAKEL 267
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 7e-51
Identities = 61/286 (21%), Positives = 118/286 (41%), Gaps = 40/286 (13%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN 572
D + +LG+G FG VYK+ + A K + +KS + LE++
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNK------------ETSVLAAAKVIDTKSEEELEDYMV 58
Query: 573 EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTD-----PARKDLLDWTTRVRIIEG 627
E+ ++A H N+V+L + + EF + L + + +
Sbjct: 59 EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQ 118
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
L YLH ++IHRDLKA N+L D + K++DFG++ + ++ +GT
Sbjct: 119 TLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGT 173
Query: 688 YGYMSPEYAL-----HGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLW 742
+M+PE + + K+DV+S G+ L+E+ + + + + +L
Sbjct: 174 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE--PPHHELNPMRVL----LKI 227
Query: 743 KDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEV 788
+ L P+ + + + C+++N R T ++
Sbjct: 228 AKSEPPTLAQPSRWSSNFKDFLKK-------CLEKNVDARWTTSQL 266
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 7e-51
Identities = 74/325 (22%), Positives = 133/325 (40%), Gaps = 56/325 (17%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLS-SKSGQGLEEFKN 572
++ ++ +GEG FG V K K+ L + A+KR+ S +F
Sbjct: 10 NDIKFQDVIGEGNFGQVLK--------ARIKKDGLR--MDAAIKRMKEYASKDDHRDFAG 59
Query: 573 EMMLIAKL-QHRNLVRLFGCCIEQGEKISIYEF--------------------DIVTDPA 611
E+ ++ KL H N++ L G C +G E+ +
Sbjct: 60 ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 119
Query: 612 RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIART 671
L + VA+G+ YL Q + IHRDL A N+L+ + KI+DFG++R
Sbjct: 120 TASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR- 175
Query: 672 FGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDS 731
G E+ +M+ E + +++ SDV+S+GVLL EI+S T +
Sbjct: 176 --GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG-TPYCGMTC 232
Query: 732 LTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791
L K + ++L P ++ +Y ++ + C +E +RP+ +++
Sbjct: 233 AEL------YEKLPQGYRLEKPLNCDDEVYDLMRQ-------CWREKPYERPSFAQILVS 279
Query: 792 L----KDEIVNLPSPHQPAFSYVQI 812
L ++ + + F+Y I
Sbjct: 280 LNRMLEERKTYVNTTLYEKFTYAGI 304
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 7e-51
Identities = 68/311 (21%), Positives = 131/311 (42%), Gaps = 41/311 (13%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLS-SKSGQGLEEFKN 572
+ + +LG+G FG VY+ + + V K VA+K ++ + S + EF N
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGV-------VKDEPETRVAIKTVNEAASMRERIEFLN 72
Query: 573 EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF--------------DIVTDPARKDLLDW 618
E ++ + ++VRL G + + I E + +
Sbjct: 73 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 132
Query: 619 TTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQ 678
+ +++ +A G+ YL+ + +HRDL A N ++ D KI DFG+ R +
Sbjct: 133 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 189
Query: 679 SNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHA 738
+ + +MSPE G+F+ SDV+SFGV+L EI + +
Sbjct: 190 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE--------------QP 235
Query: 739 WNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVN 798
+ +++ + + + + ++ +C Q N RP+ LE+++ +K+E+
Sbjct: 236 YQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM-- 293
Query: 799 LPSPHQPAFSY 809
P + +F Y
Sbjct: 294 EPGFREVSFYY 304
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 6e-50
Identities = 66/283 (23%), Positives = 108/283 (38%), Gaps = 42/283 (14%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEF 570
++F LG+G FG VY + E+ + +A+K L +
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREK------------QSKFILALKVLFKAQLEKAGVEHQL 53
Query: 571 KNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF----DIVTDPARKDLLDWTTRVRIIE 626
+ E+ + + L+H N++RL+G + I E+ + + + D I
Sbjct: 54 RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 113
Query: 627 GVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVG 686
+A L Y H RVIHRD+K N+LL S KI+DFG + + G
Sbjct: 114 ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCG 166
Query: 687 TYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDK 746
T Y+ PE + K D++S GVL E L K F +
Sbjct: 167 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQETYKRISRV----- 219
Query: 747 AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVV 789
+ P E +++R ++ N + RP + EV+
Sbjct: 220 --EFTFPDFVTEGARDLISR-------LLKHNPSQRPMLREVL 253
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 6e-50
Identities = 71/290 (24%), Positives = 113/290 (38%), Gaps = 35/290 (12%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEF 570
+ KLG+G FG V + VAVK L + +++F
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWD---------APSGKTVSVAVKCLKPDVLSQPEAMDDF 58
Query: 571 KNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF-----DIVTDPARKDLLDWTTRVRII 625
E+ + L HRNL+RL+G + K+ + E + + T R
Sbjct: 59 IREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYA 117
Query: 626 EGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFG-GDEMQSNTNRI 684
VA+G+ YL R IHRDL A N+LL + KI DFG+ R D+
Sbjct: 118 VQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 174
Query: 685 VGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD 744
+ + +PE FS SD + FGV L E+ + + + + +L + K+
Sbjct: 175 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ-EPWIGLNGSQIL---HKIDKE 230
Query: 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794
+ +L P + +Y V + C DRPT + + L +
Sbjct: 231 GE--RLPRPEDCPQDIY-------NVMVQCWAHKPEDRPTFVALRDFLLE 271
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 5e-49
Identities = 57/283 (20%), Positives = 112/283 (39%), Gaps = 44/283 (15%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK--SGQGLEEFKNEMML 576
+ ++G G F VYK ++ EVA L + + + FK E +
Sbjct: 14 DIEIGRGSFKTVYKGLDTE------------TTVEVAWCELQDRKLTKSERQRFKEEAEM 61
Query: 577 IAKLQHRNLVRLFGCCIEQGEKIS----IYEF----DIVTDPARKDLLDWTTRVRIIEGV 628
+ LQH N+VR + + + E + T R ++ +
Sbjct: 62 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQI 121
Query: 629 AQGLLYLHQYSRLRVIHRDLKASNVLLDS-DMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
+GL +LH + +IHRDLK N+ + + KI D G+A S ++GT
Sbjct: 122 LKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGT 176
Query: 688 YGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSL-TLLGHAWNLWKDDK 746
+M+PE + DV++FG+ +LE+ +S+ + + + + K
Sbjct: 177 PEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYP--YSECQNAAQIYRRVTSGVKPAS 233
Query: 747 AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVV 789
K+ P ++ + C+++N +R ++ +++
Sbjct: 234 FDKVAIPEVKE------------IIEGCIRQNKDERYSIKDLL 264
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 6e-49
Identities = 64/290 (22%), Positives = 112/290 (38%), Gaps = 43/290 (14%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRL--SSKSGQGLEEFK 571
+++ +G G +G K + +G+ + K L S + +
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRK------------SDGKILVWKELDYGSMTEAEKQMLV 51
Query: 572 NEMMLIAKLQHRNLVRLFGCCIEQGEKIS--IYEF--------DIVTDPARKDLLDWTTR 621
+E+ L+ +L+H N+VR + I++ + E+ I + LD
Sbjct: 52 SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 111
Query: 622 VRIIEGVAQGLLYLHQYSR--LRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQS 679
+R++ + L H+ S V+HRDLK +NV LD N K+ DFG+AR D +
Sbjct: 112 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA 171
Query: 680 NTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAW 739
VGT YMSPE ++ KSD++S G LL E+ + + S L
Sbjct: 172 KA--FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM---PPFTAFSQKELAGKI 226
Query: 740 NLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVV 789
K + + + + RP++ E++
Sbjct: 227 REGKFRRIPYRYSDELNE------------IITRMLNLKDYHRPSVEEIL 264
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 8e-49
Identities = 73/304 (24%), Positives = 108/304 (35%), Gaps = 46/304 (15%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQG--LEEFK 571
D LG G FG V ++ + K VAVK L +
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGI-------DKTATCRTVAVKMLKEGATHSEHRALMS 65
Query: 572 NEMMLIAKLQHRNLVRLFGCCIEQGEKISIY---------------------EFDIVTDP 610
+LI H N+V L G C + G + + + + +
Sbjct: 66 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 125
Query: 611 ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIAR 670
KD L + VA+G+ +L + IHRDL A N+LL KI DFG+AR
Sbjct: 126 LYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLAR 182
Query: 671 TFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTD 730
D +M+PE +++I+SDV+SFGVLL EI S +
Sbjct: 183 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY----P 238
Query: 731 SLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790
+ + K+ + D T + L C + RPT E+V
Sbjct: 239 GVKIDEEFCRRLKEGTRMRAPDYTTP---------EMYQTMLDCWHGEPSQRPTFSELVE 289
Query: 791 MLKD 794
L +
Sbjct: 290 HLGN 293
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 8e-48
Identities = 68/287 (23%), Positives = 115/287 (40%), Gaps = 34/287 (11%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGL-EEFKN 572
+ +GEG FG V++ I VA+K + + + E+F
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYM---------SPENPALAVAIKTCKNCTSDSVREKFLQ 57
Query: 573 EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTD-----PARKDLLDWTTRVRIIEG 627
E + + + H ++V+L G E I I E + + RK LD + +
Sbjct: 58 EALTMRQFDHPHIVKLIGVITENPVWI-IMELCTLGELRSFLQVRKYSLDLASLILYAYQ 116
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
++ L YL R +HRD+ A NVL+ S+ K+ DFG++R + D ++
Sbjct: 117 LSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLP 172
Query: 688 YGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKA 747
+M+PE F+ SDV+ FGV + EIL + + + +
Sbjct: 173 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-------NNDVIGRIENG 225
Query: 748 WKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794
+L P LYS++T+ C + + RP E+ A L
Sbjct: 226 ERLPMPPNCPPTLYSLMTK-------CWAYDPSRRPRFTELKAQLST 265
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 4e-47
Identities = 79/310 (25%), Positives = 123/310 (39%), Gaps = 45/310 (14%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRL-SSKSGQGLEEFKN 572
D LGEG FG V E + K +VAVK L S + + L + +
Sbjct: 13 DRLVLGKPLGEGAFGQVVL-----AEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLIS 67
Query: 573 EMMLIAKL-QHRNLVRLFGCCIEQGEKISIYEF--------------------DIVTDPA 611
EM ++ + +H+N++ L G C + G I E+
Sbjct: 68 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 127
Query: 612 RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIART 671
++ L V VA+G+ YL + IHRDL A NVL+ D KI+DFG+AR
Sbjct: 128 PEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARD 184
Query: 672 FGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDS 731
+ T +M+PE +++ +SDV+SFGVLL EI +
Sbjct: 185 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG--------- 235
Query: 732 LTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791
+ ++ +KL+ + + + + C + RPT ++V
Sbjct: 236 -----SPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
Query: 792 LKDEIVNLPS 801
L D IV L S
Sbjct: 291 L-DRIVALTS 299
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 1e-43
Identities = 57/282 (20%), Positives = 105/282 (37%), Gaps = 38/282 (13%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEF 570
++F LGEG F V + E E A+K L + +
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELA------------TSREYAIKILEKRHIIKENKVPYV 55
Query: 571 KNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF----DIVTDPARKDLLDWTTRVRIIE 626
E ++++L H V+L+ + + + +++ + D T
Sbjct: 56 TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT- 114
Query: 627 GVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVG 686
A+ + L +IHRDLK N+LL+ DM+ +I+DFG A+ + Q+ N VG
Sbjct: 115 --AEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 172
Query: 687 TYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDK 746
T Y+SPE SD+++ G ++ ++++ F + + L
Sbjct: 173 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL--PPFRAGNEYLIFQKIIKL----- 225
Query: 747 AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEV 788
+ P +V + + +AT R E+
Sbjct: 226 --EYDFPEKFFPKARDLVEK-------LLVLDATKRLGCEEM 258
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 156 bits (396), Expect = 1e-42
Identities = 59/284 (20%), Positives = 104/284 (36%), Gaps = 41/284 (14%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNE 573
D++ +LG G FG V++ ER G A K + + E + E
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTER------------ATGNNFAAKFVMTPHESDKETVRKE 73
Query: 574 MMLIAKLQHRNLVRLFGCCIEQGEKISIYEF-------DIVTDPARKDLLDWTTRVRIIE 626
+ ++ L+H LV L + E + IYEF + V D + + V +
Sbjct: 74 IQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMR 131
Query: 627 GVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP--KISDFGIARTFGGDEMQSNTNRI 684
V +GL ++H +H DLK N++ + + K+ DFG+ +
Sbjct: 132 QVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVT 185
Query: 685 VGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD 744
GT + +PE A +D++S GVL +LS N D + + D
Sbjct: 186 TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD 245
Query: 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEV 788
D A+ + + + + + R T+ +
Sbjct: 246 DSAFSGISE-----DGKDFIRK-------LLLADPNTRMTIHQA 277
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 155 bits (393), Expect = 3e-42
Identities = 61/300 (20%), Positives = 114/300 (38%), Gaps = 43/300 (14%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNE 573
D + +LG G FG V++ +E+ G K +++ KNE
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEK------------ATGRVFVAKFINTPYPLDKYTVKNE 76
Query: 574 MMLIAKLQHRNLVRLFGCCIEQGEKISIYEF-------DIVTDPARKDLLDWTTRVRIIE 626
+ ++ +L H L+ L ++ E + I EF D + A + + +
Sbjct: 77 ISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA--AEDYKMSEAEVINYMR 134
Query: 627 GVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP--KISDFGIARTFGGDEMQSNTNRI 684
+GL ++H ++H D+K N++ ++ KI DFG+A DE+
Sbjct: 135 QACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVT 188
Query: 685 VGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD 744
T + +PE +D+++ GVL +LS + F D L L N+ +
Sbjct: 189 TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL--SPFAGEDDLETL---QNVKRC 243
Query: 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM--LKDEIVNLPSP 802
D + + + + +Q+ R T+ + + LK + NL S
Sbjct: 244 DWEFDEDAFSSVSPEAKDFIKN-------LLQKEPRKRLTVHDALEHPWLKGDHSNLTSR 296
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 146 bits (369), Expect = 8e-40
Identities = 61/293 (20%), Positives = 115/293 (39%), Gaps = 40/293 (13%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQG---LEE 569
+D + LG GG V+ + + +VAVK L + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLR------------LHRDVAVKVLRADLARDPSFYLR 53
Query: 570 FKNEMMLIAKLQHRNLVRLFGCCIEQGEKIS----IYEF----DIVTDPARKDLLDWTTR 621
F+ E A L H +V ++ + + E+ + + +
Sbjct: 54 FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRA 113
Query: 622 VRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFG-GDEMQSN 680
+ +I Q L + H + +IHRD+K +N+++ + K+ DFGIAR +
Sbjct: 114 IEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 170
Query: 681 TNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWN 740
T ++GT Y+SPE A +SDV+S G +L E+L+ + F +++ +
Sbjct: 171 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP--FTGDSPVSVA---YQ 225
Query: 741 LWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRP-TMLEVVAML 792
++D + L ++V + + +N +R T E+ A L
Sbjct: 226 HVREDPIPPSARHEGLSADLDAVVLK-------ALAKNPENRYQTAAEMRADL 271
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 147 bits (371), Expect = 1e-39
Identities = 64/294 (21%), Positives = 124/294 (42%), Gaps = 46/294 (15%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEF 570
+F LG G FG V+ R+ NG A+K L + + +E
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRH------------NGRYYAMKVLKKEIVVRLKQVEHT 51
Query: 571 KNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF----DIVTDPARKDLLDWTTRVRIIE 626
+E ++++ + H ++R++G + + I ++ ++ + +
Sbjct: 52 NDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA 111
Query: 627 GVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVG 686
V L YLH +I+RDLK N+LLD + + KI+DFG A+ + T + G
Sbjct: 112 EVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCG 163
Query: 687 TYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDK 746
T Y++PE ++ D +SFG+L+ E+L+ FY+++++ N
Sbjct: 164 TPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT--PFYDSNTMKTYEKILN------ 215
Query: 747 AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLP 800
+L P NE + +++R + + + R L+ +++ N P
Sbjct: 216 -AELRFPPFFNEDVKDLLSR-------LITRDLSQRLGNLQNGT---EDVKNHP 258
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 147 bits (373), Expect = 2e-39
Identities = 66/298 (22%), Positives = 113/298 (37%), Gaps = 46/298 (15%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEF 570
++FS +G GGFG VY + G+ A+K L K QG
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKA------------DTGKMYAMKCLDKKRIKMKQGETLA 51
Query: 571 KNE---MMLIAKLQHRNLVRLFGCCIEQGEKISIYEF----DIVTDPARKDLLDWTTRVR 623
NE + L++ +V + + I + D+ ++ +
Sbjct: 52 LNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF 111
Query: 624 IIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNR 683
+ GL ++H V++RDLK +N+LLD + +ISD G+A F + +
Sbjct: 112 YAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHA 164
Query: 684 IVGTYGYMSPEYALHGL-FSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLW 742
VGT+GYM+PE G+ + +D FS G +L ++L R + T +
Sbjct: 165 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK------HEID 218
Query: 743 KDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLP 800
+ + P + L S++ +Q + R L A E+ P
Sbjct: 219 RMTLTMAVELPDSFSPELRSLLEG-------LLQRDVNRRLGCLGRGA---QEVKESP 266
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 144 bits (364), Expect = 6e-39
Identities = 48/307 (15%), Positives = 90/307 (29%), Gaps = 38/307 (12%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNE 573
+ + K+G G FG +Y + GEEVA+K K+ + E
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIA------------AGEEVAIKLECVKTKH--PQLHIE 52
Query: 574 MMLIAKLQHRNLVRLFGCCIEQGEKISIYEF-----DIVTDPARKDLLDWTTRVRIIEGV 628
+ +Q + C +G+ + T + + + +
Sbjct: 53 SKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQM 112
Query: 629 AQGLLYLHQYSRLRVIHRDLKASNVL---LDSDMNPKISDFGIARTFGGDE-----MQSN 680
+ Y+H IHRD+K N L I DFG+A+ +
Sbjct: 113 ISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRE 169
Query: 681 TNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWN 740
+ GT Y S L S + D+ S G +L+ + + +
Sbjct: 170 NKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 229
Query: 741 LWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLP 800
K +++ +E C D+P + + ++
Sbjct: 230 EKKMSTPIEVLCKGYPSEF--------ATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281
Query: 801 SPHQPAF 807
+ F
Sbjct: 282 FSYDYVF 288
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 9e-39
Identities = 72/315 (22%), Positives = 125/315 (39%), Gaps = 46/315 (14%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVK--RLSSKSGQGLEEFK 571
+NF + K+GEG +G VYK+ + L GE VA+K RL +++
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNK------------LTGEVVALKKIRLDTETEGVPSTAI 49
Query: 572 NEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF-----DIVTDPARKDLLDWTTRVRIIE 626
E+ L+ +L H N+V+L + + ++EF D + + +
Sbjct: 50 REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF 109
Query: 627 GVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVG 686
+ QGL + H + RV+HRDLK N+L++++ K++DFG+AR FG V
Sbjct: 110 QLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVV 164
Query: 687 TYGYMSPE-YALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLL---------- 735
T Y +PE +S D++S G + E+++ + F + L
Sbjct: 165 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL--FPGDSEIDQLFRIFRTLGTP 222
Query: 736 -GHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVAL----LCVQENATDRPTMLEVVA 790
W +K P + +V + + + R + +A
Sbjct: 223 DEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
Query: 791 M--LKDEIVNLPSPH 803
+D V P PH
Sbjct: 283 HPFFQD--VTKPVPH 295
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 3e-38
Identities = 55/284 (19%), Positives = 102/284 (35%), Gaps = 42/284 (14%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNE 573
+ + LG G FG V++ +E + + K + G K E
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETS------------SKKTYMAKFVK-VKGTDQVLVKKE 51
Query: 574 MMLIAKLQHRNLVRLFGCCIEQGEKISIYEF-------DIVTDPARKDLLDWTTRVRIIE 626
+ ++ +HRN++ L E + I+EF + + A + L+ V +
Sbjct: 52 ISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFE--LNEREIVSYVH 109
Query: 627 GVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP--KISDFGIARTFGGDEMQSNTNRI 684
V + L +LH + H D++ N++ + + KI +FG AR + N +
Sbjct: 110 QVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL---KPGDNFRLL 163
Query: 685 VGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD 744
Y +PE H + S +D++S G L+ +LS + D
Sbjct: 164 FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD 223
Query: 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEV 788
++A+K + V R + + R T E
Sbjct: 224 EEAFKEISI-----EAMDFVDR-------LLVKERKSRMTASEA 255
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 142 bits (358), Expect = 5e-38
Identities = 59/322 (18%), Positives = 116/322 (36%), Gaps = 35/322 (10%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEE-FK 571
D + + LG G F V + ++ + VA+K ++ K+ +G E +
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDK------------RTQKLVAIKCIAKKALEGKEGSME 55
Query: 572 NEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF----DIVTDPARKDLLDWTTRVRIIEG 627
NE+ ++ K++H N+V L G I + ++ K R+I
Sbjct: 56 NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQ 115
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
V + YLH + + LD D ISDFG+++ + + GT
Sbjct: 116 VLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGT 172
Query: 688 YGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKA 747
GY++PE +S D +S GV+ +L FY+ + L + K +
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY--PPFYDENDAKLF---EQILKAEYE 227
Query: 748 WKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA---MLKDEIVNLPSPHQ 804
+ +++ + ++++ R T + + + D ++
Sbjct: 228 FDSPYWDDISDSAKDFIRH-------LMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQS 280
Query: 805 PAFSYVQIVERSVLLANINAEA 826
+ + +S NA A
Sbjct: 281 VSEQIKKNFAKSKWKQAFNATA 302
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 5e-38
Identities = 55/301 (18%), Positives = 109/301 (36%), Gaps = 40/301 (13%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQG-LEEFK 571
++ + +GEG +G V + + +N VA+K++S Q +
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDN------------VNKVRVAIKKISPFEHQTYCQRTL 54
Query: 572 NEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF-------DIVTDPARKDLLDWTTRVRI 624
E+ ++ + +H N++ + + + + + L
Sbjct: 55 REIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYF 114
Query: 625 IEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNT-NR 683
+ + +GL Y+H V+HRDLK SN+LL++ + KI DFG+AR D +
Sbjct: 115 LYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 171
Query: 684 IVGTYGYMSPEYALHGLFSIKS-DVFSFGVLLLEILSSK---------------KNTRFY 727
V T Y +PE L+ KS D++S G +L E+LS++
Sbjct: 172 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 231
Query: 728 NTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLE 787
+ + + N + ++ + + + N R + +
Sbjct: 232 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 291
Query: 788 V 788
Sbjct: 292 A 292
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 141 bits (356), Expect = 7e-38
Identities = 40/301 (13%), Positives = 89/301 (29%), Gaps = 40/301 (13%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNE 573
++ ++GEG FG +++ N ++VA+K +S + ++E
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLL------------NNQQVAIKFEPRRSDA--PQLRDE 50
Query: 574 MMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGV 628
L + ++G + + T + +
Sbjct: 51 YRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQM 110
Query: 629 AQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP-----KISDFGIARTFGGDE-----MQ 678
+ +H+ +++RD+K N L+ + + DFG+ + +
Sbjct: 111 LARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPY 167
Query: 679 SNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHA 738
+ GT YMS L S + D+ + G + + L + +
Sbjct: 168 REKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT------- 220
Query: 739 WNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVN 798
N K ++ + T E + K P + + +
Sbjct: 221 -NKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279
Query: 799 L 799
L
Sbjct: 280 L 280
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 140 bits (353), Expect = 1e-37
Identities = 58/295 (19%), Positives = 114/295 (38%), Gaps = 50/295 (16%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGL------ 567
+N+ + LG G V + I + +E AVK + G
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKP------------TCKEYAVKIIDVTGGGSFSAEEVQ 50
Query: 568 ---EEFKNEMMLIAKLQ-HRNLVRLFGCCIEQGEKISIYEF----DIVTDPARKDLLDWT 619
E E+ ++ K+ H N+++L +++ ++ K L
Sbjct: 51 ELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEK 110
Query: 620 TRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQS 679
+I+ + + + LH +L ++HRDLK N+LLD DMN K++DFG + E
Sbjct: 111 ETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-- 165
Query: 680 NTNRIVGTYGYMSPEYAL------HGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLT 733
+ GT Y++PE H + + D++S GV++ +L+ F++ +
Sbjct: 166 -LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS--PPFWHRKQML 222
Query: 734 LLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEV 788
+L + + + + ++ + +V+R + R T E
Sbjct: 223 ML---RMIMSGNYQFGSPEWDDYSDTVKDLVSR-------FLVVQPQKRYTAEEA 267
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 3e-37
Identities = 57/280 (20%), Positives = 107/280 (38%), Gaps = 41/280 (14%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKN- 572
++F LG+G FG V+ + + + A+K L ++ +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFK------------KTNQFFAIKALKKDVVLMDDDVECT 49
Query: 573 ---EMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF----DIVTDPARKDLLDWTTRVRII 625
+ +L +H L +F + + E+ D++ D +
Sbjct: 50 MVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYA 109
Query: 626 EGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIV 685
+ GL +LH +++RDLK N+LLD D + KI+DFG+ + + ++NT
Sbjct: 110 AEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FC 164
Query: 686 GTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD 745
GT Y++PE L ++ D +SFGVLL E+L + + F+ D L+
Sbjct: 165 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ--SPFHGQDEE-------ELFHSI 215
Query: 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTM 785
+ P + ++ + R +
Sbjct: 216 RMDNPFYPRWLEKEAKDLLVK-------LFVREPEKRLGV 248
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 1e-36
Identities = 63/305 (20%), Positives = 115/305 (37%), Gaps = 47/305 (15%)
Query: 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFK 571
A + ++GEG +G V+K+ + G VA+KR+ ++G+
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDL-----------KNGGRFVALKRVRVQTGEEGMPLS 53
Query: 572 -----NEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDI----------VTDPARKDLL 616
+ + +H N+VRLF C + D + +
Sbjct: 54 TIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGV 113
Query: 617 DWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDE 676
T ++ + +GL +LH RV+HRDLK N+L+ S K++DFG+AR +
Sbjct: 114 PTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY---S 167
Query: 677 MQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLG 736
Q +V T Y +PE L ++ D++S G + E+ K F + + LG
Sbjct: 168 FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK--PLFRGSSDVDQLG 225
Query: 737 HAWNLW---------KDDKAWKLMDPTMQNEALYSMVTRYIKVAL----LCVQENATDRP 783
++ +D + + + + VT ++ C+ N R
Sbjct: 226 KILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI 285
Query: 784 TMLEV 788
+
Sbjct: 286 SAYSA 290
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 136 bits (342), Expect = 4e-36
Identities = 62/295 (21%), Positives = 117/295 (39%), Gaps = 38/295 (12%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVK--RLSSKSGQGLEEFK 571
+ + K+GEG +G VYK + GE A+K RL +
Sbjct: 2 EKYHGLEKIGEGTYGVVYK-------------AQNNYGETFALKKIRLEKEDEGIPSTTI 48
Query: 572 NEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDP----ARKDLLDWTTRVRIIEG 627
E+ ++ +L+H N+V+L+ + + ++E + L+ T +
Sbjct: 49 REISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQ 108
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
+ G+ Y H RV+HRDLK N+L++ + KI+DFG+AR FG + + T
Sbjct: 109 LLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVT 163
Query: 688 YGYMSPEYAL-HGLFSIKSDVFSFGVLLLEILSSK-------------KNTRFYNTDSLT 733
Y +P+ + +S D++S G + E+++ + R T +
Sbjct: 164 LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSK 223
Query: 734 LLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEV 788
+ L K D + + +P L + I + ++ + R T +
Sbjct: 224 NWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 8e-36
Identities = 69/321 (21%), Positives = 116/321 (36%), Gaps = 55/321 (17%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNE 573
++++ +G G FG VY++ +GE VA+K++ E
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLC------------DSGELVAIKKVLQDK----RFKNRE 63
Query: 574 MMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTD-------------PARKDLLDWTT 620
+ ++ KL H N+VRL GEK ++V D K L
Sbjct: 64 LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY 123
Query: 621 RVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSD-MNPKISDFGIARTFGGDEMQS 679
+ + + L Y+H + HRD+K N+LLD D K+ DFG A+ E
Sbjct: 124 VKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 180
Query: 680 NTNRIVGTYGYMSPEYALHGL-FSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHA 738
+ + + Y +PE ++ DV+S G +L E+L + + +
Sbjct: 181 SY---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237
Query: 739 WNLWKDDKAWKLMDPTMQNEALYSMVTRYIK-----------VALL--CVQENATDRPTM 785
+ + M+P + +AL ++ T R T
Sbjct: 238 VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP 297
Query: 786 LEVVAM-----LKDEIVNLPS 801
LE A L+D V LP+
Sbjct: 298 LEACAHSFFDELRDPNVKLPN 318
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 2e-35
Identities = 58/289 (20%), Positives = 108/289 (37%), Gaps = 44/289 (15%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRL------SSKSGQGL 567
D + +LG G F V K E+ G + A K + SS+ G
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREK------------STGLQYAAKFIKKRRTKSSRRGVSR 57
Query: 568 EEFKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF----DIVTDPARKDLLDWTTRVR 623
E+ + E+ ++ ++QH N++ L + + I I E ++ A K+ L
Sbjct: 58 EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 117
Query: 624 IIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP----KISDFGIARTFGGDEMQS 679
++ + G+ + L++ H DLK N++L P KI DFG+A
Sbjct: 118 FLKQILNGV---YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 172
Query: 680 NTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAW 739
I GT +++PE + +++D++S GV+ +LS A
Sbjct: 173 -FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 231
Query: 740 NLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEV 788
N +D+ + + R + ++ R T+ +
Sbjct: 232 NYEFEDEYFSNTSA-----LAKDFIRR-------LLVKDPKKRMTIQDS 268
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 3e-35
Identities = 63/312 (20%), Positives = 114/312 (36%), Gaps = 45/312 (14%)
Query: 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEE-----FKNEM 574
+ LGEG F VYK+ ++ + VA+K++ ++ E+
Sbjct: 4 DFLGEGQFATVYKARDK------------NTNQIVAIKKIKLGHRSEAKDGINRTALREI 51
Query: 575 MLIAKLQHRNLVRLFGCCIEQGEKISIYEF----DIVTDPARKDLLDWTTRVRIIEGVAQ 630
L+ +L H N++ L + +++F V +L + + Q
Sbjct: 52 KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQ 111
Query: 631 GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGY 690
GL YLHQ+ ++HRDLK +N+LLD + K++DFG+A++FG V T Y
Sbjct: 112 GLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWY 166
Query: 691 MSPEYAL-HGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWK 749
+PE ++ + D+++ G +L E+L L L + +
Sbjct: 167 RAPELLFGARMYGVGVDMWAVGCILAELLLRV--PFLPGDSDLDQLTRIFETLGTPTEEQ 224
Query: 750 LMDPTMQNEALYSMVTRYIKVALL--------------CVQENATDRPTMLEVVAM--LK 793
D + + I + + N R T + + M
Sbjct: 225 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 284
Query: 794 DEIVNLPSPHQP 805
+ P P
Sbjct: 285 NRPGPTPGCQLP 296
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 9e-35
Identities = 59/305 (19%), Positives = 114/305 (37%), Gaps = 42/305 (13%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQG--LEEFK 571
+ + K+G+G FG V+K+ R G++VA+K++ ++ +
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHR------------KTGQKVALKKVLMENEKEGFPITAL 57
Query: 572 NEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFD--IVTDPARKDLLDWTTRVR------ 623
E+ ++ L+H N+V L C + + + +V D DL + V
Sbjct: 58 REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS 117
Query: 624 -IIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFG--GDEMQSN 680
I + L L+ R +++HRD+KA+NVL+ D K++DFG+AR F + +
Sbjct: 118 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 177
Query: 681 TNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILS------SKKNTRFYNTDSLT 733
V T Y PE L + D++ G ++ E+ + S
Sbjct: 178 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237
Query: 734 LLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALL----------CVQENATDRP 783
+W + ++L + + V +K + + + R
Sbjct: 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297
Query: 784 TMLEV 788
+
Sbjct: 298 DSDDA 302
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 2e-34
Identities = 54/293 (18%), Positives = 103/293 (35%), Gaps = 41/293 (13%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEF 570
++F LG+G FG V E+ G A+K L + + +
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREK------------ATGRYYAMKILRKEVIIAKDEVAHT 52
Query: 571 KNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF---DIVTDPARKDLLDWTTRVRIIEG 627
E ++ +H L L + E+ + ++ + R R
Sbjct: 53 VTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY-- 110
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
A+ + L V++RD+K N++LD D + KI+DFG+ + D + GT
Sbjct: 111 GAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGT 168
Query: 688 YGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKA 747
Y++PE + D + GV++ E++ + FYN D L
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHERLFELILM------- 219
Query: 748 WKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLP 800
++ P + S++ ++++ R A E++
Sbjct: 220 EEIRFPRTLSPEAKSLLAG-------LLKKDPKQRLGGGPSDA---KEVMEHR 262
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 2e-33
Identities = 61/292 (20%), Positives = 109/292 (37%), Gaps = 30/292 (10%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVK--RLSSKSGQGLEEFK 571
+ + K+GEG +G V+K+ R E VA+K RL
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNR------------ETHEIVALKRVRLDDDDEGVPSSAL 49
Query: 572 NEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEF-DIVTDPARKDLLDWTTRVRIIEGVAQ 630
E+ L+ +L+H+N+VRL + ++EF D + + Q
Sbjct: 50 REICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQ 109
Query: 631 GLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGY 690
L L V+HRDLK N+L++ + K+++FG+AR F G ++ + +V +
Sbjct: 110 LLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYR 168
Query: 691 MSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTL----------LGHAWN 740
L+S D++S G + E+ ++ + N L W
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228
Query: 741 LWKDDKAWKLMDPTMQNEALYSMVTRYIKVA--LL--CVQENATDRPTMLEV 788
+K +L ++V + LL ++ N R + E
Sbjct: 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 3e-33
Identities = 55/302 (18%), Positives = 98/302 (32%), Gaps = 60/302 (19%)
Query: 521 KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEE------FKNEM 574
LG GGFG VY I + VA+K + E E+
Sbjct: 11 LLGSGGFGSVYSGIRV------------SDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 58
Query: 575 MLIAKLQ--HRNLVRLFGCCIEQGEKISIYEF-----DIVTDPARKDLLDWTTRVRIIEG 627
+L+ K+ ++RL + I E D+ + L
Sbjct: 59 VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 118
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSD-MNPKISDFGIARTFGGDEMQSNTNRIVG 686
V + + + H V+HRD+K N+L+D + K+ DFG G
Sbjct: 119 VLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD----FDG 171
Query: 687 TYGYMSPEYAL-HGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD 745
T Y PE+ H + V+S G+LL +++ + ++
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD---------------IPFEHDEEI 216
Query: 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE-IVNLPSPHQ 804
++ + ++ C+ +DRPT E+ + ++ P +
Sbjct: 217 IRGQVFFRQRVSSECQHLIRW-------CLALRPSDRPTFEEI---QNHPWMQDVLLPQE 266
Query: 805 PA 806
A
Sbjct: 267 TA 268
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 2e-32
Identities = 61/301 (20%), Positives = 119/301 (39%), Gaps = 46/301 (15%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRL--SSKSGQGLEEFK 571
+ + +G G +G V +++ G +VA+K+L +S +
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGR------------TGAKVAIKKLYRPFQSELFAKRAY 65
Query: 572 NEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPA--------RKDLLDWTTRVR 623
E+ L+ ++H N++ L +F +V + + L
Sbjct: 66 RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQF 125
Query: 624 IIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNR 683
++ + +GL Y+H +IHRDLK N+ ++ D KI DFG+AR + S
Sbjct: 126 LVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTG 177
Query: 684 IVGTYGYMSPEYALHGL-FSIKSDVFSFGVLLLEILSSKKNTRFYNTDSL---------T 733
V T Y +PE L+ + ++ D++S G ++ E+++ K + + T
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237
Query: 734 LLGHAWNLWKDDKAWKLMD--PTMQNEALYSMVTRYIKVAL----LCVQENATDRPTMLE 787
+ D+A M P ++ + S++T +A+ + +A R T E
Sbjct: 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 297
Query: 788 V 788
Sbjct: 298 A 298
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 123 bits (309), Expect = 3e-31
Identities = 66/334 (19%), Positives = 120/334 (35%), Gaps = 49/334 (14%)
Query: 477 GNMSRAKEFCEGDSAGTGKSKESWFLFFSLSSISAAT---DNFSEENKLGEGGFGPVYKS 533
GN + AK+ E +S +K + S T D F LG G FG V
Sbjct: 1 GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLV 60
Query: 534 IERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQHRNLVRLFG 590
+ +G A+K L + + +E NE ++ + LV+L
Sbjct: 61 KHK------------ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 591 CCIEQGEKISIYEFDIVTDPA----RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHR 646
+ + E+ + R + YLH L +I+R
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYR 165
Query: 647 DLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSD 706
DLK N+L+D +++DFG A+ ++ T + GT ++PE L ++ D
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNKAVD 220
Query: 707 VFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTR 766
++ GVL+ E+ + F+ + + + K+ P+ + L ++
Sbjct: 221 WWALGVLIYEMAAGY--PPFFADQPIQIYEKIVS-------GKVRFPSHFSSDLKDLLRN 271
Query: 767 YIKVALLCVQENATDRPTMLEVVAMLKDEIVNLP 800
+Q + T R L+ ++I N
Sbjct: 272 -------LLQVDLTKRFGNLKNGV---NDIKNHK 295
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 1e-29
Identities = 50/287 (17%), Positives = 98/287 (34%), Gaps = 51/287 (17%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIA 578
LG G G V + + E+ A+K L + + E+ L
Sbjct: 17 SQVLGLGINGKVLQIFNK------------RTQEKFALKMLQDC-----PKARREVELHW 59
Query: 579 KL-QHRNLVRLFGCCIEQGEKIS----IYEF-------DIVTDPARKDLLDWTTRVRIIE 626
+ Q ++VR+ + E + D + I++
Sbjct: 60 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMK 118
Query: 627 GVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP---KISDFGIARTFGGDEMQSNTNR 683
+ + + YLH + + HRD+K N+L S K++DFG A+ +
Sbjct: 119 SIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY 175
Query: 684 IVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWK 743
T Y++PE + D++S GV++ +L FY+ L + +
Sbjct: 176 ---TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY--PPFYSNHGLAISPGMKTRIR 230
Query: 744 DDKAWKLMDPTMQN--EALYSMVTRYIKVALLCVQENATDRPTMLEV 788
+ ++ +P E + ++ ++ T R T+ E
Sbjct: 231 MGQ-YEFPNPEWSEVSEEVKMLIRN-------LLKTEPTQRMTITEF 269
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 2e-29
Identities = 59/295 (20%), Positives = 109/295 (36%), Gaps = 33/295 (11%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLS----SKSGQGLEE 569
+NF LG G +G V+ V + G+ A+K L + + E
Sbjct: 24 ENFELLKVLGTGAYGKVFL-----VRKISGHD----TGKLYAMKVLKKATIVQKAKTTEH 74
Query: 570 FKNEMMLIAKLQHR-NLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWT-TRVRIIEG 627
+ E ++ ++ LV L + + I ++ + T +
Sbjct: 75 TRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY 134
Query: 628 VAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGT 687
V + +L L +L +I+RD+K N+LLDS+ + ++DFG+++ F DE + GT
Sbjct: 135 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGT 193
Query: 688 YGYMSPEYALHGL--FSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD 745
YM+P+ G D +S GVL+ E+L+ + F + +
Sbjct: 194 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA--SPFTVDGEKNSQ---AEISRRI 248
Query: 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLP 800
+ P + ++ R + ++ R A DEI
Sbjct: 249 LKSEPPYPQEMSALAKDLIQR-------LLMKDPKKRLGCGPRDA---DEIKEHL 293
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 1e-28
Identities = 52/217 (23%), Positives = 91/217 (41%), Gaps = 27/217 (12%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLS--SKSGQGLEEFK 571
+ +G G G V + + + VA+K+LS ++ +
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDA------------VLDRNVAIKKLSRPFQNQTHAKRAY 64
Query: 572 NEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLL-------DWTTRVRI 624
E++L+ + H+N++ L Q + +V + +L D +
Sbjct: 65 RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 124
Query: 625 IEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRI 684
+ + G+ +LH +IHRDLK SN+++ SD KI DFG+ART G M
Sbjct: 125 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPY 178
Query: 685 VGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSK 721
V T Y +PE L + D++S G ++ E++ K
Sbjct: 179 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 113 bits (283), Expect = 5e-28
Identities = 56/303 (18%), Positives = 112/303 (36%), Gaps = 49/303 (16%)
Query: 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNE 573
D++ KLG G + V+++I N E+V VK L ++ K E
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINIT------------NNEKVVVKILKPVK---KKKIKRE 79
Query: 574 MMLIAKLQ-HRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDL---LDWTTRVRIIEGVA 629
+ ++ L+ N++ L + + F+ V + K L L + +
Sbjct: 80 IKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEIL 139
Query: 630 QGLLYLHQYSRLRVIHRDLKASNVLLDSD-MNPKISDFGIARTFGGDEMQSNTNRIVGTY 688
+ L Y H + ++HRD+K NV++D + ++ D+G+A + + N V +
Sbjct: 140 KALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASR 193
Query: 689 GYMSPEYAL-HGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTL------LGHAWNL 741
+ PE + + ++ D++S G +L ++ K+ + + L LG
Sbjct: 194 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 253
Query: 742 WKDDKAWKLMDPTMQNEALYSMVTRYIKVALL----------------CVQENATDRPTM 785
DK +DP + R+ + ++ + R T
Sbjct: 254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 313
Query: 786 LEV 788
E
Sbjct: 314 REA 316
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 3e-26
Identities = 51/220 (23%), Positives = 93/220 (42%), Gaps = 31/220 (14%)
Query: 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLS--SKSGQGLEEF 570
+ + + +G G +G V + + G VAVK+LS +S +
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTK------------TGLRVAVKKLSRPFQSIIHAKRT 64
Query: 571 KNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVT--------DPARKDLLDWTTRV 622
E+ L+ ++H N++ L + +VT + + L
Sbjct: 65 YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 124
Query: 623 RIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTN 682
+I + +GL Y+H +IHRDLK SN+ ++ D KI DFG+AR +
Sbjct: 125 FLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 181
Query: 683 RIVGTYGYMSPEYALHGL-FSIKSDVFSFGVLLLEILSSK 721
R Y +PE L+ + ++ D++S G ++ E+L+ +
Sbjct: 182 RW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 104 bits (259), Expect = 1e-24
Identities = 40/224 (17%), Positives = 79/224 (35%), Gaps = 36/224 (16%)
Query: 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIA 578
KLG G F V+ + + +N VA+K + E ++E+ L+
Sbjct: 18 VRKLGWGHFSTVWLAKDM------------VNNTHVAMKIVR-GDKVYTEAAEDEIKLLQ 64
Query: 579 KLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLL--------------------DW 618
++ + + K+ + + ++
Sbjct: 65 RVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPL 124
Query: 619 TTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS-DMNPKISDFGIARTFGGDEM 677
+I + + GL Y+H+ R +IH D+K NVL++ D + IA
Sbjct: 125 IYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 182
Query: 678 QSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSK 721
+ + T Y SPE L + +D++S L+ E+++
Sbjct: 183 DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 90.8 bits (225), Expect = 2e-22
Identities = 22/119 (18%), Positives = 49/119 (41%), Gaps = 14/119 (11%)
Query: 34 IRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKKSPDTVVWVANRNCPILDPHGILAIN 93
+ +GE L Q ++ + ++ L ++ T VW +N +
Sbjct: 4 LTNGEGL-YAGQSLDVEPYHFIMQEDCNLVLYD---HSTSVWASNTGILG-KKGCKAVLQ 58
Query: 94 NNGNLVLLNQANGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSEGSYLWQSFDF 152
++GN V+ + ++W+S+ + + V L + GN+V+ GS +W + +
Sbjct: 59 SDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIY---------GSDIWSTGTY 108
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 92.9 bits (230), Expect = 4e-22
Identities = 32/211 (15%), Positives = 67/211 (31%), Gaps = 39/211 (18%)
Query: 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVK--RLSSKSGQ--------GLEE 569
+GEG V+ E VK ++ S + G
Sbjct: 6 KLMGEGKESAVFN-------------CYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLH 52
Query: 570 FKNEMMLIAKLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKD---LLDWTTRVRIIE 626
F + A+ + R L +L G + + + ++ + + +++
Sbjct: 53 FSVLAIRSARNEFRALQKLQGLAVPK--VYAWEGNAVLMELIDAKELYRVRVENPDEVLD 110
Query: 627 GVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNR-IV 685
+ + + + ++H DL NVL+ + I DF + G + + R +
Sbjct: 111 MILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVR 166
Query: 686 GTYGYMSPEYALHGLFSIKSDVFSFGVLLLE 716
Y S Y + D+ S +L+
Sbjct: 167 NIITYFSRTY------RTEKDINSAIDRILQ 191
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 68.5 bits (167), Expect = 1e-14
Identities = 20/110 (18%), Positives = 38/110 (34%), Gaps = 19/110 (17%)
Query: 40 LVSPSQRFELGFFSPGNSKNRYLGVWYKKSPDTVVWVANRNCPILDPHGILAINNNGNLV 99
++ + + + N V Y + +W N + +G LV
Sbjct: 25 ILFGTHVYRFIMQTDCNL------VLY--DNNNPIWATNTGGL--GNGCRAVLQPDGVLV 74
Query: 100 LLNQANGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSEGSYLWQS 149
++ N T+W S ++ +A V L N+V+ G LW +
Sbjct: 75 VITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIY---------GDALWAT 115
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 65.0 bits (158), Expect = 2e-13
Identities = 26/126 (20%), Positives = 44/126 (34%), Gaps = 21/126 (16%)
Query: 26 DSITPATFIRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKKSPDTVVWVANRNCPILD 85
+ + + GE L F N L ++ D +W N
Sbjct: 2 NILYSGETLSTGEFLNY--GSFVFIMQEDCN-----LVLYD---VDKPIWATNTGGL--S 49
Query: 86 PHGILAINNNGNLVLLNQANGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSEGSY 145
L++ +GNLV+ N +N IW+SN + + V L N+V+ G+
Sbjct: 50 RSCFLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIY---------GTD 100
Query: 146 LWQSFD 151
W +
Sbjct: 101 RWATGT 106
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 64.4 bits (156), Expect = 3e-13
Identities = 23/131 (17%), Positives = 48/131 (36%), Gaps = 19/131 (14%)
Query: 25 ADSITPATFIRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKKSPDTVVWVANRNCPIL 84
+D + + G L + + N V Y + VW + N
Sbjct: 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCNL------VLY--DNNRAVWASGTNGKAS 50
Query: 85 DPHGILAINNNGNLVLLNQANGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSEGS 144
L + N+GNLV+ + + IW+SN +++ + L N+V+ + + +
Sbjct: 51 GCV--LKMQNDGNLVIYSG-SRAIWASNTNRQNGNYYLILQRDRNVVIYD------NSNN 101
Query: 145 YLWQSFDFPSD 155
+W + +
Sbjct: 102 AIWATHTNVGN 112
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 63.4 bits (154), Expect = 9e-13
Identities = 16/98 (16%), Positives = 36/98 (36%), Gaps = 10/98 (10%)
Query: 64 VWYKKSP-DTVVWVANRNCPILDPHGILAINNNGNLVLLNQANGTIWSSNMSKEAKSPVA 122
+ Y D + + L++ + NLVL ++ + +WS+N + + A
Sbjct: 12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRA 70
Query: 123 QLLDTGNLVLRENFSNNTSEGSYLWQSFD--FPSDTLL 158
L G + + T++ +W S + +
Sbjct: 71 VLQPNGRMDVL------TNQNIAVWTSGNSRSAGRYVF 102
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 49.9 bits (119), Expect = 5e-08
Identities = 19/92 (20%), Positives = 33/92 (35%), Gaps = 5/92 (5%)
Query: 41 VSPSQRFELGFFSPGNSKNRYLGVWYKKSPDTVVWVANRNCPILDPHGILAINNNGNLVL 100
+ +Q +L + + L ++ D VW N + NG + +
Sbjct: 26 LHATQSLQLSPYRLSMETDCNLVLF---DRDDRVWSTNTAGKGTGCR--AVLQPNGRMDV 80
Query: 101 LNQANGTIWSSNMSKEAKSPVAQLLDTGNLVL 132
L N +W+S S+ A V L NL +
Sbjct: 81 LTNQNIAVWTSGNSRSAGRYVFVLQPDRNLAI 112
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 48.8 bits (116), Expect = 1e-07
Identities = 28/129 (21%), Positives = 41/129 (31%), Gaps = 23/129 (17%)
Query: 21 FSLAADSITPATFIRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKKSPDTVVWVANRN 80
F L+ + P T + L S F S N L ++ D VW +N
Sbjct: 5 FGLSHEGSHPQTLHAA-QSLELSS--FRFTMQSDCN-----LVLF---DSDVRVWASNTA 53
Query: 81 CPILDPHGILAINNNGNLVLLNQANGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNT 140
+ ++G LV+L N WSS + V L + +
Sbjct: 54 ---GATGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIY------- 103
Query: 141 SEGSYLWQS 149
G LW S
Sbjct: 104 --GPGLWDS 110
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 840 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.84 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.82 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.81 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.81 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.69 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.57 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.54 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.39 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.05 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.98 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 98.96 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.83 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.64 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.16 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.29 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.19 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.74 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.45 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.03 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 91.78 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 81.87 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-47 Score=397.10 Aligned_cols=250 Identities=26% Similarity=0.365 Sum_probs=198.7
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
.++|++.++||+|+||.||+|+++ .+|+.||||++.... ....++|.+|+++|++++|||||+++++
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~------------~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~ 71 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNR------------VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEET------------TTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEEC------------CCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeee
Confidence 357999999999999999999876 678999999997543 3345679999999999999999999999
Q ss_pred eecCCceEEEEEeec----cCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 592 CIEQGEKISIYEFDI----VTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~----~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
+.+.+..++||||.. .........+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||
T Consensus 72 ~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG 148 (271)
T d1nvra_ 72 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFG 148 (271)
T ss_dssp EEETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCT
T ss_pred eccCceeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccch
Confidence 999999999999942 223344567999999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccc
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLF-SIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDK 746 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 746 (840)
+|+.+............+||+.|||||++.+..+ +.++|||||||+||||++|+.||............. ....
T Consensus 149 ~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~-----~~~~ 223 (271)
T d1nvra_ 149 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-----KEKK 223 (271)
T ss_dssp TCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHH-----HTTC
T ss_pred hheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHH-----hcCC
Confidence 9998754444444456789999999999988876 578999999999999999999986544332211111 1110
Q ss_pred cccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 747 AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 747 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
. ...........+.+++.+||+.||++|||++|+++
T Consensus 224 ~--------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 224 T--------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp T--------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C--------CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 00111122345778999999999999999999854
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.7e-47 Score=402.53 Aligned_cols=256 Identities=27% Similarity=0.395 Sum_probs=205.9
Q ss_pred HHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 511 AATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 511 ~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
...++|++.++||+|+||.||+|.++ .+++.||||+++.. ....++|.+|+++|++++|||||+++|
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~------------~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~ 80 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWK------------KYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLG 80 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEG------------GGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEEC------------CCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCc
Confidence 34578999999999999999999765 57889999999754 445788999999999999999999999
Q ss_pred EeecCCceEEEEEeeccCCc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 591 CCIEQGEKISIYEFDIVTDP------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
+|.+.+..+++|||...... .....+++..++.|+.||+.||+|||+++ |+||||||+||||++++.+||+
T Consensus 81 ~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~ 157 (287)
T d1opja_ 81 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVA 157 (287)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEEC
T ss_pred cEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEc
Confidence 99999999999999544332 23457899999999999999999999988 9999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 665 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
|||+|+........ ......||+.|||||++.+..++.|+|||||||++|||++|+.|+..... ... .......
T Consensus 158 DFG~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-~~~----~~~~i~~ 231 (287)
T d1opja_ 158 DFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQ----VYELLEK 231 (287)
T ss_dssp CCCCTTTCCSSSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHH----HHHHHHT
T ss_pred cccceeecCCCCce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-HHH----HHHHHhc
Confidence 99999876543322 23345688999999999999999999999999999999998776532211 111 1111111
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
. .....+...++.+.+++.+||+.||++||||+||++.|+.+..
T Consensus 232 ~---------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 232 D---------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp T---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred C---------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1 1111112234568899999999999999999999999988644
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=396.87 Aligned_cols=259 Identities=25% Similarity=0.415 Sum_probs=196.2
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC--CCcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK--SGQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
.++|++.++||+|+||.||+|+.+ ..||||+++.. .....++|.+|+.+|++++|||||+++|
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---------------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~ 71 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---------------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---------------SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---------------CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeE
Confidence 467888999999999999998532 35999999754 3445678999999999999999999999
Q ss_pred EeecCCceEEEEEeeccCC----c-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 591 CCIEQGEKISIYEFDIVTD----P-ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~----~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
++.+ +..++||||....+ . .....+++..++.|+.||++||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 72 ~~~~-~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~D 147 (276)
T d1uwha_ 72 YSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGD 147 (276)
T ss_dssp EECS-SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECC
T ss_pred EEec-cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEcc
Confidence 9865 56899999943221 1 12356999999999999999999999988 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCcccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhh
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH---GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLW 742 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~ 742 (840)
||+|+...............||+.|||||++.+ ..++.++|||||||+||||+||+.||....... ... ...
T Consensus 148 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~--~~~---~~~ 222 (276)
T d1uwha_ 148 FGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QII---FMV 222 (276)
T ss_dssp CCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHH---HHH
T ss_pred ccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH--HHH---HHH
Confidence 999988765444444556789999999999864 458999999999999999999999986432211 111 111
Q ss_pred cccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCCC
Q 041702 743 KDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLP 800 (840)
Q Consensus 743 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~~ 800 (840)
... ...+.+ .......++.+.+++.+||+.||++||||+||++.|+.+...+|
T Consensus 223 ~~~----~~~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 223 GRG----YLSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp HHT----SCCCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred hcC----CCCCcc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 111 011111 11112234568899999999999999999999999999877665
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=394.17 Aligned_cols=252 Identities=28% Similarity=0.430 Sum_probs=190.7
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
.++|+..++||+|+||.||+|+++ +++.||||+++.. ....++|.+|++++++++|||||+++|+|
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-------------~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~ 69 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-------------NKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-------------TTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-------------CCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCccccccee
Confidence 357888999999999999998643 6778999999764 44568899999999999999999999999
Q ss_pred ecCCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 593 IEQGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
.+.+..++||||...... .....+++..+++|+.|||.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 70 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFG 146 (263)
T d1sm2a_ 70 LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFG 146 (263)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC
T ss_pred ccCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccc
Confidence 999999999999543321 23456899999999999999999999988 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccccc
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKA 747 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 747 (840)
+++........ ......||+.|||||++.+..++.++|||||||+||||+|++.|+.... ......... ...
T Consensus 147 la~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~-~~~~~~~~i----~~~-- 218 (263)
T d1sm2a_ 147 MTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-SNSEVVEDI----STG-- 218 (263)
T ss_dssp -------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC-CHHHHHHHH----HHT--
T ss_pred hheeccCCCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC-CHHHHHHHH----Hhc--
Confidence 99876543322 2234578999999999999999999999999999999999654432111 111111111 111
Q ss_pred ccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 041702 748 WKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEI 796 (840)
Q Consensus 748 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~ 796 (840)
.....+.. ..+.+.+++.+||+.||++||||+||++.|+++.
T Consensus 219 ~~~~~p~~-------~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 219 FRLYKPRL-------ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp CCCCCCTT-------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCccc-------cCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 11112222 2345789999999999999999999999999864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-46 Score=401.26 Aligned_cols=257 Identities=23% Similarity=0.339 Sum_probs=190.4
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
++|+..++||+|+||.||+|.++ ..-.....||||++.... ....++|.+|+++|++++|||||+++|+|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~ 96 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLK---------LPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVV 96 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEC---------C---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEe---------CCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence 45777889999999999999765 111233469999987543 34456899999999999999999999999
Q ss_pred ecCCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 593 IEQGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
.+.+..++||||...... .....++|.++++++.||++||+|||+++ |+||||||+||||+.++.+||+|||
T Consensus 97 ~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG 173 (299)
T d1jpaa_ 97 TKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFG 173 (299)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-
T ss_pred eeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcc
Confidence 999999999999533221 12346899999999999999999999988 9999999999999999999999999
Q ss_pred cceecCCCCcccc---cccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhc
Q 041702 668 IARTFGGDEMQSN---TNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWK 743 (840)
Q Consensus 668 la~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 743 (840)
+|+.+........ .....||+.|||||.+.+..++.++|||||||+||||+| |+.||...... .+.. ...
T Consensus 174 la~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--~~~~----~i~ 247 (299)
T d1jpaa_ 174 LSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--DVIN----AIE 247 (299)
T ss_dssp ----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHH----HHH
T ss_pred cceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH--HHHH----HHH
Confidence 9988754432221 223457899999999999999999999999999999998 89887543211 1111 111
Q ss_pred ccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 744 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
.+ .....+.+.+..+.+++.+||+.||++||||.||++.|++++.
T Consensus 248 ~~---------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 248 QD---------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp TT---------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred cC---------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 11 0111122334568899999999999999999999999998754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-46 Score=393.54 Aligned_cols=247 Identities=21% Similarity=0.372 Sum_probs=201.9
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCI 593 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~ 593 (840)
++|+..++||+|+||.||+|+++ .+|+.||||++........+.+.+|+++|++++|||||++++++.
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~------------~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 87 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDV------------ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBT------------TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEEC------------CCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEE
Confidence 57999999999999999999765 679999999998766666788999999999999999999999999
Q ss_pred cCCceEEEEEeeccCC---ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccce
Q 041702 594 EQGEKISIYEFDIVTD---PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIAR 670 (840)
Q Consensus 594 ~~~~~~lv~e~~~~~~---~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~ 670 (840)
+.+..++||||..... ......+++.++..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+
T Consensus 88 ~~~~~~ivmEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~ 164 (293)
T d1yhwa1 88 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (293)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred ECCEEEEEEEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhhe
Confidence 9999999999953322 233457999999999999999999999998 9999999999999999999999999999
Q ss_pred ecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccccccc
Q 041702 671 TFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWKL 750 (840)
Q Consensus 671 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (840)
.+..... ......||+.|||||++.+..++.++|||||||++|||++|+.||...... .. .........
T Consensus 165 ~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~---~~~~~~~~~---- 233 (293)
T d1yhwa1 165 QITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RA---LYLIATNGT---- 233 (293)
T ss_dssp ECCSTTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HH---HHHHHHHCS----
T ss_pred eeccccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH--HH---HHHHHhCCC----
Confidence 8754332 234567999999999999999999999999999999999999998543211 11 111111110
Q ss_pred cCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 751 MDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 751 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
+.+ ..+......+.+++.+||+.||++|||++|+++
T Consensus 234 --~~~--~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 234 --PEL--QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp --CCC--SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --CCC--CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011 111223456789999999999999999999864
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=394.82 Aligned_cols=252 Identities=27% Similarity=0.427 Sum_probs=198.7
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
..++|++.++||+|+||.||+|.++ +++.||||+++.. ....++|.+|+++|++++|||||+++|+
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~-------------~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~ 76 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYN-------------GHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAV 76 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-------------TTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CHHHeEEeEEEecCCCcEEEEEEEC-------------CCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEee
Confidence 3468899999999999999998643 5778999999754 3456889999999999999999999998
Q ss_pred eecCCceEEEEEeeccCC------ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 592 CIEQGEKISIYEFDIVTD------PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
+.+ +..++||||..... ......++|..+++|+.||++||+|||+++ |+||||||+||||++++.+||+|
T Consensus 77 ~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~D 152 (272)
T d1qpca_ 77 VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIAD 152 (272)
T ss_dssp ECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECC
T ss_pred ecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeecc
Confidence 865 56799999954332 222335899999999999999999999988 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
||+|+.+...... ......||+.|||||.+.+..++.++|||||||+||||+||+.|+..... ....... ....
T Consensus 153 FGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-~~~~~~~----i~~~ 226 (272)
T d1qpca_ 153 FGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-NPEVIQN----LERG 226 (272)
T ss_dssp CTTCEECSSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHH----HHTT
T ss_pred ccceEEccCCccc-cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-HHHHHHH----HHhc
Confidence 9999987544322 23346789999999999999999999999999999999997665432211 1111111 1111
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEI 796 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~ 796 (840)
.....+ ...++.+.+++.+||+.||++||||+||++.|++..
T Consensus 227 --~~~~~p-------~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 227 --YRMVRP-------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp --CCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCCCc-------ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 111111 123346789999999999999999999999999753
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-46 Score=395.06 Aligned_cols=260 Identities=23% Similarity=0.385 Sum_probs=193.9
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
.+.|+..++||+|+||.||+|.++. ........||||+++... ....++|.+|+++|++++|||||+++|+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~--------~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~ 77 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKT--------SSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGV 77 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC-----------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeC--------CCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEE
Confidence 3568888999999999999997651 011123579999997543 2345679999999999999999999999
Q ss_pred eecCCceEEEEEeeccCC-----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 592 CIEQGEKISIYEFDIVTD-----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~-----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
|.+.+..++||||..... ......++|.++++++.||+.||+|||+.+ |+||||||+||||+.++.+||+||
T Consensus 78 ~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DF 154 (283)
T d1mqba_ 78 ISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDF 154 (283)
T ss_dssp ECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC
T ss_pred EecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEccc
Confidence 999999999999943221 123357999999999999999999999988 999999999999999999999999
Q ss_pred ccceecCCCCccc-ccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 667 GIARTFGGDEMQS-NTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 667 Gla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
|+|+.+....... ......||+.|||||++.+..++.++|||||||+||||++|+.|+...... .... .....+
T Consensus 155 Gla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-~~~~----~~i~~~ 229 (283)
T d1mqba_ 155 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVM----KAINDG 229 (283)
T ss_dssp CC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHH----HHHHTT
T ss_pred chhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-HHHH----HHHhcc
Confidence 9998875433222 233456899999999999999999999999999999999977665332211 1111 111111
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
.....+...+..+.+|+.+||+.||++||||.||++.|+.+..
T Consensus 230 ---------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 230 ---------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp ---------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---------CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 1111122234568899999999999999999999999998744
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-46 Score=391.96 Aligned_cols=261 Identities=26% Similarity=0.398 Sum_probs=200.4
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
.++|++.+.||+|+||.||+|+++ +++.||||+++.. ....++|.+|+.++++++|||||+++|+|
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~-------------~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~ 81 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWN-------------GTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVV 81 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-------------TTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEEC-------------CCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEE
Confidence 367999999999999999998754 5568999999754 44568899999999999999999999998
Q ss_pred ecCCceEEEEEeeccCC------ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 593 IEQGEKISIYEFDIVTD------PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
.+ ++.++||||..... ......++|.+++.|+.||+.||+|||+.+ |+||||||+||||+.++++||+||
T Consensus 82 ~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~Df 157 (285)
T d1fmka3 82 SE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADF 157 (285)
T ss_dssp CS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCC
T ss_pred ec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEccc
Confidence 54 56899999954332 123456999999999999999999999998 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccc
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDK 746 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 746 (840)
|+|+.+..... .......||+.|+|||++.+..++.++|||||||+||||++|+.|+...... ....... ...
T Consensus 158 Gla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-~~~~~~i----~~~- 230 (285)
T d1fmka3 158 GLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQV----ERG- 230 (285)
T ss_dssp CTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHH----HTT-
T ss_pred chhhhccCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-HHHHHHH----Hhc-
Confidence 99987654332 2233457899999999999999999999999999999999987665432211 1111111 111
Q ss_pred cccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCCCCCCCCC
Q 041702 747 AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSPHQPA 806 (840)
Q Consensus 747 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~p~~p~ 806 (840)
..+. .....++.+.+++.+||+.||++||+|++|+++|++.....+++.+|.
T Consensus 231 ----~~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p~ 282 (285)
T d1fmka3 231 ----YRMP----CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282 (285)
T ss_dssp ----CCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCCS
T ss_pred ----CCCC----CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCCC
Confidence 0111 112234568899999999999999999999999999877776555554
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=384.96 Aligned_cols=250 Identities=26% Similarity=0.385 Sum_probs=203.0
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
.++|+..++||+|+||+||+|++ .+++.||||+++.. ....++|++|+.++++++|||||+++|+|
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~-------------~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~ 68 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKW-------------RGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEE-------------TTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEE-------------CCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEE
Confidence 36889999999999999999864 36789999999865 34568899999999999999999999999
Q ss_pred ecCCceEEEEEeeccCC-----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 593 IEQGEKISIYEFDIVTD-----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~-----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
.+.+..++||||..... ......+++..+++++.||++||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 69 ~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG 145 (258)
T d1k2pa_ 69 TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFG 145 (258)
T ss_dssp CCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCS
T ss_pred eeCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcch
Confidence 99999999999943222 234456889999999999999999999988 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhcccc
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKDDK 746 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 746 (840)
+++.+...... ......+|+.|+|||.+.+..++.|+|||||||++|||+| |+.||...... ..... ....
T Consensus 146 ~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~--~~~~~----i~~~- 217 (258)
T d1k2pa_ 146 LSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEH----IAQG- 217 (258)
T ss_dssp SCCBCSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHHH----HHTT-
T ss_pred hheeccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH--HHHHH----HHhC-
Confidence 99877544332 2334678999999999999999999999999999999998 78888654322 11111 1111
Q ss_pred cccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 747 AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 747 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
.....+. ..++.+.+++.+||+.||++|||++||++.|.++
T Consensus 218 -~~~~~p~-------~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 218 -LRLYRPH-------LASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp -CCCCCCT-------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred -CCCCCcc-------cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 1111222 2234688999999999999999999999998753
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-46 Score=387.07 Aligned_cols=242 Identities=26% Similarity=0.351 Sum_probs=198.9
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
++|++.+.||+|+||.||+|+++ .+++.||||++.+. .....+++.+|++++++++|||||++++
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~------------~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~ 73 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREK------------QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 73 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET------------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEEC------------CCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEE
Confidence 57999999999999999999876 67899999998643 2345678999999999999999999999
Q ss_pred EeecCCceEEEEEeeccCCc----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 591 CCIEQGEKISIYEFDIVTDP----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
++.+.+..++||||...... .....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 74 ~~~~~~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DF 150 (263)
T d2j4za1 74 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADF 150 (263)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEECCEEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeeccc
Confidence 99999999999999544332 24567999999999999999999999998 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccc
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDK 746 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 746 (840)
|+|+...... .....||+.|||||++.+..++.++|||||||+||||++|+.||...... ... ......+
T Consensus 151 G~a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~~~----~~i~~~~ 220 (263)
T d2j4za1 151 GWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--ETY----KRISRVE 220 (263)
T ss_dssp CSCSCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHH----HHHHTTC
T ss_pred ceeeecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH--HHH----HHHHcCC
Confidence 9998764332 23467999999999999999999999999999999999999998643211 111 1111111
Q ss_pred cccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 747 AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 747 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.... ....+.+.+++.+||+.||++|||++||++
T Consensus 221 ------~~~p----~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 221 ------FTFP----DFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ------CCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------CCCC----ccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1111 123346788999999999999999999985
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-45 Score=388.45 Aligned_cols=247 Identities=25% Similarity=0.367 Sum_probs=198.7
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCI 593 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~ 593 (840)
+.|++.++||+|+||.||+|+++ .+++.||||++........++|.+|+++|++++|||||++++++.
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~------------~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 79 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNK------------ETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEET------------TTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEEC------------CCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 56899999999999999999876 678999999998776677789999999999999999999999999
Q ss_pred cCCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccc
Q 041702 594 EQGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGI 668 (840)
Q Consensus 594 ~~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl 668 (840)
+.+..++||||...... .....+++.++..++.||+.||.|||+++ |+||||||+|||++.++++||+|||+
T Consensus 80 ~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~ 156 (288)
T d2jfla1 80 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGV 156 (288)
T ss_dssp ETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred eCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechh
Confidence 99999999999432221 12456999999999999999999999998 99999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhc
Q 041702 669 ARTFGGDEMQSNTNRIVGTYGYMSPEYAL-----HGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWK 743 (840)
Q Consensus 669 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~ 743 (840)
|+...... .......||+.|||||++. +..++.++|||||||+||||++|+.||......+ .... ...
T Consensus 157 a~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~--~~~~---i~~ 229 (288)
T d2jfla1 157 SAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR--VLLK---IAK 229 (288)
T ss_dssp CEECHHHH--HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--HHHH---HHH
T ss_pred hhccCCCc--ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH--HHHH---HHc
Confidence 97653211 1233567999999999884 4568999999999999999999999986543221 1111 111
Q ss_pred ccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 744 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.....+ ..+....+.+.+++.+||+.||++|||++|+++
T Consensus 230 -~~~~~~-------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 230 -SEPPTL-------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -SCCCCC-------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CCCCCC-------CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111 111223456789999999999999999999865
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-45 Score=394.20 Aligned_cols=266 Identities=24% Similarity=0.359 Sum_probs=207.0
Q ss_pred HHHHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcCCCC
Q 041702 506 LSSISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQHRN 584 (840)
Q Consensus 506 ~~~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~H~n 584 (840)
+.+++...++|++.++||+|+||.||+|+++.. ....+++.||||+++.... ...++|.+|+++|++++|||
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~-------~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~n 77 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGL-------LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 77 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETS-------STTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTT
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCC-------ccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCC
Confidence 344555678899999999999999999986510 1345678999999976533 33567999999999999999
Q ss_pred ccceeeEeecCCceEEEEEeeccCC----------------------------ccccCCCCHHHHHHHHHHHHHHHHHHH
Q 041702 585 LVRLFGCCIEQGEKISIYEFDIVTD----------------------------PARKDLLDWTTRVRIIEGVAQGLLYLH 636 (840)
Q Consensus 585 iv~l~g~~~~~~~~~lv~e~~~~~~----------------------------~~~~~~l~~~~~~~i~~~ia~~L~yLH 636 (840)
|++++++|...+..++++|+..... ......+++..++.|+.||+.||+|||
T Consensus 78 iv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH 157 (301)
T d1lufa_ 78 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS 157 (301)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc
Confidence 9999999999999999999942211 112335899999999999999999999
Q ss_pred hcCCCceecCCCCCCcEEecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHH
Q 041702 637 QYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLE 716 (840)
Q Consensus 637 ~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~e 716 (840)
+.+ |+||||||+|||||.++++||+|||+|+...............+|+.|+|||.+.+..++.++|||||||+|||
T Consensus 158 ~~~---ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~e 234 (301)
T d1lufa_ 158 ERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE 234 (301)
T ss_dssp HTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred cCC---eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHH
Confidence 988 99999999999999999999999999987755444444556678999999999999999999999999999999
Q ss_pred HHhCCC-CCCCCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 717 ILSSKK-NTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 717 lltG~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
|++|.. |+..... ..... ....+... ..+...+..+.+|+.+||+.+|++||||.||+++|+++
T Consensus 235 ll~~~~~p~~~~~~--~e~~~----~v~~~~~~---------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 235 IFSYGLQPYYGMAH--EEVIY----YVRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp HHTTTCCTTTTSCH--HHHHH----HHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred HHccCCCCCCCCCH--HHHHH----HHHcCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 999964 5543221 11111 11122111 11122334688999999999999999999999999987
Q ss_pred c
Q 041702 796 I 796 (840)
Q Consensus 796 ~ 796 (840)
.
T Consensus 300 ~ 300 (301)
T d1lufa_ 300 C 300 (301)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-45 Score=393.58 Aligned_cols=260 Identities=22% Similarity=0.299 Sum_probs=197.1
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcCCCCccceee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
..++|++.++||+|+||+||+|+++ .+|+.||+|+++.... ...+++.+|+.+|++++|||||++++
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~------------~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 71 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHK------------PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEET------------TTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEEC------------CCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 3578999999999999999999765 6799999999976533 33567999999999999999999999
Q ss_pred EeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceecCCCCCCcEEecCCCCceeec
Q 041702 591 CCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQY-SRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
+|.+.++.++||||....+ ......+++..+..++.||+.||.|||++ + |+||||||+||||+.++++||+|
T Consensus 72 ~~~~~~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~D 148 (322)
T d1s9ja_ 72 AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCD 148 (322)
T ss_dssp EEECSSEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECC
T ss_pred EEEECCEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEee
Confidence 9999999999999943222 23455799999999999999999999974 7 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhc--
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWK-- 743 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~-- 743 (840)
||+|+.+... .....+||+.|||||++.+..++.++|||||||+++||++|+.||...................
T Consensus 149 FGla~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~ 224 (322)
T d1s9ja_ 149 FGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 224 (322)
T ss_dssp CCCCHHHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------
T ss_pred CCCccccCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcc
Confidence 9999875322 2345689999999999999999999999999999999999999997543322110000000000
Q ss_pred ---------ccccc-cccCc--ccc--------------chhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 744 ---------DDKAW-KLMDP--TMQ--------------NEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 744 ---------~~~~~-~~~d~--~l~--------------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
..... ...+. ... ..........+.+++.+||+.||++|||++|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 225 ETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ---------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 00000 00000 000 0000012345789999999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=396.44 Aligned_cols=259 Identities=27% Similarity=0.417 Sum_probs=200.0
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC-CCcCHHHHHHHHHHHhhc-CCCCcccee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK-SGQGLEEFKNEMMLIAKL-QHRNLVRLF 589 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~-~~~~~~~f~~Ev~~l~~l-~H~niv~l~ 589 (840)
..++|++.++||+|+||+||+|+++.. +.......||||++... .......|.+|+.+|.++ +|||||+++
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~-------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~ 107 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGI-------SKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLL 107 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESC-------SSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCC-------CcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEE
Confidence 346899999999999999999987511 11223457999998754 334557899999999998 899999999
Q ss_pred eEeecCCceEEEEEeeccCCc---------------------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCc
Q 041702 590 GCCIEQGEKISIYEFDIVTDP---------------------------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLR 642 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~~~---------------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ 642 (840)
++|.+.+..++||||....+. .....+++..++.|+.||++||+|||+++
T Consensus 108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--- 184 (325)
T d1rjba_ 108 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--- 184 (325)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred EEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 999999999999999432211 11245899999999999999999999988
Q ss_pred eecCCCCCCcEEecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CC
Q 041702 643 VIHRDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SK 721 (840)
Q Consensus 643 ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~ 721 (840)
|+||||||+|||++.++.+||+|||+|+...............||+.|||||.+.+..++.++|||||||+||||+| |+
T Consensus 185 IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~ 264 (325)
T d1rjba_ 185 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 264 (325)
T ss_dssp EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCC
Confidence 99999999999999999999999999987655444334445678999999999999999999999999999999998 89
Q ss_pred CCCCCCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 041702 722 KNTRFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKD 794 (840)
Q Consensus 722 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~ 794 (840)
.||....... .+. .....+ .....+...++.+.+|+.+||+.||++||||+||++.|..
T Consensus 265 ~Pf~~~~~~~-~~~----~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 265 NPYPGIPVDA-NFY----KLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp CSSTTCCCSH-HHH----HHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCCHHH-HHH----HHHhcC---------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 9986433221 111 111111 0111112234568899999999999999999999999964
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-45 Score=388.69 Aligned_cols=256 Identities=26% Similarity=0.378 Sum_probs=199.9
Q ss_pred cCCcccc-cccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 514 DNFSEEN-KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 514 ~~f~~~~-~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
++|...+ +||+|+||.||+|.++ ...++..||||+++... ....++|.+|+++|++++|||||+++|+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~----------~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~ 77 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYR----------MRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 77 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC-------------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEe----------cCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeee
Confidence 4566666 4999999999999764 12346689999997653 3346789999999999999999999999
Q ss_pred eecCCceEEEEEeeccCC-----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 592 CIEQGEKISIYEFDIVTD-----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~-----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
|.. +..++||||..... ......+++.++.+++.||+.||+|||+++ |+||||||+||||+.++.+||+||
T Consensus 78 ~~~-~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DF 153 (285)
T d1u59a_ 78 CQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDF 153 (285)
T ss_dssp EES-SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCC
T ss_pred ecc-CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccc
Confidence 864 56899999943222 123457999999999999999999999988 999999999999999999999999
Q ss_pred ccceecCCCCcc-cccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 667 GIARTFGGDEMQ-SNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 667 Gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
|+|+.+...... .......||+.|||||.+.+..++.++|||||||++|||+| |+.||...... ... .....
T Consensus 154 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--~~~----~~i~~ 227 (285)
T d1u59a_ 154 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVM----AFIEQ 227 (285)
T ss_dssp TTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHH----HHHHT
T ss_pred hhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--HHH----HHHHc
Confidence 999987654322 22334568999999999999999999999999999999998 89998654321 111 11111
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccC
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVN 798 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~ 798 (840)
+... +.+...+..+.+|+.+||+.||++||||.+|++.|+.....
T Consensus 228 ~~~~---------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 228 GKRM---------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp TCCC---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCC---------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 1111 11122345678999999999999999999999999876543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=389.50 Aligned_cols=245 Identities=23% Similarity=0.297 Sum_probs=196.5
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
++|++.+.||+|+||.||+|+++ .+++.||||++... .....+.+.+|+++|++++||||+++++
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~------------~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~ 75 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLAREL------------ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 75 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET------------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEEC------------CCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEE
Confidence 57999999999999999999765 67899999999743 2445678999999999999999999999
Q ss_pred EeecCCceEEEEEeeccC----CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 591 CCIEQGEKISIYEFDIVT----DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~----~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
++.+.+..++||||.... .......+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+||
T Consensus 76 ~~~~~~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DF 152 (288)
T d1uu3a_ 76 TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDF 152 (288)
T ss_dssp EEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred EEEECCEEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEeccc
Confidence 999999999999994322 2334567999999999999999999999998 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccc
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDK 746 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 746 (840)
|+|+.+.............||+.|||||++.+..++.++|||||||+||||++|+.||..... ..+.. .....+
T Consensus 153 G~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--~~~~~----~i~~~~ 226 (288)
T d1uu3a_ 153 GTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--YLIFQ----KIIKLE 226 (288)
T ss_dssp TTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH----HHHTTC
T ss_pred ccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH--HHHHH----HHHcCC
Confidence 999987654444444556899999999999999999999999999999999999999864321 11111 111111
Q ss_pred cccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 041702 747 AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVV 789 (840)
Q Consensus 747 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 789 (840)
..+. ....+.+.+++.+||+.||++|||++|++
T Consensus 227 ------~~~p----~~~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 227 ------YDFP----EKFFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp ------CCCC----TTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred ------CCCC----ccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 0111 12334578999999999999999999874
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=387.86 Aligned_cols=248 Identities=26% Similarity=0.347 Sum_probs=192.0
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceeeEeecCCc
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEQGE 597 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~ 597 (840)
++||+|+||.||+|.++ ....++.||||+++... ....++|.+|+++|++++|||||+++|+|.. +.
T Consensus 13 k~iG~G~fG~Vy~~~~~----------~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~ 81 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQ----------MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ES 81 (277)
T ss_dssp EEEEECSSEEEEEEEEE----------CSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SS
T ss_pred CCcccCCCeEEEEEEEc----------cCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CC
Confidence 47999999999999754 11356789999997542 2335679999999999999999999999864 56
Q ss_pred eEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccccceecC
Q 041702 598 KISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIARTFG 673 (840)
Q Consensus 598 ~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~ 673 (840)
.++||||..... ......+++..+++|+.||++||+|||+.+ |+||||||+||||+.++.+||+|||+|+.+.
T Consensus 82 ~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~ 158 (277)
T d1xbba_ 82 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALR 158 (277)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcc
Confidence 789999943222 234567999999999999999999999988 9999999999999999999999999999875
Q ss_pred CCCcc-cccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhccccccccc
Q 041702 674 GDEMQ-SNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKDDKAWKLM 751 (840)
Q Consensus 674 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (840)
..... .......||+.|||||.+.+..++.++|||||||++|||+| |+.||...... .. ......+..
T Consensus 159 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--~~----~~~i~~~~~---- 228 (277)
T d1xbba_ 159 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EV----TAMLEKGER---- 228 (277)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HH----HHHHHTTCC----
T ss_pred ccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH--HH----HHHHHcCCC----
Confidence 44332 22344578999999999999999999999999999999998 89998643211 11 111111111
Q ss_pred CccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 041702 752 DPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEI 796 (840)
Q Consensus 752 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~ 796 (840)
...+...+..+.+|+.+||+.||++||||++|++.|+...
T Consensus 229 -----~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 229 -----MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -----CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 1111223456788999999999999999999999998753
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-46 Score=388.49 Aligned_cols=248 Identities=26% Similarity=0.380 Sum_probs=185.6
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
++|++.+.||+|+||.||+|+++ .+|+.||||++.... ....+.|.+|+++|++++|||||+++++
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~------------~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~ 71 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRK------------SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 71 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET------------TTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEEC------------CCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEE
Confidence 67999999999999999999765 678999999997653 2345679999999999999999999999
Q ss_pred eec--CCceEEEEEeeccCCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhcCC--CceecCCCCCCcEEecCCC
Q 041702 592 CIE--QGEKISIYEFDIVTDP--------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSR--LRVIHRDLKASNVLLDSDM 659 (840)
Q Consensus 592 ~~~--~~~~~lv~e~~~~~~~--------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~--~~ivHrDlkp~NILl~~~~ 659 (840)
+.+ .+..++||||...... .....+++..++.++.||+.||+|||+++. .+|+||||||+||||+.++
T Consensus 72 ~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~ 151 (269)
T d2java1 72 IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ 151 (269)
T ss_dssp EEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTS
T ss_pred EEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCC
Confidence 865 4567899999432221 234579999999999999999999998652 3599999999999999999
Q ss_pred CceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHh
Q 041702 660 NPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAW 739 (840)
Q Consensus 660 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~ 739 (840)
.+||+|||+|+.+..... ......||+.|||||.+.+..++.++|||||||+||||+||+.||...... .+.
T Consensus 152 ~vkl~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~--~~~---- 223 (269)
T d2java1 152 NVKLGDFGLARILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--ELA---- 223 (269)
T ss_dssp CEEECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHH----
T ss_pred cEEEeeccceeecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH--HHH----
Confidence 999999999988754322 234567999999999999999999999999999999999999998643211 111
Q ss_pred hhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 740 NLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 740 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.......... + +...++.+.+++.+||+.||++|||++|+++
T Consensus 224 ~~i~~~~~~~-----~----~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 224 GKIREGKFRR-----I----PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHHHHTCCCC-----C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHcCCCCC-----C----CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1111111111 1 1123346888999999999999999999875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-45 Score=392.41 Aligned_cols=252 Identities=25% Similarity=0.383 Sum_probs=193.5
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCC----ceEEEEEeccC-CCcCHHHHHHHHHHHhhcCCCCccce
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNG----EEVAVKRLSSK-SGQGLEEFKNEMMLIAKLQHRNLVRL 588 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g----~~VAvK~l~~~-~~~~~~~f~~Ev~~l~~l~H~niv~l 588 (840)
.+|+..++||+|+||+||+|.++ .+| .+||||+++.. .....++|.+|++++++++|||||++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~------------~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l 76 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWI------------PEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 76 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEEC------------C----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCE
T ss_pred HHCEEeeEEecCCCeEEEEEEEc------------CCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeE
Confidence 46999999999999999999765 233 36999998754 34567889999999999999999999
Q ss_pred eeEeecCCceEEEEEeeccCC-----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCcee
Q 041702 589 FGCCIEQGEKISIYEFDIVTD-----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKI 663 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~~~~~~-----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL 663 (840)
+|+|.+++ .++++|+..... ......+++..+++++.||+.||+|||+++ |+||||||+||||+.++.+||
T Consensus 77 ~g~~~~~~-~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl 152 (317)
T d1xkka_ 77 LGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 152 (317)
T ss_dssp EEEEESSS-EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEE
T ss_pred EEEEecCC-eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEe
Confidence 99998754 566667643322 123567999999999999999999999988 999999999999999999999
Q ss_pred eccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhh
Q 041702 664 SDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLW 742 (840)
Q Consensus 664 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 742 (840)
+|||+|+.+.............||+.|||||.+.++.++.++|||||||+||||+| |+.|+....... +.. ..
T Consensus 153 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--~~~----~i 226 (317)
T d1xkka_ 153 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISS----IL 226 (317)
T ss_dssp CCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--HHH----HH
T ss_pred eccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH--HHH----HH
Confidence 99999998765554444555678999999999999999999999999999999999 787875433221 111 11
Q ss_pred cccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 041702 743 KDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEI 796 (840)
Q Consensus 743 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~ 796 (840)
..+. ....+...+..+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 227 ~~~~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 227 EKGE---------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp HHTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HcCC---------CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 1110 01111223456788999999999999999999999988653
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=378.91 Aligned_cols=243 Identities=22% Similarity=0.347 Sum_probs=187.9
Q ss_pred cccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceeeEeec
Q 041702 517 SEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIE 594 (840)
Q Consensus 517 ~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~ 594 (840)
+..++||+|+||+||+|.++ .+++.||+|++.... ....++|.+|+++|++++|||||++++++..
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~------------~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 79 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDT------------ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWES 79 (270)
T ss_dssp EEEEEEEECSSEEEEEEEET------------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEEC------------CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee
Confidence 55568999999999999765 678899999987542 3345679999999999999999999999865
Q ss_pred ----CCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEec-CCCCceeec
Q 041702 595 ----QGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLD-SDMNPKISD 665 (840)
Q Consensus 595 ----~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~-~~~~~kL~D 665 (840)
.+..++||||..... ......+++..+..++.||++||+|||+++ ++|+||||||+|||++ +++.+||+|
T Consensus 80 ~~~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~D 158 (270)
T d1t4ha_ 80 TVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGD 158 (270)
T ss_dssp ESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECC
T ss_pred ccccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEee
Confidence 345789999953332 234567999999999999999999999875 4599999999999996 578999999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
||+|+..... ......||+.|||||++.+ .++.++|||||||+||||++|+.||...... ..+. ......
T Consensus 159 FGla~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~-~~~~----~~i~~~ 228 (270)
T d1t4ha_ 159 LGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-AQIY----RRVTSG 228 (270)
T ss_dssp TTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-HHHH----HHHTTT
T ss_pred cCcceeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH-HHHH----HHHHcC
Confidence 9999864332 2335689999999998865 6999999999999999999999998532211 1111 111111
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.. + ........+.+.+++.+||+.||++|||++|+++
T Consensus 229 ~~-----~---~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 229 VK-----P---ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp CC-----C---GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CC-----C---cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 00 0 1111122345788999999999999999999975
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-44 Score=386.22 Aligned_cols=242 Identities=29% Similarity=0.466 Sum_probs=194.2
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC---cCHHHHHHHHHHHhhcCCCCccceee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG---QGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
+.|+.+++||+|+||.||+|+++ .+++.||||+++.... ...++|.+|+++|++++|||||++++
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~------------~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~ 82 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDV------------RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEET------------TTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEEC------------CCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEE
Confidence 45899999999999999999765 6789999999975432 23457899999999999999999999
Q ss_pred EeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 591 CCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
++.+.+..++||||..... ......+++.++..++.||+.||.|||+++ |+||||||+||||+.++.+||+||
T Consensus 83 ~~~~~~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DF 159 (309)
T d1u5ra_ 83 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDF 159 (309)
T ss_dssp EEEETTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCC
T ss_pred EEEECCEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeec
Confidence 9999999999999943221 233567999999999999999999999998 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCcccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhc
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALH---GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWK 743 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~ 743 (840)
|+|+.... .....||+.|||||++.+ ..|+.++|||||||++|||++|+.||..... ... ......
T Consensus 160 G~a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~--~~~---~~~i~~ 228 (309)
T d1u5ra_ 160 GSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSA---LYHIAQ 228 (309)
T ss_dssp TTCBSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHH---HHHHHH
T ss_pred ccccccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH--HHH---HHHHHh
Confidence 99986532 234579999999999864 4689999999999999999999999854321 111 111111
Q ss_pred ccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 744 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
. .. +.... ...++.+.+++.+||+.||++|||++|+++
T Consensus 229 ~-~~-----~~~~~---~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 229 N-ES-----PALQS---GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp S-CC-----CCCSC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C-CC-----CCCCC---CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1 11 11111 112346788999999999999999999976
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.9e-44 Score=382.53 Aligned_cols=249 Identities=22% Similarity=0.297 Sum_probs=183.6
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
..+.|++.+.||+|+||.||+|+++ .+++.||||++.... ....+.+.+|+++|++++|||||++++
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~------------~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 74 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDK------------RTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEET------------TTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEEC------------CCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 3467999999999999999999765 678999999997543 233467889999999999999999999
Q ss_pred EeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEec---CCCCcee
Q 041702 591 CCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLD---SDMNPKI 663 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~---~~~~~kL 663 (840)
++.+.+..++||||....+ ......+++..+..++.||+.||+|||+.+ |+||||||+|||+. +++.+||
T Consensus 75 ~~~~~~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl 151 (307)
T d1a06a_ 75 IYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMI 151 (307)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEE
T ss_pred EEEECCEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEE
Confidence 9999999999999954332 234567999999999999999999999998 99999999999994 5789999
Q ss_pred eccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhc
Q 041702 664 SDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWK 743 (840)
Q Consensus 664 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~ 743 (840)
+|||+|+....... ....+||+.|||||.+.+..++.++|||||||+||||++|+.||...... .... ....
T Consensus 152 ~DFG~a~~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~~~---~i~~ 223 (307)
T d1a06a_ 152 SDFGLSKMEDPGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA--KLFE---QILK 223 (307)
T ss_dssp CCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHH---HHHT
T ss_pred eccceeEEccCCCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH--HHHH---HHhc
Confidence 99999987644322 23467999999999999999999999999999999999999998643211 1111 1111
Q ss_pred ccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 744 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.. ...........++.+.+++.+||+.||++|||++|+++
T Consensus 224 -~~------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 224 -AE------YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp -TC------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -cC------CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 10 01111112233456889999999999999999999987
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.4e-43 Score=385.56 Aligned_cols=249 Identities=22% Similarity=0.306 Sum_probs=201.4
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
.++|++.++||+|+||.||+|+++ .+|+.||||++........+.+.+|+.+|++++|||||++++++
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~------------~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~ 92 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTER------------ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEET------------TTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEEC------------CCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 468999999999999999999765 67999999999876555567899999999999999999999999
Q ss_pred ecCCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecC--CCCceeec
Q 041702 593 IEQGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS--DMNPKISD 665 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~--~~~~kL~D 665 (840)
.+.+..++||||....+. .....+++..+..|+.||+.||+|||+++ |+||||||+|||++. ++.+||+|
T Consensus 93 ~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~D 169 (350)
T d1koaa2 93 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLID 169 (350)
T ss_dssp EETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECC
T ss_pred EECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEee
Confidence 999999999999543322 23446999999999999999999999998 999999999999954 67899999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
||+|+.+..... .....||+.|||||++.+..++.++|||||||++|||++|+.||..... ........ ..
T Consensus 170 FG~a~~~~~~~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--~~~~~~i~----~~ 240 (350)
T d1koaa2 170 FGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--DETLRNVK----SC 240 (350)
T ss_dssp CTTCEECCTTSC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHH----HT
T ss_pred cchheecccccc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH--HHHHHHHH----hC
Confidence 999988754332 3346799999999999999999999999999999999999999864321 11111111 00
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
. ............+.+.+++.+||+.||++|||++|+++.
T Consensus 241 ~------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 241 D------WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp C------CCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred C------CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 011111122334567899999999999999999999873
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-44 Score=377.72 Aligned_cols=255 Identities=26% Similarity=0.354 Sum_probs=190.2
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
++|++.+.||+|+||.||+|+.+ ........||||++... .....++|.+|+++|++++|||||+++|
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~---------~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g 78 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWD---------APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 78 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEE---------CTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEEE---------CCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 56899999999999999999754 22233457999998754 2334578999999999999999999999
Q ss_pred EeecCCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 591 CCIEQGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
+|.+ +..++||||...... .....+++..+++++.||++||.|||+++ |+||||||+||||+.++.+||+|
T Consensus 79 ~~~~-~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~D 154 (273)
T d1u46a_ 79 VVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGD 154 (273)
T ss_dssp EECS-SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECC
T ss_pred EEee-cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeecc
Confidence 9976 467899999543332 22356999999999999999999999988 99999999999999999999999
Q ss_pred cccceecCCCCccc-ccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhc
Q 041702 666 FGIARTFGGDEMQS-NTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWK 743 (840)
Q Consensus 666 FGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 743 (840)
||+++.+....... ......++..|+|||.+.+..++.++|||||||++|||+| |+.||...... ... .....
T Consensus 155 fGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~--~~~---~~i~~ 229 (273)
T d1u46a_ 155 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QIL---HKIDK 229 (273)
T ss_dssp CTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHH---HHHHT
T ss_pred chhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH--HHH---HHHHh
Confidence 99999875543322 2334567889999999999999999999999999999998 89998643211 111 11111
Q ss_pred ccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 744 DDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 744 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
.. ...+.+...+..+.+++.+||+.||++||||+||++.|+++
T Consensus 230 ~~---------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 230 EG---------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp SC---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC---------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11 11111122334688999999999999999999999999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-44 Score=379.13 Aligned_cols=256 Identities=23% Similarity=0.325 Sum_probs=190.2
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
.++|++.+.||+|+||.||+|+++ ..-..+..||||+++.... ...+.|.+|+++|++++|||||+++|+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~---------~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 76 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYM---------SPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGV 76 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEC---------CC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEe---------cCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 467999999999999999999765 2233456899999975433 345679999999999999999999999
Q ss_pred eecCCceEEEEEeeccCC-----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 592 CIEQGEKISIYEFDIVTD-----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~-----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
+. .+..++||||..... ......+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 77 ~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~Df 152 (273)
T d1mp8a_ 77 IT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDF 152 (273)
T ss_dssp EC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-
T ss_pred Ee-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccc
Confidence 96 467899999943222 123456899999999999999999999998 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
|+|+.+..... .......||+.|+|||.+.+..++.++|||||||+||||++ |.+|+...... .+.... ...
T Consensus 153 G~a~~~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--~~~~~i----~~~ 225 (273)
T d1mp8a_ 153 GLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRI----ENG 225 (273)
T ss_dssp -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHH----HTT
T ss_pred hhheeccCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH--HHHHHH----HcC
Confidence 99987654322 22344668999999999999999999999999999999998 78887644322 111111 111
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
... ..+...++.+.+++.+||+.||++|||++||++.|+.+++
T Consensus 226 ~~~---------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 226 ERL---------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp CCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCC---------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 110 1112234568899999999999999999999999987643
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-44 Score=380.91 Aligned_cols=264 Identities=28% Similarity=0.367 Sum_probs=194.6
Q ss_pred HHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhc-CCCCcc
Q 041702 509 ISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKL-QHRNLV 586 (840)
Q Consensus 509 ~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l-~H~niv 586 (840)
++...++|++.++||+|+||.||+|.++. .+...+++.||||+++... ....++|.+|+.++.++ +|+||+
T Consensus 8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~-------~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv 80 (299)
T d1ywna1 8 WEFPRDRLKLGKPLGRGAFGQVIEADAFG-------IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 80 (299)
T ss_dssp HBCCGGGEEEEEEEEECSSCEEEEEEEES-------TTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred ccccHHHEEEeeEEeecCCeEEEEEEEcC-------CCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEE
Confidence 33445789999999999999999998651 1234567899999997543 23456788899988888 689999
Q ss_pred ceeeEeecC-CceEEEEEeeccCCc--------------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceec
Q 041702 587 RLFGCCIEQ-GEKISIYEFDIVTDP--------------------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIH 645 (840)
Q Consensus 587 ~l~g~~~~~-~~~~lv~e~~~~~~~--------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH 645 (840)
++++++.+. +..++||||...... .....+++.+++.++.||++||+|||+++ |+|
T Consensus 81 ~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivH 157 (299)
T d1ywna1 81 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIH 157 (299)
T ss_dssp CEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred EeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcC
Confidence 999998765 468999999432211 12345899999999999999999999988 999
Q ss_pred CCCCCCcEEecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCC-CC
Q 041702 646 RDLKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKK-NT 724 (840)
Q Consensus 646 rDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~-p~ 724 (840)
|||||+||||++++++||+|||+|+...............||+.|||||.+.+..++.++|||||||++|||+||.. |+
T Consensus 158 rDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~ 237 (299)
T d1ywna1 158 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 237 (299)
T ss_dssp SCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCC
Confidence 99999999999999999999999987765544444556789999999999999999999999999999999999754 55
Q ss_pred CCCCCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 041702 725 RFYNTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEI 796 (840)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~ 796 (840)
....... .+. .....+.. +.. +...++.+.+++.+||+.||++|||++||++.|++++
T Consensus 238 ~~~~~~~-~~~----~~~~~~~~-----~~~----~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 238 PGVKIDE-EFC----RRLKEGTR-----MRA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp TTCCCSH-HHH----HHHHHTCC-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCHHH-HHH----HHHhcCCC-----CCC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 4332211 111 11111111 111 1122345789999999999999999999999999864
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-43 Score=374.59 Aligned_cols=248 Identities=23% Similarity=0.328 Sum_probs=200.1
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC------CcCHHHHHHHHHHHhhcCCCCcc
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS------GQGLEEFKNEMMLIAKLQHRNLV 586 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~------~~~~~~f~~Ev~~l~~l~H~niv 586 (840)
.++|++.+.||+|+||.||+|+++ .+|+.||||++++.. ....+.|.+|+.+|++++|||||
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~------------~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv 76 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREK------------STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEET------------TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBC
T ss_pred ccCEEEeEEEecCCCeEEEEEEEC------------CCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCC
Confidence 468999999999999999999865 679999999986432 23467899999999999999999
Q ss_pred ceeeEeecCCceEEEEEeeccCCc----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCC---
Q 041702 587 RLFGCCIEQGEKISIYEFDIVTDP----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDM--- 659 (840)
Q Consensus 587 ~l~g~~~~~~~~~lv~e~~~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~--- 659 (840)
++++++.+.+..++||||...... .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 77 ~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~ 153 (293)
T d1jksa_ 77 TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPK 153 (293)
T ss_dssp CEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSS
T ss_pred cEEEEEEECCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcc
Confidence 999999999999999999543332 34567999999999999999999999998 99999999999998776
Q ss_pred -CceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHH
Q 041702 660 -NPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHA 738 (840)
Q Consensus 660 -~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~ 738 (840)
.+||+|||+|+....... .....||+.|+|||++.+..++.++|||||||+||||++|+.||...... ....
T Consensus 154 ~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~~~-- 226 (293)
T d1jksa_ 154 PRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLA-- 226 (293)
T ss_dssp CCEEECCCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH--
T ss_pred cceEecchhhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH--HHHH--
Confidence 499999999988754332 23457899999999999999999999999999999999999998643211 1111
Q ss_pred hhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 739 WNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 739 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.. ... ............+..+.+++.+||+.||++|||++|+++
T Consensus 227 -~i-~~~------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 227 -NV-SAV------NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp -HH-HTT------CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -HH-Hhc------CCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 110 111111222234556889999999999999999999986
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.2e-43 Score=384.24 Aligned_cols=253 Identities=22% Similarity=0.299 Sum_probs=203.0
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
.++|++.++||+|+||.||+|+++ .+|+.||||+++.......+.+.+|+++|++++|||||++++++
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~------------~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~ 95 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEK------------ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEET------------TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEEC------------CCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 367999999999999999999765 67999999999866545567789999999999999999999999
Q ss_pred ecCCceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEec--CCCCceeec
Q 041702 593 IEQGEKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLD--SDMNPKISD 665 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~--~~~~~kL~D 665 (840)
.+.+..++||||...... .....+++.++..|+.||+.||+|||+.+ |+||||||+||||+ .++.+||+|
T Consensus 96 ~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~D 172 (352)
T d1koba_ 96 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIID 172 (352)
T ss_dssp ECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECC
T ss_pred EECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEee
Confidence 999999999999543322 22346899999999999999999999998 99999999999998 678999999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
||+|+.+..... .....||+.|||||++.+..++.++|||||||+||||+||+.||...... ...... . ..
T Consensus 173 FGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~~~~~i---~-~~ 243 (352)
T d1koba_ 173 FGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--ETLQNV---K-RC 243 (352)
T ss_dssp CTTCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHH---H-HC
T ss_pred cccceecCCCCc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH---H-hC
Confidence 999998754432 33467899999999999999999999999999999999999998643211 111111 1 10
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhcc
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM--LKDE 795 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--Le~~ 795 (840)
+..............+.+++.+||+.||.+|||++|+++. +++.
T Consensus 244 ------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 244 ------DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp ------CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred ------CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 0111111112334567899999999999999999999873 5544
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-43 Score=371.10 Aligned_cols=244 Identities=26% Similarity=0.374 Sum_probs=186.1
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
.++|+..++||+|+||.||+|++ .|..||||+++.. ...++|.+|++++++++|||||+++|+|
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--------------~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~ 69 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--------------RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVI 69 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--------------TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--------------CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 35688889999999999999864 3678999999754 3457899999999999999999999999
Q ss_pred ec-CCceEEEEEeeccCCc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 593 IE-QGEKISIYEFDIVTDP------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 593 ~~-~~~~~lv~e~~~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
.+ .+..++||||...... .....++|..+++|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 70 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~d 146 (262)
T d1byga_ 70 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSD 146 (262)
T ss_dssp CCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECC
T ss_pred EecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecc
Confidence 65 4668999999432221 12235899999999999999999999987 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCccHhHHHhhhhcc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNTDSLTLLGHAWNLWKD 744 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 744 (840)
||+++..... .....+|..|+|||++.+..++.++|||||||++|||+| |+.|+...... ...... ..
T Consensus 147 fg~s~~~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~--~~~~~i----~~ 215 (262)
T d1byga_ 147 FGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRV----EK 215 (262)
T ss_dssp CCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHH----TT
T ss_pred cccceecCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH--HHHHHH----Hc
Confidence 9999865432 223467889999999999999999999999999999998 57665433221 211111 11
Q ss_pred cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 745 DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 745 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
+ ...+.+....+.+.+++.+||+.||++||||.+|+++|+.+
T Consensus 216 ~---------~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 216 G---------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp T---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C---------CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 1 11111222335678999999999999999999999999876
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-43 Score=378.53 Aligned_cols=245 Identities=20% Similarity=0.270 Sum_probs=200.1
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhcCCCCcccee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
.++|++.++||+|+||.||+|+++ .+|+.||||++++. .....+++.+|+.+|++++||||++++
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~------------~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~ 71 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREK------------ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET------------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEEC------------CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 367999999999999999999766 68999999999753 244678899999999999999999999
Q ss_pred eEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 590 GCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
+++.+.+..++||||..... ......+++.....++.||+.||+|||+++ |+||||||+|||+++++.+||+|
T Consensus 72 ~~~~~~~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~D 148 (337)
T d1o6la_ 72 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITD 148 (337)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECC
T ss_pred eeeccccccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEee
Confidence 99999999999999954333 234567899999999999999999999998 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
||+|+...... ......+||+.|||||++.+..++.++|||||||+||||++|+.||...... .+. ......
T Consensus 149 FG~a~~~~~~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~--~~~----~~i~~~ 220 (337)
T d1o6la_ 149 FGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--RLF----ELILME 220 (337)
T ss_dssp CTTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH----HHHHHC
T ss_pred cccccccccCC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH--HHH----HHHhcC
Confidence 99998764322 2234578999999999999999999999999999999999999998654321 111 111111
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPT-----MLEVVA 790 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 790 (840)
. ... +......+.+++.+||+.||++||+ ++|+++
T Consensus 221 ~------~~~----p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 221 E------IRF----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp C------CCC----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred C------CCC----CccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 1 011 1123345788999999999999995 777775
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=378.79 Aligned_cols=262 Identities=28% Similarity=0.399 Sum_probs=200.9
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhc-CCCCccceee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKL-QHRNLVRLFG 590 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l-~H~niv~l~g 590 (840)
.++|.+.+.||+|+||.||+|++... ......++..||||+++.... ....++.+|+..+.++ +|||||++++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~-----~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~ 86 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGL-----DKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG 86 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC---------CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCC-----CcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccc
Confidence 46888899999999999999976511 111224456899999976543 3457899999999999 8999999999
Q ss_pred EeecCCceEEEEEeeccCC--------------------ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCC
Q 041702 591 CCIEQGEKISIYEFDIVTD--------------------PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKA 650 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~--------------------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp 650 (840)
+|.+.+..++||||..... ......+++.++++++.||+.||+|||+.+ |+||||||
T Consensus 87 ~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp 163 (299)
T d1fgka_ 87 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAA 163 (299)
T ss_dssp EECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred ccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecc
Confidence 9999999999999942211 112356899999999999999999999998 99999999
Q ss_pred CcEEecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCC
Q 041702 651 SNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILS-SKKNTRFYNT 729 (840)
Q Consensus 651 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ellt-G~~p~~~~~~ 729 (840)
+|||++.++.+||+|||+++...............+|+.|+|||.+.++.++.++|||||||++|||++ |.+|+.....
T Consensus 164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 164 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp GGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred cceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 999999999999999999998766555555566789999999999999999999999999999999998 6777653221
Q ss_pred CCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 730 DSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
. .....+..+... ..+...++.+.+++.+||+.||++|||+.||++.|+++++
T Consensus 244 ~------~~~~~i~~~~~~---------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 244 E------ELFKLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp H------HHHHHHHTTCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H------HHHHHHHcCCCC---------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 1 111222211111 1111234568899999999999999999999999998743
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-43 Score=377.86 Aligned_cols=259 Identities=25% Similarity=0.392 Sum_probs=204.6
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
..++|+..++||+|+||.||+|.++.. ....+++.||||+++... ......|.+|++++++++|||||+++|
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~-------~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~ 90 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGV-------VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 90 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEE-------ETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCc-------ccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeee
Confidence 347889999999999999999987621 122456889999997543 234456999999999999999999999
Q ss_pred EeecCCceEEEEEeeccCCc--------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEec
Q 041702 591 CCIEQGEKISIYEFDIVTDP--------------ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLD 656 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~~--------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~ 656 (840)
+|...+..++||||...... .....+++..+.+++.|+|+||.|||+++ |+||||||+|||++
T Consensus 91 ~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld 167 (308)
T d1p4oa_ 91 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVA 167 (308)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEEC
T ss_pred EEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeec
Confidence 99999999999999533221 12234789999999999999999999987 99999999999999
Q ss_pred CCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCC-CCCCCCCCCCccHh
Q 041702 657 SDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSK-KNTRFYNTDSLTLL 735 (840)
Q Consensus 657 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~-~p~~~~~~~~~~~~ 735 (840)
+++++||+|||+|+.+.............+|+.|+|||.+.+..++.++||||||++||||+||+ .|+..... ..
T Consensus 168 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~--~~-- 243 (308)
T d1p4oa_ 168 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--EQ-- 243 (308)
T ss_dssp TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--HH--
T ss_pred CCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH--HH--
Confidence 99999999999998776554444455567899999999999999999999999999999999996 55533211 11
Q ss_pred HHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 041702 736 GHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDE 795 (840)
Q Consensus 736 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~ 795 (840)
.......+... ..+...+..+.+++.+||+.+|++||||++|+++|++.
T Consensus 244 --~~~~i~~~~~~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 244 --VLRFVMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp --HHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred --HHHHHHhCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 11111111111 11112335688999999999999999999999999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-43 Score=377.11 Aligned_cols=263 Identities=25% Similarity=0.369 Sum_probs=205.6
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-cCHHHHHHHHHHHhhc-CCCCcccee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-QGLEEFKNEMMLIAKL-QHRNLVRLF 589 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-~~~~~f~~Ev~~l~~l-~H~niv~l~ 589 (840)
..++|+..++||+|+||.||+|+++.. ....+++.||||+++.... ....+|.+|+.++.++ +|||||+++
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~-------~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~ 93 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGL-------IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLL 93 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESS-------SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEecc-------ccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence 347889999999999999999976510 1235778999999976533 3456799999999999 799999999
Q ss_pred eEeecCCceEEEEEeeccCC----------------------ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCC
Q 041702 590 GCCIEQGEKISIYEFDIVTD----------------------PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRD 647 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~~----------------------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrD 647 (840)
|+|.+.+..+++|||..... ......+++..+.+++.||++||+|||+++ |+|||
T Consensus 94 g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrD 170 (311)
T d1t46a_ 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRD 170 (311)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecc
Confidence 99999999999999942111 112346899999999999999999999998 99999
Q ss_pred CCCCcEEecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 041702 648 LKASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFY 727 (840)
Q Consensus 648 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~ 727 (840)
|||+|||++.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||+|++.|+...
T Consensus 171 LKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~ 250 (311)
T d1t46a_ 171 LAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250 (311)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred cccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999999876655545556678999999999999999999999999999999999955543322
Q ss_pred CCCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 728 NTDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
......+.. .... ......+...+..+.+|+.+||+.||++||||+||+++|++.+.
T Consensus 251 ~~~~~~~~~----~i~~---------~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 251 MPVDSKFYK----MIKE---------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp CCSSHHHHH----HHHH---------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHHHHHH----HHhc---------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 222211111 1111 11111112234568899999999999999999999999998654
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=371.17 Aligned_cols=263 Identities=23% Similarity=0.321 Sum_probs=198.8
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
++|++.++||+|+||+||+|.++ .+++.||||+++... ....+++.+|+++|++++|||||+++++
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~------------~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~ 69 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNK------------LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEET------------TTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEEC------------CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccc
Confidence 68999999999999999999765 678999999996542 3346789999999999999999999999
Q ss_pred eecCCceEEEEEeeccC-----CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 592 CIEQGEKISIYEFDIVT-----DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~-----~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
+.+++..++||||.... .......+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+||
T Consensus 70 ~~~~~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DF 146 (298)
T d1gz8a_ 70 IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADF 146 (298)
T ss_dssp EEETTEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECST
T ss_pred cccccceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccC
Confidence 99999999999994221 1223456999999999999999999999998 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCccccccCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcc-
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGL-FSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKD- 744 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~- 744 (840)
|+|+...... .......||+.|+|||.+.... ++.++|||||||++|||++|+.||...... ............
T Consensus 147 G~a~~~~~~~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~--~~~~~i~~~~~~~ 222 (298)
T d1gz8a_ 147 GLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTP 222 (298)
T ss_dssp THHHHHCCCS--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCC
T ss_pred CcceeccCCc--ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH--HHHHHHHHhcCCC
Confidence 9998764332 2233457999999999877665 588999999999999999999998643221 111111110000
Q ss_pred -cc----------cccccCccccc---hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhcc
Q 041702 745 -DK----------AWKLMDPTMQN---EALYSMVTRYIKVALLCVQENATDRPTMLEVVAM--LKDE 795 (840)
Q Consensus 745 -~~----------~~~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--Le~~ 795 (840)
+. ........... .......+.+.+++.+||+.||++|||++|+++. ++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 223 DEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp CTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred chhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 00 00000000000 1111234568899999999999999999999874 5554
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1e-42 Score=367.93 Aligned_cols=256 Identities=24% Similarity=0.307 Sum_probs=194.6
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC---cCHHHHHHHHHHHhhcCCCCcccee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG---QGLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
.++|++.+.||+|+||.||+|.++ .+|+.||||+++.... ...++|.+|++++++++|||||+++
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~------------~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~ 73 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDL------------RLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET------------TTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEEC------------CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCccc
Confidence 467999999999999999999765 6799999999976432 2345799999999999999999999
Q ss_pred eEeecCCc----eEEEEEeeccC----CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCc
Q 041702 590 GCCIEQGE----KISIYEFDIVT----DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP 661 (840)
Q Consensus 590 g~~~~~~~----~~lv~e~~~~~----~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 661 (840)
+++...+. .++||||.... .......+++.++..++.||+.||+|||+.+ |+||||||+|||++.++..
T Consensus 74 ~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~ 150 (277)
T d1o6ya_ 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAV 150 (277)
T ss_dssp EEEEEECSSSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCE
T ss_pred ceeeeccCCCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccc
Confidence 99987543 78999994322 2334567999999999999999999999998 9999999999999999999
Q ss_pred eeeccccceecCCCC-cccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhh
Q 041702 662 KISDFGIARTFGGDE-MQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWN 740 (840)
Q Consensus 662 kL~DFGla~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~ 740 (840)
+|+|||.+....... .........||+.|||||.+.+..++.++|||||||+||||+||+.||...... . ....
T Consensus 151 ~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~---~~~~ 225 (277)
T d1o6ya_ 151 KVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV--S---VAYQ 225 (277)
T ss_dssp EECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--H---HHHH
T ss_pred eeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH--H---HHHH
Confidence 999999987664332 222334567999999999999999999999999999999999999998643211 1 1111
Q ss_pred hhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhhcc
Q 041702 741 LWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRP-TMLEVVAMLKDE 795 (840)
Q Consensus 741 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~Le~~ 795 (840)
....... .........++.+.+++.+||+.||++|| |++++++.|.++
T Consensus 226 ~~~~~~~-------~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 226 HVREDPI-------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp HHHCCCC-------CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HHhcCCC-------CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 1111111 00111122345688999999999999999 899999988765
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.9e-43 Score=375.13 Aligned_cols=241 Identities=23% Similarity=0.296 Sum_probs=197.4
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
++|++.++||+|+||.||+|+++ .+|+.||||+++.. .....+.+.+|+.+|++++|||||++++
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~------------~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~ 71 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSR------------HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 71 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET------------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEEC------------CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheee
Confidence 57999999999999999999876 67999999999743 2455788999999999999999999999
Q ss_pred EeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 591 CCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
++.+.+..++||||..... ......+++.....++.||+.||+|||+++ |+||||||+||||+.++.+||+||
T Consensus 72 ~~~~~~~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DF 148 (316)
T d1fota_ 72 TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDF 148 (316)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCC
T ss_pred eEeeCCeeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecC
Confidence 9999999999999953322 334567888889999999999999999998 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccc
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDK 746 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 746 (840)
|+|+..... .....||+.|||||++.+..++.++|||||||+||||++|+.||...... .... ......
T Consensus 149 G~a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~----~i~~~~ 217 (316)
T d1fota_ 149 GFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--KTYE----KILNAE 217 (316)
T ss_dssp SSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHH----HHHHCC
T ss_pred ccceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH--HHHH----HHHcCC
Confidence 999886432 23468999999999999999999999999999999999999998643211 1111 111111
Q ss_pred cccccCccccchhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041702 747 AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRP-----TMLEVVA 790 (840)
Q Consensus 747 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 790 (840)
... +....+.+.+++.+||+.||++|| |++++++
T Consensus 218 ------~~~----p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 218 ------LRF----PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ------CCC----CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ------CCC----CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 011 112234577899999999999996 8999985
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=371.56 Aligned_cols=254 Identities=22% Similarity=0.281 Sum_probs=189.6
Q ss_pred ccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-----cCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 518 EENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-----QGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 518 ~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-----~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
.+++||+|+||+||+|+++ .+|+.||||+++.... ...+.+.+|+.+|++++|||||++++++
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~------------~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~ 69 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDK------------NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF 69 (299)
T ss_dssp EEEEEEEETTEEEEEEECS------------SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cceEeccCcCeEEEEEEEC------------CCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeee
Confidence 3578999999999999876 6789999999975422 1235789999999999999999999999
Q ss_pred ecCCceEEEEEeeccC----CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccc
Q 041702 593 IEQGEKISIYEFDIVT----DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGI 668 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~----~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl 668 (840)
.+.+..++||||.... .......+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 70 ~~~~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~ 146 (299)
T d1ua2a_ 70 GHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGL 146 (299)
T ss_dssp CCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred ccCCceeehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCcc
Confidence 9999999999994211 1223456889999999999999999999998 99999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccccc
Q 041702 669 ARTFGGDEMQSNTNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKA 747 (840)
Q Consensus 669 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 747 (840)
|+....... .....+||+.|+|||.+.+. .++.++|||||||+++||++|+.||...... ...............
T Consensus 147 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~--~~l~~i~~~~~~~~~ 222 (299)
T d1ua2a_ 147 AKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL--DQLTRIFETLGTPTE 222 (299)
T ss_dssp GSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCT
T ss_pred ccccCCCcc--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH--HHHHHHHHhcCCCCh
Confidence 987644322 22345799999999988754 5899999999999999999999998643321 111111111000000
Q ss_pred ------cccc----Cccccc----hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 748 ------WKLM----DPTMQN----EALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 748 ------~~~~----d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.... -..... .......+.+.+++.+||+.||++|||++|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 223 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0000 000000 011123456889999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-42 Score=370.54 Aligned_cols=254 Identities=26% Similarity=0.379 Sum_probs=194.5
Q ss_pred cccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC-CCcCHHHHHHHHHHHhhcCCCCccceeeEeec-CC
Q 041702 519 ENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK-SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIE-QG 596 (840)
Q Consensus 519 ~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~-~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~-~~ 596 (840)
.++||+|+||+||+|.+. ........||||+++.. .....++|.+|+++|++++|||||+++|+|.+ .+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~---------~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 102 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLL---------DNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 102 (311)
T ss_dssp EEEEEEETTEEEEEEEEC---------C----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTT
T ss_pred ceEEeecCCeEEEEEEEE---------CCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCC
Confidence 368999999999999765 11123347999999754 33456789999999999999999999999876 46
Q ss_pred ceEEEEEeeccCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecccccee
Q 041702 597 EKISIYEFDIVTDP-----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 597 ~~~lv~e~~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
..++||||...... .....+++..+++++.|++.||.|||+.+ |+||||||+||||++++.+||+|||+++.
T Consensus 103 ~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~ 179 (311)
T d1r0pa_ 103 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD 179 (311)
T ss_dssp EEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCC
T ss_pred ceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhh
Confidence 78999999543322 23445778899999999999999999988 99999999999999999999999999998
Q ss_pred cCCCCccc--ccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccccccc
Q 041702 672 FGGDEMQS--NTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDKAWK 749 (840)
Q Consensus 672 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (840)
........ ......||+.|+|||.+.+..++.++||||||++||||+||+.|+...... ...... ... +. .
T Consensus 180 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-~~~~~~---i~~-g~--~ 252 (311)
T d1r0pa_ 180 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVY---LLQ-GR--R 252 (311)
T ss_dssp TTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHH---HHT-TC--C
T ss_pred ccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-HHHHHH---HHc-CC--C
Confidence 75443222 233457899999999999999999999999999999999988876532211 111111 111 11 1
Q ss_pred ccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccC
Q 041702 750 LMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVN 798 (840)
Q Consensus 750 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~ 798 (840)
...+. ...+.+.+++.+||+.||++||+|.||++.|+++...
T Consensus 253 ~~~p~-------~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 253 LLQPE-------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp CCCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCcc-------cCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 11111 1234578899999999999999999999999988654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-42 Score=378.06 Aligned_cols=241 Identities=21% Similarity=0.261 Sum_probs=197.9
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
++|+++++||+|+||.||+|+++ .+|+.||||++... .....+.+.+|+++|++++|||||++++
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~------------~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~ 108 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHK------------ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET------------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEEC------------CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccc
Confidence 68999999999999999999876 68999999998643 2355678999999999999999999999
Q ss_pred EeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeecc
Q 041702 591 CCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDF 666 (840)
Q Consensus 591 ~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF 666 (840)
++.+.+..++|+||..... ......+++..+..++.||+.||.|||+++ ||||||||+||||+.++.+||+||
T Consensus 109 ~~~~~~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DF 185 (350)
T d1rdqe_ 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDF 185 (350)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred ccccccccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeec
Confidence 9999999999999953332 234567999999999999999999999998 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhcccc
Q 041702 667 GIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDDK 746 (840)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 746 (840)
|+|+.+... .....||+.|||||++.+..++.++|||||||+||||+||+.||..... ...... .....
T Consensus 186 G~a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--~~~~~~----i~~~~ 254 (350)
T d1rdqe_ 186 GFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--IQIYEK----IVSGK 254 (350)
T ss_dssp TTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHH----HHHCC
T ss_pred eeeeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH--HHHHHH----HhcCC
Confidence 999886432 2346799999999999999999999999999999999999999864321 111111 11111
Q ss_pred cccccCccccchhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041702 747 AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRP-----TMLEVVA 790 (840)
Q Consensus 747 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 790 (840)
... +......+.+++.+||+.||.+|+ |++++++
T Consensus 255 ------~~~----p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 255 ------VRF----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ------CCC----CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ------CCC----CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 001 112344578899999999999994 8999985
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-43 Score=374.03 Aligned_cols=253 Identities=25% Similarity=0.374 Sum_probs=195.9
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCc--eEEEEEeccC-CCcCHHHHHHHHHHHhhc-CCCCcccee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGE--EVAVKRLSSK-SGQGLEEFKNEMMLIAKL-QHRNLVRLF 589 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~--~VAvK~l~~~-~~~~~~~f~~Ev~~l~~l-~H~niv~l~ 589 (840)
++|+..++||+|+||.||+|.++ .++. .||||+++.. .....++|.+|+++|.++ +|||||+++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~------------~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~ 77 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIK------------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 77 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEE------------ETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEEC------------CCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEE
Confidence 67888999999999999999765 3444 5888988644 334567899999999999 799999999
Q ss_pred eEeecCCceEEEEEeeccCC--------------------ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCC
Q 041702 590 GCCIEQGEKISIYEFDIVTD--------------------PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLK 649 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~~--------------------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk 649 (840)
|+|.+.+..++||||..... ......+++..+.+++.||+.||.|||+.+ |+|||||
T Consensus 78 ~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlk 154 (309)
T d1fvra_ 78 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLA 154 (309)
T ss_dssp EEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCS
T ss_pred EEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccc
Confidence 99999999999999943222 123467999999999999999999999988 9999999
Q ss_pred CCcEEecCCCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCC-CCCCCC
Q 041702 650 ASNVLLDSDMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKK-NTRFYN 728 (840)
Q Consensus 650 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~-p~~~~~ 728 (840)
|+|||++.++.+||+|||+|+...... ......||..|+|||.+.+..++.++|||||||++|||++|.. |+....
T Consensus 155 p~NIL~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~ 231 (309)
T d1fvra_ 155 ARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 231 (309)
T ss_dssp GGGEEECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cceEEEcCCCceEEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC
Confidence 999999999999999999998653222 2234568999999999999999999999999999999999765 454322
Q ss_pred CCCccHhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCC
Q 041702 729 TDSLTLLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNL 799 (840)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~ 799 (840)
. ..+. .....+. ..+.+...++.+.+++.+||+.||++||||+||++.|+++.++.
T Consensus 232 ~--~~~~----~~i~~~~---------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 232 C--AELY----EKLPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp H--HHHH----HHGGGTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred H--HHHH----HHHHhcC---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 1 1111 1111111 11111223456889999999999999999999999999886543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-42 Score=369.07 Aligned_cols=263 Identities=21% Similarity=0.298 Sum_probs=193.4
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHH--HHHHHHHhhcCCCCccceeeE
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEF--KNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f--~~Ev~~l~~l~H~niv~l~g~ 591 (840)
++|...++||+|+||.||+|++ +|+.||||+++... .+++ ..|+..+.+++|||||+++|+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--------------~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~ 65 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--------------RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAA 65 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--------------TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--------------CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEE
Confidence 4677888999999999999853 57899999997542 2343 445556678899999999999
Q ss_pred eecCC----ceEEEEEeeccCC---ccccCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCceecCCCCCCcEEecCCC
Q 041702 592 CIEQG----EKISIYEFDIVTD---PARKDLLDWTTRVRIIEGVAQGLLYLHQYS-----RLRVIHRDLKASNVLLDSDM 659 (840)
Q Consensus 592 ~~~~~----~~~lv~e~~~~~~---~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivHrDlkp~NILl~~~~ 659 (840)
|.+.+ ..++||||..... ......++|..+++++.|+|.||+|||+.. ..+|+||||||+||||+.++
T Consensus 66 ~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~ 145 (303)
T d1vjya_ 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 145 (303)
T ss_dssp EEEECSSSEEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS
T ss_pred EEeCCCcceEEEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC
Confidence 98764 5789999954332 223457999999999999999999999741 23599999999999999999
Q ss_pred CceeeccccceecCCCCcc--cccccccccccccCccccccCC------CCccccchhHHHHHHHHHhCCCCCCCCCCCC
Q 041702 660 NPKISDFGIARTFGGDEMQ--SNTNRIVGTYGYMSPEYALHGL------FSIKSDVFSFGVLLLEILSSKKNTRFYNTDS 731 (840)
Q Consensus 660 ~~kL~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~ksDV~SlGviL~elltG~~p~~~~~~~~ 731 (840)
.+||+|||+++........ .......||+.|||||++.+.. ++.|+|||||||+||||+||..|+.......
T Consensus 146 ~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~ 225 (303)
T d1vjya_ 146 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 225 (303)
T ss_dssp CEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCC
T ss_pred CeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccc
Confidence 9999999999887543322 2334578999999999987643 6789999999999999999988764433221
Q ss_pred ccH---------hHHHhhhhcccccccccCccccch-hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 041702 732 LTL---------LGHAWNLWKDDKAWKLMDPTMQNE-ALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIV 797 (840)
Q Consensus 732 ~~~---------~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~ 797 (840)
... ........ ....+++.+... ...+.+..+.+++.+||+.||++||||.||++.|+++..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~----~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 226 LPYYDLVPSDPSVEEMRKVV----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CTTTTTSCSSCCHHHHHHHH----TTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchhhcccccchHHHHHHHH----hccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 110 00111111 111222333222 223456678999999999999999999999999987643
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.5e-41 Score=357.57 Aligned_cols=247 Identities=22% Similarity=0.302 Sum_probs=197.5
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCc---------CHHHHHHHHHHHhhcC-CC
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQ---------GLEEFKNEMMLIAKLQ-HR 583 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~---------~~~~f~~Ev~~l~~l~-H~ 583 (840)
++|++.+.||+|+||+||+|+++ .+++.||||+++..... ..+++.+|+.+|++++ ||
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~------------~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp 70 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHK------------PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 70 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET------------TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCT
T ss_pred ccCEEceEEecCcCeEEEEEEEC------------CCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 68999999999999999999765 68999999999754321 1246889999999997 99
Q ss_pred CccceeeEeecCCceEEEEEeeccCCc----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCC
Q 041702 584 NLVRLFGCCIEQGEKISIYEFDIVTDP----ARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDM 659 (840)
Q Consensus 584 niv~l~g~~~~~~~~~lv~e~~~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~ 659 (840)
|||++++++.+++..++||||....+. .....+++.++..++.||+.||+|||+++ |+||||||+|||++.++
T Consensus 71 nIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~ 147 (277)
T d1phka_ 71 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDM 147 (277)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTC
T ss_pred CeEEEEeecccCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCC
Confidence 999999999999999999999543332 34668999999999999999999999998 99999999999999999
Q ss_pred CceeeccccceecCCCCcccccccccccccccCcccccc------CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc
Q 041702 660 NPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH------GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLT 733 (840)
Q Consensus 660 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~ 733 (840)
.+||+|||+++.+..... .....||+.|+|||++.+ ..++.++||||+||+|+||++|+.||...... .
T Consensus 148 ~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~--~ 222 (277)
T d1phka_ 148 NIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM--L 222 (277)
T ss_dssp CEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--H
T ss_pred CeEEccchheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH--H
Confidence 999999999998754332 234679999999998853 45789999999999999999999998643211 1
Q ss_pred HhHHHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 734 LLGHAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.. ......+. ..........++.+.+++.+||+.||++|||++||++
T Consensus 223 ~~----~~i~~~~~------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 223 ML----RMIMSGNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HH----HHHHHTCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HH----HHHHhCCC------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11 11111111 1111112234456889999999999999999999864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9.4e-42 Score=373.36 Aligned_cols=246 Identities=25% Similarity=0.281 Sum_probs=192.7
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHH---HHHHhhcCCCCcc
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNE---MMLIAKLQHRNLV 586 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~E---v~~l~~l~H~niv 586 (840)
.++|++.++||+|+||.||+|+++ .+|+.||||++... .......+.+| +++++.++|||||
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~------------~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv 70 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKA------------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 70 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEET------------TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBC
T ss_pred HHhCeeeeEEecCCCeEEEEEEEC------------CCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEE
Confidence 368999999999999999999765 67999999998643 12333444444 6677777899999
Q ss_pred ceeeEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCce
Q 041702 587 RLFGCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPK 662 (840)
Q Consensus 587 ~l~g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 662 (840)
++++++.+.+..++||||..... ......+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|
T Consensus 71 ~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iK 147 (364)
T d1omwa3 71 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVR 147 (364)
T ss_dssp CEEEEEECSSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEE
T ss_pred EEEEEEEECCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEE
Confidence 99999999999999999954332 234567889999999999999999999998 99999999999999999999
Q ss_pred eeccccceecCCCCcccccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhh
Q 041702 663 ISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNL 741 (840)
Q Consensus 663 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~ 741 (840)
|+|||+|+.+.... .....||+.|||||++.. ..++.++|||||||+||||+||+.||........... ...
T Consensus 148 l~DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~---~~~ 220 (364)
T d1omwa3 148 ISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---DRM 220 (364)
T ss_dssp ECCCTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH---HHH
T ss_pred EeeeceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHh
Confidence 99999999775432 334679999999999874 5689999999999999999999999975443332111 010
Q ss_pred hcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 041702 742 WKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPT-----MLEVVA 790 (840)
Q Consensus 742 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 790 (840)
.... .... +....+.+.+++.+||+.||++||| ++|+++
T Consensus 221 ~~~~------~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 221 TLTM------AVEL----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp SSSC------CCCC----CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred cccC------CCCC----CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 0000 0111 1122345789999999999999999 578774
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.7e-41 Score=360.46 Aligned_cols=257 Identities=22% Similarity=0.337 Sum_probs=193.6
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC--CCcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK--SGQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
++|+..++||+|+||+||+|+++ +|+.||||+++.. .....++|.+|+.+|++++|||||+++++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-------------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~ 68 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-------------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-------------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-------------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeee
Confidence 68999999999999999998653 6789999999754 23446789999999999999999999999
Q ss_pred eecCCceEEEEEeeccC----CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 592 CIEQGEKISIYEFDIVT----DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~----~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
+.+.+..++++|+.... .......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 69 ~~~~~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG 145 (286)
T d1ob3a_ 69 IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFG 145 (286)
T ss_dssp EECSSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTT
T ss_pred cccCCceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccc
Confidence 99999999999983221 1233567999999999999999999999988 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccc-
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD- 745 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~- 745 (840)
++........ ......+++.|+|||.+.+. .++.++|||||||+++||++|+.||...... .............
T Consensus 146 ~a~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~--~~~~~i~~~~~~~~ 221 (286)
T d1ob3a_ 146 LARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA--DQLMRIFRILGTPN 221 (286)
T ss_dssp HHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCC
T ss_pred cceecccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH--HHHHHHHHhhCCCC
Confidence 9987644322 23345689999999998754 5799999999999999999999998643321 1111111110000
Q ss_pred -----------c---cccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 746 -----------K---AWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 746 -----------~---~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
+ ......+...........+.+.+++.+||+.||++|||++|+++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 222 SKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00000111111112223456889999999999999999999974
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-42 Score=368.10 Aligned_cols=244 Identities=23% Similarity=0.325 Sum_probs=196.5
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC---CCcCHHHHHHHHHHHh-hcCCCCcccee
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK---SGQGLEEFKNEMMLIA-KLQHRNLVRLF 589 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~---~~~~~~~f~~Ev~~l~-~l~H~niv~l~ 589 (840)
++|.+.++||+|+||+||+|+++ .+++.||||++++. .....+.+..|+.++. .++|||||+++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~------------~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~ 69 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFK------------KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 69 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEET------------TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred CCeEEeeEEecCCCcEEEEEEEC------------CCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEE
Confidence 67999999999999999999765 68999999999743 2345677888888776 68999999999
Q ss_pred eEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeec
Q 041702 590 GCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISD 665 (840)
Q Consensus 590 g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D 665 (840)
+++.+++..++||||..... ......+++.++..++.||+.||+|||+++ |+||||||+|||++.++++||+|
T Consensus 70 ~~~~~~~~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~D 146 (320)
T d1xjda_ 70 CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIAD 146 (320)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECC
T ss_pred EEEccCCceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccc
Confidence 99999999999999954332 234567899999999999999999999998 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
||+|+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+. ......
T Consensus 147 FG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~--~~~----~~i~~~ 218 (320)
T d1xjda_ 147 FGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--ELF----HSIRMD 218 (320)
T ss_dssp CTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH----HHHHHC
T ss_pred cchhhhccccc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH--HHH----HHHHcC
Confidence 99998654332 2334467999999999999999999999999999999999999998643321 111 111111
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTML-EVVA 790 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl~ 790 (840)
.+... ......+.+++.+||+.||++||++. ++++
T Consensus 219 ------~~~~p----~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 219 ------NPFYP----RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ------CCCCC----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ------CCCCC----ccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11111 12244578999999999999999996 6753
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-41 Score=363.92 Aligned_cols=247 Identities=21% Similarity=0.304 Sum_probs=197.2
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEe
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCC 592 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~ 592 (840)
.++|.+.+.||+|+||+||+|.++ .+++.||||+++... .....+.+|+++|++++|||||++++++
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~------------~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~ 70 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVET------------SSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESF 70 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET------------TTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEEC------------CCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 478999999999999999999776 678999999997653 2345688999999999999999999999
Q ss_pred ecCCceEEEEEeeccCCc----c-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCC--CCceeec
Q 041702 593 IEQGEKISIYEFDIVTDP----A-RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSD--MNPKISD 665 (840)
Q Consensus 593 ~~~~~~~lv~e~~~~~~~----~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~--~~~kL~D 665 (840)
.+.+..++||||....+. . ....+++.++..|+.||+.||+|||+.+ |+||||||+|||++.+ ..+||+|
T Consensus 71 ~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~D 147 (321)
T d1tkia_ 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIE 147 (321)
T ss_dssp EETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECC
T ss_pred EECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcc
Confidence 999999999999533221 1 2236899999999999999999999998 9999999999999854 4799999
Q ss_pred cccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccc
Q 041702 666 FGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD 745 (840)
Q Consensus 666 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 745 (840)
||+++...... ......+|+.|+|||.+.+..++.++|||||||++|||++|+.||...... ..... ... .
T Consensus 148 FG~~~~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~--~~~~~---i~~-~ 218 (321)
T d1tkia_ 148 FGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--QIIEN---IMN-A 218 (321)
T ss_dssp CTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHH---HHH-T
T ss_pred cchhhccccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH--HHHHH---HHh-C
Confidence 99998764432 233457899999999999999999999999999999999999998643221 11111 111 0
Q ss_pred ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 746 KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 746 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
...............+.+++.+||+.||++|||++|+++
T Consensus 219 ------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 219 ------EYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ------CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ------CCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011111111223456889999999999999999999987
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-42 Score=362.52 Aligned_cols=237 Identities=21% Similarity=0.312 Sum_probs=190.7
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC------cCHHHHHHHHHHHhhcC--CCC
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG------QGLEEFKNEMMLIAKLQ--HRN 584 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~------~~~~~f~~Ev~~l~~l~--H~n 584 (840)
.++|++.++||+|+||.||+|+++ .+|+.||||++..... ....++.+|+.+|++++ |||
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~------------~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~n 70 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRV------------SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEET------------TTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEEC------------CCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCC
Confidence 367999999999999999999765 6789999999875321 22345789999999996 899
Q ss_pred ccceeeEeecCCceEEEEEeecc-----CCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCC-
Q 041702 585 LVRLFGCCIEQGEKISIYEFDIV-----TDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSD- 658 (840)
Q Consensus 585 iv~l~g~~~~~~~~~lv~e~~~~-----~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~- 658 (840)
||++++++.+.+..++|||+... ........+++.++..++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 71 Iv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~ 147 (273)
T d1xwsa_ 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNR 147 (273)
T ss_dssp BCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTT
T ss_pred ccEEEEEEeeCCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCC
Confidence 99999999999999999998422 11234567999999999999999999999998 9999999999999855
Q ss_pred CCceeeccccceecCCCCcccccccccccccccCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHH
Q 041702 659 MNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLF-SIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGH 737 (840)
Q Consensus 659 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~ 737 (840)
+.+||+|||+|+...... .....||+.|||||++.+..+ +.++|||||||+||||++|+.||.... .
T Consensus 148 ~~vkl~DFG~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----~---- 215 (273)
T d1xwsa_ 148 GELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----E---- 215 (273)
T ss_dssp TEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----H----
T ss_pred CeEEECccccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----H----
Confidence 789999999998754322 234679999999999987775 577899999999999999999985321 0
Q ss_pred HhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 738 AWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 738 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
.... ...+.+. .+..+.+++.+||+.||++|||++|+++
T Consensus 216 ---i~~~---~~~~~~~--------~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 216 ---IIRG---QVFFRQR--------VSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ---HHHC---CCCCSSC--------CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---Hhhc---ccCCCCC--------CCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0000 0011111 2345788999999999999999999976
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-41 Score=362.05 Aligned_cols=247 Identities=19% Similarity=0.221 Sum_probs=191.7
Q ss_pred ccCCcccc-cccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhc-CCCCccceee
Q 041702 513 TDNFSEEN-KLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKL-QHRNLVRLFG 590 (840)
Q Consensus 513 ~~~f~~~~-~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g 590 (840)
.++|.+.+ .||+|+||.||+|+++ .+++.||||+++.. +.+.+|+.++.++ +|||||++++
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~------------~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~ 72 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNK------------RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVD 72 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEET------------TTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEEC------------CCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEE
Confidence 46888775 5999999999999765 67899999999643 6788999997765 8999999999
Q ss_pred Eeec----CCceEEEEEeeccCCc----c--ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecC---
Q 041702 591 CCIE----QGEKISIYEFDIVTDP----A--RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS--- 657 (840)
Q Consensus 591 ~~~~----~~~~~lv~e~~~~~~~----~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~--- 657 (840)
++.+ ....++||||....+. . ....+++.++..|+.||+.||+|||+.+ |+||||||+|||++.
T Consensus 73 ~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~ 149 (335)
T d2ozaa1 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRP 149 (335)
T ss_dssp EEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSST
T ss_pred EEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccc
Confidence 9865 4668999999432211 1 1246899999999999999999999998 999999999999985
Q ss_pred CCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHH
Q 041702 658 DMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGH 737 (840)
Q Consensus 658 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~ 737 (840)
++.+||+|||+|+....... .....||+.|||||++.+..++.++|||||||+||||+||+.||......... ..
T Consensus 150 ~~~~Kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~--~~ 224 (335)
T d2ozaa1 150 NAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--PG 224 (335)
T ss_dssp TCCEEECCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------
T ss_pred cccccccccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH--HH
Confidence 45799999999987754332 33467999999999999999999999999999999999999998654332211 00
Q ss_pred HhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 738 AWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 738 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
...... ...............+.+.+++.+||+.||++|||+.|+++
T Consensus 225 ~~~~i~------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 225 MKTRIR------MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp ---CCC------SCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHh------cCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 000000 00111112223345667899999999999999999999987
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-41 Score=360.57 Aligned_cols=259 Identities=23% Similarity=0.327 Sum_probs=192.2
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhc---CCCCccc
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKL---QHRNLVR 587 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l---~H~niv~ 587 (840)
.++|+++++||+|+||+||+|+++ ..+++.||||+++... .....++.+|+.+|+.| +||||++
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~-----------~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~ 74 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDL-----------KNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEET-----------TTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCC
T ss_pred cCCEEEEEEEecccCeEEEEEEEE-----------CCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcce
Confidence 478999999999999999999764 1346789999986532 23345677888887776 7999999
Q ss_pred eeeEeec-----CCceEEEEEeeccC-----CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecC
Q 041702 588 LFGCCIE-----QGEKISIYEFDIVT-----DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS 657 (840)
Q Consensus 588 l~g~~~~-----~~~~~lv~e~~~~~-----~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~ 657 (840)
++++|.. ....++++|+.... .......+++.....++.||+.||+|||+++ |+||||||+|||++.
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~ 151 (305)
T d1blxa_ 75 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTS 151 (305)
T ss_dssp EEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECT
T ss_pred eeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcC
Confidence 9999853 34678888884321 1224456889999999999999999999998 999999999999999
Q ss_pred CCCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHH
Q 041702 658 DMNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGH 737 (840)
Q Consensus 658 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~ 737 (840)
++.+||+|||+++..... .......||+.|||||++.+.+++.++|||||||+++||++|+.||...... .....
T Consensus 152 ~~~~kl~dfg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~~~~ 226 (305)
T d1blxa_ 152 SGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV--DQLGK 226 (305)
T ss_dssp TCCEEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHH
T ss_pred CCCeeecchhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH--HHHHH
Confidence 999999999999865322 2334568999999999999999999999999999999999999998654321 11111
Q ss_pred Hhhhhccc---------cc--cccc--CccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 738 AWNLWKDD---------KA--WKLM--DPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 738 ~~~~~~~~---------~~--~~~~--d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
........ .. .... .............+.+.+++.+||+.||++|||++|+++
T Consensus 227 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 227 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp HHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 11110000 00 0000 000001111223456788999999999999999999975
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-40 Score=362.43 Aligned_cols=260 Identities=21% Similarity=0.282 Sum_probs=191.7
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
.++|++.++||+|+||+||+|.++ .+|+.||||+++... ....+++.+|+++|++++|||||++++
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~------------~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~ 84 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDG------------RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84 (346)
T ss_dssp BSSEEEEEEC------CEEEEEET------------TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSE
T ss_pred CCcEEEEEEEecCCCeEEEEEEEC------------CCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEE
Confidence 578999999999999999999865 679999999997542 233567899999999999999999999
Q ss_pred EeecCC------ceEEEEEeec--cCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCce
Q 041702 591 CCIEQG------EKISIYEFDI--VTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPK 662 (840)
Q Consensus 591 ~~~~~~------~~~lv~e~~~--~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 662 (840)
+|...+ +.++||||.. +........+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|
T Consensus 85 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~k 161 (346)
T d1cm8a_ 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELK 161 (346)
T ss_dssp EECSCSSTTTCCCCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEE
T ss_pred EeccCccccccceEEEEEecccccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccc
Confidence 997655 4699999941 222234567999999999999999999999998 99999999999999999999
Q ss_pred eeccccceecCCCCcccccccccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhh
Q 041702 663 ISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNL 741 (840)
Q Consensus 663 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~ 741 (840)
|+|||+|+..... .....||+.|+|||.+.+. .++.++||||+||+++||++|+.|+....... ........
T Consensus 162 l~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~--~~~~~~~~ 234 (346)
T d1cm8a_ 162 ILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD--QLKEIMKV 234 (346)
T ss_dssp ECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHH
T ss_pred cccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH--HHHHHHhc
Confidence 9999999876432 2346799999999998764 57999999999999999999999986542211 11000000
Q ss_pred hccc------------------ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhcc
Q 041702 742 WKDD------------------KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM--LKDE 795 (840)
Q Consensus 742 ~~~~------------------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--Le~~ 795 (840)
.... .......... ..........+.+++.+||+.||++|||++|+++. ++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 235 TGTPPAEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred cCCCcHHHHhhhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 0000 0000000000 01111223457889999999999999999999974 6554
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4e-40 Score=352.17 Aligned_cols=261 Identities=18% Similarity=0.206 Sum_probs=196.1
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccc-eeeE
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVR-LFGC 591 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~-l~g~ 591 (840)
.++|++.++||+|+||.||+|+++ .+|+.||||++..... .+++..|++++++++|+|++. +.++
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~------------~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~ 71 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDI------------AAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWC 71 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEET------------TTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEEC------------CCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEE
Confidence 357999999999999999999765 6789999999876432 356889999999998776555 4555
Q ss_pred eecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEec---CCCCceee
Q 041702 592 CIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLD---SDMNPKIS 664 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~---~~~~~kL~ 664 (840)
..+++..++|||+..... ......+++..+..++.|++.||+|||+++ |+||||||+|||++ .+..+||+
T Consensus 72 ~~~~~~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~ 148 (299)
T d1ckia_ 72 GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYII 148 (299)
T ss_dssp EEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEEC
T ss_pred EecCCEEEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeee
Confidence 577788888999842111 123457899999999999999999999998 99999999999975 45679999
Q ss_pred ccccceecCCCCcc-----cccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHh
Q 041702 665 DFGIARTFGGDEMQ-----SNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAW 739 (840)
Q Consensus 665 DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~ 739 (840)
|||+|+.+...... .......||+.|||||.+.+..++.++|||||||+++||++|+.||...............
T Consensus 149 DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~ 228 (299)
T d1ckia_ 149 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 228 (299)
T ss_dssp CCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHH
T ss_pred ccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHh
Confidence 99999987544322 1234567999999999999999999999999999999999999998765443321111000
Q ss_pred hhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccC
Q 041702 740 NLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVN 798 (840)
Q Consensus 740 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~ 798 (840)
.... +.. .........++.+.+++.+||+.+|++||+++++.+.|+....+
T Consensus 229 ~~~~------~~~--~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 229 SEKK------MST--PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HHHH------HHS--CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred hccc------CCC--ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 0000 000 00011112345688899999999999999999999999886543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-40 Score=353.54 Aligned_cols=262 Identities=21% Similarity=0.301 Sum_probs=191.1
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC--CCcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK--SGQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
.++|++.++||+|+||+||+|+++ .+|+.||||++... .....+++.+|+++|++++||||+++++
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~------------~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~ 76 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHR------------KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 76 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEET------------TTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCCEEEEEEEecCcCeEEEEEEEC------------CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEe
Confidence 478999999999999999999765 68999999998644 3345678999999999999999999999
Q ss_pred Eeec--------CCceEEEEEeeccC----CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCC
Q 041702 591 CCIE--------QGEKISIYEFDIVT----DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSD 658 (840)
Q Consensus 591 ~~~~--------~~~~~lv~e~~~~~----~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~ 658 (840)
++.. .+..+++||+.... .......++......++.||+.||.|||+.+ |+||||||+|||++.+
T Consensus 77 ~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~ 153 (318)
T d3blha1 77 ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRD 153 (318)
T ss_dssp EEEC----------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTT
T ss_pred eeecccccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCC
Confidence 9865 34678999984211 1233456888899999999999999999998 9999999999999999
Q ss_pred CCceeeccccceecCCCCcc--cccccccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHh
Q 041702 659 MNPKISDFGIARTFGGDEMQ--SNTNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLL 735 (840)
Q Consensus 659 ~~~kL~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~ 735 (840)
+.+||+|||+++.+...... .......||+.|+|||.+.+. .++.++|||||||+++||++|+.||...... ...
T Consensus 154 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~--~~~ 231 (318)
T d3blha1 154 GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ--HQL 231 (318)
T ss_dssp SCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHH
T ss_pred CcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH--HHH
Confidence 99999999999877543322 122345799999999998765 6899999999999999999999998643221 111
Q ss_pred HHHhhhhcc-----------cccccccCc-cccchhhH------HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 736 GHAWNLWKD-----------DKAWKLMDP-TMQNEALY------SMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 736 ~~~~~~~~~-----------~~~~~~~d~-~l~~~~~~------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
......... ......+.. ........ .....+++++.+||+.||++|||++|+++.
T Consensus 232 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 232 ALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 111111000 000000000 00000111 113456789999999999999999999853
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.4e-39 Score=346.42 Aligned_cols=271 Identities=15% Similarity=0.182 Sum_probs=207.8
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCC-CCccceeeE
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQH-RNLVRLFGC 591 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H-~niv~l~g~ 591 (840)
.++|++.++||+|+||.||+|+++ .+|+.||||+++... ..+++.+|++++..++| +|++.++++
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~------------~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~ 69 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNL------------LNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYF 69 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEET------------TTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEEC------------CCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEE
Confidence 468999999999999999999765 678999999986543 23568889999999965 899999999
Q ss_pred eecCCceEEEEEeeccC---C-ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecC-----CCCce
Q 041702 592 CIEQGEKISIYEFDIVT---D-PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDS-----DMNPK 662 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~---~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-----~~~~k 662 (840)
+.++...++|||+.... . ......+++.++..++.|++.||+|||+.+ |+||||||+|||++. ++.+|
T Consensus 70 ~~~~~~~~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vk 146 (293)
T d1csna_ 70 GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIY 146 (293)
T ss_dssp EEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEE
T ss_pred eecCCccEEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceE
Confidence 99999999999994211 0 112346899999999999999999999998 999999999999974 57899
Q ss_pred eeccccceecCCCCcc-----cccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccH-hH
Q 041702 663 ISDFGIARTFGGDEMQ-----SNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTL-LG 736 (840)
Q Consensus 663 L~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~-~~ 736 (840)
|+|||+|+.+...... .......||+.|||||.+.+..++.++|||||||+++||+||+.||.......... ..
T Consensus 147 l~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~ 226 (293)
T d1csna_ 147 VVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE 226 (293)
T ss_dssp ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHH
T ss_pred EcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHH
Confidence 9999999987543221 12335679999999999999999999999999999999999999997554433211 11
Q ss_pred HHhhhhcccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccCCCCCCCCCCcc
Q 041702 737 HAWNLWKDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVAMLKDEIVNLPSPHQPAFSY 809 (840)
Q Consensus 737 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~p~~p~~~~ 809 (840)
.......... ..+.....++.+.+++..|++.+|++||+++.+.+.|+++..+......-.|+|
T Consensus 227 ~i~~~~~~~~---------~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw 290 (293)
T d1csna_ 227 RIGEKKQSTP---------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDW 290 (293)
T ss_dssp HHHHHHHHSC---------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGG
T ss_pred HHHhccCCCC---------hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 1100000000 001111233567889999999999999999999999998776665554444544
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=356.16 Aligned_cols=252 Identities=24% Similarity=0.256 Sum_probs=187.9
Q ss_pred CCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCccceeeEeec
Q 041702 515 NFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIE 594 (840)
Q Consensus 515 ~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~ 594 (840)
+|+..++||+|+||+||+|+++ .+|+.||||++..... .+.+|+++|++++||||+++++++..
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~------------~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~ 84 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLC------------DSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYS 84 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEET------------TTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEEC------------CCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEe
Confidence 6888899999999999999875 6799999999975432 23479999999999999999999864
Q ss_pred CC------ceEEEEEeeccC-------CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCC-C
Q 041702 595 QG------EKISIYEFDIVT-------DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDM-N 660 (840)
Q Consensus 595 ~~------~~~lv~e~~~~~-------~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~ 660 (840)
.. ..++||||.... .......+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .
T Consensus 85 ~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~ 161 (350)
T d1q5ka_ 85 SGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAV 161 (350)
T ss_dssp C--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCC
T ss_pred cCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCc
Confidence 32 368899984221 1223557999999999999999999999988 99999999999999875 8
Q ss_pred ceeeccccceecCCCCcccccccccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHh
Q 041702 661 PKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAW 739 (840)
Q Consensus 661 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~ 739 (840)
+||+|||+++.+..... .....||+.|+|||.+.+ ..++.++|||||||+++||++|+.||......+ ......
T Consensus 162 ~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~--~l~~i~ 236 (350)
T d1q5ka_ 162 LKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEII 236 (350)
T ss_dssp EEECCCTTCEECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HHHHHH
T ss_pred eeEecccchhhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH--HHHHHH
Confidence 99999999988754332 234579999999998775 568999999999999999999999986543211 111000
Q ss_pred -----------hhhcc----cccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 740 -----------NLWKD----DKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 740 -----------~~~~~----~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
..... ....................+.+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 237 KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 0000000000000111123446789999999999999999999985
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-39 Score=353.94 Aligned_cols=263 Identities=22% Similarity=0.288 Sum_probs=189.6
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC-CcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS-GQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
.+++|+++++||+|+||+||+|.++ .+|+.||||+++... ....+++++|+.+|++++||||+++++
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~------------~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~ 73 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDN------------VNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEET------------TTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCE
T ss_pred cCCCeEEEEEEeeccCeEEEEEEEC------------CCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEE
Confidence 3467999999999999999999765 689999999997543 234567999999999999999999999
Q ss_pred EeecCC-----ceEEEEEee--ccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCcee
Q 041702 591 CCIEQG-----EKISIYEFD--IVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKI 663 (840)
Q Consensus 591 ~~~~~~-----~~~lv~e~~--~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL 663 (840)
++.... ..++++++. .+........+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 74 ~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl 150 (345)
T d1pmea_ 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKI 150 (345)
T ss_dssp EECCSSTTTCCCEEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred EEeeccccccceEEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEE
Confidence 987543 244444431 1111223457999999999999999999999998 999999999999999999999
Q ss_pred eccccceecCCCCcc-cccccccccccccCccccc-cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhh
Q 041702 664 SDFGIARTFGGDEMQ-SNTNRIVGTYGYMSPEYAL-HGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNL 741 (840)
Q Consensus 664 ~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~ 741 (840)
+|||+|+........ ......+||+.|+|||.+. +..++.++||||+||+++||++|+.||......+ ........
T Consensus 151 ~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~--~~~~~~~~ 228 (345)
T d1pmea_ 151 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD--QLNHILGI 228 (345)
T ss_dssp CCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHH
T ss_pred cccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHH--HHHHHhhh
Confidence 999999876443322 2234567999999999985 4567899999999999999999999986433211 11000000
Q ss_pred hcccccc-------------cccCcccc----chhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041702 742 WKDDKAW-------------KLMDPTMQ----NEALYSMVTRYIKVALLCVQENATDRPTMLEVVAM 791 (840)
Q Consensus 742 ~~~~~~~-------------~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 791 (840)
....... ....+... ..........+.+++.+||+.||++|||++|+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 229 LGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000 00000000 00111223468899999999999999999999974
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-39 Score=345.00 Aligned_cols=259 Identities=23% Similarity=0.295 Sum_probs=196.5
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceeeE
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFGC 591 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~ 591 (840)
++|+++++||+|+||+||+|+++ .+++.||||+++... ....+++.+|+.+|++++||||++++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~------------~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 69 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNR------------ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEET------------TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEEC------------CCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccc
Confidence 57999999999999999999765 688999999996543 2346789999999999999999999999
Q ss_pred eecCCceEEEEEeeccC----CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceeeccc
Q 041702 592 CIEQGEKISIYEFDIVT----DPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKISDFG 667 (840)
Q Consensus 592 ~~~~~~~~lv~e~~~~~----~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG 667 (840)
+.+.+..++++|+.... .......+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 70 ~~~~~~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG 146 (292)
T d1unla_ 70 LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFG 146 (292)
T ss_dssp EECSSEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCT
T ss_pred cccccceeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecc
Confidence 99999999999984221 1234567889999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCccccccCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhhccc-
Q 041702 668 IARTFGGDEMQSNTNRIVGTYGYMSPEYALHGL-FSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLWKDD- 745 (840)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~- 745 (840)
.|+....... ......+++.|+|||.+.+.. ++.++|||||||+++||++|+.|+...... ..............
T Consensus 147 ~a~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~-~~~~~~~~~~~~~~~ 223 (292)
T d1unla_ 147 LARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQLKRIFRLLGTPT 223 (292)
T ss_dssp TCEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH-HHHHHHHHHHHCCCC
T ss_pred hhhcccCCCc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCH-HHHHHHHHhhcCCCC
Confidence 9988754322 223456788999999887665 699999999999999999999986432211 11111111111000
Q ss_pred -------------ccccccC-ccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 746 -------------KAWKLMD-PTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 746 -------------~~~~~~d-~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
....... ............+.+.+++.+||+.||++|||++||++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 224 EEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000 00011112233456788999999999999999999875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.6e-38 Score=344.32 Aligned_cols=256 Identities=19% Similarity=0.276 Sum_probs=193.2
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcC-CCCccceeeEe
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQ-HRNLVRLFGCC 592 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~-H~niv~l~g~~ 592 (840)
++|++.++||+|+||+||+|+++ .+++.||||+++.. ..+++.+|+++|.+++ ||||+++++++
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~------------~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~ 99 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINI------------TNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIV 99 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET------------TTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEEC------------CCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEE
Confidence 68999999999999999999765 68999999999743 3578999999999995 99999999998
Q ss_pred ec--CCceEEEEEeeccCCcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCC-Cceeecccc
Q 041702 593 IE--QGEKISIYEFDIVTDPA-RKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDM-NPKISDFGI 668 (840)
Q Consensus 593 ~~--~~~~~lv~e~~~~~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kL~DFGl 668 (840)
.. .+..++||||....... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+
T Consensus 100 ~~~~~~~~~~v~e~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~ 176 (328)
T d3bqca1 100 KDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGL 176 (328)
T ss_dssp ECTTTCSEEEEEECCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGG
T ss_pred EecCCCceeEEEeecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeeccccc
Confidence 74 45688999995433322 2457899999999999999999999998 99999999999998765 589999999
Q ss_pred ceecCCCCcccccccccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHH--------Hh
Q 041702 669 ARTFGGDEMQSNTNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGH--------AW 739 (840)
Q Consensus 669 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~--------~~ 739 (840)
|+....... .....+|+.|+|||.+.+. .++.++||||+||+++||++|+.|+............. ..
T Consensus 177 a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~ 253 (328)
T d3bqca1 177 AEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 253 (328)
T ss_dssp CEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHH
T ss_pred ceeccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhh
Confidence 988754332 3446789999999998765 47999999999999999999999986543221110000 00
Q ss_pred hhhcc------ccccccc--------CccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 740 NLWKD------DKAWKLM--------DPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 740 ~~~~~------~~~~~~~--------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
..... ....... ...............+.+++.+||+.||++|||++|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 0000000 000111111223456789999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-39 Score=346.33 Aligned_cols=269 Identities=20% Similarity=0.289 Sum_probs=205.3
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC----CCcCHHHHHHHHHHHhhcCC-CCccce
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK----SGQGLEEFKNEMMLIAKLQH-RNLVRL 588 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~----~~~~~~~f~~Ev~~l~~l~H-~niv~l 588 (840)
++|++.++||+|+||+||+|++. ..-.+|+.||||+++.. .....+++.+|+++|++++| |||+++
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~---------~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~ 94 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKI---------SGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTL 94 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEEC---------SSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCE
T ss_pred hceEEEEEEecCCCeEEEEEEEC---------ccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEe
Confidence 67999999999999999999764 23357899999998643 23446779999999999976 899999
Q ss_pred eeEeecCCceEEEEEeeccCC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCceee
Q 041702 589 FGCCIEQGEKISIYEFDIVTD----PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKIS 664 (840)
Q Consensus 589 ~g~~~~~~~~~lv~e~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~ 664 (840)
++++.+.+..++++||....+ ......++......++.||+.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 95 ~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~ 171 (322)
T d1vzoa_ 95 HYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLT 171 (322)
T ss_dssp EEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEES
T ss_pred eeeeccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEe
Confidence 999999999999999954333 234556788889999999999999999998 9999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCccccccC--CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhhhh
Q 041702 665 DFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHG--LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWNLW 742 (840)
Q Consensus 665 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~~~ 742 (840)
|||+|+.+...... ......|++.|+|||.+.+. .++.++|||||||+|+||++|+.||........... .....
T Consensus 172 DFG~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~--i~~~~ 248 (322)
T d1vzoa_ 172 DFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE--ISRRI 248 (322)
T ss_dssp CSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH--HHHHH
T ss_pred eccchhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHHhc
Confidence 99999876543322 23446799999999998764 478899999999999999999999876554432211 11100
Q ss_pred cccccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH--Hhhc------cccCCCCCCCCCC
Q 041702 743 KDDKAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPT-----MLEVVA--MLKD------EIVNLPSPHQPAF 807 (840)
Q Consensus 743 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~--~Le~------~~~~~~~p~~p~~ 807 (840)
... .+. .+......+.+++.+||+.||++||| ++|+++ .+++ ...++|+|-.|..
T Consensus 249 ~~~------~~~----~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~p~~p~~ 316 (322)
T d1vzoa_ 249 LKS------EPP----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVI 316 (322)
T ss_dssp HHC------CCC----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCC
T ss_pred ccC------CCC----CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCcCCCCCC
Confidence 000 011 11223456888999999999999994 788875 2322 2235677776764
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-38 Score=346.78 Aligned_cols=258 Identities=21% Similarity=0.239 Sum_probs=188.2
Q ss_pred ccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCC--CcCHHHHHHHHHHHhhcCCCCccceee
Q 041702 513 TDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKS--GQGLEEFKNEMMLIAKLQHRNLVRLFG 590 (840)
Q Consensus 513 ~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g 590 (840)
.++|+++++||+|+||+||+|+++ .+|+.||||+++... ....+++.+|+.+|++++|||||++++
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~------------~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~ 83 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDA------------VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEET------------TTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred cCCeEEEEEeecCcCeEEEEEEEC------------CCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEE
Confidence 478999999999999999999876 679999999997542 234467899999999999999999999
Q ss_pred Eeec------CCceEEEEEeeccCC-ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCcee
Q 041702 591 CCIE------QGEKISIYEFDIVTD-PARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNPKI 663 (840)
Q Consensus 591 ~~~~------~~~~~lv~e~~~~~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL 663 (840)
++.. ....++||||..... ......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|+
T Consensus 84 ~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl 160 (355)
T d2b1pa1 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKI 160 (355)
T ss_dssp EECSCCSTTTCCEEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEE
T ss_pred EEecccccccCceeEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceee
Confidence 9964 467899999942211 112346899999999999999999999998 999999999999999999999
Q ss_pred eccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHh----
Q 041702 664 SDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAW---- 739 (840)
Q Consensus 664 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~---- 739 (840)
+|||+++...... ......+|+.|+|||.+.+..++.++||||+||+++||++|+.||...+... ......
T Consensus 161 ~df~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~--~~~~i~~~~~ 235 (355)
T d2b1pa1 161 LDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID--QWNKVIEQLG 235 (355)
T ss_dssp CCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHC
T ss_pred echhhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHH--HHHHHHHhcc
Confidence 9999988764332 2344578999999999999999999999999999999999999986433111 000000
Q ss_pred ---------------hhhccc------ccccccCccc---cchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041702 740 ---------------NLWKDD------KAWKLMDPTM---QNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA 790 (840)
Q Consensus 740 ---------------~~~~~~------~~~~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 790 (840)
...... .......... ...........+.+++.+||+.||++|||++||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp CCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000 0000111111 11223445677899999999999999999999984
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-38 Score=345.17 Aligned_cols=261 Identities=21% Similarity=0.290 Sum_probs=188.5
Q ss_pred HccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC--cCHHHHHHHHHHHhhcCCCCcccee
Q 041702 512 ATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG--QGLEEFKNEMMLIAKLQHRNLVRLF 589 (840)
Q Consensus 512 ~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~ 589 (840)
..++|++.++||+|+||+||+|+++ .+|+.||||+++.... ...+++.+|+++|++++|||+|+++
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~------------~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~ 83 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDT------------KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEET------------TTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred CCCCeEEEEEEecCCCeEEEEEEEC------------CCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEE
Confidence 3678999999999999999999765 6899999999975432 3346789999999999999999999
Q ss_pred eEeecC-----CceEEEEEeec---cCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCCCCc
Q 041702 590 GCCIEQ-----GEKISIYEFDI---VTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSDMNP 661 (840)
Q Consensus 590 g~~~~~-----~~~~lv~e~~~---~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 661 (840)
+++... ...++++++.. +........+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+
T Consensus 84 ~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~ 160 (348)
T d2gfsa1 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCEL 160 (348)
T ss_dssp EEECSCSSTTTCCCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCE
T ss_pred EEEeeccccccCceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccc
Confidence 998633 23345555521 111223456999999999999999999999998 9999999999999999999
Q ss_pred eeeccccceecCCCCcccccccccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCccHhHHHhh
Q 041702 662 KISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLEILSSKKNTRFYNTDSLTLLGHAWN 740 (840)
Q Consensus 662 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~SlGviL~elltG~~p~~~~~~~~~~~~~~~~~ 740 (840)
|++|||++.... .......||+.|+|||.+.+. .++.++|||||||+++||++|+.||....... .......
T Consensus 161 kl~dfg~a~~~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~--~~~~i~~ 233 (348)
T d2gfsa1 161 KILDFGLARHTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QLKLILR 233 (348)
T ss_dssp EECCC----CCT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHH
T ss_pred cccccchhcccC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH--HHHHHHH
Confidence 999999997643 223446789999999987765 46899999999999999999999986433211 1111000
Q ss_pred hhccc------------------ccccccCccccchhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH--Hhhcc
Q 041702 741 LWKDD------------------KAWKLMDPTMQNEALYSMVTRYIKVALLCVQENATDRPTMLEVVA--MLKDE 795 (840)
Q Consensus 741 ~~~~~------------------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~Le~~ 795 (840)
..... .........+ ..........+.+++.+||+.||++|||++|+++ .+.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 234 LVGTPGAELLKKISSESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCH-HHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hcCCCChHHhhhccchhhhhhhhhcccCCCcch-hhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 00000 0000000000 0001123456789999999999999999999987 45543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.6e-35 Score=321.59 Aligned_cols=273 Identities=19% Similarity=0.262 Sum_probs=193.7
Q ss_pred cCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcC-----------C
Q 041702 514 DNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQ-----------H 582 (840)
Q Consensus 514 ~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~-----------H 582 (840)
.+|++.++||+|+||+||+|+++ .+|+.||||+++... ...+.+.+|++++++++ |
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~------------~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~ 79 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDM------------VNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGA 79 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET------------TTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHH
T ss_pred CcEEEEEEEeeCCCeEEEEEEEC------------CCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCc
Confidence 35999999999999999999765 689999999997542 23467889999998885 5
Q ss_pred CCccceeeEeecCC--ceEEEEEeeccC-------CccccCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceecCCCCCCc
Q 041702 583 RNLVRLFGCCIEQG--EKISIYEFDIVT-------DPARKDLLDWTTRVRIIEGVAQGLLYLHQ-YSRLRVIHRDLKASN 652 (840)
Q Consensus 583 ~niv~l~g~~~~~~--~~~lv~e~~~~~-------~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivHrDlkp~N 652 (840)
+||+++++++...+ ...+++++.... .......+++..+..++.||+.||+|||+ .+ |+||||||+|
T Consensus 80 ~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~N 156 (362)
T d1q8ya_ 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPEN 156 (362)
T ss_dssp TTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGG
T ss_pred CceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhH
Confidence 78999999886543 445555553221 12344567888999999999999999998 66 9999999999
Q ss_pred EEecCCCC------ceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 041702 653 VLLDSDMN------PKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLEILSSKKNTRF 726 (840)
Q Consensus 653 ILl~~~~~------~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~elltG~~p~~~ 726 (840)
|||+.++. +||+|||.|..... ......||+.|+|||.+.+..++.++||||+||+++||++|+.||..
T Consensus 157 Ill~~~~~~~~~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~ 231 (362)
T d1q8ya_ 157 VLMEIVDSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 231 (362)
T ss_dssp EEEEEEETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred eeeeccCcccccceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCC
Confidence 99987654 89999999986532 22446799999999999999999999999999999999999999865
Q ss_pred CCCCCc-----cHhHHHhhh-----------------hcccccccccCc-cc---------cchhhHHHHHHHHHHHHHc
Q 041702 727 YNTDSL-----TLLGHAWNL-----------------WKDDKAWKLMDP-TM---------QNEALYSMVTRYIKVALLC 774 (840)
Q Consensus 727 ~~~~~~-----~~~~~~~~~-----------------~~~~~~~~~~d~-~l---------~~~~~~~~~~~l~~l~~~C 774 (840)
...... .+....... .........+.. .. ...........+.+++.+|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~m 311 (362)
T d1q8ya_ 232 DEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM 311 (362)
T ss_dssp -------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGG
T ss_pred CccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHH
Confidence 432210 000000000 000000000000 00 1112345677899999999
Q ss_pred cccCCCCCCCHHHHHHH--hhcc--ccCCCCCCCCCC
Q 041702 775 VQENATDRPTMLEVVAM--LKDE--IVNLPSPHQPAF 807 (840)
Q Consensus 775 l~~dP~~RPs~~evl~~--Le~~--~~~~~~p~~p~~ 807 (840)
|+.||++|||++|+++. +++. ..+...|..|.+
T Consensus 312 L~~dP~~Rpta~e~L~Hp~f~~~~~~~~~~~p~~~~~ 348 (362)
T d1q8ya_ 312 LQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELY 348 (362)
T ss_dssp GCSSTTTCBCHHHHHTCGGGTTCTTCTTCCCTTSCTT
T ss_pred CCCChhHCcCHHHHhcCcccCCCCCcccCCCCCcccC
Confidence 99999999999999873 5533 234555555555
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.84 E-value=5.5e-21 Score=170.02 Aligned_cols=112 Identities=21% Similarity=0.391 Sum_probs=94.9
Q ss_pred cCcCCCCcccCCCCeEEcCCCeEEEEEecCCCCCceEEEEeeecCCCcEEEeecCCCCCCCCCceEEEecCCceEEecCC
Q 041702 25 ADSITPATFIRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKKSPDTVVWVANRNCPILDPHGILAINNNGNLVLLNQA 104 (840)
Q Consensus 25 ~~~~~~~~~l~~~~~l~S~~g~F~~gFf~~~~~~~~~lgiw~~~~~~tvVW~ANr~~p~~~~~~~l~~~~~G~L~l~~~~ 104 (840)
+|+|.|||.|..|++|+| |.|.|+|+..|+ |.++. +.++||.||++.|. +++.|.|+.||+|+|+|.
T Consensus 1 tDtL~~gq~L~~g~~l~~--g~~~l~~q~DGN-----Lvly~---~~~~vW~s~~~~~~--~~~~l~l~~dGnLvl~~~- 67 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYD---NNRAVWASGTNGKA--SGCVLKMQNDGNLVIYSG- 67 (112)
T ss_dssp CCEEETTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE---TTEEEEECCCTTSC--SSEEEEECTTSCEEEEET-
T ss_pred CCEecCCCEecCCCEEEE--CCEEEEEcCCCC-----EEEEc---CCcEEEEccCccCC--CCcEEEEeccccEEEEec-
Confidence 589999999999999985 999999998886 55553 46899999999874 357899999999999997
Q ss_pred CceEEEecCCCCCCCceEEEecCCCeEEEeccCCCCCCCceeEEecCCCCC
Q 041702 105 NGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSEGSYLWQSFDFPSD 155 (840)
Q Consensus 105 ~~~~Wss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~~lWqSFd~PtD 155 (840)
+.++|++++.......+|+|+|+|||||++. .+.++|||+.+|+|
T Consensus 68 ~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~------~~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 68 SRAIWASNTNRQNGNYYLILQRDRNVVIYDN------SNNAIWATHTNVGN 112 (112)
T ss_dssp TEEEEECCCCCSCCCCEEEECTTSCEEEECT------TSCEEEECCCCCCC
T ss_pred CCeEEEEeeccCCCceEEEEcCCCCEEEECC------CCcEEecCCCccCC
Confidence 6788888877665567899999999999983 34679999999986
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.82 E-value=1.6e-20 Score=165.28 Aligned_cols=107 Identities=23% Similarity=0.347 Sum_probs=92.6
Q ss_pred cCcCCCCcccCCCCeEEcCCCeEEEEEecCCCCCceEEEEeeecCCCcEEEeecCCCCCCCCCceEEEecCCceEEecCC
Q 041702 25 ADSITPATFIRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKKSPDTVVWVANRNCPILDPHGILAINNNGNLVLLNQA 104 (840)
Q Consensus 25 ~~~~~~~~~l~~~~~l~S~~g~F~~gFf~~~~~~~~~lgiw~~~~~~tvVW~ANr~~p~~~~~~~l~~~~~G~L~l~~~~ 104 (840)
.|+|.+||.|..|++|. +|.|.|+|+.+|+ |.|+. ..++||.||++.| +..+.|.++.||+|+|.|++
T Consensus 1 ~~~L~~g~~L~~G~~l~--ng~~~l~~q~DGN-----Lvly~---~~~~vW~s~~~~~--~~~~~l~l~~~Gnlvl~~~~ 68 (108)
T d1jpca_ 1 DNILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYD---VDKPIWATNTGGL--SRSCFLSMQTDGNLVVYNPS 68 (108)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEE---TTEEEEECCCTTS--CSSCEEEECTTSCEEEECTT
T ss_pred CCCccCCCEecCCCEEE--cCCEEEEECCCCe-----EEEEe---CCceeeEeCCCCC--CCccEEEEeccceEEEECCC
Confidence 37899999999999995 6999999999886 66664 4688999999987 44678999999999999999
Q ss_pred CceEEEecCCCCCCCceEEEecCCCeEEEeccCCCCCCCceeEEecCC
Q 041702 105 NGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSEGSYLWQSFDF 152 (840)
Q Consensus 105 ~~~~Wss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~~lWqSFd~ 152 (840)
|.+||+|++.......+|+|+|+|||||++. ++||||+|
T Consensus 69 g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~---------~~W~S~t~ 107 (108)
T d1jpca_ 69 NKPIWASNTGGQNGNYVCILQKDRNVVIYGT---------DRWATGTH 107 (108)
T ss_dssp CCEEEECCCCCSCSCEEEEECTTSCEEEEEC---------CCCCCCCC
T ss_pred ccceEEccccCCCCcEEEEEcCCCCEEEeCC---------CcccCCCC
Confidence 9999999977665566789999999999972 49999987
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.81 E-value=5.6e-20 Score=161.78 Aligned_cols=107 Identities=19% Similarity=0.335 Sum_probs=91.1
Q ss_pred CcCCCCcccCCCCeEEcCCCeEEEEEecCCCCCceEEEEeeecCCCcEEEeecCCCCCCCCCceEEEecCCceEEecCCC
Q 041702 26 DSITPATFIRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKKSPDTVVWVANRNCPILDPHGILAINNNGNLVLLNQAN 105 (840)
Q Consensus 26 ~~~~~~~~l~~~~~l~S~~g~F~~gFf~~~~~~~~~lgiw~~~~~~tvVW~ANr~~p~~~~~~~l~~~~~G~L~l~~~~~ 105 (840)
|+|.|||.|.+|++|. +|.|.|+|...|+ |.++. ..++||+||++.|... .+.|.|++||+|+|+|++|
T Consensus 2 ~~L~~g~~L~~g~~l~--~g~~~l~~q~dgn-----Lvl~~---~~~~vW~ant~~~~~~-~~~l~l~~dGnLvl~~~~g 70 (109)
T d1kj1a_ 2 NLLTNGEGLYAGQSLD--VEPYHFIMQEDCN-----LVLYD---HSTSVWASNTGILGKK-GCKAVLQSDGNFVVYDAEG 70 (109)
T ss_dssp CEEETTCEEETTCEEE--ETTEEEEECTTSC-----EEEEE---TTEEEEECCCCCTTCC-CCEEEECTTSCEEEECSSS
T ss_pred CCccCCCEEeCCCEEE--eCCEEEEecCCCe-----EEEEe---CCEEEEEeCCCCCCce-eEEEEEcCCceEEEEeCCC
Confidence 6899999999999997 4889999988775 44443 3689999999999753 6789999999999999999
Q ss_pred ceEEEecCCCCCCCceEEEecCCCeEEEeccCCCCCCCceeEEecCC
Q 041702 106 GTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSEGSYLWQSFDF 152 (840)
Q Consensus 106 ~~~Wss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~~lWqSFd~ 152 (840)
.+||+|+++.......|+|+|+|||||++. .+|||+-|
T Consensus 71 ~~vW~s~t~~~~~~~~l~L~ddGNlvly~~---------~~W~S~t~ 108 (109)
T d1kj1a_ 71 RSLWASHSVRGNGNYVLVLQEDGNVVIYGS---------DIWSTGTY 108 (109)
T ss_dssp CEEEECCCCCCSSCCEEEECTTSCEEEECC---------EEEECCCC
T ss_pred cEEEEEeeECCCCCEEEEEeCCCcEEEECC---------CEecCCCc
Confidence 999999987655566799999999999962 49999865
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.81 E-value=9e-21 Score=186.94 Aligned_cols=170 Identities=17% Similarity=0.180 Sum_probs=117.5
Q ss_pred cccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCC-----c-------------CHHHHHHHHHHHh
Q 041702 517 SEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSG-----Q-------------GLEEFKNEMMLIA 578 (840)
Q Consensus 517 ~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~-----~-------------~~~~f~~Ev~~l~ 578 (840)
.+.++||+|+||.||+|.+ .+|+.||||+++.... . ....+..|...+.
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~-------------~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~ 69 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYS-------------EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQ 69 (191)
T ss_dssp EEEEEEEECSSEEEEEEEE-------------TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHH
T ss_pred hhCCEeeeCcceEEEEEEC-------------CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHH
Confidence 4568999999999999864 3688999998753210 0 1123456888999
Q ss_pred hcCCCCccceeeEeecCCceEEEEEeeccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCceecCCCCCCcEEecCC
Q 041702 579 KLQHRNLVRLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNVLLDSD 658 (840)
Q Consensus 579 ~l~H~niv~l~g~~~~~~~~~lv~e~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~ 658 (840)
++.|++++..+++. ..+++||+.... ....++.....+++.|++.+|+|||+.+ |+||||||+|||++++
T Consensus 70 ~l~~~~v~~~~~~~----~~~lvme~~~~~---~~~~l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~ 139 (191)
T d1zara2 70 KLQGLAVPKVYAWE----GNAVLMELIDAK---ELYRVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE 139 (191)
T ss_dssp HTTTSSSCCEEEEE----TTEEEEECCCCE---EGGGCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT
T ss_pred HccCCCcceEEEec----CCEEEEEeeccc---cccchhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC
Confidence 99999999987653 237889984322 1223556667789999999999999998 9999999999999865
Q ss_pred CCceeeccccceecCCCCcccccccccccccccCccccccCCCCccccchhHHHHHH
Q 041702 659 MNPKISDFGIARTFGGDEMQSNTNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLL 715 (840)
Q Consensus 659 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~SlGviL~ 715 (840)
.++|+|||+|.............+.+ .. -.|. ....|..++|+||..--++
T Consensus 140 -~~~liDFG~a~~~~~~~~~~~l~rd~---~~-~~~~-f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 140 -GIWIIDFPQSVEVGEEGWREILERDV---RN-IITY-FSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp -EEEECCCTTCEETTSTTHHHHHHHHH---HH-HHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred -CEEEEECCCcccCCCCCcHHHHHHHH---HH-HHHH-HcCCCCCcccHHHHHHHHh
Confidence 48999999997653221110000000 00 0011 1356788999999765443
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.69 E-value=2.1e-17 Score=147.60 Aligned_cols=102 Identities=19% Similarity=0.319 Sum_probs=86.0
Q ss_pred EEeeecCC-CcEEEeecCCCCCCCCCceEEEecCCceEEecCCCceEEEecCCCCCCCceEEEecCCCeEEEeccCCCCC
Q 041702 63 GVWYKKSP-DTVVWVANRNCPILDPHGILAINNNGNLVLLNQANGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTS 141 (840)
Q Consensus 63 giw~~~~~-~tvVW~ANr~~p~~~~~~~l~~~~~G~L~l~~~~~~~~Wss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~ 141 (840)
-|||.+++ ++.+|++|++.|+.....+|.++.||||+|++. +.++|++++...+....|.|+|+|||||+| .
T Consensus 11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d------~ 83 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLT------N 83 (120)
T ss_dssp EECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEE------T
T ss_pred eEEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEc------C
Confidence 58998887 899999999999987778999999999999986 789999998876666789999999999998 3
Q ss_pred CCceeEEecCCCCCcccCCCccccccccCCceeEEEeccCCCCCCCceEEeecCCCCcEEE
Q 041702 142 EGSYLWQSFDFPSDTLLPGMKVGWDLKTGRERYLTSWRTADDPSPGKFTYRLDIHVLPQIF 202 (840)
Q Consensus 142 ~~~~lWqSFd~PtDtlLpg~~l~~~~~tg~~~~l~S~~s~~dps~G~~~l~~~~~~~~~~~ 202 (840)
.++++||||. +.++|.|.+.|+++|...+|
T Consensus 84 ~~~~lW~S~t-------------------------------~~~~~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 84 QNIAVWTSGN-------------------------------SRSAGRYVFVLQPDRNLAIY 113 (120)
T ss_dssp TTEEEEECCC-------------------------------CCSSSCCEEEECSSSCEEEE
T ss_pred CCCEEEEeCC-------------------------------CCCCCcEEEEECCCCcEEEe
Confidence 4578999973 23568899999999987765
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.57 E-value=9e-15 Score=129.77 Aligned_cols=101 Identities=21% Similarity=0.333 Sum_probs=81.0
Q ss_pred cccCCCCeE--EcCCCeEEEEEecCCCCCceEEEEeeecCCCcEEEeecCCCCCCCCCceEEEecCCceEEecCCCceEE
Q 041702 32 TFIRDGEKL--VSPSQRFELGFFSPGNSKNRYLGVWYKKSPDTVVWVANRNCPILDPHGILAINNNGNLVLLNQANGTIW 109 (840)
Q Consensus 32 ~~l~~~~~l--~S~~g~F~~gFf~~~~~~~~~lgiw~~~~~~tvVW~ANr~~p~~~~~~~l~~~~~G~L~l~~~~~~~~W 109 (840)
|.|.+++.| .+..|.|.|.|...|+ |.+ |. +.++||.||+..|. ..+.|.++.||+|+|.|++|.+||
T Consensus 15 ~~l~~~q~l~~~~~~~~y~l~mQ~DGN-----LVL-y~--~~~~vWssnt~~~~--~~~~l~l~~dGnLvL~d~~g~~vW 84 (119)
T d1b2pa_ 15 QILHATESLEILFGTHVYRFIMQTDCN-----LVL-YD--NNNPIWATNTGGLG--NGCRAVLQPDGVLVVITNENVTVW 84 (119)
T ss_dssp CEEETTCEEEEEETTEEEEEEECTTSC-----EEE-EE--TTEEEEECCCTTSC--SSCEEEECTTSCEEEECTTCCEEE
T ss_pred CEEeCCCeEEEecCCceEEEEECCCCc-----EEE-EE--CCeEEEEecCCCCC--cceEEEEEeCCCEEEECCCCcEEE
Confidence 444455544 6779999999999987 433 32 46889999998773 457899999999999999999999
Q ss_pred EecCCCCCCCceEEEecCCCeEEEeccCCCCCCCceeEEecC
Q 041702 110 SSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSEGSYLWQSFD 151 (840)
Q Consensus 110 ss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~~lWqSFd 151 (840)
++++.......+++|+|+|||||++ .++|||-.
T Consensus 85 sS~t~~~~~~~~l~Lq~DGNlvlYg---------~~~W~S~T 117 (119)
T d1b2pa_ 85 QSPVAGKAGHYVLVLQPDRNVVIYG---------DALWATQT 117 (119)
T ss_dssp ECSCCCCSSCEEEEECTTSCEEEEE---------SEEEECCC
T ss_pred ECCCcCCCCceEEEEcCCCCEEEEC---------CCEeccCC
Confidence 9998765555678999999999996 25999864
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.54 E-value=1.8e-15 Score=133.34 Aligned_cols=110 Identities=19% Similarity=0.224 Sum_probs=88.0
Q ss_pred EeeecC-CCcEEEeecCCCCCCCCCceEEEecCCceEEecCCCceEEEecCCCCCCCceEEEecCCCeEEEeccCCCCCC
Q 041702 64 VWYKKS-PDTVVWVANRNCPILDPHGILAINNNGNLVLLNQANGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSE 142 (840)
Q Consensus 64 iw~~~~-~~tvVW~ANr~~p~~~~~~~l~~~~~G~L~l~~~~~~~~Wss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~ 142 (840)
|||.-. +.+..|+.+.+.++.+...+|.|+.||||||+++ +.++|++++.+.. +..|.|+|+|||||++. .
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~~-~~~vW~s~t~~~~-~~~l~l~~dGNLvl~d~------~ 74 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDS-DVRVWASNTAGAT-GCRAVLQSDGLLVILTA------Q 74 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEES-SSEEECCCCCSCS-CCBCCBCSSSCBCCBCT------T
T ss_pred EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEcC-CeeEEEcccCCCC-ceEEEEeccCCEEEEcc------C
Confidence 566533 3677799999999988778999999999999885 7899999987543 57789999999999983 4
Q ss_pred CceeEEecCCCCCcccCCCccccccccCCceeEEEeccCCCCCCCceEEeecCCCCcEEEEEcCCeeeEEeCCC
Q 041702 143 GSYLWQSFDFPSDTLLPGMKVGWDLKTGRERYLTSWRTADDPSPGKFTYRLDIHVLPQIFLYKGSLKLARIGPW 216 (840)
Q Consensus 143 ~~~lWqSFd~PtDtlLpg~~l~~~~~tg~~~~l~S~~s~~dps~G~~~l~~~~~~~~~~~~~~~~~~~~~~g~w 216 (840)
+.+||||+. +.++|.|.+.|+++|...++ ..++|.+|.-
T Consensus 75 ~~~vWsS~t-------------------------------~~~~g~y~l~Lq~DGNlvlY----~~~~Wssgt~ 113 (115)
T d1dlpa1 75 NTIRWSSGT-------------------------------KGSIGNYVLVLQPDRTVTIY----GPGLWDSGTS 113 (115)
T ss_dssp TCCSCCCCC-------------------------------CCCSSCCEEEECSSSCEEEE----CSEEEECSCC
T ss_pred CCEEEEcCC-------------------------------CCCCCCEEEEECCCCcEEEe----CCCeecCCCC
Confidence 456898763 34679999999999997654 3478998863
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.39 E-value=4.2e-13 Score=117.93 Aligned_cols=99 Identities=22% Similarity=0.303 Sum_probs=78.7
Q ss_pred CcccCCCCeEEcCCCeEEEEEecCCCCCceEEEEeeecCCCcEEEeecCCCCCCCCCceEEEecCCceEEecCCCceEEE
Q 041702 31 ATFIRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKKSPDTVVWVANRNCPILDPHGILAINNNGNLVLLNQANGTIWS 110 (840)
Q Consensus 31 ~~~l~~~~~l~S~~g~F~~gFf~~~~~~~~~lgiw~~~~~~tvVW~ANr~~p~~~~~~~l~~~~~G~L~l~~~~~~~~Ws 110 (840)
.|+|.+++.| .+|.|.|.|...|+ |.++. +.++||.+|...+ ..+.+.|..||||||+|.++.+||+
T Consensus 14 ~~tl~~~~~l--~~g~~~l~~q~DGN-----LvL~~---~~~~vW~s~t~~~---~~~~l~l~~dGNLvl~d~~~~~vWs 80 (115)
T d1dlpa1 14 PQTLHAAQSL--ELSSFRFTMQSDCN-----LVLFD---SDVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIRWS 80 (115)
T ss_dssp CSCCCTTCEE--CSTTEEEEECTTSC-----EEEEE---SSSEEECCCCCSC---SCCBCCBCSSSCBCCBCTTTCCSCC
T ss_pred cceecCCCcE--EcCCEEEEECCCCe-----EEEEc---CCeeEEEcccCCC---CceEEEEeccCCEEEEccCCCEEEE
Confidence 3566666666 46779999998887 55653 4678999997642 3678999999999999999999999
Q ss_pred ecCCCCCCCceEEEecCCCeEEEeccCCCCCCCceeEEecC
Q 041702 111 SNMSKEAKSPVAQLLDTGNLVLRENFSNNTSEGSYLWQSFD 151 (840)
Q Consensus 111 s~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~~lWqSFd 151 (840)
+++.......+++|+++|||||++ .++|+|-.
T Consensus 81 S~t~~~~g~y~l~Lq~DGNlvlY~---------~~~Wssgt 112 (115)
T d1dlpa1 81 SGTKGSIGNYVLVLQPDRTVTIYG---------PGLWDSGT 112 (115)
T ss_dssp CCCCCCSSCCEEEECSSSCEEEEC---------SEEEECSC
T ss_pred cCCCCCCCCEEEEECCCCcEEEeC---------CCeecCCC
Confidence 998766656679999999999996 25999853
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.05 E-value=1.9e-10 Score=101.80 Aligned_cols=91 Identities=22% Similarity=0.288 Sum_probs=67.1
Q ss_pred cccCCCCeEEcCCCeEEEEEecCCCCCceEEEEeeecCCCcEEEeecCCCCCCCCCceEEEecCCceEEecCCCceEEEe
Q 041702 32 TFIRDGEKLVSPSQRFELGFFSPGNSKNRYLGVWYKKSPDTVVWVANRNCPILDPHGILAINNNGNLVLLNQANGTIWSS 111 (840)
Q Consensus 32 ~~l~~~~~l~S~~g~F~~gFf~~~~~~~~~lgiw~~~~~~tvVW~ANr~~p~~~~~~~l~~~~~G~L~l~~~~~~~~Wss 111 (840)
+.|..++.| ..|.|.|.|...|+ |.++- +..+||.+|-.. .+....+.|..+|||||+|.++.++|+|
T Consensus 24 ~~l~~~q~l--~~g~y~L~~q~DGN-----LvL~~---~~~~vW~s~t~~--~~~~~~~~l~~~GnLvl~d~~~~~lW~S 91 (120)
T d1dlpa2 24 QTLHATQSL--QLSPYRLSMETDCN-----LVLFD---RDDRVWSTNTAG--KGTGCRAVLQPNGRMDVLTNQNIAVWTS 91 (120)
T ss_dssp CEECSSCCC--BCSSCEEEEETTTE-----EEEEB---TTBCCSCCCCCS--SCSSCEEEEETTTEEEEEETTTEEEEEC
T ss_pred cEEcCCCee--EcCCEEEEEcCCCc-----EEEec---CCcEEEEEcccc--CCCcEEEEEeCCeeEEEEcCCCCEEEEe
Confidence 344444444 24557777776664 44442 346789988543 3456789999999999999999999999
Q ss_pred cCCCCCCCceEEEecCCCeEEEe
Q 041702 112 NMSKEAKSPVAQLLDTGNLVLRE 134 (840)
Q Consensus 112 ~~~~~~~~~~a~L~d~GNlVl~~ 134 (840)
++.......++.|+++|||||++
T Consensus 92 ~t~~~~~~~~l~Lq~DGnlvlY~ 114 (120)
T d1dlpa2 92 GNSRSAGRYVFVLQPDRNLAIYG 114 (120)
T ss_dssp CCCCSSSCCEEEECSSSCEEEEC
T ss_pred CCCCCCCcEEEEECCCCcEEEeC
Confidence 98765556678999999999995
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.98 E-value=8.9e-10 Score=97.04 Aligned_cols=85 Identities=25% Similarity=0.310 Sum_probs=66.9
Q ss_pred eEEEecCCceEEecCCCceEEEecCCCCCCCceEEEecCCCeEEEeccCCCCCCCceeEEecCCCCCcccCCCccccccc
Q 041702 89 ILAINNNGNLVLLNQANGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSEGSYLWQSFDFPSDTLLPGMKVGWDLK 168 (840)
Q Consensus 89 ~l~~~~~G~L~l~~~~~~~~Wss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~~lWqSFd~PtDtlLpg~~l~~~~~ 168 (840)
.|.+..||||||++. +.++|++++.+......+.|.++|||||+| ..+.++|+|.
T Consensus 33 ~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d------~~g~~vWsS~------------------ 87 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVIT------NENVTVWQSP------------------ 87 (119)
T ss_dssp EEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEEC------TTCCEEEECS------------------
T ss_pred EEEECCCCcEEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEEC------CCCcEEEECC------------------
Confidence 588999999999876 679999998766656789999999999998 3446688742
Q ss_pred cCCceeEEEeccCCCCCCCceEEeecCCCCcEEEEEcCCeeeEEeCC
Q 041702 169 TGRERYLTSWRTADDPSPGKFTYRLDIHVLPQIFLYKGSLKLARIGP 215 (840)
Q Consensus 169 tg~~~~l~S~~s~~dps~G~~~l~~~~~~~~~~~~~~~~~~~~~~g~ 215 (840)
+.-+.|.|.+.|+++|...++ ..+.|.++.
T Consensus 88 -------------t~~~~~~~~l~Lq~DGNlvlY----g~~~W~S~T 117 (119)
T d1b2pa_ 88 -------------VAGKAGHYVLVLQPDRNVVIY----GDALWATQT 117 (119)
T ss_dssp -------------CCCCSSCEEEEECTTSCEEEE----ESEEEECCC
T ss_pred -------------CcCCCCceEEEEcCCCCEEEE----CCCEeccCC
Confidence 122457899999999997765 246888774
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=98.96 E-value=1.2e-09 Score=94.80 Aligned_cols=87 Identities=21% Similarity=0.341 Sum_probs=66.6
Q ss_pred CceEEEecCCceEEecCCCceEEEecCCCCCCCceEEEecCCCeEEEeccCCCCCCCceeEEecCCCCCcccCCCccccc
Q 041702 87 HGILAINNNGNLVLLNQANGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSEGSYLWQSFDFPSDTLLPGMKVGWD 166 (840)
Q Consensus 87 ~~~l~~~~~G~L~l~~~~~~~~Wss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~~lWqSFd~PtDtlLpg~~l~~~ 166 (840)
.-+|.+..||||||++. +.+||++++.+....+.+.|.++|||||++ ..+.++|+|
T Consensus 20 ~~~l~~q~DGNLvly~~-~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~------~~g~~vWsS----------------- 75 (108)
T d1jpca_ 20 SFVFIMQEDCNLVLYDV-DKPIWATNTGGLSRSCFLSMQTDGNLVVYN------PSNKPIWAS----------------- 75 (108)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEEC------TTCCEEEEC-----------------
T ss_pred CEEEEECCCCeEEEEeC-CceeeEeCCCCCCCccEEEEeccceEEEEC------CCccceEEc-----------------
Confidence 35789999999999875 689999998876666789999999999998 345678875
Q ss_pred cccCCceeEEEeccCCCCCCCceEEeecCCCCcEEEEEcCCeeeEEeCC
Q 041702 167 LKTGRERYLTSWRTADDPSPGKFTYRLDIHVLPQIFLYKGSLKLARIGP 215 (840)
Q Consensus 167 ~~tg~~~~l~S~~s~~dps~G~~~l~~~~~~~~~~~~~~~~~~~~~~g~ 215 (840)
.+..+.+.|.+.|+++|...++ . .+.|.++.
T Consensus 76 --------------~t~~~~~~~~l~L~ddGNlVly--~--~~~W~S~t 106 (108)
T d1jpca_ 76 --------------NTGGQNGNYVCILQKDRNVVIY--G--TDRWATGT 106 (108)
T ss_dssp --------------CCCCSCSCEEEEECTTSCEEEE--E--CCCCCCCC
T ss_pred --------------cccCCCCcEEEEEcCCCCEEEe--C--CCcccCCC
Confidence 1222457889999999987765 2 34666553
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.83 E-value=1.1e-08 Score=88.64 Aligned_cols=88 Identities=25% Similarity=0.383 Sum_probs=66.1
Q ss_pred CceEEEecCCceEEecCCCceEEEecCCCCCC-CceEEEecCCCeEEEeccCCCCCCCceeEEecCCCCCcccCCCcccc
Q 041702 87 HGILAINNNGNLVLLNQANGTIWSSNMSKEAK-SPVAQLLDTGNLVLRENFSNNTSEGSYLWQSFDFPSDTLLPGMKVGW 165 (840)
Q Consensus 87 ~~~l~~~~~G~L~l~~~~~~~~Wss~~~~~~~-~~~a~L~d~GNlVl~~~~~~~~~~~~~lWqSFd~PtDtlLpg~~l~~ 165 (840)
.-.|.+..||||||++ .+.+||++++..... ...+.|.++|||||++ ..++++|+|
T Consensus 20 ~~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~------~~g~~vW~s---------------- 76 (109)
T d1kj1a_ 20 PYHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYD------AEGRSLWAS---------------- 76 (109)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEEC------SSSCEEEEC----------------
T ss_pred CEEEEecCCCeEEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEe------CCCcEEEEE----------------
Confidence 4678999999999987 468999999875432 4678999999999998 345678875
Q ss_pred ccccCCceeEEEeccCCCCCCCceEEeecCCCCcEEEEEcCCeeeEEeCCC
Q 041702 166 DLKTGRERYLTSWRTADDPSPGKFTYRLDIHVLPQIFLYKGSLKLARIGPW 216 (840)
Q Consensus 166 ~~~tg~~~~l~S~~s~~dps~G~~~l~~~~~~~~~~~~~~~~~~~~~~g~w 216 (840)
.+....|.|.+.|+++|...++ + .+.|.++.+
T Consensus 77 ---------------~t~~~~~~~~l~L~ddGNlvly--~--~~~W~S~t~ 108 (109)
T d1kj1a_ 77 ---------------HSVRGNGNYVLVLQEDGNVVIY--G--SDIWSTGTY 108 (109)
T ss_dssp ---------------CCCCCSSCCEEEECTTSCEEEE--C--CEEEECCCC
T ss_pred ---------------eeECCCCCEEEEEeCCCcEEEE--C--CCEecCCCc
Confidence 1112357789999999987664 3 357887653
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.64 E-value=5.4e-08 Score=84.85 Aligned_cols=89 Identities=22% Similarity=0.365 Sum_probs=66.5
Q ss_pred CceEEEecCCceEEecCCCceEEEecCCCCCCCceEEEecCCCeEEEeccCCCCCCCceeEEecCCCCCcccCCCccccc
Q 041702 87 HGILAINNNGNLVLLNQANGTIWSSNMSKEAKSPVAQLLDTGNLVLRENFSNNTSEGSYLWQSFDFPSDTLLPGMKVGWD 166 (840)
Q Consensus 87 ~~~l~~~~~G~L~l~~~~~~~~Wss~~~~~~~~~~a~L~d~GNlVl~~~~~~~~~~~~~lWqSFd~PtDtlLpg~~l~~~ 166 (840)
.-.|.+..||||||++. +.+||++++......+.+.|..+|||||++. ++.+|-|
T Consensus 20 ~~~l~~q~DGNLvly~~-~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~~-------~~~~w~s----------------- 74 (112)
T d1xd5a_ 20 GYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYSG-------SRAIWAS----------------- 74 (112)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEET-------TEEEEEC-----------------
T ss_pred CEEEEEcCCCCEEEEcC-CcEEEEccCccCCCCcEEEEeccccEEEEec-------CCeEEEE-----------------
Confidence 46799999999999874 7899999987655567899999999999983 1235532
Q ss_pred cccCCceeEEEeccCCCCCCCceEEeecCCCCcEEEEEcCCeeeEEeCC
Q 041702 167 LKTGRERYLTSWRTADDPSPGKFTYRLDIHVLPQIFLYKGSLKLARIGP 215 (840)
Q Consensus 167 ~~tg~~~~l~S~~s~~dps~G~~~l~~~~~~~~~~~~~~~~~~~~~~g~ 215 (840)
.+.-..|.|.+.|+.+|...++- ....+.|.++.
T Consensus 75 --------------~t~~~~~~~~l~L~ddGNlvly~-~~~~~~W~S~t 108 (112)
T d1xd5a_ 75 --------------NTNRQNGNYYLILQRDRNVVIYD-NSNNAIWATHT 108 (112)
T ss_dssp --------------CCCCSCCCCEEEECTTSCEEEEC-TTSCEEEECCC
T ss_pred --------------eeccCCCceEEEEcCCCCEEEEC-CCCcEEecCCC
Confidence 23334577899999999976652 22457898765
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.16 E-value=4.4e-06 Score=84.22 Aligned_cols=149 Identities=15% Similarity=0.115 Sum_probs=101.5
Q ss_pred HHHHHccCCcccccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcC-CCCcc
Q 041702 508 SISAATDNFSEENKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQ-HRNLV 586 (840)
Q Consensus 508 ~~~~~~~~f~~~~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~-H~niv 586 (840)
++......|+..+..+-++...||+.. .+++.+.||+...........+.+|+..+..+. +--+.
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~--------------~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP 73 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLV--------------GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVP 73 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEE--------------CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCC
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEE--------------eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCC
Confidence 566666788776665555557899863 356778899987665555567888999988874 44477
Q ss_pred ceeeEeecCCceEEEEEeeccCCccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--------------------------
Q 041702 587 RLFGCCIEQGEKISIYEFDIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQYSR-------------------------- 640 (840)
Q Consensus 587 ~l~g~~~~~~~~~lv~e~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~-------------------------- 640 (840)
+++.+..+++..++||++..-.... ....+.....+++.++++.++.||+...
T Consensus 74 ~vl~~~~~~~~~~lv~~~l~G~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (263)
T d1j7la_ 74 KVLHFERHDGWSNLLMSEADGVLCS-EEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLAD 152 (263)
T ss_dssp CEEEEEEETTEEEEEEECCSSEEHH-HHTTTCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSC
T ss_pred cEEEEEecCCceEEEEEeccccccc-ccccccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhh
Confidence 8888888888899999983111110 0011222334456666677777774211
Q ss_pred ------------------------------CceecCCCCCCcEEecCCCCceeecccccee
Q 041702 641 ------------------------------LRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 641 ------------------------------~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
..++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 153 VDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1278999999999998876677999998754
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.29 E-value=0.00019 Score=76.51 Aligned_cols=71 Identities=13% Similarity=0.245 Sum_probs=45.8
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccC-------CCcCHHHHHHHHHHHhhcC-C--CCcccee
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSK-------SGQGLEEFKNEMMLIAKLQ-H--RNLVRLF 589 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~-------~~~~~~~f~~Ev~~l~~l~-H--~niv~l~ 589 (840)
+.||.|....||++.+. .+++.|+||.-... -....++...|.+.|..+. + ..+++++
T Consensus 32 ~eig~G~~N~vfrV~~~------------~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~ 99 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQ------------EHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVF 99 (392)
T ss_dssp EECCSSSSEEEEEEEC----------------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEE
T ss_pred EEeCCCceEeEEEEEeC------------CCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEE
Confidence 46899999999997543 35678999974321 1223456677888887773 3 3456666
Q ss_pred eEeecCCceEEEEEe
Q 041702 590 GCCIEQGEKISIYEF 604 (840)
Q Consensus 590 g~~~~~~~~~lv~e~ 604 (840)
.+ +.+..+++||+
T Consensus 100 ~~--d~~~~~lvmE~ 112 (392)
T d2pula1 100 YS--DTEMAVTVMED 112 (392)
T ss_dssp EE--ETTTTEEEECC
T ss_pred EE--cCCCCEEEEec
Confidence 54 45567889998
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.19 E-value=0.0011 Score=65.51 Aligned_cols=131 Identities=18% Similarity=0.138 Sum_probs=82.4
Q ss_pred cccCCCC-ccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcC--CCCccceeeEeecCCc
Q 041702 521 KLGEGGF-GPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQ--HRNLVRLFGCCIEQGE 597 (840)
Q Consensus 521 ~lG~G~~-G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~--H~niv~l~g~~~~~~~ 597 (840)
.+..|.. +.||+... .++..+.+|...... ...+..|+..++.+. .-.+.+++++..+.+.
T Consensus 17 ~~~~G~s~~~v~r~~~-------------~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~ 80 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-------------QGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGR 80 (255)
T ss_dssp ECSCTTSSCEEEEEEC-------------TTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSC
T ss_pred EcCCcccCCeEEEEEe-------------CCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccc
Confidence 4455543 67898642 356678889866443 245778888888774 3446788888888888
Q ss_pred eEEEEEeeccCCccccCCCCHHHHHHHHHHHHHHHHHHHhc---------------------------------------
Q 041702 598 KISIYEFDIVTDPARKDLLDWTTRVRIIEGVAQGLLYLHQY--------------------------------------- 638 (840)
Q Consensus 598 ~~lv~e~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~--------------------------------------- 638 (840)
.+++|++..-..... .... ...++.++++.|.-||+.
T Consensus 81 ~~~v~~~i~G~~~~~-~~~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (255)
T d1nd4a_ 81 DWLLLGEVPGQDLLS-SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 156 (255)
T ss_dssp EEEEEECCSSEETTT-SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred eEEEEEeeecccccc-cccc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhh
Confidence 999999831111100 0011 122233444444444421
Q ss_pred ----------------CCCceecCCCCCCcEEecCCCCceeecccccee
Q 041702 639 ----------------SRLRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 639 ----------------~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
.++.++|+|+.|.|||++++..+-|+||+.+..
T Consensus 157 ~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 157 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 112379999999999998876678999998753
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.74 E-value=0.0042 Score=63.82 Aligned_cols=63 Identities=13% Similarity=0.095 Sum_probs=40.2
Q ss_pred ccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCCc--cceee-----EeecCCceEE
Q 041702 528 GPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRNL--VRLFG-----CCIEQGEKIS 600 (840)
Q Consensus 528 G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~ni--v~l~g-----~~~~~~~~~l 600 (840)
-.||++. ..+|+.+++|+.+.. ....+++..|...+..|....+ +..+. .....+..+.
T Consensus 36 N~vy~v~-------------~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~ 101 (325)
T d1zyla1 36 NRVYQFQ-------------DEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFA 101 (325)
T ss_dssp SEEEEEC-------------CTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEE
T ss_pred ceeEEEE-------------cCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEE
Confidence 4789864 458899999998754 3356788899999988853322 22211 1233455666
Q ss_pred EEEe
Q 041702 601 IYEF 604 (840)
Q Consensus 601 v~e~ 604 (840)
++++
T Consensus 102 l~~~ 105 (325)
T d1zyla1 102 VFPS 105 (325)
T ss_dssp EEEC
T ss_pred EEee
Confidence 7775
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.45 E-value=0.028 Score=56.95 Aligned_cols=31 Identities=35% Similarity=0.359 Sum_probs=26.8
Q ss_pred CceecCCCCCCcEEecCCCCceeecccccee
Q 041702 641 LRVIHRDLKASNVLLDSDMNPKISDFGIART 671 (840)
Q Consensus 641 ~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 671 (840)
..+||+|+.++||+++.+...-|.||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 3499999999999999887778999998753
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.03 E-value=0.097 Score=54.66 Aligned_cols=74 Identities=12% Similarity=0.098 Sum_probs=44.0
Q ss_pred ccccCCCCccEEEeecceeehhccccCcccCCceEEEEEeccCCCcCHHHHHHHHHHHhhcCCCC-ccceeeEeecCCce
Q 041702 520 NKLGEGGFGPVYKSIERYVEICNWKQGKLLNGEEVAVKRLSSKSGQGLEEFKNEMMLIAKLQHRN-LVRLFGCCIEQGEK 598 (840)
Q Consensus 520 ~~lG~G~~G~Vy~a~~~~~~~~~~~~g~~~~g~~VAvK~l~~~~~~~~~~f~~Ev~~l~~l~H~n-iv~l~g~~~~~~~~ 598 (840)
+.|+.|--=.+|++..... ........+.|.+++... ........+|..+++.+.-.+ ..++++++.+
T Consensus 48 ~~l~GGltN~~y~v~~~~~-----~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~---- 116 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEV-----YPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG---- 116 (395)
T ss_dssp EEECCCTTEEEEEEEECTT-----SCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEcCCccccceEEEEeCCC-----CccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----
Confidence 5677777788998753200 000012344566666552 233455678999999885334 4577777643
Q ss_pred EEEEEe
Q 041702 599 ISIYEF 604 (840)
Q Consensus 599 ~lv~e~ 604 (840)
..|+||
T Consensus 117 g~I~ef 122 (395)
T d1nw1a_ 117 GRLEEY 122 (395)
T ss_dssp EEEECC
T ss_pred ceEEEE
Confidence 577887
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.78 E-value=0.035 Score=34.81 Aligned_cols=32 Identities=34% Similarity=0.795 Sum_probs=25.9
Q ss_pred CCCccccCCCCCccccC-CCCCcccccCCCCcCC
Q 041702 287 DVCQNYGHCGANSICNV-DNPPKCECLKGFKPNS 319 (840)
Q Consensus 287 ~~C~~~g~CG~~g~C~~-~~~~~C~C~~GF~~~~ 319 (840)
|.|.+-..|| ||.|+. -....|.|-.||+|..
T Consensus 2 dECsignpCG-nGTCtNviGgFec~C~~GFepgp 34 (39)
T d1emoa2 2 DECSVGNPCG-NGTCKNVIGGFECTCEEGFEPGP 34 (39)
T ss_dssp CGGGTTCSSS-SSCEEECSSSEEECCSSSSCCCS
T ss_pred CccccCCccC-CceeeecccceEEeecCCcCCCc
Confidence 6799999998 688974 3456899999999854
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.87 E-value=0.2 Score=33.54 Aligned_cols=30 Identities=27% Similarity=0.702 Sum_probs=23.8
Q ss_pred CCCcc-ccCCCCCccccCC-CCCcccccCCCC
Q 041702 287 DVCQN-YGHCGANSICNVD-NPPKCECLKGFK 316 (840)
Q Consensus 287 ~~C~~-~g~CG~~g~C~~~-~~~~C~C~~GF~ 316 (840)
|.|.. ..-|..+|.|... ..-.|.|++||+
T Consensus 4 deC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~ 35 (42)
T d2vj3a1 4 DECSLGANPCEHAGKCINTLGSFECQCLQGYT 35 (42)
T ss_dssp CTTTSSSCSSSTTCEEEECSSSEEEECCTTEE
T ss_pred ccccCCCCCCCCCcEeECCCCCEEeECCCCCc
Confidence 56765 4679999999854 356899999997
|